PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Assadian, F; Kamel, W; Laurell, G; Svensson, C; Punga, T; Akusjarvi, G				Assadian, Farzaneh; Kamel, Wael; Laurell, Goran; Svensson, Catharina; Punga, Tanel; Akusjarvi, Goran			Expression profile of Epstein-Barr virus and human adenovirus small RNAs in tonsillar B and T lymphocytes	PLOS ONE			English	Article							NONCODING RNAS; MICRORNAS; DNA; TARGETS; CELLS; VAI; IDENTIFICATION; INTERFERENCE; QUANTITATION; PREVALENCE	We have used high-throughput small RNA sequencing to characterize viral small RNA expression in purified tonsillar B and T lymphocytes isolated from patients tested positive for Epstein-Barr virus (EBV) or human adenovirus (HAdV) infections, respectively. In the small set of patients analyzed, the expression profile of EBV and HAdV miRNAs could not distinguish between patients diagnosed with tonsillar hypertrophy or chronic/recurrent tonsillitis. The EBV miR-BART expression profile among the patients diagnosed with tonsillar diseases resembles most closely the pattern seen in EBV+ tumors (Latency II/I). The miRBARTs that appear to be absent in normal EBV infected cells are essentially all detectable in the diseased tonsillar B lymphocytes. In the EBV+ B cells we detected 44 EBV miRBARTs derived from the proposed BART precursor hairpins whereof five are not annotated in miRBase v21. One previously undetected miRNA, BART16b-5p, originates from the miR-BART16 precursor hairpin as an alternative 5 A miR-BART16 located precisely upstream of the annotated miR-BART16-5p. Further, our analysis revealed an extensive sequence variation among the EBV miRNAs with isomiRs having a constant 5 A end but alternative 3 A ends. A range of small RNAs was also detected from the terminal stem of the EBER RNAs and the 3 A part of v-snoRNA1. During a lytic HAdV infection in established cell lines the terminal stem of the viral non-coding VA RNAs are processed to highly abundant viral miRNAs (mivaRNAs). In contrast, mivaRNA expression in HAdV positive tonsillar T lymphocytes was very low. The small RNA profile further showed that the 5 A mivaRNA from VA RNAI and the 3 A mivaRNA from VA RNAII were as predicted, whereas the 3 A mivaRNA from VA RNAI showed an aberrant processing upstream of the expected Dicer cleavage site.	[Assadian, Farzaneh; Kamel, Wael; Svensson, Catharina; Punga, Tanel; Akusjarvi, Goran] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Laurell, Goran] Uppsala Univ, Dept Surg Sci Otorhinolaryngol & Head & Neck Surg, Uppsala, Sweden; [Assadian, Farzaneh] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	Uppsala University; Uppsala University; University of Minnesota System; University of Minnesota Twin Cities	Akusjarvi, G (corresponding author), Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.	goran.akusjarvi@imbim.uu.se	Punga, Tanel/K-9844-2019; Kamel, Wael/AAD-4645-2022	Punga, Tanel/0000-0002-0561-367X; Kamel, Wael/0000-0002-7625-2648; Akusjarvi, Goran/0000-0003-2961-5060	Swedish Cancer Society [120678, 130469]; Swedish Research Council through Uppsala RNA Research Centre [2006-5038-36531-16]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council through Uppsala RNA Research Centre	This work was supported by the Swedish Cancer Society (grant numbers 120678 and 130469, www.cancerfonden.se) and the Swedish Research Council through a grant to the Uppsala RNA Research Centre (grant number 2006-5038-36531-16, www.vr.se)	Adhikary AK, 2014, J CLIN VIROL, V61, P477, DOI 10.1016/j.jcv.2014.10.015; Alkhalaf MA, 2013, J MED VIROL, V85, P1947, DOI 10.1002/jmv.23678; Alles Julia, 2015, Non-Coding RNA, V1, P170, DOI 10.3390/ncrna1030170; Ambrosio MR, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-12; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Assadian F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154814; Assadian F, 2015, JOVE-J VIS EXP, DOI 10.3791/53374; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bavi P, 2011, J PATHOL, V224, P355, DOI 10.1002/path.2864; Bellutti F, 2015, J VIROL, V89, P1608, DOI 10.1128/JVI.02336-14; Berger C, 2007, J MED VIROL, V79, P1147, DOI 10.1002/jmv.20899; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; CLARKE PA, 1991, NUCLEIC ACIDS RES, V19, P243, DOI 10.1093/nar/19.2.243; Delecluse HJ, 2007, J CLIN PATHOL, V60, P1358, DOI 10.1136/jcp.2006.044586; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Furuse Y, 2013, VIROLOGY, V447, P140, DOI 10.1016/j.virol.2013.08.024; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Guo L, 2012, EUR J CLIN MICROBIOL, V31, P1051, DOI 10.1007/s10096-011-1406-8; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hage E, 2015, J GEN VIROL, V96, P2734, DOI 10.1099/vir.0.000196; Hooykaas MJG, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2978-6; Hudnall SD, 2005, MODERN PATHOL, V18, P519, DOI 10.1038/modpathol.3800369; Hutzinger R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000547; Ikeda T, 2000, J GEN VIROL, V81, P1211, DOI 10.1099/0022-1317-81-5-1211; Iwakiri D, 2016, VIRUS RES, V212, P30, DOI 10.1016/j.virusres.2015.08.007; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kamel W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105746; Kamel W, 2013, NUCLEIC ACIDS RES, V41, P4802, DOI 10.1093/nar/gkt172; Kang D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004979; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lu Jun, 2012, EPSTEIN BARR VIRUS E; Lu LJ, 2015, ARCH VIROL, V160, P1229, DOI 10.1007/s00705-015-2387-1; Lung RWM, 2013, INT J MOL SCI, V14, P17378, DOI 10.3390/ijms140917378; Ma YL, 1996, J VIROL, V70, P5083, DOI 10.1128/JVI.70.8.5083-5099.1996; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Nadal D, 2002, J MED VIROL, V67, P54, DOI 10.1002/jmv.2192; Nanbo A, 2002, EMBO J, V21, P954, DOI 10.1093/emboj/21.5.954; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pimienta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124638; Proenca-Modena JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042136; Punga T, 2013, FUTURE VIROL, V8, P343, DOI 10.2217/FVL.13.19; Qiu J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002193; Richman D. D., 2009, Clinical virology; Riley KJL, 2010, J VIROL, V84, P5148, DOI 10.1128/JVI.00110-10; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; ROSA MD, 1981, MOL CELL BIOL, V1, P785, DOI 10.1128/MCB.1.9.785; Samanta M, 2008, ONCOGENE, V27, P4150, DOI 10.1038/onc.2008.75; Sano M, 2006, FEBS LETT, V580, P1553, DOI 10.1016/j.febslet.2006.01.085; SHARP TV, 1993, NUCLEIC ACIDS RES, V21, P4483, DOI 10.1093/nar/21.19.4483; Skalsky RL, 2014, J VIROL, V88, P1617, DOI 10.1128/JVI.02071-13; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; VANDERVE.J, 1973, INFECT IMMUN, V7, P604, DOI 10.1128/IAI.7.4.604-609.1973; VENNSTROM B, 1978, NUCLEIC ACIDS RES, V5, P195, DOI 10.1093/nar/5.1.195; Wong AMG, 2012, CANCER-AM CANCER SOC, V118, P698, DOI 10.1002/cncr.26309; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Xing L, 2007, J VIROL, V81, P9967, DOI 10.1128/JVI.02244-06; Xu N, 2007, J VIROL, V81, P10540, DOI 10.1128/JVI.00885-07; Xu N, 2009, NUCLEIC ACIDS RES, V37, P6950, DOI 10.1093/nar/gkp764; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhao HX, 2015, VIROLOGY, V478, P99, DOI 10.1016/j.virol.2015.01.033	85	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177275	10.1371/journal.pone.0177275	http://dx.doi.org/10.1371/journal.pone.0177275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542273	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800013
J	Forde, C; Stierman, B; Ramon-Pardo, P; dos Santos, T; Singh, N				Forde, Corey; Stierman, Bryan; Ramon-Pardo, Pilar; dos Santos, Thais; Singh, Nalini			Carbapenem-resistant Klebsiella pneumoniae in Barbados: Driving change in practice at the national level	PLOS ONE			English	Article							RISK-FACTORS; PCR ASSAY; EPIDEMIOLOGY; INFECTION; IDENTIFICATION; COLONIZATION; MORTALITY; OUTBREAK; CLONES; KPC	Introduction Carbapenem-resistant Klebsiella pneumoniae (CRKP) is of growing concern globally. The risk for transmission of antimicrobial resistant organisms across several continents to the Caribbean is a real one given its tourism industry. After a cluster of cases of CRKP were detected, several studies detailed in this report were initiated to better characterize the problem. Methods A hospital-wide point prevalence study and active surveillance were performed at Queen Elizabeth Hospital (QEH) in Barbados in 2013 to assess the prevalence of CRKP infection/ colonization. Following this, a 1-year longitudinal study measured the prevalence of CRKP isolates in the hospital and across all healthcare facilities in the country. Results In 2013, eleven viable isolates of CRKP from cluster of cases were sent for molecular epidemiology studies. When sequenced, they were found to be the ST-258 clone. Identification of a cluster of cases of CRKP ST-258/512 clones indicated person-to-person transmission. In September 2013, the hospital-wide point prevalence study revealed 18% of patients (53/299) at the hospital were either colonized or infected with CRKP. The infection to colonization ratio was 1:7. Patients who were infected/colonized vs. non-colonized were older (64.7 vs. 48.7 years, p<0.0001), were hospitalized longer (42.5 days vs. 27 days, p = 0.0042), were more likely to have an invasive device (66% vs. 32%, p<0.0001), especially urinary catheters (55% vs. 24%, p<0.0001), and were more likely to have used antimicrobials within the prior 14 days (91% vs. 46%, p<0.0001). Specific antimicrobials, including fluoroquinolones and piperacillin-tazobactam, were significantly associated with infection/colonization. In 2014, the 12-month period prevalence of CRKP in Barbados was 49.6 per 100,000 population and of blood stream infections was 3.2 per 100,000 population. Conclusions This point prevalence study identified patients at-risk of acquisition of CRKP and allowed QEH to implement interventions aimed at decreasing the prevalence of CRKP. Organization of a National and regional Infection Prevention and Control Committee in 2014 aimed to strengthen antimicrobial resistance surveillance programs across the English-speaking Caribbean were established.	[Forde, Corey] Queen Elizabeth Hosp, Bridgetown, Barbados; [Stierman, Bryan; Singh, Nalini] Childrens Natl Hlth Syst, Washington, DC 20010 USA; [Ramon-Pardo, Pilar; dos Santos, Thais] Pan Amer Hlth Org, Washington, DC USA; [Singh, Nalini] George Washington Univ, Washington, DC 20052 USA	Children's National Health System; Pan American Health Organization; George Washington University	Forde, C (corresponding author), Queen Elizabeth Hosp, Bridgetown, Barbados.; Singh, N (corresponding author), Childrens Natl Hlth Syst, Washington, DC 20010 USA.; Singh, N (corresponding author), George Washington Univ, Washington, DC 20052 USA.	cfordeclinic@gmail.com; nsingh@childrensnational.org						Adler A, 2014, DIAGN MICR INFEC DIS, V78, P12, DOI 10.1016/j.diagmicrobio.2013.10.003; Ben-David D, 2010, INFECT CONT HOSP EP, V31, P620, DOI 10.1086/652528; Benenson S, 2012, J ANTIMICROB CHEMOTH, V67, P1651, DOI 10.1093/jac/dks115; BTI, TOUR PROF; CDC, 2015, FAC GUID CONTR CARB; Chroboczek T, 2013, J TRAVEL MED, V20, P283, DOI 10.1111/jtm.12047; CLSI, 2016, LAB DET REP CARB RES; Debby BD, 2012, EUR J CLIN MICROBIOL, V31, P1811, DOI 10.1007/s10096-011-1506-5; Escandon-Vargas K, 2017, EXPERT REV ANTI-INFE, V15, P277, DOI 10.1080/14787210.2017.1268918; Rueda VG, 2014, COLOMB MEDICA, V45, P54; Gomez SA, 2016, INFECT GENET EVOL, V44, P145, DOI 10.1016/j.meegid.2016.06.018; Gregory CJ, 2010, INFECT CONT HOSP EP, V31, P476, DOI 10.1086/651670; Hickey B, 2017, WHO GAP AMR NEWSLETT; Hoxha A, 2016, J HOSP INFECT, V92, P61, DOI 10.1016/j.jhin.2015.06.018; Jiao Y, 2015, PATHOG GLOB HEALTH, V109, P68, DOI 10.1179/2047773215Y.0000000004; Kochar S, 2009, INFECT CONT HOSP EP, V30, P447, DOI 10.1086/596734; Mills JP, 2016, INFECT CONT HOSP EP, V37, P55, DOI 10.1017/ice.2015.254; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Saint S, 2016, NEW ENGL J MED, V374, P2111, DOI 10.1056/NEJMoa1504906; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Singh N., 2017, CLIN MICROBIOLOGY IN; Tacconelli E, 2017, GLOBAL PRIORITY LIST; Temkin E, 2014, ANN NY ACAD SCI, V1323, P22, DOI 10.1111/nyas.12537; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Turner R., 2015, TRAVEL TOURISM EC IM; Ulu AC, 2015, MED SCI MONITOR, V21, P219, DOI 10.12659/MSM.892516; WHO, 2017, WHO PUBLISHES LIST B; Wiener-Well Y, 2010, J HOSP INFECT, V74, P344, DOI 10.1016/j.jhin.2009.07.022; World Health Organization, 2016, GUID COR COMP INF PR	29	9	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0176779	10.1371/journal.pone.0176779	http://dx.doi.org/10.1371/journal.pone.0176779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542162	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800003
J	Torres, AU; Chu, A; Read, R; MacDonald, J; Gregson, D; Louie, T; Delongchamp, J; Ward, L; McClure, J; Zhang, KY; Conly, J				Torres, Alejandra Ugarte; Chu, Angel; Read, Ron; MacDonald, Judy; Gregson, Daniel; Louie, Thomas; Delongchamp, Johanna; Ward, Linda; McClure, Joann; Zhang, Kunyan; Conly, John			The epidemiology of Staphylococcus aureus carriage in patients attending inner city sexually transmitted infections and community clinics in Calgary, Canada	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN-RESISTANT; RISK-FACTORS; UNITED-STATES; NASAL COLONIZATION; CLONE USA300; PREVALENCE; VANCOMYCIN; POPULATION	Background Although the nares represent the most common carriage site for traditional hospital-associated strains of Staphylococcus aureus (SA), the predominant site of carriage of SA in the community is less certain. Methods We conducted a cross-sectional study in 285 patients attending sexually transmitted diseases and inner-city clinics to evaluate the prevalence, body site colonisation and risk factors associated with carriage of methicillin susceptible SA (MSSA). All isolates were characterized by pulsed field gel electrophoresis, staphylococcal cassette chromosome mec, staphylococcal protein A and multilocus sequence typing. Results The prevalence of colonisation with SA was 57.5% (164/285); 162 (56.8%) participants were colonized with MSSA, and 4 (1.4%) with methicillin-resistant SA (MRSA), 2 of them were co-colonised with both MRSA and MSSA. The most common sites of colonisation were the throat (73.1%), nares (65.2%) and interdigital web spaces of the hand (21.3%). Three out of 4 MRSA isolates were USA300-MRSA strains. Twelve MSSA isolates were closely related to the USA300 CA-MRSA. We identified sexual behaviours such as having more than 6 heterosexual sexual partners in the last 6 months and trimming pubic hair to be independently associated with MSSA colonisation, and more specifically practicing oral sex as a risk factor for throat colonisation. Conclusion There is a high prevalence of MSSA carriage in this population, with a low prevalence of MRSA. The throat was the most common site of carriage and sexual behaviours were found to be risk factors for MSSA colonisation. Close strain relatedness of MSSA and USA300-MRSA isolates suggests either gain or loss of the SCCmec element, respectively.	[Torres, Alejandra Ugarte; Chu, Angel; Read, Ron; Gregson, Daniel; Louie, Thomas; Zhang, Kunyan; Conly, John] Univ Calgary, Dept Med, Div Infect Dis, Calgary, AB, Canada; [Torres, Alejandra Ugarte; Chu, Angel; Read, Ron; Gregson, Daniel; Louie, Thomas; Zhang, Kunyan; Conly, John] Alberta Hlth Serv, Calgary, AB, Canada; [Chu, Angel; Read, Ron] Alberta Hlth Serv, Sexually Transmitted Infect Clin, Calgary, AB, Canada; [Read, Ron; Louie, Thomas; Zhang, Kunyan; Conly, John] Cumming Sch Med, Dept Microbiol Infect Dis & Immunol, Calgary, AB, Canada; [Read, Ron; Gregson, Daniel; Louie, Thomas; Zhang, Kunyan; Conly, John] Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada; [MacDonald, Judy] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [MacDonald, Judy; Louie, Thomas; Ward, Linda] Alberta Hlth Serv, Infect Prevent & Control, Calgary, AB, Canada; [Gregson, Daniel; Zhang, Kunyan; Conly, John] Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB, Canada; [Gregson, Daniel; Conly, John] Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada; [Delongchamp, Johanna; McClure, Joann; Zhang, Kunyan; Conly, John] Univ Calgary, Alberta Hlth Serv, Calgary, AB, Canada; [Delongchamp, Johanna; McClure, Joann; Zhang, Kunyan; Conly, John] Alberta Hlth Serv, Ctr Antimicrobial Resistance, Calgary, AB, Canada; [Delongchamp, Johanna; McClure, Joann; Zhang, Kunyan; Conly, John] Univ Calgary, Calgary, AB, Canada; [Zhang, Kunyan; Conly, John] Alberta Hlth Serv, Calgary Lab Serv, Calgary, AB, Canada	University of Calgary; Alberta Health Services (AHS); University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary	Conly, J (corresponding author), Univ Calgary, Dept Med, Div Infect Dis, Calgary, AB, Canada.; Conly, J (corresponding author), Alberta Hlth Serv, Calgary, AB, Canada.; Conly, J (corresponding author), Cumming Sch Med, Dept Microbiol Infect Dis & Immunol, Calgary, AB, Canada.; Conly, J (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada.; Conly, J (corresponding author), Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB, Canada.; Conly, J (corresponding author), Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada.; Conly, J (corresponding author), Univ Calgary, Alberta Hlth Serv, Calgary, AB, Canada.; Conly, J (corresponding author), Univ Calgary, Calgary, AB, Canada.; Conly, J (corresponding author), Alberta Hlth Serv, Calgary Lab Serv, Calgary, AB, Canada.	john.conly@albertahealthservices.ca		MacDonald, Judy/0000-0001-9774-7220; Zhang, Kunyan/0000-0003-1078-6011; McClure, JoAnn/0000-0003-4165-744X	University of Calgary Multipurpose Research and Education Fund [753315]	University of Calgary Multipurpose Research and Education Fund	This work received support from the University of Calgary Multipurpose Research and Education Fund, Grant number 753315. The recipient of the grant is JC.	Adhikari RP, 2004, J ANTIMICROB CHEMOTH, V54, P360, DOI 10.1093/jac/dkh350; Akmatov MK, 2014, INT J INFECT DIS, V25, P4, DOI 10.1016/j.ijid.2014.01.021; Bland JM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3166; Boundy S, 2012, J CLIN MICROBIOL, V50, P469, DOI 10.1128/JCM.01063-11; Chan Edward L, 2013, Clin Lab Sci, V26, P175; Cook HA, 2007, CLIN INFECT DIS, V44, P410, DOI 10.1086/510681; Crum-Cianflone NF, 2011, MEDICINE, V90, P379, DOI 10.1097/MD.0b013e318238dc2c; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Garcia Stephen A, 2012, Clin Lab Sci, V25, P156; Gardam M, 2001, INFECT CONT HOSP EP, V22, P152, DOI 10.1086/501882; Gilbert M, 2007, CAN J INFECT DIS MED, V18, P357, DOI 10.1155/2007/597123; Gilbert M, 2006, CAN MED ASSOC J, V175, P149, DOI 10.1503/cmaj.051565; Giuliani M, 2010, EPIDEMIOL INFECT, V138, P738, DOI 10.1017/S0950268810000130; Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Lee NE, 2005, CLIN INFECT DIS, V40, P1529, DOI 10.1086/429827; Maree CL, 2010, CLIN INFECT DIS, V51, P1248, DOI 10.1086/657067; Markley JD, 2012, AM J INFECT CONTROL, V40, P1008, DOI 10.1016/j.ajic.2012.01.015; Mermel LA, 2011, J CLIN MICROBIOL, V49, P1119, DOI 10.1128/JCM.02601-10; Mertz D, 2009, ARCH INTERN MED, V169, P172, DOI 10.1001/archinternmed.2008.536; Miko BA, 2012, MICROBES INFECT, V14, P1040, DOI 10.1016/j.micinf.2012.06.004; Mongodin E, 2003, J BACTERIOL, V185, P4638, DOI 10.1128/JB.185.15.4638-4643.2003; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Nguyen D, 2005, EMERG INFECT DIS, V27, P54; NOBLE WC, 1968, BRIT MED J, V1, P417, DOI 10.1136/bmj.1.5589.417; Noto MJ, 2008, ANTIMICROB AGENTS CH, V52, P1221, DOI 10.1128/AAC.01164-07; Pan ES, 2005, J INFECT DIS, V192, P811, DOI 10.1086/432072; Pan ES, 2003, CLIN INFECT DIS, V37, P1384, DOI 10.1086/379019; Peters PJ, 2013, EMERG INFECT DIS, V19, P623, DOI 10.3201/eid1904.121353; Reipert A, 2003, ANTIMICROB AGENTS CH, V47, P568, DOI 10.1128/AAC.47.2.568-576.2003; Simor AE, 2015, INFECT CONT HOSP EP, V31, P348; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Zhang K, 2008, J CLIN MICROBIOL, V46, P1118, DOI 10.1128/JCM.01309-07; Zhang KY, 2012, MOL CELL PROBE, V26, P218, DOI 10.1016/j.mcp.2012.04.002; Zhang KY, 2004, J CLIN MICROBIOL, V42, P4947, DOI 10.1128/JCM.42.11.4947-4955.2004; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178557	10.1371/journal.pone.0178557	http://dx.doi.org/10.1371/journal.pone.0178557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542601	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800102
J	Zhou, DY; Pan, Q; Chhipi-Shrestha, G; Li, XY; Zhang, K; Hewage, K; Sadiq, R				Zhou, Deyun; Pan, Qian; Chhipi-Shrestha, Gyan; Li, Xiaoyang; Zhang, Kun; Hewage, Kasun; Sadiq, Rehan			A new weighting factor in combining belief function	PLOS ONE			English	Article							EVIDENTIAL REASONING ALGORITHM; DECISION-ANALYSIS; WATER-QUALITY; COMBINATION; UNCERTAINTY; DISTANCE; NUMBERS; IMPACT; MODEL; TBM	Dempster-Shafer evidence theory has been widely used in various applications. However, to solve the problem of counter-intuitive outcomes by using classical Dempster-Shafer combination rule is still an open issue while fusing the conflicting evidences. Many approaches based on discounted evidence and weighted average evidence have been investigated and have made significant improvements. Nevertheless, all of these approaches have inherent flaws. In this paper, a new weighting factor is proposed to address this problem. First, a modified dissimilarity measurement is proposed which is characterized by both distance and conflict between evidences. Second, a measurement of information volume of each evidence based on Deng entropy is introduced. Then two kinds of weight derived from aforementioned measurement are combined to obtain a new weighting factor and a weighted average method based on the new weighting factor is proposed. Numerical examples are used to illustrate the validity and effectiveness of the proposed method. In the end, the new method is applied to a real-life application of river water quality monitoring, which effectively identify the major land use activities contributing to river pollution.	[Zhou, Deyun; Pan, Qian; Li, Xiaoyang; Zhang, Kun] Northwestern Polytech Univ, Sch Elect & Informat, Xian, Peoples R China; [Chhipi-Shrestha, Gyan; Hewage, Kasun; Sadiq, Rehan] Univ British Columbia Okanagan, Sch Engn, Kelowna, BC, Canada	Northwestern Polytechnical University; University of British Columbia; University of British Columbia Okanagan	Pan, Q (corresponding author), Northwestern Polytech Univ, Sch Elect & Informat, Xian, Peoples R China.	panq@mail.nwpu.edu.cn	Hewage, Kasun/AAQ-2395-2020		National Natural Science Foundation of China [61401363]; Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development Grants [CRDPJ 446638-12]; Science and Technology on Avionics Integration Laboratory and Aeronautical Science Foundation [20155153034]; Fundamental Research Funds for the Central Universities [3102016AXXX005, 3102015BJIIJGZ009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Science and Technology on Avionics Integration Laboratory and Aeronautical Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 61401363) (K.Z.); Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development Grants (Grant No. CRDPJ 446638-12) (K.H.); Science and Technology on Avionics Integration Laboratory and Aeronautical Science Foundation (Grant No. 20155153034) (K.Z.); Fundamental Research Funds for the Central Universities (Grant No. 3102016AXXX005, 3102015BJIIJGZ009) (K.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work is partially supported by the National Natural Science Foundation of China (Grant No. 61401363), the Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development Grants (Grant No. CRDPJ 446638-2), the Science and Technology on Avionics Integration Laboratory and Aeronautical Science Foundation (Grant No. 20155153034), the Fundamental Research Funds for the Central Universities (Grant No. 3102016AXXX005, 3102015BJIIJGZ009).	Chhipi-Shrestha GK., 2007, THESIS; Chhipi-Shrestha GK, 2007, P INT S COMM LED MAN, P163; Chhipi-Shrestha GKaP A. M. S, 2007, J SAN STRATIGRAPHICA, V6, P55; Dempster AP, 2006, INT J INTELL SYST, V21, P283, DOI 10.1002/int.20135; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Deng XY, 2014, EXPERT SYST APPL, V41, P635, DOI 10.1016/j.eswa.2013.07.088; Deng Y, 2015, INT J UNCONVENTIONAL, V11; Deng Y., 2015, ARTIF INTELL, V6, P176; Deng Y, 2015, APPL INTELL, V43, P530, DOI 10.1007/s10489-015-0661-2; Deng Y, 2010, DEFENCE SCI J, V60, P525, DOI 10.14429/dsj.60.576; Dezert J, 2006, CS0610175 ARXIV; Dubois D., 1988, Computational Intelligence, V4, P244, DOI 10.1111/j.1467-8640.1988.tb00279.x; ERNST C., 2004, AM WATER WORKS ASS, V30, P1, DOI [10.1002/j.1551-8701.2004.tb01752.x, DOI 10.1002/J.1551-8701.2004.TB01752.X]; Cunha DGF, 2016, ECOL ENG, V94, P516, DOI 10.1016/j.ecoleng.2016.06.063; Fu C, 2014, KNOWL-BASED SYST, V59, P9, DOI 10.1016/j.knosys.2014.01.024; Garcia ML, 2005, VULNERABILITY ASSESS; Hamacher H., 1978, LOGISCHE AGGREGATION; Han DQ, 2012, SCI CHINA INFORM SCI, V55, P558, DOI 10.1007/s11432-011-4541-z; He Y, 2012, SCI CHINA INFORM SCI, V55, P312, DOI 10.1007/s11432-011-4346-0; Jiang W, 2015, INT J COMPUT COMMUN, V10, P333, DOI 10.15837/ijccc.2015.3.1656; Jiang W, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016641820; Jiang Wen, 2010, Systems Engineering and Electronics, V32, P562; Joussleme A.-L., 2001, Information Fusion, V2, P91, DOI 10.1016/S1566-2535(01)00026-4; Kang BY, 2012, KNOWL-BASED SYST, V35, P77, DOI 10.1016/j.knosys.2012.04.007; Kumar AY, 2009, ENVIRON MONIT ASSESS, V157, P223, DOI 10.1007/s10661-008-0530-0; Liu HC, 2013, IEEE T RELIAB, V62, P23, DOI 10.1109/TR.2013.2241251; Liu WR, 2006, ARTIF INTELL, V170, P909, DOI 10.1016/j.artint.2006.05.002; Liu Z-g, 2015, ADV APPL DSMT INFORM, VIV, P23; Liu ZG, 2011, DECIS SUPPORT SYST, V52, P133, DOI 10.1016/j.dss.2011.06.002; Martin A., 2008, INF FUS 2008 11 INT; McKleroy VS, 2006, AIDS EDUC PREV, V18, P59, DOI 10.1521/aeap.2006.18.supp.59; Murphy CK, 2000, DECIS SUPPORT SYST, V29, P1, DOI 10.1016/S0167-9236(99)00084-6; Rao SS, 2013, J MECH DESIGN, V135, DOI 10.1115/1.4024229; Ristic B, 2006, INFORM FUSION, V7, P276, DOI 10.1016/j.inffus.2005.04.004; Shafer G.A., 1976, MATH THEORY EVIDENCE; Smarandache F, 2006, ADV APPL DSM INFORM; Smets P, 2005, INT J APPROX REASON, V38, P133, DOI 10.1016/j.ijar.2004.05.003; SMETS P, 1994, ARTIF INTELL, V66, P191, DOI 10.1016/0004-3702(94)90026-4; SMETS P, 1990, IEEE T PATTERN ANAL, V12, P447, DOI 10.1109/34.55104; Smets P, 2008, STUD FUZZ SOFT COMP, V219, P633; Su XY, 2015, RISK ANAL, V35, P1296, DOI 10.1111/risa.12347; Tianlu C, 2006, J SYSTEMS ENG ELECT, V17, P279; Wang YN, 2015, INT J COMPUT INT SYS, V8, P75, DOI 10.1080/18756891.2014.964009; YAGER RR, 1987, INFORM SCIENCES, V41, P93, DOI 10.1016/0020-0255(87)90007-7; Yang JB, 2002, IEEE T SYST MAN CY A, V32, P289, DOI 10.1109/TSMCA.2002.802746; Yang JB, 2013, ARTIF INTELL, V205, P1, DOI 10.1016/j.artint.2013.09.003; Yong D., 2004, DECIS SUPPORT SYST, V38, P489, DOI DOI 10.1016/J.DSS.2004.04.015; Zadeh L.A., 1986, AI MAG, V7, P85, DOI DOI 10.1609/AIMAG.V7I2.542; Zhang MJ, 2017, EUR J OPER RES, V257, P1005, DOI 10.1016/j.ejor.2016.08.028; Zia H, 2013, COMPUT ELECTRON AGR, V96, P126, DOI 10.1016/j.compag.2013.05.001	50	5	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177695	10.1371/journal.pone.0177695	http://dx.doi.org/10.1371/journal.pone.0177695			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542549	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800023
J	Zhu, BY; Rippe, C; Hien, TT; Zeng, JW; Albinsson, S; Stenkula, KG; Uvelius, B; Sward, K				Zhu, Baoyi; Rippe, Catarina; Tran Thi Hien; Zeng, Jianwen; Albinsson, Sebastian; Stenkula, Karin G.; Uvelius, Bengt; Sward, Karl			Similar regulatory mechanisms of caveolins and cavins by myocardin family coactivators in arterial and bladder smooth muscle	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; URINARY-BLADDER; ACTIN DYNAMICS; UP-REGULATION; TRANSCRIPTION; MICE; DIFFERENTIATION; HYPERTROPHY; ADIPOCYTES	Caveolae are membrane invaginations present at high densities in muscle and fat. Recent work has demonstrated that myocardin family coactivators (MYOCD, MKL1), which are important for contractile differentiation and cell motility, increase caveolin (CAV1, CAV2, CAV3) and cavin (CAVIN1, CAVIN2, CAVIN3) transcription, but several aspects of this control mechanism remain to be investigated. Here, using promoter reporter assays we found that both MKL1/MRTF-A and MKL2/MRTF-B control caveolins and cavins via their proximal promoter sequences. Silencing of MKL1 and MKL2 in smooth muscle cells moreover reduced CAV1 and CAVIN1 mRNA levels by well over 50%, as did treatment with second generation inhibitors of MKL activity. GATA6, which modulates expression of smooth muscle-specific genes, reduced CAV1 and CAV2, whereas the cavins were unaffected or increased. Viral overexpression of MKL1 and myocardin induced caveolin and cavin expression in bladder smooth muscle cells from rats and humans and MYOCD correlated tightly with CAV1 and CAVIN1 in human bladder specimens. A recently described activator of MKL-driven transcription (ISX) failed to induce CAV1/CAVIN1 which may be due to an unusual transactivation mechanism. In all, these findings further support the view that myocardin family coactivators are important transcriptional drivers of caveolins and cavins in smooth muscle.	[Zhu, Baoyi; Rippe, Catarina; Tran Thi Hien; Albinsson, Sebastian; Stenkula, Karin G.; Sward, Karl] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Zhu, Baoyi; Zeng, Jianwen] Guangzhou Med Univ, Affiliated Hosp 6, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Uvelius, Bengt] Lund Univ, Dept Urol Clin Sci, Lund, Sweden	Lund University; Guangzhou Medical University; Lund University	Sward, K (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	karl.sward@med.lu.se	Rippe, Catarina/B-4110-2010; Albinsson, Sebastian/B-4105-2010	Rippe, Catarina/0000-0001-8621-9836; Stenkula, Karin/0000-0002-0739-1150; Uvelius, Bengt/0000-0003-0201-8928; Albinsson, Sebastian/0000-0001-6936-3967; Sward, Karl/0000-0002-7255-5510; Zhu, Baoyi/0000-0002-6727-3607	Swedish Research Council (Vetenskapsradet) [K2015-65X-22662-01-3, K2013-99X22245-01-5]; Crafoord Foundation; Royal Physiographic Society (Kungliga Fysiografiska Sallskapet); Hillevi Fries' foundation; Gosta Jonsson's foundation	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Crafoord Foundation; Royal Physiographic Society (Kungliga Fysiografiska Sallskapet); Hillevi Fries' foundation; Gosta Jonsson's foundation	This study was funded by The Swedish Research Council (Vetenskapsradet, http://www.vr.se/,K2015-65X-22662-01-3 (KS) and K2013-99X22245-01-5 (SA)), the Crafoord Foundation (ham://en.crafoord.se/,CR), the Royal Physiographic Society (Kungliga Fysiografiska Sallskapet, http://www.fyslografen.se/, CR) and Hillevi Fries' and Gosta Jonsson's foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bell JL, 2013, BIOORG MED CHEM LETT, V23, P3826, DOI 10.1016/j.bmcl.2013.04.080; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Boopathi E, 2011, AM J PATHOL, V178, P2236, DOI 10.1016/j.ajpath.2011.01.038; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Bruno C, 1993, GENEREVIEWS, P1993; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Ekman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082308; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Evelyn CR, 2010, BIOORG MED CHEM LETT, V20, P665, DOI 10.1016/j.bmcl.2009.11.056; Gurbuz I, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-22; Huang JH, 2015, P NATL ACAD SCI USA, V112, P4447, DOI 10.1073/pnas.1420363112; Joshi B, 2012, J CELL BIOL, V199, P425, DOI 10.1083/jcb.201207089; Karbalaei MS, 2012, EUR J PHARMACOL, V689, P179, DOI 10.1016/j.ejphar.2012.05.023; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Krawczyk KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133931; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Lai HH, 2004, NEUROCHEM INT, V45, P1185, DOI 10.1016/j.neuint.2004.06.016; McDonald ME, 2015, CELL, V160, P105, DOI 10.1016/j.cell.2014.12.005; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Nassar ZD, 2015, INT REV CEL MOL BIO, V320, P235, DOI 10.1016/bs.ircmb.2015.07.009; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Regazzetti C, 2015, ENDOCRINOLOGY, V156, P789, DOI 10.1210/en.2014-1656; Sadegh MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116784; Sadegh MK, 2011, BRIT J PHARMACOL, V162, P1156, DOI 10.1111/j.1476-5381.2010.01115.x; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sward K, 2016, J PHYSIOL-LONDON, V594, P4741, DOI 10.1113/JP271913; Hien TT, 2016, J BIOL CHEM, V291, P3552, DOI 10.1074/jbc.M115.654384; van den Heuvel APJ, 2005, BIOCHEM J, V385, P795, DOI 10.1042/BJ20041449; Velasquez LS, 2013, P NATL ACAD SCI USA, V110, P16850, DOI 10.1073/pnas.1316764110; Wang Y, 2012, P NATL ACAD SCI USA, V109, P4892, DOI 10.1073/pnas.1112129109; Woodman SE, 2004, J UROLOGY, V171, P950, DOI 10.1097/01.ju.0000105102.72295.b8; Yin F, 2005, J BIOL CHEM, V280, P4745, DOI 10.1074/jbc.M411585200; Zeng JW, 2015, EUR J PHARMACOL, V762, P82, DOI 10.1016/j.ejphar.2015.05.037	37	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0176759	10.1371/journal.pone.0176759	http://dx.doi.org/10.1371/journal.pone.0176759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542204	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800001
J	Crawford, ED; Quan, JN; Horst, JA; Ebert, D; Wu, W; DeRisi, JL				Crawford, Emily D.; Quan, Jenai; Horst, Jeremy A.; Ebert, Daniel; Wu, Wesley; DeRisi, Joseph L.			Plasmid-free CRISPR/Cas9 genome editing in Plasmodium falciparum confirms mutations conferring resistance to the dihydroisoquinolone clinical candidate SJ733	PLOS ONE			English	Article							MALARIA PARASITE; RECOMBINATION; VARIANTS; SOFTWARE; SEQUENCE; SYSTEM; PFATP4; DRUGS	Genetic manipulation of the deadly malaria parasite Plasmodium falciparum remains challenging, but the rise of CRISPR/Cas9-based genome editing tools is increasing the feasibility of altering this parasite's genome in order to study its biology. Of particular interest is the investigation of drug targets and drug resistance mechanisms, which have major implications for fighting malaria. We present a new method for introducing drug resistance mutations in P. falciparum without the use of plasmids or the need for cloning homologous recombination templates. We demonstrate this method by introducing edits into the sodium efflux channel PfATP4 by transfection of a purified CRISPR/Cas9-guide RNA ribonucleoprotein complex and a 200-nucleotide single-stranded oligodeoxynucleotide (ssODN) repair template. Analysis of whole genome sequencing data with the variant-finding program MinorityReport confirmed that only the intended edits were made, and growth inhibition assays confirmed that these mutations confer resistance to the antimalarial SJ733. The method described here is ideally suited for the introduction of mutations that confer a fitness advantage under selection conditions, and the novel finding that an ssODN can function as a repair template in P. falciparum could greatly simplify future editing attempts regardless of the nuclease used or the delivery method.	[Crawford, Emily D.; Quan, Jenai; DeRisi, Joseph L.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Crawford, Emily D.; Quan, Jenai; Horst, Jeremy A.; Ebert, Daniel; Wu, Wesley; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Crawford, Emily D.; Quan, Jenai; Ebert, Daniel; DeRisi, Joseph L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ebert, Daniel] Touro Coll Osteopath Med, Middletown, NY USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute	DeRisi, JL (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; DeRisi, JL (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; DeRisi, JL (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	joe@czbiohub.org	Crawford, Emily/AAA-9674-2019; Crawford, Emily/AAP-9565-2020	Crawford, Emily/0000-0003-4182-2337; Crawford, Emily/0000-0003-4182-2337; Quan, Jen Ai/0000-0002-2311-249X	Howard Hughes Medical Institute; Chan Zuckerberg Biohub; National Institutes of Health NIDCR [T32-DE007306]; Philippine California Advanced Research Institutes, project IHITM [63]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Chan Zuckerberg Biohub; National Institutes of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Philippine California Advanced Research Institutes, project IHITM	This work was supported by Howard Hughes Medical Institute and the Chan Zuckerberg Biohub. JAH was funded by National Institutes of Health NIDCR grant number T32-DE007306. WW was funded by the Philippine California Advanced Research Institutes, project IHITM 63. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bansal A, 2016, MBIO, V7, DOI [10.1128/mBio.02011-16, 10.1128/mbio.02011-16]; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Caro F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-22; Corey VC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11901; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Flannery EL, 2015, ACS CHEM BIOL, V10, P413, DOI 10.1021/cb500616x; Gabryszewski SJ, 2016, MOL BIOL EVOL, V33, P1554, DOI 10.1093/molbev/msw037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Horst JA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1730-2; Huskey SEW, 2016, DRUG METAB DISPOS, V44, P672, DOI 10.1124/dmd.115.069187; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; LaMonte G, 2016, MBIO, V7, DOI 10.1128/mBio.00696-16; Lee AH, 2014, MICROBIOL MOL BIOL R, V78, P469, DOI 10.1128/MMBR.00059-13; Lim MYX, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.166, 10.1038/nmicrobiol.2016.166]; Lu JN, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1487-4; Mogollon CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168362; Ng CL, 2016, MOL MICROBIOL, V101, P381, DOI 10.1111/mmi.13397; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Ruby JG, 2013, G3-GENES GENOM GENET, P3; Sonoiki E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01949-16, 10.1128/aac.01949-16]; Sonoiki E, 2016, ANTIMICROB AGENTS CH, V60, P4886, DOI 10.1128/AAC.00820-16; Spillman NJ, 2015, INT J PARASITOL-DRUG, V5, P149, DOI 10.1016/j.ijpddr.2015.07.001; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu W, 2015, ANTIMICROB AGENTS CH, V59, P356, DOI 10.1128/AAC.03342-14	34	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178163	10.1371/journal.pone.0178163	http://dx.doi.org/10.1371/journal.pone.0178163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542423	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400065
J	Ismail, B; de Kemp, RA; Croteau, E; Hadizad, T; Burns, KD; Beanlands, RS; DaSilva, JN				Ismail, Basma; de kemp, Rob A.; Croteau, Etienne; Hadizad, Tayebeh; Burns, Kevin D.; Beanlands, Rob S.; DaSilva, Jean N.			Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT(1) receptor expression as measured with PET imaging	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE CONTROL; GLOMERULAR-FILTRATION-RATE; CALCIUM-CHANNEL BLOCKERS; DIABETIC-NEPHROPATHY; ANTIHYPERTENSIVE THERAPY; ACE-INHIBITION; ALL-CAUSE; IN-VIVO; INJURY	ACE inhibitors are considered first line of treatment in patients with many forms of chronic kidney disease (CKD). Other antihypertensives such as calcium channel blockers achieve similar therapeutic effectiveness in attenuating hypertension-related renal damage progression. Our objective was to explore the value of positron emission tomography (PET) imaging of renal AT(1) receptor (AT(1)R) to guide therapy in the 5/6 subtotal-nephrectomy (Nx) rat model of CKD. Ten weeks after Nx, Sprague-Dawley rats were administered 10mg/kg/d enalapril (NxE), 30mg/kg/d diltiazem (NxD) or left untreated (Nx) for an additional 8-10 weeks. Kidney AT(1)R expression was assessed using in vivo [F-18] fluoropyridine-losartan PET and in vitro autoradiography. Compared to shams, Nx rats exhibited higher systolic blood pressure that was reduced by both enalapril and diltiazem. At 18-20 weeks, plasma creatinine and albuminuria were significantly increased in Nx, reduced to sham levels in NxE, but enhanced in NxD rats. Enalapril treatment decreased kidney angiotensin II whereas diltiazem induced significant elevations in plasma and kidney levels. Reduced PET renal AT(1)R levels in Nx were normalized by enalapril but not diltiazem, and results were supported by autoradiography. Reduction of renal blood flow in Nx was restored by enalapril, while no difference was observed in myocardial blood flow amongst groups. Enhanced left ventricle mass in Nx was not reversed by enalapril but was augmented with diltiazem. Stroke volume was diminished in untreated Nx compared to shams and restored with both therapies. [F-18] Fluoropyridine-Losartan PET allowed in vivo quantification of kidney AT(1)R changes associated with progression of CKD and with various pharmacotherapies.	[Ismail, Basma; de kemp, Rob A.; Croteau, Etienne; Hadizad, Tayebeh; Beanlands, Rob S.; DaSilva, Jean N.] Univ Ottawa, Heart Inst, Cardiac PET Ctr, Dept Med,Div Cardiol, Ottawa, ON, Canada; [Ismail, Basma; Burns, Kevin D.; Beanlands, Rob S.; DaSilva, Jean N.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Burns, Kevin D.] Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Ottawa, ON, Canada; [DaSilva, Jean N.] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada; [DaSilva, Jean N.] Univ Montreal, Hosp Res Ctr, CRCHUM, Montreal, PQ, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Universite de Montreal; Universite de Montreal	DaSilva, JN (corresponding author), Univ Ottawa, Heart Inst, Cardiac PET Ctr, Dept Med,Div Cardiol, Ottawa, ON, Canada.; DaSilva, JN (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.; DaSilva, JN (corresponding author), Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada.; DaSilva, JN (corresponding author), Univ Montreal, Hosp Res Ctr, CRCHUM, Montreal, PQ, Canada.	jean.dasilva@umontreal.ca	Beanlands, Rob S/M-2105-2017	Beanlands, Rob S/0000-0001-7857-8169	Ontario Preclinical Imaging Consortium (OPIC) grant [RE03-51]; Canadian Institutes of Health Research [MOP-80203, MOP-287694]; Molecular Function and Imaging Heart and Stroke Foundation of Ontario Program Grant [PRG6242]; University of Ottawa's Faculty of Medicine Endowed Funds for Cardiac Graduate Research; UOHI Foundation; Heart and Stroke Foundation of Ontario (HFSO); University of Ottawa Heart Institute (UOHI) Vered Chair in Cardiology; Tier 1 University of Ottawa Chair in Cardiovascular Research	Ontario Preclinical Imaging Consortium (OPIC) grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Molecular Function and Imaging Heart and Stroke Foundation of Ontario Program Grant; University of Ottawa's Faculty of Medicine Endowed Funds for Cardiac Graduate Research; UOHI Foundation; Heart and Stroke Foundation of Ontario (HFSO)(Heart & Stroke Foundation of Ontario); University of Ottawa Heart Institute (UOHI) Vered Chair in Cardiology; Tier 1 University of Ottawa Chair in Cardiovascular Research	This work was supported in part by, the Ontario Preclinical Imaging Consortium (OPIC) grant# RE03-51 (Ontario Research Foundation) and the Canadian Institutes of Health Research (MOP-80203 & MOP-287694) and by the Molecular Function and Imaging Heart and Stroke Foundation of Ontario Program Grant (#PRG6242). BI was a doctoral student co-supervised by JDS and RSB and supported by the PhD scholarship from the University of Ottawa's Faculty of Medicine Endowed Funds for Cardiac Graduate Research and the UOHI Foundation. RSB is a Career Investigator supported by the Heart and Stroke Foundation of Ontario (HFSO), the University of Ottawa Heart Institute (UOHI) Vered Chair in Cardiology and Tier 1 University of Ottawa Chair in Cardiovascular Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello S, 1998, KIDNEY INT, pS63; Allred AJ, 2000, AM J PHYSIOL-RENAL, V279, pF636, DOI 10.1152/ajprenal.2000.279.4.F636; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Arksey N, 2014, BIOORGAN MED CHEM, V22, P3931, DOI 10.1016/j.bmc.2014.06.011; Arora P, 2013, CAN MED ASSOC J, V185, pE417, DOI 10.1503/cmaj.120833; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Bader J, 2001, J MOL MED, V79, P76, DOI 10.1007/s001090100210; Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Bidani AK, 2006, NAT CLIN PRACT NEPHR, V2, P542, DOI 10.1038/ncpneph0299; Black HR, 1998, CONTROL CLIN TRIALS, V19, P370, DOI 10.1016/S0197-2456(98)00013-0; BRENNER BM, 1983, KIDNEY INT, V23, P647, DOI 10.1038/ki.1983.72; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Bruzzi I, 1997, J NEPHROL, V10, P179; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Griffin KA, 1999, KIDNEY INT, V55, P1849, DOI 10.1046/j.1523-1755.1999.00434.x; GRIFFIN KA, 1995, J CLIN INVEST, V96, P793, DOI 10.1172/JCI118125; Griffin KA, 2004, AM J PHYSIOL-RENAL, V286, pF1136, DOI 10.1152/ajprenal.00401.2003; Griffin KA, 2003, HYPERTENSION, V41, P201, DOI 10.1161/01.HYP.0000049881.25304.73; Griffin KA, 2006, CLIN J AM SOC NEPHRO, V1, P1054, DOI 10.2215/CJN.02231205; Griffin Karen A, 2008, Curr Cardiol Rep, V10, P448; Hachem M, 2015, J NUCL MED IN PRESS; Hadizad T, 2011, J LABELLED COMPD RAD, V54, P754, DOI 10.1002/jlcr.1917; Hadizad T, 2009, BIOORGAN MED CHEM, V17, P7971, DOI 10.1016/j.bmc.2009.10.016; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Ismail B, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0209-4; Ismail B, 2015, NUCL MED BIOL, V42, P850, DOI 10.1016/j.nucmedbio.2015.06.012; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Joly E, 2005, CLIN EXP PHARMACOL P, V32, P241, DOI 10.1111/j.1440-1681.2005.04181.x; Kenk M, 2007, NUCL MED BIOL, V34, P71, DOI 10.1016/j.nucmedbio.2006.10.002; Klein R, 2010, J NUCL CARDIOL, V17, P555, DOI 10.1007/s12350-010-9256-9; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kujal P, 2010, CLIN EXP PHARMACOL P, V37, P1159, DOI 10.1111/j.1440-1681.2010.05453.x; Le Corvoisier P, 2010, EUR J HEART FAIL, V12, P1171, DOI 10.1093/eurjhf/hfq146; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LOGAN J, 1987, J NEUROCHEM, V48, P73, DOI 10.1111/j.1471-4159.1987.tb13129.x; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; Lortie M, 2013, NUCL MED BIOL, V40, P252, DOI 10.1016/j.nucmedbio.2012.10.013; Macconi D, 2010, HISTOL HISTOPATHOL, V25, P655, DOI 10.14670/HH-25.655; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Moriguchi Y, BIOMED RES, V32, P83; NAKAMOTO H, 1995, HYPERTENSION, V25, P796, DOI 10.1161/01.HYP.25.4.796; Nathan S, 2005, HYPERTENSION, V46, P637, DOI 10.1161/01.HYP.0000184541.24700.c7; Noda M, 1999, KIDNEY INT, V56, P898, DOI 10.1046/j.1523-1755.1999.00614.x; Parving HH, 2001, KIDNEY INT, V60, P228, DOI 10.1046/j.1523-1755.2001.00790.x; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Podjarny E, 2004, NEPHROL DIAL TRANSPL, V19, P2223, DOI 10.1093/ndt/gfh383; PODJARNY E, 1993, NEPHROL DIAL TRANSPL, V8, P501, DOI 10.1093/ndt/8.6.501; Pohl MA, 2005, J AM SOC NEPHROL, V16, P3027, DOI 10.1681/ASN.2004110919; Rahn KH, 2005, PEDIATR NEPHROL, V20, P1208, DOI 10.1007/s00467-005-1982-x; Ruggenenti P, 1997, LANCET, V349, P1857; Segura J., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P55, DOI 10.2174/1568016052773261; Shiba N, 2011, J CARDIOL, V57, P8, DOI 10.1016/j.jjcc.2010.09.004; Sukumaran V, 2010, HYPERTENS RES, V33, P695, DOI 10.1038/hr.2010.67; Sviglerova J, 2010, PHYSIOL RES, V59, pS81, DOI 10.33549/physiolres.932003; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Toto Robert D, 2005, J Clin Hypertens (Greenwich), V7, P15, DOI 10.1111/j.1524-6175.2004.4471.x; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vaziri ND, 2007, J PHARMACOL EXP THER, V323, P85, DOI 10.1124/jpet.107.123638; Windt WAKM, 2006, J RENIN-ANGIO-ALDO S, V7, P217, DOI 10.3317/jraas.2006.041; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	67	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177451	10.1371/journal.pone.0177451	http://dx.doi.org/10.1371/journal.pone.0177451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542215	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672600010
J	Oh, SA; Park, JW; Yea, JW; Kim, SK				Oh, Se An; Park, Jae Won; Yea, Ji Woon; Kim, Sung Kyu			Evaluations of the setup discrepancy between BrainLAB 6D ExacTrac and cone-beam computed tomography used with the imaging guidance system Novalis-Tx for intracranial stereotactic radiosurgery	PLOS ONE			English	Article							RADIATION-THERAPY; METASTASES; TRIAL	The objective of this study was to evaluate the setup discrepancy between BrainLAB 6 degree-of-freedom (6D) ExacTrac and cone-beam computed tomography (CBCT) used with the imaging guidance system Novalis Tx for intracranial stereotactic radiosurgery. We included 107 consecutive patients for whom white stereotactic head frame masks (R408; Clarity Medical Products, Newark, OH) were used to fix the head during intracranial stereotactic radiosurgery, between August 2012 and July 2016. The patients were immobilized in the same state for both the verification image using 6D ExacTrac and online 3D CBCT. In addition, after radiation treatment, registration between the computed tomography simulation images and the CBCT images was performed with offline 6D fusion in an offline review. The root-mean-square of the difference in the translational dimensions between the ExacTrac system and CBCT was <1.01 mm for online matching and <1.10 mm for offline matching. Furthermore, the root-mean-square of the difference in the rotational dimensions between the ExacTrac system and the CBCT were <0.82 degrees for online matching and <0.95 degrees for offline matching. It was concluded that while the discrepancies in residual setup errors between the ExacTrac 6D X-ray and the CBCT were minor, they should not be ignored.	[Oh, Se An; Park, Jae Won; Yea, Ji Woon; Kim, Sung Kyu] Yeungnam Univ, Dept Radiat Oncol, Med Ctr, Daegu, South Korea; [Park, Jae Won; Yea, Ji Woon; Kim, Sung Kyu] Yeungnam Univ, Dept Radiat Oncol, Coll Med, Daegu, South Korea	Yeungnam University; Yeungnam University	Kim, SK (corresponding author), Yeungnam Univ, Dept Radiat Oncol, Med Ctr, Daegu, South Korea.; Kim, SK (corresponding author), Yeungnam Univ, Dept Radiat Oncol, Coll Med, Daegu, South Korea.	skkim3@ynu.ac.kr		Oh, SeAn/0000-0002-8835-2814; Kim, Sungkyu/0000-0002-5371-6964; Park, Jaewon/0000-0003-1100-5301	Yeungnam University Research Grant [216A480007]; Yeungnam University Research Grant	Yeungnam University Research Grant; Yeungnam University Research Grant	This work was supported by the 2016 Yeungnam University Research Grant (216A480007). There was no additional external funding received for this study.; This work was supported by the 2016 Yeungnam University Research Grant. There was no additional external funding received for this study.	Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Chang Z, 2010, RADIOTHER ONCOL, V95, P116, DOI 10.1016/j.radonc.2009.12.036; Eaton BR, 2015, J NEURO-ONCOL, V123, P103, DOI 10.1007/s11060-015-1767-4; Infusino E, 2015, J APPL CLIN MED PHYS, V16, P99, DOI 10.1120/jacmp.v16i2.5102; Kim J, 2012, J APPL CLIN MED PHYS, V13, P124, DOI 10.1120/jacmp.v13i3.3729; Lamba M, 2009, INT J RADIAT ONCOL, V74, P913, DOI 10.1016/j.ijrobp.2009.01.008; Ma JL, 2009, RADIOTHER ONCOL, V93, P602, DOI 10.1016/j.radonc.2009.09.009; Min Park Jong, 2016, [PROGRESS in MEDICAL PHYSICS, 의학물리], V27, P169; Molinier J, 2016, J APPL CLIN MED PHYS, V17, P92, DOI 10.1120/jacmp.v17i1.5677; Oh SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151709; Oh YK, 2014, J APPL CLIN MED PHYS, V15, P85, DOI 10.1120/jacmp.v15i2.4418; OHSEAN, 2013, [PROGRESS in MEDICAL PHYSICS, 의학물리], V24, P145, DOI 10.14316/pmp.2013.24.3.145; Ramakrishna N, 2010, RADIOTHER ONCOL, V95, P109, DOI 10.1016/j.radonc.2009.12.030; 유제상, 2015, [PROGRESS in MEDICAL PHYSICS, 의학물리], V26, P137, DOI 10.14316/pmp.2015.26.3.137; Spadea MF, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-38; Takakura T, 2010, PHYS MED BIOL, V55, P1, DOI 10.1088/0031-9155/55/1/001; Won YK, 2015, RADIAT ONCOL J, V33, P207, DOI 10.3857/roj.2015.33.3.207	19	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177798	10.1371/journal.pone.0177798	http://dx.doi.org/10.1371/journal.pone.0177798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542254	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672600024
J	Shen, YJ; Li, G; Gu, CY; Chen, B; Chen, AH; Li, H; Gao, B; Liang, CC; Wu, JS; Yang, T; Jin, L; Su, Y				Shen, Yijun; Li, Gang; Gu, Chunying; Chen, Ben; Chen, Aihua; Li, Hua; Gao, Bei; Liang, Chencai; Wu, Jingsong; Yang, Tong; Jin, Li; Su, Yong			T0001, a variant of TNFR2-Fc fusion protein, exhibits improved Fc effector functions through increased binding to membrane-bound TNF alpha	PLOS ONE			English	Article							ANTITUMOR NECROSIS FACTOR; THERAPEUTIC ANTIBODIES; AGENTS; INFLIXIMAB; CELLS; RESPONSES; DISEASE; ASSAY	T0001 is a recombinant human TNFR-Fc fusion protein mutant; it exhibits higher affinity to TNF alpha than etanercept and is now being tested in a Phase 1 study in China (ClinicalTrials. gov Identifier: NCT02481180). T0001 can inhibit the binding of soluble TNF alpha(sTNF alpha) or membrane-bound TNF alpha(mTNF alpha) to TNF receptors. When bound to mTNF alpha, the Fc-bearing TNF alpha antagonists have the potential to induce Fc-mediated effects, such as antibody-dependent cellular cytotoxicity (ADCC) and complement-mediated cytotoxicity (CDC) as well as outside-to-inside signals (apoptosis mainly). Recent studies have shown that ADCC may also play an important role in Crohn's disease (CD) and ulcerative colitis (UC). In this study, T0001 presented a higher binding activity on mTNF alpha than etanercept and similar binding activity with adalimumab and infliximab. Upon the addition of sTNF alpha, adalimumab and infliximab showed significantly increased binding to Fc gamma RIIIa and C1q than T0001 and etanercept. T0001 exhibited significantly higher ADCC and CDC activity than etanercept, and the potency and the reporter response of T0001 were very close to adalimumab and infliximab in ADCC reporter gene assays. And the similar potency of T0001 was also corroborated by PMBC-based ADCC assay. T0001, but not etanercept could induce apoptosis, while adalimumab and infliximab were more effective. These results suggest that T0001 may not only exert improved efficacy in treating rheumatoid arthritis (RA) because of its high affinity to sTNF alpha but also has a therapeutic potential in CD and UC due to its increased binding to mTNF alpha with resultant Fc-associated functions (ADCC, in particular) and improved apoptosis.	[Shen, Yijun; Jin, Li] Fudan Univ, Key Lab Contemporary Anthropol, Minist Educ, Shanghai, Peoples R China; [Shen, Yijun; Li, Gang; Gu, Chunying; Chen, Ben; Chen, Aihua; Li, Hua; Gao, Bei; Liang, Chencai; Wu, Jingsong; Yang, Tong; Su, Yong] Shanghai Fudan Zhangjiang Biopharmaceut Co Ltd, R&D Dept Genet Engn, Shanghai, Peoples R China	Fudan University	Jin, L (corresponding author), Fudan Univ, Key Lab Contemporary Anthropol, Minist Educ, Shanghai, Peoples R China.; Su, Y (corresponding author), Shanghai Fudan Zhangjiang Biopharmaceut Co Ltd, R&D Dept Genet Engn, Shanghai, Peoples R China.	lijin.fudan@gmail.com; ysu@fd-zj.com	Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; Shen, Yi/GRS-3602-2022	Jin, Li/0000-0002-4546-2415; 	Shanghai Fudan-Zhangjiang BioPharmaceutical Co, Ltd. (China)	Shanghai Fudan-Zhangjiang BioPharmaceutical Co, Ltd. (China)	This project was supported by internal funds of Shanghai Fudan-Zhangjiang BioPharmaceutical Co, Ltd. (China). The funder provided support in the form of salaries for authors, YShen, GL, CG, BC, AC, HL, BG, CL, JW, TY and YSu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arora T, 2009, CYTOKINE, V45, P124, DOI 10.1016/j.cyto.2008.11.008; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cheng ZJ, 2014, J IMMUNOL METHODS, V414, P69, DOI 10.1016/j.jim.2014.07.010; de Mattos BR, 2015, MEDIAT INFLAMM, V2015, DOI DOI 10.1155/2015/493012; Feagan BG, 2014, BIOLOGICALS, V42, P177, DOI 10.1016/j.biologicals.2014.05.005; Health Canada, 2014, SUMMARY BASIS OF DEC; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; Kollias G, 1999, ANN RHEUM DIS, V58, P32, DOI 10.1136/ard.58.2008.i32; Levin A, 2008, BIOL-TARGETS THER, V2, P379; Lis K, 2014, ARCH MED SCI, V10, P1175, DOI 10.5114/aoms.2014.47827; Mitoma H, 2005, GASTROENTEROLOGY, V128, P376, DOI 10.1053/j.gastro.2004.11.060; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; Moots RJ, 2011, CLIN EXP RHEUMATOL, V29, P26; Nesbitt A, 2007, INFLAMM BOWEL DIS, V13, P1323, DOI 10.1002/ibd.20225; Parekh BS, 2012, MABS-AUSTIN, V4, P310, DOI 10.4161/mabs.19873; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Siberil S, 2007, CRIT REV ONCOL HEMAT, V62, P26, DOI 10.1016/j.critrevonc.2006.12.003; Tilg H, 2007, EXPERT OPIN BIOL TH, V7, P1051, DOI 10.1517/14712598.7.7.1051; Van Den Brande JMH, 2003, GASTROENTEROLOGY, V124, P1774, DOI 10.1016/S0016-5085(03)00382-2; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Yang T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000669	25	2	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177891	10.1371/journal.pone.0177891	http://dx.doi.org/10.1371/journal.pone.0177891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542350	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672600029
J	Tan, QT; Jiang, X; Huang, SC; Zhang, TT; Chen, L; Xie, SW; Mo, EP; Xu, J; Cai, SH				Tan, Qiutong; Jiang, Xin; Huang, Sichao; Zhang, Tiantian; Chen, Lin; Xie, Siwen; Mo, Enpan; Xu, Jun; Cai, Shaohui			The clinical efficacy and safety evaluation of ticagrelor for acute coronary syndrome in general ACS patients and diabetic patients: A systematic review and meta-analysis	PLOS ONE			English	Review							ST-SEGMENT-ELEVATION; P2Y(12) RECEPTOR ANTAGONIST; ACUTE MYOCARDIAL-INFARCTION; OUTCOMES PLATO TRIAL; PLATELET INHIBITION; RANDOMIZED ASSESSMENT; ARTERY-DISEASE; PRASUGREL; CLOPIDOGREL; ADENOSINE	Objective In this study, a systematic evaluation was conducted to estimate the efficacy and safety of ticagrelor for treating acute coronary syndrome (ACS) in general ACS patients and a diabetes mellitus (DM) group. Methods A search of PubMed, Cochrane Central Register of Controlled Trials, Web of Science, CNKI databases was conducted to analyze relevant randomized controlled trails (RCTs) of ticagrelor treating ACS during 2007 to 2015. Article screening, quality accessing and data extracting was independently undertaken by two reviewers. A meta-analysis was performed to clarify the efficacy and safety of ticagrelor in general ACS patients, and a meta-regression analysis was taken to demonstrate the efficacy and safety of ticagrelor in DM patients compared with general ACS patients. Result Twenty-two studies with 35004 participants were included. The meta-analysis result implicated that ticagrelor could: 1) reduce the incidence of the composite endpoint [OR = 0.83, 95% CI (0.77, 0.90), P<0.00001] and the incidence of myocardial infarction [OR = 0.81, 95% CI (0.74, 0.89), P = 0.0001]; 2) not statistically reduce the incidence of cardiovascular death, the incidence of stroke and the incidence of bleeding events; 3) increase the incidence of dyspnea [OR = 1.90, 95% CI (1.73, 2.08), P<0.00001] compared with clopidogrel. Meanwhile, compared with prasugrel, ticagrelor could 1) reduce the platelet reactivity of patients at maintenance dose [MD = -44.59, 95% CI (-59.16, -30.02), P<0.00001]; 2) not statistically reduce the incidence of cardiovascular death, the platelet reactivity of patients 6 hours or 8 hours after administration, or the incidence of bleeding events; 3) induce the incidence of dyspnea [OR = 13.99, 95% CI (2.58, 75.92), P = 0.002]. Furthermore, the result of meta-regression analysis implicated that there was a positive correlation between DM patients and the platelet reactivity of patients 6 hours and 8 hours after administration, but there was no obvious correlation between DM patients and general ACS patients in other endpoints. Conclusion Ticagrelor could reduce the incidence of composite endpoint of cardiovascular death, myocardial infarction and stroke as well as platelet reactivity in DM patients with ACS, while not increasing the risk of bleeding. Because there are differences in platelet reactivity between DM patients and general ACS patients, we suggest that caution is needed when using ticagrelor in clinical applications.	[Tan, Qiutong; Zhang, Tiantian; Xie, Siwen; Xu, Jun; Cai, Shaohui] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Jiang, Xin] Renolit, Med Div, Beijing, Peoples R China; [Huang, Sichao] Zhuhai Peoples Hosp, Dept Pharm, Zhuhai, Peoples R China; [Chen, Lin; Mo, Enpan] Jinan Univ, Affiliated Hosp 1, Inst Drug Clin Trail, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Xu, J; Cai, SH (corresponding author), Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China.	goldstar_8209@163.com; csh5689@sina.com			Fund for Nurture of Scientific Innovation of Jinan University [21615432]; Medical Science and Technology Foundation of Guangdong province [201512310183971]; National Natural Science Foundation of China [81273538, 81202461]; Fund for Scientific Development and Research of Zhuhai People's Hospital	Fund for Nurture of Scientific Innovation of Jinan University; Medical Science and Technology Foundation of Guangdong province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Scientific Development and Research of Zhuhai People's Hospital	This work was supported by Fund for Nurture of Scientific Innovation of Jinan University (No. 21615432), JX, http//www.jnu.edu.cn/u2014/content.asp?newsPath=1/W_5037_77064e93cb4c47ce9f792f5740898035; Medical Science and Technology Foundation of Guangdong province (No. 201512310183971), JX, http://www.gdwskj.cn/index.html; National Natural Science Foundation of China (No. 81273538), SHC, http//ravw.nsfc.gov.cn; National Natural Science Foundation of China (No. 81202461), JX, http://wm.ristc.gov.cn; and Fund for Scientific Development and Research of Zhuhai People's Hospital (2016 No.6), SCH, http://www.zhhospitalcn/index.php.	Alexopoulos D, 2013, DIABETES CARE, V36, P2211, DOI 10.2337/dc12-2510; Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; Alexopoulos D, 2012, J AM COLL CARDIOL, V60, P193, DOI 10.1016/j.jacc.2012.03.050; Angiolillo DJ, 2014, J AM COLL CARDIOL, V63, P1500, DOI 10.1016/j.jacc.2013.11.032; Bavishi C, 2015, AM J CARDIOL, V116, P809, DOI 10.1016/j.amjcard.2015.05.058; Belchikov YG, 2013, PHARMACOTHERAPY, V33, P882, DOI 10.1002/phar.1293; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Biondi-Zoccai G, 2011, INT J CARDIOL, V150, P325, DOI 10.1016/j.ijcard.2010.08.035; Bonello L, 2014, J AM COLL CARDIOL, V63, P872, DOI 10.1016/j.jacc.2013.09.067; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Cannon CP, 2007, J AM COLL CARDIOL, V50, P1844, DOI 10.1016/j.jacc.2007.07.053; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Cattaneo M, 2014, J AM COLL CARDIOL, V63, P2503, DOI 10.1016/j.jacc.2014.03.031; Cattaneo M, 2012, THROMB HAEMOSTASIS, V108, P1031, DOI 10.1160/TH12-08-0547; Chatterjee S, 2013, J THROMB THROMBOLYS, V36, P223, DOI 10.1007/s11239-012-0838-z; Clavijo LC, 2015, CARDIOVASC REVASCULA, V16, P450, DOI 10.1016/j.carrev.2015.08.007; D'Ascenzo F, 2016, AM J CARDIOL, V117, P1714, DOI 10.1016/j.amjcard.2016.03.005; De Berardis G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4531; Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550; Hansson EC, 2014, EUR J CARDIO-THORAC, V46, P699, DOI 10.1093/ejcts/ezt662; Htun WW, 2013, EXPERT OPIN PHARMACO, V14, P237, DOI 10.1517/14656566.2013.757303; Husted S, 2009, CARDIOVASC THER, V27, P259, DOI 10.1111/j.1755-5922.2009.00096.x; James S, 2010, EUR HEART J, V31, P3006, DOI 10.1093/eurheartj/ehq325; James S, 2009, AM HEART J, V157, P599, DOI 10.1016/j.ahj.2009.01.003; Kassimis G, 2012, THROMB RES, V129, P441, DOI 10.1016/j.thromres.2011.07.022; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Laine M, 2014, THROMB HAEMOSTASIS, V111, P273, DOI 10.1160/TH13-05-0384; Lhermusier T, 2014, INT J CARDIOL, V174, P874, DOI 10.1016/j.ijcard.2014.04.208; Lhermusier T, 2015, AM J CARDIOL, V115, P716, DOI 10.1016/j.amjcard.2014.12.029; Li X, 2015, GUANGDONG MED J, V36, P1257; Liu D, 2014, CHINESE J GERONTOLOG, P2638; [孟宪丽 Meng Xianli], 2015, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V35, P1406; Motovska Z, 2016, CIRCULATION, V134, P1603, DOI 10.1161/CIRCULATIONAHA.116.024823; Pan C, 2015, ACTA U MED ANHUI, P1351; Parodi G, 2013, J AM COLL CARDIOL, V61, P1601, DOI 10.1016/j.jacc.2013.01.024; Perl L, 2015, J THROMB THROMBOLYS, V39, P1, DOI 10.1007/s11239-014-1119-9; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Springthorpe B, 2007, BIOORG MED CHEM LETT, V17, P6013, DOI 10.1016/j.bmcl.2007.07.057; Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058; Vazzana N, 2012, THROMB RES, V129, P371, DOI 10.1016/j.thromres.2011.11.052; Waksman R, 2014, J AM COLL CARDIOL, V63, pA211, DOI 10.1016/S0735-1097(14)60211-4; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yang X, 2013, CHIN J CLINICIANS EL, V7, P8696; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zhang X, 2014, CHIN J CLIN PHARM TH, P459; [张云梅 Zhang Yunmei], 2014, [中国老年学杂志, Chinese Journal of Gerontology], V34, P1450; 谷鸿秋, 2014, [中国循环杂志, Chinese Circulation Journal], V29, P147	48	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177872	10.1371/journal.pone.0177872	http://dx.doi.org/10.1371/journal.pone.0177872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545073	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700090
J	Niu, ZJ; Feng, Y; Mei, LY; Sun, J; Wang, XP; Wang, JC; Hu, ZM; Dong, YP; Chen, HS; He, CF; Liu, YL; Cai, XZ; Liu, XZ; Jiang, L				Niu, Zhijie; Feng, Yong; Mei, Lingyun; Sun, Jie; Wang, Xueping; Wang, Juncheng; Hu, Zhengmao; Dong, Yunpeng; Chen, Hongsheng; He, Chufeng; Liu, Yalan; Cai, Xinzhang; Liu, Xuezhong; Jiang, Lu			A novel frameshift mutation of SMPX causes a rare form of X-linked nonsyndromic hearing loss in a Chinese family	PLOS ONE			English	Article							DEAFNESS; PROTEIN	X-linked hearing impairment is the rarest form of genetic hearing loss (HL) and represents only a minor fraction of all cases. The aim of this study was to investigate the cause of X-linked inherited sensorineural HL in a four-generation Chinese family. A novel duplication variant (c. 217dupA, p. Ile73Asnfs* 5) in SMPX was identified by whole-exome sequencing. The frameshift mutation predicted to result in the premature truncation of the SMPX protein was co-segregated with the HL phenotype and was absent in 295 normal controls. Subpopulation screening of the coding exons and flanking introns of SMPX was further performed for 338 Chinese patients with nonsydromic HL by Sanger sequencing, and another two potential causative substitutions (c. 238C>A and c. 55A>G) in SMPX were identified in additional sporadic cases of congenital deafness. Collectively, this study is the first to report the role of SMPX in Chinese population and identify a novel frameshift mutation in SMPX that causes not only nonsyndromic late-onset progressive HL, but also congenital hearing impairment. Our findings extend the mutation and phenotypic spectrum of the SMPX gene.	[Niu, Zhijie; Feng, Yong; Mei, Lingyun; Sun, Jie; Wang, Xueping; Wang, Juncheng; Chen, Hongsheng; He, Chufeng; Liu, Yalan; Cai, Xinzhang; Liu, Xuezhong; Jiang, Lu] Cent South Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China; [Niu, Zhijie; Feng, Yong; Mei, Lingyun; Sun, Jie; Wang, Xueping; Wang, Juncheng; Chen, Hongsheng; He, Chufeng; Liu, Yalan; Cai, Xinzhang; Jiang, Lu] Key Lab Otolaryngol Major Dis Res Hunan Prov, Changsha, Hunan, Peoples R China; [Niu, Zhijie; Dong, Yunpeng; Liu, Xuezhong] Univ Miami, Miller Sch Med, Dept Otolaryngol D 48, Miami, FL 33136 USA; [Feng, Yong; Hu, Zhengmao] Cent South Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Central South University; University of Miami; Central South University	Jiang, L (corresponding author), Cent South Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China.; Jiang, L (corresponding author), Key Lab Otolaryngol Major Dis Res Hunan Prov, Changsha, Hunan, Peoples R China.	44496635@QQ.com	Niu, Zhijie/GRS-2684-2022; CAI, XINZHANG/GQZ-3111-2022	Feng, Yong/0000-0003-3824-3780; CAI, XINZHANG/0000-0003-3211-7521; Chen, Hongsheng/0000-0002-1373-6434	National 973 Basic Research Program of China [2014CB541702, 2014CB943003]; National Natural Science Foundation of China [81500803, 81470705, 81300833]; Science and Technology Projects in Hunan Province [13JJ4023]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Projects in Hunan Province	This work was supported by the National 973 Basic Research Program of China (Grant Nos. 2014CB541702 and 2014CB943003); National Natural Science Foundation of China (Grant Nos. 81500803, 81470705, and 81300833); and Science and Technology Projects in Hunan Province (Grant No. 13JJ4023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelfatah N, 2013, HUM MUTAT, V34, P66, DOI 10.1002/humu.22205; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Dobyns WB, 2006, ACTA PAEDIATR, V95, P11, DOI 10.1080/08035320600618759; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Grimsley-Myers CM, 2009, J NEUROSCI, V29, P15859, DOI 10.1523/JNEUROSCI.3998-09.2009; Huebner AK, 2011, AM J HUM GENET, V88, P621, DOI 10.1016/j.ajhg.2011.04.007; Lin X, 2012, HEARING RES, V288, P67, DOI 10.1016/j.heares.2012.01.004; Palmer S, 2001, J CELL BIOL, V153, P985, DOI 10.1083/jcb.153.5.985; Patzak D, 1999, HUM GENET, V105, P506, DOI 10.1007/s004390051138; Petersen MB, 2008, CLIN GENET, V73, P14, DOI 10.1111/j.1399-0004.2007.00913.x; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Shearer AE, 2013, J MED GENET, V50, P627, DOI 10.1136/jmedgenet-2013-101749	16	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178384	10.1371/journal.pone.0178384	http://dx.doi.org/10.1371/journal.pone.0178384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542515	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800084
J	Wang, XL; Shojaie, A; Zhang, YZ; Shelley, D; Lampe, PD; Levy, L; Peters, U; Potter, JD; White, E; Lampe, JW				Wang, Xiaoliang; Shojaie, Ali; Zhang, Yuzheng; Shelley, David; Lampe, Paul D.; Levy, Lisa; Peters, Ulrike; Potter, John D.; White, Emily; Lampe, Johanna W.			Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NF-KAPPA-B; COLORECTAL-CANCER; GENE-EXPRESSION; INFLAMMATORY MARKERS; PRECLINICAL PLASMA; NSAID USE; BIOMARKERS; PATHWAY; RISK	Long-term use of aspirin is associated with lower risk of colorectal cancer and other cancers; however, the mechanism of chemopreventive effect of aspirin is not fully understood. Animal studies suggest that COX-2, NF kappa B signaling and Wnt/beta-catenin pathways may play a role, but no clinical trials have systematically evaluated the biological response to aspirin in healthy humans. Using a high-density antibody array, we assessed the difference in plasma protein levels after 60 days of regular dose aspirin (325 mg/day) compared to placebo in a randomized double-blinded crossover trial of 44 healthy non-smoking men and women, aged 21-45 years. The plasma proteome was analyzed on an antibody microarray with similar to 3,300 full-length antibodies, printed in triplicate. Moderated paired t-tests were performed on individual antibodies, and gene-set analyses were performed based on KEGG and GO pathways. Among the 3,000 antibodies analyzed, statistically significant differences in plasma protein levels were observed for nine antibodies after adjusting for false discoveries (FDR adjusted p-value<0.1). The most significant protein was succinate dehydrogenase subunit C(SDHC), a key enzyme complex of the mitochondrial tricarboxylic acid (TCA) cycle. The other statistically significant proteins (NR2F1, MSI1, MYH1, FOXO1, KHDRBS3, NFKBIE, LYZ and IKZF1) are involved in multiple pathways, including DNA base-pair repair, inflammation and oncogenic pathways. None of the 258 KEGG and 1,139 GO pathways was found to be statistically significant after FDR adjustment. This study suggests several chemopreventive mechanisms of aspirin in humans, which have previously been reported to play a role in anti-or pro-carcinogenesis in cell systems; however, larger, confirmatory studies are needed.	[Wang, Xiaoliang; Peters, Ulrike; Potter, John D.; White, Emily; Lampe, Johanna W.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wang, Xiaoliang; Zhang, Yuzheng; Shelley, David; Lampe, Paul D.; Levy, Lisa; Peters, Ulrike; Potter, John D.; White, Emily; Lampe, Johanna W.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Shojaie, Ali] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Wang, XL (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Wang, XL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	xwang23@fredhutch.org	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Wang, Xiaoliang/0000-0001-5184-2935	National Institutes of Health [R25 CA094880, K05 CA154337, R01 CA094954]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL124050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114029] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	X. Wang received financial support from the National Institutes of Health grant R25 CA094880 (National Cancer Institute); E.White received financial support from the National Institutes of Health grant K05 CA154337 (National Cancer Institute and Office of Dietary Supplements); J. Lampe received financial support from the National Institutes of Health grant R01 CA094954. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Andersen V, 2014, ALIMENT PHARM THER, V40, P147, DOI 10.1111/apt.12807; Andersen V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-484; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Bohm J, 2017, SURGERY, V161, P808, DOI 10.1016/j.surg.2016.08.025; Bos CL, 2006, ONCOGENE, V25, P6447, DOI 10.1038/sj.onc.1209658; Buas MF, 2015, BREAST CANCER RES TR, V153, P445, DOI 10.1007/s10549-015-3554-5; Chubak J, 2015, ASPIRIN USE PREVENTI, DOI [10.1186/1471-2407-10-484, DOI 10.1186/1471-2407-10-484]; Cleary SP, 2009, GASTROENTEROLOGY, V136, P1251, DOI 10.1053/j.gastro.2008.12.050; Colebatch A, 2006, BRIT J CANCER, V95, P1239, DOI 10.1038/sj.bjc.6603421; Desideri E, 2015, CANCER LETT, V356, P217, DOI 10.1016/j.canlet.2014.02.023; Gao XR, 2009, J PHARM PHARMACOL, V61, P1505, DOI 10.1211/jpp/61.11.0010; Garrison CB, 2017, J PROTEOME RES, V16, P274, DOI 10.1021/acs.jproteome.6b00611; Goetzl EJ, 2016, FASEB J, V30, P2058, DOI 10.1096/fj.201500150R; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hayashi H, 2002, CURR BIOL, V12, P335, DOI 10.1016/S0960-9822(02)00686-3; Ikonomidis I, 1999, CIRCULATION, V100, P793, DOI 10.1161/01.CIR.100.8.793; Kambara T, 2004, GENE CHROMOSOME CANC, V40, P1, DOI 10.1002/gcc.20011; KAPLAN EH, 1954, ARCH BIOCHEM BIOPHYS, V51, P47, DOI 10.1016/0003-9861(54)90452-X; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kim H, 2005, BIOINFORMATICS, V21, P187, DOI 10.1093/bioinformatics/bth499; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kuehl GE, 2006, DRUG METAB DISPOS, V34, P199, DOI 10.1124/dmd.105.005652; Li CI, 2012, BREAST CANCER RES TR, V135, P611, DOI 10.1007/s10549-012-2204-4; Li DW, 2011, ANN SURG ONCOL, V18, P2074, DOI 10.1245/s10434-011-1567-9; Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003; Liesenfeld DB, 2016, CANCER EPIDEM BIOMAR, V25, P180, DOI 10.1158/1055-9965.EPI-15-0697; Loch CM, 2007, MOL ONCOL, V1, P313, DOI 10.1016/j.molonc.2007.08.004; Lutwak-Mann Cecilia, 1942, BIOCHEM JOUR, V36, P706; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mansouri L, 2015, J EXP MED, V212, P833, DOI 10.1084/jem.20142009; Mirus JE, 2015, CLIN CANCER RES, V21, P1764, DOI 10.1158/1078-0432.CCR-13-3474; Mirus JE, 2014, MOL CELL PROTEOMICS, V13, P3484, DOI 10.1074/mcp.M113.036517; Murff HJ, 2011, CANCER PREV RES, V4, P1799, DOI 10.1158/1940-6207.CAPR-11-0107; Nan HM, 2015, JAMA-J AM MED ASSOC, V313, P1133, DOI 10.1001/jama.2015.1815; Nan H, 2013, JNCI-J NATL CANCER I, V105, P1852, DOI 10.1093/jnci/djt331; Navarro SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117534; Navarro SL, 2011, J NUTRIGENET NUTRIGE, V4, P110, DOI 10.1159/000327782; Pan MR, 2008, CELL SIGNAL, V20, P1134, DOI 10.1016/j.cellsig.2008.02.004; Ramirez AB, 2010, CANCER BIOMARK, V8, P293, DOI 10.3233/CBM-2011-0215; Ramirez AB, 2010, MOL CELL PROTEOMICS, V9, P1449, DOI 10.1074/mcp.M900496-MCP200; Rho JH, 2016, GUT; Rho JH, 2013, J PROTEOME RES, V12, P2311, DOI 10.1021/pr4001674; Riepe MW, 1997, STROKE, V28, P2006, DOI 10.1161/01.STR.28.10.2006; Riepe MW, 1996, EXP NEUROL, V138, P15, DOI 10.1006/exnr.1996.0042; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Seufert BL, 2013, CARCINOGENESIS, V34, P79, DOI 10.1093/carcin/bgs296; Shain AH, 2015, NAT GENET, V47, P1194, DOI 10.1038/ng.3382; Slupska MM, 1996, J BACTERIOL, V178, P3885, DOI 10.1128/jb.178.13.3885-3892.1996; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Solheim S, 2003, AM J CARDIOL, V92, P843, DOI 10.1016/S0002-9149(03)00897-X; Thomas SS, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0161-6; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; van Erk MJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-5; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	63	2	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178444	10.1371/journal.pone.0178444	http://dx.doi.org/10.1371/journal.pone.0178444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542447	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800091
J	Masunaga, H; Sugimoto, Y; Magi, S; Itasaki, R; Okada-Hatakeyama, M; Kurata, H				Masunaga, Hiroyuki; Sugimoto, Yurie; Magi, Shigeyuki; Itasaki, Ryunosuke; Okada-Hatakeyama, Mariko; Kurata, Hiroyuki			Robustness analysis of the detailed kinetic model of an ErbB signaling network by using dynamic sensitivity	PLOS ONE			English	Article							SINGLE-MOLECULE ANALYSIS; SYSTEMS-BIOLOGY; BIOCHEMICAL NETWORKS; GROWTH; HEREGULIN; TOOLBOX; SURFACE; MATLAB	The ErbB receptor signaling pathway plays an important role in the regulation of cellular proliferation, survival and differentiation, and dysregulation of the pathway is linked to various types of human cancer. Mathematical models have been developed as a practical complementary approach to deciphering the complexity of ErbB receptor signaling and elucidating how the pathways discriminate between ligands to induce different cell fates. In this study, we developed a simulator to accurately calculate the dynamic sensitivity of extracellular-signal-regulated kinase (ERK) activity (ERK*) and Akt activity (Akt*), downstream of the ErbB receptors stimulated with epidermal growth factor (EGF) and heregulin (HRG). To demonstrate the feasibility of this simulator, we estimated how the reactions critically responsible for ERK* and Akt* change with time and in response to different doses of EGF and HRG, and predicted that only a small number of reactions determine ERK* and Akt*. ERK* increased steeply with increasing HRG dose until saturation, while showing a gently rising response to EGF. Akt* had a gradual wide-range response to HRG and a blunt response to EGF. Akt* was sensitive to perturbations of intracellular kinetics, while ERK* was more robust due to multiple, negative feedback loops. Overall, the simulator predicted reactions that were critically responsible for ERK* and Akt* in response to the dose of EGF and HRG, illustrated the response characteristics of ERK* and Akt*, and estimated mechanisms for generating robustness in the ErbB signaling network.	[Masunaga, Hiroyuki; Sugimoto, Yurie; Itasaki, Ryunosuke; Kurata, Hiroyuki] Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka, Japan; [Magi, Shigeyuki; Okada-Hatakeyama, Mariko] RIKEN, Ctr Integrat Med Sci IMS, Lab Integrated Cellular Syst, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Okada-Hatakeyama, Mariko] Osaka Univ, Inst Prot Res, Lab Cell Syst, Suita, Osaka, Japan; [Kurata, Hiroyuki] Kyushu Inst Technol, Biomed Informat R&D Ctr, Fukuoka, Japan	Kyushu Institute of Technology; RIKEN; Osaka University; Kyushu Institute of Technology	Kurata, H (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka, Japan.; Kurata, H (corresponding author), Kyushu Inst Technol, Biomed Informat R&D Ctr, Fukuoka, Japan.	kurata@bio.kyutech.ac.jp			Japan Society for the Promotion of Science [25280107]; Ministry of Education, Culture, Sports, Science and Technology of Japan [26119716]; JSPS KAKENHI [15KT0084]; RIKEN Epigenome and Single Cell Project	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN Epigenome and Single Cell Project	This work was supported by Grant-in-Aid for Scientific Research (B) (25280107) from Japan Society for the Promotion of Science and Grant-in-Aid for Scientific Research on Innovative Areas (26119716) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HK and JSPS KAKENHI Grant No. 15KT0084 and RIKEN Epigenome and Single Cell Project Grants to MOH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Kazuhiro Maeda for trouble shooting computational problems. This work was, in part, supported by JSPS KAKENHI Grant No.15KT0084 and RIKEN Epigenome and Single Cell Project Grants to MO-H.	Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Blinov ML, 2006, BIOSYSTEMS, V83, P136, DOI 10.1016/j.biosystems.2005.06.014; Chaouiya C, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-135; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; DICKINSON RP, 1976, J COMPUT PHYS, V21, P123, DOI 10.1016/0021-9991(76)90007-3; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Hendriks BS, 2003, J BIOL CHEM, V278, P23343, DOI 10.1074/jbc.M300477200; Hiroshima M, 2012, P NATL ACAD SCI USA, V109, P13984, DOI 10.1073/pnas.1200464109; Inoue K, 2014, BIOPROC BIOSYST ENG, V37, P1925, DOI 10.1007/s00449-014-1167-8; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kurata H, 2005, GENOME RES, V15, P590, DOI 10.1101/gr.3463705; Kurata H, 2006, PLOS COMPUT BIOL, V2, P663, DOI 10.1371/journal.pcbi.0020059; Maeda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030489; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Schmidt H, 2007, BIOINFORMATICS, V23, P646, DOI 10.1093/bioinformatics/btl668; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Teramura Y, 2006, EMBO J, V25, P4215, DOI 10.1038/sj.emboj.7601308; Thottassery JV, 2004, CANCER RES, V64, P4637, DOI 10.1158/0008-5472.CAN-03-2645; Wu WH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S17; Zi Z, 2011, IET SYST BIOL, V5, P336, DOI 10.1049/iet-syb.2011.0015	23	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178250	10.1371/journal.pone.0178250	http://dx.doi.org/10.1371/journal.pone.0178250			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542548	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500077
J	Stanik, J; Kratzsch, J; Landgraf, K; Scheuermann, K; Spielau, U; Gausche, R; Gasperikova, D; Kiess, W; Korner, A				Stanik, Juraj; Kratzsch, Juergen; Landgraf, Kathrin; Scheuermann, Kathrin; Spielau, Ulrike; Gausche, Ruth; Gasperikova, Daniela; Kiess, Wieland; Koerner, Antje			Concordance of bioactive vs. total immunoreactive serum leptin levels in children with severe early onset obesity	PLOS ONE			English	Article							ORAL DISPOSITION INDEX; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; DEFICIENCY; HUMANS; RESISTANCE; ADIPOSITY; GENE	Context Leptin secreted from adipose tissue signals peripheral energy status to the brain. Monogenic leptin deficiency results in severe early onset obesity with hyperphagia. Recently, a similar phenotype of inactivating leptin mutations but with preserved immunoreactivity and hence normal circulating immunoreactive leptin has been reported. Objective We aimed to evaluate the proportion of bioactive leptin serum levels (compared to immunoreactive leptin) as a biomarker for the screening of leptin gene mutations causing monogenic obesity. Furthermore, we aimed to compare the immunoreactive and bioactive leptin levels associations with parameters of insulin resistance and insulin secretion in obese children and adolescents. Patients and methods We measured bioactive and immunoreactive leptin levels by enzyme-linked immunosorbent assays in fasting serum samples of 70 children with severe (BMI SDS > 3) non-syndromic obesity with onset <3 years of life from our Leipzig childhood obesity cohort (n = 1204). Sanger sequencing of the leptin gene was performed in probands with proportion of bioactive/immunoreactive leptin <90%. Results The mean levels of bioactive and immunoreactive leptin were almost identical (41.1 +/- 25.2 vs. 41.1 +/- 25.4ng/mL). In three probands with the lowest bioactive leptin proportion (<90%) we did not identify mutations in the leptin gene. Compared to immunoreactive leptin, bioactive leptin showed similar and slightly better statistical associations with indices of insulin resistance in correlation and multivariate analyses. Conclusion In our sample selected for severe early onset childhood obesity, we did not identify leptin gene mutations leading to decreased proportion of bioactive leptin. Nevertheless, the bioactive leptin levels were stronger associated with selected insulin secretion/resistance indices than the immunoreactive leptin levels.	[Stanik, Juraj; Landgraf, Kathrin; Scheuermann, Kathrin; Spielau, Ulrike; Kiess, Wieland; Koerner, Antje] Univ Leipzig, Univ Hosp Children & Adolescents, Ctr Pediat Res Leipzig, Leipzig, Germany; [Stanik, Juraj] Comenius Univ, Med Fac, Dept Pediat 1, Bratislava, Slovakia; [Stanik, Juraj; Gasperikova, Daniela] Slovak Acad Sci, Inst Expt Endocrinol, Biomed Res Ctr, DIABGENE Lab, Bratislava, Slovakia; [Kratzsch, Juergen] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Landgraf, Kathrin; Scheuermann, Kathrin; Spielau, Ulrike; Kiess, Wieland; Koerner, Antje] Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Leipzig, Germany; [Gausche, Ruth] Univ Leipzig, CrescNet, Leipzig, Germany	Leipzig University; Comenius University Bratislava; Slovak Academy of Sciences; Leipzig University; Leipzig University; Leipzig University	Korner, A (corresponding author), Univ Leipzig, Univ Hosp Children & Adolescents, Ctr Pediat Res Leipzig, Leipzig, Germany.; Korner, A (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Leipzig, Germany.	antje.koerner@medizin.uni-leipzig.de	Körner, Antje/B-3988-2015; Landgraf, Kathrin/J-4937-2016; Gasperikova, Daniela/E-7824-2018; Stanik, Juraj/AAQ-6217-2021	Körner, Antje/0000-0001-6001-0356; Landgraf, Kathrin/0000-0002-6878-6033; Gasperikova, Daniela/0000-0002-5725-6424; Stanik, Juraj/0000-0002-0538-1274	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01E01001]; German Research Council (DFG) for the Clinical Research Center "Obesity Mechanisms" [CRC1052/1 C05]; LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), - European Union; European Regional Development Fund (ERFD); ESPE (European Society for Pediatric Endocrinology) Research Fellowship;  [FP7-HEALTH.2011.2.4.3-2]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); German Research Council (DFG) for the Clinical Research Center "Obesity Mechanisms"(German Research Foundation (DFG)); LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), - European Union; European Regional Development Fund (ERFD)(European Commission); ESPE (European Society for Pediatric Endocrinology) Research Fellowship; 	This work was supported by grants from the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01E01001 (IFB Adiposity Diseases), the German Research Council (DFG) for the Clinical Research Center "Obesity Mechanisms" CRC1052/1 C05, and is a collaborative project of the European FP7-HEALTH.2011.2.4.3-2 program (betaJuDOBeta-JUDO). and by the LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), funded by the European Union, by the European Regional Development Fund (ERFD) by means of the Free State of Saxony within the framework of the excellence initiative. J.S. was supported by ESPE (European Society for Pediatric Endocrinology) Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belfiore F, 1998, MOL GENET METAB, V63, P134, DOI 10.1006/mgme.1997.2658; Farooqi IS, 2014, J ENDOCRINOL, V223, pT63, DOI 10.1530/JOE-14-0480; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; Haffner SM, 1996, INT J OBESITY, V20, P904; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kratzsch J, 2002, J CLIN ENDOCR METAB, V87, P4587, DOI 10.1210/jc.2002-020001; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Landgraf K, 2012, J CLIN ENDOCR METAB, V97, pE556, DOI 10.1210/jc.2011-2937; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meier JJ, 2009, DIABETES, V58, P1595, DOI 10.2337/db08-1611; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Nowak C, 2016, DIABETES, V65, P276, DOI 10.2337/db15-0881; Paolini B, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038718; Paz G, 2015, METABOLISM, V64, P146, DOI 10.1016/j.metabol.2014.07.014; REAVEN GM, 1993, J CLIN ENDOCR METAB, V76, P44, DOI 10.1210/jc.76.1.44; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Wabitsch M, 2017, EUR J ENDOCRINOL, V176, P315, DOI 10.1530/EJE-16-0821; Wabitsch M, 2015, J CLIN ENDOCR METAB, V100, P3227, DOI 10.1210/jc.2015-2263; Wabitsch M, 2015, NEW ENGL J MED, V372, P48, DOI 10.1056/NEJMoa1406653; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178107	10.1371/journal.pone.0178107	http://dx.doi.org/10.1371/journal.pone.0178107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542631	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058800040
J	Yi, R; Stuppy-Sullivan, A; Pickover, A; Landes, RD				Yi, Richard; Stuppy-Sullivan, Allison; Pickover, Alison; Landes, Reid D.			Impact of construal level manipulations on delay discounting	PLOS ONE			English	Article							EPISODIC FUTURE THINKING; SELF-CONTROL; ACTION IDENTIFICATION; HYPOTHETICAL REWARDS; ENERGY-INTAKE; PROBABILITY; IMPULSIVITY; ALTRUISM; CHILDREN; HORIZON	Construal Level Theory states that psychologically proximal outcomes are construed concretely while psychologically distal outcomes are construed abstractly. Previous research suggests that the principles of Construal Level Theory can be applied to enhance self-control, as measured by delay discounting. The present studies replicate and expand on this work by examining whether theory-informed priming manipulations lead to delay discounting reductions in a repeated-measures design. Study 1 conceptually replicated previous work, with reduced delay discounting observed as a function of thinking abstractly. Studies 2 and 3 expanded on this work by reinterpreting (a) preference for immediate outcomes as preference for outcomes that are construed concretely, and (b) dispreference for delayed outcomes as dispreference for outcomes that are construed abstractly. Study 2 provided support for the first interpretation, as reduced delay discounting was observed as a function of thinking concretely about the future. Study 3 provided support for the second interpretation, as reduced delay discounting was observed as a function of thinking abstractly about the present. In studies 1 and 3, significant condition x order interactions were observed. In all three studies, the same impact of order of exposure to priming manipulation was observed, indicating specific carryover effects.	[Yi, Richard] Univ Florida, Dept Hlth Educ & Behav, Gainesville, FL 32611 USA; [Stuppy-Sullivan, Allison] Yale Univ, Dept Psychol, New Haven, CT USA; [Pickover, Alison] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; [Landes, Reid D.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA	State University System of Florida; University of Florida; Yale University; University of Memphis; University of Arkansas System; University of Arkansas Medical Sciences	Yi, R (corresponding author), Univ Florida, Dept Hlth Educ & Behav, Gainesville, FL 32611 USA.	ryi1@ufl.edu		Yi, Richard/0000-0002-1873-7874	NIDA [R01 DA 11692]	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This study was supported by NIDA grant R01 DA 11692. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes J, 2013, LEGAL CRIMINOL PSYCH, V18, P240, DOI 10.1111/j.2044-8333.2012.02052.x; Audrain-McGovern J, 2009, DRUG ALCOHOL DEPEN, V103, P99, DOI 10.1016/j.drugalcdep.2008.12.019; Bickel WK, 2012, PHARMACOL THERAPEUT, V134, P287, DOI 10.1016/j.pharmthera.2012.02.004; Chesson HW, 2006, J RISK UNCERTAINTY, V32, P217, DOI 10.1007/s11166-006-9520-1; Daniel TO, 2015, EAT BEHAV, V18, P20, DOI 10.1016/j.eatbeh.2015.03.006; Daniel TO, 2013, APPETITE, V71, P120, DOI 10.1016/j.appet.2013.07.010; Daniel TO, 2013, PSYCHOL SCI, V24, P2339, DOI 10.1177/0956797613488780; Du WJ, 2002, PSYCHOL REC, V52, P479, DOI 10.1007/BF03395199; Freitas AL, 2004, J EXP SOC PSYCHOL, V40, P739, DOI 10.1016/j.jesp.2004.04.003; Fujita K, 2006, J PERS SOC PSYCHOL, V90, P351, DOI 10.1037/0022-3514.90.3.351; Fujita K, 2008, SOC PERSONAL PSYCHOL, V2, P1475, DOI 10.1111/j.1751-9004.2008.00118.x; Fujita K, 2009, PSYCHOL SCI, V20, P799, DOI 10.1111/j.1467-9280.2009.02372.x; Johnson MW, 2008, EXP CLIN PSYCHOPHARM, V16, P264, DOI 10.1037/1064-1297.16.3.264; Jones BA, 2009, J EXP ANAL BEHAV, V91, P61, DOI 10.1901/jeab.2009.91-61; Kamin L. J., 1969, PUNISHMENT AVERSIVE, P279, DOI DOI 10.2105/AJPH.2006.090910; Kowal BP, 2007, BEHAV PROCESS, V75, P231, DOI 10.1016/j.beproc.2007.02.005; Liberman N, 2008, SCIENCE, V322, P1201, DOI 10.1126/science.1161958; Lin H, 2014, BEHAV NEUROSCI, V128, P12, DOI 10.1037/a0035705; MacKillop J, 2009, DRUG ALCOHOL DEPEN, V104, P197, DOI 10.1016/j.drugalcdep.2009.04.020; Madden GJ, 2003, EXP CLIN PSYCHOPHARM, V11, P139, DOI 10.1037/1064-1297.11.2.139; Malkoc SA, 2006, J MARKETING RES, V43, P618, DOI 10.1509/jmkr.43.4.618; Malkoc SA, 2010, ORGAN BEHAV HUM DEC, V113, P112, DOI 10.1016/j.obhdp.2010.07.003; Matusiewicz AK, 2013, BEHAV PROCESS, V100, P116, DOI 10.1016/j.beproc.2013.07.019; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Moore SC, 2010, PSYCHIAT RES, V179, P324, DOI 10.1016/j.psychres.2008.07.024; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Rachlin H, 2002, BEHAV BRAIN SCI, V25, P239, DOI 10.1017/S0140525X02000055; Rachlin H, 2011, BEHAV PROCESS, V87, P25, DOI 10.1016/j.beproc.2010.12.004; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Schmeichel BJ, 2011, SOC PSYCHOL PERS SCI, V2, P182, DOI 10.1177/1948550610385955; Sheffer C, 2012, AM J ADDICTION, V21, P221, DOI 10.1111/j.1521-0391.2012.00224.x; Stanger C, 2013, PSYCHOL ADDICT BEHAV, V27, P403, DOI 10.1037/a0028748; Stein JS, 2016, PSYCHOPHARMACOLOGY, V233, P3771, DOI 10.1007/s00213-016-4410-y; Stein JS, 2015, DRUG ALCOHOL DEPEN, V153, pe212; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; VALLACHER RR, 1987, PSYCHOL REV, V94, P3, DOI 10.1037/0033-295X.94.1.3; VALLACHER RR, 1989, J PERS SOC PSYCHOL, V57, P660, DOI 10.1037/0022-3514.57.4.660; Yi R., 2010, IMPULSIVITY BEHAV NE, P191, DOI DOI 10.1037/12069-007; Yi R, 2016, J EXP SOC PSYCHOL, V65, P74, DOI 10.1016/j.jesp.2016.03.005; Yi R, 2012, BEHAV PHARMACOL, V23, P358, DOI 10.1097/FBP.0b013e3283564e11	43	13	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177240	10.1371/journal.pone.0177240	http://dx.doi.org/10.1371/journal.pone.0177240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UE	28542259	gold, Green Submitted, Green Published			2022-12-27	WOS:000402058800012
J	Peach, T; Pollock, K; van der Wardt, V; das Nair, R; Logan, P; Harwood, RH				Peach, Tamsin; Pollock, Kristian; van der Wardt, Veronika; das Nair, Roshan; Logan, Pip; Harwood, Rowan H.			Attitudes of older people with mild dementia and mild cognitive impairment and their relatives about falls risk and prevention: A qualitative study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ADULTS; EXERCISE; INTERVENTIONS; METAANALYSIS; COMMUNITY; VIEWS; AGE; CAREGIVERS; TRIAL	Objective To explore the perceptions of older people with mild dementia and mild cognitive impairment, and their family carers, about falling, falls risk and the acceptability of falls prevention interventions. Design Qualitative study involving thematic analysis of semi-structured interviews with patient and relative dyads. Participants and setting 20 patient/relative dyads recruited from Memory Assessment Services and Falls Prevention Services in the United Kingdom. Results The findings are presented under four key themes: attitudes to falls, attitudes to falls prevention interventions, barriers and facilitators, and the role of relatives. Participants' attitudes to falls interventions were varied and sometimes conflicting. Some worried about falls, but many resisted identifying themselves as potential `fallers', even despite having fallen, and rejected the idea of needing the help that structured interventions signify. Participants preferred to focus on coping in the present rather than anticipating, and preparing for, an uncertain future. Falls prevention interventions were acknowledged to be valuable in principle and if required in the future but often felt to be not necessary or appropriate at present. Conclusions This study of how persons with cognitive impairment, and their relatives, view falls risk and prevention mirror findings relating to the wider population of older persons without dementia. Participants did not generally see falls prevention interventions as currently relevant to themselves. The challenge for clinicians is how to present interventions with understanding and respect for the older person's identity. They must identify and address goals that patients and relatives value. Simplistic or paternalistic approaches will likely fail. Individualised interventions which focus on maintaining independence and preserving quality of life are more likely to be acceptable by supporting a positive self-image for patients and their relatives.	[Peach, Tamsin] Nottingham CityCare Partnership, Nottingham, England; [Pollock, Kristian] Univ Nottingham, Sch Hlth Sci, Queens Med Ctr, Nottingham, England; [van der Wardt, Veronika; Logan, Pip; Harwood, Rowan H.] Univ Nottingham, Sch Med, Div Rehabil & Ageing, Nottingham, England; [das Nair, Roshan] Univ Nottingham, Sch Med, Div Psychiat & Appl Psychol, Nottingham, England; [Harwood, Rowan H.] Nottingham Univ Hosp NHS Trust, Hlth Care Older People, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust	Pollock, K (corresponding author), Univ Nottingham, Sch Hlth Sci, Queens Med Ctr, Nottingham, England.	kitstian.pollock@nottingham.ac.uk	Pollock, Kristian/B-9734-2008; van der Wardt, Veronika/ABF-3836-2021	Pollock, Kristian/0000-0002-6836-8595; van der Wardt, Veronika/0000-0003-3995-7056; das Nair, Roshan/0000-0001-8143-7893; Harwood, Rowan/0000-0002-4920-6718; Logan, Philippa/0000-0002-6657-2381	National Institute for Health Research (NIHR) under its Programme Development Grant Programme [RP-DG-0611-10013]; National Institute for Health Research [RP-PG-0614-20007, RP-DG-0611-10013] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Development Grant Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Development Grant Programme (Reference Number RP-DG-0611-10013), https://www.nihr.ac.uk/funding-and-support/. Principal Investigator: Rowan Harwood. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; Bazeley P., 2013, QUALITATIVE DATA ANA, V2nd; Beuscher L, 2009, RES GERONTOL NURS, V2, P6, DOI 10.3928/19404921-20090101-04; Blankevoort CG, 2010, DEMENT GERIATR COGN, V30, P392, DOI 10.1159/000321357; Burt RS, 2005, BROKERAGE CLOSURE IN; Burton E, 2013, PREV MED, V57, P824; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Cornwell J., 1985, HARD EARNED LIVES AC; Cox KL, 2013, PREV MED, V57, P824, DOI 10.1016/j.ypmed.2013.09.010; de Witt L, 2010, J ADV NURS, V66, P1698, DOI 10.1111/j.1365-2648.2010.05295.x; Delbaere K, 2012, AM J GERIAT PSYCHIAT, V20, P845, DOI 10.1097/JGP.0b013e31824afbc4; Dickinson A, 2011, AGE AGEING, V40, P724, DOI 10.1093/ageing/afr111; Dickinson Angela, 2011, Br J Community Nurs, V16, P174; Dollard J, 2012, J CLIN NURS, V21, P2617, DOI 10.1111/j.1365-2702.2011.03990.x; Ellingson T, 2000, J Gerontol Nurs, V26, P17; Faes MC, 2010, AGING MENT HEALTH, V14, P834, DOI 10.1080/13607861003781825; Fairhall N, 2011, AGE AGEING, V40, P666, DOI 10.1093/ageing/afr077; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Harlein J, 2009, J ADV NURS, V65, P922, DOI 10.1111/j.1365-2648.2008.04950.x; Hanson HM, 2009, DISABIL HEALTH J, V2, P36, DOI 10.1016/j.dhjo.2008.11.001; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hill AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063450; Horne M, 2014, CLIN NURS RES, V23, P94, DOI 10.1177/1054773813488938; Kearney FC, 2013, DEMENT GERIATR COGN, V36, P20, DOI 10.1159/000350031; Knapp M, 2007, DEMENTIA UK; Kuzuya M, 2006, INT J GERIATR PSYCH, V21, P740, DOI 10.1002/gps.1554; Logsdon RG, 2009, GERONTOLOGIST, V49, DOI 10.1093/geront/gnp082; Malthouse R, 2014, PHYSIOTHERAPY, V100, P169, DOI 10.1016/j.physio.2013.10.002; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; Mcintyre A, 2012, AGEING SOC, V32, P873, DOI 10.1017/S0144686X11000699; Meyer C, 2015, GERONTOLOGIST, V55, P560, DOI 10.1093/geront/gnt127; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NICE,, 2013, FALLS OLD PEOPL ASS; Nicholson C, 2012, SOC SCI MED, V75, P1426, DOI 10.1016/j.socscimed.2012.06.011; Nyman SR, 2012, AGE AGEING, V41, P16, DOI 10.1093/ageing/afr103; Olsson Roy H Jr, 2005, J Gerontol Nurs, V31, P45; Robertson MC, 2001, BRIT MED J, V322, P701, DOI 10.1136/bmj.322.7288.701; Rothman AJ, 1997, PSYCHOL BULL, V121, P3, DOI 10.1037/0033-2909.121.1.3; Royal College of Physicians, 2011, REP NAT AUD FALLS BO; Shaw FE, 2007, J NEURAL TRANSM, V114, P1259, DOI 10.1007/s00702-007-0741-5; Taylor JS, 2012, J AM GERIATR SOC, V60, P413, DOI 10.1111/j.1532-5415.2011.03847.x; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Vogel DL, 2009, PSYCHOLOGIST, V22, P20; Walker Wendy, 2011, Nurs Older People, V23, P21; Weiss D, 2012, PSYCHOL AGING, V27, P173, DOI 10.1037/a0024819; WHO, 2007, WHO GLOB REP FALLP; Womens Royal Voluntary Service, 2012, FALLS MEAS IMP OLD P; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yardley L, 2006, HEALTH EDUC RES, V21, P508, DOI 10.1093/her/cyh077; Yardley L, 2006, GERONTOLOGIST, V46, P650, DOI 10.1093/geront/46.5.650	52	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177530	10.1371/journal.pone.0177530	http://dx.doi.org/10.1371/journal.pone.0177530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PW	28542315	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672600014
J	Dondzilo, L; Rieger, E; Palermo, R; Byrne, S; Bell, J				Dondzilo, Laura; Rieger, Elizabeth; Palermo, Romina; Byrne, Susan; Bell, Jason			The mediating role of rumination in the relation between attentional bias towards thin female bodies and eating disorder symptomatology	PLOS ONE			English	Article							COGNITIVE-BEHAVIOR THERAPY; ANOREXIA-NERVOSA; BODY DISSATISFACTION; SCHEMATIC MODELS; SHAPE; EXPOSURE; WEIGHT; IMAGES; WOMEN; ATTRACTIVENESS	The present study sought to investigate the association between selective attentional processing of body images, rumination, and eating disorder symptoms in young women. Seventy-three undergraduate female students (ages 17-24) completed a modified dot-probe task to assess whether young women showed a differential attentional bias pattern towards thin and non-thin female bodies. Participants also completed self-report measures of eating disorder pathology. It was found that increased reports of dietary restraint and body dissatisfaction were associated with both greater attentional bias towards thin bodies and avoidance of non-thin bodies (as compared to neutral images), although the former relationship was stronger than the latter. The results suggest attentional vigilance to thin-ideal images plays a greater role in the potential development and/or maintenance of eating disorder symptoms, at least in a university sample of young women. Results also revealed that eating disorder-specific rumination mediated the relationship between attentional bias to thin ideal images and eating disorder symptoms. These findings build on existing research and theories, for example the impaired disengagement model of rumination, and have potential clinical applications such as specifically targeting ruminative and/or attentional processes in the prevention and/or treatment of eating disorder symptoms.	[Dondzilo, Laura; Palermo, Romina; Byrne, Susan; Bell, Jason] Univ Western Australia, Sch Psychol Sci, Perth, WA, Australia; [Dondzilo, Laura; Palermo, Romina; Bell, Jason] Macquarie Univ, ARC Ctr Excellence Cognit & its Disorders, Sydney, NSW, Australia; [Rieger, Elizabeth] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia	University of Western Australia; Macquarie University; Australian National University	Dondzilo, L (corresponding author), Univ Western Australia, Sch Psychol Sci, Perth, WA, Australia.; Dondzilo, L (corresponding author), Macquarie Univ, ARC Ctr Excellence Cognit & its Disorders, Sydney, NSW, Australia.	laura.dondzilo@research.uwa.edu.au	Palermo, Romina/G-2533-2014; Rieger, Elizabeth/ABE-7589-2020	Palermo, Romina/0000-0002-8678-4592; Dondzilo, Laura/0000-0003-3714-2662; Bell, Jason/0000-0002-1583-5292				Allison DB, 1992, PSYCHOL ASSESSMENT, V4, P391, DOI DOI 10.1037/1040-3590.4.3.391; Blechert J, 2009, PSYCHOSOM MED, V71, P907, DOI 10.1097/PSY.0b013e3181b4434d; Bradley BP, 1999, BRIT J CLIN PSYCHOL, V38, P267, DOI 10.1348/014466599162845; Carters MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137821; Cho A, 2013, BODY IMAGE, V10, P95, DOI 10.1016/j.bodyim.2012.09.005; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; Covin R, 2008, J ANXIETY DISORD, V22, P108, DOI 10.1016/j.janxdis.2007.01.002; Cowdrey FA, 2013, EUR EAT DISORD REV, V21, P411, DOI 10.1002/erv.2236; Cowdrey FA, 2012, EAT BEHAV, V13, P100, DOI 10.1016/j.eatbeh.2012.01.001; Cowdrey FA, 2011, EAT BEHAV, V12, P321, DOI 10.1016/j.eatbeh.2011.08.001; Donaldson C, 2007, BEHAV RES THER, V45, P2664, DOI 10.1016/j.brat.2007.07.002; Dondzilo L., 2016, ADV EATING DISORDERS, V4, P84, DOI [10.1080/21662630.2015.1118642, DOI 10.1080/21662630.2015.1118642]; Etu SF, 2010, BODY IMAGE, V7, P82, DOI 10.1016/j.bodyim.2009.09.004; Fairburn CG, 2003, BEHAV RES THER, V41, P509, DOI 10.1016/S0005-7967(02)00088-8; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Foster C, 2010, J BEHAV THER EXP PSY, V41, P45, DOI 10.1016/j.jbtep.2009.09.001; FREEMAN R, 1991, INT J EAT DISORDER, V10, P709, DOI 10.1002/1098-108X(199111)10:6&lt;709::AID-EAT2260100609&gt;3.0.CO;2-N; GLAUERT R, 2009, INT J EAT DISORD; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Grafton B, 2016, EMOTION, V16, P63, DOI 10.1037/emo0000103; Janelle C M, 2003, Eat Weight Disord, V8, P138; Jansen A, 2005, BEHAV RES THER, V43, P183, DOI 10.1016/j.brat.2004.01.003; Jansen A, 2016, J BEHAV THER EXP PSY, V50, P90, DOI 10.1016/j.jbtep.2015.06.002; Johansson L, 2005, PERS INDIV DIFFER, V38, P723, DOI 10.1016/j.paid.2004.05.026; Joormann J, 2006, BEHAV THER, V37, P269, DOI 10.1016/j.beth.2006.01.002; Joseph C, 2016, BODY IMAGE, V19, P216, DOI 10.1016/j.bodyim.2016.10.006; Koster EHW, 2011, CLIN PSYCHOL REV, V31, P138, DOI 10.1016/j.cpr.2010.08.005; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang P.J., 2008, A8 U FLOR; Lee Preacher, 2013, CALCULATION TEST DIF; MACLEOD C, 1988, Q J EXP PSYCHOL-A, V40, P653, DOI 10.1080/14640748808402292; Morrison R, 2008, BRIT J PSYCHOL, V99, P191, DOI 10.1348/000712607X216080; Moussally JM, 2016, BODY IMAGE, V19, P159, DOI 10.1016/j.bodyim.2016.09.006; Park RJ, 2012, INT J COGN THER, V5, P86, DOI 10.1521/ijct.2012.5.1.86; Park RJ, 2011, INT J COGN THER, V4, P415, DOI 10.1521/ijct.2011.4.4.415; Pinhas L, 2014, PSYCHIAT RES, V220, P519, DOI 10.1016/j.psychres.2014.08.006; Posavac HD, 1998, SEX ROLES, V38, P187, DOI 10.1023/A:1018729015490; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Roefs A, 2008, APPETITE, V51, P552, DOI 10.1016/j.appet.2008.04.008; Rosen JC, 1996, INT J EAT DISORDER, V20, P315, DOI 10.1002/(SICI)1098-108X(199611)20:3<315::AID-EAT11>3.0.CO;2-Z; Schmitz C, 2012, LIMESURVEY OPEN SOUR; Shafran R, 2007, INT J EAT DISORDER, V40, P369, DOI 10.1002/eat.20375; Smeets E, 2011, HEALTH PSYCHOL, V30, P360, DOI 10.1037/a0022095; Smith E, 2006, INT J EAT DISORDER, V39, P509, DOI 10.1002/eat.20291; Smith E, 2010, INT J EAT DISORDER, V43, P358, DOI 10.1002/eat.20703; Smith E, 2009, EUR EAT DISORD REV, V17, P169, DOI 10.1002/erv.921; Stice E, 2001, J SOC CLIN PSYCHOL, V20, P270, DOI 10.1521/jscp.20.3.270.22309; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; VITOUSEK KB, 1990, COGNITIVE THER RES, V14, P191, DOI 10.1007/BF01176209; Warschburger P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140813; Watkins E, 2007, BEHAV RES THER, V45, P2144, DOI 10.1016/j.brat.2006.09.018; Williamson DA, 1999, BEHAV MODIF, V23, P556, DOI 10.1177/0145445599234003	54	28	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177870	10.1371/journal.pone.0177870	http://dx.doi.org/10.1371/journal.pone.0177870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542431	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400105
J	Liao, PC; Tandarich, LC; Hollenbeck, PJ				Liao, Pin-Chao; Tandarich, Lauren C.; Hollenbeck, Peter J.			ROS regulation of axonal mitochondrial transport is mediated by Ca2+ and JNK in Drosophila	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; OXIDATIVE STRESS; REACTIVE OXYGEN; SCAFFOLD PROTEIN; NOX ENZYMES; CALCIUM; MOTOR; ACTIVATION; APOPTOSIS; CHANNEL	Mitochondria perform critical functions including aerobic ATP production and calcium (Ca2+) homeostasis, but are also a major source of reactive oxygen species (ROS) production. To maintain cellular function and survival in neurons, mitochondria are transported along axons, and accumulate in regions with high demand for their functions. Oxidative stress and abnormal mitochondrial axonal transport are associated with neurodegenerative disorders. However, we know little about the connection between these two. Using the Drosophila third instar larval nervous system as the in vivo model, we found that ROS inhibited mitochondrial axonal transport more specifically, primarily due to reduced flux and velocity, but did not affect transport of other organelles. To understand the mechanisms underlying these effects, we examined Ca2+ levels and the JNK (c-Jun N-terminal Kinase) pathway, which have been shown to regulate mitochondrial transport and general fast axonal transport, respectively. We found that elevated ROS increased Ca2+ levels, and that experimental reduction of Ca2+ to physiological levels rescued ROS-induced defects in mitochondrial transport in primary neuron cell cultures. In addition, in vivo activation of the JNK pathway reduced mitochondrial flux and velocities, while JNK knockdown partially rescued ROS-induced defects in the anterograde direction. We conclude that ROS have the capacity to regulate mitochondrial traffic, and that Ca2+ and JNK signaling play roles in mediating these effects. In addition to transport defects, ROS produces imbalances in mitochondrial fission-fusion and metabolic state, indicating that mitochondrial transport, fission-fusion steady state, and metabolic state are closely interrelated in the response to ROS.	[Liao, Pin-Chao; Tandarich, Lauren C.; Hollenbeck, Peter J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hollenbeck, PJ (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	phollenb@purdue.edu	Liao, Pin-chao/Z-2825-2019	Liao, Pin-Chao/0000-0002-1969-5565	National Institutes of Health; National Institute of Neurological Disorders and Stroke [5 R01 NS027073]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke grant: 5 R01 NS027073. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2008, FASEB J, V22, P2821, DOI 10.1096/fj.07-104224; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YM, 2013, J CELL BIOL, V202, P351, DOI 10.1083/jcb.201302040; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Devireddy S, 2015, J NEUROSCI, V35, P9391, DOI 10.1523/JNEUROSCI.1198-15.2015; Devireddy S, 2014, METHOD ENZYMOL, V547, P131, DOI 10.1016/B978-0-12-801415-8.00008-4; Elia AJ, 1999, FREE RADICAL BIO MED, V26, P1332, DOI 10.1016/S0891-5849(98)00333-5; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; Fang C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-29; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Fischer LR, 2010, ACTA NEUROPATHOL, V119, P249, DOI 10.1007/s00401-009-0631-z; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Grupe M, 2010, CELL CALCIUM, V48, P1, DOI 10.1016/j.ceca.2010.05.005; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Horiuchi D, 2005, CURR BIOL, V15, P2137, DOI 10.1016/j.cub.2005.10.047; Huang Y, 2014, MOL CELL BIOCHEM, V394, P1, DOI 10.1007/s11010-014-2073-8; Hudasek K, 2004, BIOCHEM BIOPH RES CO, V318, P135, DOI 10.1016/j.bbrc.2004.04.011; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Kim J, 2004, TOXICOL SCI, V81, P518, DOI 10.1093/toxsci/kfh221; Kim-Han JS, 2011, J NEUROSCI, V31, P7212, DOI 10.1523/JNEUROSCI.0711-11.2011; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Nagao M, 1999, ONCOGENE, V18, P4425, DOI 10.1038/sj.onc.1202832; Nayernia Z, 2014, ANTIOXID REDOX SIGN, V20, P2815, DOI 10.1089/ars.2013.5703; Nguyen TT, 2014, P NATL ACAD SCI USA, V111, pE3631, DOI 10.1073/pnas.1402449111; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Sato T, 2015, CELL DEATH DIFFER, V22, P1260, DOI 10.1038/cdd.2014.207; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Shidara Y, 2010, J NEUROSCI, V30, P11369, DOI 10.1523/JNEUROSCI.0529-10.2010; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1; Song W, 2012, NEUROBIOL DIS; Stephen TL, 2015, J NEUROSCI, V35, P15996, DOI 10.1523/JNEUROSCI.2068-15.2015; Tabet F, 2004, J CARDIOVASC PHARM, V44, P200, DOI 10.1097/00005344-200408000-00009; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18981; Zhang YY, 2015, BIOCHEM BIOPH RES CO, V456, P926, DOI 10.1016/j.bbrc.2014.12.036	66	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178105	10.1371/journal.pone.0178105	http://dx.doi.org/10.1371/journal.pone.0178105			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542430	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400142
J	Lowgren, K; Baath, R; Rasmussen, A; Boele, HJ; Koekkoek, SKE; De Zeeuw, CI; Hesslow, G				Lowgren, Karolina; Baath, Rasmus; Rasmussen, Anders; Boele, Henk-Jan; Koekkoek, Sebastiaan K. E.; De Zeeuw, Chris I.; Hesslow, Germund			Performance in eyeblink conditioning is age and sex dependent	PLOS ONE			English	Article							CEREBELLAR CORTEX; CHILDREN; DELAY; TRACE; LANGUAGE; ACQUISITION; INVOLVEMENT; ONTOGENY; PARALLEL; LESIONS	A growing body of evidence suggests that the cerebellum is involved in both cognition and language. Abnormal cerebellar development may contribute to neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD), autism, fetal alcohol syndrome, dyslexia, and specific language impairment. Performance in eyeblink conditioning, which depends on the cerebellum, can potentially be used to clarify the neural mechanisms underlying the cerebellar dysfunction in disorders like these. However, we must first understand how the performance develops in children who do not have a disorder. In this study we assessed the performance in eyeblink conditioning in 42 typically developing children between 6 and 11 years old as well as in 26 adults. Older children produced more conditioned eyeblink responses than younger children and adults produced more than children. In addition, females produced more conditioned eyeblink responses than males among both children and adults. These results highlight the importance of considering the influence of age and sex on the performance when studying eyeblink conditioning as a measure of cerebellar development.	[Lowgren, Karolina] Lund Univ, Dept Clin Sci, Lund, Sweden; [Baath, Rasmus] Lund Univ, Dept Philosophy, Cognit Sci, Lund, Sweden; [Rasmussen, Anders; Boele, Henk-Jan; Koekkoek, Sebastiaan K. E.; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [De Zeeuw, Chris I.] Royal Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Hesslow, Germund] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University; Lund University; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Lund University	Lowgren, K (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	karolina.lowgren@med.lu.se	Boele, Henk-Jan/AAI-7261-2021; Rasmussen, Anders/D-6157-2014; Boele, Henk-Jan/AAK-3836-2021	Boele, Henk-Jan/0000-0001-8449-4391; Rasmussen, Anders/0000-0003-4477-369X; Lowgren, Karolina/0000-0002-2791-8239	Swedish Research Council [349-2007-8695, 09899, 201500276]; Soderberg; Krapperup; Ahlen foundations; European Research Council (ERC-adv); Dutch Council for Medical Research; Fundamental Research; EMBO [ALTF 88-2015]; European commission [GA-2013-609409]; Marie-Curie Actions	Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg; Krapperup; Ahlen foundations; European Research Council (ERC-adv); Dutch Council for Medical Research; Fundamental Research; EMBO(European Molecular Biology Organization (EMBO)); European commission(European CommissionEuropean Commission Joint Research Centre); Marie-Curie Actions(European Commission)	We gratefully acknowledge the support from the Linnaeus centre Thinking in Time: Cognition, Communication and Learning at Lund University, financed by the Swedish Research Council (grant no. 349-2007-8695) (https.//www.vr.se/). G. Hesslow was supported by grants from the Soderberg, Krapperup and Ahlen foundations, and the Swedish Research Council (09899). C. De Zeeuw was supported by grants from the European Research Council (ERC-adv), Dutch Council for Medical Research (ZonMw), and Fundamental Research (NWO-MaGW and NWO-ALW). A. Rasmussen was supported by grants from the EMBO (ALTF 88-2015), the European commission (LTFCOFUND2013, GA-2013-609409), Marie-Curie Actions, and the Swedish Research Council (201500276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton RA, 2014, CURR BIOL, V24, P2440, DOI 10.1016/j.cub.2014.08.056; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Cheng DT, 2014, HUM BRAIN MAPP, V35, P1390, DOI 10.1002/hbm.22261; Coffin JM, 2005, CORTEX, V41, P389, DOI 10.1016/S0010-9452(08)70275-2; Dalla C, 2009, PHYSIOL BEHAV, V97, P229, DOI 10.1016/j.physbeh.2009.02.035; DAUM I, 1993, BEHAV NEUROSCI, V107, P748, DOI 10.1037/0735-7044.107.5.748; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; De Smet HJ, 2007, FOLIA PHONIATR LOGO, V59, P165, DOI 10.1159/000102927; Desmond JE, 1998, TRENDS COGN SCI, V2, P355, DOI 10.1016/S1364-6613(98)01211-X; Dimitrova A, 2008, BRAIN RES, V1198, P73, DOI 10.1016/j.brainres.2008.01.034; Durston S., 2002, DEV DISABIL RES REV, V9, P184; Fatemi SH, 2013, CEREBELLUM, V12, P778, DOI 10.1007/s12311-013-0484-9; FINKBINER RG, 1991, PSYCHOL AGING, V6, P109, DOI 10.1037/0882-7974.6.1.109; Flatters I, 2014, PLOS ONE, V9, P1; Frings M, 2010, EXP BRAIN RES, V201, P167, DOI 10.1007/s00221-009-2020-1; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Green JT, 2002, LEARN MEMORY, V9, P304, DOI 10.1101/lm.47602; Haar S, 2014, CEREB CORTEX; Hardiman MJ, 2013, BRAIN LANG, V127, P428, DOI 10.1016/j.bandl.2013.08.001; Herbert JS, 2003, BEHAV NEUROSCI, V117, P1196, DOI 10.1037/0735-7044.117.6.1196; Hesslow Germund, 2002, P86; Highnam CL, 2011, AM J SPEECH-LANG PAT, V20, P337, DOI 10.1044/1058-0360(2011/10-0096); Hodes GE, 2005, HORM BEHAV, V48, P163, DOI 10.1016/j.yhbeh.2005.02.008; Hodge SM, 2010, J AUTISM DEV DISORD, V40, P300, DOI 10.1007/s10803-009-0872-7; Ivkovich D, 2000, DEV PSYCHOBIOL, V36, P148, DOI 10.1002/(SICI)1098-2302(200003)36:2<148::AID-DEV6>3.0.CO;2-L; Ivry R B, 1992, Curr Opin Neurobiol, V2, P212, DOI 10.1016/0959-4388(92)90015-D; Jacobson SW, 2008, ALCOHOL CLIN EXP RES, V32, P365, DOI 10.1111/j.1530-0277.2007.00585.x; Jacobson SW, 2011, ALCOHOL CLIN EXP RES, V35, P250, DOI 10.1111/j.1530-0277.2010.01341.x; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koekkoek SKE, 2002, J NEUROPHYSIOL, V88, P2124, DOI 10.1152/jn.2002.88.4.2124; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MCCORMICK DA, 1982, P NATL ACAD SCI-BIOL, V79, P2731, DOI 10.1073/pnas.79.8.2731; Nanova P, 2008, CLIN NEUROPHYSIOL, V119, P1992, DOI 10.1016/j.clinph.2008.05.002; Nicolson RI, 2002, EXP BRAIN RES, V143, P42, DOI 10.1007/s00221-001-0969-5; Oristaglio J, 2013, NEUROSCIENCE, V248, P708, DOI 10.1016/j.neuroscience.2013.06.007; Paquier PF, 2005, APHASIOLOGY, V19, P3, DOI 10.1080/02687030444000615; Parker KL, 2012, CEREBELLUM, V11, P946, DOI 10.1007/s12311-012-0377-3; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Radell M, 2014, COGN AFFECT BEHAV NE, V14, P1142, DOI 10.3758/s13415-014-0263-1; Ramtekkar UP, 2010, J AM ACAD CHILD PSY, V49, P217, DOI 10.1016/j.jaac.2009.11.011; Raven J., 2008, MANUAL FOR COLOURED; Reeb-Sutherland BC, 2015, J AUTISM DEV DISORD, V45, P376, DOI 10.1007/s10803-013-1905-9; Ross LA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00185; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; SEARS LL, 1994, J AUTISM DEV DISORD, V24, P737, DOI 10.1007/BF02172283; SOLOMON PR, 1989, PSYCHOL AGING, V4, P34, DOI 10.1037/0882-7974.4.1.34; Steinmetz AB, 2010, J NEURODEV DISORD, V2, P243, DOI 10.1007/s11689-010-9058-z; Steinmetz JE, 2000, BEHAV BRAIN RES, V110, P13, DOI 10.1016/S0166-4328(99)00181-3; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Stoodley CJ, 2013, CEREBELLUM, V12, P267, DOI 10.1007/s12311-012-0407-1; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Sugiyama T, 2008, INT J PSYCHOPHYSIOL, V69, P232, DOI 10.1016/j.ijpsycho.2008.05.094; Thurling M, 2015, J NEUROSCI, V35, P1228, DOI 10.1523/JNEUROSCI.2492-14.2015; Timmann D, 2005, EXP BRAIN RES, V162, P332, DOI 10.1007/s00221-004-2181-x; Wang SSH, 2014, NEURON, V83, P518, DOI 10.1016/j.neuron.2014.07.016; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; Wolf OT, 2009, NEUROBIOL LEARN MEM, V91, P431, DOI 10.1016/j.nlm.2008.11.002; WOODRUFFPAK DS, 1988, PSYCHOL AGING, V3, P219, DOI 10.1037/0882-7974.3.3.219; WOODRUFFPAK DS, 1988, NEUROBIOL AGING, V9, P511, DOI 10.1016/S0197-4580(88)80108-8; Wu KH, 2011, PEDIATR RES, V69, P80, DOI 10.1203/PDR.0b013e3181ff2f6c; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4; YEO CH, 1984, BEHAV BRAIN RES, V13, P261, DOI 10.1016/0166-4328(84)90168-2	64	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177849	10.1371/journal.pone.0177849	http://dx.doi.org/10.1371/journal.pone.0177849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542383	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400100
J	Tang, XJ; Zhao, S; Chiu, APY; Ma, HW; Xie, X; Mei, SJ; Kong, DF; Qin, YM; Chen, ZG; Wang, X; He, DH				Tang, Xiujuan; Zhao, Shi; Chiu, Alice P. Y.; Ma, Hanwu; Xie, Xu; Mei, Shujiang; Kong, Dongfeng; Qin, Yanmin; Chen, Zhigao; Wang, Xin; He, Daihai			Modelling the transmission and control strategies of varicella among school children in Shenzhen, China	PLOS ONE			English	Article							INFECTIOUS-DISEASES; BRUCELLOSIS MODEL; SOCIAL CONTACTS; EPIDEMIOLOGY; VACCINATION; DYNAMICS; SPREAD; IMPACT; POPULATION; PATTERNS	Objectives Varicella (chickenpox) is a highly transmissible childhood disease. Between 2010 and 2015, it displayed two epidemic waves annually among school populations in Shenzhen, China. However, their transmission dynamics remain unclear and there is no school-based vaccination programme in Shenzhen to-date. In this study, we developed a mathematical model to compare a school-based vaccination intervention scenario with a baseline (i.e. no intervention) scenario. Methods Data on varicella reported cases were downloaded from the Infectious Disease Reporting Information Management System. We obtained the population size, age structure of children aged 15 or under, the class and school distribution from Shenzhen Education Bureau. We developed an Agent-Based Susceptible-Exposed-Infectious-Recovered (ABM-SEIR) Model that considered within-class, class-to-class and out-of-school transmission modes. The intervention scenario was that school-wide vaccination intervention occurred when an outbreak threshold was reached within a school. We varied this threshold level from five to ten cases. We compared the reduction of disease outbreak size and estimated the key epidemiological parameters under the intervention strategy. Results Our ABM-SEIR model provided a good model fit to the two annual varicella epidemic waves from 2013 to 2015. The transmission dynamics displayed strong seasonality. Our results suggested that a school-based vaccination strategy could effectively prevent large outbreaks at different thresholds. Conclusions There was a considerable increase in reported varicella cases from 2013 to 2015 in Shenzhen. Our modelling study provided important theoretical support for disease control decision making during school outbreaks and the development of a school-based vaccination programme.	[Tang, Xiujuan; Ma, Hanwu; Xie, Xu; Mei, Shujiang; Kong, Dongfeng; Qin, Yanmin; Chen, Zhigao; Wang, Xin] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Zhao, Shi; Chiu, Alice P. Y.; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Hong Kong Polytechnic University	Chiu, APY; He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China.	alice.py.chiu@polyu.edu.hk; daihai.he@polyu.edu.hk	He, Daihai/AAT-8735-2021; He, Daihai/A-9347-2008; Zhao, Shi/AAW-6992-2021	Zhao, Shi/0000-0001-8722-6149; He, Daihai/0000-0003-3253-654X	Shenzhen Science and Technology Innovation Project 313 [JCYJ20150402102135501]	Shenzhen Science and Technology Innovation Project 313	This study was supported by Shenzhen Science and Technology Innovation Project 313 Grant (JCYJ20150402102135501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LJ, IEEE T AUTOM CONTROL, V43, P779; Brisson M, 2000, EPIDEMIOL INFECT, V125, P651, DOI 10.1017/S0950268800004714; Brisson M, 2010, VACCINE, V28, P3385, DOI 10.1016/j.vaccine.2010.02.079; Del Fava E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163636; FINE PEM, 1982, INT J EPIDEMIOL, V11, P15, DOI 10.1093/ije/11.1.15; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Fu CX, 2010, PEDIATR INFECT DIS J, V29, P690, DOI 10.1097/INF.0b013e3181d7380e; He DH, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0156; He DH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1345; He DH, 2007, THEOR POPUL BIOL, V72, P274, DOI 10.1016/j.tpb.2007.04.004; Heininger U, 2006, LANCET, V368, P1365, DOI 10.1016/S0140-6736(06)69561-5; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099762; Lee LE, 2008, PEDIATRICS, V121, pE1548, DOI 10.1542/peds.2007-2031; Lenne X, 2006, VACCINE, V24, P6980, DOI 10.1016/j.vaccine.2006.04.051; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; Lin QY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151333; Marin M, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3741; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Poletti P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060732; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; van Hoek AJ, 2011, VACCINE, V29, P2411, DOI 10.1016/j.vaccine.2011.01.037; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220; Zeng Y, 2016, LANCET, V388, P1930, DOI 10.1016/S0140-6736(16)31405-2	30	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177514	10.1371/journal.pone.0177514	http://dx.doi.org/10.1371/journal.pone.0177514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542182	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400047
J	Walden, HDS; Slapcinsky, JD; Roff, S; Calle, JM; Goodwin, ZD; Stern, J; Corlett, R; Conway, J; McIntosh, A				Walden, Heather D. Stockdale; Slapcinsky, John D.; Roff, Shannon; Calle, Jorge Mendieta; Goodwin, Zakia Diaz; Stern, Jere; Corlett, Rachel; Conway, Julia; McIntosh, Antoinette			Geographic distribution of Angiostrongylus cantonensis in wild rats (Rattus rattus) and terrestrial snails in Florida, USA	PLOS ONE			English	Article							EOSINOPHILIC MENINGITIS; PARASTRONGYLUS-CANTONENSIS; INFECTION; MENINGOENCEPHALOMYELITIS; TRANSMISSION; NEMATODA; THAILAND; LUNGWORM; FULICA; HAWAII	The parasitic nematode Angiostrongylus cantonensis is a major cause of eosinophilic meningitis in humans, and has been documented in other incidental hosts such as birds, horses, dogs and non-human primates. It is endemic in Hawaii, and there have been sporadic reports in the southern continental United States. This parasite uses rats as definitive hosts and snails as intermediate hosts. In this study, we collected potential definitive and intermediate hosts throughout Florida to ascertain the geographic distribution in the state: Rats, environmental rat fecal samples, and snails were collected from 18 counties throughout the state. Classical diagnostics and morphological identification, along with molecular techniques were used to identify nematode species and confirm the presence of A. cantonensis. Of the 171 Rattus rattus collected, 39 (22.8%) were positive for A. cantonensis, and 6 of the 37 (16.2%) environmental rat fecal samples collected in three of the surveyed counties were also positive for this parasite by real time PCR. We examined 1,437 gastropods, which represented 32 species; 27 (1.9%) were positive for A. cantonensis from multiple sites across Florida. Three non-native gastropod species, Bradybaena similaris, Zachrysia provisoria, and Paropeas achatinaceum, and three native gastropod species, Succinea floridana, Ventridens demissus, and Zonitoides arboreus, which are newly recorded intermediate hosts for the parasite, were positive for A. cantonensis. This study indicates that A. cantonensis is established in Florida through the finding of adult and larval stages in definitive and intermediate hosts, respectively, throughout the state. The ability for this historically subtropical nematode to thrive in a more temperate climate is alarming, however as the climate changes and average temperatures rise, gastropod distributions will probably expand, leading to the spread of this parasite in more temperate areas. Through greater awareness of host species and prevalence of A. cantonensis in the United States, potential accidental infections may be avoided.	[Walden, Heather D. Stockdale; Roff, Shannon; Calle, Jorge Mendieta; Goodwin, Zakia Diaz; Stern, Jere; Corlett, Rachel; Conway, Julia; McIntosh, Antoinette] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA; [Slapcinsky, John D.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Walden, HDS (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.	hdstockdale@ufl.edu		Walden, Heather/0000-0002-5678-4938	National Center for Veterinary Parasitology (NCVP); UF [00111635]; University of Florida Open Access Publishing Fund	National Center for Veterinary Parasitology (NCVP); UF; University of Florida Open Access Publishing Fund	This work was funded by the National Center for Veterinary Parasitology (NCVP); www.ncvetp.org. HW received funding for this project in 2013, UF project #00111635. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALICATA JE, 1962, CAN J ZOOLOG, V40, P5, DOI 10.1139/z62-002; ALICATA JE, 1962, CAN J ZOOLOG, V40, P755, DOI 10.1139/z62-070; Asato R, 2004, JPN J INFECT DIS, V57, P184; ASH LR, 1968, J PARASITOL, V54, P432, DOI 10.2307/3277060; Auffenberg K, 2011, EENY, V118, P1; Bergey EA, 2014, BIOL INVASIONS, V16, P1441, DOI 10.1007/s10530-013-0581-1; BHAIBULAYA M, 1975, INT J PARASITOL, V5, P7, DOI 10.1016/0020-7519(75)90091-0; Burns RE, 2014, J VET DIAGN INVEST; CAMPBELL BG, 1988, AM J TROP MED HYG, V38, P568, DOI 10.4269/ajtmh.1988.38.568; Capinera JL, 2013, CROP PROT, V52, P57, DOI 10.1016/j.cropro.2013.05.014; Chen H. T., 1935, Annales de Parasitologie Paris, V13, P312; Costa LRR, 2000, EQUINE VET EDUC, V12, P2, DOI 10.1111/j.2042-3292.2000.tb01754.x; Cowie RH, 2008, INT J PEST MANAGE, V54, P267, DOI 10.1080/09670870802403986; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P70; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P6; Cowie Robert H., 2001, Biological Invasions, V3, P119, DOI 10.1023/A:1014529019000; Cowie RH, 2009, AM MALACOL BULL, V27, P113, DOI 10.4003/006.027.0210; CROOK JR, 1971, T ROY SOC TROP MED H, V65, P602, DOI 10.1016/0035-9203(71)90043-5; Duffy MS, 2004, EMERG INFECT DIS, V10, P2207, DOI 10.3201/eid1012.040319; Emerson JA, 2013, VET QUART, V33, P191, DOI 10.1080/01652176.2013.880005; Fanai C, 2015, PEER J; Foster CE, 2016, CLIN INFECT DIS, V63, P1475, DOI 10.1093/cid/ciw606; GARDINER CH, 1990, AM J TROP MED HYG, V42, P70, DOI 10.4269/ajtmh.1990.42.70; HEYNEMAN D, 1967, SCIENCE, V158, P1057, DOI 10.1126/science.158.3804.1057; Hochberg NS, 2007, EMERG INFECT DIS, V13, P1675, DOI 10.3201/eid1311.070367; Hochberg NS, 2011, AM J TROP MED HYG, V85, P685, DOI 10.4269/ajtmh.2011.11-0322; HORIO S R, 1961, Hawaii Med J, V21, P139; HUBRICHT L, 1985, Fieldiana Zoology, P1; Iwanowicz DD, 2015, J WILDLIFE DIS, V51, P749, DOI 10.7589/2014-06-160; Kim DY, 2002, J PARASITOL, V88, P1024, DOI 10.1645/0022-3395(2002)088[1024:PACNEI]2.0.CO;2; Kim JA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085445, 10.1371/journal.pone.0091940]; Kottwitz JJ, 2014, JAVMA-J AM VET MED A, V245, P821, DOI 10.2460/javma.245.7.821; Lai CH, 2007, AM J TROP MED HYG, V76, P399, DOI 10.4269/ajtmh.2007.76.399; Lunn JA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-70; Lv S, 2011, FRESHWATER BIOL, V56, P717, DOI 10.1111/j.1365-2427.2011.02579.x; MACKERRAS M. JOSEPHINE, 1955, AUSTRALIAN JOUR ZOOL, V3, P1, DOI 10.1071/ZO9550001; Monks DJ, 2005, J AVIAN MED SURG, V19, P289, DOI 10.1647/2004-024.1; NEW D, 1995, NEW ENGL J MED, V332, P1105, DOI 10.1056/NEJM199504203321619; Pilsbry H., 1939, ACAD NAT SCI PHILA M, V3, P1; Pilsbry H. A, 1940, ACAD NATURAL SCI MON ACAD NATURAL SCI MON, V1, P575; Pilsbry H.A., 1948, ACAD NATURAL SCI PHI, V3, P521; Pilsbry HA, 1946, ACAD NATURAL SCI PHI, V3, P1; PUNYAGUPTA S, 1970, AM J TROP MED HYG, V19, P950, DOI 10.4269/ajtmh.1970.19.950; PUNYAGUPTA S, 1975, AM J TROP MED HYG, V24, P921, DOI 10.4269/ajtmh.1975.24.921; Qvarnstrom Yvonne, 2013, Hawaii J Med Public Health, V72, P63; Qvarnstrom Y, 2010, APPL ENVIRON MICROB, V76, P5287, DOI 10.1128/AEM.00546-10; Robles MD, 2016, MEM I OSWALDO CRUZ, V111, P181, DOI 10.1590/0074-02760150371; Sawanyawisuth K, 2013, KOREAN J PARASITOL, V51, P735, DOI 10.3347/kjp.2013.51.6.735; Sinawat S, 2008, EYE, V22, P1446, DOI 10.1038/eye.2008.135; Stockdale-Walden HD, 2015, J PARASITOL, V101, P156, DOI 10.1645/14-553.1; Teem John L, 2013, Hawaii J Med Public Health, V72, P11; WALLACE G D, 1969, Malacologia, V7, P427; Wang QP, 2012, EUR J CLIN MICROBIOL, V31, P389, DOI 10.1007/s10096-011-1328-5; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Waugh CA, 2016, PARASITOLOGY, V143, P1211, DOI 10.1017/S0031182016000640; Waugh CA, 2005, EMERG INFECT DIS, V11, P1977, DOI 10.3201/eid1112.050217; Yeung Norine W, 2013, Hawaii J Med Public Health, V72, P83; York EM, 2015, EMERG INFECT DIS, V21, P1234, DOI 10.3201/eid2107.141980; York EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103831; Zajac A., 2012, PENSION FUND PERFORM, V8th edn, DOI DOI 10.1002/9781119208945.CH8	60	34	35	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177910	10.1371/journal.pone.0177910	http://dx.doi.org/10.1371/journal.pone.0177910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542310	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400112
J	Wang, XM; Liu, S; Liu, ZP				Wang, Xingmei; Liu, Shu; Liu, Zhipeng			Underwater sonar image detection: A combination of non-local spatial information and quantum-inspired shuffled frog leaping algorithm	PLOS ONE			English	Article							CLUSTERING-ALGORITHM; GENETIC ALGORITHM; OPTIMIZATION	This paper proposes a combination of non-local spatial information and quantum-inspired shuffled frog leaping algorithm to detect underwater objects in sonar images. Specifically, for the first time, the problem of inappropriate filtering degree parameter which commonly occurs in non-local spatial information and seriously affects the denoising performance in sonar images, was solved with the method utilizing a novel filtering degree parameter. Then, a quantum-inspired shuffled frog leaping algorithm based on new search mechanism (QSFLA-NSM) is proposed to precisely and quickly detect sonar images. Each frog individual is directly encoded by real numbers, which can greatly simplify the evolution process of the quantum-inspired shuffled frog leaping algorithm (QSFLA). Meanwhile, a fitness function combining intra-class difference with inter-class difference is adopted to evaluate frog positions more accurately. On this basis, recurring to an analysis of the quantum-behaved particle swarm optimization (QPSO) and the shuffled frog leaping algorithm (SFLA), a new search mechanism is developed to improve the searching ability and detection accuracy. At the same time, the time complexity is further reduced. Finally, the results of comparative experiments using the original sonar images, the UCI data sets and the benchmark functions demonstrate the effectiveness and adaptability of the proposed method.	[Wang, Xingmei] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Liu, Shu] Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing, Peoples R China; [Liu, Zhipeng] Chinese Acad Sci, Inst Comp Technol, Key Lab Intelligent Informat Proc CAS, Beijing, Peoples R China	Harbin Engineering University; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; Institute of Computing Technology, CAS	Wang, XM (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.	wangxingmei@hrbeu.edu.cn	liu, zhipeng/HCI-3638-2022; LIU, ZHIPENG/GWQ-5972-2022		National Natural Science Foundation of China [41306086]; technology innovation talent special foundation of Harbin [2014RFQXJ105]; Fundamental Research Funds for the Central Universities [HEUCF100606]; China Scholarship Council (CSC) [201506685079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); technology innovation talent special foundation of Harbin; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (No. 41306086) to XMW, http.//www.nsfc.gov.cn/, technology innovation talent special foundation of Harbin (No.2014RFQXJ105) to XMW, http://202.97.251.242:8033/, Fundamental Research Funds for the Central Universities (No.HEUCF100606) to XMW, http.//kyxt.hrbeu.edu.cn/irisweb. The first author was supported by China Scholarship Council (CSC) (No.201506685079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author was supported by China Scholarship Council (CSC) (No.201506685079).	Alireza Alfi, 2011, Acta Automatica Sinica, V37, P541, DOI 10.3724/SP.J.1004.2011.00541; Arshi SS, 2014, COMPUT PHYS COMMUN, V185, P2622, DOI 10.1016/j.cpc.2014.06.013; Bache Kevin, 2013, UCI MACHINE LEARNING; Buades A, 2008, INT J COMPUT VISION, V76, P123, DOI 10.1007/s11263-007-0052-1; Cai WL, 2007, PATTERN RECOGN, V40, P825, DOI 10.1016/j.patcog.2006.07.011; Chen SC, 2004, IEEE T SYST MAN CY B, V34, P1907, DOI 10.1109/TSMCB.2004.831165; [丁卫平 Ding Weiping], 2014, [计算机研究与发展, Journal of Computer Research and Development], V51, P743; Ding WP, 2013, J SYST ENG ELECTRON, V24, P426, DOI 10.1109/JSEE.2013.00051; Fan TH, 2012, INTELL AUTOM SOFT CO, V78, P70; Feng J, 2013, SIGNAL PROCESS, V93, P487, DOI 10.1016/j.sigpro.2012.08.024; Gao HY, 2012, INT J DIGITAL CONTEN, V6, P32; HOLLAND JH, 1992, SCI AM, V267, P66, DOI 10.1038/scientificamerican0792-66; Jau YM, 2013, APPL MATH COMPUT, V221, P282, DOI 10.1016/j.amc.2013.06.050; Krinidis S, 2010, IEEE T IMAGE PROCESS, V19, P1328, DOI 10.1109/TIP.2010.2040763; Kumar JV, 2014, APPL SOFT COMPUT, V21, P407, DOI 10.1016/j.asoc.2014.03.027; Lei DM, 2015, EXPERT SYST APPL, V42, P9333, DOI 10.1016/j.eswa.2015.08.025; [李灿飞 Li Canfei], 2012, [自动化学报, Acta Automatica Sinica], V38, P412; Ngo LT, 2015, COMPUT GEOSCI-UK, V83, P1, DOI 10.1016/j.cageo.2015.06.011; Luo JP, 2014, COMPUT IND ENG, V72, P84, DOI 10.1016/j.cie.2014.03.004; Mariani VC, 2012, APPL THERM ENG, V42, P119, DOI 10.1016/j.applthermaleng.2012.03.022; Niknam T, 2011, EXPERT SYST APPL, V38, P13301, DOI 10.1016/j.eswa.2011.04.151; Roy P, 2013, APPL SOFT COMPUT, V13, P4244, DOI 10.1016/j.asoc.2013.07.006; Sheikh Rahila H., 2008, 2008 1st International Conference on Emerging Trends in Engineering and Technology (ICETET), P314, DOI 10.1109/ICETET.2008.48; Shen Yuan-Xia, 2011, Journal of Software, V22, P695, DOI 10.3724/SP.J.1001.2011.03728; Szilagyi L, 2003, P ANN INT IEEE EMBS, V25, P724, DOI 10.1109/IEMBS.2003.1279866; Wang Lei, 2012, Journal of Huazhong University of Science and Technology (Natural Science Edition), V40, P25; Wang LG, 2013, INT CONF INSTR MEAS, P1655, DOI 10.1109/IMCCC.2013.366; Wang LG, 2013, 2013 NINTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION (ICNC), P369, DOI 10.1109/ICNC.2013.6818003; Wang XM, 2016, P CCDC YINCH CHIN, P2020, DOI 10.1109/CCDC.2016.7531310; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Wu JP, 2015, INT CONF COMM SYST, P457, DOI 10.1109/CSNT.2015.224; Xiao J, 2010, EXPERT SYST APPL, V37, P4966, DOI 10.1016/j.eswa.2009.12.017; Ye XF, 2010, OCEAN ENG, V37, P891, DOI 10.1016/j.oceaneng.2010.03.003; Zhang B, 2015, INT J HEAT MASS TRAN, V85, P300, DOI 10.1016/j.ijheatmasstransfer.2015.01.140; Zhang H, 2015, J SIGNAL PROCESS SYS, V81, P45, DOI 10.1007/s11265-014-0898-8; Zhang XD, 2012, AEU-INT J ELECTRON C, V66, P448, DOI 10.1016/j.aeue.2011.10.004; [张毅 Zhang Yi], 2013, [计算机学报, Chinese Journal of Computers], V36, P1835; Zhang YD, 2016, TECHNOL HEALTH CARE, V24, pS641, DOI 10.3233/THC-161191; Zhang YD, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/931256; Zhao F, 2015, APPL SOFT COMPUT, V30, P48, DOI 10.1016/j.asoc.2015.01.039; Zhao F, 2014, EXPERT SYST APPL, V41, P4083, DOI 10.1016/j.eswa.2014.01.003	43	13	14	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							017766	10.1371/journal.pone.0177666	http://dx.doi.org/10.1371/journal.pone.0177666			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542266	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400065
J	Zhao, XK; Mao, YM; Meng, H; Song, X; Hu, SJ; Lv, S; Cheng, R; Zhang, TJ; Han, XN; Ren, JL; Qi, YJ; Wang, LD				Zhao, Xue Ke; Mao, Yi Min; Meng, Hui; Song, Xin; Hu, Shou Jia; Lv, Shuang; Cheng, Rang; Zhang, Tang Juan; Han, Xue Na; Ren, Jing Li; Qi, Yi Jun; Wang, Li Dong			Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; GENETIC-VARIATION; POOLED ANALYSIS; NEVER SMOKERS; HAN CHINESE; RISK; POPULATION; VARIANTS; PLCE1	Background Cancers from lung and esophagus are the leading causes of cancer-related deaths in China and share many similarities in terms of histological type, risk factors and genetic variants. Recent genome-wide association studies (GWAS) in Chinese esophageal cancer patients have demonstrated six high-risk candidate single nucleotide polymorphisms (SNPs). Thus, the present study aimed to determine the risk of these SNPs predisposing to lung cancer in Chinese population. Methods A total of 1170 lung cancer patients and 1530 normal subjects were enrolled in this study from high-incidence areas for esophageal cancer in Henan, northern China. Five milliliters of blood were collected from all subjects for genotyping. Genotyping of 20 high-risk SNP loci identified from genome-wide association studies (GWAS) on esophageal, lung and gastric cancers was performed using TaqMan allelic discrimination assays. Polymorphisms were examined for deviation from Hardy-Weinberg equilibrium (HWE) using X-2 test. Bonferroni correction was performed to correct the statistical significance of 20 SNPs with the risk of lung cancer. The Pearson's X-2 test was used to compare the distributions of gender, TNM stage, histopathological type, smoking and family history by lung susceptibility genotypes. Kaplan-Meier and Cox regression analyses were carried out to evaluate the associations between genetic variants and overall survival. Results Four of the 20 SNPs identified as high-risk SNPs in Chinese esophageal cancer showed increased risk for Chinese lung cancer, which included rs3769823 (OR = 1.26; 95% CI = 1.107-1.509; P = 0.02), rs10931936 (OR = 1.283; 95% CI = 1.100-1.495; P = 0.04), rs2244438 (OR = 1.294; 95% CI = 1.098-1.525; P = 0.04) and rs13016963 (OR = 1.268; 95% CI = 1.089-1.447; P = 0.04). All these SNPs were located at 2q33 region harboringgenes of CASP8, ALS2CR12 and TRAK2. However, none of these susceptibility SNPs was observed to be significantly associated with gender, TNM stage, histopathological type, smoking, family history and overall survival. Conclusions The present study identified four high-risk SNPs at 2q33 locus for Chinese lung cancer and demonstrated the shared susceptibility loci at 2q33 region for Chinese lung and esophageal cancers.	[Zhao, Xue Ke; Mao, Yi Min; Meng, Hui; Song, Xin; Hu, Shou Jia; Lv, Shuang; Cheng, Rang; Zhang, Tang Juan; Han, Xue Na; Ren, Jing Li; Wang, Li Dong] Zhengzhou Univ, Henan Key Lab Esophageal Canc Res, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Qi, Yi Jun] Henan Univ Sci & Technol, Coll Clin Med, Affiliated Hosp 1, Henan Key Lab Canc Epigenet,Canc Inst, Luoyang, Henan, Peoples R China	Zhengzhou University; Henan University of Science & Technology	Wang, LD (corresponding author), Zhengzhou Univ, Henan Key Lab Esophageal Canc Res, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	ldwang2007@126.com		Qi, Yi-Jun/0000-0003-0239-5862; HU, SHOU JIA/0000-0002-9857-0065; Wang, Li Dong/0000-0002-7933-0410	National Natural Science Foundation of China; Guangdong Provincial People's Government of the Joint Natural Science Fund [U1301227]; Major Project of Science and Technology of Henan Province [161100311300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial People's Government of the Joint Natural Science Fund; Major Project of Science and Technology of Henan Province	The study has been funded by the National Natural Science Foundation of China, and the Guangdong Provincial People's Government of the Joint Natural Science Fund (U1301227) and Major Project of Science and Technology of Henan Province (161100311300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our study was supported by the National Natural Science Foundation of China, and the Guangdong Provincial People's Government of the Joint Natural Science Fund (U1301227) and Major Project of Science and Technology of Henan Province (161100311300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; Cote ML, 2012, EUR J CANCER, V48, P1957, DOI 10.1016/j.ejca.2012.01.038; Couch FJ, 2009, CANCER EPIDEM BIOMAR, V18, P3044, DOI 10.1158/1055-9965.EPI-09-0306; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Delahaye-Sourdeix M, 2015, PLOS ONE, V10, P3; Gavine PR, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1455-y; Grishin A, 2006, J BIOL CHEM, V281, P30104, DOI 10.1074/jbc.M602439200; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; He P, 2014, INT J MOL SCI, V15, P5446, DOI 10.3390/ijms15045446; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Huang XP, 2014, GENET MOL RES, V13, P2107, DOI 10.4238/2014.January.24.17; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Ichinose J, 2014, CHEST, V146, P644, DOI 10.1378/chest.14-0159; Lan Q, 2009, BLOOD, V114, P264, DOI 10.1182/blood-2009-01-198697; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Liu L, 2014, CANCER EPIDEMIOL, V38, P66, DOI 10.1016/j.canep.2013.12.009; Lu Y, 2014, HUM MOL GENET, V23, P6112, DOI 10.1093/hmg/ddu312; Mechanic LE, 2007, CANCER EPIDEM BIOMAR, V16, P214, DOI 10.1158/1055-9965.EPI-06-0790; Nandy N, 2013, CURR MED RES OPIN, V29, P1055, DOI 10.1185/03007995.2013.816276; Rafnar T, 2011, CANCER RES, V71, P1356, DOI 10.1158/0008-5472.CAN-10-2852; Sato N, 2010, CLIN CANCER RES, V16, P226, DOI 10.1158/1078-0432.CCR-09-1405; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Son JW, 2006, CANCER GENET CYTOGEN, V169, P121, DOI 10.1016/j.cancergencyto.2006.04.001; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Sun Y, 2013, ASIAN PAC J CANCER P, V14, P5171, DOI 10.7314/APJCP.2013.14.9.5171; Tan W, 2001, INT J CANCER, V95, P96, DOI 10.1002/1097-0215(20010320)95:2&lt;96::AID-IJC1017&gt;3.0.CO;2-2; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu C, 2014, NAT GENET, V46, P1001, DOI 10.1038/ng.3064; Xue L, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-296; Zhao Y, 2010, J CELL PHYSIOL, V225, P316, DOI 10.1002/jcp.22276; Zhou LQ, 2012, GENE, V506, P295, DOI 10.1016/j.gene.2012.07.007	37	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177504	10.1371/journal.pone.0177504	http://dx.doi.org/10.1371/journal.pone.0177504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542283	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400046
J	Coker, EA; Mitsopoulos, C; Workman, P; Al-Lazikani, B				Coker, Elizabeth A.; Mitsopoulos, Costas; Workman, Paul; Al-Lazikani, Bissan			SiGNet: A signaling network data simulator to enable signaling network inference	PLOS ONE			English	Article							RECONSTRUCTION; NOISE	Network models are widely used to describe complex signaling systems. Cellular wiring varies in different cellular contexts and numerous inference techniques have been developed to infer the structure of a network from experimental data of the network's behavior. To objectively identify which inference strategy is best suited to a specific network, a gold standard network and dataset are required. However, suitable datasets for benchmarking are difficult to find. Numerous tools exist that can simulate data for transcriptional networks, but these are of limited use for the study of signaling networks. Here, we describe SiGNet (Signal Generator for Networks): a Cytoscape app that simulates experimental data for a signaling network of known structure. SiGNet has been developed and tested against published experimental data, incorporating information on network architecture, and the directionality and strength of interactions to create biological data in silico. SiGNet is the first tool to simulate biological signaling data, enabling an accurate and systematic assessment of inference strategies. SiGNet can also be used to produce preliminary models of key biological pathways following perturbation.	[Coker, Elizabeth A.; Mitsopoulos, Costas; Workman, Paul; Al-Lazikani, Bissan] Canc Res UK, Canc Therapeut Unit, Inst Canc Res, London, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Al-Lazikani, B (corresponding author), Canc Res UK, Canc Therapeut Unit, Inst Canc Res, London, England.	bissan.al-lazikani@icr.ac.uk	Al-Lazikani, Bissan/AFK-6457-2022; Al-Lazikani, Bissan/AAG-4723-2022	Mitsopoulos, Costas/0000-0002-9116-5921; Coker, Elizabeth A./0000-0003-4934-8887; Al-Lazikani, Bissan/0000-0003-3367-2519	Medical Research Council [G1000391]; Cancer Research UK [C309/A11566]; Cancer Research UK [23187, 22897, 11566] Funding Source: researchfish; Medical Research Council [1237183] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge funding from Medical Research Council (http://www.mrc.ac.uk) Doctoral Training Grant Program G1000391 and Cancer Research UK (http://www. cancerresearchuk.org) Grant C309/A11566.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Deichmann U, 2014, FEBS J, V281, P435, DOI 10.1111/febs.12598; Di Camillo B, 2009, ANN NY ACAD SCI, V1158, P125, DOI 10.1111/j.1749-6632.2008.03756.x; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Haynes BC, 2009, BIOINFORMATICS, V25, P801, DOI 10.1093/bioinformatics/btp068; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hill SM, 2012, BIOINFORMATICS, V28, P2804, DOI 10.1093/bioinformatics/bts514; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Ladbury JE, 2012, TRENDS BIOCHEM SCI, V37, P173, DOI 10.1016/j.tibs.2012.01.001; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Molinelli EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003290; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P5823, DOI 10.1113/jphysiol.2013.263251; Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Saturno Grazia, 2013, Oncotarget, V4, P1185; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Villaverde AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096732; Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177701	10.1371/journal.pone.0177701	http://dx.doi.org/10.1371/journal.pone.0177701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545060	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700066
J	Albarino, CG; Guerrero, LW; Jenks, HM; Chakrabarti, AK; Ksiazek, TG; Rollin, PE; Nichol, ST				Albarino, Cesar G.; Guerrero, Lisa Wiggleton; Jenks, Harley M.; Chakrabarti, Ayan K.; Ksiazek, Thomas G.; Rollin, Pierre E.; Nichol, Stuart T.			Insights into Reston virus spillovers and adaption from virus whole genome sequences	PLOS ONE			English	Article							EBOLA-VIRUS; IMMUNE EVASION; SUBTYPE RESTON; FRUIT BATS; INFECTION; EVOLUTION; PHILIPPINES; ANTIBODIES; DISEASE	Reston virus (family Filoviridae) is unique among the viruses of the Ebolavirus genus in that it is considered non-pathogenic in humans, in contrast to the other members which are highly virulent. The virus has however, been associated with several outbreaks of highly lethal hemorrhagic fever in non-human primates (NHPs), specifically cynomolgus monkeys (Macaca fascicularis) originating in the Philippines. In addition, Reston virus has been isolated from domestic pigs in the Philippines. To better understand virus spillover events and potential adaption to new hosts, the whole genome sequences of representative Reston virus isolates were obtained using a next generation sequencing (NGS) approach and comparative genomic analysis and virus fitness analyses were performed. Nine virus genome sequences were completed for novel and previously described isolates obtained from a variety of hosts including a human case, non-human primates and pigs. Results of phylogenetic analysis of the sequence differences are consistent with multiple independent introductions of RESTV from a still unknown natural reservoir into non-human primates and swine farming operations. No consistent virus genetic markers were found specific for viruses associated with primate or pig infections, but similar to what had been seen with some Ebola viruses detected in the large Western Africa outbreak in 2014-2016, a truncated version of VP30 was identified in a subgroup of Reston viruses obtained from an outbreak in pigs 2008-2009. Finally, the genetic comparison of two closely related viruses, one isolated from a human case and one from an NHP, showed amino acid differences in the viral polymerase and detectable differences were found in competitive growth assays on human and NHP cell lines.	[Albarino, Cesar G.; Guerrero, Lisa Wiggleton; Jenks, Harley M.; Chakrabarti, Ayan K.; Rollin, Pierre E.; Nichol, Stuart T.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Ksiazek, Thomas G.] Univ Texas Med Branch, Galveston, TX 77555 USA	Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Medical Branch Galveston	Albarino, CG (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA USA.	calbarino@cdc.gov		Rollin, Pierre/0000-0002-4608-2641	Department of Health and Human Services, United States Government	Department of Health and Human Services, United States Government	The study was funded by the Department of Health and Human Services, United States Government. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarino CG, 2016, VIROLOGY, V496, P237, DOI 10.1016/j.virol.2016.06.011; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Basler CF, 2015, VIROLOGY, V479, P122, DOI 10.1016/j.virol.2015.03.030; Burk R, 2016, FEMS MICROBIOL REV, V40, P494, DOI 10.1093/femsre/fuw010; Cantoni D, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00322-16; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; CDC, 1989, MMWR-MORBID MORTAL W, V38, P7; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P831; Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P221; Cornish JP, 2017, GENOME ANNOUNCEMENTS, V5; DALGARD DW, 1992, LAB ANIM SCI, V42, P152; Feldmann H., 2013, FIELDS VIROLOGY, V1, P923; GEISBERT TW, 1990, J CLIN PATHOL, V43, P813, DOI 10.1136/jcp.43.10.813; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Groseth A, 2002, VIRUS RES, V87, P155, DOI 10.1016/S0168-1702(02)00087-4; Guito JC, 2017, VIROLOGY, V501, P147, DOI 10.1016/j.virol.2016.11.015; Ikegami T, 2001, ARCH VIROL, V146, P2021, DOI 10.1007/s007050170049; JAHRLING PB, 1990, LANCET, V335, P502, DOI 10.1016/0140-6736(90)90737-P; Jayme SI, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0331-3; Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522; Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099; Messaoudi I, 2015, NAT REV MICROBIOL, V13, P663, DOI 10.1038/nrmicro3524; Miranda MEG, 2011, J INFECT DIS, V204, pS757, DOI 10.1093/infdis/jir296; Morikawa S, 2007, COMP IMMUNOL MICROB, V30, P391, DOI 10.1016/j.cimid.2007.05.005; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Ng M, 2015, ELIFE, V4, DOI 10.7554/eLife.11785; Olival KJ, 2013, EMERG INFECT DIS, V19, P270, DOI 10.3201/eid1902.120524; Pan YY, 2014, ARCH VIROL, V159, P1129, DOI 10.1007/s00705-012-1477-6; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Rollin PE, 1999, J INFECT DIS, V179, pS108, DOI 10.1086/514303; Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014; Taniguchi S, 2011, EMERG INFECT DIS, V17, P1559, DOI 10.3201/eid1708.101693; Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Whitmer SLM, 2016, J INFECT DIS, V214, pS333, DOI 10.1093/infdis/jiw177; WHO, 1992, VIR HAEM FEV IMP MON; World Health Organisation, 2016, EB SIT REP 30 MARCH; Yuan JF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-236; Zhang APP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002550	42	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178224	10.1371/journal.pone.0178224	http://dx.doi.org/10.1371/journal.pone.0178224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542463	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800057
J	Cameron, SJS; Lewis, KE; Huws, SA; Hegarty, MJ; Lewis, PD; Pachebat, JA; Mur, LAJ				Cameron, Simon J. S.; Lewis, Keir E.; Huws, Sharon A.; Hegarty, Matthew J.; Lewis, Paul D.; Pachebat, Justin A.; Mur, Luis A. J.			A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; STREPTOCOCCUS-ANGINOSUS; GRANULICATELLA-ADIACENS; COMMUNITIES; INFECTION; SERVER; COPD; HEAD; DNA	Lung cancer (LC) is the most prevalent cancer worldwide, and responsible for over 1.3 million deaths each year. Currently, LC has a low five year survival rates relative to other cancers, and thus, novel methods to screen for and diagnose malignancies are necessary to improve patient outcomes. Here, we report on a pilot-sized study to evaluate the potential of the sputum microbiome as a source of non-invasive bacterial biomarkers for lung cancer status and stage. Spontaneous sputum samples were collected from ten patients referred with possible LC, of which four were eventually diagnosed with LC (LC+), and six had no LC after one year (LC-). Of the seven bacterial species found in all samples, Streptococcus viridans was significantly higher in LC+ samples. Seven further bacterial species were found only in LC-, and 16 were found only in samples from LC+. Additional taxonomic differences were identified in regards to significant fold changes between LC+ and LC- cases, with five species having significantly higher abundances in LC+, with Granulicatella adiacens showing the highest level of abundance change. Functional differences, evident through significant fold changes, included polyamine metabolism and iron siderophore receptors. G. adiacens abundance was correlated with six other bacterial species, namely Enterococcus sp. 130, Streptococcus intermedius, Escherichia coli, S. viridans, Acinetobacter junii, and Streptococcus sp. 6, in LC+ samples only, which could also be related to LC stage. Spontaneous sputum appears to be a viable source of bacterial biomarkers which may have utility as biomarkers for LC status and stage.	[Cameron, Simon J. S.; Huws, Sharon A.; Hegarty, Matthew J.; Pachebat, Justin A.; Mur, Luis A. J.] Inst Biol Environm & Rural Sci, Edward Llywd Bldg,Penglais Campus, Aberystwyth, Ceredigion, Wales; [Lewis, Keir E.] Hywel Dda Univ, Prince Phillip Hosp, Dept Resp Med, Hlth Board, Llanelli, Wales; [Lewis, Keir E.; Lewis, Paul D.] Swansea Univ, Coll Med, Swansea, W Glam, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Swansea University	Mur, LAJ (corresponding author), Inst Biol Environm & Rural Sci, Edward Llywd Bldg,Penglais Campus, Aberystwyth, Ceredigion, Wales.	lum@aber.ac.uk	Mur, Luis a. j./U-1052-2017	Mur, Luis a. j./0000-0002-0961-9817; Lewis, Keir/0000-0002-8248-6774; Pachebat, Justin/0000-0003-3369-3205; Hegarty, Matthew/0000-0001-6547-3800; Lewis, Keir/0000-0001-9756-4723; Cameron, Simon/0000-0001-9570-135X; Huws, Sharon/0000-0002-9284-2453	BBSRC (UK) [BBS/ENV/10964A01A]; Aberystwyth University; National Institute for Social Care and Health Research (NISCHR, Wales, UK); Biotechnology and Biological Sciences Research Council (BBSRC), UK; The British Council [172629373] Funding Source: researchfish	BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Aberystwyth University; National Institute for Social Care and Health Research (NISCHR, Wales, UK); Biotechnology and Biological Sciences Research Council (BBSRC), UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The British Council	BBSRC (UK) support (BBS/ENV/10964A01A) allowed the metagenomic sequencing to be carried out. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SJSC is grateful for studentship from Aberystwyth University. We wish to thank Dr Paul Griffiths, Consultant histopathologist, for sputum cytological assessment and Dr Chris Creevey and Dr Martin Swain for helpful discussion. This work is also partially supported through grants to KEL and PDL from National Institute for Social Care and Health Research (NISCHR, Wales, UK). IBERS receives strategic funding from Biotechnology and Biological Sciences Research Council (BBSRC), UK who provided the sequencing platform infrastructure to support this work. We would also like to thank the reviewers of this manuscript for their helpful and constructive criticisms of earlier drafts.	Bizzarro MJ, 2011, EMERG INFECT DIS, V17, P1971, DOI 10.3201/eid1710.101967; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Cameron SJS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149095; Cameron SJS, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv091; Caramori G, 2011, INT J BIOCHEM CELL B, V43, P1030, DOI 10.1016/j.biocel.2010.08.022; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; D'Urso V, 2013, J CELL PHYSIOL, V228, P945, DOI 10.1002/jcp.24263; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Hao F, 2013, ADV MATER RES-SWITZ, V641-642, P625, DOI 10.4028/www.scientific.net/AMR.641-642.625; Hauser PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090934; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hosgood HD, 2014, ENVIRON MOL MUTAGEN, V55, P643, DOI 10.1002/em.21878; Hubers AJ, 2013, BRIT J CANCER, V109, P530, DOI 10.1038/bjc.2013.393; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Khan AA, 2012, BBA-REV CANCER, V1826, P331, DOI 10.1016/j.bbcan.2012.05.005; Koshiol J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032106; Lewis PD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-640; Lim YW, 2013, J CYST FIBROS, V12, P154, DOI 10.1016/j.jcf.2012.07.009; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Narikiyo M, 2004, CANCER SCI, V95, P569, DOI 10.1111/j.1349-7006.2004.tb02488.x; Nowotarski SL, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.3; Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perkins A, 2003, CLIN MICROBIOL INFEC, V9, P576, DOI 10.1046/j.1469-0691.2003.00646.x; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sasaki H, 1998, CANCER RES, V58, P2991; Shiga K, 2001, ONCOL REP, V8, P245; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Tateda M, 2000, INT J MOL MED, V6, P699; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Willner D, 2011, ISME J; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Woo PCY, 2003, J MED MICROBIOL, V52, P137, DOI 10.1099/jmm.0.04950-0; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xiong W, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0028-2; Young RP, 2010, EUR RESPIR J, V36, P1375, DOI 10.1183/09031936.00033310; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208	44	83	92	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177062	10.1371/journal.pone.0177062	http://dx.doi.org/10.1371/journal.pone.0177062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542458	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800007
J	Fang, H; Liang, JJ; Hong, Z; Sugiyama, K; Nozaki, T; Kobayashi, S; Sameshima, T; Namba, H; Asakawa, T				Fang, Huan; Liang, Jingjuan; Hong, Zhen; Sugiyama, Kenji; Nozaki, Takao; Kobayashi, Susumu; Sameshima, Tetsuro; Namba, Hiroki; Asakawa, Tetsuya			Psychometric evaluation of the Chinese version of the revised American Pain Society Patient Outcome Questionnaire concerning pain management in Chinese orthopedic patients	PLOS ONE			English	Article							QUALITY; ADULTS	The present study tested the clinical efficiency (item grouping, internal consistency of the subscales, construct validity, and clinical feasibility) of a widely used pain assessment system, the Mandarin version of the American Pain Society Patient Outcome Questionnaire (APS-POQ-R-C), in Chinese patients. We also attempted to investigate the current quality of pain management provided in orthopedic inpatient units in China and provide baseline data. First, we investigated the test-retest reliability of APS-POQ-R-C. In total, 236 orthopedic patients were evaluated. Our results showed that APS-POQ-R-C has satisfactory internal consistency and construct validity, although some items are not appropriate for orthopedic patients. Test-retest reliability outcomes indicated that APS-POQ-R-C is a satisfactory battery with acceptable validity and reliability, and is therefore recommended for pain management in future studies.	[Fang, Huan] Fudan Univ, Dept Pharm, Jinshan Hosp, Shanghai, Peoples R China; [Liang, Jingjuan] Fudan Univ, Dept Orthoped, Huashan Hosp, Shanghai, Peoples R China; [Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China; [Sugiyama, Kenji; Nozaki, Takao; Kobayashi, Susumu; Sameshima, Tetsuro; Namba, Hiroki; Asakawa, Tetsuya] Hamamatsu Univ, Dept Neurosurg, Sch Med, Hamamatsu, Shizuoka, Japan	Fudan University; Fudan University; Fudan University; Hamamatsu University School of Medicine	Fang, H (corresponding author), Fudan Univ, Dept Pharm, Jinshan Hosp, Shanghai, Peoples R China.; Asakawa, T (corresponding author), Hamamatsu Univ, Dept Neurosurg, Sch Med, Hamamatsu, Shizuoka, Japan.	fanghanyu2010@163.com; asakawat1971@gmail.com	Asakawa, Tetsuya/ABE-5307-2020	Asakawa, Tetsuya/0000-0002-2300-3509	Japanese Society for the Promotion of Science [20791025, 24592157, 15k10358]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A was supported by grants from the Japanese Society for the Promotion of Science (Grant-in-Aid for Young Scientists, Type B, No. 20791025 and Grant-in-Aid for Scientific Research C, General, No. 24592157 and 15k10358). https:// www.jsps.go.jp/english/.	Anastasi AaU, 1997, PSYCHOL TESTING; Bond MR, P 7 WORLD C PAIN; Botti M, 2015, J PAIN, V16, P727, DOI 10.1016/j.jpain.2015.03.016; Dihle A, 2006, J PAIN, V7, P272, DOI 10.1016/j.jpain.2005.11.005; Dihle A, 2008, J CLIN NURS, V17, P2070, DOI 10.1111/j.1365-2702.2007.02142.x; Dong NPT, 2017, SOMATOSENS MOT RES, P1; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Erlenwein J, 2014, SCHMERZ, V28, P147, DOI 10.1007/s00482-014-1398-2; Evans CJ, 2004, PAIN, V112, P254, DOI 10.1016/j.pain.2004.09.005; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Gilson AM, 2007, CA-CANCER J CLIN, V57, P341, DOI 10.3322/CA.57.6.341; Gordon DB, 2005, ARCH INTERN MED, V165, P1574, DOI 10.1001/archinte.165.14.1574; Gordon Debra B, 2002, Pain Manag Nurs, V3, P116, DOI 10.1053/jpmn.2002.127570; Gordon DB, 2010, J PAIN, V11, P1172, DOI 10.1016/j.jpain.2010.02.012; Hansson E, 2006, PAIN MANAG NURS, V7, P93, DOI 10.1016/j.pmn.2006.06.002; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Idvall E, 2002, J ADV NURS, V37, P532, DOI 10.1046/j.1365-2648.2002.02130.x; Khan DA, 2010, J ALLERGY CLIN IMMUN, V125, pS126, DOI 10.1016/j.jaci.2009.10.028; Kwon JH, 2013, J PALLIAT MED, V16, P908, DOI 10.1089/jpm.2012.0610; Labianca R, 2012, CLIN DRUG INVEST, V32, P53, DOI 10.2165/11630080-000000000-00000; Langford RM, 2006, CLIN RHEUMATOL, V25, pS2, DOI 10.1007/s10067-006-0311-5; Lorenz KA, 2009, J AM BOARD FAM MED, V22, P291, DOI 10.3122/jabfm.2009.03.080162; Manjiani D, 2014, OCHSNER J, V14, P208; Mularski RA, 2006, J GEN INTERN MED, V21, P607, DOI 10.1111/j.1525-1497.2006.00415.x; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Shaik MM, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0509-5; Solensky R, 2010, ANN ALLERG ASTHMA IM, V105, P259, DOI 10.1016/j.anai.2010.08.002; Stockler MR, 2012, J CLIN ONCOL, V30, P1907, DOI 10.1200/JCO.2011.41.3146; Tan EC, 2008, J PAIN, V9, P849, DOI 10.1016/j.jpain.2008.04.004; Walid Mohammad Sami, 2008, Pain Pract, V8, P417, DOI 10.1111/j.1533-2500.2008.00222.x; Zoega S, 2014, PAIN MANAG NURS, V15, P143, DOI 10.1016/j.pmn.2012.08.001	31	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178268	10.1371/journal.pone.0178268	http://dx.doi.org/10.1371/journal.pone.0178268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542551	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800061
J	Malik, A; Pal, R; Gupta, SK				Malik, Ankita; Pal, Rahul; Gupta, Satish Kumar			Interdependence of JAK-STAT and MAPK signaling pathways during EGF-mediated HTR-8/SVneo cell invasion	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; SERINE PHOSPHORYLATION; HUMAN TROPHOBLAST; MATRIX METALLOPROTEINASES; EXPRESSION; PREECLAMPSIA; PROLIFERATION; RECEPTOR; TRANSCRIPTION	Invasion of trophoblast cells is spatio-temporally regulated by various cytokines and growth factors. In pregnancy, complications like preeclampsia, shallow invasion of trophoblast cells and low amounts of epidermal growth factor (EGF) have been reported. In the present study, regulatory mechanisms associated with EGF-mediated invasion in HTR-8/SVneo trophoblastic cells have been delineated. Treatment of HTR-8/SVneo cells with EGF (10 ng/ml) led to eight fold increase (p < 0.05) in invasion. Increased invasion of HTR-8/SVneo cells by EGF was associated with an increase in phosphorylation of ERK1/2. In addition, significant phosphorylation of STAT1 (ser 727) and STAT3 (both tyr 705 and ser 727 residues) was also observed, accompanied by a decrease in total STAT1. Inhibition of ERK1/2 phosphorylation by U0126 (10 mu M) led to a significant decrease in EGF-mediated invasion with simultaneous decrease in the phosphorylated forms of STAT3 and STAT1. Decrease in total STAT1 was also reversed on inhibition of ERK1/2. Interestingly, inhibition of STAT3 by siRNA led to a significant decrease in EGF-mediated invasion of HTR-8/SVneo cells and phosphorylation of STAT1, but it did not have any effect on the activation of ERK1/2. On the other hand, inhibition of STAT1 by siRNA, also led to a significant decrease in the EGF-mediated invasion of HTR-8/SVneo cells, showed concomitant decrease in ERK1/2 phosphorylation and STAT3 phosphorylation at ser 727 residue. These results suggest cross-communication between ERK1/2 and JAK-STAT pathways during EGF-mediated increase in invasion of trophoblast cells; phosphorylation at ser 727 residue of both STAT3 and STAT1 appears to be critical.	[Malik, Ankita; Gupta, Satish Kumar] Natl Inst Immunol, Reprod Cell Biol Lab, Delhi, India; [Pal, Rahul] Natl Inst Immunol, Immunoendocrinol Lab, Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Gupta, SK (corresponding author), Natl Inst Immunol, Reprod Cell Biol Lab, Delhi, India.	skgupta@nii.ac.in			J. C. Bose Fellowship - Science and Engineering Research Board, Department of Science and Technology [SB/S2/JCB-040/2015]; Department of Biotechnology, Government of India [BT/PR12312/MED/30/1424/2014]; National Institute of Immunology, NewDelhi, India	J. C. Bose Fellowship - Science and Engineering Research Board, Department of Science and Technology; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Institute of Immunology, NewDelhi, India	This research is funded by J. C. Bose Fellowship (SB/S2/JCB-040/2015) granted to SKG by Science and Engineering Research Board, Department of Science and Technology and Department of Biotechnology project number-BT/PR12312/MED/30/1424/2014, Government of India. SKG would also like to acknowledge National Institute of Immunology, NewDelhi, India for financial support. These funding sources have no role in data collection, experimental design and manuscript preparation role in data collection, experimental design and manuscript preparation.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Anteby EY, 2004, MOL HUM REPROD, V10, P229, DOI 10.1093/molehr/gah031; Armant DR, 2015, PLACENTA, V36, P270, DOI 10.1016/j.placenta.2014.12.006; BASS KE, 1994, DEV BIOL, V164, P550, DOI 10.1006/dbio.1994.1223; Biadasiewicz K, 2011, ENDOCRINOLOGY, V152, P1458, DOI 10.1210/en.2010-0936; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Chenthuran T, 2014, J OBSTET GYNAECOL RE, V40, P1235, DOI 10.1111/jog.12362; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Delgoffe Greg M, 2013, JAKSTAT, V2, pe23060, DOI 10.4161/jkst.23060; Faxen M, 1998, AM J PERINAT, V15, P9, DOI 10.1055/s-2007-993890; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Fitzgerald JS, 2008, HUM REPROD UPDATE, V14, P335, DOI 10.1093/humupd/dmn010; Fitzgerald JS, 2010, AM J REPROD IMMUNOL, V63, P492, DOI 10.1111/j.1600-0897.2010.00824.x; Goldman-Wohl D, 2002, MOL CELL ENDOCRINOL, V187, P233, DOI 10.1016/S0303-7207(01)00687-6; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Gugneja S, 1997, J BIOL CHEM, V272, P18732, DOI 10.1074/jbc.272.30.18732; Gupta SK, 2016, AM J REPROD IMMUNOL, V75, P361, DOI 10.1111/aji.12436; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jia RZ, 2014, PLACENTA, V35, P450, DOI 10.1016/j.placenta.2014.04.011; Jia RZ, 2014, CELL PHYSIOL BIOCHEM, V34, P628, DOI 10.1159/000363028; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Lindqvist P, 1999, EARLY HUM DEV, V56, P143, DOI 10.1016/S0378-3782(99)00037-7; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Liu LY, 2016, J APPL TOXICOL, V36, P946, DOI 10.1002/jat.3227; Marca HL, 2008, HUM REPROD, V23, P1733; Maruo T, 1995, REPROD FERT DEVELOP, V7, P1465, DOI 10.1071/RD9951465; MATSUO H, 1993, ACTA ENDOCRINOL-COP, V128, P225, DOI 10.1530/acta.0.1280225; Morales-Prieto DM, 2013, SCI WORLD J, DOI 10.1155/2013/259845; Ospina-Prieto S, 2015, REPROD SCI, V22, P1358, DOI 10.1177/1933719115578923; Ospina-Prieto S, 2014, PLACENTA, V35, pA104, DOI 10.1016/j.placenta.2014.06.340; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; Qiu Q, 2004, MOL HUM REPROD, V10, P677, DOI 10.1093/molehr/gah088; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Sonderegger S, 2011, HUM REPROD, V26, P2841, DOI 10.1093/humrep/der259; Sousa F L P, 2012, Pregnancy Hypertens, V2, P243, DOI 10.1016/j.preghy.2012.04.118; Staun-Ram E, 2009, PLACENTA, V30, P1029, DOI 10.1016/j.placenta.2009.09.010; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Suman P., 2013, JAK STAT, V2, DOI DOI 10.4161/JKST.25155; Suman P, 2013, FERTIL STERIL, V99, P533, DOI 10.1016/j.fertnstert.2012.10.004; Suman P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029745; Uchikura Y, 2017, REPROD SCI, V1; Uckun FM, 2012, P NATL ACAD SCI USA, V109, P18072, DOI 10.1073/pnas.1209828109; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wortman AC, 2013, OBSTET GYN CLIN N AM, V40, P137, DOI 10.1016/j.ogc.2012.12.002; Xu GX, 2001, BIOCHEM BIOPH RES CO, V287, P47, DOI 10.1006/bbrc.2001.5533; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhang Z, 2015, J MOL HISTOL, V46, P205, DOI 10.1007/s10735-015-9613-8	51	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178269	10.1371/journal.pone.0178269	http://dx.doi.org/10.1371/journal.pone.0178269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542650	gold, Green Submitted, Green Published			2022-12-27	WOS:000402062800062
J	Takeda, H; Zhou, W; Kido, K; Suno, R; Iwasaki, T; Kobayashi, T; Sawasaki, T				Takeda, Hiroyuki; Zhou, Wei; Kido, Kohki; Suno, Ryoji; Iwasaki, Takahiro; Kobayashi, Takuya; Sawasaki, Tatsuya			CP5 system, for simple and highly efficient protein purification with a C-terminal designed mini tag	PLOS ONE			English	Article							RECOMBINANT PROTEINS; STEP PURIFICATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; COUPLED RECEPTOR; AFFINITY TAG; ANTIBODY; IMMOBILIZATION; PEPTIDE; COMPLEX	There are many strategies to purify recombinant proteins of interest, and affinity purification utilizing monoclonal antibody that targets a linear epitope sequence is one of the essential techniques used in current biochemistry and structural biology. Here we introduce a new protein purification system using a very short CP5 tag. First, we selected anti-dopamine receptor D1 (DRD1) rabbit monoclonal antibody clone Ra62 (Ra62 antibody) as capture antibody, and identified its minimal epitope sequence as a 5-amino-acid sequence at C-terminal of DRD1 (GQHPT-COOH, D1CE sequence). We found that single amino acid substitution in D1CE sequence (GQHVT-COOH) increased dissociation rate up to 10-fold, and named the designed epitope sequence CP5 tag. Using Ra62 antibody and 2 peptides with different affinity, we developed a new affinity protein purification method, CP5 system. Ra62 antibody quickly captures CP5-tagged target protein, and captured CP5-tagged protein was eluted by competing with higher affinity D1CE peptide. By taking the difference of the affinity between D1CE and CP5, sharp elution under mild condition was achieved. Using CP5 system, we successfully purified deubiquitinase CYLD and E3 ubiquitin ligase MARCH3, and detected their catalytic activity. As to G protein-coupled receptors (GPCRs), 9 out of 12 cell-free synthesized ones were purified, demonstrating its purification capability of integral membrane proteins. CP5 tagged CHRM2 expressed by baculovirus-insect cell was also successfully purified by CP5 system. CP5 system offers several distinct advantages in addition to its specificity and elution performance. CP5 tag is easy to construct and handle because of its short length, which has less effect on protein characters. Mild elution of CP5 system is particulaly suitable for preparing delicate proteins such as enzymes and membrane proteins. Our data demonstrate that CP5 system provides a new promising option in protein sample preparation with high yield, purity and activity for downstream applications in functional and structural analysis.	[Takeda, Hiroyuki; Zhou, Wei; Kido, Kohki; Iwasaki, Takahiro; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime, Japan; [Suno, Ryoji; Kobayashi, Takuya] Kyoto Univ, Dept Med Chem & Cell Biol, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Kobayashi, Takuya] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo, Japan	Ehime University; Kyoto University	Sawasaki, T (corresponding author), Ehime Univ, Proteosci Ctr, Matsuyama, Ehime, Japan.	sawasaki@ehime-u.ac.jp		Suno, Ryoji/0000-0003-2378-236X; Sawasaki, Tatsuya/0000-0002-7952-0556	Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS KAKENHI [24710251, 15K08268, 25117719, 25290077, 26640130, 26750375]; Grants-in-Aid for Scientific Research [16H06579, 16H04729] Funding Source: KAKEN	Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was mainly supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan (K. T. and T. S.). This work was also partially supported by JSPS KAKENHI Grant Numbers 24710251 (H. T.), 15K08268 (R.S.), 25117719 (T.S.), 25290077 (T.S.), 26640130 (T.S.), and 26750375 (H. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IMPROVED STRATEGY EA, V55, P227; BEDOUELLE H, 1988, EUR J BIOCHEM, V171, P541, DOI 10.1111/j.1432-1033.1988.tb13823.x; Crowe J, 1994, Methods Mol Biol, V31, P371; Dalibor Milie DBV, 2015, FRONTIERS MEDIA SA, V6, P394; Einhauer A, 2001, J CHROMATOGR A, V921, P25, DOI 10.1016/S0021-9673(01)00831-7; Fujii Y, 2014, PROTEIN EXPRES PURIF, V95, P240, DOI 10.1016/j.pep.2014.01.009; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Morris J, 2016, PROTEIN EXPRES PURIF, V126, P93, DOI 10.1016/j.pep.2016.05.013; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; PRICKETT KS, 1989, BIOTECHNIQUES, V7, P580; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Sawasaki T, 2008, FEBS LETT, V582, P221, DOI 10.1016/j.febslet.2007.12.004; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takeda H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11333; Wood DW, 2014, CURR OPIN STRUC BIOL, V26, P54, DOI 10.1016/j.sbi.2014.04.006; Xu XL, 2010, PROTEIN EXPRES PURIF, V72, P149, DOI 10.1016/j.pep.2010.04.009; Yano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156716	27	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178246	10.1371/journal.pone.0178246	http://dx.doi.org/10.1371/journal.pone.0178246			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542437	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800060
J	Banno, T; Omura, T; Masaki, N; Arima, H; Xu, D; Okamoto, A; Costigan, M; Latremoliere, A; Matsuyama, Y; Setou, M				Banno, Tomohiro; Omura, Takao; Masaki, Noritaka; Arima, Hideyuki; Xu, Dongmin; Okamoto, Ayako; Costigan, Michael; Latremoliere, Alban; Matsuyama, Yukihiro; Setou, Mitsutoshi			Arachidonic acid containing phosphatidylcholine increases due to microglial activation in ipsilateral spinal dorsal horn following spared sciatic nerve injury	PLOS ONE			English	Article							IMAGING MASS-SPECTROMETRY; NEUROPATHIC PAIN; RAT MODEL; SIGNALING PATHWAYS; CORD-INJURY; MINOCYCLINE; MECHANISMS; NEURONS; LIPIDS; GLIA	Peripheral nerve injury induces substantial molecular changes in the somatosensory system that leads to maladaptive plasticity and cause neuropathic pain. Understanding the molecular pathways responsible for the development of neuropathic pain is essential to the development of novel rationally designed therapeutics. Although lipids make up to half of the dry weight of the spinal cord, their relation with the development of neuropathic pain is poorly understood. We aimed to elucidate the regulation of spinal lipids in response to neuropathic peripheral nerve injury in mice by utilizing matrix-assisted laser desorption/ionization imaging mass spectrometry, which allows visualization of lipid distribution within the cord. We found that arachidonic acid (AA) containing [PC(diacyl-16:0/20:4)+K](+) was increased temporarily at superficial ipsilateral dorsal horn seven days after spared nerve injury (SNI). The spatiotemporal changes in lipid concentration resembled microglia activation as defined by ionized calcium binding adaptor molecule 1 (Iba1) immunohistochemistry. Suppression of microglial function through minocycline administration resulted in attenuation of hypersensitivity and reduces [PC(diacyl-16:0/20:4)+K](+) elevation in the spinal dorsal horn. These data suggested that AA containing [PC(diacyl-16:0/20:4)+K](+) is related to hypersensitivity evoked by SNI and implicate microglial cell activation in this lipid production.	[Banno, Tomohiro; Omura, Takao; Arima, Hideyuki; Xu, Dongmin; Okamoto, Ayako; Matsuyama, Yukihiro] Hamamatsu Univ Sch Med, Dept Orthopaed Surg, Hamamatsu, Shizuoka, Japan; [Banno, Tomohiro; Masaki, Noritaka; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cellular & Mol Anat, Hamamatsu, Shizuoka, Japan; [Banno, Tomohiro; Masaki, Noritaka; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Int Mass Imaging Ctr, Hamamatsu, Shizuoka, Japan; [Costigan, Michael; Latremoliere, Alban] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA; [Costigan, Michael; Latremoliere, Alban] Harvard Med Sch, Boston, MA USA; [Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Inst Med Photon Res, Dept Syst Mol Anat, Preeminent Med Photon Educ & Res Ctr, Hamamatsu, Shizuoka, Japan; [Setou, Mitsutoshi] Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Setou, Mitsutoshi] Natl Inst Physiol Sci, Div Neural Systemat, Okazaki, Aichi, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Hamamatsu University School of Medicine; University of Hong Kong; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Cellular & Mol Anat, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Hamamatsu Univ Sch Med, Int Mass Imaging Ctr, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Hamamatsu Univ Sch Med, Inst Med Photon Res, Dept Syst Mol Anat, Preeminent Med Photon Educ & Res Ctr, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China.; Setou, M (corresponding author), Natl Inst Physiol Sci, Div Neural Systemat, Okazaki, Aichi, Japan.	setou@hama-med.ac.jp		Latremoliere, Alban/0000-0002-9212-1007	Japan Agency for Medical Research and Development [921910520]; Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure [25801]; JSPS KAKENHI [24592192]; NIH [NS074430]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074430] Funding Source: NIH RePORTER	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Japan Agency for Medical Research and Development (grant no. 921910520) and Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure (grant no. 25801) for M. Setou, JSPS KAKENHI (grant no. 24592192) for Y. Matsuyama and NIH (NS074430) for M. Costigan.; This work was supported by Japan Agency for Medical Research and Development (grant No.921910520) and Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure (grant No.25801) for M. Setou, JSPS KAKENHI (grant No. 24592192) for Y. Matsuyama and NIH (NS074430) for M. Costigan.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Arima H, 2014, NEUROSCIENCE, V269, P1, DOI 10.1016/j.neuroscience.2014.03.012; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; Buczynski MW, 2010, J NEUROCHEM, V114, P981, DOI 10.1111/j.1471-4159.2010.06815.x; Casas C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09185; Cirillo G, 2011, NEUROBIOL DIS, V41, P630, DOI 10.1016/j.nbd.2010.11.012; Colovic M, 2003, J CHROMATOGR B, V791, P337, DOI 10.1016/S1570-0232(03)00247-2; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Costigan M, 2010, BRAIN, V133, P2519, DOI 10.1093/brain/awq195; Cui Z, 2002, BBA-MOL CELL BIOL L, V1585, P87, DOI 10.1016/S1388-1981(02)00328-1; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Gangadharan V, 2013, PAIN, V154, P2801, DOI 10.1016/j.pain.2013.08.019; Hanada M, 2012, ANAL BIOANAL CHEM, V403, P1873, DOI 10.1007/s00216-012-5900-3; Hanrieder J, 2013, ANAL CHEM, V85, P8741, DOI 10.1021/ac401830m; Jackson SN, 2009, J CHROMATOGR B, V877, P2822, DOI 10.1016/j.jchromb.2008.11.033; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Kanda H, 2013, GLIA, V61, P943, DOI 10.1002/glia.22487; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Latremoliere A, 2015, NEURON, V86, P1393, DOI 10.1016/j.neuron.2015.05.033; Ma MT, 2012, EUR J PAIN, V16, P38, DOI 10.1016/j.ejpain.2011.06.013; Meirer K, 2014, BASIC CLIN PHARMACOL, V114, P83, DOI 10.1111/bcpt.12134; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Nalamachu S, 2013, AM J MANAG CARE, V19, pS261; O'Rielly DD, 2007, ANESTHESIOLOGY, V106, P795, DOI 10.1097/01.anes.0000264777.94662.d6; Padi SSV, 2008, EUR J PHARMACOL, V601, P79, DOI 10.1016/j.ejphar.2008.10.018; Papa M, 2014, NEUROSCI BIOBEHAV R, V42, P35, DOI 10.1016/j.neubiorev.2014.01.010; Pernia-Andrade AJ, 2009, SCIENCE, V325, P760, DOI 10.1126/science.1171870; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Piomelli D, 2012, PAIN, V153, P3, DOI 10.1016/j.pain.2011.09.026; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Scholz J, 2008, PAIN, V138, P130, DOI 10.1016/j.pain.2007.11.019; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Sugiura Y, 2006, ANAL CHEM, V78, P8227, DOI 10.1021/ac060974v; Sui P, 2014, J PROTEOME RES, V13, P3957, DOI 10.1021/pr500241q; Sung B, 2007, PAIN, V131, P121, DOI 10.1016/j.pain.2006.12.020; TAL M, 1994, PAIN, V57, P375, DOI 10.1016/0304-3959(94)90013-2; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Ueda H, 2013, BBA-MOL CELL BIOL L, V1831, P61, DOI 10.1016/j.bbalip.2012.08.014; Walker JM, 2005, PROSTAG OTH LIPID M, V77, P35, DOI 10.1016/j.prostaglandins.2004.09.017; Wang HY, 2013, PHARMACOL BIOCHEM BE, V106, P47, DOI 10.1016/j.pbb.2013.03.002; Xu DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26427; Yaksh Tony L, 2015, F1000Prime Rep, V7, P56, DOI 10.12703/P7-56; Yang HJ, 2012, J BIOL CHEM, V287, P5290, DOI 10.1074/jbc.M111.316877; Yuki D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07130	47	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177595	10.1371/journal.pone.0177595	http://dx.doi.org/10.1371/journal.pone.0177595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542572	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500033
J	Finch, JA; Guillaume, G; French, SA; Colaco, RDDR; Davies, JM; Swarbreck, SM				Finch, Jessica A.; Guillaume, Gaetan; French, Stephanie A.; Colaco, Renato D. D. R.; Davies, Julia M.; Swarbreck, Stephanie M.			Wheat root length and not branching is altered in the presence of neighbours, including blackgrass	PLOS ONE			English	Article							ARCHITECTURAL TRAITS; GRAIN-YIELD; PLANT; RECOGNITION; ADAPTATION; GROWTH; BRACHYPODIUM; PRODUCTIVITY; NUTRIENTS; RESPONSES	The effect of neighbouring plants on crop root system architecture may directly interfere with water and nutrient acquisition, yet this important and interesting aspect of competition remains poorly understood. Here, the effect of the weed blackgrass (Alopecurus myosuroides Huds.) on wheat (Triticum aestivum L.) roots was tested, since a low density of this species (25 plants m(-2)) can lead to a 10% decrease in wheat yield and herbicide resistance is problematic. We used a simplified growth system based on gelled medium, to grow wheat alongside a neighbour, either another wheat plant, a blackgrass or Brachypodium dystachion individual (a model grass). A detailed analysis of wheat seminal root system architecture showed that the presence of a neighbour principally affected the root length, rather than number or diameter under a high nutrient regime. In particular, the length of first order lateral roots decreased significantly in the presence of blackgrass and Brachypodium. However, this effect was not noted when wheat plants were grown in low nutrient conditions. This suggests that wheat may be less sensitive to the presence of blackgrass when grown in low nutrient conditions. In addition, nutrient availability to the neighbour did not modulate the neighbour effect on wheat root architecture.	[Finch, Jessica A.; Guillaume, Gaetan; French, Stephanie A.; Colaco, Renato D. D. R.; Davies, Julia M.; Swarbreck, Stephanie M.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Finch, Jessica A.] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [French, Stephanie A.] Univ Liverpool, Dept Mol & Clin Pharmacol, Inst Translat Med, Liverpool, Merseyside, England; [Colaco, Renato D. D. R.] Univ Cambridge, Dept Med, Cambridge, England	University of Cambridge; University of Warwick; University of Liverpool; University of Cambridge	Swarbreck, SM (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	ss2062@cam.ac.uk	French, Stephanie/GQB-0570-2022	Colaco, Renato Daniel dos Reis/0000-0002-9047-1468; Swarbreck, Stephanie M./0000-0001-8355-7354	European Union FP7 Marie Curie International Reintegration Grant; Gatsby Charitable Foundation; Broodbank Trust University of Cambridge; Newton Trust University of Cambridge	European Union FP7 Marie Curie International Reintegration Grant; Gatsby Charitable Foundation; Broodbank Trust University of Cambridge; Newton Trust University of Cambridge	This work was supported European Union FP7 Marie Curie International Reintegration Grant, the Gatsby Charitable Foundation, the Broodbank Trust University of Cambridge, the Newton Trust University of Cambridge.; We thank Dr. Krys Kelly (Department of Plant Sciences, University of Cambridge) and Dr. Tangyao Wang (Department of Pure Mathematics and Mathematical Statistics, University of Cambridge) for advice on statistical analyses. This work was supported by European Union FP7 Marie Curie International Reintegration Grant, the Gatsby Charitable Foundation, the Broodbank Trust and the Newton Trust University of Cambridge.	Andrew IKS, 2015, WEED RES, V55, P239, DOI 10.1111/wre.12137; Araus JL, 2008, CRIT REV PLANT SCI, V27, P377, DOI 10.1080/07352680802467736; Armas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027791; Badri DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046640; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Bazzzaz FA, 1996, PLANT CHANGING ENV L; Belter PR, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv059; Bengough AG, 2004, PLANT SOIL, V262, P63, DOI 10.1023/B:PLSO.0000037029.82618.27; Biedrzycki Meredith L, 2010, Commun Integr Biol, V3, P28; Blair AM, 1999, 1999 BRIGHTON CONFERENCE: WEEDS, VOLS 1-3, P753; Caffaro MM, 2013, PLANT GROWTH REGUL, V70, P141, DOI 10.1007/s10725-013-9786-7; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Chochois V, 2012, J EXP BOT, V63, P3467, DOI 10.1093/jxb/ers044; de Kroon H, 2007, SCIENCE, V318, P1562, DOI 10.1126/science.1150726; de Wit M, 2012, P NATL ACAD SCI USA, V109, P14705, DOI 10.1073/pnas.1205437109; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Fang SQ, 2013, P NATL ACAD SCI USA, V110, P2670, DOI 10.1073/pnas.1222821110; Fang SQ, 2011, PLANT PHYSIOL, V155, P1277, DOI 10.1104/pp.110.167304; Foulkes MJ, 2009, FIELD CROP RES, V114, P329, DOI 10.1016/j.fcr.2009.09.005; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Gersani M, 2001, J ECOLOGY; Gewin V, 2010, NATURE, V466, P552, DOI 10.1038/466552a; Gmerek J, 2010, ALLELOPATHY J, V25, P475; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Lobet G, 2011, PLANT PHYSIOL, V157, P29, DOI 10.1104/pp.111.179895; LUTMAN PJW, 2013, ALOPECURUS MYOSUROID, V53, P299, DOI DOI 10.1111/WRE.12024; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; Manschadi AM, 2006, FUNCT PLANT BIOL, V33, P823, DOI 10.1071/FP06055; Mommer L, 2012, FUNCT ECOL, V26, P66, DOI 10.1111/j.1365-2435.2011.01916.x; Moss SR, 2004, WEED SCI, V52, P864, DOI 10.1614/WS-04-012R1; Moss SR, 2007, WEED TECHNOL, V21, P300, DOI 10.1614/WT-06-087.1; Narayanan S, 2014, PLOS ONE, V9; Nord EA, 2012, FUNCTIONAL PLANT BIO; OYANAGI A, 1994, PLANT SOIL, V165, P323, DOI 10.1007/BF00008076; Paez-Garcia Ana, 2015, Plants-Basel, V4, P334, DOI 10.3390/plants4020334; Pinheiro J, 2016, R PACKAGE VERSION; Rewald B, 2011, PLANT CELL ENVIRON, V34, P33, DOI 10.1111/j.1365-3040.2010.02223.x; Reynolds MP, 2006, J AGR SCI-CAMBRIDGE, V144, P3, DOI 10.1017/S0021859606005867; RICHARDS RA, 1989, AUST J AGR RES, V40, P943, DOI 10.1071/AR9890943; Roy R, 2014, PLANT SCI, V221, P42, DOI 10.1016/j.plantsci.2014.01.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semchenko M, 2007, NEW PHYTOL, V176, P644, DOI 10.1111/j.1469-8137.2007.02211.x; Semchenko M, 2014, NEW PHYTOL, V204, P631, DOI 10.1111/nph.12930; Sparkes DL, 2008, ANN APPL BIOL, V152, P389, DOI 10.1111/j.1744-7348.2008.00230.x; Stark G., 2011, Aspects of Applied Biology, P259; Stobart RM, 2013, 509 HGCA, P1; Storkey J, 2010, WEED SCI, V58, P39, DOI 10.1614/WS-09-096.1; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Trapeznikov VK, 2003, PLANT SOIL, V252, P207, DOI 10.1023/A:1024734310214; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Wang J, 2013, ANN BOT-LONDON, V111, P1139, DOI 10.1093/aob/mct080	55	5	5	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178176	10.1371/journal.pone.0178176	http://dx.doi.org/10.1371/journal.pone.0178176			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542446	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500070
J	Murray, MH; Fassina, S; Hopkins, JB; Whittington, J; St Clair, CC				Murray, Maureen H.; Fassina, Sarah; Hopkins, John B., III; Whittington, Jesse; St Clair, Colleen C.			Seasonal and individual variation in the use of rail-associated food attractants by grizzly bears (Ursus arctos) in a national park	PLOS ONE			English	Article							LEARNED FORAGING BEHAVIOR; STABLE-ISOTOPES; BROWN BEARS; BLACK BEARS; ROADS; DIET; MORTALITY; CONFLICT; PATTERNS; COYOTES	Similar to vehicles on roadways, trains frequently kill wildlife via collisions along railways. Despite the prevalence of this mortality worldwide, little is known about the relative importance of wildlife attractants associated with railways, including spilled agricultural products, enhanced vegetation, invertebrates, and carcasses of rail-killed ungulates. We assessed the relative importance of several railway attractants to a provincially-threatened population of grizzly bears (Ursus arctos) in Banff and Yoho National Parks, Canada, for which rail-caused mortality has increased in recent decades without known cause. We examined the relationship between the use of the railway and diet by fitting 21 grizzly bears with GPS collars in 2011-2013 and measuring the stable isotope values (delta(15) N, delta(34) S) derived from their hair. We also examined the importance of rail-associated foods to grizzly bears by analyzing 230 grizzly bear scats collected from May through October in 2012-2014, some of which could be attributed to GPS-collared bears. Among the 21 collared bears, 17 used the rail rarely (< 9% of the days they were monitored), and only four bears (which included the three smallest bears and the largest bear in our sample) used the rail frequently (> 20% of their monitored days). We found no significant relationships between delta(15) N and delta(34) S values measured from the hair of grizzlies and their frequency of rail use. Instead, delta(15) N increased with body mass, especially for male bears, suggesting large males consumed more animal protein during hair growth. All four bears that used the railway frequently produced scats containing grain. Almost half the scats (43%) collected within 150 m of the railway contained grain compared to only 7% of scats found > 150 m from the railway. Scats deposited near the rail were also more likely to contain grain in the fall (85% of scats) compared to summer (14%) and spring (17%), and those containing grain were more diverse in their contents (6.8 +/- 2.2 species vs. 4.9 +/- 1.6, P < 0.001). Lastly, scats collected near the rail were more likely to contain ungulate hair and ant remains, especially in the summer. Our results support local management knowledge that some bears in the region use the railway to forage and supplement their diets with spilled grain, but that individual use of the railway and associated foods were highly variable. We suggest that managers continue to reduce the risk of bears being killed by trains by reactively removing grain and ungulate carcasses from the railway, reducing the amount of grain spilled by trains, and target mitigation to the specific individuals and locations that attract recurrent rail-based foraging.	[Murray, Maureen H.; Fassina, Sarah; Hopkins, John B., III; St Clair, Colleen C.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Whittington, Jesse] Banff Natl Pk, Banff, AB, Canada; [Murray, Maureen H.] Univ Georgia, Warne Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Hopkins, John B., III] Unity Coll, Sch Biodivers Conservat, Unity, ME USA	University of Alberta; University System of Georgia; University of Georgia	St Clair, CC (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	cstclair@ualberta.ca	St. Clair, Colleen Cassady/A-2953-2016	St. Clair, Colleen Cassady/0000-0002-3378-795X	Joint Initiative for Grizzly Bear Conservation by Parks Canada and Canadian Pacific; Natural Sciences and Engineering Council of Canada [File CRDPJ 441928-12]; Collaborative Research and Development Program of the Natural Science and Engineering Council [File CRDPJ 441928-12]	Joint Initiative for Grizzly Bear Conservation by Parks Canada and Canadian Pacific; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Collaborative Research and Development Program of the Natural Science and Engineering Council	We are grateful for funding to conduct this project from the Joint Initiative for Grizzly Bear Conservation by Parks Canada and Canadian Pacific and the Natural Sciences and Engineering Council of Canada, grant number File CRDPJ 441928-12, url: http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/-index_eng.asp. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript, but Parks Canada provided the hair samples used for the SIA analysis.; We are grateful for extensive logistical support and funding to conduct this project from the Joint Initiative for Grizzly Bear Conservation by Parks Canada and Canadian Pacific with matching funds from the Collaborative Research and Development Program of the Natural Science and Engineering Council (File CRDPJ 441928-12). We also thank Dan Tyers and Molly Runyun (USFS, Bozeman, MT) for their considerable help with scat analysis instruction. We also appreciated the capable and conscientious work of many individuals at Parks Canada (Brianna Burley, Anne Forshner, Blair Fyten, Dave Garrow, Don Gorrie, Simon Ham, Bill Hunt, Tom Hurd, Rick Kubian, Kris McCleary, Steve Michel, Saundi Norris, Dan Rafla), Canadian Pacific (Chris Bunce, Perry Busse, Ken Roberge, Lorne Hoffman, Joshua Pemberton), and NSERC (Theresa Anderson). Excellent field assistance was provided by Allison Banting, Kevan Cave, Ben Dorsey, Daniel Ellis, Patrick Gilhooly, Liam Harrap, Brittany Jackson, Julia Jackson, Megan Kinley, Pete Knamiller, Cole Lord-May, Breda Moriarty, Niels de Nijs, Gregor Pachmann, Sonya Pollock, Laurens Put, Meg Raymond, Camille Toscani, and John Tress.	Andersen Reidar, 1991, Alces, V27, P79; Ando Chieko, 2003, Mammal Study, V28, P135, DOI 10.3106/mammalstudy.28.135; [Anonymous], 2015, PARKS CAN ATT 2010 1; [Anonymous], 1987, BEARS BIOL MANAG; Arjo WM, 2002, J MAMMAL, V83, P754, DOI 10.1644/1545-1542(2002)083<0754:DOBWAC>2.0.CO;2; Babinska-Werka J, 2015, TRANSPORT RES D-TR E, V38, P6, DOI 10.1016/j.trd.2015.04.021; Barboza P. S., 2009, INT WILDL NUTR, P350, DOI 10. 1007/978-3-540-87885-8; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; Becker Earl F., 1991, Alces, V27, P161; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bertch B., 2010, GRIZZLY BEAR MONITOR; Boscagli G., 1987, INT C BEAR RES MANAG, P97; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Clark ML, 2003, DYNAMICS WHEAT BARLE; Clevenger AP, 2001, WILDLIFE SOC B, V29, P646; Coogan SCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097968; Dasgupta S, 2015, HUM DIMENS WILDL, V20, P81, DOI 10.1080/10871209.2014.937017; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Di Domenico G, 2012, MAMM BIOL, V77, P190, DOI 10.1016/j.mambio.2012.01.002; Dorsey B. P., 2011, THESIS; Dorsey B, 2015, HANDBOOK OF ROAD ECOLOGY, P219; Edwards MA, 2011, OECOLOGIA, V165, P877, DOI 10.1007/s00442-010-1869-9; Elfstrom M, 2013, WILDLIFE BIOL, V19, P317, DOI 10.2981/12-121; Elfstrom M, 2014, MAMMAL REV, V44, P5, DOI 10.1111/j.1365-2907.2012.00223.x; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Gangadharan A, 2017, ANIM CONSER IN PRESS; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; Hobson KA, 2000, CAN J ZOOL, V78, P1332, DOI 10.1139/cjz-78-8-1332; Hopkins JB, 2014, ISOT ENVIRON HEALT S, V50, P322, DOI 10.1080/10256016.2014.922555; Hopkins JB, 2014, FRONT ECOL ENVIRON, V12, P107, DOI 10.1890/130276; Hopkins JB, 2013, J MAMMAL, V94, P1214, DOI 10.1644/13-MAMM-A-009.1; Hopkins JB, 2012, J WILDLIFE MANAGE, V76, P703, DOI 10.1002/jwmg.318; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Huber D, 1998, URSUS-SERIES, V10, P167; Ito TY, 2005, CONSERV BIOL, V19, P945, DOI 10.1111/j.1523-1739.2005.004364.x; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; Jaren Vemund, 1991, Alces, V27, P93; Kershaw L, 1998, PLANTS ROCKY MOUNTAI, P49; Kusta T, 2014, TURK J ZOOL, V38, P479, DOI 10.3906/zoo-1308-18; Mazur R, 2008, ANIM BEHAV, V75, P1503, DOI 10.1016/j.anbehav.2007.10.027; Mizukami RN, 2005, URSUS, V16, P93, DOI 10.2192/1537-6176(2005)016[0093:EOFHBM]2.0.CO;2; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Murray Edwards M, 2015, P R SOC B, V282; Murray M, 2015, ECOGRAPHY, V38, P1235, DOI 10.1111/ecog.01128; Nelson RA, 1983, BEARS THEIR BIOL MAN, V5, P284, DOI [DOI 10.2307/3872551, 10.2307/3872551]; Newsome SD, 2010, J MAMMAL, V91, P1313, DOI 10.1644/09-MAMM-A-362.1; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; Pereira LM, 2014, MAMMAL REV, V44, P44, DOI 10.1111/mam.12005; Reynolds-Hogland MJ, 2007, J MAMMAL, V88, P1050, DOI 10.1644/06-MAMM-A-072R1.1; Sawaya MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034777; Schwartz C.C., 1991, ALCES, V27, P227; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Singh A. K., 2001, ELEPHANT MORTALITY T; St Clair CC, 2003, CONSERV BIOL, V17, P1151; Steiner W, 2014, ACCIDENT ANAL PREV, V66, P168, DOI 10.1016/j.aap.2014.01.020; Swenson JE, 1999, CAN J ZOOL, V77, P551, DOI 10.1139/cjz-77-4-551; Tear MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068382; Train Pissot J., 2007, P 2007 INT C EC TRAN, P64; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Van Der Grift E. A., 1999, Lutra, V42, P77; Waller JS, 2005, J WILDLIFE MANAGE, V69, P985, DOI 10.2193/0022-541X(2005)069[0985:EOTIOG]2.0.CO;2; Welbes M., 2011, RAIL MODERNIZATION S; Wells P, 1999, P 3 INT C WILDL EC T, P237; Whittington J, J APPL ECOL	70	24	24	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0175658	10.1371/journal.pone.0175658	http://dx.doi.org/10.1371/journal.pone.0175658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542218	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500002
J	Peng, JP; Zheng, H; Wang, X; Cheng, ZX				Peng, Jianping; Zheng, Hang; Wang, Xia; Cheng, Zhixiang			Upregulation of TLR4 via PKC activation contributes to impaired wound healing in high-glucose-treated kidney proximal tubular cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ISCHEMIA-REPERFUSION INJURY; ACUTE-RENAL-FAILURE; LIVER-REGENERATION; MICE; PROLIFERATION; APOPTOSIS; PATHWAY; DISEASE; REPAIR	Acute kidney injury (AKI) leads to a worse prognosis in diabetic patients compared with prognoses in non-diabetic patients, but whether and how diabetes affects kidney repair after AKI remains unknown. Here, we used scratch-wound healing and transwell migration models to examine whether and how wound healing is affected by high glucose levels in cultured kidney proximal tubular cells (RPTC). The results show that scratch-wound healing and transwell migration were significantly slower in high-glucose-treated kidney tubular cells (30 mM glucose) than in low-glucose-treated cells (5.5 mM). Toll-like receptor 4 (TLR4), MyD88, phospho-protein kinase C (PKC), phospho-p38 MAPK and monocyte chemoattractant protein-1 (MCP-1) mRNA levels were upregulated after high glucose treatments. Staurosporine, a selective PKC inhibitor, inhibited TLR4, MyD88 and p-p38 upregulation in the high-glucose-treated cells, indicating the involvement of PKC in high-glucose-induced TLR4 upregulation. The pharmacological inhibition of TLR4 or shRNA-mediated TLR4 knockdown improved wound healing and transwell migration in high-glucose-treated RPTC. In contrast, the overexpression of TLR4 in low-glucose-treated RPTC suppressed wound healing, mimicking the effects of high glucose levels. These results suggest that the upregulation of TLR4 expression via PKC activation contributes to defective wound healing in high-glucosetreated kidney tubular cells.	[Peng, Jianping; Zheng, Hang] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Peoples R China; [Wang, Xia] Wuhan Univ, Hosp Wuhan Univ, Dept Internal Med, Wuhan, Peoples R China; [Cheng, Zhixiang] Wuhan Univ, Zhongnan Hosp, Dept Gen Surg, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Zheng, H (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Peoples R China.	pengjianping@whu.edu.cn		peng, Jianping/0000-0001-8611-0718	National Nature Science Foundation of China (NSFC) [81300578]; Wuhan University Research Foundation [2042016kf1012]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Wuhan University Research Foundation	This study was funded by the National Nature Science Foundation of China (NSFC) to JPP (81300578), and the Wuhan University Research Foundation to JPP (2042016kf1012). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Campbell JS, 2006, J IMMUNOL, V176, P2522, DOI 10.4049/jimmunol.176.4.2522; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chen JL, 2011, KIDNEY INT, V79, P288, DOI 10.1038/ki.2010.381; Chen L, 2013, J INVEST DERMATOL, V133, P258, DOI 10.1038/jid.2012.267; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Dasu MR, 2013, J DIABETES COMPLICAT, V27, P417, DOI 10.1016/j.jdiacomp.2013.05.002; Dasu MR, 2012, J INVEST DERMATOL, V132, P1955, DOI 10.1038/jid.2012.208; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Goor Y, 1996, DIABETOLOGIA, V39, P1036; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kluwe J, 2009, J MOL MED, V87, P125, DOI 10.1007/s00109-008-0426-z; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Macedo L, 2007, AM J PATHOL, V171, P1774, DOI 10.2353/ajpath.2007.061048; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Peng JP, 2015, KIDNEY INT, V87, P137, DOI 10.1038/ki.2014.226; Peng JP, 2012, J PHARMACOL EXP THER, V340, P176, DOI 10.1124/jpet.111.187427; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sun L, 2008, J AM SOC NEPHROL, V19, P2293, DOI 10.1681/ASN.2008030336; Sun R, 2004, GASTROENTEROLOGY, V127, P1525, DOI 10.1053/j.gastro.2004.08.055; Tamura M, 2003, KIDNEY INT, V63, P722, DOI 10.1046/j.1523-1755.2003.00772.x; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Thakar CV, 2011, CLIN J AM SOC NEPHRO, V6, P2567, DOI 10.2215/CJN.01120211; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Xuan YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108182	34	8	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178147	10.1371/journal.pone.0178147	http://dx.doi.org/10.1371/journal.pone.0178147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542370	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500064
J	Teixeira, PL; Mendenhall, JL; Heinze, S; Weiner, B; Skwark, MJ; Meiler, J				Teixeira, Pedro L.; Mendenhall, Jeff L.; Heinze, Sten; Weiner, Brian; Skwark, Marcin J.; Meiler, Jens			Membrane protein contact and structure prediction using co-evolution in conjunction with machine learning	PLOS ONE			English	Article							TRANSMEMBRANE PROTEINS; RESIDUE CONTACTS; IDENTIFICATION; SOFTWARE	De novo membrane protein structure prediction is limited to small proteins due to the conformational search space quickly expanding with length. Long-range contacts (24+ amino acid separation)-residue positions distant in sequence, but in close proximity in the structure, are arguably the most effective way to restrict this conformational space. Inverse methods for co-evolutionary analysis predict a global set of position-pair couplings that best explain the observed amino acid co-occurrences, thus distinguishing between evolutionarily explained co-variances and these arising from spurious transitive effects. Here, we show that applying machine learning approaches and custom descriptors improves evolutionary contact prediction accuracy, resulting in improvement of average precision by 6 percentage points for the top 1L non-local contacts. Further, we demonstrate that predicted contacts improve protein folding with BCL::Fold. The mean RMSD100 metric for the top 10 models folded was reduced by an average of 2 angstrom for a benchmark of 25 membrane proteins.	[Teixeira, Pedro L.; Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37235 USA; [Mendenhall, Jeff L.; Heinze, Sten; Weiner, Brian; Skwark, Marcin J.; Meiler, Jens] Vanderbilt Univ, Dept Chem, Ctr Struct Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37235 USA.; Meiler, J (corresponding author), Vanderbilt Univ, Dept Chem, Ctr Struct Biol, Nashville, TN 37235 USA.	jens@meilerlab.org	Skwark, Marcin Jerzy/Y-4019-2018	Skwark, Marcin Jerzy/0000-0002-2022-6766; Teixeira, Pedro/0000-0002-3268-5556	National Institutes of Health (National Institute of General Medical Sciences) [R01 GM080403]; National Institute of General Medical Studies [T32 GM07347]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Studies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Meiler laboratory is supported through the National Institutes of Health (National Institute of General Medical Sciences R01 GM080403 [https://www.nigms.nih.gov/Pages/default.aspx] (JM). This work was supported by Public Health Service award T32 GM07347 [https://www.nigms.nih.gov/Pages/default.aspx)] from the National Institute of General Medical Studies for the Vanderbilt Medical-Scientist Training Program (PLT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahram Mamoun, 2006, In Silico Biology, V6, P379; Aurell E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004777; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; Baldassi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092721; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Di Lena P, 2012, BIOINFORMATICS, V28, P2449, DOI 10.1093/bioinformatics/bts475; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Engelbrecht AP, 2001, FUNDAM INFORM, V46, P219; Ezkurdia I, 2009, PROTEINS, V77, P196, DOI 10.1002/prot.22554; Feinauer C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003847; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fischer AW, 2015, PROTEINS, V83, P1947, DOI 10.1002/prot.24801; Fuchs A, 2009, PROTEINS, V74, P857, DOI 10.1002/prot.22194; Grana O, 2005, PROTEINS, V61, P214, DOI 10.1002/prot.20739; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Izarzugaza JMG, 2007, PROTEINS, V69, P152, DOI 10.1002/prot.21637; Jones DT, 2015, BIOINFORMATICS, V31, P999, DOI 10.1093/bioinformatics/btu791; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kajan L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-85; Karakas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049240; Karakas M, 2010, J COMPUT BIOL, V17, P153, DOI 10.1089/cmb.2009.0030; KENT JT, 1983, BIOMETRIKA, V70, P163, DOI 10.1093/biomet/70.1.163; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Leman JK, 2013, PROTEINS, V81, P1127, DOI 10.1002/prot.24258; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Monastyrskyy B, 2013, PROTEINS; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Raman P, 2006, CELL MOL LIFE SCI, V63, P36, DOI 10.1007/s00018-005-5350-6; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Seemayer S, 2014, BIOINFORMATICS, V30, P3128, DOI 10.1093/bioinformatics/btu500; Skwark MJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003889; Skwark MJ, 2013, BIOINFORMATICS, V29, P1815, DOI 10.1093/bioinformatics/btt259; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Weiner BE, 2014, PROTEINS, V82, P587, DOI 10.1002/prot.24427; Weiner BE, 2013, STRUCTURE, V21, P1107, DOI 10.1016/j.str.2013.04.022; Woetzel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049242; Zhang HL, 2016, PROTEINS, V84, P332, DOI 10.1002/prot.24979; Zurada JM, 1997, NEUROCOMPUTING, V14, P177, DOI 10.1016/S0925-2312(96)00031-8	44	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177866	10.1371/journal.pone.0177866	http://dx.doi.org/10.1371/journal.pone.0177866			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542325	gold, Green Published			2022-12-27	WOS:000402061500042
J	Li, Z; Gong, Y; Pan, ZS; Hu, GY				Li, Zhen; Gong, Yong; Pan, Zhisong; Hu, Guyu			An efficient semi-supervised community detection framework in social networks	PLOS ONE			English	Article								Community detection is an important tasks across a number of research fields including social science, biology, and physics. In the real world, topology information alone is often inadequate to accurately find out community structure due to its sparsity and noise. The potential useful prior information such as pairwise constraints which contain must-link and cannot-link constraints can be obtained from domain knowledge in many applications. Thus, combining network topology with prior information to improve the community detection accuracy is promising. Previous methods mainly utilize the must-link constraints while cannot make full use of cannot-link constraints. In this paper, we propose a semi-supervised community detection framework which can effectively incorporate two types of pairwise constraints into the detection process. Particularly, must-link and cannot-link constraints are represented as positive and negative links, and we encode them by adding different graph regularization terms to penalize closeness of the nodes. Experiments on multiple real-world data setss how that the proposed framework significantly improves the accuracy of community detection.	[Li, Zhen; Gong, Yong; Pan, Zhisong; Hu, Guyu] PLA Univ Sci & Technol, Coll Command Informat Syst, Nanjing, Jiangsu, Peoples R China	Army Engineering University of PLA	Hu, GY (corresponding author), PLA Univ Sci & Technol, Coll Command Informat Syst, Nanjing, Jiangsu, Peoples R China.	huguyu@189.cn			Natural Science Foundation of Jiangsu Province, China [BK20140073]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This work was supported by Natural Science Foundation of Jiangsu Province, China (No. BK20140073), the website is https://www.nsfc.gov.cn/. The author Y Gong received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdyan A E, 2010, EPL, V90, P983; [Anonymous], [No title captured]; Aurelien D., 2011, PHYS REV LETT, V107, P3337; Chiang K Y, 2013, J MACHINE LEARNING R, V15, P1177; Ding C, 2010, IEEE T PATTERN ANAL, V32, P45, DOI 10.1109/TPAMI.2008.277; Ding Chris, 2006, P 12 ACM SIGKDD INT, V2006, P126; Eaton E, 2012, 26 AAAI C ART INT; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Greene D., 2013, P WEBSCI 2013, P1; Lee DD, 2001, ADV NEUR IN, V13, P556; Lu HC, 2004, NUCLEIC ACIDS RES, V32, P4804, DOI 10.1093/nar/gkh814; Ma XK, 2010, PHYSICA A, V389, P187, DOI 10.1016/j.physa.2009.09.018; Mahmoudi A, 2016, INT J FUZZY SYST, V18, P1117, DOI 10.1007/s40815-016-0173-1; Malliaros FD, 2013, PHYS REP, V533, P95, DOI 10.1016/j.physrep.2013.08.002; Mo QY, 2012, LECT NOTES COMPUT SC, V7578, P402, DOI 10.1007/978-3-642-33786-4_30; Nadakuditi RR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.188701; Pei YL, 2015, INT C INTEL HUM MACH, DOI 10.1109/IHMSC.2015.148; Steeg GV, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/08/P08009; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Tang J, 2015, COMPUTER SCI; Tang L., 2010, COMMUNITY DETECTION, P85287; Wang F., 2008, P SIAM INT C DAT MIN, P1, DOI DOI 10.1137/1.9781611972788.1; Yang L, 2014, IEEE T CYBERNETICS, V45, P1; Zhang Z.-Y., 2013, SCI REPORTS, V3; Zhaoxian Wang, 2015, Advances in Swarm and Computational Intelligence. 6th International Conference, ICSI 2015 held in conjunction with the Second BRICS Congress, CCI 2015. Proceedings: LNCS 9141, P349, DOI 10.1007/978-3-319-20472-7_38	25	5	5	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178046	10.1371/journal.pone.0178046	http://dx.doi.org/10.1371/journal.pone.0178046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542520	gold, Green Submitted, Green Published			2022-12-27	WOS:000402058800035
J	Seok, JM; Choi, M; Bin Cho, E; Lee, HL; Kim, BJ; Lee, KH; Song, P; Joo, EY; Min, JH				Seok, Jin Myoung; Choi, Misong; Bin Cho, Eun; Lee, Hye Lim; Kim, Byoung Joon; Lee, Kwang Ho; Song, Pamela; Joo, Eun Yeon; Min, Ju-Hong			Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of lifef	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; OF-LIFE; DIAGNOSTIC-CRITERIA; SLEEP DISTURBANCES; BASAL GANGLIA; DEPRESSION; PAIN; DISABILITY; ATROPHY; AXIS	Fatigue is a prevalent symptom and major burden in neuroimmunological diseases. In neuromyelitis optica spectrum disorder (NMOSD), a severe autoimmune central nervous system (CNS) inflammatory disease with autoantibodies reactive to aquaporin-4, there are few reports about fatigue and quality of life (QOL). We aimed to evaluate the severity of fatigue and its relationship with QOL in patients with NMOSD. We prospectively studied patients with NMOSD who were in remission and seropositive for anti-aquaporin-4 antibody, and they were divided into 2 groups based on the presence of fatigue assessed using the Functional Assessment of Chronic Illness Therapy-fatigue score. Sleep quality, depression, pain, and QOL were also evaluated. A total of 35 patients were enrolled (mean age, 46.5 +/- 14.1 years; female: male = 29: 6), and the median Expanded Disability Status Scale (EDSS) score was 2.0 (range, 0 to 8.0). The patients with fatigue (N = 25, 71.4%) had poorer sleep quality and more severe depression than those without fatigue (p = 0.009 and p = 0.001). Both the physical and mental QOL scores were lower in patients with fatigue than in those without fatigue (p = 0.033 and p = 0.004). Multiple linear regression analyses showed that the degree of fatigue with EDSS score and pain were independent predictors of physical aspects of QOL (B = 0.382, p = 0.001), whereas depression was the only predictor of the mental components of QOL (B = -0.845, p = <0.001). Fatigue is a common symptom and an important predictor of QOL in patients with NMOSD.	[Seok, Jin Myoung; Choi, Misong; Kim, Byoung Joon; Lee, Kwang Ho; Joo, Eun Yeon; Min, Ju-Hong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Seok, Jin Myoung; Choi, Misong; Kim, Byoung Joon; Lee, Kwang Ho; Joo, Eun Yeon; Min, Ju-Hong] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea; [Seok, Jin Myoung] Soonchunhyang Univ, Cheonan Hosp, Dept Neurol, Coll Med, Cheonan, South Korea; [Bin Cho, Eun] Gyeongsang Natl Univ, Sch Med, Changwon Hosp, Dept Neurol, Chang Won, South Korea; [Lee, Hye Lim] Korea Univ, Guro Hosp, Dept Neurol, Seoul, South Korea; [Lee, Hye Lim] Korea Univ, Coll Med, Seoul, South Korea; [Song, Pamela] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Neurol, Goyang, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Soonchunhyang University; Gyeongsang National University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Inje University	Min, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.; Min, JH (corresponding author), Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea.	juhongm@gmail.com		Seok, Jin Myoung/0000-0002-1484-2968				Akaishi T, 2015, J NEUROIMMUNOL, V283, P70, DOI 10.1016/j.jneuroim.2015.05.007; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P585, DOI 10.1016/S0022-3999(02)00447-6; Attarian HP, 2004, ARCH NEUROL-CHICAGO, V61, P525, DOI 10.1001/archneur.61.4.525; Baba T, 2009, J NEUROL, V256, P287, DOI 10.1007/s00415-009-0139-4; Barat M., 2006, Annales de Readaptation et de Medecine Physique, V49, P365, DOI 10.1016/j.annrmp.2006.04.014; Bisecco A, 2016, MULTIPLE SCLEROSIS; Blechingberg J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046251; Bomholt SF, 2004, STRESS, V7, P1, DOI 10.1080/10253890310001650268; Calabrese M, 2012, NEUROLOGY, V79, P1671, DOI 10.1212/WNL.0b013e31826e9a96; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Cella D, 2011, SUPPORT CARE CANCER, V19, P1441, DOI 10.1007/s00520-010-0971-1; Chanson JB, 2011, EUR J NEUROL, V18, P836, DOI 10.1111/j.1468-1331.2010.03252.x; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chavarro VS, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000286; Duan YY, 2012, EUR J RADIOL, V81, pE110, DOI 10.1016/j.ejrad.2011.01.065; Giovannoni G, 2006, J NEUROL NEUROSUR PS, V77, P2, DOI 10.1136/jnnp.2005.074948; Greim B, 2007, J NEUROL, V254, P102, DOI 10.1007/s00415-007-2025-2; Guo Y, 2014, JAMA NEUROL, V71, P1025, DOI 10.1001/jamaneurol.2014.775; Haldorsen K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3487; Kanamori Y, 2011, NEUROLOGY, V77, P652, DOI 10.1212/WNL.0b013e318229e694; Kanbayashi T, 2009, ARCH NEUROL-CHICAGO, V66, P1563, DOI 10.1001/archneurol.2009.264; Kaneko K, 2016, J NEUROLOGY; Kang ES, 2012, ANN LAB MED, V32, P331, DOI 10.3343/alm.2012.32.5.331; Kong YZ, 2016, J NEUROL SCI, V368, P84, DOI 10.1016/j.jns.2016.06.041; Kroencke DC, 2000, MULT SCLER, V6, P131, DOI 10.1177/135245850000600213; Krupp L, 2006, MULT SCLER J, V12, P367, DOI 10.1191/135248506ms1373ed; Lai JS, 2011, J RHEUMATOL, V38, P672, DOI 10.3899/jrheum.100799; Malik R, 2014, MUSCLE NERVE, V50, P859, DOI 10.1002/mus.24298; Pan J, 2015, CNS NEUROSCI THER, V21, P599, DOI 10.1111/cns.12411; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Shi ZY, 2016, J NEUROIMMUNOL, V293, P54, DOI 10.1016/j.jneuroim.2016.02.011; Song YJ, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000094; Tellez N, 2008, NEURORADIOLOGY, V50, P17, DOI 10.1007/s00234-007-0304-3; Trebst C, 2014, J NEUROL, V261, P1, DOI 10.1007/s00415-013-7169-7; Veauthier C, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0073-3; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6; Zamvil SS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000062; Zekeridou A, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000110; Zhao SZ, 2014, MULT SCLER J, V20, P1658, DOI 10.1177/1352458514522103	43	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177230	10.1371/journal.pone.0177230	http://dx.doi.org/10.1371/journal.pone.0177230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542592	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058800011
J	Childs, LM; Prosper, OF				Childs, Lauren M.; Prosper, Olivia F.			Simulating within-vector generation of the malaria parasite diversity	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRANSMISSION; INFECTION; MODEL; GAMETOCYTOGENESIS; RECOMBINATION; SIGNATURE; DYNAMICS; IMPACT	Plasmodium falciparum, the most virulent human malaria parasite, undergoes asexual reproduction within the human host, but reproduces sexually within its vector host, the Anopheles mosquito. Consequently, the mosquito stage of the parasite life cycle provides an opportunity to create genetically novel parasites in multiply-infected mosquitoes, potentially increasing parasite population diversity. Despite the important implications for disease transmission and malaria control, a quantitative mapping of how parasite diversity entering a mosquito relates to diversity of the parasite exiting, has not been undertaken. To examine the role that vector biology plays in modulating parasite diversity, we develop a two-part model framework that estimates the diversity as a consequence of different bottlenecks and expansion events occurring during the vector-stage of the parasite life cycle. For the underlying framework, we develop the first stochastic model of within-vector P. falciparum parasite dynamics and go on to simulate the dynamics of two parasite subpopulations, emulating multiply infected mosquitoes. We show that incorporating stochasticity is essential to capture the extensive variation in parasite dynamics, particularly in the presence of multiple parasites. In particular, unlike deterministic models, which always predict the most fit parasites to produce the most sporozoites, we find that occasionally only parasites with lower fitness survive to the sporozoite stage. This has important implications for onward transmission. The second part of our framework includes a model of sequence diversity generation resulting from recombination and reassortment between parasites within a mosquito. Our two-part model framework shows that bottlenecks entering the oocyst stage decrease parasite diversity from what is present in the initial gametocyte population in a mosquito's blood meal. However, diversity increases with the possibility for recombination and proliferation in the formation of sporozoites. Furthermore, when we begin with two parasite subpopulations in the initial gametocyte population, the probability of transmitting more than two unique parasites from mosquito to human is over 50% for a wide range of initial gametocyte densities.	[Childs, Lauren M.] Virginia Tech, Dept Math, Blacksburg, VA 24061 USA; [Prosper, Olivia F.] Univ Kentucky, Dept Math, Lexington, KY 40506 USA	Virginia Polytechnic Institute & State University; University of Kentucky	Childs, LM (corresponding author), Virginia Tech, Dept Math, Blacksburg, VA 24061 USA.	lchilds@vt.edu		Childs, Lauren/0000-0003-3904-3895; Prosper, Olivia/0000-0002-8042-0616	National Institute of General Medical Sciences [U54GM088558]; Virginia Tech's Open Access Subvention Fun; FAS Division of Science, Research Computing Group at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Virginia Tech's Open Access Subvention Fun; FAS Division of Science, Research Computing Group at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	L.M.C. was partially supported by award number U54GM088558 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The authors also acknowledge the support of Virginia Techs Open Access Subvention Fun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank T. Bousema and W. Stone for sharing the data for replication of Figure 1 in [47]. L.M.C. was supported by award number U54GM088558 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The authors acknowledge the Odyssey cluster supported by the FAS Division of Science, Research Computing Group at Harvard University and Advanced Research Computing at Virginia Tech for providing computational resources and technical support that have contributed to the results reported within this paper.	Allen LJ., 2010, INTRO STOCHASTIC PRO; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Annan Z, 2007, P NATL ACAD SCI USA, V104, P7987, DOI 10.1073/pnas.0702715104; Bei AK, 2015, INFECT IMMUN, V83, P276, DOI 10.1128/IAI.01979-14; Branch OH, 2011, MOL BIOL EVOL, V28, P1973, DOI 10.1093/molbev/msq311; Buckee CO, 2011, P NATL ACAD SCI USA, V108, P15504, DOI 10.1073/pnas.1102445108; Carter TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140416; Childs LM, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1379; Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626; Collins WE, 2003, AM J TROP MED HYG, V68, P366, DOI 10.4269/ajtmh.2003.68.366; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; Da DF, 2015, EXP PARASITOL, V149, P74, DOI 10.1016/j.exppara.2014.12.010; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Dwivedi A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1370-y; Eckhoff P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044950; Eichner M, 2001, T ROY SOC TROP MED H, V95, P497, DOI 10.1016/S0035-9203(01)90016-1; Gerald N, 2011, EUKARYOT CELL, V10, P474, DOI 10.1128/EC.00314-10; Handel MA, 1997, MEIOSIS GAMETOGENESI; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; Jiang HY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r33; Johnston GL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003025; Juliano JJ, 2010, P NATL ACAD SCI USA, V107, P20138, DOI 10.1073/pnas.1007068107; Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; McQueen PG, 2004, P NATL ACAD SCI USA, V101, P9161, DOI 10.1073/pnas.0308256101; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; Morlais I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123777; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Nkhoma SC, 2012, P ROY SOC B-BIOL SCI, V279, P2589, DOI 10.1098/rspb.2012.0113; Nsango SE, 2012, INT J PARASITOL, V42, P589, DOI 10.1016/j.ijpara.2012.03.008; Reininger L, 2005, J BIOL CHEM, V280, P31957, DOI 10.1074/jbc.M504523200; Roitberg BD, 2005, J VECTOR ECOL, V30, P83; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P209, DOI 10.1016/0035-9203(90)90258-G; Ross A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042496; Ross R., 1911, PREVENTION MALARIA; Sandeu MM, 2016, INFECT GENET EVOL, V45, P138, DOI 10.1016/j.meegid.2016.08.025; Sinden RE, 2015, CELL MICROBIOL, V17, P451, DOI 10.1111/cmi.12413; Sinden RE, 2009, PARASITOLOGY, V136, P1427, DOI 10.1017/S0031182009990667; SINDEN RE, 1985, ANN SOC BELG MED TR, V65, P21; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Stone WJR, 2013, SCI REP-UK, V3, DOI 10.1038/srep03418; Sutton PL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-329; Taylor LH, 1997, PARASITOLOGY, V115, P121, DOI 10.1017/S0031182097001145; Teboh-Ewungkem MI, 2009, PUBLIC HEALTH 21ST C, P177; Teboh-Ewungkem MI, 2010, J THEOR BIOL, V264, P273, DOI 10.1016/j.jtbi.2009.12.017; VAUGHAN JA, 1992, J PARASITOL, V78, P716, DOI 10.2307/3283550; WHO, 2013, WORLD MALARIA REPORT 2013, P1	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177941	10.1371/journal.pone.0177941	http://dx.doi.org/10.1371/journal.pone.0177941			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542484	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400041
J	Schaebel, LK; Bonefeld-Jorgensen, EC; Vestergaard, H; Andersen, S				Schaebel, L. K.; Bonefeld-Jorgensen, E. C.; Vestergaard, H.; Andersen, S.			The influence of persistent organic pollutants in the traditional Inuit diet on markers of inflammation	PLOS ONE			English	Article							POPULATION-BASED SURVEY; CARDIOVASCULAR-DISEASE; POLYCHLORINATED-BIPHENYLS; OXIDATIVE STRESS; GREENLAND INUIT; ARCTIC SOCIETY; HEART-DISEASE; CONTAMINANTS; FOOD; TRANSITION	Concentrations of persistent organic pollutants (POPs) are high in Inuit living predominately on the traditional marine diet. Adverse effects of POPs include disruption of the immune system and cardiovascular diseases that are frequent in Greenland Inuit. We aimed to assess the association between exposure to POPs from the marine diet and inflammation, taking into account other factors such as vitamin D. We invited Inuit and non-Inuit living in settlements or the town in rural East Greenland or in the capital city Nuuk. Participants completed a food frequency questionnaire and donated a blood sample for measurement of the two markers of inflammation YKL-40 and hsCRP, 25-hydroxy-vitamin D, eleven organochlorine pesticides (OCPs), fourteen polychlorinated biphenyls (PCBs), one polybrominated biphenyl, and nine polybrominated diphenyl ethers (PBDEs) adjusted to the serum lipid content. Participants were 50 through 69 years old, living in settlements, town or city (n = 151/173/211; 95% participation rate). Sigma OCP, Sigma PCB and Sigma PBDE serum levels were higher in Inuit than in non-Inuit (p<0.001/ p<0.001/ p<0.001), in older individuals (p<0.001/ p<0.001/ p = 0.002) and in participants with the highest intake of Greenlandic food items (p<0.001/ p<0.001/ p<0.001). Both YKL-40 and hsCRP serum levels were higher in Inuit compared to non-Inuit (p<0.001/ p = 0.001), and increased with age (p<0.001/ p = 0.001) and with the intake of Greenlandic food items (p<0.001/ p = 0.002). Multivariate analysis conformed to a marked influence on both YKL-40 and hsCRP by SOCP (p<0.001/ p<0.001) and Sigma PCBs (p<0.001/ p = 0.001) after adjusting for age, BMI, vitamin D, alcohol and smoking. POP levels were associated with the intake of the traditional Inuit diet and with markers of inflammation. This supports a pro-inflammatory role of POPs to promote chronic diseases common to populations in Greenland. These data inform guidelines on 'the Arctic dilemma' and encourage follow-up on the ageing Arctic populations.	[Schaebel, L. K.; Bonefeld-Jorgensen, E. C.] Aarhus Univ, Dept Publ Hlth, Ctr Arctic Hlth, Aarhus, Denmark; [Schaebel, L. K.; Andersen, S.] Aalborg Univ, Inst Clin Med, Arctic Hlth Res Ctr, Aalborg, Denmark; [Vestergaard, H.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Fac Hlth & Med Sci, Copenhagen, Denmark; [Andersen, S.] Aalborg Univ Hosp, Dept Geriatr & Internal Med, Aalborg, Denmark; [Andersen, S.] Univ Greenland, Inst Hlth Sci, Ilisimatusarfik, Nuuk, Greenland	Aarhus University; Aalborg University; Novo Nordisk Foundation; University of Copenhagen; Aalborg University; Aalborg University Hospital	Schaebel, LK (corresponding author), Aarhus Univ, Dept Publ Hlth, Ctr Arctic Hlth, Aarhus, Denmark.; Schaebel, LK (corresponding author), Aalborg Univ, Inst Clin Med, Arctic Hlth Res Ctr, Aalborg, Denmark.	lohos@rn.dk	Andersen, Stig/J-2636-2015	Vestergaard, Henrik/0000-0003-3090-269X; Andersen, Stig/0000-0003-3632-5213	Danish Environmental Protection Agency; Greenland Government; Aalborg City Christmas Lottery; O bel Family Foundation; Northern Jutland Research Foundation; Danish Hospital Foundation; Faroe Islands and Greenland	Danish Environmental Protection Agency; Greenland Government; Aalborg City Christmas Lottery; O bel Family Foundation; Northern Jutland Research Foundation; Danish Hospital Foundation; Faroe Islands and Greenland	This work was supported by the Danish Environmental Protection Agency; Greenland Government; Aalborg City Christmas Lottery; O bel Family Foundation; Northern Jutland Research Foundation; Danish Hospital Foundation for Medical Research, Region of Copenhagen, the Faroe Islands and Greenland.; We gratefully acknowledge Karoline Berglund for her enthusiasm and thorough interviewing of Inuit, the invaluable support from the primary health care clinic in Nuuk, from Hans Chr. Florian Sorensen and from the hospital in Tasiilaq and the nursing stations in Tiniteqilaaq, Sermiligaaq, Kuummiut and Kulusuk. Also, Danish Environmental Protection Agency is acknowledged for financial support allowing for POP analysis.	Andersen S, 2005, AM J CLIN NUTR, V81, P656; Andersen S, 2013, BRIT J NUTR, V109, P928, DOI 10.1017/S0007114512002097; Arctic Monitoring and Assessment Programme (AMAP), AN AMAP ASS 2015 HUM; Aslani BA, 2016, LIFE SCI, V146, P163, DOI 10.1016/j.lfs.2016.01.014; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; Bjerregaard P, 1996, Arctic Med Res, V55 Suppl 1, P25; Bjerregaard P., 2013, SCI TOTAL ENVIRON, V454-455, P283; Deutch B, 2007, SCI TOTAL ENVIRON, V384, P106, DOI 10.1016/j.scitotenv.2007.05.042; Deutch B, 2007, SCI TOTAL ENVIRON, V372, P486, DOI 10.1016/j.scitotenv.2006.10.043; Dietz R, 1996, SCI TOTAL ENVIRON, V186, P67, DOI 10.1016/0048-9697(96)05086-3; Fang J, 2015, ENVIRON SCI POLLUT R, V22, P8989, DOI 10.1007/s11356-015-4080-z; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heilmann C, 2006, PLOS MED, V3, P1352, DOI 10.1371/journal.pmed.0030311; Hennig B, 2002, INT J HYG ENVIR HEAL, V205, P95, DOI 10.1078/1438-4639-00134; Hojskov CS, 2010, CLIN CHIM ACTA, V411, P114, DOI 10.1016/j.cca.2009.10.010; Hong MY, 2015, J NUTR, V145, P939, DOI 10.3945/jn.114.206607; Imbeault P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039931; Johansen P, 2004, SCI TOTAL ENVIRON, V331, P189, DOI 10.1016/j.scitotenv.2004.03.029; Jones KC, 1999, ENVIRON POLLUT, V100, P209, DOI 10.1016/S0269-7491(99)00098-6; Jorgensen ME, 2008, ATHEROSCLEROSIS, V196, P772, DOI 10.1016/j.atherosclerosis.2007.01.008; Kim Ki-Su, 2012, J Prev Med Public Health, V45, P62, DOI 10.3961/jpmph.2012.45.2.62; Kim MJ, 2012, ENVIRON HEALTH PERSP, V120, P508, DOI 10.1289/ehp.1104282; Kjaergaard M, 2009, ATHEROSCLEROSIS, V203, P599, DOI 10.1016/j.atherosclerosis.2008.07.027; Kumar J, 2014, ENVIRON HEALTH PERSP, V122, P977, DOI 10.1289/ehp.1307613; La Merrill M, 2013, ENVIRON HEALTH PERSP, V121, P162, DOI 10.1289/ehp.1205485; Lind L, 2012, J INTERN MED, V271, P537, DOI 10.1111/j.1365-2796.2012.02536.x; Long MH, 2015, SCI TOTAL ENVIRON, V529, P198, DOI 10.1016/j.scitotenv.2015.05.022; Milnerowicz H, 2015, J TRACE ELEM MED BIO, V29, P1, DOI 10.1016/j.jtemb.2014.04.008; Pars T., 2001, ARCTIC, P54; Perkins JT, 2016, ENVIRON SCI POLLUT R, V23, P2160, DOI 10.1007/s11356-015-4479-6; Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61; Schaebel LH, 2013, ATHEROSCLEROSIS, V228, P496, DOI 10.1016/j.atherosclerosis.2013.03.022; Schaebel LK, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.33; Stockholm convention, 2014, STOCKH CONV PERS ORG	34	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177781	10.1371/journal.pone.0177781	http://dx.doi.org/10.1371/journal.pone.0177781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542407	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600023
J	Abulseoud, OA; Ho, MC; Choi, DS; Stanojevic, A; Cupic, Z; Kolar-Anic, L; Vukojevic, V				Abulseoud, Osama A.; Ho, Man Choi; Choi, Doo-Sup; Stanojevic, Ana; Cupic, Zeljko; Kolar-Anic, Ljiljana; Vukojevic, Vladana			Corticosterone oscillations during mania induction in the lateral hypothalamic kindled rat-Experimental observations and mathematical modeling	PLOS ONE			English	Article							DEXAMETHASONE-SUPPRESSION TEST; CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL AXIS; HPA AXIS; BIPOLAR DISORDER; CEREBROSPINAL-FLUID; SEX-DIFFERENCES; ADRENOCORTICAL FUNCTION; CORTISOL RESPONSE; PREDICTIVE-VALUE	Changes in the hypothalamic-pituitary-adrenal (HPA) axis activity constitute a key component of bipolar mania, but the extent and nature of these alterations are not fully understood. We use here the lateral hypothalamic-kindled (LHK) rat model to deliberately induce an acute manic-like episode and measure serum corticosterone concentrations to assess changes in HPA axis activity. A mathematical model is developed to succinctly describe the entwined biochemical transformations that underlay the HPA axis and emulate by numerical simulations the considerable increase in serum corticosterone concentration induced by LHK. Synergistic combination of the LHK rat model and dynamical systems theory allows us to quantitatively characterize changes in HPA axis activity under controlled induction of acute manic-like states and provides a framework to study in silico how the dynamic integration of neurochemical transformations underlying the HPA axis is disrupted in these states.	[Abulseoud, Osama A.; Choi, Doo-Sup] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Abulseoud, Osama A.] NIDA, Chem & Drug Metab, IRP, NIH, Baltimore, MD 21224 USA; [Ho, Man Choi; Choi, Doo-Sup] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Stanojevic, Ana; Kolar-Anic, Ljiljana] Univ Belgrade, Fac Phys Chem, Studentski Trg 12-16, Belgrade, Serbia; [Cupic, Zeljko; Kolar-Anic, Ljiljana] Univ Belgrade, Inst Chem Technol & Met, Dept Catalysis & Chem Engn, Njegoseva 12, Belgrade, Serbia; [Vukojevic, Vladana] Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med CMM L8 01, Stockholm, Sweden	Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Mayo Clinic; University of Belgrade; University of Belgrade; Karolinska Institutet	Abulseoud, OA (corresponding author), Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA.; Abulseoud, OA (corresponding author), NIDA, Chem & Drug Metab, IRP, NIH, Baltimore, MD 21224 USA.; Vukojevic, V (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med CMM L8 01, Stockholm, Sweden.	osama.abulseoud@nih.gov; vladana.vukojevic@ki.se	Cupic, Zeljko/L-3192-2019; Ho, Ada Man-Choi/AGD-8869-2022; Vukojevic, Vladana B/AAY-3144-2021	Cupic, Zeljko/0000-0002-4939-6718; Vukojevic, Vladana/0000-0003-0873-5653; Ho, Man Choi/0000-0003-4989-8782; Stanojevic, Ana/0000-0002-8302-191X	KI-Mayo research; Swedish Research Council; Knut and Alice Wallenberg Foundation; Rajko and Maj DermanoviC Fund; Ministry of Education, Science and Technological Development of the Republic of Serbia [172015, 45001]; CMST COST Action CM1304 "Emergence and Evolution of Complex Chemical Systems"	KI-Mayo research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Rajko and Maj DermanoviC Fund; Ministry of Education, Science and Technological Development of the Republic of Serbia; CMST COST Action CM1304 "Emergence and Evolution of Complex Chemical Systems"	Support from the KI-Mayo research collaboration grant (OAA and VV), Swedish Research Council (VV), Knut and Alice Wallenberg Foundation (VV), Rajko and Maj DermanoviC Fund (ZC), Ministry of Education, Science and Technological Development of the Republic of Serbia (grants 172015 and 45001, LjKA, ZC, AS), CMST COST Action CM1304 "Emergence and Evolution of Complex Chemical Systems" (ZC, VV) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support from the KI-Mayo research collaboration grant (OAA and VV), Karolinska Institute Research Funds (VV), Swedish Research Council (VV), Knut and Alice Wallenberg Foundation (VV), Rajko and Maj Dermanovic Fund (ZC), Ministry of Education, Science and Technological Development of the Republic of Serbia (grants 172015 and 45001; LjK-A, ZC, AS), CMST COST Action CM1304 "Emergence and Evolution of Complex Chemical Systems" (ZC, VV) is gratefully acknowledged.	Abulseoud OA, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.30; Abulseoud OA, 2014, INT J BIPOLAR DISORD, V2, DOI 10.1186/s40345-014-0007-8; AKESODE A, 1976, PSYCHONEUROENDOCRINO, V1, P419, DOI 10.1016/0306-4530(76)90009-3; ALDENHOFF JB, 1983, SCIENCE, V221, P875, DOI 10.1126/science.6603658; AMSTERDAM JD, 1982, AM J PSYCHIAT, V139, P287; AMSTERDAM JD, 1983, ARCH GEN PSYCHIAT, V40, P515; Andersen M, 2013, MATH BIOSCI, V246, P122, DOI 10.1016/j.mbs.2013.08.010; ARANA GW, 1983, AM J PSYCHIAT, V140, P1521; Arita K, 2005, NEUROL MED-CHIR, V45, P221, DOI 10.2176/nmc.45.221; BAUMGARTNER A, 1986, PSYCHIAT RES, V18, P9, DOI 10.1016/0165-1781(86)90057-0; Ben-Zvi A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000273; Bhangle SD, 2013, RHEUMATOL INT, V33, P1923, DOI 10.1007/s00296-013-2750-z; Bisagno V, 2014, BEHAV PHARMACOL, V25, P445, DOI 10.1097/FBP.0000000000000049; BRADBURY MW, 1974, J PHYSIOL-LONDON, V239, P269, DOI 10.1113/jphysiol.1974.sp010568; BROOKSBANK BW, 1967, BRIT J PSYCHIAT, V113, P395, DOI 10.1192/bjp.113.497.395; BRYSON RW, 1954, LANCET, V2, P365; BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V12, P619; CARPENTER WT, 1971, ARCH GEN PSYCHIAT, V25, P270; CARROLL BJ, 1979, ARCH GEN PSYCHIAT, V36, P870; Cassidy F, 1998, BIOL PSYCHIAT, V43, P747, DOI 10.1016/S0006-3223(97)00274-6; Chen G, 2010, MOL PSYCHIATR, V15, P883, DOI 10.1038/mp.2010.3; CHRISTIE JE, 1986, BRIT J PSYCHIAT, V148, P58, DOI 10.1192/bjp.148.1.58; Chu CP, 2012, NEUROSCI LETT, V511, P79, DOI 10.1016/j.neulet.2012.01.035; CLARKE BL, 1988, CELL BIOPHYS, V12, P237, DOI 10.1007/BF02918360; COOKSON JC, 1985, BRIT J PSYCHIAT, V146, P498, DOI 10.1192/bjp.146.5.498; COOKSON JC, 1985, J AFFECT DISORDERS, V8, P233, DOI 10.1016/0165-0327(85)90021-7; COPPEN A, 1971, J NEUROL NEUROSUR PS, V34, P432, DOI 10.1136/jnnp.34.4.432; Cupic Z, 1999, ADVANCED SCIENCE AND TECHNOLOGY OF SINTERING, P75; Cupic Z., 2011, MATH MODELLING, P111; Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005; Deshauer D, 1999, BIOL PSYCHIAT, V45, P1023, DOI 10.1016/S0006-3223(98)00334-5; Deshauer D, 2003, CAN J PSYCHIAT, V48, P462, DOI 10.1177/070674370304800706; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; EVANS DL, 1983, AM J PSYCHIAT, V140, P615; Fries GR, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu043; Fries GR, 2014, INT J NEUROPSYCHOPH, V18, P1; Gallagher P, 2007, SCHIZOPHR RES, V90, P258, DOI 10.1016/j.schres.2006.11.020; GERNER RH, 1983, AM J PSYCHIAT, V140, P92; GODWIN CD, 1984, AM J PSYCHIAT, V141, P1610; GODWIN CD, 1984, J AFFECT DISORDERS, V7, P281, DOI 10.1016/0165-0327(84)90049-1; GODWIN CD, 1984, AM J PSYCHIAT, V141, P1263; GOLD PW, 1978, LANCET, V1, P1233; GRAHAM PM, 1982, J AFFECT DISORDERS, V4, P201, DOI 10.1016/0165-0327(82)90004-0; GREDEN JF, 1982, BIOL PSYCHIAT, V17, P455; Havermans R, 2011, PSYCHONEUROENDOCRINO, V36, P258, DOI 10.1016/j.psyneuen.2010.07.016; HWU HG, 1990, BIOL PSYCHIAT, V27, P609, DOI 10.1016/0006-3223(90)90528-A; Jelic S, 2005, MATH BIOSCI, V197, P173, DOI 10.1016/j.mbs.2005.06.006; Jelic Scupic, 2008, NEW RES NEUROSECRETO, p225 ; Jelic S, 2009, INT J NONLIN SCI NUM, V10, P1451; JIMERSON DC, 1980, AM J PSYCHIAT, V137, P979; JOYCE PR, 1995, J AFFECT DISORDERS, V33, P233, DOI 10.1016/0165-0327(94)00094-P; JOYCE PR, 1987, J AFFECT DISORDERS, V12, P1, DOI 10.1016/0165-0327(87)90054-1; Kassi EN, 2013, HORM-INT J ENDOCRINO, V12, P172, DOI 10.14310/horm.2002.1402; Kellendonk C, 2002, BRAIN RES BULL, V57, P73, DOI 10.1016/S0361-9230(01)00638-4; Kessler RC, 2007, ANNU REV CLIN PSYCHO, V3, P137, DOI 10.1146/annurev.clinpsy.3.022806.091444; Kolar-Anic L, 2010, CHEM ENG SCI, V65, P3718, DOI 10.1016/j.ces.2010.03.008; Kratzer S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00091; Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18; KRISHNAN RR, 1983, AM J PSYCHIAT, V140, P203; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Leszczynska-Rodziewicz A, 2012, J AFFECT DISORDERS, V138, P490, DOI 10.1016/j.jad.2012.01.025; LEVIN N, 1989, ENDOCRINOLOGY, V125, P2957, DOI 10.1210/endo-125-6-2957; Lightman S. L., 2002, Archives of Physiology and Biochemistry, V110, P90, DOI 10.1076/apab.110.1.90.899; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; LINGJAERDE P, 1964, BRIT J PSYCHIAT, V110, P423, DOI 10.1192/bjp.110.466.423; LINKOWSKI P, 1994, ARCH GEN PSYCHIAT, V51, P616; Makino S, 2002, PHARMACOL BIOCHEM BE, V73, P147, DOI 10.1016/S0091-3057(02)00791-8; Manenschijn L, 2012, PSYCHONEUROENDOCRINO, V37, P1960, DOI 10.1016/j.psyneuen.2012.04.010; Markovic VM, 2011, ENDOCR J, V58, P889, DOI 10.1507/endocrj.EJ11-0037; Miller S, 2014, J AFFECT DISORDERS, V169, pS3, DOI 10.1016/S0165-0327(14)70003-5; Miller WL., 2001, ENDOCRINOLOGY METABO, P387; Muller H, 2010, J ENDOCRINOL, V204, P85, DOI 10.1677/JOE-09-0363; Naughton M, 2014, HAND CLINIC, V124, P69, DOI 10.1016/B978-0-444-59602-4.00005-8; NINK M, 1991, KLIN WOCHENSCHR, V69, P185, DOI 10.1007/BF01646939; PERINI GI, 1984, PHARMACOPSYCHIATRY, V17, P94, DOI 10.1055/s-2007-1017415; PLATMAN SR, 1968, ARCH GEN PSYCHIAT, V18, P591; Postnova S, 2013, PHARMACOPSYCHIATRY, V46, pS36, DOI 10.1055/s-0033-1333763; Rhodes ME, 1999, BRAIN RES REV, V30, P135, DOI 10.1016/S0165-0173(99)00011-9; RIZZO ND, 1954, ANN INTERN MED, V41, P798, DOI 10.7326/0003-4819-41-4-798; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Russell GM, 2015, J NEUROENDOCRINOL, V27, P378, DOI 10.1111/jne.12247; Rybakowski JK, 1999, J PSYCHIAT RES, V33, P363, DOI 10.1016/S0022-3956(99)00014-X; Sachar E J, 1975, Prog Brain Res, V42, P81; SACHAR EJ, 1972, ARCH GEN PSYCHIAT, V26, P137; Schaffer A, 2015, BIPOLAR DISORD, V17, P1, DOI 10.1111/bdi.12271; SCHLESSER MA, 1980, ARCH GEN PSYCHIAT, V37, P737; Schmider J, 1995, BIOL PSYCHIAT, V38, P797, DOI 10.1016/0006-3223(95)00064-X; Schulkin J, 1998, PSYCHONEUROENDOCRINO, V23, P219, DOI 10.1016/S0306-4530(97)00099-1; Schulz P, 2007, DIALOGUES CLIN NEURO, V9; Shaikh S., 2012, ISRN ANESTHESIOLOGY, V2012, P1, DOI 10.5402/2012/985495; Sivukhina EV, 2016, STEROIDS; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; Spiga F, 2014, COMPR PHYSIOL, V4, P1273, DOI 10.1002/cphy.c140003; Srivastava R, 2002, J THEOR BIOL, V218, P309, DOI 10.1006/jtbi.2002.3078; Steen NE, 2014, J PSYCHIATR RES, V52, P57, DOI 10.1016/j.jpsychires.2014.01.017; Steinman MQ, 2015, PSYCHONEUROENDOCRINO, V51, P122, DOI 10.1016/j.psyneuen.2014.09.009; STOKES PE, 1984, ARCH GEN PSYCHIAT, V41, P257; SWANN AC, 1994, BIOL PSYCHIAT, V35, P803, DOI 10.1016/0006-3223(94)91143-6; SWANN AC, 1992, ACTA PSYCHIAT SCAND, V85, P270, DOI 10.1111/j.1600-0447.1992.tb01468.x; Terenius L., 2016, ADDICT BIOL, p1 ; Voyadzis JM, 2004, J NEUROSURG, V100, P212, DOI 10.3171/ped.2004.100.2.0212; Vukojevic V, 1996, J PHYS CHEM-US, V100, P17175, DOI 10.1021/jp960785o; Walker JJ, 2010, J NEUROENDOCRINOL, V22, P1226, DOI 10.1111/j.1365-2826.2010.02087.x; Waters RP, 2015, NEUROSCI BIOBEHAV R, V58, P63, DOI 10.1016/j.neubiorev.2015.07.011; Watson S, 2005, AUST NZ J PSYCHIAT, V39, P244, DOI 10.1111/j.1440-1614.2005.01560.x; Watson S, 2004, BRIT J PSYCHIAT, V184, P496, DOI 10.1192/bjp.184.6.496; Watson S, 2007, PSYCHONEUROENDOCRINO, V32, P464, DOI 10.1016/j.psyneuen.2007.02.010; WHALLEY LJ, 1989, BRIT J PSYCHIAT, V155, P455, DOI 10.1192/bjp.155.4.455; Yang J, 2005, LAB ANIM-UK, V39, P259, DOI 10.1258/0023677054307033; Zarate CA, 2008, MT SINAI J MED, V75, P226, DOI 10.1002/msj.20042; Zarzer CA, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-65; Zelena D, 2015, AMINO ACIDS, V47, P2245, DOI 10.1007/s00726-015-2026-x	114	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177551	10.1371/journal.pone.0177551	http://dx.doi.org/10.1371/journal.pone.0177551			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542167	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672400053
J	Biswas, RK; Kabir, E				Biswas, Raaj Kishore; Kabir, Enamul			Influence of distance between residence and health facilities on non-communicable diseases: An assessment over hypertension and diabetes in Bangladesh	PLOS ONE			English	Article							RISK-FACTORS; PHYSICAL-ACTIVITY; DEPRESSION; PREVALENCE; POPULATION; BURDEN; STROKE; ADULTS	Objective This paper reflected on the prevalence of hypertension and diabetes in Bangladesh, which is spreading rapidly in low-income countries. The rationale of constructing more health centers for addressing NCDs was assessed in this paper by determining the relationship between prevalence of NCDs, particularly hypertension and diabetes, and distance to health facilities. Methods From BDHS (Bangladesh Health and Demographic Survey) 2011 data set, 7544 samples were analyzed to demonstrate association between Non-communicable diseases (NCD) and distance from respondents' home to health facilities like hospitals, community clinics, pharmacies or doctors' chambers, and community facilities like market, post office or cinema hall. Bivariate analysis was conducted between accessibility to health facilities and prevalence of the diseases. The causal relationship between the spatial effects and the prevalence of the diseases were analyzed by applying Generalized Linear Mixed Model (GLMM) was fitted. Results Fitting linear mixed effect models, we found that hypertension and diabetes react differently with various spatial effects. Distance from home to hospital had significant effect (P < 0.001) on hypertension showing people living further from the facilities or town centers seemed to be less hypertensive, whereas diabetes showed no such affiliation. Conclusion Higher prevalence of diabetes (40.9%) over hypertension (26.5%) in people aging 35 or higher, have appeared to have caused the difference, which concluded that each non-communicable disease should be dealt to its own merit for policy making instead considering as a group of diseases.	[Biswas, Raaj Kishore; Kabir, Enamul] Univ Southern Queensland, Sch Agr Computat & Environm Sci, Toowoomba, Qld, Australia	University of Southern Queensland	Biswas, RK (corresponding author), Univ Southern Queensland, Sch Agr Computat & Environm Sci, Toowoomba, Qld, Australia.	RaajKishore.Biswas@usq.edu.au	Biswas, Raaj Kishore/K-4256-2018	Biswas, Raaj Kishore/0000-0003-4294-6323; Kabir, Enamul/0000-0002-6157-2753				AbuSayeed M, 1997, DIABETES CARE, V20, P551, DOI 10.2337/diacare.20.4.551; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Alam DS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004983; Alam GM, 2009, AFR J AGR RES, V4, P1334; [Anonymous], 2010, HLTH NUTR POPUL SER; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bhowmik B, 2012, DIABETES METAB J, V36, P422, DOI 10.4093/dmj.2012.36.6.422; BRONSTEIN JM, 1990, MED CARE, V28, P853, DOI 10.1097/00005650-199009000-00013; Choukem SP, 2007, DIABETES RES CLIN PR, V77, P293, DOI 10.1016/j.diabres.2006.11.007; Davidson K, 2000, ARCH INTERN MED, V160, P1495, DOI 10.1001/archinte.160.10.1495; DHS, 2011, DHS WEBS BANGL STAND; GESLER WM, 1992, SOC SCI MED, V34, P735, DOI 10.1016/0277-9536(92)90360-3; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; Gupta I, 2006, EC IMPACT CARDIOVASC; Habib SH, 2010, DIABETES METAB SYND, V4, P41, DOI 10.1016/j.dsx.2008.04.005; Hirai M, 2015, DHS OCCASIONAL PAPER, V10; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; Islam A K M Monwarul, 2012, Indian Heart J, V64, P319, DOI 10.1016/S0019-4832(12)60096-0; Jordan H., 2004, INT J HEALTH GEOGR, V3, P1; Killewo J, 2006, J HEALTH POPUL NUTR, V24, P403; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leeder S, 2004, RACE TIME CHALLENGE; Lloyd-Sherlock P, 2010, DEV POLICY REV, V28, P693, DOI 10.1111/j.1467-7679.2010.00505.x; McCulloch CE, 1997, J AM STAT ASSOC, V92, P162, DOI 10.2307/2291460; Measure DHS. Bangladesh Demographic and Health Survey, 2011, BANGL DEM HLTH SURV; Nemet GF, 2000, SOC SCI MED, V50, P1197, DOI 10.1016/S0277-9536(99)00365-2; Oladiji JO, 2009, AFR J PSYCHIATRY, V12, P47; Paripovic D, 2010, PEDIATR NEPHROL, V25, P1719, DOI 10.1007/s00467-010-1552-8; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Rahman MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118365; Rutstein S. O., 2004, DHS WEALTH INDEX; Saftlas AF, 2004, AM J EPIDEMIOL, V160, P758, DOI 10.1093/aje/kwh277; Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386; Shannon G, 1979, J Community Health, V5, P113, DOI 10.1007/BF01324013; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Timyan J, 1993, ACCESS CARE MORE PRO; WHO. World Health Organization, 2002, WORLD HLTH REP 2002, P81	41	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177027	10.1371/journal.pone.0177027	http://dx.doi.org/10.1371/journal.pone.0177027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545074	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000401672400019
J	Gonzalez-Donquiles, C; Alonso-Molero, J; Fernandez-Villa, T; Vilorio-Marques, L; Molina, AJ; Martin, V				Gonzalez-Donquiles, C.; Alonso-Molero, J.; Fernandez-Villa, T.; Vilorio-Marques, L.; Molina, A. J.; Martin, V.			The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review	PLOS ONE			English	Review							PROTEASOME ACTIVITY; OXIDATIVE STRESS; NRF2-DEFICIENT MICE; SIGNALING PATHWAYS; COLONIC CELLS; ACTIVATION; COLITIS; APOPTOSIS; EXPRESSION; MODULATION	Background Colorectal cancer is one of the most common cancers worldwide, and is influenced by the interplay of various factors, including a very strong genetic component. For instance, incorrect mitochondrial biogenesis is correlated with increased risk of developing colorectal cancer. Thus, it is important to understand the consequences of changes in both the expression and the correct function of the transcription factors that regulate mitochondrial biogenesis, namely NRF2. Objectives The main objective of this paper is to characterise the relationship between NRF2 and colorectal cancer by compiling data from an exhaustive literature search. Methods Information was obtained by defining specific search terms and searching in several databases. After a strict selection procedure, data were tabulated and the relationships between articles were assessed by measuring heterogeneity and by constructing conceptual maps. Results and discussion We found a general consensus in the literature that the presence of oxidizing agents as well as the inhibition of the NRF2 repressor Keap1 maintain NRF2 expression at basal levels. This predominantly exerts a cytoprotective effect on cells and decreases risk of colorectal cancer. However, if NRF2 is inhibited, protection against external agents disappears and risk of colorectal cancer increases. Interestingly, colorectal cancer risk is also increased when NRF2 becomes overexpressed. In this case, the increased risk arises from NRF2-induced inflammation and resistance to chemotherapy. Conclusion The proper basal function of NRF2 and Keap1 are essential for preventing oncogenic processes in the colon. Consequently, any disruption to the expression of these genes can promote the genesis and progression of colon cancer.	[Gonzalez-Donquiles, C.; Martin, V.] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Gonzalez-Donquiles, C.; Alonso-Molero, J.; Fernandez-Villa, T.; Vilorio-Marques, L.; Molina, A. J.; Martin, V.] Univ Leon, Gene Environm & Hlth Res Grp, Leon, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de Leon	Gonzalez-Donquiles, C (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.; Gonzalez-Donquiles, C (corresponding author), Univ Leon, Gene Environm & Hlth Res Grp, Leon, Spain.	cgonzd00@estudiantes.unileon.es	Martin, Vicente/ABF-2276-2021; Martin, Vicente/A-1597-2008; Martin, Vicente/GRE-8306-2022; Fernández-Villa, Tania/R-6534-2017	Martin, Vicente/0000-0003-0552-2804; Martin, Vicente/0000-0003-0552-2804; Vilorio-Marques, Laura/0000-0002-1930-1415; Alonso-Molero, Jessica/0000-0002-1939-8798				Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Bat-Chen W, 2010, NUTR CANCER, V62, P947, DOI 10.1080/01635581.2010.509837; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Chang LC, 2013, APPL IMMUNOHISTO M M, V21, P511, DOI 10.1097/PAI.0b013e318282ac20; Cheung KL, 2014, MOL CARCINOGEN, V53, P77, DOI 10.1002/mc.21950; Chiou YS, 2011, J AGR FOOD CHEM, V59, P2725, DOI 10.1021/jf2000103; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Habano W, 1999, INT J CANCER, V83, P625, DOI 10.1002/(SICI)1097-0215(19991126)83:5<625::AID-IJC10>3.0.CO;2-N; Hu TH, 2013, J BIOMED RES, V27, P283, DOI 10.7555/JBR.27.20130069; inflammatory response and elicits apoptosis, 2008, BIOCHEM PHARMACOL, V76, P1485; Ishaq M, 2014, BBA-MOL CELL RES, V1843, P2827, DOI 10.1016/j.bbamcr.2014.08.011; Jang HJ, 2016, GASTROENT RES PRACT, V2016, P1; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Ji LL, 2014, INT J CLIN EXP PATHO, V7, P1124; Jung Kyu-Won, 2013, Brain Tumor Res Treat, V1, P16, DOI 10.14791/btrt.2013.1.1.16; Kang KA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.149; Kang KA, 2016, ONCOTARGET; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kim H, 2013, FREE RADICAL BIO MED, V65, P552, DOI 10.1016/j.freeradbiomed.2013.07.015; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kruse ML, 2016, INFLAMM BOWEL DIS, V22, P2593, DOI 10.1097/MIB.0000000000000925; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Li CQ, 2009, P NATL ACAD SCI USA, V106, P14547, DOI 10.1073/pnas.0907539106; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Li Y, 2016, INT IMMUNOPHARMACOL, V40, P24, DOI 10.1016/j.intimp.2016.08.020; Lu MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26585; Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002; Myers JN, 2014, INFLAMM BOWEL DIS, V20, P1530, DOI 10.1097/MIB.0000000000000144; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Pandurangan AK, 2015, BIOFACTORS, V41, P1, DOI 10.1002/biof.1195; Pandurangan AK, 2014, ASIAN PAC J CANCER P, V15, P5501, DOI 10.7314/APJCP.2014.15.14.5501; Pandurangan AK, 2014, TOXICOL MECH METHOD, V24, P13, DOI 10.3109/15376516.2013.843111; Pandurangan AK, 2013, ASIAN PAC J CANCER P, V14, P5543, DOI 10.7314/APJCP.2013.14.10.5543; Park EJ, 2010, BIOCHIMIE, V92, P110, DOI 10.1016/j.biochi.2009.10.001; Pettersen K, 2016, FREE RADICAL BIO MED, V90, P158, DOI 10.1016/j.freeradbiomed.2015.11.018; Roberto M, 2006, BBA-BIOENERGETICS, V1757, P618, DOI 10.1016/j.bbabio.2006.04.005; Rodgers M., 2006, GUIDANCE CONDUCT NAR, DOI DOI 10.13140/2.1.1018.4643; Rodriguez-Ramiro I, 2012, EUR J NUTR, V51, P881, DOI 10.1007/s00394-011-0269-1; Saw CLL, 2011, EXPERT OPIN THER TAR, V15, P281, DOI 10.1517/14728222.2011.553602; Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Stachel I, 2014, J BIOL CHEM, V289, P1917, DOI 10.1074/jbc.M113.490920; Tan BL, 2015, WORLD J GASTROENTERO, V21, P8826, DOI 10.3748/wjg.v21.i29.8826; Trivedi PP, 2016, MOL CARCINOGEN, V55, P255, DOI 10.1002/mc.22274; Trivedi PP, 2013, FOOD CHEM TOXICOL, V59, P339, DOI 10.1016/j.fct.2013.06.019; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; Wondrak GT, 2010, MOLECULES, V15, P3338, DOI 10.3390/molecules15053338; Xi MY, 2013, J MED CHEM, V56, P7925, DOI 10.1021/jm400944k; Xu DG, 2015, ANAT REC, V298, P376, DOI 10.1002/ar.23045; Yang Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-48; Yao J, CELL DEATH DIS; Yokoo Y, 2016, CANC MED; Zhao XQ, 2015, ONCOL LETT, V10, P1287, DOI 10.3892/ol.2015.3468	54	41	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177549	10.1371/journal.pone.0177549	http://dx.doi.org/10.1371/journal.pone.0177549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542357	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672400052
J	Lin, JL; Wang, ZH; Chung, CC; Xu, JA; Dai, MM; Huang, JJ				Lin, Jialiu; Wang, Zhonghao; Chung, Chuchen; Xu, Jianan; Dai, Miaomiao; Huang, Jingjing			Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjects	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; PHYSIOLOGICAL MYDRIASIS; CHAMBER ANGLE; IRIS CHANGES; RISK-FACTOR; GLAUCOMA; PARAMETERS; SUBTYPES; CHINESE	Purpose To compare changes in anterior segment parameters under light and dark (light-to-dark) conditions among eyes with chronic primary angle-closure glaucoma (CPACG), fellow eyes with confirmed or suspect primary angle-closure (PAC or PACS), and age-matched healthy eyes. Methods Consecutive patients with CPACG in one eye and PAC/PACS in the fellow eye, as well as age-matched healthy subjects were recruited. Anterior segment optical coherence tomography measurements were conducted under light and dark conditions, and anterior chamber, lens, and iris parameters compared. Demographic and biometric factors associated with light-to-dark change in iris area were analyzed by linear regression. Results Fifty-seven patients (mean age 59.6 +/- 8.9 years) and 30 normal subjects matched for age (60.6 +/- 9.3 years) and sex ratio were recruited. In regards to differences under light-to-dark conditions, angle opening distance at 500 mu m (AOD500 mu m) and iris area during light-to-dark transition were smaller in CPACG eyes than fellow PACS/PAC eyes and normal eyes (P < 0.017). Pupil diameter change was largest in normal eyes, and larger in PACS/PAC eyes than CPACG eyes (P < 0.017). There was an average reduction of 0.145 mm(2) in iris area for each millimeter of pupil diameter increase in CPACG eyes, 0.161 mm(2) in fellow PAC/PACS eyes, and 0.165 mm(2) in normal eyes. Larger iris curvature in the dark and diagnosis of PACG were significantly associated with less light-to-dark iris area changes. Conclusions Dynamic changes in iris parameters with light-to-dark transition differed significantly among CPACG eyes, fellow PAC/PACS eyes, and normal eyes. Greater iris curvature under dark conditions was correlated with reduced light-to-dark change in iris area and pupil diameter, which may contribute to disease progression.	[Lin, Jialiu; Wang, Zhonghao; Chung, Chuchen; Xu, Jianan; Dai, Miaomiao; Huang, Jingjing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Huang, JJ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	hjjing@mail.sysu.edu.cn			Guangzhou Science Technology and Innovation Commission in China [201607010321]; Science and Technology Planning Project of Guangdong Province in China [2013B022000037]	Guangzhou Science Technology and Innovation Commission in China; Science and Technology Planning Project of Guangdong Province in China	This work is supported by the Research Grant 201607010321 from Guangzhou Science Technology and Innovation Commission in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The URLs of the funder is http://wsbs.gzsi.gov.cn/login.html. This work is also supported by Grant 2013B022000037 from Science and Technology Planning Project of Guangdong Province in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The URLs of the funder is http://pro. gdstc.gov.cn/egrantweb/.	Aung T, 2005, ARCH OPHTHALMOL-CHIC, V123, P527, DOI 10.1001/archopht.123.4.527; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Ganeshrao SB, 2012, OPTOMETRY VISION SCI, V89, P483, DOI 10.1097/OPX.0b013e31824c3731; Henzan IM, 2011, AM J OPHTHALMOL, V151, P1065, DOI 10.1016/j.ajo.2010.11.030; Hirose F, 2013, GRAEF ARCH CLIN EXP, V251, P2395, DOI 10.1007/s00417-013-2378-4; Huang JJ, 2015, J GLAUCOMA, V24, P323, DOI 10.1097/IJG.0b013e31829e55cd; KALENAK JW, 1991, AM J OPHTHALMOL, V112, P219, DOI 10.1016/S0002-9394(14)76713-3; Lee Y, 2012, INVEST OPHTH VIS SCI, V53, P693, DOI 10.1167/iovs.11-8389; Leung CKS, 2010, OPHTHALMOLOGY, V117, P1684, DOI 10.1016/j.ophtha.2010.01.026; Leung CKS, 2007, INVEST OPHTH VIS SCI, V48, P4116, DOI 10.1167/iovs.07-0010; Maslin JS, 2015, INDIAN J OPHTHALMOL, V63, P630, DOI 10.4103/0301-4738.169787; Narayanaswamy A, 2013, INVEST OPHTH VIS SCI, V54, P708, DOI 10.1167/iovs.12-10844; Nongpiur ME, 2011, OPHTHALMOLOGY, V118, P474, DOI 10.1016/j.ophtha.2010.07.025; Nongpiur ME, 2011, CURR OPIN OPHTHALMOL, V22, P96, DOI 10.1097/ICU.0b013e32834372b9; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2010, OPHTHALMOLOGY, V117, P1, DOI 10.1016/j.ophtha.2009.11.002; Quigley HA, 2009, AM J OPHTHALMOL, V148, P657, DOI 10.1016/j.ajo.2009.08.009; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Seager FE, 2014, INVEST OPHTH VIS SCI, V55, P1672, DOI 10.1167/iovs.13-13641; Sihota R, 2005, J GLAUCOMA, V14, P387, DOI 10.1097/01.ijg.0000176934.14229.32; Wang YE, 2013, INVEST OPHTH VIS SCI, V54, P7717, DOI 10.1167/iovs.13-12850; Wang ZT, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0141807, 10.1371/journal.pone.0120843]; Zhang Y, 2016, INVEST OPHTH VIS SCI, V57, P218, DOI 10.1167/iovs.15-17651; Zhang Y, 2014, INVEST OPHTH VIS SCI, V55, P4405, DOI 10.1167/iovs.13-13782	25	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177769	10.1371/journal.pone.0177769	http://dx.doi.org/10.1371/journal.pone.0177769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542344	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400080
J	Su, MZ; Ma, Y; Zhang, XF; Wang, Y; Zhang, YP				Su, Mingzhe; Ma, Yan; Zhang, Xiangfen; Wang, Yan; Zhang, Yuping			MBR-SIFT: A mirror reflected invariant feature descriptor using a binary representation for image matching	PLOS ONE			English	Article								The traditional scale invariant feature transform (SIFT) method can extract distinctive features for image matching. However, it is extremely time-consuming in SIFT matching because of the use of the Euclidean distance measure. Recently, many binary SIFT (BSIFT) methods have been developed to improve matching efficiency; however, none of them is invariant to mirror reflection. To address these problems, in this paper, we present a horizontal or vertical mirror reflection invariant binary descriptor named MBR-SIFT, in addition to a novel image matching approach. First, 16 cells in the local region around the SIFT keypoint are reorganized, and then the 128-dimensional vector of the SIFT descriptor is transformed into a reconstructed vector according to eight directions. Finally, the MBR-SIFT descriptor is obtained after binarization and reverse coding. To improve the matching speed and accuracy, a fast matching algorithm that includes a coarse-to-fine two-step matching strategy in addition to two similarity measures for the MBR-SIFT descriptor are proposed. Experimental results on the UKBench dataset show that the proposed method not only solves the problem of mirror reflection, but also ensures desirable matching accuracy and speed.	[Su, Mingzhe; Ma, Yan; Zhang, Xiangfen; Zhang, Yuping] Shanghai Normal Univ, Coll Informat Mech & Elect Engn, Shanghai, Peoples R China; [Wang, Yan] Univ Paul Sabatier, Math, Informat, Telecommun Toulouse, Toulouse, France	Shanghai Normal University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Ma, Y (corresponding author), Shanghai Normal Univ, Coll Informat Mech & Elect Engn, Shanghai, Peoples R China.	ma-yan@shnu.edu.cn			National Natural Science Foundation of China [61373004]; Shanghai Normal University Innovation Team Project [A700115001005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Normal University Innovation Team Project	This work is supported by the National Natural Science Foundation of China (No.61373004) and Shanghai Normal University Innovation Team Project (No.A700115001005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the National Natural Science Foundation of China(No.61373004) and Shanghai Normal University Innovation Team Project (No.A700115001005).	Alahi A, 2012, PROC CVPR IEEE, P510, DOI 10.1109/CVPR.2012.6247715; Brown M, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1218; Calonder M, 2010, LECT NOTES COMPUT SC, V6314, P778, DOI 10.1007/978-3-642-15561-1_56; Chen CC, 2015, J VIS COMMUN IMAGE R, V30, P86, DOI 10.1016/j.jvcir.2015.02.014; Ferrari V, 2004, LECT NOTES COMPUT SC, V3021, P40; Heikkila M, 2009, PATTERN RECOGN, V42, P425, DOI 10.1016/j.patcog.2008.08.014; Kahaki SMM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149710; Ke Y, 2004, PROC CVPR IEEE, P506; Lazebnik S, 2003, PROC CVPR IEEE, P319; Li CL, 2009, PATTERN RECOGN LETT, V30, P544, DOI 10.1016/j.patrec.2008.12.004; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Mikolajczyk K, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P525, DOI 10.1109/ICCV.2001.937561; Ni Zhen-Sheng, 2012, 2012 4th International Conference on Digital Home (ICDH 2012), P117, DOI 10.1109/ICDH.2012.69; Nister D., 2006, P IEEE COMP SOC C CO, P2161; Pollefeys M, 2002, COMMUN ACM, V45, P50, DOI 10.1145/514236.514263; Scovanner P., 2007, P 15 ACM INT C MULT, P357, DOI DOI 10.1145/1291233.1291311; Tuytelaars T, 2004, INT J COMPUT VISION, V59, P61, DOI 10.1023/B:VISI.0000020671.28016.e8; Xiaojie Guo, 2009, Computer Vision - ACCV 2009. 9th Asian Conference on Computer Vision. Revised Selected Papers, P536; Zhou WG, 2015, IEEE T IMAGE PROCESS, V24, P967, DOI 10.1109/TIP.2015.2389624	23	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178090	10.1371/journal.pone.0178090	http://dx.doi.org/10.1371/journal.pone.0178090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542537	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672400140
J	Negedu-Momoh, OR; Jegede, FE; Yakubu, A; Balogun, O; Abdullahi, M; Badru, T; Oladele, EA; Agbakwuru, C; Khamofu, H; Torpey, K				Negedu-Momoh, Olubunmi Ruth; Jegede, Feyisayo Ebenezer; Yakubu, Ali; Balogun, Oluseyi; Abdullahi, Musa; Badru, Titilope; Oladele, Edward Adekola; Agbakwuru, Chinedu; Khamofu, Hadiza; Torpey, Kwasi			Performance evaluation of BD FACSPresto (TM) point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SETTINGS; CLINICS; PIMA	Background Despite the upsurge in support and intervention of donor agencies in HIV care and treatment programing in Sub-Sahara African, antiretroviral (ART) programs are still confronted with access and coverage challenges which influence enrolment of new patients. This study investigated the validity of point of care BD FACSPresto (TM) CD4 analyzer for CD4+ cell count, overall agreement, correlation, sensitivity, and specificity in comparison to a reference standard flow cytometry method. We also assessed the feasibility of use among non-laboratorians. Methods Blood samples from 300 HIV infected individuals were analyzed for CD4+ T cell and CD4%, using finger prick capillary sample from 150 PMTCT clients and 150 ART clients at Murtala Mohammed Specialist Hospital, Kano, Nigeria. Their venous samples were compared on a flow cytometry reference method using BD FACSCount CD4+ count system. The accuracy of the BD FACSPresto machine in comparison to BD FACSCount was evaluated. Statistical analysis was carried out using STATA (version 12). Bland-Altman method and correlation analysis were used to analyze agreement between both measurements. In addition, sensitivity and specificity of both measurements were determined. Statistical significance was set at p-value <0.05. Results The mean bias and limit of agreement for CD4+ count between BD FACSPresto and BD FACS count machine were 7.49 (95% CI: 2.44 to 12.54) and -8.14 to 96.39 respectively. Further analysis revealed close agreement between BD FACSPresto and BD FACSCount with no significant difference between the two methods (p = .0.95). Using a threshold of 500 cells/mu L, sensitivity and specificity of BD FACSPresto were 95.1% and 97.1% respectively, compared to BD FACSCount. There was no statistically significant difference in the misclassification between BD FACSPresto and BD FACSCount results (p = 0.23). Furthermore, sensitivity and specificity were similar when BD FACSPresto machine was operated by a nurse or laboratory scientist, there was no substantial difference in testing variability observed between laboratory and non-laboratory operators using the BD FACSPresto analyzer. Conclusions Overall, BD FACSPresto Point of Care CD4+ count finger stick capillary blood results is a reliable method in comparison to venous sample cytometry method and no significant difference variability observed between laboratory personnel and non-laboratory operators. The BD FACSPresto is simple, more robust and easy to use equipment without significant variability in reliability by non-laboratory health care workers hence will be a valuable instrument in increasing access and coverage of CD4 estimations in developing countries. The introduction of the BD FACSPresto POC analyzer has a high potential in reducing patients waiting time and improving the overall quality of ART service and clients' satisfaction especially in rural settings.	[Negedu-Momoh, Olubunmi Ruth; Jegede, Feyisayo Ebenezer; Balogun, Oluseyi; Badru, Titilope; Oladele, Edward Adekola; Agbakwuru, Chinedu; Khamofu, Hadiza; Torpey, Kwasi] Family Hlth Int FHI360, Garki Abuja, Nigeria; [Yakubu, Ali; Abdullahi, Musa] Murtala Mohammed Specialist Hosp, Kano, Nigeria; [Torpey, Kwasi] Univ Ghana, Coll Hlth Sci, Accra, Ghana	University of Ghana	Negedu-Momoh, OR (corresponding author), Family Hlth Int FHI360, Garki Abuja, Nigeria.	onegedumomoh@ng.fhi360.org		Torpey, Kwasi/0000-0003-1628-2922; Oladele, Edward Adekola/0000-0003-4999-1397	FHI under the USAID [360]	FHI under the USAID(United States Agency for International Development (USAID))	BD Bioscience provided the BD FACSPresto machine for the pilot testing to Murtala Mohammed Specialist Hospital, Kano, one of the supported sites by FHI 360 under the USAID funding for the SIDHAS project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angira F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157939; Beckton D, 2008, BD FACSCOUNT SYTEM U, P59; Boyle DS, 2012, TRENDS BIOTECHNOL, V30, P45, DOI 10.1016/j.tibtech.2011.06.015; Bwana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145586; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Cheng XH, 2009, LAB CHIP, V9, P1357, DOI 10.1039/b818813k; Coetzee LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156266; Federal Ministry of Health Nigeria, 2016, NAT GUID HIV PREV TR; Galiwango RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088928; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Pribul V., 2013, SURGERY OXFORD, V31, P84; Rathunde L, 2014, INT J STD AIDS, V25, P956, DOI 10.1177/0956462414526862; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26; Wang SQ, 2010, BIOTECHNOL ADV, V28, P770, DOI 10.1016/j.biotechadv.2010.06.004; World Health Organization, 2016, CONS GUID US ANT DRU	22	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178037	10.1371/journal.pone.0178037	http://dx.doi.org/10.1371/journal.pone.0178037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542359	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800037
J	Picheny, V; Trepos, R; Casadebaig, P				Picheny, Victor; Trepos, Ronan; Casadebaig, Pierre			Optimization of black-box models with uncertain climatic inputs-Application to sunflower ideotype design	PLOS ONE			English	Article							MULTIOBJECTIVE OPTIMIZATION; CROP; PERFORMANCE; GENOTYPE; WHEAT	Accounting for the interannual climatic variations is a well-known issue for simulation-based studies of environmental systems. It often requires intensive sampling (e.g., averaging the simulation outputs over many climatic series), which hinders many sequential processes, in particular optimization algorithms. We propose here an approach based on a subset selection in a large basis of climatic series, using an ad-hoc similarity function and clustering. A non-parametric reconstruction technique is introduced to estimate accurately the distribution of the output of interest using only the subset sampling. The proposed strategy is non-intrusive and generic (i.e. transposable to most models with climatic data inputs), and can be combined to most "off-the-shelf" optimization solvers. We apply our approach to sunflower ideotype design using the crop model SUNFLO. The underlying optimization problem is formulated as a multi-objective one to account for risk-aversion. Our approach achieves good performances even for limited computational budgets, outperforming significantly standard strategies.	[Picheny, Victor; Trepos, Ronan] Univ Toulouse, INRA, MIAT, Castanet Tolosan, France; [Casadebaig, Pierre] Univ Toulouse, INRA, AGIR, Castanet Tolosan, France	INRAE; INRAE	Picheny, V (corresponding author), Univ Toulouse, INRA, MIAT, Castanet Tolosan, France.	victor.picheny@toulouse.inra.fr	Casadebaig, Pierre/AAL-6998-2020; Casadebaig, Pierre/AAL-3307-2020	Casadebaig, Pierre/0000-0001-7225-936X; 				Ailliot P, 2015, J SFDS, V156, P101; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2006, WORKING DYNAMIC CROP; Bergez JE, 2013, ENVIRON MODELL SOFTW, V39, P39, DOI 10.1016/j.envsoft.2012.03.011; Beyer HG, 2007, COMPUT METHOD APPL M, V196, P3190, DOI 10.1016/j.cma.2007.03.003; Brisson N, 2003, EUR J AGRON, V18, P309, DOI 10.1016/S1161-0301(02)00110-7; Brown HE, 2014, ENVIRON MODELL SOFTW, V62, P385, DOI 10.1016/j.envsoft.2014.09.005; Casadebaig P, 2011, AGR FOREST METEOROL, V151, P163, DOI 10.1016/j.agrformet.2010.09.012; Challinor AJ, 2008, AGR FOREST METEOROL, V148, P1062, DOI 10.1016/j.agrformet.2008.02.006; Connor D.J., 1997, SUNFLOWER TECHNOLOGY, VVolume 35, P113, DOI DOI 10.2134/AGR0NM0N0GR35.C4; Cools J, 2011, ENVIRON MODELL SOFTW, V26, P44, DOI 10.1016/j.envsoft.2010.04.017; Deb K., 2016, DECISION SCI THEORY, P145; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Grechi I, 2012, ECOL MODEL, V246, P47, DOI 10.1016/j.ecolmodel.2012.07.023; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Holzkamper A, 2015, ENVIRON MODELL SOFTW, V66, P27, DOI 10.1016/j.envsoft.2014.12.012; Jakoby O, 2014, J APPL ECOL, V51, P483, DOI 10.1111/1365-2664.12216; Martre P, 2015, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, 2ND EDITION, P349, DOI 10.1016/B978-0-12-417104-6.00014-5; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Olteanu M, 2015, NEUROCOMPUTING, V147, P15, DOI 10.1016/j.neucom.2013.11.047; PRATT JW, 1964, ECONOMETRICA, V32, P122, DOI 10.2307/1913738; Quilot-Turion B, 2012, EUR J AGRON, V42, P34, DOI 10.1016/j.eja.2011.11.008; Raquel CR, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P257; Rockafellar R. T., 2000, J RISK, V2, P21, DOI 10.21314/JOR.2000.038; Ruiz-Ramos M, 2010, CLIM RES, V44, P69, DOI 10.3354/cr00933; Semenov MA, 2014, J CEREAL SCI, V59, P245, DOI 10.1016/j.jcs.2014.01.006; Semenov MA, 2013, FOOD ENERGY SECUR, V2, P185, DOI 10.1002/fes3.34; Tsoukalas I, 2014, ENV MODELLING SOFTWA; Zitzler E, 2003, IEEE T EVOLUT COMPUT, V7, P117, DOI 10.1109/TEVC.2003.810758	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0176815	10.1371/journal.pone.0176815	http://dx.doi.org/10.1371/journal.pone.0176815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542198	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800004
J	Soriano, JM; Malosetti, M; Rosello, M; Sorrells, ME; Royo, C				Soriano, Jose Miguel; Malosetti, Marcos; Rosello, Martina; Sorrells, Mark Earl; Royo, Conxita			Dissecting the old Mediterranean durum wheat genetic architecture for phenology, biomass and yield formation by association mapping and QTL meta-analysis	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM ANALYSIS; THOUSAND-GRAIN WEIGHT; SPRING WHEAT; BREAD WHEAT; COMMON WHEAT; HEXAPLOID WHEAT; CANDIDATE GENES	Association mapping was used to identify genome regions affecting yield formation, crop phenology and crop biomass in a collection of 172 durum wheat landraces representative of the genetic diversity of ancient local durum varieties from the Mediterranean Basin. The collection was genotyped with 1,149 DArT markers and phenotyped in Spanish northern and southern locations during three years. A total of 245 significant marker trait associations (MTAs) (P<0.01) were detected. Some of these associations confirmed previously identified quantitative trait loci (QTL) and/or candidate genes, and others are reported for the first time here. Eighty-six MTAs corresponded with yield and yield component traits, 70 to phenology and 89 to biomass production. Twelve genomic regions harbouring stable MTAs (significant in three or more environments) were identified, while five and two regions showed specific MTAs for northern and southern environments, respectively. Sixty per cent of MTAs were located on the B genome and 29% on the A genome. The marker wPt-9859 was detected in 12 MTAs, associated with six traits in four environments and the mean across years. To refine QTL positions, a meta-analysis was performed. A total of 477 unique QTLs were projected onto a durum wheat consensus map and were condensed to 71 meta-QTLs and left 13 QTLs as singletons. Sixty-one percent of QTLs explained less than 10% of the phenotypic variance confirming the high genetic complexity of the traits analysed.	[Soriano, Jose Miguel; Rosello, Martina; Royo, Conxita] IRTA Inst Food & Agr Res & Technol, Field Crops Programme, Lleida, Spain; [Malosetti, Marcos] Wageningen Univ & Res Ctr, Biometr, Wageningen, Netherlands; [Sorrells, Mark Earl] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA	IRTA; Wageningen University & Research; Cornell University	Soriano, JM (corresponding author), IRTA Inst Food & Agr Res & Technol, Field Crops Programme, Lleida, Spain.	josemiguel.soriano@irta.cat	Malosetti, Marcos/J-7685-2013; Soriano Soriano, Jose Miguel/E-7894-2018; Royo, Conxita/J-3362-2017	Malosetti, Marcos/0000-0002-8150-1397; Soriano Soriano, Jose Miguel/0000-0003-1965-6504; Royo, Conxita/0000-0001-7939-1451	Spanish Ministry of Economy and Competitiveness [AGL-2006-09226-C02-01, AGL2015-65351-R]; CERCA Programme / Generalitat de Catalunya; Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria; Generalitat de Catalunya	Spanish Ministry of Economy and Competitiveness(Spanish Government); CERCA Programme / Generalitat de Catalunya; Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria; Generalitat de Catalunya(Generalitat de Catalunya)	This research was funded by the projects AGL-2006-09226-C02-01 (CR) and AGL2015-65351-R (JMS) from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es) and CERCA Programme / Generalitat de Catalunya (http://cerca.cat/).Jose Miguel Soriano was hired by the INIA-CCAA program funded by Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria and Generalitat de Catalunya (http://www.inia.es).; This research was funded by the projects AGL-2006-09226-C02-01 (CR) and AGL2015-65351-R (JMS) from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es) and CERCA Programme / Generalitat de Catalunya (http://cerca.cat/). JMS was hired by the INIA-CCAA program funded by Instituto Nacional de InvestigaciOn y Tecnologia Agraria y Alimentaria and Generalitat de Catalunya. Thanks are given to Dolors Villegas and Luis F. Garcia del Moral for their contribution to phenotyping and to Dr. Fred van Eeuwijk from WUR.	Ain Q, 2012, FRONT PLANT SCI, V6, P743; Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Ali ML, 2011, CROP SCI, V51, P553, DOI 10.2135/cropsci2010.06.0359; Alvaro F, 2008, AGRON J, V100, P361, DOI 10.2134/agronj2007.0075; Alvaro F, 2008, FIELD CROP RES, V106, P86, DOI 10.1016/j.fcr.2007.11.003; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Bednarek J, 2012, J EXP BOT, V63, P5945, DOI 10.1093/jxb/ers249; Bellucci A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01046; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Cane MA, 2014, MOL BREEDING, V34, P1629, DOI 10.1007/s11032-014-0177-1; Carlson SJ, 2002, PLANT MOL BIOL, V49, P15, DOI 10.1023/A:1014457901992; Carter AH, 2011, CROP SCI, V51, P84, DOI 10.2135/cropsci2010.03.0185; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Chen H, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0373-7; Cui F, 2014, THEOR APPL GENET, V127, P659, DOI 10.1007/s00122-013-2249-8; Darvasi A, 2007, BEHAV GENET, V27, P125; Deng SM, 2011, THEOR APPL GENET, V122, P281, DOI 10.1007/s00122-010-1443-1; Doyle J. J., 1987, PHYTOCHEM B, P11; Ellis MH, 2005, THEOR APPL GENET, V111, P423, DOI 10.1007/s00122-005-2008-6; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; FICK GN, 1973, GENETICS, V75, P531; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Goffinet B, 2000, GENETICS, V155, P463; Goudemand E, 2013, MOL BREEDING, V32, P563, DOI 10.1007/s11032-013-9890-4; Graziani M, 2014, CROP PASTURE SCI, V65, P80, DOI 10.1071/CP13349; Griffiths S, 2012, MOL BREEDING, V29, P159, DOI 10.1007/s11032-010-9534-x; Guo B, 2006, CROP SCI, V46, P595, DOI 10.2135/cropsci2005.04-0036-2; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hanocq E, 2007, THEOR APPL GENET, V114, P569, DOI 10.1007/s00122-006-0459-z; Hanocq E, 2004, THEOR APPL GENET, V110, P106, DOI 10.1007/s00122-004-1799-1; Hu MJ, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0449-z; Hu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130854; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Ivaro F, 2015, EUROPEAN J AGRONOMY, V68, P78; Jia HY, 2013, THEOR APPL GENET, V126, P2123, DOI 10.1007/s00122-013-2123-8; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; Kamran A, 2013, THEOR APPL GENET, V126, P1965, DOI 10.1007/s00122-013-2110-0; Laido G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095211; Lee HS, 2014, PLANT BIOTECHNOL REP, V8, P443, DOI 10.1007/s11816-014-0337-0; Lin F, 2008, EUPHYTICA, V164, P769, DOI 10.1007/s10681-008-9724-3; Liu G, 2014, THEOR APPL GENET, V127, P2415, DOI 10.1007/s00122-014-2387-7; Liu SY, 2009, CROP SCI, V49, P1955, DOI 10.2135/cropsci2009.03.0115; Loffler M, 2009, MOL BREEDING, V23, P473, DOI 10.1007/s11032-008-9250-y; Lopes MS, 2015, THEOR APPL GENET, V128, P453, DOI 10.1007/s00122-014-2444-2; Lopes MS, 2015, J EXP BOT, V66, P3477, DOI 10.1093/jxb/erv122; Ma DY, 2012, MOL BREEDING, V29, P43, DOI 10.1007/s11032-010-9524-z; Ma J, 2012, J INTEGR AGR, V11, P1399; Mac Key J., 2005, DURUM WHEAT BREEDING, VVolume 1, P3; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Maccaferri M, 2015, G3-GENES GENOM GENET, V5, P449, DOI 10.1534/g3.114.014563; Maccaferri M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-873; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Mao SL, 2010, EUPHYTICA, V174, P343, DOI 10.1007/s10681-010-0128-9; Marone D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-562; Mason RE, 2013, EUPHYTICA, V194, P243, DOI 10.1007/s10681-013-0951-x; Soriano JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160983; Mir RR, 2012, MOL BREEDING, V29, P963, DOI 10.1007/s11032-011-9693-4; MIURA H, 1994, PLANT BREEDING, V113, P160, DOI 10.1111/j.1439-0523.1994.tb00718.x; Moragues M, 2007, GENET RESOUR CROP EV, V54, P1133, DOI 10.1007/s10722-006-9005-8; Nazco R, 2012, EUPHYTICA, V185, P1, DOI 10.1007/s10681-011-0588-6; Nezhad KZ, 2012, EUPHYTICA, V186, P127, DOI 10.1007/s10681-011-0559-y; Nguyen AT, 2015, GENES GENET SYST, V90, P89, DOI 10.1266/ggs.90.89; Patil RM, 2013, EUPHYTICA, V190, P117, DOI 10.1007/s10681-012-0785-y; Pritchard JK, 2000, GENETICS, V155, P945; Quraishi UM, 2011, FUNCT INTEGR GENOMIC, V11, P71, DOI 10.1007/s10142-010-0183-2; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Rebetzke GJ, 2011, FIELD CROP RES, V124, P323, DOI 10.1016/j.fcr.2011.06.022; Reif JC, 2011, THEOR APPL GENET, V122, P961, DOI 10.1007/s00122-010-1502-7; Royo C, 2007, EUPHYTICA, V155, P259, DOI 10.1007/s10681-006-9327-9; Royo C, 2014, GENET RESOUR CROP EV, V61, P1345, DOI 10.1007/s10722-014-0116-3; Rustgi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070526; Sadras VO, 2007, FIELD CROP RES, V100, P125, DOI 10.1016/j.fcr.2006.07.004; Salvi S, 2015, CURR OPIN BIOTECH, V32, P179, DOI 10.1016/j.copbio.2015.01.001; Simmonds J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0191-9; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Soriano JM, 2015, PHYTOPATHOLOGY, V105, P1585, DOI 10.1094/PHYTO-05-15-0130-R; Sosnowski O, 2012, BIOINFORMATICS, V28, P2082, DOI 10.1093/bioinformatics/bts313; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tadesse W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141339; Tang YL, 2011, AGR SCI CHINA, V10, P1665, DOI 10.1016/S1671-2927(11)60165-X; Tsilo TJ, 2010, THEOR APPL GENET, V121, P717, DOI 10.1007/s00122-010-1343-4; Tyagi S, 2015, EUPHYTICA, V201, P367, DOI 10.1007/s10681-014-1217-y; Tyagi S., 2012, TRITICEAE GENOM GENE, V3, P9, DOI [10.5376/TGG.2012.03.0002, DOI 10.5376/TGG.2012.03.0002, 10.5376/tgg.2012.03.0002]; Veyrieras JB, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-49; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang JS, 2011, EUPHYTICA, V177, P277, DOI 10.1007/s10681-010-0267-z; Weir B. S., 1996, GENETIC DATA ANAL; Yang ZB, 2012, THEOR APPL GENET, V125, P1057, DOI 10.1007/s00122-012-1895-6; Yu LX, 2014, THEOR APPL GENET, V127, P1561, DOI 10.1007/s00122-014-2326-7; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang LY, 2010, J INTEGR PLANT BIOL, V52, P996, DOI 10.1111/j.1744-7909.2010.00967.x; Zheng BS, 2010, THEOR APPL GENET, V121, P1501, DOI 10.1007/s00122-010-1406-6	96	36	37	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178290	10.1371/journal.pone.0178290	http://dx.doi.org/10.1371/journal.pone.0178290			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542488	gold, Green Submitted, Green Published			2022-12-27	WOS:000402062800064
J	Thakur, SS; Ward, MS; Popat, A; Flemming, NB; Parat, MO; Barnett, NL; Parekh, HS				Thakur, Sachin S.; Ward, Micheal S.; Popat, Amirali; Flemming, Nicole B.; Parat, Marie-Odile; Barnett, Nigel L.; Parekh, Harendra S.			Stably engineered nanobubbles and ultrasound - An effective platform for enhanced macromolecular delivery to representative cells of the retina	PLOS ONE			English	Article							INTRAVITREAL DRUG-DELIVERY; CONTRAST AGENTS; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; GENE DELIVERY; LIPOSOMES; CAVITATION; TUMORS; SIZE; MICROBUBBLES	Herein we showcase the potential of ultrasound-responsive nanobubbles in enhancing macromolecular permeation through layers of the retina, ultimately leading to significant and direct intracellular delivery; this being effectively demonstrated across three relevant and distinct retinal cell lines. Stably engineered nanobubbles of a highly homogenous and echogenic nature were fully characterised using dynamic light scattering, B-scan ultrasound and transmission electron microscopy (TEM). The nanobubbles appeared as spherical liposome-like structures under TEM, accompanied by an opaque luminal core and darkened corona around their periphery, with both features indicative of efficient gas entrapment and adsorption, respectively. A nanobubble +/- ultrasound sweeping study was conducted next, which determined the maximum tolerated dose for each cell line. Detection of underlying cellular stress was verified using the biomarker heat shock protein 70, measured before and after treatment with optimised ultrasound. Next, with safety to nanobubbles and optimised ultrasound demonstrated, each human or mouse-derived cell population was incubated with biotinylated rabbit-IgG in the presence and absence of ultrasound +/- nanobubbles. Intracellular delivery of antibody in each cell type was then quantified using Cy3-streptavidin. Nanobubbles and optimised ultrasound were found to be negligibly toxic across all cell lines tested. Macromolecular internalisation was achieved to significant, yet varying degrees in all three cell lines. The results of this study pave the way towards better understanding mechanisms underlying cellular responsiveness to ultrasound-triggered drug delivery in future ex vivo and in vivo models of the posterior eye.	[Thakur, Sachin S.; Popat, Amirali; Parat, Marie-Odile; Parekh, Harendra S.] Univ Queensland, Sch Pharm, Woolloongabba, Qld, Australia; [Ward, Micheal S.; Popat, Amirali; Flemming, Nicole B.] Univ Queensland, Mater Res Inst, Translat Res Inst, Woolloongabba, Qld, Australia; [Ward, Micheal S.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Barnett, Nigel L.] Queensland Eye Inst, South Brisbane, Qld, Australia; [Barnett, Nigel L.] Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia; [Barnett, Nigel L.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia; [Thakur, Sachin S.] Univ Auckland, Dept Ophthalmol, Auckland, New Zealand	University of Queensland; Mater Research; University of Queensland; University of Queensland; Queensland Eye Institute; University of Queensland; Queensland University of Technology (QUT); University of Auckland	Parekh, HS (corresponding author), Univ Queensland, Sch Pharm, Woolloongabba, Qld, Australia.	h.parekh@uq.edu.au	Barnett, Nigel L/F-1226-2010; Parekh, Harendra/P-3964-2019; Parekh, Harendra S/D-6846-2011; Parat, Marie-Odile/G-4410-2010; Thakur, Sachin Sunil/AAC-4256-2019	Barnett, Nigel L/0000-0002-0704-2233; Parekh, Harendra/0000-0001-8792-4318; Parekh, Harendra S/0000-0001-8792-4318; Parat, Marie-Odile/0000-0003-4895-7381; Thakur, Sachin Sunil/0000-0003-4910-0005; Popat, Amirali/0000-0001-5401-3446; Flemming, Nicole/0000-0002-7259-443X	National Health and Medical Research Council of Australia [1023444]; Juvenile Diabetes Research Foundation International [3-2013-217]; University of Queensland School of Pharmacy Research and Maintenance Funds	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); University of Queensland School of Pharmacy Research and Maintenance Funds	This work was supported by the National Health and Medical Research Council of Australia (Grant number: 1023444); the Juvenile Diabetes Research Foundation International (Grant number: 3-2013-217); and the University of Queensland School of Pharmacy Research and Maintenance Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angius F, 2015, TOXICOL IN VITRO, V29, P314, DOI 10.1016/j.tiv.2014.11.009; APFEL RE, 1991, ULTRASOUND MED BIOL, V17, P179, DOI 10.1016/0301-5629(91)90125-G; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Birch DG, 2007, INT J NANOMED, V2, P65, DOI 10.2147/nano.2007.2.1.65; Bonilha VL, 2008, CLIN OPHTHALMOL, V2, P413; Chomas JE, 2001, J BIOMED OPT, V6, P141, DOI 10.1117/1.1352752; DEJONG N, 1991, ULTRASONICS, V29, P324, DOI 10.1016/0041-624X(91)90030-C; Deng ZT, 2014, J CONTROL RELEASE, V174, P109, DOI 10.1016/j.jconrel.2013.11.018; Endo-Takahashi Y, 2012, INT J PHARMACEUT, V422, P504, DOI 10.1016/j.ijpharm.2011.11.023; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Gao Z, 2008, ULTRASONICS, V48, P260, DOI 10.1016/j.ultras.2007.11.002; Geers B, 2012, J CONTROL RELEASE, V164, P248, DOI 10.1016/j.jconrel.2012.08.014; Goertz DE, 2007, ULTRASOUND MED BIOL, V33, P1376, DOI 10.1016/j.ultrasmedbio.2007.03.009; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Huang SL, 2001, J PHARM SCI, V90, P1917, DOI 10.1002/jps.1142; Hundt W, 2007, ACAD RADIOL, V14, P859, DOI 10.1016/j.acra.2007.04.008; Hwang TL, 2009, J PHARM SCI-US, V98, P3735, DOI 10.1002/jps.21687; Kodama T, 2010, J ELECTRON MICROSC, V59, P187, DOI 10.1093/jmicro/dfp056; Kolb H., 1995, WEBVISION ORG RETINA; Kukizaki M, 2006, J MEMBRANE SCI, V281, P386, DOI 10.1016/j.memsci.2006.04.007; Leinenga G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2512; Li HL, 2009, GENE THER, V16, P1146, DOI 10.1038/gt.2009.84; Li T, 2010, J HUAZHONG U SCI-MED, V30, P798, DOI 10.1007/s11596-010-0661-8; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Liu J, 1998, PHARMACEUT RES, V15, P918, DOI 10.1023/A:1011984817567; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Missel PJ, 2002, PHARMACEUT RES, V19, P1636, DOI 10.1023/A:1020940927675; Mitragotri S, 2005, NAT REV DRUG DISCOV, V4, P255, DOI 10.1038/nrd1662; Morgan KE, 2000, IEEE T ULTRASON FERR, V47, P1494, DOI 10.1109/58.883539; Negishi Y, 2011, J DRUG TARGET, V19, P830, DOI 10.3109/1061186X.2011.585428; Pan TL, 2012, FOOD CHEM TOXICOL, V50, P3892, DOI 10.1016/j.fct.2012.07.005; Paul S, 2014, COMPUT MECH, V53, P413, DOI 10.1007/s00466-013-0962-4; Peeters L, 2008, PHARM RES-DORDR, V25, P2657, DOI 10.1007/s11095-008-9684-2; Perera RH, 2014, PHARM RES-DORDR, V31, P1407, DOI 10.1007/s11095-013-1100-x; Pitt WG, 2008, J CONTROL RELEASE, V125, P174, DOI 10.1016/j.jconrel.2007.10.004; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; Rakoczy EP, 2015, ESSENT OPHTHALMOL, P65, DOI 10.1007/978-3-662-45188-5_6; Rickman CB, 2013, INVEST OPHTH VIS SCI, V54, pORSF68, DOI 10.1167/iovs.13-12757; Samuels IS, 2015, J NEUROPHYSIOL, V113, P1085, DOI 10.1152/jn.00761.2014; Schlicher RK, 2002, J ACOUST SOC AM, V112, P2339; Schlicher RK, 2010, ULTRASOUND MED BIOL, V36, P677, DOI 10.1016/j.ultrasmedbio.2010.01.010; Schon C, 2015, EUR J PHARM BIOPHARM, V95, P343, DOI 10.1016/j.ejpb.2015.01.009; Schroeder A, 2009, J CONTROL RELEASE, V137, P63, DOI 10.1016/j.jconrel.2009.03.007; Sonoda S, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/412752; Spitzer MS, 2006, BRIT J OPHTHALMOL, V90, P1316, DOI 10.1136/bjo.2006.095190; Suzuki R, 2008, INT J PHARMACEUT, V354, P49, DOI 10.1016/j.ijpharm.2007.10.034; Suzuki R, 2010, J CONTROL RELEASE, V142, P245, DOI 10.1016/j.jconrel.2009.10.027; Thakur SS, 2014, EXPERT OPIN DRUG DEL, V11, P1575, DOI 10.1517/17425247.2014.927864; Thakur SS, 2009, METHOD PREPARING LIP; Tian JL, 2015, ACS APPL MATER INTER, V7, P26579, DOI 10.1021/acsami.5b07778; Un K, 2010, HUM GENE THER, V21, P65, DOI 10.1089/hum.2009.106; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; World Health Organization, PRIOR EYE DIS 2014; Yang S, 2014, EUR RADIOL, V24, P2739, DOI 10.1007/s00330-014-3334-3; Yin TH, 2012, INT J NANOMED, V7, P895, DOI 10.2147/IJN.S28830; Zhou XY, 2009, CHINESE MED J-PEKING, V122, P2711, DOI 10.3760/cma.j.issn.0366-6999.2009.22.007	56	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178305	10.1371/journal.pone.0178305	http://dx.doi.org/10.1371/journal.pone.0178305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542473	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800068
J	Belviso, S; Iuliano, R; Amato, R; Perrotti, N; Menniti, M				Belviso, Stefania; Iuliano, Rodolfo; Amato, Rosario; Perrotti, Nicola; Menniti, Miranda			The human asparaginase enzyme (ASPG) inhibits growth in leukemic cells	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; GLUTAMINASE ACTIVITY; CANCER; LYSOPHOSPHOLIPASE; PROLIFERATION; APOPTOSIS; AUTOPHAGY; MIGRATION	The human protein ASPG is an enzyme with a putative antitumor activity. We generated in bacteria and then purified a recombinant GST-ASPG protein that we used to characterize the biochemical and cytotoxic properties of the human ASPG. We demonstrated that ASPG possesses asparaginase and PAF acetylhydrolase activities that depend on a critical threonine residue at position 19. Consistently, ASPG but not its T19A mutant showed cytotoxic activity in K562, NALM-6 and MOLT-4 leukemic cell lines but not in normal cells. Regarding the mechanism of action of ASPG, it was able to induce a significant apoptotic death in K562 cells. Taken together our data suggest that ASPG, combining different enzymatic activities, should be considered a promising anti-cancer agent for inhibiting the growth of leukemia cells.	[Belviso, Stefania] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Iuliano, Rodolfo; Amato, Rosario; Perrotti, Nicola; Menniti, Miranda] Magna Graecia Univ Catanzaro, Dept Human Hlth, Catanzaro, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Iuliano, R; Menniti, M (corresponding author), Magna Graecia Univ Catanzaro, Dept Human Hlth, Catanzaro, Italy.	iuliano@unicz.it; mirmenniti@unicz.it		Amato, Rosario/0000-0001-7162-1099	Associazione Italiana Ricerca contro it Cancro (AIRC) [16971 IG]	Associazione Italiana Ricerca contro it Cancro (AIRC)	NP was funded by Associazione Italiana Ricerca contro it Cancro (AIRC) project code 16971 IG 2015 and MM was granted by Programma Operativo Nazionale (PON) PONO4a2_00003 STAYWELL.	Bussolati B, 2000, AM J PATHOL, V157, P1713, DOI 10.1016/S0002-9440(10)64808-0; Dupuis F, 1997, BBA-MOL CELL RES, V1359, P241, DOI 10.1016/S0167-4889(97)00106-7; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Emadi A, 2014, CANCER CHEMOTH PHARM, V73, P875, DOI 10.1007/s00280-014-2402-3; Feuerherm AJ, 2013, MOL CELL BIOCHEM, V384, P83, DOI 10.1007/s11010-013-1784-6; FOA R, 1985, CANCER RES, V45, P4483; Nguyen HA, 2016, J BIOL CHEM, V291, P17664, DOI 10.1074/jbc.M116.728485; HOFFMAN DR, 1984, BLOOD, V63, P545; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Karamitros CS, 2014, J BIOL CHEM, V289, P12962, DOI 10.1074/jbc.M113.545038; Kawedia JD, 2014, CL LYMPH MYELOM LEUK, V14, pS14, DOI 10.1016/j.clml.2014.06.017; Kim HA, 2011, CELL PHYSIOL BIOCHEM, V27, P55, DOI 10.1159/000325205; Liu C, 2016, J CANCER, V7, P1888, DOI 10.7150/jca.15693; Maggi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117025; Menniti M, 2010, CELL PHYSIOL BIOCHEM, V26, P587, DOI 10.1159/000322326; Moorthy V, 2010, AFR J MICROBIOL RES, V4, P1862; Park JB, 2012, NAT REV CANCER, V12, P782, DOI 10.1038/nrc3379; Parmentier JH, 2015, LEUKEMIA RES, V39, P757, DOI 10.1016/j.leukres.2015.04.008; Schalk AM, 2014, J BIOL CHEM, V289, P33175, DOI 10.1074/jbc.M114.609552; Shrivastava A, 2016, CRIT REV ONCOL HEMAT, V100, P1, DOI 10.1016/j.critrevonc.2015.01.002; Song P, 2015, ONCOTARGET, V6, P3861, DOI 10.18632/oncotarget.2869; Stafforini Diana M, 2015, Enzymes, V38, P157, DOI 10.1016/bs.enz.2015.09.005; Sugimoto H, 1998, J BIOL CHEM, V273, P12536, DOI 10.1074/jbc.273.20.12536; Talarico C, 2016, ONCOTARGET, V7, DOI 10.18632/oncotarget.7520; Theilmeier G, 2000, FASEB J, V14, P2032, DOI 10.1096/fj.99-1029com; Xu SG, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2190216; Yu MS, 2012, J CELL MOL MED, V16, P2369, DOI 10.1111/j.1582-4934.2012.01547.x	27	10	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178174	10.1371/journal.pone.0178174	http://dx.doi.org/10.1371/journal.pone.0178174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542249	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500068
J	Jurca, M; Ramette, A; Dogaru, CM; Goutaki, M; Spycher, BD; Latzin, P; Gaillard, EA; Kuehni, CE				Jurca, Maja; Ramette, Alban; Dogaru, Cristian M.; Goutaki, Myrofora; Spycher, Ben D.; Latzin, Philipp; Gaillard, Erol A.; Kuehni, Claudia E.			Prevalence of cough throughout childhood: A cohort study	PLOS ONE			English	Article							DRY NIGHT COUGH; RESPIRATORY SYMPTOMS; PRESCHOOL-CHILDREN; RECURRENT COUGH; AIR-POLLUTION; NATURAL-HISTORY; YOUNG-CHILDREN; ASTHMA; WHEEZE; HEALTH	Background Cough in children is a common reason for medical consultations and affects quality of life. There are little population-based data on the epidemiology of recurrent cough in children and how this varies by age and sex, or between children with and without wheeze. We determined the prevalence of cough throughout childhood, comparing several standardised cough questions. We did this for the entire population and separately for girls and boys, and for children with and without wheeze. Methods In a population-based prospective cohort from Leicestershire, UK, we assessed prevalence of cough with repeated questionnaires from early childhood to adolescence. We asked whether the child usually coughed more than other children, with or without colds, had night-time cough or cough triggered by various factors (triggers, related to increased breathing effort, allergic or food triggers). We calculated prevalence from age 1 to 18 years using generalised estimating equations for all children, and for children with and without wheeze. Results Of 7670 children, 10% (95% CI 10-11%) coughed more than other children, 69% (69-70%) coughed usually with a cold, 34% to 55% age-dependently coughed without colds, and 25% (25-26%) had night-time cough. Prevalence of coughing more than peers, with colds, at night, and triggered by laughter varied little throughout childhood, while cough without colds and cough triggered by exercise, house dust or pollen became more frequent with age. Cough was more common in boys than in girls in the first decade of life, differences got smaller in early teens and reversed after the age of 14 years. All symptoms were more frequent in children with wheeze. Conclusions Prevalence of cough in children varies with age, sex and with the questions used to assess it, suggesting that comparisons between studies are only valid for similar questions and age groups.	[Jurca, Maja; Ramette, Alban; Goutaki, Myrofora; Spycher, Ben D.; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Dogaru, Cristian M.] Univ Campus Suffolk, Fac Arts Business & Appl Social Sci, Ipswich, Suffolk, England; [Latzin, Philipp] Univ Bern, Univ Childrens Hosp Bern, Bern, Switzerland; [Gaillard, Erol A.] Univ Leicester, Dept Infect Immun & Inflammat, Div Child Hlth, Leicester, Leics, England	University of Bern; University of Bern; University Hospital of Bern; University of Leicester	Kuehni, CE (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	claudia.kuehni@ispm.unibe.ch	Goutaki, Myrofora/J-2869-2019; Dogaru, Cristian/I-1861-2019; Ramette, Alban/E-9197-2016; Spycher, Ben D/B-3308-2008; Latzin, Philipp/F-2206-2017	Goutaki, Myrofora/0000-0001-8036-2092; Dogaru, Cristian/0000-0002-0722-6147; Ramette, Alban/0000-0002-3437-4639; Spycher, Ben D/0000-0002-1430-5695; Latzin, Philipp/0000-0002-5239-1571; Gaillard, Erol/0000-0003-0996-8133; Jurca, Maja/0000-0003-1118-002X	Swiss National Science Foundation [SNF PDFMP3-137033, 32003B-162820, 32003B144068, 32003B-122341, PDFMP3-123162]; Bestcilia EU; Asthma UK [07/048]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bestcilia EU; Asthma UK	All phases of this study were supported by the Swiss National Science Foundation (grants: SNF PDFMP3-137033, 32003B-162820, 32003B144068, 32003B-122341, PDFMP3-123162), Bestcilia EU and Asthma UK 07/048. URL: http://www.snf.ch, http://www.asthma.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; Brauer M, 2007, EUR RESPIR J, V29, P879, DOI 10.1183/09031936.00083406; Brooke AM, 1996, EUR RESPIR J, V9, P65, DOI 10.1183/09031936.96.09010065; Brooke AM, 1998, PEDIATR PULM, V26, P256, DOI 10.1002/(SICI)1099-0496(199810)26:4<256::AID-PPUL4>3.0.CO;2-O; Burr ML, 1999, THORAX, V54, P27, DOI 10.1136/thx.54.1.27; Chang AB, 1997, ARCH DIS CHILD, V77, P331, DOI 10.1136/adc.77.4.331; Chang AB, 2008, PAEDIAT CHILD HLTH, V18, P333; Chang AB, 2012, CHEST, V142, P943, DOI 10.1378/chest.11-2725; Chang AB, 2011, CHEST, V140, P324, DOI 10.1378/chest.10-2507; CLIFFORD RD, 1989, ARCH DIS CHILD, V64, P1118, DOI 10.1136/adc.64.8.1118; Dales RE, 1997, EUR J EPIDEMIOL, V13, P541, DOI 10.1023/A:1007311912777; de Benedictis D, 2007, PEDIATR PULM, V42, P683, DOI 10.1002/ppul.20650; Del Giacco SR, 2015, EUR CLIN RESPIR J, V2, DOI 10.3402/ecrj.v2.27984; Doull IJM, 1996, THORAX, V51, P630, DOI 10.1136/thx.51.6.630; Escamilla R, 2014, EUR RESPIR J, V44, P1103, DOI 10.1183/09031936.00150614; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Gehring U, 2002, EUR RESPIR J, V19, P690, DOI 10.1183/09031936.02.01182001; Gehring U, 2011, PEDIAT ALLERG IMM-UK, V22, P85, DOI 10.1111/j.1399-3038.2010.01100.x; Ghezzi M, 2013, PEDIATR PULM, V48, P295, DOI 10.1002/ppul.22581; Hay AD, 2002, BRIT J GEN PRACT, V52, P401; Hermann C, 2005, AM J EPIDEMIOL, V162, P345, DOI 10.1093/aje/kwi212; Janson C, 2001, EUR RESPIR J, V18, P647, DOI 10.1183/09031936.01.00098701; Kastelik JA, 2002, AM J RESP CRIT CARE, V166, P961, DOI 10.1164/rccm.2109061; Kauffmann F, 2011, PULM PHARMACOL THER, V24, P289, DOI 10.1016/j.pupt.2010.10.012; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Kuehni CE, 2007, INT J EPIDEMIOL, V36, P977, DOI 10.1093/ije/dym090; Leonardi GS, 2002, EUR RESPIR J, V20, P890, DOI 10.1183/09031936.02.00260802; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Liangas G, 2003, PEDIATR PULM, V36, P107, DOI 10.1002/ppul.10313; Linehan MF, 2005, ARCH DIS CHILD, V90, P516, DOI 10.1136/adc.2004.061879; LUYT DK, 1993, BMJ-BRIT MED J, V306, P1386, DOI 10.1136/bmj.306.6889.1386; Mallol J, 2006, PEDIATR PULM, V41, P482, DOI 10.1002/ppul.20398; Marchant JM, 2008, CHEST, V134, P303, DOI 10.1378/chest.07-2236; Marchant JM, 2006, CHEST, V129, P1132, DOI 10.1378/chest.129.5.1132; Morgenstern V, 2007, OCCUP ENVIRON MED, V64, P8, DOI 10.1136/oem.2006.028241; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; NINAN TK, 1995, ARCH DIS CHILD, V73, P403, DOI 10.1136/adc.73.5.403; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Ranciere F, 2013, PEDIAT ALLERG IMM-UK, V24, P131, DOI 10.1111/pai.12045; ROBERTSON CF, 1991, BMJ-BRIT MED J, V302, P1116, DOI 10.1136/bmj.302.6785.1116; ROBERTSON CF, 1993, PEDIATR PULM, V16, P219, DOI 10.1002/ppul.1950160403; SENNHAUSER FH, 1995, PEDIATR PULM, V19, P161, DOI 10.1002/ppul.1950190304; Sheel AW, 2016, EXP PHYSIOL, V101, P213, DOI 10.1113/EP085366; Silvestri M, 1999, ANN ALLERG ASTHMA IM, V83, P335, DOI 10.1016/S1081-1206(10)62674-9; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Strippoli MPF, 2007, ARCH DIS CHILD, V92, P861, DOI 10.1136/adc.2007.117978; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; TIBBLIN G, 1990, Scandinavian Journal of Primary Health Care, V8, P9, DOI 10.3109/02813439008994923; TIMONEN KL, 1995, EUR RESPIR J, V8, P1155, DOI 10.1183/09031936.95.08071155; VONMUTIUS E, 1992, BMJ-BRIT MED J, V305, P1395, DOI 10.1136/bmj.305.6866.1395; Wright AL, 2006, PEDIATR PULM, V41, P318, DOI 10.1002/ppul.20373	52	14	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177485	10.1371/journal.pone.0177485	http://dx.doi.org/10.1371/journal.pone.0177485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542270	gold, Green Published			2022-12-27	WOS:000402061500029
J	Lindahl, JR; Fisher, NE; Cooper, DJ; Rosen, RK; Britton, WB				Lindahl, Jared R.; Fisher, Nathan E.; Cooper, David J.; Rosen, Rochelle K.; Britton, Willoughby B.			The varieties of contemplative experience: A mixed-methods study of meditation-related challenges in Western Buddhists	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; RANDOMIZED-CONTROLLED-TRIAL; COGNITIVE THERAPY; PSYCHIATRIC-DISORDERS; CLINICAL-IMPLICATIONS; INTENSIVE MEDITATION; CAUSALITY ASSESSMENT; CURRENT STATE; FOLLOW-UP; DSM-IV	Buddhist-derived meditation practices are currently being employed as a popular form of health promotion. While meditation programs draw inspiration from Buddhist textual sources for the benefits of meditation, these sources also acknowledge a wide range of other effects beyond health-related outcomes. The Varieties of Contemplative Experience study investigates meditation-related experiences that are typically underreported, particularly experiences that are described as challenging, difficult, distressing, functionally impairing, and/or requiring additional support. A mixed-methods approach featured qualitative interviews with Western Buddhist meditation practitioners and experts in Theravada, Zen, and Tibetan traditions. Interview questions probed meditation experiences and influencing factors, including interpretations and management strategies. A follow-up survey provided quantitative assessments of causality, impairment and other demographic and practice-related variables. The content-driven thematic analysis of interviews yielded a taxonomy of 59 meditation-related experiences across 7 domains: cognitive, perceptual, affective, somatic, conative, sense of self, and social. Even in cases where the phenomenology was similar across participants, interpretations of and responses to the experiences differed considerably. The associated valence ranged from very positive to very negative, and the associated level of distress and functional impairment ranged from minimal and transient to severe and enduring. In order to determine what factors may influence the valence, impact, and response to any given experience, the study also identified 26 categories of influencing factors across 4 domains: practitioner-level factors, practice-level factors, relationships, and health behaviors. By identifying a broader range of experiences associated with meditation, along with the factors that contribute to the presence and management of experiences reported as challenging, difficult, distressing or functionally impairing, this study aims to increase our understanding of the effects of contemplative practices and to provide resources for mediators, clinicians, meditation researchers, and meditation teachers.	[Lindahl, Jared R.] Brown Univ, Cogut Ctr Humanities, Providence, RI 02912 USA; [Fisher, Nathan E.] Univ Calif Santa Barbara, Dept Religious Studies, Santa Barbara, CA 93106 USA; [Cooper, David J.; Britton, Willoughby B.] Brown Univ, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Rosen, Rochelle K.; Britton, Willoughby B.] Brown Univ, Dept Behav & Social Sci, Sch Publ Hlth, Providence, RI 02912 USA	Brown University; University of California System; University of California Santa Barbara; Brown University; Brown University	Britton, WB (corresponding author), Brown Univ, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA.; Britton, WB (corresponding author), Brown Univ, Dept Behav & Social Sci, Sch Publ Hlth, Providence, RI 02912 USA.	willoughby_britton@brown.edu	/V-3995-2019		National Center for Complementary and Integrative Health at the National Institutes of Health [K23-AT006328-01A1]; Bial Foundation [256/12]; Varela Research Award from the Mind and Life Institute; 40 Foundation; National Center for Complementary & Integrative Health [K23AT006328] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health at the National Institutes of Health; Bial Foundation(Bial Foundation); Varela Research Award from the Mind and Life Institute; 40 Foundation; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grant number K23-AT006328-01A1 from the National Center for Complementary and Integrative Health (https://nccah.nih.gov/) at the National Institutes of Health, grant number 256/12 from the Bial Foundation (www.bial.com) (WB), the Varela Research Award from the Mind and Life Institute (ww.mindandlife.org) (NF) and the 1440 Foundation (www.1440.org) (WB, JL). The funders had no role in the study design, data collection, decision to publish or preparation of the manuscript.	Agbabiaka TB, 2008, DRUG SAFETY, V31, P21, DOI 10.2165/00002018-200831010-00003; Aitken Robert., 1982, TAKING PATH ZEN; [Anonymous], 2015, NATL HLTH STAT REPOR; APA, 1994, 300 6 DEP DIS DIAGN; APA, 2013, 300 6 DEP DER DIS DI, P302; Ataria Y, 2015, PHILOS PSYCHOL, V28, P1128, DOI 10.1080/09515089.2014.969801; Ataria Y, 2015, CONSCIOUS COGN, V37, P133, DOI 10.1016/j.concog.2015.09.002; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bent S, 2006, ANN INTERN MED, V144, P257, DOI 10.7326/0003-4819-144-4-200602210-00007; Berkovich-Ohana A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00912; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Boorstein S, 1996, TXB TRANSPERSONAL PS; Bovin M. J., 2015, PSYCHOMETRIC PROPERT; Brattstrom O, 2015, EUR J EPIDEMIOL, V30, P151, DOI 10.1007/s10654-014-9969-1; Britton WB, 2014, ANN NY ACAD SCI, V1307, P64, DOI 10.1111/nyas.12279; BROWN D, 1984, PERCEPT MOTOR SKILL, V58, P775, DOI 10.2466/pms.1984.58.3.775; Buddhaghosa B., 1991, PATH PURIFICATION; Carlson LE, 2016, PSYCHO-ONCOLOGY, V25, P750, DOI 10.1002/pon.4150; Carrington P., 1977, MISUSE MEDITATION PR; CASTILLO RJ, 1990, PSYCHIATRY, V53, P158; Census Bureau US, 2014, ED ATT US 2014 DET T; Cermolacce M, 2007, CONSCIOUS COGN, V16, P703, DOI 10.1016/j.concog.2007.05.013; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Chan-Ob Tinnakorn, 1999, Journal of the Medical Association of Thailand, V82, P925; Chen Z, 2011, J SCI STUD RELIG, V50, P654, DOI 10.1111/j.1468-5906.2011.01606.x; Chiesa A, 2014, SUBST USE MISUSE, V49, P492, DOI 10.3109/10826084.2013.770027; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; Chiesa A, 2011, J ALTERN COMPLEM MED, V17, P83, DOI 10.1089/acm.2009.0546; Chiesa A, 2011, CLIN PSYCHOL REV, V31, P449, DOI 10.1016/j.cpr.2010.11.003; CRAVEN JL, 1989, CAN J PSYCHIAT, V34, P648, DOI 10.1177/070674378903400705; DeCuir-Gunby JT, 2011, FIELD METHOD, V23, P136, DOI 10.1177/1525822X10388468; DeHoff SL, 2015, PASTOR PSYCHOL, V64, P21, DOI 10.1007/s11089-013-0584-y; DEIKMAN AJ, 1966, J NERV MENT DIS, V142, P101, DOI 10.1097/00005053-196602000-00001; Dein S, 2011, TRANSCULT PSYCHIATRY, V48, P318, DOI 10.1177/1363461511402723; Disayavanish C, 1984, J PSYCHIAT ASS THAIL, V29, P1; Dobkin PL, 2012, MINDFULNESS, V3, P44, DOI 10.1007/s12671-011-0079-9; Dor-Ziderman Y, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00582; Droit-Volet S, 2015, CONSCIOUS COGN, V31, P86, DOI 10.1016/j.concog.2014.10.007; Eisendrath SJ, 2016, PSYCHOTHER PSYCHOSOM, V85, P99, DOI 10.1159/000442260; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Epstein M. D., 1981, J TRANSPERSONAL PSYC, V13, P137; Faugier J, 1997, J ADV NURS, V26, P790, DOI 10.1046/j.1365-2648.1997.00371.x; FENWICK P, 1983, BRIT MED J, V287, P1401, DOI 10.1136/bmj.287.6403.1401; Follette V., 2006, J RATION-EMOT COGN-B, V24, P45, DOI [DOI 10.1007/S10942-006-0025-2, https://doi.org/10.1007/s10942-006-0025-2]; Fonteyn ME, 2008, APPL NURS RES, V21, P165, DOI 10.1016/j.apnr.2006.08.005; Fowler FJ, 1998, PUBLIC OPIN QUART, V62, P29; Full GE, 2013, MINDFULNESS, V4, P55, DOI 10.1007/s12671-012-0173-7; Gallagher RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028096; Gallagher Sh, 2013, OXFORD HDB SELF; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Grant JA, 2014, ANN NY ACAD SCI, V1307, P55, DOI 10.1111/nyas.12282; Grant JA, 2009, PSYCHOSOM MED, V71, P106, DOI 10.1097/PSY.0b013e31818f52ee; Greenberg MT, 2012, CHILD DEV PERSPECT, V6, P161, DOI 10.1111/j.1750-8606.2011.00215.x; Gregory PN, 2001, RELIG AM CULT, V11, P233, DOI 10.1525/rac.2001.11.2.233; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Gyatso J, 1999, J AM ACAD RELIG, V67, P113; Hakuin, 2009, HAKUINS PRECIOUS MIR; Hanley AW, 2016, J COUNS DEV, V94, P103, DOI 10.1002/jcad.12066; HEIDE FJ, 1983, J CONSULT CLIN PSYCH, V51, P171, DOI 10.1037/0022-006X.51.2.171; Hickey WakohS., 2010, J GLOBAL BUDDHISM, V11, P1; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hill AB, 2015, J ROY SOC MED, V108, P32, DOI 10.1177/0141076814562718; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Hua H, 2003, SHURANGAMA SUTRA COM, V8; Huntington CW, 2015, J AM ACAD RELIG, V83, P624, DOI 10.1093/jaarel/lfv008; Davidson R, 2012, CHILD DEV PERSPECT, V6, P146, DOI 10.1111/j.1750-8606.2012.00240.x; Jardri R., 2013, NEUROSCIENCE HALLUCI, P43, DOI DOI 10.1007/978-1-4614-4121-2; Jaseja H, 2010, EPILEPSY BEHAV, V17, P124, DOI 10.1016/j.yebeh.2009.10.022; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Jonsson U, 2014, CONTEMP CLIN TRIALS, V38, P1, DOI 10.1016/j.cct.2014.02.005; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kabat-Zinn J, 2011, CONTEMP BUDDHISM, V12, P281, DOI 10.1080/14639947.2011.564844; Kaiser-Greenland S., 2010, THE MINDFUL CHILD; Kaliman P, 2014, PSYCHONEUROENDOCRINO, V40, P96, DOI 10.1016/j.psyneuen.2013.11.004; Kerr CE, 2011, CLIN PSYCHOL PSYCHOT, V18, P80, DOI 10.1002/cpp.700; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Kirmayer L, 2013, ADV PSYCHOSOMATIC ME, P33; Kornfield J., 1979, J TRANSPERSONAL PSY, V11, P4158; Kornfield J., 2011, BRINGING HOME DHARMA; Kriegel Uriah, 2015, VARIETIES CONSCIOUSN; Kuijpers HJH, 2007, PSYCHOPATHOLOGY, V40, P461, DOI 10.1159/000108125; KUTZ I, 1985, PSYCHOTHER PSYCHOSOM, V43, P209; Kuyken W., 2012, MINDFULNESS BASED CO; Kuyken W., 2016, JAMA PSYCHIAT; Kuyken W, 2015, LANCET, V386, P63, DOI 10.1016/S0140-6736(14)62222-4; Lindahl J, 2011, RELIGION, V41, P79, DOI 10.1080/0048721X.2011.553135; Lindahl JR, 2015, MINDFULNESS, V6, P57, DOI 10.1007/s12671-014-0380-5; Lindahl JR, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00973; Lindahl JR, 2012, PACIFIC WORLD J I BU, V3, P231; Lomas T., 2014, MINDFULNESS, V2014, P1; Lopez D.S., 2012, SCI BUDDHA HIS SHORT; Lopez Donald S., 2009, BUDDHISM SCI GUIDE P; Luhrmann TM, 2015, TOP COGN SCI, V7, P646, DOI 10.1111/tops.12158; LUKOFF D, 1995, PSYCHIAT CLIN N AM, V18, P467, DOI 10.1016/S0193-953X(18)30035-2; Lustyk M Kathleen B, 2009, Adv Mind Body Med, V24, P20; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; MacQueen K, 1998, CULTURAL ANTHR METHO, V10; Mani M, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4328; McFarlane Alexander, 2005, Journal of Integrative Neuroscience, V4, P27, DOI 10.1142/S0219635205000689; McMahan D., 2011, HDB RELIG AUTHORITY; McMahan David L., 2008, MAKING BUDDHIST MODE; Meiklejohn J, 2012, MINDFULNESS, V3, P291, DOI 10.1007/s12671-012-0094-5; Menezes A, 2010, CURR PSYCHIAT REP, V12, P174, DOI 10.1007/s11920-010-0117-7; MILLER JJ, 1995, GEN HOSP PSYCHIAT, V17, P192, DOI 10.1016/0163-8343(95)00025-M; MILLER JJ, 1993, J TRANSPERSONAL PSY, V25, P169; Monteiro LM, 2015, MINDFULNESS, V6, P1, DOI 10.1007/s12671-014-0301-7; Nakaya M., 2010, GER J PSYCHIAT, V13, P161; Namto S., 1989, INSIGHT MEDITATION P; Naranjo C A, 1986, Drug Inf J, V20, P387; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; NARANJO CA, 1982, PROG NEURO-PSYCHOPH, V6, P651, DOI 10.1016/S0278-5846(82)80162-0; NIA, 2011, NIA ADV EV SER ADV E; NIH, 2016, ADV EV SER ADV EV GU; O'Connor S, 2010, MENT HEALTH RELIG CU, V13, P171, DOI 10.1080/13674670903277984; Office for Human Research Protections (OHRP), 2007, GUID REV REP UN PROB; Olano HA, 2015, J ALTERN COMPLEM MED, V21, P100, DOI 10.1089/acm.2014.0269; Parnas J, 2005, PSYCHOPATHOLOGY, V38, P236, DOI 10.1159/000088441; Pasick RJ, 2009, HEALTH EDUC BEHAV, V36, p11S, DOI 10.1177/1090198109338917; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Perez-De-Albeniz A., 2000, INT J PSYCHOTHER, V5, P49, DOI DOI 10.1080/13569080050020263; Robins L.N., 1991, PSYCHIAT DISORDERS A; Samuelson M, 2007, PRISON J, V87, P254, DOI 10.1177/0032885507303753; Sayadaw M., 2016, MANUAL OF INSIGHT; Sayadaw M., 1965, PROGR INSIGHT MODERN; Sethi S, 2003, AUST NZ J PSYCHIAT, V37, P382; Shapiro D H Jr, 1992, Int J Psychosom, V39, P62; SHAPIRO DH, 1982, AM J PSYCHIAT, V139, P267; Shapiro SL, 2011, TEACH COLL REC, V113, P493; Sharf R., 2014, TRANSCULT PSYCHIATRY, V52, P470; SHARF RH, 1995, NUMEN, V42, P228, DOI 10.1163/1568527952598549; Sharf Robert H., 1998, CRITICAL TERMS RELIG; Shimokawa K, 2010, J CONSULT CLIN PSYCH, V78, P298, DOI 10.1037/a0019247; Shonin E., 2014, CLIN PRACTICE, V11, P389, DOI DOI 10.2217/cpr.14.23; Shonin E, 2014, INT J MENT HEALTH AD, V12, P181, DOI 10.1007/s11469-013-9460-3; Shonin E, 2014, J RELIG HEALTH, V53, P849, DOI 10.1007/s10943-013-9679-0; Shonin E, 2014, AUST NZ J PSYCHIAT, V48, P124, DOI 10.1177/0004867413512688; Sierra M, 2001, J NERV MENT DIS, V189, P629, DOI 10.1097/00005053-200109000-00010; Simeon D, 2009, DISSOCIATION DISSOCI; Sogen O., 2001, INTRO ZEN TRAINING; Stanley E. A., 2009, JOINT FORCE Q, V55, P144; Stanley EA, 2011, COGN BEHAV PRACT, V18, P566, DOI 10.1016/j.cbpra.2010.08.002; Strauss A., 1998, BASICS QUALITATIVE R; Strauss C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096110; SUDSUANG R, 1991, PHYSIOL BEHAV, V50, P543, DOI 10.1016/0031-9384(91)90543-W; Sumter Melvina T, 2009, J Correct Health Care, V15, P47, DOI 10.1177/1078345808326621; Tate A., 1993, AUTOBIOGRAPHY FOREST; Taves A, 2009, RELIGIOUS EXPERIENCE RECONSIDERED: A BUILDING-BLOCK APPROACH TO THE STUDY OF RELIGION AND OTHER SPECIAL THINGS, P1; Taves A, 2008, RELIGION, V38, P125, DOI 10.1016/j.religion.2008.01.005; Teasdale JD, 2011, CONTEMP BUDDHISM, V12, P103, DOI 10.1080/14639947.2011.564826; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Theophile H, 2010, DRUG SAFETY, V33, P1045, DOI 10.2165/11537780-000000000-00000; Turner C. F., 1992, SURVEY MEASUREMENT D, P177; TURNER RP, 1995, J NERV MENT DIS, V183, P435, DOI 10.1097/00005053-199507000-00003; Turner W M, 1984, Drug Inf J, V18, P259; VanderKooi L., 1997, J TRANSPERSONAL PSY, V29, P31; VANNUYS D, 1973, INT J CLIN EXP HYP, V21, P59, DOI 10.1080/00207147308409306; Waelde L. C., 2004, J TRAUMA DISSOCIATIO, V5, P147, DOI [10.1300/J229v05n02_08, DOI 10.1300/J229V05N02_08]; Wallace, 2006, ATTENTION REVOLUTION; Wallace B.A., 2011, STILLING MIND SHAMAT; Wallace BA, 2015, DUDJOM LINGPAS VISIO, V3; WALSH R, 1979, AM J PSYCHIAT, V136, P1085; Walsh R., 1977, J TRANSPERSONAL PSYC, V9, P151; Walsh RN, 1978, J TRANSPERSONAL PSY, V10, P1; Weissman JS, 2008, ANN INTERN MED, V149, P100, DOI 10.7326/0003-4819-149-2-200807150-00006; Wieczner J., 2016, FORTUNE, P1; Wildman Wesley J., 2011, RELIG SPIRITUAL EXPE; Williams JMG, 2014, J CONSULT CLIN PSYCH, V82, P275, DOI 10.1037/a0035036; Wilson J., 2014, MINDFUL AM MUTUAL TR; World Health Organization, 2016, US WHO UMC SYST STAN; Yorston G.A., 2001, MENTAL HLTH RELIG CU, V4, P209, DOI DOI 10.1080/713685624	175	177	178	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0176239	10.1371/journal.pone.0176239	http://dx.doi.org/10.1371/journal.pone.0176239			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EV8VE	28542181	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500004
J	Pecaut, MJ; Mao, XW; Bellinger, DL; Jonscher, KR; Stodieck, LS; Ferguson, VL; Bateman, TA; Mohney, RP; Gridley, DS				Pecaut, Michael J.; Mao, Xiao Wen; Bellinger, Denise L.; Jonscher, Karen R.; Stodieck, Louis S.; Ferguson, Virginia L.; Bateman, Ted A.; Mohney, Robert P.; Gridley, Daila S.			Is spaceflight-induced immune dysfunction linked to systemic changes in metabolism?	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; PERIPHERAL-BLOOD LEUKOCYTES; ACTIVATED RECEPTOR-GAMMA; SPACE-FLIGHT; PPAR-GAMMA; APPLIED PHYSIOLOGY; ENDOTHELIAL-CELLS; GENETIC MODELS; ANGIOTENSIN-II; C57BL/6 MOUSE	The Space Shuttle Atlantis launched on its final mission (STS-135) on July 8, 2011. After just under 13 days, the shuttle landed safely at Kennedy Space Center (KSC) for the last time. Female C57BL/6J mice flew as part of the Commercial Biomedical Testing Module-3 (CBTM-3) payload. Ground controls were maintained at the KSC facility. Subsets of these mice were made available to investigators as part of NASA's Bio-specimen Sharing Program (BSP). Our group characterized cell phenotype distributions and phagocytic function in the spleen, catecholamine and corticosterone levels in the adrenal glands, and transcriptomics/metabolomics in the liver. Despite decreases in most splenic leukocyte subsets, there were increases in reactive oxygen species (ROS)-related activity. Although there were increases noted in corticosterone levels in both the adrenals and liver, there were no significant changes in catecholamine levels. Furthermore, functional analysis of gene expression and metabolomic profiles suggest that the functional changes are not due to oxidative or psychological stress. Despite changes in gene expression patterns indicative of increases in phagocytic activity (e.g. endocytosis and formation of peroxisomes), there was no corresponding increase in genes related to ROS metabolism. In contrast, there were increases in expression profiles related to fatty acid oxidation with decreases in glycolysis-related profiles. Given the clear link between immune function and metabolism in many ground-based diseases, we propose a similar link may be involved in spaceflight-induced decrements in immune and metabolic function.	[Pecaut, Michael J.; Mao, Xiao Wen; Gridley, Daila S.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Radiat Res, Loma Linda, CA 92350 USA; [Bellinger, Denise L.] Loma Linda Univ, Dept Anat, Loma Linda, CA 92350 USA; [Jonscher, Karen R.] Univ Colorado, Sch Med, Dept Anesthesiol, Anschutz Med Campus, Denver, CO USA; [Stodieck, Louis S.; Ferguson, Virginia L.] Univ Colorado, BioServe Space Technol, Boulder, CO 80309 USA; [Bateman, Ted A.] Univ North Carolina Chapel Hill, Dept Bioengn, Chapel Hill, NC USA; [Mohney, Robert P.] Metabolon Inc, Morrisville, NC USA	Loma Linda University; Loma Linda University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Metabolon	Pecaut, MJ (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Div Radiat Res, Loma Linda, CA 92350 USA.	mpecaut@llu.edu	Pecaut, Michael J/P-6481-2015; Gridley, Daila S/P-7711-2015	Pecaut, Michael J/0000-0002-2915-9686; mao, xiao/0000-0002-4508-8689	NASA [NNX10AJ31G]; LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NASA managed cooperative agreement NNX10AJ31G and the LLUMC Department of Radiation Medicine. Metabolon provided support in the form of salaries for RM, but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. RM played a role in the study design, data collection, analysis, and preparation of the manuscript.	Allebban Z, 1996, J APPL PHYSIOL, V81, P117, DOI 10.1152/jappl.1996.81.1.117; ALLEBBAN Z, 1994, J LEUKOCYTE BIOL, V55, P209, DOI 10.1002/jlb.55.2.209; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; BATUMAN OA, 1990, BRAIN BEHAV IMMUN, V4, P105, DOI 10.1016/0889-1591(90)90013-G; BERRY CA, 1970, AEROSPACE MED, V41, P500; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Blanc S, 1998, NEUROCHEM INT, V33, P375, DOI 10.1016/S0197-0186(98)00042-4; Buckey JC, 2006, SPACE PHYSL; Chapes SK, 1999, ADV SPACE RES, V23, P1955, DOI 10.1016/S0273-1177(99)00456-1; Chapes SK, 1999, J APPL PHYSIOL, V86, P2065, DOI 10.1152/jappl.1999.86.6.2065; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Congdon CC, 1996, J APPL PHYSIOL, V81, P172, DOI 10.1152/jappl.1996.81.1.172; Da Silva MS, 2002, NUTRITION, V18, P805, DOI 10.1016/S0899-9007(02)00915-2; Dallman MF, 2007, CURR ALZHEIMER RES, V4, P199, DOI 10.2174/156720507780362236; Dallman MF, 2007, EXP NEUROL, V206, P179, DOI 10.1016/j.expneurol.2007.06.002; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Dello SAWG, 2013, CLIN NUTR, V32, P325, DOI 10.1016/j.clnu.2012.10.008; DURNOVA GN, 1976, AVIAT SPACE ENVIR MD, V47, P588; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fagette S, 1996, AVIAT SPACE ENVIR MD, V67, P458; FAREH J, 1993, AVIAT SPACE ENVIR MD, V64, P507; Gridley DS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075097, 10.1371/annotation/e66bdc4e-2409-4582-b163-7bc182db275e]; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Gridley DS, 2003, J APPL PHYSIOL, V94, P2095, DOI 10.1152/japplphysiol.01053.2002; GRINDELAND RE, 1990, FASEB J, V4, P105, DOI 10.1096/fasebj.4.1.2295371; GROVE DS, 1995, EXP CELL RES, V219, P102, DOI 10.1006/excr.1995.1210; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Jackson SM, 1999, ARTERIOSCL THROM VAS, V19, P2094, DOI 10.1161/01.ATV.19.9.2094; Jahns G, 1992, 43 C INT ASTR FED 19; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jonscher KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152877; Kaur I, 2005, BRAIN BEHAV IMMUN, V19, P547, DOI 10.1016/j.bbi.2004.12.006; Kaur I, 2004, BRAIN BEHAV IMMUN, V18, P443, DOI 10.1016/j.bbi.2003.10.005; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; LEACH CS, 1975, ACTA ASTRONAUT, V2, P115, DOI 10.1016/0094-5765(75)90048-X; LEBRETHON MC, 1994, MOL CELL ENDOCRINOL, V106, P137, DOI 10.1016/0303-7207(94)90195-3; LESNYAK AT, 1993, J LEUKOCYTE BIOL, V54, P214, DOI 10.1002/jlb.54.3.214; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mao XW, 2014, FREE RADICAL RES, V48, P890, DOI 10.3109/10715762.2014.920086; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; MEEHAN R, 1993, J LEUKOCYTE BIOL, V54, P236, DOI 10.1002/jlb.54.3.236; MEEHAN RT, 1992, IMMUNOLOGY, V76, P491; Mehta SK, 2000, J INFECT DIS, V182, P1761, DOI 10.1086/317624; Mehta SK, 2001, J APPL PHYSIOL, V91, P1814, DOI 10.1152/jappl.2001.91.4.1814; Mehta SK, 2014, BRAIN BEHAV IMMUNITY; MERRILL AH, 1992, J APPL PHYSIOL, V73, pS132, DOI 10.1152/jappl.1992.73.2.S132; Momoi A, 1999, FEBS LETT, V452, P301, DOI 10.1016/S0014-5793(99)00678-X; MORITA TM, 1995, ENDOCR J, V42, P475, DOI 10.1507/endocrj.42.475; Murao K, 1999, FEBS LETT, V454, P27, DOI 10.1016/S0014-5793(99)00765-6; NASH PV, 1992, EXP CELL RES, V202, P125, DOI 10.1016/0014-4827(92)90411-Z; Ortega MT, 2009, J APPL PHYSIOL, V106, P548, DOI 10.1152/japplphysiol.91138.2008; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, pR2072, DOI 10.1152/ajpregu.2000.279.6.R2072; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; PENHOAT A, 1994, MOL CELL ENDOCRINOL, V103, pR7, DOI 10.1016/0303-7207(94)90088-4; PENHOAT A, 1989, P NATL ACAD SCI USA, V86, P4978, DOI 10.1073/pnas.86.13.4978; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Russell TD, 2007, J LIPID RES, V48, P1463, DOI 10.1194/jlr.M600474-JLR200; Serova L V, 1980, Physiologist, V23, pS22; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Sonnenfeld G, 1998, INT J SPORTS MED, V19, pS195, DOI 10.1055/s-2007-971992; SONNENFELD G, 1992, J APPL PHYSIOL, V73, pS191, DOI 10.1152/jappl.1992.73.2.S191; Sonnenfeld G, 1998, J APPL PHYSIOL, V85, P1429, DOI 10.1152/jappl.1998.85.4.1429; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; STEIN TP, 1994, AM J PHYSIOL, V266, pE448, DOI 10.1152/ajpendo.1994.266.3.E448; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stowe RP, 2000, NEUROIMMUNOMODULAT, V8, P51, DOI 10.1159/000026453; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Stowe RP, 2001, PSYCHOSOM MED, V63, P891, DOI 10.1097/00006842-200111000-00007; Stowe RP, 2001, AVIAT SPACE ENVIR MD, V72, P884; Sung M, 2013, J MUSCULOSKEL NEURON, V13, P405; UDDEN MM, 1995, AVIAT SPACE ENVIR MD, V66, P557; Voorhees JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077935; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Wronski TJ, 1998, J APPL PHYSIOL, V85, P279, DOI 10.1152/jappl.1998.85.1.279; Zhou YC, 1999, J BIOL CHEM, V274, P2672, DOI 10.1074/jbc.274.5.2672; Zoladz PR, 2008, STRESS, V11, P259, DOI 10.1080/10253890701768613	84	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0174174	10.1371/journal.pone.0174174	http://dx.doi.org/10.1371/journal.pone.0174174			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542224	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500001
J	Burkhardt, C; Neuwirth, C; Sommacal, A; Andersen, PM; Weber, M				Burkhardt, Christian; Neuwirth, Christoph; Sommacal, Andreas; Andersen, Peter M.; Weber, Markus			Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients	PLOS ONE			English	Article							QUALITY STANDARDS SUBCOMMITTEE; NONINVASIVE VENTILATION; RESPIRATORY-FAILURE; PRACTICE PARAMETER; AMERICAN ACADEMY; FRENCH PATIENTS; DEATH; CARE; DIAGNOSIS; CRITERIA	Background Non-invasive ventilation (NIV) and percutaneous gastrostomy (PEG) are guideline-recommended interventions for symptom management in amyotrophic lateral sclerosis (ALS). Their effect on survival is controversial and the impact on causes of death is unknown. Objective To investigate the effect of NIV and PEG on survival and causes of death in ALS patients. Methods Eighty deceased ALS patients underwent a complete post mortem analysis for causes of death between 2003 and 2015. Forty-two of these patients consented for genetic testing. Effects of NIV and PEG on survival and causes of death were analyzed in a multivariable Cox proportional hazard regression. Results Six patients, who requested assisted suicide causing drug-induced hypoxia, were excluded from final analysis. Respiratory failure was the main cause of death in 72 out of 74 patients. Fifteen out of 74 died of aspiration pneumonia 23/74 of bronchopneumonia and 8/74 of a combination of aspiration pneumonia and bronchopneumonia. Twenty died of hypoxia without concomitant infection, and six patients had pulmonary embolism alone or in combination with pneumonia. NIV (p = 0.01) and PEG (p<0.01) had a significant impact on survival. In patients using NIV bronchopneumonia was significantly more frequent (p <0.04) compared to non-NIV patients. This effect was even more pronounced in limb onset patients (p<0.002). Patients with C9orf72 hexanucleotide repeat expansions showed faster disease progression and shorter survival (p = 0.01). Conclusion The use of NIV and PEG prolongs survival in ALS. This study supports current AAN and EFNS guidelines which recommend NIV and PEG as a treatment option in ALS. The risk of bronchopneumonia as cause of death may be increased by NIV.	[Burkhardt, Christian; Neuwirth, Christoph; Weber, Markus] Kantonsspital St Gallen, Neuromuscular Dis Unit, ALS Clin, St Gallen, Switzerland; [Sommacal, Andreas] Kantonsspital St Gallen, Dept Pathol, St Gallen, Switzerland; [Andersen, Peter M.] Umea Univ, Inst Pharmacol & Clin Neurosci, Umea, Sweden	Kantonsspital St. Gallen; Kantonsspital St. Gallen; Umea University	Burkhardt, C (corresponding author), Kantonsspital St Gallen, Neuromuscular Dis Unit, ALS Clin, St Gallen, Switzerland.	christian.burkhardt@kssg.ch	Weber, Markus/AAI-7138-2020; Neuwirth, Christoph/AAE-2211-2020	Burkhardt, Christian/0000-0002-8606-7905	Swiss ALS Foundation; EU Joint Programme-Neurodegenerative Disease Research (JPND) projects [SNF 31ND30_141622, 31ND30_151115]; Swedish Science Council	Swiss ALS Foundation; EU Joint Programme-Neurodegenerative Disease Research (JPND) projects; Swedish Science Council	Christian Burkhardt receives honoraria from Biogen Idec for training courses and receives research support from the Swiss ALS Foundation and the EU Joint Programme-Neurodegenerative Disease Research (JPND) projects (grant number SNF 31ND30_141622 (SOPHIA) and 31ND30_151115 (STRENGTH)). Christoph Neuwirth receives honoraria from Biogen Idec, USA, as advisory board member tasks and training courses and support from the Swiss ALS Foundation and the EU Joint Programme Neurodegenerative Disease Research (JPND) projects (grant number SNF 31ND30_141622 (SOPHIA) and 31ND30_151115 (STRENGTH)). Andreas Sommacal reports no disclosures. Peter M. Andersen receives honoraria from Biogen Idec and Neuroimmune for advisory board tasks and counselling on clinical trials. He receives numerous research grants from the Swedish Science Council and private foundations and patient organizations in Sweden and Norway. Markus Weber receives honoraria from Merz Pharma Schweiz AG, Biogen Idec, USA, as advisory board member and support from the Swiss ALS Foundation and the EU Joint Programme-Neurodegenerative Disease Research (JPND) projects (grant number SNF 31ND30_141622 (SOPHIA) and 31ND30_151115 (STRENGTH))	Akimoto C, 2014, J MED GENET, V51, P419, DOI 10.1136/jmedgenet-2014-102360; Andersen PM, 2012, EUR J NEUROL, V19, P360, DOI 10.1111/j.1468-1331.2011.03501.x; Andersen PM, 2005, EUR J NEUROL, V12, P921, DOI 10.1111/j.1468-1331.2005.01351.x; Berlowitz DJ, 2016, J NEUROL NEUROSUR PS, V87, P280, DOI 10.1136/jnnp-2014-310055; Bourke SC, 2006, LANCET NEUROL, V5, P140, DOI 10.1016/S1474-4422(05)70326-4; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burns KEA, 2014, CAN MED ASSOC J, V186, pE112, DOI 10.1503/cmaj.130974; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Choudhuri Anirban H, 2013, Int J Crit Illn Inj Sci, V3, P169, DOI 10.4103/2229-5151.119195; Colosimo C, 2003, J NEUROL NEUROSUR PS, V74, P852, DOI 10.1136/jnnp.74.7.852; Corcia P, 2008, AMYOTROPH LATERAL SC, V9, P59, DOI 10.1080/17482960701656940; Czell D, 2013, RESP CARE, V58, P838, DOI 10.4187/respcare.02024; D'Ottavianol FG, 2013, BRAZ J OTORHINOLAR, V79, P349, DOI 10.5935/1808-8694.20130061; Gil J, 2008, EUR J NEUROL, V15, P1245, DOI 10.1111/j.1468-1331.2008.02307.x; Gladman M, 2014, NEUROLOGY, V82, P1674, DOI 10.1212/WNL.0000000000000405; Higo R, 2002, LARYNGOSCOPE, V112, P911, DOI 10.1097/00005537-200205000-00024; Katzberg HD, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004030.pub3; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; KNIFFIN WD, 1994, ARCH INTERN MED, V154, P861, DOI 10.1001/archinte.154.8.861; Kurian KM, 2009, J NEUROL NEUROSUR PS, V80, P84, DOI 10.1136/jnnp.2008.149708; Lechtzin N, 2009, EUR J NEUROL, V16, P5, DOI 10.1111/j.1468-1331.2008.02327.x; Mehal JM, 2013, AMYOTROPH LAT SCL FR, V14, P346, DOI 10.3109/21678421.2013.787629; Miller RG, 2009, NEUROLOGY, V73, P1218, DOI 10.1212/WNL.0b013e3181bc0141; Miller RG, 1999, NEUROLOGY, V52, P1311, DOI 10.1212/WNL.52.7.1311; Nicolini A, 2016, CLIN RESPIR J, V10, P98, DOI 10.1111/crj.12184; Piao YS, 2003, BRAIN PATHOLOGY ZURI, V13, P10, DOI DOI 10.1111/J.1750-3639.2003.TB00002.X; Rajput AH, 2014, NEUROLOGY, V83, P386, DOI 10.1212/WNL.0000000000000653; RICKHAM PP, 1964, BRIT MED J, V2, P173; Sorenson EJ, 2007, AMYOTROPH LATERAL SC, V8, P87, DOI 10.1080/17482960601147461; Spataro R, 2010, ACTA NEUROL SCAND, V122, P217, DOI 10.1111/j.1600-0404.2009.01290.x; Spataro R, 2011, J NEUROL SCI, V304, P44, DOI 10.1016/j.jns.2011.02.016; VICTOROFF J, 1995, AM J PSYCHIAT, V152, P1476	32	49	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177555	10.1371/journal.pone.0177555	http://dx.doi.org/10.1371/journal.pone.0177555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542233	gold, Green Submitted, Green Published			2022-12-27	WOS:000402058800019
J	Lee, J; Ouh, YT; Ahn, KH; Hong, SC; Oh, MJ; Kim, HJ; Cho, GJ				Lee, Joohyun; Ouh, Yung-taek; Ahn, Ki Hoon; Hong, Soon Cheol; Oh, Min-Jeong; Kim, Hai-Joong; Cho, Geum Joon			Preeclampsia: A risk factor for gestational diabetes mellitus in subsequent pregnancy	PLOS ONE			English	Article							HYPERTENSIVE DISORDERS; INSULIN-RESISTANCE; WOMEN; INTOLERANCE; PREVALENCE; MORTALITY; CARPENTER; DISEASE; HEALTH	Preeclampsia and gestational diabetes (GDM) have several mechanisms in common. The aim of this study was to determine whether women with preeclampsia have an increased risk of GDM in a subsequent pregnancy. Study data were collected from the Korea National Health Insurance Claims Database of the Health Insurance Review and Assessment Service for 2007-2012. Patients who had their first delivery in 2007 and a subsequent delivery between 2008 and 2012 in Korea were enrolled. A model of multivariate logistic regression analysis was performed with GDM as the final outcome to evaluate the risk of GDM in the second pregnancy. Among the 252,276 women who had their first delivery in 2007, 150,794 women had their second delivery between 2008 and 2012. On the multivariate regression analysis, women with preeclampsia alone in the first pregnancy had an increased risk of GDM in the second pregnancy when compared with women who had neither of these conditions in their first pregnancy (OR 1.2, 95% CI, 1.1-1.3). Women with GDM alone in the first pregnancy were at an increased risk for GDM in the second pregnancy (OR 3.3, 95% CI 3.1-3.4). The co-presence of preeclampsia and GDM in the first pregnancy further increased the risk of GDM in the second pregnancy (OR 5.9, 95% CI, 4.0-8.6). Our study showed that a history of preeclampsia may serve as an additional risk factor for GDM in a subsequent pregnancy.	[Lee, Joohyun; Ouh, Yung-taek; Ahn, Ki Hoon; Hong, Soon Cheol; Oh, Min-Jeong; Kim, Hai-Joong; Cho, Geum Joon] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Cho, GJ (corresponding author), Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	md_cho@hanmail.net	Rhim, Sonny H./W-9532-2019					Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; American College of Obstetricians and Gynecologists Committee on Practice Bulletins D Obstetrics, 2011, OBSTET GYNECOL, V98, P525; Anastasiou E, 1998, DIABETES CARE, V21, P2111, DOI 10.2337/diacare.21.12.2111; Guimares MFBD, 2014, ARCH GYNECOL OBSTET, V290, P441, DOI 10.1007/s00404-014-3220-x; Bryson CL, 2003, AM J EPIDEMIOL, V158, P1148, DOI 10.1093/aje/kwg273; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Cheng YW, 2009, OBSTET GYNECOL, V114, P326, DOI 10.1097/AOG.0b013e3181ae8d85; Cho GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136017; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Ferrara A, 2002, DIABETES CARE, V25, P1625, DOI 10.2337/diacare.25.9.1625; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Haddad B, 2010, Ann Fr Anesth Reanim, V29, pe59, DOI 10.1016/j.annfar.2010.02.019; Heitritter SM, 2005, J CLIN ENDOCR METAB, V90, P3983, DOI 10.1210/jc.2004-2494; Hogberg U, 2005, SCAND J PUBLIC HEALT, V33, P409, DOI 10.1080/14034940500217037; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Jenkins SM, 2002, AM J OBSTET GYNECOL, V186, P790, DOI 10.1067/mob.2002.122290; Kim JY, 2006, CONSTRUCTION NATL SU; King H, 2002, DIABETES RES CLIN PR, V55, P19, DOI 10.1016/S0168-8227(01)00251-0; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Lee CH, 2013, THORAX, V68, P1105, DOI 10.1136/thoraxjnl-2012-203175; Miyakoshi K, 2004, DIABETES RES CLIN PR, V64, P201, DOI 10.1016/j.diabres.2003.11.002; Nerenberg K, 2014, CAN J CARDIOL, V30, P765, DOI 10.1016/j.cjca.2013.12.030; NISELL H, 1995, BRIT J OBSTET GYNAEC, V102, P876, DOI 10.1111/j.1471-0528.1995.tb10874.x; Ostlund I, 2004, EUR J OBSTET GYN R B, V113, P12, DOI 10.1016/j.ejogrb.2003.07.001; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Reaven GM, 1996, NEW ENGL J MED, V334, P374, DOI 10.1056/NEJM199602083340607; Retnakaran R, 2009, CURR DIABETES REV, V5, P239, DOI 10.2174/157339909789804378; Schneider S, 2012, EARLY HUM DEV, V88, P179, DOI 10.1016/j.earlhumdev.2011.08.004; Solomon CG, 2001, HYPERTENSION, V37, P232, DOI 10.1161/01.HYP.37.2.232; Vambergue A, 2002, EUR J OBSTET GYN R B, V102, P31, DOI 10.1016/S0301-2115(01)00556-5; Vikse BE, 2006, J AM SOC NEPHROL, V17, P837, DOI 10.1681/ASN.2005050492; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316	37	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178150	10.1371/journal.pone.0178150	http://dx.doi.org/10.1371/journal.pone.0178150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542483	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058400062
J	Peredo, CM; Pyenson, ND; Uhen, MD; Marshall, CD				Peredo, Carlos Mauricio; Pyenson, Nicholas D.; Uhen, Mark D.; Marshall, Christopher D.			Alveoli, teeth, and tooth loss: Understanding the homology of internal mandibular structures in mysticete cetaceans	PLOS ONE			English	Article							BALAENOPTERA-ACUTOROSTRATA; RORQUAL WHALES; GIANT ANTEATER; MINKE WHALE; NEW-ZEALAND; EVOLUTION; BALEEN; MASTICATION; MANDIBLES; MORPHOLOGY	The evolution of filter feeding in baleen whales (Mysticeti) facilitated a wide range of ecological diversity and extreme gigantism. The innovation of filter feeding evolved in a shift from a mineralized upper and lower dentition in stem mysticetes to keratinous baleen plates that hang only from the roof of the mouth in extant species, which are all edentulous as adults. While all extant mysticetes are born with a mandible lacking a specialized feeding structure (i.e., baleen), the bony surface retains small foramina with elongated sulci that often merge together in what has been termed the alveolar gutter. Because mysticete embryos develop tooth buds that resorb in utero, these foramina have been interpreted as homologous to tooth alveoli in other mammals. Here, we test this homology by creating 3D models of the internal mandibular morphology from terrestrial artiodactyls and fossil and extant cetaceans, including stem cetaceans, odontocetes and mysticetes. We demonstrate that dorsal foramina on the mandible communicate with the mandibular canal via smaller canals, which we explain within the context of known mechanical models of bone resorption. We suggest that these dorsal foramina represent distinct branches of the inferior alveolar nerve (or artery), rather than alveoli homologous with those of other mammals. As a functional explanation, we propose that these branches provide sensation to the dorsal margin of the mandible to facilitate placement and occlusion of the baleen plates during filer feeding.	[Peredo, Carlos Mauricio] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Peredo, Carlos Mauricio; Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Uhen, Mark D.] George Mason Univ, Dept Atmospher Ocean & Earth Sci, Fairfax, VA 22030 USA; [Marshall, Christopher D.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Marshall, Christopher D.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, Galveston, TX USA	George Mason University; Smithsonian Institution; Smithsonian National Museum of Natural History; George Mason University; Texas A&M University System; Texas A&M University System	Peredo, CM (corresponding author), George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA.; Peredo, CM (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA.	CPeredo@masonlive.gmu.edu	Uhen, Mark D/AAZ-3158-2020; Marshall, Christopher/AAF-9097-2019	Uhen, Mark D/0000-0002-2689-0801; Peredo, Carlos/0000-0002-7217-9850; Pyenson, Nicholas/0000-0003-4678-5782	Smithsonian Institution; NMNH Remington Kellogg Fund; Basis Foundation	Smithsonian Institution(Smithsonian Institution); NMNH Remington Kellogg Fund; Basis Foundation	CMP and NDP were supported by the Smithsonian Institution and the NMNH Remington Kellogg Fund (http://www.mnh.si.edu), and NDP was supported by the Basis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON L C, 1991, Journal of Oral Implantology, V17, P394; Boessenecker RW, 2015, ZOOL J LINN SOC-LOND, V175, P607, DOI 10.1111/zoj.12297; Boessenecker RW, 2015, PEERJ, V3, DOI 10.7717/peerj.1129; Cade DE, 2016, CURR BIOL, V26, P2617, DOI 10.1016/j.cub.2016.07.037; CARTER RB, 1971, J ANAT, V108, P433; CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X; DENIO D, 1992, J ENDODONT, V18, P161, DOI 10.1016/S0099-2399(06)81411-1; Domning DP., 1978, U CALIFORNIA PUBLICA, V118, P1; Drake R. L., 2010, GRAYS ANATOMY STUDEN; Emry RJ, 2004, B AM MUS NAT HIST, P130; Endo H, 2007, ZOOL SCI, V24, P1005, DOI 10.2108/zsj.24.1005; Evans H.E., 2013, MILLERS ANATOMY DOG; Field DJ, 2010, ANAT REC, V293, P1240, DOI 10.1002/ar.21165; Fitzgerald EMG, 2012, BIOL LETTERS, V8, P94, DOI 10.1098/rsbl.2011.0690; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Gingerich Philip D., 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P291; Gingerich Philip D., 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P331; Goldbogen JA, 2010, AM SCI, V98, P124, DOI 10.1511/2010.83.124; Hall B, 1994, HOMOLOGY HIERARCHIAL; Hall BK, 2003, BIOL REV, V78, P409, DOI 10.1017/S1464793102006097; Hassani A, 2013, TXB ADV ORAL MAXILLO; Herring SW, 2001, COMP BIOCHEM PHYS A, V131, P207, DOI 10.1016/S1095-6433(01)00472-X; HERRING SW, 1993, AM ZOOL, V33, P289; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Huang SL, 2009, MAR MAMMAL SCI, V25, P875, DOI 10.1111/j.1748-7692.2009.00288.x; ISHIKAWA H, 1995, J VET MED SCI, V57, P665, DOI 10.1292/jvms.57.665; Ishikawa H, 1999, J VET MED SCI, V61, P227, DOI 10.1292/jvms.61.227; Karlsen K., 1962, Hvalradets Skrifter, VNo. 45, P1; Kellogg R., 1968, US NATL MUSEUM B, V247, P103; Kieser J, 2005, J CRANIOFAC SURG, V16, P6, DOI 10.1097/00001665-200501000-00003; Lyson TR, 2013, EVOL DEV, V15, P317, DOI 10.1111/ede.12041; Marks SC, 1996, ANAT RECORD, V245, P374, DOI 10.1002/(SICI)1097-0185(199606)245:2<374::AID-AR18>3.0.CO;2-M; Marshall CD, 2015, MARINE MAMMAL PHYSL, P95; Marx F.G., 2016, CETACEAN PALEOBIOLOG; May NDS, 1964, ANATOMY SHEEP; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Meredith RW, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-20; Naples VL, 1999, J ZOOL, V249, P19; Norris K.S., 1980, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V28, P495; Okazaki Yoshihiko, 2012, Bulletin of the Kitakyushu Museum of Natural History and Human History Series A Natural History, P129; PACKARD EARL L., 1934, CARNEGIE INST WASHINGTON PUBL, V447, P1; Pinto SJD, 2013, J MORPHOL, V274, P947, DOI 10.1002/jmor.20154; Pyenson ND, 2013, BIOL J LINN SOC, V108, P586, DOI 10.1111/j.1095-8312.2012.02032.x; Pyenson ND, 2012, NATURE, V485, P498, DOI 10.1038/nature11135; Ridgway SH, 2009, ENCYCL NEUROSCI, V4, P1031, DOI [10.1016/B978-008045046-9.00263-1, DOI 10.1016/B978-008045046-9.00263-1]; Saint-Hilaire G., 1807, ANN MUS HIST NAT, V10, P342; Sisson S, 1953, ANATOMY DOMESTIC ANI, V3; Thewissen JGM, 2017, J ANAT, V230, P549, DOI 10.1111/joa.12579; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1; ULM CW, 1993, BRIT J ORAL MAX SURG, V31, P370, DOI 10.1016/0266-4356(93)90193-Z; Ulm CW, 1997, CLIN ORAL IMPLAN RES, V8, P125, DOI 10.1034/j.1600-0501.1997.080207.x; Vickaryous MK, 2006, J ANAT, V208, P263, DOI 10.1111/j.1469-7580.2006.00542.x; Werth AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150106; Yeh K, 2010, ARCH ORAL BIOL, V55, P663, DOI 10.1016/j.archoralbio.2010.05.014	54	10	11	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178243	10.1371/journal.pone.0178243	http://dx.doi.org/10.1371/journal.pone.0178243			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542468	Green Published, gold			2022-12-27	WOS:000401672600048
J	Ysasi, AB; Wagner, WL; Valenzuela, CD; Kienzle, A; Servais, AB; Bennett, RD; Tsuda, A; Ackermann, M; Mentzer, SJ				Ysasi, Alexandra B.; Wagner, Willi L.; Valenzuela, Cristian D.; Kienzle, Arne; Servais, Andrew B.; Bennett, Robert D.; Tsuda, Akira; Ackermann, Maximilian; Mentzer, Steven J.			Evidence for pleural epithelial-mesenchymal transition in murine compensatory lung growth	PLOS ONE			English	Article							SMOOTH-MUSCLE; PNEUMONECTOMY; MECHANISMS; CELLS; ANGIOGENESIS; INGRESSION; EXPRESSION; CYTOMETRY; MICE; FLOW	In many mammals, including rodents and humans, removal of one lung results in the compensatory growth of the remaining lung; however, the mechanism of compensatory lung growth is unknown. Here, we investigated the changes in morphology and phenotype of pleural cells after pneumonectomy. Between days 1 and 3 after pneumonectomy, cells expressing alpha-smooth muscle actin (SMA), a cytoplasmic marker of myofibroblasts, were significantly increased in the pleura compared to surgical controls (p < .01). Scanning electron microscopy of the pleural surface 3 days post-pneumonectomy demonstrated regions of the pleura with morphologic features consistent with epithelial-mesenchymal transition (EMT); namely, cells with disrupted intercellular junctions and an acquired mesenchymal (rounded and fusiform) morphotype. To detect the migration of the transitional pleural cells into the lung, a biotin tracer was used to label the pleural mesothelial cells at the time of surgery. By post-operative day 3, image cytometry of post-pneumonectomy subpleural alveoli demonstrated a 40-fold increase in biotin(+) cells relative to pneumonectomy-plus-plombage controls (p < .01). Suggesting a similar origin in space and time, the distribution of cells expressing biotin, SMA, or vimentin demonstrated a strong spatial autocorrelation in the subpleural lung (p < .001). We conclude that post-pneumonectomy compensatory lung growth involves EMT with the migration of transitional mesothelial cells into subpleural alveoli.	[Ysasi, Alexandra B.; Wagner, Willi L.; Valenzuela, Cristian D.; Kienzle, Arne; Servais, Andrew B.; Bennett, Robert D.; Mentzer, Steven J.] Harvard Med Sch, Brigham & Womens Hosp, Lab Adapt & Regenerat Biol, Boston, MA 02115 USA; [Wagner, Willi L.; Ackermann, Maximilian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Funct & Clin Anat, Mainz, Germany; [Tsuda, Akira] Harvard Sch Publ Hlth, Mol & Integrat Physiol Sci, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Johannes Gutenberg University of Mainz; Harvard University; Harvard T.H. Chan School of Public Health	Mentzer, SJ (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Lab Adapt & Regenerat Biol, Boston, MA 02115 USA.	smentzer@bwh.harvard.edu	Kienzle, Arne/AAN-3260-2021; Bennett, Robert/AAW-6353-2021	Ysasi, Alexandra/0000-0002-2932-870X; Valenzuela, Cristian/0000-0002-8694-9174; Kienzle, Arne/0000-0002-4556-2993	NIH [HL94567, HL134229, HL007734, CA009535, ES000002]; German Research Foundation [SFB1066]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007734, R56HL136476] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by NIH Grant HL94567, HL134229, HL007734, CA009535, ES000002 and the German Research Foundation (SFB1066). There was no additional external funding received for this study	ABDI K, 1993, ELECTROPHORESIS, V14, P73, DOI 10.1002/elps.1150140113; Ackermann M, 2014, ANGIOGENESIS, V17, P541, DOI 10.1007/s10456-013-9399-9; ANDREWS PM, 1973, ANAT RECORD, V177, P409, DOI 10.1002/ar.1091770307; Bennett RA, 2016, AM J PHYSIOL, V312, pL79; Butler JP, 2012, NEW ENGL J MED, V367, P244, DOI 10.1056/NEJMoa1203983; DEAN PN, 1990, CYTOMETRY, V11, P321, DOI 10.1002/cyto.990110302; Dickie R, 2007, J MORPHOL, V268, P1067; Ding L, 2011, METHODS MOL BIOL, V762, P91, DOI 10.1007/978-1-61779-185-7_7; Fehrenbach H, 2008, EUR RESPIR J, V31, P515, DOI 10.1183/09031936.00109407; Filipovic N, 2014, COMPUT METHOD BIOMEC, V17, P838, DOI 10.1080/10255842.2012.719606; Filipovic N, 2013, J APPL PHYSIOL, V115, P1370, DOI 10.1152/japplphysiol.00635.2013; FINK RD, 1985, DEV BIOL, V107, P66, DOI 10.1016/0012-1606(85)90376-8; Gibney BC, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-48; Gibney BC, 2012, EXP LUNG RES, V38, P396, DOI 10.3109/01902148.2012.715364; Gibney BC, 2011, EXP LUNG RES, V37, P301, DOI 10.3109/01902148.2011.561399; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hsia CCW, 2004, AM J RESP CRIT CARE, V170, P319, DOI 10.1164/rccm.200209-1062ST; Konerding MA, 2012, ANGIOGENESIS, V15, P23, DOI 10.1007/s10456-011-9236-y; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-98; Minot C-S, 1890, AM NAT, V24, P877; Mund SI, 2008, DEV DYNAM, V237, P2108, DOI 10.1002/dvdy.21633; Ravnic DJ, 2007, MICROSC RES TECHNIQ, V70, P776, DOI 10.1002/jemt.20463; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; SANTISTEBAN MS, 1992, J HISTOCHEM CYTOCHEM, V40, P1789, DOI 10.1177/40.11.1431064; Schechtman AM, 1935, P SOC EXP BIOL MED, V32, P1072; Schechtman AM, 1934, UNIPOLAR INGRESS IN; Voswinckel R, 2004, EUR RESPIR J, V24, P524, DOI 10.1183/09031936.04.10004904; WILSON TA, 1982, J APPL PHYSIOL, V52, P1064, DOI 10.1152/jappl.1982.52.4.1064; Yamada M, 2005, J HISTOCHEM CYTOCHEM, V53, P735, DOI 10.1369/jhc.4A6483.2005; Yamada T, 2002, ARCH HISTOL CYTOL, V65, P55, DOI 10.1679/aohc.65.55; Ysasi AB, 2015, AM J PHYSIOL-LUNG C, V308, pL1237, DOI 10.1152/ajplung.00042.2015; Ysasi AB, 2013, AM J PHYSIOL-LUNG C, V305, pL439, DOI 10.1152/ajplung.00134.2013	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177921	10.1371/journal.pone.0177921	http://dx.doi.org/10.1371/journal.pone.0177921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542402	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600031
J	Balzarini, RN; Campbell, L; Kohut, T; Holmes, BM; Lehmiller, JJ; Harman, JJ; Atkins, N				Balzarini, Rhonda N.; Campbell, Lorne; Kohut, Taylor; Holmes, Bjarne M.; Lehmiller, Justin J.; Harman, Jennifer J.; Atkins, Nicole			Perceptions of primary and secondary relationships in polyamory	PLOS ONE			English	Article							ROMANTIC RELATIONSHIPS; RELATIONSHIP QUALITY; CLOSE RELATIONSHIPS; INVESTMENT MODEL; COMMITMENT; SATISFACTION; GAY	In consensually non-monogamous relationships there is an open agreement that one, both, or all individuals involved in a romantic relationship may also have other sexual and/or romantic partners. Research concerning consensual non-monogamy has grown recently but has just begun to determine how relationships amongst partners in consensually non-monogamous arrangements may vary. The current research examines this issue within one type of consensual non-monogamy, specifically polyamory, using a convenience sample of 1,308 self-identified polyamorous individuals who provided responses to various indices of relationship evaluation (e.g. acceptance, secrecy, investment size, satisfaction level, commitment level, relationship communication, and sexual frequency). Measures were compared between perceptions of two concurrent partners within each polyamorous relationship (i.e., primary and secondary partners). Participants reported less stigma as well as more investment, satisfaction, commitment and greater communication about the relationship with primary compared to secondary relationships, but a greater proportion of time on sexual activity with secondary compared to primary relationships. We discuss how these results inform our understanding of the unique costs and rewards of primary-secondary relationships in polyamory and suggest future directions based on these findings.	[Balzarini, Rhonda N.; Campbell, Lorne; Kohut, Taylor] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Holmes, Bjarne M.] Champlain Coll, Dept Psychol, Burlington, VT USA; [Lehmiller, Justin J.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Harman, Jennifer J.] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Atkins, Nicole] Portland State Univ, Dept Psychol, Portland, OR 97207 USA; [Lehmiller, Justin J.] Ball State Univ, Dept Social Psychol & Counseling, Muncie, IN 47306 USA	Western University (University of Western Ontario); Harvard University; Colorado State University; Portland State University; Ball State University	Balzarini, RN (corresponding author), Univ Western Ontario, Dept Psychol, London, ON, Canada.	rbalzari@uwo.ca		Balzarini, Rhonda/0000-0001-7443-1266				ARON A, 1991, J PERS SOC PSYCHOL, V60, P241, DOI 10.1037/0022-3514.60.2.241; Berzon B., 1988, PERMANENT PARTNERS; Blau Peter, 1986, EXCHANGE POWER; CALL V, 1995, J MARRIAGE FAM, V57, P639, DOI 10.2307/353919; Conley TD, 2013, ANAL SOC ISS PUB POL, V13, P1, DOI 10.1111/j.1530-2415.2012.01286.x; Conley TD, 2013, PERS SOC PSYCHOL REV, V17, P124, DOI 10.1177/1088868312467087; Cook E., 2005, THESIS; Cox DW, 2013, LOVING MORE MAGAZINE; Easton D, 2009, GUIDE POLYAMORY OPEN; Fleckenstein J, 2012, WHAT DO POLYS WANT O; Foster CA, 2005, PERS RELATIONSHIP, V12, P125, DOI 10.1111/j.1350-4126.2005.00105.x; Goffman E., 1969, STRATEGIC INTERACTIO; Goffman E., 1963, STIGMA MANAGEMENT SP; Haupert M, 2016, J SEX MARIA IN PRESS; Henrich J, 2012, PHILOS T R SOC B, V367, P657, DOI 10.1098/rstb.2011.0290; HOMANS GC, 1961, SOCIAL BEHAV ITS ELE; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyde J.S., 2000, UNDERSTANDING HUMAN; JENKS RJ, 1985, J SEX RES, V21, P199, DOI 10.1080/00224498509551258; Jordan K.M., 2000, J LESBIAN STUDIES, V4, P145, DOI [DOI 10.1300/J155V04N01_09, https://doi.org/10.1300/J155v04n01_09]; Kimberly C, 2017, ARCH SEX BEHAV, V46, P789, DOI 10.1007/s10508-015-0621-2; Kirk R. E., 1982, EXPT DESIGN; Kleese C., 2006, SEXUALITIES, V9, P565, DOI [10.1177/1363460706069986, DOI 10.1177/1363460706069986]; KURDEK LA, 1985, J HOMOSEXUAL, V12, P85; Lehmiller JJ, 2006, PERS SOC PSYCHOL B, V32, P40, DOI 10.1177/0146167205278710; Lehmiller JJ, 2014, J SEX RES, V51, P74, DOI 10.1080/00224499.2012.719167; Lehmiller JJ, 2010, PERS RELATIONSHIP, V17, P81, DOI 10.1111/j.1475-6811.2010.01254.x; Lehmiller JJ, 2009, PERS SOC PSYCHOL B, V35, P1452, DOI 10.1177/0146167209342594; Mogilski JK, 2017, ARCH SEX BEHAV, V46, P407, DOI 10.1007/s10508-015-0658-2; Moors AC, 2013, ANAL SOC ISS PUB POL, V13, P52, DOI 10.1111/asap.12020; Munson M., 1999, LESBIAN POLYAMORY RE, V3, P1; PALSON C, 1972, SOCIETY, V9, P28; Peck DL, 2001, EXTRAODINARY BEHAV C; Pines A., 1981, ALTERNATIVE LIFESTYL, V4, P373, DOI DOI 10.1007/BF01257945; RAMEY JW, 1975, FAM COORD, V24, P515, DOI 10.2307/583035; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Rubel AN, 2015, J SEX RES, V52, P961, DOI 10.1080/00224499.2014.942722; Rubin J. D., 2014, J PSYCHOL, V22, P19; RUSBULT CE, 1993, J SOC PERS RELAT, V10, P175, DOI 10.1177/026540759301000202; Rusbult CE, 1998, PERS RELATIONSHIP, V5, P357, DOI 10.1111/j.1475-6811.1998.tb00177.x; RUSBULT CE, 1983, J PERS SOC PSYCHOL, V45, P101, DOI 10.1037/0022-3514.45.1.101; RUSBULT CE, 1993, NEL HAL PSY, P30; RUSBULT CE, 1980, J EXP SOC PSYCHOL, V16, P172, DOI 10.1016/0022-1031(80)90007-4; Sheff E., 2013, POLYAMORISTS NEXT DO; SPRECHER S, 1992, J MARRIAGE FAM, V54, P888, DOI 10.2307/353170; Taormino T., 2008, OPENING GUIDE CREATI; Veaux F, 2011, CARE FEEDING POLYAMO; Veaux F, 2014, MORE THAN 2 PRACTICA; Viwatpanich K, 2010, ANTHROPOL NOTEB, V16, P57; Wosick-Correa K, 2010, PSYCHOL SEX, V1, P44, DOI 10.1080/19419891003634471	50	33	33	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177841	10.1371/journal.pone.0177841	http://dx.doi.org/10.1371/journal.pone.0177841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542619	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400097
J	Sala, S; Catillon, M; Hadzic, E; Schaffner-Reckinger, E; Van Troys, M; Ampe, C				Sala, Stefano; Catillon, Marie; Hadzic, Ermin; Schaffner-Reckinger, Elisabeth; Van Troys, Marleen; Ampe, Christophe			The PET and LIM1-2 domains of testin contribute to intramolecular and homodimeric interactions	PLOS ONE			English	Article							FOCAL ADHESION PROTEIN; TUMOR-SUPPRESSOR; ACTIN; VINCULIN; ZYXIN; BREAST; EVL	The focal adhesion protein testin is a modular scaffold and tumour suppressor that consists of an N-terminal cysteine rich (CR) domain, a PET domain of unknown function and three C-terminal LIM domains. Testin has been proposed to have an open and a closed conformation based on the observation that its N-terminal half and C-terminal half directly interact. Here we extend the testin conformational model by demonstrating that testin can also form an antiparallel homodimer. In support of this extended model we determined that the testin region (amino acids 52-233) harbouring the PET domain interacts with the C-terminal LIM1-2 domains in vitro and in cells, and assign a critical role to tyrosine 288 in this interaction.	[Sala, Stefano; Van Troys, Marleen; Ampe, Christophe] Univ Ghent, Dept Biochem, Ghent, Belgium; [Catillon, Marie; Hadzic, Ermin; Schaffner-Reckinger, Elisabeth] Univ Luxembourg, Cytoskeleton & Cell Plast Lab, Life Sci Res Unit FSTC, Luxembourg, Luxembourg	Ghent University; University of Luxembourg	Ampe, C (corresponding author), Univ Ghent, Dept Biochem, Ghent, Belgium.	christophe.ampe@ugent.be		Sala, Stefano/0000-0003-3675-6849; Van Troys, Marleen/0000-0003-4283-8103; Christophe, Ampe/0000-0002-8554-3594	PhD scholarship [FWO-Inter UGent-UL G.0353.11N, FWO-Inter UGent-UL INTER/FWO/10/01]	PhD scholarship	This work was supported by PhD scholarship to SS - Fonds Wetenschappelijk Onderzoek Vlaanderen (http://www.fwo.be/); Grant FWO-Inter UGent-UL G.0353.11N to CA (http:// www.fwo.be/); PhD scholarship to EH - Fonds National de la Recherche, Luxembourg (http://fnr.lu/); and FWO-Inter UGent-UL INTER/FWO/10/01 to Evelyne Friederich, taken over by ESR (http://fnr.lu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Boeda B, 2011, J BIOL CHEM, V286, P11543, DOI 10.1074/jbc.M110.171264; Chinthalapudi K, 2015, BIOCHEMISTRY-US, V54, P2758, DOI 10.1021/acs.biochem.5b00015; Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278; Drusco A, 2005, P NATL ACAD SCI USA, V102, P10947, DOI 10.1073/pnas.0504934102; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Eyckerman S, 2016, J PROTEOME RES, V15, P3929, DOI 10.1021/acs.jproteome.6b00517; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Garvalov BK, 2003, J CELL BIOL, V161, P33, DOI 10.1083/jcb.200211015; Golji J, 2014, BIOPHYS J, V107, P1802, DOI 10.1016/j.bpj.2014.08.038; Griffith E, 2005, CELL MOTIL CYTOSKEL, V60, P140, DOI 10.1002/cm.20052; Griffith E, 2004, CELL MOTIL CYTOSKEL, V57, P133, DOI 10.1002/cm.10162; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Gu ZP, 2014, MED SCI MONITOR, V20, P980, DOI 10.12659/MSM.890544; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Hadzic E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140511; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Leyman S, 2009, MOL BIOL CELL, V20, P4509, DOI 10.1091/mbc.E09-02-0121; Li H, 2014, ONCOTARGET, V7, P45819; Ma HQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-190; Oldenburg J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17225; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Rotter B, 2005, BIOCHEM J, V388, P631, DOI 10.1042/BJ20041502; Sala S, 2017, J PROTEOME RES; Sarti M, 2005, CLIN CANCER RES, V11, P806; Sweede M, 2008, BIOCHEMISTRY-US, V47, P13524, DOI 10.1021/bi801037h; Thompson PM, 2013, FEBS LETT, V587, P1220, DOI 10.1016/j.febslet.2013.02.042; Weeks RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151341; Weeks RJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-163; Wodak SJ, 2015, BIOPHYS J ELSERVIER, V109, P1067; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126; Zhong YL, 2009, MOL CELL BIOCHEM, V320, P85, DOI 10.1007/s11010-008-9901-7; Zhu J, 2012, CANCER SCI, V103, P2092, DOI 10.1111/cas.12020	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177879	10.1371/journal.pone.0177879	http://dx.doi.org/10.1371/journal.pone.0177879			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542564	Green Published, gold			2022-12-27	WOS:000401672400106
J	Shioda, M; Muneta, T; Tsuji, K; Mizuno, M; Komori, K; Koga, H; Sekiya, I				Shioda, Mikio; Muneta, Takeshi; Tsuji, Kunikazu; Mizuno, Mitsuru; Komori, Keiichiro; Koga, Hideyuki; Sekiya, Ichiro			TNFa promotes proliferation of human synovial MSCs while maintaining chondrogenic potential	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; NF-KAPPA-B; IN-VITRO CHONDROGENESIS; BONE-MARROW; MENISCAL REGENERATION; CARTILAGE FORMATION; CAUSES NECROSIS; ADIPOSE-TISSUE; STROMAL CELLS; SERUM FACTOR	Synovial mesenchymal stem cells (MSCs) are a candidate cell source for cartilage and meniscus regeneration. If we can proliferate synovial MSCs more effectively, we can expand clinical applications to patients with large cartilage and meniscus lesions. TNFa is a pleiotropic cytokine that can affect the growth and differentiation of cells in the body. The purpose of this study was to examine the effect of TNFa on proliferation, chondrogenesis, and other properties of human synovial MSCs. Passage 1 human synovial MSCs from 2 donors were cultured with 2.5 x 10(-12) similar to 10(-7) g/ml, 10 fold dilution series of TNFa for 14 days, then the cell number and colony number was counted. The effect of the optimum dose of TNFa on proliferation was also examined in synovial MSCs from 6 donors. Chondrogenic potential of synovial MSCs pretreated with TNFa was evaluated in 6 donors. The expressions of 12 surface antigens were also examined in 3 donors. 2.5 ng/ml and higher concentration of TNFa significantly increased cell number/dish and cell number/colony in both donors. The effect of 25 ng/ml TNFa was confirmed in all 6 donors. There was no significant difference in the weight, or amount of glycosaminoglycan and DNA of the cartilage pellets between the MSCs untreated and MSCs pretreated with 25 ng/ml TNFa. TNFa decreased expression rate of CD 105 and 140b in all 3 donors. TNFa promoted proliferation of synovial MSCs with increase of cell number/colony. Pretreatment with TNFa did not affect chondrogenesis of synovial MSCs. However, TNFa affected some properties of synovial MSCs.	[Shioda, Mikio; Muneta, Takeshi; Koga, Hideyuki] Tokyo Med & Dent Univ, Grad Sch Med, Dept Joint Surg & Sports Med, Tokyo, Japan; [Tsuji, Kunikazu] Tokyo Med & Dent Univ, Grad Sch Med, Dept Cartilage Regenerat, Tokyo, Japan; [Mizuno, Mitsuru; Komori, Keiichiro; Sekiya, Ichiro] Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Sekiya, I (corresponding author), Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan.	sekiya.arm@tmd.ac.jp	Tsuji, Kunikazu/HDM-9242-2022; Mitsuru, Mizuno/K-3962-2017; Koga, Hideyuki/B-2448-2019	Tsuji, Kunikazu/0000-0002-1013-8359; Mitsuru, Mizuno/0000-0002-4410-3621; Koga, Hideyuki/0000-0003-4574-1796; Muneta, Takeshi/0000-0003-1018-2939	JSPS KAKENHI [JP16K20039]; Japan Agency for Medical Research and Development [122011A182]; Japan Society for the promotion of Science [15K10464]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by JSPS KAKENHI grant number JP16K20039, Japan Agency for Medical Research and Development #122011A182, and Japan Society for the promotion of Science #15K10464. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2014, RHEUMATOLOGY, V53, P165, DOI 10.1093/rheumatology/ket334; Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; Bocker WG, 2008, J MOL MED, V86, P1183, DOI 10.1007/s00109-008-0378-3; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Casnici C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/702057; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fan WS, 2016, BIOCHEM BIOPH RES CO, V474, P338, DOI 10.1016/j.bbrc.2016.04.101; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GREEN S, 1976, P NATL ACAD SCI USA, V73, P381, DOI 10.1073/pnas.73.2.381; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hatsushika D, 2014, OSTEOARTHR CARTILAGE, V22, P941, DOI 10.1016/j.joca.2014.04.028; Hatsushika D, 2013, J ORTHOP RES, V31, P1354, DOI 10.1002/jor.22370; Horie M, 2009, STEM CELLS, V27, P878, DOI 10.1634/stemcells.2008-0616; Ichinose S, 2010, LAB INVEST, V90, P210, DOI 10.1038/labinvest.2009.125; Jagielski M, 2014, INT J MOL SCI, V15, P15821, DOI 10.3390/ijms150915821; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Kondo S, 2016, J ORTHOPAEDIC RES OF; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Nagase T, 2008, ARTHRITIS RHEUM, V58, P1389, DOI 10.1002/art.23418; Nair S, 2011, REPROD SCI, V18, P1186, DOI 10.1177/1933719111408111; Nimura A, 2008, ARTHRITIS RHEUM, V58, P501, DOI 10.1002/art.23219; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Segawa Y, 2009, J ORTHOP RES, V27, P435, DOI 10.1002/jor.20786; Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898; Sekiya I, 2015, CLIN ORTHOP RELAT R, V473, P2316, DOI 10.1007/s11999-015-4324-8; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shirasawa S, 2006, J CELL BIOCHEM, V97, P84, DOI 10.1002/jcb.20546; Sousa BR, 2014, CYTOM PART A, V85A, P43, DOI 10.1002/cyto.a.22402; Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869; Venkatachalam K, 2009, J BIOL CHEM, V284, P14414, DOI 10.1074/jbc.M809757200; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z	43	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177771	10.1371/journal.pone.0177771	http://dx.doi.org/10.1371/journal.pone.0177771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542363	gold, Green Submitted, Green Published			2022-12-27	WOS:000401672400081
J	Song, Y; Wang, YBN; Mao, WF; Sui, HX; Yong, L; Yang, DJ; Jiang, DG; Zhang, L; Gong, YY				Song, Yan; Wang, Yibana; Mao, Weifeng; Sui, Haixia; Yong, Ling; Yang, Dajin; Jiang, Dingguo; Zhang, Lei; Gong, Yunyun			Dietary cadmium exposure assessment among the Chinese population	PLOS ONE			English	Article							RISK-ASSESSMENT; CANCER; ELEMENTS; FOOD	Cadmium, a toxic heavy metal, is widely present in food. It has been reported that chronic cadmium exposure is associated with kidney disease, osteoporosis, cardiovascular disease and cancer. The aim of this study was to assess the dietary cadmium exposure and potential health risk in different age-sex groups of the Chinese population (children aged 4-11 years, young people aged 12-17 years and adults aged over 18 years), and in the southern and northern population using a semi-probabilistic method. Cadmium was detected in 228,687 food samples from 32 food categrories by graphite furnace atomic absorption spectrometry. The dietary cadmium exposures were estimated by combining the cadmium concentration data with food consumption data derived from the China National Nutrient and Health Survey 2002, and evaluated against the Provisional Tolerable Monthly Intake (PTMI) of 25 mu g/kg BW/month established by the Joint FAO/WHO expert committee on food additives (JECFA). The mean dietary cadmium exposure of the general Chinese population (15.3 mu g/kg BW/month) was below the PTMI. The high consumer exposures (95(th) percentile, P95) for the general population and different sub-groups were higher than the PTMI. The dietary cadmium exposure of the southern population was apparently higher than that of the northern population. Rice was the most important contributor to cadmium exposure for Chinese people, especially those living in the southern areas of China. These findings indicated that the health risk from dietary cadmium exposure of the general Chinese people was low, but the health risk of cadmium exposure of certain sub-groups should be of concern.	[Song, Yan; Wang, Yibana; Mao, Weifeng; Sui, Haixia; Yong, Ling; Yang, Dajin; Jiang, Dingguo; Zhang, Lei] China Natl Ctr Food Safety Risk Assessment, Natl Hlth & Family Planning Commiss Peoples Repub, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China; [Gong, Yunyun] Univ Leeds, Leeds, W Yorkshire, England	University of Leeds	Zhang, L (corresponding author), China Natl Ctr Food Safety Risk Assessment, Natl Hlth & Family Planning Commiss Peoples Repub, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China.	zhanglei@cfsa.net.cn	Gong, Yun Yun/L-7094-2016; Gong, Yun Yun/C-8412-2018	Gong, Yun Yun/0000-0003-4927-5526; Gong, Yun Yun/0000-0003-4927-5526; Yang, Dajin/0000-0001-7032-5642; Zhang, Lei/0000-0003-0936-4356	Testing Technology of Safety and Standards of Traditional Chinese medicine [2014ZX09304307]; China Agro-scientific Research in the Public Interest [200903054-06]	Testing Technology of Safety and Standards of Traditional Chinese medicine; China Agro-scientific Research in the Public Interest	This work was partially supported by Special Fund for Testing Technology of Safety and Standards of Traditional Chinese medicine (2014ZX09304307) and China Agro-scientific Research in the Public Interest (200903054-06).	Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; Al-Rmalli SW, 2012, J FOOD SCI, V77, pT26, DOI 10.1111/j.1750-3841.2011.02467.x; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.980; ATSDR (Agency for Toxic Substances and Disease Registry), 2008, TOX PROF CA IN PRESS; Bampidis V. A., 2013, Scientific Papers: Animal Science and Biotechnologies, V46, P17; Chen J, 1997, Wei Sheng Yan Jiu, V26, P199; CHEN JS, 1993, J AOAC INT, V76, P1193; Chen L, 2006, TOXICOL APPL PHARM, V215, P93, DOI 10.1016/j.taap.2006.01.013; Chunhabundit R, 2016, TOXICOL RES-GER, V32, P65, DOI 10.5487/TR.2016.32.1.065; EC, 1997, REP SCI COMM FOOD, P67; *EUR FOOD SAF AUTH, 2012, EFSA J; European Food Safety Authorities, 2005, EFSA J, V241, P1, DOI [DOI 10.2903/J.EFSA.2005.241, DOI 10.2903/J.EFSA.2004.84]; European Food Safety Authority, 2012, EFSA J, V10, DOI [10.2903/j.efsa.2012.2551, 10.2903/j.efsa.2012.2831]; FAO/ WHO, 1989, WHO TECHN REP SER, V776; FAO/ WHO, 2001, WHO TECHN REP SER, V901; FAO/WHO, 2011, WHO TECHN REP SER, V960; Gao Jun-quan, 2006, Wei Sheng Yan Jiu, V35, P750; Huang Y, 2014, BIOMED ENVIRON SCI, V27, P819, DOI 10.3967/bes2014.119; Huff J, 2007, INT J OCCUP ENV HEAL, V13, P202, DOI 10.1179/oeh.2007.13.2.202; Il'yasova D, 2005, TOXICOL APPL PHARM, V207, P179, DOI 10.1016/j.taap.2004.12.005; International Agency for Research on Cancer (IARC), 1993, IARC MON EV CARC RIS, V58; Kazantzis G, 2004, BIOMETALS, V17, P493, DOI 10.1023/B:BIOM.0000045727.76054.f3; Kellen E, 2007, CANCER DETECT PREV, V31, P77, DOI 10.1016/j.cdp.2006.12.001; Kim M, 2011, FOOD ADDIT CONTAM A, V28, P62, DOI 10.1080/19440049.2010.529620; KJELLSTROM T, 1978, ENVIRON RES, V16, P248, DOI 10.1016/0013-9351(78)90160-3; Marcussen H, 2013, ASIA PAC J CLIN NUTR, V22, P300, DOI 10.6133/apjcn.2013.22.2.06; McElroy JA, 2006, JNCI-J NATL CANCER I, V98, P869, DOI 10.1093/jnci/djj233; Moschandreas DJ, 2002, J EXPO ANAL ENV EPID, V12, P233, DOI 10.1038/sj.jea.7500230; Nasreddine L, 2010, FOOD CHEM TOXICOL, V48, P1262, DOI 10.1016/j.fct.2010.02.020; Nawrot T, 2006, LANCET ONCOL, V7, P119, DOI 10.1016/S1470-2045(06)70545-9; Nordberg G, 2002, AMBIO, V31, P478, DOI 10.1639/0044-7447(2002)031[0478:LBDARD]2.0.CO;2; Nordberg GF, 1985, EXPOSURE DOSE METABO, V1; Ohno K, 2010, WATER SCI TECHNOL, V62, P2694, DOI 10.2166/wst.2010.392; Satarug S, 2013, ENVIRON HEALTH PERSP, V121, P531, DOI 10.1289/ehp.1104769; Sioen I, 2012, ENVIRON INT, V48, P102, DOI 10.1016/j.envint.2012.07.004; Thomas LDK, 2011, J BONE MINER RES, V26, P1601, DOI 10.1002/jbmr.386; U. S. Geological Survey, 2015, MIN COMM SUMM 2015, P36; United Nations Environment Programme, 2010, FIN REV SCI INF CADM, P87; Vinceti M, 2007, SCI TOTAL ENVIRON, V373, P77, DOI 10.1016/j.scitotenv.2006.11.005; World Health Organization (WHO), 1995, WORKSH FRAM GEMS FOO; Wu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29989; Yuan XP, 2014, J SCI FOOD AGR, V94, P373, DOI 10.1002/jsfa.6394; [詹杰 Zhan Jie], 2012, [农业环境科学学报, Journal of Agro-Environment Science], V31, P1257; Zhang L, 2016, BIOMED ENVIRON SCI, V29, P365, DOI 10.3967/bes2016.047	44	169	193	29	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177978	10.1371/journal.pone.0177978	http://dx.doi.org/10.1371/journal.pone.0177978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542445	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672400124
J	Yin, SL; Kleijn, D; Muskens, GJDM; Fouchier, RAM; Verhagen, JH; Glazov, PM; Si, YL; Prins, HHT; de Boer, WF				Yin, Shenglai; Kleijn, David; Muskens, Gerard J. D. M.; Fouchier, Ron A. M.; Verhagen, Josanne H.; Glazov, Petr M.; Si, Yali; Prins, Herbert H. T.; de Boer, Willem Frederik			No evidence that migratory geese disperse avian influenza viruses from breeding to wintering ground	PLOS ONE			English	Article							A VIRUS; BODY CONDITION; WILD BIRDS; H5N1 VIRUS; INFECTION; SURVEILLANCE; DYNAMICS; PATTERNS; SPREAD; DUCKS	Low pathogenic avian influenza virus can mutate to a highly pathogenic strain that causes severe clinical signs in birds and humans. Migratory waterfowl, especially ducks, are considered the main hosts of low pathogenic avian influenza virus, but the role of geese in dispersing the virus over long-distances is still unclear. We collected throat and cloaca samples from three goose species, Bean goose (Anser fabalis), Barnacle goose (Branta leucopsis) and Greater white-fronted goose (Anser albifrons), from their breeding grounds, spring stopover sites, and wintering grounds. We tested if the geese were infected with low pathogenic avian influenza virus outside of their wintering grounds, and analysed the spatial and temporal patterns of infection prevalence on their wintering grounds. Our results show that geese were not infected before their arrival on wintering grounds. Barnacle geese and Greater white-fronted geese had low prevalence of infection just after their arrival on wintering grounds in the Netherlands, but the prevalence increased in successive months, and peaked after December. This suggests that migratory geese are exposed to the virus after their arrival on wintering grounds, indicating that migratory geese might not disperse low pathogenic avian influenza virus during autumn migration.	[Yin, Shenglai; Si, Yali; Prins, Herbert H. T.; de Boer, Willem Frederik] Wageningen Univ & Res, Resource Ecol Grp, Wageningen, Netherlands; [Kleijn, David] Wageningen Univ & Res, Plant Ecol & Nat Conservat Grp, Wageningen, Netherlands; [Muskens, Gerard J. D. M.] Wageningen Univ & Res, Alterra, Ctr Ecosyst Studies, Wageningen, Netherlands; [Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Verhagen, Josanne H.] Linnaeus Univ, Dept Biol & Environm Sci, Kalmar, Sweden; [Glazov, Petr M.] Russian Acad Sci, Inst Geog, Lab Biogeog, Moscow, Russia; [Si, Yali] Tsinghua Univ, Minist Educ, Key Lab Earth Syst Modelling, Beijing, Peoples R China; [Si, Yali] Tsinghua Univ, Dept Earth Syst Sci, Beijing, Peoples R China	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Erasmus University Rotterdam; Erasmus MC; Linnaeus University; Institute of Geography, Russian Academy of Sciences; Russian Academy of Sciences; Tsinghua University; Tsinghua University	Yin, SL; de Boer, WF (corresponding author), Wageningen Univ & Res, Resource Ecol Grp, Wageningen, Netherlands.	shenglai.yin@wur.nl; fred.deboer@wur.nl	Yin, Shenglai/GVU-1617-2022; Si, Yali/B-3573-2012; Kleijn, David/HCH-3477-2022; Glazov, Petr/AAE-4780-2019; Fouchier, Ron A/A-1911-2014	Si, Yali/0000-0001-7107-9850; Glazov, Petr/0000-0003-3462-7031; Fouchier, Ron A/0000-0001-8095-2869; Kleijn, David/0000-0003-2500-7164; Verhagen, Josanne/0000-0003-3133-5228; Prins, Herbert/0000-0003-1131-5107	Dutch Ministry of Agriculture, Nature Conservation and Food Quality [BO-10-003-002, 2001126]; Ph.D. scholarship [201406190178]; Dutch Ministry of Economic Affairs, European Research Council project FLUPLAN [250136]; NIAID/NIH [HHSN272201400008C]	Dutch Ministry of Agriculture, Nature Conservation and Food Quality; Ph.D. scholarship; Dutch Ministry of Economic Affairs, European Research Council project FLUPLAN; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was carried out in the framework of the projects 'Flyway conservation of migratory waterbirds', BO-10-003-002, and Vooltetting monitoring ganzen en Smienten ivm het voorkomen van vogelgriepvirussen in 2008/2009', Verpl. Nr. 2001126, funded by the Dutch Ministry of Agriculture, Nature Conservation and Food Quality. The study is supported by a Ph.D. scholarship to Shenglai Yin from the Chinese Scholarship Council (Nr. 201406190178), and by the Dutch Ministry of Economic Affairs, European Research Council project FLUPLAN [250136] and NIAID/NIH contract HHSN272201400008C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Andrea K, 2016, OIKOS, V125, P1496; AP, 2007, P R SOC, P274; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Burthe S, 2008, J ANIM ECOL, V77, P110, DOI 10.1111/j.1365-2656.2007.01302.x; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Crespigny FEC, 2006, P ROY SOC B-BIOL SCI, V273, P1455, DOI 10.1098/rspb.2006.3478; Delany S., 2009, BRIT BIRDS, V102, P639; Gaidet N, 2011, P R SOC, V279; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hornman M., 2013, WATERVOGELS NEDERLAN; Hornman M, 2015, WATERVOGELS NEDERLAN; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Jonassen CM, 2007, AVIAN DIS, V51, P425, DOI 10.1637/7555-033106R1.1; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Kleijn D, 2010, P R SOC, V277; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P2347, DOI 10.1098/rspb.2009.0275; Lewis NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058534; Madsen J., 1999, GOOSE POPULATIONS W; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pasick J, 2007, EMERG INFECT DIS, V13, P1821, DOI 10.3201/eid1312.070502; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Samuel MD, 2015, ECOL APPL, V25, P1851, DOI 10.1890/14-1820.1; Scheper J, 2014, P NATL ACAD SCI USA, V111, P17552, DOI 10.1073/pnas.1412973111; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Team RC, 2014, LANG ENV STAT COMP; van Dijk JGB, 2015, OIKOS, V124, P1293, DOI 10.1111/oik.01836; van Dijk JGB, 2015, ECOL EVOL, V5, P436, DOI 10.1002/ece3.1359; Verhagen JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112366; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wang RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028873; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2013, CUM NUMB CONF HUM CA; World Health Organization, 2013, H5N1 HIGHL PATH AV I; World Organization for Animal Health, 2017, UPD HIGHL PATH AV IN	43	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177790	10.1371/journal.pone.0177790	http://dx.doi.org/10.1371/journal.pone.0177790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542340	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672400083
J	Huang, SW; Shekhar, H; Holland, CK				Huang, Shenwen; Shekhar, Himanshu; Holland, Christy K.			Comparative lytic efficacy of rt-PA and ultrasound in porcine versus human clots	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN-ACTIVATOR; TEMPORAL BONE WINDOW; ENHANCED THROMBOLYSIS; ANIMAL-MODEL; INTRAVENOUS MICROBUBBLES; TRANSCRANIAL ULTRASOUND; MECHANICAL THROMBECTOMY; CAROTID-ARTERY; DRUG-DELIVERY	Introduction Porcine thrombi are employed routinely in preclinical models of ischemic stroke. In this study, we examined the differential lytic susceptibility of porcine and human whole blood clots with and without the use of microbubbles and ultrasound (US) as an adjuvant. Materials and methods An in vitro system equipped with time-lapse microscopy was used to evaluate recombinant tissue-plasminogen activator (rt-PA) lysis of porcine and human clots in the same species or cross species plasma. Human and porcine whole blood clots were treated with rt-PA and an echo contrast agent, Definity (R), and exposed to intermittent 120 kHz US. Results and conclusions The rt-PA lytic efficacy observed for porcine clots in porcine plasma was 22 times lower than for human clots in human plasma reported previously. Further, porcine clots did not exhibit increased lysis with adjuvant Definity (R) and US exposure. However, the rt-PA lytic susceptibility of the porcine clots in human plasma was similar to that of human clots in human plasma. Human clots perfused with porcine plasma did not respond to rt-PA, but adjuvant use of Definity (R) and US enhanced lysis. These results reveal considerable differences in lytic susceptibility of porcine clots and human clots to rt-PA. The use of porcine clot models to test new human thrombolytic therapies may necessitate modulation of coagulation and thrombolytic factors to reflect human hemostasis accurately.	[Huang, Shenwen; Holland, Christy K.] Univ Cincinnati, Dept Biomed Chem & Environm Engn, Coll Engn & Appl Sci, Cincinnati, OH 45220 USA; [Shekhar, Himanshu; Holland, Christy K.] Univ Cincinnati, Div Cardiovasc Hlth & Dis, Dept Internal Med, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Huang, SW (corresponding author), Univ Cincinnati, Dept Biomed Chem & Environm Engn, Coll Engn & Appl Sci, Cincinnati, OH 45220 USA.	huangsw@mail.uc.edu	Shekhar, Himanshu/I-4093-2019	Shekhar, Himanshu/0000-0003-1226-4196	National Institute of Neurological Diseases and Disorders [R01 NS047603]; National Institute of General Medical Sciences [T32 GM 063483]; Postdoctoral research fellowship in Acoustics from the Acoustical Society of America	National Institute of Neurological Diseases and Disorders; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Postdoctoral research fellowship in Acoustics from the Acoustical Society of America	This work was supported by the National Institute of Neurological Diseases and Disorders (https.//www.ninds.nih.gov/) (Grant number: R01 NS047603). SH is a member of the University of Cincinnati Medical Scientist Training Program, which is supported by the National Institute of General Medical Sciences (T32 GM 063483). HS was supported in part by the F. V. Hunt Postdoctoral research fellowship in Acoustics from the Acoustical Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Adzerikho I, 2013, J THROMB THROMBOLYS, V36, P263, DOI 10.1007/s11239-012-0850-3; Alexandrov AV, 2010, STROKE, V41, P948, DOI 10.1161/STROKEAHA.109.577502; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Bader KB, 2015, J THROMB THROMBOLYS, V40, P144, DOI 10.1007/s11239-015-1204-8; Bader KB, 2015, ULTRASOUND MED BIOL, V41, P187, DOI 10.1016/j.ultrasmedbio.2014.08.018; Baron C, 2009, ULTRASOUND MED BIOL, V35, P1148, DOI 10.1016/j.ultrasmedbio.2008.11.014; Berkhemer OA, 2015, NEW ENGL J MED, V372, P394, DOI [DOI 10.1056/NEJMOA1411587, DOI 10.1056/NEJM0A1411587, 10.1056/NEJMoa1411587]; Bouchoux G, 2014, ULTRASOUND MED BIOL, V40, P1154, DOI 10.1016/j.ultrasmedbio.2013.12.025; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BC, 2013, NEW ENGL J MED, V368, P2431, DOI [10.1056/NEJMc1304759, 10.1056/NEJMoa1213701]; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Culp WC, 2004, STROKE, V35, P2407, DOI 10.1161/01.STR.0000140890.86779.79; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Datta S, 2008, ULTRASOUND MED BIOL, V34, P1421, DOI 10.1016/j.ultrasmedbio.2008.01.016; Datta S, 2006, ULTRASOUND MED BIOL, V32, P1257, DOI 10.1016/j.ultrasmedbio.2006.04.008; Flight SM, 2006, BLOOD COAGUL FIBRIN, V17, P417, DOI 10.1097/01.mbc.0000233374.79593.57; Flint AC, 2007, STROKE, V38, P1274, DOI 10.1161/01.STR.0000260187.33864.a7; GABRIEL DA, 1992, J BIOL CHEM, V267, P24259; Gao SJ, 2014, INVEST RADIOL, V49, P593, DOI 10.1097/RLI.0000000000000059; Gralla J, 2006, AM J NEURORADIOL, V27, P1357; Gruber MJ, 2014, J ACOUST SOC AM, V135, P646, DOI 10.1121/1.4843175; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Hashimoto T, 2016, STROKE, V47, P3035, DOI 10.1161/STROKEAHA.116.015228; Heck DV, 2014, J NEUROINTERV SURG, P1; HEDNER U, 1978, BLOOD, V51, P157; Hellstern P, 2002, THROMB RES, V107, pS3, DOI 10.1016/S0049-3848(02)00145-7; Hitchcock KE, 2011, ULTRASOUND MED BIOL, V37, P1240, DOI 10.1016/j.ultrasmedbio.2011.05.011; Holland CK, 2008, THROMB RES, V121, P663, DOI 10.1016/j.thromres.2007.07.006; Jadhav S, 2007, CURR PHARM DESIGN, V13, P1511, DOI 10.2174/138161207780765909; Jahan R, 2010, AM J NEURORADIOL, V31, P1938, DOI 10.3174/ajnr.A2169; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Kandadai MA, 2015, TRANSL STROKE RES, V6, P78, DOI 10.1007/s12975-014-0376-4; Kim EY, 2006, NEUROLOGY, V67, P1846, DOI 10.1212/01.wnl.0000244492.99737.a8; Laing ST, 2012, THROMB RES, V130, P629, DOI 10.1016/j.thromres.2011.11.010; Landskroner K, 2005, J VASC INTERV RADIOL, V16, P369, DOI 10.1097/01.RVI.0000148828.40438.D3; Lewis J.H., 1996, COMP HEMOSTASIS VERT; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Linfante I, 2002, STROKE, V33, P2066, DOI 10.1161/01.STR.0000021001.18101.A5; Marder VJ, 2006, STROKE, V37, P2086, DOI 10.1161/01.STR.0000230307.03438.94; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Meunier JM, 2007, ULTRASOUND MED BIOL, V33, P576, DOI 10.1016/j.ultrasmedbio.2006.10.010; Moore HB, 2015, J AM COLL SURGEONS, V220, P872, DOI 10.1016/j.jamcollsurg.2015.01.026; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mutch NJ, 2010, J THROMB HAEMOST, V8, P2017, DOI 10.1111/j.1538-7836.2010.03963.x; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Postert T, 1997, ULTRASOUND MED BIOL, V23, P857, DOI 10.1016/S0301-5629(97)00047-1; Ringer AJ, 2004, AM J NEURORADIOL, V25, P329; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Shaw GJ, 2007, PHYS MED BIOL, V52, P2953, DOI 10.1088/0031-9155/52/11/002; Shaw George J, 2009, BMC Res Notes, V2, P117, DOI 10.1186/1756-0500-2-117; Shaw GJ, 2009, THROMB RES, V124, P306, DOI 10.1016/j.thromres.2009.01.008; Shaw GJ, 2006, THROMB RES, V117, P603, DOI 10.1016/j.thromres.2005.05.005; Shimizu J, 2012, ULTRASOUND MED BIOL, V38, P1040, DOI 10.1016/j.ultrasmedbio.2012.02.009; Singh P, 2013, STROKE, V44, P1720, DOI 10.1161/STROKEAHA.113.000964; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Suarez JI, 1999, STROKE, V30, P2094, DOI 10.1161/01.STR.30.10.2094; Suchkova VN, 2000, CIRCULATION, V101, P2296, DOI 10.1161/01.CIR.101.19.2296; Sutton JT, 2013, EXPERT OPIN DRUG DEL, V10, P573, DOI 10.1517/17425247.2013.772578; Sutton JT, 2013, ULTRASOUND MED BIOL, V39, P813, DOI 10.1016/j.ultrasmedbio.2012.12.008; TANSWELL P, 1991, ARZNEIMITTELFORSCH, V41-2, P1310; Tsivgoulis G, 2010, STROKE, V41, P280, DOI 10.1161/STROKEAHA.109.563304; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Wijnhoud AD, 2008, ULTRASOUND MED BIOL, V34, P923, DOI 10.1016/j.ultrasmedbio.2007.11.022; Zaidat OO, 2013, NEUROLOGY, V81, P305, DOI 10.1212/WNL.0b013e31829ce1f2; ZIVIN JA, 1985, SCIENCE, V230, P1289, DOI 10.1126/science.3934754	68	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177786	10.1371/journal.pone.0177786	http://dx.doi.org/10.1371/journal.pone.0177786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545055	gold, Green Submitted, Green Published			2022-12-27	WOS:000401487700077
J	Choi, JM; Kim, SG; Kim, J; Han, SJ; Park, JY; Oh, S; Im, JP; Kim, JS; Kim, WH; Jung, HC				Choi, Ji Min; Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Park, Jae Yong; Oh, Sooyeon; Im, Jong Pil; Kim, Joo Sung; Kim, Woo Ho; Jung, Hyun Chae			Clinical implications of pre-existing adenoma in endoscopically resected early gastric cancers	PLOS ONE			English	Article							HELICOBACTER-PYLORI; MOLECULAR-BIOLOGY; EPIDEMIOLOGY; CARCINOMA; CARCINOGENESIS; PREDICTORS; RISK	Background Although gastric adenoma is widely accepted as a precursor of gastric cancer, pre-existing adenoma is not always detected in gastric cancer patients. Objective To investigate the clinical characteristics of early gastric cancer (EGC) arising from adenoma, compared with those of EGC without pre-existing adenoma. Methods Patients who underwent endoscopic resection for EGC at a single tertiary hospital were divided into two groups based on the presence (ex-adenoma group) or absence (de novo group) of pre-existing adenoma on pathologic specimens. Clinicopathologic characteristics, endoscopic features and long-term outcomes were analyzed. Results Of 1,509 patients, 236 (15.6%) were included in the ex-adenoma group. Mean age (P = 0.003) and Helicobacter pylori infection rate (P = 0.040) were significantly higher in the ex-adenoma than in the de novo group. Mean endoscopic size was significantly larger, elevated lesions were more prevalent (both P < 0.001), and carcinomas were more differentiated in the ex-adenoma group than in the de novo group (P = 0.037). The degree of atrophy (P = 0.025) or intestinal metaplasia (P < 0.001) was more advanced in the ex-adenoma group. Synchronous gastric neoplasia was significantly more prevalent in the ex-adenoma group (P < 0.001), whereas metachronous cancer recurrence rate was not significantly different between the two groups. Conclusions EGCs with pre-existing adenoma show a greater association with H. pylori-related chronic inflammation than those without, which could explain the differences in the characteristics between groups. Potential differences in carcinogenic mechanisms between the groups were explored.	[Choi, Ji Min] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Internal Med, Healthcare Res Inst, Seoul, South Korea; [Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Park, Jae Yong; Oh, Sooyeon; Im, Jong Pil; Kim, Joo Sung; Jung, Hyun Chae] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Park, Jae Yong; Oh, Sooyeon; Im, Jong Pil; Kim, Joo Sung; Jung, Hyun Chae] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kim, Woo Ho] Seoul Natl Univ, Dept Pathol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, SG (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, SG (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	harley1333@hanmail.net		Kim, Sang Gyun/0000-0003-1799-9028	Promising-Pioneering Researcher Program through Seoul National University	Promising-Pioneering Researcher Program through Seoul National University	This work was supported by Promising-Pioneering Researcher Program through Seoul National University in 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Promising-Pioneering Researcher Program through Seoul National University in 2015.	[Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Chen YC, 2016, PATHOL ONCOL RES, V22, P197, DOI 10.1007/s12253-015-9996-6; Choi J, 2014, CLIN GASTROENTEROL H, V12, P793, DOI 10.1016/j.cgh.2013.09.057; Choi JM, 2016, SURG ENDOSC, V30, P89, DOI 10.1007/s00464-015-4165-2; CORREA P, 1992, CANCER RES, V52, P6735; de Vries AC, GASTROENTEROLOGY; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Jahng J, 2012, WORLD J GASTROENTERO, V18, P3571, DOI 10.3748/wjg.v18.i27.3571; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jung SJ, 2013, SURG ENDOSC, V27, P1211, DOI 10.1007/s00464-012-2577-9; Kang HY, 2006, DIGEST DIS SCI, V51, P2310, DOI 10.1007/s10620-006-9276-0; Kanno T, 2015, J GASTROEN HEPATOL, V30, P842, DOI 10.1111/jgh.12876; Karimi P, 2014, CANCER EPIDEM BIOMAR, V23, P700, DOI 10.1158/1055-9965.EPI-13-1057; Kudo M, 2001, J GASTROENTEROL, V36, P65, DOI 10.1007/s005350170157; Kushima Ryoji, 2006, Gastric Cancer, V9, P177, DOI 10.1007/s10120-006-0381-8; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee S, 2006, ONCOL REP, V16, P747; Mueller JD, 2002, VIRCHOWS ARCH, V440, P453, DOI 10.1007/s00428-002-0623-z; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PRICE AB, 1991, J GASTROEN HEPATOL, V6, P209, DOI 10.1111/j.1440-1746.1991.tb01468.x; Shin A, 2011, J GASTRIC CANCER, V11, P135, DOI 10.5230/jgc.2011.11.3.135; TAHARA E, 1995, WORLD J SURG, V19, P484, DOI 10.1007/BF00294705; Tahara Eiichi, 2004, IARC Sci Publ, P327; Tamura G, 1996, J PATHOL, V180, P371, DOI 10.1002/(SICI)1096-9896(199612)180:4<371::AID-PATH704>3.0.CO;2-2; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Yamamoto S, 2011, DIGEST DIS SCI, V56, P2354, DOI 10.1007/s10620-011-1681-3; Yang HJ, 2015, SURG ENDOSC, V29, P1145, DOI 10.1007/s00464-014-3780-7	28	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178419	10.1371/journal.pone.0178419	http://dx.doi.org/10.1371/journal.pone.0178419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542582	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800087
J	Lee, G; Oh, SW; Hwang, SS; Yoon, JW; Kang, S; Joh, HK; Kwon, H; Kim, J; Park, D				Lee, Gyeongsil; Oh, Seung-Won; Hwang, Seung-Sik; Yoon, Ji Won; Kang, Sungchan; Joh, Hee-Kyung; Kwon, Hyuktae; Kim, Jeehyun; Park, Danbee			Comparative effectiveness of oral antidiabetic drugs in preventing cardiovascular mortality and morbidity: A network meta-analysis	PLOS ONE			English	Article							COTRANSPORTER 2 INHIBITORS; GLUCOSE-LOWERING DRUGS; TYPE-2; OUTCOMES; PIOGLITAZONE; RISK; EVENTS; ATHEROSCLEROSIS; EMPAGLIFLOZIN; ROSIGLITAZONE	. In the Guidance for Industry from the Food and Drug Administration in 2008, excess cardiovascular risk should be ruled out in trials of all new antidiabetic drugs; however, relatively few studies have focused on cardiovascular safety with antidiabetic drug use. We aimed to examine mortality and cardiovascular risk using a network meta-analysis. We searched the Medline, Embase, Cochrane, and ClinicalTrials. gov registry databases in March 2016 to identify randomized controlled trials reporting cardiovascular risk with the following oral antidiabetic drugs: metformin, sulfonylureas, thiazolidinedione (TZD), dipeptidyl peptidase-4 (DPP4) inhibitors, and sodium-glucose co-transporter-2 (SGLT2) inhibitors. We assessed the differences in the risks of all-cause mortality, cardiovascular-related mortality, acute coronary syndrome (ACS), and myocardial infarction (MI) among antidiabetic drugs with fixed effect models for direct pairwise comparisons and Bayesian network meta-analyses to integrate direct and indirect comparisons. Of the 101,183 patients in 73 randomized controlled trials, 3,434 (3.4%) died. The relative risks of all-cause mortality with SGLT2 inhibitor use were 0.68 (95% credible interval: 0.57-0.80), 0.74 (0.49-1.10), 0.63 (0.46-0.87), 0.71 (0.55-0.90), and 0.65 (0.54-0.78), compared with placebo, metformin, sulfonylurea, TZD, and DPP4 inhibitor, respectively. The relative risks of cardiovascular-related mortality with SGLT2 inhibitor use were 0.61 (0.50-0.76), 0.81(0.36-1.90), 0.52(0.31-0.88), 0.66(0.49- 0.91), and 0.61(0.48-0.77), compared with placebo, metformin, sulfonylurea, TZD, and DPP4 inhibitor, respectively. The relative risks of ACS with SGLT2 inhibitor use was consistent with that of all-cause mortality. SGLT2 inhibitor use was associated with a lower risk of ACS than the other OADs and placebo. The relative risks of MI with SGLT2 inhibitor use were 0.77 (0.63-0.93) and 0.75 (0.60-0.94), compared with placebo and DPP4 inhibitor, respectively. The currently available data provide the evidence of cardiovascular benefit from use of SGLT2 inhibitors to patients with type 2 diabetes, although additional results from ongoing studies will be pivotal.	[Lee, Gyeongsil; Kwon, Hyuktae; Kim, Jeehyun; Park, Danbee] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Oh, Seung-Won] Seoul Natl Univ Hosp, Dept Family Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea; [Hwang, Seung-Sik; Kang, Sungchan] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea; [Yoon, Ji Won] Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea; [Joh, Hee-Kyung] Seoul Natl Univ, Hlth Serv Ctr, Dept Med, Coll Med,Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Oh, SW (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea.	sw.oh@snu.ac.kr	Kwon, Hyuktae/C-4286-2013; Oh, Seung-Won/GLS-0494-2022	Kwon, Hyuktae/0000-0002-0312-3650; Joh, Hee-Kyung/0000-0003-3854-7012; Lee, Gyeongsil/0000-0003-1910-9658	Seoul National University Hospital Research Fund [23-2015-0160]; SNUH Research Fund [23-2015-0160]	Seoul National University Hospital Research Fund; SNUH Research Fund	This research was supported by grant no. 23-2015-0160 from the Seoul National University Hospital Research Fund.; This research was supported by grant no. 23-2015-0160 from the SNUH Research Fund. We thank Seung-kwon Myung, Sang-won Lee, Heon-jae Jeong, and Si-hyuk Kang for support with the development of the analytic strategy.	Ahren B, 2007, BEST PRACT RES CL EN, V21, P517, DOI 10.1016/j.beem.2007.07.005; American Diabetes Association, 2015, CLIN DIABETES, V33, P97, DOI DOI 10.2337/DIACLIN.33.2.97; Araki E, 2015, DIABETES OBES METAB, V17, P665, DOI 10.1111/dom.12464; Ashcroft FM, 2000, J DIABETES COMPLICAT, V14, P192, DOI 10.1016/S1056-8727(00)00081-7; Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Bailey CJ, 2015, DIABETIC MED, V32, P531, DOI 10.1111/dme.12624; BRADBURN MJ, 1998, META ANAL STATA, P3; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chiquette E, 2004, ARCH INTERN MED, V164, P2097, DOI 10.1001/archinte.164.19.2097; Clemens KK, 2015, CAN J DIABETES, V39, P308, DOI [10.1016/j.jcjd.2015.09.087, 10.1016/j.jcjd.2015.01.001]; Cornell JE, 2015, ANN INTERN MED, V162, P797, DOI 10.7326/M15-0930; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Ferrannini E, 2015, EUR HEART J, V36, P2288, DOI 10.1093/eurheartj/ehv239; Food and Drug Administration, 2008, GUID IND DIAB MELL E; Foote C, 2012, DIABETES VASC DIS RE, V9, P117, DOI 10.1177/1479164112441190; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Higgins J. P., 2012, BMJ-BRIT MED J, V343, pd5928; Hong J, 2013, DIABETES CARE, V36, P1304, DOI 10.2337/dc12-0719; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kumar R, 2016, EUR HEART J-CARD PHA, V2, P32, DOI 10.1093/ehjcvp/pvv035; Landstedt-Hallin L, 1999, J INTERN MED, V246, P299, DOI 10.1046/j.1365-2796.1999.00528.x; Maruthur NM, 2016, ANN INTERN MED, V164, P740, DOI 10.7326/M15-2650; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Nair S, 2010, J CLIN ENDOCR METAB, V95, P34, DOI 10.1210/jc.2009-0473; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Palmer SC, 2016, JAMA-J AM MED ASSOC, V316, P313, DOI 10.1001/jama.2016.9400; Saremi A, 2013, ARTERIOSCL THROM VAS, V33, P393, DOI 10.1161/ATVBAHA.112.300346; Scheen AJ, 2013, NAT REV CARDIOL, V10, P73, DOI 10.1038/nrcardio.2012.183; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Simpson SH, 2015, LANCET DIABETES ENDO, V3, P43, DOI 10.1016/S2213-8587(14)70213-X; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Valkenhoef G, 2012, RES SYNTH METHODS, V3, P285, DOI 10.1002/jrsm.1054; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; White IR, 2015, STATA J, V15, P951, DOI 10.1177/1536867X1501500403; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wu JHY, 2016, LANCET DIABETES ENDO, V4, P411, DOI 10.1016/S2213-8587(16)00052-8; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	42	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177646	10.1371/journal.pone.0177646	http://dx.doi.org/10.1371/journal.pone.0177646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542373	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800020
J	Nishio, M; Nakane, K; Kubo, T; Yakami, M; Emoto, Y; Nishio, M; Togashi, K				Nishio, Mizuho; Nakane, Kazuaki; Kubo, Takeshi; Yakami, Masahiro; Emoto, Yutaka; Nishio, Mari; Togashi, Kaori			Automated prediction of emphysema visual score using homology-based quantification of low-attenuation lung region	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; PULMONARY-EMPHYSEMA; PERSISTENT HOMOLOGY; CT; CANCER; MODES; CLASSIFICATION; RISK; COPD; DNA	Objective The purpose of this study was to investigate the relationship between visual score of emphysema and homology-based emphysema quantification (HEQ) and evaluate whether visual score was accurately predicted by machine learning and HEQ. Materials and methods A total of 115 anonymized computed tomography images from 39 patients were obtained from a public database. Emphysema quantification of these images was performed by measuring the percentage of low-attenuation lung area (LAA%). The following values related to HEQ were obtained: nb(0) and nb(1). LAA% and HEQ were calculated at various threshold levels ranging from -1000 HU to -700 HU. Spearman's correlation coefficients between emphysema quantification and visual score were calculated at the various threshold levels. Visual score was predicted by machine learning and emphysema quantification (LAA% or HEQ). Random Forest was used as a machine learning algorithm, and accuracy of prediction was evaluated by leave-one-patient-out cross validation. The difference in the accuracy was assessed using McNemar's test. Results The correlation coefficients between emphysema quantification and visual score were as follows: LAA% (-950 HU), 0.567; LAA% (-910 HU), 0.654; LAA% (-875 HU), 0.704; nb(0) (-950 HU), 0.552; nb(0) (-910 HU), 0.629; nb(0) (-875 HU), 0.473; nb(1) (-950 HU), 0.149; nb(1) (-910 HU), 0.519; and nb(1) (-875 HU), 0.716. The accuracy of prediction was as follows: LAA%, 55.7% and HEQ, 66.1%. The difference in accuracy was statistically significant (p = 0.0290). Conclusion LAA% and HEQ at -875 HU showed a stronger correlation with visual score than those at -910 or -950 HU. HEQ was more useful than LAA% for predicting visual score.	[Nishio, Mizuho; Kubo, Takeshi; Yakami, Masahiro; Togashi, Kaori] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Kyoto, Japan; [Nishio, Mizuho; Yakami, Masahiro] Kyoto Univ Hosp, Preempt Med & Lifestyle Dis Res Ctr, Kyoto, Kyoto, Japan; [Nakane, Kazuaki] Osaka Univ, Dept Mol Pathol, Grad Sch Med & Hlth Sci, Suita, Osaka, Japan; [Emoto, Yutaka] Kyoto Coll Med Sci, Dept Med Sci, Nantan, Kyoto, Japan; [Nishio, Mari] Kobe Univ, Dept Pathol, Grad Sch Med, Kobe, Hyogo, Japan	Kyoto University; Kyoto University; Osaka University; Kobe University	Nishio, M (corresponding author), Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Kyoto, Japan.; Nishio, M (corresponding author), Kyoto Univ Hosp, Preempt Med & Lifestyle Dis Res Ctr, Kyoto, Kyoto, Japan.	nmizuho@kuhp.kyoto-u.ac.jp	Nishio, Mari/C-9322-2016; Nishio, Mizuho/ACC-0897-2022	Nishio, Mari/0000-0002-7413-0751; 	JSPS KAKENHI [26310209, JP16K19883]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by both JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (Grant Number 26310209) and JSPS KAKENHI (Grant Number JP16K19883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock A, 2014, COMPUT VIS IMAGE UND, V121, P36, DOI 10.1016/j.cviu.2013.10.014; Bankier AA, 1999, RADIOLOGY, V211, P851, DOI 10.1148/radiology.211.3.r99jn05851; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Edelsbrunner H, 2008, CONTEMP MATH, V453, P257; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Ishida Masayuki, 2015, Advanced Materials Research, V1102, P59, DOI 10.4028/www.scientific.net/AMR.1102.59; Kusano G, 2016, PR MACH LEARN RES, V48; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu B, 2016, BIOINFORMATICS, V32, P2411, DOI 10.1093/bioinformatics/btw186; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Nakane K, 2014, MATER RES INNOV, V18, P33, DOI 10.1179/1432891713Z.000000000353; Nakane K., 2013, DIAGN PATHOL S1, V8, pS27, DOI 10.1186/1746-1596-8-S1-S27; Nakane K, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0244-x; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nishio M, ACAD RADIOL IN PRESS; Nishio M, 2016, INT J CHRONIC OBSTR, V11, P2125, DOI 10.2147/COPD.S110504; Qaiser T, 2016, PROCEDIA COMPUT SCI, V90, P119, DOI 10.1016/j.procs.2016.07.033; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Schwartz AG, 2016, CANC EPIDEMIOL BIOMA; Smith BM, 2012, LUNG CANCER, V77, P58, DOI 10.1016/j.lungcan.2012.02.019; Sorensen L, 2010, IEEE T MED IMAGING, V29, P559, DOI 10.1109/TMI.2009.2038575; Wang ZM, 2013, EUR RADIOL, V23, P975, DOI 10.1007/s00330-012-2683-z; Wille MMW, 2016, EUR RADIOL, V26, P487, DOI 10.1007/s00330-015-3826-9	31	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178217	10.1371/journal.pone.0178217	http://dx.doi.org/10.1371/journal.pone.0178217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542398	gold, Green Submitted, Green Published			2022-12-27	WOS:000402062800056
J	Niyangoda, C; Miti, T; Breydo, L; Uversky, V; Muschol, M				Niyangoda, Chamani; Miti, Tatiana; Breydo, Leonid; Uversky, Vladimir; Muschol, Martin			Carbonyl-based blue autofluorescence of proteins and amino acids	PLOS ONE			English	Article							LASER-INDUCED FLUORESCENCE; INTRINSIC FLUORESCENCE; VISIBLE FLUORESCENCE; PHOSPHORESCENCE; POLYPEPTIDES; TRANSITIONS; EXCITATION; ACETONE; STATE	Intrinsic protein fluorescence is inextricably linked to the near-UV autofluorescence of aromatic amino acids. Here we show that a novel deep-blue autofluorescence (dbAF), previously thought to emerge as a result of protein aggregation, is present at the level of monomeric proteins and even poly- and single amino acids. Just as its aggregation-related counterpart, this autofluorescence does not depend on aromatic residues, can be excited at the long wavelength edge of the UV and emits in the deep blue. Differences in dbAF excitation and emission peaks and intensities from proteins and single amino acids upon changes in solution conditions suggest dbAF's sensitivity to both the chemical identity and solution environment of amino acids. Autofluorescence comparable to dbAF is emitted by carbonyl-containing organic solvents, but not those lacking the carbonyl group. This implicates the carbonyl double bonds as the likely source for the autofluorescence in all these compounds. Using beta-lactoglobulin and proline, we have measured the molar extinction coefficients and quantum yields for dbAF in the monomeric state. To establish its potential utility in monitoring protein biophysics, we show that dbAF emission undergoes a red-shift comparable in magnitude to tryptophan upon thermal denaturation of lysozyme, and that it is sensitive to quenching by acrylamide. Carbonyl dbAF therefore provides a previously neglected intrinsic optical probe for investigating the structure and dynamics of amino acids, proteins and, by extension, DNA and RNA.	[Niyangoda, Chamani; Miti, Tatiana; Muschol, Martin] Univ S Florida, Dept Phys, Tampa, FL 33620 USA; [Breydo, Leonid; Uversky, Vladimir] USF Hlth, Dept Mol Med, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Muschol, M (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	mmuschol@usf.edu	Breydo, Leo/AAJ-7996-2020; Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857; Muschol, Martin/0000-0002-6488-0049	NIH [2R15GM097723]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM097723] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this work were supported by NIH grant 2R15GM097723.	Borisevich N. A., 2007, Journal of Applied Spectroscopy, V74, P245, DOI 10.1007/s10812-007-0038-3; Brackmann C, 2003, SPECTROCHIM ACTA A, V59, P3347, DOI 10.1016/S1386-1425(03)00163-X; Brancato G, 2008, CHEM PHYS LETT, V453, P202, DOI 10.1016/j.cplett.2008.01.045; Chan F.T.S., 2013, BIONANOIMAGING PROTE, P147, DOI [10.1016/B978-0-12-394431-3.00013-4, DOI 10.1016/B978-0-12-394431-3.00013-4]; Chan FTS, 2013, ANALYST, V138, P2156, DOI 10.1039/c3an36798c; Choudhary A, 2014, ORG LETT, V16, P3421, DOI 10.1021/ol5012967; DALTON JC, 1976, J AM CHEM SOC, V98, P398, DOI 10.1021/ja00418a013; del Mercato LL, 2007, P NATL ACAD SCI USA, V104, P18019, DOI 10.1073/pnas.0702843104; DOTY P, 1957, J POLYM SCI, V23, P851, DOI 10.1002/pol.1957.1202310429; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Foley J, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811343; Gong YY, 2013, SCI CHINA CHEM, V56, P1178, DOI 10.1007/s11426-013-4923-8; GRANT DH, 1973, J CHROMATOGR, V79, P267, DOI 10.1016/S0021-9673(01)85297-3; Guptasarma P, 2008, ARCH BIOCHEM BIOPHYS, V478, P127, DOI 10.1016/j.abb.2008.08.002; Hill SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018171; KALLMAN H, 1968, PHOTOCHEM PHOTOBIOL, V8, P65, DOI 10.1111/j.1751-1097.1968.tb05845.x; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P446; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Longworth JW, 1971, EXCITED STATES PROTE, P319; Ma HB, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4808442; MELHUISH WH, 1961, J PHYS CHEM-US, V65, P229, DOI 10.1021/j100820a009; Miti T, 2015, BIOMACROMOLECULES, V16, P326, DOI 10.1021/bm501521r; NAGASAWA M, 1964, J AM CHEM SOC, V86, P538, DOI 10.1021/ja01058a002; Parmar AS, 2007, BIOPHYS CHEM, V129, P224, DOI 10.1016/j.bpc.2007.06.002; Pinotsi D, 2016, J AM CHEM SOC, V138, P3046, DOI 10.1021/jacs.5b11012; Retailleau P, 1997, BIOPHYS J, V73, P2156, DOI 10.1016/S0006-3495(97)78246-8; Sauer M., 2011, HDB FLUORESCENCE SPE; Shukla A, 2004, ARCH BIOCHEM BIOPHYS, V428, P144, DOI 10.1016/j.abb.2004.05.007; Sizemore SM, 2015, BIOPHYS J, V109, P1038, DOI 10.1016/j.bpj.2015.07.023; Stehli D., 2015, INTRINSICALLY DISORD, V3, P1; TEALE FWJ, 1960, BIOCHEM J, V76, P381, DOI 10.1042/bj0760381; Thurber MC, 1998, APPL OPTICS, V37, P4963, DOI 10.1364/AO.37.004963; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008	33	42	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0176983	10.1371/journal.pone.0176983	http://dx.doi.org/10.1371/journal.pone.0176983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542206	Green Submitted, gold, Green Published			2022-12-27	WOS:000402062800006
J	Song, DK; Hong, YS; Sung, YA; Lee, H				Song, Do Kyeong; Hong, Young Sun; Sung, Yeon-Ah; Lee, Hyejin			Insulin resistance according to beta-cell function in women with polycystic ovary syndrome and normal glucose tolerance	PLOS ONE			English	Article							METABOLIC SYNDROME; SENSITIVITY; PREVALENCE; PCOS	Background Polycystic ovary syndrome (PCOS) is associated with insulin resistance (IR) and compensatory hyperinsulinemia. IR is recognized as a major risk factor for the development of type 2 diabetes mellitus. However, few studies have investigated IR in women with PCOS and normal glucose tolerance. The objective of this study was to evaluate IR and beta-cell function in women with PCOS and normal glucose tolerance. Additionally, we sought to evaluate the usefulness of oral glucose tolerance test (OGTT)-derived IR indices in lean women with PCOS. Methods We recruited 100 women with PCOS and normal glucose tolerance and 100 age-and BMI-matched women as controls. IR and insulin secretory indices, including the homeostasis-model assessment (HOMA)-IR, HOMA-M-120, HOMA-F and the Stumvoll index, were calculated from an OGTT. Increased beta-cell function was defined as > 75th percentile for the HOMA-F in control women. Results Women with PCOS had higher values for post-load 2-hour glucose, fasting insulin, post-load 2-hour insulin, HOMA-IR, HOMA-M120, HOMA-F and lower values for the Stumvoll index than the controls (all Ps < 0.05). Women with PCOS and increased beta-cell function showed lower Stumvoll index values than the matched controls (P < 0.05). The HOMA-F was significantly associated with the HOMA-M120 and Stumvoll index when adjusted for age and BMI in a multiple regression analysis (all Ps < 0.05). The HOMA-M120 was positively correlated with triglycerides and free testosterone, and the Stumvoll index was negatively correlated with triglycerides and free testosterone in lean women with PCOS (all Ps < 0.05). Conclusions Women with PCOS and normal glucose tolerance showed higher IR than controls matched for age, BMI, and beta-cell function. beta-cell function was increased in women with PCOS when compared to the matched controls, but not when the lean subjects were compared to the matched controls separately. Therefore, early evaluation of IR in women with PCOS and normal glucose tolerance may be needed.	[Song, Do Kyeong; Hong, Young Sun; Sung, Yeon-Ah; Lee, Hyejin] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea	Ewha Womans University	Lee, H (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea.	hyejinlee@ewha.ac.kr						Balen AH, 2003, HUM REPROD UPDATE, V9, P505, DOI 10.1093/humupd/dmg044; Carmina E, 2004, FERTIL STERIL, V82, P661, DOI 10.1016/j.fertnstert.2004.01.041; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Dunaif A, 2006, FERTIL STERIL, V86, pS13, DOI 10.1016/j.fertnstert.2006.04.011; Ehrmann DA, 2006, J CLIN ENDOCR METAB, V91, P48, DOI 10.1210/jc.2005-1329; Escobar-Morreale HF, 2012, HUM REPROD UPDATE, V18, P146, DOI 10.1093/humupd/dmr042; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; Hillman JK, 2014, FERTIL STERIL, V101, P530, DOI 10.1016/j.fertnstert.2013.10.055; Jensterle M, 2008, INT J GYNECOL OBSTET, V102, P137, DOI 10.1016/j.ijgo.2008.03.017; Kim JJ, 2013, OBSTET GYNECOL SCI, V56, P137, DOI DOI 10.5468/0GS.2013.56.3.137; Li WP, 2012, ENDOCR J, V59, P765, DOI 10.1507/endocrj.EJ12-0049; Manco M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092995; Morciano A, 2014, FERTIL STERIL, V102, P250, DOI 10.1016/j.fertnstert.2014.04.004; Song DY, 2014, DIABETES RES CLIN PR, V106, pS45, DOI 10.1016/S0168-8227(14)70293-1; Stepto NK, 2013, HUM REPROD, V28, P777, DOI 10.1093/humrep/des463; Sung Y-A, 2012, HANYANG MED REV, V32, P197; Tao T, 2012, INT J CLIN EXP PATHO, V5, P777; Toprak S, 2001, HORM RES, V55, P65, DOI 10.1159/000049972; Vrbikova J, 2002, DIABETES CARE, V25, P1217, DOI 10.2337/diacare.25.7.1217; Vrbikova J, 2004, J CLIN ENDOCR METAB, V89, P2942, DOI 10.1210/jc.2003-031378; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC	23	19	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178120	10.1371/journal.pone.0178120	http://dx.doi.org/10.1371/journal.pone.0178120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542421	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800045
J	Fernandez-Feijoo, CD; Carrasco, CC; Francisco, NV; Romero, JC; Lorenzo, JRF; Jimenez-Chillaron, JC; Camprubi, MC				Duran Fernandez-Feijoo, Cristina; Carrasco Carrasco, Cristina; Villalmazo Francisco, Nuria; Cebria Romero, Judit; Fernandez Lorenzo, Jose Ramon; Jimenez-Chillaron, J. C.; Camprubi Camprubi, Marta			Influence of catch up growth on spatial learning and memory in a mouse model of intrauterine growth restriction	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; DEPENDENT SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; LOW-BIRTH-WEIGHT; CHILDREN BORN; HIPPOCAMPAL-NEURONS; POSTNATAL-GROWTH; MALE-RAT; INSULIN; RECEPTOR	Background Intrauterine growth restriction (IUGR) and rapid postnatal weight gain or catch up growth (CUG) increase the susceptibility to metabolic syndrome during adult life. Longitudinal studies have also revealed a high incidence of learning difficulties in children with IUGR. The aim of the present study was to investigate the effect of nutrition and CUG on learning memory in an IUGR animal model. We hypothesized that synaptic protein expression and transcription, an essential mechanism for memory consolidation, might be affected by intrauterine undernutrition. Methods IUGR was induced by 50% maternal caloric undernutrition throughout late gestation. During the suckling period, dams were either fed ad libitum or food restricted. The pups were divided into: Normal prenatal diet-Normal postnatal diet (NN), Restricted prenatal diet-Normal postnatal diet + catch up growth (RN+), Normal prenatal diet-Restricted postnatal diet (NR) and Restricted prenatal diet-Restricted postnatal diet (RR). At 4 weeks of age, memory was assessed via a water maze test. To evaluate synaptic function, 2 specific synaptic proteins (postsynaptic density-95 [PSD95], synaptophysin) as well as insulin receptors (IR) were tested by Western Blot and quantitative polymerase chain reaction (qPCR). Brain-derived neurotrophic factor and serum insulin levels were also studied. Results and conclusions The RN+ group presented a learning curve similar to the NN animals. The RR animals without CUG showed learning disabilities. PSD95 was lower in the RR group than in the NN and RN+ mice. In contrast, synaptophysin was similar in all groups. IR showed an inverse expression pattern to that of the PSD95. In conclusion, perinatal nutrition plays an important role in learning. CUG after a period of prenatal malnutrition seems to improve learning skills. The functional alterations observed might be related to lower PSD95 activity and a possible dysfunction in the hormone regulation of synaptic plasticity.	[Duran Fernandez-Feijoo, Cristina; Fernandez Lorenzo, Jose Ramon] Pediat Serv, Hosp Alvaro Cunqueiro, Vigo, Spain; [Carrasco Carrasco, Cristina; Villalmazo Francisco, Nuria; Camprubi Camprubi, Marta] Univ Barcelona, Hosp Sant Joan de Deu, Barcelona Ctr Maternal Fetal & Neonatal Med, Neonatol Serv,BCNatal, Esplugas de Llobregat, Spain; [Carrasco Carrasco, Cristina; Villalmazo Francisco, Nuria; Camprubi Camprubi, Marta] Univ Barcelona, Hosp Clin, Esplugas de Llobregat, Spain; [Cebria Romero, Judit; Jimenez-Chillaron, J. C.] Inst Recerca Sant Joan de Deu, Endocrinol, Barcelona, Spain	University of Barcelona; University of Barcelona	Camprubi, MC (corresponding author), Univ Barcelona, Hosp Sant Joan de Deu, Barcelona Ctr Maternal Fetal & Neonatal Med, Neonatol Serv,BCNatal, Esplugas de Llobregat, Spain.; Camprubi, MC (corresponding author), Univ Barcelona, Hosp Clin, Esplugas de Llobregat, Spain.; Jimenez-Chillaron, JC (corresponding author), Inst Recerca Sant Joan de Deu, Endocrinol, Barcelona, Spain.	jjimenezc@fsjd.org; mcamprubic@hsjdbcn.org		Duran Fernandez-Feijoo, Cristina/0000-0002-0807-8393; Fernandez-Lorenzo, Jose Ramon/0000-0002-0559-6240	BebeDue, Santa Perpetua de Moguda, Barcelona, Spain; Premi Carmen Pedraz-SEN; BBDUE	BebeDue, Santa Perpetua de Moguda, Barcelona, Spain; Premi Carmen Pedraz-SEN; BBDUE	This work was supported by a private grant from BebeDue, Santa Perpetua de Moguda, Barcelona, Spain. This work was also supported by "Premi Carmen Pedraz-SEN". The authors confirm that the funder had no influence over the study design, content of the article, or selection of this journal.; Neonatology research was supported by BBDUE.	Akman C, 2004, EPILEPSY BEHAV, V5, P446, DOI 10.1016/j.yebeh.2004.03.008; Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112; AUSTIN KB, 1986, DEV BRAIN RES, V29, P267, DOI 10.1016/0165-3806(86)90102-1; Barker DJP, 1999, ANN MED, V31, P3, DOI 10.1080/07853890.1999.11904392; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Boersma B, 2002, HORM RES, V58, P57, DOI 10.1159/000064771; Bronzino JD, 1996, HIPPOCAMPUS, V6, P109, DOI 10.1002/(SICI)1098-1063(1996)6:2<109::AID-HIPO2>3.0.CO;2-K; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Chen MJ, 2007, CELL SIGNAL, V19, P114, DOI 10.1016/j.cellsig.2006.05.028; Corbett SS, 2007, PAEDIATR PERINAT EP, V21, P57, DOI 10.1111/j.1365-3016.2007.00783.x; Daskalakis NP, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00068; Dieni S, 2003, J NEUROBIOL, V55, P41, DOI 10.1002/neu.10194; Dou JT, 2005, LEARN MEMORY, V12, P646, DOI 10.1101/lm.88005; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Fattal-Valevski A, 2009, J CHILD NEUROL, V24, P846, DOI 10.1177/0883073808331082; Geva R, 2006, BRAIN RES, V1117, P186, DOI 10.1016/j.brainres.2006.08.004; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Ghasemi R, 2013, MOL NEUROBIOL, V47, P145, DOI 10.1007/s12035-012-8339-9; GOLDENBERG RL, 1989, AM J OBSTET GYNECOL, V161, P271, DOI 10.1016/0002-9378(89)90497-3; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Hollo O, 2002, ARCH PEDIAT ADOL MED, V156, P179, DOI 10.1001/archpedi.156.2.179; Hughes TM, 2016, BBA-MOL BASIS DIS, V1862, P983, DOI 10.1016/j.bbadis.2015.11.013; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Jain V, 2012, REV ENDOCR METAB DIS, V13, P141, DOI 10.1007/s11154-012-9216-6; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Jimenez-Chillaron JC, 2005, DIABETES, V54, P702, DOI 10.2337/diabetes.54.3.702; Jimenez-Chillaron Josep C, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P23, DOI 10.1097/MED.0b013e328013da8e; Jones RH, 2009, MOL CELL ENDOCRINOL, V297, P4, DOI 10.1016/j.mce.2008.06.020; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Latal-Hajnal B, 2003, J PEDIATR-US, V143, P163, DOI 10.1067/S0022-3476(03)00243-9; Leal G, 2015, BRAIN RES, V1621, P82, DOI 10.1016/j.brainres.2014.10.019; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; Lister JP, 2005, HIPPOCAMPUS, V15, P393, DOI 10.1002/hipo.20065; Lundgren EM, 2001, PEDIATR RES, V50, P91, DOI 10.1203/00006450-200107000-00017; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Morley R, 2004, PEDIATRICS, V113, P515, DOI 10.1542/peds.113.3.515; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muratli S, 2016, JAMA NEUROL, V73, P239, DOI 10.1001/jamaneurol.2015.3983; Murray E, 2015, BJOG-INT J OBSTET GY, V122, P1062, DOI 10.1111/1471-0528.13435; Ninan I, 2010, J NEUROSCI, V30, P8866, DOI 10.1523/JNEUROSCI.1405-10.2010; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Pattwell SS, 2012, J NEUROSCI, V32, P2410, DOI 10.1523/JNEUROSCI.5205-11.2012; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Romo Agustin, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P332; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Singhal A, 2004, CIRCULATION, V109, P1108, DOI 10.1161/01.CIR.0000118500.23649.DF; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7; Vaag A., 2006, HORMONE RES PAEDIAT, V65; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x; Varella MH, 2015, EARLY HUM DEV, V91, P491, DOI 10.1016/j.earlhumdev.2015.06.002; Vasiliadis HM, 2010, DEPRESS ANXIETY, V27, P1066, DOI 10.1002/da.20739; Zhang Y, 2013, NEUROSCIENCE, V244, P31, DOI 10.1016/j.neuroscience.2013.03.061; Zhang YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21186; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	65	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177468	10.1371/journal.pone.0177468	http://dx.doi.org/10.1371/journal.pone.0177468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542302	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500027
J	van der Hoorn, A; van Laar, PJ; Holtman, GA; Westerlaan, HE				van der Hoorn, Anouk; van Laar, Peter Jan; Holtman, Gea A.; Westerlaan, Henriette E.			Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with head and neck tumors, a systematic review and meta-analysis	PLOS ONE			English	Review							SQUAMOUS-CELL CARCINOMA; RECURRENT NASOPHARYNGEAL CARCINOMA; POSITRON-EMISSION-TOMOGRAPHY; CANCER PATIENTS; CHEMORADIOTHERAPY; FEASIBILITY; PREDICTION; THERAPY; MAP; RADIOTHERAPY	Background Novel advanced MRI techniques are investigated in patients treated for head and neck tumors as conventional anatomical MRI is unreliable to differentiate tumor from treatment related imaging changes. Purpose As the diagnostic accuracy of MRI techniques to detect tumor residual or recurrence during or after treatment is variable reported in the literature, we performed a systematic metaanalysis. Data sources Pubmed, EMBASE and Web of Science were searched from their first record to September 23 th 2014. Study selection Studies reporting diagnostic accuracy of anatomical, ADC, perfusion or spectroscopy to identify tumor response confirmed by histology or follow-up in treated patients for head and neck tumors were selected by two authors independently. Data analysis Two authors independently performed data extraction including true positives, false positives, true negatives, false negatives and general study characteristics. Meta-analysis was performed using bivariate random effect models when >= 5 studies per test were included. Data synthesis We identified 16 relevant studies with anatomical MRI and ADC. No perfusion or spectroscopy studies were identified. Pooled analysis of anatomical MRI of the primary site (11 studies, N = 854) displayed a sensitivity of 84% (95% CI 72-92) and specificity of 82% (71-89). ADC of the primary site (6 studies, N = 287) showed a pooled sensitivity of 89% (74 - 96) and specificity of 86% (69 - 94). Limitations Main limitation are the low, but comparable quality of the included studies and the variability between the studies. Conclusions The higher diagnostic accuracy of ADC values over anatomical MRI for the primary tumor location emphases the relevance to include DWI with ADC for response evaluation of treated head and neck tumor patients.	[van der Hoorn, Anouk; van Laar, Peter Jan; Westerlaan, Henriette E.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [van Laar, Peter Jan] Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Groningen, Netherlands; [Holtman, Gea A.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van der Hoorn, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands.	a.van.der.hoorn@umcg.nl	van der Hoon, Anouk/AAX-8298-2021	van der Hoorn, Anouk/0000-0003-4649-327X				Al-Shwaiheen FA, 2015, AM J OTOLARYNG, V36, P415, DOI 10.1016/j.amjoto.2015.01.024; Baer AH, 2015, AM J NEURORADIOL, V36, P757, DOI 10.3174/ajnr.A4296; Bar-Ad V, 2014, SEMIN ONCOL, V41, P798, DOI 10.1053/j.seminoncol.2014.09.018; Berrak S, 2011, ACAD RADIOL, V18, P1225, DOI 10.1016/j.acra.2011.06.009; Bhatia KSS, 2010, BRIT J RADIOL, V83, P964, DOI 10.1259/bjr/27631720; Bhatnagar P, 2013, RADIOGRAPHICS, V33, P1909, DOI 10.1148/rg.337125163; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Chan SC, 2006, EUR J NUCL MED MOL I, V33, P1032, DOI 10.1007/s00259-005-0054-6; Chawla S, 2009, FUTURE ONCOL, V5, P959, DOI [10.2217/fon.09.77, 10.2217/FON.09.77]; Chen YB, 2014, MAGN RESON IMAGING, V32, P630, DOI 10.1016/j.mri.2014.02.009; Chong VFH, 1997, RADIOLOGY, V202, P463, DOI 10.1148/radiology.202.2.9015075; Comoretto M, 2008, RADIOLOGY, V249, P203, DOI 10.1148/radiol.2491071753; Devpura S, 2014, MED PHYS, V41, DOI 10.1118/1.4870981; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Galban CJ, 2009, TRANSL ONCOL, V2, P184, DOI 10.1593/tlo.09175; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Gouhar GK, 2011, EGYPT J RADIOL NUC M, V42, P169, DOI 10.1016/j.ejrnm.2011.05.010; Hatakenaka M, 2011, INT J RADIAT ONCOL, V81, P339, DOI 10.1016/j.ijrobp.2010.05.051; HONG JS, 2013, OTOLARYNG HEAD NECK, V149, P707, DOI DOI 10.1177/0194599813496537; Hustinx R, 2010, EUR J NUCL MED MOL I, V37, P645, DOI 10.1007/s00259-009-1365-9; Hwang I, 2013, AM J NEURORADIOL, V34, P2343, DOI 10.3174/ajnr.A3603; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; King AD, 2013, AM J NEURORADIOL, V34, P1237, DOI 10.3174/ajnr.A3378; King AD, 2013, RADIOLOGY, V266, P531, DOI 10.1148/radiol.12120167; King AD, 2010, EUR RADIOL, V20, P2213, DOI 10.1007/s00330-010-1769-8; Lambrecht M, 2014, RADIOTHER ONCOL, V110, P329, DOI 10.1016/j.radonc.2013.09.023; Lell M, 2000, EUR J RADIOL, V33, P239, DOI 10.1016/S0720-048X(99)00120-5; Ljumanovic R, 2008, EUR RADIOL, V18, P2231, DOI 10.1007/s00330-008-0986-x; Maroldi R, 2014, CURR OPIN OTOLARYNGO, V22, P131, DOI 10.1097/MOO.0000000000000036; Matoba M, 2014, AM J NEURORADIOL, V35, P379, DOI 10.3174/ajnr.A3706; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mukundan Hari, 2014, Med J Armed Forces India, V70, P111, DOI 10.1016/j.mjafi.2013.12.005; Ng SH, 2010, EUR RADIOL, V20, P2229, DOI 10.1007/s00330-010-1784-9; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Ratko TA, 2014, AHRQ COMP EFFECTIVEN; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rumboldt Zoran, 2006, Curr Treat Options Oncol, V7, P23, DOI 10.1007/s11864-006-0029-2; Schindler A, 2015, CRIT REV ONCOL HEMAT, V96, P372, DOI 10.1016/j.critrevonc.2015.06.005; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sheikhbahaei S, 2015, AM J ROENTGENOL, V205, P629, DOI 10.2214/AJR.14.14166; Vandecaveye V, 2012, INT J RADIAT ONCOL, V82, P1098, DOI 10.1016/j.ijrobp.2011.02.044; Vandecaveye V, 2010, EUR RADIOL, V20, P1703, DOI 10.1007/s00330-010-1734-6; Varoquaux A, 2015, RADIOGRAPHICS, V35, P1502, DOI 10.1148/rg.2015140029; Vogel DWT, 2013, EUR RADIOL, V23, P562, DOI 10.1007/s00330-012-2596-x; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yen RF, 2003, CANCER, V98, P283, DOI 10.1002/cncr.11519; Zheng DC, 2015, J MAGN RESON IMAGING, V41, P1528, DOI 10.1002/jmri.24723	47	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177986	10.1371/journal.pone.0177986	http://dx.doi.org/10.1371/journal.pone.0177986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542474	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500049
J	Hwang, AR; Han, JH; Lim, JH; Kang, YJ; Woo, CH				Hwang, Ae-Rang; Han, Jung-Hwa; Lim, Jae Hyang; Kang, Young Jin; Woo, Chang-Hoon			Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; HEME OXYGENASE-1; NEOINTIMAL FORMATION; SIGNALING PATHWAY; ARTERIAL INJURY; CYCLE ARREST; CANCER CELLS; IN-VITRO	Advanced glycation endproduct (AGE)-induced vascular smooth muscle cell (VSMC) proliferation and reactive oxygen species (ROS) production are emerging as important mechanisms of diabetic vasculopathy, but little is known about the molecular mechanism responsible for the antioxidative effects of statins on AGEs. It has been reported that statins exert pleiotropic effects on the cardiovascular system due to decreases in AGE-induced cell proliferation, migration, and vascular inflammation. Thus, in the present study, the authors investigated the molecular mechanism by which statins decrease AGE-induced cell proliferation and VSMC migration. In cultured VSMCs, statins upregulated Nrf2-related antioxidant gene, NQO1 and HO-1, via an ERK5-dependent Nrf2 pathway. Inhibition of ERK5 by siRNA or BIX02189 (a specific ERK5 inhibitor) reduced the statin-induced upregulations of Nrf2, NQO1, and HO-1. Furthermore, fluvastatin was found to significantly increase ARE promoter activity through ERK5 signaling, and to inhibit AGE-induced VSMC proliferation and migration as determined by MTT assay, cell counting, FACS analysis, a wound scratch assay, and a migration chamber assay. In addition, AGE-induced proliferation was diminished in the presence of Ad-CA-MEK5a encoding a constitutively active mutant form of MEK5a (an upstream kinase of ERK5), whereas depletion of Nrf2 restored statin-mediated reduction of AGE-induced cell proliferation. Moreover, fluvastatin suppressed the protein expressions of cyclin D1 and Cdk4, but induced p27, and blocked VSMC proliferation by regulating cell cycle. These results suggest statin-induced activation of an ERK5-dependent Nrf2 pathway reduces VSMC proliferation and migration induced by AGEs, and that the ERK5-Nrf2 signal module be viewed as a potential therapeutic target of vasculopathy in patients with diabetes and complications of the disease.	[Hwang, Ae-Rang; Han, Jung-Hwa; Kang, Young Jin; Woo, Chang-Hoon] Yeungnam Univ, Coll Med, Dept Pharmacol, Daegu, South Korea; [Han, Jung-Hwa; Woo, Chang-Hoon] Yeungnam Univ, Coll Med, Smart Aging Convergence Res Ctr, Daegu, South Korea; [Lim, Jae Hyang] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea	Yeungnam University; Yeungnam University; Ewha Womans University	Woo, CH (corresponding author), Yeungnam Univ, Coll Med, Dept Pharmacol, Daegu, South Korea.; Woo, CH (corresponding author), Yeungnam Univ, Coll Med, Smart Aging Convergence Res Ctr, Daegu, South Korea.	changhoon_woo@yu.ac.kr		Lim, Jae Hyang/0000-0003-0972-9271	Medical Research Center Program [2015R1A5A2009124]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [NRF-2015R1D1A1A01059398]	Medical Research Center Program; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning	This research was supported by the Medical Research Center Program (2015R1A5A2009124) and Basic Science Research Program (NRF-2015R1D1A1A01059398) through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning.	Adams PD, 2001, BIOCHIM BIOPHYS ACTA, V21, pM123; Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Alegret M, 2007, TIMELY TOP MED CARDI, V18; Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519; Bierhaus A, 1997, DIABETES, V46, P1481, DOI 10.2337/diabetes.46.9.1481; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Choi HC, 2009, KOREAN J PHYSIOL PHA, V13, P309, DOI 10.4196/kjpp.2009.13.4.309; De Rosa S, 2010, CURR VASC PHARMACOL, V8, P259; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Forman HJ, 2004, FREE RADICAL BIO MED, V36, P1197, DOI 10.1016/j.freeradbiomed.2004.03.004; Fouty BW, 2003, CIRC RES, V92, P501, DOI 10.1161/01.RES.0000061180.03813.0F; Goncalves DO, 2011, BRAZ J MED BIOL RES, V44, P173, DOI 10.1590/S0100-879X2011007500001; Haendeler J, 2004, CIRCULATION, V110, P856, DOI 10.1161/01.CIR.0000138743.09012.93; Hall C, 2001, MOL CELL BIOL, V21, P1854, DOI 10.1128/MCB.21.5.1854-1865.2001; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hoque A, 2008, CANCER EPIDEM BIOMAR, V17, P88, DOI 10.1158/1055-9965.EPI-07-0531; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kim JE, 2009, BIOL PHARM BULL, V32, P1047, DOI 10.1248/bpb.32.1047; Kim M, 2012, J BIOL CHEM, V287, P40722, DOI 10.1074/jbc.M112.381509; Kim SE, 2009, EXP MOL MED, V41, P277, DOI 10.3858/emm.2009.41.4.031; Lee HH, 2010, ARCH BIOCHEM BIOPHYS, V501, P142, DOI 10.1016/j.abb.2010.06.011; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Makabe S, 2010, ATHEROSCLEROSIS, V213, P377, DOI 10.1016/j.atherosclerosis.2010.07.059; Mann GE, 2009, CURR OPIN PHARMACOL, V9, P139, DOI 10.1016/j.coph.2008.12.012; Maron DJ, 2000, AM J CARDIOL, V86, p11L; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nigro P, 2010, BLOOD, V116, P1971, DOI 10.1182/blood-2010-02-269134; Oh CJ, 2014, REDOX BIOL, V2, P855, DOI 10.1016/j.redox.2014.06.003; Pedersen TR, 2000, AM J CARDIOL, V86, P257, DOI 10.1016/S0002-9149(00)00910-3; Rao S, 1999, EXP CELL RES, V252, P211, DOI 10.1006/excr.1999.4620; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Sanchez CA, 2008, CANCER INVEST, V26, P698, DOI 10.1080/07357900701874658; Stephenson K, 2003, ARTERIOSCL THROM VAS, V23, P2027, DOI 10.1161/01.ATV.0000096394.32433.E9; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tatake RJ, 2008, BIOCHEM BIOPH RES CO, V377, P120, DOI 10.1016/j.bbrc.2008.09.087; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wassmann S, 2002, ARTERIOSCL THROM VAS, V22, P300, DOI 10.1161/hq0202.104081; Yoon SJ, 2009, EXP MOL MED, V41, P802, DOI 10.3858/emm.2009.41.11.086; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23; Zhu P, 2010, ACTA PHARMACOL SIN, V31, P1329, DOI 10.1038/aps.2010.145	48	22	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178278	10.1371/journal.pone.0178278	http://dx.doi.org/10.1371/journal.pone.0178278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542559	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058400076
J	Masschaele, D; De Ceuninck, L; Wauman, J; Defever, D; Stenner, F; Lievens, S; Peelman, F; Tavernier, J				Masschaele, Delphine; De Ceuninck, Leentje; Wauman, Joris; Defever, Dieter; Stenner, Frank; Lievens, Sam; Peelman, Frank; Tavernier, Jan			RNF41 interacts with the VPS52 subunit of the GARP and EARP complexes	PLOS ONE			English	Article							E3 UBIQUITIN-LIGASE; RETROGRADE PROTEIN COMPLEX; RECEPTOR TYROSINE KINASE; TETHERING COMPLEXES; LATE GOLGI; TRANSPORT; ERBB3; NRDP1; CYTOKINE; DEGRADATION	RNF41 (Ring Finger Protein 41) is an E3 ubiquitin ligase involved in the intracellular sorting and function of a diverse set of substrates. Next to BRUCE and Parkin, RNF41 can directly ubiquitinate ErbB3, IL-3, EPO and RARa receptors or downstream signaling molecules such as Myd88, TBK1 and USP8. In this way it can regulate receptor signaling and routing. To further elucidate the molecular mechanism behind the role of RNF41 in intracellular transport we performed an Array MAPPIT (Mammalian Protein-Protein Interaction Trap) screen using an extensive set of proteins derived from the human ORFeome collection. This paper describes the identification of VPS52, a subunit of the GARP (Golgi-Associated Retrograde Protein) and the EARP (Endosome-Associated Recycling Protein) complexes, as a novel interaction partner of RNF41. Through interaction via their coiled coil domains, RNF41 ubiquitinates and relocates VPS52 away from VPS53, a common subunit of the GARP and EARP complexes, towards RNF41 bodies.	[Masschaele, Delphine; De Ceuninck, Leentje; Wauman, Joris; Defever, Dieter; Lievens, Sam; Peelman, Frank; Tavernier, Jan] Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, Cytokine Receptor Lab, Ghent, Belgium; [Masschaele, Delphine; De Ceuninck, Leentje; Wauman, Joris; Defever, Dieter; Lievens, Sam; Peelman, Frank; Tavernier, Jan] VIB, VIB Med Biotechnol Ctr, Ghent, Belgium; [Stenner, Frank] Univ Basel, Univ Basel Hosp, Dept Oncol, Basel, Switzerland	Ghent University; Flanders Institute for Biotechnology (VIB); University of Basel	Tavernier, J (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, Cytokine Receptor Lab, Ghent, Belgium.; Tavernier, J (corresponding author), VIB, VIB Med Biotechnol Ctr, Ghent, Belgium.	jan.tavernier@vib-ugent.be	Tavernier, Jan/AAG-3636-2019; Wauman, Joris/GZL-0902-2022	Stenner, Frank/0000-0003-4541-8817	Belgian government; Belgian government (Interuniversity Attraction Poles) [P6/28, P6/3]; Research Foundation-Flanders [G.0521.12N]; ERC advanced Grant (GYRE) [340941]	Belgian government; Belgian government (Interuniversity Attraction Poles); Research Foundation-Flanders(FWO); ERC advanced Grant (GYRE)	D.M. holds an IWT grant from the Belgian government. This work was further supported by grants from the Belgian government (Interuniversity Attraction Poles Projects P6/28 and P6/36) and the Research Foundation-Flanders (Project G.0521.12N). J.T. is a recipient of an ERC advanced Grant (GYRE, #340941).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bouyain S, 2007, PROTEIN SCI, V16, P654, DOI 10.1110/ps.062700307; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Chia Pei Zhi Cheryl, 2014, F1000Prime Rep, V6, P74, DOI 10.12703/P6-74; Chou HT, 2016, NAT STRUCT MOL BIOL, V23, P761, DOI 10.1038/nsmb.3264; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; De Ceuninck L, 2013, J CELL SCI, V126, P3770, DOI 10.1242/jcs.131250; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Fasshauer D, 2003, BBA-MOL CELL RES, V1641, P87, DOI 10.1016/S0167-4889(03)00090-9; Frohlich F, 2015, ELIFE, V4, DOI 10.7554/eLife.08712; Fry WHD, 2011, MOL CELL BIOL, V31, P3009, DOI 10.1128/MCB.05105-11; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hirata T, 2015, MOL BIOL CELL, V26, P3071, DOI 10.1091/mbc.E14-11-1568; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Jing X, 2008, EXP HEMATOL, V36, P1110, DOI 10.1016/j.exphem.2008.04.001; Kim S, 2009, BIOL PSYCHIAT, V65, P425, DOI 10.1016/j.biopsych.2008.09.015; Kozakova L, 2015, CELL CYCLE, V14, P920, DOI 10.1080/15384101.2014.1000112; Lievens S, 2009, J PROTEOME RES, V8, P877, DOI 10.1021/pr8005167; Liewen H, 2005, EXP CELL RES, V306, P24, DOI 10.1016/j.yexcr.2005.01.022; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Perez-Victoria FJ, 2008, MOL BIOL CELL, V19, P2350, DOI 10.1091/mbc.E07-11-1189; Perez-Victoria FJ, 2009, MOL CELL BIOL, V29, P5251, DOI 10.1128/MCB.00495-09; Perez-Victoria FJ, 2010, MOL BIOL CELL, V21, P3386, DOI 10.1091/mbc.E10-05-0392; Perez-Victoria FJ, 2010, P NATL ACAD SCI USA, V107, P12860, DOI 10.1073/pnas.1004756107; Piper R. C., 2014, COLD SPRING HARB PER, V6, DOI [10.1101/cshperspect.a016808, DOI 10.1101/CSHPERSPECT.A016808]; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Printsev I, 2014, J BIOL CHEM, V289, P8570, DOI 10.1074/jbc.M113.527036; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Sannerud R, 2003, CURR OPIN CELL BIOL, V15, P438, DOI 10.1016/S0955-0674(03)00077-2; Schindler C, 2015, NAT CELL BIOL, V17, P639, DOI 10.1038/ncb3129; Scott CC, 2014, SEMIN CELL DEV BIOL, V31, P2, DOI 10.1016/j.semcdb.2014.03.034; Tokarev AA, 2000, LANDES BIOSCIENCE; Uyttendaele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044143; Vincent TL, 2013, BIOINFORMATICS, V29, P69, DOI 10.1093/bioinformatics/bts648; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Whyte JRC, 2002, J CELL SCI, V115, P2627; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Zhong L, 2005, J BIOL CHEM, V280, P9425, DOI 10.1074/jbc.M408955200	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178132	10.1371/journal.pone.0178132	http://dx.doi.org/10.1371/journal.pone.0178132			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542518	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400059
J	Feliciano, MAR; Uscategui, RAR; Maronezi, MC; Simoes, APR; Silva, P; Gasser, B; Pavan, L; Carvalho, CF; Canola, JC; Vicente, WRR				Rossi Feliciano, Marcus Antonio; Ramirez Uscategui, Ricardo Andres; Maronezi, Marjury Cristina; Rodrigues Simoes, Ana Paula; Silva, Priscila; Gasser, Beatriz; Pavan, Leticia; Carvalho, Cibele Figueira; Canola, Julio Carlos; Russiano Vicente, Wilter Ricardo			Ultrasonography methods for predicting malignancy in canine mammary tumors	PLOS ONE			English	Article							CONTRAST-ENHANCED ULTRASOUND; BREAST-LESIONS; POWER DOPPLER; DIFFERENTIAL-DIAGNOSIS; SPECTRAL DOPPLER; COLOR DOPPLER; B-MODE; BENIGN; ELASTOGRAPHY; TISSUE	The aim of this study was to evaluate and compare the efficacy of B-mode, Doppler, contrast- enhanced ultrasonography (CEUS), and Acoustic Radiation Force Impulse (ARFI) elastography in predicting malignancy in canine mammary masses. This was a prospective cohort study from 2014 to 2016, which included 153 bitches with one or more mammary masses. A total of 300 masses were evaluated by ultrasonography (B-mode, Doppler, CEUS, and ARFI) and subsequently classified as benign or malignant by histopathology. Each ultrasound parameters studied were compared between benign and malignant masses by Chi-square or Student tests and differences were considered significant when P < 0.01. For the variables that proved significant differences were estimated the cut-off point, sensitivity, specificity, accuracy, and area under curve (AUC) by receiver-operating characteristic curve (ROC) analysis in a logistic regression model using histopathological classification as reference, to assess and compare diagnostic performance of each technique. Out of 300 mammary masses evaluated 246 were classified as malignant and 54 as benign. B-mode measurements showed sensitivity 67.9%, and specificity 67.6% as malignancy predictors on canine mammary masses; Doppler indexes systolic (> 21.2 m/s) and diastolic velocity (> 4.8 m/s) sensitivity 79.2% and specificity 70.8%; CEUS wash-out time (< 80.5 s) sensitivity 80.2% and specificity 16.7%; and ARFI elastography shear velocity (SWV > 2.57 m/s) sensitivity 94.7% and specificity 97.2% In conclusion B-mode and Doppler ultrasound evaluations may assist in malignancy prediction of canine mammary masses with moderate sensitivity and specificity, already the SWV was an great accurate predictor. Therefore, ARFI elastography exam inclusion in veterinary clinic oncology and research is highly recommended, since it allows fast, non-invasive, and complication-free malignancy prediction of canine mammary masses.	[Rossi Feliciano, Marcus Antonio; Rodrigues Simoes, Ana Paula; Gasser, Beatriz; Pavan, Leticia; Russiano Vicente, Wilter Ricardo] Univ Estadual Paulista, UNESP, Dept Anim Reprod, Sch Agr Sci & Vet Med, Campus Jaboticabal, Jaboticabal, SP, Brazil; [Ramirez Uscategui, Ricardo Andres; Maronezi, Marjury Cristina; Silva, Priscila; Carvalho, Cibele Figueira; Canola, Julio Carlos] Univ Estadual Paulista, UNESP, Dept Vet Clin & Surg, Sch Agr Sci & Vet Med, Campus Jaboticabal, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Feliciano, MAR (corresponding author), Univ Estadual Paulista, UNESP, Dept Anim Reprod, Sch Agr Sci & Vet Med, Campus Jaboticabal, Jaboticabal, SP, Brazil.	marcusfeliciano@yahoo.com.br	Feliciano, Marcus Antonio Rossi/S-9666-2019; Carvalho, C/M-6912-2019; Maronezi, Marjury Cristina/Q-7917-2019; Maronezi, Marjury/X-3699-2018; Feliciano, Marcus Antônio Rossi MAR/S-5343-2016; Vicente, Wilter R R/J-4984-2012; Uscategui, Ricardo Andres Ramirez/K-9407-2017	Feliciano, Marcus Antonio Rossi/0000-0003-4373-6539; Maronezi, Marjury Cristina/0000-0001-9039-1751; Maronezi, Marjury/0000-0001-9039-1751; Feliciano, Marcus Antônio Rossi MAR/0000-0003-4373-6539; Vicente, Wilter R R/0000-0001-7696-0962; Uscategui, Ricardo Andres Ramirez/0000-0002-9760-8631	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/16635-2, 2013/06443-1 - MARF 2014/15117-3 - LP, 2013/06443-1, 2014/15117-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br) Research grant and young researcher award: processes 2012/16635-2; 2013/06443-1 - MARF 2014/15117-3 - LP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Fundacao de Amparo a Pesquisa do Estado de Sao Paulo hitp://www.fapesp.br for the financial support provided as well as Research grant and young researcher award: processes 2012/16635-2; 2013/06443-1 to MARF and 2014/15117-3 to LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastan A, 2009, KAFKAS UNIV VET FAK, V15, P81; Calas Maria Julia Gregorio, 2007, Radiol Bras, V40, P1, DOI 10.1590/S0100-39842007000100003; Cassali G. D., 2014, Brazilian Journal of Veterinary Pathology, V7, P38; Choi HY, 1999, CLIN IMAG, V23, P284, DOI 10.1016/S0899-7071(99)00152-7; Davoudi Y, 2014, J MED ULTRASOUND, V22, P92, DOI 10.1016/j.jmu.2013.12.001; DOCK W, 1991, RADIOLOGY, V181, P241, DOI 10.1148/radiology.181.1.1887039; Feliciano MAR, 2014, J SMALL ANIM PRACT, V55, P504, DOI 10.1111/jsap.12256; Feliciano MAR, 2012, ARQ BRAS MED VET ZOO, V64, P1094, DOI 10.1590/S0102-09352012000500002; Feliciano MAR, 2012, J SMALL ANIM PRACT, V53, P332, DOI 10.1111/j.1748-5827.2012.01227.x; Gokhale Sudheer, 2009, Indian J Radiol Imaging, V19, P242, DOI 10.4103/0971-3026.54878; Gong JJ, 2016, INT J CLIN EXP MED, V9, P8108; Ishii Masahiro, 1993, Nippon Acta Radiologica, V53, P1141; Jensen-Jarolim E, 2015, CANCER IMMUNOL IMMUN, V64, P531, DOI 10.1007/s00262-015-1684-6; Jin ZQ, 2012, CLIN BREAST CANCER, V12, P420, DOI 10.1016/j.clbc.2012.07.007; Lee SW, 2002, J CLIN ULTRASOUND, V30, P459, DOI 10.1002/jcu.10100; Li GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076322; Liberman L, 2003, AM J ROENTGENOL, V181, P519, DOI 10.2214/ajr.181.2.1810519; Liu BX, 2016, J MED ULTRASON, V43, P47, DOI 10.1007/s10396-015-0658-9; Liu H, 2008, BREAST, V17, P532, DOI 10.1016/j.breast.2008.04.004; Masciadri N, 2011, J Ultrasound, V14, P55, DOI 10.1016/j.jus.2011.03.002; Meng W, 2011, ULTRASOUND MED BIOL, V37, P1436, DOI 10.1016/j.ultrasmedbio.2011.05.022; Misdrop W, 1999, HISTOLOGICAL CLASSIF; Murad Moazzam, 2004, J Coll Physicians Surg Pak, V14, P166; Nyman HT, 2006, AM J VET RES, V67, P985, DOI 10.2460/ajvr.67.6.985; Paulinelli RR, 2005, J ULTRAS MED, V24, P635, DOI 10.7863/jum.2005.24.5.635; PETERSENGL C, 1995, BRIT J CANCER, V71, P137, DOI 10.1038/bjc.1995.28; Raza S, 2010, J ULTRAS MED, V29, P551, DOI 10.7863/jum.2010.29.4.551; Ricci P, 2014, EUR J RADIOL, V83, P429, DOI 10.1016/j.ejrad.2013.05.007; Schmillevitch Joel, 2009, Radiol Bras, V42, P241, DOI 10.1590/S0100-39842009000400010; Schroeder RJ, 2003, EUR RADIOL, V13, P68, DOI 10.1007/s00330-002-1413-3; Soler M, 2016, RES VET SCI, V107, P141, DOI 10.1016/j.rvsc.2016.05.015; Tagawa M, 2016, J VET MED SCI, V78, P521, DOI 10.1292/jvms.15-0456; Tang L, 2015, INT J CLIN EXP MED, V8, P10920; Thomas A, 2010, ACAD RADIOL, V17, P558, DOI 10.1016/j.acra.2009.12.006; Tozaki M, 2011, EUR J RADIOL, V80, pE182, DOI 10.1016/j.ejrad.2011.05.020; Visan Simona, 2016, Clujul Med, V89, P38, DOI 10.15386/cjmed-519; Wan CF, 2012, EUR J RADIOL, V81, pE444, DOI 10.1016/j.ejrad.2011.03.094; Wang YM, 2016, EUR J RADIOL, V85, P48, DOI 10.1016/j.ejrad.2015.10.017; Wojcinski S, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-47; Xia HS, 2014, EUR RADIOL, V24, P3178, DOI 10.1007/s00330-014-3375-7; Yao MH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/142504; Zhou JQ, 2014, EUR RADIOL, V24, P1659, DOI 10.1007/s00330-014-3152-7; Zhou JQ, 2013, J ULTRAS MED, V32, P285	43	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178143	10.1371/journal.pone.0178143	http://dx.doi.org/10.1371/journal.pone.0178143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542533	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400060
J	Braster, R; Grewal, S; Visser, R; Einarsdottir, HK; van Egmond, M; Vidarsson, G; Bogels, M				Braster, Rens; Grewal, Simran; Visser, Remco; Einarsdottir, Helga K.; van Egmond, Marjolein; Vidarsson, Gestur; Bogels, Marijn			Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice	PLOS ONE			English	Article							BROWN LOCUS PROTEIN; EFFECTOR FUNCTIONS; IN-VIVO; NEISSERIA-MENINGITIDIS; CHIMERIC ANTIBODIES; CELL-SURFACE; RED-CELLS; COMPLEMENT; SUBCLASSES; RITUXIMAB	Background Current anti-cancer therapeutic antibodies that are used in the clinic are predominantly humanized or fully human immunoglobulin G1 (IgG1). These antibodies bind with high affinity to the target antigen and are efficient in activating the immune system via IgG Fc receptors and/or complement. In addition to IgG1, three more isotypes are present in humans, of which IgG3 has been found to be superior compared to human IgG1 in inducing antibody dependent cell cytotoxicity (ADCC), phagocytosis or activation of complement in some models. Nonetheless, no therapeutic human IgG3 mAbs have been developed due to the short in vivo half-life of most known IgG3 allotypes. In this manuscript, we compared the efficacy of V-gene matched IgG1 and IgG3 anti-tumour mAb (TA99) in mice, using natural variants of human IgG3 with short-or long half-life, differing only at position 435 with an arginine or histidine, respectively. Results In vitro human IgG1 and IgG3 did not show any differences in opsonisation ability of B16F10-gp75 mouse melanoma cells. IgG1, however, was superior in inducing phagocytosis of tumour cells by mouse macrophages. Similarly, in a mouse peritoneal metastasis model we did not detect an improved effect of IgG3 in preventing tumour outgrowth. Moreover, replacing the arginine at position 435 for a histidine in IgG3 to enhance half-life did not result in better suppression of tumour outgrowth compared to wild type IgG3 when injected prior to tumour cell injection. Conclusion In conclusion, human IgG3 does not have improved therapeutic efficacy compared to human IgG1 in a mouse tumour model.	[Braster, Rens; Grewal, Simran; van Egmond, Marjolein; Bogels, Marijn] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Grewal, Simran; van Egmond, Marjolein; Bogels, Marijn] Vrije Univ Amsterdam, Med Ctr, Dept Surg, Amsterdam, Netherlands; [Visser, Remco; Einarsdottir, Helga K.; Vidarsson, Gestur] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunohematol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Vidarsson, G (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunohematol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.	g.vidarsson@sanquin.nl	Vidarsson, Gestur/A-9909-2009	Vidarsson, Gestur/0000-0001-5621-003X				AASE A, 1994, SCAND J IMMUNOL, V39, P581, DOI 10.1111/j.1365-3083.1994.tb03416.x; Amoroso A, 2011, FRONT BIOSCI-LANDMRK, V16, P770, DOI 10.2741/3719; BAZIN R, 1994, J IMMUNOL METHODS, V172, P209, DOI 10.1016/0022-1759(94)90108-2; Biburger M, 2014, ADV IMMUNOL, V124, P67, DOI 10.1016/B978-0-12-800147-9.00003-0; Bohlson SS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00402; Braster R, 2014, METHODS, V65, P28, DOI 10.1016/j.ymeth.2013.06.020; BROUWERS HAA, 1988, BRIT J HAEMATOL, V70, P465, DOI 10.1111/j.1365-2141.1988.tb02518.x; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chiavenna SM, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-016-0311-y; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Einarsdottir H, 2014, TRANSFUSION, V54, P665, DOI 10.1111/trf.12334; Goh YS, 2011, IMMUNOLOGY, V133, P74, DOI 10.1111/j.1365-2567.2011.03411.x; Gul N, 2014, J CLIN INVEST, V124, P812, DOI 10.1172/JCI66776; HARA I, 1995, J EXP MED, V182, P1609, DOI 10.1084/jem.182.5.1609; Hubert P, 2011, CANCER RES, V71, P5134, DOI 10.1158/0008-5472.CAN-10-4222; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; KIMURA N, 1987, EUR J IMMUNOL, V17, P1653, DOI 10.1002/eji.1830171121; Kumpel BM, 2003, CLIN EXP IMMUNOL, V132, P81, DOI 10.1046/j.1365-2249.2003.02119.x; Leoh LS, 2015, MOL IMMUNOL, V67, P407, DOI 10.1016/j.molimm.2015.07.001; Macor P, 2007, CANCER RES, V67, P10556, DOI 10.1158/0008-5472.CAN-07-1811; Melis JPM, 2015, MOL IMMUNOL, V67, P117, DOI 10.1016/j.molimm.2015.01.028; Michaelsen TE, 2009, SCAND J IMMUNOL, V70, P553, DOI 10.1111/j.1365-3083.2009.02338.x; MICHAELSEN TE, 1991, EUR J IMMUNOL, V21, P11, DOI 10.1002/eji.1830210103; Michaelsen TE, 2003, BIOCHEM SOC T, V31, P1032; Natsume A, 2008, CANCER RES, V68, P3863, DOI 10.1158/0008-5472.CAN-07-6297; Natsume A, 2009, CANCER SCI, V100, P2411, DOI 10.1111/j.1349-7006.2009.01327.x; Otten MA, 2005, J IMMUNOL, V174, P5472, DOI 10.4049/jimmunol.174.9.5472; Otten MA, 2008, J IMMUNOL, V181, P6829, DOI 10.4049/jimmunol.181.10.6829; Overdijk MB, 2012, J IMMUNOL, V189, P3430, DOI 10.4049/jimmunol.1200356; Patel D, 2008, ANTICANCER RES, V28, P2679; Perri D, 2008, TRANSFUS APHER SCI, V39, P37, DOI 10.1016/j.transci.2008.05.010; Phipps C, 2015, THER ADV HEMATOL, V6, P120, DOI 10.1177/2040620715572295; Racila E, 2008, CLIN CANCER RES, V14, P6697, DOI 10.1158/1078-0432.CCR-08-0745; Recke A, 2010, J AUTOIMMUN, V34, P435, DOI 10.1016/j.jaut.2009.11.003; Rosner T, 2013, BRIT J HAEMATOL, V161, P282, DOI 10.1111/bjh.12209; Rogers LM, 2014, IMMUNOL RES, V59, P203, DOI 10.1007/s12026-014-8542-z; ROZSNYAY Z, 1989, IMMUNOLOGY, V66, P491; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Sesarman A, 2010, CELL MOL LIFE SCI, V67, P2533, DOI 10.1007/s00018-010-0318-6; Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608; Takechi Y, 1996, CLIN CANCER RES, V2, P1837; Te Velde AA, 1992, J IMMUNOL, V149; Tebo AE, 2002, CLIN EXP IMMUNOL, V130, P300, DOI 10.1046/j.1365-2249.2002.01972.x; van der Bij GJ, 2008, CANCER LETT, V262, P77, DOI 10.1016/j.canlet.2007.11.040; van der Bij GJ, 2010, J HEPATOL, V53, P677, DOI 10.1016/j.jhep.2010.04.023; van Spriel AB, 2003, BLOOD, V101, P253, DOI 10.1182/blood.V101.1.253; Vidarsson G, 2001, J IMMUNOL, V166, P6250, DOI 10.4049/jimmunol.166.10.6250; Vidarsson G, 2001, J IMMUNOL METHODS, V249, P245, DOI 10.1016/S0022-1759(00)00337-9; Vidarsson G, 1998, CURR OPIN INFECT DIS, V11, P271, DOI 10.1097/00001432-199806000-00002; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; VIJAYASARADHI S, 1991, EXP CELL RES, V196, P233, DOI 10.1016/0014-4827(91)90256-T; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; WIENER E, 1987, IMMUNOLOGY, V62, P401; ZHOU BK, 1993, J INVEST DERMATOL, V100, P110, DOI 10.1111/1523-1747.ep12462775	60	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177736	10.1371/journal.pone.0177736	http://dx.doi.org/10.1371/journal.pone.0177736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542406	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672600021
J	Milczarek, A; Starzynski, RR; Stys, A; Jonczy, A; Staron, R; Grzelak, A; Lipinski, P				Milczarek, Anna; Starzynski, Rafal R.; Stys, Agnieszka; Jonczy, Aneta; Staron, Robert; Grzelak, Agnieszka; Lipinski, Pawel			A drastic superoxide-dependent oxidative stress is prerequisite for the down-regulation of IRP1: Insights from studies on SOD1-deficient mice and macrophages treated with paraquat	PLOS ONE			English	Article							CELLULAR IRON HOMEOSTASIS; PROTEIN-1 GENE-EXPRESSION; DISMUTASE; PROTECTION; ACONITASE; ERYTHROPOIESIS; OVEREXPRESSION; METABOLISM; MODULATION; ACTIVATION	Iron regulatory protein 1 (IRP1) is a cytosolic bifunctional [4Fe-4S] protein which exhibits aconitase activity or binds iron responsive elements (IREs) in untranslated regions of specific mRNA encoding proteins involved in cellular iron metabolism. Superoxide radical (O-2(.-)) converts IRP1 from a [4Fe-4S] aconitase to a [3Fe-4S] "null" form possessing neither aconitase nor trans-regulatory activity. Genetic ablation of superoxide dismutase 1 (SOD1), an antioxidant enzyme that acts to reduce O(2)(.-)concentration, revealed a new O-2(.-)-dependent regulation of IRP1 leading to the reduction of IRP1 protein level and in consequence to the diminution of IRP1 enzymatic and IRE-binding activities. Here, we attempted to establish whether developmental changes in SOD1 activity occurring in the mouse liver, impact IRP1 expression. We show no correlation between hepatic SOD1 activity and IRP1 protein level neither in pre-nor postnatal period probably because the magnitude of developmental fluctuations in SOD1 activity is relatively small. The comparison of SOD1 activity in regards to IRP1 protein level in the liver of threeSOD1 genotypes (Sod1(+/+), Sod1(+/-) and Sod1(-/-)) demonstrates that only drastic SOD1 deficiency leads to the reduction of IRP1 protein level. Importantly, we found that in the liver of fetuses lacking SOD1, IRP1 is not down-regulated. To investigate O-2(.-)-dependent regulation of IRP1 in a cellular model, we exposed murine RAW 264.7 and bone marrow-derived macrophages to paraquat, widely used as a redox cycler to stimulate O(2)(.-)production in cells. We showed that IRP1 protein level as well as aconitase and IRE-binding activities are strongly reduced in macrophages treated with paraquat. The analysis of the expression of IRP1-target genes revealed the increase in L-ferritin protein level resulting from the enhanced transcriptional regulation of the LFt gene and diminished translational repression of L-ferritin mRNA by IRP1. We propose that O-2(.-)-dependent up-regulation of this cellular protectant in paraquat-treated macrophages may counterbalance iron-related toxic effects of O-2(.-.)	[Milczarek, Anna; Starzynski, Rafal R.; Stys, Agnieszka; Jonczy, Aneta; Staron, Robert; Lipinski, Pawel] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Mol Biol, Jastrzebiec, Poland; [Grzelak, Agnieszka] Univ Lodz, Dept Mol Biophys, Lodz, Poland	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; University of Lodz	Lipinski, P (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Dept Mol Biol, Jastrzebiec, Poland.	p.lipinski@ighz.pl		, Rafal/0000-0002-7470-0507; Grzelak, Agnieszka/0000-0002-9695-6693; Jonczy, Aneta/0000-0002-4333-6853	National Center of Science (Narodowe Centrum Nauki) [2011/01/B/NZ3/00632]; National Center of Science [2011/01/B/NZ3/00632]	National Center of Science (Narodowe Centrum Nauki); National Center of Science(National Science Centre, Poland)	This work was supported by grant no. 2011/01/B/NZ3/00632 from the National Center of Science (Narodowe Centrum Nauki) (PL).; This work was supported by grant no. 2011/01/B/NZ3/00632 from the National Center of Science.	Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; BAGLEY AC, 1986, P NATL ACAD SCI USA, V83, P3189, DOI 10.1073/pnas.83.10.3189; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Bouton C, 1996, J BIOL CHEM, V271, P2300, DOI 10.1074/jbc.271.4.2300; Bouton C, 1997, J BIOL CHEM, V272, P19969, DOI 10.1074/jbc.272.32.19969; Bouton C, 2002, J BIOL CHEM, V277, P31220, DOI 10.1074/jbc.M203276200; Bouton Cecile, 2003, Sci STKE, V2003, ppe17, DOI 10.1126/stke.2003.182.pe17; BRITIGAN BE, 1992, BLOOD, V79, P699; Corasaniti MT, 1998, PHARMACOL TOXICOL, V83, P1, DOI 10.1111/j.1600-0773.1998.tb01434.x; Dimayuga FO, 2007, J NEUROIMMUNOL, V182, P89, DOI 10.1016/j.jneuroim.2006.10.003; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fukushima Tetsuhito, 2002, Environ Health Prev Med, V7, P89, DOI 10.1265/ehpm.2002.89; Gajowiak A, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmo1.2015.00082; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Gardner PR, 1997, BIOSCIENCE REP, V17, P33, DOI 10.1023/A:1027383100936; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; HASSAN HM, 1979, J BIOL CHEM, V254, P846; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lee M, 2001, J NEUROCHEM, V78, P209, DOI 10.1046/j.1471-4159.2001.00417.x; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Liochev SI, 1999, IUBMB LIFE, V48, P157, DOI 10.1080/152165499307161; MARTINS EAL, 1995, ARCH BIOCHEM BIOPHYS, V316, P128, DOI 10.1006/abbi.1995.1019; Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008; MCCORD JM, 1978, FEBS LETT, V86, P139, DOI 10.1016/0014-5793(78)80116-1; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Missirlis F, 2003, J BIOL CHEM, V278, P47365, DOI 10.1074/jbc.M307700200; Mollace V, 2003, NEUROSCI LETT, V335, P163, DOI 10.1016/S0304-3940(02)01168-0; Mueller S, 2001, J BIOL CHEM, V276, P23192, DOI 10.1074/jbc.M100654200; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Oliveira L, 2000, P NATL ACAD SCI USA, V97, P6550, DOI 10.1073/pnas.120571797; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Patterson AJ, 2010, CURR MOL MED, V10, P653; PHILPOTT CC, 1994, P NATL ACAD SCI USA, V91, P7321, DOI 10.1073/pnas.91.15.7321; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Siggaard-Andersen O, 1995, ACTA ANAESTHESIOL S, P107129; Srinivasan C, 2000, J BIOL CHEM, V275, P29187, DOI 10.1074/jbc.M004239200; Starzynski RR, 2009, BIOCHEM J, V420, P383, DOI 10.1042/BJ20082137; Starzynski RR, 2006, BIOCHEM J, V400, P367, DOI 10.1042/BJ20060623; Starzynski RR, 2005, J BIOL CHEM, V280, P4207, DOI 10.1074/jbc.M411055200; Stys A, 2011, J BIOL CHEM, V286, P22846, DOI 10.1074/jbc.M111.231902; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016; Velayutham M, 2005, ARCH BIOCHEM BIOPHYS, V435, P83, DOI 10.1016/j.abb.2004.11.028; Volz K, 2008, CURR OPIN STRUC BIOL, V18, P106, DOI 10.1016/j.sbi.2007.12.010; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wilkinson N, 2013, BLOOD, V122, P1658, DOI 10.1182/blood-2013-03-492454	55	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0176800	10.1371/journal.pone.0176800	http://dx.doi.org/10.1371/journal.pone.0176800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542246	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672600003
J	Choi, SR; Britigan, BE; Moran, DM; Narayanasamy, P				Choi, Seoung-ryoung; Britigan, Bradley E.; Moran, David M.; Narayanasamy, Prabagaran			Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages	PLOS ONE			English	Article							IRON ACQUISITION; ARREST; 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL; METABOLISM; GALECTIN-3; INFECTION; TARGET; CELLS; RAB5	New treatments and novel drugs are required to counter the growing problem of drug-resistant strains of Mycobacterium tuberculosis (M.tb). Our approach against drug resistant M.tb, as well as other intracellular pathogens, is by targeted drug delivery using nanoformulations of drugs already in use, as well as drugs in development. Among the latter are gallium (III) (Ga)-basedcompounds. In the current work, six different types of Ga and rifampin nanoparticles were prepared in such a way as to enhance targeting of M.tb infected-macrophages. They were then tested for their ability to inhibit growth of a fully pathogenic strain (H37Rv) or a non-pathogenic strain (H37Ra) of M.tb. Encapsulating Ga in folate-or mannose-conjugated block copolymers provided sustained Ga release for 15 days and significantly inhibited M.tb growth in human monocyte-derived macrophages. Nanoformulations with dendrimers encapsulating Ga or rifampin also showed promising anti-tuberculous activity. The nanoparticles co-localized with M.tb containing phagosomes, as measured by detection of mature cathepsin D (34 kDa, lysosomal hydrogenase). They also promoted maturation of the phagosome, which would be expected to increase macrophage-mediated killing of the organism. Delivery of Ga or rifampin in the form of nanoparticles to macrophages offers a promising approach for the development of new therapeutic anti-tuberculous drugs.	[Choi, Seoung-ryoung; Britigan, Bradley E.; Moran, David M.; Narayanasamy, Prabagaran] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE 68182 USA; [Britigan, Bradley E.] Univ Nebraska, Med Ctr, Dept Internal Med, Coll Med, Omaha, NE USA; [Britigan, Bradley E.] Vet Affairs Med Ctr Nebraska Western Iowa, Res Serv, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Narayanasamy, P (corresponding author), Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE 68182 USA.	p.narayanasamy@unmc.edu	choi, seoung/AAD-6139-2019	Narayanasamy, Prabagaran/0000-0002-9617-5555	Nebraska Research Initiative; Veterans Affairs Merit Review grant; Veterans Affairs [I01BX002504, I01CX000102] Funding Source: NIH RePORTER	Nebraska Research Initiative; Veterans Affairs Merit Review grant(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a grant from the Nebraska Research Initiative to PN and a Veterans Affairs Merit Review grant to BEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the Nebraska Research Initiative to PN and a Veterans Affairs Merit Review grant to BEB.	Ahmed H, 2015, CLIN MED INSIGHTS-ON, V9, P113, DOI 10.4137/CMO.S29462; Alexander PE, 2007, CAN J INFECT DIS MED, V18, P289, DOI 10.1155/2007/986794; [Anonymous], 2012, NANOMEDICINE-UK, V7, P1294; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Britigan BE, 2000, INFECT IMMUN, V68, P1271, DOI 10.1128/IAI.68.3.1271-1275.2000; BROWN CA, 1969, NATURE, V221, P658, DOI 10.1038/221658a0; Choi SR, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02505-16, 10.1128/aac.02505-16]; Choi SR, 2017, SCI REP-UK, V7, DOI 10.1038/srep40077; Choi SR, 2016, BIOORG MED CHEM LETT, V26, P1997, DOI 10.1016/j.bmcl.2016.02.087; Choi SR, 2016, FUTURE MED CHEM, V8, P11, DOI 10.4155/fmc.15.168; Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011; de Faria TJ, 2012, ANTIMICROB AGENTS CH, V56, P2259, DOI 10.1128/AAC.05993-11; Deretic V, 1997, ELECTROPHORESIS, V18, P2542, DOI 10.1002/elps.1150181409; Dietz AB, 2000, BIOCHEM BIOPH RES CO, V275, P731, DOI 10.1006/bbrc.2000.3372; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Edagwa BJ, 2014, FASEB J, V28, P5071, DOI 10.1096/fj.14-255786; ERICKSON AH, 1989, J CELL BIOCHEM, V40, P31, DOI 10.1002/jcb.240400104; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Kalluru R, 2013, J CELL SCI, V126, P3043, DOI 10.1242/jcs.121814; Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783; Kannan RM, 2014, J INTERN MED, V276, P579, DOI 10.1111/joim.12280; Kelley VA, 2003, MOL BIOL CELL, V14, P3366, DOI 10.1091/mbc.E02-12-0780; LIU FT, 1995, AM J PATHOL, V147, P1016; Narayanasamy P., 2014, CHEM SCI J, V5; Narayanasamy P., 2015, CHEMICAL SCIENCES JO, P6; Narayanasamy P, 2008, HETEROCYCLES, V76, P243, DOI 10.3987/COM-08-S(N)72; Narayanasamy P, 2008, TETRAHEDRON LETT, V49, P4461, DOI 10.1016/j.tetlet.2008.05.074; Narayanasamy P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08824; Narayanasamy P, 2010, CHEM BIOL, V17, P117, DOI 10.1016/j.chembiol.2010.01.013; Nowacek AS, 2009, NANOMEDICINE-UK, V4, P903, DOI [10.2217/nnm.09.71, 10.2217/NNM.09.71]; Olakanmi O, 2004, INFECT IMMUN, V72, P2022, DOI 10.1128/IAI.72.4.2022-2028.2004; Olakanmi O, 2000, INFECT IMMUN, V68, P5619, DOI 10.1128/IAI.68.10.5619-5627.2000; Olakanmi O, 2013, ANTIMICROB AGENTS CH, V57, P6074, DOI 10.1128/AAC.01543-13; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Olakanmi Y, 2005, J INVEST MED, V53, P143, DOI 10.2310/6650.2005.00310; Parat A, 2015, NANOMEDICINE-UK, V10, P977, DOI [10.2217/NNM.14.196, 10.2217/nnm.14.196]; Puligujja P, 2013, NANOMED-NANOTECHNOL, V9, P1263, DOI 10.1016/j.nano.2013.05.003; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Vergne I, 2003, TRAFFIC, V4, P600, DOI 10.1034/j.1600-0854.2003.00120.x; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099	47	34	34	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177987	10.1371/journal.pone.0177987	http://dx.doi.org/10.1371/journal.pone.0177987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542623	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400127
J	Nakajima, I; Ban, Y; Azuma, A; Onoue, N; Moriguchi, T; Yamamoto, T; Toki, S; Endo, M				Nakajima, Ikuko; Ban, Yusuke; Azuma, Akifumi; Onoue, Noriyuki; Moriguchi, Takaya; Yamamoto, Toshiya; Toki, Seiichi; Endo, Masaki			CRISPR/Cas9-mediated targeted mutagenesis in grape	PLOS ONE			English	Article							VITIS-VINIFERA; GENETIC-TRANSFORMATION; BIOLISTIC TRANSFORMATION; SOMATIC EMBRYOGENESIS; PLANTS; SYSTEM; ESTABLISHMENT; REGENERATION; CULTIVARS; EMBRYOS	RNA-guided genome editing using the CRISPR/Cas9 CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) system has been applied successfully in several plant species. However, to date, there are few reports on the use of any of the current genome editing approaches in grape-an important fruit crop with a large market not only for table grapes but also for wine. Here, we report successful targeted mutagenesis in grape (Vitis vinifera L., cv. Neo Muscat) using the CRISPR/Cas9 system. When a Cas9 expression construct was transformed to embryonic calli along with a synthetic sgRNA expression construct targeting the Vitis vinifera phytoene desaturase (VvPDS) gene, regenerated plants with albino leaves were obtained. DNA sequencing confirmed that the VvPDS gene was mutated at the target site in regenerated grape plants. Interestingly, the ratio of mutated cells was higher in lower, older, leaves compared to that in newly appearing upper leaves. This result might suggest either that the proportion of targeted mutagenized cells is higher in older leaves due to the repeated induction of DNA double strand breaks (DSBs), or that the efficiency of precise DSBs repair in cells of old grape leaves is decreased.	[Nakajima, Ikuko; Ban, Yusuke; Azuma, Akifumi; Onoue, Noriyuki; Moriguchi, Takaya; Yamamoto, Toshiya] Natl Agr & Food Res Org, Inst Fruit Tree & Tea Sci, Tsukuba, Ibaraki, Japan; [Toki, Seiichi; Endo, Masaki] Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Toki, Seiichi] Yokohama City Univ, Grad Sch Nanobiosci, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, Maioka Cho, Yokohama, Kanagawa, Japan; [Ban, Yusuke] Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Nishifukatsu Cho, Fukuyama, Hiroshima, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Yokohama City University; Yokohama City University; National Agriculture & Food Research Organization - Japan	Endo, M (corresponding author), Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	mendo@affrc.go.jp	Ban, Yusuke/AAV-1326-2020; 尾上, 典之/Q-8627-2019; Toki, Seiichi/AAR-1889-2021	ONOUE, Noriyuki/0000-0001-5765-4812	Cabinet Office, Government of Japan; Cross-Ministerial Strategic Innovation Promotion Program (SIP); Bio-oriented Technology Research Advancement Institution, NARO	Cabinet Office, Government of Japan; Cross-Ministerial Strategic Innovation Promotion Program (SIP); Bio-oriented Technology Research Advancement Institution, NARO	This work was supported by the Cabinet Office, Government of Japan, Cross-Ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Bouquet A., 2011, Genetics, genomics, and breeding of grapes, P1; Bouquet A., 2008, COMPENDIUM TRANSGENI, P189, DOI DOI 10.1002/9781405181099.K0407; Boyko A, 2006, PLANT PHYSIOL, V141, P488, DOI 10.1104/pp.105.074658; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Forner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121056; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Hoshino Y, 1998, PLANT BIOTECHNOL, V15, p29 ; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Iocco P, 2001, TRANSGENIC RES, V10, P105, DOI 10.1023/A:1008989610340; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; KAWALLECK P, 1993, PLANT MOL BIOL, V21, P673, DOI 10.1007/BF00014550; Kikkert JR, 1996, PLANT CELL REP, V15, P311, DOI 10.1007/BF00232362; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; MARTINELLI L, 1994, THEOR APPL GENET, V88, P621, DOI 10.1007/BF01253963; MATSUTA N, 1989, PLANT CELL REP, V7, P684, DOI 10.1007/BF00272061; MATSUTA N, 1992, JPN J BREED, V42, P879; Mikami M, 2015, PLANT CELL REP, V34, P1807, DOI 10.1007/s00299-015-1826-5; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakajima I, 2006, J JPN SOC HORTIC SCI, V75, P188, DOI 10.2503/jjshs.75.188; Nakajima I, 2003, VITIS, V42, P53; Nakajima I, 2000, J JPN SOC HORTIC SCI, V69, P186, DOI 10.2503/jjshs.69.186; Nakano M, 1997, VITIS, V36, P141; NITSCH JP, 1969, SCIENCE, V163, P85, DOI 10.1126/science.163.3862.85; Perl A, 1996, NAT BIOTECHNOL, V14, P624, DOI 10.1038/nbt0596-624; RAJASEKARAN K, 1983, AM J ENOL VITICULT, V34, P108; Ren C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32289; SRINIVASAN C, 1980, SCI HORTIC-AMSTERDAM, V13, P245, DOI 10.1016/0304-4238(80)90062-X; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; Vidal JR, 2006, PLANT CELL REP, V25, P807, DOI 10.1007/s00299-006-0132-7; Wang YM, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0233-5; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Yamamoto T, 2000, PLANT CELL REP, V19, P639, DOI 10.1007/s002999900174; Zhou Q, 2014, PLANT CELL TISS ORG, V118, P157, DOI 10.1007/s11240-014-0471-y	35	92	97	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177966	10.1371/journal.pone.0177966	http://dx.doi.org/10.1371/journal.pone.0177966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542349	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672400122
J	O'Reilly, P; Lee, SH; O'Sullivan, M; Cullen, W; Kennedy, C; MacFarlane, A				O'Reilly, Pauline; Lee, Siew Hwa; O'Sullivan, Madeleine; Cullen, Walter; Kennedy, Catriona; MacFarlane, Anne			Assessing the facilitators and barriers of interdisciplinary team working in primary care using normalisation process theory: An integrative review	PLOS ONE			English	Review							PRIMARY-HEALTH-CARE; GENERAL-PRACTITIONERS; NURSE-PRACTITIONERS; COLLABORATIVE PRACTICE; MEDICAL PRACTITIONERS; COMMUNITY PHARMACISTS; SOCIAL-WORK; EXPERIENCES; PROFESSIONALS; SERVICES	Background Interdisciplinary team working is of paramount importance in the reform of primary care in order to provide cost-effective and comprehensive care. However, international research shows that it is not routine practice in many healthcare jurisdictions. It is imperative to understand levers and barriers to the implementation process. This review examines interdisciplinary team working in practice, in primary care, from the perspective of service providers and analyses 1 barriers and facilitators to implementation of interdisciplinary teams in primary care and 2 the main research gaps. Methods and findings An integrative review following the PRISMA guidelines was conducted. Following a search of 10 international databases, 8,827 titles were screened for relevance and 49 met the criteria. Quality of evidence was appraised using predetermined criteria. Data were analysed following the principles of framework analysis using Normalisation Process Theory (NPT), which has four constructs: sense making, enrolment, enactment, and appraisal. The literature is dominated by a focus on interdisciplinary working between physicians and nurses. There is a dearth of evidence about all NPT constructs apart from enactment. Physicians play a key role in encouraging the enrolment of others in primary care team working and in enabling effective divisions of labour in the team. The experience of interdisciplinary working emerged as a lever for its implementation, particularly where communication and respect were strong between professionals. Conclusion A key lever for interdisciplinary team working in primary care is to get professionals working together and to learn from each other in practice. However, the evidence base is limited as it does not reflect the experiences of all primary care professionals and it is primarily about the enactment of team working. We need to know much more about the experiences of the full network of primary care professionals regarding all aspects of implementation work.	[O'Reilly, Pauline] Univ Limerick, Fac Educ & Hlth Sci, Dept Nursing & Midwifery, Limerick, Ireland; [Lee, Siew Hwa; Kennedy, Catriona] Robert Gordon Univ, Sch Nursing & Midwifery, Aberdeen, Scotland; [O'Sullivan, Madeleine; MacFarlane, Anne] Univ Limerick, Fac Educ & Hlth Sci, Grad Entry Med Sch, Limerick, Ireland; [O'Sullivan, Madeleine; MacFarlane, Anne] Univ Limerick, Hlth Res Inst, Limerick, Ireland; [Cullen, Walter] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland	University of Limerick; Robert Gordon University; University of Limerick; University of Limerick; University College Dublin	O'Reilly, P (corresponding author), Univ Limerick, Fac Educ & Hlth Sci, Dept Nursing & Midwifery, Limerick, Ireland.	Pauline.OReilly@ul.ie	Cullen, Walter/AAD-4327-2019	Cullen, Walter/0000-0003-1838-5052; O'Reilly, Pauline/0000-0002-4956-4670; Lee, Siew Hwa/0000-0002-5997-004X; Kennedy, Catriona/0000-0003-3510-9113	Health Research Board [HRA_HSR/2013/343]	Health Research Board	Funded by Health Research Board HRA_HSR/2013/343.	Allan HT, 2014, HEALTH SERV RES, V49, P93, DOI 10.1111/1475-6773.12084; Altersved E, 2011, INT J NURS PRACT, V17, P174, DOI 10.1111/j.1440-172X.2011.01923.x; [Anonymous], 2008, PRIM HLTH CAR NOW MO; [Anonymous], 2010, DIAGN PHARM MAN PARK, V113; Bailey P, 2006, J ADV NURS, V53, P381, DOI 10.1111/j.1365-2648.2006.03734.x; Balasubramanian BA, 2010, ANN FAM MED, V8, P425, DOI 10.1370/afm.1159; Boon HS, 2009, J MANIP PHYSIOL THER, V32, P715, DOI 10.1016/j.jmpt.2009.10.005; Bradley F, 2008, J INTERPROF CARE, V22, P387, DOI 10.1080/13561820802137005; Cashman Suzanne, 2004, J Interprof Care, V18, P183, DOI 10.1080/13561820410001686936; Chan BC, 2010, INT J QUAL HEALTH C, V22, P519, DOI 10.1093/intqhc/mzq057; Chesluk BJ, 2010, HEALTH AFFAIR, V29, P874, DOI 10.1377/hlthaff.2009.1093; Churchman J J, 2010, Nurs Stand, V24, P42; Courtenay M, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-57; de Brun T, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1587-z; Department of Health, 2013, NAT HLTH CAR STRAT F; Department of Health, 2014, TRANSF PRIM CAR; Department of Health and Children, 2001, PRIM CAR NEW DIR; Dieleman Sherry L, 2004, J Interprof Care, V18, P75, DOI 10.1080/13561820410001639370; Donnelly C, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-60; Drew Peter, 2010, Healthc Q, V13, P33; Drummond N, 2012, CAN FAM PHYSICIAN, V58, pE450; Effective Public Health Practice Project, 2010, QU ASS TOOL QU STUD; Elissen AMJ, 2011, HEALTH SOC CARE COMM, V19, P33, DOI 10.1111/j.1365-2524.2010.00946.x; Peres CRFB, 2011, REV ESC ENFERM USP, V45, P899; Fouche C, 2013, SOC WORK HEALTH CARE, V52, P789, DOI 10.1080/00981389.2013.827147; Freidson E., 1988, PROFESSION MED STUDY; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Garner MJ, 2008, EXPLORE-NY, V4, P18, DOI 10.1016/j.explore.2007.10.003; Greenhalgh T, 2007, PRIMARY HEALTH CARE: THEORY AND PRACTICE, P23; Ham C, 2015, IMPLEMENTING NHS 5 Y; Health Council of Canada, 2009, TEAMS ACT PRIM CAR T; Hills M, 2007, REV PANAM SALUD PUBL, V21, P125, DOI 10.1590/S1020-49892007000200007; Howard Jenna, 2012, Qual Manag Health Care, V21, P135, DOI 10.1097/QMH.0b013e31825e876a; Humbert Jennie, 2007, Can Nurse, V103, P30; Jacobson P.M., 2012, EVIDENCE SYNTHESIS E; Kennedy C, 2008, J ADV NURS, V64, P416, DOI 10.1111/j.1365-2648.2008.04621.x; Kharicha K, 2005, FAM PRACT, V22, P399, DOI 10.1093/fampra/cmi010; Kislov R, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-97; Knowles SE, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-110; Kolodziejak L, 2010, J INTERPROF CARE, V24, P274, DOI 10.3109/13561820903130149; Korabek B, 2004, HOME HLTH CARE MANAG, V16, P261; Korazim-Korosy Y, 2007, J COMMUNITY PRACT, V15, P13, DOI 10.1300/J125v15n01_02; Kvarnstrom S, 2006, J ADV NURS, V53, P244, DOI 10.1111/j.1365-2648.2006.03719.x; Legault F, 2012, J AM BOARD FAM MED, V25, P168, DOI 10.3122/jabfm.2012.02.110153; Macfarlane F, 2004, QUAL SAF HEALTH CARE, V13, P356, DOI 10.1136/qshc.2003.009332; MacNaughton K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-486; Mahmood-Yousuf K, 2008, BRIT J GEN PRACT, V58, P256, DOI 10.3399/bjgp08X279760; Martin DR, 2008, QUAL HEALTH RES, V18, P369, DOI 10.1177/1049732307311119; Mash BJ, 2008, ED HLTH CHANGE LEARN, V21, P1; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; McEvoy R, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-2; McInnes S, 2015, NURSE EDUC PRACT, V15, P437, DOI 10.1016/j.nepr.2015.04.003; Mickan S, 2010, J INTERPROF CARE, V24, P492, DOI 10.3109/13561821003676325; Miller WL, 2010, FAM SYST HEALTH, V28, P334, DOI 10.1037/a0022001; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; Naccarella L, 2009, AUST J PRIM HEALTH, V15, P312, DOI 10.1071/PY08071; Nemeth LS, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-3; Noyes J, 2007, J ADV NURS, V57, P227, DOI 10.1111/j.1365-2648.2006.04092.x; Nutting Paul A, 2010, Ann Fam Med, V8 Suppl 1, pS45, DOI 10.1370/afm.1075; O'Neill M, 2008, J CLIN NURS, V17, P3004, DOI 10.1111/j.1365-2702.2008.02068.x; O'Reilly P, 2015, ASSESSING FACILITATO; O'Sullivan M, 2015, IRISH J MED SCI, V184, P69, DOI 10.1007/s11845-014-1128-x; Phillips RL, 2010, HLTH AFFAIRS, V29; Poghosyan L, 2015, HLTH CARE MANAGEMENT; Pullon S, 2009, BRIT J GEN PRACT, V59, P191, DOI 10.3399/bjgp09X395003; Rocha PD, 2011, CIENC SAUDE COLETIVA, V16, P2853, DOI 10.1590/S1413-81232011000600023; Rodriguez C, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-15; Rubio-Valera M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-188; Schadewaldt V, 2014, J ADV NURS, V70, P1184, DOI 10.1111/jan.12269; Schadewaldt V, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-132; Schneider EF, 2014, AM J PHARM EDUC, V78, DOI 10.5688/ajpe788148; Sevin C, 2009, J AMBUL CARE MANAG, V32, P24, DOI 10.1097/01.JAC.0000343121.07844.e0; Shaw Adrienne, 2005, J Interprof Care, V19, P396, DOI 10.1080/13561820500053454; Shaw Eric K, 2012, Qual Manag Health Care, V21, P104, DOI 10.1097/QMH.0b013e31824d4984; Shaw SN, 2008, J INTERPROF CARE, V22, P229, DOI 10.1080/13561820802054721; Shortell SM, 2014, HEALTH SERV RES, V49, P1883, DOI 10.1111/1475-6773.12234; Sinsky CA, 2013, ANN FAM MED, V11, P272, DOI 10.1370/afm.1531; Snyder ME, 2010, RES SOC ADMIN PHARM, V6, P307, DOI 10.1016/j.sapharm.2009.11.008; Solhelm K, 2007, SOC SCI MED, V65, P622, DOI 10.1016/j.socscimed.2007.03.028; Tan Edwin C K, 2014, Int J Pharm Pract, V22, P28, DOI 10.1111/ijpp.12047; Tierney E, 2016, BMC FAMILY PRACTICE, P1; Vachon B, 2013, BMC HEALTH SERV RES, V13, P1; Van C, 2011, J INTERPROF CARE, V25, P366, DOI 10.3109/13561820.2011.585725; van Weel C, 2012, J AM BOARD FAM MED, V25, pS12, DOI 10.3122/jabfm.2012.02.110212; Vedel I, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-3; Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x; Wilson D.R., 2005, PRIM HEALTH CARE RES, V6, P224, DOI [https://doi.org/10.1191/1463423605pc243oa, DOI 10.1191/1463423605PC243OA]; Wilson K, 2005, AUST J ADV NURS, V23, P22; Xyrichis A, 2008, INT J NURS STUD, V45, P140, DOI 10.1016/j.ijnurstu.2007.01.015; Young S, 2009, PROF CASE MANAG, V14, P312, DOI 10.1097/NCM.0b013e3181b5de1c	90	53	54	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177026	10.1371/journal.pone.0177026	http://dx.doi.org/10.1371/journal.pone.0177026			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28545038	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400018
J	Zaldo, C; Serrano, MD; Han, XM; Cascales, C; Cantero, M; Montoliu, L; Arza, E; Caiolfa, VR; Zamai, M				Zaldo, Carlos; Dolores Serrano, Maria; Han, Xiumei; Cascales, Concepcion; Cantero, Marta; Montoliu, Lluis; Arza, Elvira; Caiolfa, Valeria R.; Zamai, Moreno			Efficient up-conversion in Yb:Er:NaT(XO4)(2) thermal nanoprobes. Imaging of their distribution in a perfused mouse	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; NANOPARTICLES; PHOTOLUMINESCENCE; LUMINESCENCE; CRYSTALS; MICROSCOPY; GREEN; CELL; NABI(XO4)(2); NANOCRYSTALS	Yb and Er codoped NaT(XO4)(2) (T = Y, La, Gd, Lu and X = Mo, W) disordered oxides show a green (Er3+ related) up-conversion (UC) efficiency comparable to that of Yb:Er:beta-NaYF4 compound and unless 3 times larger UC ratiometric thermal sensitivity. The similar UC efficiency of Yb:Er doped NaT(XO4)(2) and beta-NaYF4 compounds allowed testing equal subcutaneous depths of ex-vivo chicken tissue in both cases. This extraordinary behavior for NaT (XO4)(2) oxides with large cutoff phonon energy (h omega approximate to 920 cm(-1)) is ascribed to F-4(9/2) electron population recycling to higher energy (4)G(11/2) level by a phonon assisted transition. Crystalline nanoparticles of Yb:Er:NaLu(MoO4)(2) have been synthesized by sol-gel with sizes most commonly in the 50-80 nm range, showing a relatively small reduction of the UC efficiency with regards to bulk materials. Fluorescence lifetime and multiphoton imaging microscopies show that these nanoparticles can be efficiently distributed to all body organs of a perfused mouse.	[Zaldo, Carlos; Dolores Serrano, Maria; Han, Xiumei; Cascales, Concepcion] CSIC, ICMM, Madrid, Spain; [Cantero, Marta; Montoliu, Lluis] CSIC, CNB, Dept Biol Mol & Celular, Madrid, Spain; [Cantero, Marta; Montoliu, Lluis] Inst Salud Carlos III ISCIII, CIBERER, Madrid, Spain; [Arza, Elvira; Caiolfa, Valeria R.; Zamai, Moreno] CNIC, Unidad Microscope & Imagen Dinam, Madrid, Spain; [Caiolfa, Valeria R.] Osped San Raffaele, Ctr Imaging Sperimentale, Milan, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Zaldo, C (corresponding author), CSIC, ICMM, Madrid, Spain.	cezaldo@icmm.csic.es	Zaldo, Carlos/K-4321-2013; Serrano, Maria Dolores/B-9629-2013; CASCALES, Concepción/C-3930-2011; Caiolfa, Valeria R./H-2769-2015; Zamai, Moreno/H-5923-2015	Zaldo, Carlos/0000-0001-9586-7771; Serrano, Maria Dolores/0000-0001-7754-0417; CASCALES, Concepción/0000-0003-2513-5887; Arza, Elvira/0000-0001-9626-047X; Cantero Gonzalez, Marta Maria/0000-0001-6554-906X; Caiolfa, Valeria R./0000-0003-4814-6490; Zamai, Moreno/0000-0002-2222-6815	Ministry of Economy and Competitiveness; European Regional Development Fund [MAT2014-56607-R]; Spanish Ministry of Economy and Competitiveness support as a Severo Ochoa Center of Excellence [SEV-2015-0505]; Pro CNIC Foundation; Ministry of Economy, Industry and Competitiveness (MEIC)	Ministry of Economy and Competitiveness; European Regional Development Fund(European Commission); Spanish Ministry of Economy and Competitiveness support as a Severo Ochoa Center of Excellence; Pro CNIC Foundation; Ministry of Economy, Industry and Competitiveness (MEIC)	The authors thankfully acknowledge the financial support by Ministry of Economy and Competitiveness and the European Regional Development Fund grant number MAT2014-56607-R, the Spanish Ministry of Economy and Competitiveness support as a Severo Ochoa Center of Excellence, grant nunber SEV-2015-0505, and by the Pro CNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by the Ministry of Economy and Competitiveness (MINECO) and by the European Regional Development Fund through MAT2014-56607-R project. The CNIC is supported by the Ministry of Economy, Industry and Competitiveness (MEIC) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). Optical microscopy was carried out at the Molecular and Functional Imaging Unit, ICTS ReDIB TRIMA@CNIC. The authors are in debt with the histology facility of CNB-CSIC for tissue section preparation and with A. M. Santos Beneit (CNIC) for his help in image analysis.	Ajithkumar G, 2013, J MATER CHEM B, V1, P1561, DOI 10.1039/c3tb00551h; Ang LY, 2011, NANOMEDICINE-UK, V6, P1273, DOI [10.2217/nnm.11.108, 10.2217/NNM.11.108]; Auzel F, 1980, RADIATIONLESS PROCES, P213; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Boyer JC, 2010, NANOSCALE, V2, P1417, DOI 10.1039/c0nr00253d; Chen GY, 2014, CHEM REV, V114, P5161, DOI 10.1021/cr400425h; Cheng L, 2013, NANOSCALE, V5, P23, DOI 10.1039/c2nr32311g; Colyer RA, 2008, MICROSC RES TECHNIQ, V71, P201, DOI 10.1002/jemt.20540; Cui LR, 2015, J MATER CHEM B, V3, P7046, DOI 10.1039/c5tb00709g; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Serrano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059381; Elson D, 2004, PHOTOCH PHOTOBIO SCI, V3, P795, DOI 10.1039/b316456j; Esteban-Betegon F, 2010, CHEM MATER, V22, P2315, DOI 10.1021/cm9032622; Garcia-Cortes A, 2007, IEEE J QUANTUM ELECT, V43, P157, DOI 10.1109/JQE.2006.886450; Gimenez E, 2001, GENESIS, V30, P21, DOI 10.1002/gene.1028; Grzechnik A, 2002, J SOLID STATE CHEM, V165, P159, DOI 10.1006/jssc.2001.9525; Haase M, 2011, ANGEW CHEM INT EDIT, V50, P5808, DOI 10.1002/anie.201005159; Han X, 2007, CHEM MATER, V19, P3002, DOI 10.1021/cm070237v; Han XM, 2010, PHYSCS PROC, V8, P18, DOI 10.1016/j.phpro.2010.10.005; Huang K, 2016, SMALL, V12, P836, DOI 10.1002/smll.201502722; Idris NM, 2009, BIOMATERIALS, V30, P5104, DOI 10.1016/j.biomaterials.2009.05.062; Jaque D, 2016, ADV OPT PHOTONICS, V8, P1, DOI 10.1364/AOP.8.000001; Jiang S, 2013, NANOSCALE, V5, P3127, DOI 10.1039/c3nr34005h; Jiang S, 2010, J APPL PHYS, V108, DOI 10.1063/1.3499301; Kim CS, 2013, ADV DRUG DELIVER REV, V65, P93, DOI 10.1016/j.addr.2012.08.011; Kumar KU, 2013, J NANOSCI NANOTECHNO, V13, P6841, DOI 10.1166/jnn.2013.7788; Li AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31366; Li T, 2015, J AM CERAM SOC, V98, P2812, DOI 10.1111/jace.13698; Liao JS, 2010, MATER RES BULL, V45, P1145, DOI 10.1016/j.materresbull.2010.05.027; Liu SJ, 2014, ACS APPL MATER INTER, V6, P11013, DOI 10.1021/am5035158; Marquez G, 1998, APPL OPTICS, V37, P798, DOI 10.1364/AO.37.000798; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Nadort A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063292; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Page RH, 1998, J OPT SOC AM B, V15, P996, DOI 10.1364/JOSAB.15.000996; Provenzano PP, 2009, CLIN EXP METASTAS, V26, P357, DOI 10.1007/s10585-008-9204-0; Renero-Lecuna C, 2011, CHEM; Rico M, 2002, CHEM PHYS, V279, P73, DOI 10.1016/S0301-0104(02)00486-X; Rico M, 2001, J ALLOY COMPD, V323, P806, DOI 10.1016/S0925-8388(01)01149-5; Rode E. Ya., 1971, RUSS J INORG CHEM, V16, P905; Sedlmeier A, 2012, NANOSCALE, V4, P7090, DOI 10.1039/c2nr32314a; Siegel J, 2003, APPL OPTICS, V42, P2995, DOI 10.1364/AO.42.002995; Song F, 2006, OPT COMMUN, V259, P179, DOI 10.1016/j.optcom.2005.08.049; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Vetrone F, 2010, ACS NANO, V4, P3254, DOI 10.1021/nn100244a; Volkov V, 2002, J PHYS CHEM SOLIDS, V63, P95, DOI 10.1016/S0022-3697(01)00084-1; Voron'ko YK, 2000, INORG MATER+, V36, P947, DOI 10.1007/BF02758711; Wang HJ, 2014, ACS APPL MATER INTER, V6, P3219, DOI 10.1021/am500097f; Wang H, 2016, ACS APPL MATER INTER, V8, P4416, DOI 10.1021/acsami.5b11197; Wang W, 2014, ACS APPL MATER INTER, V6, P340, DOI 10.1021/am404389g; Barrera EW, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/7/075205; Xu H, 2011, BIOMATERIALS, V32, P9364, DOI 10.1016/j.biomaterials.2011.08.053; Yang J, 2009, CHEM-EUR J, V15, P4649, DOI 10.1002/chem.200802106; Yang XX, 2015, J AM CERAM SOC, V98, P2595, DOI 10.1111/jace.13624; Zhang F, 2015, NANOSTRUCTURE SCI TE; Zheng H, 2014, J COLLOID INTERF SCI, V420, P27, DOI 10.1016/j.jcis.2013.12.059	56	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177596	10.1371/journal.pone.0177596	http://dx.doi.org/10.1371/journal.pone.0177596			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542327	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672400055
J	Luti, S; Martellini, F; Bemporad, F; Mazzoli, L; Paoli, P; Pazzagli, L				Luti, Simone; Martellini, Federica; Bemporad, Francesco; Mazzoli, Lorenzo; Paoli, Paolo; Pazzagli, Luigia			A single amino acid mutation affects elicitor and expansins-like activities of ceratoplatanin, a non-catalytic fungal protein	PLOS ONE			English	Article							CERATO-PLATANIN; BACTERIAL EXPANSIN; ESCHERICHIA-COLI; PHYTOTOXIC PROTEIN; INCLUSION-BODIES; STRUCTURAL BASIS; PICHIA-PASTORIS; 1ST MEMBER; EXPRESSION; TRICHODERMA	Cerato-platanin (CP) is a non-catalytic, cysteine-rich protein, the first member of the ceratoplatanin family. It is a single-domain protein with a double psi/beta barrel domain resembling the D1 domain of plant and bacterial expansins. Similarly to expansins, CP shows a cell wallloosening activity on cellulose and can be defined as an expanisin-like protein, in spite of the missing D2 domain, normally present in plant expansins. The weakening activity shown on cellulose may facilitate the CP-host interaction, corroborating the role of CP in eliciting plant defence response. Indeed, CP is an elicitor of primary defences acting as a PathogenAssociated Molecular Patterns (PAMP). So far, structure-function relationship study has been mainly performed on the bacterial BsEXLX1 expansin, probably due to difficulties in expressing plant expansins in heterologous systems. Here, we report a subcloning and purification method of CP in the engineered E. coli SHuffle cells, which proved to be suitable to obtain the properly folded and biologically active protein. The method also enabled the production of the mutant D77A, rationally designed to be inactive. The wild-type and the mutated CP were characterized for cellulose weakening activity and for PAMP activity (i.e. induction of Reactive Oxygen Species synthesis and phytoalexins production). Our analysis reveals that the carboxyl group of D77 is crucial for expansin-like and PAMP activities, thus permitting to establish a correlation between the ability to weaken cellulose and the capacity to induce defence responses in plants. Our results enable the structural and functional characterization of a mono-domain eukaryotic expansin and identify the essential role of a specific aspartic residue in cellulose weakening.	[Luti, Simone; Martellini, Federica; Bemporad, Francesco; Mazzoli, Lorenzo; Paoli, Paolo; Pazzagli, Luigia] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy	University of Florence	Luti, S (corresponding author), Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy.	simone.luti@unifi.it	Paoli, Paolo/A-2040-2014	Paoli, Paolo/0000-0001-6448-7266; Luti, Simone/0000-0001-7050-6590; Bemporad, Francesco/0000-0002-0643-6249	MIUR (Mlnistero Universita e Ricerca scientifica, Universita degli Studi di Firenze anno); University of Florence	MIUR (Mlnistero Universita e Ricerca scientifica, Universita degli Studi di Firenze anno)(Ministry of Education, Universities and Research (MIUR)); University of Florence	This work was supported by MIUR (Mlnistero Universita e Ricerca scientifica, Universita degli Studi di Firenze anno 2015) that is shown by the acronym: LUIGIAPZZAGLIRICATEN15. The funding is released by University of Florence to researchers that require financial support for their research.	Baccelli I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100959; Baccelli I, 2014, APPL MICROBIOL BIOT, V98, P175, DOI 10.1007/s00253-013-4822-0; Baccelli I, 2012, FEMS MICROBIOL LETT, V327, P155, DOI 10.1111/j.1574-6968.2011.02475.x; Barsottini MRD, 2013, MOL PLANT MICROBE IN, V26, P1281, DOI 10.1094/MPMI-05-13-0148-R; Carresi L, 2006, PROTEIN EXPRES PURIF, V49, P159, DOI 10.1016/j.pep.2006.07.006; Chung WJ, 2015, PROTEIN EXPRES PURIF, V110, P79, DOI 10.1016/j.pep.2015.02.012; Cosgrove DJ, 2015, CURR OPIN PLANT BIOL, V25, P162, DOI 10.1016/j.pbi.2015.05.014; Cosgrove DJ, 2014, CURR OPIN PLANT BIOL, V22, P122, DOI 10.1016/j.pbi.2014.11.001; Crutcher FK, 2015, FUNGAL BIOL-UK, V119, P476, DOI 10.1016/j.funbio.2015.01.004; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Tovar-Herrera OE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122296; Frias M, 2013, MOL PLANT PATHOL, V14, P191, DOI 10.1111/j.1364-3703.2012.00842.x; Frischmann A, 2013, J BIOL CHEM, V288, P4278, DOI 10.1074/jbc.M112.427633; Gaderer R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-014-0333-0; Georgelis N, 2015, APPL MICROBIOL BIOT, V99, P3807, DOI 10.1007/s00253-015-6534-0; Georgelis N, 2014, CARBOHYD POLYM, V100, P17, DOI 10.1016/j.carbpol.2013.04.094; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Georgelis N, 2011, J BIOL CHEM, V286, P16814, DOI 10.1074/jbc.M111.225037; Ke N, 2014, CURR PROTOC MOL BIOL, V108, P16; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kim IJ, 2013, APPL MICROBIOL BIOT, V97, P5381, DOI 10.1007/s00253-012-4412-6; Lee SB, 2014, APPL MICROBIOL BIOT, V98, P10041, DOI 10.1007/s00253-014-6139-z; Liu XW, 2015, BIOTECHNOL LETT, V37, P1541, DOI 10.1007/s10529-015-1842-0; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Lombardi L, 2013, PHYSIOL PLANTARUM, V149, P408, DOI 10.1111/ppl.12041; Luti S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060866; Marowa P, 2016, PLANT CELL REP; Martellini F, 2013, MOL BIOTECHNOL, V55, P27, DOI 10.1007/s12033-012-9618-4; OBoyle NM, 2012, J CHEMINFORMATICS, V3, P33; Olarte-Lozano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095638; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pazzagli L, 2006, CELL BIOCHEM BIOPHYS, V44, P512, DOI 10.1385/CBB:44:3:512; Pazzagli L, 2014, PLANT SCI, V228, P79, DOI 10.1016/j.plantsci.2014.02.009; Pusztahelyi T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00573; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez-Vallet A, 2015, FEMS MICROBIOL REV, V39, P171, DOI 10.1093/femsre/fuu003; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Silveira RL, 2016, PHYS CHEM CHEM PHYS, V18, P3510, DOI 10.1039/c5cp06674c; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Suzuki H, 2014, FUNGAL GENET BIOL, V72, P115, DOI 10.1016/j.fgb.2014.05.008; Wang WC, 2014, BIOCHEM ENG J, V84, P16, DOI 10.1016/j.bej.2013.12.018; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	44	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178337	10.1371/journal.pone.0178337	http://dx.doi.org/10.1371/journal.pone.0178337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542638	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800076
J	Park, HE; Park, HT; Jung, YH; Yoo, HS				Park, Hyun-Eui; Park, Hong-Tae; Jung, Young Hoon; Yoo, Han Sang			Establishment a real-time reverse transcription PCR based on host biomarkers for the detection of the subclinical cases of Mycobacterium avium subsp paratuberculosis	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; IMMUNE-RESPONSE; FECAL CULTURE; DIAGNOSIS; EXPRESSION; INFECTION; INNATE; HAPTOGLOBIN; CATTLE; CALVES	Bovine paratuberculosis (PTB) is a chronic enteric inflammatory disease of ruminants caused by Mycobacterium avium subsp. paratuberculosis (MAP) that causes large economic losses in the dairy industry. Spread of PTB is mainly provoked by a long subclinical stage during which MAP is shed into the environment with feces; accordingly, detection of subclinical animals is very important to its control. However, current diagnostic methods are not suitable for detection of subclinical animals. Therefore, the current study was conducted to develop a diagnostic method for analysis of the expression of genes of prognostic potential biomarker candidates in the whole blood of cattle naturally infected with MAP. Real-time PCR with nine potential biomarker candidates was developed for the diagnosis of MAP subclinical infection. Animals were divided into four groups based on fecal MAP PCR and serum ELISA. Eight genes (Timp1, Hp, Serpine1, Tfrc, Mmp9, Defb1, Defb10, and S100a8) were up-regulated in MAP-infected cattle (p < 0.05). Moreover, ROC analysis revealed that eight genes (Timp1, Hp, Serpine1, Tfrc, Mmp9, Defb1, Defb10, and S100a8) showed fair diagnostic performance (AUC >= 0.8). Four biomarkers (Timp1, S100a8, Defb1, and Defb10) showed the highest diagnostic accuracy in the PCR positive and ELISA negative group (PN group) and three biomarkers (Tfrc, Hp, and Serpine1) showed the highest diagnostic accuracy in the PCR negative and ELISA positive group (NP group). Moreover, three biomarkers (S100a8, Hp, and Defb10) were considered the most reliable for the PCR positive and ELISA positive group (PP group). Taken together, our data suggest that real-time PCR based on eight biomarkers (Timp1, Hp, Serpine1, Tfrc, Mmp9, Defb1, Defb10, and S100a8) might be useful for diagnosis of JD, including subclinical stage cases.	[Park, Hyun-Eui; Park, Hong-Tae; Yoo, Han Sang] Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea; [Jung, Young Hoon] Rural Dev Adm, Natl Inst Anim Sci, Dept Anim Resoures Devlopment, Cheonan, South Korea; [Yoo, Han Sang] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea	Seoul National University (SNU); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU)	Yoo, HS (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea.; Yoo, HS (corresponding author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea.	yoohs@snu.ac.kr		YOO, HAN SANG/0000-0003-0548-0835	Cooperative Research Program for Agriculture Science & Technology Development [PJ00897001]; Rural Development Administration, National Research Foundation [2014R1A2A2A01007291]; BK21 PLUS; Research Institute for Veterinary Sciences, Seoul National University, Republic of Korea	Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, National Research Foundation; BK21 PLUS; Research Institute for Veterinary Sciences, Seoul National University, Republic of Korea	This work was supported by the Cooperative Research Program for Agriculture Science & Technology Development (Project No.PJ00897001) to HSY, Rural Development Administration, National Research Foundation (No. 2014R1A2A2A01007291) to HSY, BK21 PLUS to HSY and the Research Institute for Veterinary Sciences, Seoul National University, Republic of Korea to HSY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouiti A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002987; Al Hajri SM, 2007, VET MICROBIOL, V121, P384, DOI 10.1016/j.vetmic.2007.01.025; Allaker RP, 2008, T ROY SOC TROP MED H, V102, P3, DOI 10.1016/j.trstmh.2007.07.005; Bogli-Stuber K, 2005, J APPL MICROBIOL, V99, P587, DOI 10.1111/j.1365-2672.2005.02645.x; Cayatte C, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.2; Cha SB, 2013, J MICROBIOL BIOTECHN, V23, P1167, DOI 10.4014/jmb.1302.02021; Chen YY, 2017, MOL MED REP, V15, P483, DOI 10.3892/mmr.2016.5998; Cousins DV, 1999, MOL CELL PROBE, V13, P431, DOI 10.1006/mcpr.1999.0275; David J, 2014, VET RES, V45, DOI 10.1186/s13567-014-0096-5; David J, 2014, VET IMMUNOL IMMUNOP, V160, P107, DOI 10.1016/j.vetimm.2014.04.006; De Buck J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111872; Dehnad A, 2016, TUBERCULOSIS, V101, P1, DOI 10.1016/j.tube.2016.07.008; EATON JW, 1982, SCIENCE, V215, P691, DOI 10.1126/science.7036344; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; El-Deeb WM, 2016, JPN J VET RES, V64, P57; Englund S, 2002, FEMS MICROBIOL LETT, V209, P267, DOI 10.1111/j.1574-6968.2002.tb11142.x; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Goyal N., 2016, BIOMARKERS, V7, P1, DOI [10.1080/1354750X.2016.1265005, DOI 10.1080/1354750X.2016.1265005]; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; Kugadas A, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00085; Leach ST, 2007, SCAND J GASTROENTERO, V42, P1321, DOI 10.1080/00365520701416709; Lim JH, 2011, BIOCHEM BIOPH RES CO, V414, P67, DOI 10.1016/j.bbrc.2011.09.023; Malvisi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164461; Meade KG, 2014, PHYSIOL GENOMICS, V46, P17, DOI 10.1152/physiolgenomics.00085.2013; Mitchell RM, 2015, VET RES, V46, DOI 10.1186/s13567-015-0188-x; Mortier RAR, 2015, PREV VET MED, V121, P189, DOI 10.1016/j.prevetmed.2015.08.011; Muller MP, 2005, CLIN INFECT DIS, V40, P1079, DOI 10.1086/428577; Nielsen SS, 2008, VET MICROBIOL, V129, P217, DOI 10.1016/j.vetmic.2007.12.011; Park HT, 2016, J VET MED SCI, V78, P1537, DOI 10.1292/jvms.15-0271; Park HE, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw022; Plain KM, 2011, INFECT IMMUN, V79, P3821, DOI 10.1128/IAI.05204-11; Rossbacher J, 1999, SCAND J IMMUNOL, V50, P399, DOI 10.1046/j.1365-3083.1999.00609.x; Saeed SA, 2007, BIOCHEM BIOPH RES CO, V353, P915, DOI 10.1016/j.bbrc.2006.12.092; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Seppa-Lassila L, 2015, COMP IMMUNOL MICROB, V41, P10, DOI 10.1016/j.cimid.2015.05.004; Seth M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005478; Sevilla IA, 2014, APPL ENVIRON MICROB, V80, P3757, DOI 10.1128/AEM.01026-14; Shin MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138770; Shin MK, 2015, J MICROBIOL BIOTECHN, V25, P255, DOI 10.4014/jmb.1408.08059; SOCKETT DC, 1992, CAN J VET RES, V56, P148; Stabel JR, 2000, VET MICROBIOL, V77, P465, DOI 10.1016/S0378-1135(00)00331-X; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Tiwari A, 2006, CAN VET J, V47, P874; Verschoor CP, 2010, VET IMMUNOL IMMUNOP, V137, P1, DOI 10.1016/j.vetimm.2010.03.026; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Walker SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35820; Wang J, 2016, J BACTERIOL, V198, P857, DOI 10.1128/JB.00922-15; Wang XF, 2011, ANIM BIOTECHNOL, V22, P44, DOI 10.1080/10495398.2010.536096; Wang Z, 2013, BLOOD CELL MOL DIS, V50, P196, DOI 10.1016/j.bcmd.2012.11.005; Waters WR, 2016, CLIN VACCINE IMMUNOL, V23, P168, DOI 10.1128/CVI.00637-15; Wells SJ, 2006, CLIN VACCINE IMMUNOL, V13, P1125, DOI 10.1128/CVI.00236-06; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Whittington RJ, 2013, J CLIN MICROBIOL, V51, P3993, DOI 10.1128/JCM.01373-13; You QM, 2012, VET IMMUNOL IMMUNOP, V148, P243, DOI 10.1016/j.vetimm.2012.05.002	56	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178336	10.1371/journal.pone.0178336	http://dx.doi.org/10.1371/journal.pone.0178336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542507	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800075
J	Albrecht, L; Stallard, RF; Kalko, EKV				Albrecht, Larissa; Stallard, Robert F.; Kalko, Elisabeth K. V.			Land use history and population dynamics of free-standing figs in a maturing forest	PLOS ONE			English	Article							TROPICAL FOREST; FRUIT CHARACTERISTICS; TREE MORTALITY; BARRO COLORADO; RAIN-FOREST; BATS; DROUGHT; ECOLOGY; CLIMATE; COMMUNITIES	Figs (Ficus sp.) are often considered as keystone resources which strongly influence tropical forest ecosystems. We used long-term tree-census data to track the population dynamics of two abundant free-standing fig species, Ficus insipida and F. yoponensis, on Barro Colorado Island (BCI), a 15.6-km(2) island in Lake Gatu A n, Panama. Vegetation cover on BCI consists of a mosaic of old growth (>400 years) and maturing (about 90-150 year old) secondary rainforest. Locations and conditions of fig trees have been mapped and monitored on BCI for more than 35 years (1973-2011), with a focus on the Lutz Catchment area (25 ha). The original distribution of the fig trees shortly after the construction of the Panama Canal was derived from an aerial photograph from 1927 and was compared with previous land use and forest status. The distribution of both fig species (similar to 850 trees) is restricted to secondary forest. Of the original 119 trees observed in Lutz Catchment in 1973, >70% of F. insipida and >90% of F. yoponensis had died by 2011. Observations in other areas on BCI support the trend of declining free-standing figs. We interpret the decline of these figs on BCI as a natural process within a maturing tropical lowland forest. Senescence of the fig trees appears to have been accelerated by severe droughts such as the strong El Nino event in the year 1982/83. Because figs form such an important food resource for frugivores, this shift in resource availability is likely to have cascading effects on frugivore populations.	[Albrecht, Larissa; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Stallard, Robert F.; Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama; [Stallard, Robert F.] US Geol Survey, Boulder, CO USA	Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; United States Department of the Interior; United States Geological Survey	Albrecht, L (corresponding author), Univ Ulm, Inst Expt Ecol, Ulm, Germany.	Larissa.Albrecht@alumni.uni-ulm.de			DAAD (German Academic Exchange Service) [D/06/46336]; German Science Foundation (DFG) [KA 1241/16-1]; RFS; Smithsonian Institution	DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); German Science Foundation (DFG)(German Research Foundation (DFG)); RFS; Smithsonian Institution(Smithsonian Institution)	This work was supported by a DAAD (German Academic Exchange Service, www.daad.de) Ph.D. fellowship (D/06/46336) to LA, and by a grant (KA 1241/16-1) of the German Science Foundation (DFG, www.dfg.de) to EKVK. The U.S. Geological Survey (www.usgs.gov) and the Smithsonian Tropical Research Institute (STRI, www.stri.si.edu) supported RFS. In its earlier years, the Smithsonian Institution supported much of the fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot HL, 1907, PROBLEMS PANAMA CANA; Albrecht L, 2007, ACTA THERIOL, V52, P141, DOI 10.1007/BF03194209; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Bartlett A, 1973, VEGETATION VEGETATIO, P203; Bartlett AS, 1969, SCIENCE, V151, P642, DOI 10.1126/science.165.3891.389.; BONACCORSO F J, 1979, Bulletin of the Florida State Museum Biological Sciences, V24, P359; Chazdon RL, 2005, ECOLOGY, V86, P1808, DOI 10.1890/04-0572; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Enders R. K., 1935, Bulletin of the Museum of Comparative Zoology, V78, P385; Foster RB, 1982, ECOLOGY TROPICAL FOR, P67; Foster RB, 1990, 4 NEOTROPICAL RAINFO, P565; GAUTIERHION A, 1989, ECOLOGY, V70, P1826, DOI 10.2307/1938115; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Handley Jr CO, 1991, DEMOGRAPHY NATURAL H, P511; Hao GY, 2011, ECOLOGY, V92, P2117, DOI 10.1890/11-0269.1; Harrison RD, DROUGHT CONSEQUENCES; Krause GH, 2010, FUNCT PLANT BIOL, V37, P890, DOI 10.1071/FP10034; Hodgkison R, 2004, BIOTROPICA, V36, P522, DOI 10.1646/1593; Hubbell S.P., 1990, 4 NEOTROPICAL FOREST, P522; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Kalko EKV, 1996, J BIOGEOGR, V23, P565, DOI 10.1111/j.1365-2699.1996.tb00018.x; Kalko EKV, 2008, INTEGR COMP BIOL, V48, P60, DOI 10.1093/icb/icn030; Kalko Elisabeth K.V., 1996, P503, DOI 10.1016/B978-012178075-3/50017-9; Kenoyer LA, 1929, ECOLOGY, V10, P201, DOI 10.2307/1932295; Kissling WD, 2007, P ROY SOC B-BIOL SCI, V274, P799, DOI 10.1098/rspb.2006.0311; Korine C, 2000, OECOLOGIA, V123, P560, DOI 10.1007/PL00008861; Leigh EG, 1999, TROPICAL FOREST ECOL; Matthew GE, 1949, CHAGRES RIVER GATUN; McCullough David, 1977, PATH SEAS CREATION P, P12; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Miller F., 1927, SPECIAL MAP BARRO CO; MILTON K, 1982, ECOLOGY, V63, P752, DOI 10.2307/1936796; Milton K., 1980, FORAGING STRATEGIES; MORRISON DW, 1978, ECOLOGY, V59, P716, DOI 10.2307/1938775; Morrison DW, 1975, THESIS; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Paton S., 2002, 2001 METEOROLOGICAL; Piperno DR, 1990, ECOLOGIA BOSQUE TROP, P153; REINSCH CH, 1967, NUMER MATH, V10, P177, DOI 10.1007/BF02162161; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Svenning JC, 2004, ECOLOGY, V85, P2526, DOI 10.1890/03-0396; SWAINE MD, 1987, J TROP ECOL, V3, P359, DOI 10.1017/S0266467400002339; Terborgh J, 1997, J TROP ECOL, V13, P833, DOI 10.1017/S0266467400011020; TERBORGH J, 1986, P330; Thorington Jr RW, 1974, 1973 ENV MONITORING, P256; Weghorst JA, 2007, PRIMATES, V48, P108, DOI 10.1007/s10329-006-0025-y; Wendeln MC, 2000, BIOTROPICA, V32, P489, DOI 10.1111/j.1744-7429.2000.tb00495.x; Williamson GB, 2000, CONSERV BIOL, V14, P1538, DOI 10.1046/j.1523-1739.2000.99298.x; ZOTZ G, 1995, FLORA, V190, P265, DOI 10.1016/S0367-2530(17)30663-1	53	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177060	10.1371/journal.pone.0177060	http://dx.doi.org/10.1371/journal.pone.0177060			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542161	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500010
J	Amorim, AC; Cacciari, LP; Passaro, AC; Silveira, SRB; Amorim, CF; Loss, JF; Sacco, ICN				Amorim, Amanda C.; Cacciari, Licia P.; Passaro, Anice C.; Silveira, Simone R. B.; Amorim, Cesar F.; Loss, Jefferson F.; Sacco, Isabel C. N.			Effect of combined actions of hip adduction/abduction on the force generation and maintenance of pelvic floor muscles in healthy women	PLOS ONE			English	Article							TENDINEUS FASCIAE PELVIS; DYNAMOMETRIC MEASUREMENTS; URINARY-INCONTINENCE; CONTINENCE SOCIETY; RELIABILITY; STRENGTH; ANATOMY; TRANSMISSION; CONTRACTIONS; TERMINOLOGY	Pelvic floor muscle (PFM) force and coordination are related to urinary incontinence severity and to sexual satisfaction. Health professionals frequently combine classic PFM exercises with hip adduction/abduction contraction to treat these disorders, but the real benefits of this practice are still unknown. Based on a theoretical anatomy approach whereby the levator ani muscle is inserted into the obturator internus myofascia and in which force generated by hip movements should increase the contraction quality of PFMs, our aim was to investigate the effects of isometric hip adduction and abduction on PFM force generation. Twenty healthy, nulliparous women were evaluated using two strain-gauge dynamometers (one cylinder-like inside the vaginal cavity, and the other measuring hip adduction/abduction forces around both thighs) while performing three different tasks: (a) isolated PFM contraction; (b) PFM contraction combined with hip adduction (30% and 50% maximum hip force); and (c) PFM contraction combined with hip abduction (30% and 50% maximum hip force). Data were sampled at 100Hz and subtracted from the offset if existent. We calculated a gradient between the isolated PFM contraction and each hip condition (Delta Adduction and Delta Abduction) for all variables: Maximum force (N), instant of maximum-force occurrence (s), mean force in an 8-second window (N), and PFM force loss (N.s). We compared both conditions gradients in 30% and 50% by paired t-tests. All variables did not differ between hip conditions both in 30% and 50% of maximum hip force (p >.05). PFM contraction combined with isometric hip abduction did not increase vaginal force in healthy and nulliparous women compared to PFM contraction combined with isometric hip adduction. Therefore, so far, the use of hip adduction or abduction in PFM training and treatments are not justified for improving PFM strength and endurance.	[Amorim, Amanda C.; Cacciari, Licia P.; Passaro, Anice C.; Sacco, Isabel C. N.] Univ Sao Paulo, Sch Med, Phys Therapy Speech & Occupat Therapy, Sao Paulo, Brazil; [Silveira, Simone R. B.] Univ Sao Paulo, Univ Hosp, Sao Paulo, Brazil; [Amorim, Cesar F.] Univ City Sao Paulo UNICID, Phys Therapy Master Program, Sao Paulo, Brazil; [Loss, Jefferson F.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Cidade de Sao Paulo; Universidade Federal do Rio Grande do Sul	Sacco, ICN (corresponding author), Univ Sao Paulo, Sch Med, Phys Therapy Speech & Occupat Therapy, Sao Paulo, Brazil.	icnsacco@usp.br	Cacciari, Licia P/F-2784-2013; Sacco, Isabel/D-7172-2011; de Campos Pássaro, Anice/C-7815-2013; Sacco, Isabel/T-2630-2019; Amorim, Amanda C/J-4577-2014	Sacco, Isabel/0000-0003-1254-0007; de Campos Pássaro, Anice/0000-0001-9345-3284; Sacco, Isabel/0000-0003-1254-0007; Ferreira Amorim, Cesar/0000-0003-0137-5659; Cacciari, Licia/0000-0003-0222-6364	National Council for Scientific and Technological Development (CNPq) [MCT/CNPq 166104/2013-2]; ACA scholarship [478332/2013-0, 2013/19610-3]; LPC scholarship [2013/13820-6]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ACA scholarship; LPC scholarship	The authors are grateful to the National Council for Scientific and Technological Development (CNPq, http://www.cnpq.br/) for funding the project (MCT/CNPq 166104/2013-2) and for ACA scholarship (478332/2013-0), to the Sao Paulo State Research Foundation (FAPESP, http://www.fapesp.br/en/) for also funding this project (process 2013/19610-3), and for LPC scholarship (process 2013/13820-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab AM, 2011, NEUROUROL URODYNAM, V30, P117, DOI 10.1002/nau.20959; Ashton-Miller JA, 2007, ANN NY ACAD SCI, V1101, P266, DOI 10.1196/annals.1389.034; Ashton-Miller JA, 2014, CLIN BIOMECH, V29, P1146, DOI 10.1016/j.clinbiomech.2014.09.011; BO K, 1994, NEUROUROL URODYNAM, V13, P35, DOI 10.1002/nau.1930130106; Bo K, 2009, OBSTET GYNECOL, V113, P1279, DOI 10.1097/AOG.0b013e3181a66f40; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; CALDWELL LS, 1974, AM IND HYG ASSOC J, V35, P201, DOI 10.1080/0002889748507023; Delancey JOL, 2004, GASTROENTEROLOGY, V126, pS23, DOI 10.1053/j.gastro.2003.10.080; Devreese A, 2004, NEUROUROL URODYNAM, V23, P190, DOI 10.1002/nau.20018; Dietz HP, 2006, BJOG-INT J OBSTET GY, V113, P225, DOI 10.1111/j.1471-0528.2006.00819.x; Dumoulin C, 2004, NEUROUROL URODYNAM, V23, P134, DOI 10.1002/nau.10175; Dumoulin C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005654.pub3; Dumoulin C, 2015, NEUROUROL URODYNAM, V34, P300, DOI 10.1002/nau.22700; Frawley HC, 2006, NEUROUROL URODYNAM, V25, P236, DOI 10.1002/nau.20201; Hodges PW, 2014, J ELECTROMYOGR KINES, V24, P489, DOI 10.1016/j.jelekin.2014.03.011; HOFBAUER J, 1990, Z UROL NEPHROL, V83, P249; Huijing PA, 1999, J BIOMECH, V32, P329, DOI 10.1016/S0021-9290(98)00186-9; Huijing PA, 2009, J BIOMECH, V42, P9, DOI 10.1016/j.jbiomech.2008.09.027; Kepenekci I, 2011, DIS COLON RECTUM, V54, P85, DOI 10.1007/DCR.0b013e3181fd2356; Lamin E, 2016, CURR UROL REP, V17, DOI 10.1007/s11934-015-0572-0; Laycock J., 2001, PHYSIOTHERAPY, V87, P631, DOI [10.1016/s0031-9406(05)61108-x, DOI 10.1016/S0031-9406(05)61108-X]; Madill SJ, 2006, NEUROUROL URODYNAM, V25, P722, DOI 10.1002/nau.20285; Madill SJ, 2010, J ELECTROMYOGR KINES, V20, P804, DOI 10.1016/j.jelekin.2009.10.006; Messelink B, 2005, NEUROUROL URODYNAM, V24, P374, DOI 10.1002/nau.20144; Morin M, 2007, NEUROUROL URODYNAM, V26, P397, DOI 10.1002/nau.20334; Morin M, 2004, NEUROUROL URODYNAM, V23, P668, DOI 10.1002/nau.20069; Morin M, 2004, NEUROUROL URODYNAM, V23, P336, DOI 10.1002/nau.20021; Occelli B, 2001, EUR J OBSTET GYN R B, V97, P213, DOI 10.1016/S0301-2115(00)00527-3; Peschers UM, 2001, INT UROGYNECOL J PEL, V12, P27, DOI 10.1007/s001920170090; Pit MJ, 2003, CLIN ANAT, V16, P131, DOI 10.1002/ca.10102; Sapsford RR, 2001, NEUROUROL URODYNAM, V20, P31, DOI 10.1002/1520-6777(2001)20:1<31::AID-NAU5>3.0.CO;2-P; Tan L, 2015, INT UROGYNECOL J, V26, P1667, DOI 10.1007/s00192-015-2759-9; Toozs-Hobson P, 2012, INT UROGYNECOL J, V23, P527, DOI 10.1007/s00192-012-1726-y; Vaarbakken K, 2014, CLIN BIOMECH, V29, P794, DOI 10.1016/j.clinbiomech.2014.05.011; Voorham-van der Zalm PJ, 2013, NEUROUROL URODYNAM, V32, P341, DOI 10.1002/nau.22311; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Yucesoy CA, 2003, J BIOMECH, V36, P1797, DOI 10.1016/S0021-9290(03)00230-6; Yucesoy CA, 2010, EXERC SPORT SCI REV, V38, P128, DOI 10.1097/JES.0b013e3181e372ef	38	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177575	10.1371/journal.pone.0177575	http://dx.doi.org/10.1371/journal.pone.0177575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542276	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500032
J	Sun, WY; Lan, J; Chen, L; Qiu, JJ; Luo, ZG; Li, MZ; Wang, JY; Zhao, JG; Zhang, TH; Long, X; Chai, J; Yan, ZQ; Guo, ZY; Gun, SB				Sun, Wenyang; Lan, Jing; Chen, Lei; Qiu, Jinjie; Luo, Zonggang; Li, Mingzhou; Wang, Jinyong; Zhao, Jiugang; Zhang, Tinghuan; Long, Xi; Chai, Jie; Yan, Zunqiang; Guo, Zongyi; Gun, Shuangbao			A mutation in porcine pre-miR-15b alters the biogenesis of MiR-15b\16-1 cluster and strand selection of MiR-15b	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; MICRORNA BIOGENESIS; CANCER CELLS; EXPRESSION; SEQUENCE; COMPLEX; DROSHA; MIRNA; MICROPROCESSOR; PROLIFERATION	MicroRNAs (miRNAs) are small non-coding RNAs that are involved in translational regulation of the messenger RNA molecules. Sequence variations in the genes encoding miRNAs could influence their biogenesis and function. MiR-15b plays an important role in cellular proliferation, apoptosis and the cell cycle. Here, we report the identification of a C58T mutation in porcine pre-miR-15b. Through in vitro and in vivo experiments, we determined that this mutation blocks the transition from pri-miRNA to pre-miRNA, alters the strand selection between miR-15b-5p and miR-15b-3p, and obstructs biogenesis of the downstream miR16- 1. These results serve to highlight the importance of miRNA mutations and their impacts on miRNA biogenesis.	[Sun, Wenyang; Yan, Zunqiang; Gun, Shuangbao] Gansu Agr Univ, Coll Anim Sci & Technol, Lanzhou, Peoples R China; [Sun, Wenyang; Lan, Jing; Chen, Lei; Qiu, Jinjie; Luo, Zonggang; Wang, Jinyong; Zhao, Jiugang; Zhang, Tinghuan; Long, Xi; Chai, Jie; Yan, Zunqiang; Guo, Zongyi] Chongqing Acad Anim Sci, Minist Agr, Key Lab Pig Ind Sci, Chongqing, Peoples R China; [Luo, Zonggang] Southwest Univ, Dept Anim Sci, Chongqing, Peoples R China; [Li, Mingzhou] Sichuan Agr Univ, Inst Anim Genet & Breeding, Coll Anim Sci & Technol, Chengdu, Sichuan, Peoples R China; [Gun, Shuangbao] Gansu Res Ctr Swine Prod Engn & Technol, Lanzhou, Peoples R China	Gansu Agricultural University; Ministry of Agriculture & Rural Affairs; Southwest University - China; Sichuan Agricultural University	Guo, ZY (corresponding author), Chongqing Acad Anim Sci, Minist Agr, Key Lab Pig Ind Sci, Chongqing, Peoples R China.; Gun, SB (corresponding author), Gansu Res Ctr Swine Prod Engn & Technol, Lanzhou, Peoples R China.	guozongyi@sina.com; gunsbao056@126.com			National High Technology Research and Development Program of China (863 Program) [2013AA102502]; Basic Science research Foundation Project of Chongqing [2013cstc-jbky-00105-zj]; National Natural Science Foundation of China [31601930, 31372284, 31201770]; Chongqing Fund of application and development [cstc2013yykfC80003]; Chongqing agricultural development foundation [12404, 14440]; National ''Twelfth Five-Year'' Plan for Science & Technology Support [2015BAD03B02-6]; National Biological Breeding Capacity Building and Industrialization Projects - National Development and Reform Commission [(2014)2573]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Basic Science research Foundation Project of Chongqing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Fund of application and development; Chongqing agricultural development foundation; National ''Twelfth Five-Year'' Plan for Science & Technology Support; National Biological Breeding Capacity Building and Industrialization Projects - National Development and Reform Commission	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (2013AA102502), the Basic Science research Foundation Project of Chongqing (2013cstc-jbky-00105-zj), the National Natural Science Foundation of China (31601930, 31372284, 31201770), the Chongqing Fund of application and development (cstc2013yykfC80003), the Chongqing agricultural development foundation (12404, 14440), the National ''Twelfth Five-Year'' Plan for Science & Technology Support (2015BAD03B02-6) and the National Biological Breeding Capacity Building and Industrialization Projects [(2014)2573] sponsored by National Development and Reform Commission. The funders had no rolein study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harnprasopwat R, 2010, BIOCHEM BIOPH RES CO, V399, P117, DOI 10.1016/j.bbrc.2010.07.009; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee JS, 2013, ANIM GENET, V44, P101, DOI 10.1111/j.1365-2052.2012.02362.x; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lehmann TP, 2013, ONCOL LETT, V5, P569, DOI 10.3892/ol.2012.1040; Li W, 2009, J MED GENET, V46, P358, DOI 10.1136/jmg.2008.063123; Lovat F, 2015, P NATL ACAD SCI USA, V112, P11636, DOI 10.1073/pnas.1514954112; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Satzger I, 2010, INT J CANCER, V126, P2553, DOI 10.1002/ijc.24960; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Singh Y, 2016, IMMUNOLOGY, V149, P74, DOI 10.1111/imm.12631; Singh Y, 2015, J IMMUNOL, V195, P5667, DOI 10.4049/jimmunol.1401875; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Nguyen TA, 2015, CELL, V161, P1374, DOI 10.1016/j.cell.2015.05.010; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zhang YP, 2015, INT J CLIN EXP PATHO, V8, P15677; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	8	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178045	10.1371/journal.pone.0178045	http://dx.doi.org/10.1371/journal.pone.0178045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542522	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500056
J	Treweeke, A; Hall, J; Lambie, S; Leslie, SJ; Megson, IL; MacRury, SM				Treweeke, A.; Hall, J.; Lambie, S.; Leslie, S. J.; Megson, I. L.; MacRury, S. M.			Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACUTE CORONARY SYNDROMES; OXIDATIVE STRESS; PLATELET ACTIVATION; DIALYSIS PATIENTS; N-ACETYLCYSTEINE; NEPHROPATHY; INFLAMMATION; ANTIOXIDANT; GLUTATHIONE	Background Evidence points to activation of pro-inflammatory and pro-thrombotic stimuli during the haemodialysis process in end-stage renal disease (ESRD) with potential to predispose to cardiovascular events. Diabetes is associated with a higher incidence of cardiovascular disease in haemodialysis patients. We tested the hypothesis that a range of mediators and markers that modulate cardiovascular risk are elevated in haemodialysis patients with diabetes compared to those without. Methods Men and women with diabetes (n = 6) and without diabetes (n = 6) aged 18-90 years receiving haemodialysis were recruited. Blood samples were collected and analysed pre- and post-haemodialysis sessions for (platelet-monocyte conjugates (PMC), oxidised LDL (Ox-LDL), endothelin 1 (ET-1) and vascular endothelial growth factor (VEGF-A). Results PMC levels significantly increased after haemodialysis in both groups (diabetes p = 0.047; non-diabetes p = 0.005). Baseline VEGF-A was significantly higher in people with diabetes (p = 0.009) and post-dialysis levels were significantly reduced in both groups (P = 0.002). Ox-LDL and CRP concentrations were not significantly different between groups nor affected in either group post-dialysis. Similarly, ET-1 concentrations were comparable in all patients at baseline, with no change post-dialysis in either group. Conclusions In this pilot study, we have confirmed that circulating PMCs are increased following dialysis irrespective of diabetes status. This is likely to be a mechanistic process and offers a potential explanation for high rates of vascular events associated with haemodialysis. The higher VEGF-A concentrations between patients with and without diabetes is a previously unreported finding in diabetic ESRD. Further research is merited to establish whether VEGF-A is a marker or mediator (or both) of cardiovascular risk in haemodialysis.	[Treweeke, A.; Hall, J.; Leslie, S. J.; Megson, I. L.; MacRury, S. M.] Univ Highlands & Isl, Div Hlth Res, Inverness, Scotland; [Lambie, S.; Leslie, S. J.; MacRury, S. M.] Raigmore Hosp, Dept Med, Inverness, Scotland	UHI Millennium Institute	MacRury, SM (corresponding author), Univ Highlands & Isl, Div Hlth Res, Inverness, Scotland.; MacRury, SM (corresponding author), Raigmore Hosp, Dept Med, Inverness, Scotland.	Sandra.macrury@uhi.ac.uk	Megson, Ian/K-2195-2012	Megson, Ian/0000-0001-8287-2459; MacRury, Sandra/0000-0001-7599-1302	NHS Highland R&D endowment fund	NHS Highland R&D endowment fund	The authors received funding from NHS Highland R&D endowment fund to aid this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, US RENAL DATA SYSTEM; [Anonymous], 2010, AM J KIDNEY DIS S, V55, pS269; Aslam S, 2008, CURR OPIN NEPHROL HY, V17, P99; Avci E, 2014, RENAL FAILURE, V36, P767, DOI 10.3109/0886022X.2014.890841; Becker RC, 2005, AM HEART J, V150, P189, DOI 10.1016/j.ahj.2005.04.006; Chang JJY, 2006, SEMIN DIALYSIS, V19, P297, DOI 10.1111/j.1525-139X.2006.00176.x; Couser WG, 2011, KID INT; Davenport AP, 2016, PHARMACOL REV, V68, P357, DOI 10.1124/pr.115.011833; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Doi K, 2010, CURR VASC PHARMACOL, V8, P122, DOI 10.2174/157016110790226606; Filiopoulos V, 2009, INT J ARTIF ORGANS, V32, P872, DOI 10.1177/039139880903201206; Foley RN, 1997, DIABETOLOGIA, V40, P1307, DOI 10.1007/s001250050825; Gibson KR, 2009, J CARDIOVASC PHARM, V54, P319, DOI 10.1097/FJC.0b013e3181b6e77b; Gutierrez-Adrianzen OA, 2014, J HUM HYPERTENS, P1; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Karalliedde J, 2011, DIABETES CARE, V34, pS291, DOI 10.2337/dc11-s241; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Lim HS, 2004, DIABETES CARE, V27, P2918, DOI 10.2337/diacare.27.12.2918; MacNeil SJ, 2016, NEPHRON S1, V132, P41; Martins PD, 2004, ARTERIOSCL THROM VAS, V24, P193, DOI 10.1161/01.ATV.0000106320.40933.E5; McCullough PA, 2008, AM J KIDNEY DIS, V51, pS38, DOI 10.1053/j.ajkd.2007.12.017; Megson Ian L, 2015, J Diabetes Sci Technol, V9, P573, DOI 10.1177/1932296815570359; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; Ndip A, 2010, DIABETES CARE, V33, P1811, DOI 10.2337/dc10-0255; Nitsch D, 2007, QJM-INT J MED, V100, P551, DOI 10.1093/qjmed/hcm062; Pawlak K, 2006, THROMB RES, V117, P517, DOI 10.1016/j.thromres.2005.05.001; Pernow J, 2012, LIFE SCI, V91, P507, DOI 10.1016/j.lfs.2012.03.029; Sarma J, 2002, CIRCULATION, V105, P2166, DOI 10.1161/01.CIR.0000015700.27754.6F; Shoji T, 2005, J ATHEROSCLER THROMB, V12, P344, DOI 10.5551/jat.12.344; Sirolli V, 2006, INT J IMMUNOPATH PH, V19, P461, DOI 10.1177/039463200601900302; Treweeke AT, 2012, DIABETOLOGIA, V55, P2920, DOI 10.1007/s00125-012-2685-z; Van Dijk PC, 2005, KIDNEY INT, V67, P1489, DOI DOI 10.1111/J.1523-1755.2005.00227.X; Wang JH, 2007, INT J CARDIOL, V115, P361, DOI 10.1016/j.ijcard.2006.03.019; Yuan J, 2013, ADV MATH PHYS, V2013, P1, DOI DOI 10.1093/NDT/GFT256; Zhang SZ, 2007, CLIN CARDIOL, V30, P26, DOI 10.1002/clc.2	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178171	10.1371/journal.pone.0178171	http://dx.doi.org/10.1371/journal.pone.0178171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542479	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058800044
J	Schroder, H; Henke, A; Stieger, L; Beckers, S; Biermann, H; Rossaint, R; Sopka, S				Schroeder, Hanna; Henke, Alexandra; Stieger, Lina; Beckers, Stefan; Biermann, Henning; Rossaint, Rolf; Sopka, Sasa			Influence of learning styles on the practical performance after the four-step basic life support training approach - An observational cohort study	PLOS ONE			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; HOSPITAL CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; EUROPEAN RESUSCITATION; CHEST COMPRESSIONS; COUNCIL GUIDELINES; MEDICAL-STUDENTS; CPR PERFORMANCE; RETENTION; SKILLS	Background Learning and training basic life support (BLS)-especially external chest compressions (ECC) within the BLS-algorithm-are essential resuscitation training for laypersons as well as for health care professionals. The objective of this study was to evaluate the influence of learning styles on the performance of BLS and to identify whether all types of learners are sufficiently addressed by Peytons four-step approach for BLS training. Methods A study group of first-year medical students (n = 334) without previous medical knowledge was categorized according to learning styles using the German Lernstilinventar questionnaire based on Kolb's Learning Styles Inventory. Students' BLS performances were assessed before and after a four-step BLS training approach lasting 4 hours. Standardized BLS training was provided by an educational staff consisting of European Resuscitation Council-certified advanced life support providers and instructors. Pre- and post-intervention BLS performance was evaluated using a single-rescuer-scenario and standardized questionnaires (6-point-Likert-scales: 1 = completely agree, 6 = completely disagree). The recorded points of measurement were the time to start, depth, and frequency of ECC. Results The study population was categorized according to learning styles: diverging (5%, n = 16), assimilating (36%, n = 121), converging (41%, n = 138), and accommodating (18%, n = 59). Independent of learning styles, both male and female participants showed significant improvement in cardiopulmonary resuscitation (CPR) performance. Based on the Kolb learning styles, no significant differences between the four groups were observed in compression depth, frequency, time to start CPR, or the checklist-based assessment within the baseline assessment. A significant sex effect on the difference between pre- and post-interventional assessment points was observed for mean compression depth and mean compression frequency. Conclusions The findings of this work show that the four-step-approach for BLS training addresses all types of learners independent of their learning styles and does not lead to significant differences in the performance of CPR.	[Schroeder, Hanna; Beckers, Stefan; Rossaint, Rolf; Sopka, Sasa] Rhein Westfal TH Aachen, Univ Hosp, Dept Anaesthesiol, Aachen, North Rhine Wes, Germany; [Schroeder, Hanna; Stieger, Lina; Beckers, Stefan; Sopka, Sasa] Rhein Westfal TH Aachen, Med Fac, Aachen Interdisciplinary Training Ctr Med Educ, Aachen, North Rhine Wes, Germany; [Henke, Alexandra] Hermann Josef Hosp, Dept Internal Med, Erkelenz, North Rhine Wes, Germany; [Biermann, Henning] Agaples Elisabethenstift, Dept Internal Med, Darmstadt, Hesse, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University	Schroder, H (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Dept Anaesthesiol, Aachen, North Rhine Wes, Germany.; Schroder, H (corresponding author), Rhein Westfal TH Aachen, Med Fac, Aachen Interdisciplinary Training Ctr Med Educ, Aachen, North Rhine Wes, Germany.	hschroeder@ukaachen.de	Sopka, Sasa/M-4990-2017; Beckers, Stefan K./O-2943-2019; Schröder, Hanna/AAE-6335-2021	Sopka, Sasa/0000-0003-2165-5578; Beckers, Stefan K./0000-0002-2896-7948; 				Abella BS, 2005, CIRCULATION, V111, P428, DOI 10.1161/01.CIR.0000153811.84257.59; Al-Kadri HMF, THESIS; Barelli A, 2010, RESUSCITATION, V81, P1607, DOI 10.1016/j.resuscitation.2010.09.010; Beckers SK, 2007, RESUSCITATION, V72, P444, DOI 10.1016/j.resuscitation.2006.08.001; Beckers SK, 2007, RESUSCITATION, V72, P100, DOI 10.1016/j.resuscitation.2006.05.020; Bullock I, 2000, RESUSCITATION, V45, P139, DOI 10.1016/S0300-9572(00)00171-4; Chamberlain D, 2002, RESUSCITATION, V53, P179, DOI 10.1016/S0300-9572(02)00025-4; Chamberlain D, 2001, RESUSCITATION, V50, P27, DOI 10.1016/S0300-9572(01)00342-2; Cliffs E., 2010, KOLB EXPERIENTIAL LE; Coffield F., 2004, SHOULD WE BE USING L; Engels PT, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-51; Epstein RM, 2007, NEW ENGL J MED, V356, P4; Fabry G, 2010, GMS Z MED AUSBILD, V29, P4, DOI [10.3205/zma00826, DOI 10.3205/zma00826]; Greif R, 2010, RESUSCITATION, V81, P1692, DOI 10.1016/j.resuscitation.2010.09.478; Haller HD, PAD SEM GOTT; Handley JA, 1998, RESUSCITATION, V36, P3, DOI 10.1016/S0300-9572(97)00095-6; Koster RW, 2010, RESUSCITATION, V81, P1277, DOI 10.1016/j.resuscitation.2010.08.009; Murray C, 2011, J ALLIED HLTH, V40, P67, DOI DOI 10.3109/07380577.2012.763199; Odegaard S, 2007, RESUSCITATION, V74, P127, DOI 10.1016/j.resuscitation.2006.12.006; Orde S, 2010, RESUSCITATION, V81, P1687, DOI 10.1016/j.resuscitation.2010.05.026; Pashler Harold, 2008, Psychol Sci Public Interest, V9, P105, DOI 10.1111/j.1539-6053.2009.01038.x; Peyton JWR, 1998, TEACHING LEARNING ME; Rohrer D, 2012, MED EDUC, V46, P634, DOI 10.1111/j.1365-2923.2012.04273.x; Sarac L, 2010, RESUSCITATION, V81, P555, DOI 10.1016/j.resuscitation.2009.08.030; Schwerdtfeger K, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-104; Soar J, 2010, RESUSCITATION, V81, P1434, DOI 10.1016/j.resuscitation.2010.08.014; Wik L, 2005, JAMA-J AM MED ASSOC, V293, P299, DOI 10.1001/jama.293.3.299	27	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178210	10.1371/journal.pone.0178210	http://dx.doi.org/10.1371/journal.pone.0178210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542636	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400070
J	Choi, Y; Kim, SH; Youn, IK; Kang, BJ; Park, WC; Lee, A				Choi, Yangsean; Kim, Sung Hun; Youn, In Kyung; Kang, Bong Joo; Park, Woo-chan; Lee, Ahwon			Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype	PLOS ONE			English	Article							FEATURES; LESIONS; TUMORS; CARCINOMA; BENIGN	Purpose To investigate associations between the clinicopathologic features and MRI features of triple-negative breast cancer (TNBC) and ER-positive breast cancer (BC) via apparent diffusion coefficient (ADC) histogram analysis. Materials and methods In this study, 221 breast cancer patients with pre-operative MRI performed from August 2009 to March 2015 were included in a retrospective analysis. All patients had a pathologically confirmed diagnosis of invasive carcinoma and were grouped into ER-positive (149) or triple-negative (72) subtypes. DWI rim sign and various ADC parameters (mean; mode; 25, 50, and 75 percentiles; skewness; and kurtosis) between ER-positive and TNBC were compared using whole-lesion ADC histogram analysis. Univariate and multivariate regression analyses were used for statistical comparison. Results DWI rim signs were detected in 42.3% and 41.7% of ER-positive subtype and TNBC, respectively (P = 0.931). TNBC had poorer histologic grade (P<0.001) and higher Ki-67 expression (P<0.001) than ER-positive subtype BC. TNBC displayed higher ADC parameters (mean, mode, 50th & 75th percentiles, kurtosis on univariate analysis, all P<0.001; only kurtosis on multivariate anaylsis; P<0.001) than ER-positive subtype BC. TNBC had significantly more recurrence events than ER-positive subtype BC on univarate analysis (9.7% (7/72) vs. 2.7% (4/149), P = 0.035). Conclusion Poorer clinicopathologic outcomes were found in TNBC. Whole-lesion ADC histogram analysis revealed ADC kurtosis to be higher in TNBC than ER-positive subtype BC.	[Choi, Yangsean; Kim, Sung Hun; Youn, In Kyung; Kang, Bong Joo] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Park, Woo-chan] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Gen Surg, Seoul, South Korea; [Lee, Ahwon] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hosp Pathol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Kim, SH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Coll Med, Seoul, South Korea.	rad-ksh@catholic.ac.kr	Choi, Yangsean/AAR-5274-2020	Choi, Yangsean/0000-0003-1674-7101; Kim, Sung Hun/0000-0003-4478-9720				Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen JH, 2007, ANN ONCOL, V18, P2042, DOI 10.1093/annonc/mdm504; Costantini M, 2012, CLIN BREAST CANCER, V12, P331, DOI 10.1016/j.clbc.2012.07.002; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Elsawaf Z, 2011, BREAST CARE, V6, P273, DOI 10.1159/000331643; Guan Y, 2016, J COMPUT ASSIST TOMO, V40, P212, DOI 10.1097/RCT.0000000000000349; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Kang BJ, 2015, J MAGN RESON IMAGING, V41, P616, DOI 10.1002/jmri.24617; Kim EJ, 2015, J MAGN RESON IMAGING, V42, P1666, DOI 10.1002/jmri.24934; King AD, 2013, RADIOLOGY, V266, P531, DOI 10.1148/radiol.12120167; Krizmanich-Conniff KM, 2012, AM J ROENTGENOL, V199, P458, DOI 10.2214/AJR.10.6096; Ku YJ, 2016, AM J ROENTGENOL, V207, P1146, DOI 10.2214/AJR.16.16248; Li HT, 2015, ONCOL LETT, V9, P149, DOI 10.3892/ol.2014.2618; Li JF, 2014, MAGN RESON IMAGING, V32, P392, DOI 10.1016/j.mri.2013.12.013; Li SP, 2011, EUR RADIOL, V21, P1364, DOI 10.1007/s00330-011-2061-2; Paldino MJ, 2009, J MAGN RESON IMAGING, V29, P1199, DOI 10.1002/jmri.21732; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Sanchez-Munoz A, 2008, CLIN TRANSL ONCOL, V10, P646, DOI 10.1007/s12094-008-0265-y; Sharma U, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00126; Shindo T, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002574; Sinha S, 2002, J MAGN RESON IMAGING, V15, P693, DOI 10.1002/jmri.10116; Pereira JAS, 2015, ABDOM IMAGING, V40, P3122, DOI 10.1007/s00261-015-0524-7; Suo ST, 2014, ACAD RADIOL, V21, P1027, DOI 10.1016/j.acra.2014.03.004; Suo ST, 2016, J MAGN RESON IMAGING, V43, P894, DOI 10.1002/jmri.25043; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143308; Yamamoto Y, 2010, INT J CLIN ONCOL, V15, P341, DOI 10.1007/s10147-010-0106-1; Youk JH, 2012, EUR RADIOL, V22, P1724, DOI 10.1007/s00330-012-2425-2; Zhang Y., 2016, J MAGN RESON IMAGING	31	26	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177903	10.1371/journal.pone.0177903	http://dx.doi.org/10.1371/journal.pone.0177903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542297	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400110
J	Schaefer, S; Svenstrup, TH; Guerra, B				Schaefer, Susanne; Svenstrup, Tina H.; Guerra, Barbara			The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells	PLOS ONE			English	Article							PROTEIN-KINASE; TARGETING HSP90; CK2; 17-AAG; TANESPIMYCIN; AUTOPHAGY; SITES; DEATH	Many types of cancer express high levels of heat shock proteins (HSPs) that are molecular chaperones regulating protein folding and stability ensuring protection of cells from potentially lethal stress. HSPs in cancer cells promote survival, growth and spreading even in situations of growth factors deprivation by associating with oncogenic proteins responsible for cell transformation. Hence, it is not surprising that the identification of potent inhibitors of HSPs, notably HSP90, has been the primary research focus, in recent years. Exposure of cancer cells to HSP90 inhibitors, including 17-AAG, has been shown to cause resistance to chemotherapeutic treatment mostly attributable to induction of the heat shock response and increased cellular levels of pro-survival chaperones. In this study, we show that treatment of glioblastoma cells with 17-AAG leads to HSP90 inhibition indicated by loss of stability of the EGFR client protein, and significant increase in HSP70 expression. Conversely, co-treatment with the small-molecule kinase inhibitor D11 leads to suppression of the heat shock response and inhibition of HSF1 transcriptional activity. Beside HSP70, Western blot and differential mRNA expression analysis reveal that combination treatment causes strong down-regulation of the small chaperone protein HSP27. Finally, we demonstrate that incubation of cells with both agents leads to enhanced cytotoxicity and significantly high levels of LC3-II suggesting autophagy induction. Taken together, results reported here support the notion that including D11 in future treatment regimens based on HSP90 inhibition can potentially overcome acquired resistance induced by the heat shock response in brain cancer cells.	[Schaefer, Susanne; Svenstrup, Tina H.; Guerra, Barbara] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Southern Denmark	Guerra, B (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.	bag@bmb.sdu.dk		Guerra, Barbara/0000-0003-1136-2413	Danish Council for Independent Research-Natural Sciences [1323-00212A]	Danish Council for Independent Research-Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Council for Independent Research-Natural Sciences (Grant 1323-00212A to B. Guerra). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan A, 2012, NEOPLASIA, V14, P670, DOI 10.1593/neo.12986; Assimakopoulou M, 1997, ANTICANCER RES, V17, P2677; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chou S- D, 2012, PLOONE PUBLIC LIB, V7; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Concannon CG, 2005, CELL STRESS CHAPERON, V10, P59, DOI 10.1379/CSC-69R.1; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Dokladny K, 2013, J BIOL CHEM, V288, P14959, DOI 10.1074/jbc.M113.462408; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Gaspar N, 2009, CANCER RES, V69, P1966, DOI 10.1158/0008-5472.CAN-08-3131; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Guerra B, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0234-6; Guerra B, 2015, MOL CELL BIOCHEM, V406, P151, DOI 10.1007/s11010-015-2433-z; Guerra B, 2015, CANCER LETT, V356, P751, DOI 10.1016/j.canlet.2014.10.026; Guerra B, 2014, CANCER LETT, V345, P115, DOI 10.1016/j.canlet.2013.11.008; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Li D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.158; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; Mayer MP, 2009, NAT STRUCT MOL BIOL, V16, P2, DOI 10.1038/nsmb0109-2; Mayor-Lopez L, 2014, TRANSL ONCOL, V7, P590, DOI 10.1016/j.tranon.2014.08.001; Mercier PA, 1999, J CELL SCI, V112, P2765; Miyata Y, 2005, MOL CELL BIOCHEM, V274, P171, DOI 10.1007/s11010-005-2949-8; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Naidu SD, 2016, MOL CELL BIOL, V36, P2403, DOI 10.1128/MCB.00292-16; Olsen BB, 2010, ONCOGENE, V29, P6016, DOI 10.1038/onc.2010.337; Olsen BB, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-7; Park MA, 2008, MOL PHARMACOL, V73, P1168, DOI 10.1124/mol.107.042697; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	50	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177706	10.1371/journal.pone.0177706	http://dx.doi.org/10.1371/journal.pone.0177706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542269	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400069
J	Schmidt, I; Brunner, M; Keller, L; Scherrer, V; Wollschlager, R; Baudson, TG; Preckel, F				Schmidt, Isabelle; Brunner, Martin; Keller, Lena; Scherrer, Vsevolod; Wollschlager, Rachel; Baudson, Tanja Gabriele; Preckel, Franzis			Profile formation of academic self-concept in elementary school students in grades 1 to 4	PLOS ONE			English	Article							DIMENSIONAL COMPARISON THEORY; CONFIRMATORY FACTOR-ANALYSIS; INTERNAL/EXTERNAL FRAME; HIERARCHICAL STRUCTURE; REFERENCE MODEL; MULTIPLE DIMENSIONS; EXTERNAL FRAMES; ACHIEVEMENT; MATH; AGE	Academic self-concept (ASC) is comprised of individual perceptions of one's own academic ability. In a cross-sectional quasi-representative sample of 3,779 German elementary school children in grades 1 to 4, we investigated (a) the structure of ASC, (b) ASC profile formation, an aspect of differentiation that is reflected in lower correlations between domain-specific ASCs with increasing grade level, (c) the impact of (internal) dimensional comparisons of one's own ability in different school subjects for profile formation of ASC, and (d) the role played by differences in school grades between subjects for these dimensional comparisons. The nested Marsh/Shavelson model, with general ASC at the apex and math, writing, and reading ASC as specific factors nested under general ASC fitted the data at all grade levels. A first-order factor model with math, writing, reading, and general ASCs as correlated factors provided a good fit, too. ASC profile formation became apparent during the first two to three years of school. Dimensional comparisons across subjects contributed to ASC profile formation. School grades enhanced these comparisons, especially when achievement profiles were uneven. In part, findings depended on the assumed structural model of ASCs. Implications for further research are discussed with special regard to factors influencing and moderating dimensional comparisons.	[Schmidt, Isabelle; Scherrer, Vsevolod; Preckel, Franzis] Univ Trier, Dept Psychol, Trier, Germany; [Brunner, Martin; Keller, Lena] Univ Potsdam, Dept Educ Sci, Potsdam, Germany; [Keller, Lena] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Wollschlager, Rachel] Univ Luxembourg, Luxembourg Ctr Educ Testing LUCET, Fac Language & Literature Humanities Arts & Educ, Esch Sur Alzette, Luxembourg; [Baudson, Tanja Gabriele] TU Dortmund Univ, Fac Rehabil Sci, Dortmund, Germany	Universitat Trier; University of Potsdam; Free University of Berlin; University of Luxembourg; Dortmund University of Technology	Schmidt, I (corresponding author), Univ Trier, Dept Psychol, Trier, Germany.	schmidtisa@uni-trier.de	Schmidt, Isabelle/P-1567-2019; Baudson, Tanja Gabriele/AAA-3499-2022	Schmidt, Isabelle/0000-0002-7631-5303; Keller, Lena Kristina/0000-0002-3242-0208; Brunner, Martin/0000-0001-7182-5622	Hogrefe Publishing Company, Gottingen	Hogrefe Publishing Company, Gottingen	The data on which this study is based stem from the THINK Project by Franzis Preckel and Tanja Gabriele Baudson, a cross-sectional study on intelligence and cognitive motivation in German elementary schools. The Project was funded by the Hogrefe Publishing Company, Gottingen. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens AK, 2016, J EDUC PSYCHOL, V108, P646, DOI 10.1037/edu0000081; Arens AK, 2014, J EXP EDUC, V82, P229, DOI 10.1080/00220973.2013.813362; Arens AK, 2016, AM ED RES J; Baudson T.G., 2016, TEST ERFASSUNG INTEL; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Brunner M, 2008, MULTIVAR BEHAV RES, V43, P137, DOI 10.1080/00273170701836737; Brunner M, 2012, J PERS, V80, P796, DOI 10.1111/j.1467-6494.2011.00749.x; Brunner M, 2010, J EDUC PSYCHOL, V102, P964, DOI 10.1037/a0019644; Brunner M, 2009, LEARN INDIVID DIFFER, V19, P387, DOI 10.1016/j.lindif.2008.11.008; Chen FF, 2006, MULTIVAR BEHAV RES, V41, P189, DOI 10.1207/s15327906mbr4102_5; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Craven R.G., 2008, ED CHILD PSYCHOL, V25, P104; Davies J., 1994, BRIT EDUC RES J, V20, P447, DOI [DOI 10.1080/0141192940200406, 10.1080/0141192940200406]; Dickhauser O, 2005, BRIT J EDUC PSYCHOL, V75, P673, DOI 10.1348/000709905X37181; Dweck C. S., 2002, DEV ACHIEVEMENT MOTI, P57, DOI [10.1016/B978-012750053-9/50005-X, DOI 10.1016/B978-012750053-9/50005-X]; Ehm JH, 2014, EUR J PSYCHOL EDUC, V29, P277, DOI 10.1007/s10212-013-0198-x; Eid M, 2003, PSYCHOL METHODS, V8, P38, DOI 10.1037/1082-989X.8.1.38; Eid M., 2016, PSYCHOL METHODS; GOPNIK A, 1988, CHILD DEV, V59, P26, DOI 10.2307/1130386; Harter S., 1999, CONSTRUCTION SELF; Helm F., 2016, AERA OPEN, V2, DOI DOI 10.1177/2332858416650624; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Krajewski K, 2008, Z ENTWICKL PADAGOGIS, V40, P135, DOI 10.1026/0049-8637.40.3.135; Lau I. C., 1999, J EDUC PSYCHOL, V91, P747, DOI DOI 10.1037/0022-0663.91.4.747; Marsh H., 1988, SELF DESCRIPTION QUE; Marsh HW, 2006, INT J TEST, V6, P311, DOI 10.1207/s15327574ijt0604_1; Marsh HW, 2014, CONTEMP EDUC PSYCHOL, V39, P326, DOI 10.1016/j.cedpsych.2014.08.003; Marsh HW, 1990, EDUC PSYCHOL REV, V2, P77, DOI 10.1007/BF01322177; Marsh HW, 1985, EDUC PSYCHOL-US, V20, P107, DOI 10.1207/s15326985ep2003_1; Marsh HW, 2011, BRIT J EDUC PSYCHOL, V81, P59, DOI 10.1348/000709910X503501; MARSH HW, 1988, J EDUC PSYCHOL, V80, P366, DOI 10.1037/0022-0663.80.3.366; Marsh HW, 2002, DEV PSYCHOL, V38, P376, DOI 10.1037//0012-1649.38.3.376; MARSH HW, 1991, J EDUC PSYCHOL, V83, P377, DOI 10.1037/0022-0663.83.3.377; MARSH HW, 1990, J EDUC PSYCHOL, V82, P107, DOI 10.1037/0022-0663.82.1.107; Marsh HW, 2004, J EDUC PSYCHOL, V96, P56, DOI 10.1037/0022-0663.96.1.56; Marsh HW, 2003, J EDUC PSYCHOL, V95, P687, DOI 10.1037/0022-0663.95.4.687; Marsh HW, 1998, CHILD DEV, V69, P1030, DOI 10.2307/1132361; MARSH HW, 1989, J EDUC PSYCHOL, V81, P417, DOI 10.1037/0022-0663.81.3.417; MARSH HW, 1984, J EDUC PSYCHOL, V76, P940, DOI 10.1037/0022-0663.76.5.940; MARSH HW, 1986, AM EDUC RES J, V23, P129, DOI 10.2307/1163048; MARSH HW, 1990, J EDUC PSYCHOL, V82, P623, DOI 10.1037/0022-0663.82.4.623; MARSH HW, 1985, PSYCHOL BULL, V97, P562, DOI 10.1037/0033-2909.97.3.562; McDonald RP, 1999, TEST THEORY UNIFIED; Miller S. A., 1998, DEV RES METHODS; Millsap RE, 2004, MULTIVAR BEHAV RES, V39, P479, DOI 10.1207/S15327906MBR3903_4; Moller J, 2013, PSYCHOL REV, V120, P544, DOI 10.1037/a0032459; Moller J, 2009, REV EDUC RES, V79, P1129, DOI 10.3102/0034654309337522; Moller J, 2006, BRIT J EDUC PSYCHOL, V76, P57, DOI 10.1348/000709905X37451; Muthen B., 1997, ROBUST INFERENCE USI; Muthen L. K., 1998, MPLUS VERSION 7 31; NICHOLLS JG, 1979, J EDUC PSYCHOL, V71, P94, DOI 10.1037/0022-0663.71.1.94; Niepel C, 2014, J EDUC PSYCHOL, V106, P1170, DOI 10.1037/a0036307; Nussbeck FW, 2009, METHODOLOGY-EUR, V5, P88, DOI 10.1027/1614-2241.5.3.88; OMara A., 2006, ED PSYCHOL, V41; Pinxten M, 2015, CONTEMP EDUC PSYCHOL, V41, P124, DOI 10.1016/j.cedpsych.2014.12.003; Poloczek S, 2011, Z PADAGOG PSYCHOL, V25, P173, DOI 10.1024/1010-0652/a000045; Rauer W, 2003, FRAGBOGEN ERFASSUNG; Rauer W., 2003, FRAGEBOGEN ERFASSUNG; Robinson K, HDB RES METHODS DEV; Rost DH, 2005, LEARN INSTR, V15, P557, DOI 10.1016/j.learninstruc.2005.08.003; Rost DH, 2004, Z PADAGOG PSYCHOL, V18, P43, DOI 10.1024/1010-0652.18.1.43; Sass DA, 2011, J PSYCHOEDUC ASSESS, V29, P347, DOI 10.1177/0734282911406661; SHAVELSON RJ, 1976, REV EDUC RES, V46, P407, DOI 10.3102/00346543046003407; Skaalvik EM, 2002, EDUC PSYCHOL, V37, P233, DOI 10.1207/S15326985EP3704_3; Wigfield A., 2002, DEV ACHIEVEMENT MOTI, P91, DOI DOI 10.1016/B978-012750053-9/50006-1; Yeung AS, 2000, J EDUC PSYCHOL, V92, P556, DOI 10.1037//0022-0663.92.3.556; Yu C.-Y., 2002, THESIS	68	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177854	10.1371/journal.pone.0177854	http://dx.doi.org/10.1371/journal.pone.0177854			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542384	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400102
J	Tamura, M; Kageyama, D; Honda, N; Fujimoto, H; Kato, A				Tamura, Masaru; Kageyama, Daisuke; Honda, Naoko; Fujimoto, Hirofumi; Kato, Atsushi			Enzymatic activity necessary to restore the lethality due to Escherichia coli RNase E deficiency is distributed among bacteria lacking RNase E homologues	PLOS ONE			English	Article							23S RIBOSOMAL-RNA; MESSENGER-RNA; BACILLUS-SUBTILIS; E ESSENTIALITY; EUREMA-HECABE; HFQ BINDING; IN-VIVO; PROTEIN; GENE; MATURATION	Escherichia coli RNase E (Eco-RNase E), encoded by rne (Eco-rne), is considered the global RNA decay initiator. Although Eco-RNase E is an essential gene product in E. coli, some bacterial species, such as Bacillus subtilis, do not possess Eco-RNase E sequence homologues. B. subtilis instead possesses RNase J1/J2 (Bsu-RNase J1/J2) and RNase Y (Bsu-RNase Y) to execute RNA decay. Here we found that E. coli lacking the Eco-rne gene (Delta rne E. coli) was viable conditional on M9 minimal media by introducing Bsu-RNase J1/J2 or Bsu-RNase Y. We also cloned an extremely short Eco-RNase E homologue (Wpi-RNase E) and a canonical sized Bsu-RNase J1/J2 homologue (Wpi-RNase J) from Wolbachia pipientis, an alpha-proteobacterial endosymbiont of arthropods. We found that Wpi-RNase J restored the colony-forming ability (CFA) of Delta rne E. coli, whereas Wpi-RNase E did not. Unexpectedly, Wpi-RNase E restored defective CFA due to lack of Eco-RNase G, a paralogue of Eco-RNase E. Our results indicate that bacterial species that lack Eco-RNase E homologues or bacterial species that possess Eco-RNase E homologues which lack Eco-RNase E-like activities have a modest Eco-RNase E-like function using RNase J and/or RNase Y. These results suggest that Eco-RNase E-like activities might distribute among a wide array of bacteria and that functions of RNases may have changed dynamically during evolutionary divergence of bacterial lineages.	[Tamura, Masaru; Honda, Naoko; Fujimoto, Hirofumi; Kato, Atsushi] Natl Inst Infect Dis, Dept Qual Assurance & Radiol Protect, Shinjuku Ku, Tokyo, Japan; [Kageyama, Daisuke] Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	National Institute of Infectious Diseases (NIID); National Agriculture & Food Research Organization - Japan	Tamura, M (corresponding author), Natl Inst Infect Dis, Dept Qual Assurance & Radiol Protect, Shinjuku Ku, Tokyo, Japan.	mtamura@niid.go.jp	Kageyama, Daisuke/B-4460-2010	Kageyama, Daisuke/0000-0002-9026-9825	Japan Agency for Medical Research and Development (AMED) [48650201]; Ministry of Health, Labour and Welfare (MHLW) [10201500];  [16K08106]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); 	This study was supported by a 'Japan Agency for Medical Research and Development (AMED)' grant 48650201 and 'Ministry of Health, Labour and Welfare (MHLW)' grant 10201500 to AK, and by 'Grants-in-Aid for Scientific Research (KAKEN-HI)' 16K08106 to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Bara S, 2015, MOL MICROBIOL, V97, P1021, DOI 10.1111/mmi.13095; ALIFANO P, 1994, GENE DEV, V8, P3021, DOI 10.1101/gad.8.24.3021; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apirion D, 1980, PROCESSING RRNA TRNA; Baginsky S, 2001, RNA, V7, P1464; Baumgardt K, 2017, MICROBIOL-SGM, V163, P570, DOI 10.1099/mic.0.000442; Baumgardt K, 2014, J BACTERIOL, V196, P1435, DOI 10.1128/JB.01471-13; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chung DH, 2010, RNA, V16, P1371, DOI 10.1261/rna.2104810; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P1293, DOI 10.1073/pnas.70.5.1293; COHEN SN, 1977, J BACTERIOL, V132, P734, DOI 10.1128/JB.132.2.734-737.1977; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; Condon C, 1997, J MOL BIOL, V268, P235, DOI 10.1006/jmbi.1997.0971; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2004, MOL MICROBIOL, V51, P1205, DOI 10.1046/j.1365-2958.2003.03905.x; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003181; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Evguenieva-Hackenberg E, 2003, EMBO REP, V4, P889, DOI 10.1038/sj.embor.embor929; Figaro S, 2013, J BACTERIOL, V195, P2340, DOI 10.1128/JB.00164-13; GHORA BK, 1978, CELL, V15, P1055, DOI 10.1016/0092-8674(78)90289-1; GROS F, 1961, NATURE, V190, P581, DOI 10.1038/190581a0; Hardwick SW, 2011, NUCLEIC ACIDS RES, V39, P1449, DOI 10.1093/nar/gkq928; Hiroki M, 2004, P ROY SOC B-BIOL SCI, V271, P1751, DOI 10.1098/rspb.2004.2769; Ikeda Y, 2011, MOL MICROBIOL, V79, P419, DOI 10.1111/j.1365-2958.2010.07454.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaberdin VR, 1998, P NATL ACAD SCI USA, V95, P11637, DOI 10.1073/pnas.95.20.11637; Kageyama D, 2008, MICROB ECOL, V56, P733, DOI 10.1007/s00248-008-9392-9; Khemici V, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005577, 10.1371/journal.pgen.1006320]; Lee K, 2003, MOL MICROBIOL, V48, P349, DOI 10.1046/j.1365-2958.2003.03435.x; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; Lehnik-Habrink M, 2011, J BACTERIOL, V193, P5431, DOI 10.1128/JB.05500-11; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LINCHAO S, 1991, CELL, V65, P1233, DOI 10.1016/0092-8674(91)90018-T; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; LUNDBERG U, 1995, RNA, V1, P327; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Madhugiri R, 2009, FEBS LETT, V583, P2339, DOI 10.1016/j.febslet.2009.06.026; Maeda S., 1989, INVERTEBRATE CELL SY, P167; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mohanty BK, 2016, NUCLEIC ACIDS RES, V44, P6350, DOI 10.1093/nar/gkw517; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Narita S, 2007, FEMS MICROBIOL ECOL, V61, P235, DOI 10.1111/j.1574-6941.2007.00333.x; Narita S, 2011, ECOL ENTOMOL, V36, P309, DOI 10.1111/j.1365-2311.2011.01274.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; ONO M, 1979, J MOL BIOL, V129, P343, DOI 10.1016/0022-2836(79)90500-X; Ow MC, 2003, MOL MICROBIOL, V49, P607, DOI 10.1046/j.1365-2958.2003.03587.x; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Prud'homme-Genereux A, 2004, MOL MICROBIOL, V54, P1409, DOI 10.1111/j.1365-2958.2004.04360.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Richards J, 2016, J BIOL CHEM, V291, P5038, DOI 10.1074/jbc.M115.702555; Rische T, 2012, RNA BIOL, V9, P343, DOI 10.4161/rna.19433; Rische-Grahl T, 2014, RNA BIOL, V11, P855, DOI 10.4161/rna.29440; Sakai T, 2007, APPL MICROBIOL BIOT, V76, P183, DOI 10.1007/s00253-007-1006-9; Sambrook J., 2001, MOL CLONING LAB MANU; Schein A, 2008, RNA, V14, P1057, DOI 10.1261/rna.907608; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh D, 2009, P NATL ACAD SCI USA, V106, P864, DOI 10.1073/pnas.0810205106; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stead MB, 2011, NUCLEIC ACIDS RES, V39, P3188, DOI 10.1093/nar/gkq1242; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura M, 2006, J BACTERIOL, V188, P5145, DOI 10.1128/JB.00367-06; Tamura M, 2016, ARCH MICROBIOL, V198, P409, DOI 10.1007/s00203-016-1201-0; Tamura M, 2013, J BACTERIOL, V195, P1133, DOI 10.1128/JB.01558-12; Tamura M, 2012, J BACTERIOL, V194, P1919, DOI 10.1128/JB.06652-11; Taverniti V, 2011, MOL MICROBIOL, V82, P1260, DOI 10.1111/j.1365-2958.2011.07888.x; Umitsuki G, 2001, GENES CELLS, V6, P403, DOI 10.1046/j.1365-2443.2001.00430.x; Vanderpool CK, 2005, NAT STRUCT MOL BIOL, V12, P285, DOI 10.1038/nsmb0405-285; Wachi M, 1999, BIOCHEM BIOPH RES CO, V259, P483, DOI 10.1006/bbrc.1999.0806; Wachi M, 1997, MOL GEN GENET, V253, P515, DOI 10.1007/s004380050352; WANG M, 1994, P NATL ACAD SCI USA, V91, P10591, DOI 10.1073/pnas.91.22.10591; Woolfit M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118595; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019	83	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177915	10.1371/journal.pone.0177915	http://dx.doi.org/10.1371/journal.pone.0177915			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542621	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400113
J	Linck, H; Kruger, E; Reineke, A				Linck, Holger; Krueger, Erika; Reineke, Annette			A multiplex TaqMan qPCR assay for sensitive and rapid detection of phytoplasmas infecting Rubus species	PLOS ONE			English	Article							REAL-TIME PCR; APPLE PROLIFERATION; YELLOWS PHYTOPLASMA; ELM YELLOWS; IDENTIFICATION; AMPLIFICATION; UNIVERSAL; VECTORS; PLANTS; GENES	Rubus stunt is an economically important disease in the production of raspberries, blackberries, and loganberries. A fast, sensitive, and reliable diagnosis of phytoplasmas, the causal agent of the disease, is of prime importance to stop its spread by vegetative propagation and by insect vectors. Therefore, multiplex qPCR assays using TaqMan probes with different kinds of fluorophores in one reaction were developed, allowing the detection of phytoplasmas in general as well as a more specific detection of phytoplasmas belonging to group 16SrV and host DNA (either plant or insect). This assay now provides a practical tool for the screening of motherplants and monitoring the presence and distribution of phytoplasmas in Rubus plants of different geographic origins, cultivars, and cultivation systems, as well as in putative insect vectors like leafhoppers.	[Linck, Holger; Reineke, Annette] Hsch Geisenheim Univ, Dept Phytomed, Geisenheim, Germany; [Krueger, Erika] Hsch Geisenheim Univ, Dept Pomiculture, Geisenheim, Germany		Linck, H (corresponding author), Hsch Geisenheim Univ, Dept Phytomed, Geisenheim, Germany.	holger.linck@hs-gm.de			Federal Ministry of Food, Agriculture and Consumer Protection (BMELV);  [2814703611]	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV); 	The project was supported by funds of the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support programme (Grant number: 2814703611; URL: http://www.ble.ed/EN/00_Home/homepage_node. html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini E, 2007, J MICROBIOL METH, V68, P613, DOI 10.1016/j.mimet.2006.11.015; Baric S, 2006, PLANT MOL BIOL REP, V24, P169, DOI 10.1007/BF02914056; Baric S, 2004, J MICROBIOL METH, V57, P135, DOI 10.1016/j.mimet.2003.12.009; Bertaccini A., 1995, Acta Horticulturae, P126; Borroto Fernandez EG, 2007, B INSECTOL, V60, P391; Christensen NM, 2004, MOL PLANT MICROBE IN, V17, P1175, DOI 10.1094/MPMI.2004.17.11.1175; Christensen Nynne Meyn, 2013, Methods Mol Biol, V938, P245, DOI 10.1007/978-1-62703-089-2_21; Cieslinska M, 2011, J PLANT PATHOL, V93, P51; D'Amelio R, 2008, B INSECTOL, V61, P349; Daire X, 1997, EUR J PLANT PATHOL, V103, P507, DOI 10.1023/A:1008641411025; Danet J. L., 2010, Julius-Kuhn-Archiv, P35; Davies DL, 2000, PLANT PATHOL, V49, P86, DOI 10.1046/j.1365-3059.2000.00418.x; de FLUTTER H. J., 1953, TIJDSCHR PLANTENZIEKTEN, V59, P195, DOI 10.1007/BF01988195; Delic D., 2012, POLYMERASE CHAIN REA, P91; DENG SJ, 1991, J MICROBIOL METH, V14, P53, DOI 10.1016/0167-7012(91)90007-D; Fahmeed F, 2009, J PHYTOPATHOL, V157, P639, DOI 10.1111/j.1439-0434.2009.01549.x; Galetto L, 2005, ANN APPL BIOL, V147, P191, DOI 10.1111/j.1744-7348.2005.00030.x; Herath P, 2010, PLANT DIS, V94, P1355, DOI 10.1094/PDIS-12-09-0783; Hodgetts J, 2009, APPL ENVIRON MICROB, V75, P2945, DOI 10.1128/AEM.02610-08; Hoshi A, 2007, B INSECTOL, V60, P105; Jarausch W, 2001, EUR J PLANT PATHOL, V107, P209, DOI 10.1023/A:1011234921833; Lee I. M., 1995, Phytopathologia Mediterranea, V34, P174; LORENZ KH, 1995, PHYTOPATHOLOGY, V85, P771, DOI 10.1094/Phyto-85-771; Malandraki I, 2015, J VIROL METHODS, V213, P12, DOI 10.1016/j.jviromet.2014.11.010; Malembic-Maher S, 2011, INT J SYST EVOL MICR, V61, P2129, DOI 10.1099/ijs.0.025411-0; Marcone C, 1997, EUR J FOREST PATHOL, V27, P45; Marzachi C, 2005, MOL BIOTECHNOL, V30, P117, DOI 10.1385/MB:30:2:117; Marzachi C, 1998, ANN APPL BIOL, V133, P45, DOI 10.1111/j.1744-7348.1998.tb05801.x; MAURER R, 1995, PLANT PATHOL, V44, P244, DOI 10.1111/j.1365-3059.1995.tb02775.x; Minguzzi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146515; Monti M, 2013, MOL CELL PROBE, V27, P129, DOI 10.1016/j.mcp.2013.02.001; Nikolic P, 2010, MOL CELL PROBE, V24, P303, DOI 10.1016/j.mcp.2010.06.005; Oberhansli T, 2011, B INSECTOL, V64, pS37; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Pelletier C, 2009, VITIS, V48, P87; Rashidi M, 2014, ANN APPL BIOL, V165, P404, DOI 10.1111/aab.12146; Reeder R, 2010, PLANT PATHOL, V59, P394, DOI 10.1111/j.1365-3059.2009.02195.x; Smart CD, 1996, APPL ENVIRON MICROB, V62, P2988, DOI 10.1128/AEM.62.8.2988-2993.1996; van dersMeer F. A., 1987, VIRUS DIS SMALL FRUI, V631, P203; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039	40	11	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177808	10.1371/journal.pone.0177808	http://dx.doi.org/10.1371/journal.pone.0177808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545043	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700083
J	Tanui, CK; Shyntum, DY; Priem, SL; Theron, J; Moleleki, LN				Tanui, Collins Kipngetich; Shyntum, Divine Yutefar; Priem, Stefan Louis; Theron, Jacques; Moleleki, Lucy Novungayo			Influence of the ferric uptake regulator (Fur) protein on pathogenicity in Pectobacterium carotovorum subsp brasiliense	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; EXTRACELLULAR ENZYMES; IRON ACQUISITION; OXIDATIVE STRESS; SECRETION SYSTEM; GENES; MOTILITY; PATHOGENESIS; METALLOREGULATION	Iron is an important nutrient for the survival and growth of many organisms. In order to survive, iron uptake from the environment must be strictly regulated and maintained to avoid iron toxicity. The ferric uptake regulator protein (Fur) regulates genes involved in iron homeostasis in many bacteria, including phytopathogens. However, to date, the role played by Fur in the biology of Pectobacterium carotovorum subsp. brasiliense (Pcb1692), an important pathogen of potatoes, has not yet been studied. To this end, we used the lambda recombineering method to generate a fur mutant strain of Pcb1692 and assessed the virulence and fitness of the mutant strain. The results showed that production of siderophores in Pcb1692 Delta fur increased compared to the Pcb1692 wild-type and the complemented strain Pcb1692 Delta fur-pfur. However, production of N-acyl homoserine lactone (AHLs), biofilm formation, exopolysaccharide (EPS) production, virulence on potato tubers and swimming motility, were all significantly decreased in Pcb1692 Delta fur compared to the wild-type and complemented Pcb1692 Delta fur-pfur strains. The Pcb1692 Delta fur mutant also demonstrated significant sensitivity to oxidative stress when exposed to H2O2. Consistent with phenotypic results, qRT-PCR results demonstrated that Fur down-regulates genes which encode proteins associated with: iron uptake (HasA-extracellular heme-binding protein and FerrodoxinAED- 0004132), stress response (SodC-superoxide dismutase), plant cell wall degrading enzymes (PrtA and CelV) and motility (FlhC and MotA). We conclude that the ferric uptake regulator protein (Fur) of Pcb1692 regulates traits that are important to host-pathogens interactions.	[Tanui, Collins Kipngetich; Shyntum, Divine Yutefar; Priem, Stefan Louis; Moleleki, Lucy Novungayo] Univ Pretoria, Forestry Agr & Biotechnol Inst, Pretoria, South Africa; [Theron, Jacques; Moleleki, Lucy Novungayo] Univ Pretoria, Dept Microbiol & Plant Pathol, Pretoria, South Africa	University of Pretoria; University of Pretoria	Moleleki, LN (corresponding author), Univ Pretoria, Forestry Agr & Biotechnol Inst, Pretoria, South Africa.; Moleleki, LN (corresponding author), Univ Pretoria, Dept Microbiol & Plant Pathol, Pretoria, South Africa.	lucy.moleleki@up.ac.za	Theron, Jacques/E-4755-2010; Moleleki, Lucy/E-8951-2010	Moleleki, Lucy/0000-0002-1003-4621; shyntum, divine/0000-0002-4884-6983; Theron, Jacques/0000-0001-9091-3898; Tanui, Collins/0000-0002-0421-1708	National Research Foundation (NRF), South Africa [98993]; NRF Bioinformatics and Functional Genomics [BFG 93685]; NRF Research Technology and Transfer Fund (RTF) [98654]; University of Pretoria Bursary; NRF Grant Holder Linked Bursary; Potatoes South Africa Transformation Bursary	National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); NRF Bioinformatics and Functional Genomics; NRF Research Technology and Transfer Fund (RTF); University of Pretoria Bursary; NRF Grant Holder Linked Bursary; Potatoes South Africa Transformation Bursary	This research study was funded by the National Research Foundation (NRF), South Africa through Competitive Funding for Rated Researchers (CFRR) 98993; NRF Bioinformatics and Functional Genomics (BFG 93685) and NRF Research Technology and Transfer Fund (RTF) 98654. CKT was funded by University of Pretoria Bursary and SLP funded by the NRF Grant Holder Linked Bursary. SLP was also funded by Potatoes South Africa Transformation Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; BAGG A, 1987, MICROBIOL REV, V51, P509, DOI 10.1128/MMBR.51.4.509-518.1987; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; Burbank L, 2015, APPL ENVIRON MICROB, V81, P139, DOI 10.1128/AEM.02503-14; Charkowski A, 2012, ANNU REV PHYTOPATHOL, V50, P425, DOI 10.1146/annurev-phyto-081211-173013; Charkowski AO, 2007, THE SOFT ROT ERWINIA, P423; Chatterjee A, 2009, J BACTERIOL, V191, P4582, DOI 10.1128/JB.00154-09; CHEN L, 1993, J BACTERIOL, V175, P5428, DOI 10.1128/JB.175.17.5428-5437.1993; Collmer A, 2009, PLANT PHYSIOL, V150, P1623, DOI 10.1104/pp.109.140327; Crosa JH, 1997, MICROBIOL MOL BIOL R, V61, P319, DOI 10.1128/.61.3.319-336.1997; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Duarte V, 2004, J APPL MICROBIOL, V96, P535, DOI 10.1111/j.1365-2672.2004.02173.x; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Escolar L, 1997, MOL MICROBIOL, V26, P799, DOI 10.1046/j.1365-2958.1997.6211987.x; Fones H, 2013, FEMS MICROBIOL REV, V37, P495, DOI 10.1111/1574-6976.12004; Fones H, 2012, FEMS MICROBIOL LETT, V327, P1, DOI 10.1111/j.1574-6968.2011.02449.x; Franza T, 1999, MOL PLANT MICROBE IN, V12, P119, DOI 10.1094/MPMI.1999.12.2.119; Franza T, 2010, IRON UPTAKE AND HOMEOSTASIS IN MICROORGANISMS, P101; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; Hassett DJ, 1996, J BACTERIOL, V178, P3996, DOI 10.1128/jb.178.14.3996-4003.1996; Hossain MM, 2005, PHYSIOL MOL PLANT P, V66, P134, DOI 10.1016/j.pmpp.2005.06.001; Kubheka GC, 2013, PHYTOPATHOLOGY; Lamont I, 2009, BIOMETALS, V22, P53, DOI 10.1007/s10534-008-9197-9; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Liu HQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149280; Louden BC, 2011, J MICROBIOL BIOL EDU, V12, P51, DOI 10.1128/jmbe.v12i1.249; Marcotte L, 2007, ANAL BIOCHEM, V361, P7, DOI 10.1016/j.ab.2006.11.009; Marquez-Villavicencio MD, 2011, PLANT DIS, V95, P232, DOI 10.1094/PDIS-07-10-0526; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Moleleki L, 2016, MOLECULAR PLANT PATH; Onkendi E, 2017, PLANT DIS, V101, P279; OToole R, 1996, MOL MICROBIOL, V19, P625, DOI 10.1046/j.1365-2958.1996.412927.x; Panda P., 2012, New Disease Reports, V26, P15, DOI 10.5197/j.2044-0588.2012.026.015; Perez-Mendoza D, 2011, MICROBIOL-SGM, V157, P3340, DOI 10.1099/mic.0.050450-0; Sambrook J, 1989, MOL CLONING; Sauvage C, 1996, J BACTERIOL, V178, P1227, DOI 10.1128/jb.178.4.1227-1231.1996; Shyntum DY, 2015, MOL PLANT MICROBE IN, V28, P420, DOI 10.1094/MPMI-07-14-0219-R; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; van der Merwe JJ, 2010, EUR J PLANT PATHOL, V126, P175, DOI 10.1007/s10658-009-9531-2; Velkov T, 2005, PROTEIN EXPRES PURIF, V44, P23, DOI 10.1016/j.pep.2005.04.006	44	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177647	10.1371/journal.pone.0177647	http://dx.doi.org/10.1371/journal.pone.0177647			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545065	gold, Green Submitted, Green Published			2022-12-27	WOS:000401487700060
J	Koster, B; Sondergaard, J; Nielsen, JB; Christensen, KB; Allen, M; Olsen, A; Bentzen, J				Koster, Brian; Sondergaard, Jens; Nielsen, Jesper Bo; Christensen, Karl Bang; Allen, Martin; Olsen, Anja; Bentzen, Joan			Knowledge deficit, attitude and behavior scales association to objective measures of sun exposure and sunburn in a Danish population based sample	PLOS ONE			English	Article							SKIN-CANCER PREVENTION; ULTRAVIOLET-RADIATION; RISK-FACTORS; RECALL BIAS; PROTECTION; MELANOMA; AUSTRALIA; PREDICTORS; SUNSMART; EDUCATION	The objective of this study was to develop new scales measuring knowledge and attitude about UVR and sun related behavior, and to examine their association to sun related behavior objectively measured by personal dosimetry. During May-August 2013, 664 Danes wore a personal electronic UV-dosimeter for one week that measured their UVR exposure. Afterwards, they answered a questionnaire on sun-related items. We applied descriptive analysis, linear and logistic regression analysis to evaluate the associations between the questionnaire scales and objective UVR measures. Perceiving protection as routine and important were positively correlated with protective behavior. Knowledge deficit of UV and risk of melanoma, perceived benefits and importance of protection behavior was also correlated with use of protection. 'Knowledge deficit of UV and risk of melanoma and Perceived barrier towards sun avoidance between 12 and 15' were both associated with increased risk of sunburn. Attitude towards tan was associated to both outdoor time and exposure as well as use of protection, but not to sunburn. The results regarding Knowledge deficit of UV and risk of melanoma associated to UVR exposure and Perceived barrier towards sun avoidance between 12 and 15 emphasize the importance of awareness of melanoma risk and the priority of the skin cancer prevention advice. Shifting activities to outside the suns peak-hours could be an approach for structural and campaign preventive measures. Knowledge of items predicting exposure to UVR, use of protection and sunburn are important for planning of preventive interventions and melanoma research.	[Koster, Brian; Bentzen, Joan] Danish Canc Soc, Dept Prevent & Informat, Strandblvd 49, Copenhagen O, Denmark; [Koster, Brian; Sondergaard, Jens; Nielsen, Jesper Bo] Univ Southern Denmark, Res Unit Gen Practice, Odense, Denmark; [Christensen, Karl Bang] Univ Copenhagen, Biostat Sect, Dept Publ Hlth, Copenhagen, Denmark; [Allen, Martin] Univ Canterbury, Elect & Comp Engn, Christchurch, New Zealand; [Olsen, Anja] Danish Canc Soc, Res Ctr, Copenhagen, Denmark	Danish Cancer Society; University of Southern Denmark; University of Copenhagen; University of Canterbury; Danish Cancer Society	Koster, B (corresponding author), Danish Canc Soc, Dept Prevent & Informat, Strandblvd 49, Copenhagen O, Denmark.; Koster, B (corresponding author), Univ Southern Denmark, Res Unit Gen Practice, Odense, Denmark.	Koester_brian@yahoo.com	Christensen, Karl Bang/I-2650-2019; Søndergaard, Jens js/F-3031-2013	Christensen, Karl Bang/0000-0003-4518-5187; Søndergaard, Jens js/0000-0002-1629-1864; Koster, Brian/0000-0001-8352-3066; Allen, Martin/0000-0001-8786-6429	TrygFonden; Danish Board of Research and Innovation	TrygFonden; Danish Board of Research and Innovation	This study was supported by TrygFonden and The Danish Board of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2005, PHOTOCH PHOTOBIO SCI, V4, P429, DOI 10.1039/b418942f; ARMSTRONG BK, 1993, MELANOMA RES, V3, P395, DOI 10.1097/00008390-199311000-00002; Bogh MKB, 2011, BRIT J DERMATOL, V164, P163, DOI 10.1111/j.1365-2133.2010.10082.x; Branstrom R, 2004, PREV MED, V39, P992, DOI 10.1016/j.ypmed.2004.04.004; Branstrom R, 2001, EUR J CANCER PREV, V10, P337, DOI 10.1097/00008469-200108000-00007; Branstrom R, 2010, CANCER EPIDEM BIOMAR, V19, P2199, DOI 10.1158/1055-9965.EPI-10-0196; Bray F, 2012, INTJCANCER; Buller DB, 1998, CLIN DERMATOL, V16, P447, DOI 10.1016/S0738-081X(98)00018-2; Buller DB, 1999, HEALTH EDUC BEHAV, V26, P317, DOI 10.1177/109019819902600304; Cargill J, 2012, PHOTOCHEM PHOTOBIOL, V89, P7; Carley A, 2015, J AGROMEDICINE, V20, P85, DOI 10.1080/1059924X.2015.1010059; Diffey BL, 2009, BRIT J DERMATOL, V160, P1292, DOI 10.1111/j.1365-2133.2009.09149.x; Dobbinson S, 2006, TRENDS SUN PROTECTIO; Dobbinson SJ, 2008, AM J PREV MED, V34, P94, DOI 10.1016/j.amepre.2007.09.024; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Forsea AM, 2013, J EUR ACAD DERMATOL, V27, P1317, DOI 10.1111/jdv.12060; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gefeller O, 2014, INT J ENV RES PUB HE, V11, P4768, DOI 10.3390/ijerph110504768; Gefeller O, 2009, AM J EPIDEMIOL, V169, P267, DOI 10.1093/aje/kwn362; Geller AC, 2002, J AM ACAD DERMATOL, V46, P683, DOI 10.1067/mjd.2002.121034; Gilaberte Y, 2008, HEALTH PROMOT INT, V23, P209, DOI 10.1093/heapro/dan020; Godar DE, 2012, ENVIRON HEALTH PERSP, V120, P139, DOI 10.1289/ehp.1003195; Hansen L, 2016, SUN EXPOSURE GUIDE L; Hansen MR, 2014, PUBLIC HEALTH, V128, P777, DOI 10.1016/j.puhe.2014.07.002; Hobart J, 2009, IMPROVING EVALUATION; IARC, 2012, INT AGENCY RES CANC; IARC group Ww, 2008, VIT D CANC, V5, P1; Icek A, 2006, CONTRUCTING TPB QUES, P1; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jensen M.P., 2015, DANSKERNES SOLVANER; Koster B, 2016, BR J DERMATOL; Koster Brian, 2016, Prev Med Rep, V3, P367, DOI 10.1016/j.pmedr.2016.04.002; Koster B, 2015, PHOTODERMATOL PHOTO, V31, P252, DOI 10.1111/phpp.12179; Koster B, 2010, SCAND J PUBLIC HEALT, V38, P548, DOI 10.1177/1403494810371250; Lucas RM, 2008, INT J EPIDEMIOL, V37, P654, DOI 10.1093/ije/dyn017; Melia J, 2000, BRIT J DERMATOL, V143, P701, DOI 10.1046/j.1365-2133.2000.03764.x; Montague M, 2001, HEALTH EDUC BEHAV, V28, P290, DOI 10.1177/109019810102800304; Morris J, 1996, HEALTH PROMOT INT, V11, P321, DOI 10.1093/heapro/11.4.321; Parr CL, 2009, AM J EPIDEMIOL, V169, P257, DOI 10.1093/aje/kwn363; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Saiag P, 2015, J EUR ACAD DERMATOL, V29, P11, DOI 10.1111/jdv.12896; Saraiya M, 2004, AM J PREV MED, V27, P422, DOI 10.1016/j.amepre.2004.08.009; Sinclair CA, 2014, AM J PUBLIC HEALTH, V104, pE7, DOI 10.2105/AJPH.2013.301703; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Stanton WR, 2004, HEALTH PROMOT INT, V19, P369, DOI 10.1093/heapro/dah310; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Thieden E, 2000, PHOTODERMATOL PHOTO, V16, P57, DOI 10.1034/j.1600-0781.2000.d01-4.x; Tripp MK, 2013, AM J PREV MED, V44, P265, DOI 10.1016/j.amepre.2012.10.027; Tripp MK, 2012, HLTH EDUCRES; Veierod MB, 2010, CANCER EPIDEM BIOMAR, V19, P111, DOI 10.1158/1055-9965.EPI-09-0567; Wright CY, 2007, PHOTOCHEM PHOTOBIOL, V83, P749, DOI 10.1562/2006-08-22-RA-1010; Youl PH, 2013, BRIT J DERMATOL, V168, P136, DOI 10.1111/j.1365-2133.2012.11064.x	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178190	10.1371/journal.pone.0178190	http://dx.doi.org/10.1371/journal.pone.0178190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542543	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800050
J	Wang, YY; Li, FF; Ruan, XL; Song, J; Lv, L; Chai, LY; Yang, ZH; Luo, L				Wang, Yangyang; Li, Fangfang; Ruan, Xinling; Song, Jian; Lv, Lv; Chai, Liyuan; Yang, Zhihui; Luo, Lin			Biodegradation of di-n-butyl phthalate by bacterial consortium LV-1 enriched from river sludge	PLOS ONE			English	Article							DIBUTYL PHTHALATE; HEAVY-METALS; DI-(2-ETHYLHEXYL) PHTHALATE; ACID ESTERS; GAS-PHASE; DEGRADATION; STRAIN; GROWTH; MANGANESE; SEDIMENT	A stable bacterial consortium (LV-1) capable of degrading di-n-butyl phthalate (DBP) was enriched from river sludge. Community analysis revealed that the main families of LV-1 are Brucellaceae (62.78%) and Sinobacteraceae (14.83%), and the main genera of LV-1 are Brucella spp. (62.78%) and Sinobacter spp. (14.83%). The optimal pH and temperature for LV-1 to degrade DBP were pH 6.0 and 30 degrees C, respectively. Inoculum size influenced the degradation ratio when the incubation time was < 24 h. The initial concentration of DBP also influenced the degradation rates of DBP by LV-1, and the degradation rates ranged from 69.0 +/- 775.0 mg/l/d in the first 24 h. Degradation of DBP was best fitted by first-order kinetics when the initial concentration was < 300 mg/l. In addition, Cd2+, Cr6+, and Zn2+ inhibited DBP degradation by LV-1 at all considered concentrations, but low concentrations of Pb2+, Cu2+, and Mn2+ enhanced DBP degradation. The main intermediates (mono-ethyl phthalate [MEP], mono-butyl phthalate [MBP], and phthalic acid [PA]) were identified in the DBP degradation process, thus a new biochemical pathway of DBP degradation is proposed. Furthermore, LV-1 also degraded other phthalates with shorter ester chains (DMP, DEP, and PA).	[Wang, Yangyang; Luo, Lin] Hunan Agr Univ, Sch Resources & Environm, Changsha, Hunan, Peoples R China; [Wang, Yangyang; Ruan, Xinling] Henan Univ, Key Res Inst Yellow River Civilizat & Sustainable, Kaifeng, Peoples R China; [Wang, Yangyang; Ruan, Xinling] Henan Univ, Collaborat Innovat Ctr Yellow River Civilizat Hen, Kaifeng, Peoples R China; [Wang, Yangyang; Li, Fangfang; Ruan, Xinling; Song, Jian; Lv, Lv] Henan Univ, Inst Nat Resources & Environm, Kaifeng, Peoples R China; [Chai, Liyuan; Yang, Zhihui] Cent S Univ, Sch Met & Environm, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Henan University; Henan University; Henan University; Central South University	Luo, L (corresponding author), Hunan Agr Univ, Sch Resources & Environm, Changsha, Hunan, Peoples R China.	luolinwei0@163.com	Wang, Yangyang/GXH-5679-2022		National Natural Science Foundation of China [41430637]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [161RTSTHN012]; Science and technology development project of Henan Province [152102310297]; Opening Foundation of the Chinese National Engineering Research Center for Control and Treatment of Heavy Metal Pollution, Changsha [2015CNERC-CTHMP-]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team (in Science and Technology) in University of Henan Province; Science and technology development project of Henan Province; Opening Foundation of the Chinese National Engineering Research Center for Control and Treatment of Heavy Metal Pollution, Changsha	This work was supported by a grant from the National Natural Science Foundation of China (41430637); Program for Innovative Research Team (in Science and Technology) in University of Henan Province (161RTSTHN012); Science and technology development project of Henan Province (152102310297); Opening Foundation of the Chinese National Engineering Research Center for Control and Treatment of Heavy Metal Pollution, Changsha, 410083, China (No. 2015CNERC-CTHMP-).	ADAMS LF, 1985, APPL ENVIRON MICROB, V49, P556, DOI 10.1128/AEM.49.3.556-562.1985; Amir S, 2005, PROCESS BIOCHEM, V40, P2183, DOI 10.1016/j.procbio.2004.08.012; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chen YH, 2009, J HAZARD MATER, V172, P20, DOI 10.1016/j.jhazmat.2009.06.122; Dou JF, 2009, J HAZARD MATER, V165, P325, DOI 10.1016/j.jhazmat.2008.10.002; Fang CR, 2010, INT BIODETER BIODEGR, V64, P442, DOI 10.1016/j.ibiod.2010.04.010; Fang HHP, 2007, BIORESOURCE TECHNOL, V98, P717, DOI 10.1016/j.biortech.2006.02.010; Guerfali M, 2009, J MOL CATAL B-ENZYM, V57, P242, DOI 10.1016/j.molcatb.2008.09.011; Hashizume K, 2002, BIOL PHARM BULL, V25, P209, DOI 10.1248/bpb.25.209; HATTORI H, 1992, SOIL SCI PLANT NUTR, V38, P93, DOI 10.1080/00380768.1992.10416956; He ZX, 2013, BIORESOURCE TECHNOL, V128, P526, DOI 10.1016/j.biortech.2012.10.107; Herrmann S, 2010, ENVIRON MICROBIOL, V12, P401, DOI 10.1111/j.1462-2920.2009.02077.x; Hudcova T, 2011, J HAZARD MATER, V192, P605, DOI 10.1016/j.jhazmat.2011.05.061; Lertsirisopon R, 2009, J ENVIRON SCI-CHINA, V21, P285, DOI 10.1016/S1001-0742(08)62265-2; Liang DW, 2008, APPL MICROBIOL BIOT, V80, P183, DOI 10.1007/s00253-008-1548-5; Liao CS, 2010, CHEMOSPHERE, V78, P342, DOI 10.1016/j.chemosphere.2009.10.020; Lovitt B, 2010, BIOCHEMISTRY-US, V49, P3092, DOI 10.1021/bi901726c; Mrvcic J, 2011, 7 INT C FOOD TECHN B, P20; Muthukumar N, 2003, ELECTROCHEM COMMUN, V5, P421, DOI 10.1016/S1388-2481(03)00093-6; Navacharoen A, 2011, INT BIODETER BIODEGR, V65, P818, DOI 10.1016/j.ibiod.2011.05.005; Patil NK, 2006, CURR MICROBIOL, V52, P369, DOI 10.1007/s00284-005-5258-2; Prakash O, 2010, BIOTECHNOL APPL BIOC, V57, P105, DOI 10.1042/BA20100262; RAMADAN MA, 1990, APPL ENVIRON MICROB, V56, P1392, DOI 10.1128/AEM.56.5.1392-1396.1990; Ravikumar S, 2007, J ENVIRON BIOL, V28, P109; Saratale RG, 2009, BIORESOURCE TECHNOL, V100, P2493, DOI 10.1016/j.biortech.2008.12.013; Schossler P, 2011, SCI TOTAL ENVIRON, V409, P4031, DOI 10.1016/j.scitotenv.2011.06.012; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Sevinc N., 2011, J BIOL ENV SCI, V5, P95; Vela-Cano M., 2014, ADV MICROBIOL, V48851, DOI [10.4236/aim.2014.410070, DOI 10.4236/AIM.2014.410070]; Wang YY, 2012, PROCESS BIOCHEM, V47, P936, DOI 10.1016/j.procbio.2012.02.027; Weschler CJ, 2008, ATMOS ENVIRON, V42, P1449, DOI 10.1016/j.atmosenv.2007.11.014; Wolski EA, 2006, WATER SA, V32, P93; Wu Q, 2013, INT BIODETER BIODEGR, V76, P102, DOI 10.1016/j.ibiod.2012.06.013; Wu XL, 2010, B ENVIRON CONTAM TOX, V85, P235, DOI 10.1007/s00128-010-0080-3; Wu XL, 2011, PROCESS BIOCHEM, V46, P1090, DOI 10.1016/j.procbio.2011.01.031; Wu XL, 2010, J HAZARD MATER, V176, P262, DOI 10.1016/j.jhazmat.2009.11.022; Xiao YH, 2015, APPL MICROBIOL BIOT, V99, P10311, DOI 10.1007/s00253-015-6881-x; Xu G, 2008, SCI TOTAL ENVIRON, V393, P333, DOI 10.1016/j.scitotenv.2008.01.001; Xu XR, 2005, INT BIODETER BIODEGR, V55, P9, DOI 10.1016/j.ibiod.2004.05.005; Yu Lei, 2015, Advanced Materials Research, V1073-1076, P726, DOI 10.4028/www.scientific.net/AMR.1073-1076.726; Yuan SY, 2010, J HAZARD MATER, V184, P826, DOI 10.1016/j.jhazmat.2010.08.116; Zeng F, 2008, ENVIRON INT, V34, P372, DOI 10.1016/j.envint.2007.09.002; Zhang Fei, 2015, Environmental Science & Technology (China), V38, P44; Zhou J, 2008, J LIAONING NORMAL U, V31, P343	46	25	27	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178213	10.1371/journal.pone.0178213	http://dx.doi.org/10.1371/journal.pone.0178213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542471	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800054
J	Galan, I; Slmon, L; Boldo, E; Ortiz, C; Fernandez-Cuenca, R; Linares, C; Medrano, MJ; Pastor-Barriuso, R				Galan, Inaki; Slmon, Lorena; Boldo, Elena; Ortiz, Cristina; Fernandez-Cuenca, Rafael; Linares, Cristina; Jose Medrano, Maria; Pastor-Barriuso, Roberto			Changes in hospitalizations for chronic respiratory diseases after two successive smoking bans in Spain	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; EMERGENCY-DEPARTMENT VISITS; FREE LEGISLATION; CHILDHOOD ASTHMA; SPANISH SMOKING; BAR WORKERS; IMPACT; IMPLEMENTATION; METAANALYSIS; HEALTH	Background Existing evidence on the effects of smoke-free policies on respiratory diseases is scarce and inconclusive. Spain enacted two consecutive smoke-free regulations: a partial ban in 2006 and a comprehensive ban in 2011. We estimated their impact on hospital admissions via emergency departments for chronic obstructive pulmonary disease (COPD) and asthma. Methods Data for COPD (ICD-9 490-492, 494-496) came from 2003-2012 hospital admission records from the fourteen largest provinces of Spain and from five provinces for asthma (ICD-9 493). We estimated changes in hospital admission rates within provinces using Poisson additive models adjusted for long-term linear trends and seasonality, day of the week, temperature, influenza, acute respiratory infections, and pollen counts (asthma models). We estimated immediate and gradual effects through segmented-linear models. The coefficients within each province were combined through random-effects multivariate meta-analytic models. Results The partial ban was associated with a strong significant pooled immediate decline in COPD-related admission rates (14.7%, 95% CI: 5.0, 23.4), sustained over time with a one-year decrease of 13.6% (95% CI: 2.9, 23.1). The association was consistent across age and sex groups but stronger in less economically developed Spanish provinces. Asthma-related admission rates decreased by 7.4% (95% CI: 0.2, 14.2) immediately after the comprehensive ban was implemented, although the one-year decrease was sustained only among men (9.9%, 95% CI: 3.9, 15.6). Conclusions The partial ban was associated with an immediate and sustained strong decline in COPD-related admissions, especially in less economically developed provinces. The comprehensive ban was related to an immediate decrease in asthma, sustained for the medium-term only among men.	[Galan, Inaki; Slmon, Lorena; Boldo, Elena; Ortiz, Cristina; Fernandez-Cuenca, Rafael; Jose Medrano, Maria; Pastor-Barriuso, Roberto] Inst Salud Carlos III, Natl Ctr Epidemiol, Madrid, Spain; [Galan, Inaki] Univ Autonoma Madrid, IdiPAZ, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Boldo, Elena; Fernandez-Cuenca, Rafael; Pastor-Barriuso, Roberto] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Boldo, Elena] Puerta de Hierro Biomed Res Inst, Madrid, Spain; [Linares, Cristina] Inst Salud Carlos III, Natl Sch Publ Hlth, Madrid, Spain	Instituto de Salud Carlos III; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III	Galan, I (corresponding author), Inst Salud Carlos III, Natl Ctr Epidemiol, Madrid, Spain.; Galan, I (corresponding author), Univ Autonoma Madrid, IdiPAZ, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain.	igalan@isciii.es	Pastor-Barriuso, Roberto/AAA-6746-2019; Boldo, Elena/L-6610-2014; Galán, Ignacio/P-6451-2015	Pastor-Barriuso, Roberto/0000-0002-7325-3960; Boldo, Elena/0000-0003-0027-1989; Galán, Ignacio/0000-0003-0624-9993	Institute of Health Carlos III, Ministry of Economy and Competitiveness [FIS PI11/01276]	Institute of Health Carlos III, Ministry of Economy and Competitiveness	This work was supported by Grant FIS PI11/01276 from the Institute of Health Carlos III, Ministry of Economy and Competitiveness. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Burke DL, 2017, STAT MED, V36, P855, DOI 10.1002/sim.7141; Hidalgo AC, 2014, GAC SANIT, V28, P456, DOI 10.1016/j.gaceta.2014.05.006; Comhair SAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018574; Croghan IT, 2015, BMC PULM MED, V15, DOI 10.1186/1471-2466-15-6; Dusemund F, 2015, TOB CONTROL, V24, P404, DOI 10.1136/tobaccocontrol-2013-051290; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Fernandez E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004244; Flouris AD, 2011, CURR OPIN PULM MED, V17, P110, DOI 10.1097/MCP.0b013e328343165d; Frazer K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub3; Galan I, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008892; Gan WQ, 2015, TOB CONTROL, V24, P568, DOI 10.1136/tobaccocontrol-2014-051660; Gasparrini A, 2012, STAT MED, V31, P3821, DOI 10.1002/sim.5471; Gaudreau K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056102; Gershon AS, 2012, COPD, V9, P216, DOI 10.3109/15412555.2011.648030; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Hahn EJ, 2014, AM J PUBLIC HEALTH, V104, P1059, DOI 10.2105/AJPH.2014.301887; Hartl S, 2016, EUR RESPIR J, V47, P113, DOI 10.1183/13993003.01391-2014; Head P, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120079; Herman PM, 2011, AM J PUBLIC HEALTH, V101, P491, DOI 10.2105/AJPH.2009.179572; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Humair JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090417; Hunsberger S, 2002, BIOSTATISTICS, V3, P289, DOI 10.1093/biostatistics/3.2.289; Jimenez-Ruiz CA, 2008, EUR J PUBLIC HEALTH, V18, P622, DOI 10.1093/eurpub/ckn066; Kent BD, 2012, CHEST, V142, P673, DOI 10.1378/chest.11-2757; Landers G, 2014, AM J PUBLIC HEALTH, V104, pE74, DOI 10.2105/AJPH.2013.301697; Larrauri A., 2006, Boletin Epidemiologico Semanal, V14, P85; Lopez MJ, 2013, NICOTINE TOB RES, V15, P992, DOI 10.1093/ntr/nts218; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Millett C, 2013, PEDIATRICS, V131, pE495, DOI 10.1542/peds.2012-2592; Moraros J, 2010, INT J ENV RES PUB HE, V7, P4169, DOI 10.3390/ijerph7124169; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; Rayens MK, 2008, J ALLERGY CLIN IMMUN, V122, P537, DOI 10.1016/j.jaci.2008.06.029; Shetty KD, 2011, J POLICY ANAL MANAG, V30, P6, DOI 10.1002/pam.20548; Spanish Society of Epidemiology, ASS IMP SPAN SMOK LA; Stallings-Smith S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098617; Svanes C, 2004, THORAX, V59, P295, DOI 10.1136/thx.2003.009746; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; US Dept of Health and Human Services, 2014, HLTH CONS SMOK 50 YE HLTH CONS SMOK 50 YE; US Surgeon General, 2006, HLTH CONS INV EXP TO; Vander W. M. W., 2012, HEALTH AFFAIR, V31, P2699, DOI DOI 10.1377/HLTHAFF.2011.0385; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374	44	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177979	10.1371/journal.pone.0177979	http://dx.doi.org/10.1371/journal.pone.0177979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542337	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500048
J	Kao, CC; Yang, JY; Chen, L; Chao, CT; Peng, YS; Chiang, CK; Huang, JW; Hung, KY				Kao, Chih-Chin; Yang, Ju-Yeh; Chen, Likwang; Chao, Chia-Ter; Peng, Yu-Sen; Chiang, Chih-Kang; Huang, Jenq-Wen; Hung, Kuan-Yu			Factors associated with poor outcomes of continuous renal replacement therapy	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; PERITONEAL-DIALYSIS; REQUIRING CRRT; FAILURE; DISEASE; MORTALITY; RISK; HEMODIALYSIS; CIRRHOSIS	Continuous renal replacement therapy (CRRT) is one of the dialysis modalities for critically ill patients. Despite intensive dialysis care, a high mortality rate is found in these patients. Our objective was to investigate the factors associated with poor outcomes in these patients. We conducted a retrospective cohort study using the National Health Insurance Research Database. Records of critically ill patients who received CRRT between 2007 and 2011 were retrieved, and the patients were categorized into two groups: those with acute kidney injury (AKI) and those with history of end-stage renal disease (ESRD). Our primary and secondary outcomes were in-hospital mortality and long-term survival and non-renal recovery (long-term dialysis dependence), respectively, in the AKI group. We enrolled 15,453 patients, with 13,204 and 2249 in the AKI and ESRD groups, respectively. Overall, 66.5% patients died during hospitalization. In-hospital mortality did not differ significantly between groups (adjusted odds ratio, 0.93; 95% CI, 0.84-1.02). Age, chronic liver disease, and cancer history were identified as independent risk factors for in-hospital mortality in both groups. Hypertension was associated with higher risk of in-hospital mortality in patients with AKI. Age, coronary artery disease, and admission to the medical intensive care unit (MICU) were risk factors for long-term dialysis dependence in patients with AKI. Patients with AKI and ESRD have similarly poor outcomes after CRRT. Older age and presence of chronic liver disease and cancer were associated with higher mortality. Older age, presence of coronary artery disease, and admission to MICU were associated with lower renal recovery rate in patients with AKI.	[Kao, Chih-Chin] Taipei Med Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Kao, Chih-Chin] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan; [Kao, Chih-Chin] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Yang, Ju-Yeh; Peng, Yu-Sen] Far Eastern Mem Hosp, Div Nephrol, New Taipei, Taiwan; [Yang, Ju-Yeh] Far Eastern Mem Hosp, Dept Qual Management Ctr, New Taipei, Taiwan; [Yang, Ju-Yeh] Oriental Inst Technol, Dept Ind Management, New Taipei, Taiwan; [Chen, Likwang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Chao, Chia-Ter; Chiang, Chih-Kang; Huang, Jenq-Wen; Hung, Kuan-Yu] Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Asia Eastern University of Science & Technology; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital	Huang, JW (corresponding author), Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan.	jenqwen@gmail.com	peng, yu/GXW-2071-2022; Chao, Chia-Ter/H-7994-2019	Chao, Chia-Ter/0000-0003-2892-7986; Yang, Ju-Yeh/0000-0003-3034-021X; HUANG, JENQ-WEN/0000-0001-8011-2317; HUNG, KUAN-YU/0000-0003-3472-5512; CHIANG, CHIH-KANG/0000-0001-9021-4616				Allegretti AS, 2013, CRIT CARE, V17, DOI 10.1186/cc12780; Arulkumaran N, 2013, BRIT J ANAESTH, V110, P13, DOI 10.1093/bja/aes401; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc8037; Belcher JM, 2013, HEPATOLOGY, V57, P753, DOI 10.1002/hep.25735; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003; Campbell GA, 2014, ADV CHRONIC KIDNEY D, V21, P64, DOI 10.1053/j.ackd.2013.08.002; Case J, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/479730; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Durairaj L, 2005, CHEST, V128, P1682, DOI 10.1378/chest.128.3.1682; Duran PA, 2014, HEMODIAL INT, V18, pS1, DOI 10.1111/hdi.12216; Fagundes C, 2013, J HEPATOL, V59, P474, DOI 10.1016/j.jhep.2013.04.036; Faubel S, 2008, ADV CHRONIC KIDNEY D, V15, P284, DOI 10.1053/j.ackd.2008.04.008; Fortrie G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121482; GINES A, 1993, GASTROENTEROLOGY, V105, P229, DOI 10.1016/0016-5085(93)90031-7; Grams ME, 2012, KIDNEY INT, V81, P942, DOI 10.1038/ki.2011.241; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; Hobson EV, 2012, PERITON DIALYSIS INT, V32, P590, DOI 10.3747/pdi.2012.00152; Hsu CY, 2007, CURR OPIN NEPHROL HY, V16, P221, DOI 10.1097/MNH.0b013e3280895ad9; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Iwagami M, 2015, NEPHROL DIAL TRANSPL, V30, P988, DOI 10.1093/ndt/gfv069; Jung YS, 2012, HEMODIAL INT, V16, P456, DOI 10.1111/j.1542-4758.2012.00694.x; Liu JN, 2010, KIDNEY INT, V77, P141, DOI 10.1038/ki.2009.413; Oh HJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0454-8; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pannu Neesh, 2005, Ther Clin Risk Manag, V1, P141, DOI 10.2147/tcrm.1.2.141.62908; Ronco C, 2001, NEPHROL DIAL TRANSPL, V16, P230, DOI 10.1093/ndt/16.2.230; Salahudeen AK, 2013, CLIN J AM SOC NEPHRO, V8, P347, DOI 10.2215/CJN.03530412; Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005; Sligl WI, 2010, CRIT CARE MED, V38, P2126, DOI 10.1097/CCM.0b013e3181eedaeb; Srisawat N, 2010, CRIT CARE, V14, DOI 10.1186/cc8933; Strijack B, 2009, J AM SOC NEPHROL, V20, P2441, DOI 10.1681/ASN.2009040366; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vonesh EF, 2004, KIDNEY INT, V66, P2389, DOI 10.1111/j.1523-1755.2004.66028.x; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Walcher A, 2011, RENAL FAILURE, V33, P935, DOI 10.3109/0886022X.2011.615964; Yang JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12816	38	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177759	10.1371/journal.pone.0177759	http://dx.doi.org/10.1371/journal.pone.0177759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542272	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500037
J	Lau, HH; Huang, WC; Su, TH				Lau, Hui-Hsuan; Huang, Wen-Chu; Su, Tsung-Hsien			Urinary leakage during sexual intercourse among women with incontinence: Incidence and risk factors	PLOS ONE			English	Article							URODYNAMIC STRESS-INCONTINENCE; COITAL INCONTINENCE; DETRUSOR OVERACTIVITY; QUESTIONNAIRE; SYMPTOM	Background Coital incontinence is an under-reported disorder among women with urinary incontinence. Women seldom voluntarily report this condition, and as such, related data remains limited and is at times conflicting. Aims and objectives To investigate the incidence and quality of life in women with coital incontinence and to determine associated predictors. Methods This observational study involved 505 sexually active women attending the urogynecologic clinic for symptomatic urinary incontinence at a tertiary medical center. All of the patients were consulted about the experience of coital incontinence and completed evaluations including urodynamics, and valid questionnaires including the short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, the Urogenital Distress Inventory and the Incontinence Impact Questionnaire. Results Of these women, 281 (56%) had coital incontinence, while 224 (44%) did not. Among women with coital incontinence, 181 (64%) had urodynamic-proven stress incontinence, 29 (10%) had mixed incontinence, and 15 (5%) had detrusor overactivity. Only 25 (9%) sought consultation for this disorder before direct questioning. Fifty percent (84/281) of the women rarely or sometimes had incontinence during coitus, while 33% (92/281) often had incontinence, and 17% (48/281) always had incontinence. The frequency of coital incontinence was not different regarding the types of incontinence (p = 0.153). Women with mixed incontinence had the worst sexual quality of life and incontinence-related symptom distress. Based on univariate analysis, higher body mass index (OR 2.47, p = 0.027), and lower maximal urethral closure pressure (<= 30 cmH2O) (OR 4.56, p = 0.007) were possible predictors for coital incontinence. Multivariate analysis showed lower MUCP was independently significant predictors (OR3.93, p = 0.042) Conclusions The prevalence of coital intercourse in urinary incontinence women was high. Coital incontinence in these women was associated with abnormal urodynamic diagnosis and urethral dysfunction.	[Lau, Hui-Hsuan; Huang, Wen-Chu] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Lau, Hui-Hsuan; Huang, Wen-Chu] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Lau, Hui-Hsuan; Huang, Wen-Chu] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Su, Tsung-Hsien] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan	Mackay Medical College; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital	Su, TH (corresponding author), Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan.	drthsu571@gmail.com			Spirox Education Foundation	Spirox Education Foundation	We thank all study participants, and the Spirox Education Foundation supported the research and travel expenses of Hui-Hsuan Lau for the 2016 IUGA Annual Meeting.	Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Coksuer H, 2011, EUR J OBSTET GYN R B, V159, P213, DOI 10.1016/j.ejogrb.2011.06.024; El-Azab AS, 2011, NEUROUROL URODYNAM, V30, P520, DOI 10.1002/nau.21041; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; HILTON P, 1988, BRIT J OBSTET GYNAEC, V95, P377, DOI 10.1111/j.1471-0528.1988.tb06609.x; Huang WC, 2009, J OBSTET GYNAECOL RE, V35, P946, DOI 10.1111/j.1447-0756.2009.01032.x; Jha S, 2012, INT UROGYNECOL J, V23, P633, DOI 10.1007/s00192-011-1583-0; Madhu C, 2015, UROLOGY, V85, P1034, DOI 10.1016/j.urology.2015.02.007; Moran P. A., 1999, Journal of Obstetrics and Gynaecology (Abingdon), V19, P286; Pastor Z, 2013, J SEX MED, V10, P1682, DOI 10.1111/jsm.12166; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Serati M, 2011, NEUROUROL URODYNAM, V30, P1415, DOI 10.1002/nau.21115; Serati M, 2009, J SEX MED, V6, P40, DOI 10.1111/j.1743-6109.2008.01055.x; Su TH, 2010, J SEX MED, V7, P3940, DOI 10.1111/j.1743-6109.2010.01891.x; UEBERSAX JS, 1995, NEUROUROL URODYNAM, V14, P131, DOI 10.1002/nau.1930140206; Urwitz-Lane R, 2006, AM J OBSTET GYNECOL, V195, P1758, DOI 10.1016/j.ajog.2006.07.028	16	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177075	10.1371/journal.pone.0177075	http://dx.doi.org/10.1371/journal.pone.0177075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542221	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500012
J	Lera, I; Perez, T; Guerrero, C; Eguiluz, VM; Juiz, C				Lera, Isaac; Perez, Toni; Guerrero, Carlos; Eguiluz, Victor M.; Juiz, Carlos			Analysing human mobility patterns of hiking activities through complex network theory	PLOS ONE			English	Article							MOVEMENT PATTERNS; SCALING LAWS; PARK	The exploitation of high volume of geolocalized data from social sport tracking applications of outdoor activities can be useful for natural resource planning and to understand the human mobility patterns during leisure activities. This geolocalized data represents the selection of hike activities according to subjective and objective factors such as personal goals, personal abilities, trail conditions or weather conditions. In our approach, human mobility patterns are analysed from trajectories which are generated by hikers. We propose the generation of the trail network identifying special points in the overlap of trajectories. Trail crossings and trailheads define our network and shape topological features. We analyse the trail network of Balearic Islands, as a case of study, using complex weighted network theory. The analysis is divided into the four seasons of the year to observe the impact of weather conditions on the network topology. The number of visited places does not decrease despite the large difference in the number of samples of the two seasons with larger and lower activity. It is in summer season where it is produced the most significant variation in the frequency and localization of activities from inland regions to coastal areas. Finally, we compare our model with other related studies where the network possesses a different purpose. One finding of our approach is the detection of regions with relevant importance where landscape interventions can be applied in function of the communities.	[Lera, Isaac; Guerrero, Carlos; Juiz, Carlos] Univ Illes Balears, Dept Matemat & Informat, Palma de Mallorca, Spain; [Perez, Toni; Eguiluz, Victor M.] CSIC UIB, IFISC, Palma de Mallorca, Spain	Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona	Lera, I (corresponding author), Univ Illes Balears, Dept Matemat & Informat, Palma de Mallorca, Spain.	isaac.lera@uib.es	Lera, Isaac ILC/E-5467-2011; Eguíluz, Víctor M./B-9655-2008; Guerrero, Carlos/E-9221-2012; Juiz, Carlos/L-4018-2014	Lera, Isaac ILC/0000-0002-2826-5970; Eguíluz, Víctor M./0000-0003-1133-1289; Guerrero, Carlos/0000-0003-2969-0597; Juiz, Carlos/0000-0001-6517-5395	Departament de Matematiques i Informatica de la Universitat de les Illes Balears; SPASIMM [FIS2016-80067-P AEI/FEDER, UE]; program Juan de la Cierva of the Spanish Ministry of Economy and Competitiveness	Departament de Matematiques i Informatica de la Universitat de les Illes Balears; SPASIMM; program Juan de la Cierva of the Spanish Ministry of Economy and Competitiveness	All authors acknowledge financial support from the Departament de Matematiques i Informatica de la Universitat de les Illes Balears. VME acknowledges financial support through project SPASIMM (FIS2016-80067-P AEI/FEDER, UE). TP acknowledges support from the program Juan de la Cierva of the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors acknowledge financial support from the Departament de Matematiques i Informatica de la Universitat de les Illes Balears. VME acknowledges financial support through project SPASIMM (FIS2016-80067-P AEI/FEDER, UE). TP acknowledges support from the program Juan de la Cierva of the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Arase Y., 2010, P 18 ACM INT C MULT, P133, DOI DOI 10.1145/1873951.1873971; Arrowsmith C, 2002, TOURISM MANAGE, V23, P295, DOI 10.1016/S0261-5177(01)00088-7; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bassolas A, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0073-5; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Beeco JA, 2014, LANDSCAPE URBAN PLAN, V127, P136, DOI 10.1016/j.landurbplan.2014.04.002; Beeco JA, 2013, APPL GEOGR, V45, P147, DOI 10.1016/j.apgeog.2013.09.001; Biljecki F, 2013, INT J GEOGR INF SCI, V27, P385, DOI 10.1080/13658816.2012.692791; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brakatsoulas S., 2005, P 31 INT C VERY LARG, P853; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Chowell G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066102; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Coombes EG, 2009, COAST MANAGE, V37, P94, DOI 10.1080/08920750802527127; Cortes R, 2014, SPORT TRACKERS BIG D; de Montjoye YA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01376; Douglas D.H., 1973, CARTOGRAPHICA INT J, V10, P112, DOI [10.3138/FM57-6770-U75U-7727, DOI 10.3138/FM57-6770-U75U-7727]; Farrell T. A., 2001, Leisure/Loisir, V26, P31, DOI 10.1080/14927713.2001.9649928; Frias-Martinez V, 2014, ENG APPL ARTIF INTEL, V35, P237, DOI 10.1016/j.engappai.2014.06.019; Friedman J. H., 1977, ACM Transactions on Mathematical Software, V3, P209, DOI 10.1145/355744.355745; Giannotti F, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P330; Giannotti F, 2011, VLDB J, V20, P695, DOI 10.1007/s00778-011-0244-8; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hoogendoorn SP, 2005, NETW SPAT ECON, V5, P193, DOI 10.1007/s11067-005-2629-y; Huang YT, 2009, MDM: 2009 10TH INTERNATIONAL CONFERENCE ON MOBILE DATA MANAGEMENT, P379, DOI 10.1109/MDM.2009.61; Kisilevich S, 2010, P 1 INT C EXH COMP G, V10, P38, DOI DOI 10.1145/1823854.1823897; Knights AM, 2013, ECOL APPL, V23, P755, DOI 10.1890/12-1137.1; Latora V, 2002, PHYSICA A, V314, P109, DOI 10.1016/S0378-4371(02)01089-0; Lera I., 2017, DATASET HUMAN HIKING; Lera I., 2016, MATCHGPX PYTHON ALGO; Li W, 2007, PHYSICA A, V382, P693, DOI 10.1016/j.physa.2007.04.031; Meijles EW, 2014, COMPUT ENVIRON URBAN, V47, P44, DOI 10.1016/j.compenvurbsys.2013.07.005; Moreira A, 2010, LECT NOTES GEOINF CA, P61, DOI 10.1007/978-3-642-12326-9_4; Mulligann C, 2011, ANAL SPATIAL SEMANTI, P350; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Orellana D, 2012, TOURISM MANAGE, V33, P672, DOI 10.1016/j.tourman.2011.07.010; Paldino S, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0043-3; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Shang S, 2014, VLDB J, V23, P449, DOI 10.1007/s00778-013-0331-0; Shoval N, 2010, INFORMATION AND COMMUNICATION TECHNOLOGIES IN TOURISM 2010, P171, DOI 10.1007/978-3-211-99407-8_15; Sienkiewicz J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046127; Soh H, 2010, PHYSICA A, V389, P5852, DOI 10.1016/j.physa.2010.08.015; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szabo A G, 2004, CLUSTERING COMPLEX N, P139; Tian Z, 2016, PROCEDIA ENGINEER, V138, P537, DOI 10.1016/j.proeng.2016.01.290; Vlachos M, 2002, PROC INT CONF DATA, P673, DOI 10.1109/ICDE.2002.994784; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yuan J., 2012, P 18 ACM SIGKDD INT, P186, DOI [DOI 10.1145/2339530.2339561, 10.1145/2339530.2339561]; Zhang XL, 2016, MULTIMED TOOLS APPL, V75, P17553, DOI 10.1007/s11042-016-3376-4; Zheng YT, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2168752.2168770	54	11	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177712	10.1371/journal.pone.0177712	http://dx.doi.org/10.1371/journal.pone.0177712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542280	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500035
J	McGuire, AL; Mulroney, KT; Carson, CF; Ram, R; Morahan, G; Chakera, A				McGuire, Amanda L.; Mulroney, Kieran T.; Carson, Christine F.; Ram, Ramesh; Morahan, Grant; Chakera, Aron			Analysis of early mesothelial cell responses to Staphylococcus epidermidis isolated from patients with peritoneal dialysis-associated peritonitis	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; INNATE IMMUNITY; MESSENGER-RNA; CYTOKINES; ENDOTHELIN-1; EXPRESSION; INFECTION; RECEPTOR; OUTCOMES	The major complication of peritoneal dialysis (PD) is the development of peritonitis, an infection within the abdominal cavity, primarily caused by bacteria. PD peritonitis is associated with significant morbidity, mortality and health care costs. Staphylococcus epidermidis is the most frequently isolated cause of PD-associated peritonitis. Mesothelial cells are integral to the host response to peritonitis, and subsequent clinical outcomes, yet the effects of infection on mesothelial cells are not well characterised. We systematically investigated the early mesothelial cell response to clinical and reference isolates of S. epidermidis using primary mesothelial cells and the mesothelial cell line Met-5A. Using an unbiased whole genome microarray, followed by a targeted panel of genes known to be involved in the human antibacterial response, we identified 38 differentially regulated genes (adj. p-value < 0.05) representing 35 canonical pathways after 1 hour exposure to S. epidermidis. The top 3 canonical pathways were TNFR2 signaling, IL-17A signaling, and TNFR1 signaling (adj. p-values of 0.0012, 0.0012 and 0.0019, respectively). Subsequent qPCR validation confirmed significant differences in gene expression in a number of genes not previously described in mesothelial cell responses to infection, with heterogeneity observed between clinical isolates of S. epidermidis, and between Met-5A and primary mesothelial cells. Heterogeneity between different S. epidermidis isolates suggests that specific virulence factors may play critical roles in influencing outcomes from peritonitis. This study provides new insights into early mesothelial cell responses to infection with S. epidermidis, and confirms the importance of validating findings in primary mesothelial cells.	[McGuire, Amanda L.; Mulroney, Kieran T.; Carson, Christine F.; Chakera, Aron] Harry Perkins Inst Med Res, Translat Renal Res Grp, Nedlands, WA, Australia; [McGuire, Amanda L.; Mulroney, Kieran T.; Carson, Christine F.; Chakera, Aron] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Ram, Ramesh; Morahan, Grant] Harry Perkins Inst Med Res, Ctr Diabet Res, Nedlands, WA, Australia; [Chakera, Aron] Sir Charles Gairdner Hosp, Dept Renal Med, Nedlands, WA, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; Harry Perkins Institute of Medical Research; University of Western Australia	McGuire, AL (corresponding author), Harry Perkins Inst Med Res, Translat Renal Res Grp, Nedlands, WA, Australia.; McGuire, AL (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia.	Amanda.McGuire@uwa.edu.au	Morahan, Grant/T-7501-2019; Carson, Christine F/F-1521-2013	Carson, Christine F/0000-0003-3669-1651; McGuire, Amanda/0000-0002-1261-9236; Mulroney, Kieran/0000-0001-5036-1339	Sir Charles Gairdner Osborne Park Health Care Group (SCGOPHCG)'s Research Advisory Committee (RAC) [RAC 2015-16/044]; University, State and Commonwealth Governments; Diabetes Research Foundation WA, NHMRC [1069173]; NHMRC Program [53000400, 37612600]	Sir Charles Gairdner Osborne Park Health Care Group (SCGOPHCG)'s Research Advisory Committee (RAC); University, State and Commonwealth Governments; Diabetes Research Foundation WA, NHMRC; NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this research was provided to AC (RAC 2015-16/044) by the Sir Charles Gairdner Osborne Park Health Care Group (SCGOPHCG)'s Research Advisory Committee (RAC), in conjunction with the Charlies Foundation for Research, http://www.scgh.health.wa.gov.au/Research/RAGFunding.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Lavinia Gordon from the Australian Genome Research Facility (AGRF), Melbourne, Australia for bioinformatics assistance with the microarray data, Professor Tim Inglis and Kate Trojer from PathWest Laboratory Medicine WA for assistance obtaining clinical and reference isolates, and Zen-Bio Inc. for providing the human primary mesothelial cells used in this study. The authors acknowledge the facilities, and the scientific and technical assistance of Cytometry Core at the Centre for Microscopy, Characterisation & Analysis, The University of Western Australia, a facility funded by the University, State and Commonwealth Governments. RR is supported by the Diabetes Research Foundation WA, NHMRC Project Grant 1069173 and by NHMRC Program Grants 53000400 and 37612600.	Anand S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072860; [Anonymous], 2014, R LANG ENV STAT COMP; ANZDATA Registry, 2015, 37 ANZDATA REG; Barretti P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-212; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birnie KA, 2015, MOL CANCER RES, V13, P1106, DOI 10.1158/1541-7786.MCR-14-0442; Brewis IA, 2010, NEPHROL DIAL TRANSPL, V25, P1749, DOI 10.1093/ndt/gfq145; BROWN AL, 1991, J HOSP INFECT, V18, P109, DOI 10.1016/0195-6701(91)90155-2; Brown MC, 2011, PERITON DIALYSIS INT, V31, P639, DOI 10.3747/pdi.2010.00185; Busnadiego O, 2015, J AM SOC NEPHROL, V26, P173, DOI 10.1681/ASN.2013070799; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Cass A, 2010, EC IMPACT END STAGE; Chaudhry V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19263; Colmont CS, 2011, NEPHROL DIAL TRANSPL, V26, P4079, DOI 10.1093/ndt/gfr217; Conlan S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r64; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Davenport A, 2009, PERITON DIALYSIS INT, V29, P297; del Peso G, 2005, NEPHROL DIAL TRANSPL, V20, P1201, DOI 10.1093/ndt/gfh793; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghali JR, 2011, PERITON DIALYSIS INT, V31, P651, DOI 10.3747/pdi.2010.00131; Heath CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142773; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Jones JSP, 2001, LUNG, V179, P397, DOI 10.1007/s004080000075; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kinnaert P, 1996, ANN SURG, V224, P749, DOI 10.1097/00000658-199612000-00010; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Kratochvill F, 2015, CANCER RES, V75, P3054, DOI 10.1158/0008-5472.CAN-15-0205; McGuire A, 2015, PERIT DIAL INT; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Mizgerd JP, 2001, J IMMUNOL, V166, P4042, DOI 10.4049/jimmunol.166.6.4042; Mutsaers SE, 2016, TXB PLEURAL DIS, P27; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Rodrigues-Diez R, 2014, KIDNEY INT; Rodriguez-Pascual F, 2014, LIFE SCI, V118, P156, DOI 10.1016/j.lfs.2013.12.024; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shin JH, 2011, PERITON DIALYSIS INT, V31, P340, DOI 10.3747/pdi.2010.00073; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Varano Della Vergiliana JF, 2013, PLOS ONE, V8; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Wang HH, 2011, J CHIN MED ASSOC, V74, P11, DOI 10.1016/j.jcma.2011.01.002; Wesener DA, 2015, NAT STRUCT MOL BIOL, V22, P603, DOI 10.1038/nsmb.3053; WEST TE, 1986, J CLIN MICROBIOL, V23, P809, DOI 10.1128/JCM.23.5.809-812.1986; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Wong YY, 2013, PERITON DIALYSIS INT, V33, P507, DOI 10.3747/pdi.2012.00281; Yao YF, 2005, INFECT IMMUN, V73, P1856, DOI 10.1128/IAI.73.3.1856-1860.2005; Zhou Q, 2016, KIDNEY INT, V90, P515, DOI 10.1016/j.kint.2016.03.040	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178151	10.1371/journal.pone.0178151	http://dx.doi.org/10.1371/journal.pone.0178151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542390	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500066
J	Perrier, L; Blondal, E; Ayala, AP; Dearborn, D; Kenny, T; Lightfoot, D; Reka, R; Thuna, M; Trimble, L; MacDonald, H				Perrier, Laure; Blondal, Erik; Ayala, A. Patricia; Dearborn, Dylanne; Kenny, Tim; Lightfoot, David; Reka, Roger; Thuna, Mindy; Trimble, Leanne; MacDonald, Heather			Research data management in academic institutions: A scoping review	PLOS ONE			English	Review								Objective The purpose of this study is to describe the volume, topics, and methodological nature of the existing research literature on research data management in academic institutions. Materials and methods We conducted a scoping review by searching forty literature databases encompassing a broad range of disciplines from inception to April 2016. We included all study types and data extracted on study design, discipline, data collection tools, and phase of the research data lifecycle. Results We included 301 articles plus 10 companion reports after screening 13,002 titles and abstracts and 654 full-text articles. Most articles (85%) were published from 2010 onwards and conducted within the sciences (86%). More than three-quarters of the articles (78%) reported methods that included interviews, cross-sectional, or case studies. Most articles (68%) included the Giving Access to Data phase of the UK Data Archive Research Data Lifecycle that examines activities such as sharing data. When studies were grouped into five dominant groupings (Stakeholder, Data, Library, Tool/Device, and Publication), data quality emerged as an integral element. Conclusion Most studies relied on self-reports (interviews, surveys) or accounts from an observer (case studies) and we found few studies that collected empirical evidence on activities amongst data producers, particularly those examining the impact of research data management interventions. As well, fewer studies examined research data management at the early phases of research projects. The quality of all research outputs needs attention, from the application of best practices in research data management studies, to data producers depositing data in repositories for long-term use.	[Perrier, Laure; Ayala, A. Patricia; Dearborn, Dylanne] Univ Toronto, Gerstein Sci Informat Ctr, Toronto, ON, Canada; [Blondal, Erik] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Kenny, Tim] UNT Hlth Sci Ctr, Gibson D Lewis Hlth Sci Lib, Ft Worth, TX USA; [Lightfoot, David] St Michaels Hosp, St Michaels Hosp Lib, Toronto, ON, Canada; [Reka, Roger] Univ Toronto, Fac Informat, Toronto, ON, Canada; [Thuna, Mindy] Univ Toronto, Engn & Comp Sci Lib, Toronto, ON, Canada; [Trimble, Leanne] Univ Toronto, Map & Data Lib, Toronto, ON, Canada; [MacDonald, Heather] Carleton Univ, MacOdrum Lib, Ottawa, ON, Canada	University of Toronto; University of Toronto; University of North Texas System; University of North Texas Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Carleton University	Perrier, L (corresponding author), Univ Toronto, Gerstein Sci Informat Ctr, Toronto, ON, Canada.	l.perrier@utoronto.ca	Reka, Roger/AAF-4937-2022; thuna, mindy/AHD-5581-2022; Reka, Roger/AFJ-8071-2022; Ayala, Ana Patricia/P-8955-2015; MacDonald, Heather/H-1704-2014; Dearborn, Dylanne/F-7159-2019; Lightfoot, David T/C-7094-2018; Perrier, Laure/D-4638-2011	Reka, Roger/0000-0001-5900-5664; Reka, Roger/0000-0001-5900-5664; Ayala, Ana Patricia/0000-0002-3613-2270; MacDonald, Heather/0000-0001-9480-2677; Dearborn, Dylanne/0000-0002-6301-8473; Lightfoot, David T/0000-0002-2221-200X; Perrier, Laure/0000-0001-9941-7129; thuna, mindy/0000-0003-4223-8028; Trimble, Leanne/0000-0001-8148-9298				[Anonymous], 2016, PRESS PEER REV EL SE; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Averkamp S, 2012, REPORT U LIB DATA MA; Borgman CL, 2012, J AM SOC INF SCI TEC, V63, P1059, DOI 10.1002/asi.22634; Bull S, 2015, J EMPIR RES HUM RES, V10, P225, DOI 10.1177/1556264615594767; Butler D., 2016, NATURE, V530, P5, DOI DOI 10.1038/530005A; DCC (Digital Curation Centre), OV FUND DAT POL; den Besten M, 2009, J BIOMED DISCOV COLL, V4; Diekmann F, 2012, J AGRIC FOOD INF, V13, P14, DOI 10.1080/10496505.2012.636005; Fecher B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118053; Gonzalez A, 2015, NATURE, V520, P436, DOI 10.1038/520436c; Government of Canada, 2011, RES DAT; Greenhalgh T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008567; Hayes J., 2012, COMMITTEE CASE INT S, P29; Holdren JP, 2013, INCREASING ACCESS RE; Hruby GW, 2013, J AM MED INFORM ASSN, V20, P563, DOI 10.1136/amiajnl-2012-001302; Hurwitz B, 2008, NARRATIVE RES HLTH I, P349; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Ivezic Z., 2012, COMMITTEE CASE INT S, P41; KANSA EC, 2014, INT J DIGITAL CURATI, V0009; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McKay D, 2010, LECT NOTES COMPUT SC, V6102, P236, DOI 10.1007/978-3-642-13654-2_29; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Murad M Hassan, 2016, Evid Based Med, V21, P125, DOI 10.1136/ebmed-2016-110401; OECD, 2004, DECL OP ACC PUBL FUN; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Piwowar HA, 2010, J INFORMETR, V4, P148, DOI 10.1016/j.joi.2009.11.010; Research Data Canada, GLOSS RES DAT MAN; Rodgers M., 2009, EVALUATION-US, V15, P49, DOI [10.1177/1356389008097871, DOI 10.1177/1356389008097871]; Roos A., 2014, CASE STUDY DEV RES D; ROSENTHAL R, 1978, PSYCHOL BULL, V85, P185, DOI 10.1037/0033-2909.85.1.185; Shearer K., 2015, COMPREHENSIVE BRIEF; The Joanna Briggs Institute, J BRIGGS I REV MAN 2; van Noorden R., NATURE NEWSBLOG; Varvel Virgil E.  Jr., 2013, New Review of Academic Librarianship, V19, P224, DOI 10.1080/13614533.2013.768277; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Willoughby C, 2014, J CHEM INF MODEL, V54, P3268, DOI 10.1021/ci500469f; Wynholds LA, 2012, P 12 ACM IEEE CS JOI, P19, DOI DOI 10.1145/2232817.2232822	38	26	26	9	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178261	10.1371/journal.pone.0178261	http://dx.doi.org/10.1371/journal.pone.0178261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542450	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058800052
J	Shen, TNY; Kanazawa, S; Kado, M; Okada, K; Luo, L; Hayashi, A; Mizuno, H; Tanaka, R				Shen, Tsubame Nishikai-Yan; Kanazawa, Shigeyuki; Kado, Makiko; Okada, Kayoko; Luo, Lin; Hayashi, Ayato; Mizuno, Hiroshi; Tanaka, Rica			Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice	PLOS ONE			English	Article							MACROPHAGE DIFFERENTIATION; OXIDATIVE STRESS; CELL-MIGRATION; ARGINASE-II; INFLAMMATION; ACTIVATION; PHENOTYPE; RECEPTOR; KINASE; WOUNDS	Persistent inflammatory environment and abnormal macrophage activation are characteristics of chronic diabetic wounds. Here, we attempted to characterize the differences in macrophage activation and temporal variations in cytokine expression in diabetic and nondiabetic wounds, with a focus on interleukin (IL)-6 mRNA expression and the p38 MAPK and PI3K/Akt signaling pathways. Cutaneous wound closure, CD68-and arginase-1 (Arg1)-expressing macrophages, and cytokine mRNA expression were examined in non-diabetic and streptozotocin-induced type 1 diabetic mice at different time points after injury. The effect of IL-6 on p38 MAPK and Akt phosphorylation was investigated, and an in vitro scratch assay was performed to determine the role of IL-6 in primary skin fibroblast migration. Before injury, mRNA expression levels of the inflammatory markers iNOS, IL-6, and TNF-alpha were higher in diabetic mice; however, IL-6 expression was significantly lower 6 h post injury in diabetic wounds than that in non-diabetic wounds. Non-diabetic wounds exhibited increased p38 MAPK and Akt phosphorylation; however, no such increase was found in diabetic wounds. In fibroblasts from non-diabetic mice, IL-6 increased the phosphorylation of p38 MAPK and levels of its downstream factor CREB, and also significantly increased Akt phosphorylation and levels of its upstream factor P13K. These effects of IL-6 were not detected in fibroblasts derived from the diabetic mice. In scratch assays, IL-6 stimulated the migration of primary cultured skin fibroblasts from the non-diabetic mice, and the inhibition of p38 MAPK was found to markedly suppress IL-6-stimulated fibroblast migration. These findings underscore the critical differences between diabetic and non-diabetic wounds in terms of macrophage activation, cytokine mRNA expression profile, and involvement of the IL-6-stimulated p38 MAPK-Akt signaling pathway. Aberrant macrophage activation and abnormalities in the cytokine mRNA expression profile during different phases of wound healing should be addressed when designing effective therapeutic modalities for refractory diabetic wounds.	[Shen, Tsubame Nishikai-Yan; Kanazawa, Shigeyuki; Kado, Makiko; Okada, Kayoko; Luo, Lin; Hayashi, Ayato; Mizuno, Hiroshi; Tanaka, Rica] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Kanazawa, Shigeyuki] Osaka Univ, Grad Sch Med, Dept Plast Surg, Osaka, Japan	Juntendo University; Osaka University	Tanaka, R (corresponding author), Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan.	rtanaka@juntendo.ac.jp			JSPS KAKENHI [26713051]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research is supported by the JSPS KAKENHI (Grants-in-Aid for Scientific Research) Grant Number 26713051 and MEXT-Supported Program for the Strategic Research Foundation at Private Universities.; Cactus Communications provided fact checking; referencing and editorial support in the form of medical writing based on the authors' detailed directions and collated author comments; and copyediting. We also thank Mr. Yusuke Kakinuma at Juntendou University School of Medicine Department of Plastic and Reconstructive Surgery for helpful technical support. This research is supported by the JSPS KAKENHI (Grants-in-Aid for Scientific Research) Grant Number 26713051 and MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Arranz-Valsero I, 2014, EXP EYE RES, V125, P183, DOI 10.1016/j.exer.2014.06.012; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Chesnokova V, 2002, ENDOCRINOLOGY, V143, P1571, DOI 10.1210/en.143.5.1571; Clahsen T, 2008, J LEUKOCYTE BIOL, V84, P1521, DOI 10.1189/jlb.0308178; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Das LM, 2015, J INVEST DERMATOL, V135, P389, DOI 10.1038/jid.2014.375; Fernando MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094188; Garash R, 2016, EXP BIOL MED, V241, P1054, DOI 10.1177/1535370216649444; Guest CB, 2008, FRONT BIOSCI-LANDMRK, V13, P5187, DOI 10.2741/3074; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Joko T, 2013, EXP EYE RES, V108, P23, DOI 10.1016/j.exer.2012.11.018; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Kim JH, 2009, J APPL PHYSL 1985, V107, P1249, DOI DOI 10.1152/JAPPLPHYSI0L.91393.2008; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; LI G, 2016, LAB INVEST, V6, P741, DOI DOI 10.1016/J.CYTO.2014.09.005; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Loughlin DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018676; Gavito AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157956; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; MAUER J, 2014, NATURE IMMUNOLOGY, V8, P423, DOI DOI 10.1189/JLB.0308178; Miao MY, 2012, WOUND REPAIR REGEN, V20, P203, DOI 10.1111/j.1524-475X.2012.00772.x; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza RE, 2015, CYTOKINE, V71, P409, DOI 10.1016/j.cyto.2014.09.005; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Misson P, 2004, J LEUKOCYTE BIOL, V76, P926, DOI 10.1189/jlb.0104019; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nelson AM, 2015, CELL STEM CELL, V17, P139, DOI 10.1016/j.stem.2015.07.008; O'Shea JJ, 2011, J IMMUNOL, V187, P5475, DOI 10.4049/jimmunol.1102913; Okizaki S, 2016, AM J PATHOL, V186, P1481, DOI 10.1016/j.ajpath.2016.02.014; Park CH, 2015, J MED FOOD, V18, P337, DOI 10.1089/jmf.2014.3174; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Salazar JJ, 2016, J DIABETES COMPLICAT, V30, P746, DOI 10.1016/j.jdiacomp.2015.12.017; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang Z, 2006, INVEST OPHTH VIS SCI, V47, P5267, DOI 10.1167/iovs.06-0642; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yang ZH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00149; Yepuri G, 2012, AGING CELL, V11, P1005, DOI 10.1111/acel.12001; Yu Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0113-z	56	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178232	10.1371/journal.pone.0178232	http://dx.doi.org/10.1371/journal.pone.0178232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542434	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058800048
J	Yang, ZH; Liu, JG; Yu, CR; Han, JT				Yang, Zhen-Hua; Liu, Jian-Guo; Yu, Chang-Rui; Han, Jing-Ti			Quantifying the effect of investors' attention on stock market	PLOS ONE			English	Article							VOLUME RETURN PREMIUM; GOOGLE-TRENDS; BIPARTITE NETWORKS; FINANCIAL NEWS; TIME-SERIES; UNIT-ROOT; INFORMATION; VOLATILITY; BEHAVIOR; SEARCH	The investors' attention has been extensively used to predict the stock market. Different from existing proxies of the investors' attention, such as the Google trends, Baidu index (BI), we argue the collective attention from the stock trading platforms could reflect the investors' attention more closely. By calculated the increments of the attention volume for each stock (IAVS) from the stock trading platforms, we investigate the effect of investors' attention measured by the IAVS on the movement of the stock market. The experimental results for Chinese Securities Index 100 (CSI100) show that the BI is significantly correlated with the returns of CSI100 at 1% significance level only in 2014. However, it should be emphasized that the correlation of the new proposed measure, namely IAVS, is significantly at 1% significance level in 2014 and 2015. It shows that the effect of the measure IAVS on the movement of the stock market is more stable and significant than BI. This study yields important invest implications and better understanding of collective investors' attention.	[Yang, Zhen-Hua; Yu, Chang-Rui] Shanghai Univ Finance & Econ, Sch Informat Management Engn, Shanghai 200433, Peoples R China; [Liu, Jian-Guo; Han, Jing-Ti] Shanghai Univ Finance & Econ, Data Sci & Cloud Serv Res Ctr, Shanghai 200433, Peoples R China; [Yang, Zhen-Hua] Huzhou Univ, Business Sch, Huzhou 313000, Peoples R China; [Liu, Jian-Guo] Fribourg Univ, Dept Phys, CH-1700 Fribourg, Switzerland	Shanghai University of Finance & Economics; Shanghai University of Finance & Economics; Huzhou University	Yu, CR (corresponding author), Shanghai Univ Finance & Econ, Sch Informat Management Engn, Shanghai 200433, Peoples R China.; Liu, JG (corresponding author), Shanghai Univ Finance & Econ, Data Sci & Cloud Serv Res Ctr, Shanghai 200433, Peoples R China.; Liu, JG (corresponding author), Fribourg Univ, Dept Phys, CH-1700 Fribourg, Switzerland.	liujg004@ustc.edu.cn; yu.changrui@mail.shufe.edu.cn	Liu, Jianguo/B-4492-2012; Chanelian, Serena/ABE-4873-2021	Liu, Jianguo/0000-0002-5641-0266; Chanelian, Serena/0000-0001-5727-6137	National Natural Science Foundation of China [61374177, 71371125, 71271026]; Project of Teaching Reform for Higher Education in Zhejiang Province [kg2015409]; Shanghai Institutions of Higher Learning - Shuguang Program Project of Shanghai Educational Committee [14SG42]; Sino Swiss Science and Technology Cooperation [09-032016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Teaching Reform for Higher Education in Zhejiang Province; Shanghai Institutions of Higher Learning - Shuguang Program Project of Shanghai Educational Committee; Sino Swiss Science and Technology Cooperation	This work is supported by the National Natural Science Foundation of China (Nos. 61374177, 71371125 and 71271026), the Project of Teaching Reform for Higher Education in Zhejiang Province (No:kg2015409), JGL is supported by The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Supported by Shuguang Program Project of Shanghai Educational Committee (Grant No.14SG42), and the Sino Swiss Science and Technology Cooperation(No. 09-032016).; The authors acknowledge the fruitful discussion with Professor Hsing Kenneth Cheng, as well as the eastmoney.com for the data set. This work is supported by the National Natural Science Foundation of China (Nos. 61374177, 71371125 and 71271026), the Project of Teaching Reform for Higher Education in Zhejiang Province (No:kg2015409), JGL is supported by The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Supported by Shuguang Program Project of Shanghai Educational Committee (Grant No.14SG42), and the Sino Swiss Science and Technology Cooperation(No. 09-032016).	Ackert LF, 2016, INT REV FINANC ANAL, V45, P39, DOI 10.1016/j.irfa.2016.02.001; Alanyali M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03578; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Aouadi A, 2013, ECON MODEL, V35, P674, DOI 10.1016/j.econmod.2013.08.034; ap Gwilym O, 2014, INT REV FINANC ANAL, V34, P212, DOI 10.1016/j.irfa.2014.03.001; Avramov D, 2006, J FINANC, V61, P2365, DOI 10.1111/j.1540-6261.2006.01060.x; Azuma T, 2014, INT REV FINANC, V14, P29, DOI 10.1111/irfi.12027; Bank M, 2011, FINANC MARK PORTFOLI, V25, P239, DOI 10.1007/s11408-011-0165-y; Barber BM, 2008, REV FINANC STUD, V21, P785, DOI 10.1093/rfs/hhm079; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; Casnici N, 2015, PLOS ONE, V10; Corwin SA, 2008, J FINANC, V63, P3031, DOI 10.1111/j.1540-6261.2008.01420.x; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; Da Z, 2011, J FINANC, V66, P1461, DOI 10.1111/j.1540-6261.2011.01679.x; Daniel K, 2002, J MONETARY ECON, V49, P139, DOI 10.1016/S0304-3932(01)00091-5; Daniel K, 1998, J FINANC, V53, P1839, DOI 10.1111/0022-1082.00077; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Dimpfl T, 2016, EUR FINANC MANAG, V22, P171, DOI 10.1111/eufm.12058; Dzielinski M, 2012, FINANC RES LETT, V9, P167, DOI 10.1016/j.frl.2011.10.003; Epaphra M., 2016, J MATH FINANC, V7, P121; Gervais S, 2001, J FINANC, V56, P877, DOI 10.1111/0022-1082.00349; Guo Q, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/28004; Hirshleifer D, 2001, J FINANC, V56, P1533, DOI 10.1111/0022-1082.00379; Hou L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06560; Huang Z., 2011, J FINANC RES, V34, P1, DOI DOI 10.1111/J.1475-6803.2010.01283.X; Huberman G, 2001, REV FINANC STUD, V14, P659, DOI 10.1093/rfs/14.3.659; Humala A, 2013, STUD ECON FINANC, V30, P139, DOI 10.1108/10867371311325444; Jacobs H., 2015, MANAGEMENT REV Q, V65, P217, DOI DOI 10.1007/s11301-015-0112-5; Joseph K, 2011, INT J FORECASTING, V27, P1116, DOI 10.1016/j.ijforecast.2010.11.001; Kahneman D., 1973, ATTENTION EFFORT; Kaniel R, 2012, J FINANC ECON, V103, P255, DOI 10.1016/j.jfineco.2011.08.012; Kenett DY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02110; Kristoufek L, 2013, SCI REP-UK, V3, DOI [10.1038/srep03415, 10.1038/srep02857]; Kristoufek L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02713; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; Li Q, 2014, INFORM SCIENCES, V278, P826, DOI 10.1016/j.ins.2014.03.096; Li RD, 2016, PHYS LETT A, V380, P3460, DOI 10.1016/j.physleta.2016.08.043; Lim KP, 2016, N AM J ECON FINANC, V36, P1, DOI 10.1016/j.najef.2015.11.003; Lin MF, 2013, MANAGE SCI, V59, P17, DOI 10.1287/mnsc.1120.1560; Liu JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep18653; Liu JG, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40328-4; Loh RK, 2010, FINANC MANAGE, V39, P1223, DOI 10.1111/j.1755-053X.2010.01110.x; Lou D, 2014, REV FINANC STUD, V644, P1797; Mandel T., 1996, RULES NET ON LINE OP; MERTON RC, 1987, J FINANC, V42, P483, DOI 10.2307/2328367; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Nofer M, 2015, BUS INFORM SYST ENG+, V57, P229, DOI 10.1007/s12599-015-0390-4; Piskorec M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05038; Preis T, 2015, EARLY SIGNS FINANCIA, P85; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Ranco G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146576; Sankaraguruswamy S, 2008, SSRN ELECT J, V87, P1357; SeasholesM S, 2007, J EMPIR FINANC, V14, P590; Shen DH, 2016, PHYSICA A, V451, P519, DOI 10.1016/j.physa.2016.01.086; Statman M, 2006, REV FINANC STUD, V19, P1531, DOI 10.1093/rfs/hhj032; Sun XQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03711; Takeda F, 2014, PAC-BASIN FINANC J, V27, P1, DOI 10.1016/j.pacfin.2014.01.003; [卫强 Wei Qiang], 2016, [系统工程理论与实践, Systems Engineering-Theory & Practice], V36, P1361; Wu DD, 2014, IEEE T SYST MAN CY-S, V44, P1077, DOI 10.1109/TSMC.2013.2295353; Yu Q J, 2012, J FINANC RES, V386, P152; Zhang JNL, 2016, J BUS ECON STAT, V34, P547, DOI 10.1080/07350015.2015.1110525; Zhang W, 2016, PHYSICA A, V460, P201, DOI 10.1016/j.physa.2016.05.026; Zhang W, 2013, ECON MODEL, V33, P613, DOI 10.1016/j.econmod.2013.03.018; Zhang YJ, 2016, ECON MODEL, V56, P43, DOI 10.1016/j.econmod.2016.03.020; Zhang YJ, 2014, PHYSICA A, V399, P70, DOI 10.1016/j.physa.2013.12.034; Zheludev I N, 2015, CAN SOCIAL MEDIA LEA	67	9	9	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0176836	10.1371/journal.pone.0176836	http://dx.doi.org/10.1371/journal.pone.0176836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UE	28542216	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058800004
J	Ooga, M; Wakayama, T				Ooga, Masatoshi; Wakayama, Teruhiko			FRAP analysis of chromatin looseness in mouse zygotes that allows full-term development	PLOS ONE			English	Article							PREIMPLANTATION DEVELOPMENT; TRANSCRIPTION; PLURIPOTENCY; INVOLVEMENT; EMBRYOS	Chromatin looseness, which can be analyzed by fluorescence recovery after photobleaching (FRAP) using eGFP-tagged core histone proteins, is an important index of the differentiation potential of blastomere cells and embryonic stem cells. Whether chromatin looseness is a reliable index of the developmental potential of embryos during ontogenesis is not known. As a necessary first step toward answering this question, we investigated whether FRAP-analyzed embryos are capable of normal preimplantation and full-term development. All tested concentrations (50, 100, and 250 ng/mu L) of microinjected eGFP-H2B mRNA were sufficient for detecting differences in chromatin looseness between male and female pronuclei. After FRAP analysis, most of the zygotes developed into blastocysts. Importantly, a considerable number of offspring developed from the FRAP analyzed zygotes (32/78; 41.0%) and grew into healthy adults. The offspring of zygotes injected with 250 ng/mu L of eGFP-H2B mRNA and bleached using 110 mu W laser power for 5 s were not genetically modified. Interestingly, bleaching using a 3-fold stronger laser intensity for a 6-fold longer time did not cause toxicity during preimplantation development, indicating that bleaching did not critically affect preimplantation development. Finally, we confirmed that similar results were obtained using two different types of confocal laser-scanning microscopes. This FRAP protocol would be useful for investigating the association between chromatin looseness and development.	[Ooga, Masatoshi; Wakayama, Teruhiko] Univ Yamanashi, Adv Biotechnol Ctr, Kofu, Yamanashi, Japan; [Ooga, Masatoshi; Wakayama, Teruhiko] Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Ooga, M (corresponding author), Univ Yamanashi, Adv Biotechnol Ctr, Kofu, Yamanashi, Japan.; Ooga, M (corresponding author), Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi, Japan.	mohga@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology program for promoting the reform of national universities; Japan Society for the Promotion of Science [16H02593]; Asada Science Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [16H02593] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology program for promoting the reform of national universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asada Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially funded by Ministry of Education, Culture, Sports, Science and Technology program for promoting the reform of national universities to M.O.; the Japan Society for the Promotion of Science (16H02593), Asada Science Foundation, and the Takeda Science Foundation to T.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Abe K, 2015, EMBO J, V34, P1523, DOI 10.15252/embj.201490648; Akiyama T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002279; Boskovic A, 2014, GENE DEV, V28, P1042, DOI 10.1101/gad.238881.114; Burton A, 2014, NAT REV MOL CELL BIO, V15, P722, DOI 10.1038/nrm3885; Burton A, 2010, BRIEF FUNCT GENOMICS, V9, P444, DOI 10.1093/bfgp/elq027; CHATOT CL, 1990, BIOL REPROD, V42, P432, DOI 10.1095/biolreprod42.3.432; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Lepikhov Konstantin, 2004, BMC Developmental Biology, V4, P1; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Nashun B, 2010, DEVELOPMENT, V137, P3785, DOI 10.1242/dev.051805; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Ooga M, 2016, EPIGENETICS-US, V11, P85, DOI 10.1080/15592294.2015.1136774; Ooga M, 2015, J REPROD DEVELOP, V61, P179, DOI 10.1262/jrd.2014-137; Ooga M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113258; QUINN P, 1984, AUST J BIOL SCI, V37, P147, DOI 10.1071/BI9840147; Terashita Y, 2011, J REPROD DEVELOP, V57, P564, DOI 10.1262/jrd.11-015H; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166	20	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178255	10.1371/journal.pone.0178255	http://dx.doi.org/10.1371/journal.pone.0178255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542635	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058400074
J	Abaye, GE; Abebe, T; Worku, A; Tolessa, D; Ameni, G; Mihret, A				Abaye, Gizaw E.; Abebe, Tamrat; Worku, Adane; Tolessa, Debela; Ameni, Gobena; Mihret, Adane			Detection of Mycobacterium tuberculosis from the stool of HIV sero-positive individuals suspected of pulmonary tuberculosis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SPUTUM INDUCTION; XPERT MTB/RIF; SOUTH-AFRICA; INFECTION; DIAGNOSIS; SAMPLES; SPECIMENS; COMPLEX; EPIDEMIOLOGY	Background The impact of tuberculosis (TB) is exacerbated in Africa because of the human immunodeficiency virus (HIV) pandemic. Pulmonary tuberculosis (PTB) diagnosis is difficult in HIVinfected patients and negative sputum results are more common which leads to diagnostic delay and increases morbidity and mortality. Extra-pulmonary samples such as stool may be easier to obtain and our approach may therefore significantly improve PTB detection in people living with HIV. Objective To detect Mycobacterium tuberculosis from the stool of HIV sero-positive individuals suspected of pulmonary TB. Method A total of 117 HIV-infected individuals from three public health facilities in Addis Ababa, Ethiopia were enrolled consecutively in the study. Paired morning sputum and stool samples were simultaneously collected from anti-retroviral therapy (ART) naive individuals living with HIV and suspected for PTB. The diagnostic accuracy of the smear microscopy, culture and region of difference (RD)9-based polymerase chain reaction (PCR) in stool was compared with the accuracy of sputum testing. Chi-square test and kappa value were used to compare different method used. Results Sputum culture positivity for mycobacteria was confirmed in 33(28.2%) of the study subjects. Of 33 individuals positive for sputa culture, 10 individuals were observed to be stools culture positive. Of the 84 individuals negative for mycobacteria by sputum culture, three 3.6%) were stool culture positive and thus, the sensitivity and agreement between stool culture as compare to sputum culture were 30.3% and 0.33, respectively. Of 117 individuals, 11(9.4%) were sputum smear positive and of 11 sputum smear positive three were also stool smear positive. While of the 106 sputum smear negative individuals', only one was stool smear positive resulting in 12.1% sensitivity and 0.18 agreements against sputum culture. On the other hand, the sensitivity of RD9-based PCR directly on stool was 69.7% by considering sputum culture as a reference standard. Moreover, RD9-based PCR directly on sputum detected 7(6.0%) individuals who were sputum culture negative for M. tuberculosis. Conclusion M. tuberculosis was detected in stool of individuals living with HIV who were negative for sputum smear microscopy and culture. Hence, examination of stool samples alongside with sputum samples increases the detection of PTB in individuals living with HIV.	[Abaye, Gizaw E.] Arsi Univ, Dept Med Lab Sci, Coll Hlth Sci, Asella, Ethiopia; [Abebe, Tamrat; Mihret, Adane] Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Coll Hlth Sci, Fac Med, Addis Ababa, Ethiopia; [Worku, Adane; Ameni, Gobena] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Tolessa, Debela] Arsi Univ, Dept Biomed Sci, Coll Hlth Sci, Asella, Ethiopia; [Mihret, Adane] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Abaye, GE (corresponding author), Arsi Univ, Dept Med Lab Sci, Coll Hlth Sci, Asella, Ethiopia.	gizaweshetu@yahoo.cam	Kempker, Russell/F-5776-2017; Ameni, Gobena/AAR-4201-2020	Ameni, Gobena/0000-0003-3987-0671; Eshetu, Gizaw/0000-0001-8169-1453; Mihret, Adane/0000-0003-3183-4772	NIH/Fogarty International Center Global Infectious Diseases [D43TW009127]	NIH/Fogarty International Center Global Infectious Diseases	Tamrat Abebe is supported by a fellowship from NIH/Fogarty International Center Global Infectious Diseases grant (D43TW009127).	Banada PP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151980; BARNES PF, 1991, NEW ENGL J MED, V324, P1644, DOI 10.1056/NEJM199106063242307; BATUNGWANAYO J, 1992, AM REV RESPIR DIS, V146, P53, DOI 10.1164/ajrccm/146.1.53; BEST M, 1990, J CLIN MICROBIOL, V28, P2234, DOI 10.1128/JCM.28.10.2234-2239.1990; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; COLEBUNDERS R, 1990, ANN SOC BELG MED TR, V70, P303; Conde MB, 2003, AM J RESP CRIT CARE, V167, P723, DOI 10.1164/rccm.2111019; Cordova J, 2010, J CLIN MICROBIOL, V48, P1820, DOI 10.1128/JCM.01161-09; DiNardo AR, 2015, INT J INFECT DIS, V41, P50, DOI 10.1016/j.ijid.2015.10.022; Farid Z, 1999, J Egypt Public Health Assoc, V74, P473; Ferroni A, 2006, J CLIN MICROBIOL, V44, P2237, DOI 10.1128/JCM.00285-06; Franchi LM, 1998, LANCET, V352, P1681, DOI 10.1016/S0140-6736(05)61454-7; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Hartung TK, 2002, SAMJ S AFR MED J, V92, P455; Hassim S, 2010, CLIN INFECT DIS, V50, P1053, DOI 10.1086/651119; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Hudson CP, 2000, INT J TUBERC LUNG D, V4, P240; Khe-chine AE, 2009, MICROB, V155, P2384; Kokuto H, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv074; KUBICA GP, 1964, AM REV RESPIR DIS, V89, P284; Lawn SD, 2005, AIDS, V19, P1113, DOI 10.1097/01.aids.0000176211.08581.5a; Lawn SD, 2001, INT J TUBERC LUNG D, V5, P200; LIESENFELD O, 1995, J CLIN MICROBIOL, V33, P745, DOI 10.1128/JCM.33.3.745-747.1995; Maartens G, 2002, CURR OPIN PULM MED, V8, P173, DOI 10.1097/00063198-200205000-00004; Marcy O, 2016, CLIN INFECT DIS, V62, P1161, DOI 10.1093/cid/ciw036; Maynard-Smith L, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0709-7; Moore D, 2005, LANCET, V365, P1541, DOI 10.1016/S0140-6736(05)66453-7; Nicol MP, 2013, XPERT MTB RIF TESTIN, P57; Oberhelman RA, 2006, PEDIATRICS, V118, pE100, DOI 10.1542/peds.2005-2623; Oramasionwu GE, 2013, INT J TUBERC LUNG D, V17, P1023, DOI 10.5588/ijtld.13.0061; Pape Jean William, 2004, Top HIV Med, V12, P144; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Saranchuk P, 2007, SAMJ S AFR MED J, V97, P517; Sonnenberg P, 2007, J INFECT DIS, V19, P150; Tortoli E, 2005, INT J SYST EVOL MICR, V55, P1101, DOI 10.1099/ijs.0.63485-0; Ulmar D, 1933, J AMER MED ASSOC, V101, P835, DOI 10.1001/jama.1933.02740360015006; Wolf H, 2008, AM J TROP MED HYG, V79, P893, DOI 10.4269/ajtmh.2008.79.893; World Health Organization, 2014, WHO REPORT	42	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177529	10.1371/journal.pone.0177529	http://dx.doi.org/10.1371/journal.pone.0177529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542255	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672600013
J	Conn, JR; Catchpoole, EM; Runnegar, N; Mapp, SJ; Markey, KA				Conn, Jason R.; Catchpoole, Elizabeth M.; Runnegar, Naomi; Mapp, Sally J.; Markey, Kate A.			Low rates of antibiotic resistance and infectious mortality in a cohort of high-risk hematology patients: A single center, retrospective analysis of blood stream infection	PLOS ONE			English	Article							FEBRILE NEUTROPENIA; CANCER; IMPACT; CARE	Febrile neutropenia (FN) is a medical emergency and can represent a life-threatening complication for hematology patients treated with intensive chemotherapy regimens. In clinical practice, the diagnostic yield of blood cultures and other investigations which aim to identify a causative organism or site of infection is low. We have retrospectively examined all blood cultures collected in a "real world" cohort of patients receiving chemotherapy for acute leukemia and patients with aggressive lymphoma treated with Hyper-CVAD/MTX-cytarabine, at a single tertiary center over a five-year period. In this cohort, the 30-day mortality following confirmed blood stream infection (BSI) was 5.9%, which is lower than most reports in the recent literature. We compared the blood culture results of inpatients undergoing induction chemotherapy and outpatients presenting with fevers and found a significantly higher rate of proven BSI in the outpatient group. In all settings, gram-negative organisms were most common. The rate of resistance to first-line empiric antibiotics among pathogenic isolates was 11.6% in the whole cohort, independent of blood culture circumstances. There was a trend to higher resistance rates among inpatients undergoing induction chemotherapy compared to patients presenting to the emergency department (17.4% vs 7.5%) but this did not reach statistical significance. We also report low rates of ciprofloxacin resistance (5% of isolates), in a center where universal fluoroquinolone prophylaxis is not employed. Our low resistance and mortality rates support our current therapeutic strategies, however presence of resistant organisms across the spectrum of indications for BC collection highlights the importance of surveilling local patterns, escalating antimicrobial therapy in the deteriorating patient, and considering advanced techniques for the rapid identification of resistance in this patient population.	[Conn, Jason R.; Mapp, Sally J.; Markey, Kate A.] Princess Alexandra Hosp, Div Canc Serv, Brisbane, Qld, Australia; [Catchpoole, Elizabeth M.] Royal Brisbane & Womens Hosp, Pathol Queensland, Brisbane, Qld, Australia; [Runnegar, Naomi; Mapp, Sally J.; Markey, Kate A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Runnegar, Naomi] Princess Alexandra Hosp, Infect Management Serv, Brisbane, Qld, Australia; [Markey, Kate A.] Royal Brisbane & Womens Hosp, Haematol & Bone Marrow Transplantat Unit, Brisbane, Qld, Australia; [Markey, Kate A.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Markey, Kate A.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia	Royal Brisbane & Women's Hospital; University of Queensland; Royal Brisbane & Women's Hospital; QIMR Berghofer Medical Research Institute; University of Queensland	Markey, KA (corresponding author), Princess Alexandra Hosp, Div Canc Serv, Brisbane, Qld, Australia.; Markey, KA (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld, Australia.; Markey, KA (corresponding author), Royal Brisbane & Womens Hosp, Haematol & Bone Marrow Transplantat Unit, Brisbane, Qld, Australia.; Markey, KA (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.; Markey, KA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	kate.markey@qimrberghofer.edu.au	Runnegar, Naomi/ABF-6386-2021; Runnegar, Naomi J/N-2911-2016; Markey, Kate/A-5385-2016	Runnegar, Naomi/0000-0003-1196-4131; Runnegar, Naomi J/0000-0003-1196-4131; Markey, Kate/0000-0002-7064-2362				Australian Commission on Safety and Quality in Health Care, 2014, PREL REP ANT US RES; Bennett CL, 2013, NEW ENGL J MED, V368, P1131, DOI 10.1056/NEJMct1210890; Bucaneve G, 2005, NEW ENGL J MED, V353, P977, DOI 10.1056/NEJMoa044097; Buckley SA, 2014, AM J HEMATOL, V89, P423, DOI 10.1002/ajh.23661; Caggiano V, 2005, CANCER-AM CANCER SOC, V103, P1916, DOI 10.1002/cncr.20983; CLSI, 2011, M100S20 CLSI, P172; Empirical Therapy for Febrile Neutropenia, 2016, SEV SEPS SEPT SHOCK; Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00008; Gea-Banacloche J, 2013, HEMATOL-AM SOC HEMAT, P414, DOI 10.1182/asheducation-2013.1.414; Hauck Christopher G, 2016, Pathog Immun, V1, P234, DOI 10.20411/pai.v1i2.115; Horasan ES, 2011, MED SCI MONITOR, V17, pCR304, DOI 10.12659/MSM.881773; Iland HJ, 2012, BLOOD, V120, P1570, DOI 10.1182/blood-2012-02-410746; Jacob LA, 2014, INDIAN J CANCER, V51, P464, DOI 10.4103/0019-509X.175330; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Klastersky J, 2004, CLIN INFECT DIS, V39, pS32, DOI 10.1086/383050; Klastersky J, 2013, SUPPORT CARE CANCER, V21, P1487, DOI 10.1007/s00520-013-1758-y; Koya R, 1998, BONE MARROW TRANSPL, V21, P923, DOI 10.1038/sj.bmt.1701201; Legrand M, 2012, CRIT CARE MED, V40, P43, DOI 10.1097/CCM.0b013e31822b50c2; Marin M, 2014, J INFECTION, V69, P417, DOI 10.1016/j.jinf.2014.05.018; Morrissey CO, 2008, INTERN MED J, V38, P477, DOI 10.1111/j.1445-5994.2008.01724.x; Rosa RG, 2014, ANTIMICROB AGENTS CH, V58, P3799, DOI 10.1128/AAC.02561-14; Rosa RG, 2014, CAN J INFECT DIS MED, V25, pE14, DOI 10.1155/2014/702621; Skoetz N, 2015, COCHRANE DB SYST REV, V12; Taj M, 2015, J ONCOL, V2015, DOI 10.1155/2015/596504; The European Committee on Antimicrobial Susceptibility Testing, 2014, BREAKP TAB INT MICS; Trecarichi EM, 2014, CURR OPIN INFECT DIS, V27, P200, DOI 10.1097/QCO.0000000000000038; Trecarichi EM, 2016, AM J HEMATOL, V91, P1076, DOI 10.1002/ajh.24489; Trubiano JA, 2015, BRIT J CLIN PHARMACO, V79, P195, DOI 10.1111/bcp.12310; Villafuerte Gutierrez P., 2014, ADV HEMATOL, V2014, P1, DOI [DOI 10.1155/2014/986938, 10.1155/2014/986938]; Wang L, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001931	30	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178059	10.1371/journal.pone.0178059	http://dx.doi.org/10.1371/journal.pone.0178059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542412	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600043
J	Mutanga, CN; Muboko, N; Gandiwa, E				Mutanga, Chiedza Ngonidzashe; Muboko, Never; Gandiwa, Edson			Protected area staff and local community viewpoints: A qualitative assessment of conservation relationships in Zimbabwe	PLOS ONE			English	Article							GONAREZHOU NATIONAL-PARK; HUMAN-WILDLIFE CONFLICTS; BIODIVERSITY CONSERVATION; PEOPLE; PERCEPTIONS; ATTITUDES; MANAGEMENT; TOURISM; RESIDENTS; FRAMEWORK	With the increase in illegal resource harvesting in most protected areas (PAs), the need to understand the determinants and relationships between PAs and local communities to enhance wildlife conservation is increasingly becoming important. Using focus group discussions and interviews, we established the determinants of PA staff-community relationship from both PA staff and local communities' viewpoints, and assessedperceptions of their relationship with each other. The study was guided by the following main research question, 'What is the nature of the relationship between PA staff and local communities and what are the main factors influencing the relationship?' Data were collected through focus group discussions and interviews from four PAs and their adjacent communities in Zimbabwe between July 2013 and February 2014. Our results showed that a total of seven determinants were identified as influencing PA staff-community relationship, i.e., benefit-sharing, human-wildlife conflict, compensation for losses from wildlife attacks, communication between PA staff and local communities, community participation in the management of CAMPFIRE projects, lack of community participation in tourism in PAs, and community perceptions of PA staff or PA staff perceptions of the community. Of the seven, only one determinant, benefit-sharing, was recorded as the main factor that differentially influencesthe perceptions of community and PA staff on their relationship. Furthermore, both the communities and PA staff reported mixed perceptions on their relationship with each other. We conclude that both communities' and PA staff's views on determinants are largely similar in all studied PAs irrespective of PA ownership, management and/or land use. Our findings could be relevant in policy making especially in developing countries in developing PA-community relationship framework in natural resource conservation.	[Mutanga, Chiedza Ngonidzashe] Chinhoyi Univ Technol, Sch Hospitality & Tourism, Private Bag 7724, Chinhoyi, Zimbabwe; [Muboko, Never; Gandiwa, Edson] Chinhoyi Univ Technol, Sch Wildlife Ecol & Conservat, Private Bag 7724, Chinhoyi, Zimbabwe		Mutanga, CN (corresponding author), Chinhoyi Univ Technol, Sch Hospitality & Tourism, Private Bag 7724, Chinhoyi, Zimbabwe.	cnmutanga@gmail.com	Gandiwa, Edson/I-2925-2019; Mutanga, Chiedza Ngonidzashe/HFZ-8677-2022; Mutanga, Chiedza/AAH-5461-2020	Gandiwa, Edson/0000-0003-0708-350X; Mutanga, Chiedza Ngonidzashe/0000-0002-3684-9052	Chinhoyi University of Technology [PG4404]	Chinhoyi University of Technology	The work was supported by Chinhoyi University of Technology PG4404, www.cut.ac.zw, to CNM. The funders had no role in study design, data collection and analysis, decision to publish, or preperation of the manuscript.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Allendorf TD, 2010, INT J SUST DEV WORLD, V17, P417, DOI 10.1080/13504501003788180; [Anonymous], 2004, CONSERVATION GLOBALI; Babbie E.R., 2020, PRACTICE SOCIAL RES, V15th; Baral N., 2007, ENVIRON CONSERV, V34, P1; Bennett NJ, 2014, MAR POLICY, V44, P107, DOI 10.1016/j.marpol.2013.08.017; BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Blackburn S, 2016, J APPL ECOL; Bock B., 2006, RURAL GENDER RELATIO; BOND I, 2001, AFRICAN WILDLIFE LIV; Bond I, 2005, CAMPFIRE PAYMENT ENV; Brockington Dan, 2002, FORTRESS CONSERVATIO; Bruyere B, 2009, ENVIRON MANAGE, V43, P49, DOI 10.1007/s00267-008-9190-7; Child B, PARKS IN TRANSITION; Child G., 1995, ORYX, V29, P54; Fiallo EA, 1995, ENVIRON CONSERV, V22, P241, DOI 10.1017/S037689290001064X; Fischer C, 2011, ENVIRON RESOUR ECON, V48, P303, DOI 10.1007/s10640-010-9409-y; Frank B, 2016, SOC NATUR RESOUR, V29, P738, DOI 10.1080/08941920.2015.1103388; Furze B., 1996, CULTURE CONSERVATION; Gadd ME, 2005, ENVIRON CONSERV, V32, P50, DOI 10.1017/S0376892905001918; Gandiwa E., 2012, Journal of Sustainable Development in Africa, V14, P252; Gandiwa E, 2013, ECOL SOC, V18, DOI 10.5751/ES-05817-180407; Gandiwa E, 2013, J NAT CONSERV, V21, P133, DOI 10.1016/j.jnc.2012.11.009; Garforth, 1997, GUIDE EXTENSION TRAI; Gobosho L., 2016, J ECOLOGY NATURAL EN, V8, P49, DOI [10.5897/JENE2015.0543, DOI 10.5897/JENE2015.0543]; Gockel CK, 2009, ECOL SOC, V14; Haralambos M., 2008, SOCIOLOGY THEMES PER; Holmes G., 2007, CONSERV SOC, V5, P184; Holmes G, 2013, CONSERV SOC, V11, P72, DOI 10.4103/0972-4923.110940; Kent ML, 2002, PUBLIC RELAT REV, V28, P21, DOI 10.1016/S0363-8111(02)00108-X; Kideghesho JR, 2007, BIODIVERS CONSERV, V16, P2213, DOI 10.1007/s10531-006-9132-8; Martin RB, 1986, 186 CAMPFIRE DEP NAT; Matema S, 2015, J MOD AFR STUD, V53, P93, DOI 10.1017/S0022278X14000664; McCleave J, 2006, SOC NATUR RESOUR, V19, P547, DOI 10.1080/08941920600664001; Mhlanga L., 2001, CONFLICT WILDLIFE PE, V28; Molina-Murillo SA, 2016, PARKS, V22, P79; Mombeshora S, 2009, BIODIVERS CONSERV, V18, P2601, DOI 10.1007/s10531-009-9676-5; Muboko N, 2014, J NAT CONSERV, V22, P206, DOI 10.1016/j.jnc.2013.12.002; Muchapondwa E, 2009, 395 U GOTH DEP EC; Mutanga CN, 2015, J NAT CONSERV, V25, P8, DOI 10.1016/j.jnc.2015.02.006; Mutanga CN, INT J BIODIVERSITY S; Newing H., 2010, CONDUCTING RES CONSE; Ormsby A, 2005, ENVIRON CONSERV, V32, P156, DOI 10.1017/S0376892905002146; Patton MQ, 2005, QUAL RES; Redford KH, 2006, CONSERV BIOL, V20, P1, DOI 10.1111/j.1523-1739.2006.00350.x; Redpath SM, 2013, TRENDS ECOLOGY EVOLU, V28; Romanach S, 2011, ATTITUDES PREDATORS; Roth R., 2004, ASIA PACIFIC VIEWPOI, V45, P13, DOI DOI 10.1111/j.1467-8376.2004.00225.x; Saska Petrova, 2014, ASH STUD ENV POL PR; Scott James C., 1990, DOMINATION ARTS RESI; Simelane T. S., 2006, Koedoe, V49, P85; Snyman SL, 2012, J SUSTAIN TOUR, V20, P395, DOI 10.1080/09669582.2012.657202; Songorwa AN, 1999, WORLD DEV, V27, P2061, DOI 10.1016/S0305-750X(99)00103-5; Sponarski CC, 2015, SOC NATUR RESOUR, V28, P720, DOI 10.1080/08941920.2015.1014595; Strickland-Munro J, 2013, J SUSTAIN TOUR, V21, P26, DOI 10.1080/09669582.2012.680466; Swanson T. M., 1992, EC WILDS WILDLIFE WI; Tessema ME, 2010, SOC NATUR RESOUR, V23, P489, DOI 10.1080/08941920903177867; Tomicevic J, 2010, FOREST POLICY ECON, V12, P157, DOI 10.1016/j.forpol.2009.09.006; Wilkie DS, 2006, CONSERV BIOL, V20, P247, DOI 10.1111/j.1523-1739.2005.00291.x; Zunza E, 2012, LOCAL LEVEL BENEFITS	60	18	19	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177153	10.1371/journal.pone.0177153	http://dx.doi.org/10.1371/journal.pone.0177153			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PW	28542185	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600005
J	Barbaret, C; Brosse, C; Rhondali, W; Ruer, M; Monsarrat, L; Michaud, P; Schott, AM; Delgado-Guay, M; Bruera, E; Sanchez, S; Filbet, M				Barbaret, Cecile; Brosse, Christelle; Rhondali, Wadih; Ruer, Murielle; Monsarrat, Lea; Michaud, Patrick; Schott, Anne Marie; Delgado-Guay, Marvin; Bruera, Eduardo; Sanchez, Stephane; Filbet, Marilene			Financial distress in patients with advanced cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; CELL LUNG-CANCER; HEALTH-CARE; FACT-G; DEPRESSION; ASSOCIATIONS; SURVIVAL; TOXICITY; BURDEN; STRAIN	Purpose We examined the frequency and severity of financial distress (FD) and its association with quality of life (QOL) and symptoms among patients with advanced cancer in France. Design In this cross-sectional study, 143 patients with advanced cancer were enrolled. QOL was assessed using the Functional Assessment of Cancer General (FACT-G) and symptoms assessed using Edmonton Assessment System (ESAS) and Hospital Anxiety and Depression Scale (HADS). FD was assessed using a self-rated numeric scale from 0 to 10. Results Seventy-three (51%) patients reported having FD. Patients reported having FD were most likely to be younger (53.8 (16,7SD) versus 62 (10.5SD), p<0.001), single (33 (62%) versus 40 (44%), p = 0.03) and had a breast cancer (26 (36%), p = 0.024). Patients with FD had a lower FACT-G score (59 versus 70, p = 0.005). FD decreased physical (14 versus 18, p = 0.008), emotional (14 versus 16, p = 0.008), social wellbeing (17 versus 19, p = 0.04). Patients with FD had higher HADS-D (8 versus 6 p = 0.007) and HADS-A (9 versus 7, p = 0.009) scores. FD was linked to increased ESAS score (59 (18SD) versus 67 (18SD), p = 0.005) and spiritual suffering (22(29SD) versus 13(23SD), p = 0.045). Conclusion The high rate of patient-reported FD was unexpected in our studied population, as the French National Health Insurance covers specific cancer treatments. The FD was associated with a poorer quality of life. Having a systematic assessment, with a simple tool, should lead to future research on interventions that will increase patients' QOL.	[Barbaret, Cecile] CHU Grenoble, Dept Support & Palliat Care, Grenoble, France; [Brosse, Christelle] Inst Cancerol Loire, Dept Palliat Care, St Etienne, France; [Rhondali, Wadih; Michaud, Patrick; Filbet, Marilene] Ctr Hosp Lyon Sud, Dept Support & Palliat Care, Lyon, France; [Ruer, Murielle; Monsarrat, Lea; Schott, Anne Marie] Hosp Civils Lyon, Pole IMER, Lyon, France; [Delgado-Guay, Marvin; Bruera, Eduardo] MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Houston, TX USA; [Sanchez, Stephane] Hop Champagne Sud, Dept Med Informat Evaluat & Performance, Troyes, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Cancerologie de la Loire; CHU Lyon; CHU Lyon; University of Texas System; UTMD Anderson Cancer Center	Filbet, M (corresponding author), Ctr Hosp Lyon Sud, Dept Support & Palliat Care, Lyon, France.	marilene.filbet@chu-lyon.fr	Sanchez, Stephane/ABD-3014-2020; Bruera, Eduardo/AAA-1550-2022; Schott, Anne-Marie/V-7580-2018	Sanchez, Stephane/0000-0002-0925-6948; Schott, Anne-Marie/0000-0003-3337-4474; Barbaret, Cecile/0000-0001-7144-7115				Arndt V, 2004, EUR J CANCER, V40, P673, DOI 10.1016/j.ejca.2003.12.007; Bailey W., 1998, PERSONAL FINANCES 2, V2, P198; Banthin JS, 2008, HEALTH AFFAIR, V27, P188, DOI 10.1377/hlthaff.27.1.188; Bernard DSM, 2011, J CLIN ONCOL, V29, P2821, DOI 10.1200/JCO.2010.33.0522; Bernard DM, 2006, MED CARE, V44, P210, DOI 10.1097/01.mlr.0000199729.25503.60; Bradshaw M, 2010, SOC SCI MED, V71, P196, DOI 10.1016/j.socscimed.2010.03.015; Bruera E, 1991, J Palliat Care, V7, P6; Conroy T, 2004, EUR J CANCER, V40, P2243, DOI 10.1016/j.ejca.2004.06.010; Costet N, 2005, QUAL LIFE RES, V14, P1427, DOI 10.1007/s11136-004-5531-z; Cunningham PJ, 2010, HEALTH AFFAIR, V29, P1037, DOI 10.1377/hlthaff.2009.0493; de Souza JA, 2014, CANCER-AM CANCER SOC, V120, P3245, DOI 10.1002/cncr.28814; Delgado-Guay M, 2015, ONCOLOGIST, V20, P1092, DOI 10.1634/theoncologist.2015-0026; Emanuel EJ, 2000, ANN INTERN MED, V21, P132; Gupta D, 2007, SUPPORT CARE CANCER, V15, P1051, DOI 10.1007/s00520-007-0214-2; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; Joo S., 1998, PERSONAL FINANCES WO, V2, P162; Joo S, 2004, J FAM ECON ISS, V25, P162, DOI [10.1023/B:JEEI.0000016722.37994.9f, DOI 10.1023/B:JEEI.0000016722.37994.9F]; Kendall J, 2011, PSYCHO-ONCOLOGY, V20, P594, DOI 10.1002/pon.1907; Markman M, 2010, J ONCOL PRACT, V6, P69, DOI 10.1200/JOP.091074; Nekolaichuk C, 2008, PALLIATIVE MED, V22, P111, DOI 10.1177/0269216307087659; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pautex S., 2010, VERS VERSION FRANCOP; Perrone F, 2016, ANN ONCOL, V27, P2224, DOI 10.1093/annonc/mdw433; Pirl WF, 2008, PSYCHOSOMATICS, V49, P218, DOI 10.1176/appi.psy.49.3.218; Pirl WF, 2012, J CLIN ONCOL, V30, P1310, DOI 10.1200/JCO.2011.38.3166; RAZAVI D, 1989, REV PSYCHOL APPL, V39, P295; Selenko E, 2011, SOC SCI MED, V73, P1725, DOI 10.1016/j.socscimed.2011.09.022; Sharp L, 2013, PSYCHO-ONCOLOGY, V22, P745, DOI 10.1002/pon.3055; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Walson C, 1993, J FAM ECON ISS, V14, P193, DOI DOI 10.1007/BF01022177; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	34	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176470	10.1371/journal.pone.0176470	http://dx.doi.org/10.1371/journal.pone.0176470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28545063	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400007
J	Jensen, JL; Schjonning, P; Watts, CW; Christensen, BT; Munkholm, LJ				Jensen, Johannes Lund; Schjonning, Per; Watts, Christopher W.; Christensen, Bent T.; Munkholm, Lars J.			Soil texture analysis revisited: Removal of organic matter matters more than ever	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; WATER-CONTENT; CLAY CONTENT; CARBON; FRACTIONS; PEROXIDE; DENSITY	Exact estimates of soil clay (< 2 mu m) and silt (2-20 mu m) contents are crucial as these size fractions impact key soil functions, and as pedotransfer concepts based on clay and silt contents are becoming increasingly abundant. We examined the effect of removing soil organic matter (SOM) by H2O2 before soil dispersion and determination of clay and silt. Soil samples with gradients in SOM were retrieved from three long-term field experiments each with uniform soil mineralogy and texture. For soils with less than 2 g C 100 g(-1) minerals, clay estimates were little affected by SOM. Above this threshold, underestimation of clay increased dramatically with increasing SOM content. Silt contents were systematically overestimated when SOM was not removed; no lower SOM threshold was found for silt, but the overestimation was more pronounced for finer textured soils. When exact estimates of soil particles < 20 mu m are needed, SOM should always be removed before soil dispersion.	[Jensen, Johannes Lund; Schjonning, Per; Christensen, Bent T.; Munkholm, Lars J.] Aarhus Univ, Dept Agroecol, Tjele, Denmark; [Watts, Christopher W.] Rothamsted Res, Dept Sustainable Agr Sci, Harpenden, Herts, England	Aarhus University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Jensen, JL (corresponding author), Aarhus Univ, Dept Agroecol, Tjele, Denmark.	jlj@agro.au.dk	Watts, Chris/AAA-2409-2021; Jensen, Johannes Lund/AAC-2102-2022; Schjønning, Per/F-1417-2016; watts, chris/P-6701-2015; Munkholm, Lars Juhl/E-1278-2016	watts, chris/0000-0002-7223-1444; Munkholm, Lars Juhl/0000-0002-4506-9488; Schjonning, Per/0000-0002-9362-1003; Jensen, Johannes Lund/0000-0002-0415-6665	Green Development and Demonstration Programme (GUDP) of the Ministry of Environment and Food of Denmark through the "Cover crops for optimization of cereal based cropping systems" project [3405-11-0225]; Green Development and Demonstration Programme (GUDP) of the Ministry of Environment and Food of Denmark through Optimized soil tillage in cereal based cropping systems project [34009-12-0502]; EU 7th Research Framework Programme, Distributed Infrastructure for Experimentation in Ecosystem Research (ExpeER) through the project "Identification of soil organic carbon thresholds for sustained soil functions in agroecosystems" [262060]; UK Biotechnology and Biological Sciences Research Council [BBS/E/C/00005189]; Lawes Agricultural Trust; Biotechnology and Biological Sciences Research Council [BBS/E/C/000J0300] Funding Source: researchfish; BBSRC [BBS/E/C/000J0300] Funding Source: UKRI	Green Development and Demonstration Programme (GUDP) of the Ministry of Environment and Food of Denmark through the "Cover crops for optimization of cereal based cropping systems" project; Green Development and Demonstration Programme (GUDP) of the Ministry of Environment and Food of Denmark through Optimized soil tillage in cereal based cropping systems project; EU 7th Research Framework Programme, Distributed Infrastructure for Experimentation in Ecosystem Research (ExpeER) through the project "Identification of soil organic carbon thresholds for sustained soil functions in agroecosystems"; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lawes Agricultural Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Green Development and Demonstration Programme (GUDP) of the Ministry of Environment and Food of Denmark (http://lfst.dk/tvaergaaende/gudp/) through the "Cover crops for optimization of cereal based cropping systems" (Grant No. 3405-11-0225) and Optimized soil tillage in cereal based cropping systems (Grant No. 34009-12-0502) projects coordinated by LJM, and by the EU 7th Research Framework Programme, Distributed Infrastructure for Experimentation in Ecosystem Research (ExpeER) (www.expeeronline.eu/) through the project Identification of soil organic carbon thresholds for sustained soil functions in agroecosystems (Grant No. 262060) coordinated by LJM. The Rothamsted Long-term Experiments National Capability (LTE-NCG) is supported by the UK Biotechnology and Biological Sciences Research Council (BBS/E/C/00005189) and the Lawes Agricultural Trust (www.rothamsted.ac.uk/long-term-experiments-national-capability). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials, 1998, 2000 ANN BOOK ASTM S, P518; [Anonymous], 2002, METHODS SOIL ANAL, DOI DOI 10.2136/SSSABOOKSER5.4.C12; Arthur E, 2015, EUR J SOIL SCI, V66, P206, DOI 10.1111/ejss.12191; Avery B. W., 1995, SOILS ROTHAMSTED, P1; Baver LD, 1930, J AM SOC AGRON, V24, P703; Beale OW, 1939, SOIL SCI, V48, P475, DOI 10.1097/00010694-193912000-00004; Chen C, 2014, SOIL SCI SOC AM J, V78, P119, DOI 10.2136/sssaj2013.06.0247; CHRISTENSEN BT, 1989, J SOIL SCI, V40, P641, DOI 10.1111/j.1365-2389.1989.tb01305.x; Eden M, 2012, SOIL SCI, V177, P1, DOI 10.1097/SS.0b013e31823745a9; Getahun GT, 2016, GEODERMA, V264, P94, DOI 10.1016/j.geoderma.2015.10.002; Hermansen C, 2016, SOIL SCI SOC AM J, V80, P1486, DOI 10.2136/sssaj2016.05.0159; Jensen DK, 2015, J HYDROL, V521, P498, DOI 10.1016/j.jhydrol.2014.12.018; Jensen JL, 2017, SOIL RES; Karup D, 2016, J CONTAM HYDROL, V192, P194, DOI 10.1016/j.jconhyd.2016.08.001; Knadel M, 2017, BIOSYST ENG, V156, P157, DOI 10.1016/j.biosystemseng.2017.01.007; Leifeld J, 2001, SOIL BIOL BIOCHEM, V33, P2155, DOI 10.1016/S0038-0717(01)00127-4; LEINWEBER P, 1989, Z PFLANZ BODENKUNDE, V152, P373, DOI 10.1002/jpln.19891520406; Merante P, 2017, SOIL TILL RES, V165, P95, DOI 10.1016/j.still.2016.08.001; Mikutta R, 2005, SOIL SCI SOC AM J, V69, P120, DOI 10.2136/sssaj2005.0120; Moberg JP, 1986, BERETNING NR S 1870, V1870, P1; Nocita M, 2015, ADV AGRON, V132, P139, DOI 10.1016/bs.agron.2015.02.002; Plante AF, 2004, EUR J SOIL SCI, V55, P471, DOI 10.1111/j.1365-2389.2004.00626.x; Poeplau C, 2015, SOIL TILL RES, V145, P181, DOI 10.1016/j.still.2014.09.021; Pribyl DW, 2010, GEODERMA, V156, P75, DOI 10.1016/j.geoderma.2010.02.003; Robinson GW, 1922, J AGR SCI, V12, P287, DOI 10.1017/S0021859600005347; Schjonning P, 2017, GEODERMA, V286, P83, DOI 10.1016/j.geoderma.2016.10.020; Schjonning P, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0067; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Watts CW, 2000, EUR J SOIL SCI, V51, P305, DOI 10.1046/j.1365-2389.2000.00311.x; Watts CW, 1997, SOIL TILL RES, V42, P253, DOI 10.1016/S0167-1987(97)00009-3	30	37	39	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178039	10.1371/journal.pone.0178039	http://dx.doi.org/10.1371/journal.pone.0178039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542416	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400133
J	Kitano, T; Miyagawa, M; Nishio, S; Moteki, H; Oda, K; Ohyama, K; Miyazaki, H; Hidaka, H; Nakamura, K; Murata, T; Matsuoka, R; Ohta, Y; Nishiyama, N; Kumakawa, K; Furutate, S; Iwasaki, S; Yamada, T; Ohta, Y; Uehara, N; Noguchi, Y; Usami, S				Kitano, Tomohiro; Miyagawa, Maiko; Nishio, Shin-ya; Moteki, Hideaki; Oda, Kiyoshi; Ohyama, Kenji; Miyazaki, Hiromitsu; Hidaka, Hiroshi; Nakamura, Ken-ichi; Murata, Takaaki; Matsuoka, Rina; Ohta, Yoko; Nishiyama, Nobuhiro; Kumakawa, Kozo; Furutate, Sakiko; Iwasaki, Satoshi; Yamada, Takechiyo; Ohta, Yumi; Uehara, Natsumi; Noguchi, Yoshihiro; Usami, Shin-ichi			POU4F3 mutation screening in Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis identified novel variants associated with autosomal dominant hearing loss	PLOS ONE			English	Article							DEAFNESS; FAMILY; DFNA15; LOCALIZATION; IMPAIRMENT; EXPRESSION; ETIOLOGY; DISEASE; BRN-3C	A variant in a transcription factor gene, POU4F3, is responsible for autosomal dominant nonsyndromic hereditary hearing loss, DFNA15. To date, 14 variants, including a whole deletion of POU4F3, have been reported to cause HL in various ethnic groups. In the present study, genetic screening for POU4F3 variants was carried out for a large series of Japanese hearing loss (HL) patients to clarify the prevalence and clinical characteristics of DFNA15 in the Japanese population. Massively parallel DNA sequencing of 68 target candidate genes was utilized in 2,549 unrelated Japanese HL patients (probands) to identify genomic variations responsible for HL. The detailed clinical features in patients with POU4F3 variants were collected from medical charts and analyzed. Novel 12 POU4F3 likely pathogenic variants (six missense variants, three frameshift variants, and three nonsense variants) were successfully identified in 15 probands (2.5%) among 602 families exhibiting autosomal dominant HL, whereas no variants were detected in the other 1,947 probands with autosomal recessive or inheritance pattern unknown HL. To obtain the audiovestibular configuration of the patients harboring POU4F3 variants, we collected audiograms and vestibular symptoms of the probands and their affected family members. Audiovestibular phenotypes in a total of 24 individuals from the 15 families possessing variants were characterized by progressive HL, with a large variation in the onset age and severity with or without vestibular symptoms observed. Pure-tone audiograms indicated the most prevalent configuration as mid-frequency HL type followed by high-frequency HL type, with asymmetry observed in approximately 20% of affected individuals. Analysis of the relationship between age and pure-tone average suggested that individuals with truncating variants showed earlier onset and slower progression of HL than did those with non-truncating variants. The present study showed that variants in POU4F3 were a common cause of autosomal dominant HL.	[Kitano, Tomohiro; Miyagawa, Maiko; Nishio, Shin-ya; Moteki, Hideaki; Usami, Shin-ichi] Shinshu Univ, Dept Otorhinolaryngol, Sch Med, Matsumoto, Nagano, Japan; [Miyagawa, Maiko; Nishio, Shin-ya; Moteki, Hideaki; Noguchi, Yoshihiro; Usami, Shin-ichi] Shinshu Univ, Dept Hearing Implant Sci, Sch Med, Matsumoto, Nagano, Japan; [Oda, Kiyoshi; Ohyama, Kenji] Tohoku Rosai Hosp, Dept Otorhinolaryngol, Sendai, Miyagi, Japan; [Miyazaki, Hiromitsu; Hidaka, Hiroshi] Tohoku Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Sendai, Miyagi, Japan; [Nakamura, Ken-ichi] Jichi Med Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Shimotsuke, Japan; [Murata, Takaaki] Gunma Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Maebashi, Gunma, Japan; [Matsuoka, Rina] Juntendo Univ, Dept Otorhinolaryngol, Fac Med, Tokyo, Japan; [Ohta, Yoko; Nishiyama, Nobuhiro] Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan; [Kumakawa, Kozo] Toranomon Gen Hosp, Dept Otorhinolaryngol, Tokyo, Japan; [Furutate, Sakiko; Iwasaki, Satoshi] Int Univ Hlth & Welf, Mita Hosp, Dept Otorhinolaryngol, Tokyo, Japan; [Yamada, Takechiyo] Univ Fukui, Dept Otorhinolaryngol Head & Neck Surg, Fukui, Japan; [Ohta, Yumi] Osaka Univ, Dept Otorhinolaryngol Head & Neck Surg, Grad Sch Med, Osaka, Japan; [Uehara, Natsumi] Kobe Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Kobe, Hyogo, Japan	Shinshu University; Shinshu University; Tohoku University; Jichi Medical University; Gunma University; Juntendo University; Tokyo Medical University; Toranomon Hospital; International University of Health & Welfare; University of Fukui; Osaka University; Kobe University	Usami, S (corresponding author), Shinshu Univ, Dept Otorhinolaryngol, Sch Med, Matsumoto, Nagano, Japan.; Usami, S (corresponding author), Shinshu Univ, Dept Hearing Implant Sci, Sch Med, Matsumoto, Nagano, Japan.	usami@shinshu-u.ac.jp	Hidala, Hiroshi/N-2957-2016	Hidala, Hiroshi/0000-0001-5214-3159; Nishio, Shin-ya/0000-0001-6640-2297; Kitano, Tomohiro/0000-0003-2317-8672	Ministry of Health, Labour and Welfare of Japan [H26-Nanchito (Nan)-Ippan-032]; Japan Agency for Medical Research and Development (AMED) [16ek0109114h0002]; Ministry of Education, Science and Culture of Japan [15H02565]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Research on rare and intractable diseases (H26-Nanchito (Nan)-Ippan-032) from the Ministry of Health, Labour and Welfare of Japan (S.U.), Practical Research Project for Rare / Intractable Disease from Japan Agency for Medical Research and Development (AMED) (S.U.) (16ek0109114h0002), and by a Grant-in-Aid for Scientific Research (A) (15H02565) from the Ministry of Education, Science and Culture of Japan (S.U.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baek JI, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-60; Cai XZ, 2017, J HUM GENET, V62, P317, DOI 10.1038/jhg.2016.102; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Collin RWJ, 2008, HUM MUTAT, V29, P545, DOI 10.1002/humu.20693; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Freitas EL, 2014, EUR J MED GENET, V57, P125, DOI 10.1016/j.ejmg.2014.02.006; Frejo L, 2016, J NEUROL, V263, pS45, DOI 10.1007/s00415-015-7988-9; Frydman M, 2000, ARCH OTOLARYNGOL, V126, P633, DOI 10.1001/archotol.126.5.633; HE L, 2016, NEURAL PLAST, V2016, DOI DOI 10.1155/2016/9890827; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Kim H.-S., 2013, J NANOMATER, V2013, P4, DOI [10.1155/2013/679758, DOI 10.12826/18333575.2013.0016.KIM]; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee HK, 2010, BIOCHEM BIOPH RES CO, V396, P626, DOI 10.1016/j.bbrc.2010.04.132; Miyagawa M, 2016, OTOL NEUROTOL, V37, pE126, DOI 10.1097/MAO.0000000000000936; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075793; Moteki H, 2012, J HUM GENET, V57, P587, DOI 10.1038/jhg.2012.73; Mutai H, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-172; Naito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063231; Narahara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100924; Pauw RJ, 2008, ARCH OTOLARYNGOL, V134, P294, DOI 10.1001/archotol.134.3.294; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Usami S, 1999, HUM GENET, V104, P188, DOI 10.1007/s004390050933; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Van Camp G, HEREDITARY HEARING L; van Drunen FJW, 2009, AUDIOL NEURO-OTOL, V14, P303, DOI 10.1159/000212109; Verstreken M, 2001, OTOL NEUROTOL, V22, P874, DOI 10.1097/00129492-200111000-00028; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei QJ, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0311-1; Weiss S, 2003, MOL CELL BIOL, V23, P7957, DOI 10.1128/MCB.23.22.7957-7964.2003; Xia JH, 2002, J HUM GENET, V47, P635, DOI 10.1007/s100380200098; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; Yang T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-85; ZHANG C, 2016, NEURAL PLAST, V2016, DOI DOI 10.1155/2016/1512831	42	24	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177636	10.1371/journal.pone.0177636	http://dx.doi.org/10.1371/journal.pone.0177636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545070	gold, Green Submitted, Green Published			2022-12-27	WOS:000401487700059
J	Kashima, S; Inoue, K; Matsumoto, M				Kashima, Saori; Inoue, Kazuo; Matsumoto, Masatoshi			Have the tsunami and nuclear accident following the Great East Japan Earthquake affected the local distribution of hospital physicians?	PLOS ONE			English	Article							HEALTH-CARE; KATRINA	Objective The Great East Japan Earthquake occurred on 11 March 2011 near the northeast coast of the main island, 'Honshu', of Japan. It wreaked enormous damage in two main ways: a giant tsunami and an accident at the Fukushima Daiichi Nuclear Power Plant (FDNPP). This disaster may have affected the distribution of physicians in the region. Here, we evaluate the effect of the disaster on the distribution of hospital physicians in the three most severely affected prefectures (Iwate, Miyagi, and Fukushima). Methods We obtained individual information about physicians from the Physician Census in 2010 (pre-disaster) and 2012 (post-disaster). We examined geographical distributions of physicians in two ways: (1) municipality-based analysis for demographic evaluation; and (2) hospital- based analysis for geographic evaluation. In each analysis, we calculated the rate of change in physician distributions between pre-and post-disaster years at various distances from the tsunami-affected coast, and from the restricted area due to the FDNPP accident. Results The change in all, hospital, and clinic physicians were 0.2%, 0.7%, and -0.7%, respectively. In the municipality-based analysis, after taking account of the decreased population, physician numbers only decreased within the restricted area. In the hospital-based analysis, hospital physician numbers did not decrease at any distance from the tsunami-affected coast. In contrast, there was a 3.3% and 2.3% decrease in hospital physicians 0-25 km and 25-50 km from the restricted area surrounding the FDNPP, respectively. Additionally, decreases were larger and increases were smaller in areas close to the FDNPP than in areas further away. Conclusions Our results suggest that the tsunami did not affect the distribution of physicians in the affected regions. However, the FDNPP accident changed physician distribution in areas close to the power plant.	[Kashima, Saori] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Matsumoto, Masatoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Community Based Med Syst, Hiroshima, Japan	Hiroshima University; Teikyo University; Hiroshima University	Kashima, S (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan.	saori.ksm@gmail.com	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191; Matsumoto, Masatoshi/0000-0002-8341-9303	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP25516015]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number JP25516015 (http://www.jsps.go.jp/english/e-grants/index.html). The founder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SUMM STAT DYN SURV M; Cabinet Office Government of Japan, 2011, WHIT PAP DIS MAN 201; Griffies WS, 2010, PSYCHIAT SERV, V61, P70, DOI 10.1176/appi.ps.61.1.70; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Ishii M., 2012, J JAPAN MED ASS, V141, P32; Kashima S, PLOS ONE IN PRESS; Madamala K, 2007, DISASTER MED PUBLIC, V1, P21, DOI 10.1097/DMP.0b013e3180679118; Ministry of Education Culture Sports Science and Technology J, 2011, RES 4 AIRB MON SURV; Ministry of Health Labour and Welfare Japan, 2011, SURV PHYS DENT PHARM; Ministry of Health Labour and Welfare Japan, 2012, RESP GREAT E JAP EAR; Ministry of Health Labour and Welfare Japan, 2012, DAM SIT MEAS TAK GRE; Ministry of Health Labour and Welfare Japan, 2013, SURV PHYS DENT PHARM; Morioka N, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0067-6; National Police Agency of Japan, 2015, DAM SIT POL COUNT; Nikkei Medical, 2012, DISASTER MED RESULT, V6; Nikkei Medical, 2012, DISASTER MED RESULT, V5; Nikkei Medical, 2012, DISASTER MED RESULT, V7; [Nuclear Emergency Response Headquarters Cabinet Office Japan Support Team for Residents Affected by Nuclear Incidents], 2013, REV AR EV ORD; U.S. Government Accountability Office, 2006, GAO06576R; UN, SOURC EFF RISKS I 1; World Health Organization, 2011, DIS RISK MAN HLTH OV; World Nuclear Association, 2015, FUK ACC	22	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178020	10.1371/journal.pone.0178020	http://dx.doi.org/10.1371/journal.pone.0178020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542461	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800036
J	Arnesen, R; Moll, AP; Shenoi, SV				Arnesen, Rachel; Moll, Anthony P.; Shenoi, Sheela V.			Predictors of loss to follow-up among patients on ART at a rural hospital in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY INITIATION; SCALE-UP; ADHERENCE; CARE; DETERMINANTS; MORTALITY; RISK; PUSH	Introduction Improved HIV outcomes as a result of expanded antiretroviral therapy (ART) access is threatened by increasing rates of loss to follow up (LTFU) among those on ART, largely reported in urban populations. Some reports suggest that LTFU rates are overestimated due to patient movement to other facilities and inadequate medical records. Study objective To define the proportion disengaging from HIV care as well as the characteristics of those LTFU in order to design and implement appropriate interventions to increase retention. Methods We performed a retrospective review of patients who discontinued ART at a central hospital ART clinic in rural South Africa and compared with patients receiving care at the 15 primary health clinics (PHCs) to determine the true proportion of those who were LTFU. We also compared those who discontinued ART with those who did not at the central hospital ART clinic to determine predictors of loss to follow up. Results Among 3242 patients on ART, 820 were originally marked as LTFU. Among all patients, 272 (8.4%) were found at a clinic on treatment, 56 (1.7%) were found at a clinic from which they had since discontinued treatment, and 10 (0.3%) returned to care between June and July 2016, leaving 475 (14.7%) unaccounted for and thus categorized as 'true' LTFU. Factors found to be associated with discontinuation include being male, age 18-35, having a CD4 count under 200 cells/mu L, and being on ART for under six months. Conclusions Young men with low CD4 counts early after ART initiation are at highest risk of ART disengagement in this rural South African HIV clinic. Novel interventions targeting this group are needed to improve retention in care.	[Arnesen, Rachel] Yale Univ, Jackson Inst Global Affairs, New Haven, CT USA; [Moll, Anthony P.] Church Scotland Hosp, Antiretroviral Programme, Tugela Ferry, Kwazulu Natal, South Africa; [Shenoi, Sheela V.] Yale Univ, Sect Infect Dis, AIDS Program, Sch Med, New Haven, CT 06520 USA	Yale University; Yale University	Shenoi, SV (corresponding author), Yale Univ, Sect Infect Dis, AIDS Program, Sch Med, New Haven, CT 06520 USA.	sheela.shenoi@yale.edu	Shenoi, Sheela/GRY-6103-2022; Shenoi, Sheela/Z-2641-2019	Shenoi, Sheela/0000-0001-7654-4344	Yale College, Program for Global Affairs; National Institutes of Allergy and Infectious Diseases [K23AI089260]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089260] Funding Source: NIH RePORTER	Yale College, Program for Global Affairs; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RA received funding from Yale College, Program for Global Affairs, http://catalog.yale.edu/ycps/subjects-of-instruction/global-affairs/. SVS received funding from National Institutes of Allergy and Infectious Diseases, K23AI089260. The spouse of author Sheela V Shenoi works part time for Amgen Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Uria G, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21682; [Anonymous], 2015, GLOB HLTH SECT RESP; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Billong SC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1991-3; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Budgell EP, 2015, JAIDS-J ACQ IMM DEF, V70, P323, DOI 10.1097/QAI.0000000000000755; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Fox M., 2016, 21 INT AIDS C DURB; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021797; Grey A, 2015, SAMJ S AFRICAN MED J, V105; Grimsrud A, 2016, J EPIDEMIOL COMMUN H, V70, P549, DOI 10.1136/jech-2015-206629; Grimsrud A, 2016, JAIDS-J ACQ IMM DEF, V71, pE16, DOI 10.1097/QAI.0000000000000863; Kanters S, 2016, LANCET HIV; Kanters S, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21141; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Lecher S, 2016, MMWR-MORBID MORTAL W, V65, P1332, DOI 10.15585/mmwr.mm6547a2; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Loeliger KB, 2016, AIDS PATIENT CARE ST, V30, P385, DOI 10.1089/apc.2016.0096; Loeliger KB, 2016, AIDS CARE, V28, P982, DOI 10.1080/09540121.2016.1164292; Magadzire BP, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1164-x; Mantell JE, 2014, HEALTH EDUC RES, V29, P456, DOI 10.1093/her/cyu004; Marson KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078900; Massyn N., 2014, DURBAN HLTH SYSTEMS; Mberi MN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0912-2; Musumari PM, 2013, AIDS CARE, V25, P1271, DOI 10.1080/09540121.2013.764391; Osler M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18908; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rutstein SE, 2016, AIDS CARE, V28, P1, DOI 10.1080/09540121.2015.1058896; Shisana O., 2014, AFRICAN NATL HIV P; Shubber Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002183; Tabatabai J, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24795; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Yehia BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129376	36	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177168	10.1371/journal.pone.0177168	http://dx.doi.org/10.1371/journal.pone.0177168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542309	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500014
J	Dangles, O; Rabatel, A; Kraemer, M; Zeballos, G; Soruco, A; Jacobsen, D; Anthelme, F				Dangles, Olivier; Rabatel, Antoine; Kraemer, Martin; Zeballos, Gabriel; Soruco, Alvaro; Jacobsen, Dean; Anthelme, Fabien			Ecosystem sentinels for climate change? Evidence of wetland cover changes over the last 30 years in the tropical Andes	PLOS ONE			English	Article							HABITAT QUALITY; WATER-RESOURCES; PEATLANDS; LANDSCAPE; GLACIERS; BOLIVIA; RESPONSES; PATTERNS; ECOLOGY; IMPACTS	While the impacts of climate change on individual species and communities have been well documented there is little evidence on climate-mediated changes for entire ecosystems. Pristine alpine environments can provide unique insights into natural, physical and ecological response to climate change yet broad scale and long-term studies on these potential 'ecosystem sentinels' are scarce. We addressed this issue by examining cover changes of 1689 high-elevation wetlands (temporarily or perennial water-saturated grounds) in the Bolivian Cordillera Real, a region that has experienced significant warming and glacier melting over the last 30 years. We combined high spatial resolution satellite images from PLEIADES with the long-term images archive from LANDSAT to 1) examine environmental factors (e.g., glacier cover, wetland and watershed size) that affected wetland cover changes, and 2) identify wetlands' features that affect their vulnerability (using habitat drying as a proxy) in the face of climate change. Over the (1984-2011) period, our data showed an increasing trend in the mean wetland total area and number, mainly related to the appearance of wet grassland patches during the wetter years. Wetland cover also showed high inter-annual variability and their area for a given year was positively correlated to precipitation intensities in the three months prior to the image date. Also, round wetlands located in highly glacierized catchments were less prone to drying, while relatively small wetlands with irregularly shaped contours suffered the highest rates of drying over the last three decades. High Andean wetlands can therefore be considered as ecosystem sentinels for climate change, as they seem sensitive to glacier melting. Beyond the specific focus of this study, our work illustrates how satellite-based monitoring of ecosystem sentinels can help filling the lack of information on the ecological consequences of current and changing climate conditions, a common and crucial issue especially in less-developed countries.	[Dangles, Olivier; Kraemer, Martin] IRD, EGCE, Gif Sur Yvette, France; [Dangles, Olivier; Kraemer, Martin] Univ Paris Sud, Orsay, France; [Dangles, Olivier] Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Quito, Ecuador; [Dangles, Olivier] Univ Mayor San Andres, Inst Ecol, Unidad Limnol, La Paz, Bolivia; [Rabatel, Antoine] Univ Grenoble Alpes, CNRS, IRD, IGE, Grenoble, France; [Zeballos, Gabriel] Escuela Mil Ingn, Carrera Ingn Geog, La Paz, Bolivia; [Zeballos, Gabriel] Ohio State Univ, Dept Geog, Byrd Polar & Climate Res Ctr, Columbus, OH 43210 USA; [Soruco, Alvaro] IGEMA, Campus Univ UMSA, La Paz, Bolivia; [Jacobsen, Dean] Univ Copenhagen, Biol Dept, Freshwater Biol Lab, Copenhagen, Denmark; [Anthelme, Fabien] Univ Montpellier, CNRS, INRA, AMAP,IRD,CIRAD, Montpellier, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Pontificia Universidad Catolica del Ecuador; Universidad Mayor de San Andres; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Recherche pour le Developpement (IRD); University System of Ohio; Ohio State University; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CIRAD; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Dangles, O (corresponding author), IRD, EGCE, Gif Sur Yvette, France.; Dangles, O (corresponding author), Univ Paris Sud, Orsay, France.; Dangles, O (corresponding author), Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Quito, Ecuador.; Dangles, O (corresponding author), Univ Mayor San Andres, Inst Ecol, Unidad Limnol, La Paz, Bolivia.	olivier.dangles@ird.fr	Rabatel, Antoine/AAA-1769-2022; Jacobsen, Dean/K-4920-2014; Rabatel, Antoine/L-5249-2015; Rabatel, Antoine/AAA-1413-2021	Rabatel, Antoine/0000-0002-5304-1055; Jacobsen, Dean/0000-0001-5137-297X; 	Fond Francais pour I'Environnement Mondial (FFEM); Fondation pour la Recherche sur la Biodiversite (FRB) (Modeling BlOdiversity and land use interactions under changing glacial water availability in Tropical High Andean Wetlands" BIOTHAW) [AAP-SCEN-2011-II]; CNES/SPOT-Image ISIS program [FC18473]; LabEx OSUG (Investissements d'avenir) [ANR10 LABX56]	Fond Francais pour I'Environnement Mondial (FFEM); Fondation pour la Recherche sur la Biodiversite (FRB) (Modeling BlOdiversity and land use interactions under changing glacial water availability in Tropical High Andean Wetlands" BIOTHAW); CNES/SPOT-Image ISIS program; LabEx OSUG (Investissements d'avenir)(French National Research Agency (ANR))	This work was funded by the Fond Francais pour I'Environnement Mondial (FFEM) and the Fondation pour la Recherche sur la Biodiversite (FRB) (Modeling BlOdiversity and land use interactions under changing glacial water availability in Tropical High Andean Wetlands" BIOTHAW, AAP-SCEN-2011-II). The work was also conducted within the framework of the International Joint Laboratory GREAT-ICE and GLACIOCLIM Observatory, initiatives of the French Institut de Recherche pour le Developpement (IRD) and universities and institutions in Bolivia and Ecuador. Special thanks to the USGS-EDC for allowing free access to Landsat images. Pleiades images were provided through the CNES/SPOT-Image ISIS program, contract #FC18473. Antoine Rabatel acknowledges the support of LabEx OSUG@2020 (Investissements d'avenir - ANR10 LABX56).r Special thanks to the USGS-EDC for allowing free access to Landsat images. Pleiades images were provided through the CNES/SPOT-Image ISIS program, contract #FC18473. We are grateful to two anonymous referees for their comments in an earlier version of the manuscript.	Anderson EP., 2011, CLIMATE CHANGE BIODI, P1, DOI DOI 10.13140/2.1.3718.4969; Anthelme F, 2014, ECOL BOL, V49, P1; Anthelme F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00387; Anthelme F, 2012, PERSPECT PLANT ECOL, V14, P363, DOI 10.1016/j.ppees.2012.05.002; Baraer M, 2012, J GLACIOL, V58, P134, DOI 10.3189/2012JoG11J186; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Belyea LR, 2004, GLOBAL CHANGE BIOL, V10, P1043, DOI 10.1111/j.1529-8817.2003.00783.x; Benavides JC, 2013, J GEOPHYS RES-BIOGEO, V118, P1627, DOI 10.1002/2013JG002419; Bookhagen B, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P223; Bradley RS, 2006, SCIENCE, V312, P1755, DOI 10.1126/science.1128087; Bragazza L, 2016, GLOBAL CHANGE BIOL, V22, P4114, DOI 10.1111/gcb.13319; Buttolph LP, 2004, J APPL ECOL, V41, P664, DOI 10.1111/j.0021-8901.2004.00921.x; Buytaert W, 2011, GLOBAL ECOL BIOGEOGR, V20, P19, DOI 10.1111/j.1466-8238.2010.00585.x; Cannone N, 2007, FRONT ECOL ENVIRON, V5, P360, DOI 10.1890/1540-9295(2007)5[360:UIOCCO]2.0.CO;2; Cauvy-Fraunie S, 2013, HYDROL EARTH SYST SC, V17, P4803, DOI 10.5194/hess-17-4803-2013; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cooper DJ, 2010, ARCT ANTARCT ALP RES, V42, P19, DOI 10.1657/1938-4246-42.1.19; Dangles O, 2011, ECOLOGY, V92, P733, DOI 10.1890/10-0329.1; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; Delarue F, 2016, GLOBAL CHANGE BIOL, V22, P3253, DOI 10.1111/gcb.13433; Earle LR, 2002, Q RES, V59, P2; Erschbamer B, 2007, ARCT ANTARCT ALP RES, V39, P237, DOI 10.1657/1523-0430(2007)39[237:WALOCC]2.0.CO;2; Famiglietti JS, 2015, SCIENCE, V349, P684, DOI 10.1126/science.aac9238; Freeman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082404; Gardner RC, 2011, WETLANDS: INTEGRATING MULTIDISCIPLINARY CONCEPTS, P189, DOI 10.1007/978-94-007-0551-7_11; Garreaud R, 2003, PALAEOGEOGR PALAEOCL, V194, P5, DOI 10.1016/S0031-0182(03)00269-4; Grabherr G, 2000, MT RES DEV, V20, P190, DOI 10.1659/0276-4741(2000)020[0190:GAGORI]2.0.CO;2; HALL DK, 1995, REMOTE SENS ENVIRON, V54, P127, DOI 10.1016/0034-4257(95)00137-P; Hannah DM, 2007, AQUAT CONSERV, V17, P636, DOI 10.1002/aqc.800; Haylock MR, 2006, J CLIMATE, V19, P1490, DOI 10.1175/JCLI3695.1; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Jacobsen D, 2014, FRESHWATER BIOL, V59, P2038, DOI 10.1111/fwb.12405; Jones MC, 2010, P NATL ACAD SCI USA, V107, P7347, DOI 10.1073/pnas.0911387107; Kramer B, 2012, BIOL CONSERV, V152, P253, DOI 10.1016/j.biocon.2012.03.038; KUPFER JA, 1995, PROG PHYS GEOG, V19, P18, DOI 10.1177/030913339501900102; Loza Herrera Susi, 2015, Ecología en Bolivia, V50, P39; Telleria JL, 2006, ARDEOLA, V53, P271; Matthews JA., 1992, ECOLOGY RECENTLY DEG; Matthews KR, 1999, J HERPETOL, V33, P615, DOI 10.2307/1565578; Michelutti N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115338; Nagy L, 2009, BIOL ALPINE HABITATS; Otto M, 2011, HYDROL EARTH SYST SC, V15, P1713, DOI 10.5194/hess-15-1713-2011; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Prigent C, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007847; Quenta E, 2016, GLOBAL CHANGE BIOL, V22, P3196, DOI 10.1111/gcb.13310; Rabatel A, 2013, CRYOSPHERE, V7, P81, DOI 10.5194/tc-7-81-2013; Rabatel A, 2012, J GLACIOL, V58, P1027, DOI 10.3189/2012JoG12J027; Reveillet M, 2015, ANN GLACIOL, V56, P89, DOI 10.3189/2015AoG70A113; Ronchail J, 2006, INT J CLIMATOL, V26, P1223, DOI 10.1002/joc.1296; Ruthsatz B, 2012, PHYTOCOENOLOGIA, V42, P133, DOI 10.1127/0340-269X/2012/0042-0535; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Schindler DW, 1996, LIMNOL OCEANOGR, V41, P1004, DOI 10.4319/lo.1996.41.5.1004; Seiler C, 2013, J APPL METEOROL CLIM, V52, P1303, DOI 10.1175/JAMC-D-12-0224.1; Skidmore AK, 2015, NATURE, V523, P403, DOI 10.1038/523403a; Soruco A, 2015, ANN GLACIOL, V56, P147, DOI 10.3189/2015AoG70A001; Soruco A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036238; Squeo FA, 2006, REV CHIL HIST NAT, V79, P245; Thibeault JM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012718; Uden DR, 2014, ECOL APPL, V24, P1569, DOI 10.1890/13-1755.1; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Vuille M., 2013, IDBTN515; Vuille M, 2008, EARTH-SCI REV, V89, P79, DOI 10.1016/j.earscirev.2008.04.002; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Wang XL, 2014, METHODS ECOL EVOL, V5, P634, DOI 10.1111/2041-210X.12198; Wieder RK, 2001, ECOL APPL, V11, P327, DOI 10.2307/3060892; Williamson CE, 2014, LIMNOL OCEANOGR, V59, P840, DOI 10.4319/lo.2014.59.3.0840; Williamson CE, 2009, SCIENCE, V323, P887, DOI 10.1126/science.1169443	70	44	44	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0175814	10.1371/journal.pone.0175814	http://dx.doi.org/10.1371/journal.pone.0175814			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542172	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500003
J	St Clair, R; Hutto, T; MacBeth, C; Newstetter, W; McCarty, NA; Melkers, J				St Clair, Rebekah; Hutto, Tamara; MacBeth, Cora; Newstetter, Wendy; McCarty, Nael A.; Melkers, Julia			The "new normal" : Adapting doctoral trainee career preparation for broad career paths in science	PLOS ONE			English	Article							SOCIAL COGNITIVE THEORY; JOB SEARCH; OCCUPATIONAL-STATUS; STUDENTS; RESOURCES; GRADUATE; PHD; INCENTIVES; EMPLOYMENT; BEHAVIORS	Doctoral recipients in the biomedical sciences and STEM fields are showing increased interest in career opportunities beyond academic positions. While recent research has addressed the interests and preferences of doctoral trainees for non-academic careers, the strategies and resources that trainees use to prepare for a broad job market (non-academic) are poorly understood. The recent adaptation of the Social Cognitive Career Theory to explicitly highlight the interplay of contextual support mechanisms, individual career search efficacy, and self-adaptation of job search processes underscores the value of attention to this explicit career phase. Our research addresses the factors that affect the career search confidence and job search strategies of doctoral trainees with non-academic career interests and is based on nearly 900 respondents from an NIH-funded survey of doctoral students and postdoctoral fellows in the biomedical sciences at two U.S. universities. Using structural equation modeling, we find that trainees pursuing non-academic careers, and/or with low perceived program support for career goals, have lower career development and search process efficacy (CDSE), and receive different levels of support from their advisors/supervisors. We also find evidence of trainee adaptation driven by their career search efficacy, and not by career interests.	[St Clair, Rebekah; Melkers, Julia] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA; [Hutto, Tamara] Emory Univ, Atlanta BEST Program, Atlanta, GA 30322 USA; [Hutto, Tamara] Georgia Inst Technol, Atlanta, GA 30332 USA; [MacBeth, Cora] Emory Univ, Emory Coll Arts & Sci, Atlanta, GA 30322 USA; [Newstetter, Wendy] Georgia Inst Technol, Coll Engn, Atlanta, GA 30332 USA; [McCarty, Nael A.] Emory Univ, Sch Med, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University	Melkers, J (corresponding author), Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA.	jmelkers@gatech.edu	Melkers, Julia/C-4310-2019	Melkers, Julia/0000-0001-5045-4068	Atlanta BEST, National Institutes of Health; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP7OD018424] Funding Source: NIH RePORTER	Atlanta BEST, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by Atlanta BEST, National Institutes of Health.	Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Biomedical Research Workforce Working Group, 2012, BIOMEDICAL RES WORKF; BLACKBURN RT, 1981, RES HIGH EDUC, V15, P315, DOI 10.1007/BF00973512; Bollen KA, 1987, SOCIOL METHODOL, P17; Bourdieu P, 1986, HDB THEORY RES SOCIO, V241, P258; Brownell SE, 2012, CBE-LIFE SCI EDUC, V11, P339, DOI 10.1187/cbe.12-09-0163; Campbell SP, 2005, FRONT ECOL ENVIRON, V3, P153, DOI 10.1890/1540-9295(2005)003[0153:LBRIDE]2.0.CO;2; Case D, 2016, LOOKING INFORM SURVE, V4th; DEGRAAF ND, 1988, SOC FORCES, V67, P452, DOI 10.2307/2579190; Denecke D., 2017, PROFESSIONAL DEV SHA; Dowd KO, 2005, HUM RELAT, V58, P699, DOI 10.1177/0018726705057156; Fillman VM, 2015, NURS EDUC TODAY, V35, P251, DOI 10.1016/j.nedt.2014.08.011; FOGARTY TJ, 1993, RES HIGH EDUC, V34, P427, DOI 10.1007/BF00991853; Fuhrmann CN, 2011, CBE-LIFE SCI EDUC, V10, P239, DOI 10.1187/cbe.11-02-0013; Fuhrmann CN, 2016, HUM GENE THER, V27, P871, DOI 10.1089/hum.2016.154; Gefen D., 2000, COMMUN ASSOC INF SYS, V4, DOI [10.17705/1cais.00407, DOI 10.17705/1CAIS.00407, 10.17705/1CAIS.00407]; Gibbs KD, 2015, CELL BIOL ED, V14; Gibbs KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114736; Gibbs KD, 2013, CBE-LIFE SCI EDUC, V12, P711, DOI 10.1187/cbe.13-02-0021; Golde CM, 2001, CROSS PURPOSES EXP T; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Juliano RL, 2001, ACAD MED, V76, P1005, DOI 10.1097/00001888-200110000-00007; Lam A, 2015, HUM RELAT, V68, P811, DOI 10.1177/0018726714545483; Layton RL, 2016, CELL BIOL ED, V15; Lent RW, 2016, J VOCAT BEHAV, V93, P47, DOI 10.1016/j.jvb.2015.12.007; Lent RW, 2013, J COUNS PSYCHOL, V60, P557, DOI 10.1037/a0033446; LENT RW, 1994, J VOCAT BEHAV, V45, P79, DOI 10.1006/jvbe.1994.1027; Lim RH, 2016, J COUNS PSYCHOL, V63, P594, DOI 10.1037/cou0000154; LIN N, 1981, SOC FORCES, V59, P1163, DOI 10.2307/2577987; Lin N., 2003, CREATION RETURN SOCI, P145; Lin N., 2002, SOCIAL CAPITAL THEOR, V19; Lortie D.C., 1975, SCHOOLTEACHER SOCIOL; Mangematin V, 2000, RES POLICY, V29, P741, DOI 10.1016/S0048-7333(99)00047-5; MARSDEN PV, 1988, SOC FORCES, V66, P1038, DOI 10.2307/2579435; Mason MA, 2009, ACADEME, V95; Noy S, 2012, J HIGH EDUC-UK, V83, P876, DOI 10.1353/jhe.2012.0036; Nyquist J.D., 1999, CHANGE, V31, P18, DOI DOI 10.1080/00091389909602686; Paglis LL, 2006, RES HIGH EDUC, V47, P451, DOI 10.1007/s11162-005-9003-2; Roach M, 2010, RES POLICY, V39, P422, DOI 10.1016/j.respol.2010.01.004; Saks AM, 1999, J VOCAT BEHAV, V54, P335, DOI 10.1006/jvbe.1998.1665; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; Schillebeeckx M, 2013, NAT BIOTECHNOL, V31, P938, DOI 10.1038/nbt.2706; Trowler PR., 2001, ACAD TRIBES TERRITOR; van Emmerik I. J. H., 2004, CAREER DEV INT, V9, P578, DOI [10.1108/13620430410559160, DOI 10.1108/13620430410559160]; Weidman JC, 2003, RES HIGH EDUC, V44, P641, DOI 10.1023/A:1026123508335; Wood Christine V, 2016, J Women Minor Sci Eng, V22, P159, DOI 10.1615/JWomenMinorScienEng.2016014000; Zhao CM, 2007, J FURTH HIGH EDUC, V31, P263, DOI 10.1080/03098770701424983; Zikic J, 2009, J VOCAT BEHAV, V74, P117, DOI 10.1016/j.jvb.2008.11.001; Zolas N, 2015, SCIENCE, V350, P1367, DOI 10.1126/science.aac5949	49	39	39	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177035	10.1371/journal.pone.0177035	http://dx.doi.org/10.1371/journal.pone.0177035			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542304	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500009
J	Stawski, R; Walczak, K; Kosielski, P; Meissner, P; Budlewski, T; Padula, G; Nowak, D				Stawski, Robert; Walczak, Konrad; Kosielski, Piotr; Meissner, Pawel; Budlewski, Tomasz; Padula, Gianluca; Nowak, Dariusz			Repeated bouts of exhaustive exercise increase circulating cell free nuclear and mitochondrial DNA without development of tolerance in healthy men	PLOS ONE			English	Article							FREE PLASMA DNA; MENSTRUAL-CYCLE; BONE-MARROW; MARATHON; RELEASE; BLOOD; MARKERS; IMPACT	Objective Acute single strenuous exercise increases circulating cell free DNA (cf DNA). We tested whether three repeated bouts of exhaustive exercise induced the cf DNA response without development of tolerance in healthy men. Methods Eleven average-trained men (age 34.0 +/- 5.2 years, body mass index 26.2 +/- 3.1 kg/m2, maximal oxygen consumption-VO(2)max 49.6 +/- 4.5 ml/kg*min) performed three treadmill exercise tests to exhaustion at speed corresponding to 70% VO(2)max separated by 72 hours of resting. Blood was collected before and after each bout of exercise for determination of cell free nuclear and mitochondrial DNA (cf n-DNA, cf mt-DNA) by real-time PCR, selected markers of muscle damage, and blood cell count. Results Each bout induced the increase (p<0.05) in plasma cf n-DNA: from 3.4 +/- 1.4 to 38.5 +/- 27.5, from 4.1 +/- 3.3 to 48.5 +/- 26.2, and 3.1 +/- 1.6 to 53.8 +/- 39.9 ng/mL after the first, second, and third exercise, respectively. In a congruent way, cf mt-DNA rose significantly after the second (from 229 +/- 216 to 450 +/- 228*103 GE/mL) and third bout of exercise (from 173 +/- 120 to 462 +/- 314*103 GE/mL). Pre-exercise cf mt-DNA decreased (p<0.05) by 2-times (from 355 +/- 219 before the first bout to 173 +/- 120*103 GE/mL before the third bout) over the study period and were accompanied by significant increase in white blood cells, platelets, creatine kinase, creatinine and lactate after each bout. However, the exercise induced percentage increment of cf n-DNA was always many times higher than corresponding increments of the afore-mentioned markers at any occasion. Conclusions Repeated bouts of exhaustive exercise induced remarkable increase in circulating cf n-DNA without signs of tolerance development. Baseline cf mt-DNA decreased in response to series of strenuous exercise. Since percentage increments of cf n-DNA in response to exercise were many times higher than those observed for other markers, measurement of circulating cf n-DNA could be a sensitive tool for monitoring acute exercise effects in human body.	[Stawski, Robert; Nowak, Dariusz] Med Univ Lodz, Dept Clin Physiol, Lodz, Poland; [Walczak, Konrad] Med Univ Lodz, Dept Internal Med & Nephrodiabetol, Lodz, Poland; [Kosielski, Piotr; Meissner, Pawel; Padula, Gianluca] Med Univ Lodz, Acad Lab Movement & Human Phys Performance, Lodz, Poland; [Budlewski, Tomasz] Cent Hosp Vet Lodz, Dept Internal Med, Mil Med Acad, Univ Hosp, Lodz, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz	Nowak, D (corresponding author), Med Univ Lodz, Dept Clin Physiol, Lodz, Poland.	dariusz.nowak@umed.lodz.pl	Stawski, Robert/G-8585-2014	Stawski, Robert/0000-0003-4164-4817; Padula, Gianluca/0000-0002-2748-9681; Nowak, Dariusz/0000-0003-3445-6930	Medical University of Lodz [503/1-079-01/503-11-001]	Medical University of Lodz	This study was supported by a research grant from Medical University of Lodz, no. 503/1-079-01/503-11-001.	Atamaniuk J, 2004, CLIN CHEM, V50, P1668, DOI 10.1373/clinchem.2004.034553; Atamaniuk J, 2008, EUR J APPL PHYSIOL, V104, P711, DOI 10.1007/s00421-008-0827-2; Atamaniuk J, 2010, EUR J APPL PHYSIOL, V110, P695, DOI 10.1007/s00421-010-1532-5; ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; Beiter T, 2014, J APPL PHYSIOL, V117, P325, DOI 10.1152/japplphysiol.00173.2014; Beiter T, 2011, CLIN CHEM, V57, P633, DOI 10.1373/clinchem.2010.158030; Bergeron R, 1999, J APPL PHYSIOL, V87, P111, DOI 10.1152/jappl.1999.87.1.111; Bergeron R, 2001, AM J PHYSIOL-REG I, V281, pR1854, DOI 10.1152/ajpregu.2001.281.6.R1854; Bogdanis GC, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00142; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Breitbach S, 1985, J APPL PHYSIOL, V2014, P119; Breitbach S, 2012, SPORTS MED, V42, P565, DOI 10.2165/11631380-000000000-00000; Brown WMC, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0032-x; Castell LM, 1997, EUR J APPL PHYSIOL O, V75, P47; Chandrananda D, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0107-z; CHAPMAN CB, 1948, J CLIN INVEST, V27, P639, DOI 10.1172/JCI102011; Chiu TW, 2006, CLIN CHEM LAB MED, V44, P13, DOI 10.1515/CCLM.2006.003; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; de Jonge XAKJ, 2003, SPORTS MED, V33, P833; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Elshimali YI, 2013, INT J MOL SCI, V14, P18925, DOI 10.3390/ijms140918925; Fatouros IG, 2010, CLIN BIOCHEM, V43, P1368, DOI 10.1016/j.clinbiochem.2010.08.020; Garcia-Souza LF, 2014, INT J BIOCHEM CELL B, V50, P156, DOI 10.1016/j.biocel.2014.02.015; Gleeson Michael, 2002, J Sports Sci Med, V1, P31; Helmig S, 2015, EUR J APPL PHYSIOL, V115, P2271, DOI 10.1007/s00421-015-3207-8; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Jiang N, 2005, J LEUKOCYTE BIOL, V77, P296, DOI 10.1189/jlb.0704411; Julian R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173951; Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105; Kratz A, 2006, AM J CLIN PATHOL, V125, P296, DOI 10.1309/PRF5N7P2XM6E243H; Li L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23992; Lippi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112892; Lo YMD, 2000, CLIN CHEM, V46, P319; Lui YNYN, 2002, CLIN CHEM, V48, P421; Nasi M, 2016, INT J SPORT PHYSIOL, V11, P116, DOI 10.1123/ijspp.2014-0461; Nieman DC, 2012, J INTERF CYTOK RES, V32, P12, DOI 10.1089/jir.2011.0038; Polcher M, 2010, ANTICANCER RES, V30, P2235; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Shockett PE, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12672; Staynov DZ, 2000, NUCLEIC ACIDS RES, V28, P3092, DOI 10.1093/nar/28.16.3092; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; Traiperm N, 2013, MED SCI SPORT EXER, V45, P1182, DOI 10.1249/MSS.0b013e3182831a93; Tug S, 2015, EXERC IMMUNOL REV, V21, P164; Velders M, 2014, CLIN BIOCHEM, V47, P471, DOI 10.1016/j.clinbiochem.2013.12.017; Wimberger P, 2011, INT J CANCER, V128, P2572, DOI 10.1002/ijc.25602; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96	47	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178216	10.1371/journal.pone.0178216	http://dx.doi.org/10.1371/journal.pone.0178216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542490	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500074
J	Wu, ZQ; Gu, CH; Tembrock, LR; Zhang, D; Ge, S				Wu, Zhiqiang; Gu, Cuihua; Tembrock, Luke R.; Zhang, Dong; Ge, Song			Characterization of the whole chloroplast genome of Chikusichloa mutica and its comparison with other rice tribe (Oryzeae) species	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GENE ORGANIZATION; PLASTID GENOMES; DNA-SEQUENCES; POACEAE; EVOLUTION; PATTERNS; MITOCHONDRIAL; ANGIOSPERMS; EXPRESSION	Chloroplast genomes are a significant genomic resource in plant species and have been used in many research areas. The complete genomic information from wild crop species could supply a valuable genetic reservoir for breeding. Chikusichloa mutica is one of the most important wild distant relatives of cultivated rice. In this study, we sequenced and characterized its complete chloroplast (cp) genome and compared it with other species in the same tribe. The whole cp genome sequence is 136,603 bp in size and exhibits a typical quadripartite structure with large and small single-copy regions (LSC, 82,327 bp; SSC, 12,598 bp) separated by a pair of 20,839-bp inverted repeats (IRA, B). A total of 110 unique genes are annotated, including 76 protein-coding genes, 4 ribosomal RNA genes and 30 tRNA genes. The genome structure, gene order, GC content, and other features are similar to those of other angiosperm cp genomes. When comparing the cp genomes between Oryzinae and Zizaniinae subtribes, the main differences were found between the junction regions and distribution of simple sequence repeats (SSRs). In comparing the two Chikusichloa species, the genomes were only 40 bp different in length and 108 polymorphic sites, including 83 single nucleotide substitutions (SNPs) and 25 insertion-deletions (Indels), were found between the whole cp genomes. The complete cp genome of C. mutica will be an important genetic tool for future breeding programs and understanding the evolution of wild rice relatives.	[Wu, Zhiqiang; Ge, Song] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Gu, Cuihua] Zhejiang Agr & Forestry Univ, Sch Landscape & Architecture, Hangzhou, Zhejiang, Peoples R China; [Tembrock, Luke R.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Zhang, Dong] Iowa State Univ, Dept Stat, Ames, IA USA	Chinese Academy of Sciences; Institute of Botany, CAS; Zhejiang A&F University; Colorado State University; Iowa State University	Wu, ZQ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	wu.zhiqiang.1020@gmail.com	Wu, Zhiqiang/CAG-6688-2022	Wu, Zhiqiang/0000-0002-4238-7317	Zhejiang Provincial Natural Science Foundation of China [LY17C160003]; National Natural Science Foundation of China [30990240, 31300581]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Zhejiang Provincial Natural Science Foundation of China (No.LY17C160003) and by the National Natural Science Foundation of China (30990240 and 31300581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Zhejiang Provincial Natural Science Foundation of China (No. LY17C160003) and by the National Natural Science Foundation of China (30990240 and 31300581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also thank the editor and two anonymous reviewers for their constructive comments, which helped us to improve the manuscript.	Ai B, 2012, EVOLUTION, V66, P3302, DOI 10.1111/j.1558-5646.2012.01674.x; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Bayly MJ, 2013, MOL PHYLOGENET EVOL, V69, P704, DOI 10.1016/j.ympev.2013.07.006; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Cotton JL, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0563-9; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Daniell H, 2007, P NATL ACAD SCI USA, V104, P6879, DOI 10.1073/pnas.0702219104; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; DeGray G, 2001, PLANT PHYSIOL, V127, P852, DOI 10.1104/pp.010233; Diekmann K, 2012, ANN BOT-LONDON, V110, P1327, DOI 10.1093/aob/mcs044; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Dong ZY, 2006, THEOR APPL GENET, V113, P196, DOI 10.1007/s00122-006-0286-2; Eizenga GC, 2009, GENET RESOUR CROP EV, V56, P65, DOI 10.1007/s10722-008-9345-7; Gao L, 2010, J SYST EVOL, V48, P77, DOI 10.1111/j.1759-6831.2010.00071.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Guo YL, 2005, AM J BOT, V92, P1548, DOI 10.3732/ajb.92.9.1548; Howe CJ, 2003, PHILOS T ROY SOC B, V358, P99, DOI 10.1098/rstb.2002.1176; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jiao WB, 2017, CURR OPIN PLANT BIOL, V36, P64, DOI 10.1016/j.pbi.2017.02.002; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim H, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r45; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li ZM, 2011, THEOR APPL GENET, V123, P21, DOI 10.1007/s00122-011-1563-2; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mardis ER, 2013, ANNU REV ANAL CHEM, V6, P287, DOI 10.1146/annurev-anchem-062012-092628; Michelangeli FA, 2003, AM J BOT, V90, P93, DOI 10.3732/ajb.90.1.93; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Muse SV, 1997, GENETICS, V146, P393; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Ronquist F., 2012, SYST BIOL; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2014, AM J BOT, V101, P1987, DOI 10.3732/ajb.1400398; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Tang L, 2015, MOL PHYLOGENET EVOL, V84, P232, DOI 10.1016/j.ympev.2015.01.011; Tang L, 2010, MOL PHYLOGENET EVOL, V54, P266, DOI 10.1016/j.ympev.2009.08.007; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025896; Wang L, 2010, MOL PHYLOGENET EVOL, V54, P211, DOI 10.1016/j.ympev.2009.08.032; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wu FH, 2009, TREE PHYSIOL, V29, P847, DOI 10.1093/treephys/tpp015; Wu Z., 2015, J PROTEOM BIOINFORM, V8, P253, DOI [10.4172/jpb.1000377, DOI 10.4172/JPB.1000377]; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wu ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118019; Wu ZY, 2006, FLORA CHINA, V22; Xu XW, 2015, AM J BOT, V102, P239, DOI 10.3732/ajb.1400323; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zhang J, 2016, MITOCHONDRIAL DNA A, V27, P2771, DOI 10.3109/19401736.2015.1053058; Zhang QJ, 2014, P NATL ACAD SCI USA, V111, pE4954, DOI 10.1073/pnas.1418307111; Zou XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14876	63	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177553	10.1371/journal.pone.0177553	http://dx.doi.org/10.1371/journal.pone.0177553			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542519	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500031
J	De Castro, O; Comparone, M; Di Maio, A; Del Guacchio, E; Menale, B; Troisi, J; Aliberti, F; Trifuoggi, M; Guida, M				De Castro, Olga; Comparone, Maria; Di Maio, Antonietta; Del Guacchio, Emanuele; Menale, Bruno; Troisi, Jacopo; Aliberti, Francesco; Trifuoggi, Marco; Guida, Marco			What is in your cup of tea? DNA Verity Test to characterize black and green commercial teas	PLOS ONE			English	Article							TRNL UAA INTRON; MOLECULAR PHYLOGENY; CHLOROPLAST GENOME; ITALIAN TRIANGLE; CAMELLIA; AUTHENTICATION; BARCODE; QUALITY; IDENTIFICATION; TECHNOLOGIES	In this study, we used several molecular techniques to develop a fast and reliable protocol (DNA Verity Test, DVT) for the characterization and confirmation of the species or taxa present in herbal infusions. As a model plant for this protocol, Camellia sinensis, a traditional tea plant, was selected due to the following reasons: its historical popularity as a (healthy) beverage, its high selling value, the importation of barely recognizable raw product (i.e., crushed), and the scarcity of studies concerning adulterants or contamination. The DNA Verity Test includes both the sequencing of DNA barcoding markers and genotyping of labeled-PCR DNA barcoding fragments for each sample analyzed. This protocol (DVT) was successively applied to verify the authenticity of 32 commercial teas (simple or admixture), and the main results can be summarized as follows: (1) the DVT protocol is suitable to detect adulteration in tea matrices (contaminations or absence of certified ingredients), and the method can be exported for the study of other similar systems; (2) based on the BLAST analysis of the sequences of rbcL+ matK +/- rps7-trnV (GAC) chloroplast markers, C. sinensis can be taxonomically characterized; (3) rps7-trnV (GAC) can be employed to discriminate C. sinensis from C. pubicosta; (4) ITS2 is not an ideal DNA barcode for tea samples, reflecting potential incomplete lineage sorting and hybridization/introgression phenomena in C. sinensis taxa; (5) the genotyping approach is an easy, inexpensive and rapid pre-screening method to detect anomalies in the tea templates using the trnH (GUG)-psbA barcoding marker; (6) two herbal companies provided no authentic products with a contaminant or without some of the listed ingredients; and (7) the leaf matrices present in some teabags could be constituted using an admixture of different C. sinensis haplotypes and/or allied species (C. pubicosta).	[De Castro, Olga; Comparone, Maria; Di Maio, Antonietta; Menale, Bruno] Univ Naples Federico II, Dept Biol, Bot Garden, Naples, Italy; [Del Guacchio, Emanuele] Univ Naples Federico II, Bot Garden, Naples, Italy; [Troisi, Jacopo] Univ Salerno, Dept Med & Surg & Dent, Salerno, Italy; [Aliberti, Francesco; Guida, Marco] Univ Naples Federico II, Dept Biol, Naples, Italy; [Trifuoggi, Marco] Univ Naples Federico II, Dept Chem Sci, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Salerno; University of Naples Federico II; University of Naples Federico II	De Castro, O (corresponding author), Univ Naples Federico II, Dept Biol, Bot Garden, Naples, Italy.	odecastr@unina.it	guida, Marco/K-2262-2013; Troisi, Jacopo/ABC-1348-2021	Troisi, Jacopo/0000-0003-2962-7379; DE CASTRO, Olga/0000-0002-4861-3960; Del Guacchio, Emanuele/0000-0001-9349-1328				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2013, PLANT LIST VERSION 1; Arlt VM, 2002, MUTAGENESIS, V17, P265, DOI 10.1093/mutage/17.4.265; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bhattacharjya DK, 2008, INDIAN J TRADIT KNOW, V7, P501; Bianchi F, 2004, LANCET ONCOL, V5, P710, DOI 10.1016/S1470-2045(04)01645-6; Bruni I, 2015, FOOD CHEM, V170, P308, DOI 10.1016/j.foodchem.2014.08.060; Bruni I, 2010, INT J LEGAL MED, V124, P595, DOI 10.1007/s00414-010-0447-3; CHANG HD, 1998, TOMUS, V49, P1; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; Danezis GP, 2016, TRAC-TREND ANAL CHEM, V85, P123, DOI 10.1016/j.trac.2016.02.026; De Castro O, 2012, BOT J LINN SOC, V170, P12, DOI 10.1111/j.1095-8339.2012.01268.x; De Medici D, 2015, FOOD ANAL METHOD, V8, P255, DOI 10.1007/s12161-014-9915-6; Dhiman B, 2003, PLANTA MED, V69, P882, DOI 10.1055/s-2003-43211; Di Maio A, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200158; EFSA, 2009, EFSA J, V7, DOI [10.2903/j.efsa.2009.282r, 10.2903/j.efsa.2010.1828]; Ekor M, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00177; Ellis DI, 2012, CHEM SOC REV, V41, P5706, DOI 10.1039/c2cs35138b; Fazekas AJ, 2010, TAXON, V59, P694, DOI 10.1002/tax.593002; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Forgacs E., 2003, FOOD AUTHENTICITY TR, V1st ed, P197; Galimberti A, 2015, FOOD RES INT, V69, P424, DOI 10.1016/j.foodres.2015.01.017; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Gutman R. L., 1996, HerbalGram, P33; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Jiarui C, 2003, FLORA OF CHINA 5; Jiyin G., 2005, COLLECTED SPECIES GE; Kaundun SS, 2011, J SCI FOOD AGR, V91, P2660, DOI 10.1002/jsfa.4508; Kravtsova T. I., 2003, Kew Bulletin, V58, P297, DOI 10.2307/4120618; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lee S-C, 2016, J FOOD DRUG IN PRESS; Li PY, 2011, J SERB CHEM SOC, V76, P709, DOI 10.2298/JSC100818063L; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Menale B, 2016, J ETHNOPHARMACOL, V192, P320, DOI 10.1016/j.jep.2016.07.049; Merrill E. D., 1942, JOUR ARNOLD ARBORETUM, V23, P156; Mezzasalma V, 2017, INT J LEGAL MED, V131, P1, DOI 10.1007/s00414-016-1460-y; Min T, 2007, FLORA CHINA, V12; Mishra P, 2016, PLANT BIOTECHNOL J, V14, P8, DOI 10.1111/pbi.12419; Nath TN, 2013, J ADV RES, V1, P561; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Pang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048833; Peris M, 2016, TRENDS FOOD SCI TECH, V58, P40, DOI 10.1016/j.tifs.2016.10.014; Primrose S, 2010, TRENDS FOOD SCI TECH, V21, P582, DOI 10.1016/j.tifs.2010.09.006; Ratnam K.V., 2008, ETHNOBOT LEAFL, V12, P19; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ravikumar C, 2014, J PHARM SCI RES, V6, P236; Reygaert WC, 2017, BEVERAGES, V3, DOI 10.3390/beverages3010006; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sarma Hemen, 2016, Emerging Contaminants, V2, P119, DOI 10.1016/j.emcon.2016.05.004; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Senior K, 2004, LANCET ONCOL, V5, P525, DOI 10.1016/S1470-2045(04)01561-X; Shi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059620; Singh RK, 2010, INDIAN J TRADIT KNOW, V9, P754; Soukand R, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-58; Spaniolas S, 2010, FOOD CHEM, V122, P850, DOI 10.1016/j.foodchem.2010.02.039; Spink J, 2011, J FOOD SCI, V76, pR157, DOI 10.1111/j.1750-3841.2011.02417.x; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; Sumpio BE, 2006, J AM COLL SURGEONS, V202, P813, DOI 10.1016/j.jamcollsurg.2006.01.018; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tate JA, 2003, SYST BOT, V28, P723; Vancouver JF, 2011, J TEA SCI RES, V1, P1; Vijayan K, 2008, BOT STUD, V49, P177; Vijayan K, 2009, AM J BOT, V96, P1348, DOI 10.3732/ajb.0800205; Wheeler L, 2015, IUCN RED LIST THREAT; Wheeler L, 2015, IUCN RED LIST THREAT; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921; Wilmot-Dear CM, 2013, BLUMEA, V58, P85, DOI 10.3767/000651913X674116; Wilmot-Dear CM, 2004, NORD J BOT, V24, P5, DOI 10.1111/j.1756-1051.2004.tb00825.x; Wilmot-Dear C. M., 2009, Edinburgh Journal of Botany, V66, P51, DOI 10.1017/S096042860900523X; Wilmot-Dear C.M., 1996, OPERA BOT, V129, P1; Wilmot-Dear CM, 2015, NORD J BOT, V33, P354, DOI 10.1111/njb.00675; Wilmot-Dear CM, 2011, NORD J BOT, V29, P691, DOI 10.1111/j.1756-1051.2011.01386.x; World Health Organization, 2015, FOOD SAF WHAT YOU SH; Yang Jun-Bo, 2006, Acta Botanica Yunnanica, V28, P108; Yang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073053; Zhang YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157847	82	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178262	10.1371/journal.pone.0178262	http://dx.doi.org/10.1371/journal.pone.0178262			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542606	gold, Green Submitted, Green Published			2022-12-27	WOS:000402058800053
J	Luitz, MP; Barth, A; Crevenna, AH; Bomblies, R; Lamb, DC; Zacharias, M				Luitz, Manuel P.; Barth, Anders; Crevenna, Alvaro H.; Bomblies, Rainer; Lamb, Don C.; Zacharias, Martin			Covalent dye attachment influences the dynamics and conformational properties of flexible peptides	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; PHOTOINDUCED ELECTRON-TRANSFER; RIBONUCLEASE-A; CIRCULAR-DICHROISM; AQUEOUS-SOLUTION; FORCE-FIELD; S-PROTEIN; BINDING; SIMULATION; BIOMOLECULES	Fluorescence spectroscopy techniques like Forster resonance energy transfer (FRET) and fluorescence correlation spectroscopy (FCS) have become important tools for the in vitro and in vivo investigation of conformational dynamics in biomolecules. These methods rely on the distance-dependent quenching of the fluorescence signal of a donor fluorophore either by a fluorescent acceptor fluorophore (FRET) or a non-fluorescent quencher, as used in FCS with photoinduced electron transfer (PET). The attachment of fluorophores to the molecule of interest can potentially alter the molecular properties and may affect the relevant conformational states and dynamics especially of flexible biomolecules like intrinsically disordered proteins (IDP). Using the intrinsically disordered S-peptide as a model system, we investigate the impact of terminal fluorescence labeling on the molecular properties. We perform extensive molecular dynamics simulations on the labeled and unlabeled peptide and compare the results with in vitro PET-FCS measurements. Experimental and simulated timescales of end-to-end fluctuations were found in excellent agreement. Comparison between simulations with and without labels reveal that the p-stacking interaction between the fluorophore labels traps the conformation of S-peptide in a single dominant state, while the unlabeled peptide undergoes continuous conformational rearrangements. Furthermore, we find that the open to closed transition rate of S-peptide is decreased by at least one order of magnitude by the fluorophore attachment. Our approach combining experimental and in silico methods provides a benchmark for the simulations and reveals the significant effect that fluorescence labeling can have on the conformational dynamics of small biomolecules, at least for inherently flexible short peptides. The presented protocol is not only useful for comparing PET-FCS experiments with simulation results but provides a strategy to minimize the influence on molecular properties when chosing labeling positions for fluorescence experiments.	[Luitz, Manuel P.; Bomblies, Rainer; Zacharias, Martin] Tech Univ Munich, Dept Phys, T38, D-85748 Garching, Germany; [Barth, Anders; Lamb, Don C.] Ludwig Maximilians Univ Munchen, Dept Chem, Phys Chem, D-81377 Munich, Germany; [Crevenna, Alvaro H.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780157 Oeiras, Portugal	Technical University of Munich; University of Munich; Universidade Nova de Lisboa	Zacharias, M (corresponding author), Tech Univ Munich, Dept Phys, T38, D-85748 Garching, Germany.	mzacharias@mytum.de	Crevenna, Alvaro/Q-4476-2019; Barth, Anders/S-8301-2019; Lamb, Don C/G-9501-2014	Crevenna, Alvaro/0000-0002-5580-3711; Barth, Anders/0000-0003-3671-3072; Lamb, Don C/0000-0002-0232-1903	Deutsche Forschungsgemeinschaf [DFG/SFB1035, B02]; LRZ supercomputer center (Leibniz Rechenzentrum) [pr48po]; Ludwig-Maximilians-Universitat through the Center for NanoScience; Biolmaging Network	Deutsche Forschungsgemeinschaf(German Research Foundation (DFG)); LRZ supercomputer center (Leibniz Rechenzentrum); Ludwig-Maximilians-Universitat through the Center for NanoScience; Biolmaging Network	The authors thank the Deutsche Forschungsgemeinschaft (DFG/SFB1035 project All and B02) for financial support. This work was also supported by the LRZ supercomputer center (Leibniz Rechenzentrum) through grant pr48po. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully thank Christina Stutzer for her kind introduction into circular dichroism spectrometry and the Micro-Chemistry Core Facility of the Max Planck Institute of Biochemistry (Martinsried, Germany) for peptide synthesis. We gratefully acknowledge the support from the Ludwig-Maximilians-Universitat through the Center for NanoScience and the Biolmaging Network.	Bachmann A, 2011, P NATL ACAD SCI USA, V108, P3952, DOI 10.1073/pnas.1012668108; Bastos M, 2001, PROTEINS, V42, P523, DOI 10.1002/1097-0134(20010301)42:4<523::AID-PROT100>3.0.CO;2-B; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cole R, 2002, BIOCHEMISTRY-US, V41, P6072, DOI 10.1021/bi025655m; Crevenna AH, 2012, BIOPHYS J, V102, P907, DOI 10.1016/j.bpj.2012.01.035; Daidone I, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000645; de Silva AP, 1997, CHEM REV, V97, P1515, DOI 10.1021/cr960386p; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; Felekyan S, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1946088; Felekyan S, 2012, CHEMPHYSCHEM, V13, P1036, DOI 10.1002/cphc.201100897; FINN FM, 1972, BIOCHEMISTRY-US, V11, P455, DOI 10.1021/bi00753a025; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Frisch M. J, GAUSSIAN 09 REVISION; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoefling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019791; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; KAVARNOS GJ, 1986, CHEM REV, V86, P401, DOI 10.1021/cr00072a005; Kavarnos GJ, 1994, FUNDAMENTALS PHOTOIN, V98; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Kurtsiefer C, 2001, BREAKDOWN FLASH SILI, P2039; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li X, 2011, J PHYS CHEM B, V115, P6265, DOI 10.1021/jp200455b; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Marshall GR, 2008, BIOPOLYMERS, V90, P259, DOI 10.1002/bip.20845; MetsU E, 1997, CHEM PHYS; Michalet X, 2003, ANNU REV BIOPH BIOM, V32, P161, DOI 10.1146/annurev.biophys.32.110601.142525; Milles S, 2012, J AM CHEM SOC, V134, P5187, DOI 10.1021/ja210587q; Moerner WE, 2003, REV SCI INSTRUM, V74, P3597, DOI 10.1063/1.1589587; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; Nettels D, 2007, P NATL ACAD SCI USA, V104, P2655, DOI 10.1073/pnas.0611093104; Neuweiler H, 2004, CURR PHARM BIOTECHNO, V5, P285, DOI 10.2174/1389201043376896; Neuweiler H, 2009, P NATL ACAD SCI USA, V106, P18569, DOI 10.1073/pnas.0910860106; Noe F, 2011, P NATL ACAD SCI USA, V108, P4822, DOI 10.1073/pnas.1004646108; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; RICHARDS FM, 1958, P NATL ACAD SCI USA, V44, P162, DOI 10.1073/pnas.44.2.162; Sahoo H, 2011, CHEMPHYSCHEM, V12, P532, DOI 10.1002/cphc.201000776; Sauer M, 2014, METHODS MOL BIOL, V1076, P597, DOI 10.1007/978-1-62703-649-8_27; Schroder GF, 2005, BIOPHYS J, V89, P3757, DOI 10.1529/biophysj.105.069500; SIMONS ER, 1968, J BIOL CHEM, V243, P218; TAMBURRO A M, 1968, Febs Letters, V1, P298, DOI 10.1016/0014-5793(68)80137-1; Tinnefeld P, 2005, ANGEW CHEM INT EDIT, V44, P2642, DOI 10.1002/anie.200300647; Vaiana AC, 2003, J AM CHEM SOC, V125, P14564, DOI 10.1021/ja036082j; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Weiss S, 2000, NATURE STRUCTURAL BI; Weller A, 1982, Z PHYS CHEM; Zhang Y, 2013, J PHYS CHEM B, V117, P7308, DOI 10.1021/jp404466f; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11873, DOI 10.1073/pnas.211440298	60	11	11	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177139	10.1371/journal.pone.0177139	http://dx.doi.org/10.1371/journal.pone.0177139			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542243	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058800009
J	Oh, EH; Oh, K; Han, M; Seo, H; Chang, K; Lee, SH; Kim, GU; Song, EM; Seo, M; Lee, HS; Hwang, SW; Park, SH; Yang, DH; Kim, KJ; Byeon, JS; Myung, SJ; Yang, SK; Ye, BD				Oh, Eun Hye; Oh, Kyunghwan; Han, Minkyu; Seo, Hyungil; Chang, Kiju; Lee, Sun-Ho; Kim, Gwang-Un; Song, Eun Mi; Seo, Myeongsook; Lee, Ho-Su; Hwang, Sung Wook; Park, Sang Hyoung; Yang, Dong-Hoon; Kim, Kyung-Jo; Byeon, Jeong-Sik; Myung, Seung-Jae; Yang, Suk-Kyun; Ye, Byong Duk			Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors	PLOS ONE			English	Article							EARLY COMBINED IMMUNOSUPPRESSION; RANDOMIZED CONTROLLED-TRIAL; INFLAMMATORY-BOWEL-DISEASE; HOSPITAL-BASED COHORT; CONVENTIONAL MANAGEMENT; COMBINATION THERAPY; CERTOLIZUMAB PEGOL; INFLIXIMAB; AZATHIOPRINE; MAINTENANCE	Although early treatment of Crohn's disease (CD) patients with anti-tumor necrosis factor (TNF) agents or immunomodulators (IMs) may improve long-term outcomes, especially those with poor prognostic factors, their effectiveness in Asians remains unclear. In this study, Korean patients with CD naive to both intestinal surgery and intestinal complications, and with at least two risk factors for progression (diagnosis at age <40 years, systemic corticosteroid treatment <3 months after diagnosis, and perianal fistula at diagnosis) were retrospectively analyzed. Patients were classified into those who started anti-TNFs, or IMs but not anti-TNFs, within 2 years of diagnosis, and those who started anti-TNFs and/or IMs later. Their probabilities of intestinal surgery and intestinal complications were compared. A total of 670 patients were enrolled, 79 in the early anti-TNF, 286 in the early IM, and 305 in the late treatment group. Kaplan-Meier analysis with the log-rank test showed that from starting anti-TNFs/IMs, times to intestinal surgery (P < 0.001), stricturing complications (P = 0.002), and penetrating complications (P < 0.001) were significantly longer in the early anti-TNF/IM groups than in the late treatment group. Multivariate Cox regression analysis showed that, from starting anti-TNFs/IMs, late anti-TNF/IM treatment was independently associated with higher risks of intestinal surgery (adjusted hazard ratio [aHR] 2.321, 95% confidence interval [CI] 1.503-3.584, P < 0.001), behavioral progression (aHR 2.001, 95% CI 1.449-2.763, P < 0.001), stricturing complications (aHR 1.736, 95% CI 1.209-2.493, P = 0.003), and penetrating complications (aHR 3.315, 95% CI 2.094-5.249, P < 0.001) than early treatment. In conclusion, treatment of Asian CD patients having poor prognostic factors with anti-TNFs/IMs within 2 years of diagnosis is associated with better clinical outcomes than later treatment.	[Oh, Eun Hye; Oh, Kyunghwan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Han, Minkyu] Univ Ulsan, Coll Med, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Seo, Hyungil; Chang, Kiju; Lee, Sun-Ho; Kim, Gwang-Un; Song, Eun Mi; Seo, Myeongsook; Hwang, Sung Wook; Park, Sang Hyoung; Yang, Dong-Hoon; Kim, Kyung-Jo; Byeon, Jeong-Sik; Myung, Seung-Jae; Yang, Suk-Kyun; Ye, Byong Duk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Lee, Ho-Su] Univ Ulsan, Coll Med, Asan Med Ctr, Hlth Screening & Promot Ctr, Seoul, South Korea; [Hwang, Sung Wook; Park, Sang Hyoung; Kim, Kyung-Jo; Yang, Suk-Kyun; Ye, Byong Duk] Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Inflammatory Bowel Dis, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Ye, BD (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea.; Ye, BD (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Inflammatory Bowel Dis, Seoul, South Korea.	bdye@amc.seoul.kr	Park, Sang Hyoung/CAH-4735-2022; Ye, Byong Duk/AAF-4955-2020; Yang, Dong-Hoon/B-3437-2015	Ye, Byong Duk/0000-0001-6647-6325; Yang, Dong-Hoon/0000-0001-7756-2704				Aberra FN, 2015, CLIN GASTROENTEROL H, V13, P1702, DOI 10.1016/j.cgh.2015.02.032; Antunes O, 2014, BEST PRACT RES CL GA, V28, P473, DOI 10.1016/j.bpg.2014.05.001; Baert F, 2010, GASTROENTEROLOGY, V138, P463, DOI 10.1053/j.gastro.2009.09.056; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Colombel JF, 2014, CLIN GASTROENTEROL H, V12, P414, DOI 10.1016/j.cgh.2013.06.019; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Cosnes J, 2013, GASTROENTEROLOGY, V145, P758, DOI 10.1053/j.gastro.2013.04.048; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Danese S, 2011, ALIMENT PHARM THER, V33, P857, DOI 10.1111/j.1365-2036.2011.04598.x; De Cruz P, 2015, LANCET, V385, P1406, DOI 10.1016/S0140-6736(14)61908-5; Franchimont DP, 1998, EUR J GASTROEN HEPAT, V10, P821, DOI 10.1097/00042737-199810000-00001; Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Khanna R, 2015, LANCET, V386, P1825, DOI 10.1016/S0140-6736(15)00068-9; Lakatos PL, 2012, AM J GASTROENTEROL, V107, P579, DOI 10.1038/ajg.2011.448; Lakatos PL, 2009, WORLD J GASTROENTERO, V15, P3504, DOI 10.3748/wjg.15.3504; Lichtenstein GR, 2006, AM J GASTROENTEROL, V101, P1030, DOI 10.1111/j.1572-0241.2006.00463.x; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; Loly C, 2008, SCAND J GASTROENTERO, V43, P948, DOI 10.1080/00365520801957149; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ng WK, 2016, INTEST RES, V14, P111, DOI 10.5217/ir.2016.14.2.111; Ordas I, 2011, GUT, V60, P1754, DOI 10.1136/gutjnl-2011-300934; Osterman MT, 2015, CLIN GASTROENTEROL H, V13, P1293, DOI 10.1016/j.cgh.2015.02.017; Osterman MT, 2015, CLIN GASTROENTEROL H, V13, pe1272; Ott C, 2014, INT J COLORECTAL DIS, V29, P1329, DOI 10.1007/s00384-014-2002-z; Panaccione R, 2014, GASTROENTEROLOGY, V146, P392, DOI 10.1053/j.gastro.2013.10.052; Panes J, 2013, GASTROENTEROLOGY, V145, P766, DOI 10.1053/j.gastro.2013.06.009; Park SH, 2016, DIGEST DIS SCI, V61, P2060, DOI 10.1007/s10620-016-4105-6; Park SH, 2014, INFLAMM BOWEL DIS, V20, P488, DOI 10.1097/01.MIB.0000441203.56196.46; Qiu Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001148; Rogler G, 2013, J CROHNS COLITIS, V7, P670, DOI [10.1016/j.crohns.2013.02.014, 10.1016/j.crohns.2012.10.012]; Rogler G, 2013, DIGEST DIS, V31, P83, DOI 10.1159/000347190; Romberg-Camps MJL, 2009, AM J GASTROENTEROL, V104, P371, DOI 10.1038/ajg.2008.38; Rubin DT, 2012, INFLAMM BOWEL DIS, V18, P2225, DOI 10.1002/ibd.22925; Rutgeerts P, 2012, GASTROENTEROLOGY, V142, P1102, DOI 10.1053/j.gastro.2012.01.035; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2014, J CROHNS COLITIS, V8, P927, DOI 10.1016/j.crohns.2014.02.021; Schreiber S, 2007, NEW ENGL J MED, V357, P239, DOI 10.1056/NEJMoa062897; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Solberg IC, 2007, CLIN GASTROENTEROL H, V5, P1430, DOI 10.1016/j.cgh.2007.09.002; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310; Yang SK, 2016, DIGEST DIS, V34, P165, DOI 10.1159/000443134	46	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177479	10.1371/journal.pone.0177479	http://dx.doi.org/10.1371/journal.pone.0177479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542298	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058800018
J	Shen, BZ; Zhu, CL; Gao, X; Liu, G; Song, JC; Yu, Y				Shen, Bingzheng; Zhu, Chengliang; Gao, Xiang; Liu, Gang; Song, Jinchun; Yu, Yan			Oligopeptides as full-length New Delhi metallo-beta-lactamase-1 (NDM-1) inhibitors	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; IMP-1; RESISTANCE; ERTAPENEM; BACTERIA; REVEALS	'Superbug' bacteria producing NDM-1 enzyme causing wide public concern were first detected in a patient who visited India in 2008. It's an effective approach to combining beta-lactam antibiotics with NDM-1 inhibitor for treating NDM-1 producing strain infection. In our research, we designed ten oligopeptides, tested IC50 values against NDM-1 enzyme, determined the MIC values of synergistic antibacterial effect and explored the binding model. We found that the oligopeptides 2 (Cys-Phe) and 5 (Cys-Asp) respectively presented IC50 values of 113 mu M and 68 mu M and also displayed favorable synergistic effects of the inhibitors in combination with ertapenem against genetic engineering-host E. coli BL21 (DE3)/pET30aNDM-1 and a clinical isolate of P. aeruginosa with bla(NDM-1). Flexible docking and partial charge study suggested the interaction between oligopeptide and NDM-1. Three types of action effects, hydrogen bond, electrostatic effect and pi-pi interaction, contributed to the inhibitory activities.	[Shen, Bingzheng; Liu, Gang; Song, Jinchun] Wuhan Univ, Renmin Hosp, Dept Pharm, Wuhan, Peoples R China; [Shen, Bingzheng] Wuhan Univ, State Key Lab Virol, Wuhan, Peoples R China; [Zhu, Chengliang] Wuhan Univ, Renmin Hosp, Dept Clin Lab, Wuhan, Peoples R China; [Gao, Xiang] Wuhan Univ, Renmin Hosp, Cent Lab, Wuhan, Peoples R China; [Yu, Yan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Tongji Med Coll, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Huazhong University of Science & Technology	Song, JC (corresponding author), Wuhan Univ, Renmin Hosp, Dept Pharm, Wuhan, Peoples R China.; Yu, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Tongji Med Coll, Wuhan, Peoples R China.	jcsong@live.cn; yyu_hust@yeah.net	Song, Jin/HHS-8731-2022; Li, Hongpu/B-7707-2014	Li, Hongpu/0000-0003-2323-6107	Open Research Fund Program of State Key Laboratory of Virology of China [2016KF002]; National Natural Science Foundation of China [31100253, 81672079]	Open Research Fund Program of State Key Laboratory of Virology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Open Research Fund Program of State Key Laboratory of Virology of China (2016KF002) and the National Natural Science Foundation of China (Grant No. 31100253 and 81672079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-Bentley J, 2013, ANTIMICROB AGENTS CH, V57, P3085, DOI 10.1128/AAC.00297-13; [Anonymous], 2009, DISC STUD VERS 2 5 U; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Chen JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062082, 10.1371/journal.pone.0069704, 10.1371/journal.pone.0066841]; Clinical and Laboratory Standards Institute, 2013, 23 CLSI; Fischer J, 2013, J ANTIMICROB CHEMOTH, V68, P2954, DOI 10.1093/jac/dkt260; Giedraitiene A, 2011, MEDICINA-LITHUANIA, V47, P137, DOI 10.3390/medicina47030019; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Gupta Kalpana, 2013, PLoS One, V8, pe53674, DOI 10.1371/journal.pone.0053674; Hammond GG, 1999, FEMS MICROBIOL LETT, V179, P289, DOI 10.1111/j.1574-6968.1999.tb08740.x; Hoesly FJ, 2011, ARCH DERMATOL, V147, P1418, DOI 10.1001/archdermatol.2011.320; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; King D, 2011, PROTEIN SCI, V20, P1484, DOI 10.1002/pro.697; Laraki N, 1999, ANTIMICROB AGENTS CH, V43, P902, DOI 10.1128/AAC.43.4.902; Moloughney JG, 2005, FEMS MICROBIOL LETT, V243, P65, DOI 10.1016/j.femsle.2004.11.042; Musson DG, 2003, J CHROMATOGR B, V783, P1, DOI 10.1016/S1570-0232(02)00240-4; Nix DE, 2004, J ANTIMICROB CHEMOTH, V53, P23, DOI 10.1093/jac/dkh205; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Samuelsen O, 2008, ANTIMICROB AGENTS CH, V52, P2905, DOI 10.1128/AAC.00166-08; Shen BZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062955; Toleman MA, 2012, ANTIMICROB AGENTS CH, V56, P2773, DOI 10.1128/AAC.06297-11; Wailan AM, 2014, EXPERT REV ANTI-INFE, V12, P91, DOI 10.1586/14787210.2014.856756; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; WICKENS H, 2005, PHARM J, V274, P501; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036; Zhang WJ, 2013, J ANTIMICROB CHEMOTH, V68, P1681, DOI 10.1093/jac/dkt066	30	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177293	10.1371/journal.pone.0177293	http://dx.doi.org/10.1371/journal.pone.0177293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542279	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058800015
J	Chen, TM; Huang, YX; Liu, RC; Xie, Z; Chen, SL; Hu, GQ				Chen, Tianmu; Huang, Yuanxiu; Liu, Ruchun; Xie, Zhi; Chen, Shuilian; Hu, Guoqing			Evaluating the effects of common control measures for influenza A (H1N1) outbreak at school in China: A modeling study	PLOS ONE			English	Article							PANDEMIC INFLUENZA; INFECTION; VIRUS	Background Influenza A (H1N1) outbreaks have become common at schools in China since 2009. However, the effects of common countermeasures for school influenza outbreak have not been quantified so far, including isolation, vaccination, antivirus and school closure. We conducted a mathematically modeling study to address this unsolved issue. Methods We collected data of all small-scale school outbreaks caused by influenza A that occurred in Changsha city between January 2009 and December 2013. Two outbreaks (one was in 2009 and the other one was in 2013) were used for simulating the effects of single and combined use of common measures, including isolation (Iso), therapeutics (T), prophylactics (P), vaccinating 70% of susceptible individuals prior to the outbreak (V-P70), vaccinating 70% of susceptible individuals every day during the outbreak (V-D70) and school closure of one week (S1w). A susceptible D exposed D infectious/asymptomatic D recovered (SEIR) model was developed to implement the simulations based on the natural history of influenza A. Results When no control measures are taken, the influenza is expected to spread quickly at school for the selected outbreak in 2013; the outbreak would last 56 days, and the total attack rate (TAR) would reach up to 46.32% (95% CI: 46.12-46.52). Of all single control measures, V-P70 is most effective to control the epidemic (TAR = 8.68%), followed by V-P50, V-D70, V-D50 and Iso. The use of V-P70 with any other measure can reduce TAR to 3.37-14.04% and showed better effects than any other combination of two kinds of measures. The best two-measure combination is 'S1w+V-P70' (TAR = 3.37%, DO = 41 days). All combinations of three kinds of measures were not satisfactory when V-p70 and V-D70 were excluded. The most effective three-intervention combination was 'Iso+S1w+V-P70' (with TAR = 3.23%). When V-P70 or V-D70 is included, the combinations of four or five kinds of interventions are very effective, reducing TAR to lower than 5%. But the TAR of combination of 'T+P+Iso+S1w' is 23.20%. Similar simulation results were observed for the selected outbreak in 2009. Conclusion Vaccinating no less than 70% of individuals prior to the outbreak and isolation are recommended as single measures to control H1N1 outbreak at school. The combination of V-P70+S1w can achieve very good control for school outbreak.	[Chen, Tianmu; Huang, Yuanxiu; Liu, Ruchun; Xie, Zhi; Chen, Shuilian] Changsha Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Changsha, Hunan, Peoples R China; [Hu, Guoqing] Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China	Central South University	Hu, GQ (corresponding author), Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	huguoging009@gmail.com		Hu, Guoqing/0000-0002-5002-8015				Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Chen TM, 2014, TRAVEL MED INFECT DI, V12, P650, DOI 10.1016/j.tmaid.2014.10.015; [陈田木 Chen Tianmu], 2014, [中国卫生统计, Chinese Journal of Health Statistics], V31, P390; Chen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095006; Dushoff J, 2004, PNAS, V101, P16195; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Hsieh YH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-80; Liu R, 2015, PLOS ONE, V10; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Lv M, 2016, VACCINE, V34, P2135, DOI 10.1016/j.vaccine.2016.02.032; National Health and Family Planning Commission of the People's Republic of China, 2011, DIAGN TREATM GUID IN; National Health and Family Planning Commission of the People's Republic of China, 2010, INFL SURV PROGR CHIN; National Health and Family Planning Commission of the People's Republic of China, 2013, CLIN ED GEN PRACTICE, V11, P123; Patrozou E, 2009, PUBLIC HEALTH REP, V124, P193, DOI 10.1177/003335490912400205; Shi Jing-hong, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P62; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Sun Yihong, 2010, J Cardiovasc Dis Res, V1, P10, DOI 10.4103/0975-3583.59978; Tracht SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009018; Wang LG, 2014, SCI REP-UK, V4, DOI 10.1038/srep05982; Yang P, 2014, VACCINE, V32, P5285, DOI 10.1016/j.vaccine.2014.07.083; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zhang L, 2016, PEDIAT INFECT D 1128	23	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177672	10.1371/journal.pone.0177672	http://dx.doi.org/10.1371/journal.pone.0177672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542360	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672600019
J	Zeng, T; Wang, D; Chen, J; Tian, YY; Cai, XF; Peng, H; Zhu, LY; Huang, AL; Tang, H				Zeng, Tao; Wang, Dan; Chen, Juan; Tian, Yuanyuan; Cai, Xuefei; Peng, Hong; Zhu, Liying; Huang, Ailong; Tang, Hua			LncRNA-AF113014 promotes the expression of Egr2 by interaction with miR-20a to inhibit proliferation of hepatocellular carcinoma cells	PLOS ONE			English	Article							LONG NONCODING RNA; GROWTH-RESPONSE 2; GASTRIC-CANCER PROLIFERATION; MESENCHYMAL TRANSITION; GENE EGR2; MIRNA; BINDING; DIFFERENTIATION; TRANSCRIPTION; BIOMARKERS	Long non-coding RNAs (lncRNAs), tentatively identified as non-protein coding RNA, are transcripts more than 200nt in length and accounting for 98% of the whole genome of human being. Accumulating evidence showed aberrant expressions of lncRNAs are strongly correlated to the development of cancers. In this study, AF113014 is a new lncRNA identified from Microarray. We found AF113014 is differentially expressed between HCC cell lines and normal hepatocytes. Functionally, AF113014 inhibited proliferation of HCC cells both in vitro and in vivo, whereas the opposite effect was observed when AF113014 knockdown. Moreover, we identified that Egr2, a tumor suppressor gene, was a downstream target gene of AF113014. Furthermore, we discovered that AF113014 up-regulated Egr2 expression through interacting with miR-20a by using dual-luciferase reporter assay, qRT-PCR and Western blotting analysis. Our data provides a new insight for understanding the mechanisms of HCC.	[Zeng, Tao; Wang, Dan; Chen, Juan; Cai, Xuefei; Peng, Hong; Zhu, Liying; Huang, Ailong; Tang, Hua] Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis,Minist Educ,Inst Vira, Chongqing, Peoples R China; [Tian, Yuanyuan] Qingdao Women & Children Hosp, Qingdao, Peoples R China; [Huang, Ailong] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chongqing Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Huang, AL; Tang, H (corresponding author), Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis,Minist Educ,Inst Vira, Chongqing, Peoples R China.; Huang, AL (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	ahuang1964@163.com; tanghua86162003@cqmu.edu.cn	WANG, DAN/U-5790-2019		Major National ST Program [2013ZX10002002]; Chongqing Science & Technology Commission [cstc2013jcyjC10002]; Natural Science Foundation [20101385359, 2010BB5359]; Nature Science Foundation of China [81471946]	Major National ST Program; Chongqing Science & Technology Commission(Natural Science Foundation Project of CQ CSTC); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Major National S&T Program (2013ZX10002002, ALH), the major project of Chongqing Science & Technology Commission (cstc2013jcyjC10002, ALH), the Natural Science Foundation Project of CQ CSTC (20101385359, ALH), the Nature Science Foundation of China (81471946, ALH).; This work was supported by the Major National S&T Program (2013ZX10002002, ALH), the major project of Chongqing Science & Technology Commission (cstc2013jcyjC10002, ALH), the Natural Science Foundation Project of CQ CSTC (2010BB5359), the Nature Science Foundation of China (81471946).	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Burns FR, 2016, GENE, V578, P281, DOI 10.1016/j.gene.2015.12.041; Cai H, 2015, ONCOTARGET, V6, P19759, DOI 10.18632/oncotarget.4331; Cameron SJS, 2016, LUNG CANCER, V94, P88, DOI 10.1016/j.lungcan.2016.02.006; Cao YY, 2014, BIOCHEM J, V461, P315, DOI 10.1042/BJ20140515; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Chang S, 2016, ONCOL REP, V35, P3577, DOI 10.3892/or.2016.4743; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Doncel-Perez E, 2016, J IMMUNOL, V196, P1102, DOI 10.4049/jimmunol.1502100; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Fang F, 2011, AM J PATHOL, V178, P2077, DOI 10.1016/j.ajpath.2011.01.035; Gabet Y, 2010, BLOOD, V116, P3964, DOI 10.1182/blood-2010-01-263830; Ge YX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005726; Grunewald TGP, 2015, NAT GENET, V47, P1073, DOI 10.1038/ng.3363; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hatano R, 2015, J IMMUNOL, V194, P960, DOI 10.4049/jimmunol.1402143; Huang JL, 2015, ONCOTARGET, V6, P33791, DOI 10.18632/oncotarget.5667; Hunten S, 2015, MOL CELL PROTEOMICS, V14, P2609, DOI 10.1074/mcp.M115.050237; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ca H, 2012, ANTICANCER RES, V32, P1379; Jia SQ, 2016, ANTICANCER RES, V36, P1111; Jiang YW, 2014, CANCER DISCOV, V4, P995, DOI 10.1158/2159-8290.CD-14-0743; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lewis A, 2016, J CACHEXIA SARCOPENI; Li S., 2016, PROC IEEE2ND ANN SOU, P1, DOI DOI 10.1016/J.STR.2016.01.004; Li XS, 2013, INT J MOL SCI, V14, P16226, DOI 10.3390/ijms140816226; Liang WC, 2015, ONCOTARGET, V6, P22513, DOI 10.18632/oncotarget.4154; Lin Z, 2015, NEOPLASMA, V62, P846, DOI 10.4149/neo_2015_103; Liu YW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.150; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CC, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0367-2; Mattick JS, 2010, DEV CELL, V19, P485, DOI 10.1016/j.devcel.2010.10.003; Nafez S, 2015, MOL CELL NEUROSCI, V64, P95, DOI 10.1016/j.mcn.2014.12.008; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Ogbe A, 2015, J BIOL CHEM, V290, P20455, DOI 10.1074/jbc.M114.634816; Paraskevopoulou MD, 2016, METHODS MOL BIOL, V1402, P271, DOI 10.1007/978-1-4939-3378-5_21; Patil VS, 2014, CRIT REV BIOCHEM MOL, V49, P16, DOI 10.3109/10409238.2013.844092; Su YJ, 2015, INT J MOL SCI, V16, P13322, DOI 10.3390/ijms160613322; Sun M, 2015, ENDOCR REV, V36, P25, DOI 10.1210/er.2014-1034; Tan JY, 2016, BIOESSAYS, V38, P295, DOI 10.1002/bies.201500148; To SQ, 2013, BREAST CANCER RES TR, V138, P193, DOI 10.1007/s10549-013-2413-5; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115; Unoki M, 2003, FEBS LETT, V554, P67, DOI 10.1016/S0014-5793(03)01092-5; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Wang J, 2015, ONCOTARGET, V6, P37852, DOI 10.18632/oncotarget.5635; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xin WJ, 2015, AM J TRANSL RES, V7, P2433; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yasumo H, 2000, BBA-GENE STRUCT EXPR, V1490, P189, DOI 10.1016/S0167-4781(99)00244-4; Yin P, 2011, FERTIL STERIL, V96, P439, DOI 10.1016/j.fertnstert.2011.05.062; Yiu AJ, 2016, ANTICANCER RES, V36, P1093; Yokota I, 2010, INT J ONCOL, V37, P1407, DOI 10.3892/ijo_00000792; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Zhang L, 2013, CARCINOGENESIS, V34, P577, DOI 10.1093/carcin/bgs381; Zhang M, 2015, INFLAMMATION, V38, P972, DOI 10.1007/s10753-014-0059-z; Zhong Y, 2014, J BIOL CHEM, V289, P26021, DOI 10.1074/jbc.M114.561134; Zhou XY, 2015, DIGEST DIS SCI, V60, P3271, DOI 10.1007/s10620-015-3782-x; Zhuo WK, 2015, MOL MED REP, V12, P4989, DOI 10.3892/mmr.2015.4098	68	18	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177843	10.1371/journal.pone.0177843	http://dx.doi.org/10.1371/journal.pone.0177843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542387	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672600025
J	Artamonova, EY; Vasskog, T; Eilertsen, HC				Artamonova, E. Y.; Vasskog, T.; Eilertsen, H. C.			Lipid content and fatty acid composition of Porosira glacialis and Attheya longicornis in response to carbon dioxide (CO2) aeration	PLOS ONE			English	Article							CHLORELLA-PYRENOIDOSA; SCENEDESMUS-OBLIQUUS; MICROALGAE; BIOFIXATION; METABOLISM; DIATOMS	In the current study two novel psychrophilic diatoms Porosira glacialis and Attheya longicornis were tested for suitability to CO2 mitigation coupled with production of the physiologically requisite omega-3 fatty acids. This study is in line with the worldwide conducted research aimed at applying biorefinery concept to heavy polluting industries. Since the production of algal high value compounds, i.e. essential fatty acids, relies on utilization of residual CO2 emissions coming from industry, the costs of such production maybe substantially reduced. Besides, the ecological benefits of the biorefinery concept being implemented are obvious, since CO2 is one of the major greenhouse gases. The current research has shown that one of the tested microalgal species, the diatom P. glacialis showed good tolerance to high (20-25%) levels of CO2 and maintained growth rates comparable to controls. The total lipid content in the CO2 aerated culture increased from 8.91 to 10.57% in cell dry mass. Additionally, the content of docosahexaenoic acid (DHA) increased from 3.90 to 5.75%, while the concentration of eicosapentaenoic acid (EPA) decreased from 26.59 to 23.66%. In contrast, A. longicornis did not demonstrate any significant increase in total lipid content. Besides, its growth was hampered by high levels of CO2 aeration.	[Artamonova, E. Y.; Eilertsen, H. C.] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway; [Vasskog, T.] Norut Northern Res Inst, Tromso, Norway	UiT The Arctic University of Tromso	Artamonova, EY (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway.	elena.artamonova@uit.no			Forskningsrad [N208463]	Forskningsrad	The study was funded by Forskningsrad (N208463, http://www.forskringsradet.no/no/ Forsider/1173185591033). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carvalho AP, 2005, MAR BIOTECHNOL, V7, P381, DOI 10.1007/s10126-004-4047-4; Cequier-Sanchez E, 2008, J AGR FOOD CHEM, V56, P4297, DOI 10.1021/jf073471e; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Chiu SY, 2009, BIORESOURCE TECHNOL, V100, P833, DOI 10.1016/j.biortech.2008.06.061; d'Ippolito G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0212-4; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Huseby S., THESIS; KATES M, 1966, BIOCHIM BIOPHYS ACTA, V116, P264, DOI 10.1016/0005-2760(66)90009-9; Koller M, 2014, ALGAL RES, V6, P52, DOI 10.1016/j.algal.2014.09.002; Lam MK, 2012, INT J GREENH GAS CON, V10, P456, DOI 10.1016/j.ijggc.2012.07.010; Li SW, 2013, BIORESOURCE TECHNOL, V136, P267, DOI 10.1016/j.biortech.2013.03.025; Morais MG, 2011, Z NATURFORSCH C, V66, P313, DOI 10.5560/ZNC.2011.66c0313; Muhlroth A, 2013, MAR DRUGS, V11, P4662, DOI 10.3390/md11114662; Nakanishi A, 2014, BIORESOURCE TECHNOL, V152, P247, DOI 10.1016/j.biortech.2013.11.009; SAKAI N, 1995, ENERG CONVERS MANAGE, V36, P693, DOI 10.1016/0196-8904(95)00100-R; SILVA HJ, 1984, J GEN MICROBIOL, V130, P2833; STOFFEL W, 1959, ANAL CHEM, V31, P307, DOI 10.1021/ac60146a047; Sydney EB, 2010, BIORESOURCE TECHNOL, V101, P5892, DOI 10.1016/j.biortech.2010.02.088; Tang DH, 2011, BIORESOURCE TECHNOL, V102, P3071, DOI 10.1016/j.biortech.2010.10.047; Thomas DM, 2016, ENVIRON SCI POLLUT R, V23, P16926, DOI 10.1007/s11356-016-7158-3; Wang XW, 2014, BIORESOURCE TECHNOL, V161, P124, DOI 10.1016/j.biortech.2014.03.012; WATANABE Y, 1992, ENERG CONVERS MANAGE, V33, P545, DOI 10.1016/0196-8904(92)90054-Z; Yang Y, 2003, J APPL PHYCOL, V15, P379, DOI 10.1023/A:1026021021774; Yoo C, 2010, BIORESOURCE TECHNOL, V101, pS71, DOI 10.1016/j.biortech.2009.03.030	25	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177703	10.1371/journal.pone.0177703	http://dx.doi.org/10.1371/journal.pone.0177703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542308	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400068
J	Benozzo, D; Jylanki, P; Olivetti, E; Avesani, P; van Gerven, MAJ				Benozzo, Danilo; Jylanki, Pasi; Olivetti, Emanuele; Avesani, Paolo; van Gerven, Marcel A. J.			Bayesian estimation of directed functional coupling from brain recordings	PLOS ONE			English	Article							GRANGER CAUSALITY ANALYSIS; EFFECTIVE CONNECTIVITY; AUTOREGRESSIVE MODELS; MULTIVARIATE; REGRESSION; TOOLBOX	In many fields of science, there is the need of assessing the causal influences among time series. Especially in neuroscience, understanding the causal interactions between brain regions is of primary importance. A family of measures have been developed from the parametric implementation of the Granger criteria of causality based on the linear autoregressive modelling of the signals. We propose a new Bayesian method for linear model identification with a structured prior (GMEP) aiming to apply it as linear regression method in the context of the parametric Granger causal inference. GMEP assumes a Gaussian scale mixture distribution for the group sparsity prior and it enables flexible definition of the coefficient groups. Approximate posterior inference is achieved using Expectation Propagation for both the linear coefficients and the hyperparameters. GMEP is investigated both on simulated data and on empirical fMRI data in which we show how adding information on the sparsity structure of the coefficients positively improves the inference process. In the same simulation framework, GMEP is compared with others standard linear regression methods. Moreover, the causal inferences derived from GMEP estimates and from a standard Granger method are compared across simulated datasets of different dimensionality, density connection and level of noise. GMEP allows a better model identification and consequent causal inference when prior knowledge on the sparsity structure are integrated in the structured prior.	[Benozzo, Danilo; Olivetti, Emanuele; Avesani, Paolo] Bruno Kessler Fdn, NeuroInformat Lab NILab, Trento, Italy; [Benozzo, Danilo] Univ Trento, Informat Engn & Comp Sci Dept DISI, Trento, Italy; [Olivetti, Emanuele; Avesani, Paolo] Univ Trento, Ctr Mind & Brain Sci CIMeC, Trento, Italy; [Jylanki, Pasi; van Gerven, Marcel A. J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Fondazione Bruno Kessler; University of Trento; University of Trento; Radboud University Nijmegen	Benozzo, D (corresponding author), Bruno Kessler Fdn, NeuroInformat Lab NILab, Trento, Italy.; Benozzo, D (corresponding author), Univ Trento, Informat Engn & Comp Sci Dept DISI, Trento, Italy.	danilo.benozzo@gmail.com	van Gerven, Marcel A. J./D-7800-2012; Olivetti, Emanuele/AAT-2384-2020; Avesani, Paolo/AAY-9704-2021	van Gerven, Marcel A. J./0000-0002-2206-9098; Olivetti, Emanuele/0000-0001-7653-1519; Avesani, Paolo/0000-0001-8943-8911	Netherlands Organization for Scientific Research (NWO) [612.001.211, 639.072.513]; Bruno Kessler Foundation (FBK); Finnish Cultural Foundation	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Bruno Kessler Foundation (FBK); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This research was supported by grant numbers 612.001.211 and 639.072.513 of The Netherlands Organization for Scientific Research (NWO) and by funds from the Bruno Kessler Foundation (FBK) and the Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babacan SD, 2014, IEEE T SIGNAL PROCES, V62, P2906, DOI 10.1109/TSP.2014.2319775; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Barrett AB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041907; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Garrigues PJ, 2010, P ADV NEUR INF PROC, V23, P676, DOI DOI 10.1007/978-3-319-59463-7_51; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Harrison L, 2003, NEUROIMAGE, V19, P1477, DOI 10.1016/S1053-8119(03)00160-5; Haufe S, 2009, SPARSE CAUSAL DISCOV; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Haufe S, 2010, IEEE T BIO-MED ENG, V57, P1954, DOI 10.1109/TBME.2010.2046325; Hernandez-Lobato D, 2013, J MACH LEARN RES, V14, P1891; Huang J, 2009, THE BENEFIT OF GROUP; Kaufmann RK, 1997, NATURE, V388, P39, DOI 10.1038/40332; Lee A, 2010, A HIERARCHICAL BAYES; Hernandez-Lobato JM, 2015, MACH LEARN, V99, P437, DOI 10.1007/s10994-014-5475-7; Minka T. P., 2001, P 17 C UNC ART INT, P362; MORF M, 1978, IEEE T GEOSCI REMOTE, V16, P85, DOI 10.1109/TGE.1978.294569; Nagarajan R, 2008, BIOINFORMATICS, V24, P1029, DOI 10.1093/bioinformatics/btm586; Nardi Y, 2008, ELECTRON J STAT, V2, P605, DOI 10.1214/08-EJS200; Nickisch H, 2008, J MACH LEARN RES, V9, P2035; Nishimoto S., 2014, GALLANT LAB NATURAL; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Penny WD, 2002, IEE P-VIS IMAGE SIGN, V149, P33, DOI 10.1049/ip-vis:20020149; Qi Y., 2008, P 25 INT C MACH LEAR, P768; Rao A, 2006, INT CONF ACOUST SPEE, P2276; Riihima E, 2012, NESTED EXPECTATION P; Sanchez-Bornot JM, 2008, STAT SINICA, V18, P1501; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Schlogl A, 2006, SIGNAL PROCESS, V86, P2426, DOI 10.1016/j.sigpro.2005.11.007; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; SIMS CA, 1972, AM ECON REV, V62, P540; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; Valdes-Sosa PA, 2004, NEUROINFORMATICS, V2, P239, DOI 10.1385/NI:2:2:239; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; VINOD HD, 1978, REV ECON STAT, V60, P121, DOI 10.2307/1924340; Wiener N., 1956, MODERN MATHEMATICS F; Wipf DP, 2007, IEEE T SIGNAL PROCES, V55, P3704, DOI 10.1109/TSP.2007.894265; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x	44	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177359	10.1371/journal.pone.0177359	http://dx.doi.org/10.1371/journal.pone.0177359			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545066	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400038
J	Byberg, S; Ostergaard, MD; Rodrigues, A; Martins, C; Benn, CS; Aaby, P; Fisker, AB				Byberg, Stine; Ostergaard, Marie D.; Rodrigues, Amabelia; Martins, Cesario; Benn, Christine S.; Aaby, Peter; Fisker, Ane B.			Analysis of risk factors for infant mortality in the 1992-3 and 2002-3 birth cohorts in rural Guinea-Bissau	PLOS ONE			English	Article							CHILD-MORTALITY; SURVIVAL; DETERMINANTS; VACCINE; MEASLES; TRENDS	Introduction Though still high, the infant mortality rate in Guinea-Bissau has declined. We aimed to identify risk factors including vaccination coverage, for infant mortality in the rural population of Guinea-Bissau and assess whether these risk factors changed from 1992-3 to 2002-3. Methods The Bandim Health Project (BHP) continuously surveys children in rural Guinea-Bissau. We investigated the association between maternal and infant factors (especially DTP and measles coverage) and infant mortality. Hazard ratios (HR) were calculated using Cox regression. We tested for interactions with sex, age groups (defined by current vaccination schedule) and cohort to assess whether the risk factors were the same for boys and girls, in different age groups in 1992-3 and in 2002-3. Results The infant mortality rate declined from 148/1000 person years (PYRS) in 1992-3 to 124/1000 PYRS in 2002-3 (HR = 0.88; 95% CI: 0.77-0.99); this decline was significant for girls (0.77; 0.64-0.94) but not for boys (0.97; 0.82-1.15) (p = 0.10 for interaction). Risk factors did not differ significantly by cohort in either distribution or effect. Mortality decline was most marked among girls aged 9-11 months (0.56; 0.37-0.83). There was no significant mortality decline for girls 1.5-8 months of age (0.93; 0.68-1.28) (p = 0.05 for interaction). DTP and measles coverage increased from 1992-3 to 2002-3. Conclusions Risk factors did not change with the decline in mortality. Due to beneficial non-specific effects for girls, the increased coverage of measles vaccination may have contributed to the disproportional decline in mortality by sex and age group.	[Byberg, Stine; Ostergaard, Marie D.; Rodrigues, Amabelia; Martins, Cesario; Benn, Christine S.; Aaby, Peter; Fisker, Ane B.] Bandim Hlth Project, Indepth Network, Bissau, Guinea Bissau; [Byberg, Stine; Benn, Christine S.; Aaby, Peter; Fisker, Ane B.] Statens Serum Inst, Res Ctr Vitamins & Vaccines CVIVA, Bandim Hlth Project, Copenhagen, Denmark; [Byberg, Stine; Benn, Christine S.; Fisker, Ane B.] Univ Southern Denmark, Inst Clin Res, Odense Univ Hosp, OPEN,Odense Patient Data Explorat Network, Odense, Denmark	Statens Serum Institut; University of Southern Denmark; Odense University Hospital	Byberg, S (corresponding author), Bandim Hlth Project, Indepth Network, Bissau, Guinea Bissau.; Byberg, S (corresponding author), Statens Serum Inst, Res Ctr Vitamins & Vaccines CVIVA, Bandim Hlth Project, Copenhagen, Denmark.; Byberg, S (corresponding author), Univ Southern Denmark, Inst Clin Res, Odense Univ Hosp, OPEN,Odense Patient Data Explorat Network, Odense, Denmark.	s.byberg@bandim.org	Fisker, Ane B/E-9283-2019	Fisker, Ane B/0000-0002-8521-0992; Aaby, Peter/0000-0001-8331-1389; Byberg, Stine/0000-0002-3626-3609	Danish Council for Independent Research [DFF-1333-00192]; DANIDA [104.Dan.8-920]; European Union FP7 support for OPTIMUNISE [Health-F3-2011-261375]; Danish National Research Foundation [DNRF108]; European Research Council [ERC-2009-StG-243149]; Odense University Hospital [A70]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); DANIDA; European Union FP7 support for OPTIMUNISE; Danish National Research Foundation(Danmarks Grundforskningsfond); European Research Council(European Research Council (ERC)European Commission); Odense University Hospital	This work was supported by Danish Council for Independent Research (DFF-1333-00192), DANIDA (grant: 104.Dan.8-920), European Union FP7 support for OPTIMUNISE (grant: Health-F3-2011-261375). The Bandim Health Project received support from Danish National Research Foundation via support to CVIVA (grant: DNRF108). CSB holds a starting grant from the European Research Council (grant ERC-2009-StG-243149). SB received one year of salary from Odense University Hospital (grant A70). The funding agencies had no role in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Aaby P., 2016, WHO REV POSSIBLE NON; Aaby P., 2011, HUMAN VACCINES, V7; Aaby P, 1996, ESTUDO SAUDE MULHERE; Aaby P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000707; Aaby P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6495; Andersen A, 2017, NATL IMMUNIZATION CA; [Anonymous], 2012, UNICEF PROGR REPORT; Arevshatian L., 2007, B WHO, V85; Becher H, 2004, B WORLD HEALTH ORGAN, V82, P265; Delaunay V, 2001, INT J EPIDEMIOL, V30, P1286, DOI 10.1093/ije/30.6.1286; Diallo A, 2012, BMC PUBLIC HEALTH, P12; Drevenstedt GL, 2008, P NATL ACAD SCI USA, V105, P5016, DOI 10.1073/pnas.0800221105; Dube L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-401; Fisker AB, 2015, PEDIATR INFECT DIS J, V34, P1369, DOI 10.1097/INF.0000000000000896; Fisker AB, 2014, PEDIATRICS, V134, pE739, DOI 10.1542/peds.2014-0550; Fisker AB, 2014, VACCINE, V32, P598, DOI 10.1016/j.vaccine.2013.11.074; Jensen H, 2007, TROP MED INT HEALTH, V12, P5, DOI 10.1111/j.1365-3156.2006.01773.x; JPT Higgins KS-W. A Reingold, 2014, SYSTEMATIC REV NONSP; Lawn JE, 2008, PAEDIATR PERINAT EP, V22, P410, DOI 10.1111/j.1365-3016.2008.00960.x; Lund N, 2015, CLIN INFECT DIS, V61, P1504, DOI 10.1093/cid/civ617; Ministry of Health Republic of Guinea-Bissau, 2009, COMPR MULT PLAN EXP; Mturi AJ, 1995, HEALTH POLICY PLANN, V10, P384, DOI 10.1093/heapol/10.4.384; Nankabirwa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019674; Ogunlesi TA, 2010, J TROP PEDIATRICS, V56, P379, DOI 10.1093/tropej/fmq009; Rodrigues A., 2011, PREVALENCIA VIH POPU; Rodrigues A, 2006, SEGUIMENTO INDICADOR; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Ronsmans C, 1996, INT J EPIDEMIOL, V25, P989, DOI 10.1093/ije/25.5.989; Rutstein SO, 2000, B WORLD HEALTH ORGAN, V78, P1256; Sacarlal J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-67; Sartorius BKD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-645; Singh A, 2013, PEERJ, V1, DOI 10.7717/peerj.75; UNICEF, 2020, LEV TRENDS CHILD MOR; UNICEF, 2014, STAT WORLDS CHILDR 2; Ursing J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086801; Walker N, 2002, LANCET, V360, P284, DOI 10.1016/S0140-6736(02)09550-8; Whitworth A, 2002, SOC SCI MED, V55, P2107, DOI 10.1016/S0277-9536(02)00002-3	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177984	10.1371/journal.pone.0177984	http://dx.doi.org/10.1371/journal.pone.0177984			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542646	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400126
J	Gao, C; Howard-Quijano, K; Rau, C; Takamiya, T; Song, Y; Shivkumar, K; Wang, YB; Mahajan, A				Gao, Chen; Howard-Quijano, Kimberly; Rau, Christoph; Takamiya, Tatsuo; Song, Yang; Shivkumar, Kalyanam; Wang, Yibin; Mahajan, Aman			Inflammatory and apoptotic remodeling in autonomic nervous system following myocardial infarction	PLOS ONE			English	Article							THORACIC EPIDURAL-ANESTHESIA; REFRACTORY VENTRICULAR-ARRHYTHMIAS; STELLATE GANGLION; ATRIAL-FIBRILLATION; ELECTRICAL STORM; STIMULATION; ISCHEMIA; NEURONS; MECHANISMS; HEART	Background Chronic myocardial infarction (MI) triggers pathological remodeling in the heart and cardiac nervous system. Abnormal function of the autonomic nervous system (ANS), including stellate ganglia (SG) and dorsal root ganglia (DRG) contribute to increased sympathoexcitation, cardiac dysfunction and arrythmogenesis. ANS modulation is a therapeutic target for arrhythmia associated with cardiac injury. However, the molecular mechanism involved in the pathological remodeling in ANS following cardiac injury remains to be established. Methods and results In this study, we performed transcriptome analysis by RNA-sequencing in thoracic SG and (T1-T4) DRG obtained from Yorkshire pigs following either acute (3 to 5 hours) or chronic (8 weeks) myocardial infarction. By differential expression and weighted gene co-expression network analysis (WGCNA), we identified significant transcriptome changes and specific gene modules in the ANS tissues in response to myocardial infarction at either acute or chronic phases. Both differential expressed genes and the member genes of the WGCNA gene module associated with post-infarct condition were significantly enriched for inflammatory signaling and apoptotic cell death. Targeted validation analysis supported a significant induction of inflammatory and apoptotic signal in both SG and DRG following myocardial infarction, along with cellular evidence of apoptosis induction based on TUNEL analysis. Importantly, these molecular changes were observed specifically in the thoracic segments but not in their counterparts obtained from lumbar sections. Conclusion Myocardial injury leads to time-dependent global changes in gene expression in the innervating ANS. Induction of inflammatory gene expression and loss of neuron cell viability in SG and DRG are potential novel mechanisms contributing to abnormal ANS function which can promote cardiac arrhythmia and pathological remodeling in myocardium.	[Gao, Chen; Rau, Christoph; Song, Yang; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Los Angeles, CA 90095 USA; [Gao, Chen; Howard-Quijano, Kimberly; Rau, Christoph; Takamiya, Tatsuo; Song, Yang; Wang, Yibin; Mahajan, Aman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol & Perioperat Med, Los Angeles, CA 90095 USA; [Shivkumar, Kalyanam] Univ Calif Los Angeles, David Geffen Sch Med, Cardiac Arrhythmia Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Los Angeles, CA 90095 USA.; Wang, YB; Mahajan, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol & Perioperat Med, Los Angeles, CA 90095 USA.	yibinwang@mednet.ucla.edu; amahajan@mednet.ucla.edu	Rau, Christoph/AAC-3943-2020; Shivkumar, Kalyanam/AAI-1085-2019	Rau, Christoph/0000-0002-0782-207X; Shivkumar, Kalyanam/0000-0002-4121-1766; Wang, Yibin/0000-0003-0852-0767	NHLBI NIH HHS [R01 HL122737, R01 HL129639] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129639, R01HL122737] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ajijola OA, 2015, HEART RHYTHM, V12, P1027, DOI 10.1016/j.hrthm.2015.01.045; Ajijola OA, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1010, DOI 10.1161/CIRCEP.112.972836; Ardell JL, 2009, AM J PHYSIOL-REG I, V297, pR470, DOI 10.1152/ajpregu.90821.2008; Armour JA, 2010, HEART RHYTHM, V7, P994, DOI 10.1016/j.hrthm.2010.02.014; Armour JA, 1997, ANAT REC, V247, P289, DOI 10.1002/(SICI)1097-0185(199702)247:2<289::AID-AR15>3.0.CO;2-L; Nguyen BL, 2012, CARDIOVASC PATHOL, V21, P143, DOI 10.1016/j.carpath.2011.08.001; BLOMBERG S, 1988, ACTA ANAESTH SCAND, V32, P173, DOI 10.1111/j.1399-6576.1988.tb02710.x; Bourke T, 2010, CIRCULATION, V121, P2255, DOI 10.1161/CIRCULATIONAHA.109.929703; Chen PS, 2014, CIRC RES, V114, P1500, DOI 10.1161/CIRCRESAHA.114.303772; Gao C, 2016, J CLIN INVEST, V126, P195, DOI 10.1172/JCI84015; Groban L, 1999, J CARDIOTHOR VASC AN, V13, P579, DOI 10.1016/S1053-0770(99)90011-3; Han S, 2012, J AM COLL CARDIOL, V59, P954, DOI 10.1016/j.jacc.2011.11.030; Hardwick JC, 2012, AM J PHYSIOL-REG I, V303, pR950, DOI 10.1152/ajpregu.00223.2012; Hardwick JC, 2008, AM J PHYSIOL-REG I, V295, pR1926, DOI 10.1152/ajpregu.90306.2008; KAMIBAYASHI T, 1995, ANESTHESIOLOGY, V82, P129, DOI 10.1097/00000542-199501000-00017; Kawashima T, 2005, ANAT EMBRYOL, V209, P425, DOI 10.1007/s00429-005-0462-1; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Mahajan A, 2005, HEART RHYTHM, V2, P1359, DOI 10.1016/j.hrthm.2005.09.004; Nakahara S, 2011, HEART RHYTHM, V8, P1060, DOI 10.1016/j.hrthm.2011.02.029; Nakamura M, 2016, TRANSPL P, V48, P874, DOI 10.1016/j.transproceed.2015.12.108; Pauza DH, 2002, CELLS TISSUES ORGANS, V172, P297, DOI 10.1159/000067198; Pinheiro AD, 2015, CURR MED RES OPIN, V31, P1849, DOI 10.1185/03007995.2015.1074065; Rajendran PS, 2016, J PHYSIOL-LONDON, V594, P321, DOI 10.1113/JP271165; SCHWARTZ PJ, 1992, J CARDIOVASC ELECTR, V3, P2, DOI 10.1111/j.1540-8167.1992.tb01090.x; SCHWARTZ PJ, 1984, CIRCULATION, V69, P790, DOI 10.1161/01.CIR.69.4.790; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; Shen MJ, 2011, CIRCULATION, V123, P2204, DOI 10.1161/CIRCULATIONAHA.111.018028; Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vaseghi M, 2008, PROG CARDIOVASC DIS, V50, P404, DOI 10.1016/j.pcad.2008.01.003; Vaseghi M, 2014, HEART RHYTHM, V11, P360, DOI 10.1016/j.hrthm.2013.11.028; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064611; Yagishita D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P174, DOI 10.1161/CIRCEP.114.002195; Yamakawa K, 2016, AM J PHYSIOL-REG I, V310, pR414, DOI 10.1152/ajpregu.00252.2015; Yamakawa K, 2015, AM J PHYSIOL-HEART C, V309, pH1579, DOI 10.1152/ajpheart.00558.2015; Zheng C, 2016, CURR PHARM DESIGN, V22, P485, DOI 10.2174/1381612822666151222160810; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3; Zhou W, 2015, J CARDIOTHOR VASC AN, V29, P1148, DOI 10.1053/j.jvca.2014.12.008; Zhou W, 2012, AM J PHYSIOL-HEART C, V302, pH1818, DOI 10.1152/ajpheart.00030.2012	39	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177750	10.1371/journal.pone.0177750	http://dx.doi.org/10.1371/journal.pone.0177750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542617	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400076
J	Prada, ETA; Orth, M; Nolting, S; Spottl, G; Maurer, J; Auernhammer, C				Prada, Elke Tatjana Aristizabal; Orth, Michael; Noelting, Svenja; Spoettl, Gerald; Maurer, Julian; Auernhammer, Christoph			The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells	PLOS ONE			English	Article							OXIDATIVE STRESS; RADIATION ONCOLOGY; CANCER-TREATMENT; MTOR INHIBITORS; DNA-DAMAGE; DNTP POOL; PATHWAY; RESISTANCE; THERAPY; GROWTH	Modulation of the redox system in cancer cells has been considered a promising target for anti-cancer therapy. The novel MTH1 inhibitor TH588 proved tremendous potential in terms of cancer cell eradication, yet its specificity has been questioned by recent reports, indicating that TH588 may also induce cancer cell death by alternative mechanisms than MTH1 inhibition. Here we used a panel of heterogeneous neuroendocrine tumor cells in order to assess cellular mechanisms and molecular signaling pathways implicated in the effects of TH588 alone as well as dual-targeting approaches combining TH588 with everolimus, cytotoxic 5-fluorouracil or Y-irradiation. Our results reflect that TH588 alone efficiently decreased the survival of neuroendocrine cancer cells by PI3K-Akt-mTOR axis downregulation, increased apoptosis and oxidative stress. However, in the dual-targeting approaches cell survival was further decreased due to an even stronger downregulation of the PI3K-Akt-mTOR axis and augmentation of apoptosis but not oxidative stress. Furthermore, we could attribute TH588 chemo- and radio-sensitizing properties. Collectively our data not only provide insights into how TH588 exactly kills cancer cells but also depict novel perspectives for combinatorial treatment approaches encompassing TH588.	[Prada, Elke Tatjana Aristizabal; Noelting, Svenja; Spoettl, Gerald; Maurer, Julian; Auernhammer, Christoph] Ludwig Maximilians Univ Munchen, Interdisciplinary Ctr Neuroendocrine Tumours Gast, Univ Hosp, Dept Internal Med 2, Campus Grosshadern, Bavaria, Germany; [Orth, Michael] Ludwig Maximilians Univ Munchen, Dept Radiat Oncol, Campus Grosshadern, Bavaria, Germany	University of Munich; University of Munich	Auernhammer, C (corresponding author), Ludwig Maximilians Univ Munchen, Interdisciplinary Ctr Neuroendocrine Tumours Gast, Univ Hosp, Dept Internal Med 2, Campus Grosshadern, Bavaria, Germany.	christoph.auernhammer@med.uni-muenchen.de	Orth, Michael/AAQ-7299-2021	Orth, Michael/0000-0002-4608-7151; Nolting, Svenja/0000-0002-7064-590X				Babu V, 2013, PANCREAS, V42, P912, DOI 10.1097/MPA.0b013e31827ae993; Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Cakir M, 2011, EXPERT OPIN THER TAR, V15, P457, DOI 10.1517/14728222.2011.555403; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Capozzi M, 2015, INT J SURG, V21, pS89, DOI 10.1016/j.ijsu.2015.06.064; Chan DL, 2017, THER ADV GASTROENTER, V10, P132, DOI 10.1177/1756283X16674660; CHENG KC, 1992, J BIOL CHEM, V267, P166; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Georgakilas AG, 2012, CANCER LETT, V327, P3, DOI 10.1016/j.canlet.2012.03.032; Haghdoost S, 2006, FREE RADICAL BIO MED, V41, P620, DOI 10.1016/j.freeradbiomed.2006.05.003; He K, 2016, ONCOTARGET; Hennel R, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-85; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Kawamura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26521; Kettle JG, 2016, J MED CHEM, V59, P2346, DOI 10.1021/acs.jmedchem.5b01760; Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Kolby L, 2001, AM J PATHOL, V158, P745, DOI 10.1016/S0002-9440(10)64017-5; Kong LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137888; Leung EY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131400; Luo MH, 2010, ANTIOXID REDOX SIGN, V12, P1247, DOI 10.1089/ars.2009.2698; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Nolting S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143830; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Orth M, 2014, RADIAT ENVIRON BIOPH, V53, P1, DOI 10.1007/s00411-013-0497-2; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Petrocchi A, 2016, BIOORG MED CHEM LETT, V26, P1503, DOI 10.1016/j.bmcl.2016.02.026; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Reuther C, 2016, NEUROENDOCRINOLOGY, V103, P383, DOI 10.1159/000439431; Ringborg U, 2003, ACTA ONCOL, V42, P357, DOI 10.1080/02841860310010826; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Shipkova M, 2016, THER DRUG MONIT, V38, P143, DOI 10.1097/FTD.0000000000000260; Spampatti M, 2014, WORLD J GASTROENTERO, V20, P10038, DOI 10.3748/wjg.v20.i29.10038; Tong LY, 2015, CANCER LETT, V367, P18, DOI 10.1016/j.canlet.2015.07.008; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tu YY, 2016, AM J TRANSL RES, V8, P2803; Vandamme T, 2016, BRIT J CANCER, V114, P650, DOI 10.1038/bjc.2016.25; Vera-Ramirez L, 2012, CANCER LETT, V327, P134, DOI 10.1016/j.canlet.2011.12.029; Wagle N, 2014, NEW ENGL J MED, V371, P1426, DOI 10.1056/NEJMoa1403352; Wang JY, 2016, J INVESTIGATIVE DERM; Warpman Berglund U, 2016, ANN ONCOLOGY OFFICIA; Wolin EM, 2013, CANCER LETT, V335, P1, DOI 10.1016/j.canlet.2013.02.016; Yao JC, 2016, LANCET, V387, P968, DOI 10.1016/S0140-6736(15)00817-X; Yao JC, 2016, J CLIN ONCOLOGY OFFI; Zatelli MC, 2016, ENDOCR-RELAT CANCER, V23, pR173, DOI 10.1530/ERC-15-0413; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zitzmann K, 2007, NEUROENDOCRINOLOGY, V85, P54, DOI 10.1159/000100057	51	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178375	10.1371/journal.pone.0178375	http://dx.doi.org/10.1371/journal.pone.0178375			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542590	Green Published, Green Accepted, gold			2022-12-27	WOS:000402062800083
J	Yu, GM; Kubota, H; Okita, M; Maeda, T				Yu, Guang-Min; Kubota, Hirokazu; Okita, Miki; Maeda, Teruo			The anti-inflammatory and antioxidant effects of melatonin on LPS-stimulated bovine mammary epithelial cells	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-INDUCED MASTITIS; ACUTE-PHASE PROTEINS; OXIDATIVE STRESS; AMNIOTIC-FLUID; EXPRESSION; PEROXYNITRITE; ACTIVATION; CHEMOKINES; NITRATION; DIAGNOSIS	Mastitis is the most prevalent disease in dairy cattle worldwide and not only causes huge economic losses in the dairy industry but also threatens public health. To evaluate the therapeutic potential of melatonin in mastitis, we examined the ability of melatonin to protect bovine mammary epithelial cells (bMECs) from the harmful effects of lipopolysaccharide (LPS). We found that melatonin inhibited the LPS-binding protein-CD14-TLR4 signaling pathway in bMECs, which had opposing effects on pro-inflammatory and anti-inflammatory mediators. Melatonin decreased LPS-induced expression of pro-inflammatory cytokines, chemokines, and positive acute-phase proteins (APPs), including tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-6, granulocyte-monocyte colony-stimulating factor, chemokine CC motif ligand (CCL)(2), CCL5, serum amyloid A, haptoglobin, C-reactive protein, ceruloplasmin, and alpha-1 antitrypsin, and increased expression of the anti-inflammatory cytokine IL-1Ra and the negative APP fibrinogen. In addition, melatonin increased dityrosine levels but suppressed nitrite levels by upregulating the expression of Nrf2 and heme oxygenase-1 in the Nrf2 antioxidant defense pathway. Finally, melatonin administration increased the viability of LPS-stimulated bMECs. These results suggest that melatonin protects bMECs from LPS-induced inflammatory and oxidant stress damage and provide evidence that melatonin might have therapeutic utility in mastitis.	[Yu, Guang-Min; Maeda, Teruo] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Bioresource Sci, Higashihiroshima, Japan; [Kubota, Hirokazu; Okita, Miki; Maeda, Teruo] Hiroshima Univ, Grad Sch Biosphere Sci, Setouchi Field Sci Ctr, Higashihiroshima, Japan; [Okita, Miki; Maeda, Teruo] Hiroshima Univ, Res Ctr Anim Sci, Higashihiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Maeda, T (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Dept Bioresource Sci, Higashihiroshima, Japan.; Maeda, T (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Setouchi Field Sci Ctr, Higashihiroshima, Japan.; Maeda, T (corresponding author), Hiroshima Univ, Res Ctr Anim Sci, Higashihiroshima, Japan.	temaeda@hiroshima-u.ac.jp						Abdel-Rahman MA, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/198652; Agil A, 2012, J PINEAL RES, V52, P203, DOI 10.1111/j.1600-079X.2011.00928.x; Andrukhov O, 2013, J CLIN PERIODONTOL, V40, P916, DOI 10.1111/jcpe.12145; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Boulanger V, 2002, J DAIRY SCI, V85, P562, DOI 10.3168/jds.S0022-0302(02)74109-X; Carrillo-Vico A, 2013, INT J MOL SCI, V14, P8638, DOI 10.3390/ijms14048638; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Eriksson L, 1998, ACTA VET SCAND, V39, P301; Fernandez B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174474; Fox LK, 2009, VET MICROBIOL, V134, P82, DOI 10.1016/j.vetmic.2008.09.005; Fu YH, 2014, FEBS J, V281, P2543, DOI 10.1111/febs.12801; Galano A, 2014, RSC ADV, V4, P5220, DOI 10.1039/c3ra44604b; Hardeland R, 2015, PROG NEUROBIOL, V127, P46, DOI 10.1016/j.pneurobio.2015.02.001; Hattori Y, 2015, J CLIN BIOCHEM NUTR, V56, P57, DOI 10.3164/jcbn.14-82; Hogeveen H, 2011, NEW ZEAL VET J, V59, P16, DOI 10.1080/00480169.2011.547165; Huang KP, 2013, FREE RADICAL BIO MED, V65, P528, DOI 10.1016/j.freeradbiomed.2013.07.029; Hughes MN, 2008, METHOD ENZYMOL, V436, P3, DOI 10.1016/S0076-6879(08)36001-7; Kang JW, 2012, J PINEAL RES, V53, P67, DOI 10.1111/j.1600-079X.2012.00972.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lowes DA, 2013, BRIT J ANAESTH, V110, P472, DOI 10.1093/bja/aes577; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; Moreira AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144517; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Nduhirabandi F, 2016, J PINEAL RES, V60, P39, DOI 10.1111/jpi.12286; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Osman KM, 2010, COMP IMMUNOL MICROB, V33, P85, DOI 10.1016/j.cimid.2008.08.009; Pareek Ravi, 2005, Journal of Applied Genetics, V46, P171; Peschke E, 2015, J PINEAL RES, V59, P1, DOI 10.1111/jpi.12240; Pfeiffer S, 2000, J BIOL CHEM, V275, P6346, DOI 10.1074/jbc.275.9.6346; Pinho BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024098; Radogna F, 2010, BIOCHEM PHARMACOL, V80, P1844, DOI 10.1016/j.bcp.2010.07.041; Radogna F, 2009, ANN NY ACAD SCI, V1171, P509, DOI 10.1111/j.1749-6632.2009.04900.x; Reiter RJ, 2016, J PINEAL RES, V61, P253, DOI 10.1111/jpi.12360; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sakemi Y, 2011, J DAIRY RES, V78, P118, DOI 10.1017/S0022029910000828; Schmitz S, 2004, DOMEST ANIM ENDOCRIN, V26, P111, DOI 10.1016/j.domaniend.2003.09.003; Shao GX, 2015, INT IMMUNOPHARMACOL, V29, P263, DOI 10.1016/j.intimp.2015.11.011; Soderquist F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164354; Soulere L, 2001, BIOCHEM J, V360, P563, DOI 10.1042/0264-6021:3600563; Tamaki N, 2014, FREE RADICAL BIO MED, V75, P222, DOI 10.1016/j.freeradbiomed.2014.07.034; Thomas FC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0533-3; Tothova C, 2014, VET MED-CZECH, V59, P163, DOI 10.17221/7478-VETMED; Tyagi E, 2010, EUR J PHARMACOL, V640, P206, DOI 10.1016/j.ejphar.2010.04.041; Wellnitz O, 2006, VET MED-CZECH, V51, P125, DOI 10.17221/5531-VETMED; Wu UI, 2011, J PINEAL RES, V50, P159, DOI 10.1111/j.1600-079X.2010.00825.x; Xia MZ, 2012, J PINEAL RES, V53, P325, DOI 10.1111/j.1600-079X.2012.01002.x; Xu DX, 2007, J PINEAL RES, V43, P74, DOI 10.1111/j.1600-079X.2007.00445.x; Yu GM, 2017, TRENDS BIOTECHNOL; Yu GM, 2017, J POULT SCI IN PRESS; Yu GM, 2016, REPROD BIOL, V16, P295, DOI 10.1016/j.repbio.2016.10.006; Yu GM, 2015, PAK VET J, V35, P53; Zhang N, 2015, J EXP BOT, V66, P647, DOI 10.1093/jxb/eru336; Zheng JM, 2006, INFECT IMMUN, V74, P1907, DOI 10.1128/IAI.74.3.1907-1915.2006; Zhou W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166442; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	59	89	93	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178525	10.1371/journal.pone.0178525	http://dx.doi.org/10.1371/journal.pone.0178525			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542575	Green Submitted, gold, Green Published			2022-12-27	WOS:000402062800100
J	Raj, A; Shah, P; Agrawal, N				Raj, Akanksha; Shah, Prasanna; Agrawal, Namita			Dose-dependent effect of silver nanoparticles (AgNPs) on fertility and survival of Drosophila: An in-vivo study	PLOS ONE			English	Article							OXIDATIVE STRESS; GOLD NANOPARTICLES; FRUIT-FLY; TOXICITY; GENOTOXICITY; CYTOTOXICITY; APOPTOSIS; FECUNDITY; RESPONSES; CELLS	Silver nanoparticles (AgNPs) containing consumer products have been proliferating in the market due to its unique antimicrobial property, however, lack of in-depth knowledge about their potential effect on human health in a longer run is of great concern. Therefore, we investigated dose-dependent in vivo effect of AgNPs using Drosophila as a model system. Drosophila, a genetically tractable organism with distinct developmental stages, short life cycle and significant homology with human serves as an ideal organism to study nanomaterial- mediated toxicity. Our studies suggest that ingestion of AgNPs in Drosophila during adult stage for short and long duration significantly affects egg laying capability along with impaired growth of ovary. Additionally, dietary intake of AgNPs from larval stage has more deleterious effects that result in reduced survival, longevity, ovary size and egg laying capability at a further lower dosage. Interestingly, the trans-generational effect of AgNPs was also observed without feeding progeny with AgNPs, thereby suggesting its impact from previous generation. Our results strongly imply that higher doses of AgNPs and its administration early during development is detrimental to the reproductive health and survival of Drosophila that follows in generations to come without feeding them to AgNPs.	[Raj, Akanksha; Agrawal, Namita] Univ Delhi, Dept Zool, Delhi, India; [Shah, Prasanna] Acropolis Inst Technol & Res, Indore, Madhya Pradesh, India	University of Delhi	Agrawal, N (corresponding author), Univ Delhi, Dept Zool, Delhi, India.	nagrawaluci@gmail.com		, Namita/0000-0002-9459-385X	DU/DST-PURSE grant from University of Delhi; R & D grant from University of Delhi; University Grants Commission (UGC) [JRF/AA/80/2012-13]	DU/DST-PURSE grant from University of Delhi; R & D grant from University of Delhi; University Grants Commission (UGC)(University Grants Commission, India)	This work was supported by DU/DST-PURSE grant and R & D grant from University of Delhi to N.A.A.R. acknowledges University Grants Commission (UGC) for the financial assistance provided in the form of research fellowship (Ref no. Sch. No/ JRF/AA/80/2012-13).	Affleck JG, 2006, TOXICOL SCI, V89, P495, DOI 10.1093/toxsci/kfj036; Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Armstrong N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053186; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; Arora S, 2009, TOXICOL APPL PHARM, V236, P310, DOI 10.1016/j.taap.2009.02.020; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Avalos A, 2015, FOOD CHEM TOXICOL, V85, P114, DOI 10.1016/j.fct.2015.06.024; Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Chen Jiong, 2006, Zhonghua Wai Ke Za Zhi, V44, P50; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Cheng D., 2004, CHIN MED EQUIP J, V4, P26; Choi JE, 2010, AQUAT TOXICOL, V100, P151, DOI 10.1016/j.aquatox.2009.12.012; Cohen Michael S, 2007, Surg Infect (Larchmt), V8, P397, DOI 10.1089/sur.2006.032; Demir ER, 2011, NANOTOXICOLOGY, V5, P417, DOI 10.3109/17435390.2010.529176; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Furno F, 2004, J ANTIMICROB CHEMOTH, V54, P1019, DOI 10.1093/jac/dkh478; Hanson FB, 1929, J EXP ZOOL, V54, P485, DOI 10.1002/jez.1400540307; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Ju-Nam Y, 2008, SCI TOTAL ENVIRON, V400, P396, DOI 10.1016/j.scitotenv.2008.06.042; Key C.S., 2011, ATLAS J BIOL, V1, P52, DOI DOI 10.5147/AJB.2011.0048; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim KT, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/11/115101; Kim SW, 2013, ENVIRON SCI TECHNOL, V47, P5393, DOI 10.1021/es304511z; Kim S, 2013, J APPL TOXICOL, V33, P78, DOI 10.1002/jat.2792; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Lansdown Alan B G, 2006, Curr Probl Dermatol, V33, P17; Lee HY, 2007, CHEM COMMUN, P2959, DOI 10.1039/b703034g; Liu XL, 2010, CHEMMEDCHEM, V5, P468, DOI 10.1002/cmdc.200900502; Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025; Moon J, 2017, ENVIRON POLLUT, V220, P46, DOI 10.1016/j.envpol.2016.09.021; Muangman Pornprom, 2006, Journal of the Medical Association of Thailand, V89, P953; Poma A, 2014, ADV EXP MED BIOL, V811, P235, DOI 10.1007/978-94-017-8739-0_12; Posgai R, 2011, CHEMOSPHERE, V85, P34, DOI 10.1016/j.chemosphere.2011.06.040; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001; Rejeski D, 2009, MICRO NANO TECHNOL, P509, DOI 10.1016/B978-0-8155-1578-4.50043-3; Roth S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001891; Shapiro H, 1932, BIOL BULL-US, V63, P456, DOI 10.2307/1537346; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sung JH, 2008, INHAL TOXICOL, V20, P567, DOI 10.1080/08958370701874671 ; Uryu O, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-015-0031-2; Wilson International Center for Scholars, 2007, NAN CONS PROD INV; Wu YA, 2010, AQUAT TOXICOL, V100, P160, DOI 10.1016/j.aquatox.2009.11.014	51	36	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178051	10.1371/journal.pone.0178051	http://dx.doi.org/10.1371/journal.pone.0178051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542630	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500059
J	Zou, SY; Teixeira, AM; Kostadima, M; Astle, WJ; Radhakrishnan, A; Simon, LM; Truman, L; Fang, JS; Hwa, J; Zhang, PX; van der Harst, P; Bray, PF; Ouwehand, WH; Frontini, M; Krause, DS				Zou, Siying; Teixeira, Alexandra M.; Kostadima, Myrto; Astle, William J.; Radhakrishnan, Aparna; Simon, Lukas Mikolaj; Truman, Lucy; Fang, Jennifer S.; Hwa, John; Zhang, Ping-xia; van der Harst, Pim; Bray, Paul F.; Ouwehand, Willem H.; Frontini, Mattia; Krause, Diane S.			SNP in human ARHGEF3 promoter is associated with DNase hypersensitivity, transcript level and platelet function, and Arhgef3 KO mice have increased mean platelet volume	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; CARDIOVASCULAR-DISEASE; THROMBUS FORMATION; MOUSE PLATELETS; SHAPE CHANGE; RHOA; DIFFERENTIATION; EXPRESSION; PATHWAYS; INSIGHTS	Genome-wide association studies have identified a genetic variant at 3p14.3 (SNP rs1354034) that strongly associates with platelet number and mean platelet volume in humans. While originally proposed to be intronic, analysis of mRNA expression in primary human hematopoietic subpopulations reveals that this SNP is located directly upstream of the predominantly expressed ARHGEF3 isoform in megakaryocytes (MK). We found that ARHGEF3, which encodes a Rho guanine exchange factor, is dramatically upregulated during both human and murine MK maturation. We show that the SNP (rs1354034) is located in a DNase I hypersensitive region in human MKs and is an expression quantitative locus (eQTL) associated with ARHGEF3 expression level in human platelets, suggesting that it may be the causal SNP that accounts for the variations observed in human platelet traits and ARHGEF3 expression. In vitro human platelet activation assays revealed that rs1354034 is highly correlated with human platelet activation by ADP. In order to test whether ARHGEF3 plays a role in MK development and/or platelet function, we developed an Arhgef3 KO/LacZ reporter mouse model. Reflecting changes in gene expression, LacZ expression increases during MK maturation in these mice. Although Arhgef3 KO mice have significantly larger platelets, loss of Arhgef3 does not affect baseline MK or platelets nor does it affect platelet function or platelet recovery in response to antibody-mediated platelet depletion compared to littermate controls. In summary, our data suggest that modulation of ARHGEF3 gene expression in humans with a promoter-localized SNP plays a role in human MKs and human platelet function-a finding resulting from the biological follow-up of human genetic studies. Arhgef3 KO mice partially recapitulate the human phenotype.	[Zou, Siying; Krause, Diane S.] Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Teixeira, Alexandra M.; Krause, Diane S.] Yale Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kostadima, Myrto; Astle, William J.; Radhakrishnan, Aparna; Ouwehand, Willem H.; Frontini, Mattia] Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge, England; [Simon, Lukas Mikolaj] Baylor Coll Med, Dept Struct & Computat Biol, Houston, TX 77030 USA; [Truman, Lucy] Addenbrookes Hosp, Dept ENT, Cambridge Biomed Campus, Cambridge, England; [Fang, Jennifer S.; Hwa, John] Yale Univ, Sch Med, Dept Cardiol, Yale Cardiovasc Res Ctr, New Haven, CT USA; [Zhang, Ping-xia; Krause, Diane S.] Yale Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Zhang, Ping-xia; Krause, Diane S.] Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Bray, Paul F.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Bray, Paul F.] Univ Utah, Program Mol Med, Salt Lake City, UT USA; [Astle, William J.; Bray, Paul F.] Univ Cambridge, Dept Publ Hlth & Primary Care, MRC, BHF Cardiovasc Epidemiol Unit, Cambridge, England	Yale University; Yale University; University of Cambridge; Baylor College of Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Yale University; Yale University; Yale University; University of Groningen; University of Groningen; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Cambridge	Krause, DS (corresponding author), Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.; Krause, DS (corresponding author), Yale Sch Med, Dept Pathol, New Haven, CT 06510 USA.; Krause, DS (corresponding author), Yale Sch Med, Dept Lab Med, New Haven, CT 06510 USA.; Krause, DS (corresponding author), Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA.	diane.krause@yale.edu	Fang, Jennifer S./AAK-8044-2020	Fang, Jennifer S./0000-0001-5703-2239; Simon, Lukas/0000-0001-6148-8861; Astle, William John/0000-0001-8866-6672; Kostadima, Myrto Areti/0000-0002-1818-4050	NIH [DK094934, DK086267, DK0724429, HL102482]; Cardeza Foundation for Hematologic Research; American Heart Association Fellowship [14PRE20480196]; BHF Cambridge Centre of Excellence [RE/13/6/30180]; Landsteiner Foundation for Blood Transfusion Research [LSBR1133]; Leukaemia & Lymphoma Research Fellowship [09018]; EU-FP7 project BLUEPRINT [282510]; National Institute for Health Research (NIHR); British Heart Foundation [RP-PG 0310-1002, RG/09/12/28096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102482, R01HL115247, R01HL122815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094934, U54DK106857, P30DK072442, R01DK086267] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, RP-PG-0310-1002] Funding Source: researchfish; MRC [MR/L003120/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardeza Foundation for Hematologic Research; American Heart Association Fellowship(American Heart Association); BHF Cambridge Centre of Excellence; Landsteiner Foundation for Blood Transfusion Research; Leukaemia & Lymphoma Research Fellowship; EU-FP7 project BLUEPRINT; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support was provided by NIH grants DK094934, DK086267, and DK0724429 to DSK, HL102482 to PB, the Cardeza Foundation for Hematologic Research (PB), and American Heart Association Fellowship 14PRE20480196 to LMS. MF is supported by the BHF Cambridge Centre of Excellence RE/13/6/30180. PvdH is supported by the Landsteiner Foundation for Blood Transfusion Research (http://www.lsbr.nl/) grant LSBR1133. LAT was supported by Leukaemia & Lymphoma Research Fellowship (https://bloodwise.org.uk/research-grants) 09018. Research in the Ouwehand laboratory is supported by EU-FP7 project BLUEPRINT (282510) and by program grants from the National Institute for Health Research (NIHR, https://urldefense.prootpoint.com/v2/url?u=http-3A_www.nihr.ac.uk&d=DwlGaQ&c=-dg2m7zWuuDZ0MUcV7Sdqw&r= IVJ7vXcRnyL00aM8sf1WCy6DaxDq9QZgZyV=Gu4EPUE&m=CCUk_ 5v_hCkySZw2q9_QnB0h-NkYalFaP5wzOg_Vatc&s=76dYk8ktWIfNj0CYx7 OMuQKSQuA1DVdNkhjdZd4_gpo&and the British Heart Foundation under numbers RP-PG 0310-1002 and RG/09/12/28096 (https://url defense.proofpointcornA/2/url?u=http-3A_www.bhf.org.uk&d=DWIGaQ&c=dg2m7zWuuDZ0MUcV7Sdqw& =IVJ7vXcRnyL00aM8sf1WCy6DaxDq9qZgZyV-GuT4EPUE&m=CCUk_5v_hCkySZkv2q9_ B0h-NkYaLFaP5wz0q_Vatc&s=QMKIHKMTw709uRS_rTJ8d 5qQ5UQNJKgar50gt9GG6U&e=). The laboratory receives funding from NHS Blood and Transplant for facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Chad D. Sanada for helpful discussions. Financial support provided by NIH grants DK094934, DK086267, and DK0724429 to DSK, HL102482 to PFB, the Cardeza Foundation for Hematologic Research (PFB), and American Heart Association Fellowship 14PRE20480196 to LMS. MF is supported by the BHF Cambridge Centre of Excellence RE/13/ 6/30180. Research in the Ouwehand laboratory is supported by EU-FP7 project BLUEPRINT (282510) and by program grants from the National Institute for Health Research (NIHR, hitp://www.nihr.ac.uk); and the British Heart Foundation under numbers RP-PG-0310-1002 and RG/09/12/28096 (http://www.bhf.org.uk). The laboratory receives funding from NHS Blood and Transplant for facilities.	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; BESSMAN JD, 1981, AM J CLIN PATHOL, V76, P289; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; D'Amato L, 2015, EPIGENETICS-US, V10, P6, DOI 10.4161/15592294.2014.988035; Dimasi DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022103; Edelstein LC, 2013, NAT MED, V19, P1609, DOI 10.1038/nm.3385; Eicher JD, 2016, AM J HUM GENET, V99, P40, DOI 10.1016/j.ajhg.2016.05.005; Fuhrken PG, 2007, EXP HEMATOL, V35, P476, DOI 10.1016/j.exphem.2006.10.017; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Jones CI, 2007, J THROMB HAEMOST, V5, P1756, DOI 10.1111/j.1538-7836.2007.02632.x; Jones CI, 2009, BLOOD, V114, P1405, DOI 10.1182/blood-2009-02-202614; Kim YB, 1999, PLATELETS, V10, P399; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Longenecker G, 2009, CURR PROTOC CELL BIO; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Parekh C, 2013, J CLIN IMMUNOL, V33, P711, DOI 10.1007/s10875-012-9844-3; Rivera J, 2009, HAEMATOL-HEMATOL J, V94, P700, DOI 10.3324/haematol.2008.003178; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Serbanovic-Canic J, 2011, BLOOD, V118, P4967, DOI 10.1182/blood-2011-02-337295; Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; van der Ende MY, 2017, INT J CARDIOL, V228, P495, DOI 10.1016/j.ijcard.2016.11.061; Zhang XL, 2014, HUM MOL GENET, V23, P782, DOI 10.1093/hmg/ddt461	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178095	10.1371/journal.pone.0178095	http://dx.doi.org/10.1371/journal.pone.0178095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542600	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800037
J	Bunnell, BE; Escobar, JF; Bair, KL; Sutton, MD; Crane, JK				Bunnell, Bryan E.; Escobar, Jillian F.; Bair, Kirsten L.; Sutton, Mark D.; Crane, John K.			Zinc blocks SOS-induced antibiotic resistance via inhibition of RecA in Escherichia coli	PLOS ONE			English	Article							TOXIN PRODUCTION; III SECRETION; INDUCTION; EVOLUTION; VIRULENCE; GENE; EXPRESSION; INFECTION; MUTATIONS; PHENOTYPE	Zinc inhibits the virulence of diarrheagenic E. coli by inducing the envelope stress response and inhibiting the SOS response. The SOS response is triggered by damage to bacterial DNA. In Shiga-toxigenic E. coli, the SOS response strongly induces the production of Shiga toxins (Stx) and of the bacteriophages that encode the Stx genes. In E. coli, induction of the SOS response is accompanied by a higher mutation rate, called the mutator response, caused by a shift to error-prone DNA polymerases when DNA damage is too severe to be repaired by canonical DNA polymerases. Since zinc inhibited the other aspects of the SOS response, we hypothesized that zinc would also inhibit the mutator response, also known as hypermutation. We explored various different experimental paradigms to induce hypermutation triggered by the SOS response, and found that hypermutation was induced not just by classical inducers such as mitomycin C and the quinolone antibiotics, but also by antiviral drugs such as zidovudine and anti-cancer drugs such as 5-fluorouracil, 6-mercaptopurine, and azacytidine. Zinc salts inhibited the SOS response and the hypermutator phenomenon in E. coli as well as in Klebsiella pneumoniae, and was more effective in inhibiting the SOS response than other metals. We then attempted to determine the mechanism by which zinc, applied externally in the medium, inhibits hypermutation. Our results show that zinc interferes with the actions of RecA, and protects LexA from RecA-mediated cleavage, an early step in initiation of the SOS response. The SOS response may play a role in the development of antibiotic resistance and the effect of zinc suggests ways to prevent it.	[Bunnell, Bryan E.; Escobar, Jillian F.; Bair, Kirsten L.; Crane, John K.] SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14228 USA; [Sutton, Mark D.] SUNY Buffalo, Dept Biochem, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Crane, JK (corresponding author), SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14228 USA.	jcrane@buffalo.edu	Crane, John K./H-2539-2013	Crane, John K./0000-0002-1341-5665	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R21 Al 102212-01, 2T35A1089693]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102212, T35AI089693] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: R21 Al 102212-01, National Institute of Allergy and Infectious Diseases, National Institutes of Health; to JKC, PI; https://www.niai.nih.gov; 2T35A1089693, National Institute of Allergy and Infectious Diseases, National Institutes of Health; to Timothy F. Murphy, PI; Bryan E. Bunnell, Trainee; https://www.niai.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi JA, 2015, COMP BIOCHEM PHYS C, V172, P7, DOI 10.1016/j.cbpc.2015.04.001; Avison MB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-243; Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Bridges BA, 2001, PHILOS T ROY SOC B, V356, P29, DOI 10.1098/rstb.2000.0745; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Crane JK, 2007, INFECT IMMUN, V75, P5974, DOI 10.1128/IAI.00750-07; Crane JK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-145; Crane JK, 2013, VIRULENCE, V4, P589, DOI 10.4161/viru.26504; Crane JK, 2013, INFECT IMMUN, V81, P1129, DOI 10.1128/IAI.01124-12; Crane JK, 2011, INFECT IMMUN, V79, P1696, DOI 10.1128/IAI.01099-10; Errol CF, 2006, SECOND EDITION AMERI; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fuchs S, 1999, MICROB PATHOGENESIS, V27, P13, DOI 10.1006/mpat.1999.0279; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Grad YH, 2013, MBIO, V4, DOI 10.1128/mBio.00452-12; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V290, P397, DOI 10.1006/bbrc.2001.6152; Handel N, 2015, ANTIMICROBIAL AGENTS; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; Jolivet-Gougeon A, 2011, J MED MICROBIOL, V60, P563, DOI 10.1099/jmm.0.024083-0; Kim JC, 2016, EMERG INFECT DIS, V22, P802, DOI 10.3201/eid2205.151584; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Leonardi AN, 2013, NUCLEIC ACIDS RES, P1; Leverton LQ, 2005, INFECT IMMUN, V73, P1034, DOI 10.1128/IAI.73.2.1034-1043.2005; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; Lynn S, 1997, MUTAGENESIS, V12, P353, DOI 10.1093/mutage/12.5.353; MAMBER SW, 1990, ANTIMICROB AGENTS CH, V34, P1237, DOI 10.1128/AAC.34.6.1237; Maul RW, 2005, J BACTERIOL, V187, P7607, DOI 10.1128/JB.187.22.7607-7618.2005; MCHUGH GL, 1975, LANCET, V1, P235; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mellies JL, 2007, J BACTERIOL, V189, P2863, DOI 10.1128/JB.01859-06; Mellies JL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-123; Mellmann A, 2005, CLIN INFECT DIS, V41, P785, DOI 10.1086/432722; Mellmann A, 2009, GASTROENTEROLOGY, V136, P1925, DOI 10.1053/j.gastro.2008.12.072; MERSCHSUNDERMANN V, 1994, MUTAGENESIS, V9, P205, DOI 10.1093/mutage/9.3.205; Monday SR, 2001, J INFECT DIS, V184, P918, DOI 10.1086/323154; ODA Y, 1987, MUTAT RES, V183, P103, DOI 10.1016/0167-8817(87)90051-4; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Olsen CH, 2014, INFECT IMMUN, V82, P916, DOI 10.1128/IAI.00811-13; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; PRIESTLEY GC, 1980, ACTA DERM-VENEREOL, V60, P145; Russo TA, 1996, INFECT IMMUN, V64, P2343, DOI 10.1128/IAI.64.6.2343-2348.1996; SCOTLAND SM, 1990, J INFECT DIS, V162, P1069, DOI 10.1093/infdis/162.5.1069; SOMMER S, 1993, MOL GEN GENET, V239, P137, DOI 10.1007/BF00281612; Vareille M, 2007, P NATL ACAD SCI USA, V104, P10199, DOI 10.1073/pnas.0702589104; VUOPIOVARKILA J, 1991, J EXP MED, V174, P1167, DOI 10.1084/jem.174.5.1167; Wagner PL, 2001, INFECT IMMUN, V69, P1934, DOI 10.1128/IAI.69.3.1934-1937.2001; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; Wigle TJ, 2009, J BIOMOL SCREEN, V14, P1092, DOI 10.1177/1087057109342126; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239; Zhang YX, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-121	57	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178303	10.1371/journal.pone.0178303	http://dx.doi.org/10.1371/journal.pone.0178303			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542496	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058400078
J	Kandel, JS; Krishnan, V; Jiwan, D; Chen, XM; Skinner, DZ; See, DR				Kandel, Jinita Sthapit; Krishnan, Vandhana; Jiwan, Derick; Chen, Xianming; Skinner, Daniel Z.; See, Deven R.			Mapping genes for resistance to stripe rust in spring wheat landrace PI 480035	PLOS ONE			English	Article							F-SP TRITICI; ADULT-PLANT RESISTANCE; PUCCINIA-STRIIFORMIS; HIGH-TEMPERATURE; UNITED-STATES; BREAD WHEAT; AESTIVUM L.; LEAF RUST; RACES; MAP	Stripe rust caused by Puccinia striiformis Westend. f. sp. tritici Erikks. is an economically important disease of wheat (Triticum aestivum L.). Hexaploid spring wheat landrace PI 480035 was highly resistant to stripe rust in the field in Washington during 2011 and 2012. The objective of this research was to identify quantitative trait loci (QTL) for stripe rust resistance in PI 480035. A spring wheat, "Avocet Susceptible" (AvS), was crossed with PI 480035 to develop a biparental population of 110 recombinant inbred lines (RIL). The population was evaluated in the field in 2013 and 2014 and seedling reactions were examined against three races (PSTv-14, PSTv-37, and PSTv-40) of the pathogen under controlled conditions. The population was genotyped with genotyping-by-sequencing and microsatellite markers across the whole wheat genome. A major QTL, QYr.wrsggl1-1BS was identified on chromosome 1B. The closest flanking markers were Xgwm273, Xgwm11, and Xbarc187 1.01 cM distal to QYr.wrsggl1-1BS, Xcfd59 0.59 cM proximal and XA365 3.19 cM proximal to QYr.wrsggl1-1BS. Another QTL, QYr.wrsggl1-3B, was identified on 3B, which was significant only for PSTv-40 and was not significant in the field, indicating it confers a race-specific resistance. Comparison with markers associated with previously reported Yr genes on 1B (Yr64, Yr65, and YrH52) indicated that QYr.wrsggl1-1BS is potentially a novel stripe rust resistance gene that can be incorporated into modern breeding materials, along with other all-stage and adult-plant resistance genes to develop cultivars that can provide durable resistance.	[Kandel, Jinita Sthapit; Chen, Xianming; See, Deven R.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Kandel, Jinita Sthapit] ARS, USDA, Crop Improvement & Protect Res Unit, Salinas, CA USA; [Krishnan, Vandhana; Jiwan, Derick; Skinner, Daniel Z.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Krishnan, Vandhana] Stanford Univ, Sch Med, Stanford Ctr Genom & Personalized Med, Palo Alto, CA 94304 USA; [Chen, Xianming; Skinner, Daniel Z.; See, Deven R.] ARS, USDA, Wheat Hlth Genet & Qual Res Unit, Pullman, WA 99164 USA	Washington State University; United States Department of Agriculture (USDA); Washington State University; Stanford University; United States Department of Agriculture (USDA)	See, DR (corresponding author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA.; See, DR (corresponding author), ARS, USDA, Wheat Hlth Genet & Qual Res Unit, Pullman, WA 99164 USA.	deeven_see@wsu.edu	Krishnan, Vandhana/AAP-7826-2020	Krishnan, Vandhana/0000-0002-6475-8019; Sthapit Kandel, Jinita/0000-0002-9250-7874	USD-AARS; Washington Grain Commission [2011-68002-30029]; Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences; Agricultural Research Center [0727]; Washington State University, Pullman, USA [WA 99164-6430]	USD-AARS(United States Department of Agriculture (USDA)); Washington Grain Commission; Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences; Agricultural Research Center; Washington State University, Pullman, USA	This research was funded by a USD-AARS special research initiative on stem rust, the Washington Grain Commission, and Triticeae Coordinated Agricultural Project(T-CAP). 2011-68002-30029, Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center, Project No. 0727, Washington State University, Pullman, WA 99164-6430, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by a USDA-ARS special research initiative on stem rust, the Washington Grain Commission, and Triticeae Coordinated Agricultural Project (T-CAP). 2011-68002-30029, Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center, Project No. 0727, Washington State University, Pullman, WA 99164-6430, USA.	[Anonymous], 2014, ANN WHEAT NEWSL; Banana H, 2010, EUPHYTICA, V176, P251; Bansal UK, 2010, EUPHYTICA, V171, P121, DOI 10.1007/s10681-009-0007-4; Case AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091758; Chen X. M., 1994, Phytopathology, V84, P1116; Chen X. M., 2013, American Journal of Plant Sciences, V4, P608; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; CHEN XM, 1992, PHYTOPATHOLOGY, V82, P1428, DOI 10.1094/Phyto-82-1428; CHEN XM, 1992, PHYTOPATHOLOGY, V82, P633, DOI 10.1094/Phyto-82-633; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P1362, DOI 10.1094/Phyto-85-1362; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P567, DOI 10.1094/Phyto-85-567; Cheng P, 2014, THEOR APPL GENET, V127, P2267, DOI 10.1007/s00122-014-2378-8; Jia JQ, 2011, CEREAL RES COMMUN, V39, P88, DOI 10.1556/CRC.39.2011.1.9; Khlestkina EK, 2007, EUPHYTICA, V153, P1, DOI 10.1007/s10681-006-9182-8; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Li GQ, 2006, THEOR APPL GENET, V112, P1434, DOI 10.1007/s00122-006-0245-y; Lin F, 2008, THEOR APPL GENET, V116, P797, DOI 10.1007/s00122-008-0713-7; Lin F, 2007, THEOR APPL GENET, V114, P1277, DOI 10.1007/s00122-007-0518-0; Line RF, 1991, USDA TECH B, P1968; Luo PG, 2008, CAN J PLANT PATHOL, V30, P254, DOI 10.1080/07060661.2008.10540540; MACER RCF, 1975, T BRIT MYCOL SOC, V65, P351; Mascher M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076925; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Melichar JPE, 2008, THEOR APPL GENET, V117, P391, DOI 10.1007/s00122-008-0783-6; Milus EA, 2009, PHYTOPATHOLOGY, V99, P89, DOI 10.1094/PHYTO-99-1-0089; Murphy LR, 2009, CROP SCI, V49, P1786, DOI 10.2135/cropsci2008.10.0621; Newcomb M, 2013, PLANT DIS, V97, P882, DOI 10.1094/PDIS-02-12-0200-RE; Pahalawatta V, 2005, PHYTOPATHOLOGY, V95, P427, DOI 10.1094/PHYTO-95-0427; Peng JH, 2000, GENETICA, V109, P199, DOI 10.1023/A:1017573726512; QAYOUM A, 1985, PHYTOPATHOLOGY, V75, P1121, DOI 10.1094/Phyto-75-1121; Randhawa MS, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0270-0; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Singh Ravi Prakash, 2005, Turkish Journal of Agriculture and Forestry, V29, P121; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Sthapit J, 2014, CROP SCI, V54, P2131, DOI 10.2135/cropsci2013.07.0438; Sthapit J, 2012, PLANT DIS, V96, P737, DOI 10.1094/PDIS-07-11-0612; Suenaga K, 2003, PHYTOPATHOLOGY, V93, P881, DOI 10.1094/PHYTO.2003.93.7.881; Wan AM, 2014, PLANT DIS, V98, P1534, DOI 10.1094/PDIS-01-14-0071-RE; Wan AM, 2016, PLANT DIS, V100, P966, DOI 10.1094/PDIS-10-15-1122-RE; Wang C, 2008, EUPHYTICA, V159, P359, DOI 10.1007/s10681-007-9524-1; Wang LM, 2009, CEREAL RES COMMUN, V37, P209, DOI 10.1556/CRC.37.2009.2.7; Wang LF, 2002, EUPHYTICA, V124, P71, DOI 10.1023/A:1015689817857; Wang S., 2011, WINDOWS QTL CARTOGRA; Wellings CR, 2004, P 11 INT CER RUSTS P, pA1; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; ZADOKS J. C., 1961, TIJDSCHR PLANTEZIEKTEN, V67, P69, DOI 10.1007/BF01984044	47	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177898	10.1371/journal.pone.0177898	http://dx.doi.org/10.1371/journal.pone.0177898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542451	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600030
J	Peng, TJ; Ma, LY; Feng, X; Tao, JM; Nan, MH; Liu, YD; Li, JK; Shen, L; Wu, XL; Yu, RL; Liu, XD; Qiu, GZ; Zeng, WM				Peng, Tangjian; Ma, Liyuan; Feng, Xue; Tao, Jiemeng; Nan, Meihua; Liu, Yuandong; Li, Jiaokun; Shen, Li; Wu, Xueling; Yu, Runlan; Liu, Xueduan; Qiu, Guanzhou; Zeng, Weimin			Genomic and transcriptomic analyses reveal adaptation mechanisms of an Acidithiobacillus ferrivorans strain YL15 to alpine acid mine drainage	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACIDOPHILIC MICROORGANISMS; BIOFILM FORMATION; METAL RESISTANCE; WEB SERVER; PROTEIN; BACTERIAL; DATABASE; SHOCK; DNA	Acidithiobacillus ferrivorans is an acidophile that often occurs in low temperature acid mine drainage, e.g., that located at high altitude. Being able to inhabit the extreme environment, the bacterium must possess strategies to copy with the survival stress. Nonetheless, information on the strategies is in demand. Here, genomic and transcriptomic assays were performed to illuminate the adaptation mechanisms of an A. ferrivorans strain YL15, to the alpine acid mine drainage environment in Yulong copper mine in southwest China. Genomic analysis revealed that strain has a gene repertoire for metal-resistance, e.g., genes coding for the mer operon and a variety of transporters/efflux proteins, and for low pH adaptation, such as genes for hopanoid-synthesis and the sodium: proton antiporter. Genes for various DNA repair enzymes and synthesis of UV-absorbing mycosporine-like amino acids precursor indicated hypothetical UV radiation-resistance mechanisms in strain YL15. In addition, it has two types of the acquired immune system-type III-B and type I-F CRISPR/Cas modules against invasion of foreign genetic elements. RNA-seq based analysis uncovered that strain YL15 uses a set of mechanisms to adapt to low temperature. Genes involved in protein synthesis, transmembrane transport, energy metabolism and chemotaxis showed increased levels of RNA transcripts. Furthermore, a bacterioferritin Dps gene had higher RNA transcript counts at 6 degrees C, possibly implicated in protecting DNA against oxidative stress at low temperature. The study represents the first to comprehensively unveil the adaptation mechanisms of an acidophilic bacterium to the acid mine drainage in alpine regions.	[Peng, Tangjian; Ma, Liyuan; Feng, Xue; Tao, Jiemeng; Nan, Meihua; Liu, Yuandong; Li, Jiaokun; Shen, Li; Wu, Xueling; Yu, Runlan; Liu, Xueduan; Qiu, Guanzhou; Zeng, Weimin] Cent South Univ, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China; [Liu, Yuandong; Li, Jiaokun; Shen, Li; Wu, Xueling; Yu, Runlan; Liu, Xueduan; Qiu, Guanzhou; Zeng, Weimin] Cent South Univ, Minist Educ, Key Lab Biomet, Changsha, Hunan, Peoples R China; [Li, Jiaokun] Cent South Univ, Sch Met & Environm, Changsha, Hunan, Peoples R China; [Zeng, Weimin] CSIRO Proc Sci & Engn, Clayton, Vic, Australia	Central South University; Central South University; Central South University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Zeng, WM (corresponding author), Cent South Univ, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China.; Zeng, WM (corresponding author), Cent South Univ, Minist Educ, Key Lab Biomet, Changsha, Hunan, Peoples R China.; Zeng, WM (corresponding author), CSIRO Proc Sci & Engn, Clayton, Vic, Australia.	zengweimin1024@sina.com		Ma, Liyuan/0000-0001-7351-836X; Peng, Tangjian/0000-0002-5265-6592	National Natural Science Foundation of China [31470230, 51320105006, 51604308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31470230, 51320105006, 51604308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alreshidi MM, 2015, J PROTEOMICS, V121, P44, DOI 10.1016/j.jprot.2015.03.010; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Baker-Austin C, 2007, TRENDS MICROBIOL, V15, P165, DOI 10.1016/j.tim.2007.02.005; Barahona S, 2014, RES MICROBIOL, V165, P782, DOI 10.1016/j.resmic.2014.07.015; Bardy SL, 2003, MICROBIOL-SGM, V149, P295, DOI 10.1099/mic.0.25948-0; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Bayir H, 2005, CRIT CARE MED, V33, pS498, DOI 10.1097/01.CCM.0000186787.64500.12; Berger F, 1996, J BACTERIOL, V178, P2999, DOI 10.1128/jb.178.11.2999-3007.1996; BLAIR DF, 1990, CELL, V60, P439, DOI 10.1016/0092-8674(90)90595-6; Bresolin G, 2006, J BACTERIOL, V188, P2945, DOI 10.1128/JB.188.8.2945-2958.2006; Cavicchioli R, 2016, ISME J, V10, P793, DOI 10.1038/ismej.2015.160; Chen L-x, 2014, ISME J, pe245; Chen LX, 2013, ENVIRON MICROBIOL, V15, P2431, DOI 10.1111/1462-2920.12114; Chen ZJ, 2012, ENV MICROBIOL REP, V4, P633, DOI 10.1111/j.1758-2229.2012.00389.x; Christel S, 2016, EXTREMOPHILES, V20, P903, DOI 10.1007/s00792-016-0882-2; Christel S, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw057; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dopson M, 2007, BIOTECHNOL BIOENG, V97, P1205, DOI 10.1002/bit.21312; Dopson M, 2014, APPL MICROBIOL BIOT, V98, P8133, DOI 10.1007/s00253-014-5982-2; Elberling B, 2000, J CONTAM HYDROL, V41, P225, DOI 10.1016/S0169-7722(99)00085-6; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Gabani P, 2013, APPL MICROBIOL BIOT, V97, P993, DOI 10.1007/s00253-012-4642-7; GADD GM, 1978, MICROBIAL ECOL, V4, P303, DOI 10.1007/BF02013274; Gonzalez C, 2014, RES MICROBIOL, V165, P726, DOI 10.1016/j.resmic.2014.08.005; Goodchild A, 2004, MOL MICROBIOL, V53, P309, DOI 10.1111/j.1365-2958.2004.04130.x; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guazzaroni ME, 2013, ENVIRON MICROBIOL, V15, P1088, DOI 10.1111/1462-2920.12021; Hallberg KB, 2010, EXTREMOPHILES, V14, P9, DOI 10.1007/s00792-009-0282-y; Hua Z, 2014, ISME J; Johnson DB, 2005, SCI TOTAL ENVIRON, V338, P3, DOI 10.1016/j.scitotenv.2004.09.002; JOHNSON DB, 1995, J MICROBIOL METH, V23, P205, DOI 10.1016/0167-7012(95)00015-D; Johnson DB, 2001, ENVIRON MICROBIOL, V3, P630, DOI 10.1046/j.1462-2920.2001.00234.x; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Keto-Timonen R, 2016, FRONT MICROBIOL, P7; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Levin BR, 2013, PLOS GENET, V9; Liljeqvist M, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv011; Liljeqvist M, 2013, APPL ENVIRON MICROB, V79, P951, DOI 10.1128/AEM.02989-12; Liljeqvist M, 2011, J BACTERIOL, V193, P4304, DOI 10.1128/JB.05373-11; Lin YF, 2006, P NATL ACAD SCI USA, V103, P15617, DOI 10.1073/pnas.0603974103; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093289; Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Morgante V, 2014, ENV MICROBIOL; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Rastogi RP, 2010, J IND MICROBIOL BIOT, V37, P537, DOI 10.1007/s10295-010-0718-5; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Talla E, 2014, RES MICROBIOL, V165, P753, DOI 10.1016/j.resmic.2014.08.002; Talla E, 2013, ADV MATER RES-SWITZ, V825, P145, DOI 10.4028/www.scientific.net/AMR.825.145; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang YG, 2012, BIORESOURCE TECHNOL, V121, P348, DOI 10.1016/j.biortech.2012.06.114; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Williams TJ, 2010, J PROTEOME RES, V9, P640, DOI 10.1021/pr900509n; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xiao Y, 2016, APPL MICROBIOL BIOT, P1; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	75	23	26	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178008	10.1371/journal.pone.0178008	http://dx.doi.org/10.1371/journal.pone.0178008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542527	gold, Green Submitted, Green Published			2022-12-27	WOS:000401672600040
J	de Sousa, AMYR; Takayasu, H; Takayasu, M				de Sousa, Arthur Matsuo Yamashita Rios; Takayasu, Hideki; Takayasu, Misako			Detection of statistical asymmetries in non-stationary sign time series: Analysis of foreign exchange data	PLOS ONE			English	Article							CROSS-CORRELATIONS; HURST EXPONENT; ENTROPY; ECONOPHYSICS; ECONOMICS; PHASE; PRICE	We extend the concept of statistical symmetry as the invariance of a probability distribution under transformation to analyze binary sign time series data of price difference from the foreign exchange market. We model segments of the sign time series as Markov sequences and apply a local hypothesis test to evaluate the symmetries of independence and time reversion in different periods of the market. For the test, we derive the probability of a binary Markov process to generate a given set of number of symbol pairs. Using such analysis, we could not only segment the time series according the different behaviors but also characterize the segments in terms of statistical symmetries. As a particular result, we find that the foreign exchange market is essentially time reversible but this symmetry is broken when there is a strong external influence.	[de Sousa, Arthur Matsuo Yamashita Rios; Takayasu, Misako] Tokyo Inst Technol, Sch Comp, Dept Math & Comp Sci, Midori Ku, Yokohama, Kanagawa, Japan; [Takayasu, Hideki] Sony Comp Sci Labs, Shinagawa Ku, Tokyo, Japan; [Takayasu, Hideki; Takayasu, Misako] Tokyo Inst Technol, Inst Innovat Res, Adv Data Anal & Modeling Unit, Midori Ku, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Takayasu, M (corresponding author), Tokyo Inst Technol, Sch Comp, Dept Math & Comp Sci, Midori Ku, Yokohama, Kanagawa, Japan.; Takayasu, M (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Adv Data Anal & Modeling Unit, Midori Ku, Yokohama, Kanagawa, Japan.	takayasu.m.aa@m.titech.ac.jp	; Takayasu, Misako/H-9890-2014	Yamashita Rios de Sousa, Arthur Matsuo/0000-0003-3813-1295; Takayasu, Misako/0000-0002-2467-614X	Monbukagakusho MEXT Scholarship (Japanese Ministry of Education, Culture, Sports, Science and Technology);  [26310207]	Monbukagakusho MEXT Scholarship (Japanese Ministry of Education, Culture, Sports, Science and Technology); 	Author A.M.Y.R.S. acknowledges funding from Monbukagakusho MEXT Scholarship (Japanese Ministry of Education, Culture, Sports, Science and Technology). This work was partially supported by a Grant-in-Aid for Scientific Research (B) 26310207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author H.T. is employed by Sony Computer Science Laboratories. Sony Computer Science Laboratories provided support in the form of salaries for author H.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of manuscript. All authors were involved in all stages of the present work.	Alvarez-Ramirez J, 2008, PHYSICA A, V387, P6159, DOI 10.1016/j.physa.2008.06.056; [Anonymous], 2011, BANK JAP COORD CENTR; Ausloos M, 2000, PHYSICA A, V284, P385, DOI 10.1016/S0378-4371(00)00290-9; Baker M, 2016, NATURE, V531, P151, DOI 10.1038/nature.2016.19503; BIRMAN JL, 1985, J STAT PHYS, V38, P371, DOI 10.1007/BF01017868; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Darbellay GA, 2000, PHYSICA A, V287, P429, DOI 10.1016/S0378-4371(00)00382-4; Denisov SI, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046137; Dionisio A, 2004, PHYSICA A, V344, P326, DOI 10.1016/j.physa.2004.06.144; Fiedor P, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052801; Fractals Feder J., 2013, SPRINGER SCI BUSINES; Gaspard P, 2004, J STAT PHYS, V117, P599, DOI 10.1007/s10955-004-3455-1; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; Ito A., 2011, BLOOMBERG; Kullmann L, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026125; Levinson M, 2006, GUIDE FINANCIAL MARK; Mantegna RN, 1999, INTRO ECONOPHYSICS C; Maskawa J, 2002, PHYSICA A, V311, P563, DOI 10.1016/S0378-4371(02)00818-X; Matos JAO, 2008, PHYSICA A, V387, P3910, DOI 10.1016/j.physa.2008.01.060; McCauley JL, 2003, PHYSICA A, V329, P199, DOI 10.1016/S0378-4371(03)00591-0; Mizuno T, 2006, PHYSICA A, V364, P336, DOI 10.1016/j.physa.2005.08.079; Mood AM, 1940, ANN MATH STAT, V11, P367, DOI 10.1214/aoms/1177731825; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Ohira T, 2002, PHYSICA A, V308, P368, DOI 10.1016/S0378-4371(02)00561-7; Pathria R.K., 2011, STAT MECH, V3rd ed.; Podobnik B, 2009, P NATL ACAD SCI USA, V106, P22079, DOI 10.1073/pnas.0911983106; Porporato A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.094101; Rehn JA, 2012, BRAZ J PHYS, V42, P410, DOI 10.1007/s13538-012-0108-8; Snijders C, 2012, INT J INTERNET SCI, V7, P1; Sornette D, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/6/062001; Sousa AMYR, 2015, P INT C SOC MOD SIM, p3 ; Sousa T, 2006, PHYSICA A, V371, P492, DOI 10.1016/j.physa.2006.04.058; Stanley HE, 1999, PHYSICA A, V269, P156, DOI 10.1016/S0378-4371(99)00185-5; Takayasu H, 2000, PARADIGMS OF COMPLEXITY, P243; Waclawczyk M, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.013022; Wald A, 1940, ANN MATH STAT, V11, P147, DOI 10.1214/aoms/1177731909; Watanabe K, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056110; Yamada K, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051120; Yura Yoshihiro, 2012, International Journal of Modern Physics: Conference Series, V16, P136, DOI 10.1142/S2010194512007830; Yura Y, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.042811; Yura Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.098703; Zapart CA, 2009, PHYSICA A, V388, P1157, DOI 10.1016/j.physa.2008.11.047; Zhou WX, 2007, EUR PHYS J B, V55, P175, DOI 10.1140/epjb/e2006-00391-6	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177652	10.1371/journal.pone.0177652	http://dx.doi.org/10.1371/journal.pone.0177652			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542208	gold, Green Submitted, Green Published			2022-12-27	WOS:000401672400063
J	Kemmish, H; Fasnacht, M; Yan, LS				Kemmish, Helen; Fasnacht, Marc; Yan, Lisa			Fully automated antibody structure prediction using BIOVIA tools: Validation study	PLOS ONE			English	Article							MODELING ASSESSMENT; CANONICAL STRUCTURES; VARIABLE DOMAINS; LOOP PREDICTION; IMMUNOGLOBULIN; COMBINATION	We describe the methodology and results from our validation study of the fully automated antibody structure prediction tool available in the BIOVIA (formerly Accelrys) protein modeling suite. Extending our previous study, we have validated the automated approach using a larger and more diverse data set (157 unique antibody Fv domains versus 11 in the previous study). In the current study, we explore the effect of varying several parameter settings in order to better understand their influence on the resulting model quality. Specifically, we investigated the dependence on different methods of framework model construction, antibody numbering schemes (Chothia, IMGT, Honegger and Kabat), the influence of compatibility of loop templates using canonical type filtering, wider exploration of model solution space, and others. Our results show that our recently introduced Top5 framework modeling method results in a small but significant improvement in model quality whereas the effect of other parameters is not significant. Our analysis provides improved guidelines of best practices for using our protocol to build antibody structures. We also identify some limitations of the current computational model which will enhance proper evaluation of model quality by users and suggests possible future enhancements.	[Kemmish, Helen; Fasnacht, Marc; Yan, Lisa] Dassault Syst Biovia Corp, San Diego, CA 92121 USA; [Fasnacht, Marc] Illumina Inc, Santa Clara, CA USA	Illumina	Yan, LS (corresponding author), Dassault Syst Biovia Corp, San Diego, CA 92121 USA.	Lisa.Yan@3ds.com						Al-Lazikani B, 2001, CURR OPIN CHEM BIOL, V5, P51, DOI 10.1016/S1367-5931(00)00164-2; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Almagro JC, 2014, PROTEINS, V82, P1553, DOI 10.1002/prot.24567; Almagro JC, 2011, PROTEINS, V79, P3050, DOI 10.1002/prot.23130; [Anonymous], 2015, DOSC STUD MOD ENV RE; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berrondo M, 2014, PROTEINS, V82, P1636, DOI 10.1002/prot.24595; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Dunbar J, 2013, PROTEIN ENG DES SEL, V26, P611, DOI 10.1093/protein/gzt020; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fasnacht M, 2014, PROTEINS, V82, P1583, DOI 10.1002/prot.24604; Honegger A, 2001, J MOL BIOL, V309, P657, DOI 10.1006/jmbi.2001.4662; Kabat EA, 1992, SEQUENCES PROTEINS I; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Maier JKX, 2014, PROTEINS, V82, P1599, DOI 10.1002/prot.24576; Marcatili P, 2014, NAT PROTOC, V9, P2771, DOI 10.1038/nprot.2014.189; Morea V, 2000, METHODS, V20, P267, DOI 10.1006/meth.1999.0921; Moult J, 1995, PROTEINS STRUCTURE F, V23; Ponomarenko N, 2014, ACTA CRYSTALLOGR D, V70, P708, DOI 10.1107/S1399004713032446; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shirai H, 2014, PROTEINS, V82, P1624, DOI 10.1002/prot.24591; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Teplyakov A, 2014, PROTEINS, V82, P1563, DOI 10.1002/prot.24554; Weitzner BD, 2014, PROTEINS, V82, P1611, DOI 10.1002/prot.24534; Zhu K, 2014, PROTEINS, V82, P1646, DOI 10.1002/prot.24551	28	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177923	10.1371/journal.pone.0177923	http://dx.doi.org/10.1371/journal.pone.0177923			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542300	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400115
J	Louzolo, A; Gustavsson, P; Tigerstrom, L; Ingvar, M; Olsson, A; Petrovic, P				Louzolo, Anais; Gustavsson, Petter; Tigerstrom, Lars; Ingvar, Martin; Olsson, Andreas; Petrovic, Predrag			Delusion-proneness displays comorbidity with traits of autistic-spectrum disorders and ADHD	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; BIPOLAR DISORDER; PSYCHOSIS PRONENESS; WORKING-MEMORY; RISK-FACTORS; QUOTIENT AQ; SCHIZOPHRENIA; ATTENTION; CHILDHOOD; PSYCHOPATHOLOGY	There is an increasing body of evidence suggesting a significant comorbidity between psychotic disorders such as schizophrenia and attention-deficit/hyperactivity disorder (ADHD) or autism-spectrum disorders (ASD). Recently, research on psychosis-proneness in otherwise healthy individuals has been a promising way to better understand the mechanisms underlying psychosis. As both ADHD and ASD symptoms show a normal distribution in the general population, such trait comorbidity may confound studies on psychosis-proneness. Thus, understanding the extent to which psychosis-proneness relates to ADHD and ASD symptoms in healthy subjects is crucial for studies focusing on at-risk or psychosis-prone populations. In the present paper we tested the robustness of overlap between psychosis-proneness and ADHD/ASD symptoms, by studying correlations between the scores of three commonly-used questionnaires assessing delusion-proneness (Peters' Delusion Inventory), ADHD tendencies (Adult ADHD Self-Report Scale) and ASD tendencies (Autism Quotient), on a large sample of healthy individuals (n = 925) using raw scores, prototypical questions and a factor analysis. The results showed consistently positive correlations between psychosis-proneness and ADHD-, as well as ASD-symptoms. While the effect was weak for ASD, it was moderate for ADHD. The findings support the idea that when investigating psychosis-proneness it is crucial to also take ADHD-and ASD-tendencies into account, in order to conclude that the reported results in a given study are specific to psychosis-proneness. The observed trait correlations also suggest a common pathway in the underlying information processing of these states.	[Louzolo, Anais; Gustavsson, Petter; Tigerstrom, Lars; Olsson, Andreas; Petrovic, Predrag] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Ingvar, Martin] Karolinska Univ Sjukhuset, Dept Neuroradiol, Stockholm, Sweden	Karolinska Institutet	Louzolo, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	anais.louzolo@ki.se	Petrovic, Predrag/AAS-6736-2020	Petrovic, Predrag/0000-0002-5536-945X; Louzolo, Anais/0000-0002-6769-652X; Ingvar, Martin/0000-0002-9041-5714				Abi-Dargham A, 2004, BIOL PSYCHIAT, V55, P1001, DOI 10.1016/j.biopsych.2004.01.018; Aleman A, 1999, AM J PSYCHIAT, V156, P1358; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Barrantes-Vidal N, 2015, SCHIZOPHRENIA BULL, V41, pS408, DOI 10.1093/schbul/sbu191; BELLAK L, 1987, PSYCHIAT DEV, V5, P239; Biederman J, 2006, PSYCHOL MED, V36, P167, DOI 10.1017/S0033291705006410; Blum Kenneth, 2008, Neuropsychiatr Dis Treat, V4, P893; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Chisholm K, 2015, NEUROSCI BIOBEHAV R, V55, P173, DOI 10.1016/j.neubiorev.2015.04.012; CORNBLATT BA, 1994, SCHIZOPHRENIA BULL, V20, P31, DOI 10.1093/schbul/20.1.31; Crosbie J, 2013, J ABNORM CHILD PSYCH, V41, P497, DOI 10.1007/s10802-012-9693-9; Dalsgaard S, 2014, EUR PSYCHIAT, V29, P259, DOI 10.1016/j.eurpsy.2013.06.004; Das D, 2012, PLOS ONE, P7; de Lacy N, 2013, ANNU REV CLIN PSYCHO, V9, P555, DOI 10.1146/annurev-clinpsy-050212-185627; Driver DI, 2013, CHILD ADOL PSYCH CL, V22, P539, DOI 10.1016/j.chc.2013.04.001; Elman I, 1998, ISRAEL J PSYCHIAT, V35, P280; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Forbes NF, 2009, PSYCHOL MED, V39, P889, DOI 10.1017/S0033291708004558; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; JONES P, 1994, LANCET, V344, P1398, DOI 10.1016/S0140-6736(94)90569-X; Keshaven MS, 2003, SCHIZOPHR RES, V59, P85, DOI 10.1016/S0920-9964(01)00400-5; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kwapil TR, 2002, J CLIN PSYCHOL, V58, P1601, DOI 10.1002/jclp.10078; Lahey BB, 2012, J ABNORM PSYCHOL, V121, P971, DOI 10.1037/a0028355; Larsson H, 2013, BRIT J PSYCHIAT, V203, P103, DOI 10.1192/bjp.bp.112.120808; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lincoln TM, 2007, SCHIZOPHR RES, V93, P211, DOI 10.1016/j.schres.2007.02.013; Linscott RJ, 2010, ANNU REV CLIN PSYCHO, V6, P391, DOI 10.1146/annurev.clinpsy.032408.153506; Louzolo A, 2015, PLOS ONE, P10; Marsh HW, 2014, ANNU REV CLIN PSYCHO, V10, P85, DOI 10.1146/annurev-clinpsy-032813-153700; Muthen L., 2007, MPLUS USERS GUIDE VE; Pallanti S, 2015, WORLD J PSYCHIATR, V5, P47, DOI 10.5498/wjp.v5.i1.47; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Peters E, 2004, SCHIZOPHRENIA BULL, V30, P1005, DOI 10.1093/oxfordjournals.schbul.a007116; Petrovic P, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00070; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Rho A, 2015, SCHIZOPHR RES, V165, P128, DOI 10.1016/j.schres.2015.03.031; Rubino IA, 2009, PSYCHOPATHOLOGY, V42, P325, DOI 10.1159/000232975; Ruzich E, 2015, MOL AUTISM, V6, DOI [10.1186/s13229-015-0038-8, 10.1186/2040-2392-6-2]; Schmack K, 2013, J NEUROSCI, V33, P13701, DOI 10.1523/JNEUROSCI.1778-13.2013; Shattuck PT, 2007, J AUTISM DEV DISORD, V37, P1735, DOI 10.1007/s10803-006-0307-7; Silver H, 2003, AM J PSYCHIAT, V160, P1809, DOI 10.1176/appi.ajp.160.10.1809; Silverstein ML, 2003, SCHIZOPHR RES, V61, P271, DOI 10.1016/S0920-9964(02)00312-2; Stark R, 2011, NEUROPSYCHOLOGIA, V49, P426, DOI 10.1016/j.neuropsychologia.2010.12.012; Stone William S, 2011, N Am J Med Sci (Boston), V4, P124; SULLIVAN EV, 1994, BIOL PSYCHIAT, V36, P641, DOI 10.1016/0006-3223(94)91173-8; Sullivan PF, 2012, ARCH GEN PSYCHIAT, V69, P1099, DOI 10.1001/archgenpsychiatry.2012.730; Teufel C, 2015, P NATL ACAD SCI USA, V112, P13401, DOI 10.1073/pnas.1503916112	51	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177820	10.1371/journal.pone.0177820	http://dx.doi.org/10.1371/journal.pone.0177820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542365	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400090
J	Ortega, MS; Kurian, JJ; McKenna, R; Hansen, PJ				Ortega, M. Sofia; Kurian, Justin J.; McKenna, Robert; Hansen, Peter J.			Characteristics of candidate genes associated with embryonic development in the cow: Evidence for a role for WBP1 in development to the blastocyst stage	PLOS ONE			English	Article							GENOME ACTIVATION; SIGNALING PATHWAY; BOVINE EMBRYOS; HEAT-SHOCK; I-TASSER; PROTEIN; CONSEQUENCES; EXPRESSION; COMPONENTS; APOPTOSIS	The goal was to gain understanding of how 12 genes containing SNP previously related to embryo competence to become a blastocyst (BRINP3, C1QB, HSPA1L, IRF9, MON1B, PARM1, PCCB, PMM2, SLC18A2, TBC1D24, TTLL3 and WBP1) participate in embryonic development. Gene expression was evaluated in matured oocytes and embryos. BRINP3 and C1QB were not detected at any stage. For most other genes, transcript abundance declined as the embryo developed to the blastocyst stage. Exceptions were for PARM1 and WBP1, where steady-state mRNA increased at the 9-16 cell stage. The SNP in WBP1 caused large differences in the predicted three-dimensional structure of the protein while the SNP in PARM1 caused smaller changes. The mutation in WBP1 causes an amino acid substitution located close to a P-P-X-Y motif involved in protein-protein interactions. Moreover, the observation that the reference allele varies between mammalian species indicates that the locus has not been conserved during mammalian evolution. Knockdown of mRNA for WBP1 decreased the percent of putative zygotes becoming blastocysts and reduced the number of trophectoderm cells and immunoreactive CDX2 in the resulting blastocysts. WBP1 is an important gene for embryonic development in the cow. Further research to identify how the SNP in WBP1 affects processes leading to differentiation of the embryo into TE and ICM lineages is warranted.	[Ortega, M. Sofia; Hansen, Peter J.] Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA; [Ortega, M. Sofia; Hansen, Peter J.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Kurian, Justin J.; McKenna, Robert] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Ortega, M. Sofia] Univ Missouri, Div Anim Sci, Columbia, MO USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Missouri System; University of Missouri Columbia	Hansen, PJ (corresponding author), Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA.; Hansen, PJ (corresponding author), Univ Florida, Genet Inst, Gainesville, FL 32611 USA.	pjhansen@ufl.edu	Kurian, Justin/AAG-7500-2019; Hansen, Peter/AAI-4693-2021; Ortega, Sofia/ABA-3654-2020	Hansen, Peter/0000-0003-3061-9333; Ortega, Sofia/0000-0003-4027-7314	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2013-68004-20365]; Southeast Milk Inc. Milk Check-off Program; L.E. "Red" Larson Endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007110] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; Southeast Milk Inc. Milk Check-off Program; L.E. "Red" Larson Endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-68004-20365 from the USDA National Institute of Food and Agriculture, a grant from the Southeast Milk Inc. Milk Check-off Program, and funds from the L.E. Red Larson Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basirico L, 2011, CELL STRESS CHAPERON, V16, P441, DOI 10.1007/s12192-011-0257-7; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; BRAUDE P, 1979, NATURE, V282, P102, DOI 10.1038/282102a0; Cerri RLA, 2009, REPRODUCTION, V137, P813, DOI 10.1530/REP-08-0242; Chandolia RK, 1999, BIOL REPROD, V61, P1644, DOI 10.1095/biolreprod61.6.1644; Chebel RC, 2008, THERIOGENOLOGY, V69, P98, DOI 10.1016/j.theriogenology.2007.09.008; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; Cochran SD, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111260; Cochran SD, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-49; Dobson H, 2007, REPROD DOMEST ANIM, V42, P17, DOI 10.1111/j.1439-0531.2007.00906.x; Fear JM, 2011, BIOL REPROD, V84, P43, DOI 10.1095/biolreprod.110.086249; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Graf A, 2014, ANIM REPROD SCI, V149, P46, DOI 10.1016/j.anireprosci.2014.05.016; Graf A, 2014, P NATL ACAD SCI USA, V111, P4139, DOI 10.1073/pnas.1321569111; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; Hendricks KEM, 2010, AUST VET J, V88, P307, DOI 10.1111/j.1751-0813.2010.00585.x; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Isodono K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009746; Kaufmann M, 2012, FUNCTIONAL GENOMICS; Khatib H, 2008, J ANIM SCI, V86, P2063, DOI 10.2527/jas.2007-0791; Khatib H, 2008, J DAIRY SCI, V91, P784, DOI 10.3168/jds.2007-0669; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; La Rosa I, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-18; Lee E, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0286-4; Lee KB, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-67; Li G, 2012, J DAIRY RES, V79, P310, DOI 10.1017/S0022029912000210; Lorthongpanich C, 2013, GENE DEV, V27, P1441, DOI 10.1101/gad.219618.113; Maillo V, 2012, J DAIRY SCI, V95, P3865, DOI 10.3168/jds.2011-5270; McDonald CB, 2011, BIOCHEMISTRY-US, V50, P9616, DOI 10.1021/bi201286p; Nakanishi N, 2012, BIOCHEM BIOPH RES CO, V428, P500, DOI 10.1016/j.bbrc.2012.10.078; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Ortega MS, 2016, J DAIRY SCI, V99, P9152, DOI 10.3168/jds.2016-11501; Pei JM, 2012, CELL SIGNAL, V24, P758, DOI 10.1016/j.cellsig.2011.11.011; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; Santos JEP, 2008, THERIOGENOLOGY, V69, P88, DOI 10.1016/j.theriogenology.2007.09.010; Sartori R, 2002, J DAIRY SCI, V85, P2803, DOI 10.3168/jds.S0022-0302(02)74367-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sirard MA, 2012, REPROD DOMEST ANIM, V47, P148, DOI 10.1111/j.1439-0531.2012.02069.x; Suzuki Y, 2011, REPRODUCTION, V142, P733, DOI 10.1530/REP-11-0275; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	49	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178041	10.1371/journal.pone.0178041	http://dx.doi.org/10.1371/journal.pone.0178041			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542629	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400134
J	Barha, CK; Salvante, KG; Hanna, CW; Wilson, SL; Robinson, WP; Altman, RM; Nepomnaschy, PA				Barha, Cindy K.; Salvante, Katrina G.; Hanna, Courtney W.; Wilson, Samantha L.; Robinson, Wendy P.; Altman, Rachel M.; Nepomnaschy, Pablo A.			Child mortality, hypothalamic-pituitaryadrenal axis activity and cellular aging in mothers	PLOS ONE			English	Article							LEUKOCYTE TELOMERE LENGTH; OXIDATIVE STRESS; CORTISOL-LEVELS; PSYCHOLOGICAL STRESS; ENDOCRINE; URINARY; WOMEN; EVOLUTIONARY; CREATININE; PREGNANCY	Psychological challenges, including traumatic events, have been hypothesized to increase the age-related pace of biological aging. Here we test the hypothesis that psychological challenges can affect the pace of telomere attrition, a marker of cellular aging, using data from an ongoing longitudinal-cohort study of Kaqchikel Mayan women living in a population with a high frequency of child mortality, a traumatic life event. Specifically, we evaluate the associations between child mortality, maternal telomere length and the mothers' hypothalamic-pituitary-adrenal axis (HPAA), or stress axis, activity. Child mortality data were collected in 2000 and 2013. HPAA activity was assessed by quantifying cortisol levels in first morning urinary specimens collected every other day for seven weeks in 2013. Telomere length (TL) was quantified using qPCR in 55 women from buccal specimens collected in 2013. Results: Shorter TL with increasing age was only observed in women who experienced child mortality (p = 0.015). Women with higher average basal cortisol (p = 0.007) and greater within-individual variation (standard deviation) in basal cortisol (p = 0.053) presented shorter TL. Non-parametric bootstrapping to estimate mediation effects suggests that HPAA activity mediates the effect of child mortality on TL. Our results are, thus, consistent with the hypothesis that traumatic events can influence cellular aging and that HPAA activity may play a mediatory role. Future large-scale longitudinal studies are necessary to confirm our results and further explore the role of the HPAA in cellular aging, as well as to advance our understanding of the underlying mechanisms involved.	[Barha, Cindy K.; Salvante, Katrina G.; Nepomnaschy, Pablo A.] Simon Fraser Univ, Maternal & Child Hlth Lab, Fac Hlth Sci, Burnaby, BC, Canada; [Salvante, Katrina G.; Nepomnaschy, Pablo A.] Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC, Canada; [Hanna, Courtney W.; Wilson, Samantha L.; Robinson, Wendy P.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Hanna, Courtney W.; Wilson, Samantha L.; Robinson, Wendy P.; Nepomnaschy, Pablo A.] Child & Family Res Inst, Vancouver, BC, Canada; [Altman, Rachel M.] Simon Fraser Univ, Stat & Actuarial Sci, Burnaby, BC, Canada; [Barha, Cindy K.] Univ British Columbia, Dept Phys Therapy, Fac Med, Vancouver, BC, Canada; [Hanna, Courtney W.] Babraham Inst, Babraham Res Campus, Cambridge, England	Simon Fraser University; Simon Fraser University; University of British Columbia; Child & Family Research Institute; Simon Fraser University; University of British Columbia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Nepomnaschy, PA (corresponding author), Simon Fraser Univ, Maternal & Child Hlth Lab, Fac Hlth Sci, Burnaby, BC, Canada.; Nepomnaschy, PA (corresponding author), Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC, Canada.; Nepomnaschy, PA (corresponding author), Child & Family Res Inst, Vancouver, BC, Canada.	pan2@sfu.ca	Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174; Hanna, Courtney/0000-0002-4063-5575; Salvante, Katrina/0000-0002-8608-8001; Wilson, Samantha/0000-0003-4346-9696; Barha, Cindy/0000-0003-3149-5539; Nepomnaschy, Pablo/0000-0002-8989-7381	Canadian Institutes of Health Research Post-Doctoral Fellowship; Canadian Institutes of Health Research Training Grant; Child and Family Research Institute Graduate Studentship; Child and Family Research Institute; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research (Institute for Gender and Health) Operating Grant [106705]; Simon Fraser University Presidents Start-up Grant; Simon Fraser University Community Trust Endowment Fund Grant through Simon Fraser Universitys Human Evolutionary Studies Program; Michael Smith Foundation for Health Research Career Investigator Scholar Award	Canadian Institutes of Health Research Post-Doctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Training Grant(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute Graduate Studentship; Child and Family Research Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research (Institute for Gender and Health) Operating Grant(Canadian Institutes of Health Research (CIHR)); Simon Fraser University Presidents Start-up Grant; Simon Fraser University Community Trust Endowment Fund Grant through Simon Fraser Universitys Human Evolutionary Studies Program; Michael Smith Foundation for Health Research Career Investigator Scholar Award	This project was funded by a Canadian Institutes of Health Research Post-Doctoral Fellowship to CKB (http://www.cihr-irsc.gc.ca/e/193.html); a Canadian Institutes of Health Research Training Grant to CWH (http://www.cihr-irsc.gc.ca/e/193.html); a Child and Family Research Institute Graduate Studentship to SLW (http://www.cfri.ca/); a Child and Family Research Institute salary award to WPR (http://www.cfri.ca/); a Natural Sciences and Engineering Research Council of Canada Discovery Grant to RMA (http://www.nserc-crsng.gc.ca/index_eng.asp); a Canadian Institutes of Health Research (Institute for Gender and Health) Operating Grant #106705 (http://www.cihr-irsc.gc.ca/e/193.html), a Simon Fraser University Presidents Start-up Grant (https://www.sfu.ca/vpacademic/FinBdgt_Mgmnt/prsg.html), a Simon Fraser University Community Trust Endowment Fund Grant through Simon Fraser Universitys Human Evolutionary Studies Program (https://www.sfu.ca/vpresearch/ctef.html), and a Michael Smith Foundation for Health Research Career Investigator Scholar Award (http://www.msfhr.org/) to PAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker C, 2013, NEUROPSYCHOPHARMACOL, V38, P872, DOI 10.1038/npp.2012.253; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Aulinas A, 2013, CLIN ENDOCRINOL, V79, P751, DOI 10.1111/cen.12310; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Barha CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146424; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Benetos A, 2013, AGING CELL, V12, P615, DOI 10.1111/acel.12086; Bernabe DG, 2011, BRAIN BEHAV IMMUN, V25, P574, DOI 10.1016/j.bbi.2010.12.012; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; Carroll JE, 2016, SLEEP, V39, P559, DOI 10.5665/sleep.5526; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Cohen S, 2013, BRAIN BEHAV IMMUN, V34, P31, DOI 10.1016/j.bbi.2013.06.009; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Daubenmier J, 2012, PSYCHONEUROENDOCRINO, V37, P917, DOI 10.1016/j.psyneuen.2011.10.008; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Eisenberg DTA, 2011, AM J HUM BIOL, V23, P149, DOI 10.1002/ajhb.21127; Ellison PT, 2003, FERTIL STERIL, V80, P1279, DOI 10.1016/S0015-0282(03)02158-7; Epel ES, 2014, J GERONTOL A-BIOL, V69, pS10, DOI 10.1093/gerona/glu055; Epel ES, 2010, BRAIN BEHAV IMMUN, V24, P531, DOI 10.1016/j.bbi.2009.11.018; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; FIBIGER W, 1984, NEUROSCI BIOBEHAV R, V8, P523, DOI 10.1016/0149-7634(84)90009-5; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Hanna CW, 2009, HUM REPROD, V24, P1206, DOI 10.1093/humrep/dep007; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Humphreys J, 2012, BIOL RES NURS, V14, P115, DOI 10.1177/1099800411398479; Itagaki T, 2005, GUT, V54, P1782, DOI 10.1136/gut.2005.053278; Jasienska G, 2001, FOUND HUM B, P59; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; KIRSCHBAUM C, 1995, PSYCHOSOM MED, V57, P468, DOI 10.1097/00006842-199509000-00009; Kroenke CH, 2011, PSYCHOSOM MED, V73, P533, DOI 10.1097/PSY.0b013e318229acfc; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Kyo S, 1999, CANCER RES, V59, P5917; Lopes LM, 2015, DETERMINATION NIGHTT; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; Malan S, 2011, DEPRESS ANXIETY, V28, P1081, DOI 10.1002/da.20903; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1673, DOI 10.1093/ije/dyu191; Michaeli TF, 2015, FERTIL STERIL, V103, P1125, DOI 10.1016/j.fertnstert.2015.02.034; Miller DB, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.33184; Miller MW, 2014, MOL PSYCHIATR, V19, P1156, DOI 10.1038/mp.2014.111; Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292; Muezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003; Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103; Nepomnaschy PA, 2004, AM J HUM BIOL, V16, P523, DOI 10.1002/ajhb.20057; Nepomnaschy PA, 2012, AM J HUM BIOL, V24, P515, DOI 10.1002/ajhb.22259; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pardon MC, 2008, NEUROSCI BIOBEHAV R, V32, P1103, DOI 10.1016/j.neubiorev.2008.03.005; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Abrao ALP, 2014, REV BRAS GINECOL OBS, V36, P72, DOI [10.1590/S0100-72032014000100005, 10.1590/S0100-72032014000200005]; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Puterman E, 2015, MOL PSYCHIATR, V20, P529, DOI 10.1038/mp.2014.70; Puterman E, 2012, SOC PERSONAL PSYCHOL, V6, P807, DOI 10.1111/j.1751-9004.2012.00465.x; Raymond AR, 2015, AM J HYPERTENS, V28, P623, DOI 10.1093/ajh/hpu212; Revesz D, 2014, NEUROBIOL AGING, V35, P1422, DOI 10.1016/j.neurobiolaging.2013.12.027; Salvante KG, 2012, AM J HUM BIOL, V24, P81, DOI 10.1002/ajhb.21229; Sarkar PL, 2013, AM J HUM BIOL, V25, P351, DOI 10.1002/ajhb.22376; Savolainen K, 2015, PSYCHONEUROENDOCRINO, V53, P179, DOI 10.1016/j.psyneuen.2014.12.020; Shalev C, 2013, PSYCHONEUROENDOCRINO, V38, P1835, DOI 10.1016/j.psyneuen.2013.03.010; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; SMITH R, 1987, HORM METAB RES, V19, P41, DOI 10.1055/s-2007-1011733; Stearns S.C., 1992, pi; Tomiyama AJ, 2012, PHYSIOL BEHAV, V106, P40, DOI 10.1016/j.physbeh.2011.11.016; Uhart M, 2006, PSYCHONEUROENDOCRINO, V31, P642, DOI 10.1016/j.psyneuen.2006.02.003; van der Pompe G, 2001, INT J SPORTS MED, V22, P447; Verhoeven J. E., 2015, PSYCHOSOM MED; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; White BC, 2010, AM J PRIMATOL, V72, P1082, DOI 10.1002/ajp.20867; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003	82	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177869	10.1371/journal.pone.0177869	http://dx.doi.org/10.1371/journal.pone.0177869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542264	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800027
J	Gastal, GDA; Hamilton, A; Alves, BG; de Tarso, SGS; Feugang, JM; Banz, WJ; Apgar, GA; Nielsen, CK; Gastal, EL				Gastal, G. D. A.; Hamilton, A.; Alves, B. G.; de Tarso, S. G. S.; Feugang, J. M.; Banz, W. J.; Apgar, G. A.; Nielsen, C. K.; Gastal, E. L.			Ovarian features in white-tailed deer (Odocoileus virginianus) fawns and does	PLOS ONE			English	Article							PREANTRAL FOLLICLE POPULATION; EPIDERMAL-GROWTH-FACTOR; FERTILITY PRESERVATION; IN-SITU; TISSUE; VIABILITY; SURVIVAL; EXPRESSION; MANAGEMENT; APOPTOSIS	The knowledge about ovarian reserve is essential to determine the reproductive potential and to improve the methods of fertility control for overpopulated species, such as whitetailed deer (Odocoileus virginianus). The goal of this study was to evaluate the effect of age on the female reproductive tract of white-tailed deer, focusing on ovarian features. Genital tracts from 8 prepubertal and 10 pubertal females were used to characterize the preantral follicle population and density, morphology, distribution of follicular classes; stromal cell density; and apoptosis in the ovary. In addition, uterus and ovary weights and dimensions were recorded; and the number and the size of antral follicles and corpus luteum in the ovary were quantified. Overall, fawns had a greater (P < 0.05) preantral follicle population, percentage of normal follicles, and preantral follicle density than does. The mean stromal cell density in ovaries of fawns and does differed among animals but not between age groups. The apoptotic signaling did not differ (P > 0.05) between the ovaries of fawns and does. However, apoptotic ovarian cells negatively (P < 0.001) affected the preantral follicle morphology and density, and conversely, a positive correlation was observed with stromal cell density. As expected, the uteri and ovaries were larger (P < 0.002) and heavier (P < 0.001) in does than in fawns. In conclusion, this study has shown, for the first time, the preantral follicle population and distribution of classes, rate of morphologically normal follicles, and density of preantral follicles and stromal cells in white-tailed deer. Therefore, the findings herein described lead to a better understanding of the white-tailed deer ovarian biology, facilitating the development of new methods of fertility control.	[Gastal, G. D. A.; Hamilton, A.; Alves, B. G.; de Tarso, S. G. S.; Banz, W. J.; Apgar, G. A.; Gastal, E. L.] Southern Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA; [Feugang, J. M.] Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA; [Nielsen, C. K.] Southern Illinois Univ, Dept Forestry, Cooperat Wildlife Res Lab, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Mississippi State University; Southern Illinois University System; Southern Illinois University	Gastal, EL (corresponding author), Southern Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA.	egastal@siu.edu	Gastal, Gustavo Desire Antunes/K-7424-2013; Alves, Benner/D-3599-2014; Gastal, Eduardo Leite/O-8359-2019; Gastal, Eduardo Leite/Q-9854-2017	Gastal, Gustavo Desire Antunes/0000-0002-5317-2207; Alves, Benner/0000-0001-9465-8054; Gastal, Eduardo Leite/0000-0002-8855-6980; Gastal, Eduardo Leite/0000-0002-8855-6980	CNPq, Brazil [246741/2012-0]; i2i Program at College of Agricultural Sciences, Southern Illinois University; USDA-ARSgrant [58-6402-3-018]	CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); i2i Program at College of Agricultural Sciences, Southern Illinois University; USDA-ARSgrant	G.D.A. Gastal was a recipient of a PhD scholarship from CNPq (grant #246741/2012-0), Brazil. Research supported by i2i Program at College of Agricultural Sciences, Southern Illinois University, and USDA-ARSgrant #58-6402-3-018 (to J. M. Feugang)	Alves KA, 2016, REPROD FERTIL DEV; Alves KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149693; Asher GW, 2011, ANIM REPROD SCI, V124, P170, DOI 10.1016/j.anireprosci.2010.08.026; Block E., 1952, CELLS TISSUES ORGANS, V14, P108; Bodensteiner KJ, 2004, TOXICOL SCI, V80, P83, DOI 10.1093/toxsci/kfh135; Chambers EL, 2010, HUM REPROD, V25, P2559, DOI 10.1093/humrep/deq192; Comizzoli P, 2015, ASIAN J ANDROL, V17, P640, DOI 10.4103/1008-682X.153849; Comizzoli P, 2014, REPROD FERT DEVELOP, V26, P91, DOI 10.1071/RD13259; Commin L, 2012, REPROD FERT DEVELOP, V24, P461, DOI 10.1071/RD11166; DRIANCOURT MA, 1985, J REPROD FERTIL, V73, P93, DOI 10.1530/jrf.0.0730093; Fabbri R, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/910698; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; Findlay JK, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.133652; Fortin NL, 2015, WILDLIFE SOC B, V39, P56, DOI 10.1002/wsb.498; Fransolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091073; Fujihara M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115089; Gaytan F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144099; GOSDEN RG, 1987, J ZOOL, V211, P169, DOI 10.1111/j.1469-7998.1987.tb07460.x; GOUGEON A, 1987, J REPROD FERTIL, V81, P433; Haag KT, 2013, THERIOGENOLOGY, V79, P599, DOI 10.1016/j.theriogenology.2012.11.012; Hedgeland MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146611; HULSHOF SCJ, 1994, VET QUART, V16, P78, DOI 10.1080/01652176.1994.9694423; Albamonte MI, 2013, HUM REPROD, V28, P698, DOI 10.1093/humrep/des453; Kieser DC, 2014, BIO-MED MATER ENG, V24, P1693, DOI 10.3233/BME-140981; Kirkpatrick JF, 1997, REPROD FERT DEVELOP, V9, P105, DOI 10.1071/R96052; KOERING MJ, 1983, AM J ANAT, V166, P429, DOI 10.1002/aja.1001660405; Kristensen SG, 2011, HUM REPROD, V26, P157, DOI 10.1093/humrep/deq318; Lima GL, 2013, ANAT HISTOL EMBRYOL, V42, P304, DOI 10.1111/ahe.12021; Liu GM, 2010, CHINESE MED J-PEKING, V123, P2379, DOI 10.3760/cma.j.issn.0366-6999.2010.17.018; Lucci CM, 1999, ANIM REPROD SCI, V56, P223, DOI 10.1016/S0378-4320(99)00045-7; Malcolm KD, 2010, ANIM REPROD SCI, V117, P261, DOI 10.1016/j.anireprosci.2009.05.003; McCabe Thomas R., 1997, P11; McClellan KA, 2003, DEV BIOL, V258, P334, DOI 10.1016/S0012-1606(03)00132-5; Nichols SM, 2005, HUM REPROD, V20, P79, DOI 10.1093/humrep/deh576; Nielsen CK, 2011, WILDLIFE SOC B, V35, P124, DOI 10.1002/wsb.54; Paulini F, 2016, REPROD BIOMED ONLINE, V33, P425, DOI 10.1016/j.rbmo.2016.05.003; Pavlik EJ, 2000, GYNECOL ONCOL, V77, P410, DOI 10.1006/gyno.2000.5783; Powers JG, 2014, WILDLIFE SOC B, V38, P650, DOI 10.1002/wsb.434; Praxedes ECG, 2015, REPROD FERT DEVELOP, V29, P594; Qu JP, 2000, FERTIL STERIL, V74, P113, DOI 10.1016/S0015-0282(00)00549-5; Schmidt KLT, 2003, HUM REPROD, V18, P2654, DOI 10.1093/humrep/deg500; SEVERINGHAUS CW, 1949, J WILDLIFE MANAGE, V13, P195, DOI 10.2307/3796089; Silva-Santos KC, 2011, THERIOGENOLOGY, V76, P1051, DOI 10.1016/j.theriogenology.2011.05.008; Smith P, 2014, J ENDOCRINOL, V221, pR145, DOI 10.1530/JOE-14-0062; Soares M, 2015, HUM REPROD, V30, P1589, DOI 10.1093/humrep/dev101; Spencer TE, 2012, MOL CELL ENDOCRINOL, V354, P34, DOI 10.1016/j.mce.2011.09.035; Stansfield FJ, 2011, ANIM REPROD SCI, V129, P96, DOI 10.1016/j.anireprosci.2011.10.009; Turner JW, 2008, WILDLIFE RES, V35, P555, DOI 10.1071/WR07159; Vaskivuo TE, 2001, J CLIN ENDOCR METAB, V86, P3421, DOI 10.1210/jc.86.7.3421; VerCauteren KC, 2006, WILDLIFE SOC B, V34, P191, DOI 10.2193/0091-7648(2006)34[191:FADMAR]2.0.CO;2; Walker ML, 2009, REPRODUCTION, V138, P793, DOI 10.1530/REP-08-0449; Wallace WH, 2004, HUM REPROD, V19, P1612, DOI 10.1093/humrep/deh285; Wang Y, 2015, INT J MORPHOL, V33, P105, DOI 10.4067/S0717-95022015000100018; Wasinpongwanich K., 2014, J SPINE, V3, P187; Wright R, 1993, RENEWABLE RESOURCES, V11, P18	55	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177357	10.1371/journal.pone.0177357	http://dx.doi.org/10.1371/journal.pone.0177357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542265	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800015
J	Gray, H; Pearce, B; Thiele, A; Rowe, C				Gray, Helen; Pearce, Bradley; Thiele, Alexander; Rowe, Candy			The use of preferred social stimuli as rewards for rhesus macaques in behavioural neuroscience	PLOS ONE			English	Article							BONNET MACAQUES; RESPONSE PATTERNS; FLUID CONTROL; VIDEO REWARD; MONKEYS; FOOD; REINFORCEMENT; ANIMALS; HUMANS; PELLET	Macaques are often motivated to perform in neuroscientific experiments by implementing fluid restriction protocols. Daily access to water is controlled and the monkeys are rewarded with droplets of fluid for performing correct trials in the laboratory. Although these protocols are widely used and highly effective, it is important from a 3Rs perspective to investigate refinements that may help to lessen the severity of the fluid restriction applied. We assessed the use of social stimuli (images of conspecifics) as rewards for four rhesus macaques performing simple cognitive tasks. We found that individual preferences for images of male faces, female perinea and control stimuli could be identified in each monkey. However, using preferred images did not translate into effective motivators on a trial-by-trial basis: animals preferred fluid rewards, even when fluid restriction was relaxed. There was no difference in the monkeys' performance of a task when using greyscale versus colour images. Based on our findings, we cannot recommend the use of social stimuli, in this form, as a refinement to current fluid restriction protocols. We discuss the potential alternatives and possibilities for future research.	[Gray, Helen; Pearce, Bradley; Thiele, Alexander; Rowe, Candy] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England; [Gray, Helen] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England	Newcastle University - UK; University of Leeds	Gray, H (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England.; Gray, H (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	h.e.gray@leeds.ac.uk		Gray, Helen/0000-0001-8335-7432; Rowe, Candy/0000-0001-5379-843X; Thiele, Alexander/0000-0003-4894-0213	National Centre for the Replacement Refinement and Reduction of Animals in Research [NC/K500410/1]; Wellcome Trust [093104]; National Centre for the Replacement [NC/K500410/1] Funding Source: researchfish	National Centre for the Replacement Refinement and Reduction of Animals in Research; Wellcome Trust(Wellcome TrustEuropean Commission); National Centre for the Replacement	This work was supported by the National Centre for the Replacement Refinement and Reduction of Animals in Research, NC/K500410/1, https://www.nc3rs.org.uk/; and The Wellcome Trust, 093104, https://wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 1998, BEHAV PROCESS, V42, P159, DOI 10.1016/S0376-6357(97)00074-0; Andrews MW, 2002, AM J PRIMATOL, V57, P213, DOI 10.1002/ajp.10044; ANDREWS MW, 1995, LEARN MOTIV, V26, P370, DOI 10.1016/S0023-9690(05)80002-5; Andrews MW, 2001, LEARN MOTIV, V32, P401, DOI 10.1006/lmot.2001.1092; ANDREWS MW, 1993, PERCEPT MOTOR SKILL, V77, P755, DOI 10.2466/pms.1993.77.3.755; BUTLER RA, 1954, J EXP PSYCHOL, V48, P19, DOI 10.1037/h0063578; CHAMOVE A S, 1989, Animal Technology, V40, P155; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; DEMARIA C, 1988, PRIMATES, V29, P237, DOI 10.1007/BF02381125; Dobkins KR, 2000, J OPT SOC AM A, V17, P545, DOI 10.1364/JOSAA.17.000545; FUJITA K, 1986, PRIMATES, V27, P283, DOI 10.1007/BF02382072; Gray H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0195-16.2016; HAUDE RH, 1976, PERCEPT MOTOR SKILL, V43, P231, DOI 10.2466/pms.1976.43.1.231; Higham JP, 2010, BEHAV ECOL, V21, P739, DOI 10.1093/beheco/arq047; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Lindburg D. G., 1977, P223; NC3Rs, 2006, NC3RS GUID PRIM ACC; Ogura T, 2012, J APPL ANIM WELF SCI, V15, P101, DOI 10.1080/10888705.2012.624887; Ogura T, 2011, ANIM COGN, V14, P427, DOI 10.1007/s10071-010-0377-y; Orlans F Barbara, 1991, Ilar News, V33, P48; Platt DM, 1997, APPL ANIM BEHAV SCI, V52, P139, DOI 10.1016/S0168-1591(96)01093-3; Prescott MJ, 2010, J NEUROSCI METH, V193, P167, DOI 10.1016/j.jneumeth.2010.09.003; Ramirez-Cardenas A, 2015, CURR BIOL, P1285; SACKETT GP, 1965, PERCEPT MOTOR SKILL, V20, P1027, DOI 10.2466/pms.1965.20.3c.1027; Sanayei M, 2015, EUR J NEUROSCI, V41, P947, DOI 10.1111/ejn.12857; Southwick C.H., 1965, PRIMATES BEHAV FIELD, P111, DOI DOI 10.1016/J.JHEALECO.2003.08.004; SWARTZ KB, 1980, ANIM LEARN BEHAV, V8, P311, DOI 10.3758/BF03199611; Thiele A, 2006, J NEUROSCI METH, V158, P207, DOI 10.1016/j.jneumeth.2006.05.032; Waitt C, 2003, P ROY SOC B-BIOL SCI, V270, pS144, DOI 10.1098/rsbl.2003.0065; Washburn DA, 1997, LEARN MOTIV, V28, P510, DOI 10.1006/lmot.1997.0981; WASHBURN DA, 1994, PERCEPT MOTOR SKILL, V78, P48, DOI 10.2466/pms.1994.78.1.48; Watson KK, 2012, ANIM COGN, V15, P401, DOI 10.1007/s10071-011-0467-5; Westlund K, 2012, J NEUROSCI METH, V204, P202, DOI 10.1016/j.jneumeth.2011.03.021; Willems RA, 2009, LAB ANIMAL, V38, P325, DOI 10.1038/laban1009-325	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178048	10.1371/journal.pone.0178048	http://dx.doi.org/10.1371/journal.pone.0178048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542356	Green Published, gold			2022-12-27	WOS:000402062800039
J	Nikiema, L; Huybregts, L; Martin-Prevel, Y; Donnen, P; Lanou, H; Grosemans, J; Offoh, P; Dramaix-Wilmet, M; Sondo, B; Roberfroid, D; Kolsteren, P				Nikiema, Laetitia; Huybregts, Lieven; Martin-Prevel, Yves; Donnen, Philippe; Lanou, Hermann; Grosemans, Joep; Offoh, Priscilla; Dramaix-Wilmet, Michele; Sondo, Blaise; Roberfroid, Dominique; Kolsteren, Patrick			Effectiveness of facility-based personalized maternal nutrition counseling in improving child growth and morbidity up to 18 months: A cluster-randomized controlled trial in rural Burkina Faso	PLOS ONE			English	Article							COMPLEMENTARY FEEDING PRACTICES; COMMUNITY-HEALTH WORKERS; MIDDLE-INCOME COUNTRIES; YOUNG-CHILDREN; EDUCATIONAL INTERVENTION; UNDERNUTRITION; PROMOTION; CHALLENGES	The period from conception to 24 months of age is a crucial window for nutrition interventions. Personalized maternal counseling may improve childbirth outcomes, growth, and health. We assessed the effectiveness of facility-based personalized maternal nutrition counseling (from pregnancy to 18 months after birth) in improving child growth and health in rural Burkina Faso. We conducted a paired cluster randomized controlled trial in a rural district of Burkina Faso with 12 primary health centers (clusters). Healthcare providers in the intervention centers received patient-centered communication and nutrition counseling training. Pregnant women in the third trimester living in the center catchment areas and intending to stay for the next 2 years were prospectively included. We followed 2253 mother-child pairs quarterly until the child was aged 18 months. Women were interviewed about counseling experiences, dietary practices during pregnancy, and their child's feeding practices and morbidity history. Anthropometric measurements were taken at each visit using standardized methods. The primary outcomes were the cumulative incidence of wasting, and changes in child weight-for-height z-score (WHZ). Secondary outcomes were the women's prenatal dietary practices, early breastfeeding practices, exclusive breastfeeding, timely introduction of complementary food, child's feeding frequency and dietary diversity, children's mean birth weight, endpoint prevalence of stunting, and cumulative incidence of diarrhea, fever, and acute respiratory infection. All analyses were by intention-to-treat using mixed effects models. The intervention and control arms each included six health centers. Mothers in the intervention arm had a significantly higher exposure to counseling with 11.2% for breastfeeding techniques to 75.7% for counseling on exclusive breastfeeding. Mothers of infants below 6 months of age in the intervention arm were more likely to exclusively breastfeed (54.3% vs 42.3%; Difference of Proportion (DP) 12.8%; 95% CI: 2.1, 23.6; p = 0.020) as compared to the control arm. Between 6 and 18 months of age, more children in the intervention arm benefited from the required feeding frequency (68.8% vs 53.4%; DP 14.1%; 95% CI: 9.0, 19.2; p<0.001) and a larger proportion had a minimum dietary diversity (28.6% vs 22.0%; DP 5.9%; 95% CI: 2.7, 9.2; p<0.001). Birth weight of newborns in the intervention arm was on average 84.8 g (p = 0.037) larger compared to the control arm. However, we found no significant differences in child anthropometry or morbidity between study arms. Facility-based personalized maternal nutrition counseling was associated with an improved prenatal dietary practices, Infant and Young Child Feeding practices, and child birth weight. Complementary strategies are warranted to obtain meaningful impact on child growth and morbidity. This includes strategies to ensure good coverage of facility-based services and effective nutrition/care practices in early childhood.	[Nikiema, Laetitia; Lanou, Hermann; Sondo, Blaise] Minist Sci Res & Innovat, IRSS, Ouagadougou, Burkina Faso; [Huybregts, Lieven] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Martin-Prevel, Yves] Inst Rech Dev, Res Unit Nutripass 204, Montpellier, France; [Donnen, Philippe; Dramaix-Wilmet, Michele] Univ Libre Bruxelles, Ctr Rech Polit & Syst Sante Sante Int, Ecole Sante Publ, Campus Erasme, Brussels, Belgium; [Grosemans, Joep] PXL Univ Coll, Healthcare Dept, Guffenslaan, Hasselt, Belgium; [Offoh, Priscilla] PAMHI, Dept Software Management & Programming PAMHI, Okota Lagos, Nigeria; [Roberfroid, Dominique] Inst Trop Med, Dept Publ Hlth, Child Hlth & Nutr Unit, Antwerp, Belgium; [Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, Ghent, Belgium	CGIAR; International Food Policy Research Institute (IFPRI); Institut de Recherche pour le Developpement (IRD); Universite Libre de Bruxelles; Institute of Tropical Medicine (ITM); Ghent University	Nikiema, L (corresponding author), Minist Sci Res & Innovat, IRSS, Ouagadougou, Burkina Faso.	louedraogo@irss.bf	LANOU, Hermann Biénou/GXF-4468-2022; Huybregts, Lieven/B-9578-2009	Huybregts, Lieven/0000-0002-3068-2853; Grosemans, Joep/0000-0001-9222-0470	Nutrition Third World; Belgian Ministry of Development	Nutrition Third World; Belgian Ministry of Development	This work was funded by Nutrition Third World. We thank the Belgian Ministry of Development for the scholarship that allowed Laetitia Nikiema to undertake her PhD in the context of this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahmed T, 2012, ANN NUTR METAB, V61, P8, DOI 10.1159/000345165; Andolo CG, 2007, GUIDE PRATIQUE DE LA; Arsenault JE, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.53; Bhandari N, 2004, J NUTR, V134, P2342; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Cegala DJ, 2000, ARCH FAM MED, V9, P57, DOI 10.1001/archfami.9.1.57; de Onis M, 2013, MATERN CHILD NUTR, V9, P6, DOI 10.1111/mcn.12075; Dewey KG, 2001, J NUTR, V131, P1879, DOI 10.1093/jn/131.7.1879; DIvernois JF, 2004, APPROCHE PEDAGOGIQUE; Fitzmaurice G. M., 2004, APPLIED LONGITUDINAL; Gibson RS, 1990, PRINCIPLES OF NUTRIT; Gilmore B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-847; Girard AW, 2012, PAEDIATR PERINAT EP, V26, P191, DOI 10.1111/j.1365-3016.2012.01278.x; Glenton C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010414.pub2; Gordon M., 1994, NURSING DIAGNOSIS PR; Gordon M, 1991, DIAGNOSTIC INFIRMIER; Guldan GS, 2000, J NUTR, V130, P1204, DOI 10.1093/jn/130.5.1204; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Haroon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S20; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Huybregts L, 2009, AM J CLIN NUTR, V90, P1593, DOI 10.3945/ajcn.2009.28253; Iandolo C., 2001, GUIDE PRATIQUE DE LA; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25; Institute on Medicine, CROSSING THE QUALITY; Kok MC, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0001-3; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; Lauritsen J BM, 2003, EPIDATA VERSION 3 TH; Leroy J.L., 2011, ZSCORE06 STATA COMMA; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Little P, 2001, BMJ-BRIT MED J, V322, P468, DOI 10.1136/bmj.322.7284.468; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Mbuya M. N. N., 2015, MATERN CHILD NUTR; Moore AC, 2006, SOC SCI MED, V62, P1917, DOI 10.1016/j.socscimed.2005.08.058; Ota E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000032.pub3; Ota E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000032.pub2; Patel A, 2012, MATERN CHILD NUTR, V8, P28, DOI 10.1111/j.1740-8709.2011.00385.x; Pelto GH, 2004, J NUTR, V134, P357, DOI 10.1093/jn/134.2.357; Penny ME, 2005, LANCET, V365, P1863, DOI 10.1016/S0140-6736(05)66426-4; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; Rah JH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005180; Roberfroid D, 2007, TROP MED INT HEALTH, V12, P1074, DOI 10.1111/j.1365-3156.2007.01890.x; Roberfroid D, 2005, J HEALTH POPUL NUTR, V23, P207; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Rouquette C., 2004, EDUCATION ET CONSEIL; [Secretariat General Direction generale des etudes et des statistiques sector-ielles Ministere sante], 2014, SECRETARIAT GENERAL; Shi L, 2010, PUBLIC HEALTH NUTR, V13, P556, DOI 10.1017/S1368980009991364; Stewart M, 2003, PATIENT CENTERED MED; Sunguya Bruno F, 2013, Front Public Health, V1, P37, DOI 10.3389/fpubh.2013.00037; Sunguya BF, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-66; [UNICEF WHO], 2005, HANDBOOK INTEGRATED; [UNICEF WHO], 2006, INFANT AND YOUNG CHI; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2012, THE 2012 REPORT; World Health Organization, 2006, WHO CHILD GROWTH STA; World Health Organization, 2008, INDICATORS FOR ASSES	58	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177839	10.1371/journal.pone.0177839	http://dx.doi.org/10.1371/journal.pone.0177839			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542391	Green Published, gold			2022-12-27	WOS:000402062800026
J	In, HJ; Lim, H; Lee, JA; Kim, HJ; Kim, JW; Hyeon, JY; Yeo, SG; Lee, JW; Yoo, JS; Choi, YK; Lee, SW				In, Hyun Ju; Lim, Heeji; Lee, Jung-Ah; Kim, Hye Jin; Kim, Jin-Won; Hyeon, Ji-Yeon; Yeo, Sang-Gu; Lee, June-Woo; Yoo, Jung Sik; Choi, Young Ki; Lee, Sang-Won			An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; EV71 VACCINE; DOUBLE-BLIND; LIPID-A; ADJUVANT; SAFETY	Enterovirus 71 (EV71) is a major causative agent of hand-foot-and-mouth disease (HFMD) frequently occurring in children. HFMD induced by EV71 can cause serious health problems and has been reported worldwide, particularly in the Asia-Pacific region. In this study, we assessed the immunogenicity of a formalin-inactivated HFMD vaccine using an EV71 strain (FI-EV71 C4a) isolated from a Korean patient. The vaccine candidate was evaluated in mice to determine the vaccination doses and vaccine schedules. BALB/c mice were intra-muscularly administered 5, 10, or 20 mu g FI-EV71 vaccine, followed by a booster 2 weeks later. EV71-specific antibodies and neutralizing antibodies were induced and maintained until the end of the experimental period in all vaccinated groups. To determine the effectiveness of adjuvant for the EV71 vaccine, three adjuvants, i.e., aluminium hydroxide gel, monophosphoryl lipid A, and polyinosinic-polycytidylic acid, were administered separately with the FI-EV71 vaccine to mice via the intramuscular route. Mice administered the FI-EV71 vaccine formulated with all three adjuvants induced a significantly increased antibody response compared with that of the single adjuvant groups. The vaccinated group with triple adjuvants exhibited more rapid induction of EV71-specific and neutralizing antibodies than the other groups. These results suggested that the role of adjuvant in inactivated vaccine was important for eliciting effective immune responses against EV71. In conclusion, our results showed that FI-EV71 was a potential candidate vaccine for prevention of EV71 infection.	[In, Hyun Ju; Lim, Heeji; Lee, Jung-Ah; Kim, Hye Jin; Kim, Jin-Won; Hyeon, Ji-Yeon; Yeo, Sang-Gu; Lee, June-Woo; Yoo, Jung Sik; Lee, Sang-Won] Korea Ctr Dis Control & Prevent, Korea Natl Res Inst Hlth, Div Vaccine Res, Cheongju, Chungcheongbuk, South Korea; [In, Hyun Ju; Lim, Heeji; Choi, Young Ki] Chungbuk Natl Univ, Coll Med, Cheongju, Chungcheongbuk, South Korea; [In, Hyun Ju; Lim, Heeji; Choi, Young Ki] Chungbuk Natl Univ, Med Res Inst, Cheongju, Chungcheongbuk, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Chungbuk National University; Chungbuk National University	Lee, SW (corresponding author), Korea Ctr Dis Control & Prevent, Korea Natl Res Inst Hlth, Div Vaccine Res, Cheongju, Chungcheongbuk, South Korea.	epilsw@korea.kr	IN, HYUN JU/A-5623-2017	IN, HYUN JU/0000-0002-7783-4877	Korea National Institute of Health [NIH 4800-4845-300]	Korea National Institute of Health	This work was supported by grants from the Korea National Institute of Health (grant no. NIH 4800-4845-300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving CR, 2008, VACCINE, V26, P3036, DOI 10.1016/j.vaccine.2007.12.002; Ann J, 2014, VACCINE, V32, P5730, DOI 10.1016/j.vaccine.2014.08.029; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chong P, 2012, HUM VACC IMMUNOTHER, V8, P1775, DOI 10.4161/hv.21739; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Didierlaurent AM, 2014, J IMMUNOL, V193, P1920, DOI 10.4049/jimmunol.1400948; Dochez C, 2014, VACCINE, V32, P1595, DOI 10.1016/j.vaccine.2013.10.081; Fortier ME, 2004, AM J PHYSIOL-REG I, V287, pR759, DOI 10.1152/ajpregu.00293.2004; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; GERMANN T, 1995, EUR J IMMUNOL, V25, P823, DOI 10.1002/eji.1830250329; Heinsbroek E, 2010, VACCINE, V28, P3778, DOI 10.1016/j.vaccine.2010.02.095; Khong WX, 2011, J VIROL, V85, P3067, DOI 10.1128/JVI.01779-10; Kim KH, 2009, KOREAN J PEDIAT, V53, P616, DOI DOI 10.3345/KJP.2010.53.5.616; Ku ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057601; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Liang Z, 2012, FRONTIERMED, V7, P111; Liang ZL, 2013, HUM VACC IMMUNOTHER, V9, P1701, DOI 10.4161/hv.24949; Liang ZL, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.24; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; Rappuoli R, 2011, PHILOS T R SOC B, V366, P2756, DOI 10.1098/rstb.2011.0075; Rumke HC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-348; Ryu WS, 2010, EMERG INFECT DIS, V16, P1764, DOI 10.3201/eid1611.100104; Schwarz TF, 2008, GYNECOL ONCOL, V110, pS1, DOI 10.1016/j.ygyno.2008.05.036; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Vogel FR, 2000, CLIN INFECT DIS, V30, pS266, DOI 10.1086/313883; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1	39	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178259	10.1371/journal.pone.0178259	http://dx.doi.org/10.1371/journal.pone.0178259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542556	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500079
J	Iwakura, N; Yokoyama, T; Quaglia, F; Mitsuoka, K; Mio, K; Shigematsu, H; Shirouzu, M; Kaji, A; Kaji, H				Iwakura, Nobuhiro; Yokoyama, Takeshi; Quaglia, Fabio; Mitsuoka, Kaoru; Mio, Kazuhiro; Shigematsu, Hideki; Shirouzu, Mikako; Kaji, Akira; Kaji, Hideko			Chemical and structural characterization of a model Post-Termination Complex (PoTC) for the ribosome recycling reaction: Evidence for the release of the mRNA by RRF and EF-G	PLOS ONE			English	Article							ELONGATION-FACTOR-G; FACTOR-DEPENDENT RELEASE; INITIATION-FACTOR IF-3; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; BACTERIAL RIBOSOME; RIBONUCLEIC-ACID; 70S RIBOSOMES; TRANSLATION; SUBUNITS	A model Post-Termination Complex (PoTC) used for the discovery of Ribosome Recycling Factor (RRF) was purified and characterized by cryo-electron microscopic analysis and biochemical methods. We established that the model PoTC has mostly one tRNA, at the P/E or P/P position, together with one mRNA. The structural studies were supported by the biochemical measurement of bound tRNA and mRNA. Using this substrate, we establish that the release of tRNA, release of mRNA and splitting of ribosomal subunits occur during the recycling reaction. Order of these events is tRNA release first followed by mRNA release and splitting almost simultaneously. Moreover, we demonstrate that IF3 is not involved in any of the recycling reactions but simply prevents the re-association of split ribosomal subunits. Our finding demonstrates that the important function of RRF includes the release of mRNA, which is often missed by the use of a short ORF with the Shine-Dalgarno sequence near the termination site.	[Iwakura, Nobuhiro; Quaglia, Fabio; Kaji, Hideko] Thomas Jefferson Univ, Jefferson Med Coll, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Iwakura, Nobuhiro; Quaglia, Fabio; Kaji, Akira] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yokoyama, Takeshi; Shigematsu, Hideki; Shirouzu, Mikako] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa, Japan; [Quaglia, Fabio] Univ Camerino, Sch Biosci & Vet Med, Camerino, Italy; [Mitsuoka, Kaoru] Osaka Univ, Res Ctr Ultrahigh Voltage Electron Microscopy, Osaka, Japan; [Mio, Kazuhiro] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo, Japan; [Mio, Kazuhiro] Natl Inst Adv Ind Sci & Technol, OPERANDO Open Innovat Lab, Tokyo, Japan	Jefferson University; University of Pennsylvania; RIKEN; University of Camerino; Osaka University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Kaji, H (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.; Kaji, A (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	kaji@mail.med.upenn.edu; hideko.kaji@jefferson.edu	Iwakura, Nobuhiro/D-5394-2012; Shirouzu, Mikako/A-6521-2016; Mio, Kazuhiro/L-7488-2018; Shigematsu, Hideki/E-1052-2017	Mio, Kazuhiro/0000-0002-1655-8231; Shigematsu, Hideki/0000-0003-3951-8651; Mitsuoka, Kaoru/0000-0003-1782-675X	Creative Biomedical Research Institute, Philadelphia, (PA)	Creative Biomedical Research Institute, Philadelphia, (PA)	This work was supported by funding from Creative Biomedical Research Institute, Philadelphia, (PA). FQ is a PhD student of the University of Camerino, Camerino, Italy.; This work was supported by funds from the Creative Biomedical Research Institute, Philadelphia, (PA). FQ is a PhD student of the University of Camerino, Camerino, Italy.	Agrawal RK, 2004, P NATL ACAD SCI USA, V101, P8900, DOI 10.1073/pnas.0401904101; Barat C, 2007, MOL CELL, V27, P250, DOI 10.1016/j.molcel.2007.06.005; Borg A, 2016, RNA, V22, P10, DOI 10.1261/rna.053157.115; Cougot N, 2013, J MOL BIOL; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Gao N, 2005, MOL CELL, V18, P663, DOI 10.1016/j.molcel.2005.05.005; GOTTLIEB M, 1975, P NATL ACAD SCI USA, V72, P4238, DOI 10.1073/pnas.72.11.4238; GUALERZI C, 1971, BIOCHEM BIOPH RES CO, V45, P1312, DOI 10.1016/0006-291X(71)90162-8; HIRASHIM.A, 1970, BIOCHEM BIOPH RES CO, V41, P877, DOI 10.1016/0006-291X(70)90165-8; HIRASHIM.A, 1973, J BIOL CHEM, V248, P7580; HIRASHIMA A, 1972, BIOCHEMISTRY-US, V11, P4037, DOI 10.1021/bi00772a005; HIRASHIMA A, 1972, J MOL BIOL, V65, P43, DOI 10.1016/0022-2836(72)90490-1; Hirokawa G, 2006, TRENDS BIOCHEM SCI, V31, P143, DOI 10.1016/j.tibs.2006.01.007; Hirokawa G, 2005, RNA, V11, P1317, DOI 10.1261/rna.2520405; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; HOU Y, 1994, J BACTERIOL, V176, P7038, DOI 10.1128/JB.176.22.7038-7044.1994; Inokuchi Y, 2000, EMBO J, V19, P3788, DOI 10.1093/emboj/19.14.3788; ISHITSUKA H, 1970, J BIOL CHEM, V245, P3346; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; Janosi L, 1996, ADV BIOPHYS, V32, P121, DOI 10.1016/0065-227X(96)84743-5; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; KAEMPFER R, 1972, J MOL BIOL, V71, P583, DOI 10.1016/0022-2828(72)90033-8; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; KAZIRO Y, 1968, J BIOCHEM-TOKYO, V64, P423, DOI 10.1093/oxfordjournals.jbchem.a128913; Kurata S, 2010, P NATL ACAD SCI USA, V107, P10854, DOI 10.1073/pnas.1006247107; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; MATTHAEI H, 1961, BIOCHEM BIOPH RES CO, V4, P404, DOI 10.1016/0006-291X(61)90298-4; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Nierhaus K., 1990, RIBOSOMES PROTEIN SY, V1990, P161; OGAWA K, 1975, BIOCHIM BIOPHYS ACTA, V402, P288, DOI 10.1016/0005-2787(75)90266-X; Orelle C, 2015, NATURE, V524, P119, DOI 10.1038/nature14862; Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; REMME J, 1989, EUR J BIOCHEM, V183, P281, DOI 10.1111/j.1432-1033.1989.tb14925.x; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; RYOJI M, 1981, P NATL ACAD SCI-BIOL, V78, P5973, DOI 10.1073/pnas.78.10.5973; Savelsbergh A, 2009, RNA, V15, P772, DOI 10.1261/rna.1592509; Selmer M, 1999, SCIENCE, V286, P2349, DOI 10.1126/science.286.5448.2349; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; SHIMIZU I, 1991, J BACTERIOL, V173, P5181, DOI 10.1128/jb.173.16.5181-5187.1991; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Singh NS, 2005, NUCLEIC ACIDS RES, V33, P5591, DOI 10.1093/nar/gki864; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Vivanco-Dominguez S, 2012, J MOL BIOL, V417, P425, DOI 10.1016/j.jmb.2012.02.008; WAHBA AJ, 1969, COLD SPRING HARB SYM, V34, P291, DOI 10.1101/SQB.1969.034.01.035; Yamamoto H, 2016, P NATL ACAD SCI USA, V113, pE1180, DOI 10.1073/pnas.1524554113; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Yokoyama T, 2012, EMBO J, V31, P1836, DOI 10.1038/emboj.2012.22; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016; Zhang YQ, 2015, NAT STRUCT MOL BIOL, V22, P906, DOI 10.1038/nsmb.3103; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086	55	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177972	10.1371/journal.pone.0177972	http://dx.doi.org/10.1371/journal.pone.0177972			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542628	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500047
J	Rosso, DE; d'Errico, F; Queffelec, A				Rosso, Daniela Eugenia; d'Errico, Francesco; Queffelec, Alain			Patterns of change and continuity in ochre use during the late Middle Stone Age of the Horn of Africa: The Porc-Epic Cave record	PLOS ONE			English	Article							MODERN HUMAN-BEHAVIOR; SOUTH-AFRICA; OBSIDIAN ARTIFACTS; COMPLEX COGNITION; EASTERN AFRICA; WESTERN CAPE; SYMBOLIC USE; SIBUDU CAVE; DIRE-DAWA; ETHIOPIA	Ochre is found at numerous Middle Stone Age (MSA) sites and plays a key role in early modern human archaeology. Here we analyse the largest known East African MSA ochre assemblage, comprising 40 kg of ochre, found at Porc-Epic Cave, Ethiopia, spanning a period of at least 4,500 years. Visual characterisation of ochre types, microscopic identification of traces of modification, morphological and morphometric analysis of ochre pieces and modified areas, experimental reproduction of grinding processes, surface texture analysis of archaeological and experimentally ground ochre facets, laser granulometry of ochre powder produced experimentally on different grindstones and by Hamar and Ovahimba women from Ethiopia and Namibia respectively, were, for the first time, combined to explore diachronic shifts in ochre processing technology. Our results identify patterns of continuity in ochre acquisition, treatment and use reflecting both persistent use of the same geological resources and similar uses of iron-rich rocks by late MSA Porc-Epic inhabitants. Considering the large amount of ochre processed at the site, this continuity can be interpreted as the expression of a cohesive cultural adaptation, largely shared by all community members and consistently transmitted through time. A gradual shift in preferred processing techniques and motions is interpreted as reflecting cultural drift within this practice. Evidence for the grinding of ochre to produce small quantities of powder throughout the sequence is consistent with a use in symbolic activities for at least part of the ochre assemblage from Porc-Epic Cave.	[Rosso, Daniela Eugenia] Univ Barcelona, Dept Hist & Arqueol, SERP, Barcelona, Spain; [Rosso, Daniela Eugenia; d'Errico, Francesco; Queffelec, Alain] Univ Bordeaux, CNRS, PACEA, UMR CNRS 5199, Pessac, France; [d'Errico, Francesco] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [d'Errico, Francesco] Univ Witwatersrand, DST NRF Ctr Excellence Palaeosci, Johannesburg, South Africa; [d'Errico, Francesco] Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa	University of Barcelona; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Rosso, DE (corresponding author), Univ Barcelona, Dept Hist & Arqueol, SERP, Barcelona, Spain.; Rosso, DE (corresponding author), Univ Bordeaux, CNRS, PACEA, UMR CNRS 5199, Pessac, France.	d.rosso@pacea.u-bordeaux1.fr	Queffelec, Alain/AAD-9531-2019; Rosso, Daniela Eugenia/ABB-2595-2021	Rosso, Daniela Eugenia/0000-0003-0499-0497; Queffelec, Alain/0000-0002-9763-7600	Generalitat de Catalunya (Ajuts per a la contractacio de personal investigador novell, FI-DGR); Doctoral Research scholarship Programme of the Martine Aublet Foundation; Eiffel Excellence Scholarship Programme of the French Ministry of Foreign Affairs and International Development; Wenner-Gren Foundation [8786]; LaScArBx research programme; ANR [ANR-10-LABX-52]; European Research Council Advanced Grant, TRACSYMBOLS under the FP7 program [249587]	Generalitat de Catalunya (Ajuts per a la contractacio de personal investigador novell, FI-DGR); Doctoral Research scholarship Programme of the Martine Aublet Foundation; Eiffel Excellence Scholarship Programme of the French Ministry of Foreign Affairs and International Development; Wenner-Gren Foundation; LaScArBx research programme; ANR(French National Research Agency (ANR)); European Research Council Advanced Grant, TRACSYMBOLS under the FP7 program	Research by DR was funded by the Generalitat de Catalunya (Ajuts per a la contractacio de personal investigador novell, FI-DGR), the Doctoral Research scholarship Programme of the Martine Aublet Foundation, and the Eiffel Excellence Scholarship Programme of the French Ministry of Foreign Affairs and International Development. This research was conducted with the financial support of the Wenner-Gren Foundation (Gr. 8786), the LaScArBx research programme, supported by the ANR ANR-10-LABX-52, and the European Research Council Advanced Grant, TRACSYMBOLS No. 249587 awarded under the FP7 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1939, NONFLINT RAW MAT USE; Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; [Anonymous], 1989, THESIS U ILLINOIS UR; [Anonymous], 2012, 25178 ISO; [Anonymous], 2005, J AFRICAN ARCHAEOLOG, DOI DOI 10.3213/1612-1651-10040; [Anonymous], 2009, 25178 ISOCD; [Anonymous], 1984, AFR ARCHAEOL REV, DOI DOI 10.1007/BF01117225; Anovitz LM, 1999, J ARCHAEOL SCI, V26, P735, DOI 10.1006/jasc.1998.0342; Assefa Z, 2008, CURR ANTHROPOL, V49, P746, DOI 10.1086/589509; Assefa Z, 2006, J HUM EVOL, V51, P50, DOI 10.1016/j.jhevol.2006.01.004; Barham LS, 2002, CURR ANTHROPOL, V43, P181, DOI 10.1086/338292; Barham LS, 2000, MIDDLE STONE AGE ZAM; Brandt SA, 2012, QUATERN INT, V274, P38, DOI 10.1016/j.quaint.2012.03.047; Breuil H, 1934, ANTHROPOLOGIE, V44, P473; Breuil H, 1951, ANTHROPOLOGIE, V55, P219; Charrie-Duhaut A, 2013, J ARCHAEOL SCI, V40; Clark J. D., 1978, ANN ETHIOPIE, V11, P19, DOI DOI 10.3406/ETHIO.1978.902; CLARK JD, 1988, J WORLD PREHIST, V2, P235, DOI 10.1007/BF00975618; Conard NJ, 2005, TOOLS SYMBOLS EARLY, P294; D'Errico F, 2003, EVOL ANTHROPOL, V12, P188, DOI 10.1002/evan.10113; d'Errico F, 2013, CURR ANTHROPOL, V54, pS371, DOI 10.1086/673388; d'Errico F, 2012, J ARCHAEOL SCI, V39, P942, DOI 10.1016/j.jas.2011.10.032; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; Dayet L, 2016, ARCHAEOMETRY, V58, P807, DOI 10.1111/arcm.12202; Dayet L, 2013, J ARCHAEOL SCI, V40, P3492, DOI 10.1016/j.jas.2013.01.025; Dayet L., 2012, THESIS; de Beaune S. Archambault, 2000, ARCHEOLOGIE GESTE BR; De Chardin PT, 1940, ANTHROPOLOGIE, V49, P497; DeGarmo E. P., 2007, DEGARMOS MAT PROCESS; dErrico F., 2008, CURRENT THEMES MIDDL, V10, P168; Dubreuil B, 2013, STUDIES LANGUAGE COM, P147; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Hodgskiss T, 2014, CAMB ARCHAEOL J, V24, P405, DOI 10.1017/S0959774314000663; Hodgskiss T, 2013, J AFR ARCHAEOL, V11, P75, DOI 10.3213/2191-5784-10232; Hodgskiss T, 2012, SOUTH AFR HUMANIT, V24, P99; Hodgskiss T, 2010, J ARCHAEOL SCI, V37, P3344, DOI 10.1016/j.jas.2010.08.003; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1790, DOI 10.1016/j.jas.2007.11.028; Jercher M, 1998, ARCHAEOMETRY, V40, P383, DOI 10.1111/j.1475-4754.1998.tb00845.x; Knight C, 1995, CAMB ARCHAEOL J, V5, P75, DOI [10.1017/S0959774300001190, DOI 10.1017/S0959774300001190]; Knight C., 2014, SOCIAL ORIGINS LANGU; Kozowyk PRB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150436; Leach R., 2014, CHARACTERISATION ARE; Leakey LSB, 1943, J E AFR NAT HIST SOC, V17, P199; Leplongeon A, 2013, THESIS; Leplongeon A, 2014, QUATERN INT, V343, P100, DOI 10.1016/j.quaint.2013.12.002; Lydall J, 1979, WORK J; Lydall J, 1979, HAMAR SO ETHIOPIA BA; Marean CA., 1984, AFR ARCHAEOL REV, V2, P37, DOI DOI 10.1007/BF01117225; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mie G, 1908, ANN PHYS-BERLIN, V25, P377, DOI 10.1002/andp.19083300302; Moyo S, 2016, QUATERN INT, V404, P20, DOI 10.1016/j.quaint.2015.09.041; Moysey F, 1943, J E AFR UGANDA NAT H, V17, P196; Negash A, 2006, ARCHAEOMETRY, V48, P1, DOI 10.1111/j.1475-4754.2006.00239.x; Pleurdeau D, 2003, ANTHROPOLOGIE, V107, P15, DOI 10.1016/S0003-5521(02)00003-1; PLEURDEAU D, 2005, AFR ARCHAEOL REV, V22, P177, DOI DOI 10.1007/S10437-006-9000-7); Popelka-Filcoff RS, 2008, J ARCHAEOL SCI, V35, P752, DOI 10.1016/j.jas.2007.05.018; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Reexamen C., 1974, ANTHROPOL, V78, P529; Ridings R, 1996, AM ANTIQUITY, V61, P136, DOI 10.2307/282308; Rifkin RE, 2015, S AFR ARCHAEOL BULL, V70, P64; Rifkin RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136090; Rifkin RF, 2015, S AFR J SCI, V111, P65; Rifkin RF, 2012, J ANTHROPOL ARCHAEOL, V31, P174, DOI 10.1016/j.jaa.2011.11.004; Rifkin RF, 2011, J AFR ARCHAEOL, V9, P131, DOI 10.3213/2191-5784-10199; Robinson JR, 2017, J HUM EVOL, V106, P19, DOI 10.1016/j.jhevol.2017.01.013; Rossano MJ, 2010, CURR ANTHROPOL, V51, pS89, DOI 10.1086/650481; Rosso DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164793; Rosso DE, 2014, QUATERN INT, V343, P85, DOI 10.1016/j.quaint.2013.10.019; Soriano S, 2009, J AFR ARCHAEOL, V7, P41, DOI 10.3213/1612-1651-10121; Strecker I., 1979, HAMAR SO ETHIOPIA CO; Teilhard de Chardin P, 1930, PALEOLITHIQUE SOMALI, V40, P331; Tryon CA, 2013, CURR ANTHROPOL, V54, pS234, DOI 10.1086/673752; Vallois HV, 1951, ANTHROPOLOGIE, V55, P231; VELO J, 1984, CURR ANTHROPOL, V25, P674, DOI 10.1086/203205; Villa P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131273; Vogel N, 2006, J ARCHAEOL SCI, V33, P1749, DOI 10.1016/j.jas.2006.03.008; Wadley L, 2005, J HUM EVOL, V49, P587, DOI 10.1016/j.jhevol.2005.06.007; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Wadley L, 2006, SOUTH AFR HUMANIT, V18, P1; Wadley L., 2005, FARMING, V3, P1, DOI DOI 10.3828/BFARM.2005.3.1; Wadley L, 2007, J HUM EVOL, V52, P681, DOI 10.1016/j.jhevol.2007.01.002; Wadley L, 2010, J ARCHAEOL SCI, V37, P2397, DOI 10.1016/j.jas.2010.04.012; Wadley L, 2010, CURR ANTHROPOL, V51, pS111, DOI 10.1086/649836; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Watts I, 2002, S AFR ARCHAEOL BULL, V57, P1, DOI 10.2307/3889102; Watts I, 1999, EVOLUTION CULTURE, P113; Watts I., 2017, ENCY GEOARCHAEOLOGY, P664, DOI [10.1007/978-1-4020-4409-0_37, DOI 10.1007/978-1-4020-4409-0_37]; Watts I., 2014, SOCIAL ORIGINS LANGU, P208; Watts I, 1998, THESIS U LONDON; Watts I, 2009, CRADLE LANGUAGE, P62; Watts I., 2015, HDB COLOR P, P317; Watts I, 2010, J HUM EVOL, V59, P392, DOI 10.1016/j.jhevol.2010.07.006; Williamson BS, 2004, S AFR J SCI, V100, P174; Wynn T, 2010, CURR ANTHROPOL, V51, pS5, DOI 10.1086/650526; Yellen John, 2005, Paleoanthropology, V3, P25; Zilhao J., 2011, HOMOSYMBOLICUS DAWN, P111; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107; Zipkin AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112560	103	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177298	10.1371/journal.pone.0177298	http://dx.doi.org/10.1371/journal.pone.0177298			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542305	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500019
J	Routray, P; Torondel, B; Clasen, T; Schmidt, WP				Routray, Parimita; Torondel, Belen; Clasen, Thomas; Schmidt, Wolf-Peter			Women's role in sanitation decision making in rural coastal Odisha, India	PLOS ONE			English	Article							HEALTH-CARE; AUTONOMY; LIFE	Background While women and girls face special risks from lack of access to sanitation facilities, their ability to participate and influence household-level sanitation is not well understood. This paper examines the association between women's decision-making autonomy and latrine construction in rural areas of Odisha, India. Methods We conducted a mixed-method study among rural households in Puri district. This included a cross sectional survey among 475 randomly selected households. These were classified as either having a functional latrine, a non-functional latrine or no latrine at all. We also conducted 17 in-depth interviews and 9 focus group discussions among household members of these three categories of households. Results Decisions on the construction of household level sanitation facilities were made exclusively by the male head in 80% of households; in 11% the decision was made by men who consulted or otherwise involved women. In only 9% of households the decision was made by women. Households where women were more involved in general decision making processes were no more likely to build a latrine, compared to households where they were excluded from decisions. Qualitative research revealed that women's non-involvement in sanitation decision making is attributed to their low socio-economic status and inability to influence the household's financial decisions. Female heads lacked confidence to take decisions independently, and were dependent on their spouse or other male family members for most decisions. The study revealed the existence of power hierarchies and dynamics within households, which constrained female's participation in decision-making processes regarding sanitation. Conclusions Though governments and implementers emphasize women's involvement in sanitation programmes, socio-cultural factors and community and household level dynamics often prevent women from participating in sanitation-related decisions. Measures are needed for strengthening sanitation policies and effective implementation of programmes to address gender power relations and familial relationships that influence latrine adoption and use.	[Routray, Parimita; Torondel, Belen; Clasen, Thomas; Schmidt, Wolf-Peter] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Clasen, Thomas] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of London; London School of Hygiene & Tropical Medicine; Emory University; Rollins School Public Health	Routray, P (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.	Parimita.Routray@lshtm.ac.uk		Schmidt, Wolf-Peter/0000-0001-7449-4152	DFID's SHARE consortium	DFID's SHARE consortium	This research was sponsored by DFID's SHARE consortium. The funding agency did not have any role in the designing of the study, data collection and its analysis, interpretation of data or in writing the manuscript.	Acharya DR, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-15; [Anonymous], 2006, GEND WAT SAN POL BRI; [Anonymous], 2010, GOV IND GUID TOT SAN; [Anonymous], 2012, MANTRA EXPERIENCES G; [Anonymous], 2012, 1 3 WOMEN LACK ACCES; [Anonymous], 2010, WORLD BANK WORK PAP; Arooj S, 2013, ADV APPL SOCIOLOGY, P3; Baliyan K., 2014, FACTORS AFFECTING PA; Banerjee S., 2015, J EC BUSINESS MANAGE, V3, P1037, DOI [10.7763/JOEBM.2015.V3.330, DOI 10.7763/JOEBM.2015.V3.330]; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Boisson Sophie, 2014, BMC Res Notes, V7, P486, DOI 10.1186/1756-0500-7-486; Caruso B., 2015, THESIS; Centre for Social Development Humanitarian Affairs (United Nations) United Nations. Dept. for Policy Coordination Sustainable Development United Nations. Division for the Advancement of Women, 1989, WORLD SURV ROL WOM D; Chambers R., 2009, IDS PRACT PAP, V2009, P01; Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9; Clasen T, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-7; Coffey D., 2014, ECON POLIT WEEKLY, P43; Dankelman I., 2009, MAKING SUSTAINABLE S; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Fisher Julie, 2006, WATER SANITATION HYG; Government of India, 2014, SWACHH BHAR MISS GRA; Government of India, 2012, NIRM BHAR ABH GUID; Hirai M, 2016, J WATER SANIT HYG DE, V6, P151, DOI 10.2166/washdev.2016.128; Hueso A, 2013, WATER POLICY, V15, P1001, DOI 10.2166/wp.2013.032; Jejeebhoy SJ, 2002, STUD FAMILY PLANN, V33, P299, DOI 10.1111/j.1728-4465.2002.00299.x; Jenkins MW, 2007, SOC SCI MED, V64, P2427, DOI 10.1016/j.socscimed.2007.03.010; Jenkins MW, 2005, SOC SCI MED, V61, P2446, DOI 10.1016/j.socscimed.2005.04.036; Kabeer N., WORLD SURVEY ROLE WO, P9; Kar K, 2008, HDB COMMUNITY LED TO; Khanna T, 2016, GLOB PUBLIC HEALTH, V11, P1185, DOI 10.1080/17441692.2015.1062905; Mara D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000363; Mehar M, 2015, INDIAN J ECON DEV, V11, P755, DOI 10.5958/2322-0430.2015.00083.9; Mistry R, 2009, SOC SCI MED, V69, P926, DOI 10.1016/j.socscimed.2009.07.008; Mohanty SR, 2013, INT J SCI RES PUBLIC, V3; Mudey AB., 2010, GLOBAL J HLTH SCI, V2, P225; O'Connell, 2014, WHAT INFLUENCES OPEN; O'Reilly K, 2014, HEALTH PLACE, V29, P43, DOI 10.1016/j.healthplace.2014.05.007; O'Reilly K, 2010, DEV PRACT, V20, P45, DOI 10.1080/09614520903436976; Pattanayak SK, 2009, B WORLD HEALTH ORGAN, V87, P580, DOI 10.2471/BLT.08.057422; Routray P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2206-3; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; Senarath U, 2009, ASIA-PAC J PUBLIC HE, V21, P137, DOI 10.1177/1010539509331590; Srivastav N., 2015, WIRE; Stopnitzky Y., 2012, BARGAINING POWER MIS; Sunny Jose, 2010, Economic and Political Weekly, V45, P83; UNHRC, 2011, WOM GIRLS THEIR RIGH; Wakeman W, 1996, SOURCEBOOK GENDER IS; Wijk-Sijbesma C.V., 1998, GENDER WATER RESOURC	48	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178042	10.1371/journal.pone.0178042	http://dx.doi.org/10.1371/journal.pone.0178042			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542525	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000402061500054
J	Shi, K; Gu, JY; Guo, HJ; Zhao, LS; Xie, YD; Xiong, HC; Li, JH; Zhao, SR; Song, XY; Liu, LX				Shi, Kui; Gu, Jiayu; Guo, Huijun; Zhao, Linshu; Xie, Yongdun; Xiong, Hongchun; Li, Junhui; Zhao, Shirong; Song, Xiyun; Liu, Luxiang			Transcriptome and proteomic analyses reveal multiple differences associated with chloroplast development in the spaceflight-induced wheat albino mutant mta	PLOS ONE			English	Article							RNA-SEQ DATA; PROTEIN EXTRACTION; DNA METHYLATION; CHLOROPHYLL; BIOGENESIS; DIVISION; GENES; LOCUS; PIF3	Chloroplast development is an integral part of plant survival and growth, and occurs in parallel with chlorophyll biosynthesis. However, little is known about the mechanisms underlying chloroplast development in hexaploid wheat. Here, we obtained a spaceflight-induced wheat albino mutant mta. Chloroplast ultra-structural observation showed that chloroplasts of mta exhibit abnormal morphology and distribution compared to wild type. Photosynthetic pigments content was also significantly decreased in mta. Transcriptome and chloroplast proteome profiling of mta and wild type were done to identify differentially expressed genes (DEGs) and proteins (DEPs), respectively. In total 4,588 DEGs including 1,980 up-and 2,608 down-regulated, and 48 chloroplast DEPs including 15 up-and 33 down-regulated were identified in mta. Classification of DEGs revealed that most were involved in chloroplast development, chlorophyll biosynthesis, or photosynthesis. Besides, transcription factors such as PIF3, GLK and MYB which might participate in those pathways were also identified. The correlation analysis between DEGs and DEPs revealed that the transcript-toprotein in abundance was functioned into photosynthesis and chloroplast relevant groups. Real time qPCR analysis validated that the expression level of genes encoding photosynthetic proteins was significantly decreased in mta. Together, our results suggest that the molecular mechanism for albino leaf color formation in mta is a thoroughly regulated and complicated process. The combined analysis of transcriptome and proteome afford comprehensive information for further research on chloroplast development mechanism in wheat. And spaceflight provides a potential means for mutagenesis in crop breeding.	[Shi, Kui; Song, Xiyun; Liu, Luxiang] Qingdao Agr Univ, Sch Life Sci, Qingdao, Shandong, Peoples R China; [Shi, Kui; Gu, Jiayu; Guo, Huijun; Zhao, Linshu; Xie, Yongdun; Xiong, Hongchun; Li, Junhui; Zhao, Shirong; Liu, Luxiang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China	Qingdao Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Song, XY; Liu, LX (corresponding author), Qingdao Agr Univ, Sch Life Sci, Qingdao, Shandong, Peoples R China.; Liu, LX (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	songxy@qau.edu.cn; liuluxiang@caas.cn			National Key Research and Development Program of China [2016YFD0102101]; National 973 Program [2014C6138101]; Core Research Budget of the Non-profit Governmental Research Institutions	National Key Research and Development Program of China; National 973 Program(National Basic Research Program of China); Core Research Budget of the Non-profit Governmental Research Institutions	This work was supported by the National Key Research and Development Program of China: grant no. 2016YFD0102101, the National 973 Program: grant no. 2014C6138101, and Core Research Budget of the Non-profit Governmental Research Institutions (ICS, CMS).	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bao WK., 2005, CHIN J APP ENV BIOL, V11, P235, DOI DOI 10.3321/J.ISSN:1006-687X.2005.02.026; Barry CS, 2012, PLANT PHYSIOL, V159, P1086, DOI 10.1104/pp.112.197483; Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; Chan KX, 2016, ANNU REV PLANT BIOL, V67, P25, DOI 10.1146/annurev-arplant-043015-111854; Chiang YH, 2012, PLANT PHYSIOL, V160, P332, DOI 10.1104/pp.112.198705; de Luna-Valdez LA, 2014, J PROTEOMICS, V111, P148, DOI 10.1016/j.jprot.2014.07.003; Deng XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099564; Eckstein A, 2016, PHYSIOL PLANTARUM, V156, P351, DOI 10.1111/ppl.12396; Fan PX, 2009, ELECTROPHORESIS, V30, P3024, DOI 10.1002/elps.200900172; Fitter DW, 2002, PLANT J, V31, P713, DOI 10.1046/j.1365-313X.2002.01390.x; Gabruk M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116990; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu JY, 2014, PLANT GENET RESOUR-C, V12, pS99, DOI 10.1017/S1479262114000367; Guo HJ, 2012, J INTEGR AGR, V11, P888, DOI 10.1016/S2095-3119(12)60079-3; Hellinger R, 2015, J PROTEOME RES, V14, P4851, DOI 10.1021/acs.jproteome.5b00681; Hou DY, 2009, BMB REPORTS; Jung SH, 2014, BIOMETRICAL J, V56, P129, DOI 10.1002/bimj.201300048; Kamal AM, 2013, J PROTEOMICS, V93, P326, DOI 10.1016/j.jprot.2013.03.009; Kumar D, 2016, PROTEOMICS, V16, P226, DOI 10.1002/pmic.201500263; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin YP, 2014, PLANT J, V80, P14, DOI 10.1111/tpj.12611; Ma CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33369; Maple J, 2007, ANN BOT-LONDON, V99, P565, DOI 10.1093/aob/mcl249; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Ou XF, 2009, MUTAT RES-FUND MOL M, V662, P44, DOI 10.1016/j.mrfmmm.2008.12.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pogson BJ, 2015, BBA-BIOENERGETICS, V1847, P1017, DOI 10.1016/j.bbabio.2015.02.003; Pogson BJ, 2008, TRENDS PLANT SCI, V13, P602, DOI 10.1016/j.tplants.2008.08.008; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Rossini L, 2001, PLANT CELL, V13, P1231, DOI 10.1105/tpc.13.5.1231; Sakuraba Y, 2013, PLANT J, V74, P122, DOI 10.1111/tpj.12110; Sanchez C, 2014, FOOD CHEM, V163, P37, DOI 10.1016/j.foodchem.2014.04.041; Sandhu D, 2016, PLANT SCI, V252, P76, DOI 10.1016/j.plantsci.2016.07.006; Shi DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080107; Stephenson PG, 2009, P NATL ACAD SCI USA, V106, P7654, DOI 10.1073/pnas.0811684106; Uimari A, 1997, PLANT J, V12, P1273, DOI 10.1046/j.1365-313x.1997.12061273.x; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Vazquez A-O, 2014, PLANT CELL, V26, P2524; Vincent A, 2011, CLIN CANCER RES, V17, P4341, DOI 10.1158/1078-0432.CCR-10-3431; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XC, 2007, ELECTROPHORESIS, V28, P3976, DOI 10.1002/elps.200600805; Waters MT, 2008, PLANT J, V56, P432, DOI 10.1111/j.1365-313X.2008.03616.x; Waters MT, 2009, EMBO J, V28, P2861, DOI 10.1038/emboj.2009.264; Yang J, 2012, GENET MOL RES, V11, P3379, DOI 10.4238/2012.September.25.6; Yang YX, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00139; Yasumura Y, 2005, PLANT CELL, V17, P1894, DOI 10.1105/tpc.105.033191; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhao YX, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-18; Zhou KN, 2013, PLANTA, V237, P279, DOI 10.1007/s00425-012-1756-1; Zienkiewicz A, 2014, METHODS MOL BIOL, V1072, P85, DOI 10.1007/978-1-62703-631-3_7	54	16	17	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177992	10.1371/journal.pone.0177992	http://dx.doi.org/10.1371/journal.pone.0177992			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542341	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500051
J	Zaza, G; Gassa, AD; Felis, G; Granata, S; Torriani, S; Lupo, A				Zaza, Gianluigi; Gassa, Alessandra Dalla; Felis, Giovanna; Granata, Simona; Torriani, Sandra; Lupo, Antonio			Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen	PLOS ONE			English	Article							IV PILI; ANTIBIOTIC-RESISTANCE; GUT MICROBIOTA; II SECRETION; OBESITY; INACTIVATION; VIRULENCE; ALIGNMENT; RECURRENT; COMPLEX	Background The gut microbiome is the full set of microbes living in the gastrointestinal tract and is emerging as an important dynamic/fluid system that, if altered by environmental, dietetic or pharmacological factors, could considerably influence drug response. However, the immunosuppressive drug-induced modifications of this system are still poorly defined. Methods We employed an innovative bioinformatics approach to assess differences in the whole-gut microbial metagenomic profile of 20 renal transplant recipients undergoing maintenance treatment with two different immunosuppressive protocols. Nine patients were treated with everolimus plus mycophenolate mofetil (EVE+MMF group), and 11 patients were treated with a standard therapy with tacrolimus plus mycophenolate mofetil (TAC+MMF group). Results A statistical analysis of comparative high-throughput data demonstrated that although similar according to the degree of Shannon diversity (alpha diversity) at the taxonomic level, three functional genes clearly discriminated EVE+MMF versus TAC+MMF (cutoff: log2 fold change >= 1, FDR <= 0.05). Flagellar motor switch protein (fliNY) and type IV pilus assembly protein pilM (pilM) were significantly enriched in TAC+MMF-treated patients, while macrolide transport system mrsA (msrA) was more abundant in patients treated with EVE+MMF. Finally, PERMANOVA revealed that among the variables analyzed and included in our model, only the consumption of sugar significantly influenced beta diversity. Conclusions Our study, although performed on a relatively small number of patients, showed, for the first time, specific immunosuppressive-related effects on fecal microbiome of renal transplant recipients and it suggested that the analysis of the gut microbes community could represent a new tool to better understand the effects of drugs currently employed in organ transplantations. However, multicenter studies including healthy controls should be undertaken to better address this objective.	[Zaza, Gianluigi; Gassa, Alessandra Dalla; Granata, Simona; Lupo, Antonio] Univ Hosp Verona, Dept Med, Renal Unit, Verona, Italy; [Felis, Giovanna; Torriani, Sandra] Univ Verona, Dept Biotechnol, Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Zaza, G (corresponding author), Univ Hosp Verona, Dept Med, Renal Unit, Verona, Italy.	gianluigi.zaza@univr.it	Felis, Giovanna/AAX-7268-2020; Torriani, Sandra/K-6147-2019; Felis, Giovanna/ABC-9038-2020; Zaza, Gianluigi/K-3827-2018	Felis, Giovanna/0000-0002-6506-6911; Zaza, Gianluigi/0000-0002-6004-6196; Dalla Gassa, Alessandra/0000-0001-7701-7204				Abdel-Nour M, 2014, IMMUNOL CELL BIOL, V92, P346, DOI 10.1038/icb.2014.3; Andersen JL, 2015, INT J ENV RES PUB HE, V12, P1487, DOI 10.3390/ijerph120201487; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; Bodro M, 2015, AM J TRANSPLANT, V15, P1021, DOI 10.1111/ajt.13075; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; D'Argenio V, 2015, CLIN CHIM ACTA, V451, P97, DOI 10.1016/j.cca.2015.01.003; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Fricke WF, 2014, AM J TRANSPLANT, V14, P416, DOI 10.1111/ajt.12588; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Index Shannon's Diversity, 1948, BELL SYST TECH J, V27, P379; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Kasai C, 2016, ONCOL REP, V35, P325, DOI 10.3892/or.2015.4398; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122399; Lee JR, 2014, TRANSPLANTATION, V98, P697, DOI 10.1097/TP.0000000000000370; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li CH, 2010, MOL MICROBIOL, V75, P1563, DOI 10.1111/j.1365-2958.2010.07078.x; Liao SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-253; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MARTEL AY, 1989, J CLIN MICROBIOL, V27, P1486, DOI 10.1128/JCM.27.7.1486-1489.1989; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Mitra Subhashis, 2011, Curr Infect Dis Rep, V13, P579, DOI 10.1007/s11908-011-0210-z; Mulcahy-O'Grady H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00029; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; Persat A, 2015, P NATL ACAD SCI USA, V112, P7563, DOI 10.1073/pnas.1502025112; Rani A, 2017, TRANSL RES, V181, P59, DOI 10.1016/j.trsl.2016.08.008; Rani A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33327; ROSS JI, 1990, MOL MICROBIOL, V4, P1207, DOI 10.1111/j.1365-2958.1990.tb00696.x; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Schmieder R, 2012, FUTURE MICROBIOL, V7, P73, DOI [10.2217/fmb.11.135, 10.2217/FMB.11.135]; Silva C, 2013, TRANSPL P, V45, P1092, DOI 10.1016/j.transproceed.2013.02.019; Tammam S, 2011, MOL MICROBIOL, V82, P1496, DOI 10.1111/j.1365-2958.2011.07903.x; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Wilson ID, 2017, TRANSL RES, V179, P204, DOI 10.1016/j.trsl.2016.08.002; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089	51	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178228	10.1371/journal.pone.0178228	http://dx.doi.org/10.1371/journal.pone.0178228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542523	Green Published, gold			2022-12-27	WOS:000402061500076
J	Obsa, BT; Eglinton, J; Coventry, S; March, T; Guillaume, M; Le, TP; Hayden, M; Langridge, P; Fleury, D				Obsa, Bulti Tesso; Eglinton, Jason; Coventry, Stewart; March, Timothy; Guillaume, Maxime; Le, Thanh Phuoc; Hayden, Matthew; Langridge, Peter; Fleury, Delphine			Quantitative trait loci for yield and grain plumpness relative to maturity in three populations of barley (Hordeum vulgare L.) grown in a low rain-fall environment	PLOS ONE			English	Article							AGRONOMIC TRAITS; VERNALIZATION RESPONSE; QTL ANALYSIS; PHOTOPERIOD; ADAPTATION; DROUGHT; GENES; IDENTIFICATION; DETERMINES; STABILITY	Identifying yield and grain plumpness QTL that are independent of developmental variation or phenology is of paramount importance for developing widely adapted and stable varieties through the application of marker assisted selection. The current study was designed to dissect the genetic basis of yield performance and grain plumpness in southern Australia using three doubled haploid (DH) populations developed from crosses between adapted parents that are similar in maturity and overall plant development. Three interconnected genetic populations, Commander x Fleet (CF), Commander x WI4304 (CW), and Fleet x WI4304 (FW) developed from crossing of Australian elite barley genotypes, were used to map QTL controlling yield and grain plumpness. QTL for grain plumpness and yield were analysed using genetic linkage maps made of genotyping-by-sequencing markers and major phenology genes, and field trials at three drought prone environments for two growing seasons. Seventeen QTL were detected for grain plumpness. Eighteen yield QTL explaining from 1.2% to 25.0% of the phenotypic variation were found across populations and environments. Significant QTL x environment interaction was observed for all grain plumpness and yield QTL, except QPlum. FW-4H.1 and QYld.FW-2H.1. Unlike previous yield QTL studies in barley, none of the major developmental genes, including Ppd-H1, Vrn-H1, Vrn-H2 and Vrn-H3, that drive barley adaption significantly affected grain plumpness and yield here. Twenty-two QTL controlled yield or grain plumpness independently of known maturity QTL or genes. Adjustment for maturity effects through co-variance analysis had no major effect on these yield QTL indicating that they control yield per se.	[Obsa, Bulti Tesso; Langridge, Peter; Fleury, Delphine] Univ Adelaide, Waite Res Inst, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia; [Eglinton, Jason; Coventry, Stewart; March, Timothy; Langridge, Peter] Univ Adelaide, Waite Res Inst, Sch Agr Food & Wine, Glen Osmond, SA, Australia; [Guillaume, Maxime] Montpellier SupAgro, Montpellier, France; [Le, Thanh Phuoc] Can Tho Univ, Coll Agr & Appl Biol, Dept Plant Protect, Can Tho, Vietnam; [Hayden, Matthew] La Trobe Univ, Dept Econ Dev Jobs Transport & Resources, Agribio, Bundoora, Vic, Australia	University of Adelaide; University of Adelaide; Institut Agro; Montpellier SupAgro; Can Tho University; La Trobe University	Fleury, D (corresponding author), Univ Adelaide, Waite Res Inst, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia.	delphine.fleury@adelaide.edu.au	Fleury, Delphine L/G-4464-2010; Langridge, Peter/G-5864-2010; Guilllaume, Maxime/G-6389-2018	Fleury, Delphine L/0000-0002-7077-4103; Langridge, Peter/0000-0001-9494-400X; Hayden, Matthew/0000-0003-3117-5500	South Australia Grain Industry Trust Fund [UA 1202]; Australian Research Council; Grains Research and Development Corporation; South Australian Government; Department of Further Education, Employment, Science and Technology; University of Adelaide through the Australian Centre for Plant Functional Genomics	South Australia Grain Industry Trust Fund; Australian Research Council(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp); South Australian Government; Department of Further Education, Employment, Science and Technology; University of Adelaide through the Australian Centre for Plant Functional Genomics	This work is partially funded by the South Australia Grain Industry Trust Fund (UA 1202), and by Australian Research Council, Grains Research and Development Corporation, the South Australian Government, the Department of Further Education, Employment, Science and Technology, and The University of Adelaide through the Australian Centre for Plant Functional Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Anthony Smith, Donna Marks and the Barley Program team, University of Adelaide, and Davis Leigh from Minnipa Agricultural Research Centre for their assistance to the field trials. We also thank Priyanka Kalambettu and Florian Krimpzer for assisting in the SNP genotyping. This work is partially funded by the South Australia Grain Industry Trust Fund (UA 1202), Australian Research Council, Grains Research and Development Corporation, the South Australian Government, the Department of Further Education, Employment, Science and Technology, and The University of Adelaide. The presented results were obtained by support of the International Barley Genome Sequencing Consortium through providing pre-publication access to the annotated barley reference sequence RefSeq v1.0 (downloadable after registration).	ABARES, 2012, AGR COMM; Alqudah AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113120; Barr AR, 2003, AUST J AGR RES, V54, P1125, DOI 10.1071/AR02215; Baum M, 2003, THEOR APPL GENET, V107, P1215, DOI 10.1007/s00122-003-1357-2; Burger W., 1985, BARLEY, V26, P367, DOI [10.2134/agronmonogr26.c13, DOI 10.2134/AGRONMONOGR26.C13]; Cantalapiedra CP, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0253-1; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Cockram J, 2007, THEOR APPL GENET, V115, P993, DOI 10.1007/s00122-007-0626-x; Comadran J, 2008, EUPHYTICA, V161, P35, DOI 10.1007/s10681-007-9508-1; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Coventry SJ, 2003, AUST J AGR RES, V54, P1103, DOI 10.1071/AR02194; Cuesta-Marcos A, 2009, PLANT BREEDING, V128, P46, DOI 10.1111/j.1439-0523.2008.01510.x; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Deng WW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6882; Dunford RP, 2005, THEOR APPL GENET, V110, P925, DOI 10.1007/s00122-004-1912-5; Eshghi R., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P95; FAOSTAT, 2014, FOOD AGR ORG UN STAT; Fox GP, 2006, J CEREAL SCI, V43, P198, DOI 10.1016/j.jcs.2005.08.004; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; GTA, 2014, GTA BARL STAND; Houston K, 2013, P NATL ACAD SCI USA, V110, P16675, DOI 10.1073/pnas.1311681110; Kalladan R, 2013, MOL BREEDING, V32, P71, DOI 10.1007/s11032-013-9853-9; Kandemir N, 2000, MOL BREEDING, V6, P157, DOI 10.1023/A:1009602514106; Karakousis A, 2003, AUST J AGR RES, V54, P1131, DOI 10.1071/AR02179; Karsai I, 1999, PLANT BREEDING, V118, P399, DOI 10.1046/j.1439-0523.1999.00408.x; Kikuchi R, 2009, PLANT PHYSIOL, V149, P1341, DOI 10.1104/pp.108.132134; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; LANDER ES, 1989, GENETICS, V121, P185; Laurie D, 1995, CROSS GENOME, V38; LAURIE DA, 1994, HEREDITY, V72, P619, DOI 10.1038/hdy.1994.85; Le T, 2011, GENOTHPING 3 PARENTA; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Swamy BPM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-319; Mansour E, 2014, MOL BREEDING, V33, P249, DOI 10.1007/s11032-013-9946-5; Mathews KL, 2008, THEOR APPL GENET, V117, P1077, DOI 10.1007/s00122-008-0846-8; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nishida H, 2013, PLANT PHYSIOL, V163, P804, DOI 10.1104/pp.113.222570; Obsa B, 2016, THEORETICAL AND APPL; Rollins JA, 2013, THEOR APPL GENET, V126, P2803, DOI 10.1007/s00122-013-2173-y; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shahinnia F., 2014, Seed and Plant Improvement Journal, V30, pPe85; Smith A, 2001, AUST NZ J STAT, V43, P129, DOI 10.1111/1467-842X.00163; Szucs P, 2006, THEOR APPL GENET, V112, P1277, DOI 10.1007/s00122-006-0229-y; Talame V, 2004, ANN APPL BIOL, V144, P309, DOI 10.1111/j.1744-7348.2004.tb00346.x; Taylor J, 2015, LINKAGE MAP CONSTRUC, P36; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Teulat B, 2001, THEOR APPL GENET, V103, P774, DOI 10.1007/s001220100619; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Tondelli A, 2014, EUPHYTICA, V197, P73, DOI 10.1007/s10681-013-1053-5; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Walker CK, 2013, THEOR APPL GENET, V126, P2533, DOI 10.1007/s00122-013-2153-2; Wang JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104882, 10.1371/journal.pone.0094096]; Xue DW, 2010, J ZHEJIANG UNIV-SC B, V11, P169, DOI 10.1631/jzus.B0900332; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; ZENG ZB, 1994, GENETICS, V136, P1457	55	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178111	10.1371/journal.pone.0178111	http://dx.doi.org/10.1371/journal.pone.0178111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542571	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800041
J	Park, J; Lee, SH; Han, S; Jee, HS; Lee, SK; Choi, GS; Kim, GS				Park, Jungchan; Lee, Seung Hwa; Han, Sangbin; Jee, Hyun Sook; Lee, Suk-Koo; Choi, Gyu-Seong; Kim, Gaab Soo			Preoperative cardiac troponin level is associated with all-cause mortality of liver transplantation recipients	PLOS ONE			English	Article							NONCARDIAC SURGERY; MYOCARDIAL INJURY; ELEVATION; SURVIVAL	This study was aimed to evaluate the association between preoperative high-sensitivity cardiac troponin I (hs-cTnI) level and mortality in patients undergoing liver transplantation (LT). From January 2011 to May 2016, preoperative hs-cTnI level was measured in consecutive 487 patients scheduled for LT. Patients with elevated preoperative hs-cTnI were compared with those who had normal level. The primary outcome was all-cause death in follow-up period of 30 days to 1 year after operation. Of the 487 patients, 58 (11.9%) had elevated preoperative hs-cTnI and 429 (88.1%) had normal preoperative hs-cTnI. In multivariate analysis, the rate of 1-year mortality and 30-day mortality were higher in elevated preoperative hs-cTnI group (hazard ratio [HR], 3.69; confidence interval [CI] 95%, 1.83-7.42; p < 0.001, HR, 6.61; CI, 1.91-22.82; p = 0.003, respectively). After adjustment with inverse probability weighting (IPW), the incidence of 1-year mortality and 30-day mortality were higher in elevated group (HR, 4.66; CI, 3.56-6.1; p < 0.001, HR, 10.31; CI, 6.39-16.66; p < 0.001, respectively). In conclusion, this study showed that in patients who underwent LT, elevation of preoperative hs-cTnI level was associated with 1-year mortality and 30-day mortality.	[Park, Jungchan; Han, Sangbin; Jee, Hyun Sook; Kim, Gaab Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Lee, Seung Hwa] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, Seoul, South Korea; [Lee, Suk-Koo; Choi, Gyu-Seong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, GS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	gskim@skku.edu		Lee, Seung Hwa/0000-0001-5508-7519				Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Beckman JA, 2013, CIRCULATION, V127, P2253, DOI 10.1161/CIRCULATIONAHA.113.003195; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Caselli C, 2016, CLIN CHIM ACTA, V458, P68, DOI 10.1016/j.cca.2016.04.029; Coss E, 2011, LIVER TRANSPLANT, V17, P23, DOI 10.1002/lt.22140; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Giannitsis E, 2000, CIRCULATION, V102, P211, DOI 10.1161/01.CIR.102.2.211; Gijsberts CM, 2016, NETH HEART J, V24, P188, DOI 10.1007/s12471-015-0798-y; Gorgun E, 2016, ANN SURG, V264, P605, DOI 10.1097/SLA.0000000000001854; Levy M, 2011, ANESTHESIOLOGY, V114, P796, DOI 10.1097/ALN.0b013e31820ad503; Mahajan VS, 2011, CIRCULATION, V124, P2350, DOI 10.1161/CIRCULATIONAHA.111.023697; Maile MD, 2016, ANESTH ANALG, V123, P135, DOI 10.1213/ANE.0000000000001309; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Moini M, 2011, CLIN TRANSPLANT, V25, P638, DOI 10.1111/j.1399-0012.2010.01350.x; Nishio Y, 2007, CIRC J, V71, P631, DOI 10.1253/circj.71.631; Parekh NK, 2007, HEPATOLOGY, V45, P1489, DOI 10.1002/hep.21640; Safadi A, 2009, CIRCULATION, V120, P1189, DOI 10.1161/CIRCULATIONAHA.108.847178; Snipelisky D, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/252838; van Waes JAR, 2013, CIRCULATION, V127, P2264, DOI 10.1161/CIRCULATIONAHA.113.002128; Watt KDS, 2010, LIVER TRANSPLANT, V16, P990, DOI 10.1002/lt.22102; Zanchin T, 2016, CIRC-CARDIOVASC INTE, P9	24	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177838	10.1371/journal.pone.0177838	http://dx.doi.org/10.1371/journal.pone.0177838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542299	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058800028
J	Zhang, Y; Dai, XB; Yang, S; Zhang, C; Han, M; Huang, HF; Fan, JX				Zhang, Yong; Dai, Xiaobei; Yang, Shuai; Zhang, Chen; Han, Mi; Huang, He-Feng; Fan, Jianxia			Maternal low thyroxin levels are associated with adverse pregnancy outcomes in a Chinese population	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; 5-MONOPHOSPHATE-ACTIVATED PROTEIN-KINASE; SUBCLINICAL THYROID-DISEASE; TANDEM MASS-SPECTROMETRY; TPO-ANTIBODY POSITIVITY; INCREASED RISK; CARDIOVASCULAR-SYSTEM; GENERATION R; HORMONE; DYSFUNCTION	Although thyroid dysfunction in early pregnancy may have adverse effects on pregnancy outcomes, few studies have examined the relationship between maternal low free thyroxin (FT4) levels in both first and third trimesters of pregnancy and the incidence of adverse pregnancy outcomes. We hypothesized that low FT4 levels in either first or third trimesters of pregnancy may have different effects on pregnancy outcomes. The study included 6,031 mothers who provided both first and third pregnancy serum samples for analyses of thyroid function. Adverse pregnancy outcomes, such as gestational diabetes mellitus (GDM), pregnancy-induced hypertension and preeclampsia, were diagnosed using the oral glucose tolerance test, blood pressure and urine protein test. Serum metabolites like adenosine and its analogues were identified using hydrophilic interaction liquid chromatography (HILIC)-tandem mass spectrometry (MS/MS). The incidence of hypothyroidism in pregnant women tended to increase with age and pre-pregnancy body mass index (BMI). The incidence of GDM was negatively correlated with maternal FT4 levels during early pregnancy while the incidence of preeclampsia was negatively correlated with maternal FT4 levels during late pregnancy. The incidence of pregnancy-induced hypertension was not significantly correlated with maternal FT4 levels. The women who had isolated maternal hypothyroxemia (IMH) in the third trimester of pregnancy had an increased risk of developing preeclampsia. Some metabolites like adenosine and its analogues in the serum were significantly changed in pregnant mothers with IMH. In conclusion, low FT4 levels during pregnancy are a risk factor for GDM and preeclampsia. Adenosine and its analogues may be important bridges between IMH and preeclampsia.	[Zhang, Yong; Dai, Xiaobei; Yang, Shuai; Zhang, Chen; Han, Mi; Huang, He-Feng; Fan, Jianxia] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Zhang, Yong; Huang, He-Feng] Shanghai Jiao Tong Univ, Sch Med, Inst Embryo Fetal Original Adult Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, HF; Fan, JX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China.; Huang, HF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Embryo Fetal Original Adult Dis, Shanghai, Peoples R China.	huanghefg@hotmail.com; fanjianxia122@126.com	Huang, Hefeng/AAR-7184-2021; Huang, He-Feng/AAN-7985-2020; Huang, Hefeng/ABF-1117-2020	Huang, He-Feng/0000-0003-4344-8019; Fan, Jianxia/0000-0003-3338-877X	National Natural Science Foundation of China [81471516, 81501274]; Shanghai Pujiang Program [15PJ1408900]; Shanghai Municipal Commission of Health and Family Planning [15GWZK0701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Municipal Commission of Health and Family Planning	This work was supported by grants from the National Natural Science Foundation of China (81471516) to JF, National Natural Science Foundation of China (81501274) to YZ, Shanghai Pujiang Program (15PJ1408900) to YZ and the Shanghai Municipal Commission of Health and Family Planning (No. 15GWZK0701) to JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarawal N, 2014, GYNECOL OBSTET INVES, V77, P94, DOI 10.1159/000357615; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Breathnach FM, 2013, AUST NZ J OBSTET GYN, V53, P553, DOI 10.1111/ajo.12131; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Casey BM, 2007, OBSTET GYNECOL, V109, P1129, DOI 10.1097/01.AOG.0000262054.03531.24; Chan S, 2015, CLIN ENDOCRINOL, V82, P313, DOI 10.1111/cen.12605; Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Dutta D, 2016, JOURNAL OF POSTGRADU; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; Guzman-Gutierrez E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00136; Guzman-Gutierrez E, 2014, MICROCIRCULATION, V21, P26, DOI 10.1111/micc.12077; Hamm MP, 2009, J OBSTET GYNAECOL CA, V31, P1015, DOI 10.1016/S1701-2163(16)34345-6; Karakosta P, 2012, J CLIN ENDOCR METAB, V97, P4464, DOI 10.1210/jc.2012-2540; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Korevaar TIM, 2013, J CLIN ENDOCR METAB, V98, P4382, DOI 10.1210/jc.2013-2855; Kumru P, 2015, ARCH GYNECOL OBSTET, V291, P1047, DOI 10.1007/s00404-014-3533-9; Mannisto T, 2013, J CLIN ENDOCR METAB, V98, P2725, DOI 10.1210/jc.2012-4233; Mannisto T, 2010, J CLIN ENDOCR METAB, V95, P1084, DOI 10.1210/jc.2009-1904; Matsumoto T, 2015, BRIT J PHARMACOL, V172, P3980, DOI 10.1111/bph.13205; Medici M, 2014, J CLIN ENDOCR METAB, V99, pE2591, DOI 10.1210/jc.2014-1505; Napoli R, 2001, CIRCULATION, V104, P3076, DOI 10.1161/hc5001.100621; Olivieri A, 2000, EUR J ENDOCRINOL, V143, P741, DOI 10.1530/eje.0.1430741; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Qian W, 2013, GYNECOL ENDOCRINOL, V29, P1059, DOI 10.3109/09513590.2013.829448; Saki F, 2015, ENDOCR RES, V40, P139, DOI 10.3109/07435800.2014.966384; Salomon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040578; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Smallridge RC, 2001, J CLIN ENDOCR METAB, V86, P2349, DOI 10.1210/jc.86.6.2349; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Tudela CM, 2012, OBSTET GYNECOL, V119, P983, DOI 10.1097/AOG.0b013e318250aeeb; Vargas R, 2013, J BIOL REG HOMEOS AG, V27, P989; Vargas R, 2017, IMMUNOL LETT, V184, P92, DOI 10.1016/j.imlet.2017.01.007; Velkoska NV, 2010, SEC BIOL SCI MASA, V31, P51; Warth B, 2015, J CHROMATOGR A, V1423, P183, DOI 10.1016/j.chroma.2015.10.070; Westermeier F, 2011, DIABETES, V60, P1677, DOI 10.2337/db11-0155; Wilson KL, 2012, OBSTET GYNECOL, V119, P315, DOI 10.1097/AOG.0b013e318240de6a; Xian H, 2017, GENE; Yamauchi M, 2008, MOL ENDOCRINOL, V22, P893, DOI 10.1210/me.2007-0249; Yang S, 2016, J CLIN ENDOCR METAB, V101, P4237, DOI 10.1210/jc.2016-1506; Ying H, 2016, ENDOCRINE, V54, P742, DOI 10.1007/s12020-016-1022-6; Zhang GD, 2014, J CHROMATOGR A, V1325, P129, DOI 10.1016/j.chroma.2013.12.017; Zhu L, 2016, ADVANCES IN COMMUNICATIONS-BASED TRAIN CONTROL SYSTEMS, P1	43	32	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178100	10.1371/journal.pone.0178100	http://dx.doi.org/10.1371/journal.pone.0178100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542464	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058800039
J	Yang, YD; Song, JY; Wang, S; Liu, FH; Zhang, YN; Shang, XR; Wang, HJ; Ma, J				Yang, Yi-De; Song, Jie-Yun; Wang, Shuo; Liu, Fang-Hong; Zhang, Yi-Ning; Shang, Xiao-Rui; Wang, Hai-Jun; Ma, Jun			Genetic variations in sterol regulatory element binding protein cleavage-activating protein (SCAP) are associated with blood pressure in overweight/obese Chinese children	PLOS ONE			English	Article							BODY-MASS INDEX; LIPID-LOWERING RESPONSE; CARDIOVASCULAR-DISEASE; HYPERTENSION; OBESITY; VARIANTS; SREBP-2; RISK; POLYMORPHISM; METAANALYSIS	Objective Previous studies demonstrated a role of variations in sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) in obesity and blood lipids. But the associations between SCAP polymorphisms and blood pressure (BP) are not clear. This study aimed to investigate the relationship between genetic variations in SCAP and BP phenotypes in a Chinese pediatric population. Methods A case-control study on 702 high blood pressure (HBP) children and 1319 controls was conducted to explore the correlation between single nucleotide polymorphism markers (rs12487736 and rs12490383) of SCAP and BP phenotypes. The associations with continuous and categorical variables were examined by linear regression and logistic regression models under a dominant genetic model for the minor rs12487736 A allele and rs12490383 T allele. Results The rs12487736 polymorphism was significantly associated with systolic BP (SBP) (beta = 1.66, P = 0.003) and diastolic BP (DBP) (beta = 1.35, P = 0.024) with age, age-squared, sex, study population and body mass index (BMI) adjusted under the dominant genetic model. The rs12490383 polymorphism was significantly associated with SBP (beta = 1.71, P = 0.004) and SHBP (OR = 1.39, 95% CI: 1.04-1.86, P = 0.027). When analyzed by BMI categories, in the normal-weight children, no significant association between the SCAP polymorphisms and BP phenotypes was observed (all P > 0.05). However, in the overweight/obese children, rs12487736 was significantly associated with SBP (beta = 1.6, P = 0.019) and SHBP (OR = 1.36, 95% CI: 1.02-1.82; P = 0.037), rs12490383 was associated with SBP (beta = 2.04, P = 0.004) and SHBP (OR = 1.50, 95% CI: 1.10-2.05; P = 0.01). Conclusions This study demonstrated that SCAP rs12487736 and rs12490383 were significantly associated with SBP and SHBP in overweight/obese Chinese children. It provided the evidence for association of SCAP with SBP.	[Yang, Yi-De; Song, Jie-Yun; Wang, Shuo; Liu, Fang-Hong; Zhang, Yi-Ning; Shang, Xiao-Rui; Wang, Hai-Jun; Ma, Jun] Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China	Peking University	Wang, HJ; Ma, J (corresponding author), Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China.	majunt@bjmu.edu.cn; whjun1@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903; Yang, Yide/0000-0003-3297-1306	National Natural Science Foundation of China [81573170]; Major State Basic Research and Development Program of China (973 Program) [2012CB517501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research and Development Program of China (973 Program)(National Basic Research Program of China)	This study was supported by Grants from National Natural Science Foundation of China (81573170, HJW, http//www.nsfc.gov.cn/) and the Major State Basic Research and Development Program of China (973 Program) (2012CB517501, JM, http/www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, WS T 456 2014; [Anonymous], CHIN J EVID BASED PE; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chen Z, 2011, MOL BIOL REP, V38, P2895, DOI 10.1007/s11033-010-9951-2; Commodore-Mensah Y, 2014, J HYPERTENS, V32, P464, DOI 10.1097/HJH.0000000000000061; Daniels SR, 2011, CIRCULATION, V124, P1673, DOI 10.1161/CIRCULATIONAHA.110.016170; Dong B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009050; Dong B, 2013, BIOMED ENVIRON SCI, V26, P437, DOI 10.3967/0895-3988.2013.06.004; Durst R, 2006, ATHEROSCLEROSIS, V189, P443, DOI 10.1016/j.atherosclerosis.2006.01.001; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fan YM, 2008, THROMB J, V6, DOI 10.1186/1477-9560-6-17; Fiegenbaum M, 2005, PHARMACOGENOMICS J, V5, P359, DOI 10.1038/sj.tpj.6500334; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Friedlander Y, 2008, ATHEROSCLEROSIS, V196, P896, DOI 10.1016/j.atherosclerosis.2007.02.006; Galbete C, 2013, OBESITY, V21, P1486, DOI 10.1002/oby.20150; Haffner SM, 1996, ARCH INTERN MED, V156, P1994, DOI 10.1001/archinte.156.17.1994; Halperin RO, 2006, HYPERTENSION, V47, P45, DOI 10.1161/01.HYP.0000196306.42418.0e; Iwaki K, 1999, J HUM GENET, V44, P421, DOI 10.1007/s100380050193; Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390; Lagos J, 2014, MOL DIAGN THER, V18, P435, DOI 10.1007/s40291-014-0094-3; Le Hellard S, 2009, MOL PSYCHIATR, V14, P308, DOI 10.1038/sj.mp.4002133; Liu FH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/538564; Liu XL, 2010, ATHEROSCLEROSIS, V208, P421, DOI 10.1016/j.atherosclerosis.2009.08.011; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Rafeeq MM, 2016, PHARMACOGENOMICS, V17, P2015, DOI 10.2217/pgs.16.30; Riggio S, 2010, EUR J CLIN INVEST, V40, P250, DOI 10.1111/j.1365-2362.2010.02260.x; Salek L, 2002, J MOL MED-JMM, V80, P737, DOI 10.1007/s00109-002-0381-z; SELBY JV, 1991, JAMA-J AM MED ASSOC, V265, P2079, DOI 10.1001/jama.265.16.2079; Snieder H, 2003, HYPERTENSION, V41, P1196, DOI 10.1161/01.HYP.0000072269.19820.0D; Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268	33	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177973	10.1371/journal.pone.0177973	http://dx.doi.org/10.1371/journal.pone.0177973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542467	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672600037
J	Florin, E; Vuvan, D; Peretz, I; Baillet, S				Florin, Esther; Vuvan, Dominique; Peretz, Isabelle; Baillet, Sylvain			Pre-target neural oscillations predict variability in the detection of small pitch changes	PLOS ONE			English	Article							NEURONAL OSCILLATIONS; FREQUENCY OSCILLATIONS; CORTICAL OSCILLATIONS; CONGENITAL AMUSIA; AUDITORY-CORTEX; BRAIN; PHASE; SPEECH; PERCEPTION; EEG	Pitch discrimination is important for language or music processing. Previous studies indicate that auditory perception depends on pre-target neural activity. However, so far the pre-target electrophysiological conditions which enable the detection of small pitch changes are not well studied, but might yield important insights into pitch-processing. We used magnetoen-cephalography (MEG) source imaging to reveal the pre-target effects of successful auditory detection of small pitch deviations from a sequence of standard tones. Participants heard a sequence of four pure tones and had to determine whether the last target tone was different or identical to the first three standard sounds. We found that successful pitch change detection could be predicted from the amplitude of theta (4-8 Hz) oscillatory activity in the right inferior frontal gyrus (IFG) as well as beta (12-30 Hz) oscillatory activity in the right auditory cortex. These findings confirm and extend evidence for the involvement of theta as well as beta-band activity in auditory perception.	[Florin, Esther; Baillet, Sylvain] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Florin, Esther] Heinrich Heine Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Med Fac, Dusseldorf, Germany; [Vuvan, Dominique; Peretz, Isabelle] Ctr Res Brain Language & Mus, Montreal, PQ, Canada; [Vuvan, Dominique] Skidmore Coll, Psychol Dept, Saratoga Springs, NY 12866 USA; [Peretz, Isabelle] Univ Montreal, Dept Psychol, Int Lab Brain Mus & Sound Res, Montreal, PQ, Canada	McGill University; Heinrich Heine University Dusseldorf; Skidmore College; Universite de Montreal	Florin, E (corresponding author), McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada.; Florin, E (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Med Fac, Dusseldorf, Germany.	esther.florin@hhu.de	Florin, Esther/GWC-1118-2022; Baillet, Sylvain/AAF-6512-2019	Florin, Esther/0000-0001-8276-2508; Baillet, Sylvain/0000-0002-6762-5713	Centre for Research on Brain, Language and Music; "Deutsche Forschungsgemeinschaft" (DFG) [FL 760 2-1]; Montreal Neurological Institute's National Bank Fellowship (Canada); Killam Foundation, a Senior-Researcher grant from the Fonds de Recherche du Quebec - Sante, a Discovery Grant from the National Science and Engineering Research Council of Canada; IARPA Knowledge Representation in Neural Systems Program [FA8650-14-C-7357]; NIH [2R01EB009048-05]	Centre for Research on Brain, Language and Music; "Deutsche Forschungsgemeinschaft" (DFG)(German Research Foundation (DFG)); Montreal Neurological Institute's National Bank Fellowship (Canada); Killam Foundation, a Senior-Researcher grant from the Fonds de Recherche du Quebec - Sante, a Discovery Grant from the National Science and Engineering Research Council of Canada; IARPA Knowledge Representation in Neural Systems Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported through an award from the Centre for Research on Brain, Language and Music. EF gratefully acknowledges support from "Deutsche Forschungsgemeinschaft" (DFG: FL 760 2-1, Germany) and the Montreal Neurological Institute's National Bank Fellowship (Canada). SB was supported by the Killam Foundation, a Senior-Researcher grant from the Fonds de Recherche du Quebec - Sante, a Discovery Grant from the National Science and Engineering Research Council of Canada, the IARPA Knowledge Representation in Neural Systems Program (FA8650-14-C-7357) and the NIH (2R01EB009048-05).	Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Albouy P, 2013, BRAIN, V136, P1639, DOI 10.1093/brain/awt082; Attal Y, 2009, IRBM, V30, P133, DOI 10.1016/j.irbm.2009.01.005; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Bokil H, 2007, J NEUROSCI METH, V159, P337, DOI 10.1016/j.jneumeth.2006.07.011; Bregman A.S., 1994, AUDITORY SCENE ANAL; Brochard R, 2013, COGNITION, V127, P214, DOI 10.1016/j.cognition.2013.01.007; Busch NA, 2010, P NATL ACAD SCI USA, V107, P16048, DOI 10.1073/pnas.1004801107; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; Doelling KB, 2014, NEUROIMAGE, V85, P761, DOI 10.1016/j.neuroimage.2013.06.035; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Fujioka T, 2009, ANN NY ACAD SCI, V1169, P89, DOI 10.1111/j.1749-6632.2009.04779.x; Gaab N, 2003, NEUROIMAGE, V19, P1417, DOI 10.1016/S1053-8119(03)00224-6; GIARD MH, 1988, ELECTROEN CLIN NEURO, V69, P371, DOI 10.1016/0013-4694(88)90008-9; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Henry M.J., 2014, TIMING TIME PERCEPT, V2, P62, DOI [10.1163/22134468-00002011, DOI 10.1163/22134468-00002011]; Henry MJ, 2014, P NATL ACAD SCI USA, V111, P14935, DOI 10.1073/pnas.1408741111; Henry MJ, 2012, P NATL ACAD SCI USA, V109, P20095, DOI 10.1073/pnas.1213390109; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Hyde KL, 2011, CEREB CORTEX, V21, P292, DOI 10.1093/cercor/bhq094; Iversen JR, 2009, ANN NY ACAD SCI, V1169, P58, DOI 10.1111/j.1749-6632.2009.04579.x; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Kayser C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002717; Keil J, 2012, CEREB CORTEX, V22, P221, DOI 10.1093/cercor/bhr125; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lange J, 2011, NEUROIMAGE, V54, P1395, DOI 10.1016/j.neuroimage.2010.09.031; Lappe C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00260; Lappe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061296; Lenz D, 2008, BRAIN RES, V1220, P81, DOI 10.1016/j.brainres.2007.10.053; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Loui P, 2009, J NEUROSCI, V29, P10215, DOI 10.1523/JNEUROSCI.1701-09.2009; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Luo H, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00170; Macmillan NA, 2005, DETECTION THEORY USE; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Mazaheri A, 2014, NEUROIMAGE, V87, P356, DOI 10.1016/j.neuroimage.2013.10.052; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Muller N, 2012, CEREB CORTEX, V22, P1604, DOI 10.1093/cercor/bhr232; Naatanen R, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P125; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Ng BSW, 2012, J NEUROSCI, V32, P12268, DOI 10.1523/JNEUROSCI.1877-12.2012; Nolte G, 1999, IEEE T BIO-MED ENG, V46, P400, DOI 10.1109/10.752937; Peretz I, 2005, ANN NEUROL, V58, P478, DOI 10.1002/ana.20606; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Riecke L, 2015, CURR BIOL, V25, P3196, DOI 10.1016/j.cub.2015.10.045; Riecke L, 2015, BRAIN STIMUL, V8, P777, DOI 10.1016/j.brs.2015.04.004; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Siedenberg R, 1996, ELECTROEN CLIN NEURO, V99, P191, DOI 10.1016/0013-4694(96)95215-3; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Strauss A, 2015, J NEUROSCI, V35, P3256, DOI 10.1523/JNEUROSCI.3357-14.2015; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; TARKKA IM, 1995, EVOKED POTENTIAL, V96, P538, DOI 10.1016/0013-4694(95)00087-F; Tillmann B, 2006, NEUROIMAGE, V31, P1771, DOI 10.1016/j.neuroimage.2006.02.028; Tillmann B, 2003, COGNITIVE BRAIN RES, V16, P145, DOI 10.1016/S0926-6410(02)00245-8; Trainor LJ, 2009, ANN NY ACAD SCI, V1169, P133, DOI 10.1111/j.1749-6632.2009.04589.x; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Weisz N, 2014, HEARING RES, V307, P16, DOI 10.1016/j.heares.2013.07.009; Wyart V, 2009, J NEUROSCI, V29, P8715, DOI 10.1523/JNEUROSCI.0962-09.2009; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zoefel B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00262	70	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177836	10.1371/journal.pone.0177836	http://dx.doi.org/10.1371/journal.pone.0177836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542644	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400096
J	Hu, RR; Wang, CK; Racette, L				Hu, Rongrong; Wang, Chenkun; Racette, Lyne			Comparison of matrix frequency-doubling technology perimetry and standard automated perimetry in monitoring the development of visual field defects for glaucoma suspect eyes	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; LASER-OPHTHALMOSCOPY-ANCILLARY; OCULAR HYPERTENSION; AFRICAN DESCENT; PROGRESSION; VARIABILITY; THRESHOLD; TESTS; CELLS; ONSET	Background Perimetry is indispensable for the clinical management of glaucoma suspects. Our goal is to compare the performance of standard automated perimetry (SAP) and Matrix frequency-doubling technology (FDT) perimetry in monitoring the development of visual field (VF) defects in glaucoma suspect eyes. Methods Longitudinal data of paired SAP and FDT from 221 eyes of 155 glaucoma suspects enrolled in the Diagnostic Innovations in Glaucoma Study or the African Descent and Glaucoma Evaluation Study were included. All eyes had glaucomatous optic neuropathy or ocular hypertension, but normal SAP and FDT results at baseline. The development of glaucomatous VF defects was defined as the presence of a cluster of >= 3 (less conservative) or >= 4 (more conservative) locations confirmed on >= 2 additional consecutive tests. Risk factors for the development of VF defects were analyzed by COX proportional hazard models. After conversion into common logarithmic units, the rates of change of global VF indices were fitted with linear mixed models. Results FDT detected more eyes that developed VF defects than SAP using the less conservative criterion, and no significant difference was observed using the more conservative criterion. For those eyes detected by both SAP and FDT, FDT detected the development of VF defects either earlier than SAP or simultaneously in most cases. Baseline structural measurements were not significantly associated with an increased risk for the development of glaucomatous VF defects on either SAP or FDT. Older age was significantly associated with the development of VF defects on FDT but not on SAP. Both SAP and FDT detected a progressing worsening trend of pattern standard deviation over time with a similar rate of change between these test types. Conclusions Matrix FDT would be useful to monitor the onset of VF defects in glaucoma suspects and may outperform SAP in the early stage of glaucomatous VF damage.	[Hu, Rongrong] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Ophthalmol, Hangzhou, Zhejiang, Peoples R China; [Hu, Rongrong; Racette, Lyne] Indiana Univ, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46204 USA; [Wang, Chenkun] Indiana Univ, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Wang, Chenkun] Vertex Pharmaceut Inc, Boston, MA USA	Zhejiang University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Vertex Pharmaceuticals	Racette, L (corresponding author), Indiana Univ, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46204 USA.	lracette@iupui.edu	Racette, Lyne/AAX-3088-2020	Hu, Rongrong/0000-0002-2238-3431	NIH grant [EY025756]; Zhejiang Provincial Natural Science Foundation of China [LQ17H120003, LY13H120003]; Health and Family Planning Commission of Zhejiang Province, China [2016KYA089]; Glaucoma Research Foundation; Indiana University-Purdue University Indianapolis DRIVE; NIH [P30EY022589, EY021818, EY11008, U1OEY14267, EY019869]; Eyesight Foundation of Alabama; New York Glaucoma Research Institute, New York, NY; Research to Prevent Blindness, New York, New York; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY025756] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Health and Family Planning Commission of Zhejiang Province, China; Glaucoma Research Foundation; Indiana University-Purdue University Indianapolis DRIVE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eyesight Foundation of Alabama; New York Glaucoma Research Institute, New York, NY; Research to Prevent Blindness, New York, New York(Research to Prevent Blindness (RPB)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by NIH grant EY025756 (LR) and by grants from the Zhejiang Provincial Natural Science Foundation of China (grant no: LQ17H120003 and LY13H120003, RH) and from the Health and Family Planning Commission of Zhejiang Province, China (grant no: 2016KYA089, RH).; Acknowledgment is made to the donors of the National Glaucoma Research, a program of BrightFocus Foundation (LR), for support of this research. This work was also supported in part by a Shaffer grant from the Glaucoma Research Foundation (LR), by an Indiana University-Purdue University Indianapolis DRIVE award (LR), and by an unrestricted grant from Research to Prevent Blindness (LR). The DIGS and ADAGES studies were supported by NIH Grants P30EY022589, EY021818, EY11008, U1OEY14267, EY019869; Eyesight Foundation of Alabama; Edith C. Blum Research Fund of the New York Glaucoma Research Institute, New York, NY; and unrestricted grant from Research to Prevent Blindness, New York, New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AJ, 2005, INVEST OPHTH VIS SCI, V46, P1540, DOI 10.1167/iovs.04-0968; Anderson AJ, 2011, OPTOMETRY VISION SCI, V88, P806, DOI 10.1097/OPX.0b013e31821861bd; Anderson DR., 1999, AUTOMATED STATIC PER; Artes PH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1528, DOI 10.1001/archophthalmol.2010.292; Artes PH, 2005, INVEST OPHTH VIS SCI, V46, P2451, DOI 10.1167/iovs.05-0135; Burgansky-Eliash Z, 2007, BRIT J OPHTHALMOL, V91, P933, DOI 10.1136/bjo.2006.110437; Centofanti M, 2005, OPHTHALMOLOGY, V112, P366, DOI 10.1016/j.ophtha.2004.11.030; Chauhan BC, 1999, INVEST OPHTH VIS SCI, V40, P648; Fingeret M, 2005, THE ESSENTIAL HRT PR; Fredette MJ, 2015, OPTOMETRY VISION SCI, V92, P527, DOI 10.1097/OPX.0000000000000583; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Haymes SA, 2005, INVEST OPHTH VIS SCI, V46, P547, DOI 10.1167/iovs.04-0973; Hu RR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002618; Hu RR, 2014, INVEST OPHTH VIS SCI, V55, P8086, DOI 10.1167/iovs.14-14928; Keltner JL, 2006, OPHTHALMOLOGY, V113, P1603, DOI 10.1016/j.ophtha.2006.05.061; Kim KE, 2016, OPHTHALMOLOGY, V123, P532, DOI 10.1016/j.ophtha.2015.11.004; Kim TW, 2007, OPHTHALMOLOGY, V114, P1053, DOI 10.1016/j.ophtha.2006.09.015; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee E, 1992, COX TYPE REGRESSION; Leeprechanon N, 2007, AM J OPHTHALMOL, V143, P263, DOI 10.1016/j.ajo.2006.10.033; Liu S, 2014, INVEST OPHTH VIS SCI, V55, P2862, DOI 10.1167/iovs.13-13225; Liu S, 2014, JAMA OPHTHALMOL, V132, P77, DOI 10.1001/jamaophthalmol.2013.5511; Liu S, 2011, INVEST OPHTH VIS SCI, V52, P7325, DOI 10.1167/iovs.11-7795; Maddess T, 1998, VISION RES, V38, P1843, DOI 10.1016/S0042-6989(97)00344-1; Malik R, 2012, CLIN EXP OPHTHALMOL, V40, P369, DOI 10.1111/j.1442-9071.2012.02770.x; Marin-Franch I, 2013, J VISION, V13, DOI 10.1167/13.4.10; Medeiros FA, 2004, AM J OPHTHALMOL, V137, P863, DOI 10.1016/j.ajo.2003.12.009; Miglior S, 2007, OPHTHALMOLOGY, V114, P3, DOI 10.1016/j.ophtha.2006.05.075; Nouri-Manhavi K, 2014, CAN J OPHTHALMOL, V49, P497, DOI 10.1016/j.jcjo.2014.10.002; Patel A, 2007, OPHTHALMOLOGY, V114, P480, DOI 10.1016/j.ophtha.2006.08.009; Peli E, 1997, VISION RES, V37, P3217, DOI 10.1016/S0042-6989(96)00262-3; Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58; Redmond T, 2013, JAMA OPHTHALMOL, V131, P1565, DOI 10.1001/jamaophthalmol.2013.4382; Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187; Spry PGD, 2001, INVEST OPHTH VIS SCI, V42, P1404; Spry PGD, 2005, BRIT J OPHTHALMOL, V89, P1031, DOI 10.1136/bjo.2004.057778; Spry PGD, 2002, J GLAUCOMA, V11, P315, DOI 10.1097/00061198-200208000-00007; Sun H, 2006, OPTOMETRY VISION SCI, V83, P455, DOI 10.1097/01.opx.0000225103.18087.5d; Swanson WH, 2011, INVEST OPHTH VIS SCI, V52, P764, DOI 10.1167/iovs.10-6158; Wall M, 2009, INVEST OPHTH VIS SCI, V50, P974, DOI 10.1167/iovs.08-1789; Weinreb RN, 2010, OPHTHALMOLOGY, V117, P1674, DOI 10.1016/j.ophtha.2010.03.044; White AJR, 2002, INVEST OPHTH VIS SCI, V43, P3590; Xin DY, 2011, INVEST OPHTH VIS SCI, V52, P519, DOI 10.1167/iovs.10-5174; Zangwill LM, 2005, ARCH OPHTHALMOL-CHIC, V123, P1188, DOI 10.1001/archopht.123.9.1188; Zeppieri M, 2008, OPTOMETRY VISION SCI, V85, P318, DOI 10.1097/OPX.0b013e31816be9fd	45	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178079	10.1371/journal.pone.0178079	http://dx.doi.org/10.1371/journal.pone.0178079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542536	gold, Green Published			2022-12-27	WOS:000401672400139
J	Ingram, WS; Yang, JZ; Beadle, BM; Wendt, R; Rao, A; Wang, XA; Court, LE				Ingram, W. Scott; Yang, Jinzhong; Beadle, Beth M.; Wendt, Richard, III; Rao, Arvind; Wang, Xin A.; Court, Laurence E.			The feasibility of endoscopy-CT image registration in the head and neck without prospective endoscope tracking	PLOS ONE			English	Article							3-DIMENSIONAL MOTION TRACKING; SURGERY; VIDEO; BRONCHOSCOPE; ACCURACY; SYSTEM	Purpose Endoscopic examinations are frequently-used procedures for patients with head and neck cancer undergoing radiotherapy, but radiation treatment plans are created on computed tomography (CT) scans. Image registration between endoscopic video and CT could be used to improve treatment planning and analysis of radiation-related normal tissue toxicity. The purpose of this study was to explore the feasibility of endoscopy-CT image registration without prospective physical tracking of the endoscope during the examination. Methods A novel registration technique called Location Search was developed. This technique uses physical constraints on the endoscope's view direction to search for the virtual endoscope coordinates that maximize the similarity between the endoscopic video frame and the virtual endoscopic image. Its performance was tested on phantom and patient images and compared to an established registration technique, Frame-To-Frame Tracking. Results In phantoms, Location Search had average registration errors of 0.55 +/- 0.60 cm for point measurements and 0.29 +/- 0.15 cm for object surface measurements. Frame-To-Frame Tracking achieved similar results on some frames, but it failed on others due to the virtual endoscope becoming lost. This weakness was more pronounced in patients, where Frame-To-Frame tracking could not make it through the nasal cavity. On successful patient video frames, Location Search was able to find endoscope positions with an average distance of 0.98 +/- 0.53 cm away from the ground truth positions. However, it failed on many frames due to false similarity matches caused by anatomical structural differences between the endoscopic video and the virtual endoscopic images. Conclusions Endoscopy-CT image registration without prospective physical tracking of the endoscope is possible, but more development is required to achieve an accuracy suitable for clinical translation.	[Ingram, W. Scott; Yang, Jinzhong; Wang, Xin A.; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Ingram, W. Scott; Yang, Jinzhong; Wendt, Richard, III; Rao, Arvind; Wang, Xin A.; Court, Laurence E.] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77204 USA; [Beadle, Beth M.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Wendt, Richard, III] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Rao, Arvind] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ingram, WS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA.; Ingram, WS (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77204 USA.	scottingram312@gmail.com		Beadle, Beth/0000-0001-5497-2831; Court, Laurence/0000-0002-3241-6145	National Institutes of Health through the Cancer Center [P30CA01672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health through the Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful for the support of Mr. and Mrs. William D. Rollnick and The University of Texas MD Anderson Center for Radiation Oncology Research. This work was supported in part by the National Institutes of Health through the Cancer Center Support Grant P30CA01672 for The University of Texas MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anayama T, 2015, ANN THORAC SURG, V99, P224, DOI 10.1016/j.athoracsur.2014.07.050; Bradski G., 2008, LEARNING OPENCV COMP; Burschka D, 2005, MED IMAGE ANAL, V9, P413, DOI 10.1016/j.media.2005.05.005; Deligianni F, 2003, LECT NOTES COMPUT SC, V2878, P311; Fried MP, 1997, LARYNGOSCOPE, V107, P594, DOI 10.1097/00005537-199705000-00008; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Luo XB, 2014, PROC CVPR IEEE, P1250, DOI 10.1109/CVPR.2014.163; Luo XB, 2014, IEEE T MED IMAGING, V33, P1248, DOI 10.1109/TMI.2014.2307052; Mirota DJ, 2013, IEEE T MED IMAGING, V32, P1215, DOI 10.1109/TMI.2013.2243464; Mori K, 2002, MED IMAGE ANAL, V6, P321, DOI 10.1016/S1361-8415(02)00089-0; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Pluim JPW, 2000, LECT NOTES COMPUT SC, V1935, P452; Qiu J, 2012, PHYS MED BIOL, V57, P6601, DOI 10.1088/0031-9155/57/20/6601; Schroeder W., 2006, VISUALIZATION TOOLKI, V4th; Weersink RA, 2011, MED PHYS, V38, P6458, DOI 10.1118/1.3658569	15	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177886	10.1371/journal.pone.0177886	http://dx.doi.org/10.1371/journal.pone.0177886			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542331	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400107
J	Milne, E; Dickinson, A; Smith, R				Milne, Elizabeth; Dickinson, Abigail; Smith, Richard			Adults with autism spectrum conditions experience increased levels of anomalous perception	PLOS ONE			English	Article							PSYCHOTIC EXPERIENCES; SENSORY EXPERIENCES; CHILDREN; DISORDERS; ASSOCIATION; POPULATION; EXPRESSION	Autism spectrum condition (ASC) is characterised by differences in social interaction and behavioural inflexibility. In addition to these core symptoms, atypical sensory responses are prevalent in the ASC phenotype. Here we investigated anomalous perception, i.e. hallucinatory and/or out of body experiences in adults with ASC. Thirty participants with an ASC diagnosis and thirty neurotypical controls completed the Cardiff Anomalous Perception Scale (CAPS) and the Social Responsiveness Scale (SRS-2). The CAPS is a 32-item questionnaire that asks participants to indicate whether or not they experience a range of anomalous and out of body experiences, and to rate how intrusive and distressing these experiences are. The SRS-2 asks participants to rate the extent to which they identify with a series of 65 statements that describe behaviours associated with the autism phenotype. We found that total CAPS score was significantly higher in the participants with ASC (mean = 14.8, S.D. = 7.9) than the participants without ASC (mean = 3.6, S.D. = 4.1). In addition, the frequency of anomalous perception, the level of distraction and the level of distress associated with the experience were significantly increased in participants with ASC. Importantly, both the frequency of anomalous perceptual experiences and the level of distress caused by anomalous perception in this sample of adults with ASC were very similar to that reported previously in a sample of non-autistic participants who were being treated in hospital for a current psychotic episode. These data indicate that anomalous perceptual experiences are common in adults with ASC and are associated with a high level of distress. The origins of anomalous perception in ASC and the implication of this phenomenon are considered.	[Milne, Elizabeth; Dickinson, Abigail] Univ Sheffield, Dept Psychol, Sheffield Autism Res Lab, Sheffield, S Yorkshire, England; [Smith, Richard] Sheffield Hlth & Social Care NHS Trust, Sheffield Adult Autism & Neurodev Serv, Sheffield, S Yorkshire, England	University of Sheffield	Milne, E (corresponding author), Univ Sheffield, Dept Psychol, Sheffield Autism Res Lab, Sheffield, S Yorkshire, England.	E.Milne@sheffield.ac.uk						American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bell V, 2006, SCHIZOPHRENIA BULL, V32, P366, DOI 10.1093/schbul/sbj014; Braithwaite JJ, 2013, CORTEX, V49, P793, DOI 10.1016/j.cortex.2011.11.013; Braithwaite JJ, 2011, CORTEX, V47, P839, DOI 10.1016/j.cortex.2010.05.002; Bunney WE, 1999, SCHIZOPHRENIA BULL, V25, P577, DOI 10.1093/oxfordjournals.schbul.a033402; Cappadocia MC, 2012, J AUTISM DEV DISORD, V42, P266, DOI 10.1007/s10803-011-1241-x; CESARONI L, 1991, J AUTISM DEV DISORD, V21, P303, DOI 10.1007/BF02207327; Constantino JN., 2012, SRS2 SOCIAL RESPONSI, V2nd ed; Dickinson A, 2016, BRAIN RES, V1648, P277, DOI 10.1016/j.brainres.2016.07.011; Dickinson A, 2016, J ABNORM PSYCHOL, V125, P412, DOI 10.1037/abn0000148; Gandal MJ, 2012, GENES BRAIN BEHAV, V11, P740, DOI 10.1111/j.1601-183X.2012.00816.x; Gillberg IC, 2016, J AUTISM DEV DISORD, V46, P74, DOI 10.1007/s10803-015-2544-0; GLOOR P, 1990, BRAIN, V113, P1673, DOI 10.1093/brain/113.6.1673; Horder J, 2014, J AUTISM DEV DISORD, V44, P1461, DOI 10.1007/s10803-013-2012-7; Huang J, 2011, CEPHALALGIA, V31, P925, DOI 10.1177/0333102411409076; Jardri R, 2016, SCHIZOPHRENIA B; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; Lataster T, 2006, SOC PSYCH PSYCH EPID, V41, P423, DOI 10.1007/s00127-006-0060-4; Little Liza, 2002, Issues Compr Pediatr Nurs, V25, P43, DOI 10.1080/014608602753504847; Mouridsen SE, 2008, J NEURAL TRANSM, V115, P135, DOI 10.1007/s00702-007-0798-1; Persinger MA, 2001, J NEUROPSYCH CLIN N, V13, P515, DOI 10.1176/appi.neuropsych.13.4.515; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Smith RS, 2013, J AUTISM DEV DISORD, V43, P891, DOI 10.1007/s10803-012-1633-6; Stahlberg O, 2004, J NEURAL TRANSM, V111, P891, DOI 10.1007/s00702-004-0115-1; Steel C, 2009, SOC PSYCH PSYCH EPID, V44, P917, DOI 10.1007/s00127-009-0038-0; Sullivan S, 2013, J AM ACAD CHILD PSY, V52, P806, DOI 10.1016/j.jaac.2013.05.010; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; van Os J, 2000, SCHIZOPHR RES, V45, P11, DOI 10.1016/S0920-9964(99)00224-8	29	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177804	10.1371/journal.pone.0177804	http://dx.doi.org/10.1371/journal.pone.0177804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542171	Green Accepted, gold, Green Published			2022-12-27	WOS:000401672400085
J	Monaro, M; Gamberini, L; Sartori, G				Monaro, Merylin; Gamberini, Luciano; Sartori, Giuseppe			The detection of faked identity using unexpected questions and mouse dynamics	PLOS ONE			English	Article							PUBLIC-GOODS GAME; LIE; DECEPTION; LIARS; TRUTH	The detection of faked identities is a major problem in security. Current memory-detection techniques cannot be used as they require prior knowledge of the respondent's true identity. Here, we report a novel technique for detecting faked identities based on the use of unexpected questions that may be used to check the respondent identity without any prior autobiographical information. While truth-tellers respond automatically to unexpected questions, liars have to "build" and verify their responses. This lack of automaticity is reflected in the mouse movements used to record the responses as well as in the number of errors. Responses to unexpected questions are compared to responses to expected and control questions (i.e., questions to which a liar also must respond truthfully). Parameters that encode mouse movement were analyzed using machine learning classifiers and the results indicate that the mouse trajectories and errors on unexpected questions efficiently distinguish liars from truth-tellers. Furthermore, we showed that liars may be identified also when they are responding truthfully. Unexpected questions combined with the analysis of mouse movement may efficiently spot participants with faked identities without the need for any prior information on the examinee.	[Monaro, Merylin] Univ Padua, PhD Program Brain Mind & Comp Sci, Padua, Italy; [Gamberini, Luciano] Univ Padua, Human Inspired Technol Res Ctr, Padua, Italy; [Gamberini, Luciano; Sartori, Giuseppe] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua; University of Padua; University of Padua	Sartori, G (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	giuseppe.sartori@unipd.it	Sartori, Giuseppe/B-8140-2008; Monaro, Merylin/AAM-3066-2021	Monaro, Merylin/0000-0001-5598-691X				Abney DH, 2015, PSYCHON B REV, V22, P1020, DOI 10.3758/s13423-014-0771-6; Agosta S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00519; Barber S, 2015, DIRECT LINK IDENTITY; Barca L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035932; Benussi V, 1914, ARCH GESAMTE PSYCHOL, V31, P244; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; Dale R, 2011, COGNITIVE SCI, V35, P983, DOI 10.1111/j.1551-6709.2010.01164.x; Debey E, 2015, PSYCHOL RES-PSYCH FO, V79, P478, DOI 10.1007/s00426-014-0582-4; Donath J.S., 1999, COMMUNITIES CYBERSPA, P29; Duran ND, 2010, PSYCHON B REV, V17, P486, DOI 10.3758/PBR.17.4.486; Dwork C, 2015, SCIENCE, V349, P636, DOI 10.1126/science.aaa9375; Freeman JB, 2016, PSYCHOL SCI, V27, P502, DOI 10.1177/0956797615627418; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Hartwig M, 2007, PSYCHOL CRIME LAW, V13, P213, DOI 10.1080/10683160600750264; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kleinberg B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118715; Lancaster GLJ, 2013, APPL COGNITIVE PSYCH, V27, P107, DOI 10.1002/acp.2879; Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Meixner JB, 2011, PSYCHOPHYSIOLOGY, V48, P149, DOI 10.1111/j.1469-8986.2010.01050.x; Platt J, 1999, ADV KERNEL METHODS; Quetard B, 2015, COGN PROCESS, V16, pS343, DOI 10.1007/s10339-015-0673-1; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; Rosenfeld JP, 2009, WILEY ENCY FORENSIC; Sartori G, 2008, PSYCHOL SCI, V19, P772, DOI 10.1111/j.1467-9280.2008.02156.x; UEFA, 2002, WILL REAL ER STAND U; Van Bockstaele B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00526; Verschuere B, 2016, J FORENSIC SCI, V61, pS237, DOI 10.1111/1556-4029.12960; Vrij A., 2015, COGNITIVE APPROACH L; Vrij A, 2009, LAW HUMAN BEHAV, V33, P159, DOI 10.1007/s10979-008-9143-y; Vrij Aldert, 2008, J INVEST PSYCHOL OFF, V5, P39, DOI DOI 10.1002/JIP.82; Wang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167083; Warmelink L, 2013, PSYCHIAT PSYCHOL LAW, V20, P29, DOI 10.1080/13218719.2011.619058	38	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177851	10.1371/journal.pone.0177851	http://dx.doi.org/10.1371/journal.pone.0177851			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542248	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400101
J	Tan, XB; Dai, QY				Tan, Xiaobing; Dai, Qingyuan			Characterization of microRNAs expression profiles in human dental-derived pluripotent stem cells	PLOS ONE			English	Article							SELF-RENEWAL; IDENTIFICATION; TARGET	Induced pluripotent stem cells (iPSCs) technology provides a powerful means to generate and regenerate unlimited pluripotent stem cells directly from body tissue cells. Stem cells from apical papilla (SCAP) and Dental pulp stem cells (DPSCs) are present in 'cell-rich zones' within the dental pulp region, which are capable of regenerating pulp and dentin tissues in vivo. In this study, we investigated the difference of miRNAs expression in SCAPs and DPSCs before and after the reprogramming. Using miRNA microarray, 134 and 265 differentially expressed miRNAs in DPSCs-and SCAP-iPSCs were up-regulated compared to these before reprogramming. 117 specific miRNAs with enhanced more than 2-fold were identified in both DPSCs-and SCAP-iPSCs. Among the co-regulated miRNAs, miR-19a-3p, miR-92b-3p and miR-130b-3p showed the maximum difference, which had involvement in the cell cycle, TGF beta signaling pathway and epithelial mesenchymal transition. Using qRT-PCR analysis, the expression of miR-19a-3p, miR-92b-3p and miR-130b-3p indicated substantial increases in DPSCs-iPSCs and SCAP-iPSCs. The findings suggest that miRNAs play a part in the difference between DPSCs-iPSCs and DPSCs, as well as between SCAP-iPSCs and SCAP. The variation of miRNA expression in reprogrammed dental-derived pluripotent stem cells revealed different characteristics induced by iPSC generation.	[Tan, Xiaobing] First Peoples Hosp Yunnan Prov, Dept Cariol & Endodont, Kunming, Peoples R China; [Tan, Xiaobing] Kunming Univ Sci & Technol, Affiliated Hosp, Dept Cariol & Endodont, Kunming, Peoples R China; [Dai, Qingyuan] Kunming Med Univ, Dept Cardiol, Affiliated Hosp 1, Kunming, Peoples R China	Kunming University of Science & Technology; Kunming Medical University	Dai, QY (corresponding author), Kunming Med Univ, Dept Cardiol, Affiliated Hosp 1, Kunming, Peoples R China.	dqy_km@163.com			National Natural Science Foundation of China [81360161]; Yunnan Provincial Department of Education Science Foundation of China [2015Y153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Department of Education Science Foundation of China	This study was supported by National Natural Science Foundation of China (81360161) and Yunnan Provincial Department of Education Science Foundation of China (2015Y153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Natural Science Foundation of China (81360161) and Yunnan Provincial Department of Education Science Foundation of China (2015Y153).	Balaga O, 2012, NUCLEIC ACIDS RES, V40, P9404, DOI 10.1093/nar/gks759; Barrett JR, 2004, ENVIRON HEALTH PERSP, V112, pA944; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Busch S, 2015, J IMMUNOL, V194, P1646, DOI 10.4049/jimmunol.1402163; Choi J, 2015, NAT BIOTECHNOL, V33, P1173, DOI 10.1038/nbt.3388; Galvin-Burgess KE, 2013, STEM CELLS, V31, P48, DOI 10.1002/stem.1252; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; He XL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086982, 10.1371/journal.pone.0104323, 10.1371/journal.pone.0105373]; Hu KJ, 2014, STEM CELLS DEV, V23, P1285, DOI 10.1089/scd.2013.0620; Jonsson ME, 2015, DEVELOPMENT, V142, P3166, DOI 10.1242/dev.122747; La Noce M, 2014, J DENT, V42, P761, DOI 10.1016/j.jdent.2014.02.018; Li S., 2016, PLOS ONE, V11; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Papapetrou EP, 2011, NAT PROTOC, V6, P1251, DOI 10.1038/nprot.2011.374; Sharma Amit, 2013, Methods Mol Biol, V936, P247; Skreka K, 2012, NUCLEIC ACIDS RES, V40, P6001, DOI 10.1093/nar/gks311; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tirino Virginia, 2012, Methods Mol Biol, V879, P443, DOI 10.1007/978-1-61779-815-3_26; Tokudome T, 2015, ONCOL LETT, V10, P2269, DOI 10.3892/ol.2015.3594; Vasanthan P, 2015, J CELL MOL MED, V19, P566, DOI 10.1111/jcmm.12381; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wang Z., 2015, PLOS ONE, V10; Wend P, 2010, SEMIN CELL DEV BIOL, V25, P254; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zou XY, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt134	27	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177832	10.1371/journal.pone.0177832	http://dx.doi.org/10.1371/journal.pone.0177832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542487	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400095
J	Osazuwa-Peters, N; Boakye, EA; Hussaini, AS; Sujijantarat, N; Ganesh, RN; Snider, M; Thompson, D; Varvares, MA				Osazuwa-Peters, Nosayaba; Boakye, Eric Adjei; Hussaini, Adnan S.; Sujijantarat, Nanthiya; Ganesh, Rajan N.; Snider, Matthew; Thompson, Devin; Varvares, Mark A.			Characteristics and predictors of oral cancer knowledge in a predominantly African American community	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NECK-CANCER; INFORMATION LEAFLET; EXAMINATION EXPERIENCES; OROPHARYNGEAL CANCER; PHARYNGEAL CANCER; CIGARETTE-SMOKING; SCREENING-PROGRAM; SOUTH-CAROLINA; RISK-FACTORS	Purpose To characterize smoking and alcohol use, and to describe predictors of oral cancer knowledge among a predominantly African-American population. Methods A cross-sectional study was conducted between September, 2013 among drag racers and fans in East St. Louis. Oral cancer knowledge was derived from combining questionnaire items to form knowledge score. Covariates examined included age, sex, race, marital status, education status, income level, insurance status, tobacco and alcohol use. Adjusted linear regression analysis measured predictors of oral cancer knowledge. Results Three hundred and four participants completed questionnaire; 72.7% were African Americans. Smoking rate was 26.7%, alcohol use was 58.3%, and mean knowledge score was 4.60 +/- 2.52 out of 17. In final adjusted regression model, oral cancer knowledge was associated with race and education status. Compared with Caucasians, African Americans were 29% less likely to have high oral cancer knowledge (beta = - 0.71; 95% CI: -1.35, -0.07); and participants with a high school diploma or less were 124% less likely to have high oral cancer knowledge compared with college graduates (beta = -1.24; 95% CI: -2.44, -0.41). Conclusions There was lower oral cancer knowledge among African Americans and those with low education. The prevalence of smoking was also very high. Understanding predictors of oral cancer knowledge is important in future design of educational interventions specifically targeted towards high-risk group for oral cancer.	[Osazuwa-Peters, Nosayaba; Varvares, Mark A.] St Louis Univ, Canc Ctr, St Louis, MO 63103 USA; [Osazuwa-Peters, Nosayaba; Varvares, Mark A.] St Louis Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63103 USA; [Boakye, Eric Adjei] St Louis Univ, Ctr Outcomes Res, St Louis, MO 63103 USA; [Hussaini, Adnan S.; Sujijantarat, Nanthiya; Ganesh, Rajan N.; Snider, Matthew; Thompson, Devin] St Louis Univ, Sch Med, St Louis, MO USA; [Varvares, Mark A.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA USA	Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Osazuwa-Peters, N (corresponding author), St Louis Univ, Canc Ctr, St Louis, MO 63103 USA.; Osazuwa-Peters, N (corresponding author), St Louis Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63103 USA.	nosazuwa@slu.edu	Adjei Boakye, Eric/D-4448-2015	Adjei Boakye, Eric/0000-0001-9163-8103; Osazuwa-Peters, Nosayaba/0000-0002-1390-9753				American Cancer Society, 2015, CANC FACTS FIG 2015; Cannick GF, 2005, J AM DENT ASSOC, V136, P373, DOI 10.14219/jada.archive.2005.0180; Carter JM, 2013, LARYNGOSCOPE, V123, P1439, DOI 10.1002/lary.23981; Carter Lachlan M, 2007, BMC Med Educ, V7, P44; Choi Y, 2008, PATIENT EDUC COUNS, V71, P41, DOI 10.1016/j.pec.2007.11.011; Cruz GD, 2002, J AM DENT ASSOC, V133, P1064, DOI 10.14219/jada.archive.2002.0330; D'Souza G, 2011, PREV MED, V53, pS5, DOI 10.1016/j.ypmed.2011.08.001; Dwojak S, 2015, AM J PUBLIC HEALTH, V105, P1155, DOI 10.2105/AJPH.2014.302177; Gilman SE, 2008, INT J EPIDEMIOL, V37, P615, DOI 10.1093/ije/dym250; Gourin CG, 2009, LARYNGOSCOPE, V119, P679, DOI 10.1002/lary.20093; Hapner ER, 2011, J VOICE, V25, P480, DOI 10.1016/j.jvoice.2009.12.004; Hapner ER, 2011, OTOLARYNGOLOGY HEAD; Harris MS, 2013, JAMA OTOLARYNGOL, V139, P568, DOI 10.1001/jamaoto.2013.3153; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Horowitz AM, 1998, J PUBLIC HEALTH DENT, V58, P281, DOI 10.1111/j.1752-7325.1998.tb03010.x; Howell JL, 2013, PSYCHO-ONCOLOGY, V22, P1306, DOI 10.1002/pon.3137; Humphris GM, 2001, ORAL ONCOL, V37, P99, DOI 10.1016/S1368-8375(00)00069-5; Humphris GM, 1999, ORAL ONCOL, V35, P575, DOI 10.1016/S1368-8375(99)00040-8; Llewellyn CD, 2004, ORAL SURG ORAL MED O, V97, P707, DOI 10.1016/j.tripleo.2004.01.007; Lopez-Jornet P, 2013, PSYCHO-ONCOLOGY, V22, P1618, DOI 10.1002/pon.3189; Luryi AL, PUBLIC AWARENESS HEA; Malloy KM, 2013, JAMA OTOLARYNGOL, V139, P1037, DOI 10.1001/jamaoto.2013.4452; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Maybury C, 2012, J PUBLIC HEALTH DENT, V72, pS34, DOI 10.1111/j.1752-7325.2012.00320.x; Morse DE, 2006, J AM DENT ASSOC, V137, P203, DOI 10.14219/jada.archive.2006.0146; Moyer VA, 2014, ANN INTERN MED, V160, P55, DOI 10.7326/M13-2568; Oh JH, 2008, J PUBLIC HEALTH DENT, V68, P30, DOI 10.1111/j.1752-7325.2007.00075.x; Osazuwa-Peters N, 2013, VACCINE, V31, P5500, DOI 10.1016/j.vaccine.2013.09.031; Osazuwa-Peters N, 2016, HEAD NECK-J SCI SPEC, V38, pE1826, DOI 10.1002/hed.24327; Osazuwa-Peters N, 2015, ORAL ONCOL, V51, P452, DOI 10.1016/j.oraloncology.2015.01.011; Ostroff JS, 1999, PSYCHOL HEALTH, V14, P979, DOI 10.1080/08870440008407362; Patton LL, 2004, J PUBLIC HEALTH DENT, V64, P173, DOI 10.1111/j.1752-7325.2004.tb02748.x; Petti S, 2007, ORAL ONCOL, V43, P408, DOI 10.1016/j.oraloncology.2006.04.010; Prevention CfDCa, 2015, CURR CIG SMOK AD US; Ragin CC, 2011, HEAD NECK-J SCI SPEC, V33, P1092, DOI 10.1002/hed.21584; Reed SG, 2005, J CANCER EDUC, V20, P136, DOI 10.1207/s15430154jce2003_6; Riley JL, 2013, J RURAL HEALTH, V29, P294, DOI 10.1111/jrh.12003; Rodriguez T, 2004, ORAL ONCOL, V40, P207, DOI 10.1016/j.oraloncology.2003.08.014; Sankaranarayanan R, 2005, LANCET, V365, P1927, DOI 10.1016/S0140-6736(05)66658-5; Services UDoHaH Oral Health in America, REP SURG GEN EX SUMM; Shepperd JA, 2014, PSYCHO-ONCOLOGY, V23, P276, DOI 10.1002/pon.3415; Siahpush M, 2006, TOB CONTROL, V15, P65, DOI 10.1136/tc.2005.013276; Silverman S, 2001, J AM DENT ASSOC, V132, p7S, DOI 10.14219/jada.archive.2001.0382; Subramanian S, 2013, JAMA OTOLARYNGOL, V139, P489, DOI 10.1001/jamaoto.2013.2549; Subramanian S, 2009, B WORLD HEALTH ORGAN, V87, P198, DOI 10.2471/BLT.08.053231; Tomar SL, 2005, J PUBLIC HEALTH DENT, V65, P221, DOI 10.1111/j.1752-7325.2005.tb03022.x; Warnakulasuriya KAAS, 1999, BRIT DENT J, V187, P319, DOI 10.1038/sj.bdj.4800269a; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; White LJ, 2012, OTOLARYNG HEAD NECK, V147, P63, DOI 10.1177/0194599812438662; White LJ, 2014, AM J CANC PREVENT, V2, P14	50	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177787	10.1371/journal.pone.0177787	http://dx.doi.org/10.1371/journal.pone.0177787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DX	28545057	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700078
J	Franco-Hermida, JJ; Quintero, MF; Cabrera, RI; Guzman, JM				Jairo Franco-Hermida, John; Fernanda Quintero, Maria; Iskander Cabrera, Raul; Miguel Guzman, Jose			Determination of diagnostic standards on saturated soil extracts for cut roses grown in greenhouses	PLOS ONE			English	Article							NUTRITIONAL DIAGNOSIS; DRIS NORMS; CALCIUM; ACCUMULATION; RESPONSES; INDEXES; BALANCE; PLANTS; YIELD; PH	This work comprises the theoretical determination and validation of diagnostic standards for the analysis of saturated soil extracts for cut rose flower crops (Rosa spp.) growing in the Bogota Plateau, Colombia. The data included 684 plant tissue analyses and 684 corresponding analyses of saturated soil extracts, all collected between January 2009 and June 2013. The tissue and soil samples were selected from 13 rose farms, and from cultivars grafted on the 'Natal Briar' rootstock. These concurrent samples of soil and plant tissues represented 251 production units (locations) of approximately 10,000 m(2) distributed across the study area. The standards were conceived as a tool to improve the nutritional balance in the leaf tissue of rose plants and thereby define the norms for expressing optimum productive potential relative to nutritional conditions in the soil. To this end, previously determined diagnostic standard for rose leaf tissues were employed to obtain rates of foliar nutritional balance at each analyzed location and as criteria for determining the diagnostic norms for saturated soil extracts. Implementing this methodology to foliar analysis, showed a higher significant correlation for diagnostic indices. A similar behavior was observed in saturated soil extracts analysis, becoming a powerful tool for integrated nutritional diagnosis. Leaf analyses determine the most limiting nutrients for high yield and analyses of saturated soil extracts facilitate the possibility of correcting the fertigation formulations applied to soils or substrates. Recommendations are proposed to improve the balance in soil-plant system with which the possibility of yield increase becomes more probable. The main recommendations to increase and improve rose crop flower yields would be: continuously check pH values of SSE, reduce the amounts of P, Fe, Zn and Cu in fertigation solutions and carefully analyze the situation of Mn in the soil-plant system.	[Jairo Franco-Hermida, John] GR Chia SA, Tech Dept, Ctr Empresarial Chia, Chia, Colombia; [Fernanda Quintero, Maria] San Luis Potosi Autonomous Univ, Fac Agron, Dept Controlled Prod Syst, San Luis Potosi, Mexico; [Iskander Cabrera, Raul] Rutgers State Univ, Dept Plant Biol, Bridgeton, NJ USA; [Miguel Guzman, Jose] Cei A3 CIEMBITAL Almeria Univ, Dept Agron, Almeria, Spain	Rutgers State University New Brunswick	Quintero, MF (corresponding author), San Luis Potosi Autonomous Univ, Fac Agron, Dept Controlled Prod Syst, San Luis Potosi, Mexico.; Guzman, JM (corresponding author), Cei A3 CIEMBITAL Almeria Univ, Dept Agron, Almeria, Spain.	maria.quintero@uaslp.mx; mguzman@ual.es	Guzmán, Miguel/H-6111-2011; Quintero Castellanos, Maria Fernanda/A-9572-2015	Guzmán, Miguel/0000-0002-5648-7554; Quintero Castellanos, Maria Fernanda/0000-0002-9130-0679; Cabrera, Raul I/0000-0003-0011-6778	GR Chia, Cundinamarca, Colombia	GR Chia, Cundinamarca, Colombia	This study was financially supported by GR Chia, Cundinamarca, Colombia under contract. John J. Franco-Hermida (JJF-H) is employed by GR Chia. GR Chia provided support in the form of salary for this author (JJF-H), but did not have any additional role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Arboleda V. C., 1988, Agronomia Colombiana, V5, P17; Bar-Tal A, 2001, AGRONOMIE, V21, P393, DOI 10.1051/agro:2001132; Barber S.A., 1995, SOIL NUTR BIOAVAILAB; Beaufils E., 1973, DIAGNOSIS RECOMMENDA, V1st; Beaufils E. R., 1973, Bulletin, Department of Soil Science and Agro-Meteorology, Natal University; Cabrera RI, 2009, HORTSCIENCE, V44, P2000, DOI 10.21273/HORTSCI.44.7.2000; Cabrera RI, 2003, HORTSCIENCE, V38, P533, DOI 10.21273/HORTSCI.38.4.533; Cabrera RI, 2003, SCI HORTIC-AMSTERDAM, V97, P297, DOI 10.1016/S0304-4238(02)00151-6; Cabrera RI, 2003, ENCY ROSE SCI, P573; Cadahia C., 2005, FERTIRRIGACION CULTI; Da Silva GGC, 2005, REV BRASILEIRA CIENC, P755; de Hoog Jr J., 2001, APPL PLANT RES; GANMORENEUMANN R, 1993, PLANT SOIL, V155, P151, DOI 10.1007/BF00025006; Gonzalez-Lazaro AJ, WORLD C AGR INF IT I, P381; Grattan SR, 1999, SCI HORTIC-AMSTERDAM, V78, P127, DOI 10.1016/S0304-4238(98)00192-7; Guzman M, 2006, AVANCES FERTIRRIEGO, P145; IGAC, 2000, EST GEN SUEL ZON TIE, P1; Jackson BE, 2009, HORTSCIENCE, V44, P1983, DOI 10.21273/HORTSCI.44.7.1983; Hermida JJF, 2013, HORTSCIENCE, V48, P1403, DOI 10.21273/HORTSCI.48.11.1403; JOHANSSON J, 1978, ACTA AGR SCAND, V28, P363, DOI 10.1080/00015127809435194; JONES CA, 1981, COMMUN SOIL SCI PLAN, V12, P785, DOI 10.1080/00103628109367194; KHASAWNEH FE, 1971, SOIL SCI SOC AM PRO, V35, P426, DOI 10.2136/sssaj1971.03615995003500030029x; Khiari L, 2001, AGRON J, V93, P802, DOI 10.2134/agronj2001.934802x; LINDSAY WL, 2001, CHEM EQUILIBRIA SOIL; Lopez J, 2002, J PLANT NUTR, V25, P1585, DOI 10.1081/PLN-120005409; Lucena JJ, 1997, ACTA HORTIC, P179, DOI 10.17660/ActaHortic.1997.448.28; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Modesto V. C., 2014, American Journal of Plant Sciences, V5, P497, DOI 10.4236/ajps.2014.54064; Montes RM, 2016, REV BRAS CIENC SOLO, V40; Mourao FDA, 2004, SCI AGRIC, V61, P550, DOI 10.1590/S0103-90162004000500015; Parent L. E., 2013, American Journal of Plant Sciences, V4, P1508; PARENT LE, 1992, J AM SOC HORTIC SCI, V117, P239, DOI 10.21273/JASHS.117.2.239; Parent LE, 1997, CAN J SOIL SCI, V77, P571, DOI 10.4141/S96-073; PARENT LE, 1993, HORTSCIENCE, V28, P1041, DOI 10.21273/HORTSCI.28.10.1041; Parent LE, 2011, REV BRAS FRUTIC, V33, P321, DOI 10.1590/S0100-29452011000100041; Parent S. E., 2012, SOIL FERTILITY, V83, P114; Parent SE, 2013, P 5 INT WORKSH COMP, P131; Parent SE, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00039, 10.3389/fpls.2013.00449]; Ramos-Miras JJ, 2011, J GEOCHEM EXPLOR, V110, P186, DOI 10.1016/j.gexplo.2011.05.009; Reis RD, 2003, PESQUI AGROPECU BRAS, V38, P379, DOI 10.1590/S0100-204X2003000300007; Richards LA, 1954, SOIL SCI SOC AM J, V18, P348; Rodriguez O, 1997, COMMUN SOIL SCI PLAN, V28, P1461, DOI 10.1080/00103629709369887; Wadt PGS, 2010, PESQUI AGROPECU BRAS, V45, P1180, DOI 10.1590/S0100-204X2010001000018; Schlotter D, 2012, J PLANT NUTR SOIL SC, V175, P236, DOI 10.1002/jpln.201000399; Silva Mojica Francisco, METODOS ANALITICOS L; Sparnaaij LD, 1996, EUPHYTICA, V90, P183, DOI 10.1007/BF00023857; Starkey KR, 1997, J AM SOC HORTIC SCI, V122, P863, DOI 10.21273/JASHS.122.6.863; SUMNER ME, 1977, PLANT SOIL, V46, P359, DOI 10.1007/BF00010092; Torre S, 1999, PHYSIOL PLANTARUM, V107, P214, DOI 10.1034/j.1399-3054.1999.100209.x; VOLPIN H, 1991, PHYTOPATHOLOGY, V81, P1390, DOI 10.1094/Phyto-81-1390; Wadt P. G. S., 1998, Revista Brasileira de Ciencia do Solo, V22, P661, DOI 10.1590/S0100-06831998000400011; Wadt PGS, 1996, MATH CHANCE METHODS; WALWORTH JL, 1986, SOIL SCI SOC AM J, V50, P123, DOI 10.2136/sssaj1986.03615995005000010024x; Walworth JL, 1987, ADV SOIL SCI; White J., 1987, FERTILIZATION ROSES, P87; ZIESLIN N, 1989, SCI HORTIC-AMSTERDAM, V37, P339, DOI 10.1016/0304-4238(89)90145-3	57	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178500	10.1371/journal.pone.0178500	http://dx.doi.org/10.1371/journal.pone.0178500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542547	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800098
J	Mosienko, V; Chang, AJ; Alenina, N; Teschemacher, AG; Kasparov, S				Mosienko, Valentina; Chang, Andy J.; Alenina, Natalia; Teschemacher, Anja G.; Kasparov, Sergey			Rodents and humans are able to detect the odour of L-Lactate	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; OLFACTORY RECEPTORS; FUNCTIONAL EXPRESSION; PARKINSONS-DISEASE; SEX-DIFFERENCES; IDENTIFICATION; DIAGNOSIS; DISCRIMINATION; SPECIFICITY; METABOLISM	L-Lactate (LL) is an essential cellular metabolite which can be used to generate energy. In addition, accumulating evidence suggests that LL is used for inter-cellular signalling. Some LL-sensitive receptors have been identified but we recently proposed that there may be yet another unknown G-protein coupled receptor (GPCR) sensitive to LL in the brain. Olfactory receptors (ORs) represent the largest family of GPCRs and some of them are expressed outside the olfactory system, including brain, making them interesting candidates for non-olfactory LL signalling. One of the "ectopically" expressed ORs, Olfr78 in mice (Olr59 in rats and OR51E2 in humans), reportedly can be activated by LL. This implies that both rodents and humans should be able to detect the LL odour. Surprisingly, this has never been demonstrated. Here we show that mice can detect the odour of LL in odour detection and habituation- dishabituation tasks, and discriminate it from peppermint and vanilla odours. Behaviour of the Olfr78 null mice and wildtype mice in odour detection task was not different, indicating that rodents are equipped with more than one LL-sensitive OR. Rats were also able to use the smell of LL as a cue in an odour-reward associative learning task. When presented to humans, more than 90% of participants detected a smell of LL in solution. Interestingly, LL was perceived differently than acetate or propionate-LL was preferentially reported as a pleasant sweet scent while acetate and propionate were perceived as repulsive sour/acid smells. Subjective perception of LL smell was different in men and women. Taken together, our data demonstrate that both rodents and humans are able to detect the odour of LL. Moreover, in mice, LL perception is not purely mediated by Olfr78. Discovery of further LL-sensitive OR might shed the light on their contribution to LL signalling in the body.	[Mosienko, Valentina; Teschemacher, Anja G.; Kasparov, Sergey] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England; [Chang, Andy J.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Chang, Andy J.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Alenina, Natalia] Max Delbruck Ctr Mol Med MDC Berlin Buch, Berlin, Germany; [Kasparov, Sergey] Balt Fed Univ, Kaliningrad, Russia; [Chang, Andy J.] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA; [Chang, Andy J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA	University of Bristol; Stanford University; Howard Hughes Medical Institute; Stanford University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Immanuel Kant Baltic Federal University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kasparov, S (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England.; Kasparov, S (corresponding author), Balt Fed Univ, Kaliningrad, Russia.	Sergey.Kasparov@bristol.ac.uk	Kasparov, Sergey/AAH-5286-2019; Mosienko, Valentina/AAN-5983-2020	Kasparov, Sergey/0000-0002-1824-1764; Mosienko, Valentina/0000-0002-8562-532X	BBSRC [BB/L019396/1, BB/K009192/1]; MRC [MR/L020661/1]; Biotechnology and Biological Sciences Research Council [BB/L019396/1, BB/K009192/1] Funding Source: researchfish; Medical Research Council [MR/L020661/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by BBSRC: BB/L019396/1, BB/K009192/1; and MRC MR/L020661/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arctander S., 1969, PERFUME FLAVOR CHEM, VI; Audouze K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093037; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Bozzo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071721; Brand G, 2001, Q J EXP PSYCHOL-B, V54, P259, DOI 10.1080/02724990143000045; Brand G, 2006, NEUROSCI BIOBEHAV R, V30, P908, DOI 10.1016/j.neubiorev.2006.01.002; Buono MJ, 2010, J PHYSIOL SCI, V60, P103, DOI 10.1007/s12576-009-0073-3; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Chang AJ, 2015, NATURE, V527, P240, DOI 10.1038/nature15721; Conzelmann S, 2000, EUR J NEUROSCI, V12, P3926, DOI 10.1046/j.1460-9568.2000.00286.x; Cunha AC, 2006, CANCER LETT, V236, P229, DOI 10.1016/j.canlet.2005.05.021; Deeb J, 2010, QJM-INT J MED, V103, P941, DOI 10.1093/qjmed/hcq142; Dewan A, 2013, NATURE, V497, P486, DOI 10.1038/nature12114; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Fleischer J, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.009.2009; Hummel T, 2002, INT ARCH OCC ENV HEA, V75, P305, DOI 10.1007/s00420-002-0315-7; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Laska M, 1999, CHEM SENSES, V24, P161, DOI 10.1093/chemse/24.2.161; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Leen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042745; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; Liu CL, 2012, J PHARMACOL EXP THER, V341, P794, DOI 10.1124/jpet.112.192799; LUCAS F, 1995, BEHAV NEUROSCI, V109, P446, DOI 10.1037/0735-7044.109.3.446; MAGISTRETTI PJ, 1993, DEV NEUROSCI-BASEL, V15, P306, DOI 10.1159/000111349; Mainland JD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.2; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matsui T, 2012, J PHYSIOL-LONDON, V590, P607, DOI 10.1113/jphysiol.2011.217919; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Moberg PJ, 1997, AM J PSYCHIAT, V154, P1016; Mosienko V, 2015, J CEREBR BLOOD F MET, V35, P1069, DOI 10.1038/jcbfm.2015.77; Oz G, 2009, DIABETES, V58, P1978, DOI 10.2337/db09-0226; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Picillo M, 2014, NEUROL SCI, V35, P379, DOI 10.1007/s10072-013-1522-6; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Raming K, 1998, RECEPTOR CHANNEL, V6, P141; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Scheijen JLJM, 2012, EXP DIABETES RES, DOI 10.1155/2012/234812; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Silveira-Moriyama L, 2008, MOVEMENT DISORD, V23, P2328, DOI 10.1002/mds.22241; Smith DR, 1998, NEUROSCIENCE, V86, P135, DOI 10.1016/S0306-4522(97)00608-8; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stamps JJ, 2013, J NEUROL SCI, V333, P19, DOI 10.1016/j.jns.2013.06.033; Steib BM, 2001, CHEM SENSES, V26, P523, DOI 10.1093/chemse/26.5.523; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Tekus E, 2012, ACTA BIOL HUNG, V63, P89, DOI 10.1556/ABiol.63.2012.Suppl.1.9; Tronel S, 2002, LEARN MEMORY, V9, P105, DOI 10.1101/lm.47802; Turin L, 2003, HDB OLFACTION GUSTAT, P275; Ugur T, 2005, EUR ARCH PSY CLIN N, V255, P94, DOI 10.1007/s00406-004-0536-8; Wang YYY, 2011, J GEN PHYSIOL, V137, P493, DOI 10.1085/jgp.201110615; Xu LL, 2000, CANCER RES, V60, P6568	56	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178478	10.1371/journal.pone.0178478	http://dx.doi.org/10.1371/journal.pone.0178478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542639	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000402062800094
J	Chalacheva, P; Khaleel, M; Sunwoo, J; Shah, P; Detterich, JA; Kato, RM; Thuptimdang, W; Meiselman, HJ; Sposto, R; Tsao, J; Wood, JC; Zeltzer, L; Coates, TD; Khoo, MCK				Chalacheva, Patjanaporn; Khaleel, Maha; Sunwoo, John; Shah, Payal; Detterich, Jon A.; Kato, Roberta M.; Thuptimdang, Wanwara; Meiselman, Herbert J.; Sposto, Richard; Tsao, Jennie; Wood, John C.; Zeltzer, Lonnie; Coates, Thomas D.; Khoo, Michael C. K.			Biophysical markers of the peripheral vasoconstriction response to pain in sickle cell disease	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; ENDOTHELIAL DYSFUNCTION; CLINICAL SEVERITY; NITRIC-OXIDE; CONSTRICTION; ANEMIA; SYSTEM; DEEP	Painful vaso-occlusive crisis (VOC), a complication of sickle cell disease (SCD), occurs when sickled red blood cells obstruct flow in the microvasculature. We postulated that exaggerated sympathetically mediated vasoconstriction, endothelial dysfunction and the synergistic interaction between these two factors act together to reduce microvascular flow, promoting regional vaso-occlusions, setting the stage for VOC. We previously found that SCD subjects had stronger vasoconstriction response to pulses of heat-induced pain compared to controls but the relative degrees to which autonomic dysregulation, peripheral vascular dysfunction and their interaction are present in SCD remain unknown. In the present study, we employed a mathematical model to decompose the total vasoconstriction response to pain into: 1) the neurogenic component, 2) the vascular response to blood pressure, 3) respiratory coupling and 4) neurogenic-vascular interaction. The model allowed us to quantify the contribution of each component to the total vasoconstriction response. The most salient features of the components were extracted to represent biophysical markers of autonomic and vascular impairment in SCD and controls. These markers provide a means of phenotyping severity of disease in sickle-cell anemia that is based more on underlying physiology than on genotype. The marker of the vascular component (BMv) showed stronger contribution to vasoconstriction in SCD than controls (p = 0.0409), suggesting a dominant myogenic response in the SCD subjects as a consequence of endothelial dysfunction. The marker of neurogenic-vascular interaction (BMn-v) revealed that the interaction reinforced vasoconstriction in SCD but produced vasodilatory response in controls (p = 0.0167). This marked difference in BMn-v suggests that it is the most sensitive marker for quantifying combined alterations in autonomic and vascular function in SCD in response to heatinduced pain.	[Chalacheva, Patjanaporn; Sunwoo, John; Thuptimdang, Wanwara; Wood, John C.; Khoo, Michael C. K.] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Khaleel, Maha; Shah, Payal; Coates, Thomas D.] Childrens Hosp Los Angeles, Childrens Ctr Canc & Blood Dis, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA; [Detterich, Jon A.; Wood, John C.] Childrens Hosp Los Angeles, Div Cardiol, Los Angeles, CA 90027 USA; [Detterich, Jon A.; Kato, Roberta M.; Coates, Thomas D.] Univ Southern Calif, Dept Pediat, Keck Sch Med, Los Angeles, CA 90089 USA; [Kato, Roberta M.] Childrens Hosp Los Angeles, Div Pulmonol, Los Angeles, CA 90027 USA; [Meiselman, Herbert J.] Univ Southern Calif, Dept Physiol & Biophys, Keck Sch Med, Los Angeles, CA 90089 USA; [Sposto, Richard] Univ Southern Calif, Dept Preventat Med, Keck Sch Med, Los Angeles, CA USA; [Tsao, Jennie; Zeltzer, Lonnie] Univ Calif Los Angeles, David Geffen Sch Med, Pediat Pain Program, Los Angeles, CA 90095 USA	University of Southern California; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chalacheva, P (corresponding author), Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	chalache@usc.edu	Coates, Thomas/AAN-3556-2020	Coates, Thomas/0000-0001-9878-6029; Sunwoo, John/0000-0003-4314-7232	National Institutes of Health National Heart, Lung, and Blood Institute [U01 HL117718]; National Institute of Biomedical Imaging and Bioengineering [P41 EB001978]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL119627, U01HL117718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001978] Funding Source: NIH RePORTER	National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health National Heart, Lung, and Blood Institute grant U01 HL117718 (http://www.nhlbi.nih.gov) and National Institute of Biomedical Imaging and Bioengineering grant P41 EB001978 (https://www.nibib.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health National Heart, Lung, and Blood Institute grant U01 HL117718 and National Institute of Biomedical Imaging and Bioengineering grant P41 EB001978.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Amiya Eisuke, 2014, Ann Vasc Dis, V7, P109, DOI 10.3400/avd.ra.14-00048; Belhassen L, 2001, BLOOD, V97, P1584, DOI 10.1182/blood.V97.6.1584; Blum A, 2005, J THROMB THROMBOLYS, V19, P83, DOI 10.1007/s11239-005-1377-7; Bolton B, 1936, J PHYSIOL-LONDON, V86, P83, DOI 10.1113/jphysiol.1936.sp003345; Bruno RM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00284; Bruno RM, 2011, HYPERTENSION, V57, P79, DOI 10.1161/HYPERTENSIONAHA.110.163584; Burton AR, 2009, J PHYSIOL-LONDON, V587, P183, DOI 10.1113/jphysiol.2008.162230; Camm AJ, 1996, EUR HEART J, V17, P354; Chalacheva P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12463; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Detterich JA, 2015, BLOOD, V126, P703, DOI 10.1182/blood-2014-12-614370; EATON WA, 1976, BLOOD, V47, P621; Elgendi M, 2012, CURR CARDIOL REV, V8, P14, DOI 10.2174/157340312801215782; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; FALCONE JC, 1991, AM J PHYSIOL, V260, pH130, DOI 10.1152/ajpheart.1991.260.1.H130; Gulati A, 1997, AM J PHYSIOL-HEART C, V273, pH1177, DOI 10.1152/ajpheart.1997.273.3.H1177; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hijmering ML, 2002, J AM COLL CARDIOL, V39, P683, DOI 10.1016/S0735-1097(01)01786-7; HUANG A, 1993, HYPERTENSION, V22, P913, DOI 10.1161/01.HYP.22.6.913; Khaleel M, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.67.67; Khoo MC, 2007, CARDIOVASC ENG; Khoo MCK, 2016, SLEEP MED CLIN, V11, P489, DOI 10.1016/j.jsmc.2016.07.003; L'Esperance VS, 2013, EXP PHYSIOL, V98, P49, DOI 10.1113/expphysiol.2011.064055; Malpas SC, 2001, IEEE ENG MED BIOL, V20, P17, DOI 10.1109/51.917720; Mestre JCR, 1997, CLIN AUTON RES, V7, P121, DOI 10.1007/BF02308838; Metivier F, 2000, NEPHROL DIAL TRANSPL, V15, P14, DOI 10.1093/oxfordjournals.ndt.a027970; Nakamura K, 1999, J CARDIOVASC PHARM, V33, P876, DOI 10.1097/00005344-199906000-00007; Nordin M, 1995, J PHYSIOL-LONDON, V489, P885, DOI 10.1113/jphysiol.1995.sp021101; Patel KP, 2001, EXP BIOL MED, V226, P814, DOI 10.1177/153537020122600902; Pearson SR, 2005, CLIN AUTON RES, V15, P400, DOI 10.1007/s10286-005-0300-9; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; SACKNER MA, 1989, J APPL PHYSIOL, V66, P410, DOI 10.1152/jappl.1989.66.1.410; SAKUMA I, 1992, CIRC RES, V70, P607, DOI 10.1161/01.RES.70.3.607; Sangkatumvong S, 2011, AM J RESP CRIT CARE, V184, P474, DOI 10.1164/rccm.201103-0537OC; Schobel HP, 1996, PAIN, V66, P117, DOI 10.1016/0304-3959(96)03079-5; SEALS DR, 1993, CIRC RES, V72, P440, DOI 10.1161/01.RES.72.2.440; Secomb T, 2008, MICROCIRCULATION, V15, P765, DOI 10.1080/10739680802350112; Sverrisdottir YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009257	39	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178353	10.1371/journal.pone.0178353	http://dx.doi.org/10.1371/journal.pone.0178353			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542469	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500082
J	Kwak, D; Kim, W				Kwak, Doyeon; Kim, Wonjoon			Understanding the process of social network evolution: Online-offline integrated analysis of social tie formation	PLOS ONE			English	Article								It is important to consider the interweaving nature of online and offline social networks when we examine social network evolution. However, it is difficult to find any research that examines the process of social tie formation from an integrated perspective. In our study, we quantitatively measure offline interactions and examine the corresponding evolution of online social network in order to understand the significance of interrelationship between online and offline social factors in generating social ties. We analyze the radio signal strength indicator sensor data from a series of social events to understand offline interactions among the participants and measure the structural attributes of their existing online Facebook social networks. By monitoring the changes in their online social networks before and after offline interactions in a series of social events, we verify that the ability to develop an offline interaction into an online friendship is tied to the number of social connections that participants previously had, while the presence of shared mutual friends between a pair of participants disrupts potential new connections within the pre-designed offline social events. Thus, while our integrative approach enables us to confirm the theory of preferential attachment in the process of network formation, the common neighbor theory is not supported. Our dual-dimensional network analysis allows us to observe the actual process of social network evolution rather than to make predictions based on the assumption of self-organizing networks.	[Kwak, Doyeon] Korea Adv Inst Sci & Technol, Grad Sch Culture Technol, Daejeon, South Korea; [Kim, Wonjoon] Korea Adv Inst Sci & Technol, Sch Business & Technol Management, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, W (corresponding author), Korea Adv Inst Sci & Technol, Sch Business & Technol Management, Daejeon, South Korea.	wonjoon.kim@kaist.edu	Kim, Wonjoon/C-1649-2011	Kim, Wonjoon/0000-0002-2568-2066	National Research Foundation of Korea - Korean Government [NRF-2015-S1A3A-2046742]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2015-S1A3A-2046742) WK http://www.nrf.re.kr/.	Agarwal R, 2008, INFORM SYST RES, V19, P243, DOI 10.1287/isre.1080.0200; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], THESIS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERGER SM, 1981, J PERS SOC PSYCHOL, V40, P479; Blanchard A, 1998, SOC SCI COMPUT REV, V16, P293, DOI 10.1177/089443939801600306; Bourdieu P., 1992, INVITATION REFLEXIVE; Choe S., 2016, AWE PARTYLYTICS; Ellison N, 2006, J COMPUT-MEDIAT COMM, V11; Festinger Leon, 1957, THEORY COGNITIVE DIS; Gillan R, 2007, CHEM COMMUN, P1; Heaney MT, 2014, SOC NETWORKS, V36, P66, DOI 10.1016/j.socnet.2012.11.003; Hlebec V, 2006, NEW MEDIA SOC, V8, P9, DOI 10.1177/1461444806058166; Hsu CW, 2011, CYBERPSYCH BEH SOC N, V14, P473, DOI 10.1089/cyber.2010.0267; Kane GC, 2008, INFORM SYST RES, V19, P253, DOI 10.1287/isre.1070.0158; Kujath CL, 2011, CYBERPSYCH BEH SOC N, V14, P75, DOI 10.1089/cyber.2009.0311; Lev-On A, 2015, COMPUT HUM BEHAV, V48, P448, DOI 10.1016/j.chb.2015.02.009; Lin N., 2001, SOCIAL CAPITAL THEOR; Newman MEJ, 2002, COMPUT PHYS COMMUN, V147, P40, DOI 10.1016/S0010-4655(02)00201-1; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; SAMPSON EE, 1964, J ABNORM SOC PSYCH, V68, P184, DOI 10.1037/h0041242; SYKES RE, 1983, HUM COMMUN RES, V10, P27, DOI 10.1111/j.1468-2958.1983.tb00003.x; Trier M, 2008, INFORM SYST RES, V19, P335, DOI 10.1287/isre.1080.0191; Tsugawa S, 2016, PLOS ONE; Valente Thomas W, 2004, Subst Use Misuse, V39, P1685, DOI 10.1081/JA-200033210; Vergeer M, 2009, J COMPUT-MEDIAT COMM, V15, P189, DOI 10.1111/j.1083-6101.2009.01499.x; White, 2008, IDENTITY AND CONTROL; Yeh T, 2009, C P EECS MIT CSAIL; Zywica J, 2008, J COMPUT-MEDIAT COMM, V14, P1, DOI 10.1111/j.1083-6101.2008.01429.x	30	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177729	10.1371/journal.pone.0177729	http://dx.doi.org/10.1371/journal.pone.0177729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542367	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500036
J	Laiseca, JE; Ladelfa, MF; Cotignola, J; Peche, LY; Pascucci, FA; Castano, BA; Galigniana, MD; Schneider, C; Monte, M				Laiseca, Julieta E.; Ladelfa, Maria F.; Cotignola, Javier; Peche, Leticia Y.; Pascucci, Franco A.; Castano, Bryan A.; Galigniana, Mario D.; Schneider, Claudio; Monte, Martin			Functional interaction between co-expressed MAGE-A proteins	PLOS ONE			English	Article							ANDROGEN RECEPTOR; CANCER/TESTIS ANTIGENS; UBIQUITIN LIGASE; CANCER GENOMICS; P53 FUNCTION; METHYLATION; MELANOMA; HYPOMETHYLATION; EXPRESSION; COMPLEXES	MAGE-A (Melanoma Antigen Genes-A) are tumor-associated proteins with expression in a broad spectrum of human tumors and normal germ cells. MAGE-A gene expression and function are being increasingly investigated to better understand the mechanisms by which MAGE proteins collaborate in tumorigenesis and whether their detection could be useful for disease prognosis purposes. Alterations in epigenetic mechanisms involved in MAGE gene silencing cause their frequent co-expression in tumor cells. Here, we have analyzed the effect of MAGE-A gene co-expression and our results suggest that MageA6 can potentiate the androgen receptor (AR) co-activation function of MageA11. Database search confirmed that MageA11 and MageA6 are co-expressed in human prostate cancer samples. We demonstrate that MageA6 and MageA11 form a protein complex resulting in the stabilization of MageA11 and consequently the enhancement of AR activity. The mechanism involves association of the Mage A6-MHD domain to MageA11, prevention of MageA11 ubiquitinylation on lysines 240 and 245 and decreased proteasome-dependent degradation. We experimentally demonstrate here for the first time that two MAGE-A proteins can act together in a non-redundant way to potentiate a specific oncogenic function. Overall, our results highlight the complexity of the MAGE gene networking in regulating cancer cell behavior.	[Laiseca, Julieta E.; Ladelfa, Maria F.; Pascucci, Franco A.; Castano, Bryan A.; Monte, Martin] Univ Buenos Aires, Dept Quim Biol, Lab Oncol Mol, Buenos Aires, DF, Argentina; [Laiseca, Julieta E.; Ladelfa, Maria F.; Pascucci, Franco A.; Castano, Bryan A.; Monte, Martin] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, IQUIBICEN UBA, Buenos Aires, DF, Argentina; [Cotignola, Javier] Univ Buenos Aires, Dept Quim Biol, Lab Inflamac & Canc, Buenos Aires, DF, Argentina; [Cotignola, Javier] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN UBA, CONICET, Buenos Aires, DF, Argentina; [Peche, Leticia Y.; Schneider, Claudio] Lab Nazl Consorzio Interuniv Biotecnol, Area Sci Pk, Trieste, Italy; [Galigniana, Mario D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Biol Mol & Celular, Buenos Aires, DF, Argentina; [Galigniana, Mario D.] Consejo Nacl Invest Cient & Tecn, IBYME, Lab Receptores Nucl, Buenos Aires, DF, Argentina; [Schneider, Claudio] Univ Udine, Dipartimento Sci & Tecnol Biomed, Ple Kolbe 4, Udine, Italy	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Monte, M (corresponding author), Univ Buenos Aires, Dept Quim Biol, Lab Oncol Mol, Buenos Aires, DF, Argentina.; Monte, M (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, IQUIBICEN UBA, Buenos Aires, DF, Argentina.	mmonte@qb.fcen.uba.ar	Cotignola, Javier/H-3343-2019; castano, bryan/AIC-7343-2022	Cotignola, Javier/0000-0003-4473-9854; Monte, Martin/0000-0002-5068-563X; Peche, Leticia Yamila/0000-0002-1666-9433	Fundacion Rene Baron; Ministry of Science and Technology-ANPCyT [PICT12/0866]; University of Buenos Aires [UBACyT13/0013BA]; National Council for Science and Technology-CONICET [PIP13/0411]; CONICET; ANPCyT;  [UBACyT14/0318BA]	Fundacion Rene Baron; Ministry of Science and Technology-ANPCyT; University of Buenos Aires(University of Buenos Aires); National Council for Science and Technology-CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); 	This work was supported by Fundacion Rene Baron and UBACyT14/0318BA to M. Galigniana and the Ministry of Science and Technology-ANPCyT (PICT12/0866), the University of Buenos Aires (UBACyT13/0013BA), and the National Council for Science and Technology-CONICET (PIP13/0411) to M. Monte. JEL and FAP are recipients of PhD fellowships from CONICET and ANPCyT, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Fundacion Rene Baron and UBACyT14/0318BA to M.Galigniana and the Ministry of Science and Technology-ANPCyT (PICT12/0866), the University of Buenos Aires (UBACyT13/0013BA), and the National Council for Science and Technology-CONICET (PIP13/0411) to M. Monte JEL and FAP are recipients of PhD fellowships from CONICET and ANPCyT, respectively.	Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Ayyoub M, 2014, J IMMUNOTHER, V37, P73, DOI 10.1097/CJI.0000000000000013; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Ladelfa MF, 2012, CANCER LETT, V325, P11, DOI 10.1016/j.canlet.2012.05.031; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Hao JQ, 2015, ONCOTARGET, V6, P42028, DOI 10.18632/oncotarget.5973; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Laduron S, 2004, NUCLEIC ACIDS RES, V32, P4340, DOI 10.1093/nar/gkh735; Marcar L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127713; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Meek DW, 2012, CANCER LETT, V324, P126, DOI 10.1016/j.canlet.2012.05.011; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Newman JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148762; Peche LY, 2012, CELL DEATH DIFFER, V19, P926, DOI 10.1038/cdd.2011.173; Peche LY, 2015, J BIOL CHEM, V290, P29652, DOI 10.1074/jbc.M115.671982; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Rao M, 2011, CANCER RES, V71, P4192, DOI 10.1158/0008-5472.CAN-10-2442; RENNIE PS, 1988, AM J CLIN ONCOL-CANC, V11, pS13, DOI 10.1097/00000421-198801102-00004; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Su SF, 2013, J BIOL CHEM, V288, P24809, DOI 10.1074/jbc.M113.468579; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Xu YZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12104; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478	33	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178370	10.1371/journal.pone.0178370	http://dx.doi.org/10.1371/journal.pone.0178370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542476	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500084
J	Stidham, T; Patnaik, R; Krishan, K; Singh, B; Ghosh, A; Singla, A; Kotla, SS				Stidham, Thomas; Patnaik, Rajeev; Krishan, Kewal; Singh, Bahadur; Ghosh, Abhik; Singla, Ankita; Kotla, Simran S.			The first darter (Aves: Anhingidae) fossils from India (late Pliocene)	PLOS ONE			English	Article							BIRDS	New fossils from the latest Pliocene portion of the Tatrot Formation exposed in the Siwalik Hills of northern India represent the first fossil record of a darter (Anhingidae) from India. The darter fossils possibly represent a new species, but the limited information on the fossil record of this group restricts their taxonomic allocation. The Pliocene darter has a deep pit on the distal face of metatarsal trochlea IV not reported in other anhingids, it has an open groove for the m. flexor perforatus et perforans digiti II tendon on the hypotarsus unlike New World anhingid taxa, and these darter specimens are the youngest of the handful of Neogene records of the group from Asia. These fossil specimens begin to fill in a significant geographic and temporal gap in the fossil record of this group that is largely known from other continents and other time periods. The presence of a darter and pelican (along with crabs, fish, turtles, and crocodilians) in the same fossil-bearing horizon strongly indicates the past presence of a substantial water body (large pond, lake, or river) in the interior of northern India in the foothills of the Himalayan Mountains.	[Stidham, Thomas] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Patnaik, Rajeev; Singla, Ankita; Kotla, Simran S.] Panjab Univ, Dept Geol, Chandigarh, India; [Krishan, Kewal; Singh, Bahadur; Ghosh, Abhik] Panjab Univ, Dept Anthropol, Chandigarh, India	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Panjab University; Panjab University	Stidham, T (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	presbyornis@gmail.com	Singh, Bahadur/H-5783-2019; Krishan, Kewal/I-3285-2014; Ghosh, Abhik/AAH-1277-2020	Singh, Bahadur/0000-0002-5370-6029; Krishan, Kewal/0000-0001-5321-0958; Ghosh, Abhik/0000-0003-1161-6364; Kotla, Simran Singh/0000-0001-9360-066X	National Natural Science Foundation of China [NSFC41472025]; Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) [XDB03020501]; Ministry of Earth Science project [MoES/P.O. (Geoscience)/46/2015]; Council of Scientific and Industrial Research (CSIR) Fellowship; Promotion of University Research and Scientific Excellence (PURSE) grant; University Grants Commission (UGC) Center for Advanced Study (CAS) grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences (CAS); Ministry of Earth Science project; Council of Scientific and Industrial Research (CSIR) Fellowship; Promotion of University Research and Scientific Excellence (PURSE) grant; University Grants Commission (UGC) Center for Advanced Study (CAS) grant	TAS is funded by the National Natural Science Foundation of China (NSFC41472025) http://www.nsfc.gov.cn/ and the Strategic Priority Research Program of the Chinese Academy of Sciences (CAS, XDB03020501) http://english.cas.cn/. RP is supported by Ministry of Earth Science project (MoES/P.O. (Geoscience)/46/2015) http://www.moes.gov.in/, and SSK is supported by a Council of Scientific and Industrial Research (CSIR) Fellowship http://www.csirhrdg.res.in/jrfsrfra2.htm. BS, KK, and AG are funded by a Promotion of University Research and Scientific Excellence (PURSE) grant http://www.fist-dst.org/html-flies/purse.htm and the University Grants Commission (UGC) Center for Advanced Study (CAS) grant awarded to the Department of Anthropology, Panjab University, Chandigarh, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga HMF, 2003, J VERTEBR PALEONTOL, V23, P614, DOI 10.1671/1890; Ballmann Peter, 1987, P113; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Brisson M.J., 1760, ORNITHOLOGIE METHOD, V1; BRODKORB P, 1982, Geobios (Villeurbanne), V15, P505, DOI 10.1016/S0016-6995(82)80071-5; Cheneval J., 1991, Journal of Southeast Asian Earth Sciences, V6, P117, DOI 10.1016/0743-9547(91)90103-5; Christidis L, 2008, SYSTEMATICS TAXONOMY; Davies W., 1880, GEOL MAG, V7, P18, DOI [10.1017/S0016756800146904, DOI 10.1017/S0016756800146904]; Dorst J., 1979, CHECK LIST BIRDS WOR, P155; Dyke GJ, 2008, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2008)3610[1:NROFWF]2.0.CO;2; Grimmett R, 2011, BIRDS INDIAN SUBCONT; Harris John M., 2003, P161; Harrison C.J.O., 1982, Tertiary Research, V4, P53; HARRISON CJO, 1978, EMU, V78, P230, DOI 10.1071/MU9780230; Hasegawa Y., 1977, B MIZUNAMI FOSSIL MU, V4, P169; Jonhsgard PA, 1993, CORMORANTS DARTERS P; Jukar AM, 2016, J VERT PALEO, V2016, P163; Klein S, FRESHWATER CRAB PLIO; Lambrecht K., 1916, MITTEILUNGEN JB KONI, V24, P1; Lesson RP., 1831, TRAITE ORNITHOLOGIE; Louchart A, 2005, ACTA PALAEONTOL POL, V50, P549; Louchart Antoine, 2008, Oryctos, V7, P147; Louchart A, 2008, J HUM EVOL, V55, P513, DOI 10.1016/j.jhevol.2008.06.002; Mackness B, 1995, EMU, V95, P265, DOI 10.1071/MU9950265; Mayr G, 2016, ACTA ZOOL-STOCKHOLM, V97, P196, DOI 10.1111/azo.12117; Mayr G, 2010, J VERTEBR PALEONTOL, V30, P467, DOI 10.1080/02724631003617357; Meijer HJM, 2014, PEERJ, V2, DOI 10.7717/peerj.295; MILLER AH, 1966, CONDOR, V68, P315, DOI 10.2307/1365447; Milne-Edwards A., 1867, RECHERCHES ANATOMIQU; Noriega Jorge I., 2002, P41; Patnaik Rajeev, 1994, Journal of the Palaeontological Society of India, V39, P77; Patnaik R, 2016, CR PALEVOL, V15, P889, DOI 10.1016/j.crpv.2015.11.004; Rich P.V., 1972, NOTES SERVICE GEOLOG, V35, P29; RICH PV, 1986, GEOBIOS-LYON, V19, P755, DOI 10.1016/S0016-6995(86)80106-1; SAIFF EI, 1978, ZOOL J LINN SOC-LOND, V63, P315, DOI 10.1111/j.1096-3642.1978.tb02099.x; Sharpe R.B., 1891, P 2 INT ORN C, V1891, P1; Stewart J.R., 2006, HIST BIOL, V18, P103; Stidham TA, 2016, PALAEONTOL ELECTRON, V19; Stidham TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111210; Worthy TH, 2012, AUK, V129, P96, DOI 10.1525/auk.2012.11204; Worthy TH, 2011, ZOOL J LINN SOC-LOND, V163, P277, DOI 10.1111/j.1096-3642.2011.00693.x; [No title captured]	42	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177129	10.1371/journal.pone.0177129	http://dx.doi.org/10.1371/journal.pone.0177129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542291	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500013
J	Kim, J; Lee, W; Won, JU; Yoon, JH; Seok, H; Kim, YK; Lee, S; Roh, J				Kim, Jihyun; Lee, Wanhyung; Won, Jong-Uk; Yoon, Jin-Ha; Seok, Hongdeok; Kim, Yeong-Kwang; Lee, Seunghyun; Roh, Jaehoon			The relationship between occupational noise and vibration exposure and headache/eyestrain, based on the fourth Korean Working Condition Survey (KWCS)	PLOS ONE			English	Article							ASSESSMENT MIDAS SCORE; CHRONIC HEADACHES; TRAFFIC NOISE; MIGRAINE; SENSITIVITY; POPULATION; PREVALENCE; SYMPTOMS; VALIDITY; RELIABILITY	Introduction The individual and combined effect of occupational noise and vibration exposures, on workers' health has not been thoroughly investigated. In order to find better ways to prevent and manage workers' headache, this study aimed to investigate the effects of occupational noise and vibration exposure on headache/eyestrain. Methods We used data from the fourth Korean Working Condition Survey (2014). After applying inclusion and exclusion criteria, 25,751 workers were included. Occupational noise and vibration exposure and the prevalence of headache/eyestrain were investigated by self-reported survey. Chi-square tests were used to compare differences in baseline characteristics between the group with headache/eyestrain and the group without. Odds ratios and 95% confidence intervals were estimated using a logistic regression model adjusted for several covariates. Area under the receiver operating characteristics curve (AUROC) analysis was used to evaluate the effect of occupational noise and/or vibration exposure. Results Among the 25,751 study subjects, 4,903 had experienced headache/eyestrain in the preceding year. There were significant differences in age, education level, household income, occupational classification, shift work, occupational vibration exposure, and occupational noise exposure between the two groups (all p<0.05). The odds ratios between each exposure and headache/eyestrain increased proportionally with the level of exposure, increasing from 1.08 to 1.26 with increasing vibration exposure, and from 1.25 to 1.41 with increasing noise exposure. According to the AUROC analysis, the predictive power of each exposure was significant, and increased when the two exposures were considered in combination. Discussion The findings of this study show that both occupational noise and vibration exposures are associated with headache/eyestrain; noise exposure more strongly so. However, when the two exposures are considered in combination, the explanatory power for headache/eyestrain is increased. Therefore, efforts aimed at reducing and managing occupational noise and vibration exposure are crucial to maintaining workers' health.	[Kim, Jihyun; Lee, Wanhyung; Won, Jong-Uk; Yoon, Jin-Ha; Seok, Hongdeok; Kim, Yeong-Kwang; Roh, Jaehoon] Yonsei Univ, Univ Coll Med, Inst Occupat Hlth, Seoul, South Korea; [Kim, Jihyun; Lee, Wanhyung; Won, Jong-Uk; Yoon, Jin-Ha; Seok, Hongdeok; Kim, Yeong-Kwang; Roh, Jaehoon] Yonsei Univ, Grad Sch Publ Hlth, Coll Med, Seoul, South Korea; [Kim, Jihyun; Lee, Wanhyung; Won, Jong-Uk; Yoon, Jin-Ha; Seok, Hongdeok; Kim, Yeong-Kwang; Roh, Jaehoon] Incheon Workers Hlth Ctr, Incheon, South Korea; [Won, Jong-Uk; Yoon, Jin-Ha; Roh, Jaehoon] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Lee, Seunghyun] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka, Japan	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Occupational & Environmental Health - Japan	Roh, J (corresponding author), Yonsei Univ, Univ Coll Med, Inst Occupat Hlth, Seoul, South Korea.; Roh, J (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Coll Med, Seoul, South Korea.; Roh, J (corresponding author), Incheon Workers Hlth Ctr, Incheon, South Korea.; Roh, J (corresponding author), Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.	jhroh@yuhs.ac		Yoon, Jin-Ha/0000-0003-4198-2955; Won, Jong-Uk/0000-0002-9200-3297				Aaseth K, 2008, CEPHALALGIA, V28, P705, DOI 10.1111/j.1468-2982.2008.01577.x; Ahmed HO, 2004, INT J HYG ENVIR HEAL, V207, P227, DOI 10.1078/1438-4639-00291; Bussone G, 2004, NEUROL SCI, V25, pS239, DOI 10.1007/s10072-004-0295-3; Carruthers Alastair, 1999, Headache, V39, P662, DOI 10.1046/j.1526-4610.1999.3909662.x; Chakravarty A, 2010, MED HYPOTHESES, V74, P225, DOI 10.1016/j.mehy.2009.08.034; Erdogan E, 2009, AFR J AGR RES, V4, P1015; Granet DB, 2005, STRABISMUS, V13, P163, DOI 10.1080/09273970500455436; Griffin MJ, 1997, OCCUP ENVIRON MED, V54, P73, DOI 10.1136/oem.54.2.73; Harada N, 1994, AUTONOMIC NERVOUS FU; Jiao K, 2004, INT ARCH OCC ENV HEA, V77, P205, DOI 10.1007/s00420-003-0493-y; Jungsun P, 2009, IND HLTH, V47, P50; Justice AC, 1999, J ACQ IMMUN DEF SYND, V21, P126; Kim YS, 2013, SAF HEALTH WORK, V4, P111, DOI 10.1016/j.shaw.2013.05.001; LANG T, 1992, INT ARCH OCC ENV HEA, V63, P369, DOI 10.1007/BF00386929; Lanteri-Minet M, 2013, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-013-0385-0; Lee HS, 2000, J INTEL MAT SYST STR, V11, P80, DOI 10.1106/412A-2GMA-BTUL-MALT; MARCHESI C, 1989, J AFFECT DISORDERS, V16, P33, DOI 10.1016/0165-0327(89)90052-9; Martin PR, 2006, HEADACHE, V46, P962, DOI 10.1111/j.1526-4610.2006.00468.x; Martin PR, 2005, HEADACHE, V45, P1353, DOI 10.1111/j.1526-4610.2005.00268.x; MATOBA T, 1977, TOHOKU J EXP MED, V123, P57, DOI 10.1620/tjem.123.57; Olesen J, 2011, NEW PLANS HEADACHE C; Olesen J, 2009, FUTURE HEADACHE CLAS; Paiva T, 1997, ARCH INTERN MED, V157, P1701, DOI 10.1001/archinte.157.15.1701; Palmer KT, 2000, OCCUP ENVIRON MED, V57, P237, DOI 10.1136/oem.57.4.237; Rylander R, 2004, J SOUND VIB, V277, P471, DOI 10.1016/j.jsv.2004.03.008; Sadri G, 2015, IRAN J MED SCI, V27, P39; Seong JC, 2011, ENVIRON INT, V37, P1336, DOI 10.1016/j.envint.2011.05.019; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; Spierings ELH, 1998, HEADACHE, V38, P191, DOI 10.1046/j.1526-4610.1998.3803191.x; Spierings ELH, 2001, HEADACHE, V41, P554, DOI 10.1046/j.1526-4610.2001.041006554.x; Stewart WF, 1999, NEUROLOGY, V53, P988, DOI 10.1212/WNL.53.5.988; Stewart WF, 2000, PAIN, V88, P41, DOI 10.1016/S0304-3959(00)00305-5; Stewart WF, 2001, NEUROLOGY, V56, pS20, DOI 10.1212/WNL.56.suppl_1.S20; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; TAKEUCHI T, 1986, SCAND J WORK ENV HEA, V12, P280, DOI 10.5271/sjweh.2140; Tian LG, 1996, INT J IND ERGONOM, V18, P221; VINCENT AJP, 1989, HEADACHE, V29, P523, DOI 10.1111/j.1526-4610.1989.hed2908523.x; Vingen JV, 1998, CEPHALALGIA, V18, P243, DOI 10.1046/j.1468-2982.1998.1805243.x; VIROKANNAS H, 1992, INT ARCH OCC ENV HEA, V64, P377, DOI 10.1007/BF00379549; Vukovic V, 2009, MIGRAINE PATHOPHYSIO, P33; Wada K, 2013, IND HEALTH, V51, P482, DOI 10.2486/indhealth.2013-0016; Wilkins K, 1998, Health Rep, V10, P47; WOODHOUSE A, 1993, CEPHALALGIA, V13, P417, DOI 10.1046/j.1468-2982.1993.1306417.x	43	6	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177846	10.1371/journal.pone.0177846	http://dx.doi.org/10.1371/journal.pone.0177846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542287	gold, Green Submitted, Green Published			2022-12-27	WOS:000402058800029
J	Kwacz, M; Solyga, M; Mrowka, M; Kamieniecki, K				Kwacz, Monika; Solyga, Magdalena; Mrowka, Maciej; Kamieniecki, Konrad			New chamber stapes prosthesis - A preliminary assessment of the functioning of the prototype	PLOS ONE			English	Article							FINITE-ELEMENT MODEL; ADVANCED OTOSCLEROSIS; PISTON DIAMETER; HEARING-LOSS; STAPEDOTOMY; TINNITUS; MIDDLE; STAPEDECTOMY; VIBRATION; SURGERY	Piston-stapedotomy is the most common method for hearing restoration in patients with otosclerosis. In this study, we have experimentally examined a prototype of a new chamber stapes prosthesis. The prototype was implanted in a human cadaver temporal bone. The round window vibrations before and after implantation were measured for the acoustic signal (90 dB SPL, 0.8-8 kHz) in the external auditory canal. In comparison with a 0.4-mm piston prosthesis, the chamber prosthesis induced significantly higher vibration of the round window, especially for frequencies above 1.5 kHz. Based on the results, it can be surmised that stapedotomy with a chamber stapes prosthesis could provide better hearing results in comparison with the piston-stapedotomy.	[Kwacz, Monika; Kamieniecki, Konrad] Warsaw Univ Technol, Inst Micromech & Photon, Warsaw, Poland; [Solyga, Magdalena] Warsaw Univ Technol, Inst Radioelect, Warsaw, Poland; [Mrowka, Maciej] Inst Physiol & Pathol Hearing, Kajetany, Nadarzyn, Poland	Warsaw University of Technology; Warsaw University of Technology; Institute of Physiology & Hearing Pathology	Kwacz, M (corresponding author), Warsaw Univ Technol, Inst Micromech & Photon, Warsaw, Poland.	m.kwacz@mchtr.pw.edu.pl	Kwacz, Monika/AAC-4869-2019	Kamieniecki, Konrad/0000-0003-2481-4554; Kwacz, Monika/0000-0002-6101-0435; Solyga, Magdalena/0000-0003-2969-2963	Polish National Centre for Research and Development [266457/NCBR/2015]	Polish National Centre for Research and Development	This work was partially supported by the Polish National Centre for Research and Development (Research Project No. 266457/NCBR/2015).There was no additional external funding received for this study.	AWENGEN DF, 1995, ANN OTO RHINOL LARYN, V104, P311, DOI 10.1177/000348949510400411; Ayache D, 2003, OTOL NEUROTOL, V24, P48, DOI 10.1097/00129492-200301000-00011; Bagger-Sjoback D, 2015, SCI REP-UK, V5, DOI 10.1038/srep13341; Bakhos D, 2010, EUR ANN OTORHINOLARY, V127, P177, DOI 10.1016/j.anorl.2010.07.012; Bast F, 2013, AURIS NASUS LARYNX, V40, P530, DOI 10.1016/j.anl.2013.04.006; Bohnke F, 2007, ADV OTO-RHINO-LARYNG, V65, P150, DOI 10.1159/000098793; Calmels MN, 2007, ACTA OTO-LARYNGOL, V127, P574, DOI 10.1080/00016480600987768; De la Cruz A, 2000, OTOLARYNG HEAD NECK, V123, P728, DOI 10.1067/mhn.2000.111285; Dubreuil C, 1994, Ann Otolaryngol Chir Cervicofac, V111, P249; Dumon T, 2007, ADV OTO-RHINO-LARYNG, V65, P320, DOI 10.1159/000098852; FARRIOR J, 1991, LARYNGOSCOPE, V101, P1155; Gambin W, Patent PL, Patent No. [271562 B1, 271562]; Gersdorff M, 2000, EUR ARCH OTO-RHINO-L, V257, P314, DOI 10.1007/s004059900138; Grolman W, 1997, EUR ARCH OTO-RHINO-L, V254, P422, DOI 10.1007/BF02439972; Gros A, 2005, OTOL NEUROTOL, V26, P1143, DOI 10.1097/01.mao.0000172414.64907.9d; Grossohmichen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119601; Hausler R, 2004, MIDDLE EAR SURG, P105; Honda N, 2004, PROCEEDINGS OF THE 3RD SYMPOSIUM ON MIDDLE EAR MECHANICS IN RESEARCH AND OTOLOGY, P203; Huber AM, 2006, OTOL NEUROTOL, V27, P1104, DOI 10.1097/01.mao.0000244352.49824.e6; Huber AM, 2003, LARYNGOSCOPE, V113, P853, DOI 10.1097/00005537-200305000-00015; Huttenbrink KB, 2003, OTOL NEUROTOL, V24, P548; Ismi O, 2016, BRAZ J OTORHINOLARYN; Kirikae I, 1960, STRUCTURE FUNCTION M, P38; Koike T, 2001, ASS RES OT ARO 24 MI, P221; Kwacz M, 2015, JARO-J ASSOC RES OTO, V16, P433, DOI 10.1007/s10162-015-0525-9; Kwacz M, 2014, HEARING RES, V310, P13, DOI 10.1016/j.heares.2014.01.004; Kwacz M, 2013, BIOMECH MODEL MECHAN, V12, P1243, DOI 10.1007/s10237-013-0479-y; Kwacz M, 2012, ACTA BIOENG BIOMECH, V14, P67, DOI 10.5277/abb120209; Kwacz M, 2012, BIOCYBERN BIOMED ENG, V32, P27, DOI 10.1016/S0208-5216(12)70030-X; Lesinski S George, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P347, DOI 10.1097/00020840-200310000-00007; Lesinski SG, 2002, OTOL NEUROTOL, V23, P281, DOI 10.1097/00129492-200205000-00009; Marchese MR, 2007, AUDIOL NEURO-OTOL, V12, P221, DOI 10.1159/000101329; Merkus P, 2011, LARYNGOSCOPE, V121, P1935, DOI 10.1002/lary.21904; Moller P, 2007, ADV OTO-RHINO-LARYNG, V65, P169, DOI 10.1159/000098802; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P186, DOI 10.1016/S0194-5998(95)70103-6; Olson ES, 1998, J ACOUST SOC AM, V103, P3445, DOI 10.1121/1.423083; RIZER FM, 1993, OTOLARYNG CLIN N AM, V26, P443; ROSOWSKI JJ, 1995, AM J OTOL, V16, P486; SCHULNECHT H, 1968, Archives of Otolaryngology, V87, P129; Sennaroglu L, 2001, OTOLARYNG HEAD NECK, V124, P279, DOI 10.1067/mhn.2001.112431; Sim JH, 2013, JARO-J ASSOC RES OTO, V14, P159, DOI 10.1007/s10162-012-0369-5; Sim JH, 2012, EAR HEARING, V33, pE24, DOI 10.1097/AUD.0b013e318258c7a6; Skinner M, 2003, LARYNGOSCOPE, V113, P647, DOI 10.1097/00005537-200304000-00012; Somers T, 2006, ANN OTO RHINOL LARYN, V115, P880, DOI 10.1177/000348940611501203; Stenfelt S, 2004, HEARING RES, V198, P10, DOI 10.1016/j.heares.2004.07.008; Teig E, 1999, OTO RHINO LARYN NOVA, V9, P252, DOI 10.1159/000027931; Vincent R, 2006, OTOL NEUROTOL, V27, pS25, DOI 10.1097/01.mao.0000235311.80066.df; Wysocki J, 2011, LARYNGOSCOPE, V121, P1958, DOI 10.1002/lary.22081	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178133	10.1371/journal.pone.0178133	http://dx.doi.org/10.1371/journal.pone.0178133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542633	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800043
J	Lyda, TA; Wagner, EL; Bourg, AX; Peng, C; Tomaraei, GN; Dean, D; Kennedy, MS; Marcotte, WR				Lyda, Todd A.; Wagner, Elizabeth L.; Bourg, Andre X.; Peng, Congyue; Tomaraei, Golnaz Najaf; Dean, Delphine; Kennedy, Marian S.; Marcotte, William R., Jr.			A Leishmania secretion system for the expression of major ampullate spidroin mimics	PLOS ONE			English	Article							SPIDER DRAGLINE SILK; LUTZOMYIA-LONGIPALPIS; ESCHERICHIA-COLI; NEPHILA-CLAVIPES; PICHIA-PASTORIS; PROTEIN; FIBER; GENES; PROTEOPHOSPHOGLYCANS; PROMASTIGOTES	Spider major ampullate silk fibers have been shown to display a unique combination of relatively high fracture strength and toughness compared to other fibers and show potential for tissue engineering scaffolds. While it is not possible to mass produce native spider silks, the potential ability to produce fibers from recombinant spider silk fibers could allow for an increased innovation rate within tissue engineering and regenerative medicine. In this pilot study, we improved upon a prior fabrication route by both changing the expression host and additives to the fiber pulling precursor solution to improve the performance of fibers. The new expression host for producing spidroin protein mimics, protozoan parasite Leishmania tarentolae, has numerous advantages including a relatively low cost of culture, rapid growth rate and a tractable secretion pathway. Tensile testing of hand pulled fibers produced from these spidroin-like proteins demonstrated that additives could significantly modify the fiber's mechanical and/or antimicrobial properties. Cross-linking the proteins with glutaraldehyde before fiber pulling resulted in a relative increase in tensile strength and decrease in ductility. The addition of ampicillin into the spinning solution resulted in the fibers being able to inhibit bacterial growth.	[Lyda, Todd A.; Wagner, Elizabeth L.; Bourg, Andre X.; Peng, Congyue; Marcotte, William R., Jr.] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA; [Tomaraei, Golnaz Najaf; Kennedy, Marian S.] Clemson Univ, Dept Mat Sci & Engn, Clemson, SC USA; [Dean, Delphine] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Lyda, Todd A.] High Point Univ, Dept Biol, High Point, NC USA	Clemson University; Clemson University; Clemson University	Marcotte, WR (corresponding author), Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA.	marcotw@clemson.edu	Marcotte, William/AAD-8354-2019; Dean, Delphine/AAZ-7907-2021; Kennedy, Marian S/F-7283-2010; Peng, Congyue/AAK-3850-2020	Marcotte, William/0000-0003-4580-1939; Dean, Delphine/0000-0002-8631-2640; Kennedy, Marian S/0000-0003-4395-3154; Peng, Congyue/0000-0002-9992-5737	National Science Foundation [DMR-1105307]; Div Of Chem, Bioeng, Env, & Transp Sys [1254609] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The authors received funding for this work from the National Science Foundation (Award No. DMR-1105307 to WRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, PROTOCOL 0013 ELECTR, P1; Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133; Arcidiacono Steven, 2013, Methods Mol Biol, V996, P43, DOI 10.1007/978-1-62703-354-1_3; Barr LA, 2004, MOL BREEDING, V13, P345, DOI 10.1023/B:MOLB.0000034089.92263.ff; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; Clayton C, 1998, MOL BIOCHEM PARASIT, V97, P221, DOI 10.1016/S0166-6851(98)00115-7; do Vale VF, 2007, J INSECT PHYSIOL, V53, P1151, DOI 10.1016/j.jinsphys.2007.06.005; ELWASILA M, 1988, PARASITOL RES, V74, P591, DOI 10.1007/BF00531640; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884; Fritsche C, 2007, J BASIC MICROB, V47, P384, DOI 10.1002/jobm.200710111; Gaines WA, 2008, INSECT MOL BIOL, V17, P465, DOI 10.1111/j.1365-2583.2008.00828.x; Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121; Ghedin E, 1998, J BIOL CHEM, V273, P22997, DOI 10.1074/jbc.273.36.22997; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hauptmann V, 2013, BIOTECHNOL J, V8, P1183, DOI 10.1002/biot.201300204; Heidebrecht A, 2015, ADV MATER, V27, P2189, DOI 10.1002/adma.201404234; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; Ittah S, 2010, BIOPOLYMERS, V93, P458, DOI 10.1002/bip.21362; Jacobson RL, 2007, FOLIA PARASIT, V54, P301, DOI 10.14411/fp.2007.039; Lai JY, 2014, RSC ADV, V4, P18871, DOI 10.1039/c4ra01930j; Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024; Lucas F., 1968, Comprehensive Biochem, V26, P475; LUCAS FRED, 1964, DISCOVERY, V25, P20; Lyda TA, 2015, MOL CELL BIOCHEM, V404, P53, DOI 10.1007/s11010-015-2366-6; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; Meier C, 2011, BIOMACROMOLECULES, V12, P3453, DOI 10.1021/bm2005752; Peng CA, 2016, TRANSGENIC RES; Reddy N, 2015, TRENDS BIOTECHNOL, V33, P362, DOI 10.1016/j.tibtech.2015.03.008; Rogers ME, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00223; Rogers ME, 2010, MICROBES INFECT, V12, P875, DOI 10.1016/j.micinf.2010.05.014; Sallach RE, 2009, BIOTECHNOL PROGR, V25, P1810, DOI 10.1002/btpr.208; Sambook J., 1989, MOL CLONING LAB MANU, P743; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; STIERHOF YD, 1994, J CELL BIOL, V125, P321, DOI 10.1083/jcb.125.2.321; Stierhof YD, 1999, EUR J CELL BIOL, V78, P675, DOI 10.1016/S0171-9335(99)80036-3; Teule F, 2007, J MATER SCI, V42, P8974, DOI 10.1007/s10853-007-1642-6; Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250; UNICEF/UNDP/WorldBank/World Health Organization, 2010, CONTR LEISHM REP M W; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2; Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2; Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107; Xu GQ, 2014, SOFT MATTER, V10, P2116, DOI 10.1039/c3sm52845f; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zama M, 1997, Nucleic Acids Symp Ser, P179; Zama M, 1999, Nucleic Acids Symp Ser, P81; Zhang YS, 2008, MOL BIOL REP, V35, P329, DOI 10.1007/s11033-007-9090-6; Zhou SB, 2008, J PHYS CHEM B, V112, P11209, DOI 10.1021/jp800913k; ZUREK W, 1981, FIBRE SCI TECHNOL, V15, P223, DOI 10.1016/0015-0568(81)90006-3	51	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178201	10.1371/journal.pone.0178201	http://dx.doi.org/10.1371/journal.pone.0178201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542539	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058800046
J	Wei, TS; Liu, PT; Chang, LW; Liu, SY				Wei, Ta-Sen; Liu, Peng-Ta; Chang, Liang-Wey; Liu, Sen-Yung			Gait asymmetry, ankle spasticity, and depression as independent predictors of falls in ambulatory stroke patients	PLOS ONE			English	Article							RISK-FACTORS; INPATIENT REHABILITATION; ATTENTION DEFICITS; TIME-COURSE; BALANCE; COMMUNITY; PEOPLE; PREVALENCE; CHILDREN; IDENTIFY	Background Falls are the leading cause of injury in stroke patients. However, the cause of a fall is complicated, and several types of risk factors are involved. Therefore, a comprehensive model to predict falls with high sensitivity and specificity is needed. Methods This study was a prospective study of 112 inpatients in a rehabilitation ward with follow-up interviews in patients' homes. Evaluations were performed 1 month after stroke and included the following factors: (1) status of cognition, depression, fear of fall and limb spasticity; (2) functional assessments [walking velocity and the Functional Independence Measure (FIM)]; and (3) objective, computerized gait and balance analyses. The outcome variable was the number of accidental falls during the 6-month follow-up period after baseline measurements. Results The non-faller group exhibited significantly better walking velocity and FIM scale compared to the faller group (P < .001). The faller group exhibited higher levels of spasticity in the affected limbs, asymmetry of gait parameters in single support (P < .001), double support (P = .027), and step time (P = .003), and lower stability of center of gravity in the medial-lateral direction (P = .008). Psychological assessments revealed that the faller group exhibited more severe depression and lower confidence without falling. A multivariate logistic regression model identified three independent predictors of falls with high sensitivity (82.6%) and specificity (86.5%): the asymmetry ratio of single support [adjusted odds ratio, aOR = 2.2, 95% CI (1.2-3.8)], the level of spasticity in the gastrocnemius [aOR = 3.2 (1.4-7.3)], and the degree of depression [aOR = 1.4 (1.2-1.8)]. Conclusions This study revealed depression, in additional to gait asymmetry and spasticity, as another independent factor for predicting falls. These results suggest that appropriate gait training, reduction of ankle spasticity, and aggressive management of depression may be critical to prevent falls in stroke patients.	[Wei, Ta-Sen; Chang, Liang-Wey] Natl Taiwan Univ, Coll Engn, Inst Biomed Engn, Taipei, Taiwan; [Wei, Ta-Sen; Chang, Liang-Wey] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Wei, Ta-Sen; Liu, Peng-Ta; Liu, Sen-Yung] Changhua Christian Hosp, Dept Phys Med & Rehabil, Changhua, Taiwan; [Wei, Ta-Sen; Liu, Peng-Ta; Liu, Sen-Yung] Changhua Christian Hosp, Fall Prevent Ctr, Changhua, Taiwan	National Taiwan University; National Taiwan University; Changhua Christian Hospital; Changhua Christian Hospital	Chang, LW (corresponding author), Natl Taiwan Univ, Coll Engn, Inst Biomed Engn, Taipei, Taiwan.; Chang, LW (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	bmechlw@ntu.edu.tw						Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Alzahrani MA, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/470648; Ashburn A, 2008, AGE AGEING, V37, P270, DOI 10.1093/ageing/afn066; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Chan ACM, 1996, J AGING HEALTH, V8, P238, DOI 10.1177/089826439600800205; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; Dusing SC, 2007, GAIT POSTURE, V25, P135, DOI 10.1016/j.gaitpost.2006.06.003; FELLOWS SJ, 1993, J NEUROL NEUROSUR PS, V56, P531, DOI 10.1136/jnnp.56.5.531; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garland SJ, 2007, ARCH PHYS MED REHAB, V88, P218, DOI 10.1016/j.apmr.2006.11.023; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Harris JE, 2005, PHYS THER, V85, P150, DOI 10.1093/ptj/85.2.150; Hill KD, 1996, ARCH PHYS MED REHAB, V77, P1025, DOI 10.1016/S0003-9993(96)90063-5; Hosmer DW, 2005, APPL LOGISTIC REGRES, P143, DOI DOI 10.1002/0471722146; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Hyndman D, 2003, DISABIL REHABIL, V25, P817, DOI 10.1080/0963828031000122221; Hyndman D, 2002, ARCH PHYS MED REHAB, V83, P165, DOI 10.1053/apmr.2002.28030; Jalayondeja C, 2014, GERIATR GERONTOL INT, V14, P778, DOI 10.1111/ggi.12164; Johnson CA, 2004, ARCH PHYS MED REHAB, V85, P902, DOI 10.1016/j.apmr.2003.08.081; Jorgensen L, 2002, STROKE, V33, P542, DOI 10.1161/hs0202.102375; Ju MS, 2000, J ELECTROMYOGR KINES, V10, P1, DOI 10.1016/S1050-6411(99)00018-8; Kerse N, 2008, STROKE, V39, P1890, DOI 10.1161/STROKEAHA.107.509885; Kim CM, 2003, GAIT POSTURE, V18, P23, DOI 10.1016/S0966-6362(02)00122-4; Kouwenhoven SE, 2011, DISABIL REHABIL, V33, P539, DOI 10.3109/09638288.2010.505997; Lamb SE, 2003, STROKE, V34, P494, DOI 10.1161/01.STR.0000053444.00582.B7; Lee JE, 2008, AM J PHYS MED REHAB, V87, P341, DOI 10.1097/PHM.0b013e31816ddc01; Maeda N, 2009, J INT MED RES, V37, P697, DOI 10.1177/147323000903700313; Mansfield A, PHYSIOTHERAPY; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Paolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145; Patterson KK, 2008, ARCH PHYS MED REHAB, V89, P304, DOI 10.1016/j.apmr.2007.08.142; Patterson KK, 2010, NEUROREHABIL NEURAL; Persson CU, 2011, J REHABIL MED, V43, P348, DOI 10.2340/16501977-0677; Petitpierre NJ, 2010, AGE AGEING, V39, P326, DOI 10.1093/ageing/afq010; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Ring H, 1997, ARCH PHYS MED REHAB, V78, P630, DOI 10.1016/S0003-9993(97)90429-9; Saverino A, 2006, Eura Medicophys, V42, P179; Schwesig R, 2013, CLIN REHABIL, V27, P183, DOI 10.1177/0269215512452880; Soyuer F, 2007, DISABIL REHABIL, V29, P679, DOI 10.1080/09638280600925860; Stapleton T, 2001, CLIN REHABIL, V15, P437, DOI 10.1191/026921501678310243; Suzuki T, 2005, EXP AGING RES, V31, P457, DOI 10.1080/03610730500206881; Swanenburg J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-162; Teasell R, 2002, ARCH PHYS MED REHAB, V83, P329, DOI 10.1053/apmr.2002.29623; THILMANN AF, 1991, BRAIN, V114, P233; Thorbahn LDB, 1996, PHYS THER, V76, P576, DOI 10.1093/ptj/76.6.576; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; van de Port IG, 2008, J REHABIL MED, V40, P23, DOI 10.2340/16501977-0114; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; Weerdesteyn V, 2008, DIFFERENCES, V33, P36; Wei TS, 2001, OSTEOPOROSIS INT, V12, P1050, DOI 10.1007/PL00004184; Wong AMK, 2004, AM J PHYS MED REHAB, V83, P284, DOI 10.1097/01.PHM.0000118038.02326.CA	53	47	54	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177136	10.1371/journal.pone.0177136	http://dx.doi.org/10.1371/journal.pone.0177136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542281	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058800008
J	Holmboe, S; Hansen, PL; Thisgaard, H; Block, I; Muller, C; Langkjaer, N; Hollund-Carlsen, PF; Olsen, BB; Mollenhauer, J				Holmboe, Sif; Hansen, Pernille Lund; Thisgaard, Helge; Block, Ines; Mueller, Carolin; Langkjaer, Niels; Hollund-Carlsen, Poul Flemming; Olsen, Birgitte Brinkmann; Mollenhauer, Jan			Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411	PLOS ONE			English	Article							IDENTIFICATION	Cancer stem cells represent the putative tumor-driving subpopulation thought to account for drug resistance, relapse, and metastatic spread of epithelial and other cancer types. Accordingly, cell surface markers for therapeutic delivery to cancer stem cells are subject of intense research. Somatostatin receptor 2 and nucleolin are known to be overexpressed by various cancer types, which have elicited comprehensive efforts to explore their therapeutic utilization. Here, we evaluated somatostatin receptor 2 targeting and nucleolin targeting for therapeutic delivery to cancer stem cells from lung cancer. Nucleolin is expressed highly but not selectively, while somatostatin receptor 2 is expressed selectively but not highly by cancer cells. The non-small cell lung cancer cell lines A549 and H1299, displayed average levels of both surface molecules as judged based on analysis of a larger cell line panel. H1299 compared to A549 cells showed significantly elevated sphere-forming capacity, indicating higher cancer stem cell content, thus qualifying as suitable test system. Nucleolin-targeting 57 Co-DOTA-AS1411 aptamer showed efficient internalization by cancer cells and, remarkably, at even higher efficiency by cancer stem cells. In contrast, somatostatin receptor 2 expression levels were not sufficiently high in H1299 cells to confer efficient uptake by either non-cancer stem cells or cancer stem cells. The data provides indication that the nucleolintargeting AS1411 aptamer might be used for therapeutic delivery to non-small cell lung cancer stem cells.	[Holmboe, Sif; Hansen, Pernille Lund; Block, Ines; Mueller, Carolin] Univ Southern Denmark, Lundbeckfonden Ctr Excellence NanoCAN, Odense, Denmark; [Holmboe, Sif; Hansen, Pernille Lund; Block, Ines; Mueller, Carolin; Mollenhauer, Jan] Univ Southern Denmark, Mol Oncol, Odense, Denmark; [Thisgaard, Helge; Langkjaer, Niels; Hollund-Carlsen, Poul Flemming; Olsen, Birgitte Brinkmann; Mollenhauer, Jan] Odense Univ Hosp, Dept Nucl Med, Odense, Denmark; [Thisgaard, Helge; Hollund-Carlsen, Poul Flemming] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	Lundbeckfonden; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Hansen, PL (corresponding author), Univ Southern Denmark, Lundbeckfonden Ctr Excellence NanoCAN, Odense, Denmark.; Hansen, PL (corresponding author), Univ Southern Denmark, Mol Oncol, Odense, Denmark.	plhansen@health.sdu.dk	Olsen, Birgitte B/U-2382-2017; Block, Ines/Q-5507-2016; Langkjær, Niels/Y-1403-2019; Thisgaard, Helge/B-9362-2017; Hansen, Pernille Lund/F-3919-2016	Olsen, Birgitte B/0000-0002-6130-0387; Block, Ines/0000-0003-1964-6031; Langkjær, Niels/0000-0002-8729-937X; Thisgaard, Helge/0000-0001-9492-448X; Hansen, Pernille Lund/0000-0001-8284-4917	Danish Council for Independent Research; Medical Sciences [DFF-4004-00268]; Lundbeck Foundation grant	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Medical Sciences; Lundbeck Foundation grant	This work was supported by: Danish Council for Independent Research; Medical Sciences (DFF-4004-00268) littp://ufm.dk/ forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad, Receiver: JM; Lundbeck Foundation grant to the Nanomedicine Research Center for Cancer Stem Cell-Targeting Therapeutics (NanoCAN) http://www.lundbeckfonden.com/, Receiver: JM.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bates P. J., 2016, BIOCH BIOPHYS ACTA; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bodei L, 2009, J ENDOCRINOL INVEST, V32, P360, DOI 10.1007/BF03345728; Charpentier Monica, 2013, Cancers (Basel), V5, P1545, DOI 10.3390/cancers5041545; Chung LY, 2015, ONCOTARGET, V6, P4936, DOI 10.18632/oncotarget.3210; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Delpassand ES, 2014, PANCREAS, V43, P518, DOI 10.1097/MPA.0000000000000113; Ding YP, 2012, ARTERIOSCL THROM VAS, V32, pE126, DOI 10.1161/ATVBAHA.112.247502; El Khoury D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-325; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fonseca NA, 2015, BIOMATERIALS, V69, P76, DOI 10.1016/j.biomaterials.2015.08.007; Hu J, 2015, CHEM-ASIAN J, V10, P1519, DOI 10.1002/asia.201500187; Koutsioumpa M, 2014, RECENT PAT ANTI-CANC, V9, DOI 10.2174/1574892808666131119095953; Malhi S, 2015, EXPERT OPIN DRUG DEL, V12, P1177, DOI 10.1517/17425247.2015.998648; Moghbeli M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0069-6; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pofahl M, 2014, NUCLEIC ACID THER, V24, P171, DOI 10.1089/nat.2013.0472; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Reyes-Reyes EM, 2015, MOL ONCOL, V9, P1392, DOI 10.1016/j.molonc.2015.03.012; Reyes-Reyes EM, 2010, CANCER RES, V70, P8617, DOI 10.1158/0008-5472.CAN-10-0920; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Subramanian N, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.70; Thisgaard H, 2014, J NUCL MED, V55, P1311, DOI 10.2967/jnumed.114.137182; World Health Organization, 2012, INT AG CANC RES POP; Wu Y, 2011, MOL PHARMACEUT, V8, P1381, DOI 10.1021/mp2002076; Xu CY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/917968; Zhong YA, 2014, BIOMACROMOLECULES, V15, P1955, DOI 10.1021/bm5003009; Zou Y, 2009, ONCOL REP, V21, P379, DOI 10.3892/or_00000233	29	18	18	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178286	10.1371/journal.pone.0178286	http://dx.doi.org/10.1371/journal.pone.0178286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542563	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400077
J	Nicklisch, N; Ramsthaler, F; Meller, H; Friederich, S; Alt, KW				Nicklisch, Nicole; Ramsthaler, Frank; Meller, Harald; Friederich, Susanne; Alt, Kurt W.			The face of war: Trauma analysis of a mass grave from the Battle of Lutzen (1632)	PLOS ONE			English	Article							ADULT SKELETAL AGE; RIGOR-MORTIS; INJURIES; PATTERNS; BONE	Contemporary accounts of battles are often incomplete or even erroneous because they reflect the-oftenbiased-viewpoints of the authors. Battlefield archaeology faces the task of compiling an historical analysis of a battle and of gathering all the available facts. Besides cultural historical evidence and artefacts, the human remains of those who have fallen in battle also provide invaluable information. In studying mass graves from a military context, the injury types and patterns are significant. They allow us to reconstruct the circumstances surrounding the soldiers' deaths and provide information on the hostilities that occurred on the battlefield. One such mass grave was discovered in 2011 at Lutzen, Saxony-Anhalt (Germany). Based on its geographical location and on the results obtained from archaeological examinations carried out in the area, the grave could be dated to the Thirty Years War (1618-1648). Further archaeological research confirmed that the dead had been soldiers from the Battle of Lutzen (1632). The mass grave was block-lifted and then comprehensively examined at the State Museum of Prehistory in Halle (Saale). As well as osteological examinations to determine age, sex, height, state of health, i.e. diseases or injuries, imaging methods were also employed and histological and isotopic analyses carried out. The focus of this study was on the injuries sustained by the soldiers both prior to and during the battle. The results revealed that the 47 deceased had been between the ages of 15 and 50 when they died. Numerous healed injuries showed that the men had often been involved in violent encounters. Approximately three in every four soldiers had injuries that could have been fatal. Wounds inflicted by handguns, particularly to the skull, were predominant. The integrative analysis of the archaeological and anthropological data allowed us to conclude that the majority had been killed during a cavalry attack.	[Nicklisch, Nicole; Meller, Harald; Friederich, Susanne; Alt, Kurt W.] State Museum Prehist, State Off Heritage Management & Archaeol Saxony A, Halle, Saale, Germany; [Nicklisch, Nicole; Alt, Kurt W.] Danube Private Univ, Krems Stein, Austria; [Ramsthaler, Frank] Saarland Univ, Inst Legal Med, Homburg, Saar, Germany	Universitatsklinikum des Saarlandes	Nicklisch, N (corresponding author), State Museum Prehist, State Off Heritage Management & Archaeol Saxony A, Halle, Saale, Germany.; Nicklisch, N (corresponding author), Danube Private Univ, Krems Stein, Austria.	nnicklisch@archlsa.de		Nicklisch, Nicole/0000-0001-7423-8343	Federal Government for Culture and the Media; Stiftung zur Forderung der Archaologie in Sachsen-Anhalt	Federal Government for Culture and the Media; Stiftung zur Forderung der Archaologie in Sachsen-Anhalt	This work was supported by Federal Government for Culture and the Media (no grant number), and Stiftung zur Forderung der Archaologie in Sachsen-Anhalt (no grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Ackerknecht E. H, 1992, GESCH MED; Acsadi G, 1970, HIST HUMAN LIFE SPAN; Alt KW, 2009, MUMIEN UND MUSEEN, P83; Alt KW, 2009, WETTER KLIMA MENSCHH, P170; [Anonymous], 1980, J HUM EVOL, V9, P517; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; Banks I, 2011, J CONFL ARCHAEOL, V6, P124, DOI 10.1179/157407811X13027741134148; Barta P, 2007, RADIOCARBON, V49, P465, DOI 10.1017/S0033822200042399; Behringer W., 2005, CULTURAL CONSEQUENCE; Berryman H.E., 1998, FORENSIC OSTEOLOGY A, P333; Betz P, 1996, INT J LEGAL MED, V109, P58, DOI 10.1007/BF01355517; Binder M. Der, 2008, MONOGRAFIEN STADTARC; Boylston A., 2007, BLOOD RED ROSES ARCH, P45; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Buikstra JE, 1994, ARKANSAS ARCHEOLOGIC; Byers SN., 2010, INTRO FORENSIC ANTHR; Cappella A, 2014, FORENSIC SCI INT, V244, DOI 10.1016/j.forsciint.2014.09.003; Constantinescu M, 2015, INT J OSTEOARCHAEOL; Cooper C., 2006, B SCHWEIZERISCHEN GE, V12, P23; Cooper C., 2010, THESIS; Coughlan J, 2007, BLOOD RED ROSES ARCH, P60; Courtwright DT, 2001, FORCES HABIT DRUGS M; Der Soldat Parker G., 2004, MENSCH BAROCK, P47; Dettmeyer RB, 2014, FORENSIC MED FUNDAME, P33; Dirkmaat DC, 2008, YEARB PHYS ANTHROPOL, V51, P33, DOI 10.1002/ajpa.20948; Dittrich R, 1989, ALTEN HANDFEUERWAFFE, P7; Eickhoff S, 2014, FORSCHUNGEN ARCHAOLO; Eickhoff S, 1636, IHRE LETZTE SCHLACHT; Elmer P, 2007, HLTH DIS SOC EUROPE; Engerisser P., KALIBERTABELLEN ABME; Engerisser P., 2007, KRONACH NACH NORDI 2; Fahr J., 2015, KRIEG EINE ARCHAOLOG, P433; Fahr J, 2008, ARCHAOLOGIE KALKTEIC, P105; Fiorato V, 2007, BLOOD RED ROSES HIST; Flieger A, 2016, INT J LEGAL MED, V130, P1401, DOI 10.1007/s00414-016-1407-3; Foard G., 1995, DECISIVE CAMPAIGN; Freeman P, 2001, BAR INTERNAT SER; Freytag G. Der, 2005, DREISSIGJAHRIGE KRIE; Friederich S, 2016, ARCHAOLOGIE DEUTSCHL, V2, P50; Friederich S, 2015, ARCHAOLOGISCHE SPURE, P399; Galloway A., 2014, BROKEN BONES ANTHR A, P133; Galloway A., 2014, BROKEN BONES ANTHR A, V2nd, P47; Galloway A., 2014, BROKEN BONES ANTHR A, P195; Galloway A, 1999, BROKEN BONES ANTHR A; Galloway A., 2014, BROKEN BONES ANTHR A, P91; Galloway A., 2014, BROKEN BONES ANTHR A, P59; Gowland RL, 2005, ANTIQUITY, V79, P146, DOI 10.1017/S0003598X00113766; Greene Jerome A., 2004, FINDING SAND CREEK H; Grippe Vasold M., 2010, GRIPPE PEST CHOLERA; Grothe A, 2015, ARCHAOLOGISCHE SPURE, P391; Grothe A, 2009, SCHLACHTFELDARCHAOLO, V2, P163; Grothe A., 2015, KRIEG ARCHAOLOGISCHE, P386; Grupe G, 2012, POPULATION DYNAMICS, P323; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Homann A., 2013, HIST ARCHAEOLOGY CEN, P203; Homann A, 2009, J CONFL ARCHAEOL, V5, P27, DOI 10.1163/157407709X12634580640218; Ingelmark BE, 1993, ARMOUR BATTLE WISBY, P149; Jankauskas R, 2011, ANTHROPOL ANZ, V68, P393, DOI 10.1127/0003-5548/2011/0150; Jungklaus B, 2011, EUBRANDENBURGER MOS, V35, P10; Jungklaus B, 2014, FORSCHUNGEN ZRCHAOLO, V15, P285; Jungklaus B. Ein, 2014, FORSCHUNGEN ARCHAOLO, V15, P341; Jurmain R., 1999, STORIES SKELETON BEH; Kimmerle EH, 2008, SKELETAL TRAUMA: IDENTIFICATION OF INJURIES RESULTING FROM HUMAN RIGHTS ABUSE AND ARMED CONFLICT, P1, DOI 10.1201/9781420009118; Kjellstrom A, 2005, INT J OSTEOARCHAEOL, V15, P23, DOI 10.1002/oa.746; Knarrstrom B., 2009, SCHLACHTFELDARCHAOLO, V2, P187; Kneubuehl BP, 2011, WOUND BALLISTICS: BASICS AND APPLICATIONS, P253; Kneubuehl BP, 2011, WOUND BALLISTICS: BASICS AND APPLICATIONS, P163; Knusel C.J., 2005, WARFARE VIOLENCE SLA, P49; Knusel CJ, 1996, AM J PHYS ANTHROPOL, V100, P427; Komar D, 2008, CURR ANTHROPOL, V49, P123, DOI 10.1086/524761; Konig HG, 2006, FRUHE SPUREN GEWALT, V41, P11; Kroener BR, 2008, KRIEGERISCHE GEWALT; Kroener BR, 1648, KRIEG FRIEDEN EUROPA, P285; KROMPECHER T, 1981, FORENSIC SCI INT, V17, P19, DOI 10.1016/0379-0738(81)90184-5; Lavater HC, 1659, KRIEGS BUCHLEIN IST; Leben Evers B., 2011, LEBEN STERBEN SCHLAC, P125; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P15, DOI 10.1002/ajpa.1330680103; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lovell NC, 1997, YEARB PHYS ANTHROPOL, V40, P139; Lutzen Brzezinski R., 1632, CLIMAX 30 YEARS WAR; Maples W. R., 1986, FORENSIC OSTEOLOGY A, P218; Martin DL, 2015, AM J PHYS ANTHROPOL, V156, P116, DOI 10.1002/ajpa.22662; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Meller H, 2015, ARCHAOLOGISCHE SPURE; Meyer C, 2013, MYSTERIOSE STEINZEIT, P290; Meyer C., 2004, JAHRESSCHRIFT MITTEL, V88, P31; Meyer C, 2015, P NATL ACAD SCI USA, V112, P11217, DOI 10.1073/pnas.1504365112; MILNER GR, 1989, AM J PHYS ANTHROPOL, V79, P43, DOI 10.1002/ajpa.1330790105; Misterek K., 2012, BERICHTE BAYERISCHEN, V53, P361; Montanari M., 1993, HUNGER UBERFLUSS KUL; Moraitis Konstantinos, 2006, Forensic Sci Med Pathol, V2, P221, DOI 10.1385/FSMP:2:4:221; Morke O., 2015, ARCHAOLOGISCHE SPURE, P359; Murphy K, 2013, CAN ASSOC RADIOL J, V64, P10, DOI 10.1016/j.carj.2012.12.001; Neis P, 1998, UNFALLCHIRURG, V101, P402, DOI 10.1007/s001130050287; Nicklisch N, 2015, ARCHAOLOGISCHE SPURE, P405; Novak S. A., 2000, BLOOD RED ROSES ARCH, V1461, P90; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Parker G., 1997, 30 YEARS WAR; PETERS J., 2012, P HAGENDORF TAGEBUCH; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; Piek J., 2008, TRAUMATOLOGISCHE PAT, P9; Plomp KA, 2012, AM J PHYS ANTHROPOL, V149, P572, DOI 10.1002/ajpa.22168; Plum M., 2012, BERICHTE BAYERISCHEN, V53, P393; Pokines JT., 2014, MANUAL FORENSIC TAPH, P73; Pollard T., 2015, CURR WORLD ARCHAEOL, V74, P28; Posthuma de Boer J, 2016, J EMERG MED; Quatrehomme G, 1998, FORENSIC SCI INT, V93, P45, DOI 10.1016/S0379-0738(98)00030-9; Reichel M., 2009, SCHLACHTFELDARCHAOLO, P127; Reichel M, 2015, ARCHAOLOGISCHE SPURE, P453; Roberts Charlotte, 2005, ARCHAEOLOGY DIS; Rodriguez-Martin C, 2006, FORENSIC ANTHROPOLOGY AND MEDICINE: COMPLEMENTARY SCIENCES FROM RECOVERY TO CAUSE OF DEATH, P197, DOI 10.1007/978-1-59745-099-7_8; Ruster D., 1991, ALTE CHIRURGIE LEGEN; Ryff WH, GROSS CHIRURGEI ODER; Sauer N.J., 1998, FORENSIC OSTEOLOGY A, VSecond, P321; Schats R, 2014, ROUTLEDGE HDB BIOARC, P455; Schlachtfeldarchaologie Meller H., 2009, LANDESAMT DENKMALPFL, V2, P9; Schulting R., 2012, STICKS STONES BROKEN; Schurger A., 2015, ARCHAOLOGISCHE SPURE, P377; Schurger A., 2009, SCHLACHTFELDARCHAOLO, V2, P135; Schurger A., 2011, LEBEN STERBEN SCHLAC, P103; SCHUTKOWSKI H, 1993, AM J PHYS ANTHROPOL, V90, P199, DOI 10.1002/ajpa.1330900206; Scott D., 1989, ARCHAEOLOGICAL PERSP; Shkrum M.J., 2007, FORENSIC PATHOLOGY T; Stahl A., 2015, ARCHAOLOGISCHE SPURE, P387; Sutherland T, 2005, BATTLEFIELD ARCHAEOL; Symes S.A., 2002, ADV FORENSIC TAPHONO, P403, DOI [10.1201/9781420058352-26, DOI 10.1201/9781420058352-26]; Symes SA, 2012, BLACKW COMPANION ANT, P340; Trautmann I, 2015, ARCHAOLOGISCHE SPURE, P438; Ubelaker D.H., 1989, HUMAN SKELETAL REMAI, V3rd; van Swieten G., 1759, KURZE BESCHREIBUNG H; Varetto L, 2005, FORENSIC SCI INT, V147, P31, DOI 10.1016/j.forsciint.2004.03.033; Villstrand N., 2011, LEBEN STERBEN SCHLAC, P121; Vom Meller H., 2011, LEBEN STERBEN SCHLAC, P92; von See C, 2009, FORENSIC SCI INT, V190, P38, DOI 10.1016/j.forsciint.2009.05.009; Walker PL, 2001, ANNU REV ANTHROPOL, V30, P573, DOI 10.1146/annurev.anthro.30.1.573; Weber J, 2001, AM J PHYS ANTHROPOL, V114, P352, DOI 10.1002/ajpa.1047; Wedel V.L., 2014, BROKEN BONES ANTHR A, V2nd ed.; Welck MJ, 2015, INJURY; Weston DA, 2008, AM J PHYS ANTHROPOL, V137, P48, DOI 10.1002/ajpa.20839; White T.D., 2000, HUMAN OSTEOLOGY	140	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178252	10.1371/journal.pone.0178252	http://dx.doi.org/10.1371/journal.pone.0178252			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542491	gold, Green Submitted, Green Published			2022-12-27	WOS:000402058400073
J	Kitterer, D; Biegger, D; Segerer, S; Braun, N; Alscher, MD; Latus, J				Kitterer, Daniel; Biegger, Dagmar; Segerer, Stephan; Braun, Niko; Alscher, M. Dominik; Latus, Joerg			Alteration of membrane complement regulators is associated with transporter status in patients on peritoneal dialysis	PLOS ONE			English	Article							SOLUTE TRANSPORT; MESOTHELIAL CELLS; ULTRAFILTRATION FAILURE; INTERLEUKIN-6 SYSTEM; WATER PERMEABILITY; ENDOTHELIAL-CELLS; GENE-EXPRESSION; NUCLEAR-FACTOR; CAPD PATIENTS; ACTIVATION	Introduction A growing body of evidence from animal models and cell culture studies indicate an important role of a local regulatory complement system (CS) in peritoneal injury during peritoneal dialysis (PD). We investigated the expression of the local regulatory CS (reflected by CD46, CD55, CD59) in the peritoneal tissue of patients with different membrane function characteristics. Patients and methods Biopsies from the parietal peritoneum were taken from 24 patients on PD, 22 uremic patients prior to PD. PD patients were grouped according to the dialysate-to-plasma ratio of creatinine (D/P Cre) and ratio of dialysate glucose at 4 hours versus dialysate glucose at time zero (D/D0 glucose) into low or low-average peritoneal transport status (L/LA) and high-average or high-transport status (HA/H) groups. CD46, CD55, and CD59 RNA expression were analyzed by real-time polymerase chain reaction (RT-PCR). Further localization of membrane complement regulators (CRegs) and semiquantitatively analysis was done by immunohistochemistry (IHC). Results CD46 and CD59 expression were similar in all groups. CD55 expression was significantly decreased in the HA/H group compared to the L/LA group and to uremic controls (p < 0.05 and p = 0.05, respectively). No statistically significant differences in CD46, CD55, and CD55 expression were detected when considering the history of peritonitis. There was no statistically significant correlation between PD duration and the expressions of CD46, CD55, and CD59. IHC revealed strong CD46, CD55, and CD59 expression in mesothelial cells. CD55 and CD59 were additionally detected in the vasculature. Using IHC, CD46 was lower in PD patients compared to uremic controls (p> 0.05), but there was no difference between the L/LA compared to the H/HA group. Moreover IHC confirmed decreased expression of CD55 in the HA/H group compared to the L/LA group and uremic controls (p<0.0001 and p = 0.0001, respectively). Conclusion CD55 expression is decreased in patients with fast transporter membrane function, whereas peritonitis and PD duration do not appear to alter CReg expression.	[Kitterer, Daniel; Alscher, M. Dominik; Latus, Joerg] Robert Bosch Krankenhaus, Div Nephrol, Dept Internal Med, Stuttgart, Germany; [Biegger, Dagmar] Univ Tubingen, Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Segerer, Stephan] Kantonsspital Aarau, Div Nephrol Dialysis & Transplantat, Aarau, Switzerland; [Braun, Niko] Nephrol Ctr Stuttgart, Stuttgart, Germany	Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Kantonsspital Aarau AG (KSA)	Kitterer, D (corresponding author), Robert Bosch Krankenhaus, Div Nephrol, Dept Internal Med, Stuttgart, Germany.	Daniel.kitterer@gmail.com			Else Kroner-Fresenius Stiftung; Fundacao Pesquisa e Desenvolvimento Humanitario; Robert Bosch Foundation	Else Kroner-Fresenius Stiftung; Fundacao Pesquisa e Desenvolvimento Humanitario; Robert Bosch Foundation	This work was supported by Else Kroner-Fresenius Stiftung, Fundacao Pesquisa e Desenvolvimento Humanitario, Robert Bosch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbano G, 1999, ADV PERIT D, V15, P253; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Braun N, 2011, NEPHROL DIAL TRANSPL, V26, P1033, DOI 10.1093/ndt/gfq488; Brimble KS, 2006, J AM SOC NEPHROL, V17, P2591, DOI 10.1681/ASN.2006030194; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Combet S, 2000, J AM SOC NEPHROL, V11, P717, DOI 10.1681/ASN.V114717; Cueto-Manzano AM, 2009, PERITON DIALYSIS INT, V29, pS90; Davies SJ, 1998, KIDNEY INT, V54, P2207, DOI 10.1046/j.1523-1755.1998.00180.x; Davies SJ, 1996, NEPHROL DIAL TRANSPL, V11, P498; Devuyst O, 2013, KIDNEY INT; Diaz-Buxo JA, 1999, ADV PERIT D, V15, P96; DIMITRIADIS A, 1990, ADV PERIT D, V6, P155; Flessner MF, 2007, J AM SOC NEPHROL, V18, P2294, DOI 10.1681/ASN.2006121417; Hasler U, 2011, CELL CYCLE, V10, P364, DOI 10.4161/cc.10.3.14520; HEIMBURGER O, 1990, KIDNEY INT, V38, P495, DOI 10.1038/ki.1990.231; Higuchi C, 2006, THER APHER DIAL, V10, P372, DOI 10.1111/j.1744-9987.2006.00391.x; Honda K, 1996, NEPHRON, V72, P171, DOI 10.1159/000188837; Honda K, 2008, CLIN J AM SOC NEPHRO, V3, P720, DOI 10.2215/CJN.03630807; Johnson DW, 2004, PERITON DIALYSIS INT, V24, P460; Kinashi H, 2013, J AM SOC NEPHROL, V24, P1627, DOI 10.1681/ASN.2012030226; Kitterer D, 2015, AM J PHYSIOL-RENAL, V308, pF1247, DOI 10.1152/ajprenal.00617.2014; Krediet RT, 2013, NAT REV NEPHROL, V9, P419, DOI 10.1038/nrneph.2013.99; Kuper C, 2012, CRIT CARE MED, V40, P1887, DOI 10.1097/CCM.0b013e31824e1186; Lambie M, 2013, J AM SOC NEPHROL, V24, P2071, DOI 10.1681/ASN.2013030314; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Mizuno M, 2012, AM J PHYSIOL-RENAL, V302, pF1245, DOI 10.1152/ajprenal.00652.2011; Mizuno M, 2009, J IMMUNOL, V183, P1403, DOI 10.4049/jimmunol.0804245; Mizuno T, 2013, AM J PHYSIOL-RENAL, V305, pF1603, DOI 10.1152/ajprenal.00681.2012; Mizuno T, 2011, NEPHROL DIAL TRANSPL, V26, P1821, DOI 10.1093/ndt/gfq683; Morelle J, 2016, PERITON DIALYSIS INT, V36, P227, DOI 10.3747/pdi.2015.00188; Neusser MA, 2010, KIDNEY INT, V77, P801, DOI 10.1038/ki.2010.6; Ni J, 2006, KIDNEY INT, V69, P1518, DOI 10.1038/sj.ki.5000285; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Numata M, 2003, PERITON DIALYSIS INT, V23, P116; Oh KH, 2010, NEPHROL DIAL TRANSPL, V25, P1639, DOI 10.1093/ndt/gfp670; Okada M, 1998, ARTERIOSCL THROM VAS, V18, P894, DOI 10.1161/01.ATV.18.6.894; Parikova A, 2006, KIDNEY INT, V70, P1988, DOI 10.1038/sj.ki.5001861; Pecoits R, 2006, PERITON DIALYSIS INT, V26, P53; REDDINGIUS RE, 1995, PERITON DIALYSIS INT, V15, P49; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rumpsfeld M, 2006, J AM SOC NEPHROL, V17, P271, DOI 10.1681/ASN.2005050566; Sei Y, 2015, MOL IMMUNOL, V65, P302, DOI 10.1016/j.molimm.2015.02.005; STRUIJK DG, 1994, KIDNEY INT, V45, P1739, DOI 10.1038/ki.1994.226; Tang S, 2004, CLIN EXP IMMUNOL, V136, P85, DOI 10.1111/j.1365-2249.2004.02407.x; TWARDOWSKI ZJ, 1987, PERITON DIALYSIS INT, V7, P138; VERGER C, 1983, KIDNEY INT, V23, P823, DOI 10.1038/ki.1983.101; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang BX, 1999, AM J PHYSIOL-CELL PH, V276, pC76, DOI 10.1152/ajpcell.1999.276.1.C76; Yool AJ, 2013, J AM SOC NEPHROL, V24, P1045, DOI 10.1681/ASN.2012080869; YOUNG GA, 1993, NEPHROL DIAL TRANSPL, V8, P1372; Yu ZZ, 2014, CLIN J AM SOC NEPHRO, V9, P326, DOI 10.2215/CJN.04420413; Zhai YH, 2012, PEDIATR NEPHROL, V27, P1165, DOI 10.1007/s00467-012-2120-1; Zhang W, 2016, MATH PROBL ENG, V2016, P1, DOI DOI 10.7554/ELIFE.11324	55	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177487	10.1371/journal.pone.0177487	http://dx.doi.org/10.1371/journal.pone.0177487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542228	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600011
J	Tondolo, JSM; Loreto, ES; Ledur, PC; Jesus, FPK; Silva, TM; Kommers, GD; Alves, SH; Santurio, JM				Tondolo, Juliana S. M.; Loreto, Erico S.; Ledur, Pauline C.; Jesus, Francielli P. K.; Silva, Taiara M.; Kommers, Glaucia D.; Alves, Sydney H.; Santurio, Janio M.			Chemically induced disseminated pythiosis in BALB/c mice: A new experimental model for Pythium insidiosum infection	PLOS ONE			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; IN-VITRO; IMMUNITY; IMMUNOTHERAPY; CELLS	Pythiosis is a severe and life-threatening disease that affects humans and various animal species. We report a model of vascular/disseminated pythiosis occurring after subcutaneous inoculation of 2 x 10(4) Pythium insidiosum zoospores/mL in immunocompromised BALB/c mice. For this model, we carried out two rounds of experiments. First, we evaluated two protocols of immunosuppression before inoculation: cyclophosphamide at 150 mg/kg (CYP group) and cyclophosphamide 200 mg/kg plus hydrocortisone acetate at 250 mg/kg (CYP+HCA group). It was not possible to obtain mortality in the CYP group; however, the combination of CYP+HCA altered disease outcomes, with mortality rates reaching 60%. Second, we used the CYP+HCA immunosuppression protocol to analyze the histological and immunological statuses triggered by disease. When we inoculated immunocompetent mice with P. insidiosum zoospores, self-healing occurred via increased levels of IL-2, IFN-gamma and IL-17A, which are characteristic of the Th1/Th17 cytokine response. For infected and immunosuppressed mice, the cytokine profiles showed high levels of IL-10, IL-6 and TNF-alpha. Increased IL-10 values are related to fungal infection susceptibility and led us to speculate that infection may be established through suppression of the host immune response. In addition, histopathological evaluation of the kidneys and liver demonstrated the presence of hyphae and the cellular findings suggested an acute vascular inflammation that mimics vascular/disseminated pythiosis in humans. This is the first murine model for pythiosis that is useful both for understanding the pathogenesis of this disease and for evaluating new treatment approaches.	[Tondolo, Juliana S. M.; Loreto, Erico S.; Ledur, Pauline C.; Santurio, Janio M.] Univ Fed Santa Maria, Dept Microbiol & Parasitol, Programa Posgrad Farmacol, Ctr Ciencias Saude, Santa Maria, RS, Brazil; [Loreto, Erico S.; Alves, Sydney H.] Univ Fed Santa Maria, Dept Microbiol & Parasitol, Programa Posgrad Ciencias Farmaceut, Ctr Ciencias Saude, Santa Maria, RS, Brazil; [Jesus, Francielli P. K.] Univ Fed Rio Grande do Sul, Inst Quim, Lab Proc Tecnol & Catalise, Programa Posgrad Quim Organ, Porto Alegre, RS, Brazil; [Silva, Taiara M.] Univ Fed Santa Maria, Dept Patol, Ctr Ciencias Rurais, Programa Posgrad Med Vet, Santa Maria, RS, Brazil; [Kommers, Glaucia D.] Univ Fed Santa Maria, Dept Patol, Ctr Ciencias Saude, Lab Patol Vet, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade Federal do Rio Grande do Sul; Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM)	Santurio, JM (corresponding author), Univ Fed Santa Maria, Dept Microbiol & Parasitol, Programa Posgrad Farmacol, Ctr Ciencias Saude, Santa Maria, RS, Brazil.	janio.santurio@gmail.com	de Loreto, Érico Silva/E-1605-2013; Tondolo, Juliana/AAA-4385-2021	de Loreto, Érico Silva/0000-0003-0408-5294; Tondolo, Juliana/0000-0001-5036-3270; Christ Ledur, Pauline/0000-0002-0781-7721; Santurio, Janio/0000-0001-6286-9076	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	E. S. L. is a PhD fellow of Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil (PNPD-CAPES), and J. M. S. is a Scholarship Research Productivity of CNPq.	Azevedo MI, 2012, VET MICROBIOL, V159, P141, DOI 10.1016/j.vetmic.2012.03.030; Balloy V, 2005, INFECT IMMUN, V73, P494, DOI 10.1128/IAI.73.1.494-503.2005; Belmonte R, 2014, INFECT IMMUN, V82, P4518, DOI 10.1128/IAI.02196-14; Botton SA, 2011, CURR MICROBIOL, V62, P1225, DOI 10.1007/s00284-010-9781-4; Capilla J, 2007, MED MYCOL, V45, P657, DOI 10.1080/13693780701644140; Cenci E, 2000, J IMMUNOL, V165, P381, DOI 10.4049/jimmunol.165.1.381; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; DIXON DM, 1989, INFECT IMMUN, V57, P1452, DOI 10.1128/IAI.57.5.1452-1456.1989; dos Santos CEP, 2014, J EQUINE VET SCI, V34, P270, DOI 10.1016/j.jevs.2013.06.003; Dycus DL, 2015, J AM ANIM HOSP ASSOC, V51, P385, DOI 10.5326/JAAHA-MS-6217; Gaastra W, 2010, VET MICROBIOL, V146, P1, DOI 10.1016/j.vetmic.2010.07.019; Gabriel AL, 2008, PESQUI VET BRASIL, V28, P583, DOI 10.1590/S0100-736X2008001200003; Hahtapornsawan S, 2014, ANN VASC SURG, V28, DOI 10.1016/j.avsg.2014.04.020; Huang HB, 2010, MBIO, V1, DOI 10.1128/mBio.00164-10; Huyan XH, 2011, INT IMMUNOPHARMACOL, V11, P1293, DOI 10.1016/j.intimp.2011.04.011; Jesus FPK, 2016, ANTIMICROB AGENTS CH, V60, P87, DOI 10.1128/AAC.01480-15; Kirkpatrick WR, 2013, CURR FUNGAL INFECT R, V7, P68, DOI 10.1007/s12281-012-0126-6; Krajaejun T, 2008, J INFECT DIS ANTIMIC, V25, P45; Krajaejun T, 2006, CLIN INFECT DIS, V43, P569, DOI 10.1086/506353; Lass-Florl C, 2013, MYCOSES, V56, P403, DOI 10.1111/myc.12052; Lerksuthirat T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02352-16, 10.1128/aac.02352-16]; Lewis RE, 2009, MED MYCOL, V47, pS271, DOI 10.1080/13693780802227159; Li Xiao-hong, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1; Loreto ES, 2014, ANTIMICROB AGENTS CH, V58, P7534, DOI 10.1128/AAC.02680-13; Mendoza L, 2004, MYCOSES, V47, P14, DOI 10.1046/j.1439-0507.2003.00950.x; MENDOZA L, 1988, MYCOPATHOLOGIA, V104, P59, DOI 10.1007/BF00437925; MENDOZA L, 1993, J CLIN MICROBIOL, V31, P2967, DOI 10.1128/JCM.31.11.2967-2973.1993; Mendoza L, 2013, CURR FUNGAL INFECT R, V7, P198, DOI 10.1007/s12281-013-0144-z; Permpalung N, 2015, J ANTIMICROB CHEMOTH, V70, P1885, DOI 10.1093/jac/dkv008; Ramappa Muralidhar, 2017, Cornea, V36, P511, DOI 10.1097/ICO.0000000000001162; Romani L, 2006, TRENDS MICROBIOL, V14, P183, DOI 10.1016/j.tim.2006.02.003; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Santurio JM, 2003, VACCINE, V21, P2535, DOI 10.1016/S0264-410X(03)00035-5; Sheppard DC, 2004, ANTIMICROB AGENTS CH, V48, P1908, DOI 10.1128/AAC.48.5.1908-1911.2004; Tondolo JSM, 2017, CARBOHYD POLYM, V157, P719, DOI 10.1016/j.carbpol.2016.10.053; Wanachiwanawin W, 2004, VACCINE, V22, P3613, DOI 10.1016/j.vaccine.2004.03.031; Wuthrich M, 2011, J CLIN INVEST, V121, P554, DOI 10.1172/JCI43984; Zanette RA, 2013, MICROBIOL IMMUNOL, V57, P732, DOI 10.1111/1348-0421.12082	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177868	10.1371/journal.pone.0177868	http://dx.doi.org/10.1371/journal.pone.0177868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542438	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672600026
J	Takagi, K				Takagi, Kosuke			A distribution model of functional connectome based on criticality and energy constraints	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; SMALL-WORLD; NEURONAL AVALANCHES; EVOLVING NETWORKS; CONNECTIVITY; DYNAMICS; ARCHITECTURE; FREQUENCY	The analysis of the network structure of the functional connectivity data constructed from fMRI images provides basic information about functions and features of the brain activity. We focus on the two features which are considered as relevant to the brain activity, the criticality and the constraint regarding energy consumptions. Within a wide variety of complex systems, the critical state occurs associated with a phase transition between distinct phases, random one and order one. Although the hypothesis that human brain activity is also in a state of criticality is supported by some experimental results, it still remains controversial. One issue is that experimental distributions exhibit deviations from the power law predicted by the criticality. Based on the assumption that constraints on brain from the biological costs cause these deviations, we derive a distribution model. The evaluation using the information criteria indicates an advantage of this model in fitting to experimental data compared to other representative distribution models, the truncated power law and the power law. Our findings also suggest that the mechanism underlying this model is closely related to the cost effective behavior in human brain with maximizing the network efficiency for the given network cost.	[Takagi, Kosuke] Uwado Shinmachi 5-4, Kawagoe, Saitama, Japan		Takagi, K (corresponding author), Uwado Shinmachi 5-4, Kawagoe, Saitama, Japan.	coutakagi@mse.biglobe.ne.jp						Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brown J, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00028; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Expert P, 2011, J R SOC INTERFACE, V8, P472, DOI 10.1098/rsif.2010.0416; Freyer F, 2009, J NEUROSCI, V29, P8512, DOI 10.1523/JNEUROSCI.0754-09.2009; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Haimovici A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178101; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; NOEVER DA, 1993, PHYS REV E, V47, P724, DOI 10.1103/PhysRevE.47.724; Ricotta C, 2001, ECOL MODEL, V141, P307, DOI 10.1016/S0304-3800(01)00272-1; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns Olaf, 2002, Complexity, V8, P56, DOI 10.1002/cplx.10047; Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Takagi K, 2010, PHYSICA A, V389, P2143, DOI 10.1016/j.physa.2010.01.034; Touboul J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008982; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Xulvi-Brunet R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026118; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	58	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177446	10.1371/journal.pone.0177446	http://dx.doi.org/10.1371/journal.pone.0177446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545048	Green Submitted, Green Published, gold			2022-12-27	WOS:000401487700049
J	Coutinho, CC; Rosa, ID; Teixeira, JDO; Andrade, LR; Costa, ML; Mermelstein, C				Coutinho, Cristiano C.; Rosa, Ivone de Andrade; de Oliveira Teixeira, John Douglas; Andrade, Leonardo R.; Costa, Manoel Luis; Mermelstein, Claudia			Cellular migration, transition and interaction during regeneration of the sponge Hymeniacidon heliophila	PLOS ONE			English	Article							CHONDROSIA-RENIFORMIS NARDO; MARINE SPONGES; MORPHOLOGICAL STRATEGIES; MULTICELLULARITY; DEMOSPONGIAE; PRIMMORPHS; EVOLUTION; RECOVERY; COLLAGEN; GROWTH	Sponges have a high capacity for regeneration and this process improves biomass production in some species, thus contributing to a solution for the biomass supply problem for biotechnological applications. The aim of this work is to characterize the dynamics of cell behavior during the initial stages of sponge regeneration, using bright-field microscopy, confocal microscopy and SEM. We focused on the first 20 h of regeneration, during which blastema formation and epithelium initialization occur. An innovative sponge organotypic culture of the regenerating internal region is described and investigated by confocal microscopy, cell transplantation and vital staining. Cell-cell interaction and cell density are shown to affect events in morphogenesis such as epithelial/mesenchymal and mesenchymal/epithelial transitions as well as distinct cell movements required for regeneration. Extracellular matrix was organized according to the morphogenetic process observed, with evidence for cell-signaling instructions and remodeling. These data and the method of organotypic culture described here provide support for the development of viable sponge biomass production.	[Coutinho, Cristiano C.; Rosa, Ivone de Andrade; de Oliveira Teixeira, John Douglas; Andrade, Leonardo R.; Costa, Manoel Luis; Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Biomed Sci, UFRJ, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Mermelstein, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, UFRJ, Rio De Janeiro, RJ, Brazil.	mermelstein@histo.ufrj.br	Coutinho, Cristiano/V-4693-2018; Costa, Manoel/B-5009-2010; mermelstein, Claudia S/C-1464-2010	Coutinho, Cristiano/0000-0002-7768-1292; Costa, Manoel/0000-0002-9037-0085; mermelstein, Claudia S/0000-0002-8897-8526	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [300787/2013-8]; Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/203.185/2015]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Brazilian grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-grant number 300787/2013-8 for CM and Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) grant number E-26/203.185/2015 for CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BE, 2015, PEERJ, V3, DOI 10.7717/peerj.820; AYLING AL, 1983, BIOL BULL, V165, P343, DOI 10.2307/1541200; Borisenko IE, 2015, PEERJ, V3, DOI 10.7717/peerj.1211; Boury-Esnault N., 1997, THESAURUS SPONGE MOR; Brooke NM, 2003, CURR OPIN GENET DEV, V13, P599, DOI 10.1016/j.gde.2003.09.002; Chernogor LI, 2011, MAR BIOTECHNOL, V13, P782, DOI 10.1007/s10126-010-9340-9; Custodio MR, 1998, MECH AGEING DEV, V105, P45, DOI 10.1016/S0047-6374(98)00078-5; Degnan BM, 2005, INTEGR COMP BIOL, V45, P335, DOI 10.1093/icb/45.2.335; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Eerkes-Medrano D, 2015, INVERTEBR BIOL, V134, P1, DOI 10.1111/ivb.12072; Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P141, DOI 10.1016/j.ijbiomac.2010.05.009; Granito RN, 2016, J BIOMED MATER RES B, V10, P1; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; Hoffmann F, 2003, J BIOTECHNOL, V100, P109, DOI 10.1016/S0168-1656(02)00258-4; Hooper JNA, 2002, SYSTEMA PORIFERA GUI, P721; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; Kornberg TB, 2014, WIRES DEV BIOL, V3, P445, DOI 10.1002/wdev.151; Lavrov AI, 2014, RUSS J DEV BIOL+, V45, P205, DOI 10.1134/S1062360414040067; Maldonado M, 2004, INVERTEBR BIOL, V123, P1; Muller WEG, 2009, APPL MICROBIOL BIOT, V83, P397, DOI 10.1007/s00253-009-2014-8; Nakanishi N, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-26; Needham A. E., 1952, REGENERATION WOUND H; Nickel M, 2003, J BIOTECHNOL, V100, P147, DOI 10.1016/S0168-1656(02)00256-0; Oren U, 2001, ECOLOGY, V82, P802, DOI 10.2307/2680199; Osinga R, 1999, MAR BIOTECHNOL, V1, P509, DOI 10.1007/PL00011807; Pozzolini M, 2012, MAR BIOTECHNOL, V14, P281, DOI 10.1007/s10126-011-9415-2; Ruiz C, 2013, MAR BIOTECHNOL, V15, P571, DOI 10.1007/s10126-013-9510-7; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Simpson T., 1984, CELL BIOL SPONGES; Sipkema D, 2005, BIOTECHNOL BIOENG, V90, P201, DOI 10.1002/bit.20404; Sipkema D, 2003, J BIOTECHNOL, V100, P127, DOI 10.1016/S0168-1656(02)00253-5; Sogabe S, 2016, EVODEVO, V7, DOI 10.1186/s13227-016-0042-x; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Wulff JL, 2006, FUNCT ECOL, V20, P699, DOI 10.1111/j.1365-2435.2006.01143.x; Wulff J, 2013, INTEGR COMP BIOL, V53, P512, DOI 10.1093/icb/ict059; Wulff J, 2010, INTEGR COMP BIOL, V50, P494, DOI 10.1093/icb/icq100; Yin Z, 2015, PNAS, V9, pE1453	37	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178350	10.1371/journal.pone.0178350	http://dx.doi.org/10.1371/journal.pone.0178350			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542651	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800080
J	Elsner, J; Hofreiter, M; Schibler, J; Schlumbaum, A				Elsner, Julia; Hofreiter, Michael; Schibler, Joerg; Schlumbaum, Angela			Ancient mtDNA diversity reveals specific population development of wild horses in Switzerland after the Last Glacial Maximum	PLOS ONE			English	Article							EVOLUTION; RESPONSES; FLUCTUATIONS; EXTINCTIONS; GENETICS; SEQUENCE; CYCLE; ALPS	On large geographical scales, changes in animal population distribution and abundance are driven by environmental change due to climatic and anthropogenic processes. However, so far, little is known about population dynamics on a regional scale. We have investigated 92 archaeological horse remains from nine sites mainly adjacent to the Swiss Jura Mountains dating from c. 41,000-5,000 years BP. The time frame includes major environmental turning points such as the Last Glacial Maximum (LGM), followed by steppe vegetation, afforestation and initial re-opening of the landscape by human agricultural activities. To investigate matrilinear population dynamics, we assembled 240 base pairs of the mitochondrial d-loop. F-ST values indicate large genetic differentiation of the horse populations that were present during and directly after the LGM. After the retreat of the ice, a highly diverse population expanded as demonstrated by significantly negative results for Tajima's D, Fu's FS and mismatch analyses. At the same time, a different development took place in Asia where populations declined after the LGM. This first comprehensive investigation of wild horse remains on a regional scale reveals a discontinuous colonisation of succeeding populations, a pattern that diverges from the larger Eurasian trend.	[Elsner, Julia; Schibler, Joerg; Schlumbaum, Angela] Univ Basel, Integrat Prehist & Archaeol Sci, Basel, Switzerland; [Hofreiter, Michael] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	University of Basel; University of Potsdam	Elsner, J (corresponding author), Univ Basel, Integrat Prehist & Archaeol Sci, Basel, Switzerland.	Julia.Elsner@email.de	Hofreiter, Michael/A-3996-2017		Swiss National Science Foundation [K-31K1_120528/1]; Freiwillige Akademische Gesellschaft Basel; Bertha Burckhardt-Burgin-Foundation; Nikolaus	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Freiwillige Akademische Gesellschaft Basel(General Electric); Bertha Burckhardt-Burgin-Foundation; Nikolaus	Julia Elsner was funded by Swiss National Science Foundation (K-31K1_120528/1), Freiwillige Akademische Gesellschaft Basel, and Nikolaus and Bertha Burckhardt-Burgin-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Samples were kindly provided by Kantonsarchaologie Aargau (Mumpf), Archaologische Bodenforschung Basel-Stadt (Riehen-Ausserberg), Naturhistorisches Museum Basel (AllschwilZiegelei, Birseck-Ermitage, Miinchenstein-Steinbruch, Schalberghohle), Archaologie and Kantonsmuseum Basel-Landschaft (Brugglihohle, Kohlerhohle), Archaologischer Dienst Bern (Abri Neumiihle, Twann-Bahnhof), Universite de Neuchatel (Hauterive-Champreveyres, Monruz), Kontansarchaologie Schaffhausen (Kesslerloch, Schweizersbild), Kantonsarchaologie Solothurn (Kasloch, Rislisberg) and by J. Sedlmeier. The authors thank L. Orlando and M. Muschick for help with statistical analysis. This study was funded by Swiss National Science Foundation (K -31K1_120528/1), Freiwillige Akademische Gesellschaft Basel, and Nikolaus and Bertha Burckhardt-Biirgin-Foundation.	Ammann B, 2013, PALAEOGEOGR PALAEOCL, V391, P40, DOI 10.1016/j.palaeo.2012.07.010; Ammann B, 2013, PALAEOGEOGR PALAEOCL, V391, P3, DOI 10.1016/j.palaeo.2013.11.006; Andersen KK, 2006, QUATERNARY SCI REV, V25, P3246, DOI 10.1016/j.quascirev.2006.08.002; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Buoncristiani JF, 2004, DEV QUA SCI, V2, P101; CalPal-2007, 2012, ONLINE; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Crees JJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2152; Cupillard C, 2014, QUATERN INT; Elsner J, 2016, J ARCHAEOL SCI-REP, V6, P386, DOI 10.1016/j.jasrep.2016.03.007; Elsner J, 2015, ARCHAEOL ANTHROP SCI, V7, P505, DOI 10.1007/s12520-014-0213-4; Erny-Rodmann C., 1997, JB SCHWEIZERISCHEN G, V80, P27; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; FU YX, 1994, GENETICS, V138, P1375; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heiri O, 2014, QUATERNARY SCI REV, V106, P186, DOI 10.1016/j.quascirev.2014.05.021; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Hughes PD, 2013, EARTH-SCI REV, V125, P171, DOI 10.1016/j.earscirev.2013.07.003; Ivy-Ochs S, 2004, ECLOGAE GEOL HELV, V97, P47, DOI 10.1007/s00015-004-1110-0; Ivy-Ochs S, 2008, J QUATERNARY SCI, V23, P559, DOI 10.1002/jqs.1202; Ivy-Ochs S, 2006, GEOL SOC AM SPEC PAP, V415, P43, DOI 10.1130/2006.2415(04); Jager H, 2015, CATENA, V128, P63, DOI 10.1016/j.catena.2015.01.018; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Leesch D., 1993, SCHWEIZ PALAOLITHIKU, P153; Leesch D, 2012, QUATERN INT, V272, P191, DOI 10.1016/j.quaint.2012.04.010; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Luis C, 2006, J ANIM BREED GENET, V123, P399, DOI 10.1111/j.1439-0388.2006.00612.x; McCain CM, 2014, GLOBAL CHANGE BIOL; McGahern A, 2006, ANIM GENET, V37, P494, DOI 10.1111/j.1365-2052.2006.01495.x; Nielsen E, 2009, PALAOLITHIKUM MESOLI; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Preusser F., 2011, QUATERNARY SCI J, V60, P282, DOI [10.3285/eg.60.2-3.06, DOI 10.3285/EG.60.2-3.06]; R Development Core Team RDCT, 2014, R LANG ENV STAT COMP; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Schibler J, 1995, SPM 2 NEOLITHIKUM, P76; Schibler J, 2006, ENVIRON ARCHAEOL, V11, P49, DOI 10.1179/174963106x97052; Shapiro B, 2012, METHODS MOL BIOL, V840, P1, DOI 10.1007/978-1-61779-516-9; Stuart AJ, 2015, GEOL J, V50, P338, DOI 10.1002/gj.2633; Studer J, 1998, SCHWEIZ PALAOLITHIKU, P171; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Tajima F., 1983, GENETICS, V105; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Vinther BM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006921; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013; XU XF, 1994, GENE, V148, P357, DOI 10.1016/0378-1119(94)90713-7; Yang Y, 2016, ANIMAL SCI J	55	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177458	10.1371/journal.pone.0177458	http://dx.doi.org/10.1371/journal.pone.0177458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542345	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500025
J	Gonzalez-Andrade, B; Santos-Lartigue, R; Flores-Trevino, S; Ramirez-Ochoa, NS; Bocanegra-Ibarias, P; Huerta-Torres, FJ; Mendoza-Olazaran, S; Villarreal-Trevino, L; Camacho-Ortiz, A; Villarreal-Vazquez, H; Garza-Gonzalez, E				Gonzalez-Andrade, Baltazar; Santos-Lartigue, Ramiro; Flores-Trevino, Samantha; Sonia Ramirez-Ochoa, Natalie; Bocanegra-Ibarias, Paola; Huerta-Torres, Francisco J.; Mendoza-Olazaran, Soraya; Villarreal-Trevino, Licet; Camacho-Ortiz, Adrian; Villarreal-Vazquez, Hipolito; Garza-Gonzalez, Elvira			The carriage of interleukin-1B-31*C allele plus Staphylococcus aureus and Haemophilus influenzae increases the risk of recurrent tonsillitis in a Mexican population	PLOS ONE			English	Article							BIOFILM FORMATION; TONSILLECTOMY; POLYMORPHISMS; PROMOTER	The aim of the present study was to estimate the relative contribution of immunogenetic and microbiological factors in the development of recurrent tonsillitis in a Mexican population. Patients (n = 138) with recurrent tonsillitis and an indication of tonsillectomy (mean age: 6.05 years +/- 3.00; median age: 5 years, female: 58; age range: 1 - 15 years) and 195 non-related controls older than 18 years and a medical history free of recurrent tonsillitis were included. To evaluate the microbial contribution, tonsil swab samples from both groups and extracted tonsil samples from cases were cultured. Biofilm production of isolated bacteria was measured. To assess the immunogenetic component, DNA from peripheral blood was genotyped for the TNFA-308G/A single-nucleotide polymorphism (SNP) and for the IL1B -31C/T SNP. Normal microbiota, but no pathogens or potential pathogens, were identified from all control sample cultures. The most frequent pathogenic species detected in tonsils from cases were Staphylococcus aureus (48.6%, 67/138) and Haemophilus influenzae (31.9%, 44/138), which were found more frequently in patient samples than in samples from healthy volunteers (P < 0.0001). Importantly, 41/54 (75.9%) S. aureus isolates were biofilm producers (18 weak and 23 strong), whereas 17/25 (68%) H. influenzae isolates were biofilm producers (10 weak, and 7 strong biofilm producers). Patients with at least one copy of the IL1B-31*C allele had a higher risk of recurrent tonsillitis (OR = 4.03; 95% CI = 1.27 - 14.27; P = 0.013). TNFA-308 G/A alleles were not preferentially distributed among the groups. When considering the presence of IL1B-31*C plus S. aureus, IL1B-31*C plus S. aureus biofilm producer, IL1B-31*C plus H. influenzae or IL1B-31*C plus H. influenzae biofilm producer, the OR tended to infinite. Thus, the presence of IL1B-31*C allele plus the presence of S. aureus and/or H. influenzae could be related to the development of tonsillitis in this particular Mexican population.	[Gonzalez-Andrade, Baltazar; Santos-Lartigue, Ramiro] Univ Autonoma Nuevo Leon, Serv Otorrinolaringol, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Flores-Trevino, Samantha; Bocanegra-Ibarias, Paola; Huerta-Torres, Francisco J.; Mendoza-Olazaran, Soraya; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Serv Gastroenterol, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Sonia Ramirez-Ochoa, Natalie] Hosp Materno Infantil Alta Especialidad, Secretaria Salud Nuevo Leon, Monterrey, Nuevo Leon, Mexico; [Villarreal-Trevino, Licet; Villarreal-Vazquez, Hipolito] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Dept Microbiol, Monterrey, Nuevo Leon, Mexico; [Camacho-Ortiz, Adrian] Univ Autonoma Nuevo Leon, Coordinac Epidemiol Hosp, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Garza-Gonzalez, E (corresponding author), Univ Autonoma Nuevo Leon, Serv Gastroenterol, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico.	elvira_garza_gzz@yahoo.com	Flores-Treviño, Samantha M/E-8601-2019; Flores-Treviño, Samantha/AAB-4537-2020	Flores-Treviño, Samantha M/0000-0003-1259-7425; Flores-Treviño, Samantha/0000-0003-1259-7425; Bocanegra-Ibarias, Paola/0000-0003-4602-3817; Mendoza-Olazaran, Soraya/0000-0001-5649-4810				Abdallah AN, 1999, EUR J IMMUNOGENET, V26, P249, DOI 10.1046/j.1365-2370.1999.00128.x; Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Bisno AL, 2004, CLIN INFECT DIS, V38, P1535, DOI 10.1086/392520; Capper R, 2001, CLIN OTOLARYNGOL, V26, P484, DOI 10.1046/j.1365-2273.2001.00508.x; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Furuta T, 2002, GASTROENTEROLOGY, V123, P92, DOI 10.1053/gast.2002.34156; Galli J, 2007, Acta Otorhinolaryngol Ital, V27, P134; Garza-Gonzalez E, 2005, INT J CANCER, V114, P237, DOI 10.1002/ijc.20718; Garza-Gonzalez E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-70; GLEZEN WP, 1967, J AMER MED ASSOC, V202, P455, DOI 10.1001/jama.202.6.455; Liadaki K, 2011, CLIN VACCINE IMMUNOL, V18, P217, DOI 10.1128/CVI.00460-10; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McKerrow WS, 2002, AM FAM PHYSICIAN, V66, P1735; Mizrahi A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-400; Pelucchi C, 2012, CLIN MICROBIOL INFEC, V18, P1, DOI 10.1111/j.1469-0691.2012.03766.x; Prim MP, 2002, INT J PEDIATR OTORHI, V65, P35, DOI 10.1016/S0165-5876(02)00128-3; Puig C, 2014, INFECT IMMUN, V82, P1591, DOI 10.1128/IAI.01445-13; Randel A, 2011, AM FAM PHYSICIAN, V84, P566; Todorovic MM, 2013, BOSNIAN J BASIC MED, V13, P230; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Woo JH, 2012, ACTA OTO-LARYNGOL, V132, P1115, DOI 10.3109/00016489.2012.689859; Zautner AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009452	23	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178115	10.1371/journal.pone.0178115	http://dx.doi.org/10.1371/journal.pone.0178115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542534	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000402061500062
J	Miller, KI; Nadheeh, I; Jauharee, AR; Anderson, RC; Adam, MS				Miller, Kelsey I.; Nadheeh, Ibrahim; Jauharee, A. Riyaz; Anderson, R. Charles; Adam, M. Shiham			Bycatch in the Maldivian pole-and-line tuna fishery	PLOS ONE			English	Article							INDIAN-OCEAN; BY-CATCH; MORTALITY; DISCARDS; IMPACTS; CAUGHT	Tropical tuna fisheries are among the largest worldwide, with some having significant bycatch issues. However, pole-and-line tuna fisheries are widely believed to have low bycatch rates, although these have rarely been quantified. The Maldives has an important pole-and-line fishery, targeting skipjack tuna (Katsuwonus pelamis). In the Maldives, 106 pole-and-line tuna fishing days were observed between August 2014 and November 2015. During 161 fishing events, tuna catches amounted to 147 t: 72% by weight was skipjack, 25% yellowfin tuna (Thunnus albacares) and 3% other tunas. Bycatch (all non-tuna species caught plus all tuna discards) amounted to 951 kg (0.65% of total tuna catch). Most of the bycatch (95%) was utilized, and some bycatch was released alive, so dead discards were particularly low (0.02% of total tuna catch, or 22 kg per 100 t). Rainbow runner (Elagatis bipinnulata) and dolphinfish (Coryphaena hippurus) together constituted 93% of the bycatch. Live releases included small numbers of silky sharks (Carcharhinus falciformis) and seabirds (noddies, Anous tenuirostris and A. stolidus). Pole-and-line tuna fishing was conducted on free schools and schools associated with various objects (Maldivian anchored fish aggregating devices [aFADs], drifting FADs from western Indian Ocean purse seine fisheries, other drifting objects and seamounts). Free school catches typically included a high proportion of large skipjack and significantly less bycatch. Associated schools produced more variable tuna catches and higher bycatch rates. Fishing trips in the south had significantly lower bycatch rates than those in the north. This study is the first to quantify bycatch rates in the Maldives pole-and-line tuna fishery and the influence of school association on catch composition. Ratio estimator methods suggest roughly 552.6 t of bycatch and 27.9 t of discards are caught annually in the fishery (based on 2015 national catch), much less than other Indian Ocean tuna fisheries, e.g. gillnet, purse-seine, and longline.	[Miller, Kelsey I.; Nadheeh, Ibrahim; Anderson, R. Charles; Adam, M. Shiham] Int Pole & Line Fdn, London, England; [Jauharee, A. Riyaz; Adam, M. Shiham] Marine Res Ctr Male, Male, Maldives		Adam, MS (corresponding author), Int Pole & Line Fdn, London, England.; Adam, MS (corresponding author), Marine Res Ctr Male, Male, Maldives.	shiham.adam@ipnlf.org	Fennell, Hannah/AAI-1408-2019	Miller, Kelsey/0000-0002-3561-5836	International Pole & Line Foundation (IPNLF); Marine Research Centre of the Ministry of Fisheries and Agriculture	International Pole & Line Foundation (IPNLF); Marine Research Centre of the Ministry of Fisheries and Agriculture	Funding was from International Pole & Line Foundation (IPNLF) who works in the Maldives with the Ministry of Fisheries and Agriculture. Funding support was the for the authors KIM and IN in supporting their remunerations. The Marine Research Centre of the Ministry of Fisheries and Agriculture supported the logistics work and supported authors' work at the Centre.	Adam MS, 1998, TUNA FISHERY RESOURC, V3; Adam MS, 2006, COUNTRY REV MALDIVES, P383; Adam MS, 2015, IOTC2015SC18NR17; Adam MS, 2013, IOTC2013SC16NR17; Adam MS, 2014, IOTC2014SC17NR17; Adam MS, 2014, IOTC2014WPTT1626; Agnew DJ, 2014, ICES J MAR SCI, V71, P216, DOI 10.1093/icesjms/fst091; Ahusan M, 2016, JAUHAREE MALDIVES NA; Ali K., 2015, NATL PLAN ACTION CON; Amanda MJ, 2012, ICEJ MARINE SCI J; Amande J. M., 2008, IOTC2008WPEB12; Amande MJ, 2010, AQUAT LIVING RESOUR, V23, P353, DOI 10.1051/alr/2011003; Anderson R. C., 1991, IPTP, V6, P50; Anderson R. C., 1996, RASAIN NEWSLETTER, V16, P134; Anderson R.C., 1993, SHARK FISHERIES MALD; Anderson RC, 2009, IOTC2009WPEB08; Anderson RC, 2009, TECHNICAL ASSISTANCE; Anderson RC, 1997, PUBLIC ADM Q, P69; Anderson RC, 1996, P EXP CONS IND OC TU, P333; Anderson RC, 2009, IOTC2009WPEB07; Anderson RC, 1992, N S VARIATIONS DISTR, V10, P226; Anderson RC, 1996, REV MALDIVIAN TUNA F, V9, P30; Anderson RC, 1996, MALDIVES MARINE RES, V2, P41; Anderson RC, 1998, MALDIVES MARINE RES, V3, P1; Ardill D, 2011, REV BYCATCH DISCARD; Ash J. S., 1994, FORKTAIL, V10, P3; Bailey K, 1996, BY CATCH DISCARDS W; Baske A, 2012, ESTIMATING USE DRIFT; Bugoni L, 2008, FISH RES, V90, P217, DOI 10.1016/j.fishres.2007.10.013; Chassot E, 2011, ICES J MAR SCI, V68, P651, DOI 10.1093/icesjms/fsq195; Clucas I., 1997, FAO FISH CIRC; Dayaratne P., 1993, BOBPREP56; EPA, 2010, PROT BIRDS MALD, P3; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ 2; Filmalter JD, 2013, FRONT ECOL ENVIRON, V11, P291, DOI 10.1890/130045; Fonteneau A, 1999, WORLDWIDE REV PURSE; Gillett R, 2011, 560 FAO; Gillett R, 2016, 6 IPNLF; Gillett R., 2013, MALDIVES LIVEBAIT FI; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Hafiz A, 1988, IPTP COLLECTIVE VOLU, V3, P334; Hall MA, 1998, REV FISH BIOL FISHER, V8, P1, DOI 10.1023/A:1008854816580; Hall SJ, 2005, FISH FISH, V6, P134, DOI 10.1111/j.1467-2979.2005.00183.x; Hernandez-Garcia V, 2014, IOTC2014WPTT1618; Huang HW, 2010, FISH RES, V106, P261, DOI 10.1016/j.fishres.2010.08.005; IOTC, 2015, IOTC2015S19RE, P155; IOTC, 2015, IOTC2015WPEBRE; IOTC, 2009, IOTC2009WPEBRE; IOTC, 2015, IOTC2015SC18RE; IOTC, 2013, IOTC2013WPEB09INF17, P1; Ishimura G., 2010, FAO FISH AQUAC TECH; Itano D, 2004, INFFTWG317 TH STAND; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jauharee A.R., 2012, IOTC212WPTT1, P4; Jauharee AR, 2012, IOTC2012WPEB839; Jauharee AR, 2015, MALDIVES POLE AND LI; JOSEPH J, 1994, OCEAN DEV INT LAW, V25, P1, DOI 10.1080/00908329409546023; Kelleher Kieran, 2005, FAO FISHERIES TECHNI; Kirby DS, 2014, MAR POLICY, V44, P419, DOI 10.1016/j.marpol.2013.10.008; Kumar KVA, 2015, J APPL ICHTHYOL, V31, P301, DOI 10.1111/jai.12682; Lawson I, 2001, 14 M STAND COMM TUN, V14, P42; Macfadyen G, 2009, LOST OTHERWISE DISCA; Maldeniya R, 1990, IPTP COLLECTIVE VOLU, V4, P108; MANIKU H, 1990, ACIAR PROC, V30, P22; Maufroy A, 2014, IOTC2014WPTT1621; Maufroy A, 2017, ICES J MAR SCI, V74, P215, DOI 10.1093/icesjms/fsw175; McCreary JP, 2013, PROG OCEANOGR, V112, P15, DOI 10.1016/j.pocean.2013.03.002; Miller KI, 2014, MALDIVES POLE AND LI; Moazzam Muhammad, 2014, Journal of the Marine Biological Association of India, V56, P85, DOI 10.6024/jmbai.2014.56.1.01750s-13; MoFA, 2014, BAS FISH STAT 2014; MoFA, 2012, BAS FISH STAT 2012; MRC, 1997, FISH MALD; NAQVI WA, 1991, OCEANOL ACTA, V14, P281; Nawaz R, 2014, ASSESSMENT CETACEAN, P89; Pauly D, 2016, NATURE COMMUNICATION, P7; Petersen SL, 2009, AFR J MAR SCI, V31, P191, DOI 10.2989/AJMS.2009.31.2.7.879; Poisson F, 2014, CAN J FISH AQUAT SCI, V71, P795, DOI 10.1139/cjfas-2013-0561; Romanov E, 2000, IOTC2000WPTT31; Shafeeg A, 1993, DHIVEHI RAAJEGI KAND; Shafeeg A, 1991, RASAIN, V11, P74; Shainee M, 2011, FISH RES, V109, P42, DOI 10.1016/j.fishres.2011.01.015; Sharma R, 2014, IOTC2014WPTT1642; Stelfox MR, 2015, HIGH MORTALITY OLIVE; Thiebot JB, 2016, AQUAT CONSERV, V26, P674, DOI 10.1002/aqc.2578; United Nations, 1982, UN CONV LAW SEA UN; Varghese SP, 2015, INDIAN J GEO-MAR SCI, V44, P26; Varghese SP, 2013, IOTC2013WPEB0936	87	16	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177391	10.1371/journal.pone.0177391	http://dx.doi.org/10.1371/journal.pone.0177391			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542258	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500021
J	Naik, MU; Naik, TU; Summer, R; Naik, UP				Naik, Meghna U.; Naik, Tejal U.; Summer, Ross; Naik, Ulhas P.			Binding of CIB1 to the alpha(IIb) tail of alpha(IIb)beta(3) is required for FAK recruitment and activation in platelets	PLOS ONE			English	Article							FOCAL ADHESION KINASE; GLYCOPROTEIN IIB/IIIA; CYTOPLASMIC TAIL; CALCIUM-BINDING; INTEGRIN; PROTEIN; SRC; ALPHA-IIB-BETA-3; PHOSPHORYLATION; FAMILY	Background It is believed that activation of c-Src bound to the integrin beta(3) subunit initiates outside-in signaling. The involvement of alpha(IIb)beta(3) in outside-in signaling is poorly understood. Objectives We have previously shown that CIB1 specifically interacts with the cytoplasmic domain of alpha(IIb) and is required for alpha(IIb)beta(3) outside-in signaling. Here we evaluated the role of CIB1 in regulating outside-in signaling in the absence of inside-out signaling. Methods We used alpha(IIb) cytoplasmic domain peptide and CIB1-function blocking antibody to inhibit interaction of CIB1 with alpha(IIb) subunit as well as Cib1(-/-) platelets to evaluate the consequence of CIB1 interaction with alpha(IIb) on outside-in signaling. Results Fibrinogen binding to alpha(IIb)beta(3) results in calcium-dependent interaction of CIB1 with alpha(IIb), which is not required for filopodia formation. Dynamic rearrangement of cytoskeleton results in CIB1-dependent recruitment of FAK to the alpha(IIb) complex and its activation. Disruption of the association of CIB1 and a IIb by incorporation of alpha(IIb) peptide or anti-CIB1 inhibited both FAK association and activation. Furthermore, FAK recruitment to the integrin complex was required for c-Src activation. Inhibition of c-Src had no effect on CIB1 accumulation with the integrin at the filopodia, suggesting that c-Src activity is not required for the formation of CIB1-alpha(IIb)-FAK complex. Conclusion Our results suggest that interaction of CIB1 with a IIb is one of the early events occurring during outside-in signaling. Furthermore, CIB1 recruits FAK to the alpha(IIb)beta(3) complex at the filopodia where FAK is activated, which in turn activates c-Src, resulting in propagation of outside-in signaling leading to platelet spreading.	[Naik, Meghna U.; Naik, Tejal U.; Summer, Ross; Naik, Ulhas P.] Thomas Jefferson Univ, Dept Med, Cardeza Ctr Vasc Biol, Philadelphia, PA 19107 USA	Jefferson University	Naik, UP (corresponding author), Thomas Jefferson Univ, Dept Med, Cardeza Ctr Vasc Biol, Philadelphia, PA 19107 USA.	ulhas.naik@jefferson.edu			National Heart Lung and Blood Institute [R01 HL57630, HL113188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113188] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart Lung and Blood Institute grant R01 HL57630 and HL113188 to UPN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; CARR ME, 1995, THROMB HAEMOSTASIS, V73, P499; CLARK EA, 1994, TRENDS BIOCHEM SCI, V19, P464, DOI 10.1016/0968-0004(94)90131-7; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Judd BA, 2000, P NATL ACAD SCI USA, V97, P12056, DOI 10.1073/pnas.97.22.12056; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Liu JL, 2005, BLOOD, V105, P4345, DOI 10.1182/blood-2004-07-2718; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Naik MU, 2009, J THROMB HAEMOST, V7, P1906, DOI 10.1111/j.1538-7836.2009.03581.x; Naik MU, 2014, BLOOD, V123, P1393, DOI 10.1182/blood-2013-04-496232; Naik MU, 2012, BLOOD, V119, P3352, DOI 10.1182/blood-2011-12-397398; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik MU, 2016, BLOOD; Naik U P, 1997, Curr Opin Hematol, V4, P317; NAIK UP, 1991, BIOCHIM BIOPHYS ACTA, V1092, P256, DOI 10.1016/0167-4889(91)90165-T; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; NAIK UP, 1995, BIOCHEM J, V310, P155, DOI 10.1042/bj3100155; Niu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047356; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; PELLETIER AJ, 1995, J BIOL CHEM, V270, P18133, DOI 10.1074/jbc.270.30.18133; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Shock DD, 1999, BIOCHEM J, V342, P729, DOI 10.1042/0264-6021:3420729; Stephens G, 1998, J BIOL CHEM, V273, P20317, DOI 10.1074/jbc.273.32.20317; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Tsuboi S, 2006, EMBO REP, V7, P506, DOI 10.1038/sj.embor.7400665; Tsuboi S, 2002, J BIOL CHEM, V277, P1919, DOI 10.1074/jbc.M110643200; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Yoon KW, 2009, P NATL ACAD SCI USA, V106, P17389, DOI 10.1073/pnas.0812259106; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131	40	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0176602	10.1371/journal.pone.0176602	http://dx.doi.org/10.1371/journal.pone.0176602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542214	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500006
J	Totenhagen, JW; Bernstein, A; Yoshimaru, ES; Erickson, RP; Trouard, TP				Totenhagen, John W.; Bernstein, Adam; Yoshimaru, Eriko S.; Erickson, Robert P.; Trouard, Theodore P.			Quantitative magnetic resonance imaging of brain atrophy in a mouse model of Niemann-Pick type C disease	PLOS ONE			English	Article							NEUROFIBRILLARY TANGLES; SINGLE INJECTION; CORPUS-CALLOSUM; CHOLESTEROL; MICE; NEURODEGENERATION; CEREBELLAR; NPC1; DEGENERATION; EXPRESSION	In vivo magnetic resonance imaging (MRI) was used to investigate regional and global brain atrophy in the neurodegenerative Niemann Pick Type C1 (NPC1) disease mouse model. Imaging experiments were conducted with the most commonly studied mouse model of NPC1 disease at early and late disease states. High-resolution in vivo images were acquired at early and late stages of the disease and analyzed with atlas-based registration to obtain measurements of twenty brain region volumes. A two-way ANOVA analysis indicated eighteen of these regions were different due to genotype and thirteen showed a significant interaction with age and genotype. The ability to measure in vivo neurodegeneration evidenced by brain atrophy adds to the ability to monitor disease progression and treatment response in the mouse model.	[Totenhagen, John W.; Bernstein, Adam; Yoshimaru, Eriko S.; Trouard, Theodore P.] Univ Arizona, Biomed Engn Program, Tucson, AZ 85721 USA; [Erickson, Robert P.] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; [Erickson, Robert P.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Erickson, Robert P.; Trouard, Theodore P.] Univ Arizona, Inst B105, Tucson, AZ 85721 USA; [Trouard, Theodore P.] Univ Arizona, Dept Med Imaging, Tucson, AZ 85721 USA; [Trouard, Theodore P.] Univ Arizona, McKight Brain Inst, Tucson, AZ 85721 USA; [Totenhagen, John W.] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Alabama System; University of Alabama Birmingham	Trouard, TP (corresponding author), Univ Arizona, Biomed Engn Program, Tucson, AZ 85721 USA.; Trouard, TP (corresponding author), Univ Arizona, Inst B105, Tucson, AZ 85721 USA.; Trouard, TP (corresponding author), Univ Arizona, Dept Med Imaging, Tucson, AZ 85721 USA.; Trouard, TP (corresponding author), Univ Arizona, McKight Brain Inst, Tucson, AZ 85721 USA.	trouard@email.arizona.edu		Trouard, Theodore/0000-0001-9461-2283	NIH NIBIB [R01EB000343]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB000809] Funding Source: NIH RePORTER	NIH NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the NIH NIBIB, R01EB000343. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2005, J NEUROSCI RES, V82, P811, DOI 10.1002/jnr.20685; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bae JS, 2010, CELL TISSUE RES, V340, P357, DOI 10.1007/s00441-010-0942-3; Battisti C, 2003, MOVEMENT DISORD, V18, P1405, DOI 10.1002/mds.10541; Borbon I, 2012, J ALZHEIMERS DIS, V30, P875, DOI 10.3233/JAD-2012-120199; Bowman EA, 2015, J NEUROL, V262, P2106, DOI 10.1007/s00415-015-7819-z; Calabrese E, 2015, DIFFUSION MRI TRACTO, P4628; Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4; Caporali P, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0370-z; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Elrick MJ, 2010, HUM MOL GENET, V19, P837, DOI 10.1093/hmg/ddp552; German DC, 2001, J COMP NEUROL, V433, P415, DOI 10.1002/cne.1149; HIGASHI Y, 1993, ACTA NEUROPATHOL, V85, P175; Hsu YS, 1999, BONE MARROW TRANSPL, V24, P103, DOI 10.1038/sj.bmt.1701826; Huang JY, 2011, J FORMOS MED ASSOC, V110, P537, DOI 10.1016/S0929-6646(11)60080-6; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Iturriaga C, 2006, J NEUROL SCI, V249, P1, DOI 10.1016/j.jns.2006.05.054; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lau MW, 2016, DISEASES, V4, P1; Lee R, 2014, PEDIATR NEUROL, V51, P669, DOI 10.1016/j.pediatrneurol.2014.07.028; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lope-Piedrafita S, 2008, J NEUROSCI RES, V86, P2802, DOI 10.1002/jnr.21707; Luan Z, 2008, J NEUROL SCI, V268, P108, DOI 10.1016/j.jns.2007.11.018; Ma Y, 2008, FRONT NEUROANAT, V2, DOI 10.3389/neuro.05.001.2008; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Nusca S, 2014, NEUROBIOL DIS, V70, P117, DOI 10.1016/j.nbd.2014.06.012; PALMERI S, 1994, NEURORADIOLOGY, V36, P20, DOI 10.1007/BF00599187; Patterson MC, 2003, NEUROLOGIST, V9, P301, DOI 10.1097/01.nrl.0000094627.78754.5b; Patterson MC, 2004, BBA-MOL CELL BIOL L, V1685, P77, DOI 10.1016/j.bbalip.2004.08.013; Paxinos George F K, 2012, PAULO, P360; Prasad A, 2000, J NEUROCHEM, V75, P1250, DOI 10.1046/j.1471-4159.2000.0751250.x; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Runz H, 2008, HUM MUTAT, V29, P345, DOI 10.1002/humu.20636; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Sevin M, 2007, BRAIN, V130, P120, DOI 10.1093/brain/awl260; SUZUKI K, 1995, ACTA NEUROPATHOL, V89, P227; Totenhagen JW, 2012, J MAGN RESON IMAGING, V35, P528, DOI 10.1002/jmri.22837; Trouard TP, 2005, PEDIATR NEUROL, V33, P325, DOI 10.1016/j.pediatrneurol.2005.05.004; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van Eede MC, 2013, NEUROIMAGE, V82, P226, DOI 10.1016/j.neuroimage.2013.06.004; Vance JE, 2011, CURR OPIN LIPIDOL, V22, P204, DOI 10.1097/MOL.0b013e3283453e69; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Voikar V, 2002, BEHAV BRAIN RES, V132, P1, DOI 10.1016/S0166-4328(01)00380-1; Walterfang M, 2010, NEUROLOGY; WEINTRAUB H, 1987, ACTA NEUROPATHOL, V74, P374, DOI 10.1007/BF00687215; Yamada A, 2001, BRAIN DEV-JPN, V23, P288, DOI 10.1016/S0387-7604(01)00209-1	50	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178179	10.1371/journal.pone.0178179	http://dx.doi.org/10.1371/journal.pone.0178179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542381	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500071
J	von Steinbuchel, N; Real, RGL; Sasse, N; Wilson, L; Otto, C; Mullins, R; Behr, R; Deinsberger, W; Martinez-Olivera, R; Puschendorf, W; Petereit, W; Rohde, V; Schmidt, H; Sehmisch, S; Sturmer, KM; von Wild, K; Gibbons, H				von Steinbuechel, Nicole; Real, Ruben G. L.; Sasse, Nadine; Wilson, Lindsay; Otto, Christiane; Mullins, Ryan; Behr, Robert; Deinsberger, Wolfgang; Martinez-Olivera, Ramon; Puschendorf, Wolfgang; Petereit, Werner; Rohde, Veit; Schmidt, Holger; Sehmisch, Stephan; Stuermer, Klaus Michael; von Wild, Klaus; Gibbons, Henning			German validation of Quality of Life after Brain Injury (QOLIBRI) assessment and associated factors	PLOS ONE			English	Article							NEUROREHABILITATION UNIT; OUTCOME MEASURES; HEALTH; SATISFACTION; DISABILITY; SCALE; REHABILITATION; TBI; SYMPTOMATOLOGY; DEPRESSION	The consequences of traumatic brain injury (TBI) for health-related quality of life (HRQoL) are still poorly understood, and no TBI-specific instrument has hitherto been available. This paper describes in detail the psychometrics and validity of the German version of an internationally developed, self-rated HRQoL tool after TBI-the QOLIBRI (Quality of Life after Brain Injury). Factors associated with HRQoL, such as the impact of cognitive status and awareness, are specifically reported. One-hundred seventy-two participants after TBI were recruited from the records of acute clinics, most of whom having a Glasgow Coma Scale (GCS) 24-hour worst score and a Glasgow Outcome Scale (GOSE) score. Participants had severe (24%), moderate (11%) and mild (56%) injuries as assessed on the GCS, 3 months to 15 years post-injury. The QOLIBRI uses 37 items to measure "satisfaction" in the areas of "Cognition", "Self", "Daily Life and Autonomy", and "Social Relationships", and "feeling bothered" by "Emotions" and "Physical Problems". The scales meet standard psychometric criteria (alpha =.84 to.96; intra-class correlation-ICC =.72 to.91). ICCs (0.68 to 0.90) and as (. 83 to.96) were also good in a subgroup of participants with lower cognitive performance. The six-subscale structure of the international sample was reproduced for the German version using confirmatory factor analyses and Rasch analysis. Scale validity was supported by systematic relationships observed between the QOLIBRI and the GOSE, Patient Competency Rating Scale for Neurorehabilitation (PCRS-NR), Hospital Anxiety and Depression Scale HADS), Profile of Mood States (POMS), Short Form 36 (SF-36), and Satisfaction with Life Scale (SWLS). The German QOLIBRI contains novel information not provided by other currently available measures and has good psychometric criteria. It is potentially useful for clinicians and researchers, in post-acute and rehabilitation studies, on a group and individual level.	[von Steinbuechel, Nicole; Real, Ruben G. L.; Sasse, Nadine; Otto, Christiane; Mullins, Ryan; Schmidt, Holger; Gibbons, Henning] Univ Med Ctr Goettingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling, Scotland; [Otto, Christiane] Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat, Psychotherapy & Psychosomat, Hamburg, Germany; [Behr, Robert] Clin Ctr Fulda, Dept Neurosurg, Fulda, Germany; [Deinsberger, Wolfgang] Clin Ctr Kassel, Dept Neurosurg, Kassel, Germany; [Martinez-Olivera, Ramon] Bergmannsheil Univ Hosp Bochum, Dept Neurosurg & Neurotraumatol, Bochum, Germany; [Puschendorf, Wolfgang] Westend Neurol Clin, Bad Wildungen, Germany; [Petereit, Werner] Clin Ctr Bernburg, Dept Neurosurg, Bernburg, Germany; [Rohde, Veit] Univ Med Ctr Goettingen, Dept Neurosurg, Gottingen, Germany; [Schmidt, Holger] Univ Med Ctr Goettingen, Dept Neurol, Gottingen, Germany; [Sehmisch, Stephan; Stuermer, Klaus Michael] Univ Med Ctr Goettingen, Trauma Surg Plast & Reconstruct Surg, Gottingen, Germany; [von Wild, Klaus] KvW Neurosci Consulting, Munster, Germany; [Gibbons, Henning] Univ Bonn, Dept Psychol, Bonn, Germany	University of Gottingen; University of Stirling; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruhr University Bochum; University of Gottingen; University of Gottingen; University of Gottingen; University of Bonn	Real, RGL (corresponding author), Univ Med Ctr Goettingen, Inst Med Psychol & Med Sociol, Gottingen, Germany.	ruben.real@med.uni-goettingen.de	Wilson, Lindsay/A-3659-2009	Wilson, Lindsay/0000-0003-4113-2328; Schmidt, Hartmut/0000-0002-2402-7764	ZNS Hannelore Kohl Foundation [2008014]; German Research Foundation; Open Access Publication Funds of the Gottingen University	ZNS Hannelore Kohl Foundation; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	This project was funded by the ZNS Hannelore Kohl Foundation (project number 2008014; www.hannelore-kohl-stiftung.de), the German Research Foundation, and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by ZNS Hannelore Kohl Foundation (project number 2008014; www.hannelore-kohl-stifiung.de). We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.	Acquadro C., 1996, QUALITY LIFE PHARMAC, P575; Ahmadi SA, 2010, BRAIN INJURY, V24, P1539, DOI 10.3109/02699052.2010.523049; Albani C, 2005, PSYCHOTHER PSYCH MED, V55, P324, DOI 10.1055/s-2004-834727; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Bergner M., 1988, QUALITY LIFE ASSESSM, P79; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bond TG., 2020, APPL RASCH MODEL FUN; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Brandt J., 2003, TELEPHONE INTERVIEW; Brown M, 2004, ARCH PHYS MED REHAB, V85, pS13, DOI 10.1016/j.apmr.2003.08.110; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; BULLINGER M, 1993, QUAL LIFE RES, V2, P451, DOI 10.1007/BF00422219; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; FLEISS JL, 1986, CONTROL CLIN TRIALS, V7, P267, DOI 10.1016/0197-2456(86)90034-6; Formisano R, 2017, NEUROL SCI, V38, P279, DOI 10.1007/s10072-016-2755-y; Gladis MM, 1999, J CONSULT CLIN PSYCH, V67, P320, DOI 10.1037/0022-006X.67.3.320; Guillamondegui OD, 2011, TRAUMATIC BRAIN INJU, V25; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hofer S, 2005, PSYCHOSOMATICS, V46, P212, DOI 10.1176/appi.psy.46.3.212; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Hutter BO, 2001, ZBL NEUROCHIR, V62, P37, DOI 10.1055/s-2002-19476; JENNETT B, 1975, LANCET, V1, P480; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Lane AK, 2011, NEUROREHABILITATION, V28, P221, DOI 10.3233/NRE-2011-0651; Laxe S, 2011, NEUROREHABILITATION, V29, P99, DOI 10.3233/NRE-2011-0683; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Moosbrugger H., 2007, TESTTHEORIE FRAGEBOG; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Novella JL, 2001, AGING CLIN EXP RES, V13, P362, DOI 10.1007/BF03351504; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Riemsma R P, 2001, Health Technol Assess, V5, P1; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stucki G, 1997, Z RHEUMATOL, V56, P266, DOI 10.1007/s003930050041; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; von Steinbuchel N, 2002, STUDY PROTOCOL COGNI; von Steinbuchel N., 1996, THESIS LEOPOLD FRANZ; von Steinbuchel Nicole, 2006, Eur J Ageing, V3, P116, DOI 10.1007/s10433-006-0024-2; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Whiting M.D., 2006, ANIMAL MODELCOGNIT; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson L, 1998, STRUCTURED INTERVIEW, V15, P573; Wlodarczyk JH, 2004, ARCH GERONTOL GERIAT, V39, P25, DOI 10.1016/j.archger.2003.12.004; World Medical Association, 2009, DECL HELS ETH PRINC; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	82	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0176668	10.1371/journal.pone.0176668	http://dx.doi.org/10.1371/journal.pone.0176668			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542226	Green Published, gold			2022-12-27	WOS:000402061500007
J	Htar, MTT; Stuurman, AL; Ferreira, G; Alicino, C; Bollaerts, K; Paganino, C; Reinert, RR; Schmitt, HJ; Trucchi, C; Vestraeten, T; Ansaldi, F				Htar, Myint Tin Tin; Stuurman, Anke L.; Ferreira, Germano; Alicino, Cristiano; Bollaerts, Kaatje; Paganino, Chiara; Reinert, Ralf Rene; Schmitt, Heinz-Josef; Trucchi, Cecilia; Vestraeten, Thomas; Ansaldi, Filippo			Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies	PLOS ONE			English	Review							COMMUNITY-ACQUIRED PNEUMONIA; HIV-INFECTED PATIENTS; POLYSACCHARIDE VACCINE; CLINICAL EFFECTIVENESS; ELDERLY PERSONS; OLDER-ADULTS; MYOCARDIAL-INFARCTION; CONJUGATE VACCINE; INFLUENZA; DISEASE	Introduction S. pneumoniae can cause a wide spectrum of diseases, including invasive pneumococcal disease and pneumonia. Two types of pneumococcal vaccines are indicated for use in adults: 23-valent pneumococcal polysaccharide vaccines (PPV23) and a 13-valent pneumococcal conjugate vaccine (PCV13). Objective To systematically review the literature assessing pneumococcal vaccine effectiveness (VE) against community-acquired pneumonia (CAP) in adults among the general population, the immunocompromised and subjects with underlying risk factors in real-world settings. Methods We searched for peer-reviewed observational studies published between 1980 and 2015 in Pubmed, SciELO or LILACS, with pneumococcal VE estimates against CAP, pneumococcal CAP or nonbacteremic pneumococcal CAP. Meta-analyses and meta-regression for VE against CAP requiring hospitalization in the general population was performed. Results 1159 unique articles were retrieved of which 33 were included. No studies evaluating PCV13 effectiveness were found. Wide ranges in PPV23 effectiveness estimates for any-CAP were observed among adults >= 65 years (-143% to 60%). The meta-analyzed VE estimate for any-CAP requiring hospitalization in the general population was 10.2% (95% CI: -12.6; 33.0). The meta-regression indicates that VE against any-CAP requiring hospitalization is significantly lower in studies with a maximum time since vaccination >= 60 months vs. <60 months and in countries with the pediatric PCV vaccine available on the private market. However, these results should be interpreted cautiously due to the high influence of two studies. The VE estimates for pneumococcal CAP hospitalization ranged from 32% (95% CI: -18; 61) to 51% (95% CI: 16; 71) in the general population. Conclusions Wide ranges in PPV23 effectiveness estimates for any-CAP were observed, likely due to a great diversity of study populations, circulation of S. pneumoniae serotypes, coverage of pediatric pneumococcal vaccination, case definition and time since vaccination. Despite some evidence for short-term protection, effectiveness of PPV23 against CAP was not consistent in the general population, the immunocompromised and subjects with underlying risk factors.	[Htar, Myint Tin Tin] Pfizer Inc, Pfizer Vaccines Clin Epidemiol, Paris, France; [Stuurman, Anke L.; Ferreira, Germano; Bollaerts, Kaatje; Vestraeten, Thomas] P95 Epidemiol & Pharmacovigilance Consulting & Se, P95, Leuven, Belgium; [Alicino, Cristiano; Paganino, Chiara; Trucchi, Cecilia; Ansaldi, Filippo] Univ Genoa, Dept Hlth Sci DiSSal, Genoa, Italy; [Reinert, Ralf Rene; Schmitt, Heinz-Josef] Pfizer Inc, Pfizer Vaccines Med Dev & Sci Clin Affairs, Paris, France	Pfizer; University of Genoa; Pfizer	Htar, MTT (corresponding author), Pfizer Inc, Pfizer Vaccines Clin Epidemiol, Paris, France.	Myint.TinTinHtar@pfizer.com		Stuurman, Anke/0000-0002-4157-1315	Pfizer, Paris, France	Pfizer, Paris, France	The study was funded by Pfizer, Paris, France. The funder provided support in the form of salaries for Pfizer authors (MTTH, JS, RRR) and consulting fees under a service contract with the commercial company P95 Epidemiology and Pharmacovigilance Consulting and Services (ALS, GF, KB, TV). Authors from University of Genoa (CA, CP, CT, FA) were not funded by Pfizer nor by P95 for their contributions. The specific roles of the authors, including the Pfizer authors, are described in the 'author contributions' section. Pfizer authors contributed to the protocol, analysis and interpretation of the results. The authors take full responsibility for the content of this article.	[Anonymous], 2008, Wkly Epidemiol Rec, V83, P373; [Anonymous], 2003, MEDIFAM, P61; Ansaldi F, 2005, J INT MED RES, V33, P490, DOI 10.1177/147323000503300503; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Chan MCW, 2013, J CLIN VIROL, V56, P219, DOI 10.1016/j.jcv.2012.11.002; Chan TC, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2013.10.008; Christenson B, 2004, EUR RESPIR J, V23, P363, DOI 10.1183/09031936.04.00063504; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dominguez A, 2010, EUR RESPIR J, V36, P608, DOI 10.1183/09031936.00171309; Dransfield MT, 2012, CLIN INFECT DIS, V55, pE35, DOI 10.1093/cid/cis513; European Centre for Disease Prevention and Control SE, 2015, SURV INV BACT DIS EU; Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7; GABLE CB, 1990, JAMA-J AM MED ASSOC, V264, P2910, DOI 10.1001/jama.264.22.2910; Guerrero M, 1999, AIDS, V13, P1971, DOI 10.1097/00002030-199910010-00021; Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804; Halloran E, 2010, DESIGN ANAL VACCINE; Hechter RC, 2012, VACCINE, V30, P5625, DOI 10.1016/j.vaccine.2012.06.085; Hung CC, 2004, VACCINE, V22, P2006, DOI 10.1016/j.vaccine.2003.10.030; Hung IFN, 2010, CLIN INFECT DIS, V51, P1007, DOI 10.1086/656587; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; Kraicer-Melamed H, 2016, EFFECTIVENESS PNEUMO; Leventer-Roberts M, 2015, CLIN INFECT DIS, V60, P1472, DOI 10.1093/cid/civ096; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lopez-Palomo C, 2004, J MED VIROL, V72, P517, DOI 10.1002/jmv.20045; Merck, 2015, PNEUM 23 HIGHL PRESC; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Musher DM, 2006, CLIN INFECT DIS, V43, P1004, DOI 10.1086/507699; Nichol KL, 1999, ARCH INTERN MED, V159, P2437, DOI 10.1001/archinte.159.20.2437; Nichol KL, 1999, VACCINE, V17, pS91, DOI 10.1016/S0264-410X(99)00114-0; Ochoa-Gondar O, 2014, VACCINE, V32, P252, DOI 10.1016/j.vaccine.2013.11.017; Ochoa-Gondar O, 2008, VACCINE, V26, P1955, DOI 10.1016/j.vaccine.2008.02.021; Ochoa-Gondar O, 2014, CLIN INFECT DIS, V58, P909, DOI 10.1093/cid/ciu002; Pfizer, 2015, PREVNAR 13 D HIGHL P; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Saadatian-Elahi M, 2016, EFFICACY FULL PUBLIC; Schiffner-Rohe J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146338; Song JY, 2015, CLIN VACCINE IMMUNOL, V22, P229, DOI 10.1128/CVI.00673-14; Teshale EH, 2008, VACCINE, V26, P5830, DOI 10.1016/j.vaccine.2008.08.032; Tsai YH, 2015, VACCINE, V33, P2897, DOI 10.1016/j.vaccine.2015.04.068; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vila Corcoles A, 2003, Aten Primaria, V31, P272; Vila Corcoles Angel, 2006, Aten Primaria, V38, P299, DOI 10.1157/13092990; Vila-Corcoles A, 2012, HUM VACC IMMUNOTHER, V8, P639, DOI [10.4161/hv.18548, 10.4161/hv.19466]; Vila-Corcoles A, 2009, VACCINE, V27, P1504, DOI 10.1016/j.vaccine.2009.01.013; Wagner C, 2003, GERONTOLOGY, V49, P246, DOI 10.1159/000070405; Wells G.A., NEWCASTLE OTTAWA SCA; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Wiemken TL, 2014, VACCINE, V32, P2198, DOI 10.1016/j.vaccine.2014.02.048	51	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177985	10.1371/journal.pone.0177985	http://dx.doi.org/10.1371/journal.pone.0177985			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542347	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058800032
J	Araki, KS; Kubo, T; Kudoh, H				Araki, Kiwako S.; Kubo, Takuya; Kudoh, Hiroshi			Genet-specific DNA methylation probabilities detected in a spatial epigenetic analysis of a clonal plant population	PLOS ONE			English	Article							SENSITIVE AMPLIFICATION POLYMORPHISM; CYTOSINE METHYLATION; CPG METHYLATION; AFLP; RICE; ARABIDOPSIS; INHERITANCE; PATTERN; AUTOCORRELATION; MAINTENANCE	In sessile organisms such as plants, spatial genetic structures of populations show long-lasting patterns. These structures have been analyzed across diverse taxa to understand the processes that determine the genetic makeup of organismal populations. For many sessile organisms that mainly propagate via clonal spread, epigenetic status can vary between clonal individuals in the absence of genetic changes. However, fewer previous studies have explored the epigenetic properties in comparison to the genetic properties of natural plant populations. Here, we report the simultaneous evaluation of the spatial structure of genetic and epigenetic variation in a natural population of the clonal plant Cardamine leucantha. We applied a hierarchical Bayesian model to evaluate the effects of membership of a genet (a group of individuals clonally derived from a single seed) and vegetation cover on the epigenetic variation between ramets (clonal plants that are physiologically independent individuals). We sampled 332 ramets in a 20 m X 20 m study plot that contained 137 genets (identified using eight SSR markers). We detected epigenetic variation in DNA methylation at 24 methylation-sensitive amplified fragment length polymorphism (MS-AFLP) loci. There were significant genet effects at all 24 MS-AFLP loci in the distribution of subepiloci. Vegetation cover had no statistically significant effect on variation in the majority of MS-AFLP loci. The spatial aggregation of epigenetic variation is therefore largely explained by the aggregation of ramets that belong to the same genets. By applying hierarchical Bayesian analyses, we successfully identified a number of genet-specific changes in epigenetic status within a natural plant population in a complex context, where genotypes and environmental factors are unevenly distributed. This finding suggests that it requires further studies on the spatial epigenetic structure of natural populations of diverse organisms, particularly for sessile clonal species.	[Araki, Kiwako S.; Kudoh, Hiroshi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Araki, Kiwako S.] Ritsumeikan Univ, Fac Life Sci, Dept Biotechnol, Kusatsu, Shiga, Japan; [Kubo, Takuya] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan	Kyoto University; Ritsumeikan University; Hokkaido University	Araki, KS (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.; Araki, KS (corresponding author), Ritsumeikan Univ, Fac Life Sci, Dept Biotechnol, Kusatsu, Shiga, Japan.	kiwakosa@fc.ritsumei.ac.jp	Kubo, Takuya/A-3414-2012; Kudoh, Hiroshi/AAF-9497-2019; Araki, Kiwako/E-8739-2013	Kubo, Takuya/0000-0001-6202-9624; Kudoh, Hiroshi/0000-0001-9777-4886; Araki, Kiwako/0000-0001-9134-7488	Global COE program of Kyoto University [A06]; Grants for Excellent Graduate Schools program of the Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS) Research Fellow [201100907]; MEXT [26840148, 26221106]; Grants-in-Aid for Scientific Research [26840148] Funding Source: KAKEN	Global COE program of Kyoto University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants for Excellent Graduate Schools program of the Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Research Fellow(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Global COE program (A06) of Kyoto University; the Grants for Excellent Graduate Schools program of the Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan; Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Research Fellow 201100907 to KSA; the Grant-in-Aid for Young Scientists (B) 26840148, MEXT to KSA; the Grant-in-Aid for Scientific Research (S) 26221106, MEXT to HK.	Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; Akimoto K, 2007, ANN BOT-LONDON, V100, P205, DOI 10.1093/aob/mcm110; Araki K, 2007, PLANT ECOL, V189, P175, DOI 10.1007/s11258-006-9173-9; Araki KS, 2011, AM J BOT, V98, pE385, DOI 10.3732/ajb.1100242; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Ashikawa I, 2001, PLANT MOL BIOL, V45, P31, DOI 10.1023/A:1006457321781; Barnerjee S, 2004, HIERARCHICAL MODELIN; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Boyko A, 2004, MUTAT RES, V572, P73; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Charpentier A, 2001, EVOL ECOL, V15, P521, DOI 10.1023/A:1016057503722; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Chybicki IJ, 2011, HEREDITY, V107, P589, DOI 10.1038/hdy.2011.51; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; de Kroon J.M, 1990, CLONAL GROWTH PLANTS; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; Douhovnikoff V, 2015, PLANT ECOL, V216, P227, DOI 10.1007/s11258-014-0430-z; Fang JG, 2007, PLANT BIOLOGY, V9, P526, DOI 10.1055/s-2007-964934; Franks SJ, 2004, AM J BOT, V91, P1345, DOI 10.3732/ajb.91.9.1345; Gao LX, 2010, PLANT CELL ENVIRON, V33, P1820, DOI 10.1111/j.1365-3040.2010.02186.x; Gelman A., 2003, BAYESIAN DATA ANAL; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Iida S, 2004, ADV BIOPHYS, V38, P141, DOI 10.1016/S0065-227X(04)80136-9; Imazio S, 2002, PLANT BREEDING, V121, P531, DOI 10.1046/j.1439-0523.2002.00762.x; Jackson J. B. C., 1985, POPULATION BIOL EVOL; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; Jump AS, 2007, MOL ECOL, V16, P925, DOI 10.1111/j.1365-294X.2006.03203.x; KEMPERMAN JA, 1976, CAN J BOT, V54, P2603, DOI 10.1139/b76-280; Keyte AL, 2006, J HERED, V97, P444, DOI 10.1093/jhered/esl023; Kudoh H, 1999, J ECOL, V87, P244, DOI 10.1046/j.1365-2745.1999.00355.x; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Li XueLin, 2009, Acta Agronomica Sinica, V35, P588, DOI 10.3724/SP.J.1006.2009.00588; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lu GY, 2007, J INTEGR PLANT BIOL, V49, P1599, DOI 10.1111/j.1774-7909.2007.00566.x; Monteuuis O, 2008, TREES-STRUCT FUNCT, V22, P779, DOI 10.1007/s00468-008-0238-3; PARKS JC, 1993, AM J BOT, V80, P537, DOI 10.2307/2445369; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Richards CL, 2010, NEW PHYTOL, V187, P562, DOI 10.1111/j.1469-8137.2010.03369.x; Richards CL, 2004, ECOL LETT, V7, P1155, DOI 10.1111/j.1461-0248.2004.00674.x; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards EJ, 2011, CURR OPIN PLANT BIOL, V14, P204, DOI 10.1016/j.pbi.2011.03.009; Roff Derek A., 1992; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schmitz RJ, 2012, TRENDS PLANT SCI, V17, P149, DOI 10.1016/j.tplants.2012.01.001; Schulz B, 2014, MOL ECOL, V23, P3523, DOI 10.1111/mec.12835; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; Sherman JD, 2002, GENOME, V45, P253, DOI 10.1139/g01-147; SILANDER JA, 1979, SCIENCE, V203, P658, DOI 10.1126/science.203.4381.658; Silvertown J, 2008, INT J PLANT SCI, V169, P157, DOI 10.1086/523357; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Takata M, 2005, BREEDING SCI, V55, P57, DOI 10.1270/jsbbs.55.57; TUOMI J, 1989, TRENDS ECOL EVOL, V4, P209, DOI 10.1016/0169-5347(89)90075-X; Van Kleunen M, 2001, ECOLOGY, V82, P3309, DOI 10.1890/0012-9658(2001)082[3309:AEOPFR]2.0.CO;2; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wenzel MA, 2014, MOL ECOL, V23, P4256, DOI 10.1111/mec.12833; Wright S, 1943, GENETICS, V28, P114; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Yang CY, 2011, AFR J BIOTECHNOL, V10, P874; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010; Zhao XX, 2007, PLANT SCI, V172, P930, DOI 10.1016/j.plantsci.2007.01.002	75	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178145	10.1371/journal.pone.0178145	http://dx.doi.org/10.1371/journal.pone.0178145			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542457	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058400061
J	Eckhardt, B; Winkelstein, ER; Shu, MA; Carden, MR; McKnight, C; Jarlais, DCD; Glesby, MJ; Marks, K; Edlin, BR				Eckhardt, Benjamin; Winkelstein, Emily R.; Shu, Marla A.; Carden, Michael R.; McKnight, Courtney; Jarlais, Don C. Des; Glesby, Marshall J.; Marks, Kristen; Edlin, Brian R.			Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention	PLOS ONE			English	Article							VIRUS-INFECTION; SAN-FRANCISCO; UNITED-STATES; USERS; PREVALENCE; INTERVENTIONS; BALTIMORE; EXCHANGE; MARYLAND	Background Hepatitis C virus (HCV) infection remains a significant problem in the United States, with people who inject drugs (PWID) disproportionately afflicted. Over the last decade rates of heroin use have more than doubled, with young persons (18-25 years) demonstrating the largest increase. Methods We conducted a cross-sectional study in New York City from 2005 to 2012 among young people who injected illicit drugs, and were age 18 to 35 or had injected drugs for <= 5 years, to examine potentially modifiable factors associated with HCV among young adults who began injecting during the era of syringe services. Results Among 714 participants, the median age was 24 years; the median duration of drug injection was 5 years; 31% were women; 75% identified as white; 69% reported being homeless; and 48% [95% CI 44-52] had HCV antibodies. Factors associated with HCV included older age (adjusted odds ratio [AOR], 1.99 [1.52-2.63]; p<0.001), longer duration of injection drug use (AOR, 1.68 [1.39-2.02]; p<0.001), more frequent injection (AOR, 1.26 [1.09-1.45]; p = 0.001), using a used syringe with more individuals (AOR, 1.26 [1.10-1.46]; p = 0.001), less confidence in remaining uninfected (AOR, 1.32 [1.07-1.63]; p<0.001), injecting primarily in public or outdoors spaces (AOR, 1.90 [1.33-2.72]; p<0.001), and arrest for carrying syringes (AOR, 3.17 [1.95-5.17]; p<0.001). Conclusions Despite the availability of harm reduction services, the seroprevalence of HCV in young PWID in New York City remained high and constant during 2005-2012. Age and several injection behaviors conferred independent risk. Individuals were somewhat aware of their own risk. Public and outdoor injection and arrest for possession of a syringe are risk factors for HCV that can be modified through structural interventions.	[Eckhardt, Benjamin; Glesby, Marshall J.; Marks, Kristen] Weill Cornell Med, Dept Med, Div Infect Dis, New York, NY 10065 USA; [Winkelstein, Emily R.; Shu, Marla A.; Carden, Michael R.; Edlin, Brian R.] Natl Dev & Res Inst, Inst Infect Dis Res, New York, NY USA; [Shu, Marla A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [McKnight, Courtney; Jarlais, Don C. Des] Icahn Sch Med Mt Sinai, Dept Psychiat, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY 10029 USA; [Edlin, Brian R.] Weill Cornell Med, Dept Med, New York, NY USA	Cornell University; National Development & Research Institutes, Inc; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University	Eckhardt, B (corresponding author), Weill Cornell Med, Dept Med, Div Infect Dis, New York, NY 10065 USA.	bje8@cornell.edu	Edlin, Brian R/F-2966-2018	Edlin, Brian R/0000-0001-8172-8797; Eckhardt, Benjamin/0000-0002-2846-9762; McKnight, Courtney A/0000-0001-8685-5381	National Institute on Drug Abuse [R01 DA016159, R01 DA021550, R01 DA029512]; Agency for Healthcare Research and Quality [T32 HS000066]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by the National Institute on Drug Abuse [grant number R01 DA016159, R01 DA021550, and R01 DA029512]; and the Agency for Healthcare Research and Quality [grant number T32 HS000066].	Beletsky L, 2011, DRUG ALCOHOL DEPEN, V119, P145, DOI 10.1016/j.drugalcdep.2011.05.034; BELL J, 1990, MED J AUSTRALIA, V153, P274, DOI 10.5694/j.1326-5377.1990.tb136900.x; CDC Division of Viral Hepatitis, 2014, VIR HEP SURV; Coyle S L, 1998, Public Health Rep, V113 Suppl 1, P19; Diaz T, 2001, AM J PUBLIC HEALTH, V91, P23, DOI 10.2105/AJPH.91.1.23; Edlin BR, 2011, NATURE, V474, pS18, DOI 10.1038/474S18a; Edlin BR, 2009, GASTROENTEROLOGY, V136, P2412, DOI 10.1053/j.gastro.2009.04.040; Foderaro L., 2016, NY TIMES, pA1; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Hagan H, 1999, AM J EPIDEMIOL, V149, P203, DOI 10.1093/oxfordjournals.aje.a009792; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; Hahn JA, 2002, J INFECT DIS, V186, P1558, DOI 10.1086/345554; Hahn JA, 2001, HEPATOLOGY, V34, P180, DOI 10.1053/jhep.2001.25759; Jones CM, 2015, MMWR MORB MORTAL WKL, V64; Jordan AE, 2015, DRUG ALCOHOL DEPEN, V152, P194, DOI 10.1016/j.drugalcdep.2015.03.039; Klevens RM, 2012, CLIN INFECT DIS, V55, pS3, DOI 10.1093/cid/cis393; Kwon JA, 2012, AIDS, V26, P2201, DOI 10.1097/QAD.0b013e3283578b5d; Lorvick J, 2001, AM J PUBLIC HEALTH, V91, P46, DOI 10.2105/AJPH.91.1.46; Ly KN, 2016, CLIN INFECT DIS; Morales JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065216; Marshall BDL, 2011, LANCET, V377, P1429, DOI 10.1016/S0140-6736(10)62353-7; Mateu-Gelabert P, 2015, J SUBST ABUSE TREAT, V48, P13, DOI 10.1016/j.jsat.2014.07.002; Mihailovic A, 2015, AIDS BEHAV, V19, P1792, DOI 10.1007/s10461-015-1048-4; NYSDOH/AIDS Institute -Harm Reduction Unit, 2015, NYS AUTH SYR EXCH PR; Page K, 2013, CLIN INFECT DIS, V57, pS32, DOI 10.1093/cid/cit300; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Potier C, 2014, DRUG ALCOHOL DEPEN, V145, P48, DOI 10.1016/j.drugalcdep.2014.10.012; Pouget ER, 2011, APHA 139 ANN M EXP W; Schulte M, 2015, J COMMUN HEALTH, V40, P940, DOI 10.1007/s10900-015-0016-2; Seal KH, 2005, J URBAN HEALTH, V82, P303, DOI 10.1093/jurban/jti053; Strathdee SA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008958; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Tempalski B, 2013, TRENDS POPULATION PR, V8; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Thorpe LE, 1999, HEPATITIS C VIRUS IN, P1997; Tseng FC, 2007, HEPATOLOGY, V46, P666, DOI 10.1002/hep.21765; Villano SA, 1997, J CLIN MICROBIOL, V35, P3274, DOI 10.1128/JCM.35.12.3274-3277.1997; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	39	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177341	10.1371/journal.pone.0177341	http://dx.doi.org/10.1371/journal.pone.0177341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PW	28542351	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672600008
J	Chover-Sierra, E; Martinez-Sabater, A; Lapena-Monux, YR				Chover-Sierra, Elena; Martinez-Sabater, Antonio; Lapena-Monux, Yolanda Raquel			An instrument to measure nurses' knowledge in palliative care: Validation of the Spanish version of Palliative Care Quiz for Nurses	PLOS ONE			English	Article							CONTENT VALIDITY; NURSING PCQN	Background Palliative care is nowadays essential in nursing care, due to the increasing number of patients who require attention in final stages of their life. Nurses need to acquire specific knowledge and abilities to provide quality palliative care. Palliative Care Quiz for Nurses is a questionnaire that evaluates their basic knowledge about palliative care. The Palliative Care Quiz for Nurses (PCQN) is useful to evaluate basic knowledge about palliative care, but its adaptation into the Spanish language and the analysis of its effectiveness and utility for Spanish culture is lacking. Purpose To report the adaptation into the Spanish language and the psychometric analysis of the Palliative Care Quiz for Nurses. Method The Palliative Care Quiz for Nurses-Spanish Version (PCQN-SV) was obtained from a process including translation, back-translation, comparison with versions in other languages, revision by experts, and pilot study. Content validity and reliability of questionnaire were analyzed. Difficulty and discrimination indexes of each item were also calculated according to Item Response Theory (IRT). Findings Adequate internal consistency was found (S-CVI = 0.83); Cronbach's alpha coefficient of 0.67 and KR-20 test result of 0,72 reflected the reliability of PCQN-SV. The questionnaire had a global difficulty index of 0,55, with six items which could be considered as difficult or very difficult, and five items with could be considered easy or very easy. The discrimination indexes of the 20 items, show us that eight items are good or very good while six items are bad to discriminate between good and bad respondents. Discussion Although in shows internal consistency, reliability and difficulty indexes similar to those obtained by versions of PCQN in other languages, a reformulation of the items with lowest content validity or discrimination indexes and those showing difficulties with their comprehension is an aspect to take into account in order to improve the PCQN-SV. Conclusion The PCQN-SV is a useful Spanish language instrument for measuring Spanish nurses' knowledge in palliative care and it is adequate to establish international comparisons.	[Chover-Sierra, Elena] Univ Valencia, Dept Nursing, Valencia, Spain; [Chover-Sierra, Elena; Martinez-Sabater, Antonio] Hosp Gen Univ Valencia, Valencia, Spain; [Lapena-Monux, Yolanda Raquel] Univ Jaume 1, Dept Nursing, Castellon De La Plana, Spain	University of Valencia; Hospital Clinic Universitari de Valencia; Universitat Jaume I	Chover-Sierra, E (corresponding author), Univ Valencia, Dept Nursing, Valencia, Spain.; Chover-Sierra, E (corresponding author), Hosp Gen Univ Valencia, Valencia, Spain.	elena.chover@uv.es	Chover-Sierra, Elena/L-9665-2019; Chover-Sierra, Elena/GQH-1530-2022	Chover-Sierra, Elena/0000-0002-4141-6956; Martinez-Sabater, Antonio/0000-0002-6440-1431				Adriaansen MJM, 2004, INT J NURS STUD, V41, P107, DOI 10.1016/S0020-7489(03)00073-7; Autor SH, 2013, J HOSP PALLIAT NURS, V15, P307, DOI 10.1097/NJH.0b013e3182930800; Barrio-Cantalejo IM, 2009, REV CALID ASSIST, V24, P192, DOI 10.1016/j.cali.2009.02.003; Brajtman S, 2007, INT J PALLIAT NURS, V13, P213, DOI 10.12968/ijpn.2007.13.5.23491; Brazil K, 2012, INT J PALLIAT NURS, V18, P77, DOI 10.12968/ijpn.2012.18.2.77; Calculo M., 2015, PUBLICANDO, V2, P62; Cardoso Ribeiro C., 2010, FISIOTERAPIA, V32, P264, DOI [10.1016/j.ft.2010.05.001, DOI 10.1016/J.FT.2010.05.001]; Carroll G, 2005, J PALLIAT CARE, V21, P27, DOI 10.1177/082585970502100105; Choi M, 2012, J CONTIN EDUC NURS, V43, P379, DOI 10.3928/00220124-20120615-35; Chover-Sierra E, 2017, REV LAT AM ENFERMAGE, V25; Escobar-Bravo M. A., 2004, ENFERM CLIN, V14, P102; Gaite L, 1997, ARCH NEUROBIOL, V60, P91; Gomez-Batiste X, 2013, BMJ SUPPORT PALLIAT, V3, P300, DOI 10.1136/bmjspcare-2012-000211; González-Consuegra Renata Virginia, 2010, Gerokomos, V21, P80, DOI 10.4321/s1134-928x2010000200007; Iranmanesh S, 2014, PALLIAT SUPPORT CARE, V12, P203, DOI 10.1017/S1478951512001058; Kim Boon Han, 2012, [Korean Journal of Adult Nursing, 성인간호학회지], V24, P390; Kim HS, 2011, J HOSP PALLIAT NURS, V13, P222, DOI 10.1097/NJH.0b013e318210fdec; Knapp CA, 2009, INT J PALLIAT NURS, V15, P432, DOI 10.12968/ijpn.2009.15.9.44255; Larkin P, 2005, INT J PALLIAT NURS, V11, P420, DOI 10.12968/ijpn.2005.11.8.19610; Romero-Sanchez JM, 2013, J ADV NURS, V69, P2759, DOI 10.1111/jan.12128; Martin-Moreno JM, 2008, PALLIATIVE CARE EURO; Ministry of Health (Spain), 2007, ESTR CUID PAL SIST N; Ministry of Health (Spain), 2011, ESTR CUID PAL SIST N; Orts-Cortes Maria Isabel, 2013, Appl Nurs Res, V26, pe5, DOI 10.1016/j.apnr.2013.08.006; Orts-Cortes MI, 2011, THESIS; Pessini L., 2006, ACTA BIOETH, V12, P231, DOI DOI 10.4067/S1726-569X2006000200012; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Praena Crespo M, 2009, AN PEDIAT, V70; Radbruch L, 2010, EUR J PALLIAT CARE, V17, P22; Radbruch L, 2010, EUROPEAN J PALLIATIV, V16, P278; Raudonis BM, 2002, GERIATR NURS, V23, P296, DOI 10.1067/mgn.2002.130270; Ronaldson S, 2008, INT J OLDER PEOPLE N, V3, P258, DOI 10.1111/j.1748-3743.2008.00136.x; Ross MM, 1996, J ADV NURS, V23, P126; Sirera-Vercher M.J., 2010, REV ESP CIR ORTOP TR, V54, P211, DOI [10.1016/j.recot.2010.02.006, DOI 10.1016/J.RECOT.2010.02.006]; Squires A, 2013, INT J NURS STUD, V50, P264, DOI 10.1016/j.ijnurstu.2012.02.015; Valles-Fernandez P., 2013, MED PALIAT, V12, DOI [10.1016/j.medipa.2013.03.003., DOI 10.1016/J.MEDIPA.2013.03.003]; World Health Organization, 2004, PALL CAR SOL FACTS	38	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177000	10.1371/journal.pone.0177000	http://dx.doi.org/10.1371/journal.pone.0177000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28545037	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400016
J	Laspas, P; Culmann, PD; Grus, FH; Prokosch-Willing, V; Poplawksi, A; Pfeiffer, N; Hoffmann, EM				Laspas, P.; Culmann, P. D.; Grus, F. H.; Prokosch-Willing, V.; Poplawksi, A.; Pfeiffer, N.; Hoffmann, E. M.			Revision of encapsulated blebs after trabeculectomy: Long-term comparison of standard bleb needling and modified needling procedure combined with transconjunctival scleral flap sutures	PLOS ONE			English	Article							FILTRATION SURGERY; EFFICACY; HYPOTONY; OUTCOMES; SAFETY	Purpose To compare two surgical approaches for treating encapsulated blebs after trabeculectomy with mitomycin C, in terms of the development of intraocular pressure and progression of glaucoma in a long-term follow up: 1. bleb needling alone vs. 2. a combined approach of needling with additional transconjunctival scleral flap sutures, to prevent early ocular hypotony. Methods Forty-six patients with failing blebs after trabeculectomy with mitomycin C were enrolled in this study. Patients received either needling revision alone (group 1; n = 23) or a combined needling with additional transconjuctival flap sutures, if intraoperatively the intraocular pressure was estimated to be low (group 2; n = 23). Intraocular pressure (IOP), visual acuity, visual fields, and optic nerve head configuration by means of Heidelberg Retina Tomograph (HRT (R)) were analysed over time. Results from both groups were compared using Mann-Whitney U-test for single timepoints. Results IOP did not differ significantly between the two groups during follow-up at three months (P = 0.13), six months (P = 0.12), one year (P = 0.92) and two years (P = 0.57) after surgery. Furthermore, there was no significant difference in the course of glaucoma concerning the optic nerve anatomy between the two groups (Rim Area Change in the Moorfields Regression Analysis of HRT (R)) till two years after surgery (P = 0.289). No functional impairment in visual acuity and visual fields was found in the groups of the study. Conclusions Single needling procedure is a standard successful method for restoring the function of encapsulated blebs. Postoperative hypotony represents a possible hazard, which can be minimized by additional transconjunctival flap sutures. Long-term results suggest that this modification is equally effective in lowering the IOP and preventing the progression of glaucoma as the standard needling procedure. To our knowledge this is the first study to investigate the long-term effect of tranconjunctival sutures for the prevention of hypotony.	[Laspas, P.; Culmann, P. D.; Grus, F. H.; Prokosch-Willing, V.; Poplawksi, A.; Pfeiffer, N.; Hoffmann, E. M.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany	Johannes Gutenberg University of Mainz	Laspas, P (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany.	panoslaspas@gmail.com	Hoffmann, Esther/AAO-5968-2021; Poplawski, Alicia/U-4910-2019; Hoffmann, Esther/AAY-3575-2020; Pfeiffer, Norbert/AAO-7586-2020	Hoffmann, Esther/0000-0002-0949-4268; Schulze, Alicia/0000-0003-2527-0763				Anand N, 2009, J GLAUCOMA, V18, P513, DOI 10.1097/IJG.0b013e3181911271; Azuara-Blanco A, 1998, SURV OPHTHALMOL, V43, P93, DOI 10.1016/S0039-6257(98)00025-3; Chang Shirley Hsueh-Li, 2002, Chang Gung Med J, V25, P97; De Fendi LI, 2013, CLIN EXP OPHTHALMOL, V41, P798, DOI 10.1111/ceo.12097; Duman F, 2016, EUR J OPHTHALMOL, V26, P307, DOI 10.5301/ejo.5000718; Eha J, 2013, AM J OPHTHALMOL, V155, P864, DOI 10.1016/j.ajo.2012.12.004; Errico D, 2011, CLIN OPHTHALMOL, V5, P1679, DOI 10.2147/OPTH.S25611; Green E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001132.pub2; Jeganathan VSE, 2008, BRIT J OPHTHALMOL, V92, P1393, DOI 10.1136/bjo.2008.141689; Kapasi MS, 2009, J GLAUCOMA, V18, P144, DOI 10.1097/IJG.0b013e318170a71c; Koukkoulli A, 2015, GRAEF ARCH CLIN EXP, V253, P99, DOI 10.1007/s00417-014-2810-4; Laspas P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157320; Letartre L, 2009, CAN J OPHTHALMOL, V44, P567, DOI 10.3129/i09-123; Occleston NL, 1997, INVEST OPHTH VIS SCI, V38, P1998; Rahman A, 2000, INT OPHTHALMOL CLIN, V40, P127, DOI 10.1097/00004397-200040010-00013; Rotchford AP, 2008, OPHTHALMOLOGY, V115, P1148, DOI 10.1016/j.ophtha.2007.10.023; Rulli E, 2013, JAMA OPHTHALMOL, V131, P1573, DOI 10.1001/jamaophthalmol.2013.5059; SHERWOOD MB, 1987, ARCH OPHTHALMOL-CHIC, V105, P1517, DOI 10.1001/archopht.1987.01060110063032	18	9	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178099	10.1371/journal.pone.0178099	http://dx.doi.org/10.1371/journal.pone.0178099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542372	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672400141
J	Martenot, C; Gervais, O; Chollet, B; Houssin, M; Renault, T				Martenot, Claire; Gervais, Ophelie; Chollet, Bruno; Houssin, Maryline; Renault, Tristan			Haemocytes collected from experimentally infected Pacific oysters, Crassostrea gigas: Detection of ostreid herpesvirus 1 DNA, RNA, and proteins in relation with inhibition of apoptosis	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; TO-CELL SPREAD; OSHV-1 MU-VAR; IMMUNE-RESPONSE; TOMALES BAY; MORTALITY; THUNBERG; TRANSMISSION; CALIFORNIA; TYPE-1	Recent transcriptomic approaches focused on anti-viral immunity in molluscs lead to the assumption that the innate immune system, such as apoptosis, plays a crucial role against ostreid herpesvirus type 1 (OsHV-1), infecting Pacific cupped oyster, Crassostrea gigas. Apoptosis constitutes a major mechanism of anti-viral response by limiting viral spread and eliminating infected cells. In this way, an OsHV-1 challenge was performed and oysters were monitored at three times post injection to investigate viral infection and host response: 2h (early after viral injection in the adductor muscle), 24h (intermediate time), and 48h (just before first oyster mortality record). Virus infection, associated with high cumulative mortality rates (74% and 100%), was demonstrated in haemocytes by combining several detection techniques such as real-time PCR, real-time RT PCR, immunofluorescence assay, and transmission electron microscopy examination. High viral DNA amounts ranged from 5.46x10(4) to 3.68x10(5) DNA copies ng(-1) of total DNA, were detected in dead oysters and an increase of viral transcripts was observed from 2, 24, and 48hpi for the five targeted OsHV-1 genes encoding three putative membrane proteins (ORFs 25, 41, and 72), a putative dUTPase (ORF 75), and a putative apoptosis inhibitor (ORF 87). Apoptosis was studied at molecular and cellular levels with an early marker (phosphatidyl-serine externalisation measured by flow cytometry and epifluorescence microscopy) and a later parameter (DNA fragmentation by terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling assay (TUNEL)). The down-regulation of genes encoding proteins involved in the activation of the apoptotic pathway (TNF and caspase 3) and the up-regulation of genes encoding anti-apoptotic proteins (IAP-2, and Bcl-2) suggested an important anti-apoptosis phenomenon in haemocytes from OsHV-1 infected oysters at 24 and 48hpi. Additionally, more phosphatidyl-serines were externalized and more cells with DNA fragmentation were observed in haemocytes collected from artificial seawater injected oysters than in haemocytes collected from OsHV-1 infected oysters at 24 and 48hpi, suggesting an inhibition of the apoptotic process in presence of the virus. In conclusion, this study is the first to focus on C. gigas haemocytes, cells involved in the host immune defense, during an OsHV-1 challenge in controlled conditions by combining various and original approaches to investigate apoptosis at molecular and cellular levels.	[Martenot, Claire; Gervais, Ophelie; Chollet, Bruno] IFREMER, Inst Francais Rech Exploitat Mer, Lab Genet & Pathol Mollusques Marins, La Tremblade, France; [Houssin, Maryline] LABEO Frank Duncombe, Caen, France; [Renault, Tristan] IFREMER, Dept Ressources Biol & Environm, Nantes, France	Ifremer; Ifremer	Martenot, C (corresponding author), IFREMER, Inst Francais Rech Exploitat Mer, Lab Genet & Pathol Mollusques Marins, La Tremblade, France.	claire.martenot@ifremer.fr		Gervais, Ophelie/0000-0002-4303-3289	Institut Francais de Recherche pour l'Exploitation de la Mer; European project "MOLecular TRacing of viral pathogens in AQuaculture" (MOLTRAQ); European project "improving European mollusc aquaculture: disease detection and management" (Bivalife)	Institut Francais de Recherche pour l'Exploitation de la Mer; European project "MOLecular TRacing of viral pathogens in AQuaculture" (MOLTRAQ); European project "improving European mollusc aquaculture: disease detection and management" (Bivalife)	This study was supported by the Institut Francais de Recherche pour l'Exploitation de la Mer. This work received financial support from the European projects "MOLecular TRacing of viral pathogens in AQuaculture" (MOLTRAQ) and "improving European mollusc aquaculture: disease detection and management" (Bivalife). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaitua F, 2013, J VIROL, V87, P7921, DOI 10.1128/JVI.01172-13; Aleman N, 2001, J VIROL, V75, P469, DOI 10.1128/JVI.75.1.469-479.2001; Aranguren R., 2012, DETECTION HERPESVIRU; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Batista FM, 2014, AQUAC RES; Bingham P., 2013, Surveillance (Wellington), V40, P20; Bivlaves Cheng T., 1981, INVERTEBRATE BLOOD C; Burge CA, 2006, DIS AQUAT ORGAN, V72, P31, DOI 10.3354/dao072031; Burge CA, 2011, DIS AQUAT ORGAN, V94, P107, DOI 10.3354/dao02314; Clegg TA, 2014, PREV VET MED, V113, P257, DOI 10.1016/j.prevetmed.2013.10.023; Cocchi F, 2000, J VIROL, V74, P3909, DOI 10.1128/JVI.74.8.3909-3917.2000; Corbeil S, 2015, J VIROL METHODS, V211, P43, DOI 10.1016/j.jviromet.2014.10.007; Cuff S, 1996, IMMUNOL CELL BIOL, V74, P527, DOI 10.1038/icb.1996.86; da Silva PM, 2008, DIS AQUAT ORGAN, V78, P181, DOI 10.3354/dao01874; Davison AJ, 2005, J GEN VIROL, V86, P41, DOI 10.1099/vir.0.80382-0; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; De Decker S, 2013, AQUACULTURE, V392, P1, DOI 10.1016/j.aquaculture.2013.01.033; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Domeneghetti S, 2014, FISH SHELLFISH IMMUN, V41, P37, DOI 10.1016/j.fsi.2014.05.023; Du T, 2012, P NATL ACAD SCI USA, V109, P14616, DOI 10.1073/pnas.1212661109; Dundon WG, 2011, AQUACULTURE, V314, P49, DOI 10.1016/j.aquaculture.2011.02.005; Estevez-Calvar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061502; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Fisher W.S., 1986, P25; Friedman CS, 2005, DIS AQUAT ORGAN, V63, P33, DOI 10.3354/dao063033; Gagnaire B, 2006, FISH SHELLFISH IMMUN, V20, P536, DOI 10.1016/j.fsi.2005.07.003; Gagnaire B, 2004, FISH SHELLFISH IMMUN, V16, P501, DOI 10.1016/j.fsi.2003.08.007; Gagnaire B, 2007, AQUAT TOXICOL, V84, P92, DOI 10.1016/j.aquatox.2007.06.002; Gervais O, 2015, FISH SHELLFISH IMMUN, V46, P232, DOI 10.1016/j.fsi.2015.05.046; Green TJ, 2015, FISH SHELLFISH IMMUN, V47, P435, DOI 10.1016/j.fsi.2015.09.025; Grijalva-Chon JM, 2013, J FISH DIS, V36, P965, DOI 10.1111/jfd.12028; Hwang JY, 2013, J FISH DIS, V36, P969, DOI 10.1111/jfd.12093; Jee B.Y., 2013, DETECTION OSTREID HE; Jenkins C, 2013, DIS AQUAT ORGAN, V105, P109, DOI 10.3354/dao02623; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Jerome KR, 1999, J VIROL, V73, P8950, DOI 10.1128/JVI.73.11.8950-8957.1999; Jouaux A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-590; Keeling SE, 2014, DIS AQUAT ORGAN, V109, P231, DOI 10.3354/dao02735; Kleinschmidt MC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-49; Koyama AH, 2000, MICROBES INFECT, V2, P1111, DOI 10.1016/S1286-4579(00)01265-X; Lagunoff M, 2003, INT REV IMMUNOL, V22, P373, DOI 10.1080/08830180305218; Le Bouffant R, 2008, EXP CELL RES, V314, P961, DOI 10.1016/j.yexcr.2007.12.014; Le Deuff RM, 1999, J GEN VIROL, V80, P1317, DOI 10.1099/0022-1317-80-5-1317; Lynch SA, 2012, PARASITOLOGY, V139, P1526, DOI 10.1017/S0031182012000881; Martenot C, 2012, AQUACULTURE, V338, P293, DOI 10.1016/j.aquaculture.2011.12.030; Martenot C, 2010, J VIROL METHODS, V170, P86, DOI 10.1016/j.jviromet.2010.09.003; Martenot C, 2016, J INVERTEBR PATHOL, V136, P124, DOI 10.1016/j.jip.2016.04.002; Martenot C, 2015, AQUACULTURE, V439, P1, DOI 10.1016/j.aquaculture.2015.01.012; Martenot C, 2011, VIRUS RES, V160, P25, DOI 10.1016/j.virusres.2011.04.012; Montagnaro S, 2013, J CELL BIOCHEM, V114, P2809, DOI 10.1002/jcb.24628; Moreau P, 2015, AUTOPHAGY; Morga B, 2009, FISH SHELLFISH IMMUN, V26, P836, DOI 10.1016/j.fsi.2009.03.018; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Negoescu A., 1997, BIOCHEMICA, P12; Nguyen ML, 2007, ADV VIRUS RES, V69, P67, DOI 10.1016/S0065-3527(06)69002-7; O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833; Paul-Pont I, 2014, AQUACULTURE, V422, P146, DOI 10.1016/j.aquaculture.2013.12.009; Paul-Pont I, 2013, AQUACULTURE, V412, P202, DOI 10.1016/j.aquaculture.2013.07.038; Paul-Pont I, 2013, DIS AQUAT ORGAN, V105, P127, DOI 10.3354/dao02615; Peeler EJ, 2012, PREV VET MED, V105, P136, DOI 10.1016/j.prevetmed.2012.02.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prasad A, 2013, J VIROL, V87, P10641, DOI 10.1128/JVI.01178-13; RENAULT T, 1994, REV MED VET-TOULOUSE, V145, P735; Renault T, 2011, DEV COMP IMMUNOL, V35, P725, DOI 10.1016/j.dci.2011.02.004; Renault T, 1995, CELL TISSUE ORGAN CU, V17, P199; Renault T, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-3; Renault T, 2012, J VIROL, V86, P5942, DOI 10.1128/JVI.06534-11; Roque A, 2012, AQUACULTURE, V324, P303, DOI 10.1016/j.aquaculture.2011.10.018; Rosani U., 2014, ENV MICROBIOL; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Scherubl Christoph, 2005, J Inflamm (Lond), V2, P7, DOI 10.1186/1476-9255-2-7; Schikorski D, 2011, VIRUS RES, V155, P28, DOI 10.1016/j.virusres.2010.07.031; Schikorski D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-27; Segarra A, 2014, VET RES, P45; Segarra A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-580; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Silva MC, 2005, P NATL ACAD SCI USA, V102, P2081, DOI 10.1073/pnas.0409597102; Whittington RJ, 2015, AQUACULTURE, V437, P10, DOI 10.1016/j.aquaculture.2014.11.016; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	80	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177448	10.1371/journal.pone.0177448	http://dx.doi.org/10.1371/journal.pone.0177448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542284	Green Published, gold			2022-12-27	WOS:000401672400045
J	Porte, L; Garcia, P; Braun, S; Ulloa, MT; Lafourcade, M; Montana, A; Miranda, C; Acosta-Jamett, G; Weitzel, T				Porte, Lorena; Garcia, Patricia; Braun, Stephanie; Ulloa, Maria Teresa; Lafourcade, Monica; Montana, Alisson; Miranda, Carolina; Acosta-Jamett, Gerardo; Weitzel, Thomas			Head-to-head comparison of Microflex LT and Vitek MS systems for routine identification of microorganisms by MALDI-TOF mass spectrometry in Chile	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; CLINICAL MICROBIOLOGY; RAPID DETECTION; ANTIBIOTIC-RESISTANCE; YEAST IDENTIFICATION; BACTERIA; RELIABILITY; ORGANISMS; PLATFORMS; DIFFICULT	Background Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS) is a new and revolutionary identification method for microorganisms and has recently been introduced into clinical microbiology in many industrialized countries in Europe and North America. Objectives Our study aimed to compare the performance and practicality of two commercial MALDI-TOF MS platforms in a head-to head manner at a routine laboratory in Chile. Methods During a five-month period in 2012-13, the diagnostic efficiency (correct identification rate) and agreement between Microflex LT (Bruker Daltonics) and Vitek MS (bioMerieux) was compared in a parallel manner to conventional identification including genotypic analysis for difficult-to-identify strains. The study included 804 microbial isolates: 252 Enterobacteriaceae, 126 non-fermenters, 36 other gram-negative rods, 279 gram-positive cocci, 32 gram-positive rods, 32 anaerobes, and 47 yeasts. Other relevant factors of the two devices such as user friendliness and connectivity were also evaluated and compared. Results Both systems correctly identified the vast majority (98%) of the isolates to the genus level. Vitek MS reached higher rates of identification to species and species complex level than Microflex LT ( 81% vs. 85% and 87% vs. 93%, respectively), which was mainly based on the higher performance among coagulase negative staphylococci and Candida isolates. The evaluation of user friendliness and other technical aspects showed only marginal differences, which slightly favored Vitek MS, mainly due to its ready-to-use supplies, easier connectivity and workflow integration, and availability of local technical support. Conclusions Both MALDI-TOF MS systems permitted fast and accurate identification of most microbial strains and showed a high level of user-friendliness. The observed differences were marginal and slightly favored Vitek MS, mainly due to practicality and connectivity issues within our setting.	[Porte, Lorena; Montana, Alisson; Weitzel, Thomas] Univ Desarrollo, Lab Clin, Clin Alemana Santiago, Fac Med Clin Alemana, Santiago, Chile; [Porte, Lorena; Braun, Stephanie] Hosp Mil, Lab Clin, Unidad Microbiol, Santiago, Chile; [Garcia, Patricia] Pontificia Univ Catolica Chile, Dept Lab Clin, Escuela Med, Santiago, Chile; [Ulloa, Maria Teresa] Univ Chile, ICBM Fac Med, Programa Microbiol, Santiago, Chile; [Lafourcade, Monica; Montana, Alisson] Clin Santa Maria, Lab Microbiol, Santiago, Chile; [Miranda, Carolina] Red Salud UC CHRISTUS, Lab Microbiol, Serv Lab Clin, Santiago, Chile; [Acosta-Jamett, Gerardo] Univ Austral Chile, Inst Med Prevent Vet, Fac Ciencias Vet, Valdivia, Chile	Clinica Alemana; Universidad del Desarrollo; Universidad de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad Austral de Chile	Porte, L (corresponding author), Univ Desarrollo, Lab Clin, Clin Alemana Santiago, Fac Med Clin Alemana, Santiago, Chile.; Porte, L (corresponding author), Hosp Mil, Lab Clin, Unidad Microbiol, Santiago, Chile.	lporte@alemana.cl		, Lorena/0000-0001-7766-7995; Acosta, Gerardo/0000-0002-9645-3551; Weitzel, Thomas/0000-0002-9804-2123				Alby K, 2013, J CLIN MICROBIOL, V51, P3852, DOI 10.1128/JCM.01618-13; Bailey D, 2013, CLIN CHEM, V59, P1435, DOI 10.1373/clinchem.2013.204644; Balada-Llasat JM, 2013, J CLIN MICROBIOL, V51, P2875, DOI 10.1128/JCM.00819-13; Bilecen K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/516410; Biswas S, 2013, J MICROBIOL METH, V92, P14, DOI 10.1016/j.mimet.2012.10.014; Bizzini A, 2011, J CLIN MICROBIOL, V49, P693, DOI 10.1128/JCM.01463-10; Carrasco G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00542; Cassagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028425; Chalupova J, 2014, BIOTECHNOL ADV, V32, P230, DOI 10.1016/j.biotechadv.2013.11.002; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Clinical and laboratory standards institute (CLSI), MM18A CLSI; Conville PS, 2015, MANUAL CLIN MICROBIO, P504, DOI 10.1128/9781555817381.ch29; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Culebras E, 2016, ENFERM INFEC MICR CL, V34, P42, DOI 10.1016/S0213-005X(16)30190-2; Deak E, 2015, DIAGN MICR INFEC DIS, V81, P27, DOI 10.1016/j.diagmicrobio.2014.09.018; Degand N, 2008, J CLIN MICROBIOL, V46, P3361, DOI 10.1128/JCM.00569-08; DeMarco ML, 2013, CLIN LAB MED, V33, P611, DOI 10.1016/j.cll.2013.03.013; Dieckmann R, 2011, APPL ENVIRON MICROB, V77, P4136, DOI 10.1128/AEM.02418-10; Dixon P, 2015, EUR J CLIN MICROBIOL, V34, P863, DOI 10.1007/s10096-015-2322-0; Emonet S, 2010, CLIN MICROBIOL INFEC, V16, P1604, DOI 10.1111/j.1469-0691.2010.03368.x; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; Gaillot O, 2011, J CLIN MICROBIOL, V49, P4412, DOI 10.1128/JCM.05429-11; Garcia P, 2012, REV CHIL INFECTOL, V29, P263, DOI 10.4067/S0716-10182012000300003; Garner O, 2014, CLIN MICROBIOL INFEC, V20, P335, DOI 10.1111/1469-0691.12317; Hrabak J, 2013, CLIN MICROBIOL REV, V26, P103, DOI 10.1128/CMR.00058-12; Jamal W, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0289-0; Kiyosuke M, 2015, J MED MICROBIOL, V64, P1144, DOI 10.1099/jmm.0.000136; Kostrzewa M, 2013, PROTEOM CLIN APPL, V7, P767, DOI 10.1002/prca.201300042; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lartigue MF, 2013, INFECT GENET EVOL, V13, P230, DOI 10.1016/j.meegid.2012.10.012; Lau SKP, 2014, J CLIN PATHOL, V67, P361, DOI 10.1136/jclinpath-2013-201818; Leber AL, 2016, CLIN MICROBIOLOGY PR; Lo CI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145889; Lohmann C, 2013, J CLIN MICROBIOL, V51, P1231, DOI 10.1128/JCM.03268-12; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; Martiny D, 2012, J CLIN MICROBIOL, V50, P1313, DOI 10.1128/JCM.05971-11; Mirande C, 2015, EUR J CLIN MICROBIOL, V34, P2225, DOI 10.1007/s10096-015-2473-z; Moon HW, 2013, J MED MICROBIOL, V62, P1301, DOI 10.1099/jmm.0.062950-0; Nomura F, 2015, BBA-PROTEINS PROTEOM, V1854, P528, DOI 10.1016/j.bbapap.2014.10.022; Oviano M, 2016, ENFERM INFEC MICR CL, V34, P36, DOI 10.1016/S0213-005X(16)30189-6; Paauw A, 2015, INT J MED MICROBIOL, V305, P446, DOI 10.1016/j.ijmm.2015.04.001; Patel R, 2015, CLIN CHEM, V61, P100, DOI 10.1373/clinchem.2014.221770; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Posterard B, 2013, EXPERT REV PROTEOMIC, V10, P151, DOI [10.1586/EPR.13.8, 10.1586/epr.13.8]; Ranque S, 2014, MYCOSES, V57, P135, DOI 10.1111/myc.12115; Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Spinali S, 2015, J CLIN MICROBIOL, V53, P760, DOI 10.1128/JCM.01635-14; Tan KE, 2012, J CLIN MICROBIOL, V50, P3301, DOI 10.1128/JCM.01405-12; TeKippe EM, 2014, EUR J CLIN MICROBIOL, V33, P2163, DOI 10.1007/s10096-014-2183-y; Toh BEW, 2015, J MICROBIOL METH, V118, P128, DOI 10.1016/j.mimet.2015.09.006; van Prehn J, 2016, DIAGN MICR INFEC DIS, V85, P9, DOI 10.1016/j.diagmicrobio.2016.01.012; Vaneechoute M, 2000, J CLIN MICROBIOL, V38, P3870, DOI 10.1128/JCM.38.10.3870-3871.2000; Vega-Castano S, 2012, ENFERM INFEC MICR CL, V30, P597, DOI 10.1016/j.eimc.2012.03.002; Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589; Wang H, 2012, J CLIN MICROBIOL, V50, P3952, DOI 10.1128/JCM.01130-12; Welker M, 2011, PROTEOMICS, V11, P3143, DOI 10.1002/pmic.201100049; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; Wilck MB, 2001, J CLIN MICROBIOL, V39, P2025, DOI 10.1128/JCM.39.5.2025-2027.2001; Yong PVC, 2008, MYCOPATHOLOGIA, V165, P81, DOI 10.1007/s11046-007-9086-8; Zhang L, 2014, J CLIN MICROBIOL, V52, P572, DOI 10.1128/JCM.02543-13	63	24	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177929	10.1371/journal.pone.0177929	http://dx.doi.org/10.1371/journal.pone.0177929			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542393	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400116
J	Shang, FF; Gan, YK; Guo, YF				Shang, Feifei; Gan, Yangke; Guo, Yufei			Hexahedral mesh generation via constrained quadrilateralization	PLOS ONE			English	Article							CONNECTIVITY-BASED METHOD; ALGORITHM; GEOMETRY; QUALITY	Decomposing a volume into high-quality hexahedral cells is a challenging task in finite element simulations and computer graphics. Inspired by the use of a spatial twist continuum and frame field in previous hexahedral mesh generation methods, we present a method of hexahedral mesh generation via constrained quadrilateralization that combines a spatial twist continuum and frame fields. Given a volume represented by a tetrahedral mesh, surface quadrilateral mesh and frame field, we first extend the loop of the surface of a solid to a layer of hexahedral elements, then divide the solid into two smaller sub-solids by the layer, and finally handle them recursively until all of the sub-solids are empty. In our hexahedral mesh generation framework, we apply constrained quadrilateralization to extend the loop to a layer of hexahedral elements. The "divide-and-conquer" strategy used in this method is suitable for parallelization. This method can potentially lead to easier and more robust implementations that are more parallelizable and less dependent on heavy numerical libraries. The testing results show that the quality of the meshes generated by this method is similar to those produced by current state-of-the-art mesh generation methods.	[Shang, Feifei; Gan, Yangke; Guo, Yufei] Peking Univ, Coll Engn, Dept Mech & Engn Sci, Beijing, Peoples R China	Peking University	Shang, FF (corresponding author), Peking Univ, Coll Engn, Dept Mech & Engn Sci, Beijing, Peoples R China.	ffshang@pku.edu.cn			National Natural Science Foundation of China [11172005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (grant number: 11172005), http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blacker T, 2001, ENG COMPUT-GERMANY, V17, P201, DOI 10.1007/PL00013384; Blacker T, 2000, P 9 INT MESH ROUNDT; BLACKER TD, 1993, ENG COMPUT, V9, P83, DOI 10.1007/BF01199047; Calvo NA, 2000, COMPUT METHOD APPL M, V182, P371, DOI 10.1016/S0045-7825(99)00199-1; Canann S., 1992, PLASTERING NEW APPRO; Cook WA, 1982, COMPUTERS MECH ENG, V1, P67; Folwell NT, 1999, ENG COMPUT, V15, P292, DOI 10.1007/s003660050024; Gregson J, 2011, COMPUT GRAPH FORUM, V30, P1407, DOI 10.1111/j.1467-8659.2011.02015.x; Huang J., 2012, TECH REP; Huang J, 2014, ACM T GRAPHIC, V33, DOI [10.1145/2602141, 10.1145/2601097.2601205]; Huang J, 2011, ACM T GRAPHIC, V30, DOI 10.1145/2024156.2024177; Jiang TF, 2014, IEEE T VIS COMPUT GR, V20, P1189, DOI 10.1109/TVCG.2013.250; Kawamura Y, 2008, ENG COMPUT-GERMANY, V24, P215, DOI 10.1007/s00366-008-0092-3; KNUPP P, 2013, MESQUITE MESH QUALIT; Knupp PM, 2000, INT J NUMER METH ENG, V48, P1165, DOI 10.1002/(SICI)1097-0207(20000720)48:8<1165::AID-NME940>3.0.CO;2-Y; Kowalski N, 2014, PROCEDIA ENGINEER, V82, P59, DOI 10.1016/j.proeng.2014.10.373; Kowalski N, 2015, COMPUTER AIDED DESIG; Kremer M, 2013, P 22 INT MESH ROUNDT, P147; Ledoux F, 2008, PROCEEDINGS OF THE 16TH INTERNATIONAL MESHING ROUNDTABLE, P215, DOI 10.1007/978-3-540-75103-8_13; Li Yufei, 2012, ACM T GRAPHIC, V31, P1; Lin H, 2012, 2012002 TR ZJUCAD ZH; Lin HW, 2015, COMPUT AIDED DESIGN, V67-68, P107, DOI 10.1016/j.cad.2015.05.004; Lin JC, 2008, LECT NOTES COMPUT SC, V4975, P3; Liu L, 2015, COMPUT AIDED DESIGN, V58, P162, DOI 10.1016/j.cad.2014.08.020; Livesu M, 2016, COMPUTER GRAPHICS FO; Livesu M, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2508363.2508388; Marechal L, 2009, PROCEEDINGS OF THE 18TH INTERNATIONAL MESHING ROUNDTABLE, P65, DOI 10.1007/978-3-642-04319-2_5; Melander DJ, 1997, GENERATION MULTIMILL; Muller-Hannemann M, 1999, ENG COMPUT, V15, P269, DOI 10.1007/s003660050022; Murdoch P, 1997, FINITE ELEM ANAL DES, V28, P137, DOI 10.1016/S0168-874X(97)81956-7; Owen S.J., 1998, P 7 INT MESH ROUNDT; Owen SJ, 2000, INT J NUMER METH ENG, V49, P289, DOI 10.1002/1097-0207(20000910/20)49:1/2<289::AID-NME934>3.0.CO;2-L; Sarrate Ramos J, 2014, COMPUTATIONAL TECHNO; Schneiders R, 1996, ENG COMPUT, V12, P168, DOI 10.1007/BF01198732; Schneiders R., 1996, P 5 INT MESH ROUNDT; Staten ML, 2006, PROCEEDINGS OF THE 15TH INTERNATIONAL MESHING ROUNDTABLE, P469, DOI 10.1007/978-3-540-34958-7_27; Staten ML, 2010, INT J NUMER METH ENG, V81, P135, DOI 10.1002/nme.2679; Staten ML, 2005, Proceedings of the 14th International Meshing Roundtable, P399, DOI 10.1007/3-540-29090-7_24; Tarini M, 2004, ACM T GRAPHIC, V23, P853, DOI 10.1145/1015706.1015810; Tautges TJ, 1996, INT J NUMER METH ENG, V39, P3327; Tautges TJ, 2001, INT J NUMER METH ENG, V50, P2617, DOI 10.1002/nme.139; Tautges TJ, 1995, P 4 INT MESH ROUNDT; Yu WY, 2015, INT CONF COMP SCI ED, P697, DOI 10.1109/ICCSE.2015.7250335; Zhang YJ, 2006, PROCEEDINGS OF THE 15TH INTERNATIONAL MESHING ROUNDTABLE, P73, DOI 10.1007/978-3-540-34958-7_5	44	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177603	10.1371/journal.pone.0177603	http://dx.doi.org/10.1371/journal.pone.0177603			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542355	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400057
J	Ly, AT; Noto, JP; Walwyn, OL; Tanz, RR; Shulman, ST; Kabat, W; Bessen, DE				Ly, Anhphan T.; Noto, John P.; Walwyn, Odaelys L.; Tanz, Robert R.; Shulman, Stanford T.; Kabat, William; Bessen, Debra E.			Differences in SpeB protease activity among group A streptococci associated with superficial, invasive, and autoimmune disease	PLOS ONE			English	Article							ACUTE RHEUMATIC-FEVER; CYSTEINE PROTEASE; VIRULENCE FACTORS; TISSUE TROPISM; UNITED-STATES; HEART-DISEASE; M PROTEINS; EMM TYPES; INFECTIONS; PYOGENES	The secreted cysteine proteinase SpeB is an important virulence factor of group A streptococci (GAS), whereby SpeB activity varies widely among strains. To establish the degree to which SpeB activity correlates with disease, GAS organisms were recovered from patients with pharyngitis, impetigo, invasive disease or acute rheumatic fever (ARF), and selected for analysis using rigorous sampling criteria; > 300 GAS isolates were tested for SpeB activity by casein digestion assays, and each GAS isolate was scored as a SpeB-producer or non-producer. Highly significant statistical differences (p < 0.01) in SpeB production are observed between GAS recovered from patients with ARF (41.5% SpeB-non-producers) compared to pharyngitis (20.5%), invasive disease (16.7%), and impetigo (5.5%). SpeB activity differences between pharyngitis and impetigo isolates are also significant, whereas pharyngitis versus invasive isolates show no significant difference. The disproportionately greater number of SpeB-non-producers among ARF-associated isolates may indicate an altered transcriptional program for many rheumatogenic strains and/or a protective role for SpeB in GAS-triggered autoimmunity.	[Ly, Anhphan T.; Noto, John P.; Walwyn, Odaelys L.; Bessen, Debra E.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Tanz, Robert R.; Shulman, Stanford T.; Kabat, William] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL USA; [Tanz, Robert R.; Shulman, Stanford T.; Kabat, William] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA	New York Medical College; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago	Bessen, DE (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	debra_bessen@nymc.edu			NIH [AI065572, AI117088]; The National Institutes of Health [AI065572, AI117088]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH AI065572 and AI117088 (www.nih.gov) to D.E.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the many investigators who have provided bacterial strains over past years. This work was supported by The National Institutes of Health (AI065572 and AI117088, to D.E.B.).	Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; BESSEN D, 1989, J EXP MED, V169, P269, DOI 10.1084/jem.169.1.269; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842; Bessen DE., 2016, STREPTOCOCCUS PYOGEN; Bessen DE, 2016, CURR OPIN INFECT DIS, V29, P295, DOI 10.1097/QCO.0000000000000262; Bessen DE, 2015, INFECT GENET EVOL, V33, P393, DOI 10.1016/j.meegid.2014.10.011; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; BISNO AL, 1977, J INFECT DIS, V136, P278, DOI 10.1093/infdis/136.2.278; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 1996, MED J AUSTRALIA, V164, P146, DOI 10.5694/j.1326-5377.1996.tb122012.x; Carroll RK, EPIDEMICS, V3, P159; Carroll RK, 2011, MOL MICROBIOL, V81, P588, DOI 10.1111/j.1365-2958.2011.07709.x; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cunningham MW, 2012, CURR OPIN RHEUMATOL, V24, P408, DOI 10.1097/BOR.0b013e32835461d3; Fiorentino TR, 1997, J INFECT DIS, V176, P177, DOI 10.1086/514020; Gewitz MH, 2015, CIRCULATION, V131, P1806, DOI 10.1161/CIR.0000000000000205; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hauknes HA, 2002, J INFECT DIS, V185, P915, DOI 10.1086/339407; HOLLINGSHEAD SK, 1993, MOL MICROBIOL, V8, P707, DOI 10.1111/j.1365-2958.1993.tb01614.x; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kuttner AG, 1941, J CLIN INVEST, V20, P273, DOI 10.1172/JCI101220; Lizano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003450; Lynskey NN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005137; McGregor KF, 2004, J INFECT DIS, V189, P717, DOI 10.1086/381452; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; McMillan DJ, 2013, CLIN MICROBIOL INFEC, V19, pE222, DOI 10.1111/1469-0691.12134; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Olsen RJ, 2015, INFECT IMMUN, V83, P4750, DOI 10.1128/IAI.00989-15; Olsen RJ, 2010, P NATL ACAD SCI USA, V107, P888, DOI 10.1073/pnas.0911811107; POTTER EV, 1978, J PEDIATR-US, V92, P325, DOI 10.1016/S0022-3476(78)80036-5; Quinn A, 2001, INFECT IMMUN, V69, P4072, DOI 10.1128/IAI.69.6.4072-4078.2001; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Shulman ST, 2006, CLIN INFECT DIS, V42, P441, DOI 10.1086/499812; Shulman ST, 2004, CLIN INFECT DIS, V39, P325, DOI 10.1086/421949; Shulman ST, 2014, CLIN INFECT DIS, V59, P1651, DOI 10.1093/cid/ciu649; Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; STOLLERMAN GH, 1991, CLIN IMMUNOL IMMUNOP, V61, P131, DOI 10.1016/S0090-1229(05)80019-4; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Veasy LG, 2004, PEDIATRICS, V113, pE168, DOI 10.1542/peds.113.3.e168; VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; WANNAMAKER LW, 1970, NEW ENGL J MED, V282, P23, DOI 10.1056/NEJM197001082820206; Williamson DA, 2015, J CLIN MICROBIOL, V53, P3618, DOI 10.1128/JCM.02129-15	53	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177784	10.1371/journal.pone.0177784	http://dx.doi.org/10.1371/journal.pone.0177784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545045	gold, Green Published			2022-12-27	WOS:000401487700075
J	Loas, G; Braun, S; Delhaye, M; Linkowski, P				Loas, Gwenole; Braun, Stephanie; Delhaye, Marie; Linkowski, Paul			The measurement of alexithymia in children and adolescents: Psychometric properties of the Alexithymia Questionnaire for Children and the twenty-item Toronto Alexithymia Scale in different non-clinical and clinical samples of children and adolescents	PLOS ONE			English	Article							RATING DEPRESSION SCALE; PSYCHIATRIC OUTPATIENTS; OVERLAPPING CONSTRUCTS; INTERNAL CONSISTENCY; VALIDATION; RELIABILITY; POPULATION; PREVALENCE; FACTORIAL; DISORDER	This study had two aims. Firstly, the psychometric properties of the 20-item Toronto Alexithymia Scale (TAS-20) and the Alexithymia Questionnaire for Children (AQC) that measure the three dimensions of alexithymia (DIF, difficulty identifying feelings; DDF, difficulty describing feelings; EOT, externally-oriented thinking) were explored in various samples of children, adolescents or young adults to detect the best factor-structure and to examine if the Externally-Oriented Thinking (EOT) factor must be deleted or not. Secondly, the capacity for adolescents to distinguish between alexithymia and depression was studied using factorial analyses of items of self-report of alexithymia and depression scales. Four groups were examined (80 healthy children, 105 adolescents with various psychiatric disorders, 333 healthy older adolescents and 505 young adults recruited from universities). The first two groups filled out the AQC and the latter two the TAS-20. Confirmatory factorial analyses (CFA) showed that the two-factor model (DIF, DDF) provided acceptable fits and had significant advantages over the three-factor model (DIF, DDF, EOT). Low alpha coefficients for the EOT subscale were reported (range from 0.18-0.61). Except for the children sample, exploratory factorial analyses (EFA) were performed on the items of the TAS-20 or AQC without the EOT items and the Beck depression inventory-II (BDI-II) or the Zung Self-Rating Depression Scale (SDS). The items of the AQC and BDI-II or items of the TAS-20 and SDS loaded on separate factors with only a minor overlap suggesting that adolescents were able to differentiate alexithymia and depression when self-assessments were used. Alexithymia can be reliably assessed in adolescents using the TAS-20 or AQC without the eight items rating the EOT dimension.	[Loas, Gwenole] ULB, Dept Psychiat, Brussels, Belgium; ULB, Lab Psychiat Res ULB 266, Clin Univ Bruxelles, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Loas, G (corresponding author), ULB, Dept Psychiat, Brussels, Belgium.	Gwenole.Loas@erasme.ulb.ac.be			Belgian National Funds for Scientific Research [1.5.123.04, 1.5.175.06, 3.4.553.01.F]	Belgian National Funds for Scientific Research(Fonds de la Recherche Scientifique - FNRS)	The present study was supported partly (samples 3 and 4) by the Belgian National Funds for Scientific Research (grants 1.5.123.04, 1.5.175.06 and 3.4.553.01.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bermond B, 1999, PSYCHOTHER PSYCHOSOM, V68, P241, DOI 10.1159/000012340; Berthoz S., 2000, EUROPEAN REV APPL PS, V50, P359; Braun S, 2015, PSYCHOL REP, V117, P735, DOI 10.2466/08.02.PR0.117c23z6; BRIGGS SR, 1986, J PERS, V54, P106, DOI 10.1111/j.1467-6494.1986.tb00391.x; Cattell R.B., 1978, SCI USE FACTOR ANAL, DOI [DOI 10.1007/978-1-4684-2262-7_5, 10.1007/978-1-4684-2262-7_5]; Centre de Psychologie Appliquee, 1996, VAL VERS FRANC BDI 2; Craparo G, 2015, PSYCHIAT INVEST, V12, P500, DOI 10.4306/pi.2015.12.4.500; Garisch JA, 2010, BRIT J CLIN PSYCHOL, V49, P151, DOI 10.1348/014466509X441709; Gorsuch R., 1983, FACTOR ANAL; Heaven PCL, 2010, PERS INDIV DIFFER, V49, P222, DOI 10.1016/j.paid.2010.03.039; Hintikka J, 2001, COMPR PSYCHIAT, V42, P234, DOI 10.1053/comp.2001.23147; Joukamaa M, 2007, J PSYCHOSOM RES, V63, P373, DOI 10.1016/j.jpsychores.2007.01.018; Karukivi Max, 2010, Eat Disord, V18, P226, DOI 10.1080/10640261003719518; Kitamura T, 2004, PSYCHIAT RES, V128, P281, DOI 10.1016/j.psychres.2004.06.003; Kooiman CG, 2002, J PSYCHOSOM RES, V53, P1083, DOI 10.1016/S0022-3999(02)00348-3; Korner-Bitensk N, 1990, TRADUCTION ECHELLE A; Lane RD, 2015, NEUROSCI BIOBEHAV R, V55, P594, DOI 10.1016/j.neubiorev.2015.06.007; Ling Y, 2016, J PSYCHIATR MENT HLT, V23, P179, DOI 10.1111/jpm.12298; LOAS G, 1995, ENCEPHALE, V21, P117; Loas G, 2010, ENCEPHALE, V36, P302, DOI 10.1016/j.encep.2009.06.009; Loas G, 2012, J PSYCHOSOM RES, V72, P147, DOI 10.1016/j.jpsychores.2011.11.006; Ludtke J, 2016, PSYCHIAT RES, V239, P346, DOI 10.1016/j.psychres.2016.02.026; Marchesi C, 2014, COMPR PSYCHIAT, V55, P972, DOI 10.1016/j.comppsych.2013.12.008; Meganck R, 2012, PSYCHOL REP, V111, P393, DOI 10.2466/02.08.15.PR0.111.5.393-404; Morera OF, 2005, J PSYCHOSOM RES, V58, P289, DOI 10.1016/j.jpsychores.2004.09.001; Nishimura H, 2009, BIOPSYCHOSOC MED, V3, DOI 10.1186/1751-0759-3-12; Parker JDA, 2010, PSYCHOL ASSESSMENT, V22, P798, DOI 10.1037/a0020256; PARKER JDA, 1991, COMPR PSYCHIAT, V32, P387, DOI 10.1016/0010-440X(91)90015-5; Rieffe C, 2006, PERS INDIV DIFFER, V40, P123, DOI 10.1016/j.paid.2005.05.013; Sakkinen P, 2007, PSYCHOSOMATICS, V48, P154, DOI 10.1176/appi.psy.48.2.154; StatSoft, 2004, STAT 7 1 VERS; Tanaka JS, 1993, TESTING STRUCTURAL E, P10; Taylor G.J., 1997, DISORDERS AFFECT REG; West S. G., 1995, STRUCTURAL EQUATION, P56; Wise TN, 2000, PSYCHOL REP, V87, P127, DOI 10.2466/PR0.87.5.127-132; Zech E, 1999, EUR J PERSONALITY, V13, P511; Zimmermann G, 2007, ENCEPHALE, V33, P941, DOI 10.1016/j.encep.2006.12.006; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	40	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177982	10.1371/journal.pone.0177982	http://dx.doi.org/10.1371/journal.pone.0177982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542508	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800032
J	Reed, P; Romano, M; Re, F; Roaro, A; Osborne, LA; Vigano, C; Truzoli, R				Reed, Phil; Romano, Michela; Re, Federica; Roaro, Alessandra; Osborne, Lisa A.; Vigano, Caterina; Truzoli, Roberto			Differential physiological changes following internet exposure in higher and lower problematic internet users	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; BLOOD-PRESSURE; ADDICTION; WITHDRAWAL; IMPULSIVITY; PREFERENCE; INVENTORY; DISORDER; PEOPLE; MDMA	Problematic internet use (PIU) has been suggested as in need of further research with a view to being included as a disorder in future Diagnostic and Statistical Manual (DSM) of the American Psychiatric Association, but lack of knowledge about the impact of internet cessation on physiological function remains a major gap in knowledge and a barrier to PIU classification. One hundred and forty-four participants were assessed for physiological (blood pressure and heart rate) and psychological (mood and state anxiety) function before and after an internet session. Individuals also completed a psychometric examination relating to their usage of the internet, as well as their levels of depression and trait anxiety. Individuals who identified themselves as having PIU displayed increases in heart rate and systolic blood pressure, as well as reduced mood and increased state of anxiety, following cessation of internet session. There were no such changes in individuals with no self-reported PIU. These changes were independent of levels of depression and trait anxiety. These changes after cessation of internet use are similar to those seen in individuals who have ceased using sedative or opiate drugs, and suggest PIU deserves further investigation and serious consideration as a disorder.	[Reed, Phil] Swansea Univ, Swansea, W Glam, Wales; [Romano, Michela; Re, Federica; Roaro, Alessandra; Vigano, Caterina; Truzoli, Roberto] Univ Milan, Milan, Italy; [Osborne, Lisa A.] Abertawe Bro Morgannwg Univ Hlth Board, Swansea, W Glam, Wales	Swansea University; University of Milan	Reed, P (corresponding author), Swansea Univ, Swansea, W Glam, Wales.	p.reed@swansea.ac.uk	Vigano', Caterina Adele/G-2820-2017; TRUZOLI, ROBERTO/Q-1928-2019; Viganò, Caterina/ABD-8056-2020	Vigano', Caterina Adele/0000-0001-7937-1266; TRUZOLI, ROBERTO/0000-0001-7420-7053; Viganò, Caterina/0000-0001-7937-1266; Reed, Phil/0000-0002-8157-0747	University of Milan	University of Milan	We received no external funding for this manuscript, but may be able to access open access publishing funds from the University of Milan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin A., 2011, INT ONLINE J ED SCI, V3, P138; American Psychiatric Association, 2013, DSM 5; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Belanger RE, 2011, PEDIATRICS, V127, pE330, DOI 10.1542/peds.2010-1235; Bernardi S, 2009, COMPR PSYCHIAT, V50, P510, DOI 10.1016/j.comppsych.2008.11.011; Bexis S, 2006, BRIT J PHARMACOL, V147, P926, DOI 10.1038/sj.bjp.0706688; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Caplan S.E., 2011, INTERNET ADDICTION H, P35; Casale S, 2013, PERS INDIV DIFFER, V54, P524, DOI 10.1016/j.paid.2012.10.023; Ceccanti M, 2006, ALCOHOL ALCOHOLISM, V41, P5, DOI 10.1093/alcalc/agh221; Chang MK, 2008, COMPUT HUM BEHAV, V24, P2597, DOI 10.1016/j.chb.2008.03.001; Cheever NA, 2014, COMPUT HUM BEHAV, V37, P290, DOI 10.1016/j.chb.2014.05.002; Christakis DA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-61; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Fortson BL, 2007, J AM COLL HEALTH, V56, P137, DOI 10.3200/JACH.56.2.137-146; Griffiths MD, 2012, ADDICT RES THEORY, V20, P111, DOI 10.3109/16066359.2011.588351; Gundogar A, 2012, EUR PSYCHIAT, V27; Han DH, 2010, EXP CLIN PSYCHOPHARM, V18, P297, DOI 10.1037/a0020023; Hardie E, 2007, AUST J EMERG TECH SO, V5, P34, DOI DOI 10.1016/S0092-6566(03)00046-1; HUGHES JR, 1994, ADDICTION, V89, P1461, DOI 10.1111/j.1360-0443.1994.tb03744.x; Kalant H, 2001, CAN MED ASSOC J, V165, P917; Kaptsis D, 2016, CLIN PSYCHOL REV, V43, P58, DOI 10.1016/j.cpr.2015.11.006; Kelley KJ, 2013, J BEHAV ADDICT, V2, P108, DOI 10.1556/JBA.1.2012.016; Kim J, 2009, J COMPUT-MEDIAT COMM, V14, P988, DOI 10.1111/j.1083-6101.2009.01478.x; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Ko CH, 2014, COMPREHENSIVE PSYCHI; Kross E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069841; Lee HW, 2012, CYBERPSYCH BEH SOC N, V15, P373, DOI 10.1089/cyber.2012.0063; Lu DW, 2010, CYBERPSYCH BEH SOC N, V13, P371, DOI 10.1089/cyber.2009.0254; Marazziti D, 2007, STRESS, V10, P93, DOI 10.1080/10253890601170563; May RW, 2015, STRESS, V18, P11, DOI 10.3109/10253890.2014.969703; Osborne LA, 2016, J CLIN PSYCHIAT, V77, P269, DOI 10.4088/JCP.15m10073; Reed P, 2015, HIGH EDUC, V70, P711, DOI 10.1007/s10734-015-9862-1; Reed P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134538; Reed P, 2015, COMPUT HUM BEHAV, V49, P512, DOI 10.1016/j.chb.2015.03.064; Romano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055162; Spielberger C. D., 1983, MIND GARDEN; Vandrey R, 2011, J ADDICT MED, V5, P16, DOI 10.1097/ADM.0b013e3181d2b309; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; Wesson DR, 2003, J PSYCHOACTIVE DRUGS, V35, P253, DOI 10.1080/02791072.2003.10400007; Widyanto L, 2004, CYBERPSYCHOL BEHAV, V7, P443, DOI 10.1089/cpb.2004.7.443; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Yen CF, 2014, COMPREHENSIVE PSYCHI; Yeomans MR, 1998, PSYCHOPHARMACOLOGY, V137, P401, DOI 10.1007/s002130050636	46	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178480	10.1371/journal.pone.0178480	http://dx.doi.org/10.1371/journal.pone.0178480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542470	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800096
J	Santos, CL; Santos, RS; Moraes, L; Samary, CS; Felix, NS; Silva, JD; Morales, MM; Huhle, R; Abreu, MG; Schanaider, A; Silva, PL; Pelosi, P; Rocco, PRM				Santos, Cintia L.; Santos, Raquel S.; Moraes, Lillian; Samary, Cynthia S.; Felix, Nathane S.; Silva, Johnatas D.; Morales, Marcelo M.; Huhle, Robert; Abreu, Marcelo G.; Schanaider, Alberto; Silva, Pedro L.; Pelosi, Paolo; Rocco, Patricia R. M.			Effects of pressure support and pressure-controlled ventilation on lung damage in a model of mild extrapulmonary acute lung injury with intra-abdominal hypertension	PLOS ONE			English	Article							ABDOMINAL COMPARTMENT SYNDROME; END-EXPIRATORY PRESSURE; CRITICALLY-ILL PATIENTS; MECHANICAL VENTILATION; BIOLOGICAL IMPACT; PULMONARY; AIRWAY; OXYGENATION; VOLUME; INFLAMMATION	Intra-abdominal hypertension (IAH) may co-occur with the acute respiratory distress syndrome (ARDS), with significant impact on morbidity and mortality. Lung-protective controlled mechanical ventilation with low tidal volume and positive end-expiratory pressure (PEEP) has been recommended in ARDS. However, mechanical ventilation with spontaneous breathing activity may be beneficial to lung function and reduce lung damage in mild ARDS. We hypothesized that preserving spontaneous breathing activity during pressure support ventilation (PSV) would improve respiratory function and minimize ventilator-induced lung injury (VILI) compared to pressure-controlled ventilation (PCV) in mild extrapulmonary acute lung injury (ALI) with IAH. Thirty Wistar rats (334 +/- 55g) received Escherichia coli lipopolysaccharide intraperitoneally (1000 mu g) to induce mild extrapulmonary ALI. After 24h, animals were anesthetized and randomized to receive PCV or PSV. They were then further randomized into subgroups without or with IAH (15 mmHg) and ventilated with PCV or PSV (PEEP = 5cmH(2)O, driving pressure adjusted to achieve tidal volume = 6mL/kg) for 1h. Six of the 30 rats were used for molecular biology analysis and were not mechanically ventilated. The main outcome was the effect of PCV versus PSV on mRNA expression of interleukin (IL)-6 in lung tissue. Regardless of whether IAH was present, PSV resulted in lower mean airway pressure (with no differences in peak airway or peak and mean transpulmonary pressures) and less mRNA expression of biomarkers associated with lung inflammation (IL-6) and fibrogenesis (type III procollagen) than PCV. In the presence of IAH, PSV improved oxygenation; decreased alveolar collapse, interstitial edema, and diffuse alveolar damage; and increased expression of surfactant protein B as compared to PCV. In this experimental model of mild extrapulmonary ALI associated with IAH, PSV compared to PCV improved lung function and morphology and reduced type 2 epithelial cell damage.	[Santos, Cintia L.; Santos, Raquel S.; Moraes, Lillian; Samary, Cynthia S.; Felix, Nathane S.; Silva, Johnatas D.; Silva, Pedro L.; Rocco, Patricia R. M.] Univ Fed Rio de Janeiro, Lab Pulm Invest, Carlos Chagas Filho Inst Biophys, Av Carlos Chagas Filho S-N,Bloco G-014, Rio De Janeiro, RJ, Brazil; [Santos, Cintia L.; Schanaider, Alberto] Univ Fed Rio de Janeiro, Lab Expt Surg, Fac Med, Av Prof Rodolpho Paulo Rocco 225, Rio De Janeiro, RJ, Brazil; [Morales, Marcelo M.] Univ Fed Rio de Janeiro, Lab Cellular & Mol Physiol, Carlos Chagas Filho Inst Biophys, Av Carlos Chagas Filho S-N,Bloco G2-048, Rio De Janeiro, RJ, Brazil; [Huhle, Robert; Abreu, Marcelo G.] Tech Univ Dresden, Dept Anesthesiol & Intens Care Therapy, Pulm Engn Grp, Univ Hosp Carl Gustav Carus, Fetschertsr 74, Dresden, Germany; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, IRCCS AOU San Martino IST, Largo Rosanna Benzi 8, Genoa, Italy	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Genoa; IRCCS AOU San Martino IST	Rocco, PRM (corresponding author), Univ Fed Rio de Janeiro, Lab Pulm Invest, Carlos Chagas Filho Inst Biophys, Av Carlos Chagas Filho S-N,Bloco G-014, Rio De Janeiro, RJ, Brazil.	prmrocco@gmail.com	Rocco, Patricia/I-7460-2012; Silva, Johnatas D/I-6478-2017; Silva, Pedro Leme/AAD-8236-2019; Huhle, Robert/GYQ-7985-2022	Rocco, Patricia/0000-0003-1412-7136; Silva, Johnatas D/0000-0003-4379-4237; Silva, Pedro Leme/0000-0001-5838-4949; samary, cynthia/0000-0002-1860-4166; Pelosi, Paolo/0000-0001-5055-3023	Carlos Chagas Filho Rio de Janeiro State Research Foundation (FAPERJ), Rio de Janeiro, Brazil [E-26/103.118/2014]; Brazilian Council for Scientific and Technological Development (CNPq)), Brasilia, Brazil [471438/2012-0]	Carlos Chagas Filho Rio de Janeiro State Research Foundation (FAPERJ), Rio de Janeiro, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Council for Scientific and Technological Development (CNPq)), Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Carlos Chagas Filho Rio de Janeiro State Research Foundation (FAPERJ; grant number E-26/103.118/2014), Rio de Janeiro, Brazil; and the Brazilian Council for Scientific and Technological Development (CNPq; grant number 471438/2012-0), Brasilia, Brazil.	Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; BAYDUR A, 1982, AM REV RESPIR DIS, V126, P788; Blanch L, 2015, INTENS CARE MED, V41, P633, DOI 10.1007/s00134-015-3692-6; Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP; Carvalho AR, 2009, ANESTH ANALG, V109, P856, DOI 10.1213/ane.0b013e3181aff245; Carvalho NC, 2014, CRIT CARE MED, V42, pE702, DOI 10.1097/CCM.0000000000000605; Cortes-Puentes GA, 2015, CRIT CARE MED, V43, pE287, DOI 10.1097/CCM.0000000000001036; Cortes-Puentes GA, 2013, J TRAUMA ACUTE CARE, V74, P1468, DOI 10.1097/TA.0b013e31829243a7; De Waele JJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0879-8; Deeren DH, 2005, INTENS CARE MED, V31, P1577, DOI 10.1007/s00134-005-2802-2; Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005; Grasso F, 2008, AM J RESP CRIT CARE, V177, P412, DOI 10.1164/rccm.200707-1004OC; Guldner A, 2016, CRIT CARE MED, V44, pE854, DOI 10.1097/CCM.0000000000001721; Guldner A, 2014, ANESTHESIOLOGY, V120, P673, DOI 10.1097/ALN.0000000000000124; Henzler D, 2010, INTENS CARE MED, V36, P1427, DOI 10.1007/s00134-010-1827-3; Holodinsky JK, 2013, CRIT CARE, V17, DOI 10.1186/cc13075; Ke L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033125; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; Kiss T, 2016, BRIT J ANAESTH, V116, P708, DOI 10.1093/bja/aew093; Kopernik G, 1998, AM J OBSTET GYNECOL, V179, P1503, DOI 10.1016/S0002-9378(98)70016-X; Lima Ricardo Antonio Correia, 2011, Rev Col Bras Cir, V38, P417; Malbrain MLNG, 2014, MINERVA ANESTESIOL, V80, P293; Malbrain MLNG, 2004, INTENS CARE MED, V30, P822, DOI 10.1007/s00134-004-2169-9; Malbrain MLNG, 2005, CRIT CARE MED, V33, P315, DOI 10.1097/01.CCM.0000153408.09806.1B; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Moraes L, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0474-4; MUTOH T, 1992, J APPL PHYSIOL, V72, P575, DOI 10.1152/jappl.1992.72.2.575; Neumann P, 2005, CRIT CARE MED, V33, P1090, DOI 10.1097/01.CCM.0000163226.34868.0A; Padilha Gisele de A, 2016, Intensive Care Med Exp, V4, P35; Pellegrini M, 2016, AM J RESP CRIT CARE; Pelosi P, 2007, ACTA CLIN BELG, V62, P78, DOI 10.1179/acb.2007.62.s1.011; Pelosi P, 2012, CRIT CARE, V16, DOI 10.1186/cc11874; Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011; Quintel M, 2004, AM J RESP CRIT CARE, V169, P534, DOI 10.1164/rccm.200209-1060OC; Regli A, 2012, CRIT CARE, V16, DOI 10.1186/cc11840; Regli A, 2012, CRIT CARE MED, V40, P1879, DOI 10.1097/CCM.0b013e31824e0e80; Riva DR, 2008, CRIT CARE MED, V36, P1900, DOI 10.1097/CCM.0b013e3181760e5d; Roberts DJ, 2016, CURR OPIN CRIT CARE, V22, P174, DOI 10.1097/MCC.0000000000000289; Rocco PRM, 2012, CURR OPIN ANESTHESIO, V25, P123, DOI 10.1097/ACO.0b013e32834f8c7f; Rocco PRM, 2001, AM J RESP CRIT CARE, V164, P1067, DOI 10.1164/ajrccm.164.6.2007062; Saddy F, 2013, CRIT CARE, V17, DOI 10.1186/cc13051; Saddy F, 2010, INTENS CARE MED, V36, P1417, DOI 10.1007/s00134-010-1808-6; Samary CS, 2015, ANESTHESIOLOGY, V123, P423, DOI 10.1097/ALN.0000000000000716; Santos CL, 2012, INTENS CARE MED, V38, P499, DOI 10.1007/s00134-011-2451-6; Santos CL, 2014, CRIT CARE, V18, DOI 10.1186/cc13920; Santos CL SR, 2015, INTENS CARE MED, V3, pA806; Schmittgen Thomas D., 2008, V429, P89, DOI 10.1007/978-1-60327-040-3_7; Silva PL, 2016, EXPERT REV RESP MED, V10, P1243, DOI 10.1080/17476348.2016.1251842; Spieth PM, 2015, ANESTHESIOLOGY, V122, P106, DOI 10.1097/ALN.0000000000000415; Spieth PM, 2011, CRIT CARE MED, V39, P746, DOI 10.1097/CCM.0b013e318206bda6; Thille AW, 2006, INTENS CARE MED, V32, P1515, DOI 10.1007/s00134-006-0301-8; Vidal MG, 2008, CRIT CARE MED, V36, P1823, DOI 10.1097/CCM.0b013e31817c7a4d; Wrigge H, 2005, CRIT CARE, V9, pR780, DOI 10.1186/cc3908; Wrigge H, 2003, ANESTHESIOLOGY, V99, P376, DOI 10.1097/00000542-200308000-00019; Yoshida T, 2016, AM J RESP CRIT CARE; Yoshida T, 2017, AM J RESP CRIT CARE, V195, P985, DOI 10.1164/rccm.201604-0748CP; Yoshida T, 2016, CRIT CARE MED, V44, pE678, DOI 10.1097/CCM.0000000000001649; Yoshida T, 2013, AM J RESP CRIT CARE, V188, P1420, DOI 10.1164/rccm.201303-0539OC; Yoshida T, 2012, CRIT CARE MED, V40, P1578, DOI 10.1097/CCM.0b013e3182451c40	59	5	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178207	10.1371/journal.pone.0178207	http://dx.doi.org/10.1371/journal.pone.0178207			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542443	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800053
J	Yang, Y; Wang, N; Guo, XY; Zhang, Y; Ye, BP				Yang, Yi; Wang, Na; Guo, Xinyan; Zhang, Yi; Ye, Boping			Comparative analysis of bacterial community structure in the rhizosphere of maize by high-throughput pyrosequencing	PLOS ONE			English	Article							MICROBIAL COMMUNITY; DIVERSITY; SOILS; BULK; SEQUENCES	In this study, we designed a microcosm experiment to explore the composition of the bacterial community in the rhizosphere of maize and bulk soil by sequencing the V3-V4 region of the 16S rRNA gene on the Illumina system. 978-1239 OTUs (cut off level of 3%) were found in rhizosphere and bulk soil samples. Rhizosphere shared features with the bulk soil, such as predominance of Acidobacteria, Proteobacteria, Actinobacteria, Bacteroidetes, Chloroflexi, Firmicutes, Gemmatimonadetes and TM7. At genus level, many of the dominant rhizosphere genera (Chitinophaga, Nitrospira, Flavobacterium, etc.) displayed different patterns of temporal changes in the rhizosphere as opposed to the bulk soil, showing rhizosphere has more impact on soil microorganisms. Besides, we found that significant growth-related dynamic changes in bacterial community structure were mainly associated with phylum Bacteroidetes, Proteobacteria and Actinobacteria (mainly genera Burkholderia, Flavisolibacter and Pseudomonas), indicating that different growth stages affected the bacterial community composition in maize soil. Furthermore, some unique genera in especial Plant-Growth Promoting Rhizobacteria (PGPR) such as Nonomuraea, Thiobacillus and Bradyrhizobium etc., which were beneficial for the plant growth appeared to be more abundant in the rhizosphere than bulk soil, indicating that the selectivity of root to rhizosphere microbial is an important mechanism leading to the differences in the bacteria community structure between rhizosphere and bulk soil.	[Yang, Yi; Ye, Boping] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Wang, Na; Guo, Xinyan; Zhang, Yi] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Ye, BP (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China.; Wang, N (corresponding author), Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China.	wangna@nies.org; yebp@cpu.edu.cn			Natural Science Foundation of China [21507037]; Commonwealth and Environmental Protection Project [201309031]; Fundamental Research Funds for NIES in "Source Apportionment Research of antibiotics pollution in typical drinking water resource"	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Commonwealth and Environmental Protection Project; Fundamental Research Funds for NIES in "Source Apportionment Research of antibiotics pollution in typical drinking water resource"	This study was financially support by the Natural Science Foundation of China (No. 21507037), Commonwealth and Environmental Protection Project granted by the MEP (No. 201309031), as well as the Fundamental Research Funds for NIES in 2016 Source Apportionment Research of antibiotics pollution in typical drinking water resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesemoye AO, 2009, MICROB ECOL, V58, P921, DOI 10.1007/s00248-009-9531-y; Adesemoye AO, 2009, APPL MICROBIOL BIOT, V85, P1, DOI 10.1007/s00253-009-2196-0; [Anonymous], 2016, BMC MICROBIOL, DOI [DOI 10.1186/s12866-016-0743-2, DOI 10.1007/s11104-016-2826-0]; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dohrmann AB, 2013, ISME J, V7, P37, DOI 10.1038/ismej.2012.77; Fierer N., 2012, P NATL ACAD SCI USA, V109, P21390, DOI [10.1073/pnas.1215210110., DOI 10.1073/pnas.1215210110]; Garcia-Salamanca A, 2013, MICROB BIOTECHNOL, V6, P36, DOI 10.1111/j.1751-7915.2012.00358.x; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Houlden A, 2008, FEMS MICROBIOL ECOL, V65, P193, DOI 10.1111/j.1574-6941.2008.00535.x; Liebner S, 2008, INT MICROBIOL, V11, P195, DOI 10.2436/20.1501.01.60; Liu JJ, 2014, SOIL BIOL BIOCHEM, V70, P113, DOI 10.1016/j.soilbio.2013.12.014; Mougel C, 2006, NEW PHYTOL, V170, P165, DOI 10.1111/j.1469-8137.2006.01650.x; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Sood SG, 2003, FEMS MICROBIOL ECOL, V45, P219, DOI 10.1016/S0168-6496(03)00155-7; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zhang XX, 2017, SOIL BIOL BIOCHEM, V104, P208, DOI 10.1016/j.soilbio.2016.10.023	22	96	103	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178425	10.1371/journal.pone.0178425	http://dx.doi.org/10.1371/journal.pone.0178425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542542	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800088
J	Daigle, RM; Archambault, P; Halpern, BS; Lowndes, JSS; Cote, IM				Daigle, Remi M.; Archambault, Philippe; Halpern, Benjamin S.; Lowndes, Julia S. Stewart; Cote, Isabelle M.			Incorporating public priorities in the Ocean Health Index: Canada as a case study	PLOS ONE			English	Article							ECOSYSTEM; INDICATORS; MANAGEMENT; BENEFITS	The Ocean Health Index (OHI) is a framework to assess ocean health by considering many benefits (called 'goals') provided by the ocean provides to humans, such as food provision, tourism opportunities, and coastal protection. The OHI framework can be used to assess marine areas at global or regional scales, but how various OHI goals should be weighted to reflect priorities at those scales remains unclear. In this study, we adapted the framework in two ways for application to Canada as a case study. First, we customized the OHI goals to create a national Canadian Ocean Health Index (COHI). In particular, we altered the list of iconic species assessed, added methane clathrates and subsea permafrost as carbon storage habitats, and developed a new goal, 'Aboriginal Needs', to measure access of Aboriginal people to traditional marine hunting and fishing grounds. Second, we evaluated various goal weighting schemes based on preferences elicited from the general public in online surveys. We quantified these public preferences in three ways: using Likert scores, simple ranks from a best-worst choice experiment, and model coefficients from the analysis of elicited choice experiment. The latter provided the clearest statistical discrimination among goals, and we recommend their use because they can more accurately reflect both public opinion and the trade-offs faced by policy-makers. This initial iteration of the COHI can be used as a baseline against which future COHI scores can be compared, and could potentially be used as a management tool to prioritise actions on a national scale and predict public support for these actions given that the goal weights are based on public priorities.	[Daigle, Remi M.; Archambault, Philippe] Univ Quebec Rimouski, Inst Sci Mer, Rimouski, PQ, Canada; [Daigle, Remi M.; Halpern, Benjamin S.; Lowndes, Julia S. Stewart] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Daigle, Remi M.; Cote, Isabelle M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Daigle, Remi M.; Archambault, Philippe] Univ Laval, Dept Biol, Quebec City, PQ, Canada; [Archambault, Philippe] Stanford Univ, Hopkins Marine Stn, Stanford, CA 94305 USA; [Halpern, Benjamin S.] Imperial Coll London, Silwood Pk, Ascot, Berks, England; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA USA	University of Quebec; Universite du Quebec a Rimouski; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Simon Fraser University; Laval University; Stanford University; Imperial College London; University of California System; University of California Santa Barbara	Daigle, RM (corresponding author), Univ Quebec Rimouski, Inst Sci Mer, Rimouski, PQ, Canada.; Daigle, RM (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.; Daigle, RM (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada.; Daigle, RM (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ, Canada.	remi.daigle.1@ulaval.ca	Cote, Isabelle/ABD-5898-2021	Daigle, Remi/0000-0001-8832-4189; Lowndes, Julia/0000-0003-1682-3872	Natural Sciences and Engineering Research Council of Canada (NSERC) [NETGP 468437-14]; Quebec-Ocean (Fonds de recherche du Quebec Nature et technologies) [186795]; Fisheries and Ocean Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec-Ocean (Fonds de recherche du Quebec Nature et technologies); Fisheries and Ocean Canada	Funding for this study was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC)-funded Canadian Healthy Ocean Network (CHONe; NETGP 468437-14), Quebec-Ocean (Fonds de recherche du Quebec Nature et technologies 186795), and Fisheries and Ocean Canada.	Aboriginal Affairs and Northern Development Canada, 2013, 1 NAT PROF INT MAP; Aboriginal Affairs and Northern Development Canada, 2010, REG RES PRIC SURV; Aboriginal Affairs and Northern Development Canada, 2013, IN NUN MAP; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Archer D, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000854; Berghofer A, 2008, MAR POLICY, V32, P243, DOI 10.1016/j.marpol.2007.09.014; Brothers LL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052222; CAIRNS J, 1993, HYDROBIOLOGIA, V263, P1, DOI 10.1007/BF00006084; Canadian Index of Wellbeing. How are Canadians Really Doing?, 2012, AR CAN REALL DOING 2, P82; Chhun S, 2015, MAR RESOUR ECON, V30, P261, DOI 10.1086/681052; Cooke SJ, 2015, FISHERIES MANAG ECOL, V22, P1, DOI 10.1111/fme.12005; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2015, COMM STAT END WILDL; Costanza Robert, 1992, P239; Daigle RM, 2016, MAR POLICY, V74, P77, DOI 10.1016/j.marpol.2016.09.012; Daigle RM, 2017, ANAL FIGURE CREATION; Daigle RM, 2017, DATA WRANGLING INCOR; Dlugokencky E., 2014, TRENDS ATMOSPHERIC C; Downing A, 2011, INDIAN J TRADIT KNOW, V10, P57; Elfes CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092589; Fenical W, 1999, MONSOONS MICROBES UN; Fetterer F, 2013, SEA ICE INDEX; FINN A, 1992, J PUBLIC POLICY MARK, V11, P12, DOI 10.1177/074391569201100202; Fisheries and Oceans Canada G of C, 2008, AB FISH STRAT; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Granek EF, 2010, CONSERV BIOL, V24, P207, DOI 10.1111/j.1523-1739.2009.01355.x; Halpern BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117863; Halpern BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098995; Halpern BS, 2013, MAR POLICY, V42, P68, DOI 10.1016/j.marpol.2013.01.019; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Heinz Center, 2008, STAT NAT EC 2008 MEA, P133; Inuit Circumpolar Council-Canada (ICC-Canada), 2008, SEA IC IS OUR HIGHW; Kershner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025248; Knap A, 2002, ENVIRON HEALTH PERSP, V110, P839, DOI 10.1289/ehp.02110839; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Lowndes JSS, 2015, PEERJ, V3, DOI 10.7717/peerj.1503; Portnov A, 2014, J GEOPHYS RES-BIOGEO, V119, P2082, DOI 10.1002/2014JG002685; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Selig ER, 2015, ECOSYST SERV, V16, P403, DOI 10.1016/j.ecoser.2014.11.007; Statistics Canada, 2014, TABL 326 0009 AV RET; Statistics Canada, 2014, TABL 326 0015 INT IN; Statistics Canada, 2014, TABL 326 0021 CONS P; Supreme Court of Canada, 1990, SUPR COURT JUDGM R V; UNESCO, 1996, STRAT PLAN ASS PRED; Whiteman G, 2013, NATURE, V499, P401, DOI 10.1038/499401a	46	12	13	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178044	10.1371/journal.pone.0178044	http://dx.doi.org/10.1371/journal.pone.0178044			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542394	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500055
J	Martinez, M; Sorzano, COS; Pascual-Montano, A; Carazo, JM				Martinez, Marta; Sorzano, Carlos O. S.; Pascual-Montano, Alberto; Carazo, Jose M.			Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE DEACETYLASE INHIBITOR; PROSTATE-CANCER; MOUSE MODELS; CELL-LINES; EXPRESSION; BIOINFORMATICS; BIOMARKER; DEATH; HMGA2	Benign neurofibromas, the main phenotypic manifestations of the rare neurological disorder neurofibromatosis type 1, degenerate to malignant tumors associated to poor prognosis in about 10% of patients. Despite efforts in the field of (epi) genomics, the lack of prognostic biomarkers with which to predict disease evolution frustrates the adoption of appropriate early therapeutic measures. To identify potential biomarkers of malignant neurofibroma transformation, we integrated four human experimental studies and one for mouse, using a gene score-based meta-analysis method, from which we obtained a score-ranked signature of 579 genes. Genes with the highest absolute scores were classified as promising disease biomarkers. By grouping genes with similar neurofibromatosis-related profiles, we derived panels of potential biomarkers. The addition of promoter methylation data to gene profiles indicated a panel of genes probably silenced by hypermethylation. To identify possible therapeutic treatments, we used the gene signature to query drug expression databases. Trichostatin A and other histone deacetylase inhibitors, as well as cantharidin and tamoxifen, were retrieved as putative therapeutic means to reverse the aberrant regulation that drives to malignant cell proliferation and metastasis. This in silico prediction corroborated reported experimental results that suggested the inclusion of these compounds in clinical trials. This experimental validation supported the suitability of the meta-analysis method used to integrate several sources of public genomic information, and the reliability of the gene signature associated to the malignant evolution of neurofibromas to generate working hypotheses for prognostic and drug-responsive biomarkers or therapeutic measures, thus showing the potential of this in silico approach for biomarker discovery.	[Martinez, Marta; Sorzano, Carlos O. S.; Pascual-Montano, Alberto; Carazo, Jose M.] CSIC, Nacl Ctr Biotechnol, Biocomp Unit, Campus Univ Autonoma Madrid, Madrid, Spain; [Sorzano, Carlos O. S.] Univ CEU San Pablo, Bioengn Lab, Campus Urb Monteprincipe, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); San Pablo CEU University	Martinez, M (corresponding author), PerkinElmer Espana SL, Madrid, Spain.	mmmtnez@cnb.csic.es	Garcia, Jose Maria Carazo/E-9234-2016; S. Sorzano, Carlos Oscar/ABE-4884-2021; Sorzano, Carlos Oscar S S./F-2639-2016	Garcia, Jose Maria Carazo/0000-0003-0788-8447; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; Martinez, Marta/0000-0002-8435-5540	Children's Tumor Foundation (US) [2013-04-005]; Children's Tumor Foundation	Children's Tumor Foundation (US); Children's Tumor Foundation	This work was supported by Grant 2013-04-005 from the Children's Tumor Foundation (US) (http://www.ctf.org/) to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the support of the Children's Tumor Foundation.	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Berner JM, 1999, GENE CHROMOSOME CANC, V26, P151, DOI 10.1002/(SICI)1098-2264(199910)26:2<151::AID-GCC7>3.0.CO;2-A; Bottillo I, 2009, J PATHOL, V217, P693, DOI 10.1002/path.2494; Brosius SN, 2014, J NEUROPATH EXP NEUR, V73, P1078, DOI 10.1097/NEN.0000000000000126; Burns TC, 2015, EUR J PHARMACOL, V759, P101, DOI 10.1016/j.ejphar.2015.03.021; Byer SJ, 2011, NEURO-ONCOLOGY, V13, P28, DOI 10.1093/neuonc/noq146; Carroll SL, 2016, AM J PATHOL, V186, P464, DOI 10.1016/j.ajpath.2015.10.023; Castellsague J, 2015, EMBO MOL MED, V7, P608, DOI 10.15252/emmm.201404430; Cornago M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.412; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Danielsen SA, 2015, NEURO-ONCOLOGY, V17, P63, DOI 10.1093/neuonc/nou140; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Deng RZ, 2015, ONCOL LETT, V9, P2129, DOI 10.3892/ol.2015.3002; Di Fazio P, 2016, ONCOTARGET, V7, P28998, DOI 10.18632/oncotarget.8585; Ekins S, 2011, DRUG DISCOV TODAY, V16, P298, DOI 10.1016/j.drudis.2011.02.016; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fang YQ, 2009, ANTICANCER RES, V29, P1255; Feber A, 2011, GENOME RES, V21, P515, DOI 10.1101/gr.109678.110; Feng W, 2015, BIOMED PHARMACOTHER, V74, P257, DOI 10.1016/j.biopha.2015.08.017; Fujiwara S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115400; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glaab E, 2012, BIOINFORMATICS, V28, pI451, DOI 10.1093/bioinformatics/bts389; Gligorijevic V, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0571; Henderson SR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r76; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Hui P, 2005, MODERN PATHOL, V18, P1519, DOI 10.1038/modpathol.3800464; Hull EE, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8797206; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Jia HQ, 2015, P NATL ACAD SCI USA, V112, pE56, DOI 10.1073/pnas.1415195112; Kadia TM, 2010, BRIT J HAEMATOL, V150, P72, DOI 10.1111/j.1365-2141.2010.08211.x; Karamchandani JR, 2012, APPL IMMUNOHISTO M M, V20, P445, DOI 10.1097/PAI.0b013e318244ff4b; Khattar Vinayak, 2013, J Cancer Ther, V4, P1341; Kohli L, 2013, CANCER RES, V73, P4395, DOI 10.1158/0008-5472.CAN-12-3765; Kolberg M, 2015, MOL ONCOL, V9, P1129, DOI 10.1016/j.molonc.2015.02.005; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Lakshmaiah KC, 2014, J CANCER RES THER, V10, P469, DOI 10.4103/0973-1482.137937; Levy P, 2007, CLIN CANCER RES, V13, P398, DOI 10.1158/1078-0432.CCR-06-0182; Levy P, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-20; Li GH, 2012, MED RES REV, V32, P999, DOI 10.1002/med.20231; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lopez G, 2011, CANCER RES, V71, P185, DOI 10.1158/0008-5472.CAN-10-2799; Ma XJ, 2016, TUMOR BIOL, V37, P7165, DOI 10.1007/s13277-015-4565-x; Mahajan A, 2010, MODERN PATHOL, V23, P673, DOI 10.1038/modpathol.2010.49; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Miller SJ, 2006, CANCER RES, V66, P2584, DOI 10.1158/0008-5472.CAN-05-3330; Murko C, 2013, DIFFERENTIATION, V85, P55, DOI 10.1016/j.diff.2012.12.001; Ni XG, 2008, MOL MED, V14, P582, DOI 10.2119/2008-00020.Ni; Pallante P, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00015; Rasche A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-310; Ruscetti M, 2016, ONCOGENE, V35, P3781, DOI 10.1038/onc.2015.444; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarkar S, 2011, ANTICANCER RES, V31, P2723; Semenova G, 2017, BIOCHIMIE, V135, P1, DOI 10.1016/j.biochi.2017.01.001; Setoain J, 2015, NUCLEIC ACIDS RES, V43, pW193, DOI 10.1093/nar/gkv445; Sommariva S, 2016, EUR UROL, V69, P107, DOI 10.1016/j.eururo.2014.11.038; Sun DC, 2013, MOL CANCER RES, V11, P616, DOI 10.1158/1541-7786.MCR-12-0593; Tao YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126566; Thomas LE, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0025-3; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vilardell M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-229; Wang XX, 2015, BIOCHEM BIOPH RES CO, V456, P320, DOI 10.1016/j.bbrc.2014.11.079; Watson MA, 2004, BRAIN PATHOL, V14, P297; Whelan JT, 2012, J CELL PHYSIOL, V227, P1235, DOI 10.1002/jcp.22899; Wu JJ, 2015, ONCOL REP, V34, P1494, DOI 10.3892/or.2015.4120; Yoon Somy, 2016, Chonnam Med J, V52, P1, DOI 10.4068/cmj.2016.52.1.1; Zhang M, 2014, NAT GENET, V46, P1170, DOI 10.1038/ng.3116	68	0	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178316	10.1371/journal.pone.0178316	http://dx.doi.org/10.1371/journal.pone.0178316			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542306	Green Published, gold			2022-12-27	WOS:000402061500081
J	Simkova, O; Frydlova, P; Zampachova, B; Frynta, D; Landova, E				Simkova, Olgas; Frydlova, Petra; Zampachova, Barbora; Frynta, Daniel; Landova, Eva			Development of behavioural profile in the Northern common boa (Boa imperator): Repeatable independent traits or personality?	PLOS ONE			English	Article							CONSISTENT INDIVIDUAL-DIFFERENCES; LIFE-HISTORY STRATEGIES; ANTIPREDATOR RESPONSES; GARTER SNAKE; GREAT TITS; COPING STYLES; OPEN-FIELD; INCUBATION-TEMPERATURE; DIGESTIVE PERFORMANCE; EXPLORATORY-BEHAVIOR	Recent studies of animal personality have focused on its proximate causation and ecological and evolutionary significance in particular, but the question of its development was largely overlooked. The attributes of personality are defined as between-individual differences in behaviour, which are consistent over time (differential consistency) and contexts (contextual generality) and both can be affected by development. We assessed several candidates for personality variables measured in various tests with different contexts over several life-stages (juveniles, older juveniles, subadults and adults) in the Northern common boa. Variables describing foraging/feeding decision and some of the defensive behaviours expressed as individual average values are highly repeatable and consistent. We found two main personality axes-one associated with foraging/feeding and the speed of decision, the other reflecting agonistic behaviour. Intensity of behaviour in the feeding context changes during development, but the level of agonistic behaviour remains the same. The juveniles and adults have a similar personality structure, but there is a period of structural change of behaviour during the second year of life (subadults). These results require a new theoretical model to explain the selection pressures resulting in this developmental pattern of personality. We also studied the proximate factors and their relationship to behavioural characteristics. Physiological parameters (heart and breath rate stress response) measured in adults clustered with variables concerning the agonistic behavioural profile, while no relationship between the juvenile/adult body size and personality concerning feeding/foraging and the agonistic behavioural profile was found. Our study suggests that it is important for studies of personality development to focus on both the structural and differential consistency, because even though behaviour is differentially consistent, the structure can change.	[Simkova, Olgas; Frydlova, Petra; Zampachova, Barbora; Frynta, Daniel; Landova, Eva] Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic; [Zampachova, Barbora; Frynta, Daniel; Landova, Eva] Natl Inst Mental Hlth, Klecany, Czech Republic	Charles University Prague; National Institute of Mental Health - Czech Republic	Frynta, D; Landova, E (corresponding author), Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic.; Frynta, D; Landova, E (corresponding author), Natl Inst Mental Hlth, Klecany, Czech Republic.	frynta@centrum.cz; evalandova@seznam.cz	Landova, Eva/R-8759-2017; Frynta, Daniel/L-7350-2016; Frýdlová, Petra/P-5008-2016; Zampachova, Barbora/R-9320-2017	Landova, Eva/0000-0001-8365-8710; Frynta, Daniel/0000-0002-1375-7972; Frýdlová, Petra/0000-0001-9385-9743; Zampachova, Barbora/0000-0002-6285-0495	MEYS under NPU I program; Grant Agency of Charles University [1310414, 346315]; Czech Science Foundation (GACR) [17-15991S];  [LO1611]	MEYS under NPU I program; Grant Agency of Charles University; Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); 	This study is a result of the research funded by the project Nr. LO1611 with financial support from the MEYS under the NPU I program (DF EL BZ) (http://www.msmt.cz/vyzkum-a-vyvoj-2/npu-i-lo-1). The project was supported by the Grant Agency of Charles University (1310414 and 346315) (DF EL) (http://www.cuni.cz/UKEN-65.html) and by the Czech Science Foundation (GACR) project Nr. 17-15991S (EL DF) (https://gacr.cz/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi AM, 1998, BRAIN RES BULL, V47, P57, DOI 10.1016/S0361-9230(98)00063-X; Aplin LM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1016; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; ARNOLD SJ, 1984, ANIM BEHAV, V32, P1108, DOI 10.1016/S0003-3472(84)80227-4; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; Bergmuller R, 2010, TRENDS ECOL EVOL, V25, P504, DOI 10.1016/j.tree.2010.06.012; Besson AA, 2016, BIOL REV, V91, P1065, DOI 10.1111/brv.12210; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Bousquet CAH, 2015, ANIM BEHAV, V110, P145, DOI 10.1016/j.anbehav.2015.09.024; Briard L, 2015, ETHOLOGY, V121, P888, DOI 10.1111/eth.12402; BRODIE ED, 1993, ANIM BEHAV, V45, P851, DOI 10.1006/anbe.1993.1106; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; CANDLAND DK, 1969, ANN NY ACAD SCI, V159, P831, DOI 10.1111/j.1749-6632.1969.tb12982.x; Carazo P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3275; Card DC, 2016, MOL PHYLOGENET EVOL, V102, P104, DOI 10.1016/j.ympev.2016.05.034; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Carere C, 2010, CURR ZOOL, V56, P728, DOI 10.1093/czoolo/56.6.728; Carrasco JL, 2005, STAT MED, V24, P4021, DOI 10.1002/sim.2397; Carter AW, 2016, PHYSIOL BEHAV, V155, P46, DOI 10.1016/j.physbeh.2015.11.034; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Chapman BB, 2013, PLOS ONE, V8; CHISZAR D, 1976, ANIM LEARN BEHAV, V4, P273, DOI 10.3758/BF03214049; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Class B, 2016, BEHAV ECOL SOCIOBIOL, V70, P733, DOI 10.1007/s00265-016-2096-0; Cote J, 2007, P R SOC B, V274, P383, DOI 10.1098/rspb.2006.3734; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; de Boer SF, 2017, NEUROSCI BIOBEHAV R, V74, P401, DOI 10.1016/j.neubiorev.2016.07.008; delBarrio V, 1997, PERS INDIV DIFFER, V23, P327, DOI 10.1016/S0191-8869(97)00030-5; Dingemanse NJ, 2010, PHILOS T R SOC B, V365, P3947, DOI 10.1098/rstb.2010.0221; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; DuRant SE, 2008, GEN COMP ENDOCR, V156, P126, DOI 10.1016/j.ygcen.2007.12.004; Edenbrow M, 2013, OIKOS, V122, P667, DOI 10.1111/j.1600-0706.2012.20556.x; FLORES D, 1994, PHYSIOL BEHAV, V55, P1067, DOI 10.1016/0031-9384(94)90389-1; Frynta D, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1369-9; Gardner-Santana LC, 2009, COPEIA, P363, DOI 10.1643/CP-07-271; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Guenther A, 2014, ANIM BEHAV, V90, P131, DOI 10.1016/j.anbehav.2014.01.032; Guenther A, 2013, BEHAV ECOL, V24, P402, DOI 10.1093/beheco/ars177; Gullone E, 2000, J ADOLESCENCE, V23, P393, DOI 10.1006/jado.2000.0327; Gyuris E, 2012, ANIM BEHAV, V84, P103, DOI 10.1016/j.anbehav.2012.04.014; Hawlena D, 2006, BEHAV ECOL, V17, P889, DOI 10.1093/beheco/arl023; Hedrick AV, 2012, BEHAV ECOL SOCIOBIOL, V66, P407, DOI 10.1007/s00265-011-1286-z; Herborn KA, 2011, J EXP BIOL, V214, P1732, DOI 10.1242/jeb.051383; Herczeg G, 2013, J EVOLUTION BIOL, V26, P955, DOI 10.1111/jeb.12103; HERZOG H A JR, 1974, Herpetologica, V30, P285; HERZOG HA, 1992, DEV PSYCHOBIOL, V25, P199, DOI 10.1002/dev.420250305; HERZOG HA, 1988, ETHOLOGY, V77, P250; HERZOG HA, 1987, J COMP PSYCHOL, V101, P387, DOI 10.1037/0735-7036.101.4.387; HERZOG HA, 1986, J COMP PSYCHOL, V100, P372, DOI 10.1037/0735-7036.100.4.372; HERZOG HA, 1989, DEV PSYCHOBIOL, V22, P489, DOI 10.1002/dev.420220507; Hudson R, 2011, DEV PSYCHOBIOL, V53, P564, DOI 10.1002/dev.20535; Hynkova I, 2009, ZOOL SCI, V26, P623, DOI 10.2108/zsj.26.623; Jones KA, 2010, P ROY SOC B-BIOL SCI, V277, P625, DOI 10.1098/rspb.2009.1607; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kralj-Fiser S, 2014, ANIM BEHAV, V91, P41, DOI 10.1016/j.anbehav.2014.02.016; Landova E, 2013, BEHAV ECOL SOCIOBIOL, V67, P1113, DOI 10.1007/s00265-013-1536-3; Langkilde T, 2006, J EXP BIOL, V209, P1035, DOI 10.1242/jeb.02112; Le Galliard JF, 2015, J EVOLUTION BIOL, V28, P1144, DOI 10.1111/jeb.12641; Le Galliard JF, 2013, FUNCT ECOL, V27, P136, DOI 10.1111/1365-2435.12017; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Li H, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0217; Lillywhite HB, 1999, COMP BIOCHEM PHYS A, V124, P369, DOI 10.1016/S1095-6433(99)00129-4; LIND AJ, 1994, ANIM BEHAV, V48, P1261, DOI 10.1006/anbe.1994.1362; Lopez P, 2005, ANIM BEHAV, V69, P1, DOI 10.1016/j.anbehav.2004.05.010; Luttbeg B, 2010, PHILOS T R SOC B, V365, P3977, DOI 10.1098/rstb.2010.0207; Magnhagen C, 2007, BEHAV ECOL SOCIOBIOL, V61, P525, DOI 10.1007/s00265-006-0280-3; Mayer M, 2016, BEHAVIOUR, V153, P313, DOI 10.1163/1568539X-00003343; McCowan LSC, 2015, BEHAV ECOL, V26, P735, DOI 10.1093/beheco/aru239; McEvoy J, 2015, J ZOOL, V296, P58, DOI 10.1111/jzo.12217; Mell H, 2016, BEHAV ECOL SOCIOBIOL, V70, P951, DOI 10.1007/s00265-016-2117-z; Miller RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149849; MONTGOMERY GG, 1978, COPEIA, P532; Montiglio PO, 2014, J ANIM ECOL, V83, P720, DOI 10.1111/1365-2656.12174; Montiglio PO, 2012, ANIM BEHAV, V84, P1071, DOI 10.1016/j.anbehav.2012.08.010; Muller T, 2015, FRONT ZOOL, V12, DOI 10.1186/1742-9994-12-S1-S8; Naguib M, 2011, DEV PSYCHOBIOL, V53, P592, DOI 10.1002/dev.20533; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nyqvist MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031619; OSSENKOPP KP, 1994, BEHAV PROCESS, V31, P129, DOI 10.1016/0376-6357(94)90001-9; Ott BD, 2007, J EXP BIOL, V210, P340, DOI 10.1242/jeb.02626; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Petelle MB, 2013, ANIM BEHAV, V86, P1147, DOI 10.1016/j.anbehav.2013.09.016; Reale D, 2009, J EVOLUTION BIOL, V22, P1599, DOI 10.1111/j.1420-9101.2009.01781.x; Reale D, 2012, ANIMAL PERSONALITY E; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rodda G.H., 2009, GIANT CONSTRICTORS B; Schuett GW, 2005, J ZOOL, V267, P363, DOI 10.1017/S0952836905007624; Secor SM, 2001, COMP BIOCHEM PHYS A, V128, P565, DOI 10.1016/S1095-6433(00)00325-1; Secor SM, 2000, J EXP BIOL, V203, P2447; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; Siviter H, 2017, ANIM COGN, V20, P109, DOI 10.1007/s10071-016-1030-1; Smith BR, 2012, BEHAVIOUR, V149, P187, DOI 10.1163/156853912X634133; Snijders L, 2015, ANIM BEHAV, V109, P45, DOI 10.1016/j.anbehav.2015.07.037; Sommer-Trembo C, 2016, J ETHOL, V34, P155, DOI 10.1007/s10164-016-0460-1; Stamps JA, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00069; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stamps JA, 2016, CURR OPIN BEHAV SCI, V12, P18, DOI 10.1016/j.cobeha.2016.08.008; Stamps JA, 2014, AM NAT, V184, P647, DOI 10.1086/678116; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; Statsoft S, 2001, STATISTICA; STINNER JN, 1993, AM J PHYSIOL, V264, pR79, DOI 10.1152/ajpregu.1993.264.1.R79; Stowe M, 2007, J ORNITHOL, V148, pS179, DOI 10.1007/s10336-007-0145-1; Suchomelova P, 2015, BEHAV PROCESS, V120, P14, DOI 10.1016/j.beproc.2015.08.005; Talarovicova A, 2009, HORM BEHAV, V55, P235, DOI 10.1016/j.yhbeh.2008.10.010; Team RDC, 2012, R LANG ENV STAT COMP; Trillmich F, 2011, DEV PSYCHOBIOL, V53, P505, DOI 10.1002/dev.20573; Trnik M, 2011, J COMP PSYCHOL, V125, P22, DOI 10.1037/a0021186; Urszan TJ, 2015, OECOLOGIA, V178, P129, DOI 10.1007/s00442-014-3207-0; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Verbeek MEM, 1996, EXPLORATION AGGRESSI, P11; Vetter SG, 2016, ANIM BEHAV, V115, P193, DOI 10.1016/j.anbehav.2016.03.026; Webb JK, 2003, AUSTRAL ECOL, V28, P601, DOI 10.1046/j.1442-9993.2003.t01-1-01316.x; Weiss A, 2007, AM J PRIMATOL, V69, P1264, DOI 10.1002/ajp.20428; Wilson ADM, 2012, BEHAV ECOL, V23, P1316, DOI 10.1093/beheco/ars123; Wilson D, 2007, BIOL LETT-UK, V3, P40, DOI 10.1098/rsbl.2006.0574; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wuerz Y, 2015, FRONT ZOOL, V12, DOI 10.1186/1742-9994-12-S1-S9; Zhao DP, 2015, CURR ZOOL, V61, P966, DOI 10.1093/czoolo/61.6.966	127	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177911	10.1371/journal.pone.0177911	http://dx.doi.org/10.1371/journal.pone.0177911			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542424	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500044
J	Hou, YY; Tian, JH; Zhang, J; Yun, RR; Zhang, ZG; Chen, KH; Zhang, CY; Wang, B				Hou, Yuying; Tian, Jinhui; Zhang, Jun; Yun, Rongrong; Zhang, Zhigang; Chen, Kee-Hsin; Zhang, Caiyun; Wang, Bo			Quality of meta-analysis in nursing fields: An exploration based on the JBI guidelines	PLOS ONE			English	Article								Background Meta-analysis is often regarded as one of the best sources of evidence for clinical nurses due to its rigorous design and scientific reflection of the true results of nursing interventions. The quality of a meta-analysis is critical to the work of clinical decision-makers. Therefore, the objective of this study was to use the JBI guidelines to summarize the quality of RCT-based meta-analyses of reports published in domestic nursing professional journals, with a view to standardizing the research process and reporting methods. Methods We performed a comprehensive literature search for RCT-based meta-analyses published in Chinese professional nursing journals, from their inception to December 31, 2015, using bibliographic databases (e.g. CNKI, WanFang Database). March 1, 2017, supplementary search 2016 literature. Candidate reviews were assessed for inclusion by two independent reviewers using pre-specified eligibility criteria. We evaluated the quality of reporting of the included meta-analyses using the systematic review literature reporting specification of JBI. Analyses were performed using Excel and STATA 12.0 software. Results Three hundred and twenty-two meta-analyses were included. According to the JBI guidelines, the overall quality of the meta-analysis report was poor. The quality of core journal reports and the implementation of retrieval were better than those of non-core journals. The nature of the authors and the availability of funding support had no significant impact on the quality of the meta-analyses. Multi-unit and multi-author collaboration can help improve the quality of meta-analyses with significant impact. Conclusion The understanding and implementation of systematic evaluation and meta-analyses in domestic nursing professional journals is worthy of recognition, and there is more work that can be done to improve the quality of these reports. Systematic review / Meta-analysis (SR/MA) makers should include the findings of this study. Multi-institutional and multi-author collaborations appear to improve research capacity and provide more reliable evidence support for clinicians.	[Hou, Yuying] Lanzhou Univ, Clin Med Coll 1, Lanzhou, Peoples R China; [Tian, Jinhui] Lanzhou Univ, Evidence Based Med Ctr, Lanzhou, Peoples R China; [Zhang, Jun] Gansu Univ Tradit Chinese Med, Sch Nursing, Lanzhou, Peoples R China; [Yun, Rongrong] Lanzhou Univ, Sch Nursing, Lanzhou, Peoples R China; [Zhang, Zhigang] Lanzhou Univ, Dept Intens Care Unit, Hosp 1, Lanzhou, Peoples R China; [Chen, Kee-Hsin] Taipei Med Univ, Taipei Municipal Wanfang Hosp, Dept Nursing, Taipei, Taiwan; [Chen, Kee-Hsin] Taipei Med Univ, Taipei Municipal Wanfang Hosp, Evidence Based Knowledge Translat Ctr, Taipei, Taiwan; [Chen, Kee-Hsin] Taipei Med Univ, Sch Nursing, Taipei, Taiwan; [Zhang, Caiyun] Lanzhou Univ, Dept Nursing, Hosp 1, Lanzhou, Peoples R China; [Wang, Bo] Rehabil Hosp Gansu Prov, Dept Nursing, Lanzhou, Peoples R China	Lanzhou University; Lanzhou University; Gansu University of Chinese Medicine; Lanzhou University; Lanzhou University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Lanzhou University	Zhang, ZG (corresponding author), Lanzhou Univ, Dept Intens Care Unit, Hosp 1, Lanzhou, Peoples R China.; Zhang, CY (corresponding author), Lanzhou Univ, Dept Nursing, Hosp 1, Lanzhou, Peoples R China.	zzg3444@163.com; 1131640321@qq.com	Chen, Kee-Hsin/W-3576-2019	Chen, Kee-Hsin/0000-0001-9772-482X				Bagshaw SM, 2006, ARCH INTERN MED, V166, P161, DOI 10.1001/archinte.166.2.161; Biondi-Zoccai GG, 2006, BMJ-BRIT MED J, V322, P202; Feng Sun, 2015, EXPLANATION MED RES, V265; Jun-Feng Xu, 2013, CHIN J EVID BASED PE, V13, P605; Ni An, 2013, CHIN J EVID BASED PE, V8, P110; Paul M, 2014, CLIN MICROBIOL INFEC, V20, P97, DOI 10.1111/1469-0691.12489; Pearson A, 2005, INT J EVID-BASED HEA, V3, P207, DOI 10.1111/j.1479-6988.2005.00026.x; Yan Hu, 2015, SHANGHAI NURSING, V15, P89; Yan Hu, 2002, NURS J CHIN PLA, V19, P3; You-Ping Li, 2014, EVIDENCE BASED MED, P110	10	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177648	10.1371/journal.pone.0177648	http://dx.doi.org/10.1371/journal.pone.0177648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542330	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058800021
J	Ren, MY; Feng, RJ; Shi, HR; Lu, LF; Yun, TY; Peng, M; Guan, X; Zhang, H; Wang, JY; Zhang, XY; Li, CL; Chen, YJ; He, P; Zhang, YD; Xie, JH				Ren, Meng Yun; Feng, Ren Jun; Shi, Hou Rui; Lu, Li Fang; Yun, Tian Yan; Peng, Ming; Guan, Xiao; Zhang, Heng; Wang, Jing Yi; Zhang, Xi Yan; Li, Cheng Liang; Chen, Yan Jun; He, Peng; Zhang, Yin Dong; Xie, Jiang Hui			Expression patterns of members of the ethylene signaling-related gene families in response to dehydration stresses in cassava	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PROLINE ACCUMULATION; MANIHOT-ESCULENTA; LOW-TEMPERATURE; ARABIDOPSIS; DROUGHT; PATHWAY; RECEPTOR; OVEREXPRESSION; RESISTANCE	Drought is the one of the most important environment stresses that restricts crop yield worldwide. Cassava (Manihot esculenta Crantz) is an important food and energy crop that has many desirable traits such as drought, heat and low nutrients tolerance. However, the mechanisms underlying drought tolerance in cassava are unclear. Ethylene signaling pathway, from the upstream receptors to the downstream transcription factors, plays important roles in environmental stress responses during plant growth and development. In this study, we used bioinformatics approaches to identify and characterize candidate Manihot esculenta ethylene receptor genes and transcription factor genes. Using computational methods, we localized these genes on cassava chromosomes, constructed phylogenetic trees and identified stress-responsive cis-elements within their 5' upstream regions. Additionally, we measured the trehalose and proline contents in cassava fresh leaves after drought, osmotic, and salt stress treatments, and then it was found that the regulation patterns of contents of proline and trehalose in response to various dehydration stresses were differential, or even the opposite, which shows that plant may take different coping strategies to deal with different stresses, when stresses come. Furthermore, expression profiles of these genes in different organs and tissues under non-stress and abiotic stress were investigated through quantitative real-time PCR (qRT-PCR) analyses in cassava. Expression profiles exhibited clear differences among different tissues under non-stress and various dehydration stress conditions. We found that the leaf and tuberous root tissues had the greatest and least responses, respectively, to drought stress through the ethylene signaling pathway in cassava. Moreover, tuber and root tissues had the greatest and least reponses to osmotic and salt stresses through ethylene signaling in cassava, respectively. These results show that these plant tissues had differential expression levels of genes involved in ethylene signaling in response to the stresses tested. Moreover, after several gene duplication events, the spatiotemporally differential expression pattern of homologous genes in response to abiotic and biotic stresses may imply their functional diversity as a mechanism for adapting to the environment. Our data provide a framework for further research on the molecular mechanisms of cassava resistance to drought stress and provide a foundation for breeding drought-resistant new cultivars.	[Ren, Meng Yun; Shi, Hou Rui; Yun, Tian Yan; Zhang, Heng; Li, Cheng Liang; Chen, Yan Jun; Zhang, Yin Dong] Hainan Univ, Coll Agron, Haikou, Peoples R China; [Feng, Ren Jun; Peng, Ming; Wang, Jing Yi; Zhang, Xi Yan; Xie, Jiang Hui] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou, Peoples R China; [Lu, Li Fang] Hainan Inst Sci & Technol, Haikou, Peoples R China; [Guan, Xiao] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [He, Peng] Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Key Lab Rubber Biol, Danzhou, Hainan, Peoples R China	Hainan University; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Research Academy of Environmental Sciences; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Zhang, YD (corresponding author), Hainan Univ, Coll Agron, Haikou, Peoples R China.; Xie, JH (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou, Peoples R China.; He, P (corresponding author), Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Key Lab Rubber Biol, Danzhou, Hainan, Peoples R China.	penghe1974@163.com; 23300558@163.com; 2453880045@qq.com	WANG, JINGYI/GSJ-1241-2022		National Nature Science Foundation of China [31201603, 31501043]; National High Technology Research and Development Program of China (863 Programme) [2012AA101204-2]; Major Science and Technology program of Hainan [ZDZX2013023-1]; Hainan Natural Science Foundation [312050, 312051]; Graduate Outstanding Dissertation Cultivation Plan of Hainan University [15]; Natural Science Foundation of Hainan Province [312050, 312051]; Major Science and Technology Program of Hainan Province [ZDZX2013023-1]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Programme)(National High Technology Research and Development Program of China); Major Science and Technology program of Hainan; Hainan Natural Science Foundation; Graduate Outstanding Dissertation Cultivation Plan of Hainan University; Natural Science Foundation of Hainan Province; Major Science and Technology Program of Hainan Province	This study was supported by the National Nature Science Foundation of China (31201603, 31501043) to RJF; the National High Technology Research and Development Program of China (863 Programme; no. 2012AA101204-2) to MP; the Major Science and Technology program of Hainan (ZDZX2013023-1) to MP; the Hainan Natural Science Foundation (312050, 312051) to RJF and JYW; and the Graduate Outstanding Dissertation Cultivation Plan of Hainan University (15) to MYR; This research was supported by grants from the National Nature Science Foundation of China (31201603, 31501043), the National High Technology Research and Development Program of China (863 Programme; No. 2012AA101204-2), the Major Science and Technology Program of Hainan Province (CN) (ZDZX2013023-1), the Natural Science Foundation of Hainan Province (CN) (312050, 312051), and the Graduate Outstanding Dissertation Cultivation Plan of Hainan University (CN) (15).	Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; Alves AAC, 2004, ANN BOT-LONDON, V94, P605, DOI 10.1093/aob/mch179; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; An FY, 2010, PLANT CELL, V22, P2384, DOI 10.1105/tpc.110.076588; Benavente LM, 2006, MOL BIOSYST, V2, P165, DOI 10.1039/b513874d; Calatayud PA, 2000, PHOTOSYNTHETICA, V38, P97, DOI 10.1023/A:1026704226276; Carretero CL, 2008, J PLANT NUTR, V31, P959, DOI 10.1080/01904160802043296; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Curtis J, 2004, PLANT PHYSIOL, V136, P3313, DOI 10.1104/pp.104.044024; DANIELLO A, 1985, ANAL BIOCHEM, V144, P610, DOI 10.1016/0003-2697(85)90160-5; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; El-Sharkawy MA, 2006, PHOTOSYNTHETICA, V44, P481, DOI 10.1007/s11099-006-0063-0; ELSHARKAWY MA, 1987, PLANT SOIL, V100, P345, DOI 10.1007/BF02370950; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Freitas FZ, 2004, MOL GENET GENOMICS, V272, P550, DOI 10.1007/s00438-004-1086-5; Garcia AB, 1997, PLANT PHYSIOL, V115, P159, DOI 10.1104/pp.115.1.159; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Gleadow R, 2016, J EXP BOT, V67, P5403, DOI 10.1093/jxb/erw302; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Hays DB, 2007, PLANT SCI, V172, P1113, DOI 10.1016/j.plantsci.2007.03.004; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jansson C, 2009, APPL ENERG, V86, pS95, DOI 10.1016/j.apenergy.2009.05.011; Ji XM, 2011, PLANT PHYSIOL, V156, P647, DOI 10.1104/pp.111.176164; Kato K, 2009, PLANT PHYSIOL, V149, P1945, DOI 10.1104/pp.109.135582; Kim H, 2011, PLANT PHYSIOL, V156, P417, DOI 10.1104/pp.110.170621; Kondrak M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-74; Laban T. F., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P212; Lashbrook CC, 1998, PLANT J, V15, P243, DOI 10.1046/j.1365-313X.1998.00202.x; Laurentin A, 2003, ANAL BIOCHEM, V315, P143, DOI 10.1016/S0003-2697(02)00704-2; Li HJ, 2007, J PLANT GROWTH REGUL, V26, P106, DOI 10.1007/s00344-007-0015-3; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nassar NMA, 2008, GENET MOL RES, V7, P16, DOI 10.4238/vol7-1gmr389; Okogbenin E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00093; Olsen KM, 2001, AM J BOT, V88, P131, DOI 10.2307/2657133; Peng JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004664; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato-Nara K, 1999, PLANT PHYSIOL, V120, P321, DOI 10.1104/pp.120.1.321; [山蓝 Shan Lan], 2002, [植物生理学通讯, Plant Physiology Communications], V38, P463; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tardieu F, 2014, PLANT PHYSIOL, V164, P1628, DOI 10.1104/pp.113.233353; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verslues PE, 2014, PLANT PHYSIOL, V164, P144, DOI 10.1104/pp.113.224014; WALDREN RP, 1974, PLANT SOIL, V40, P689, DOI 10.1007/BF00010525; Walker AK, 2000, J BIOL CHEM, V275, P22166, DOI 10.1074/jbc.M001746200; Wang H, 2004, PLANT MOL BIOL, V55, P183, DOI 10.1007/s11103-004-0113-6; Whankaew S., 2015, African Journal of Biotechnology, V14, P745; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; Xu ZS, 2007, PLANT MOL BIOL, V65, P719, DOI 10.1007/s11103-007-9237-9; Yan SC, 2011, J SCI FOOD AGR, V91, P650, DOI 10.1002/jsfa.4226; Yau CP, 2004, J EXP BOT, V55, P547, DOI 10.1093/jxb/erh055; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhang HB, 2004, PLANT MOL BIOL, V55, P825, DOI 10.1007/s11103-005-2140-3; Zhang ZY, 2007, J EXP BOT, V58, P2993, DOI 10.1093/jxb/erm151; Zhang ZJ, 2010, PLANTA, V232, P765, DOI 10.1007/s00425-010-1208-8; Zhuang J, 2011, MOL BIOL REP, V38, P745, DOI 10.1007/s11033-010-0162-7	63	9	11	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177621	10.1371/journal.pone.0177621	http://dx.doi.org/10.1371/journal.pone.0177621			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542282	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058800020
J	McDonald, JT; Gao, XF; Steber, C; Breed, JL; Pollock, C; Ma, LL; Hlatky, L				McDonald, J. Tyson; Gao, Xuefeng; Steber, Cole; Breed, Jawon Lee; Pollock, Caitlin; Ma, Lili; Hlatky, Lynn			Host mediated inflammatory influence on glioblastoma multiforme recurrence following high-dose ionizing radiation	PLOS ONE			English	Article							LARGE GENE LISTS; TEMOZOLOMIDE ERA; SURVIVAL; CELLS; RADIOTHERAPY; SENESCENCE; PHENOTYPE; EXPOSURE; GROWTH; BETA	Despite optimal clinical treatment, glioblastoma multiforme (GBM) inevitably recurs. Standard treatment of GBM, exposes patients to radiation which kills tumor cells, but also modulates the molecular fingerprint of any surviving tumor cells and the cross-talk between those cells and the host. Considerable investigation of short-term (hours to days) post-irradiation tumor cell response has been undertaken, yet long-term responses (weeks to months) which are potentially even more informative of recurrence, have been largely overlooked. To better understand the potential of these processes to reshape tumor regrowth, molecular studies in conjunction with in silico modeling were used to examine short- and long-term growth dynamics. Despite survival of 2.55% and 0.009% following 8 or 16Gy, GBM cell populations in vitro showed a robust escape from cellular extinction and a return to pre-irradiated growth rates with no changes in long-term population doublings. In contrast, these same irradiated GBM cell populations injected in vivo elicited tumors which displayed significantly suppressed growth rates compared to their pre-irradiated counterparts. Transcriptome analysis days to weeks after irradiation revealed, 281 differentially expressed genes with a robust increase for cytokines, histones and C-C or C-X-C motif chemokines in irradiated cells. Strikingly, this same inflammatory signature in vivo for IL1A, CXCL1, IL6 and IL8 was increased in xenografts months after irradiation. Computational modeling of tumor cell dynamics indicated a host-mediated negative pressure on the surviving cells was a source of inhibition consistent with the findings resulting in suppressed tumor growth. Thus, tumor cells surviving irradiation may shift the landscape of population doubling through inflammatory mediators interacting with the host in a way that impacts tumor recurrence and affects the efficacy of subsequent therapies. Clues to more effective therapies may lie in the development and use of pre-clinical models of post-treatment response to target the source of inflammatory mediators that significantly alter cellular dynamics and molecular pathways in the early stages of tumor recurrence.	[McDonald, J. Tyson; Gao, Xuefeng; Steber, Cole; Breed, Jawon Lee; Pollock, Caitlin; Ma, Lili; Hlatky, Lynn] Ctr Canc Syst Biol, Boston, MA 02215 USA; [McDonald, J. Tyson] Hampton Univ, Canc Res Ctr, Hampton, VA 23668 USA; [Gao, Xuefeng] Shenzhen HRK Biotech Co Ltd, Shenzhen, Guangdong, Peoples R China	Hampton University	McDonald, JT (corresponding author), Ctr Canc Syst Biol, Boston, MA 02215 USA.; McDonald, JT (corresponding author), Hampton Univ, Canc Res Ctr, Hampton, VA 23668 USA.	john.mcdonald@hamptonu.edu		McDonald, John/0000-0003-4300-6827	National Institutes of Health's National Cancer Institute Integrative Cancer Biology Program (ICBP) [1U54CA149233]; ICBP Summer Cancer Research Fellowship/Internship Program; NCI Summer Cancer Research Fellowship/Internship Education	National Institutes of Health's National Cancer Institute Integrative Cancer Biology Program (ICBP); ICBP Summer Cancer Research Fellowship/Internship Program; NCI Summer Cancer Research Fellowship/Internship Education	This study was supported by the National Institutes of Health's National Cancer Institute Integrative Cancer Biology Program (ICBP, 1U54CA149233) to L.H.; the efforts of research fellows, J.L.B. and C.S., were generously supported by the ICBP Summer Cancer Research Fellowship/Internship Program. Shenzhen HRK Bio-tech provided support in the form of salaries for author Xuefeng Gao, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We would like to acknowledge the contributions of Betty Tarnowski of the NCI, along with Clare Lamont and Melissa Klumpar of CCSB, in facilitating the NCI Summer Cancer Research Fellowship/Internship Education and Outreach efforts under the NIH ICBP.	Beheshti A, 2015, CANCER RES, V75, P1134, DOI 10.1158/0008-5472.CAN-14-1053; Blaylock Russell L, 2013, Surg Neurol Int, V4, P15, DOI 10.4103/2152-7806.106577; Brush JM, 2009, INT J RADIAT BIOL, V85, P483, DOI 10.1080/09553000902883794; Chan JL, 2002, J CLIN ONCOL, V20, P1635, DOI 10.1200/JCO.20.6.1635; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Darefsky AS, 2012, CANCER-AM CANCER SOC, V118, P2163, DOI 10.1002/cncr.26494; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Gao X, 2012, CANCER RES, V73, P1481, DOI DOI 10.1158/0008-5472.CAN-12-3429; Gao XF, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00138; Gao XF, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/249309; Hardee ME, 2012, CANCER RES, V72, P4119, DOI 10.1158/0008-5472.CAN-12-0546; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Lorimore SA, 2003, ONCOGENE, V22, P7058, DOI 10.1038/sj.onc.1207044; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; McDonald JT, 2014, INT J RADIAT BIOL, V90, P231, DOI 10.3109/09553002.2014.877175; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nicklin MJH, 2002, GENOMICS, V79, P718, DOI 10.1006/geno.2002.6751; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Roninson IB, 2003, CANCER RES, V63, P2705; Segerstrom L, 2008, INT J ONCOL, V33, P341, DOI 10.3892/ijo_00000014; Sen E, 2011, DRUG DISCOV TODAY, V16, P1044, DOI 10.1016/j.drudis.2011.09.003; Shaw E, 2000, INT J RADIAT ONCOL, V47, P291, DOI 10.1016/S0360-3016(99)00507-6; Sintupisut N, 2013, NUCL ACIDS RES; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Yeung YT, 2012, J NEURO-ONCOL, V109, P35, DOI 10.1007/s11060-012-0875-7; Zhang M, 2011, CANCER RES, V71, P7155, DOI 10.1158/0008-5472.CAN-11-1212	34	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178155	10.1371/journal.pone.0178155	http://dx.doi.org/10.1371/journal.pone.0178155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542439	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400063
J	Kontson, K; Marcus, I; Myklebust, B; Civillico, E				Kontson, Kimberly; Marcus, Ian; Myklebust, Barbara; Civillico, Eugene			Targeted box and blocks test: Normative data and comparison to standard tests	PLOS ONE			English	Article							TRANSRADIAL PROSTHESIS USERS; RELIABILITY; MOVEMENTS; STRATEGIES; DEXTERITY; VALIDITY; MOTION	Background The Box and Block Test (BBT) is a functional outcome measure that is commonly used across multiple clinical populations due to its benefits of ease and speed of implementation; reliable, objective measurement; and repetition of motion. In this study, we introduce a novel outcome measure called the targeted BBT that allows for the study of initiation, grasping, and transport of objects, and also of object release. These modifications to the existing test may increase the ecological validity of the measure while still retaining the previously stated benefits of the standard BBT. Methods 19 able-bodied subjects performed the targeted BBT and two other standard tests. Using an integrated movement analysis framework based on motion capture and ground force data, quantitative information about how subjects completed these tests were captured. Kinematic parameters at the wrist, elbow, shoulder, thorax, and head, as well as measures of postural control, were calculated and statistically compared across the three tests. Results In general, the targeted BBT required significantly higher RoM at the elbow, shoulder, thorax and head when compared to standard tests. Peak angles at these joints were also higher during performance of the targeted BBT. Peak angles and RoM values for the targeted BBT were close to those found in studies of movements of able-bodied individuals performing activities of daily living. Conclusion The targeted BBT allows analysis of repetitive movements, and may more closely model common real-world object manipulation scenarios in which a user is required to control a movement from pick-up to release.	[Kontson, Kimberly; Myklebust, Barbara; Civillico, Eugene] US FDA, Ctr Devices & Radiol Hlth, Off Sci & Engn Labs, Div Biomed Phys, Silver Spring, MD 20993 USA; [Marcus, Ian] US FDA, Ctr Devices & Radiol Hlth, Off Device Evaluat, Div Neurol & Phys Med Devices, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Kontson, K (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Off Sci & Engn Labs, Div Biomed Phys, Silver Spring, MD 20993 USA.	Kimberly.Kontson@fda.hhs.gov	CIVILLICO, EUGENE/I-4417-2019	CIVILLICO, EUGENE/0000-0003-2209-9147; KONTSON, KIMBERLY/0000-0002-4978-6011	DARPA-BTO [IAA 224-14-6009]; FDA Critical Path Initiative [CPOSEL13]; DARPA HAPTIX through DARPA-FDA IAA [224-14-6009]	DARPA-BTO; FDA Critical Path Initiative; DARPA HAPTIX through DARPA-FDA IAA	This work was funded in part by an interagency agreement with DARPA-BTO (IAA 224-14-6009), and by the FDA Critical Path Initiative (CPOSEL13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Sophie Wang (University of Maryland), Sydney Barovsky (Marquette University), Heather Benz (FDA), Tiffany Ryan (Advanced Arm Dynamics) and Jacqueline Hebert (University of Alberta) for assistance with data acquisition and/or interpretation. This work was funded in part by DARPA HAPTIX under the auspices of Dr. Doug Weber through the DARPA-FDA IAA No. 224-14-6009, and by the FDA Critical Path Initiative (CPOSEL13). Disclaimer: The mention of commercial products, their sources, or their use in connection with material reported herein is not to be construed as an actual or implied endorsement of such products by DHHS.	Alt Murphy M, 2015, BMC NEUROLOGY, V15, P1; Bouwsema H, 2010, CLIN BIOMECH, V25, P523, DOI 10.1016/j.clinbiomech.2010.02.011; Canny ML, 2009, AM J OCCUP THER, V63, P506, DOI 10.5014/ajot.63.4.506; Carey SL, 2008, CLIN BIOMECH, V23, P1128, DOI 10.1016/j.clinbiomech.2008.05.008; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; Cornwell AS, 2012, J REHABIL RES DEV, V49, P395, DOI 10.1682/JRRD.2011.03.0040; Cromwell F., 1976, OCCUPATIONAL THERAPI; DESROSIERS J, 1994, ARCH PHYS MED REHAB, V75, P751; Gates DH, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.015487; Hebert JS, 2014, J REHABIL RES DEV, V51, P919, DOI 10.1682/JRRD.2013.10.0228; Hebert JS, 2012, J REHABIL RES DEV, V49, P1163, DOI 10.1682/JRRD.2011.10.0207; Karimi MT, 2011, J RES MED SCI, V16, P530; Karst Gregory M, 2005, J Neurol Phys Ther, V29, P170; Kontson K, 2017, IEEE T NEURAL SYST R; Lee G, 2008, SURG ENDOSC, V22, P1087, DOI 10.1007/s00464-007-9664-3; Levin MF, 2016, NEUROREHAB NEURAL RE, V30, P635, DOI 10.1177/1545968315613863; Liu W, 2013, J REHABIL RES DEV, V50, P71, DOI 10.1682/JRRD.2011.04.0074; Major MJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-132; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Metzger AJ, 2012, ARCH PHYS MED REHAB, V93, P2029, DOI 10.1016/j.apmr.2012.03.011; Mobini A, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0070-0; Muray IA, 1999, DETERMINING UPPER LI; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Resnik L, 2014, J REHABIL RES DEV, V51, P351, DOI 10.1682/JRRD.2013.08.0180	28	35	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177965	10.1371/journal.pone.0177965	http://dx.doi.org/10.1371/journal.pone.0177965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542374	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600036
J	Hyseni, L; Elliot-Green, A; Lloyd-Williams, F; Kypridemos, C; O'Flaherty, M; McGill, R; Orton, L; Bromley, H; Cappuccio, FP; Capewell, S				Hyseni, Lirije; Elliot-Green, Alex; Lloyd-Williams, Ffion; Kypridemos, Chris; O'Flaherty, Martin; McGill, Rory; Orton, Lois; Bromley, Helen; Cappuccio, Francesco P.; Capewell, Simon			Systematic review of dietary salt reduction policies: Evidence for an effectiveness hierarchy?	PLOS ONE			English	Review							COST-EFFECTIVENESS ANALYSIS; CHRONIC DISEASE PREVENTION; MEN AGED 40; SODIUM-INTAKE; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RESPONSIBILITY DEAL; ECONOMIC-EVALUATION; EDUCATION-PROGRAM; PHYSICAL-ACTIVITY	Background Non-communicable disease (NCD) prevention strategies now prioritise four major risk factors: food, tobacco, alcohol and physical activity. Dietary salt intake remains much higher than recommended, increasing blood pressure, cardiovascular disease and stomach cancer. Substantial reductions in salt intake are therefore urgently needed. However, the debate continues about the most effective approaches. To inform future prevention programmes, we systematically reviewed the evidence on the effectiveness of possible salt reduction interventions. We further compared "downstream, agentic" approaches targeting individuals with "upstream, structural" policy-based population strategies. Methods We searched six electronic databases (CDSR, CRD, MEDLINE, SCI, SCOPUS and the Campbell Library) using a pre-piloted search strategy focussing on the effectiveness of population interventions to reduce salt intake. Retrieved papers were independently screened, appraised and graded for quality by two researchers. To facilitate comparisons between the interventions, the extracted data were categorised using nine stages along the agentic/structural continuum, from "downstream" : dietary counselling (for individuals, worksites or communities), through media campaigns, nutrition labelling, voluntary and mandatory reformulation, to the most "upstream" regulatory and fiscal interventions, and comprehensive strategies involving multiple components. Results After screening 2,526 candidate papers, 70 were included in this systematic review (49 empirical studies and 21 modelling studies). Some papers described several interventions. Quality was variable. Multi-component strategies involving both upstream and downstream interventions, generally achieved the biggest reductions in salt consumption across an entire population, most notably 4g/day in Finland and Japan, 3g/day in Turkey and 1.3g/day recently in the UK. Mandatory reformulation alone could achieve a reduction of approximately 1.45g/day (three separate studies), followed by voluntary reformulation (-0.8g/day), school interventions (-0.7g/day), short term dietary advice (-0.6g/day) and nutrition labelling (-0.4g/day), but each with a wide range. Tax and community based counselling could, each typically reduce salt intake by 0.3g/day, whilst even smaller population benefits were derived from health education media campaigns (-0.1g/day). Worksite interventions achieved an increase in intake (+0.5g/day), however, with a very wide range. Long term dietary advice could achieve a -2g/day reduction under optimal research trial conditions; however, smaller reductions might be anticipated in unselected individuals. Conclusions Comprehensive strategies involving multiple components (reformulation, food labelling and media campaigns) and "upstream" population-wide policies such as mandatory reformulation generally appear to achieve larger reductions in population-wide salt consumption than "downstream", individually focussed interventions. This 'effectiveness hierarchy' might deserve greater emphasis in future NCD prevention strategies.	[Hyseni, Lirije; Elliot-Green, Alex; Lloyd-Williams, Ffion; Kypridemos, Chris; O'Flaherty, Martin; McGill, Rory; Orton, Lois; Bromley, Helen; Capewell, Simon] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Cappuccio, Francesco P.] Univ Warwick, WHO, Collaborating Ctr, Warwick Med Sch, Coventry, W Midlands, England	University of Liverpool; University of Warwick; World Health Organization	Hyseni, L (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool, Merseyside, England.	L.hyseni@liv.ac.uk	PAN, ZEQIANG/X-6341-2018; Kypridemos, Chris/I-4172-2019	Kypridemos, Chris/0000-0002-0746-9229; Orton, Lois/0000-0002-9641-523X	LiLaC/NIHR; National Institute for Health Research's School for Public Health Research (NIHR SPHR); National Institute for Health Research (NIHR); HEFCE; MRC [G0900847] Funding Source: UKRI; Medical Research Council [G0900847] Funding Source: researchfish	LiLaC/NIHR; National Institute for Health Research's School for Public Health Research (NIHR SPHR); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); HEFCE(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Lirije Hyseni, Rory McGill and Lois Orton were funded by LiLaC/NIHR. This article presents independent research funded by the National Institute for Health Research's School for Public Health Research (NIHR SPHR). The School for Public Health Research (SPHR) is funded by the National Institute for Health Research (NIHR). SPHR is a partnership between the Universities of Sheffield, Bristol, Cambridge, Exeter, UCL; The London School for Hygiene and Tropical Medicine; the LiLaC collaboration between the Universities of Liverpool and Lancaster and Fuse; The Centre for Translational Research in Public Health. The work was carried out under the remit of the WHO Collaborating Centre for Nutrition of the University of Warwick. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health or the World Health Organization. All other authors were funded by HEFCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Adams J, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1001990, 10.1371/journal.pmed.1002045]; Aldana SG, 2005, J OCCUP ENVIRON MED, V47, P558, DOI 10.1097/01.jom.0000165743.18570.66; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Babio N, 2014, PUBLIC HEALTH NUTR, V17, P1403, DOI 10.1017/S1368980013001274; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Bech-Larsen T, 2012, J MACROMARKETING, V32, P208, DOI 10.1177/0276146711435262; Beckmann S, 1995, AM J HYPERTENS, V8; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Brownson RC, 2010, PREV CHRONIC DIS, V7; Brunner E, 1997, AM J PUBLIC HEALTH, V87, P1415, DOI 10.2105/AJPH.87.9.1415; Campos S, 2011, PUBLIC HEALTH NUTR, V14, P1496, DOI 10.1017/S1368980010003290; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Cappuccio FP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-13; Cappuccio FP., 2015, FUNCTIONAL FOOD REV, V7, P41, DOI DOI 10.2310/6180.2015.00005; Cappuccio FP, 2007, BMJ-BRIT MED J, V334, P859, DOI 10.1136/bmj.39175.364954.BE; Cappuccio FP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007467; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Chen J, 2008, OBES REV, V9, P142, DOI 10.1111/j.1467-789X.2007.00456.x; Choi SE, 2015, MEDICAL DECISION MAK; Cobiac LJ, 2013, ANNU REV NUTR, V33, P373, DOI 10.1146/annurev-nutr-071812-161133; Cobiac LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041842; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Collins M, 2014, VALUE HEALTH, V17, P517, DOI 10.1016/j.jval.2014.03.1722; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cotter J, 2013, J HYPERTENS, V31, P1966, DOI 10.1097/HJH.0b013e328363572f; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI [10.1079/PHN2005666, 10.1079/PHN2004666]; D'Elia L, 2012, CLIN NUTR, V31, P489, DOI 10.1016/j.clnu.2012.01.003; de Menezes EW, 2013, FOOD CHEM, V140, P547, DOI 10.1016/j.foodchem.2013.02.031; Dodhia H, 2012, J HYPERTENS, V30, P217, DOI 10.1097/HJH.0b013e32834d86ee; Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121; Duc AH, 2011, HEALTH POLICY PLANN, V26, P210, DOI 10.1093/heapol/czq045; Elfassy T, 2015, J ACAD NUTR DIET, V115, P278, DOI 10.1016/j.jand.2014.08.027; Enkhtungalag B, 2015, CARDIOVASC DIAGN THE, V5, P229, DOI 10.3978/j.issn.2223-3652.2015.04.11; Fair Society, 2010, PUBLISHED BY THE MAR, P1; Fattore G, 2014, NUTR REV, V72, P691, DOI 10.1111/nure.12142; Forshee RA, 2008, NUTR REV, V66, P280, DOI 10.1111/j.1753-4887.2008.00033.x; Francis SL, 2009, J AM DIET ASSOC, V109, P2052, DOI 10.1016/j.jada.2009.09.002; Fransen ML, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01201; Gase LN, 2011, AM J PUBLIC HEALTH, V101, P1501, DOI 10.2105/AJPH.2011.300138; Gillespie DOS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127927; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He F. J., 2013, BMJ, V346; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h770; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; Heino T, 2000, ACTA PAEDIATR, V89, P406, DOI 10.1080/080352500750028096; Hendriksen MAH, 2014, AM J CLIN NUTR, V99, P446, DOI 10.3945/ajcn.113.062018; Hogberg L, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.130567; Hooper L, 2002, BMJ-BRIT MED J, V325, P628, DOI 10.1136/bmj.325.7365.628; Ji C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002246; Ji C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005683; Joossens JV, 1996, INT J EPIDEMIOL, V25, P494, DOI 10.1093/ije/25.3.494; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Katz DL, 2011, J SCHOOL HEALTH, V81, P21, DOI 10.1111/j.1746-1561.2010.00553.x; Knai C, 2015, FOOD POLICY, V54, P1, DOI 10.1016/j.foodpol.2015.04.002; Kokanovic Ana, 2014, Med Glas (Zenica), V11, P234; Konfino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073824; Krieger N, 2008, AM J PUBLIC HEALTH, V98, P221, DOI 10.2105/AJPH.2007.111278; Laatikainen T, 2006, EUR J CLIN NUTR, V60, P965, DOI 10.1038/sj.ejcn.1602406; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Levin SM, 2010, PUBLIC HEALTH NUTR, V13, P1629, DOI 10.1017/S136898000999303X; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lloyd-Williams F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1195; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luft FC, 1997, AM J CLIN NUTR, V65; MacGregor GA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1936; Mason H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084445; McGill R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1781-7; McKinlay JB, 2000, INT J HEALTH SERV, V30, P49, DOI 10.2190/2V5H-RHBR-FTM1-KGCF; McLaren L, 2010, INT J EPIDEMIOL, V39, P372, DOI 10.1093/ije/dyp315; Mhurchu CN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128477; Mhurchu CN, 2011, AM J CLIN NUTR, V93, P594, DOI 10.3945/ajcn.110.004481; Miura K, 2013, HYPERTENS RES, V36, P1020, DOI 10.1038/hr.2013.105; Mohan S, 2009, CAN MED ASSOC J, V181, P605, DOI 10.1503/cmaj.090361; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mols F, 2015, EUR J POLIT RES, V54, P81, DOI 10.1111/1475-6765.12073; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; National Institutes of Health, 2014, IRAN J PUBL HLTH; Nghiem N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123915; NICE Public Health Guidance, 2010, PREVENTION OF CARDIO; Niebylski ML, 2015, NUTRITION, V31, P787, DOI 10.1016/j.nut.2014.12.010; Nuffield Council on Bioethics, 2007, PUBLIC HEALTH ETHICA, P31; Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2; Orton L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021704; Otsuka R, 2011, J AM DIET ASSOC, V111, P844, DOI 10.1016/j.jada.2011.03.020; Owen L, 2012, J PUBLIC HEALTH-UK, V34, P37, DOI 10.1093/pubmed/fdr075; Parekh S, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-108; PERRY IJ, 1992, J HUM HYPERTENS, V6, P23; Petersen KS, 2013, APPETITE, V68, P147, DOI 10.1016/j.appet.2013.04.028; Pietinen P, 2008, PUBLIC HEALTH NUTR, V11, P335, DOI 10.1017/S1368980007000249; Pietinen P, 2010, PUBLIC HEALTH NUTR, V13, P901, DOI 10.1017/S1368980010001072; Robare JF, 2010, PUBLIC HEALTH NUTR, V13, P606, DOI 10.1017/S1368980009991583; Rodriguez-Fernandez R, 2014, PUBLIC HEALTH NUTR, V17, P1894, DOI 10.1017/S136898001300195X; Roodenburg AJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072378; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Rubinstein A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-627; Rubinstein Adolfo, 2009, Cost Eff Resour Alloc, V7, P10, DOI 10.1186/1478-7547-7-10; Sasaki N., 1979, PROPHYLACTIC APPROAC, P467; Shankar B, 2013, HEALTH ECON, V22, P243, DOI 10.1002/hec.2772; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; Strazzullo Pasquale, 2009, BMJ, V339, pb4567, DOI 10.1136/bmj.b4567; Takahashi Y, 2006, J HYPERTENS, V24, P451, DOI 10.1097/01.hjh.0000209980.36359.16; Temme EHM, 2011, PUBLIC HEALTH NUTR, V14, P635, DOI 10.1017/S1368980010002089; Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123; Tian HG, 1995, J HUM HYPERTENS, V9, P959; Trieu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130247; van de Vijver S, 2012, ETHNIC HEALTH, V17, P651, DOI 10.1080/13557858.2012.754409; Van Vliet BN, 2011, CAN J CARDIOL, V27, P437, DOI 10.1016/j.cjca.2011.04.012; Vos T, GLOBAL BURDEN OF DIS; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wang GJ, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0349-1; Wang GJ, 2011, J HYPERTENS, V29, P1693, DOI 10.1097/HJH.0b013e328349ba18; Wang JS, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-163; Wang XQ, 2009, WORLD J GASTROENTERO, V15, P2204, DOI 10.3748/wjg.15.2204; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; Webster JL, 2010, AM J CLIN NUTR, V91, P413, DOI 10.3945/ajcn.2009.28688; Wilcox M, 2015, INT J PUBLIC HEALTH, V60, pS23, DOI 10.1007/s00038-014-0577-3; World Health Organization, 2012, GUIDELINE SODIUM INT; World Health Organization, 2010, SALT REDUCTION; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966; Yanek LR, 2001, PUBLIC HEALTH REP, V116, P68, DOI 10.1093/phr/116.S1.68	131	128	135	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177535	10.1371/journal.pone.0177535	http://dx.doi.org/10.1371/journal.pone.0177535			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542317	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400049
J	Jacob, K; Rasmussen, A; Tyler, P; Servos, MM; Sylla, M; Prado, C; Daniele, E; Sharp, JS; Purdy, AE				Jacob, Kristin; Rasmussen, Anna; Tyler, Paul; Servos, Mariah M.; Sylla, Mariame; Prado, Cecilia; Daniele, Elizabeth; Sharp, Josh S.; Purdy, Alexandra E.			Regulation of acetyl-CoA synthetase transcription by the CrbS/R two-component system is conserved in genetically diverse environmental pathogens	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; HYBRID SENSOR KINASE; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; CYSTIC-FIBROSIS; ORAL INFECTION; HOST; VIRULENCE	The CrbS/R two-component signal transduction system is a conserved regulatory mechanism through which specific Gram-negative bacteria control acetate flux into primary metabolic pathways. CrbS/R governs expression of acetyl-CoA synthase (acsA), an enzyme that converts acetate to acetyl-CoA, a metabolite at the nexus of the cell's most important energy-harvesting and biosynthetic reactions. During infection, bacteria can utilize this system to hijack host acetate metabolism and alter the course of colonization and pathogenesis. In toxigenic strains of Vibrio cholerae, CrbS/R-dependent expression of acsA is required for virulence in an arthropod model. Here, we investigate the function of the CrbS/R system in Pseudomonas aeruginosa, Pseudomonas entomophila, and non-toxigenic V. cholerae strains. We demonstrate that its role in acetate metabolism is conserved; this system regulates expression of the acsA gene and is required for growth on acetate as a sole carbon source. As a first step towards describing the mechanism of signaling through this pathway, we identify residues and domains that may be critical for phosphotransfer. We further demonstrate that although CrbS, the putative hybrid sensor kinase, carries both a histidine kinase domain and a receiver domain, the latter is not required for acsA transcription. In order to determine whether our findings are relevant to pathogenesis, we tested our strains in a Drosophila model of oral infection previously employed for the study of acetate-dependent virulence by V. cholerae. We show that non-toxigenic V. cholerae strains lacking CrbS or CrbR are significantly less virulent than are wild-type strains, while P. aeruginosa and P. entomophila lacking CrbS or CrbR are fully pathogenic. Together, the data suggest that the CrbS/R system plays a central role in acetate metabolism in V. cholerae, P. aeruginosa, and P. entomophila. However, each microbe's unique environmental adaptations and pathogenesis strategies may dictate conditions under which CrbS/R-mediated acs expression is most critical.	[Jacob, Kristin; Sharp, Josh S.] Northern Michigan Univ, Dept Biol, Marquette, MI 49855 USA; [Rasmussen, Anna; Tyler, Paul; Servos, Mariah M.; Sylla, Mariame; Prado, Cecilia; Daniele, Elizabeth; Purdy, Alexandra E.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Jacob, Kristin] Univ Michigan, Ann Arbor, MI 48109 USA; [Rasmussen, Anna] Stanford Univ, Dept Earth Syst Sci, Palo Alto, CA 94304 USA; [Tyler, Paul] Yale Univ, Yale Combined Program Biol & Biomed Sci, New Haven, CT USA; [Servos, Mariah M.] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Sylla, Mariame] Harvard Med Sch, Boston, MA USA	Northern Michigan University; Amherst College; University of Michigan System; University of Michigan; Stanford University; Yale University; Dartmouth College; Harvard University; Harvard Medical School	Sharp, JS (corresponding author), Northern Michigan Univ, Dept Biol, Marquette, MI 49855 USA.; Purdy, AE (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.	jsharp@nmu.edu; apurdy@amherst.edu		Rasmussen, Anna/0000-0002-0031-2835	Amherst College; Northern Michigan University	Amherst College; Northern Michigan University	The authors received funding from start up funds from Amherst College and Northern Michigan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007167; Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Blow NS, 2005, PLOS PATHOG, V1, P92, DOI 10.1371/journal.ppat.0010008; Borisova SA, 2011, J BIOL CHEM, V286, P22283, DOI 10.1074/jbc.M111.237735; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Deutschbauer A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002385; DORING G, 1983, J INFECT DIS, V147, P744, DOI 10.1093/infdis/147.4.744; Fauvarque Marie-Odile, 2014, Cell Microbiol, V16, P824, DOI 10.1111/cmi.12292; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Freeman JA, 2000, MOL MICROBIOL, V35, P139, DOI 10.1046/j.1365-2958.2000.01684.x; Georgescu M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1396-3; Geszvain K, 2008, J BACTERIOL, V190, P4437, DOI 10.1128/JB.00055-08; Goldman SR, 2011, MOL CELL, V42, P817, DOI 10.1016/j.molcel.2011.06.005; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hang SY, 2014, CELL HOST MICROBE, V16, P592, DOI 10.1016/j.chom.2014.10.006; He K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004002; Hentchel KL, 2015, MICROBIOL MOL BIOL R, V79, P321, DOI 10.1128/MMBR.00020-15; JAFFARBANDJEE MC, 1995, J CLIN MICROBIOL, V33, P924, DOI 10.1128/JCM.33.4.924-929.1995; Jimenez-Pearson MA, 2005, MICROBIOL-SGM, V151, P3299, DOI 10.1099/mic.0.28217-0; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kim MJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0418-4; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110; Korycinski M, 2015, J MOL BIOL, V427, P3327, DOI 10.1016/j.jmb.2015.08.017; Kretzschmar U, 2010, ARCH MICROBIOL, V192, P685, DOI 10.1007/s00203-010-0593-5; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Limmer S, 2011, P NATL ACAD SCI USA, V108, P17378, DOI 10.1073/pnas.1114907108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Merrell DS, 2000, J BACTERIOL, V182, P5342, DOI 10.1128/JB.182.19.5342-5350.2000; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mulcahy H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002299; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; Opota O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002259; Panayidou S, 2014, VIRULENCE, V5, P253, DOI 10.4161/viru.27524; Purdy A, 2005, J BACTERIOL, V187, P2992, DOI 10.1128/JB.187.9.2992-3001.2005; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Sourjik V, 1998, BIOCHEMISTRY-US, V37, P2327, DOI 10.1021/bi972330a; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Studer SV, 2008, J BACTERIOL, V190, P5915, DOI 10.1128/JB.00148-08; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; UHL MA, 1994, P NATL ACAD SCI USA, V91, P1163, DOI 10.1073/pnas.91.3.1163; Vallet-Gely I, 2010, CELL MICROBIOL, V12, P1666, DOI 10.1111/j.1462-5822.2010.01501.x; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Vodovar N, 2004, TRENDS MICROBIOL, V12, P235, DOI 10.1016/j.tim.2004.03.007; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Walker KA, 2010, J BACTERIOL, V192, P5887, DOI 10.1128/JB.00745-10; Wang F- F, 2013, ENVIRON MICROBIOL, V18, P1534; Watve SS, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01396-16; Wise AA, 2010, J BACTERIOL, V192, P1534, DOI 10.1128/JB.01007-09; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; Yeung ATY, 2011, J BACTERIOL, V193, P918, DOI 10.1128/JB.00911-10; Zaoui C, 2012, MOL MICROBIOL, V83, P536, DOI 10.1111/j.1365-2958.2011.07947.x; Zhang XX, 2015, J BACTERIOL, V197, P2867, DOI 10.1128/JB.00361-15	67	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177825	10.1371/journal.pone.0177825	http://dx.doi.org/10.1371/journal.pone.0177825			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542616	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672400091
J	Aquino-Martinez, R; Artigas, N; Gamez, B; Rosa, JL; Ventura, F				Aquino-Martinez, Ruben; Artigas, Natalia; Gamez, Beatriz; Luis Rosa, Jose; Ventura, Francesc			Extracellular calcium promotes bone formation from bone marrow mesenchymal stem cells by amplifying the effects of BMP-2 on SMAD signalling	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-2; OSTEOGENIC DIFFERENTIATION; EXPRESSION; PHOSPHORYLATION; STRATEGIES; RECEPTOR; SCAFFOLD; PATHWAY; CULTURE	Understanding the molecular events that regulate osteoblast differentiation is essential for the development of effective approaches to bone regeneration. In this study, we analysed the osteoinductive properties of extracellular calcium in bone marrow-derived mesenchymal stem cell (BM-MSC) differentiation. We cultured BM-MSCs in 3D gelatin scaffolds with Ca2+ and BMP-2 as osteoinductive agents. Early and late osteogenic gene expression and bone regeneration in a calvarial critical-size defect model demonstrate that extracellular Ca2+ enhances the effects of BMP-2 on Osteocalcin, Runx2 and Osterix expression and promotes bone regeneration in vivo. Moreover, we analysed the molecular mechanisms involved and observed an antagonistic effect between Ca2+ and BMP-2 on SMAD1/5, ERK and S6K signalling after 24 hours. More importantly, a cooperative effect between Ca2+ and BMP-2 on the phosphorylation of SMAD1/5, S6, GSK3 and total levels of beta-CATENIN was observed at a later differentiation time (10 days). Furthermore, Ca2+ alone favoured the phosphorylation of SMAD1, which correlates with the induction of Bmp2 and Bmp4 gene expression. These data suggest that Ca2+ and BMP-2 cooperate and promote an autocrine/paracrine osteogenic feed-forward loop. On the whole, these results demonstrate the usefulness of calcium-based bone grafts or the addition of exogenous Ca2+ in bone tissue engineering.	[Aquino-Martinez, Ruben; Artigas, Natalia; Gamez, Beatriz; Luis Rosa, Jose; Ventura, Francesc] Univ Barcelona, IDIBELL, Dept Ciencias Fisiol, Lhospitalet De Llobregat, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Ventura, F (corresponding author), Univ Barcelona, IDIBELL, Dept Ciencias Fisiol, Lhospitalet De Llobregat, Spain.	fventura@ub.edu	Rosa, Jose Luis/K-6685-2014; Ventura, Francesc/K-9700-2014; Ventura, Francesc/ABG-2285-2020	Rosa, Jose Luis/0000-0002-6161-5688; Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Artigas, Natalia/0000-0003-3290-2052; Aquino-Martinez, Ruben/0000-0003-1564-2279	Ministry of Education and Science of Spain [BFU2014-56313P]; Fundacio La Marato de TV3 [120330]; University of Barcelona	Ministry of Education and Science of Spain(Spanish Government); Fundacio La Marato de TV3; University of Barcelona	This work was supported by grants from the Ministry of Education and Science of Spain (BFU2014-56313P) and Fundacio La Marato de TV3 (120330). N. Artigas received a fellowship from the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino-Martinez R, 2016, TISSUE ENG PT A, V22, P41, DOI [10.1089/ten.tea.2015.0181, 10.1089/ten.TEA.2015.0181]; Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003; Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020; Berger CEM, 2001, J BONE MINER RES, V16, P2092, DOI 10.1359/jbmr.2001.16.11.2092; Boskey Adele L, 2013, Bonekey Rep, V2, P447, DOI 10.1038/bonekey.2013.181; Carstens MH, 2005, J CRANIOFAC SURG, V16, P1023, DOI 10.1097/01.scs.0000186310.10957.2b; Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002; Chattopadhyay N, 2004, ENDOCRINOLOGY, V145, P3451, DOI 10.1210/en.2003-1127; Chenard KE, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/601549; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Fromigue O, 2010, J BIOL CHEM, V285, P25251, DOI 10.1074/jbc.M110.110502; Gamez B, 2016, J BONE MINER RES; Gamez B, 2014, J MOL ENDOCRINOL, V52, pR179, DOI 10.1530/JME-13-0294; Hassan AH, 2015, J LIPOSOME RES, P1; Henkel J, 2013, BONE RES, V1, P216, DOI 10.4248/BR201303002; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Leclerc C, 2011, BIOCHIMIE, V93, P2102, DOI 10.1016/j.biochi.2011.06.032; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; Maeda H, 2010, J ENDODONT, V36, P647, DOI 10.1016/j.joen.2009.12.024; Mandal CC, 2016, J BIOL CHEM, V291, P1148, DOI 10.1074/jbc.M115.668939; Moreau R, 1997, J BONE MINER RES, V12, P1984, DOI 10.1359/jbmr.1997.12.12.1984; Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09; Perez RA, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412439555; Rawashdeh MA, 2008, BRIT J ORAL MAX SURG, V46, P665, DOI 10.1016/j.bjoms.2008.07.184; Riccardi D, 2009, PFLUG ARCH EUR J PHY, V458, P1007, DOI 10.1007/s00424-009-0681-z; Rodriguez-Carballo E, 2011, J BONE MINER RES, V26, P718, DOI 10.1002/jbmr.260; Rohanizadeh R, 2008, J MATER SCI-MATER M, V19, P1173, DOI 10.1007/s10856-007-3154-y; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Stanovici J, 2016, CURR RES TRANSL MED, V64, P83, DOI 10.1016/j.retram.2016.04.006; Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]; Tada H, 2010, BIOCHEM BIOPH RES CO, V394, P1093, DOI 10.1016/j.bbrc.2010.03.135; Takagishi Y, 2006, TISSUE ENG, V12, P927, DOI 10.1089/ten.2006.12.927; Tang M, 2014, J PERIODONTOL, V85, P1806, DOI 10.1902/jop.2014.140244; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Vaccaro Alexander R, 2002, Spine J, V2, P206, DOI 10.1016/S1529-9430(02)00180-8; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000	41	55	58	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178158	10.1371/journal.pone.0178158	http://dx.doi.org/10.1371/journal.pone.0178158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542453	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800046
J	Gupta, S; Bhar, A; Chatterjee, M; Ghosh, A; Das, S				Gupta, Sumanti; Bhar, Anirban; Chatterjee, Moniya; Ghosh, Amartya; Das, Sampa			Transcriptomic dissection reveals wide spread differential expression in chickpea during early time points of Fusarium oxysporum f. sp ciceri Race 1 attack	PLOS ONE			English	Article							MAP KINASE 6; CELL-DEATH; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; PLANT DEFENSE; PURINE BIOSYNTHESIS; ARIETINUM L.; KEY ENZYMES; DNA-DAMAGE; RESISTANCE	Plants' reaction to underground microorganisms is complex as sessile nature of plants compels them to prioritize their responses to diverse microorganisms both pathogenic and symbiotic. Roots of important crops are directly exposed to diverse microorganisms, but investigations involving root pathogens are significantly less. Thus, more studies involving root pathogens and their target crops are necessitated to enrich the understanding of underground interactions. Present study reported the molecular complexities in chickpea during Fusarium oxysporum f. sp. ciceri Race 1 (Foc1) infection. Transcriptomic dissections using RNA-seq showed significantly differential expression of molecular transcripts between infected and control plants of both susceptible and resistant genotypes. Radar plot analyses showed maximum expressional undulations after infection in both susceptible and resistant plants. Gene ontology and functional clustering showed large number of transcripts controlling basic metabolism of plants. Network analyses demonstrated defense components like peptidyl cis/trans isomerase, MAP kinase, beta 1,3 glucanase, serine threonine kinase, patatin like protein, lactolylglutathione lyase, coproporphyrinogen III oxidase, sulfotransferases; reactive oxygen species regulating components like respiratory burst oxidase, superoxide dismutases, cytochrome b5 reductase, glutathione reductase, thioredoxin reductase, ATPase; metabolism regulating components, myo inositol phosphate, carboxylate synthase; transport related gamma tonoplast intrinsic protein, and structural component, ubiquitins to serve as important nodals of defense signaling network. These nodal molecules probably served as hub controllers of defense signaling. Functional characterization of these hub molecules would not only help in developing better understanding of chickpea-Foc1 interaction but also place them as promising candidates for resistance management programs against vascular wilt of legumes.	[Gupta, Sumanti; Bhar, Anirban; Chatterjee, Moniya; Ghosh, Amartya; Das, Sampa] Bose Inst, Div Plant Biol, CIT Scheme, VII M, Centenary Campus,P 1-12, Kolkata, W Bengal, India; [Gupta, Sumanti] Rabindra Mahavidyalaya, Dept Bot, Pin, W Bengal, India; [Bhar, Anirban] Ramakrishna Mission Vivekananda Centenary Coll, Post Grad Dept Bot, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Das, S (corresponding author), Bose Inst, Div Plant Biol, CIT Scheme, VII M, Centenary Campus,P 1-12, Kolkata, W Bengal, India.	sampa@jcbose.ac.in	Bhar, Anirban/ADE-5445-2022; Gupta, Vijai Kumar/O-2445-2014	Gupta, Vijai Kumar/0000-0003-1565-5918; BHAR, ANIRBAN/0000-0002-7535-3447	Genotypic Technology, Pvt. Ltd., Bangalore, India; Bose Institute; Council of Scientific and Industrial Research, India [09/015(0378)/2009EMR-1, 09/015(0481)/2015-EMR-1]; central instrumentation facilities	Genotypic Technology, Pvt. Ltd., Bangalore, India; Bose Institute(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); central instrumentation facilities	The authors are indebted to Director, Bose Institute for providing the central instrumentation facilities. The authors would like to acknowledge the support on data generation, processing and analysis from Genotypic Technology, Pvt. Ltd., Bangalore, India. The authors express their gratitude to Prof. Debabrata Basu, Bose Institute for many of his valuable suggestions during the course of this study.; The authors are indebted to Director, Bose Institute for partially supporting the funds to perform the present study and providing the central instrumentation facilities. SG and MC are thankful to Bose Institute for their fellowships as Research Associates. AB (09/015(0378)/2009EMR-1) and AG (09/015(0481)/2015-EMR-1) are grateful to Council of Scientific and Industrial Research, India for their fellowships. There was no additional external funding received for this study.	Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Andolfo G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00987; Arasimowicz-Jelonek M, 2014, MOL PLANT PATHOL, V15, P406, DOI 10.1111/mpp.12095; Arner ES, 2001, CURRENT PROTOC TOXIC; Ashraf N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-415; Aumuller T, 2010, BIOCHEMISTRY-US, V49, P1042, DOI 10.1021/bi901813e; Bethke G, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0810206106; Buono RA, 2016, PLANT PHYSIOL, V171, P251, DOI 10.1104/pp.16.00240; Cha JY, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1017698; Chatterjee M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-949; Chen Y, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-33; Cheung AY, 2014, PLANT PHYSIOL, V166, P748, DOI 10.1104/pp.114.246926; Choi DS, 2015, PLANT MOL BIOL, V89, P99, DOI 10.1007/s11103-015-0354-6; Chung K, 2011, PLANT CELL PHYSIOL, V52, P1657, DOI 10.1093/pcp/pcr099; Clement M, 2011, PLANT PHYSIOL, V156, P1481, DOI 10.1104/pp.111.174425; Cui FQ, 2013, NEW PHYTOL, V200, P634, DOI 10.1111/nph.12456; De Coninck B, 2015, TRENDS PLANT SCI, V20, P91, DOI 10.1016/j.tplants.2014.09.007; Ding B, 2012, PLANT CELL, V24, P3783, DOI 10.1105/tpc.112.101972; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Durand M, 2016, PLANT PHYSIOL, V170, P1460, DOI 10.1104/pp.15.01926; Elmore JM, 2011, MOL PLANT, V4, P416, DOI 10.1093/mp/ssq083; Eshraghi L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-68; Ewald R, 2014, PLANT PHYSIOL, V165, P978, DOI 10.1104/pp.114.238311; Fernandez J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02398; Ferrari S., 2013, Frontiers in Plant Science, V4, P49; Flandez-Galvez H, 2003, THEOR APPL GENET, V106, P1447, DOI 10.1007/s00122-003-1199-y; Fukuchi-Mizutani M, 1999, PLANT PHYSIOL, V119, P353, DOI 10.1104/pp.119.1.353; Gallardo K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00580; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Giovannetti M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00480; Giri AP, 1998, PLANT PATHOL, V47, P693, DOI 10.1046/j.1365-3059.1998.00299.x; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Guo CY, 2013, PLANT CELL REP, V32, P687, DOI 10.1007/s00299-013-1403-8; Gupta S., 2016, DNA RES; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073163; Gupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009030; Gupta S, 2009, PHYTOPATHOLOGY, V99, P1245, DOI 10.1094/PHYTO-99-11-1245; Ha JM, 2012, G3-GENES GENOM GENET, V2, P321, DOI 10.1534/g3.111.001834; Hamann T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00077; HAWARE MP, 1982, PLANT DIS, V66, P809, DOI 10.1094/PD-66-809; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Hirschmann F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00556; Hossain M. M., 2013, African Journal of Biotechnology, V12, P4699; Hutin C, 2003, P NATL ACAD SCI USA, V100, P4921, DOI 10.1073/pnas.0736939100; Hwang IS, 2011, PLANT J, V67, P749, DOI 10.1111/j.1365-313X.2011.04622.x; Jing HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8395; John F, 2011, PLANT SIGNAL BEHAV, V6, P1700, DOI 10.4161/psb.6.11.17662; Johnson KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025154; Jones AME, 2006, PLANT PHYSIOL, V142, P1603, DOI 10.1104/pp.106.086231; Kalunke RM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00146; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; Kobayashi Y, 1997, PLANT J, V11, P525, DOI 10.1046/j.1365-313X.1997.11030525.x; Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139; Koprivova A, 2008, PLANT PHYSIOL, V146, P1408, DOI 10.1104/pp.107.113175; Korasick DA, 2010, J BIOL CHEM, V285, P23340, DOI 10.1074/jbc.M109.090787; Kumar M, 2009, MOL PLANT, V2, P152, DOI 10.1093/mp/ssn095; La Camera S, 2009, MOL PLANT MICROBE IN, V22, P469, DOI 10.1094/MPMI-22-4-0469; Lapin D, 2013, TRENDS PLANT SCI, V18, P546, DOI 10.1016/j.tplants.2013.05.005; Lee JH, 2012, MOL CELLS, V34, P109, DOI 10.1007/s10059-012-0121-3; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Levy A, 2007, PLANT SIGNAL BEHAV, V2, P404, DOI 10.4161/psb.2.5.4334; Li XH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00717; Liu JZ, 2014, MOL PLANT MICROBE IN, V27, P824, DOI 10.1094/MPMI-11-13-0350-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano-Duran R, 2015, MOL PLANT MICROBE IN, V28, P511, DOI 10.1094/MPMI-10-14-0322-CR; Malinovsky FG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00178; Manova V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00885; Meadows R., 2013, PLOS BIOL, V1; Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x; Morkunas I, 2014, ACTA PHYSIOL PLANT, V36, P1607, DOI 10.1007/s11738-014-1559-z; Navas-Cortes JA, 2000, PHYTOPATHOLOGY, V90, P1269, DOI 10.1094/PHYTO.2000.90.11.1269; Nimbalkar SB, 2006, PHYSIOL MOL PLANT P, V68, P176, DOI 10.1016/j.pmpp.2006.10.003; Nomura Y, 2014, BIOSCI BIOTECH BIOCH, V78, P1022, DOI 10.1080/09168451.2014.910103; Padmanaban S, 2007, PLANT PHYSIOL, V144, P82, DOI 10.1104/pp.106.092155; Papdi C, 2015, PLANT J, V82, P772, DOI 10.1111/tpj.12848; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Poraty-Gavra L, 2013, PLANT PHYSIOL, V161, P1172, DOI 10.1104/pp.112.213165; Proels RK, 2014, MOL PLANT PATHOL, V15, P858, DOI 10.1111/mpp.12139; Qamar A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00503; Rachwal-Rosiak D, 2015, CRIT REV FOOD SCI, V55, P1135, DOI 10.1080/10408398.2012.687418; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; Sadanandom A, 2012, NEW PHYTOL, V196, P13, DOI 10.1111/j.1469-8137.2012.04266.x; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Schoch GA, 2003, PLANT PHYSIOL, V133, P1198, DOI 10.1104/pp.103.020305; Schubert V, 2009, CYTOGENET GENOME RES, V124, P202, DOI 10.1159/000218126; Schussler MD, 2008, PLANT J, V56, P756, DOI 10.1111/j.1365-313X.2008.03632.x; Seifert GJ, 2014, ANN BOT-LONDON, V114, P1125, DOI 10.1093/aob/mcu010; Seltzer V, 2007, PLANT J, V52, P322, DOI 10.1111/j.1365-313X.2007.03240.x; Sharma B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00806; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Shiwen WU, 2014, J INTEG AGR, V13, P926; Singh D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00895; Singh VK, 2016, PLANT BIOTECHNOL J, V14, P1183, DOI 10.1111/pbi.12470; Stanley D, 2005, BIOLOGIA, V60, P65; Stratmann JW, 2012, PLANT SCI, V185, P50, DOI 10.1016/j.plantsci.2011.10.004; Summerell BA, 2003, PLANT DIS, V87, P117, DOI 10.1094/PDIS.2003.87.2.117; Thuleau P, 2013, BIOCHIM BIOPHYS ACTA, V7, P1590; Tian SP, 2007, PHYTOPATHOLOGY, V97, P260, DOI 10.1094/PHYTO-97-3-0260; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2009, CURR OPIN PLANT BIOL, V12, P202, DOI 10.1016/j.pbi.2008.12.004; Voiniciuc C, 2015, INT J MOL SCI, V16, P3452, DOI 10.3390/ijms16023452; Wang CX, 2006, PLANT CELL, V18, P350, DOI 10.1105/tpc.105.037044; Wang F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004243; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang PC, 2010, PLANT CELL, V22, P2981, DOI 10.1105/tpc.109.072959; Watt G, 2004, PLANT PHYSIOL, V134, P1337, DOI 10.1104/pp.103.037192; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Xu YH, 2012, J EXP BOT, V63, P1095, DOI 10.1093/jxb/err315; Zeng WQ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002291; Zhai H, 2016, PLANT BIOTECHNOL J, V14, P592, DOI 10.1111/pbi.12402; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439	117	16	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178164	10.1371/journal.pone.0178164	http://dx.doi.org/10.1371/journal.pone.0178164			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542579	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800047
J	Stram, AR; Wagner, GR; Fogler, BD; Pride, PM; Hirschey, MD; Payne, RM				Stram, Amanda R.; Wagner, Gregory R.; Fogler, Brian D.; Pride, P. Melanie; Hirschey, Matthew D.; Payne, R. Mark			Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy	PLOS ONE			English	Article							FATTY-ACID OXIDATION; SIRT3 DEACETYLATES; CARDIAC-FUNCTION; DEFICIENCY; METABOLISM; STRESS; DEHYDROGENASE; REPERFUSION; DYSFUNCTION; FRATAXIN	Introduction The childhood heart disease of Friedreich's Ataxia (FRDA) is characterized by hypertrophy and failure. It is caused by loss of frataxin (FXN), a mitochondrial protein involved in energy homeostasis. FRDA model hearts have increased mitochondrial protein acetylation and impaired sirtuin 3 (SIRT3) deacetylase activity. Protein acetylation is an important regulator of cardiac metabolism and loss of SIRT3 increases susceptibility of the heart to stress-induced cardiac hypertrophy and ischemic injury. The underlying pathophysiology of heart failure in FRDA is unclear. The purpose of this study was to examine in detail the physiologic and acetylation changes of the heart that occur over time in a model of FRDA heart failure. We predicted that increased mitochondrial protein acetylation would be associated with a decrease in heart function in a model of FRDA. Methods A conditional mouse model of FRDA cardiomyopathy with ablation of FXN (FXN KO) in the heart was compared to healthy controls at postnatal days 30, 45 and 65. We evaluated hearts using echocardiography, cardiac catheterization, histology, protein acetylation and expression. Results Acetylation was temporally progressive and paralleled evolution of heart failure in the FXN KO model. Increased acetylation preceded detectable abnormalities in cardiac function and progressed rapidly with age in the FXN KO mouse. Acetylation was also associated with cardiac fibrosis, mitochondrial damage, impaired fat metabolism, and diastolic and systolic dysfunction leading to heart failure. There was a strong inverse correlation between level of protein acetylation and heart function. Conclusion These results demonstrate a close relationship between mitochondrial protein acetylation, physiologic dysfunction and metabolic disruption in FRDA hypertrophic cardiomyopathy and suggest that abnormal acetylation contributes to the pathophysiology of heart disease in FRDA. Mitochondrial protein acetylation may represent a therapeutic target for early intervention. Conclusion These results demonstrate a close relationship between mitochondrial protein acetylation, physiologic dysfunction and metabolic disruption in FRDA hypertrophic cardiomyopathy and suggest that abnormal acetylation contributes to the pathophysiology of heart disease in FRDA. Mitochondrial protein acetylation may represent a therapeutic target for early intervention.	[Stram, Amanda R.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Stram, Amanda R.; Payne, R. Mark] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Stram, Amanda R.; Fogler, Brian D.; Pride, P. Melanie; Payne, R. Mark] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Wagner, Gregory R.; Hirschey, Matthew D.] Duke Univ, Div Endocrinol Metab & Nutr, Durham, NC USA; [Payne, R. Mark] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Duke University; Indiana University System; Indiana University Bloomington	Payne, RM (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA.; Payne, RM (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.; Payne, RM (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	rpayne@iu.edu		Hirschey, Matthew/0000-0003-4541-5376	NHLBI NRSA fellowship grant [F31HL126489]; Friedreich's Ataxia Research Alliance (FARA); Muscular Dystrophy Association (MDA); NIH/NIDDK training grant [2T32-DK007012-36A1]	NHLBI NRSA fellowship grant; Friedreich's Ataxia Research Alliance (FARA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); NIH/NIDDK training grant	This work was supported by an NHLBI NRSA fellowship grant #F31HL126489 to ARS, grants from the Friedreichs Ataxia Research Alliance (FARA) and Muscular Dystrophy Association (MDA) to RMP, and an NIH/NIDDK training grant to Duke University Department of Endocrinology, Metabolism, and Nutrition (2T32-DK007012-36A1) to GRW. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chen CJ, 2013, BIOCHEM BIOPH RES CO, V430, P798, DOI 10.1016/j.bbrc.2012.11.066; Chen TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118909; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hsu YHR, 2016, HEART FAIL REV, V21, P103, DOI 10.1007/s10741-015-9524-5; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Koentges C, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0493-6; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Porter GA, 2014, AM J PHYSIOL-HEART C, V306, pH1602, DOI 10.1152/ajpheart.00027.2014; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Raffaele R B Lodi, 2001, CARDIOVASC RES, V125, P1626; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shinmura K, 2011, CIRC RES, V109, P396, DOI 10.1161/CIRCRESAHA.111.243097; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023; Turer AT, 2009, CIRCULATION, V119, P1736, DOI 10.1161/CIRCULATIONAHA.108.816116; Vyas PM, 2012, HUM MOL GENET, V21, P1230, DOI 10.1093/hmg/ddr554; Wagner GR, 2013, IUPUI SCHOLARWORKS I; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; Xiong DD, 2014, AM J PHYSIOL-HEART C, V306, pH326, DOI 10.1152/ajpheart.00931.2012; Zhang YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122297	42	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178354	10.1371/journal.pone.0178354	http://dx.doi.org/10.1371/journal.pone.0178354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542596	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800081
J	Caracuta, V; Vardi, J; Paz, Y; Boaretto, E				Caracuta, Valentina; Vardi, Jacob; Paz, Ytzhak; Boaretto, Elisabetta			Farming legumes in the pre-pottery Neolithic: New discoveries from the site of Ahihud (Israel)	PLOS ONE			English	Article							PLANT REMAINS; VEGETAL FOOD; LATE BRONZE; DOMESTICATION; PULSES; IDENTIFICATION; ARCHAEOBOTANY; AGRICULTURE; CULTIVATION; CONSUMPTION	New discoveries of legumes in the lower Galilee at the prehistoric site of Ahihud in Israel shed light on early farming systems in the southern Levant. Radiocarbon dating of twelve legumes from pits and floors indicate that the farming of legumes was practiced in southern Levant as early as 10.240-10.200 (1 sigma) ago. The legumes were collected from pits and other domestic contexts dated to the Early Pre-Pottery Neolithic B. The legumes identified include Vicia faba L. (faba bean), V. ervilia (bitter vetch), V. narbonensis (narbon vetch), Lens sp. (lentil), Pisum sp. (pea), Lathyrus inconspicuus (inconspicuous pea) and L. hirosolymitanus (jerusalem vetchling). Comparison with coeval sites in the region show how the presence of peas, narbon vetches, inconspicuous peas, jerusalem vetchlings and bitter vetches together with faba bean and lentils is unique to the Pre-Pottery Neolithic, and might indicate specific patterns in farming or storing at the onset of agriculture.	[Caracuta, Valentina; Boaretto, Elisabetta] Max Planck Weizmann Ctr Integrat Archaeol & Anthr, Rehovot, Israel; [Caracuta, Valentina; Boaretto, Elisabetta] D REAMS Radiocarbon Lab, Rehovot, Israel; [Vardi, Jacob; Paz, Ytzhak] Israel Antiqu Author, Jerusalem, Israel; [Caracuta, Valentina] Univ Salento, Lab Archeobot & Palaeoecol, Lecce, Italy	University of Salento	Caracuta, V (corresponding author), Max Planck Weizmann Ctr Integrat Archaeol & Anthr, Rehovot, Israel.; Caracuta, V (corresponding author), D REAMS Radiocarbon Lab, Rehovot, Israel.; Caracuta, V (corresponding author), Univ Salento, Lab Archeobot & Palaeoecol, Lecce, Italy.	valentina.caracuta@unisalento.it	CARACUTA, Valentina/AAN-4127-2020		Weizmann Institute-Max Planck Gesellaschaft Center for Integrative Archaeology and Anthropology; Israel Antiquities Authority	Weizmann Institute-Max Planck Gesellaschaft Center for Integrative Archaeology and Anthropology; Israel Antiquities Authority	This research was funded by the Weizmann Institute-Max Planck Gesellaschaft Center for Integrative Archaeology and Anthropology "Timing of Cultural Changes" and the Israel Antiquities Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Weizmann Institute-Max Planck Gesellaschaft Center for Integrative Archaeology and Anthropology "Timing of Cultural Changes" and the Israel Antiquities Authority. Samples were dated at the Dangoor Research Accelerator Mass Spectrometer (D-REAMS), Weizmann Institute of Science. The Israel Antiquities Authority granted the permission to excavate the site (Authorization number 6663). The authors are grateful to Dr. Alon Singer, from the Israel Plant Gene Bank ARO Volcani Center,-Bet Dagan and the Leibniz Institute of Plant Genetics and Crop Plant Research (IPK)-Germany, for providing specimens of modern wild legumes for comparison. Special thanks to Dr. Eugenia Mintz and Dr. Lior Regev who assisted with the samples preparation and radiocarbon dating. All our appreciation to Prof. Steve Weiner from the Weizmann Institute of Science, Rehovot, and Dr. John Kolinski from the Hebrew University, Jerusalem, Israel for their insightful comments on the early draft of the paper. The authors want to express their appreciation for the two editors and the five reviewers who commented on the paper.	Abbo S, 2011, ANN BOT-LONDON, V107, P1399, DOI 10.1093/aob/mcr081; Abbo S, 2008, J ARCHAEOL SCI, V35, P3172, DOI 10.1016/j.jas.2008.07.004; Allen SE., 2002, SHAAR HAGOLAN NEOLIT, P236; [Anonymous], 2010, BAR INT SERIES; Balbo AL, 2015, ENVIRON ARCHAEOL, V20, P390, DOI 10.1179/1749631414Y.0000000044; Bar-Oz G, 2004, EPIPALEOLITHIC SUBSI; Berna F, 2007, J ARCHAEOL SCI, V34, P358, DOI 10.1016/j.jas.2006.05.011; BOROJEVIC K., 2006, MONOGRAPHS I ARCHAEO, V24, P519; Braadbaart F, 2004, J ARCHAEOL SCI, V31, P821, DOI 10.1016/j.jas.2003.12.001; Butler A., 1989, Foraging and farming: the evolution of plant exploitation., P390; Butler A., 2000, ARCHAEOLOGY DRY LAND, P181; CAMPBELL CG, 1994, EUPHYTICA, V73, P167, DOI 10.1007/BF00027192; Caracuta V., 2014, NEOLITHICS, V14, P33; Caracuta V, 2016, SCI REPORTS, P6; Caracuta V, 2015, SCI REP-UK, V5, DOI 10.1038/srep14370; CHERNOFF M, 1992, ISRAEL J BOT, V41, P167; Chernoff MC, 1998, J FIELD ARCHAEOL, V25, P397, DOI 10.1179/009346998792005289; Colledge, 2001, PLANT EXPL EP PAL EA; Crawford P, 1987, BRIT ARCHAEOLOGICAL, V340, P691; Danin A, 1999, VEGETATION OF ISRAEL, VI; Danin A., 2004, DISTRIBUTION ATLAS P; de Moulins D, 1997, 683 BAR IS; DEMOULINS D, 2000, VILLAGE EUPHRATES FO, P399; DENNELL RW, 1976, J ARCHAEOL SCI, V3, P229, DOI 10.1016/0305-4403(76)90057-1; Dollfus G, 1988, BAR INT SERIES, V369, P597; Edwards P. C., 2004, PALEORIENT, V30, P21, DOI DOI 10.3406/PALEO.2004.1010; Enneking D., 1995, EVOLUTION CROP PLANT, P316; Fatkin DS, 2011, ANN DEP ANTIQUITIES, V55, P249; Fisher PM, 2008, TELL ABU AL KHARAZ J, VI, P307; Flanagan JW, 1990, ANN DEP ANTIQUITIES, V34, P131; Fraser RA, 2013, J ARCHAEOL SCI, V40, P4754, DOI 10.1016/j.jas.2013.01.032; Fuller D.Q., 2005, J INTERDISC STUD HIS, V2, P93; Fuller DQ, 2006, ENVIRON ARCHAEOL, V11, P219, DOI 10.1179/174963106x123232; Fuller DQ, 2012, J EXP BOT, V63, P617, DOI 10.1093/jxb/err307; Giambalvo D, 2012, PLANT SOIL, V360, P215, DOI 10.1007/s11104-012-1224-5; Gilliland D, 1986, HESBAN 2, P122; Gunn CR, 1970, SEED TEST ASS, V35, P773; Healbak H, 1966, PALESTINE EXPLORATIO, V98, P61; HILLMAN G, 1993, WORLD ARCHAEOL, V25, P94, DOI 10.1080/00438243.1993.9980230; Hillman GC, 1991, MODELLING ECOLOGICAL, P27; Hillman GC., 1981, FARMING PRACTICE BRI, P123; Hopf M, 1987, PLANT REMAINS HAYONI, V13; Issar A, 1972, GEOLOGICAL SURVEY IS, V53, P1; JONES G, 1987, J ARCHAEOL SCI, V14, P311, DOI 10.1016/0305-4403(87)90019-7; Kafafi Z, 1988, PREHIST JORDAN STATE, P451; Khalaily H, 2007, PALEORIENT, V33, P5, DOI DOI 10.3406/PALE0.2007.5218; Khalaily H., 2008, NEOLITHICS, V2, P3; Kislev M, 2000, IAA REPORTS, VVIII, P206; Kislev M.E., 2006, TIMNAH TEL BATASH 3, P295; Kislev M. E., 1985, EXCAVATIONS TELL Q 2, V20, P140; Kislev M.E., 2012, VILLAGE COMMUNITIES, V29, P1321; Kislev M.E., 1993, SHILOH ARCHAEOLOGY B, V10, P354; Kislev M.E., 2009, APHEK ANTIPATRIS 2 R, V27, P499; Kislev ME, 2004, J ARCHAEOL SCI, V31, P1301, DOI 10.1016/j.jas.2004.02.010; KISLEV ME, 1985, SCIENCE, V228, P319, DOI 10.1126/science.228.4697.319; KISLEV ME, 1992, REV PALAEOBOT PALYNO, V73, P161, DOI 10.1016/0034-6667(92)90054-K; KISLEV ME, 1992, REV PALAEOBOT PALYNO, V73, P153, DOI 10.1016/0034-6667(92)90053-J; Kislev ME, 1987, BAR INT SERIES, V356, p[251, 548]; Kislev ME, LAND GESHUR PROJECT, VI; Kislev ME, 1980, SERIES ARCHAEOLOGICA, V1, P361; LADIZINSKY G, 1993, ECON BOT, V47, P60, DOI 10.1007/BF02862206; Lennstrom HA, 1995, AM ANTIQUITY, V60, P701, DOI 10.2307/282054; Leonard Jr A., 1987, ANN DEP ANTIQUITIES, V31, P343; Lev E, 2005, J ARCHAEOL SCI, V32, P475, DOI 10.1016/j.jas.2004.11.006; Levy T. E., 1987, BAR INT SERIES, V356, P251; Liphschitz N., 1997, TEL AVIV, V24, P237; Liphschitz N, 1998, IAA REPORTS, VVI, P339; Mahler-Slasky Y, 2010, J ARCHAEOL SCI, V37, P2477, DOI 10.1016/j.jas.2010.05.008; McCreery D, 1983, ANN AM SCH ORIENTAL, V47, P103; McCreery D.W., 2003, B AB EDH DHR EXCAVAT, P449; McCreery D.W., 1981, ANN AM SCH ORIENTAL, V46, P165; Mekbib H, 1991, PLANT GENETIC RESOUR, P329; Metzger MC., 1984, B AM SCH ORIENT RES, V255, P68; MINNIS PE, 1981, AM ANTIQUITY, V46, P143, DOI 10.2307/279993; Neef R, 1997, NEOLITHICS, V2, P8; Neef R., 2012, DIGITAL ATLAS EC PLA; Neef R., 1989, PICKING THREADS CONT, P30; Neef Reineer, 2004, BASTA, P187; Negbi M, 1955, ISRAEL EXPLOR J, V5, P257; Pasternak R, 1998, ORIGINS AGR CROP DOM, P170; Paz Y., 2014, HADASHOT ARKHEOLOGIY, P126; PERRINO P, 1984, Kulturpflanze, V32, P103; Radwan S, 2013, ACTA AGR SLOVENICA, V101; Ramsay J, 2015, VEGET HIST ARCHAEOBO; Ramsay J, 2015, GARDEN VARIETY SEEDS; Ramsay J, 2013, J ARID ENVIRON, V99, P51, DOI 10.1016/j.jaridenv.2013.09.005; Ramsay J, 2010, INT J NAUT ARCHAEOL, V39, P376, DOI 10.1111/j.1095-9270.2010.00267.x; Ramsay J, 2010, VEG HIST ARCHAEOBOT, V19, P235, DOI 10.1007/s00334-010-0238-2; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Reddy B. S., 2006, Indian Journal of Traditional Knowledge, V5, P87; Regev L, 2010, J ARCHAEOL SCI, V37, P3022, DOI 10.1016/j.jas.2010.06.027; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Riehl S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/532481; Riehl S, 2004, Z DTSCH PALASTINA VE, V120; Riehl S, 2013, SCIENCE, V341, P65, DOI 10.1126/science.1236743; ROLLEFSON G, 1985, MITTEILUNGEN DTSCH O, V117, P69; Rubiales D, 2012, AGRON SUSTAIN DEV, V32, P433, DOI 10.1007/s13593-011-0045-x; Sapir-Hen L, PLOS ONE; Savard M, 2006, WORLD ARCHAEOL, V38, P179, DOI 10.1080/00438240600689016; SCHIFFER MB, 1972, AM ANTIQUITY, V37, P156, DOI 10.2307/278203; Simchoni O, 2006, EXCAVATIONS TEL BETH, V1, P679; Simchoni O, 2009, ISRAEL EXPLOR J, V59, P47; SMARTT J, 1985, GRAIN LEGUME CROPS, P37; Snir A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131422; Syouf MQ, 1996, LATHYRUS GENETIC RES, P67; Tanno K, 2006, VEGETATION HIST ARCH; Tholbecq L., 2008, ANN DEP ANTIQUITIES, V52, P235; Toffolo M, J ARCHAEOLOGICAL SCI; Tsartsidou G, 2007, J ARCHAEOL SCI, V34, P1262, DOI 10.1016/j.jas.2006.10.017; Valamoti SM, 2011, VEG HIST ARCHAEOBOT, V20, P381, DOI 10.1007/s00334-011-0302-6; Van Zeist W., 1973, PALEORIENT, V1, P21, DOI DOI 10.3406/PALEO.1973.897; Van Zeist W., 1984, PALAEOHISTORIA, V26, P171; Weiss E., 2007, Israel Journal of Earth Sciences, V56, P163, DOI 10.1560/IJES.56.2-4.163; Weiss E, 2004, J ARCHAEOL SCI, V31, P1, DOI 10.1016/S0305-4403(03)00072-4; Weiss E., 2011, EXCAVATIONS KHIRBET, V2187, P166; WERKER E, 1979, ANN BOT-LONDON, V43, P765, DOI 10.1093/oxfordjournals.aob.a085691; White CE, 2014, ANTIQUITY, V88, P363, DOI 10.1017/S0003598X0010105X; White CE, 2012, VEG HIST ARCHAEOBOT, V21, P85, DOI 10.1007/s00334-011-0309-z; Willcox G., 1981, JAWA LOST CITY BLACK, P247; Willcox G, 2008, VEG HIST ARCHAEOBOT, V17, P313, DOI 10.1007/s00334-007-0121-y; Yizhaq M, 2005, RADIOCARBON, V47, P193, DOI 10.1017/S003382220001969X; Zapata L, 2016, VEGET HIST ARCHAEOBO; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary D, 2004, ECON BOT, V58, P5, DOI 10.1663/0013-0001(2004)058[0005:USATEO]2.0.CO;2; ZOHARY D, 1973, SCIENCE, V182, P887, DOI 10.1126/science.182.4115.887; Zohary M., 1972, FLORA PALAESTINA 2; [No title captured]; [No title captured]; [No title captured]; [No title captured]	130	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177859	10.1371/journal.pone.0177859	http://dx.doi.org/10.1371/journal.pone.0177859			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EV8VE	28542358	gold, Green Published			2022-12-27	WOS:000402061500040
J	Mayfield, AB; Chen, CS; Dempsey, AC				Mayfield, Anderson B.; Chen, Chii-Shiarng; Dempsey, Alexandra C.			Identifying corals displaying aberrant behavior in Fiji's Lau Archipelago	PLOS ONE			English	Article							REEF-BUILDING CORAL; POCILLOPORA-DAMICORNIS; ELEVATED-TEMPERATURE; GENE-EXPRESSION; PHYSIOLOGY; ANTHOZOAN; SYSTEM; HEALTH	Given the numerous threats against Earth's coral reefs, there is an urgent need to develop means of assessing reef coral health on a proactive timescale. Molecular biomarkers may prove useful in this endeavor because their expression should theoretically undergo changes prior to visible signs of health decline, such as the breakdown of the coral-dinoflagellate (genus Symbiodinium) endosymbiosis. Herein 13 molecular-and physiologicalscale biomarkers spanning both eukaryotic compartments of the anthozoan-Symbiodinium mutualism were assessed across 70 pocilloporid coral colonies sampled from reefs of Fiji's easternmost province, Lau. Eleven colonies were identified as outliers upon employment of a detection method based partially on the Mahalanobis distance; these corals were hypothesized to have been displaying aberrant sub-cellular behavior with respect to their gene expression signatures, as they were characterized not only by lower Symbiodinium densities, but also by higher levels of expression of several stress-targeted genes. Although these findings could suggest that the sampled colonies were physiologically compromised at the time of sampling, further studies are warranted to state conclusively whether these 11 scleractinian coral colonies are more stress-prone than nearby conspecifics that demonstrated statistically normal phenotypes.	[Mayfield, Anderson B.; Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Mayfield, Anderson B.; Dempsey, Alexandra C.] Khaled bin Sultan Living Oceans Fdn, Annapolis, MD USA; [Mayfield, Anderson B.; Chen, Chii-Shiarng] Taiwan Coral Res Ctr, Pingtung, Taiwan; [Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; National Sun Yat Sen University	Mayfield, AB (corresponding author), Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan.; Mayfield, AB (corresponding author), Khaled bin Sultan Living Oceans Fdn, Annapolis, MD USA.; Mayfield, AB (corresponding author), Taiwan Coral Res Ctr, Pingtung, Taiwan.	andersonblairmayfield@gmail.com		Mayfield, Anderson/0000-0003-0138-7844	Khaled bin Sultan Living Oceans Foundation	Khaled bin Sultan Living Oceans Foundation	The Khaled bin Sultan Living Oceans Foundation funded this work in its entirety, including a postdoctoral research fellowship to ABM. One author (ACD) is an employee of the funding organization and had a role in data collection and manuscript preparation.	Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Cheng YR, 2016, ZOOTAXA, V4174, P291, DOI 10.11646/zootaxa.4174.1.20; Clarke KR, 1994, CHANGE MARINE COMMUN; Correa AMS, 2009, MAR BIOL, V156, P2403, DOI 10.1007/s00227-009-1263-5; Downs CA, 2005, MAR POLLUT BULL, V51, P558, DOI 10.1016/j.marpolbul.2005.04.017; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Feder M.E., 1996, Society for Experimental Biology Seminar Series, V59, P79; Furla P, 2005, INTEGR COMP BIOL, V45, P595, DOI 10.1093/icb/45.4.595; GATES RD, 1990, CORAL REEFS, V8, P193, DOI 10.1007/BF00265010; Hochachka P. W., 2002, BIOCH ADAPTATION; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Huang YCA, 2011, MAR ECOL PROG SER, V423, P83, DOI 10.3354/meps08944; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Liu PJ, 2012, MAR POLLUT BULL, V64, P1129, DOI 10.1016/j.marpolbul.2012.03.031; Mayfield AB, 2013, CORAL REEFS, V32, P909, DOI 10.1007/s00338-013-1067-4; Mayfield AB, 2014, INT J MARINE SCI, V4, P1, DOI DOI 10.5376/IJMS.2014.04.0050; MAYFIELD AB, 2013, J MAR BIOL, V2013, P69369, DOI DOI 10.1155/2013/569361; Mayfield AB, 2016, CORAL REEFS ECOSYSTE, P13; Mayfield AB, 2007, COMP BIOCHEM PHYS A, V147, P1, DOI 10.1016/j.cbpa.2006.12.042; Mayfield AB, 2016, J MAR SCI ENG, V4, DOI 10.3390/jmse4030063; Mayfield Anderson B., 2016, Platax, V13, P1; Mayfield Anderson B., 2015, Platax, V12, P1; Mayfield AB, 2016, MOL ECOL, V25, P5944, DOI 10.1111/mec.13896; Mayfield Anderson B., 2014, Platax, V11, P1; Mayfield Anderson B., 2013, Platax, V10, P1; Mayfield AB, 2014, MOL ECOL, V23, P5816, DOI 10.1111/mec.12982; Mayfield Anderson B., 2012, Platax, V9, P1; Mayfield AB, 2013, MAR ENVIRON RES, V86, P1, DOI 10.1016/j.marenvres.2013.01.004; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; Mayfield AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026529; Mayfield AB, 2010, J EXP MAR BIOL ECOL, V395, P215, DOI 10.1016/j.jembe.2010.09.007; Mayfield AB, 2009, MOL ECOL RESOUR, V9, P462, DOI 10.1111/j.1755-0998.2008.02349.x; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; Saul S, 2015, REMOTE SENS-BASEL, V7, P15894, DOI 10.3390/rs71215810; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Smith EG, 2013, CORAL REEFS, V32, P463, DOI 10.1007/s00338-012-0994-9; Sokal RR, 1995, BIOMETRY; Traylor-Knowles N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-585; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700	42	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177267	10.1371/journal.pone.0177267	http://dx.doi.org/10.1371/journal.pone.0177267			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542245	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500017
J	Meshram, NM; Shashank, PR; Sinha, T				Meshram, Naresh M.; Shashank, Pathour R.; Sinha, Twinkle			A new genus of leafhopper subtribe Paraboloponina (Hemiptera: Cicadellidae) with molecular phylogeny of related genera	PLOS ONE			English	Article							ALIGNMENT	A new leafhopper genus Chandra and species Chandra dehradunensis gen. nov., sp. nov. are described, illustrated from India and placed in the subtribe Paraboloponina (Cidadellidae: Deltocephalinae: Drabescini). This genus is closely associated with the genus Parabolopona Webb but differs in shape of the head, placement of antennae, male genitalia and molecular analysis using Histone H3 and COI genes confirmed the difference. The taxonomic and phylogenetic position of Chandra is discussed using morphological characters and preliminary molecular evidence of the new genus and related genus Parabolopona.	[Meshram, Naresh M.; Shashank, Pathour R.; Sinha, Twinkle] Indian Agr Res Inst, ICAR, Div Entomol, Natl Pusa Collect, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Meshram, NM (corresponding author), Indian Agr Res Inst, ICAR, Div Entomol, Natl Pusa Collect, New Delhi, India.	nmmeshram@gmail.com	PR, Shashank/A-2724-2016	PR, Shashank/0000-0002-8177-6091	DST-SERB [SB/YS/LS-126/2014]; Department of Science and Technology [SB/YS/LS-126/2014]	DST-SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); Department of Science and Technology(Department of Science & Technology (India))	Indian Agricultural Research Institute provided research facilities. Second author received funding for collections of insects from DST-SERB (SB/YS/LS-126/2014), this led to the discovery of new genus.; The author gratefully acknowledges Prof. C.A. Viraktamath for guidance on leafhoppers and Head, Division of Entomology, Indian Council of Agriculture Research-IARI, New Delhi for providing necessary permission. We thank Dr. V.V. Ramamurthy, Ex-professor, Division of Entomology, Indian Council of Agriculture Research-IARI, New Delhi for his guidance and encouragement. Department of Science and Technology grant (SB/YS/LS-126/2014) is gratefully acknowledged.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Dmitriev DA, 2004, ORIENT INSECTS, V38, P235, DOI 10.1080/00305316.2004.10417390; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KNIGHT W. J., 1965, ENTOMOL GAZ, V16, P129; Meshram NM, 2016, ZOOTAXA, V4114, P182, DOI 10.11646/zootaxa.4114.2.7; Ogden TH, 2003, CLADISTICS, V19, P432, DOI [10.1111/j.1096-0031.2003.tb00313.x, 10.1016/S0748-3007(03)00083-5]; OMAN PAUL WILSON, 1949, MEM ENT SOC WASHINGTON, V3, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shashank PR, 2014, APPL ENTOMOL ZOOL, V49, P283, DOI 10.1007/s13355-014-0248-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Virakatamath C.A., 1998, Bulletin of the Natural History Museum Entomology Series, V67, P153; Webb M.D., 1981, Bulletin of the British Museum (Natural History) Entomology, V43, P39; Zahniser JN, 2013, EUR J TAXON, V45, P1, DOI 10.5852/ejt.2013.45; Zhang Y., 1996, Bulletin of the Natural History Museum Entomology Series, V65, P1	16	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177644	10.1371/journal.pone.0177644	http://dx.doi.org/10.1371/journal.pone.0177644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542237	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500034
J	Taylor, GC; Hill, JM; Jackson, MC; Peel, RA; Weyl, OLF				Taylor, Geraldine C.; Hill, Jaclyn M.; Jackson, Michelle C.; Peel, Richard A.; Weyl, Olaf L. F.			Estimating delta N-15 fractionation and adjusting the lipid correction equation using Southern African freshwater fishes	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; FOOD-WEB; CARBON ISOTOPES; TROPHIC POSITION; STOMACH CONTENT; MIXING MODELS; BODY-SIZE; DELTA-C-13; DIET; NITROGEN	Stable isotope analysis is an important tool for characterising food web structure; however, interpretation of isotope data can often be flawed. For instance, lipid normalisation and trophic fractionation values are often assumed to be constant, but can vary considerably between ecosystems, species and tissues. Here, previously determined lipid normalisation equations and trophic fractionation values were re-evaluated using freshwater fish species from three rivers in the Upper Zambezian floodplain ecoregion in southern Africa. The parameters commonly used in lipid normalisation equations were not correct for the 18 model species ( new D and I parameters were estimated as D = 4.46 parts per thousand [95% CI: 2.62, 4.85] and constant I = 0 [ 95% CI: 0, 0.17]). We suggest that future isotopic analyses on freshwater fishes use our new values if the species under consideration do not have a high lipid content in their white muscle tissue. Nitrogen fractionation values varied between species and river basin; however, the average value closely matched that calculated in previous studies on other species (delta N-15 fractionation factor of 3.37 +/- 1.30 parts per thousand). Here we have highlighted the need to treat stable isotope data correctly in food web studies to avoid misinterpretation of the data.	[Taylor, Geraldine C.; Hill, Jaclyn M.; Jackson, Michelle C.; Peel, Richard A.; Weyl, Olaf L. F.] SOUTH African Inst Aquat Biodivers, Grahamstown, South Africa; [Taylor, Geraldine C.; Peel, Richard A.; Weyl, Olaf L. F.] Rhodes Univ, Dept Ichthyol & Fisheries Sci, Grahamstown, South Africa; [Hill, Jaclyn M.] Rhodes Univ, Dept Zool & Entomol, Grahamstown, South Africa; [Jackson, Michelle C.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England; [Peel, Richard A.] NNF EU Community Conservat Fisheries KAZA Project, Katima Mulilo, Namibia	National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; Rhodes University; Rhodes University; Imperial College London	Taylor, GC (corresponding author), SOUTH African Inst Aquat Biodivers, Grahamstown, South Africa.; Taylor, GC (corresponding author), Rhodes Univ, Dept Ichthyol & Fisheries Sci, Grahamstown, South Africa.	gc88taylor@gmail.com	Hill, Jaclyn/D-3780-2012	Hill, Jaclyn/0000-0003-0703-3772; Weyl, Olaf/0000-0002-8935-3296; Jackson, Michelle/0000-0003-2227-1111	Southern African Scientific Service Centre for Climate Change and Adaptive Land Management; Nedbank Namibia Go Green Fund through the NNF-EU Community Conservation in Fisheries in KAZA Project; Joint Research Committee of Rhodes University; National Research foundation of South Africa [74015, 77444]	Southern African Scientific Service Centre for Climate Change and Adaptive Land Management; Nedbank Namibia Go Green Fund through the NNF-EU Community Conservation in Fisheries in KAZA Project; Joint Research Committee of Rhodes University; National Research foundation of South Africa(National Research Foundation - South Africa)	Funding was provided by the Southern African Scientific Service Centre for Climate Change and Adaptive Land Management and Nedbank Namibia Go Green Fund which was channelled through the NNF-EU Community Conservation in Fisheries in KAZA Project. Personal funding was provided by the Joint Research Committee of Rhodes University and the National Research foundation of South Africa (UID: 74015; 77444). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington DA, 2002, ECOLOGY, V83, P2145, DOI 10.1890/0012-9658(2002)083[2145:HODFRO]2.0.CO;2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOUTTON T W, 1991, P155; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Efron GP, 1980, JACKNIFE BOOTSTRAP O; Focken U, 1998, OECOLOGIA, V115, P337, DOI 10.1007/s004420050525; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Gorokhova E, 1999, CAN J FISH AQUAT SCI, V56, P2203, DOI 10.1139/cjfas-56-11-2203; HARRIGAN P, 1989, B MAR SCI, V44, P65; Hussey NE, 2014, ECOL LETT, V17, P239, DOI 10.1111/ele.12226; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Jepsen DB, 2002, OIKOS, V96, P46, DOI 10.1034/j.1600-0706.2002.960105.x; Kadye WT, 2012, BIOL INVASIONS, V14, P779, DOI 10.1007/s10530-011-0116-6; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; MCCLELLAND G, 1995, CAN J FISH AQUAT SCI, V52, P161, DOI 10.1139/f95-016; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Pedreschi D, 2015, J FISH BIOL, V87, P876, DOI 10.1111/jfb.12755; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Pinnegar JK, 2000, OECOLOGIA, V122, P399, DOI 10.1007/s004420050046; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Renones O, 2002, J FISH BIOL, V61, P122, DOI [10.1006/jfbi.2002.2024, 10.1111/j.1095-8649.2002.tb01741.x]; Rojbek MC, 2014, ICES J MAR SCI, V71, P56, DOI 10.1093/icesjms/fst106; Sherwood GD, 2005, ESTUAR COAST SHELF S, V63, P537, DOI 10.1016/j.ecss.2004.12.010; Skinner MM, 2016, RAPID COMMUN MASS SP, V30, P881, DOI 10.1002/rcm.7480; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V352, P165, DOI 10.1016/j.jembe.2007.07.007; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V340, P1, DOI 10.1016/j.jembe.2006.07.023; Sweeting CJ, 2006, RAPID COMMUN MASS SP, V20, P595, DOI 10.1002/rcm.2347; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z	38	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178047	10.1371/journal.pone.0178047	http://dx.doi.org/10.1371/journal.pone.0178047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542647	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500057
J	Backstrom, M; Bjorklund, F				Backstrom, Martin; Bjorklund, Fredrik			Increasing systematicity leads to better selection decisions: Evidence from a computer paradigm for evaluating selection tools	PLOS ONE			English	Article							JOB ANALYSIS; INTERVIEW VALIDITY; ACCURACY; COMBINATION; RATERS	A computerized paradigm was created to allow for testing in the laboratory whether increasing systematicity helps the recruiter make better selection decisions. Participants were introduced to the job and the applicants on the computer screen and asked to select who they thought should be considered for the job and who should not. Level of systematicity, i.e. the extent to which the recruitment is methodical and uses prepared tools, was manipulated between subjects. Depending on experimental condition participants were helped by means of a tool for extracting judgment criteria (job analysis) and a tool for making judgments related to selected criteria (including calculation of a final score). The general prediction that increased systematicity leads to the selection of more qualified candidates was supported by the results, particularly when the motivation to put time and effort into the task was higher. The results support the claim from Industrial/Organizational psychologists that systematicity is a desirable characteristic in selection processes. The fact that increasing systematicity led to better selection decisions in a controlled laboratory experiment, along with process-related measures, suggests that this kind of paradigm could be useful when evaluating new tools for improving selection decisions, before they are tested in large (and costly) field studies of actual personnel selection.	[Backstrom, Martin; Bjorklund, Fredrik] Lund Univ, Dept Psychol, Lund, Sweden	Lund University	Backstrom, M (corresponding author), Lund Univ, Dept Psychol, Lund, Sweden.	martin.backstrom@psy.lu.se		Bjorklund, Fredrik/0000-0001-9970-6465; Backstrom, Martin/0000-0002-8544-7404	Forskningsradet for halsa, arbetsliv och valfard (FORTE) [2008-1017]	Forskningsradet for halsa, arbetsliv och valfard (FORTE)	This work was supported by Grant No. 2008-1017: Forskningsradet for halsa, arbetsliv och valfard (FORTE) http://forte.sei. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinis H, 2009, PERS PSYCHOL, V62, P405, DOI 10.1111/j.1744-6570.2009.01144.x; Arkes HR, 2010, J BEHAV DECIS MAKING, V23, P250, DOI 10.1002/bdm.655; ARKES HR, 1986, ORGAN BEHAV HUM DEC, V37, P93, DOI 10.1016/0749-5978(86)90046-4; Boatsman JR, 1997, ORGAN BEHAV HUM DEC, V71, P211, DOI 10.1006/obhd.1997.2720; DAWES RM, 1974, PSYCHOL BULL, V81, P95, DOI 10.1037/h0037613; Dipboye RL, 1994, RES PERSON HUM RESOU, V12, P79; Furnham A, 2008, INT J SELECT ASSESS, V16, P300, DOI 10.1111/j.1468-2389.2008.00436.x; HAHN DC, 1988, J APPL PSYCHOL, V73, P146, DOI 10.1037/0021-9010.73.2.146; Highhouse S, 2008, IND ORGAN PSYCHOL-US, V1, P333, DOI 10.1111/j.1754-9434.2008.00058.x; Huffcutt AI, 1999, J ORGAN BEHAV, V20, P549, DOI 10.1002/(SICI)1099-1379(199907)20:4<549::AID-JOB921>3.0.CO;2-Q; HUFFCUTT AI, 1994, J APPL PSYCHOL, V79, P184, DOI 10.1037/0021-9010.79.2.184; Konig CJ, 2010, INT J SELECT ASSESS, V18, P17; Kuncel NR, 2013, J APPL PSYCHOL, V98, P1060, DOI 10.1037/a0034156; Lievens F, 2007, J APPL PSYCHOL, V92, P812, DOI 10.1037/0021-9010.92.3.812; Lodato MA, 2011, J MANAGE PSYCHOL, V26, P352, DOI 10.1108/02683941111138985; Morgeson FP, 1997, J APPL PSYCHOL, V82, P627, DOI 10.1037/0021-9010.82.5.627; Morgeson FP, 2016, J MANAGE, V42, P1904, DOI 10.1177/0149206314522298; Roch SG, 2012, J OCCUP ORGAN PSYCH, V85, P370, DOI 10.1111/j.2044-8325.2011.02045.x; Ryan AM, 2014, ANNU REV PSYCHOL, V65, P693, DOI 10.1146/annurev-psych-010213-115134; SANCHEZ JI, 1994, J BUS PSYCHOL, V9, P47, DOI 10.1007/BF02230986; Whitecotton S. M., 1998, BEHAV RES ACCOUNT S, V10, P182; Whitecotton SM, 1998, ORGAN BEHAV HUM DEC, V76, P325, DOI 10.1006/obhd.1998.2809	22	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178276	10.1371/journal.pone.0178276	http://dx.doi.org/10.1371/journal.pone.0178276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UA	28542456	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400075
J	AlBadri, A; Lai, K; Wei, J; Landes, S; Mehta, PK; Li, Q; Johnson, D; Reis, SE; Kelsey, SF; Bittner, V; Sopko, G; Shaw, LJ; Pepine, CJ; Merzl, CNB				AlBadri, Ahmed; Lai, Kha; Wei, Janet; Landes, Sofy; Mehta, Puja K.; Li, Quanlin; Johnson, Delia; Reis, Steven E.; Kelsey, Sheryl F.; Bittner, Vera; Sopko, George; Shaw, Leslee J.; Pepine, Carl J.; Merzl, C. Noel Bairey			Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SERUM AMYLOID-A; CARDIOVASCULAR-DISEASE; CHEST-PAIN; MARKERS; INTERLEUKIN-6; RISK; ACTIVATION; DYSFUNCTION; OBESITY	Background Women with signs and symptoms of ischemia, no obstructive coronary artery disease (CAD) and preserved left ventricular ejection fraction (EF) often have diastolic dysfunction and experience elevated rates of major adverse cardiac events (MACE), including heart failure (HF) hospitalization with preserved ejection fraction (HFpEF). We evaluated the predictive value of inflammatory biomarkers for long-term HF hospitalization and all-cause mortality in these women. Methods We performed a cross-sectional analysis to investigate the relationships between inflammatory biomarkers [serum interleukin-6 (IL-6), C-reactive protein (hs-CRP) and serum amyloid A (SAA)] and median of 6 years follow-up for all-cause mortality and HF hospitalization among women with signs and symptoms of ischemia, non-obstructive CAD and preserved EF. Multivariable Cox regression analysis tested associations between biomarker levels and adverse outcomes. Results Among 390 women, mean age 56 +/- 11 years, median follow up of 6 years, we observed that there is continuous association between IL-6 level and HF hospitalization (adjusted hazard ratio [AHR] 2.5 [1.2-5.0], p = 0.02). In addition, we found significant association between IL6, SAA levels and all-cause mortality AHR (1.8 [1.1-3.0], p = 0.01) (1.5 [1.0-2.1], p = 0.04), respectively. Conclusion In women with signs and symptoms of ischemia, non-obstructive CAD and preserved EF, elevated IL-6 predicted HF hospitalization and all-cause mortality, while SAA level was only associated with all-cause mortality. These results suggest that inflammation plays a role in the pathogenesis of development of HFpEF, as well all-cause mortality.	[AlBadri, Ahmed; Lai, Kha; Wei, Janet; Landes, Sofy; Mehta, Puja K.; Merzl, C. Noel Bairey] Cedars Sinai Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA; [Li, Quanlin] Cedars Sinai Med Ctr, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA; [Johnson, Delia; Reis, Steven E.; Kelsey, Sheryl F.] Univ Pittsburgh, Cardiovasc Inst, Pittsburgh, PA USA; [Bittner, Vera] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Sopko, George] NHLBI, Div Cardiovasc Dis, NIH, Bldg 10, Bethesda, MD 20892 USA; [Shaw, Leslee J.] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA; [Pepine, Carl J.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Emory University; State University System of Florida; University of Florida	Merzl, CNB (corresponding author), Cedars Sinai Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA.	Noel.BaireylMerz@cshs.org		Reis, Steven/0000-0001-8023-0102; Pepine, Carl/0000-0002-6011-681X	National Heart, Lung and Blood Institutes [N01-HV-68161, N01-HV-68162, N01-HV68163, N01-HV-68164]; National Institute on Aging [U0164829, U01 HL649141, U01 HL649241, K23HL105787, T32HL69751, R01 HL090957, 1R03AG032631]; National Center for Research Resources [M01-RR00425]; National Center for Advancing Translational Sciences Grant [UL1TR000124, UL1TR001427]; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc.; Laurence Harbor, NJ; Edythe L. Broad; Constance Austin Women's Heart Research Fellowships; Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles; Society for Women's Health Research (SWHR), Washington, D.C.; Linda Joy Pollin Women's Heart Health Program; Erika Glazer Women's Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California	National Heart, Lung and Blood Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences Grant; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc.; Laurence Harbor, NJ; Edythe L. Broad; Constance Austin Women's Heart Research Fellowships; Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles; Society for Women's Health Research (SWHR), Washington, D.C.; Linda Joy Pollin Women's Heart Health Program; Erika Glazer Women's Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California	This work was supported by contracts from the National Heart, Lung and Blood Institutes nos. N01-HV-68161, N01-HV-68162, N01-HV68163, N01-HV-68164, grants U0164829, U01 HL649141, U01 HL649241, K23HL105787, T32HL69751, R01 HL090957, 1R03AG032631 from the National Institute on Aging, GCRC grant M01-RR00425 from the National Center for Research Resources, the National Center for Advancing Translational Sciences Grant UL1TR000124 and UL1TR001427, and grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ, The Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA, The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA, and QMED, Inc., Laurence Harbor, NJ, the Edythe L. Broad and the Constance Austin Women's Heart Research Fellowships, Cedars-Sinai Medical Center, Los Angeles, California, the Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, The Society for Women's Health Research (SWHR), Washington, D.C., The Linda Joy Pollin Women's Heart Health Program, and the Erika Glazer Women's Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California. This work is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or National Institutes of Health.`	Bakir M, 2016, INT J CARDIOL, V223, P936, DOI 10.1016/j.ijcard.2016.07.301; Cosin-Sales J, 2003, J AM COLL CARDIOL, V41, P1468, DOI 10.1016/S0735-1097(03)00243-2; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; Janssen SPM, 2005, CIRCULATION, V111, P996, DOI 10.1161/01.CIR.0000156469.96135.0D; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kip KE, 2005, AM HEART J, V150, P900, DOI 10.1016/j.ahj.2005.02.002; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Marroquin OC, 2005, AM HEART J, V150, P109, DOI 10.1016/j.ahj.2004.08.003; Merz CNB, 1999, J AM COLL CARDIOL, V33, P1453; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pischon T, 2003, OBES RES, V11, P1055, DOI 10.1038/oby.2003.145; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Shainkin-Kestenbaum R, 1996, Biomed Pept Proteins Nucleic Acids, V2, P79; Szmitko PE, 2003, CIRCULATION, V108, P2041, DOI 10.1161/01.CIR.0000089093.75585.98; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Vilaro HT JR, 2014, CIRCULATION, V2014, P130; Wei J, 2016, AM J PHYSIOL-HEART C, V310, pH14, DOI 10.1152/ajpheart.00612.2015; Wollert KC, 1997, J MOL MED-JMM, V75, P492, DOI 10.1007/s001090050134; Yu XW, 2005, J PHYSIOL-LONDON, V566, P341, DOI 10.1113/jphysiol.2005.087478; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zhang HC, 2007, AM J PHYSIOL-HEART C, V292, pH2408, DOI 10.1152/ajpheart.01150.2006	30	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177684	10.1371/journal.pone.0177684	http://dx.doi.org/10.1371/journal.pone.0177684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542263	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672600020
J	Diniz, I; Figueiredo, A; Loureiro, A; Batista, D; Azinheira, H; Varzea, V; Pereira, AP; Gichuru, E; Moncada, P; Guerra-Guimaraes, L; Oliveira, H; Silva, MD				Diniz, Ines; Figueiredo, Andreia; Loureiro, Andreia; Batista, Dora; Azinheira, Helena; Varzea, Vitor; Pereira, Ana Paula; Gichuru, Elijah; Moncada, Pilar; Guerra-Guimaraes, Leonor; Oliveira, Helena; Silva, Maria do Ceu			A first insight into the involvement of phytohormones pathways in coffee resistance and susceptibility to Colletotrichum kahawae	PLOS ONE			English	Article							SALICYLIC-ACID; BERRY DISEASE; DEFENSE RESPONSES; ETHYLENE BIOSYNTHESIS; GENE-EXPRESSION; PLANT IMMUNITY; CELL-DEATH; NICOTIANA-BENTHAMIANA; ARABICA COFFEE; JASMONIC ACID	Understanding the molecular mechanisms underlying coffee-pathogen interactions are of key importance to aid disease resistance breeding efforts. In this work the expression of genes involved in salicylic acid (SA), jasmonic acid (JA) and ethylene (ET) pathways were studied in hypocotyls of two coffee varieties challenged with the hemibiotrophic fungus Colletotrichum kahawae, the causal agent of Coffee Berry Disease. Based on a cytological analysis, key time-points of the infection process were selected and qPCR was used to evaluate the expression of phytohormones biosynthesis, reception and responsive-related genes. The resistance to C. kahawae was characterized by restricted fungal growth associated with early accumulation of phenolic compounds in the cell walls and cytoplasmic contents, and deployment of hypersensitive reaction. Similar responses were detected in the susceptible variety, but in a significantly lower percentage of infection sites and with no apparent effect on disease development. Gene expression analysis suggests a more relevant involvement of JA and ET phytohormones than SA in this pathosystem. An earlier and stronger activation of the JA pathway observed in the resistant variety, when compared with the susceptible one, seems to be responsible for the successful activation of defense responses and inhibition of fungal growth. For the ET pathway, the down or non-regulation of ET receptors in the resistant variety, together with a moderate expression of the responsive-related gene ERF1, indicates that this phytohormone may be related with other functions besides the resistance response. However, in the susceptible variety, the stronger activation of ERF1 gene at the beginning of the necrotrophic phase, suggests the involvement of ET in tissue senescence. As far as we know, this is the first attempt to unveil the role of phytohormones in coffee-C. kahawae interactions, thus contributing to deepen our understanding on the complex mechanisms of plant signaling and defense.	[Diniz, Ines; Batista, Dora; Azinheira, Helena; Varzea, Vitor; Pereira, Ana Paula; Guerra-Guimaraes, Leonor; Silva, Maria do Ceu] Univ Lisbon, CIFC, ISA, Oeiras, Portugal; [Diniz, Ines; Loureiro, Andreia; Batista, Dora; Azinheira, Helena; Varzea, Vitor; Guerra-Guimaraes, Leonor; Oliveira, Helena; Silva, Maria do Ceu] Univ Lisbon, Linking Landscape Environm Agr & Food LEAF, ISA, Lisbon, Portugal; [Figueiredo, Andreia] Univ Lisbon, Fac Ciencias, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal; [Batista, Dora] Univ Lisbon, Fac Ciencias, Computat Biol & Populat Genom Grp, cE3c, Lisbon, Portugal; [Gichuru, Elijah] Kenya Agr & Livestock Res Org, Coffee Res Inst, Ruiru, Kenya; [Moncada, Pilar] Ctr Nacl Invest Cafe Cenicafe, Manizales, Colombia	Universidade de Lisboa; Universidade de Lisboa; BIOISI; Universidade de Lisboa; Universidade de Lisboa	Diniz, I (corresponding author), Univ Lisbon, CIFC, ISA, Oeiras, Portugal.; Diniz, I (corresponding author), Univ Lisbon, Linking Landscape Environm Agr & Food LEAF, ISA, Lisbon, Portugal.	inesdiniz@isa.ulisboa.pt	Figueiredo, Andreia/G-2887-2014; Diniz, Inês/ABB-7791-2020; Azinheira, Helena/ADX-1184-2022; Loureiro, Andreia/Q-6716-2019; do Céu ML Silva, Maria/M-6236-2013; Batista, Dora/N-7385-2013; do Céu Silva, Maria/AAP-9668-2021	Figueiredo, Andreia/0000-0001-8156-7700; Diniz, Inês/0000-0003-0193-4385; Azinheira, Helena/0000-0002-9007-0082; Loureiro, Andreia/0000-0002-8886-545X; do Céu ML Silva, Maria/0000-0002-1628-7128; Batista, Dora/0000-0003-4031-8999; do Céu Silva, Maria/0000-0002-1628-7128; Varzea, Vitor/0000-0002-9507-3311; Oliveira, Helena/0000-0002-8274-9757; Guerra-Guimaraes, Leonor/0000-0002-9676-1036; Pereira, Ana Paula Mira Carmo/0000-0001-7469-8147	Portuguese national funds through Fundacao para a Ciencia e a Tecnologia [PTDC/AGR-GPL/112217/2009]; LEAF [UI/AGR/04129/2013];  [LEAF-AGR/04129/BPD/2015];  [SFRH/BPD/ 99712/2014];  [SFRH/BPD/104629/2014];  [SFRH/BD/ 84188/2012]	Portuguese national funds through Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); LEAF; ; ; ; 	This work was funded by Portuguese national funds through Fundacao para a Ciencia e a Tecnologia (www.fct.pt/) (PTDC/AGR-GPL/112217/2009), LEAF (UI/AGR/04129/2013) and grants LEAF-AGR/04129/BPD/2015, SFRH/BPD/ 99712/2014, SFRH/BPD/104629/2014, SFRH/BD/ 84188/2012 attributed to AL, AF, DB, ID.	Ahmad P, 2016, FRONT PLANT SCI; Amil-Ruiz F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01036; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Andolfo G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00987; Balmer D, 2013, PLANT J, V74, P213, DOI 10.1111/tpj.12114; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bennett M, 1996, PLANT J, V9, P851, DOI 10.1046/j.1365-313X.1996.9060851.x; BILES CL, 1990, PHYTOPATHOLOGY, V80, P732, DOI 10.1094/Phyto-80-732; Castro A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00580; Chen N, 2003, J EXP BOT, V54, P2449, DOI 10.1093/jxb/erg289; Damm U, 2014, STUD MYCOL, P49, DOI 10.1016/j.simyco.2014.09.003; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Diniz I, 2015, PROCEEDINGS OF 25TH; Diniz I, 2014, XVI INTERNATIONAL CO; Diniz I, 2012, EUR J PLANT PATHOL, V133, P141, DOI 10.1007/s10658-011-9925-9; Silva Maria do Céu, 2006, Braz. J. Plant Physiol., V18, P119, DOI 10.1590/S1677-04202006000100010; Duan L, 2014, PHYSIOL PLANTARUM, V152, P486, DOI 10.1111/ppl.12192; Duan ZB, 2014, EUR J PLANT PATHOL, V140, P169, DOI 10.1007/s10658-014-0453-2; Figueiredo A, 2015, EUR J PLANT PATHOL, V142, P645, DOI 10.1007/s10658-015-0634-7; Figueiredo Andreia, 2013, BMC Res Notes, V6, P388, DOI 10.1186/1756-0500-6-388; Fino J, 2015, PROCEEDINGS OF 25TH; Firman ID, 1977, COFFEE BERRY DISEASE; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Gallie D. R., 2015, F1000PRIME REPORTS, V7, P1; Gichuru E. K., 2007, Agronomie Africaine, V19, P233; Gichuru EK, 2008, PLANT PATHOL, V57, P1117, DOI 10.1111/j.1365-3059.2008.01846.x; Gichuru E. K., 1997, Kenya Coffee, V62, P2441; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grellet-Bournonville CF, 2012, PLANT PHYSIOL BIOCH, V54, P10, DOI 10.1016/j.plaphy.2012.01.019; Groen SC, 2014, J CHEM ECOL, V40, P700, DOI 10.1007/s10886-014-0474-5; Guerreiro A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00565; He J, 2016, J FOOD SAF; Heath MC, 1998, EUR J PLANT PATHOL, V104, P117, DOI 10.1023/A:1008645520976; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hindorf H, 2011, J ADV RES, V2, P109, DOI 10.1016/j.jare.2010.08.006; Janda M, 2015, ENVIRON EXP BOT, V114, P117, DOI 10.1016/j.envexpbot.2014.07.003; Jaulneau V, 2010, MOL PLANT MICROBE IN, V23, P1107, DOI 10.1094/MPMI-23-9-1107; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; KENDE H, 1989, PLANT PHYSIOL, V91, P1, DOI 10.1104/pp.91.1.1; Kevany BM, 2008, PLANT BIOTECHNOL J, V6, P295, DOI 10.1111/j.1467-7652.2007.00319.x; Kubo Y, 2016, PHYSIOL MOL PLANT P, V95, P32, DOI 10.1016/j.pmpp.2016.02.008; Kumar D, 2014, PLANT SCI, V228, P127, DOI 10.1016/j.plantsci.2014.04.014; Lahey KA, 2004, MOL PLANT MICROBE IN, V17, P1394, DOI 10.1094/MPMI.2004.17.12.1394; Li W, 2003, J AM SOC HORTIC SCI, V128, P578, DOI 10.21273/JASHS.128.4.0578; Litholdo CG, 2015, PLANT CELL REP, V34, P1747, DOI 10.1007/s00299-015-1821-x; Liu GS, 2007, MOL PLANT MICROBE IN, V20, P1308, DOI 10.1094/MPMI-20-10-1308; Lou reiro A, 2013, PROCEEDINGS OF 24TH; Loureiro A, 2012, PHYSIOL MOL PLANT P, V77, P23, DOI 10.1016/j.pmpp.2011.11.002; Ma KW, 2016, PLANT MOL BIOL, V91, P713, DOI 10.1007/s11103-016-0452-0; MASABA DM, 1982, NETH J PLANT PATHOL, V88, P19, DOI 10.1007/BF01976423; McDonald L., 1926, T BR MYCOL SOC, V11, P145; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Miles TD, 2011, MOL PLANT PATHOL, V12, P463, DOI 10.1111/j.1364-3703.2010.00687.x; Muencha S, 2008, J PLANT PHYSIOL, V165, P41, DOI 10.1016/j.jplph.2007.06.008; Ohtsubo N, 1999, PLANT CELL PHYSIOL, V40, P808, DOI 10.1093/oxfordjournals.pcp.a029609; Omondi CO, 2006, PROCEEDINGS OF 21ST; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pieterse MJ, 2012, ANNU REV DEV BIOL, V28, P489; Portal O, 2011, PLANT CELL REP, V30, P913, DOI 10.1007/s00299-011-1008-z; Prathima PT, 2013, APPL BIOCHEM BIOTECH, V171, P488, DOI 10.1007/s12010-013-0346-4; Ramiro DA, 2009, PLANT PATHOL, V58, P944, DOI 10.1111/j.1365-3059.2009.02122.x; RODRIGUES CJ, 1991, J PHYTOPATHOL, V131, P205, DOI 10.1111/j.1439-0434.1991.tb01189.x; Sa M., 2014, J SCI FOOD AGR, V94, P529, DOI [DOI 10.1002/JSFA.6288, 10.1002/jsfa.6288]; Sasek V, 2012, MOL PLANT MICROBE IN, V25, P1238, DOI 10.1094/MPMI-02-12-0033-R; Shan XC, 2006, PLANT CELL REP, V25, P241, DOI 10.1007/s00299-005-0063-8; Shantanu Das, 2015, Agricultural Reviews, V36, P133; Shibata Y, 2010, MOL PLANT MICROBE IN, V23, P1130, DOI 10.1094/MPMI-23-9-1130; Silva MC, 2002, PHYSIOL MOL PLANT P, V60, P169, DOI 10.1006/pmpp.2002.0389; Silva MC, 1999, INT J PLANT SCI, V160, P79, DOI 10.1086/314113; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Sugano S, 2013, PLANT PATHOL, V62, P1048, DOI 10.1111/ppa.12011; Tang WL, 2010, POSTHARVEST BIOL TEC, V57, P86, DOI 10.1016/j.postharvbio.2010.02.007; Torregrosa C, 2004, MOL PLANT MICROBE IN, V17, P909, DOI 10.1094/MPMI.2004.17.8.909; van der Vossen HAM, 2009, EUPHYTICA, V165, P105, DOI 10.1007/s10681-008-9769-3; VANDERVOSSEN HAM, 1980, EUPHYTICA, V29, P777, DOI 10.1007/BF00023225; VANDERVOSSEN HAM, 1976, EUPHYTICA, V25, P733, DOI 10.1007/BF00041613; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas WA, 2012, PLANT PHYSIOL, V158, P1342, DOI 10.1104/pp.111.190397; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wanigasekara UWNP, 2014, J NATL SCI FOUND SRI, V42, P101, DOI 10.4038/jnsfsr.v42i2.6994; Wasternack C, 2014, PLANT CELL REP, V33, P707, DOI 10.1007/s00299-014-1608-5; Yan SP, 2014, CURR OPIN PLANT BIOL, V20, P64, DOI 10.1016/j.pbi.2014.04.006; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yu MM, 2009, POSTHARVEST BIOL TEC, V54, P153, DOI 10.1016/j.postharvbio.2009.07.001; Zubini P, 2009, PLANT PHYSIOL, V150, P1235, DOI 10.1104/pp.109.139543	86	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178159	10.1371/journal.pone.0178159	http://dx.doi.org/10.1371/journal.pone.0178159			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542545	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600046
J	Oses, C; Olivares, B; Ezquer, M; Acosta, C; Bosch, P; Donoso, M; Leniz, P; Ezquerl, F				Oses, Carolina; Olivares, Belen; Ezquer, Marcelo; Acosta, Cristian; Bosch, Paul; Donoso, Macarena; Leniz, Patricio; Ezquerl, Fernando			Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; NERVE GROWTH-FACTOR; QUALITY-OF-LIFE; STROMAL CELLS; OXIDATIVE STRESS; BONE-MARROW; IN-VITRO; EPINEURIAL ARTERIOLES; PERIPHERAL NEUROPATHY; REPERFUSION INJURY	Diabetic neuropathy (DN) is one of the most frequent and troublesome complications of diabetes mellitus. Evidence from diabetic animal models and diabetic patients suggests that reduced availability of neuroprotective and pro-angiogenic factors in the nerves in combination with a chronic pro-inflammatory microenvironment and high level of oxidative stress, contribute to the pathogenesis of DN. Mesenchymal stem cells (MSCs) are of great interest as therapeutic agents for regenerative purposes, since they can secrete a broad range of cytoprotective and anti-inflammatory factors. Therefore, the use of the MSC secretome may represent a promising approach for DN treatment. Recent data indicate that the paracrine potential of MSCs could be boosted by preconditioning these cells with an environmental or pharmacological stimulus, enhancing their therapeutic efficacy. In the present study, we observed that the preconditioning of human adipose tissue-derived MSCs (AD-MSCs) with 150 mu M or 400 mu M of the iron chelator deferoxamine (DFX) for 48 hours, increased the abundance of the hypoxia inducible factor 1 alpha (HIF-1 alpha) in a concentration dependent manner, without affecting MSC morphology and survival. Activation of HIF-1 alpha led to the upregulation of the mRNA levels of pro-angiogenic factors like vascular endothelial growth factor alpha and angiopoietin 1. Furthermore this preconditioning increased the expression of potent neuroprotective factors, including nerve growth factor, glial cell-derived neurotrophic factor and neurotrophin-3, and cytokines with anti-inflammatory activity like IL4 and IL5. Additionally, we observed that these molecules, which could also be used as therapeutics, were also increased in the secretome of MSCs preconditioned with DFX compared to the secretome obtained from non-preconditioned cells. Moreover, DFX preconditioning significantly increased the total antioxidant capacity of the MSC secretome and they showed neuroprotective effects when evaluated in an in vitro model of DN. Altogether, our findings suggest that DFX preconditioning of AD-MSCs improves their therapeutic potential and should be considered as a potential strategy for the generation of new alternatives for DN treatment.	[Oses, Carolina; Ezquer, Marcelo; Ezquerl, Fernando] Univ Desarrollo, Fac Med, Clin Alemana, Ctr Med Regenerat, Av Las Condes, Santiago, Chile; [Olivares, Belen] Univ Desarrollo, Fac Med, Clin Alemana, Ctr Quim Med, Av Las Condes, Santiago, Chile; [Acosta, Cristian] Univ Nacl Cuyo, Fac Med, Inst Histol & Embriol Mendoza IHEM CONICET, Mendoza, Argentina; [Bosch, Paul; Donoso, Macarena] Univ Desarrollo, Fac Ingn, Av Plaza, Santiago, Chile; [Leniz, Patricio] Clin Alemana, Unidad Cirugia Plast Reparadora & Estet, Santiago, Chile	Clinica Alemana; Universidad del Desarrollo; Clinica Alemana; Universidad del Desarrollo; University Nacional Cuyo Mendoza; Universidad del Desarrollo; Clinica Alemana	Ezquerl, F (corresponding author), Univ Desarrollo, Fac Med, Clin Alemana, Ctr Med Regenerat, Av Las Condes, Santiago, Chile.	eezquer@udd.cl	Ezquer, Fernando/AHC-7601-2022	Acosta, Cristian/0000-0001-9333-5843; Ezquer, Fernando/0000-0002-7696-4215; Ezquer, Marcelo/0000-0002-2064-3041	FONDECYT [CIF-16 UDD, 1170712]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the CIF-16 UDD grant and FONDECYT 1170712 grant awarded to Dr. Fernando Ezquer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Markus Uhrig, Dr. Anne Bliss and Dr. Carolina Rodriguez for proofreading the manuscript. This work was supported by the CIF-16 UDD grant and FONDECYT 1170712 grant awarded to Dr. Fernando Ezquer.	Acosta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050442; Albers JW, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0473-5; Angoulvant D, 2011, J HEART LUNG TRANSPL, V30, P95, DOI 10.1016/j.healun.2010.08.023; Anitha M, 2006, J CLIN INVEST, V116, P344, DOI 10.1172/JCI26295; Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; Apfel SC, 1999, AM J MED, V107, P345; Argoff CE, 2006, MAYO CLIN PROC, V81, pS12, DOI 10.1016/S0025-6196(11)61475-4; Argoff CE, 2006, MAYO CLIN PROC, V81, pS3, DOI 10.1016/S0025-6196(11)61474-2; Bansal V, 2006, POSTGRAD MED J, V82, P95, DOI 10.1136/pgmj.2005.036137; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Carriere A, 2009, ARTERIOSCL THROM VAS, V29, P1093, DOI 10.1161/ATVBAHA.109.188318; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chen J, 2015, CELL PHYSIOL BIOCHEM, V37, P1830, DOI 10.1159/000438545; Chu K, 2008, BRAIN RES, V1207, P182, DOI 10.1016/j.brainres.2008.02.043; Coppey LJ, 2003, FREE RADICAL RES, V37, P33, DOI 10.1080/1071576021000028442; Coppey LJ, 2001, DIABETES, V50, P1927, DOI 10.2337/diabetes.50.8.1927; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Francia S, 2012, J CHROMATOGR B, V893, P127, DOI 10.1016/j.jchromb.2012.02.047; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ezquer M, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0299-y; Figueroa-Romero C, 2008, REV ENDOCR METAB DIS, V9, P301, DOI 10.1007/s11154-008-9104-2; Fiore M, 2009, REV NEUROSCIENCE, V20, P133; Frausin S, 2015, ACTA HISTOCHEM, V117, P329, DOI 10.1016/j.acthis.2015.02.005; Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487; Greenberger JS, 2008, GENE THER, V15, P100, DOI 10.1038/sj.gt.3303004; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Han JW, 2016, CELL TRANSPLANT, V25, P313, DOI 10.3727/096368915X688209; Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110; Howland MA, 1996, J TOXICOL-CLIN TOXIC, V34, P491, DOI 10.3109/15563659609028006; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kalichman MW, 1998, ACTA NEUROPATHOL, V95, P47, DOI 10.1007/s004010050764; Keats E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038752; Keilhoff G, 2006, CELL MOL NEUROBIOL, V26, P1235, DOI 10.1007/s10571-006-9029-9; Khan M, 2011, STEM CELLS DEV, V20, P67, DOI 10.1089/scd.2009.0397; Kim Bae Jin, 2011, Lab Anim Res, V27, P171, DOI 10.5625/lar.2011.27.2.171; Kim WS, 2008, J DERMATOL SCI, V49, P133, DOI 10.1016/j.jdermsci.2007.08.004; Kishi M, 2002, DIABETES, V51, P819, DOI 10.2337/diabetes.51.3.819; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Langlois A, 2008, TRANSPL P, V40, P473, DOI 10.1016/j.transproceed.2008.01.003; Lee HC, 2012, CIRC J, V76, P1750, DOI 10.1253/circj.CJ-11-1135; Lee SC, 2015, SURGERY, V157, P934, DOI 10.1016/j.surg.2014.12.016; Leinninger GM, 2006, NEUROBIOL DIS, V23, P11, DOI 10.1016/j.nbd.2006.01.017; Leinninger GM, 2004, J PERIPHER NERV SYST, V9, P26, DOI 10.1111/j.1085-9489.2004.09105.x; Liu LQ, 2013, CELL BIOL INT, V37, P551, DOI 10.1002/cbin.10097; Matsunaga A, 2007, EUR J PHARMACOL, V554, P12, DOI 10.1016/j.ejphar.2006.09.072; Miyajima S, 2006, DIABETES RES CLIN PR, V71, P272, DOI 10.1016/j.diabres.2005.07.005; Mizisin AP, 2004, DIABETES, V53, P1807, DOI 10.2337/diabetes.53.7.1807; Mizukami H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00045; Naruse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027458; Nishimori M, 2002, BLOOD, V99, P1995, DOI 10.1182/blood.V99.6.1995; Nouri F, 2016, CELL MOL NEUROBIOL, V36, P689, DOI 10.1007/s10571-015-0249-8; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Potier E, 2008, J TISSUE ENG REGEN M, V2, P272, DOI 10.1002/term.92; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Sart S, 2014, BIORESEARCH OPEN ACC, V3, P137, DOI 10.1089/biores.2014.0012; Schmeichel AM, 2003, DIABETES, V52, P165, DOI 10.2337/diabetes.52.1.165; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; Shi XH, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-69; Shibata T, 2008, DIABETES, V57, P3099, DOI 10.2337/db08-0031; Shimoshige Y, 2009, BRAIN RES, V1247, P182, DOI 10.1016/j.brainres.2008.10.018; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Sterne GD, 1997, EUR J NEUROSCI, V9, P1388, DOI 10.1111/j.1460-9568.1997.tb01493.x; Stevens MJ, 2000, DIABETES, V49, P1006, DOI 10.2337/diabetes.49.6.1006; Stubbs SL, 2012, STEM CELLS DEV, V21, P1887, DOI 10.1089/scd.2011.0289; Thum T, 2005, J AM COLL CARDIOL, V46, P1799, DOI 10.1016/j.jacc.2005.07.053; Tosaki T, 2008, EXP NEUROL, V213, P381, DOI 10.1016/j.expneurol.2008.06.017; Trivedi P, 2010, STEM CELLS DEV, V19, P1109, DOI 10.1089/scd.2009.0465; Ueno Y, 2002, J NUTR, V132, P897, DOI 10.1093/jn/132.5.897; Veves A, 2001, J CLIN INVEST, V107, P1215, DOI 10.1172/JCI13038; Vincent AM, 2005, ANTIOXID REDOX SIGN, V7, P1494, DOI 10.1089/ars.2005.7.1494; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Waszak P, 2012, STEM CELLS DEV, V21, P2789, DOI 10.1089/scd.2010.0566; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7; Yang D, 2016, CHIN J INTEGR MED, V22, P19, DOI 10.1007/s11655-015-2103-8; Yao YW, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-74; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0	84	71	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178011	10.1371/journal.pone.0178011	http://dx.doi.org/10.1371/journal.pone.0178011			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542352	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672600041
J	Wilcox, SM; Arora, H; Munro, L; Xin, J; Fenninger, F; Johnson, LA; Pfeifer, CG; Choi, KB; Hou, J; Hoodless, PA; Jefferies, WA				Wilcox, Sara M.; Arora, Hitesh; Munro, Lonna; Xin, Jian; Fenninger, Franz; Johnson, Laura A.; Pfeifer, Cheryl G.; Choi, Kyung Bok; Hou, Juan; Hoodless, Pamela A.; Jefferies, Wilfred A.			The role of the innate immune response regulatory gene ABCF1 in mammalian embryogenesis and development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BINDING CASSETTE PROTEIN; INITIATION-FACTOR 2; TRANSLATIONAL CONTROL; KINASE GCN2; ABC50 INTERACTS; MOUSE; EIF2; PHOSPHORYLATION; DISRUPTION	ABCF1 is an ABC transporter family protein that has been shown to regulate innate immune response and is a risk gene for autoimmune pancreatitis and arthritis. Unlike other members of ABC transporter family, ABCF1 lacks trans-membrane domains and is thought to function in translation initiation through an interaction with eukaryotic translation initiation factor 2 (eIF2). To study ABCF1 expression and function in development and disease, we used a single gene trap insertion in the Abcf1 gene in murine embryonic stem cells (ES cells) that allowed lineage tracing of the endogenous Abcf1 promoter by following the expression of a beta-galactosidase reporter gene. From the ES cells, heterozygous mice (Abcf1+/-) were produced. No live born Abcf1-/-progeny were ever generated, and the lethality was not mouse strain-specific. Thus, we have determined that Abcf1 is an essential gene in development. Abcf1-/- mice were found to be embryonic lethal at 3.5 days post coitum (dpc), while Abcf1 +/- mice appeared developmentally normal. Abcf1+/- mice were fertile and showed no significant differences in their anatomy when compared with their wild type littermates. The Abcf1 promoter was found to be active in all organs in adult mice, but varies in levels of expression in specific cell types within tissues. Furthermore, we observed high promoter activity in the blastocysts and embryos. Overall, Abcf1 expression in embryos is required for development and its expression in adults was highly correlated with actively proliferating and differentiating cell types.	[Wilcox, Sara M.; Arora, Hitesh; Munro, Lonna; Xin, Jian; Fenninger, Franz; Johnson, Laura A.; Pfeifer, Cheryl G.; Choi, Kyung Bok; Jefferies, Wilfred A.] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Wilcox, Sara M.; Arora, Hitesh; Fenninger, Franz; Jefferies, Wilfred A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Johnson, Laura A.; Jefferies, Wilfred A.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Hou, Juan; Hoodless, Pamela A.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Hoodless, Pamela A.] Univ British Columbia, Dept Dev & Cell Biol, Vancouver, BC, Canada; [Hoodless, Pamela A.; Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Jefferies, WA (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.	wilf@msi.ubc.ca		Hoodless, Pamela/0000-0003-1371-0725	CIHR [MOP-86739, MOP-133634, MOP-97900, NHG-107769]	CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR MOP-86739, CIHR MOP-133634, CIHR MOP-97900, and CIHR NHG-107769.	Bolon B, 2008, TOXICOL PATHOL, V36, P265, DOI 10.1177/0192623307312693; Bundschu K, 2006, GENE EXPR PATTERNS, V6, P247, DOI 10.1016/j.modgep.2005.08.003; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kaufman MH, 1999, ANATOMICAL BASIS MOU, Vxii; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; Ota M, 2007, IMMUNOGENETICS, V59, P45, DOI 10.1007/s00251-006-0178-2; Paytubi S, 2008, BIOCHEM J, V409, P223, DOI 10.1042/BJ20070811; Paytubi S, 2009, J BIOL CHEM, V284, P24061, DOI 10.1074/jbc.M109.031625; Phillips R, PLOS PATHOG, V6; Richard M, 1998, GENOMICS, V53, P137, DOI 10.1006/geno.1998.5480; Sood R, 2000, GENETICS, V154, P787; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	28	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0175918	10.1371/journal.pone.0175918	http://dx.doi.org/10.1371/journal.pone.0175918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542262	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672600001
J	Ganapathy, V; Manyanga, J; Brame, L; McGuire, D; Sadhasivam, B; Floyd, E; Rubenstein, DA; Ramachandran, I; Wagener, T; Queimado, L				Ganapathy, Vengatesh; Manyanga, Jimmy; Brame, Lacy; McGuire, Dehra; Sadhasivam, Balaji; Floyd, Evan; Rubenstein, David A.; Ramachandran, Ilangovan; Wagener, Theodore; Queimado, Lurdes			Electronic cigarette aerosols suppress cellular antioxidant defenses and induce significant oxidative DNA damage	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; CARBONYL-COMPOUNDS; SMOKE EXTRACTS; VAPOR EXTRACT; TOBACCO; CANCER; NICOTINE; MUTAGENICITY; SENESCENCE; ASSAY	Background Electronic cigarette (EC) aerosols contain unique compounds in addition to toxicants and carcinogens traditionally found in tobacco smoke. Studies are warranted to understand the public health risks of ECs. Objective The aim of this study was to determine the genotoxicity and the mechanisms induced by EC aerosol extracts on human oral and lung epithelial cells. Methods Cells were exposed to EC aerosol or mainstream smoke extracts and DNA damage was measured using the primer anchored DNA damage detection assay (q-PADDA) and 8-oxodG ELISA assay. Cell viability, reactive oxygen species (ROS) and total antioxidant capacity (TAC) were measured using standard methods. mRNA and protein expression were evaluated by RT-PCR and western blot, respectively. Results EC aerosol extracts induced DNA damage in a dose-dependent manner, but independently of nicotine concentration. Overall, EC aerosol extracts induced significantly less DNA damage than mainstream smoke extracts, as measured by q-PADDA. However, the levels of oxidative DNA damage, as indicated by the presence of 8-oxo-dG, a highly mutagenic DNA lesion, were similar or slightly higher after exposure to EC aerosol compared to mainstream smoke extracts. Mechanistically, while exposure to EC extracts significantly increased ROS, it decreased TAC as well as the expression of 8-oxoguanine DNA glycosylase (OGG1), an enzyme essential for the removal of oxidative DNA damage. Conclusions Exposure to EC aerosol extracts suppressed the cellular antioxidant defenses and led to significant DNA damage. These findings emphasize the urgent need to investigate the potential long-term cancer risk of exposure to EC aerosol for vapers and the general public.	[Ganapathy, Vengatesh; Manyanga, Jimmy; Brame, Lacy; McGuire, Dehra; Sadhasivam, Balaji; Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Dept Otorhinolaryngol, Oklahoma City, OK 73106 USA; [Manyanga, Jimmy; Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol Hlth, Oklahoma City, OK 73106 USA; [Floyd, Evan] Univ Oklahoma, Hlth Sci Ctr, Dept Occupat & Environm Hlth, Oklahoma City, OK 73106 USA; [Rubenstein, David A.] SUNY Stony Brook, Dept Biomed Engn, New York, NY USA; [Ramachandran, Ilangovan] Univ Madras, Dept Endocrinol, Dr ALM Post Grad Inst Basic Med Sci, Taramani Campus, Madras, Tamil Nadu, India; [Wagener, Theodore; Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Wagener, Theodore; Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Tobacco Res Ctr, Oklahoma City, OK 73106 USA; [Wagener, Theodore; Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73106 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Madras; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Queimado, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Otorhinolaryngol, Oklahoma City, OK 73106 USA.; Queimado, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol Hlth, Oklahoma City, OK 73106 USA.; Queimado, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA.; Queimado, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Tobacco Res Ctr, Oklahoma City, OK 73106 USA.; Queimado, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73106 USA.	lurdes-queimado@ouhsc.edu	Queimado, Lurdes/L-7465-2013; Sadhasivam, Balaji/B-2084-2016; Queimado, Lurdes/AAY-2545-2021; Ganapathy, Vengatesh/B-6034-2019; Rubenstein, David/H-3570-2011	Queimado, Lurdes/0000-0002-1106-4873; Sadhasivam, Balaji/0000-0002-3207-4392; Queimado, Lurdes/0000-0002-1106-4873; Ganapathy, Vengatesh/0000-0002-1662-4921; Rubenstein, David/0000-0002-9495-9049	Oklahoma Tobacco Research Center; Presbyterian Health Foundation; Oklahoma Center for the Advancement of Science Technology; NATIONAL CANCER INSTITUTE [R33CA202898] Funding Source: NIH RePORTER	Oklahoma Tobacco Research Center; Presbyterian Health Foundation; Oklahoma Center for the Advancement of Science Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Oklahoma Tobacco Research Center (LQ), the Presbyterian Health Foundation (LQ) and by the Oklahoma Center for the Advancement of Science & Technology (LQ). Dr. Queimado holds a Presbyterian Health Foundation Endowed Chair in Otorhinolaryngology Position. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Administration USFaD Services DoHaP], 2012, HARMF POT HARMF CONS; Administration USFaD, 2014, SUMM RES LAB AN EL C, p[1, 1]; [Anonymous], 2012, AG CLASS IARC MON; Arrazola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; Behar RZ, 2016, TOB CONTROL, V25, pii94, DOI 10.1136/tobaccocontrol-2016-053224; Bekki K, 2014, INT J ENV RES PUB HE, V11, P11192, DOI 10.3390/ijerph111111192; Bettcher DW, 2008, ANN ONCOL, V19, P230, DOI 10.1093/annonc/mdn435; Bian L, 2011, MED ONCOL, V28, pS560, DOI 10.1007/s12032-010-9655-4; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Cahn Z, 2011, J PUBLIC HEALTH POL, V32, P16, DOI 10.1057/jphp.2010.41; CDC, 2016, TOB BRAND PREF; Cheng TR, 2014, TOB CONTROL, V23, P11, DOI 10.1136/tobaccocontrol-2013-051482; Collins A, 2003, FREE RADICAL BIO MED, V34, P1089, DOI 10.1016/s0891-5849(03)00041-8; Cressey D, 2014, NATURE, V508, P159, DOI 10.1038/508159a; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dillon D, 1998, MUTAGENESIS, V13, P19, DOI 10.1093/mutage/13.1.19; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Farsalinos KE, 2014, THER ADV DRUG SAF, V5, P67, DOI 10.1177/2042098614524430; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P2500, DOI 10.3390/ijerph10062500; (FDA) UFaDA, DEEM TOB PROD BE SUB; Fracasso ME, 2006, TOXICOL LETT, V167, P131, DOI 10.1016/j.toxlet.2006.09.003; Friedberg Errol C., 2005, DNA REPAIR MUTAGENES; Ganapathy V, 2015, AM J PREV MED, V48, pS102, DOI 10.1016/j.amepre.2014.08.017; Gellner Candice A, 2016, Curr Protoc Neurosci, V77, DOI 10.1002/cpns.14; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Goniewicz ML, 2015, INT J DRUG POLICY; Hajek P, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0225-z; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Ji EH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154447; Kanaji N, 2014, AM J PHYSIOL-LUNG C, V307, pL364, DOI 10.1152/ajplung.00041.2014; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kaplan A, 2015, YES CAN FAM PHYS, V61, pe255; Kaplan A, 2015, CAN FAM PHYSICIAN, V61, P499; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Kux L., 2016, DEEMING TOBACCO PROD; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Leigh NJ, 2016, TOB CONTROL, V25, pii81, DOI 10.1136/tobaccocontrol-2016-053205; Lerner CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116732; Lerner CA, 2015, ENVIRON POLLUT, V198, P100, DOI 10.1016/j.envpol.2014.12.033; Levitz Suzanne, 2015, Can Fam Physician, V61, P500; Levitz Suzanne, 2015, Can Fam Physician, V61, pe258; Lindell G, 1996, EUR J CLIN PHARMACOL, V51, P315, DOI 10.1007/s002280050204; Margham J, 2016, CHEM RES TOXICOL, V29, P1662, DOI 10.1021/acs.chemrestox.6b00188; Marian C, 2009, CANCER EPIDEM BIOMAR, V18, P3305, DOI 10.1158/1055-9965.EPI-09-1014; Maritz Gert S, 2009, Ther Adv Respir Dis, V3, P193, DOI 10.1177/1753465809343712; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; McAuley TR, 2012, INHAL TOXICOL, V24, P850, DOI 10.3109/08958378.2012.724728; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334; Mincer J., 2015, E CIGARETTE USAGE SU; Misra M, 2014, INT J ENV RES PUB HE, V11, P11325, DOI 10.3390/ijerph111111325; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; MULLENBACH R, 1989, TRENDS GENET, V5, P391; Neumann AS, 2005, MOL CARCINOGEN, V42, P65, DOI 10.1002/mc.20069; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Nyunoya T, 2009, AM J RESP CRIT CARE, V179, P279, DOI 10.1164/rccm.200802-320OC; Park SJ, 2014, CLIN CANCER RES, V20, DOI 10.1158/1078-0432.14AACRIASLC-B16; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Public Health England, 2015, E CIGARETTES EVIDENC; Queimado L, 1999, INT J CANCER, V81, P793, DOI 10.1002/(SICI)1097-0215(19990531)81:5<793::AID-IJC21>3.0.CO;2-4; Ramachandran I, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.219; Reis AMC, 2012, NUCLEIC ACIDS RES, V40, P206, DOI 10.1093/nar/gkr704; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Roemer E, BEITRAGE TABAK FORSC, P316; Romagna G, 2013, INHAL TOXICOL, V25, P354, DOI 10.3109/08958378.2013.793439; Ruan Yong-hua, 2007, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V25, P331; Rubenstein D, 2004, CIRCULATION, V109, P78, DOI 10.1161/01.CIR.0000108395.12766.25; Rubenstein DA, 2015, MOL IMMUNOL; Services USDoHaH, 2010, TOB SMOK CAUS DIS BI; Shukla PC, 2010, CAN J CARDIOL, V26, p13A, DOI 10.1016/S0828-282X(10)71055-2; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Sussan TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116861; Tackett AP, 2015, ADDICTION, V110, P868, DOI 10.1111/add.12878; Tayyarah R., 2014, ELECT CIGARETTE AERO; Thorne D, 2016, MUTAT RES-GEN TOX EN, V812, P29, DOI 10.1016/j.mrgentox.2016.10.005; Thorne D, 2017, TOXICOL LETT, V265, P170, DOI 10.1016/j.toxlet.2016.12.006; Thorne D, 2015, INHAL TOXICOL, V27, P629, DOI 10.3109/08958378.2015.1080773; Tudek B, 2007, MOL ASPECTS MED, V28, P258, DOI 10.1016/j.mam.2007.05.003; Wagener T.L., 2016, TOB CONTROL; Wagener TL, 2012, ADDICTION, V107, P1545, DOI 10.1111/j.1360-0443.2012.03826.x; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; Westenberger BJ, 2009, EVALUATION E CIGARET; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Wood L., RES MARKETS E CIGARE; Yu V, 2016, ORAL ONCOL, V52, P58, DOI 10.1016/j.oraloncology.2015.10.018; Zhou G, 2014, MOL CELL, V54, P960, DOI 10.1016/j.molcel.2014.04.024	92	87	91	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177780	10.1371/journal.pone.0177780	http://dx.doi.org/10.1371/journal.pone.0177780			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542301	gold, Green Published			2022-12-27	WOS:000401672400082
J	Michel, G; Blery, P; Henoux, M; Guicheux, J; Weiss, P; Brouard, S; Malard, O; Espitalier, F				Michel, Guillaume; Blery, Pauline; Henoux, Michael; Guicheux, Jerome; Weiss, Pierre; Brouard, Sophie; Malard, Olivier; Espitalier, Florent			Bone marrow cell extract promotes the regeneration of irradiated bone	PLOS ONE			English	Article							CALCIUM-PHOSPHATE SCAFFOLD; STEM-CELLS; RECONSTRUCTION; ANGIOGENESIS; OSTEORADIONECROSIS; INJECTION; RADIATION	Mandibular osteoradionecrosis is a severe side effect of radiotherapy after the treatment of squamous cell carcinomas of the upper aerodigestive tract. As an alternative to its treatment by micro-anastomosed free-flaps, preclinical tissular engineering studies have been developed. Total bone marrow (TBM) associated with biphasic calcium phosphate (BCP) significantly enhanced bone formation in irradiated bone. One mechanism, explaining how bone marrow cells can help regenerate tissues like this, is the paracrine effect. The bone marrow cell extract (BMCE) makes use of this paracrine mechanism by keeping only the soluble factors such as growth factors and cytokines. It has provided significant results in repairing various tissues, but has not yet been studied in irradiated bone reconstruction. The purpose of this study was to evaluate the effect of BMCE via an intraosseous or intravenous delivery, with a calcium phosphate scaffold, in irradiated bone reconstruction. Twenty rats were irradiated on their hind limbs with a single 80-Gy dose. Three weeks later, surgery was performed to create osseous defects. The intraosseous group (n = 12) studied the effect of BMCE in situ, with six combinations (empty defect, BCP, TBM, BCP-TBM, lysate only, BCP-lysate). After four different combinations of implantation (empty defect, BCP, TBM, BCP-TBM), the intravenous group (n = 8) received four intravenous injections of BMCE for 2 weeks. Five weeks after implantation, samples were explanted for histological and scanning electron microscopy analysis. Lysate immunogenicity was studied with various mixed lymphocyte reactions. Intravenous injections of BMCE led to a significant new bone formation compared to the intraosseous group. The BCP-TBM mixture remained the most effective in the intraosseous group. However, intravenous injections were more effective, with TBM placed in the defect, with or without biomaterials. Histologically, highly cellularized bone marrow was observed in the defects after intravenous injections, and not after an in situ use of the lysate. The mixed lymphocyte reactions did not show any proliferation after 3, 5, or 7 days of lysate incubation with lymphocytes from another species. This study evaluated the role of BMCE in irradiated bone reconstruction. There were significant results arguing in favor of BMCE intravenous injections. This could open new perspectives to irradiated bone reconstruction.	[Michel, Guillaume; Henoux, Michael; Malard, Olivier; Espitalier, Florent] CHU, Serv ORL & Chirurg & Cerv Faciale, Nantes, France; [Michel, Guillaume; Blery, Pauline; Henoux, Michael; Guicheux, Jerome; Weiss, Pierre; Malard, Olivier; Espitalier, Florent] Univ Nantes, LIOAD, INSERM, UMRS 791, Nantes, France; [Blery, Pauline; Weiss, Pierre] CHU, Serv Odontol Restauratrice & Chirurg, Nantes, France; [Brouard, Sophie] Univ Nantes, INSERM, UMR 1064, ITUN, Nantes, France	Nantes Universite; CHU de Nantes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Michel, G (corresponding author), CHU, Serv ORL & Chirurg & Cerv Faciale, Nantes, France.; Michel, G (corresponding author), Univ Nantes, LIOAD, INSERM, UMRS 791, Nantes, France.	guillaumemichel@live.fr	guicheux, Jerome/F-7767-2013; Weiss, Pierre/P-1372-2014; Espitalier, Florent/P-6582-2014; Bléry, Pauline/P-6279-2014; Malard, Olivier/A-4742-2012; WEISS, Pierre/AAE-9260-2020	guicheux, Jerome/0000-0003-2754-3024; Weiss, Pierre/0000-0002-6159-8590; Malard, Olivier/0000-0003-1783-5066; WEISS, Pierre/0000-0002-6159-8590; Dugast, Emilie/0000-0001-7439-1903	"Ligue contre le cancer" foundation	"Ligue contre le cancer" foundation	The authors received grants from "Ligue contre le cancer" foundation. For the whole project, we recived 20 000 euros (https://www.ligue-cancer.net/).	Albersen M, 2010, J SEX MED, V7, P3331, DOI 10.1111/j.1743-6109.2010.01875.x; Angeli FS, 2012, OPEN CARDIOVASC MED, V6, P38, DOI 10.2174/1874192401206010038; Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013; Bendeck MP, 2004, CIRC RES, V94, P138, DOI 10.1161/01.RES.0000117525.23089.1A; Byeon YE, 2010, CYTOTHERAPY, V12, P626, DOI 10.3109/14653249.2010.481665; Chang EI, 2012, HEAD NECK-J SCI SPEC, V34, P207, DOI 10.1002/hed.21715; Chen JJ, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140184; Dambrain R., 1993, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V94, P140; Delanian S, 2005, HEAD NECK-J SCI SPEC, V27, P114, DOI 10.1002/hed.20121; Dudziak ME, 2000, PLAST RECONSTR SURG, V106, P1049, DOI 10.1097/00006534-200010000-00015; Epstein JB, 2012, CA-CANCER J CLIN, V62, P401, DOI 10.3322/caac.21157; Espitalier F, 2009, BIOMATERIALS, V30, P763, DOI 10.1016/j.biomaterials.2008.10.051; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Fang DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16017; Fenner M, 2010, J CRANIO MAXILL SURG, V38, P47, DOI 10.1016/j.jcms.2009.07.011; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Goh BT, 2008, INT J ORAL MAX SURG, V37, P597, DOI 10.1016/j.ijom.2008.03.002; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Hopewell JW, 2003, MED PEDIATR ONCOL, V41, P208, DOI 10.1002/mpo.10338; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lerouxel E, 2006, BIOMATERIALS, V27, P4566, DOI 10.1016/j.biomaterials.2006.04.027; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Malard O, 2005, BONE, V36, P323, DOI 10.1016/j.bone.2004.07.018; MARX RE, 1983, J ORAL MAXIL SURG, V41, P351, DOI 10.1016/S0278-2391(83)80005-6; Misuno K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087158; Mueller CK, 2009, RADIOTHER ONCOL, V93, P581, DOI 10.1016/j.radonc.2009.08.009; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Richmond J, 2014, J CELL PHYSIOL, V229, P139, DOI 10.1002/jcp.24441; SARRUT D, 2014, MED PHYS, V41, DOI DOI 10.1118/1.4871617; SKEDROS JG, 1993, J BIOMED MATER RES, V27, P57, DOI 10.1002/jbm.820270108; Timmers L, 2008, STEM CELL RES, V1, P129, DOI 10.1016/j.scr.2008.02.002; Tran SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061632; Wang YY, 2011, EUR J CELL BIOL, V90, P642, DOI 10.1016/j.ejcb.2011.03.005; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85	35	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178060	10.1371/journal.pone.0178060	http://dx.doi.org/10.1371/journal.pone.0178060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542343	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400137
J	Mohr, E; Daniels, J; Beko, B; Isaakidis, P; Cox, V; Steele, SJ; Muller, O; Snyman, L; De Azevedo, V; Shroufi, A; Duran, LT; Hughes, J				Mohr, Erika; Daniels, Johnny; Beko, Busisiwe; Isaakidis, Petros; Cox, Vivian; Steele, Sarah Jane; Muller, Odelia; Snyman, Leigh; De Azevedo, Virginia; Shroufi, Amir; Duran, Laura Trivino; Hughes, Jennifer			DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting	PLOS ONE			English	Article							TREATMENT OUTCOMES; ADHERENCE; PATIENT; INTERVENTIONS; KHAYELITSHA; DEFAULT; MODEL	Background Daily directly-observed therapy (DOT) is recommended for rifampicin-resistant tuberculosis (RR-TB) patients throughout treatment. We assessed the impact of self-administered treatment (SAT) in a South African township with high rates of RR-TB and HIV. Methods Community-supported SAT for patients who completed the intensive phase was piloted in five primary care clinics in Khayelitsha. We compared final treatment outcomes among RRTB patients initiating treatment before (standard-of-care (SOC)-cohort, January 2010-July 2013) and after the implementation of the pilot (SAT-cohort, January 2012-December 2014). All patients with outcomes before January 1, 2017 were considered in the analysis of outcomes. Results One-hundred-eighteen patients in the SOC-cohort and 174 patients in the SAT-cohort had final RR-TB treatment outcomes; 70% and 73% were HIV-co-infected, respectively. The proportion of patients with a final outcome of loss to follow-up (LTFU) did not differ whether treated in the SOC (25/118, 21.2%) or SAT-cohort (31/174, 17.8%) (P = 0.47). There were no significant differences in the time to 24-month LTFU among HIV-infected and uninfected patients (HR 0.90, 95% CI: 0.51-1.6, P = 0.71), or among patients enrolled in the SOC-cohort versus the SAT-cohort (HR 0.83, 95% CI: 0.49-1.4, P = 0.50) who received at least 6-months of RR-TB treatment. Conclusion The introduction of SAT during the continuation phase of RR-TB treatment does not adversely affect final RR-TB treatment outcomes in a high TB and HIV-burden setting. This differentiated, patient-centred model of care could be considered in RR-TB programmes to decrease the burden of DOT on patients and health facilities.	[Mohr, Erika; Daniels, Johnny; Beko, Busisiwe; Muller, Odelia; Snyman, Leigh; Duran, Laura Trivino; Hughes, Jennifer] MSF, Khayelitsha, South Africa; [Isaakidis, Petros] MSF, South African Med Unit, Cape Town, South Africa; [Cox, Vivian] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Steele, Sarah Jane; Shroufi, Amir] MSF, Cape Town, South Africa; [De Azevedo, Virginia] City Cape Town Hlth Dept, Cape Town, South Africa	Doctors Without Borders; Doctors Without Borders; University of Cape Town; Doctors Without Borders	Mohr, E (corresponding author), MSF, Khayelitsha, South Africa.	msfocb-khayelitsha-drtb-epi@burssels.msf.org		Mohr, Erika/0000-0001-5269-6503; Isaakidis, Petros/0000-0002-7881-1554; Hughes, Jennifer/0000-0002-5349-9509	MSF; Cape Town City Health	MSF; Cape Town City Health	MSF funded the current study, while MSF and Cape Town City Health funded the implementation of the SAT programme.	Benbaba S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144936; Birch S, 2016, HEALTH POLICY PLANN, V31, P454, DOI 10.1093/heapol/czv084; Cape Town City Health, 2013, CIT CAP TOWN 2011 CE; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Cox H., 2012, C P; Cox HS, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv014; Cox HS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001760; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Daftary A, 2014, GLOB PUBLIC HEALTH, V9, P1107, DOI 10.1080/17441692.2014.934266; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Horter S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-81; Hughes J, 2015, ERJ; Isaakidis P, 2015, INT J TUBERC LUNG D, V19, P969, DOI 10.5588/ijtld.15.0123; Kaplan R, 2016, INT J TUBERC LUNG D, V20, P1185, DOI 10.5588/ijtld.15.0855; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Kendall EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083480; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; Medecins Sans Frontieres, 2011, SCAL UP DIAGN TREATM; Medecins Sans Frontieres, 2014, PAT SUPP INT IMPR AD; Mohr E, 2015, SAMJ S AFR MED J, V105, P631, DOI [10.7196/SAMJNEW.7803, 10.7196/SAMJnew.7803, 10.7196/samj.10093]; Mohr E, 2015, T ROY SOC TROP MED H, V109, P425, DOI 10.1093/trstmh/trv037; National Department of Health, 2013, MAN DRUG RES TUB POL; Ndjeka N, 2015, INT J TUBERC LUNG D, V19, P979, DOI 10.5588/ijtld.14.0944; O'Donnell MR, 2016, INT J TUBERC LUNG D, V20, P430, DOI 10.5588/ijtld.15.0360; Shean K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063057; Shringarpure KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150849; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Tupasi T, 2017, INT J TUBERC LUNG D, V21, P23, DOI 10.5588/ijtld.16.0433; Vasudevan K, 2014, J CLIN DIAGN RES, V8; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; Wolf M. R. O, 2015, J ACQ IMMUN DEF SYND, V67, P22; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2013, DEFINITIONS REPORTIN; Yin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150511	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178054	10.1371/journal.pone.0178054	http://dx.doi.org/10.1371/journal.pone.0178054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542441	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400135
J	Moore, C; Parrish, JK; Jedlicka, P				Moore, Colin; Parrish, Janet K.; Jedlicka, Paul			MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth	PLOS ONE			English	Article							REPRESSES CELL-PROLIFERATION; PLASMINOGEN-ACTIVATOR UPA; TUMOR PROGRESSION; MICRORNAS; CANCER; SUPPRESSOR	Ewing Sarcoma is an aggressive, oncofusion-driven, malignant neoplasm of bone and soft tissue affecting predominantly children and young adults. Seeking to identify potential novel therapeutic targets/agents for this disease, our previous studies uncovered microRNAs regulated by EWS/Fli1, the most common oncofusion, with growth modulatory properties. In the present study, we sought to identify EWS/Fli1-repressed, growth suppressive, microRNAs potentially amenable to replacement in Ewing Sarcoma cells. Eight microRNAs (143, 153, 184, 193b, 195, 203, 206 and 223) were selected for evaluation as EWS/Fli1-repressed and underexpressed in Ewing Sarcoma cells, and reported to be growth suppressive in other pediatric or/and adult cancers. The selected miRs, and appropriate non-targeting controls, were introduced into two different Ewing Sarcoma cell lines (A673 and SK-ES-1), and effects on growth were examined using a high and low-density growth assay. MiR-193b was growth inhibitory in both assays and cell lines. In subsequent analyses, we found that stable overexpression of miR-193b also inhibits anchorage-independent growth in both A673 and SK-ES-1 cells. We further show that miR-193b negatively regulates expression of the ErbB4 oncogene in A673 and SK-ES-1 cells, and that depletion of ErbB4 is itself inhibitory to anchorage-independent growth in the same cell lines. Together, our studies show that the EWS/Fli1-repressed miR-193b is growth suppressive in Ewing Sarcoma, and identify ErbB4 as a target gene and candidate mediator of this growth suppression.	[Moore, Colin] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA; [Parrish, Janet K.; Jedlicka, Paul] Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80204 USA; [Moore, Colin] Johns Hopkins All Childrens Hosp, Vincent Lecavalier Pediat Canc & Blood Disorders, St Petersburg, FL USA	Children's Hospital Colorado; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Johns Hopkins University; Johns Hopkins Medicine	Jedlicka, P (corresponding author), Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80204 USA.	paul.jedlicka@ucdenver.edu			Cancer League of Colorado; Ruth L. Kirschstein National Research Service Award Institutional Training Grant; Boettcher Foundation's Webb-Waring Biomedical Research Program; Alex's Lemonade Stand Foundation for Childhood Cancer; University of Colorado Cancer Center and School of Medicine;  [P30-CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Cancer League of Colorado; Ruth L. Kirschstein National Research Service Award Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boettcher Foundation's Webb-Waring Biomedical Research Program; Alex's Lemonade Stand Foundation for Childhood Cancer; University of Colorado Cancer Center and School of Medicine; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank the University of Colorado Cancer Center DNA Sequencing, Flow Cytometry and Functional Genomics Core Facilities, supported by P30-CA046934. Funding support for this work was provided by the Cancer League of Colorado (CM), Ruth L. Kirschstein National Research Service Award Institutional Training Grant (CM), Boettcher Foundation's Webb-Waring Biomedical Research Program (PJ), Alex's Lemonade Stand Foundation for Childhood Cancer (PJ), and the University of Colorado Cancer Center and School of Medicine (PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Dylla L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063032; Dylla L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00065; Gao XN, 2011, LEUKEMIA RES, V35, P1226, DOI 10.1016/j.leukres.2011.06.010; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Haetscher N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9928; Jedlicka P, 2010, INT J CLIN EXP PATHO, V3, P338; Jin XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125515; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Lenarduzzi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053765; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; Liang HW, 2015, J BIOL CHEM, V290, P926, DOI 10.1074/jbc.M114.621409; Linger RMA, 2009, BLOOD, V114, P2678, DOI 10.1182/blood-2009-03-209247; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Mendoza-Naranjo A, 2013, EMBO MOL MED, V5, P1087, DOI 10.1002/emmm.201202343; Mets E, 2015, LEUKEMIA, V29, P798, DOI 10.1038/leu.2014.276; Mitra AK, 2015, ONCOGENE; Nana-Sinkam SP, 2011, TRANSL RES, V157, P216, DOI 10.1016/j.trsl.2011.01.013; Niemeyer BF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116895; Parrish JK, 2015, ONCOGENE, V34, P257, DOI 10.1038/onc.2013.541; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Xie C, 2013, ONCOGENE, V32, P2282, DOI 10.1038/onc.2012.251; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Yu T, 2015, ONCOGENE, V34, P413, DOI 10.1038/onc.2013.574	33	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178028	10.1371/journal.pone.0178028	http://dx.doi.org/10.1371/journal.pone.0178028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542597	gold, Green Submitted, Green Published			2022-12-27	WOS:000401672400131
J	Subramaniam, M; Chong, SA; Browning, C; Thomas, S				Subramaniam, Mythily; Chong, Siow Ann; Browning, Colette; Thomas, Shane			Cognitive distortions among older adult gamblers in an Asian context	PLOS ONE			English	Article							OAKS GAMBLING SCREEN; CHINESE; PERCEPTIONS; PREVALENCE; COMMUNITY; BELIEFS; CHANCE; SKILL; LUCK	Aims The study aims to describe the construct of cognitive distortions based on the narratives of older adult gamblers (aged 60 years and above) in Singapore. Methods Singapore residents (citizens or permanent residents) aged 60 years and above, who were current or past regular gamblers were included in the study. Participants were recruited using a combination of venue based approach, referrals from service providers as well as by snowball sampling. In all, 25 in-depth interviews were conducted with older adult gamblers. The six-step thematic network analysis methodology was adopted for data analysis. Results The mean age of the participants was 66.2 years. The majority were male (n = 18), of Chinese ethnicity (n = 16), with a mean age of gambling initiation at 24.5 years. Among older adult gamblers, cognitive distortions emerged as a significant global theme comprising three organizing themes-illusion of control, probability control and interpretive control. The organizing themes comprised nine basic themes: perception of gambling as a skill, near miss, concept of luck, superstitious beliefs, entrapment, gambler's fallacy, chasing wins, chasing losses, and beliefs that wins are more than losses. Conclusions Cognitive distortions were endorsed by all gamblers in the current study and were shown to play a role in both maintaining and escalating the gambling behaviour. While the surface characteristics of the distortions had a culture-specific appearance, the deeper characteristics of the distortions may in fact be more universal than previously thought. Future research must include longitudinal studies to understand causal relationships between cognitive distortions and gambling as well as the role of culture-specific distortions both in the maintenance and treatment of the disorder.	[Subramaniam, Mythily; Chong, Siow Ann] Inst Mental Hlth, Res Div, Singapore, Singapore; [Browning, Colette] Royal Dist Nursing Serv Ltd, Melbourne, Vic, Australia; [Browning, Colette; Thomas, Shane] Int Primary Hlth Care Res Inst, Shenzhen, Peoples R China; [Browning, Colette; Thomas, Shane] Monash Univ, Melbourne, Vic, Australia	Monash University	Subramaniam, M (corresponding author), Inst Mental Hlth, Res Div, Singapore, Singapore.	Mythily@imh.com.sg	Browning, Colette/AAD-3387-2020	Browning, Colette/0000-0001-6739-0152; Thomas, Shane/0000-0003-3116-6022	Ministry of Health, National Medical Research Council (NMRC), Research Training Fellowship Grant [MH 095:003/008-1019]; Centre Grant Programme [NMRC/CG/004/2013]	Ministry of Health, National Medical Research Council (NMRC), Research Training Fellowship Grant(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Centre Grant Programme	Funding for this study was provided by Ministry of Health, National Medical Research Council (NMRC), Research Training Fellowship Grant (MH 095:003/008-1019). The first author (MS) was awarded a fellowship under the grant as well as from the funding by Centre Grant Programme (Grant No.: NMRC/CG/004/2013). NMRC had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.	Abdin E, 2012, INT GAMBL STUD, V12, P275, DOI 10.1080/14459795.2012.669777; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2015, STESASERA390 UN DEP; Ariyabuddhiphongs V, 2007, J GAMBL STUD, V23, P201, DOI 10.1007/s10899-006-9035-3; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Billieux J, 2012, BRIT J PSYCHOL, V103, P412, DOI 10.1111/j.2044-8295.2011.02083.x; Brockner J., 1985, ENTRAPMENT ESCALATIN; Cantinotti M, 2004, PSYCHOL ADDICT BEHAV, V18, P143, DOI 10.1037/0893-164X.18.2.143; Clark L, 2010, PHILOS T R SOC B, V365, P319, DOI 10.1098/rstb.2009.0147; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Goodie AS, 2005, J GAMBL STUD, V21, P481, DOI 10.1007/s10899-005-5559-1; Hing N, 2014, 2 AGRC; Jacobsen LH, 2007, NORD PSYCHOL, V59, P347, DOI 10.1027/1901-2276.59.4.347; Joukhador J, 2004, J GAMBL STUD, V20, P171, DOI 10.1023/B:JOGS.0000022308.27774.2b; Ladouceur R, 2004, ADDICT BEHAV, V29, P555, DOI 10.1016/j.addbeh.2003.08.025; Ladouceur R., 1996, TRENDS COGNITIVE BEH; Ladouceur R., 2002, UNDERSTANDING TREATI; Ladouceur R, 2004, CAN J PSYCHIAT, V49, P501, DOI 10.1177/070674370404900801; Lai DWL, 2006, J GAMBL STUD, V22, P121, DOI 10.1007/s10899-005-9006-0; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Loo JMY, 2008, CLIN PSYCHOL REV, V28, P1152, DOI 10.1016/j.cpr.2008.04.001; Matute H, 1996, PSYCHOL SCI, V7, P289, DOI 10.1111/j.1467-9280.1996.tb00376.x; McNeilly D. P., 2002, J CLIN GEROPSYCHOLOG, V8, P75, DOI DOI 10.1023/A:1014679507988; Michalczuk R, 2011, PSYCHOL MED, V41, P2625, DOI 10.1017/S003329171100095X; Miller NV, 2008, J GAMBL STUD, V24, P257, DOI 10.1007/s10899-008-9089-5; Myrseth H, 2010, J GAMBL STUD, V26, P561, DOI 10.1007/s10899-010-9180-6; National Council on Problem Gambling, 2015, REP SURV PART GAMBL; Ohtsuka K., 2010, ASIAN J GAMBLING ISS, V1, P34, DOI [DOI 10.1186/2195-3007-1-34, 10.1186/BF03342117, DOI 10.1186/BF03342117]; Ohtsuka K, 2010, GAMBLING RES, V22, P18; Ohtsuka K, 2014, ASIAN J GAMBL ISSUES, V4, P4, DOI DOI 10.1186/S40405-014-0004-Y; Papineau E, 2005, J GAMBL STUD, V21, P157, DOI 10.1007/s10899-005-3030-y; Raylu N, 2004, ADDICTION, V99, P757, DOI 10.1111/j.1360-0443.2004.00753.x; Reid R. L, 1986, J GAMBLING BEHAV, V2, P32, DOI [DOI 10.1007/BF01019932, 10.1007/BF01019932]; Rossini-Dib D, 2015, PSYCHIAT RES, V227, P17, DOI 10.1016/j.psychres.2015.03.003; Statistics Singapore, 2015, POPULATION TRENDS; Subramaniam Mythily, 2015, Addict Behav Rep, V1, P57, DOI 10.1016/j.abrep.2015.04.004; Subramaniam M, 2015, PSYCHIAT RES, V227, P198, DOI 10.1016/j.psychres.2015.03.033; Subramaniam M, 2015, ADDICT BEHAV, V41, P199, DOI 10.1016/j.addbeh.2014.10.007; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Toneatto T, 1997, J Gambl Stud, V13, P253, DOI 10.1023/A:1024983300428; Toneatto T, 1999, SUBST USE MISUSE, V34, P1593, DOI 10.3109/10826089909039417; Tse S, 2013, PSYCHIAT RES, V210, P607, DOI 10.1016/j.psychres.2013.06.017; Wardle H., 2007, BRIT GAMBLING PREVAL; WHO, 2017, HLTH SIT TREND ASS; Wohl MJA, 2007, SUBST USE MISUSE, V42, P43, DOI 10.1080/10826080601094223; Wood WS, 2005, J GAMBL STUD, V21, P411, DOI 10.1007/s10899-005-5556-4; Xian H, 2008, PSYCHIAT RES, V160, P300, DOI 10.1016/j.psychres.2007.08.007; Yvonna S., 1985, NATURALISTIC INQUIRY; Zhou K, 2012, J GAMBL STUD, V28, P379, DOI 10.1007/s10899-011-9263-z; Zitzow D, 1996, AM INDIAN ALASKA NAT, V7, P14	51	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178036	10.1371/journal.pone.0178036	http://dx.doi.org/10.1371/journal.pone.0178036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542389	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672400132
J	Hammer, Y; Soudry, A; Levi, A; Talmor-Barkan, Y; Leshem-Lev, D; Singer, J; Kornowski, R; Lev, EI				Hammer, Yoav; Soudry, Alissa; Levi, Amos; Talmor-Barkan, Yeela; Leshem-Lev, Dorit; Singer, Joel; Kornowski, Ran; Lev, Eli I.			Effect of vitamin D on endothelial progenitor cells function	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; CARDIOVASCULAR EVENTS; HEMODIALYSIS-PATIENTS; DYSFUNCTION; POPULATION; RISK; NEOVASCULARIZATION; MOBILIZATION	Background Endothelial progenitor cells (EPCs) are a population of bone marrow-derived cells, which have an important role in the process of endothelialization and vascular repair following injury. Impairment of EPCs, which occurs in patients with diabetes, was shown to be related to endothelial dysfunction, coronary artery disease (CAD) and adverse clinical outcomes. Recent evidence has shown that calcitriol, the active hormone of vitamin D, has a favorable impact on the endothelium and cardiovascular system. There is limited data on the effect of vitamin D on EPCs function. Aim To examine the in vitro effects of Calcitriol on EPCs from healthy subjects and patients with diabetes. Methods Fifty-one patients with type 2 diabetes (60 +/- 11 years, 40% women, HbA1C: 9.1 +/- 0.8%) and 23 healthy volunteers were recruited. EPCs were isolated and cultured with and without calcitriol. The capacity of the cells to form colony-forming units (CFUs), their viability (measured by MTT assay), KLF-10 levels and angiogenic markers were evaluated after 1 week of culture. Results In diabetic patients, EPC CFUs and cell viability were higher in EPCs exposed to calcitriol vs. EPCs not exposed to calcitriol [EPC CFUs: 1.25 (IQR 1.0-2.0) vs. 0.5 (IQR 0.5-1.9), p < 0.001; MTT: 0.62 (IQR 0.44-0.93) vs. 0.52 (IQR 0.31-0.62), p = 0.001]. KLF-10 levels tended to be higher in EPCs exposed to vitamin D, with no differences in angiopoietic markers. In healthy subjects, calcitriol supplementation also resulted in higher cell viability [MTT: 0.23 (IQR 0.11-0.46) vs. 0.19 (0.09-0.39), p = 0.04], but without differences in CFU count or angiopoietic markers. Conclusion In patients with diabetes mellitus, in vitro vitamin D supplementation improved EPCs capacity to form colonies and viability. Further studies regarding the mechanisms by which vitamin D exerts its effect are required.	[Hammer, Yoav; Soudry, Alissa; Levi, Amos; Talmor-Barkan, Yeela; Singer, Joel; Kornowski, Ran; Lev, Eli I.] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; [Hammer, Yoav; Soudry, Alissa; Levi, Amos; Talmor-Barkan, Yeela; Leshem-Lev, Dorit; Kornowski, Ran; Lev, Eli I.] Felsenstein Med Res Inst, Petah Tiqwa, Israel; [Hammer, Yoav; Levi, Amos; Talmor-Barkan, Yeela; Kornowski, Ran; Lev, Eli I.] Beilinson Hasharon Hosp, Rabin Med Ctr, Cardiol Inst, Petah Tiqwa, Israel; [Singer, Joel] Beilinson Hasharon Hosp, Rabin Med Ctr, Endocrinol Inst, Petah Tiqwa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center	Lev, EI (corresponding author), Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel.; Lev, EI (corresponding author), Felsenstein Med Res Inst, Petah Tiqwa, Israel.; Lev, EI (corresponding author), Beilinson Hasharon Hosp, Rabin Med Ctr, Cardiol Inst, Petah Tiqwa, Israel.	elilev01@gmail.com						Chen Jian, 2010, MODERN DESIGN ADV MA, V3, P25; Chen JX, 2010, J BIOL CHEM, V285, P37041, DOI 10.1074/jbc.M110.157115; Cianciolo G, 2013, BLOOD PURIFICAT, V35, P187, DOI 10.1159/000347102; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2007, DIABETES CARE, V30, P1305, DOI 10.2337/dc06-2305; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Lev EI, 2014, EUR J PREV CARDIOL, V21, P1153, DOI 10.1177/2047487313488300; Mizwicki MT, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275re4; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Park CW, 1999, AM J KIDNEY DIS, V33, P73, DOI 10.1016/S0272-6386(99)70260-X; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shoji T, 2004, NEPHROL DIAL TRANSPL, V19, P179, DOI 10.1093/ndt/gfg513; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Talmor Y, 2008, EUR J CLIN INVEST, V38, P548, DOI 10.1111/j.1365-2362.2008.01977.x; Thum T, 2005, J AM COLL CARDIOL, V46, P1693, DOI 10.1016/j.jacc.2005.04.066; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wara AK, 2011, BLOOD, V118, P6450, DOI 10.1182/blood-2011-06-363713; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801; Yiu YF, 2011, J CLIN ENDOCR METAB, V96, pE830, DOI 10.1210/jc.2010-2212; Zehnder D, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133621	28	17	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0178057	10.1371/journal.pone.0178057	http://dx.doi.org/10.1371/journal.pone.0178057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545072	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700105
J	Gross, C; Ellison, B; Buchman, AS; Terasawa, E; VanderHorst, VG				Gross, Cassandra; Ellison, Brian; Buchman, Aron S.; Terasawa, Ei; VanderHorst, Veronique G.			A novel approach for assigning levels to monkey and human lumbosacral spinal cord based on ventral horn morphology	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURONS; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; RHESUS-MONKEY; ONUFS NUCLEUS; PELVIC FLOOR; ORGANIZATION; MUSCLES; MOTONEURONS	Proper identification of spinal cord levels is crucial for clinical-pathological and imaging studies in humans, but can be a challenge given technical limitations. We have previously demonstrated in non-primate models that the contours of the spinal ventral horn are determined by the position of motoneuron pools. These positions are preserved within and among individuals and can be used to identify lumbosacral spinal levels. Here we tested the hypothesis that this approach can be extended to identify monkey and human spinal levels. In 7 rhesus monkeys, we retrogradely labeled motoneuron pools that represent rostral, middle and caudal landmarks of the lumbosacral enlargement. We then aligned the lumbosacral enlargements among animals using absolute length, segmental level or a relative scale based upon rostral and caudal landmarks. Inter-animal matching of labeled motoneurons across the lumbosacral enlargement was most precise when using internal landmarks. We then reconstructed 3 human lumbosacral spinal cords, and aligned these based upon homologous internal landmarks. Changes in shape of the ventral horn were consistent among human subjects using this relative scale, despite marked differences in absolute length or age. These data suggest that the relative position of spinal motoneuron pools is conserved across species, including primates. Therefore, in clinical-pathological or imaging studies in humans, one can assign spinal cord levels to even single sections by matching ventral horn shape to standardized series.	[Gross, Cassandra; Ellison, Brian; VanderHorst, Veronique G.] Harvard Med Sch, Div Movement Disorders, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Buchman, Aron S.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Terasawa, Ei] Wisconsin Natl Primate Res Ctr, Madison, WI USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Rush University	VanderHorst, VG (corresponding author), Harvard Med Sch, Div Movement Disorders, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	vvanderh@bidmc.harvard.edu		Gross, Cassandra/0000-0001-6566-333X	National Institutes of Health, National Institute for Aging [R01 AG-47976]; National Institutes of Health of the Wisconsin National Primate Research Center [39-026]; RJG Foundation; NATIONAL INSTITUTE ON AGING [R01AG047976] Funding Source: NIH RePORTER	National Institutes of Health, National Institute for Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health of the Wisconsin National Primate Research Center; RJG Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institutes of Health, National Institute for Aging R01 AG-47976; National Institutes of Health, Grant 39-026 of the Wisconsin National Primate Research Center; and the RJG Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacskai T, 2014, BRAIN STRUCT FUNCT, V219, P303, DOI 10.1007/s00429-012-0501-7; Brettschneider J, 2014, ACTA NEUROPATHOL, V128, P423, DOI 10.1007/s00401-014-1299-6; Cruz-Sanchez FF, 1998, J NEURAL TRANSM, V105, P689, DOI 10.1007/s007020050088; Del Tredici K, 2012, ACTA NEUROPATHOL, V124, P643, DOI 10.1007/s00401-012-1028-y; Dugger BN, 2013, J ALZHEIMERS DIS, V34, P529, DOI 10.3233/JAD-121864; HARDMAN VJ, 1985, NEUROSCI LETT, V60, P325, DOI 10.1016/0304-3940(85)90598-1; ILIYA AR, 1984, EXP NEUROL, V86, P272, DOI 10.1016/0014-4886(84)90186-9; Kennedy PGE, 1997, REV MED VIROL, V7, P131; Ko HY, 2004, SPINAL CORD, V42, P35, DOI 10.1038/sj.sc.3101538; KONNO H, 1986, J NEUROL SCI, V73, P193, DOI 10.1016/0022-510X(86)90130-9; KUTSCHER CL, 1987, BRAIN RES BULL, V19, P161, DOI 10.1016/0361-9230(87)90181-X; Langlet C, 2005, J NEUROPHYSIOL, V93, P2474, DOI 10.1152/jn.00909.2004; Mannen T, 2000, NEUROPATHOLOGY, V20, pS30; Onuf-Onufrowicz B., 1899, J NERV MENT DIS, V26, P498, DOI [DOI 10.1097/00005053-189908000-00006, 10.1097/00005053-189908000-00006]; Pullen AH, 1997, J ANAT, V191, P201, DOI 10.1046/j.1469-7580.1997.19120201.x; ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209; ROPPOLO JR, 1985, J COMP NEUROL, V234, P475, DOI 10.1002/cne.902340406; Routal RV, 1999, J ANAT, V195, P211, DOI 10.1046/j.1469-7580.1999.19520211.x; Saito Y, 2000, NEUROLOGY, V55, P1727, DOI 10.1212/WNL.55.11.1727; SCHRODER HD, 1980, J COMP NEUROL, V192, P567, DOI 10.1002/cne.901920313; Schuld C, 2016, J SPINAL CORD MED, V39, P504, DOI 10.1080/10790268.2016.1180831; Sherrington C S, 1892, J Physiol, V13, P621; Shimizu H, 2010, ACTA NEUROPATHOL, V120, P439, DOI 10.1007/s00401-010-0699-5; Sumikura H, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0236-9; UEYAMA T, 1985, J COMP NEUROL, V232, P548, DOI 10.1002/cne.902320411; VanderHorst VG, 2015, ANN NEUROL, V78, P142, DOI 10.1002/ana.24430; VanderHorst VGJM, 2000, J COMP NEUROL, V424, P233, DOI 10.1002/1096-9861(20000821)424:2<233::AID-CNE4>3.0.CO;2-C; Vanderhorst VGJM, 1997, J COMP NEUROL, V382, P46; Wheeler-Kingshott CA, 2014, NEUROIMAGE, V84, P1082, DOI 10.1016/j.neuroimage.2013.07.014; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; WITELSON SF, 1991, SCHIZOPHRENIA BULL, V17, P583, DOI 10.1093/schbul/17.4.583; Yakovenko S, 2002, J NEUROPHYSIOL, V87, P1542, DOI 10.1152/jn.00479.2001; Yoshida M, 2007, NEUROPATHOLOGY, V27, P484, DOI 10.1111/j.1440-1789.2007.00841.x; Zariffa J, 2012, SPINE J, V12, P389, DOI 10.1016/j.spinee.2012.03.028	34	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177243	10.1371/journal.pone.0177243	http://dx.doi.org/10.1371/journal.pone.0177243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542213	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500016
J	Lin, WC; Chen, CW; Chao, L; Chao, JL; Lin, YS				Lin, Wei-Chieh; Chen, Chang-Wen; Chao, Lee; Chao, Julie; Lin, Yee-Shin			Plasma kallistatin in critically ill patients with severe sepsis and septic shock	PLOS ONE			English	Article							TISSUE KALLIKREIN INHIBITOR; OXIDATIVE STRESS; BINDING PROTEIN; ORGAN INJURY; INFLAMMATION; ANGIOGENESIS; APOPTOSIS; CELLS; MICE	Kallistatin, an endogenous serine proteinase inhibitor, is protective against sepsis in animal models. The aim of this study was to determine the plasma concentration of kallistatin in intensive care unit (ICU) patients with severe sepsis and septic shock and to determine their potential correlation with disease severity and outcomes. We enrolled 86 ICU patients with severe sepsis and septic shock. Their plasma concentrations of kallistatin, kallikrein, tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6, and IL-8 were measured by enzyme-linked immunosorbent assay. The association of kallistatin levels with disease severity and patient outcomes was evaluated. The relationship between kallistatin and other biomarkers was also analyzed. Plasma kallistatin levels on day 1 of ICU admission were lower in patients with septic shock compared with patients with severe sepsis (p = 0.004). Twenty-nine patients who died in the hospital had significantly lower day 1 kallistatin levels than patients who survived (p = 0.031). Using the optimal cutoff value (4 mu g/ml) of day 1 plasma kallistatin determined by receiver operating characteristic curves for 60-day mortality, we found that high kallistatin levels were associated with a preferable 60-day survival (p = 0.012) by Kaplan-Meier analysis and lower Sequential Organ Failure Assessment (SOFA) scores over the first 5 days in the ICU (p = 0.001). High kallistatin levels were also independently associated with a decreased risk of septic shock, the development of acute respiratory distress syndrome, and positive blood cultures. In addition, there were inverse correlations between day 1 kallistatin levels and the levels of TNF-alpha, IL-1 beta, IL-6, and C-reactive protein, and SOFA scores on day 1. Our results indicate that during severe sepsis and septic shock, a decrease in plasma concentrations of kallistatin reflects increased severity and poorer outcome of disease.	[Lin, Wei-Chieh; Chen, Chang-Wen] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Coll Med, Tainan, Taiwan; [Chao, Lee; Chao, Julie] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Lin, Yee-Shin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan, Taiwan; [Lin, Yee-Shin] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Medical University of South Carolina; National Cheng Kung University; National Cheng Kung University	Lin, WC (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Coll Med, Tainan, Taiwan.	wclin@mail.ncku.edu.tw		Lin, Wei-Chieh/0000-0002-5138-8477	Ministry of Science and Technology, Taiwan [MOST 105-2314-B-006-056]; National Cheng Kung University Hospital [NCKUH-10506004]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital	This study was supported by the Ministry of Science and Technology, Taiwan (MOST 105-2314-B-006-056), and National Cheng Kung University Hospital (NCKUH-10506004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAO J, 1986, BIOCHEM J, V239, P325, DOI 10.1042/bj2390325; Chao JL, 1996, J LAB CLIN MED, V127, P612, DOI 10.1016/S0022-2143(96)90152-3; Chao JL, 1997, J CLIN INVEST, V100, P11, DOI 10.1172/JCI119502; Chao J, 2006, HUM GENE THER, V17, P1201, DOI 10.1089/hum.2006.17.1201; Chen LM, 1997, LIFE SCI, V60, P1431, DOI 10.1016/S0024-3205(97)00094-5; Cheng ZY, 2015, ACTA PHARM SIN B, V5, P194, DOI 10.1016/j.apsb.2015.02.003; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Gao L, 2008, LAB INVEST, V88, P1157, DOI 10.1038/labinvest.2008.85; Li PF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0919-4; Li PF, 2014, IMMUNOLOGY, V142, P216, DOI 10.1111/imm.12242; Lin WC, 2015, SCI REP-UK, V5, DOI 10.1038/srep12463; Lin WC, 2013, CRIT CARE, V17, DOI 10.1186/cc12507; Linder A, 2012, CRIT CARE, V16, DOI 10.1186/cc11353; Liu YY, 2012, AM J PHYSIOL-RENAL, V303, pF1230, DOI 10.1152/ajprenal.00257.2012; Lu SL, 2013, ANTIMICROB AGENTS CH, V57, P5366, DOI 10.1128/AAC.00322-13; Miao RQ, 2002, BLOOD, V100, P3245, DOI 10.1182/blood-2002-01-0185; Oberholzer A, 2005, SHOCK, V23, P488, DOI 10.1097/01.shk.0000163802.46355.59; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; PITTET D, 1995, INTENS CARE MED, V21, P302, DOI 10.1007/BF01705408; Ryu JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138150; SALVO I, 1995, INTENS CARE MED, V21, pS244, DOI 10.1007/BF01740762; Seymour CW, 2015, JAMA-J AM MED ASSOC, V314, P708, DOI 10.1001/jama.2015.7885; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Shen B, 2010, AM J PHYSIOL-HEART C, V299, pH1419, DOI 10.1152/ajpheart.00591.2010; Stadnicki A, 2003, INT IMMUNOPHARMACOL, V3, P939, DOI 10.1016/S1567-5769(03)00054-7; Ticinesi A, 2016, EUR J INTERN MED; Wang CR, 2005, ARTHRITIS RHEUM-US, V52, P1319, DOI 10.1002/art.20991; ZHOU GX, 1992, J BIOL CHEM, V267, P25873	29	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178387	10.1371/journal.pone.0178387	http://dx.doi.org/10.1371/journal.pone.0178387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542440	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500085
J	Gottfried, MD; Samonds, KE; Ostrowski, SA; Andrianavalona, TH; Ramihangihajason, TN				Gottfried, Michael D.; Samonds, Karen E.; Ostrowski, Summer A.; Andrianavalona, Tsiory Harimalala; Ramihangihajason, Tolotra Niaina			New evidence indicates the presence of barracuda (Sphyraenidae) and supports a tropical marine environment in the Miocene of Madagascar	PLOS ONE			English	Article							MAHAJANGA BASIN; BIODIVERSITY; REEF	Recent exploration of Miocene-age deposits at Nosy Makamby, a small island similar to 50 km southwest of Mahajanga city in northwestern Madagascar, has led to the recovery of a large sample [82] of isolated barracuda teeth (Sphyraena sp.). in a tropical marine fauna that also includes diverse marine invertebrates, chondrichthyans, bony fishes, turtles, crocodylians, and sirenians. Characteristically for barracudas, the teeth are labiolingually flattened and fang-like with a broadly triangular and blade-like acuminate outline and sharply edged but unserrated cutting margins. These barracudas inhabited an environment that included coral reefs (based on fossil scleractinians) and seagrass beds (evidenced by the epiphytic benthic foraminifera Elphidium sp.). The relatively common occurrence of Miocene barracuda at Nosy Makamby corroborates the presence of a tropical marine ecosystem encircling Madagascar by the Miocene, likely similar overall to the environment found there today.	[Gottfried, Michael D.] Michigan State Univ, Dept Earth & Environm Sci, E Lansing, MI 48824 USA; [Samonds, Karen E.] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL USA; [Ostrowski, Summer A.] Univ Wisconsin Parkside, Dept Biol Sci, Kenosha, WI USA; [Andrianavalona, Tsiory Harimalala; Ramihangihajason, Tolotra Niaina] Univ Antananarivo, Dept Paleontol & Anthropol Biol, Antananarivo, Madagascar	Michigan State University; Northern Illinois University; University of Wisconsin System; University of Wisconsin Parkside; University Antananarivo	Gottfried, MD (corresponding author), Michigan State Univ, Dept Earth & Environm Sci, E Lansing, MI 48824 USA.	gottfrie@msu.edu	Samonds, Karen/AAL-1766-2021	Samonds, Karen/0000-0003-3597-9215	National Geographic Society Committee for Research and Exploration	National Geographic Society Committee for Research and Exploration(National Geographic Society)	This work was supported by National Geographic Society Committee for Research and Exploration grant to KES for field research exploring the fossil record of Madagascar https://www.nationalgeographic.org/grants.; We thank the Ministry of Culture and Ministry of Mines (Madagascar) for permission to conduct this research, and the Department of Paleontology and Biological Anthropology at the University of Antananarivo, including A. Rasomiaramanana and H. Andriamialison for the opportunity to collaborate. Fieldwork was performed under a collaborative accord between Northern Illinois University and the Universite d'Anatananarivo. We are grateful to all of the dedicated personnel who participated in the field expeditions, to the fishermen of Nosy Makamby, and to Charlan Boutou for facilitating our visits to the island. MDG thanks Lance Grande and William Simpson (Field Museum of Natural History, Chicago), John Maisey, Alana Gishlik, and Carl Mehling (American Museum of Natural History, New York), and Zerina Johanson and Martha Richter (Natural History Museum, London) for access to examine comparative materials. SAO thanks Fossilworks and its contributors for fossil distribution information. Funding for the field component of this research was provided by a grant to KES from the National Geographic Society Committee for Research and Exploration.	Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Andrianavalona TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129444; Betancur-R Ricardo, 2013, PLoS Curr, V5, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Charbonnier S, 2012, GEODIVERSITAS, V34, P873, DOI 10.5252/g2012n4a9; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; Daly-Engel TS, 2012, MAR BIOL, V159, P975, DOI 10.1007/s00227-012-1878-9; De Beaufort L.F, 1926, JB MIJNWEZEN NEDERLA, V1925, P113; Evans SE, 2008, P NATL ACAD SCI USA, V105, P2951, DOI 10.1073/pnas.0707599105; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Gaffney ES, 2011, AM MUS NOVIT, P1; Goodman S, 2014, ATLAS SELECTED LAND, P308; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Gottfried M, 2014, J VERTEBR PALEONTOL, V140; Juan-Jorda MJ, 2013, REV FISH BIOL FISHER, V23, P135, DOI 10.1007/s11160-012-9284-4; Krause D.W., 2010, J VERTEBR PALEONTOL; Krause David W., 1997, P3; Krause DW, 2014, NATURE, V515, P512, DOI 10.1038/nature13922; Krause DW, 2003, J VERTEBR PALEONTOL, V23, P842, DOI 10.1671/9; Laduke TC, 2010, J VERTEBR PALEONTOL, V30, P109, DOI 10.1080/02724630903409188; Mehrotra D.K., 1981, J PALAEONTOL SOC IND, V25, P76; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Ramihangihajason TN, 2014, J AFR EARTH SCI, V100, P409, DOI 10.1016/j.jafrearsci.2014.07.013; Samonds KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062086; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Santini F, 2015, ITAL J ZOOL, V82, P133, DOI 10.1080/11250003.2014.962630; Stiassny Melanie L., 1994, Systematics Association Special Volume Series, V50, P235; Uhen M., 2015, TAXONOMIC OCCURRENCE; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239	31	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0176553	10.1371/journal.pone.0176553	http://dx.doi.org/10.1371/journal.pone.0176553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542538	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058800002
J	Huh, CW; Youn, YH; Chung, H; Lee, YC; Park, H				Huh, Cheal Wung; Youn, Young Hoon; Chung, Hyunsoo; Lee, Yong Chan; Park, Hyojin			Functional restoration of the esophagus after peroral endoscopic myotomy for achalasia	PLOS ONE			English	Article							MOTILITY DISORDERS; POEM; OUTCOMES	Purpose Peroral endoscopic myotomy (POEM) is a new efficacious treatment option for achalasia. We propose to define "esophageal remodeling" as the functional restoration of the esophagus that involves decreased lower esophageal sphincter (LES) pressure, recovery of esophageal body peristalsis, and reduction of luminal diameter. The aim of this study was to investigate "esophageal remodeling" after POEM for achalasia. Materials and methods We analyzed data from a prospectively collected database of POEM subjects, which included preoperative and 2-month postoperative Eckardt symptom scores, and results from esophageal high resolution manometry (HRM) and barium esophagogram (BE). We recruited 23 patients (13 male; mean age: 53.9 years) whose preoperative and postoperative HRM and BE results were available, from among 30 patients with achalasia who underwent POEM at two institutions between July 2013 and December 2015. Results All patients achieved clinical treatment success (Eckardt score <= 3). Partial recovery of esophageal body peristalsis was noted in 1/5 patients with type I (20%), 6/11 with type II (54.5%), and 7/7 with type III (100%) achalasia after POEM. Pan-esophageal pressurization disappeared after POEM in 10/11 type II achalasia patients. The average diameter of the esophageal body after POEM was significantly decreased in all types of achalasia. Conclusion POEM provided excellent clinical symptomatic relief and esophageal remodeling in terms of restoration of peristalsis and reduction in diameter of the esophageal body, especially in patients with type III achalasia.	[Huh, Cheal Wung; Youn, Young Hoon; Lee, Yong Chan; Park, Hyojin] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Huh, Cheal Wung; Youn, Young Hoon; Park, Hyojin] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, Seoul, South Korea; [Chung, Hyunsoo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Youn, YH (corresponding author), Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Youn, YH (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, Seoul, South Korea.; Chung, H (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	dryoun@yuhs.ac; hschungmd@gmail.com	Chung, Hyunsoo/AAD-3634-2020	Chung, Hyunsoo/0000-0001-5159-357X; Huh, Cheal Wung/0000-0001-7327-8503; Lee, Yong Chan/0000-0001-8800-6906; park, hyojin/0000-0003-4814-8330; Youn, Young Hoon/0000-0002-0071-229X	Yonsei University College of Medicine [6-20103-0187]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant of Yonsei University College of Medicine (6-20103-0187). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a faculty research grant of Yonsei University College of Medicine (6-20103-0187)	Chan SM, 2016, DIGEST ENDOSC, V28, P27, DOI 10.1111/den.12507; Chiu PWY, 2013, GASTROINTEST ENDOSC, V77, P29, DOI 10.1016/j.gie.2012.08.018; Gockel I, 2007, AM SURGEON, V73, P327; Goldblum JR, 1996, GASTROENTEROLOGY, V111, P648, DOI 10.1053/gast.1996.v111.pm8780569; Hirano I, 2014, GASTROENTEROL CLIN N, V43, P297, DOI 10.1016/j.gtc.2014.02.015; Hu Y, 2016, J GASTROENTEROL, V51, P458, DOI 10.1007/s00535-015-1123-7; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Kahrilas PJ, 2015, NEUROGASTROENT MOTIL, V27, P160, DOI 10.1111/nmo.12477; Kim TH, 2016, AM J PHYSIOL-GASTR L, V310, pG689, DOI 10.1152/ajpgi.00459.2015; Ling TS, 2014, J DIGEST DIS, V15, P352, DOI 10.1111/1751-2980.12153; Moon Jong Tae, 2008, Korean J Gastroenterol, V52, P16; Pandolfino JE, 2005, GASTROENTEROLOGY, V128, P209, DOI 10.1053/j.gastro.2004.11.008; Patel K, 2015, DIS ESOPHAGUS; Sharata AM, 2015, J GASTROINTEST SURG, V19, P161, DOI 10.1007/s11605-014-2610-5; Teitelbaum EN, 2014, SURG ENDOSC, V28, P3359, DOI 10.1007/s00464-014-3628-1; Ujiki MB, 2013, SURGERY, V154, P893, DOI 10.1016/j.surg.2013.04.042; Vaezi MF, 2013, AM J GASTROENTEROL, V108, P1238, DOI 10.1038/ajg.2013.196; Yao SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125942	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178414	10.1371/journal.pone.0178414	http://dx.doi.org/10.1371/journal.pone.0178414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542509	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800056
J	Zhuge, WZ; Hou, CP; Jiao, YY; Yue, J; Tao, H; Yi, DY				Zhuge, Wenzhang; Hou, Chenping; Jiao, Yuanyuan; Yue, Jia; Tao, Hong; Yi, Dongyun			Robust auto-weighted multi-view subspace clustering with common subspace representation matrix	PLOS ONE			English	Article							REGRESSION; ALGORITHM	In many computer vision and machine learning applications, the data sets distribute on certain low-dimensional subspaces. Subspace clustering is a powerful technology to find the underlying subspaces and cluster data points correctly. However, traditional subspace clustering methods can only be applied on data from one source, and how to extend these methods and enable the extensions to combine information from various data sources has become a hot area of research. Previous multi-view subspace methods aim to learn multiple subspace representation matrices simultaneously and these learning task for different views are treated equally. After obtaining representation matrices, they stack up the learned representation matrices as the common underlying subspace structure. However, for many problems, the importance of sources and the importance of features in one source both can be varied, which makes the previous approaches ineffective. In this paper, we propose a novel method called Robust Auto-weighted Multi-view Subspace Clustering (RAMSC). In our method, the weight for both the sources and features can be learned automatically via utilizing a novel trick and introducing a sparse norm. More importantly, the objective of our method is a common representation matrix which directly reflects the common underlying subspace structure. A new efficient algorithm is derived to solve the formulated objective with rigorous theoretical proof on its convergency. Extensive experimental results on five benchmark multi-view datasets well demonstrate that the proposed method consistently outperforms the state-of-the-art methods.	[Zhuge, Wenzhang; Hou, Chenping; Tao, Hong; Yi, Dongyun] Natl Univ Def Technol, Dept Math & Syst Sci, Changsha, Hunan, Peoples R China; [Jiao, Yuanyuan] Natl Univ Def Technol, Coll Nine, Changsha, Hunan, Peoples R China; [Yue, Jia] Taiyuan Satellite Launch Ctr, Key Lab, Taiyuan, Shanxi, Peoples R China	National University of Defense Technology - China; National University of Defense Technology - China	Hou, CP (corresponding author), Natl Univ Def Technol, Dept Math & Syst Sci, Changsha, Hunan, Peoples R China.	hcpnudt@hotmail.com			National Natural Science Foundation of China [61473302, 61503396]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (61473302, 61503396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuncion A, 2007, UCI MACHINE LEARNING; BARTELS RH, 1972, COMMUN ACM, V15, P820, DOI 10.1145/361573.361582; Cai X., 2013, IJCAI; Cao XC, 2015, PROC CVPR IEEE, P586, DOI 10.1109/CVPR.2015.7298657; Costeira JP, 1998, INT J COMPUT VISION, V29, P159, DOI 10.1023/A:1008000628999; Dueck D, 2007, IEEE I CONF COMP VIS, P198; Elhamifar E, 2013, IEEE T PATTERN ANAL, V35, P2765, DOI 10.1109/TPAMI.2013.57; Fanti C, 2004, ADV NEUR IN, V16, P1603; Fei-Fei L., 2004, C COMP VIS PATT REC, P178, DOI [10.1109/CVPR.2004.109, DOI 10.1109/CVPR.2004.109]; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Gao HC, 2015, IEEE I CONF COMP VIS, P4238, DOI 10.1109/ICCV.2015.482; Gu Q, 2011, AAAI; Gu Q., 2009, P 18 ACM C INF KNOWL, P1337; Gu QQ, 2009, IEEE DATA MINING, P159, DOI 10.1109/ICDM.2009.32; Gui J, 2017, IEEE T NEUR NET LEAR, V28, P1490, DOI 10.1109/TNNLS.2016.2551724; Gui J, 2014, IEEE T CIRC SYST VID, V24, P211, DOI 10.1109/TCSVT.2013.2273652; Gui J, 2012, PATTERN RECOGN, V45, P2884, DOI 10.1016/j.patcog.2012.02.005; Gui J, 2010, NEUROCOMPUTING, V73, P2696, DOI 10.1016/j.neucom.2010.04.017; He X., 2005, ADV NEURAL INFORM PR, V16, P186; Hou CP, 2014, IEEE T CYBERNETICS, V44, P793, DOI 10.1109/TCYB.2013.2272642; Hu H, 2014, PROC CVPR IEEE, P3834, DOI 10.1109/CVPR.2014.484; Karasuyama M, 2012, IEEE T NEURAL NETWOR, V24, P1999; Karasuyama M, 2013, IEEE T NEUR NET LEAR, V24, P1999, DOI 10.1109/TNNLS.2013.2271327; Kumar A., 2011, ADV NEURAL INFORM PR, P1413; Lee YJ, 2009, INT J COMPUT VISION, V85, P143, DOI 10.1007/s11263-009-0252-y; Li YQ, 2015, AAAI CONF ARTIF INTE, P2750; Liu GC, 2013, IEEE T PATTERN ANAL, V35, P171, DOI 10.1109/TPAMI.2012.88; Lu CY, 2012, LECT NOTES COMPUT SC, V7578, P347, DOI 10.1007/978-3-642-33786-4_26; Luo D, 2011, IEEE T SYST MAN CY B, V6912, P405, DOI DOI 10.1109/TSMCB.2012.2202901; Luo DJ, 2011, LECT NOTES ARTIF INT, V6912, P405, DOI 10.1007/978-3-642-23783-6_26; Ng AY, 2002, ADV NEUR IN, V14, P849; Nie F., 2017, AAAI; Nie F., 2016, IJCAI; Nie F., 2010, ADV NEURAL INFORM PR, V2, P1813; Nie F., 2012, PROC 26 AAAI C ARTIF, P655; Nie FP, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P977, DOI 10.1145/2623330.2623726; Nie Feiping, 2016, AAAI; Shen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082409; Sindhwani V., 2005, P 22 INT C MACHINE L, P74, DOI DOI 10.1145/1102351.1102455; Sun SL, 2011, LECT NOTES ARTIF INT, V7121, P209; Vidal R., 2005, TPAMI, V27, P1945, DOI DOI 10.1109/TPAMI.2005.244; Vidal R, 2011, IEEE SIGNAL PROC MAG, V28, P52, DOI 10.1109/MSP.2010.939739; Wang S, 2011, EFFICIENT SUBSPACE S; Winn J, 2005, IEEE I CONF COMP VIS, P756; Wu BY, 2014, INT C PATT RECOG, P1964, DOI 10.1109/ICPR.2014.343; Zhang CQ, 2015, IEEE I CONF COMP VIS, P1582, DOI 10.1109/ICCV.2015.185; Zhang Z, 2013, IEEE T IMAGE PROCESS, V22, P4640, DOI 10.1109/TIP.2013.2277780; Zhang Z, 2013, IEEE T KNOWL DATA EN, V25, P2192, DOI 10.1109/TKDE.2012.217	50	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0176769	10.1371/journal.pone.0176769	http://dx.doi.org/10.1371/journal.pone.0176769			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542234	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800003
J	Yang, MM; Chadwick, AE; Dart, C; Kamishima, T; Quayle, JM				Yang, Mingming; Chadwick, Amy E.; Dart, Caroline; Kamishima, Tomoko; Quayle, John M.			Bioenergetic profile of human coronary artery smooth muscle cells and effect of metabolic intervention	PLOS ONE			English	Article							K-ATP CHANNELS; MITOCHONDRIAL BIOENERGETICS; SYSTEM; GROWTH; RATIO	Bioenergetics of artery smooth muscle cells is critical in cardiovascular health and disease. An acute rise in metabolic demand causes vasodilation in systemic circulation while a chronic shift in bioenergetic profile may lead to vascular diseases. A decrease in intracellular ATP level may trigger physiological responses while dedifferentiation of contractile smooth muscle cells to a proliferative and migratory phenotype is often observed during pathological processes. Although it is now possible to dissect multiple building blocks of bioenergetic components quantitatively, detailed cellular bioenergetics of artery smooth muscle cells is still largely unknown. Thus, we profiled cellular bioenergetics of human coronary artery smooth muscle cells and effects of metabolic intervention. Mitochondria and glycolysis stress tests utilizing Seahorse technology revealed that mitochondrial oxidative phosphorylation accounted for 54.5% of ATP production at rest with the remaining 45.5% due to glycolysis. Stress tests also showed that oxidative phosphorylation and glycolysis can increase to a maximum of 3.5 fold and 1.25 fold, respectively, indicating that the former has a high reserve capacity. Analysis of bioenergetic profile indicated that aging cells have lower resting oxidative phosphorylation and reduced reserve capacity. Intracellular ATP level of a single cell was estimated to be over 1.1 mM. Application of metabolic modulators caused significant changes in mitochondria membrane potential, intracellular ATP level and ATP: ADP ratio. The detailed breakdown of cellular bioenergetics showed that proliferating human coronary artery smooth muscle cells rely more or less equally on oxidative phosphorylation and glycolysis at rest. These cells have high respiratory reserve capacity and low glycolysis reserve capacity. Metabolic intervention influences both intracellular ATP concentration and ATP: ADP ratio, where subtler changes may be detected by the latter.	[Yang, Mingming; Kamishima, Tomoko; Quayle, John M.] Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England; [Chadwick, Amy E.] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England; [Dart, Caroline] Univ Liverpool, Dept Biochem, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; University of Liverpool	Quayle, JM (corresponding author), Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England.	jquayle@liv.ac.uk	Chadwick, Amy E/D-8633-2015	Chadwick, Amy E/0000-0002-7399-8655; Dart, Caroline/0000-0002-3509-8349; Yang, Mingming/0000-0003-4484-0979	China Scholarship Council; University of Liverpool	China Scholarship Council(China Scholarship Council); University of Liverpool	This work was supported by the China Scholarship Council and University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; DAUT J, 1990, SCIENCE, V247, P1341, DOI 10.1126/science.2107575; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Foster MN, 2016, PHYSIOL REV, V96, P177, DOI 10.1152/physrev.00003.2015; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Kamishima T, 2002, AM J PHYSIOL-HEART C, V283, pH2431, DOI 10.1152/ajpheart.00865.2001; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li J, 2013, DIABETOLOGIA, V56, P1577, DOI 10.1007/s00125-013-2894-0; McCarron JG, 2013, MICROCIRCULATION, V20, P317, DOI 10.1111/micc.12039; Mercer JR, 2014, PHARMACOL THERAPEUT, V141, P13, DOI 10.1016/j.pharmthera.2013.07.011; PAUL RJ, 1983, AM J PHYSIOL, V244, pC399, DOI 10.1152/ajpcell.1983.244.5.C399; PAUL RJ, 1980, HDB PHYSL          2, V2, P201; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Pung YF, 2013, AM J PHYSIOL-HEART C, V305, pH1275, DOI 10.1152/ajpheart.00077.2013; Quayle JM, 2006, AM J PHYSIOL-HEART C, V291, pH71, DOI 10.1152/ajpheart.01107.2005; QUAYLE JM, 1994, J PHYSIOL-LONDON, V475, P9, DOI 10.1113/jphysiol.1994.sp020045; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Uebelhoer M, 2016, VASC PHARMACOL, V83, P4, DOI 10.1016/j.vph.2016.06.002	25	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177951	10.1371/journal.pone.0177951	http://dx.doi.org/10.1371/journal.pone.0177951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542339	gold, Green Submitted, Green Published			2022-12-27	WOS:000401672600032
J	Bottcher, L; Woolley-Meza, O; Brockmann, D				Bottcher, Lucas; Woolley-Meza, Olivia; Brockmann, Dirk			Temporal dynamics of online petitions	PLOS ONE			English	Article							BENFORDS LAW; HEAVY TAILS	Online petitions are an important avenue for direct political action, yet the dynamics that determine when a petition will be successful are not well understood. Here we analyze the temporal characteristics of online-petition signing behavior in order to identify systematic differences between popular petitions, which receive a high volume of signatures, and unpopular ones. We find that, in line with other temporal characterizations of human activity, the signing process is typically non-Poissonian and non-homogeneous in time. However, this process exhibits anomalously high memory for human activity, possibly indicating that synchronized external influence or contagion play and important role. More interestingly, we find clear differences in the characteristics of the inter-event time distributions depending on the total number of signatures that petitions receive, independently of the total duration of the petitions. Specifically, popular petitions that attract a large volume of signatures exhibit more variance in the distribution of inter-event times than unpopular petitions with only a few signatures, which could be considered an indication that the former are more bursty. However, petitions with large signature volume are less bursty according to measures that consider the time ordering of inter-event times. Our results, therefore, emphasize the importance of accounting for time ordering to characterize human activity.	[Bottcher, Lucas] Swiss Fed Inst Technol, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland; [Woolley-Meza, Olivia] Swiss Fed Inst Technol, Clausiusstr 50, CH-8092 Zurich, Switzerland; [Brockmann, Dirk] Humboldt Univ, Philippestr 13,Bldg 4, D-10115 Berlin, Germany; [Brockmann, Dirk] Robert Koch Inst, Nordufer 20, D-13353 Berlin, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Humboldt University of Berlin; Robert Koch Institute	Bottcher, L (corresponding author), Swiss Fed Inst Technol, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland.	lucasb@ethz.ch		Bottcher, Lucas/0000-0003-1700-1897	ETH Risk Center; European Research Council [FP7-319968, FP7-3242247]; European Community's H2020 Program [641191]	ETH Risk Center; European Research Council(European Research Council (ERC)European Commission); European Community's H2020 Program	We acknowledge financial support from the ETH Risk Center (to LB) and ERC Advanced grants numbers FP7-319968 (to LB) and FP7-3242247 (to OWM) of the European Research Council. This work was partially funded by the European Community's H2020 Program under the funding scheme "FETPROACT-1-2014: Global Systems Science (GSS)," grant agreement 641191 "CIMPLEX: Bringing Citizens, Models and Data together in Participatory, Interactive SociaL EXploratories" (to OWM) (http://www.ciplex-project.eu).; We thank openPetition for providing us with the data and their continued support. We acknowledge financial support from the ETH Risk Center and ERC Advanced grants numbers FP7-319968 and FP7-3242247 of the European Research Council. This work was partially funded by the European Community's H2020 Program under the funding scheme "FET-PROACT-1-2014: Global Systems Science (GSS)", grant agreement 641191 "CIMPLEX: Bringing CItizens, Models and Data together in Participatory, Interactive SociaL EXploratories" (http://www.cirnplex-project.eu). We thank Konstantin Schaar for performing preliminary analyses of the signature time series during the initial phase of the project. LB thanks Jan Nagler for helpful discussions. LB also thanks Hans Herrmann for useful inputs and valuable comments.	Anderson HR, 2003, FIXED BROADBAND WIRE; Aoki T, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.042313; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Daley DJ, 2008, INTRO THEORY POINT P, VII; Diekmann A, 2007, J APPL STAT, V34, P321, DOI 10.1080/02664760601004940; Diekmann A, 2010, GER ECON REV, V11, P397, DOI 10.1111/j.1468-0475.2010.00510.x; DOMENICO MD, 2013, SCI REP, V3, DOI DOI 10.1038/SREP02980; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Hale S. A., 2013, P 5 ANN ACM WEB SCI; Jo HH, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013055; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; McCaughey Martha, 2003, CYBERACTIVISM ONLINE; Omi T, 2011, NEURAL COMPUT, V23, P3125, DOI 10.1162/NECO_a_00213; Sanli C, 2015, FRONT PHYS-LAUSANNE, V3, DOI 10.3389/fphy.2015.00079; Sanli C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131704; Shinomoto S, 2003, NEURAL COMPUT, V15, P2823, DOI 10.1162/089976603322518759; Shinomoto S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000433; Yasseri T., 2013, ARXIV13080239	19	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178062	10.1371/journal.pone.0178062	http://dx.doi.org/10.1371/journal.pone.0178062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542492	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400138
J	De la Rosa, D; Martinez-Garcia, MA; Giron, RM; Vendrell, M; Olveira, C; Borderias, L; Maiz, L; Torres, A; Martinez-Moragon, E; Rajas, O; Casas, F; Cordovilla, R; de Gracia, J				De la Rosa, David; Martinez-Garcia, Miguel-Angel; Maria Giron, Rosa; Vendrell, Montserrat; Olveira, Casilda; Borderias, Luis; Maiz, Luis; Torres, Antoni; Martinez-Moragon, Eva; Rajas, Olga; Casas, Francisco; Cordovilla, Rosa; de Gracia, Javier			Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; AIRWAY BACTERIA; ADULT PATIENTS; EXACERBATIONS; PREVALENCE; PREVENTION; COLONIZATION; ANTIBIOTICS; MORTALITY; ETIOLOGY	Background Few studies have evaluated the coexistence of bronchiectasis (BE) and chronic obstructive pulmonary disease (COPD) in series of patients diagnosed primarily with BE. The aim of this study was to analyse the characteristics of patients with BE associated with COPD included in the Spanish Bronchiectasis Historical Registry and compare them to the remaining patients with non-cystic fibrosis BE. Methods We conducted a multicentre observational study of historical cohorts, analysing the characteristics of 1,790 patients who had been included in the registry between 2002 and 2011. Of these, 158 (8.8%) were registered as BE related to COPD and were compared to the remaining patients with BE of other aetiologies. Results Patients with COPD were mostly male, older, had a poorer respiratory function and more frequent exacerbations. There were no differences in the proportion of patients with chronic bronchial colonisation or in the isolated microorganisms. A significantly larger proportion of patients with COPD received treatment with bronchodilators, inhaled steroids and intravenous antibiotics, but there was no difference in the use of long term oral or inhaled antibiotherapy. During a follow-up period of 3.36 years, the overall proportion of deaths was 13.8%. When compared to the remaining aetiologies, patients with BE associated with COPD presented the highest mortality rate. The multivariate analysis showed that the diagnosis of COPD in a patient with BE as a primary diagnosis increased the risk of death by 1.77. Conclusion Patients with BE related to COPD have the same microbiological characteristics as patients with BE due to other aetiologies. They receive treatment with long term oral and inhaled antibiotics aimed at controlling chronic bronchial colonisation, even though the current COPD treatment guidelines do not envisage this type of therapy. These patients' mortality is notably higher than that of remaining patients with non-cystic fibrosis BE.	[De la Rosa, David] Hosp Plato, Dept Pneumol, Barcelona, Spain; [Martinez-Garcia, Miguel-Angel] Hosp Requena, Dept Pneumol, Valencia, Spain; [Maria Giron, Rosa; Rajas, Olga] Hosp Univ Princesa, Inst Invest Sanitaria, Dept Pneumol, Madrid, Spain; [Vendrell, Montserrat] Hosp Josep Trueta Biomed Res Inst IDIBGI, Dept Pneumol, Girona, Spain; [Olveira, Casilda] Hosp Reg Univ Malaga, Inst Biomed Malaga IBIMA, Fac Med Malaga, Dept Pneumol, Malaga, Spain; [Borderias, Luis] Hosp Gen San Jorge, Dept Pneumol, Huesca, Spain; [Maiz, Luis] Hosp Ramon & Cajal, Dept Pneumol, Madrid, Spain; [Torres, Antoni] Hosp Clin Barcelona, Resp Inst, Barcelona, Spain; [Martinez-Moragon, Eva] Hosp Sagunto, Dept Pneumol, Valencia, Spain; [Casas, Francisco] Hosp Univ San Cecilio, Dept Pneumol, Granada, Spain; [Cordovilla, Rosa] Hosp Univ Salamanca, Dept Pneumol, Salamanca, Spain; [de Gracia, Javier] Hosp Univ Vall dHebron, Dept Pneumol, Barcelona, Spain; [Martinez-Garcia, Miguel-Angel] Hosp Univ & Politecn La Fe, Dept Pneumol, Valencia, Spain; [Martinez-Moragon, Eva] Hosp Univ Doctor Peset, Dept Pneumol, Valencia, Spain	Hospital de La Princesa; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Universidad de Malaga; Hospital Universidad San Jorge; Hospital Universitario Ramon y Cajal; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario San Cecilio; Hospital Universitari Vall d'Hebron; Hospital Universitari i Politecnic La Fe	De la Rosa, D (corresponding author), Hosp Plato, Dept Pneumol, Barcelona, Spain.	david.rosa@hospitalplato.com	De Gracia, Javier/H-8746-2017; Martinez-Garcia, Miguel/AAA-6349-2019; Vendrell, Montserrat/AAP-3635-2021; Torres, Antoni/H-6128-2017; De La Rosa Carrillo, David/AET-0317-2022	De Gracia, Javier/0000-0003-2830-1991; Martinez-Garcia, Miguel/0000-0002-7321-1891; Vendrell, Montserrat/0000-0002-6879-5757; Torres, Antoni/0000-0002-8643-2167; De La Rosa Carrillo, David/0000-0003-0753-1771; Casas, Francisco/0000-0002-8007-9323				Aliberti S, 2016, EUR RESPIR J, V47, P1113, DOI 10.1183/13993003.01899-2015; Martinez-Garcia MA, 2011, CHEST, V140, P1130, DOI 10.1378/chest.10-1758; Anwar GA, 2013, RESP MED, V107, P1001, DOI 10.1016/j.rmed.2013.04.013; BARKER AF, 1988, AM REV RESPIR DIS, V137, P969, DOI 10.1164/ajrccm/137.4.969; Brill SE, 2015, THORAX, V70, P930, DOI 10.1136/thoraxjnl-2015-207194; Canton R, 2005, CLIN MICROBIOL INFEC, V11, P690, DOI 10.1111/j.1469-0691.2005.01217.x; Chalmers JD, 2014, AM J RESP CRIT CARE, V189, P576, DOI 10.1164/rccm.201309-1575OC; Chevalier-Bidaud B, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-148; Dal Negro R, 2008, ADV THER, V25, P1019, DOI 10.1007/s12325-008-0105-2; Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605; Donath E, 2013, RESP MED, V107, P1385, DOI 10.1016/j.rmed.2013.05.004; Du QX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150532; Finch S, 2015, ANN AM THORAC SOC, V12, P1602, DOI 10.1513/AnnalsATS.201506-333OC; Gao YH, 2016, RESPIROLOGY; Garcha DS, 2012, THORAX, V67, P1075, DOI 10.1136/thoraxjnl-2012-201924; Garcia-Vidal C, 2009, EUR RESPIR J, V34, P1072, DOI 10.1183/09031936.00003309; Gatheral T, 2014, COPD, V11, P605, DOI 10.3109/15412555.2014.922174; Goeminne PC, 2014, RESP MED, V108, P287, DOI 10.1016/j.rmed.2013.12.015; Habesoglu MA, 2011, ANN THORAC MED, V6, P131, DOI 10.4103/1817-1737.82443; Haworth CS, 2014, RESP MED, V108, P1397, DOI 10.1016/j.rmed.2014.09.005; Keddissi JI, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/498205; Keistinen T, 1997, EUR RESPIR J, V10, P2784, DOI 10.1183/09031936.97.10122784; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; King PT, 2006, RESP MED, V100, P2183, DOI 10.1016/j.rmed.2006.03.012; Lonni S, 2015, ANN AM THORAC SOC, V12, P1764, DOI 10.1513/AnnalsATS.201507-472OC; Martinez-Garcia C., 2003, HAEMATOLOGICA S6, V87, P204; Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1357, DOI 10.1183/09031936.00026313; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; Martinez-Garcia MA, 2013, AM J RESP CRIT CARE, V187, P823, DOI 10.1164/rccm.201208-1518OC; Pasteur MC, 2010, THORAX, V65, P577, DOI 10.1136/thx.2010.142778; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Patel IS, 2004, AM J RESP CRIT CARE, V170, P400, DOI 10.1164/rccm.200305-648OC; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Quint JK, 2016, EUR RESPIR J, V47, P186, DOI 10.1183/13993003.01033-2015; Roberts HR, 2000, THORAX, V55, P198, DOI 10.1136/thorax.55.3.198; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Sethi S, 2012, AM J RESP CRIT CARE, V185, pA3037; Sethi S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-10; Shoemark A, 2007, RESP MED, V101, P1163, DOI 10.1016/j.rmed.2006.11.008; Vendrell M, 2008, ARCH BRONCONEUMOL, V44, P629, DOI 10.1016/S1579-2129(08)60117-2; Wilson CB, 1997, EUR RESPIR J, V10, P1754, DOI 10.1183/09031936.97.10081754; Wilson R, 2013, J INFECTION, V67, P497, DOI 10.1016/j.jinf.2013.08.010	42	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177931	10.1371/journal.pone.0177931	http://dx.doi.org/10.1371/journal.pone.0177931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542286	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672400117
J	Honda, H; Hirano, T; Ueda, M; Kojima, S; Mashiba, S; Hayase, Y; Michihata, T; Shishido, K; Takahashi, K; Hosaka, N; Ikeda, M; Sanada, D; Shibata, T				Honda, Hirokazu; Hirano, Tsutomu; Ueda, Masashi; Kojima, Shiho; Mashiba, Shinichi; Hayase, Yasuyuki; Michihata, Tetsuo; Shishido, Kanji; Takahashi, Keiko; Hosaka, Nozomu; Ikeda, Misa; Sanada, Daisuke; Shibata, Takanori			Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis	PLOS ONE			English	Article							A-II; CHOLESTEROL EFFLUX; HDL; RISK; DISEASE; ATHEROSCLEROSIS; METABOLISM; MORTALITY; PROTEIN	Apolipoproteins are associated with survival among patients on hemodialysis (HD), but these associations might be influenced by dysfunctional (oxidized) high-density lipoprotein (HDL). We assessed associations among apolipoproteins and oxidized HDL, mortality and cardiovascular disease (CVD) events in patients on HD. This prospective observational study examined 412 patients on prevalent HD. Blood samples were obtained before dialysis at baseline to measure lipids, apolipoproteins, oxidized LDL, oxidized HDL, high-sensitivity C-reactive protein (hs-CRP) and interleukin (IL)-6 at baseline, and HDL-C and hs-CRP were measured 12 months later. Patients were then prospectively followed-up (mean, 40 months) and all-cause mortality and composite CVD events were analyzed. Associations between variables at baseline and clinical outcome were assessed by Cox proportional hazards modeling (n = 412) and Cox hazards modeling with a time-varying covariate with HDL-C and hs-CRP (n = 369). Quartiles of apolipoproteins and oxidized HDL were not associated with all-cause mortality. However, Cox proportional hazards models with quartiles of each variable adjusted for confounders and hs-CRP or IL-6 identified apolipoprotein (apo) B-to-apoA-I ratio (apoB/apoA-I) and oxidized HDL, but not apoA-I or apoA-II, as independent risk factors for composite CVD events. These associations were confirmed by Cox proportional hazards modeling with time-varying covariates for hs-CRP. ApoB/apoA-I was independently associated with composite CVD events in 1-standard deviation (SD) increase-of-variables models adjusted for the confounders, oxidized HDL and hs-CRP. However, these associations disappeared from the model adjusted with IL-6 instead of hs-CRP, and oxidized HDL and IL-6 were independently associated with composite CVD events. Findings resembled those from Cox proportional hazards modeling using time-varying covariates with HDL-C adjusted with IL-6. In conclusion, both oxidized HDL and apoB/apoA-I might be associated with CVD events in patients on prevalent HD, while associations of apoB/apoA-I with CVD events differed between models of apoB/apoA-I quartiles and 1-SD increases, and were influenced by IL-6.	[Honda, Hirokazu; Hosaka, Nozomu] Showa Univ, Koto Toyosu Hosp, Dept Med, Div Nephrol, Tokyo, Japan; [Honda, Hirokazu; Hosaka, Nozomu; Ikeda, Misa; Sanada, Daisuke; Shibata, Takanori] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan; [Hirano, Tsutomu] Showa Univ, Sch Med, Dept Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Ueda, Masashi; Kojima, Shiho; Mashiba, Shinichi; Hayase, Yasuyuki] Ikagaku, Res Dev, Kyoto, Japan; [Michihata, Tetsuo] Ebara Clin, Dept Dialysis, Tokyo, Japan; [Shishido, Kanji] Kawasaki Clin, Dept Dialysis, Kawasaki, Kanagawa, Japan; [Takahashi, Keiko] Kitami Higashiyama Clin, Div Dialysis, Tokyo, Japan	Showa University; Showa University; Showa University	Honda, H (corresponding author), Showa Univ, Koto Toyosu Hosp, Dept Med, Div Nephrol, Tokyo, Japan.; Honda, H (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan.	hondah@med.showa-u.ac.jp		Honda, Hirokazu/0000-0002-5634-6145				Alaupovic P, 1997, ARTERIOSCL THROM VAS, V17, P715, DOI 10.1161/01.ATV.17.4.715; [Anonymous], 2000, AM J KIDNEY DIS, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517; Birjmohun RS, 2007, CIRCULATION, V116, P2029, DOI 10.1161/CIRCULATIONAHA.107.704031; Chadwick AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123138; Corsetti JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039110; Gugliucci A, 2015, CLIN CHIM ACTA, V439, P5, DOI 10.1016/j.cca.2014.09.016; Gugliucci A, 2012, J LIPIDS, V2012, DOI 10.1155/2012/726048; Holzer M, 2011, J AM SOC NEPHROL, V22, P1631, DOI 10.1681/ASN.2010111144; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Honda H, 2016, J ATHEROSCLER THROMB, V23, P81, DOI 10.5551/jat.30015; Honda H, 2012, ATHEROSCLEROSIS, V220, P493, DOI 10.1016/j.atherosclerosis.2011.10.038; Honda H, 2010, CLIN J AM SOC NEPHRO, V5, P1021, DOI 10.2215/CJN.06110809; HUANG YD, 1995, ARTERIOSCL THROM VAS, V15, P1412, DOI 10.1161/01.ATV.15.9.1412; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Ikewaki K, 2014, CLIN EXP NEPHROL, V18, P261, DOI 10.1007/s10157-013-0881-x; JOHNSON WJ, 1991, J LIPID RES, V32, P1993; Kalantar-Zadeh K, 2007, KIDNEY INT, V72, P1149, DOI 10.1038/sj.ki.5002491; Kaysen GA, 2014, NEPHROL DIAL TRANSPL, V29, P430, DOI 10.1093/ndt/gft370; Keane WF, 2013, J ATHEROSCLER THROMB, V20, P123, DOI 10.5551/jat.12849; Kennedy DJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000104; Kidney Disease Outcomes Quality Initiative (K/DOQI) Group, 2003, AM J KIDNEY DIS S, V41, pI; Kollerits B, 2016, NEPHROL DIAL TRANSPL, V31, P1901, DOI 10.1093/ndt/gfv428; Lubrano Valter, 2015, World J Exp Med, V5, P218, DOI 10.5493/wjem.v5.i4.218; Malle E, 2006, ARCH BIOCHEM BIOPHYS, V445, P245, DOI 10.1016/j.abb.2005.08.008; Nakajima T, 2000, ANN CLIN BIOCHEM, V37, P179, DOI 10.1258/0004563001899186; Navab KD, 2011, CURR PHARM DESIGN, V17, P17; Navab M, 2009, J LIPID RES, V50, pS145, DOI 10.1194/jlr.R800036-JLR200; Sato Y, 2016, CLIN J AM SOC NEPHRO, V11, P840, DOI 10.2215/CJN.09830915; Silbernagel G, 2015, J AM SOC NEPHROL, V26, P484, DOI 10.1681/ASN.2013080816; Sun J, 2016, CLIN J AM SOC NEPHRO, V11, P1163, DOI 10.2215/CJN.10441015; Sweetnam PM, 2000, EUR J CLIN INVEST, V30, P947, DOI 10.1046/j.1365-2362.2000.00725.x; Ueda M, 2007, CLIN CHIM ACTA, V378, P105, DOI 10.1016/j.cca.2006.11.002; Umemoto T, 2013, CIRC RES, V112, P1345, DOI 10.1161/CIRCRESAHA.111.300581; Vaziri ND, 2010, NAT REV NEPHROL, V6, P287, DOI 10.1038/nrneph.2010.36; Wang Y, 2013, ARTERIOSCL THROM VAS, V33, P224, DOI 10.1161/ATVBAHA.112.300445; Wiswedel I, 2008, BIOMARK INSIGHTS, V3, P419; Yamamoto S, 2012, J AM COLL CARDIOL, V60, P2372, DOI 10.1016/j.jacc.2012.09.013	37	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177980	10.1371/journal.pone.0177980	http://dx.doi.org/10.1371/journal.pone.0177980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542510	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400125
J	Lopopolo, A; Frank, SL; van den Bosch, A; Willems, RM				Lopopolo, Alessandro; Frank, Stefan L.; van den Bosch, Antal; Willems, Roel M.			Using stochastic language models (SLM) to map lexical, syntactic, and phonological information processing in the brain	PLOS ONE			English	Article							CORTEX; COMPREHENSION; FREQUENCY; SYSTEM; MEMORY; WORDS; AREAS; LOBE; TIME	Language comprehension involves the simultaneous processing of information at the phonological, syntactic, and lexical level. We track these three distinct streams of information in the brain by using stochastic measures derived from computational language models to detect neural correlates of phoneme, part-of-speech, and word processing in an fMRI experiment. Probabilistic language models have proven to be useful tools for studying how language is processed as a sequence of symbols unfolding in time. Conditional probabilities between sequences of words are at the basis of probabilistic measures such as surprisal and perplexity which have been successfully used as predictors of several behavioural and neural correlates of sentence processing. Here we computed perplexity from sequences of words and their parts of speech, and their phonemic transcriptions. Brain activity time locked to each word is regressed on the three model-derived measures. We observe that the brain keeps track of the statistical structure of lexical, syntactic and phonological information in distinct areas.	[Lopopolo, Alessandro; Frank, Stefan L.; van den Bosch, Antal; Willems, Roel M.] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands; [Willems, Roel M.] Radboud Univ Nijmegen, Donders Inst, Nijmegen, Netherlands; [van den Bosch, Antal] Royal Netherlands Acad Sci & Arts, Meertens Inst, Amsterdam, Netherlands; [Willems, Roel M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Meertens Institute (KNAW); Max Planck Society	Lopopolo, A (corresponding author), Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands.	a.lopopolo@donders.ru.nl	van den Bosch, Antal/AAC-2164-2019	van den Bosch, Antal/0000-0003-2493-656X; Willems, Roel/0000-0002-4963-5387	Netherlands Organisation for Scientific Research (NWO) [024.001.006]; NWO Vidi [NWO-Vidi 276-89-007]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO Vidi(Netherlands Organization for Scientific Research (NWO))	The work presented here was funded by Netherlands Organisation for Scientific Research (NWO) Gravitation Grant 024.001.006 to the Language in Interaction Consortium and by NWO Vidi grant (NWO-Vidi 276-89-007).	Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Anderson A. J., 2013, P 2013 C EMP METH NA, P1960; Anderson AJ, 2015, NEUROIMAGE, V120, P309, DOI 10.1016/j.neuroimage.2015.06.093; Baayen H. R., 1995, CELEX LEXICAL DATABA; Bar M., 2011, PREDICTIONBRAIN US, DOI [10.1093/acprof:Oso/9780195395518.001.0001, DOI 10.1093/ACPROF:OSO/9780195395518.001.0001]; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Boston MF, 2008, J EYE MOVEMENT RES, V2; Brennan J, 2012, BRAIN LANG, V120, P163, DOI 10.1016/j.bandl.2010.04.002; Brennan JR, 2016, BRAIN LANG, V157, P81, DOI 10.1016/j.bandl.2016.04.008; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Busser B, 1999, 6 EUR C SPEECH COMM, P1999; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Daelemans W, MEMORY BASED LANGUAG, P3; Dronkers NF, 2004, COGNITION, V92, P145, DOI 10.1016/j.cognition.2003.11.002; Frank S., 2012, P 34 ANN C COGN SCI, P1554; Frank SL, 2015, BRAIN LANG, V140, P1, DOI 10.1016/j.bandl.2014.10.006; Frank SL, 2013, TOP COGN SCI, V5, P475, DOI 10.1111/tops.12025; Frank SL, 2011, PSYCHOL SCI, V22, P829, DOI 10.1177/0956797611409589; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; Haeseryn Walter, 1997, ALGEMENE NEDERLANDSE; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00416; Hale John, 2001, 2 M N AM CHAPT ASS C; Herrmann B, 2012, HUM BRAIN MAPP, V33, P584, DOI 10.1002/hbm.21235; Hertrich I, 2016, NEUROSCI BIOBEHAV R, V68, P602, DOI 10.1016/j.neubiorev.2016.06.030; Indefrey P, 2004, PRELEXICAL LEXICAL P; Jackendoff R. S., 2002, FDN LANGUAGE BRAIN M; Jackendoff R, 2007, BRAIN RES, V1146, P2, DOI 10.1016/j.brainres.2006.08.111; Kemmerer David, 2014, COGNITIVE NEUROSCIEN; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Mendoza JE, 2011, HESCHLS GYRUS, P1243; Monsalve Irene Fernandez, 2012, P 13 C EUR CHAPT ASS, P398; Nastase S, 2014, HUM BRAIN MAPP, V35, P1111, DOI 10.1002/hbm.22238; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Obleser J, 2011, NEUROIMAGE, V56, P2310, DOI 10.1016/j.neuroimage.2011.03.035; Oostdijk N., 2000, P 2 INT C LANG RES E, P887; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Poser BA, 2010, NEUROIMAGE, V51, P261, DOI 10.1016/j.neuroimage.2010.01.108; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Sato M, 2009, BRAIN LANG, V111, P1, DOI 10.1016/j.bandl.2009.03.002; Schafer R, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P486; Schlesewsky M., 2012, OPEN MED IMAGING J, V6, P47, DOI DOI 10.2174/1874347101206010047; Smith NJ, 2013, COGNITION, V128, P302, DOI 10.1016/j.cognition.2013.02.013; Snijders TM, 2009, CEREB CORTEX, V19, P1493, DOI 10.1093/cercor/bhn187; Stolcke A., 2002, P INT C SPOK LANG PR, V2, P901; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Thompson-Schill SL, 2009, CURR DIR PSYCHOL SCI, V18, P259, DOI 10.1111/j.1467-8721.2009.01648.x; Tremblay P, 2016, NEUROIMAGE, V136, P106, DOI 10.1016/j.neuroimage.2016.05.018; Tremblay P, 2011, NEUROIMAGE, V57, P1561, DOI 10.1016/j.neuroimage.2011.05.067; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; Willems RM, 2016, CEREB CORTEX, V26, P2506, DOI 10.1093/cercor/bhv075; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058	63	26	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177794	10.1371/journal.pone.0177794	http://dx.doi.org/10.1371/journal.pone.0177794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542396	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400084
J	Operario, DJ; Koeppel, AF; Turner, SD; Bao, YD; Pholwat, S; Banu, S; Foongladda, S; Mpagama, S; Gratz, J; Ogarkov, O; Zhadova, S; Heysell, SK; Houpt, ER				Operario, Darwin J.; Koeppel, Alexander F.; Turner, Stephen D.; Bao, Yongde; Pholwat, Suporn; Banu, Sayera; Foongladda, Suporn; Mpagama, Stellah; Gratz, Jean; Ogarkov, Oleg; Zhadova, Svetlana; Heysell, Scott K.; Houpt, Eric R.			Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DIAGNOSIS; SAMPLES	Amplicon-based Next Generation Sequencing (NGS)is an emerging method for Mycobacterium tuberculosis drug susceptibility testing (DST) but has not been well described. We examined 158 clinical multidrug-resistant M. tuberculosis isolates via NGS of 11 resistance-associated gene regions covering 3519 nucleotides. Across these gene regions, complete resistance or heteroresistance (defined as 1%-99% mutation) was present in at least one isolate in 6.3% of loci. The number of isolates with heteroresistance was highest for gyrA codon 94, rpoB codons 526 and 531, and embB codons 306, 372 and 406 (range 11-26% of isolates exhibited heteroresistance). 57% of MDR strains had heteroresistance of one or more recognized resistance-associated mutation. Heteroresistant loci generally exhibited high or low degrees of mutation (>90% or <10%). The deep sensitivity of NGS for detecting low level pncA heteroresistance appeared to improve genotypic-phenotypic PZA susceptibility correlations over that of Sanger. NGS demonstrates that heteroresistance in TB in the regions of key genes is common and will need to be bioinformatically managed. The clinical significance of such heteroresistance is unclear, and further study of pncA should be pursued.	[Operario, Darwin J.; Pholwat, Suporn; Gratz, Jean; Heysell, Scott K.; Houpt, Eric R.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA; [Koeppel, Alexander F.; Turner, Stephen D.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Bao, Yongde] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Banu, Sayera] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Foongladda, Suporn] Mahidol Univ, Siriraj Hosp, Bangkok, Thailand; [Mpagama, Stellah] Kibongoto Infect Dis Hosp, Kilimanjaro, Tanzania; [Ogarkov, Oleg; Zhadova, Svetlana] Sci Ctr Family Hlth & Human Reprod Problems, Irkutsk, Siberia, Russia	University of Virginia; University of Virginia; University of Virginia; International Centre for Diarrhoeal Disease Research (ICDDR); Mahidol University; Irkutsk Science Centre of the Russian Academy of Sciences; Scientific Centre for Family Health & Human Reproduction Problems	Houpt, ER (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	erh6k@virginia.edu	Pholwat, Suporn/CAG-9380-2022; Ogarkov, Oleg/A-1715-2014; Turner, Stephen/GXM-4654-2022; Ogarkov, Oleg B./G-6966-2011	Ogarkov, Oleg/0000-0002-3168-1983; Ogarkov, Oleg B./0000-0002-3168-1983; Turner, Stephen/0000-0001-9140-9028; Banu, Sayera/0000-0002-5121-1962	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01 AI093358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI099019, R01AI093358] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, R01 AI093358 to Eric R. Houpt. The funder had no role in study design, collection, analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Aronesty E ea-utils, 2011, COMMAND LINE TOOLS P; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bradley P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10063; Cabibbe A M, 2016, Int J Mycobacteriol, V5 Suppl 1, pS40, DOI 10.1016/j.ijmyco.2016.09.010; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cegielski JP, 2016, CLIN INFECT DIS, V62, P418, DOI 10.1093/cid/civ910; Cirillo D M, 2016, Int J Mycobacteriol, V5 Suppl 1, pS33, DOI 10.1016/j.ijmyco.2016.11.009; Colman RE, 2016, J CLIN MICROBIOL, V54, P2058, DOI 10.1128/JCM.00535-16; Colman RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126626; Daum LT, 2012, J CLIN MICROBIOL, V50, P3831, DOI 10.1128/JCM.01893-12; Dolinger David L, 2016, Int J Mycobacteriol, V5 Suppl 1, pS27, DOI 10.1016/j.ijmyco.2016.09.021; Doughty EL, 2014, PEERJ, V2, DOI 10.7717/peerj.585; Eilertson B, 2014, ANTIMICROB AGENTS CH, V58, P3270, DOI 10.1128/AAC.02066-13; Faksri K, 2016, INFECT GENET EVOL, V45, P359, DOI 10.1016/j.meegid.2016.09.013; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Foongladda S, 2016, INT J TUBERC LUNG D, V20, P1105, DOI 10.5588/ijtld.15.0896; Garrison E, 2012, ARXIV 12073907; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maningi NE, 2015, J CLIN MICROBIOL, V53, P3779, DOI 10.1128/JCM.01179-15; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X; Petkau A, 2016, SNVPHYL SINGLE NUCL; Pholwat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057238; ReSeq TB, 2016, RELATIONAL SEQUENCIN; Rinder H, 2001, J MED MICROBIOL, V50, P1018, DOI 10.1099/0022-1317-50-12-1018; Salamon H, 2015, J INFECT DIS, V211, pS50, DOI 10.1093/infdis/jiu816; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; World Health Organization, 2016, US MOL LIN PROB ASS; World Health Organization, 2015, GLOB TUB REP 2015; Yakrus MA, 2015, TUBERC RES TREAT, V2015; Zheng C, 2015, J CLIN MICROBIOL, V53, P2138, DOI 10.1128/JCM.03507-14	35	48	52	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176522	10.1371/journal.pone.0176522	http://dx.doi.org/10.1371/journal.pone.0176522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545050	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400010
J	Burton, EN; Cohn, LA; Reinero, CN; Rindt, H; Moore, SG; Ericsson, AC				Burton, Erin N.; Cohn, Leah A.; Reinero, Carol N.; Rindt, Hans; Moore, Stephen G.; Ericsson, Aaron C.			Characterization of the urinary microbiome in healthy dogs	PLOS ONE			English	Article							COMPANION ANIMALS; EXTENDED-SPECTRUM; TRACT INFECTIONS; PHYLOGENETIC CHARACTERIZATION; SKIN MICROBIOME; 16S RDNA; CANINE; BACTERIURIA; PREVALENCE; RECURRENT	The urinary bladder in healthy dogs has dogmatically been considered free of bacteria. This study used culture independent techniques to characterize the healthy canine urinary microbiota. Urine samples collected by antepubic cystocentesis from dogs without urinary infection were used for DNA extraction. Genital tract and rectal samples were collected simultaneously from the same dogs. The V4 hypervariable region of the 16S rRNA bacterial gene was amplified and compared against Greengenes database for OTU assignment and relative abundance for urine, genital, and rectal samples. After excluding 4 dogs with cultivable bacteria, samples from 10 male (M; 1 intact) and 10 female (F) spayed dogs remained. All samples provided adequate genetic material for analysis. Four taxa (Pseudomonas sp., Acinetobacter sp., Sphingobium sp. and Bradyrhizobiaceae) dominated the urinary microbiota in all dogs of both sexes. These taxa were also detected in the genital swabs of both sexes, while the rectal microbiota differed substantially from the other sample sites. Principal component (PC) analysis of PC1 through PC3 showed overlap of urinary and genital microbiota and a clear separation of rectal swabs from the other sample sites along PC1, which explained 44.94% variation. Surprisingly, the urinary microbiota (mean # OTU 92.6 F, 90.2 M) was significantly richer than the genital (67.8 F, 66.6 M) or rectal microbiota (68.3 F, 71.2 M) (p < 0.0001), with no difference between sexes at any sample site. The canine urinary bladder is not a sterile environment and possesses its own unique and diverse microbiota compared to the rectal and genital microbiota. There was no difference between the sexes at any microbiota sample site (urine, genital, and rectal). The predominant bacterial genus for either sex in the urine and genital tracts was Pseudomonas sp.	[Burton, Erin N.; Ericsson, Aaron C.] Univ Missouri, Coll Vet Med, Dept Vet Pathol, Columbia, MO 65211 USA; [Cohn, Leah A.; Reinero, Carol N.; Rindt, Hans] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Ericsson, Aaron C.] Univ Missouri, Metagen Ctr, Columbia, MO USA; [Moore, Stephen G.] Univ Missouri, Div Anim Sci, Coll Agr Food & Nat Resources, Columbia, MO USA; [Burton, Erin N.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, Minneapolis, MN 55455 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Minnesota System; University of Minnesota Twin Cities	Burton, EN (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathol, Columbia, MO 65211 USA.; Burton, EN (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, Minneapolis, MN 55455 USA.	burt0233@umn.edu	Burton, Erin/H-9993-2019; Ericsson, Aaron C./AAJ-1406-2021; Moore, Stephen/K-2507-2019	Burton, Erin/0000-0001-9364-3205; Ericsson, Aaron C./0000-0002-3053-7269; Moore, Stephen/0000-0001-9896-8519	College of Veterinary Medicine at the University of Missouri; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019924] Funding Source: NIH RePORTER	College of Veterinary Medicine at the University of Missouri; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this study was provided by a Clinician Scientist grant from the College of Veterinary Medicine at the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakken JS, 2009, ANAEROBE, V15, P285, DOI 10.1016/j.anaerobe.2009.09.007; Barsanti J, 2012, INFECT DIS DOG CAT, P1013; Bradley CW, 2016, J INVEST DERMATOL, V136, P1182, DOI 10.1016/j.jid.2016.01.023; Brubaker L, 2016, CURR OPIN OBSTET GYN, V28, P407, DOI 10.1097/GCO.0000000000000298; Clare S, 2014, J VET INTERN MED, V28, P818, DOI 10.1111/jvim.12324; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154646; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Ewers C, 2011, BERL MUNCH TIERARZTL, V124, P94, DOI 10.2376/0005-9366-124-94; Ewers C, 2011, INT J ANTIMICROB AG, V37, P86, DOI 10.1016/j.ijantimicag.2010.09.007; Fouts DE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-174; Fricke WF, 2014, AM J TRANSPLANT, V14, P416, DOI 10.1111/ajt.12588; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; Hutchins RG, 2014, J VET INTERN MED, V28, P300, DOI 10.1111/jvim.12299; Karstens L, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00078; Khasriya R, 2013, J CLIN MICROBIOL, V51, P2054, DOI 10.1128/JCM.03314-12; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; LEES GE, 1986, J AM VET MED ASSOC, V189, P648; Lewis DA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00041; Ling GV, 2001, J VET INTERN MED, V15, P341, DOI 10.1892/0891-6640(2001)015&lt;0341:IOOPSC&gt;2.3.CO;2; LING GV, 1984, J AM VET MED ASSOC, V185, P1162; Liu FP, 2017, ONCOTARGET, V8, P3798, DOI 10.18632/oncotarget.14028; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McGhie JA, 2014, AUST VET J, V92, P33, DOI 10.1111/avj.12140; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Nelson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036298; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Norris CR, 2000, J AM ANIM HOSP ASSOC, V36, P484, DOI 10.5326/15473317-36-6-484; Pearce MM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.009; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Prescott JF, 2002, CAN VET J, V43, P107; Price TK, 2016, J CLIN MICROBIOL, V54, P1216, DOI 10.1128/JCM.00044-16; Rodrigues Hoffmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083197; Rubin TA, 2013, ANAEROBE, V19, P22, DOI 10.1016/j.anaerobe.2012.11.004; Rudick CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109321; Salipante SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065226; Seguin MA, 2003, J VET INTERN MED, V17, P622, DOI 10.1892/0891-6640(2003)017&lt;0622:PUTIAR&gt;2.3.CO;2; Siddiqui H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-205; Siddiqui H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-244; Stapleton AE, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0025-2016; Stapleton AE, 2014, INFECT DIS CLIN N AM, V28, P149, DOI 10.1016/j.idc.2013.10.006; Stapleton AE, 2011, CLIN INFECT DIS, V52, P1212, DOI 10.1093/cid/cir183; Sturgeon A, 2012, VET DERMATOLOGY S, V68; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Thomas-White K. J., 2016, AM J OBSTET GYNECOL; Thomas-White K, 2016, CURR BLADDER DYSFUNC, V11, P18, DOI 10.1007/s11884-016-0345-8; Thomas-White KJ, 2016, INT UROGYNECOL J, V27, P723, DOI 10.1007/s00192-015-2847-x; Thompson MF, 2011, VET J, V190, P22, DOI 10.1016/j.tvjl.2010.11.013; Thompson MF, 2011, VET MICROBIOL, V147, P205, DOI 10.1016/j.vetmic.2010.06.007; Wagner S, 2014, VET MICROBIOL, V169, P171, DOI 10.1016/j.vetmic.2014.01.003; Wan SY, 2014, JAVMA-J AM VET MED A, V245, P106, DOI 10.2460/javma.245.1.106; Weese JS, 2013, VET DERMATOL, V24, P137, DOI 10.1111/j.1365-3164.2012.01076.x; Willner D, 2014, MBIO, V5, DOI 10.1128/mBio.01064-13; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; WOOLEY RE, 1976, J CLIN MICROBIOL, V4, P326; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	61	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177783	10.1371/journal.pone.0177783	http://dx.doi.org/10.1371/journal.pone.0177783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545071	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700074
J	Phillip, V; Schwab, M; Haf, D; Algul, H				Phillip, Veit; Schwab, Miriam; Haf, David; Alguel, Hana			Identification of risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in a high volume center	PLOS ONE			English	Article							ERCP PANCREATITIS; COMPLICATIONS; SPHINCTEROTOMY	Background/Objectives Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Several patients A or procedure related risk factors for post-ERCP pancreatitis (PEP) have been suggested. The aim of this study was to validate the risk factors for PEP in a high-volume center. Methods All patients undergoing first time ERCP at a tertiary referral center between December 2010 and October 2013 were retrospectively included. PEP was defined according to the Atlanta Classification. Results 344 patients were included in the final analysis. The risk to develop PEP was increased in patients with chronic pancreatitis (odds ratio 3.7) and after inadvertent cannulation of the pancreatic duct (odds ratio 2.2), which occurred in 26.5% of the patients. Inadvertent cannulation occurred significantly more frequently in patients with difficult cannulation of the papilla duodeni major (odds ratio 12.7; p<0.001). ERCP on call was associated with an increased risk for difficult cannulation (odds ratio 3.0). Conclusion Inadvertent cannulation of the pancreatic duct is a procedure related risk factor for PEP. Measurements on preventing inadvertent cannulation of the pancreatic duct should be established and studies on prophylactic measurements should focus particularly on patients with inadvertent cannulation of the pancreatic duct.	[Phillip, Veit; Schwab, Miriam; Haf, David; Alguel, Hana] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Innere Med 2, Munich, Germany	Technical University of Munich	Algul, H (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Innere Med 2, Munich, Germany.	hana.alguel@mri.tum.de	Phillip, Veit/ABE-4899-2021	Phillip, Veit/0000-0002-0921-2523; Algul, Hana/0000-0002-5067-7031				Anderson MA, 2012, GASTROINTEST ENDOSC, V75, P467, DOI 10.1016/j.gie.2011.07.010; Andriulli A, 2007, AM J GASTROENTEROL, V102, P1781, DOI 10.1111/j.1572-0241.2007.01279.x; [Anonymous], 1989, GASTROINTEST ENDOSC, V35, p189A; Bradley EL, 1992, SUMM INT S AC PANCR; BUB H, 1983, SCAND J GASTROENTERO, V18, P581, DOI 10.3109/00365528309181642; CHEN YK, 1994, AM J GASTROENTEROL, V89, P327; Dickinson RJ, 1998, EUR J GASTROEN HEPAT, V10, P423, DOI 10.1097/00042737-199805000-00012; Dumonceau JM, 2014, ENDOSCOPY, V46, P798, DOI 10.1055/s-0034-1377875; Freeman ML, 2007, CLIN GASTROENTEROL H, V5, P1354, DOI 10.1016/j.cgh.2007.09.007; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Freeman ML, 2001, GASTROINTEST ENDOSC, V54, P425, DOI 10.1067/mge.2001.117550; Johnson GK, 1997, GASTROINTEST ENDOSC, V46, P217, DOI 10.1016/S0016-5107(97)70089-0; Kapral C, 2012, EUR J GASTROEN HEPAT, V24, P1447, DOI 10.1097/MEG.0b013e3283583c6f; Kochar B, 2015, GASTROINTEST ENDOSC, V81, P143, DOI 10.1016/j.gie.2014.06.045; Lesina M, 2014, SEMIN IMMUNOL, V26, P80, DOI 10.1016/j.smim.2014.01.002; Loperfido S, 1998, GASTROINTEST ENDOSC, V48, P1, DOI 10.1016/S0016-5107(98)70121-X; Masci E, 2003, ENDOSCOPY, V35, P830; SHERMAN S, 1991, GASTROENTEROLOGY, V101, P1068, DOI 10.1016/0016-5085(91)90735-4; SHERMAN S, 1991, PANCREAS, V6, P350, DOI 10.1097/00006676-199105000-00013; Testoni Pier Alberto, 2002, JOP, V3, P195; Thiruvengadam NR, 2016, GASTROENTEROLOGY, V151, P288, DOI 10.1053/j.gastro.2016.04.048; Zhao ZH, 2017, GASTROINTEST ENDOSC	22	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177874	10.1371/journal.pone.0177874	http://dx.doi.org/10.1371/journal.pone.0177874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545067	gold, Green Published, Green Submitted			2022-12-27	WOS:000401487700091
J	Nakamura, K; Kusama, K; Bai, R; Ishikawa, S; Fukushima, S; Suda, Y; Imakawa, K				Nakamura, Keigo; Kusama, Kazuya; Bai, Rulan; Ishikawa, Sadamasa; Fukushima, Sayuri; Suda, Yoshihito; Imakawa, Kazuhiko			Increase in complement iC3b is associated with anti-inflammatory cytokine expression during late pregnancy in mice	PLOS ONE			English	Article							CELLS; ACTIVATION; C3; DIFFERENTIATION; MECHANISMS; TOLERANCE; COMPONENT; TISSUE; CRRY	Immunological tolerance between fetal allograft and mother is crucial for pregnancy establishment and maintenance; however, these mechanisms particularly those during the latter part of pregnancy have not been definitively elucidated. The aim of this study was to examine the presence and potential function of innate immunity characteristic to the middle to late pregnancy. We first characterized up-regulated proteins in decidua from day 11 pregnant (P11) mice using 2D-PAGE, followed by MALDI-TOF/MS analysis. These analyses identified increased complement component 3 (C3) and its derivatives in P11 decidua. We then found that in the decidual tissues, C3 mRNA increased on P15 and remained high on P19. C3 is converted to C3b and then iC3b by complement component factor I (Cfi) and complement receptor 1-like protein (Crry), both of which were present in P19 placentas. In addition, iC3b proteins and its receptor CR3 (Cd11b/Cd18) in decidual and placental tissues increased toward the latter phase of pregnancy. Moreover, CR3 subunit CD11b protein was predominantly localized to spongiotrophoblast layer in the P19 placenta. Because iC3b is known to induce anti-inflammatory cytokine production, the analysis was extended to examine changes in pro-and anti-inflammatory cytokines, Il12, Il10, and Tgfb1. Il12 expression decreased in P15 and P19 placenta, while high mRNA expression of Il10 and Tgfb1 was found in P19 placental tissues. Furthermore, placental Il10 and Tgfb1 mRNAs were downregulated when pregnant mice were treated with an anti-C3 antibody, detecting C3, C3b and iC3b. These results indicated that C3 derivatives, in particular, iC3b and its receptor CR3 were up-regulated at the fetal-maternal interface, and suggest that iC3b may regulate the placental expression of anti-inflammatory cytokines, IL10 and TGFB1, during the latter phase of pregnancy.	[Nakamura, Keigo; Kusama, Kazuya; Bai, Rulan; Imakawa, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Kasama, Ibaraki, Japan; [Ishikawa, Sadamasa; Fukushima, Sayuri; Suda, Yoshihito] Miyagi Univ, Dept Food Agr & Environm, Taihaku Ku, Sendai, Miyagi, Japan	University of Tokyo; Miyagi University	Imakawa, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Kasama, Ibaraki, Japan.; Suda, Y (corresponding author), Miyagi Univ, Dept Food Agr & Environm, Taihaku Ku, Sendai, Miyagi, Japan.	suda@myu.ac.jp; akaz@mail.ecc.u-tokyo.ac.jp	Kusama, Kazuya/K-9716-2018; Imakawa, Kazuhiko/AAD-3211-2022	Kusama, Kazuya/0000-0002-9120-0475; Imakawa, Kazuhiko/0000-0002-3798-3560	Japan Society for Promotion of Science [15K18767]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Young Scientists (B) from Japan Society for Promotion of Science (15K18767, https://www.jsps.go.jp/english/index.html) (to KK), and Grants-in-Aid for Scientific Research (A) from Japan Society for Promotion of Science (15K18767, https://www.jsps.go.jp/english/index.html) (to KI). The funder had roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard-Tillery KM, 2006, SEMIN FETAL NEONAT M, V11, P279, DOI 10.1016/j.siny.2006.04.003; Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343; Amdahl H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172675; ANDERSON DJ, 1979, BIOL REPROD, V21, P1143, DOI 10.1095/biolreprod21.5.1143; Billington WD., NORMAL FETOMATERNAL; BRANDON JM, 1995, J REPROD FERTIL, V103, P9, DOI 10.1530/jrf.0.1030009; Bulla R, 2009, J REPROD IMMUNOL, V82, P119, DOI 10.1016/j.jri.2009.06.124; Buurma A, 2012, HYPERTENSION, V60, P1332, DOI 10.1161/HYPERTENSIONAHA.112.194324; Cazander G, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/534291; Chaouat G, 1988, Reg Immunol, V1, P143; Chow WN, 2009, MOL REPROD DEV, V76, P647, DOI 10.1002/mrd.21013; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Davila J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005458; Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361; LANMAN JT, 1965, J EXP MED, V122, P579, DOI 10.1084/jem.122.3.579; Lebel ME, 2016, J IMMUNOL IN PRESS; Lokki AI, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00312; Markiewski MM, 2004, J IMMUNOL, V173, P747, DOI 10.4049/jimmunol.173.2.747; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Miao J, 2014, KIDNEY INT, V86, P726, DOI 10.1038/ki.2014.103; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Molina H, 2005, IMMUNOL RES, V32, P187, DOI 10.1385/IR:32:1-3:187; Nakamura K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158278; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782; OHKAWA R, 1984, ADV EXP MED BIOL, V176, P111; Renaud SJ, 2009, PLACENTA, V30, P313, DOI 10.1016/j.placenta.2009.01.001; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Schmidt BZ, 2000, IMMUNOL REV, V178, P166, DOI 10.1034/j.1600-065X.2000.17801.x; Shamonki JM, 2007, AM J OBSTET GYNECOL, V196; Sheldon M, 2004, VET CLIN N AM-FOOD A, V20, P569, DOI 10.1016/j.cvfa.2004.06.008; Singh J, 2011, HYPERTENSION, V58, P716, DOI 10.1161/HYPERTENSIONAHA.111.175919; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; Williams EJ, 2005, THERIOGENOLOGY, V63, P102, DOI 10.1016/j.theriogenology.2004.03.017; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; Yamakoshi S, 2012, REPRODUCTION, V143, P377, DOI 10.1530/REP-11-0364; Zenclussen AC, 2003, CYTOKINE, V24, P150, DOI 10.1016/j.cyto.2003.08.002	36	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178442	10.1371/journal.pone.0178442	http://dx.doi.org/10.1371/journal.pone.0178442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542608	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800090
J	Rocchi, J; Tsui, EYL; Saad, D				Rocchi, Jacopo; Tsui, Enoch Yan Lok; Saad, David			Emerging interdependence between stock values during financial crashes	PLOS ONE			English	Article							TIME-SERIES; INFORMATION-FLOW; BEHAVIOR; NETWORKS	To identify emerging interdependencies between traded stocks we investigate the behavior of the stocks of FTSE 100 companies in the period 2000-2015, by looking at daily stock values. Exploiting the power of information theoretical measures to extract direct influences between multiple time series, we compute the information flow across stock values to identify several different regimes. While small information flows is detected in most of the period, a dramatically different situation occurs in the proximity of global financial crises, where stock values exhibit strong and substantial interdependence for a prolonged period. This behavior is consistent with what one would generally expect from a complex system near criticality in physical systems, showing the long lasting effects of crashes on stock markets.	[Rocchi, Jacopo; Saad, David] Aston Univ, Nonlinear & Complex Res Grp, Birmingham B4 7ET, W Midlands, England; [Tsui, Enoch Yan Lok] Hong Kong Univ Sci & Technol, Dept Phys, Kowloon, Hong Kong, Peoples R China	Aston University; Hong Kong University of Science & Technology	Rocchi, J (corresponding author), Aston Univ, Nonlinear & Complex Res Grp, Birmingham B4 7ET, W Midlands, England.	j.rocchi@aston.ac.uk		Saad, David/0000-0001-9821-2623; Tsui, Enoch Yan Lok/0000-0003-1621-0443	Leverhulme Trust [RPG-2013-48]; Lee Hysan Foundation of Hong Kong	Leverhulme Trust(Leverhulme Trust); Lee Hysan Foundation of Hong Kong	This work is supported by The Leverhulme Trust grant RPG-2013-48 (https://www.leverhulme.ac.uk/). Enoch Yan Lok Tsui thanks the Lee Hysan Foundation of Hong Kong (http://sl.polyu.edu.hk/07_5_LHF_Scholarship. html) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank David Lowe for interesting discussions. This work is supported by The Leverhulme Trust grant RPG-2013-48. E.T. also wishes to thank the Lee Hysan Foundation of Hong Kong for funding.	Allen F, 2008, NETWORK CHALLENGE ST; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Bonanno G, 2004, EUR PHYS J B, V38, P363, DOI 10.1140/epjb/e2004-00129-6; Borge-Holthoefer J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501158; Bossomaier T, 2013, COMPLEX ADAPT SYST M, V1, DOI 10.1186/2194-3206-1-9; Bouchaud J., 2003, THEORY FINANCIAL RIS; Bouchaud JP, 2008, FLOW MARKETS SLOWLY; Curme C, 2015, QUANT FINANC, V15, P1375, DOI 10.1080/14697688.2015.1032545; Curty P, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/03/P03013; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; ELTON EJ, 1971, J BUS, V44, P432, DOI 10.1086/295403; FAMA EF, 1965, J BUS, V38, P34, DOI 10.1086/294743; Fenn DJ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026109; Fiedor P, 2015, J NETW THEORY FINANC, V1, P53; Fiedor P, 2014, IEEE C COMP INTEL FI, P247, DOI 10.1109/CIFEr.2014.6924080; Fiedor P, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-50108-3; GRANGER CWJ, 1988, J ECONOMETRICS, V39, P199, DOI 10.1016/0304-4076(88)90045-0; Gualdi S, 2015, J ECON DYN CONTROL, V50, P29, DOI 10.1016/j.jedc.2014.08.003; Haldane Andrew G., 2013, FRAGILE STABILITAT S, P243, DOI DOI 10.1007/978-3-658-02248-8; Harre M, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18009; Kwon O, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/68003; Laloux L., 2000, INT J THEOR APPL FIN, V3, P391, DOI DOI 10.1142/S0219024900000255; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; MANTEGNA RN, 2000, INTRO ECONOPHYSICS C; Marschinski R, 2002, EUR PHYS J B, V30, P275, DOI 10.1140/epjb/e2002-00379-2; Onnela JP, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056110; Plerou V, 2000, PHYSICA A, V279, P443, DOI 10.1016/S0378-4371(00)00010-8; Plerou V, 1999, PHYS REV LETT, V83, P1471, DOI 10.1103/PhysRevLett.83.1471; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00752; Preis T, 2011, P NATL ACAD SCI USA, V108, P7674, DOI 10.1073/pnas.1019484108; Reigneron PA, 2011, PHYSICA A, V390, P3026, DOI 10.1016/j.physa.2011.04.007; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schreiber T, 1998, PHYS REV LETT, V80, P2105, DOI 10.1103/PhysRevLett.80.2105; Sornette D, 1998, PHYS REP, V297, P239, DOI 10.1016/S0370-1573(97)00076-8; Sornette D, 2012, EUR PHYS J-SPEC TOP, V205, P1, DOI 10.1140/epjst/e2012-01559-5; Sornette D., 2001, Quantitative Finance, V1, P452, DOI 10.1088/1469-7688/1/4/305; Souza TT, 2016, ARXIV160104535; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Theiler J, 1996, PHYSICA D, V94, P221, DOI 10.1016/0167-2789(96)00050-4; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tumminello M, 2007, EUR PHYS J B, V55, P209, DOI 10.1140/epjb/e2006-00414-4; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; WILSON KG, 1971, PHYS REV B, V4, P3174, DOI 10.1103/PhysRevB.4.3174	48	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0176764	10.1371/journal.pone.0176764	http://dx.doi.org/10.1371/journal.pone.0176764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542278	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000402062800002
J	Turnbull, AE; Hashem, MD; Rabiee, A; To, A; Chessare, CM; Needham, DM				Turnbull, Alison E.; Hashem, Mohamed D.; Rabiee, Anahita; To, An; Chessare, Caroline M.; Needham, Dale M.			Evaluation of a strategy for enrolling the families of critically ill patients in research using limited human resources	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; END-OF-LIFE; PROLONGED MECHANICAL VENTILATION; POSTTRAUMATIC STRESS; DECISION-MAKING; QUALITY; MEMBERS; SURROGATES; COMMUNICATION; SYMPTOMS	Rationale Clinical trials of interventions aimed at the families of intensive care unit (ICU) patients have proliferated but recruitment for these trials can be challenging. Objectives To evaluate a strategy for recruiting families of patients currently being treated in an ICU using limited human resources and time-varying daily screening over 7 consecutive days Methods We screened the Johns Hopkins Hospital medical ICU census 7 days per week to identify eligible family members. We then made daily, in-person attempts to enroll eligible families during a time-varying 2-hour enrollment period until families declined participation, consented, or were no longer eligible. Measurements and main results The primary outcome was the proportion of eligible patients for whom >= 1 family member was enrolled. Secondary outcomes included enrollment of legal healthcare proxies, the consent rate among families approached for enrollment, and success rates for recruiting at different times during the day and week. Among 284 eligible patients, 108 (38%, 95% CI 32%-44%) had >= 1 family member enrolled, and 75 (26%, 95% CI 21%-32%) had their legal healthcare proxy enrolled. Among 117 family members asked to participate, 108 (92%, 95% CI 86%-96%) were enrolled. Patients with versus without an enrolled proxy were more likely to be white (44% vs. 30%, P = .02), live in a zip code with a median income of >=$100,000 15% vs. 5%, P = .01), be mechanically ventilated (63% vs. 47%, P = .01), die in the ICU (19% vs. 9%, P = .03), and to have longer ICU stays (median 5.0 vs. 1.8 days, P<.001). Day of the week and time of day were not associated with family presence in the ICU or consent rate. Conclusions Family members were recruited for more than one third of eligible patients, and >90% of approached consented to participate. There are important demographic differences between patients with vs without an enrolled family member.	[Turnbull, Alison E.; Hashem, Mohamed D.; Rabiee, Anahita; To, An; Chessare, Caroline M.; Needham, Dale M.] Johns Hopkins Univ, Outcomes Crit Illness & Surg Grp, Baltimore, MD 21218 USA; [Turnbull, Alison E.; To, An; Chessare, Caroline M.; Needham, Dale M.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Sch Med, Baltimore, MD 21218 USA; [Turnbull, Alison E.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Hashem, Mohamed D.] Cleveland Clin, Dept Med, Cleveland, OH 44106 USA; [Rabiee, Anahita] Yale Univ, Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Needham, Dale M.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cleveland Clinic Foundation; Yale University; Johns Hopkins University	Turnbull, AE (corresponding author), Johns Hopkins Univ, Outcomes Crit Illness & Surg Grp, Baltimore, MD 21218 USA.; Turnbull, AE (corresponding author), Johns Hopkins Univ, Div Pulm & Crit Care Med, Sch Med, Baltimore, MD 21218 USA.; Turnbull, AE (corresponding author), Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	turnbull@jhmi.edu	Rabiee, Anahita/AAI-2450-2019	Turnbull, Alison/0000-0002-1564-6547; To, An/0000-0003-3170-2999; Rabiee, Anahita/0000-0002-8833-3592	Johns Hopkins School of Medicine, Division of Pulmonary and Critical Care Medicine	Johns Hopkins School of Medicine, Division of Pulmonary and Critical Care Medicine	This research was supported by the Johns Hopkins School of Medicine, Division of Pulmonary and Critical Care Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; Anderson WG, 2008, J GEN INTERN MED, V23, P1871, DOI 10.1007/s11606-008-0770-2; Anderson WG, 2014, ANN AM THORAC SOC, V12, P142; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Burns KEA, 2015, INTENS CARE MED, V41, P58, DOI 10.1007/s00134-014-3558-3; Burns KEA, 2017, ANN AM THORAC SOC, V14, P238, DOI 10.1513/AnnalsATS.201606-425OC; Burns KEA, 2013, AM J RESP CRIT CARE, V187, P1212, DOI 10.1164/rccm.201208-1537OC; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Chiarchiaro J, 2015, ANN AM THORAC SOC, V12, P526, DOI 10.1513/AnnalsATS.201411-495OC; Chiarchiaro J, 2015, CRIT CARE MED, V43, P542, DOI 10.1097/CCM.0000000000000719; Choi J, 2012, CRIT CARE MED, V40, P1546, DOI 10.1097/CCM.0b013e3182451c58; Cohen AB, 2015, JAMA INTERN MED, V175, P1687, DOI 10.1001/jamainternmed.2015.3956; Cox CE, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0045-0; Cox CE, 2012, CRIT CARE MED, V40, P2327, DOI 10.1097/CCM.0b013e3182536a63; Curtis JR, 2016, AM J RESP CRIT CARE, V193, P154, DOI 10.1164/rccm.201505-0900OC; Curtis JR, 2015, AM J RESPIR CRIT CAR; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Davidson JE, 2012, CRIT CARE MED, V40, P1675, DOI 10.1097/CCM.0b013e318249594a; Davidson JE, 2012, CRIT CARE MED, V40, P671, DOI 10.1097/CCM.0b013e3182372998; Douglas Sara L, 2010, J Crit Care, V25, DOI 10.1016/j.jcrc.2009.09.004; Douglas SL, 2005, CHEST, V128, P3925, DOI 10.1378/chest.128.6.3925; Downar J, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.11.024; Ernecoff NC, 2016, J CRIT CARE, V33, P19, DOI 10.1016/j.jcrc.2016.01.030; Grap MJ, 2003, HEART LUNG, V32, P162, DOI 10.1016/S0147-9563(03)00031-1; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hwang DY, J CRIT CARE; Jones C, 2004, INTENS CARE MED, V30, P456, DOI 10.1007/s00134-003-2149-5; Kon AA, 2015, CRIT CARE MED; Kross EK, 2012, J PAIN SYMPTOM MANAG, V44, P671, DOI 10.1016/j.jpainsymman.2011.11.008; Kynoch Kate, 2016, JBI Database System Rev Implement Rep, V14, P181, DOI 10.11124/JBISRIR-2016-2477; Larkin ME, 2013, CLIN TRIALS, V10, P93, DOI 10.1177/1740774512464727; LeClaire MM, 2005, CHEST, V128, P1728, DOI 10.1378/chest.128.3.1728; Lemiale V, 2010, J PALLIAT MED, V13, P1131, DOI 10.1089/jpm.2010.0109; Marks MAZ, 2008, MED DECIS MAKING, V28, P524, DOI 10.1177/0272989X08315244; McAdam JL, 2012, AM J CRIT CARE, V21, P386, DOI 10.4037/ajcc2012582; Mistraletti G., 2016, INTENS CARE MED, V1, P1; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Nelson JE, 2010, CRIT CARE MED, V38, P808, DOI 10.1097/CCM.0b013e3181c5887c; Netzer Giora, 2014, Ann Am Thorac Soc, V11, P435, DOI 10.1513/AnnalsATS.201309-308OT; Nunez ER, 2015, CRIT CARE MED, V43, P2387, DOI 10.1097/CCM.0000000000001270; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Rusinova K, 2009, CRIT CARE MED, V37, pS140, DOI [10.1097/CCM.0b013e31819207e7, 10.1097/CCM.0b013e3181b6e145]; Schenker Y, 2012, J GEN INTERN MED, V27, P1657, DOI 10.1007/s11606-012-2129-y; Schuster RA, 2014, CRIT CARE MED, V42, P328, DOI 10.1097/CCM.0b013e3182a27598; Schwartz AAGJS, 2006, DEFINING HEALTH CARE; Sudore RL, 2014, J PAIN SYMPTOM MANAG, V48, P1108, DOI 10.1016/j.jpainsymman.2014.04.001; Torke AM, 2014, JAMA INTERN MED, V174, P370, DOI 10.1001/jamainternmed.2013.13315; Van Pelt DC, 2007, AM J RESP CRIT CARE, V175, P167, DOI 10.1164/rccm.200604-493OC; Volandes AE, 2009, J AM MED DIR ASSOC, V10, P575, DOI 10.1016/j.jamda.2009.05.006; White DB, 2007, ANN INTERN MED, V147, P34, DOI 10.7326/0003-4819-147-1-200707030-00006	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177741	10.1371/journal.pone.0177741	http://dx.doi.org/10.1371/journal.pone.0177741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542632	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800024
J	Guan, F; Lu, XJ; Li, CH; Chen, J				Guan, Feng; Lu, Xin-Jiang; Li, Chang-Hong; Chen, Jiong			Molecular characterization of mudskipper (Boleophthalmus pectinirostris) hypoxia-inducible factor-1 alpha(HIF-1 alpha) and analysis of its function in monocytes/ macrophages	PLOS ONE			English	Article							FACTOR-ALPHA SUBUNITS; NF-KAPPA-B; IMMUNE-RESPONSES; EXPRESSION ANALYSIS; MESSENGER-RNA; TELEOST FISH; FACTOR HIF; HIF-1-ALPHA; LIPOPOLYSACCHARIDE; FACTOR-1	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) plays a critical role in immune and inflammatory responses and is important in controlling a variety of processes in monocytes and macrophages. However, very little information is available about the functions of HIF-1a in fish monocytes/macrophages (MO/M phi). In this study, the cDNA sequence of the mudskipper (Boleophthalmus pectinirostris) HIF-1 alpha gene (BpHIF-1 alpha) was determined. Sequence comparison and phylogenetic tree analysis showed that BpHIF-1 alpha is clustered in the fish HIF-1a tree. Constitutive expression of BpHIF-1 alpha mRNA was detected by real-time quantitative PCR in all tested tissues, and the expression was found to be dramatically increased in the skin, liver, spleen, and kidney after Edwardsiella tarda infection. In addition, hypoxia and infection induced the expression of the BpHIF-1a transcript and protein in MO/M., respectively. Hypoxia caused an increase in phagocytic and bactericidal capacity of mudskipper MO/M. in a BpHIF-1 alpha-dependent manner. BpHIF-1 alpha induced an anti-inflammatory status in MO/M. upon E. tarda infection and hypoxia. Therefore, BpHIF-1 alpha may play a predominant role in the modulation of mudskipper MO/M. function in the innate immune system.	[Guan, Feng; Lu, Xin-Jiang; Li, Chang-Hong; Chen, Jiong] Ningbo Univ, Sch Marine Sci, Lab Biochem & Mol Biol, Ningbo, Zhejiang, Peoples R China; [Guan, Feng] Zhejiang Wanli Univ, Coll Biol & Environm Sci, Ningbo, Zhejiang, Peoples R China; [Chen, Jiong] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China	Ningbo University; Zhejiang Wanli University; Ningbo University	Chen, J (corresponding author), Ningbo Univ, Sch Marine Sci, Lab Biochem & Mol Biol, Ningbo, Zhejiang, Peoples R China.; Chen, J (corresponding author), Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China.	jchen1975@163.com			Program for the National Natural Science Foundation of China [31472300]; Zhejiang Provincial Natural Science Foundation of China [LY17C190003]; Young Talent Cultivation Project of Zhejiang Association for Science and Technology [2016YCGC003]	Program for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Young Talent Cultivation Project of Zhejiang Association for Science and Technology	The project was supported by the Program for the National Natural Science Foundation of China (31472300) (http://www.nsfc.gov.cn/), Zhejiang Provincial Natural Science Foundation of China (LY17C190003) (http://www.zinsf.gov.cn/), and Young Talent Cultivation Project of Zhejiang Association for Science and Technology (2016YCGC003) (http://www.zast.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Chen J, 2014, FISH SHELLFISH IMMUN, V41, P586, DOI 10.1016/j.fsi.2014.10.012; Chen N, 2012, GENE, V498, P81, DOI 10.1016/j.gene.2011.12.058; Chen Q, 2016, ZOOL RES, V37, P96, DOI 10.13918/j.issn.2095-8137.2016.2.96; Choi K, 2007, J AQUAT ANIM HEALTH, V19, P128, DOI 10.1577/H06-010.1; Couturier CS, 2013, COMP BIOCHEM PHYS A, V166, P482, DOI 10.1016/j.cbpa.2013.07.025; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Ellis AE, 1999, FISH SHELLFISH IMMUN, V9, P291, DOI 10.1006/fsim.1998.0192; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Hagberg H, 1996, PEDIATR RES, V40, P603, DOI 10.1203/00006450-199610000-00015; Herbert N.A., 2013, P129; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kvamme BO, 2013, FISH SHELLFISH IMMUN, V34, P55, DOI 10.1016/j.fsi.2012.10.006; Law SHW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-15; Legendre C, 2012, INFECT IMMUN, V80, P3985, DOI 10.1128/IAI.00554-12; Li XF, 2016, FISH SHELLFISH IMMUN, V49, P298, DOI 10.1016/j.fsi.2016.01.004; Lu XJ, 2009, NEUROSCIENCE, V162, P404, DOI 10.1016/j.neuroscience.2009.05.011; Lu XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12719; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Mi Z, 2008, CELL CYCLE, V7, P232, DOI 10.4161/cc.7.2.5193; Mulder IE, 2007, FISH SHELLFISH IMMUN, V23, P747, DOI 10.1016/j.fsi.2007.02.002; Ng KT, 2011, J PERIODONTOL, V82, P136, DOI 10.1902/jop.2010.100100; Ni M, 2014, FISH SHELLFISH IMMUN, V36, P325, DOI 10.1016/j.fsi.2013.12.002; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Rahman MS, 2007, GENE, V396, P273, DOI 10.1016/j.gene.2007.03.009; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Seppola M, 2008, MOL IMMUNOL, V45, P887, DOI 10.1016/j.molimm.2007.08.003; Sharma M, 2011, CELL MICROBIOL, V13, P1573, DOI 10.1111/j.1462-5822.2011.01642.x; Sollid J, 2006, J COMP PHYSIOL B, V176, P359, DOI 10.1007/s00360-005-0059-2; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terova G, 2008, AQUACULTURE, V279, P150, DOI 10.1016/j.aquaculture.2008.03.041; Tingbo MG, 2012, FISH SHELLFISH IMMUN, V33, P582, DOI 10.1016/j.fsi.2012.06.025; Tsang PS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-101; Walmsley SR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2632; Wei H, 2015, FISH SHELLFISH IMMUN, V44, P445, DOI 10.1016/j.fsi.2015.03.023; Wiegertjes GF, 2016, MOL IMMUNOL, V69, P146, DOI 10.1016/j.molimm.2015.09.026; Wiese M, 2012, INFECT IMMUN, V80, P1455, DOI 10.1128/IAI.05972-11; Wiley M, 2010, J BIOL CHEM, V285, P26852, DOI 10.1074/jbc.M110.147041; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang GJ, 2015, FISH SHELLFISH IMMUN, V44, P603, DOI 10.1016/j.fsi.2015.03.037; You XX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6594; Zhang RC, 2011, FISH SHELLFISH IMMUN, V31, P911, DOI 10.1016/j.fsi.2011.08.008; Zhao Y, 2015, AQUACULTURE RES; Zhu CD, 2013, J COMP PHYSIOL B, V183, P1005, DOI 10.1007/s00360-013-0762-3; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	52	16	20	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177960	10.1371/journal.pone.0177960	http://dx.doi.org/10.1371/journal.pone.0177960			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542591	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500046
J	Magzal, F; Sela, S; Szuchman-Sapir, A; Tamir, S; Michelis, R; Kristal, B				Magzal, Faiga; Sela, Shifra; Szuchman-Sapir, Andrea; Tamir, Snait; Michelis, Regina; Kristal, Batya			In-vivo oxidized albumin - a pro-inflammatory agent in hypoalbuminemia	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; RENAL-DISEASE; HEMODIALYSIS	Hypoalbuminemia of Hemodialysis (HD) patients is an independent cardiovascular risk factor, however, there is no mechanistic explanation between hypoalbuminemia and vascular injury. In the event of oxidative stress and inflammation to which HD patients are exposed, albumin is oxidized and undetected by common laboratory methods, rendering an apparent hypoalbuminemia. We wanted to show that these circulating modified oxidized albumin molecules cause direct vascular damage, mediating inflammation. Once these in-vivo albumin modifications were reduced in-vitro, the apparent hypoalbuminemia concomitantly with its inflammatory effects, were eliminated. Albumin modification profiles from 14 healthy controls (HC) and 14 HD patients were obtained by mass spectrometry (MS) analyses before and after reduction in-vitro, using redox agent 1,4 dithiothreitol (DTT). Their inflammatory effects were explored by exposing human umbilical endothelial cells (HUVEC) to all these forms of albumin. Albumin separated from hypoalbuminemic HD patients increased endothelial mRNA expression of cytokines and adhesion molecules, and augmented secretion of IL-6. This endothelial inflammatory state was almost fully reverted by exposing HUVEC to the in-vitro reduced HD albumin. MS profile of albumin modifications peaks was similar between HD and HC, but the intensities of the various peaks were significantly different. Abolishing the reversible oxidative modifications by DTT prevented endothelial injury and increased albumin levels. The irreversible modifications such as glycation and sulfonation show low intensities in HD albumin profiles and are nearly unobserved in HC. We showed, for the first time, a mechanistic link between hypoalbuminemia and the pro-inflammatory properties of in-vivo oxidized albumin, initiating vascular injury.	[Magzal, Faiga; Sela, Shifra; Michelis, Regina] Galilee Med Ctr, Eliachar Res Lab, Nahariyya, Israel; [Magzal, Faiga; Sela, Shifra; Kristal, Batya] Bar Ilan Univ, Fac Med Galilee, Safed, Israel; [Magzal, Faiga; Szuchman-Sapir, Andrea; Tamir, Snait] MIGAL Galilee Res Inst, Lab Human Hlth & Nutr Sci, Kiryat Shmona, Israel; [Kristal, Batya] Galilee Med Ctr, Dept Hypertens & Nephrol, Nahariyya, Israel	Western Galilee Hospital; Bar Ilan University; Western Galilee Hospital	Kristal, B (corresponding author), Bar Ilan Univ, Fac Med Galilee, Safed, Israel.; Kristal, B (corresponding author), Galilee Med Ctr, Dept Hypertens & Nephrol, Nahariyya, Israel.	BatyaK@gmc.gov.il			Bar IIan University Faculty of Medicine; Council for Higher Education in Israel scholarship	Bar IIan University Faculty of Medicine; Council for Higher Education in Israel scholarship	This work was supported by Bar IIan University Faculty of Medicine - grant to Faiga Magzal; and Council for Higher Education in Israel scholarship to Faiga Magzal. There are no other funding sources.	Anraku M, 2001, J PHARM SCI, V100, P3968; Bar-Or D, 2005, CRIT CARE MED, V33, P1638, DOI 10.1097/01.CCM.0000169876.14858.91; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Danielski M, 2003, AM J KIDNEY DIS, V42, P286, DOI 10.1016/S0272-6386(03)00653-X; FORSTERMANN U, 1994, HYPERTENSION, V23, P1121, DOI 10.1161/01.HYP.23.6.1121; Jofre R, 2006, J AM SOC NEPHROL, V17, pS274, DOI 10.1681/ASN.2006080926; Kalantar-Zadeh K, 2005, NEPHROL DIAL TRANSPL, V20, P1880, DOI 10.1093/ndt/gfh941; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Lim PS, 2007, NEPHROLOGY, V12, P18, DOI 10.1111/j.1440-1797.2006.00745.x; Mao P, 2014, J PROTEOME RES, V13, P1560, DOI 10.1021/pr401074t; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; Mera K, 2005, BIOCHEM BIOPH RES CO, V334, P1322, DOI 10.1016/j.bbrc.2005.07.035; Michelis R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159839; Michelis R, 2013, FREE RADICAL BIO MED, V60, P49, DOI 10.1016/j.freeradbiomed.2013.02.005; Michelis R, 2010, BIOCHEM BIOPH RES CO, V401, P137, DOI 10.1016/j.bbrc.2010.09.027; Nagumo K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085216; Ogasawara Y, 2007, J CHROMATOGR B, V845, P157, DOI 10.1016/j.jchromb.2006.08.006; Rashid G, 2004, KIDNEY INT, V66, P1099, DOI 10.1111/j.1523-1755.2004.00860.x; Regazzoni L, 2013, FREE RADICAL RES, V47, P172, DOI 10.3109/10715762.2012.756139; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Soejima A, 2004, BLOOD PURIFICAT, V22, P525, DOI 10.1159/000082524; Spoto B, 2012, NUTR METAB CARDIOVAS, V22, P981, DOI 10.1016/j.numecd.2011.01.005; Taverna M, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-4; Vielhauer V, 2004, KIDNEY BLOOD PRESS R, V27, P226, DOI 10.1159/000079867; Xiao S, 2001, AM J PHYSIOL-RENAL, V280, pF989, DOI 10.1152/ajprenal.2001.280.6.F989	25	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177799	10.1371/journal.pone.0177799	http://dx.doi.org/10.1371/journal.pone.0177799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542419	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500038
J	Ondrakova, M; Motovska, Z; Waldauf, P; Knot, J; Havluj, L; Bittner, L; Bartoska, R; Gurlich, R; Krbec, M; Dzupa, V; Grill, R; Widimsky, P				Ondrakova, Martina; Motovska, Zuzana; Waldauf, Petr; Knot, Jiri; Havluj, Lukas; Bittner, Lukas; Bartoska, Radek; Gurlich, Robert; Krbec, Martin; Dzupa, Valer; Grill, Robert; Widimsky, Petr			Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study	PLOS ONE			English	Article							RECURRENT VENOUS THROMBOEMBOLISM; RISK; MORTALITY; ASPIRIN; STROKE; PREDICTION	Background The study investigated the discharge antithrombotic medication in patients with atrial fibrillation (AF) after major non-cardiac surgery and the impact on one-year outcomes. Methods A subgroup of 366 patients (mean age 75.9 +/- 10.5 years, women 42.3%, acute surgery 42.9%) undergoing major non-cardiac surgery and having any form of AF (30.6% of the total population enrolled in the PRAGUE-14 study) was followed for 1 year. Results Antithrombotics (interrupted due to surgery) were resumed until discharge in 51.8% of patients; less frequently in men (OR 0.6 (95% CI 0.95 to 0.35); p = 0.029), and in patients undergoing elective surgery (OR 0.6 (95% CI 0.91 to 0.33); p = 0.021). Dual antiplatelet therapy was resumed more often (91.7%) in comparison to aspirin monotherapy (57.3%; p = 0.047), and vitamin K antagonist (56.3%; p = 0.042). Patients with AF had significantly higher one-year mortality (22.1%) than patients without AF (14.1%, p = 0.001). The causes of death were: ischaemic events (32.6% of deaths), bleeding events (8.1%), others (N = 51; 59.3%, 20 of them died due to cancer). Non-reinstitution of aspirin until discharge was associated with higher one-year mortality (17.6% vs. 34.8%; p = 0.018). Conclusion Preoperatively interrupted antithrombotics were re-administrated at discharge only in half of patients with AF, less likely in male patients and those undergoing elective surgery. The presence of AF was recognized as a predictor of one-year mortality, especially if aspirin therapy was not resumed until discharge.	[Motovska, Zuzana] Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Prague, Czech Republic; Charles Univ Prague, Fac Med 3, Prague, Czech Republic	Charles University Prague; University Hospital Vinohrady; Charles University Prague	Motovska, Z (corresponding author), Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Prague, Czech Republic.	motovska.zuzana@gmail.com	Motovska, Zuzana/J-1122-2016; Widimsky, Petr/P-8088-2016; Dzupa, Valer/D-1423-2018; Waldauf, Petr/K-6785-2017	Motovska, Zuzana/0000-0002-5319-473X; Widimsky, Petr/0000-0001-5686-7752; Dzupa, Valer/0000-0002-0291-6456; Waldauf, Petr/0000-0003-4668-5837				Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Fleisher LA, 1999, ANESTH ANALG, V89, P849, DOI 10.1097/00000539-199910000-00007; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Gialdini G, 2014, JAMA-J AM MED ASSOC, V312, P616, DOI 10.1001/jama.2014.9143; Kakkar AK, 2012, AM HEART J, V163, P13, DOI 10.1016/j.ahj.2011.09.011; Kannel WB, 2008, MED CLIN N AM, V92, P17, DOI 10.1016/j.mcna.2007.09.002; Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Lip GYH, 2014, AM J MED, V127, P519, DOI 10.1016/j.amjmed.2013.12.022; McAlister FA, 2015, J THROMB HAEMOST, V13, P1768, DOI 10.1111/jth.13110; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Naughton C, 2007, INT J CLIN PRACT, V61, P768, DOI 10.1111/j.1742-1241.2007.01304.x; Simes J, 2014, CIRCULATION, V130, P1062, DOI 10.1161/CIRCULATIONAHA.114.008828; van Diepen S, 2011, CIRCULATION, V124, P289, DOI 10.1161/CIRCULATIONAHA.110.011130; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Widimsky P, 2014, NETH HEART J, V22, P372, DOI 10.1007/s12471-014-0575-3; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481	19	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177519	10.1371/journal.pone.0177519	http://dx.doi.org/10.1371/journal.pone.0177519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542316	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500030
J	Petry, SF; Sharifpanah, F; Sauer, H; Linn, T				Petry, Sebastian Friedrich; Sharifpanah, Fatemeh; Sauer, Heinrich; Linn, Thomas			Differential expression of islet glutaredoxin 1 and 5 with high reactive oxygen species production in a mouse model of diabesity	PLOS ONE			English	Article							NF-KAPPA-B; PANCREATIC BETA-CELLS; DIETARY IRON RESTRICTION; S-GLUTATHIONYLATION; INTERACTING PROTEIN; GLUCOSE TOXICITY; OXIDATIVE STRESS; REDOX CONTROL; 3 PICOT; THIOREDOXIN	The onset and progression of diabetes mellitus type 2 is highly contingent on the amount of functional beta-cell mass. An underlying cause of beta-cell decay in diabetes is oxidative stress, which markedly affects the insulin producing pancreatic cells due to their poor antioxidant defence capacity. Consequently, disturbances of cellular redox signaling have been implicated to play a major role in beta-cell loss in diabetes mellitus type 2. There is evidence suggesting that the glutaredoxin (Grx) system exerts a protective role for pancreatic islets, but the exact mechanisms have not yet been elucidated. In this study, a mouse model for diabetes mellitus type 2 was used to gain further insight into the significance of Grx for the islets of Langerhans in the diabetic metabolism. We have observed distinct differences in the expression levels of Grx in pancreatic islets between obese, diabetic db mice and lean, non-diabetic controls. This finding is the first report about a decrease of Grx expression levels in pancreatic islets of diabetic mice which was accompanied by declining insulin secretion, increase of reactive oxygen species (ROS) production level, and cell cycle alterations. These data demonstrate the essential role of the Grx system for the beta-cell during metabolic stress which may provide a new target for diabetes mellitus type 2 treatment.	[Petry, Sebastian Friedrich; Linn, Thomas] Justus Liebig Univ, Ctr Internal Med, Clin Res Unit, Giessen, Germany; [Sharifpanah, Fatemeh; Sauer, Heinrich] Justus Liebig Univ, Dept Physiol, Fac Med, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Petry, SF (corresponding author), Justus Liebig Univ, Ctr Internal Med, Clin Res Unit, Giessen, Germany.	sebastian.petry@innere.med.uni-giessen.de	Sharifpanah, Fatemeh/I-5199-2018	Sharifpanah, Fatemeh/0000-0001-7435-1805; Petry, Sebastian Friedrich/0000-0002-3496-9894	University of Giessen; Center of Internal Medicine	University of Giessen; Center of Internal Medicine	General funding from University of Giessen and Center of Internal Medicine granted to Clinical Research Unit were used for realization of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; ARKHAMMAR P, 1994, J BIOL CHEM, V269, P2743; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Bolt HM, 2009, EXCLI J, V8, P241; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; Curi R, 2016, PLOS ONE, V11; Daily D, 2001, J BIOL CHEM, V276, P1335, DOI 10.1074/jbc.M008121200; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; DISIMPLICIO P, 1995, EUR J CLIN INVEST, V25, P665; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dong KL, 2016, FREE RADICAL BIO MED, V101, P334, DOI 10.1016/j.freeradbiomed.2016.10.007; Du YT, 2014, ACTA DIABETOL, V51, P225, DOI 10.1007/s00592-013-0498-2; Enoksson M, 2005, BIOCHEM BIOPH RES CO, V327, P774, DOI 10.1016/j.bbrc.2004.12.067; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Gavin JR, 1999, DIABETES CARE, V22, pS5; Godoy JR, 2011, BBA-GEN SUBJECTS, V1810, P2, DOI 10.1016/j.bbagen.2010.05.006; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Hanschmann EM, 2011, THESIS; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Haunhorst P, 2013, MOL BIOL CELL, V24, P1895, DOI 10.1091/mbc.E12-09-0648; Haunhorst P, 2010, BIOCHEM BIOPH RES CO, V394, P372, DOI 10.1016/j.bbrc.2010.03.016; Hirota K, 2000, BIOCHEM BIOPH RES CO, V274, P177, DOI 10.1006/bbrc.2000.3106; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Ikeda Y, 2013, AM J PHYSIOL-RENAL, V304, pF1028, DOI 10.1152/ajprenal.00473.2012; ISLAM MS, 1993, FEBS LETT, V319, P128, DOI 10.1016/0014-5793(93)80051-U; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Kato N, 2008, CELL IMMUNOL, V251, P62, DOI 10.1016/j.cellimm.2008.04.005; Kilimnik G, 2009, AM J PHYSIOL-ENDOC M, V297, pE1331, DOI 10.1152/ajpendo.00479.2009; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; KRIPPEITDREWS P, 1994, PFLUG ARCH EUR J PHY, V426, P552, DOI 10.1007/BF00378534; Kubisch HM, 1997, DIABETES, V46, P1563, DOI 10.2337/diabetes.46.10.1563; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; Lekli I, 2010, GENE THER, V17, P478, DOI 10.1038/gt.2010.9; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li N, 2012, DIABETES, V61, P2842, DOI 10.2337/db12-0009; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Liu XJ, 2015, BIOCHEM BIOPH RES CO, V464, P730, DOI 10.1016/j.bbrc.2015.07.016; Lundberg M, 2004, BIOCHEM BIOPH RES CO, V319, P801, DOI 10.1016/j.bbrc.2004.04.199; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Reinbothe TM, 2009, MOL ENDOCRINOL, V23, P893, DOI 10.1210/me.2008-0306; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Sauer H, 2012, INT J ONCOL, V40, P501, DOI 10.3892/ijo.2011.1230; Seghieri G, 2000, CLIN CHIM ACTA, V299, P109, DOI 10.1016/S0009-8981(00)00283-7; Shelton MD, 2007, J BIOL CHEM, V282, P12467, DOI 10.1074/jbc.M610863200; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Takahashi HK, 2014, BIOCHEM J, V460, P411, DOI 10.1042/BJ20131361; Takashima Y, 1999, IMMUNOL LETT, V68, P397, DOI 10.1016/S0165-2478(99)00087-5; THORENS B, 1992, J CLIN INVEST, V90, P77, DOI 10.1172/JCI115858; Tretter L, 2000, J NEUROSCI, V20, P8972; Ullrich V, 2006, J INORG BIOCHEM, V100, P2079, DOI 10.1016/j.jinorgbio.2006.09.019; Ward NE, 2000, BIOCHEMISTRY-US, V39, P10319, DOI 10.1021/bi000781g; Warwar N, 2006, DIABETES, V55, P590, DOI 10.2337/diabetes.55.03.06.db05-0001; Wetzelberger K, 2010, J BIOL CHEM, V285, P26135, DOI 10.1074/jbc.M110.146423; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902	72	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0176267	10.1371/journal.pone.0176267	http://dx.doi.org/10.1371/journal.pone.0176267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542222	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500005
J	Chen, L; Lu, D; Wang, T; Li, Z; Zhao, Y; Jiang, Y; Zhang, Q; Cao, Q; Fang, K; Xing, Y; Qin, L				Chen, Liangke; Lu, Dan; Wang, Teng; Li, Zhi; Zhao, Yanyan; Jiang, Yichen; Zhang, Qing; Cao, Qingqin; Fang, Kefeng; Xing, Yu; Qin, Ling			Identification and expression analysis of starch branching enzymes involved in starch synthesis during the development of chestnut (Castanea mollissima Blume) cotyledons	PLOS ONE			English	Article							RICE ENDOSPERM; PHYSICOCHEMICAL PROPERTIES; AMYLOPECTIN BIOSYNTHESIS; ESCHERICHIA-COLI; AMYLOSE; INCREASES; ISOFORMS; GRAINS; GENES; MAIZE	Chinese chestnut (Castanea mollissima Blume) is native to China and distributes widely in arid and semi-arid mountain area with barren soil. As a perennial crop, chestnut is an alternative food source and acts as an important commercial nut tree in China. Starch is the major metabolite in nuts, accounting for 46 similar to 64% of the chestnut dry weight. The accumulation of total starch and amylopectin showed a similar increasing trend during the development of nut. Amylopectin contributed up to 76% of the total starch content at 80 days after pollination (DAP). The increase of total starch mainly results from amylopectin synthesis. Among genes associated with starch biosynthesis, CmSBEs (starch branching enzyme) showed significant increase during nut development. Two starch branching enzyme isoforms, CmSBE I and CmSBE II, were identified from chestnut cotyledon using zymogram analysis. CmSBE I and CmSBE II showed similar patterns of expression during nut development. The accumulations of CmSBE transcripts and proteins in developing cotyledons were characterized. The expressions of two CmSBE genes increased from 64 DAP and reached the highest levels at 77 DAP, and SBE activity reached its peak at 74 DAP. These results suggested that the CmSBE enzymes mainly contributed to amylopectin synthesis and influenced the amylopectin content in the developing cotyledon, which would be beneficial to chestnut germplasm selection and breeding.	[Chen, Liangke; Lu, Dan; Wang, Teng; Li, Zhi; Zhao, Yanyan; Jiang, Yichen; Xing, Yu; Qin, Ling] Beijing Agr Univ, Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Coll Plant Sci & Technol, Beijing, Peoples R China; [Zhang, Qing] Beijing Agr Univ, Beijing Key Lab Agr Applicat & New Tech, Beijing, Peoples R China; [Cao, Qingqin] Minist Agr, Key Lab Urban Agr North China, Beijing, Peoples R China; [Fang, Kefeng] Beijing Agr Univ, Coll Landscape Architecture, Beijing, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture; Ministry of Agriculture & Rural Affairs; Beijing University of Agriculture	Xing, Y; Qin, L (corresponding author), Beijing Agr Univ, Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Coll Plant Sci & Technol, Beijing, Peoples R China.	xingyubua@163.com; qinlingbac@126.com		Qin, Ling/0000-0002-9814-5771	National Natural Science Foundation of China [31370679, 31672135]; Beijing Science and Technology Plan Project [Z161100000916011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Plan Project	This work was supported by the National Natural Science Foundation of China (Grant No. 31370679, No. 31672135) and Beijing Science and Technology Plan Project (Z161100000916011).	Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; Botticella E, 2012, MOL GENET GENOMICS, V287, P515, DOI 10.1007/s00438-012-0694-8; BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4; Brummell DA, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0143-y; Carciofi M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-223; Chang JW, 2010, J AGR FOOD CHEM, V58, P10437, DOI 10.1021/jf102129f; Cheng L., 2009, BIOLOGY, P10; Cogez V, 2013, PLOS ONE, V8; Crofts N, 2015, J EXP BOT, V66, P4469, DOI 10.1093/jxb/erv212; Diego F, 2013, AM J POTATO RES; Gounga ME, 2008, J ZHEJIANG UNIV-SC B, V9, P675, DOI 10.1631/jzus.B0820138; GUAN HP, 1995, P NATL ACAD SCI USA, V92, P964, DOI 10.1073/pnas.92.4.964; Hamada S, 2002, J BIOL CHEM, V277, P16538, DOI 10.1074/jbc.M110497200; Hanyu YC, 2013, J AGR FOOD CHEM, V61, P379; He ZF, 1981, PROG BIOCHEM BIOPHYS, V1, P70; Higgins JE, 2013, J SCI FOOD AGR, V93, P2137, DOI 10.1002/jsfa.6019; Hikaru S, 2008, PLANT CELL, V20, P1833; Jiang LL, 2013, TRANSGENIC RES, V22, P1133, DOI 10.1007/s11248-013-9717-4; Kim WS, 2005, PLANTA, V220, P689, DOI 10.1007/s00425-004-1386-3; Ko YT, 2009, J AGR FOOD CHEM, V57, P871, DOI 10.1021/jf802544b; Kubo A, 2005, PLANT PHYSIOL, V137, P43, DOI 10.1104/pp.104.051359; Lai YC, 2016, FOOD CHEM, V199, P556, DOI 10.1016/j.foodchem.2015.12.053; Li C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125507; Li Q, 2016, FOOD CHEM, V201, P80, DOI 10.1016/j.foodchem.2016.01.068; Li XL, 2016, CARBOHYD POLYM, V137, P459, DOI 10.1016/j.carbpol.2015.10.079; Lin JH, 2013, CARBOHYD POLYM, V98, P1553, DOI 10.1016/j.carbpol.2013.07.039; Liu FS, 2016, PLANT BIOTECHNOL J, V14, P976, DOI 10.1111/pbi.12453; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MARTIN C, 1995, PLANT CELL, V7, P971, DOI 10.1105/tpc.7.7.971; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; Nozaki K, 2001, BIOSCI BIOTECH BIOCH, V65, P1141, DOI 10.1271/bbb.65.1141; Qin GZ, 2007, MOL CELL PROTEOMICS, V6, P425, DOI 10.1074/mcp.M600179-MCP200; Rahman S, 2001, PLANT PHYSIOL, V125, P1314, DOI 10.1104/pp.125.3.1314; Regina A, 2006, P NATL ACAD SCI USA, V103, P3546, DOI 10.1073/pnas.0510737103; Smith AM, 1997, ANNU REV PLANT PHYS, V48, P65, DOI 10.1146/annurev.arplant.48.1.67; Sun CX, 1996, PHYSIOL PLANTARUM, V96, P474, DOI 10.1111/j.1399-3054.1996.tb00461.x; Syahariza ZA, 2013, FOOD CHEM, V136, P742, DOI 10.1016/j.foodchem.2012.08.053; Szydlowski N, 2011, J EXP BOT, V62, P4547, DOI 10.1093/jxb/err172; TAIRA K, 1991, NUCLEIC ACIDS RES, V19, P5125, DOI 10.1093/nar/19.19.5125; Takeda Y, 1999, CARBOHYD POLYM, V38, P109, DOI 10.1016/S0144-8617(98)00105-2; Tetlow IJ, 2011, SEED SCI RES, V21, P5, DOI 10.1017/S0960258510000292; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Wang GP, 2008, HEBEI FRUITS, V4, P6; Wei CX, 2010, J AGR FOOD CHEM, V58, P11097, DOI 10.1021/jf1024533; Wu AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065768; Yandeau-Nelson MD, 2011, PLANT PHYSIOL, V156, P479, DOI 10.1104/pp.111.174094; Zhang L, 2015, J AGR FOOD CHEM, V63, P929, DOI 10.1021/jf505247d	51	8	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177792	10.1371/journal.pone.0177792	http://dx.doi.org/10.1371/journal.pone.0177792			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542293	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058800026
J	Lewandowska, DW; Schreiber, PW; Schuurmans, MM; Ruehe, B; Zagordi, O; Bayard, C; Greiner, M; Geissberger, FD; Capaul, R; Zbinden, A; Boni, J; Benden, C; Mueller, NJ; Trkola, A; Huber, M				Lewandowska, Dagmara W.; Schreiber, Peter W.; Schuurmans, Mace M.; Ruehe, Bettina; Zagordi, Osvaldo; Bayard, Cornelia; Greiner, Michael; Geissberger, Fabienne D.; Capaul, Riccarda; Zbinden, Andrea; Boni, Jurg; Benden, Christian; Mueller, Nicolas J.; Trkola, Alexandra; Huber, Michael			Metagenomic sequencing complements routine diagnostics in identifying viral pathogens in lung transplant recipients with unknown etiology of respiratory infection	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS SYNDROME; DNA LEVELS; TT VIRUS; HERPESVIRUSES; CHILDREN; LIBRARY; IMPACT; TRACT; HHV-7	Background Lung transplant patients are a vulnerable group of immunosuppressed patients that are prone to frequent respiratory infections. We studied 60 episodes of respiratory symptoms in 71 lung transplant patients. Almost half of these episodes were of unknown infectious etiology despite extensive routine diagnostic testing. Methods We re-analyzed respiratory samples of all episodes with undetermined etiology in order to detect potential viral pathogens missed/not accounted for in routine diagnostics. Respiratory samples were enriched for viruses by filtration and nuclease digestion, whole nucleic acids extracted and randomly amplified before high throughput metagenomic virus sequencing. Viruses were identified by a bioinformatic pipeline and confirmed and quantified using specific real-time PCR. Results In completion of routine diagnostics, we identified and confirmed a viral etiology of infection by our metagenomic approach in four patients (three Rhinovirus A, one Rhinovirus B infection) despite initial negative results in specific multiplex PCR. Notably, the majority of samples were also positive for Torque teno virus (TTV) and Human Herpesvirus 7 (HHV-7). While TTV viral loads increased with immunosuppression in both throat swabs and blood samples, HHV-7 remained at low levels throughout the observation period and was restricted to the respiratory tract. Conclusion This study highlights the potential of metagenomic sequencing for virus diagnostics in cases with previously unknown etiology of infection and in complex diagnostic situations such as in immunocompromised hosts.	[Lewandowska, Dagmara W.; Ruehe, Bettina; Zagordi, Osvaldo; Geissberger, Fabienne D.; Capaul, Riccarda; Zbinden, Andrea; Boni, Jurg; Trkola, Alexandra; Huber, Michael] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Schreiber, Peter W.; Bayard, Cornelia; Greiner, Michael; Mueller, Nicolas J.] Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Schuurmans, Mace M.; Benden, Christian] Univ Hosp Zurich, Div Pulm Med, Zurich, Switzerland; [Ruehe, Bettina] London Sch Hyg & Trop Med, London, England	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of London; London School of Hygiene & Tropical Medicine	Huber, M (corresponding author), Univ Zurich, Inst Med Virol, Zurich, Switzerland.	huber.michael@virology.uzh.ch	Mueller, Nicolas J./B-6864-2013; Trkola, Alexandra/K-2115-2012; Boeni, Juerg/B-8386-2015; Huber, Michael/B-8509-2015; Benden, Christian/E-9774-2012	Mueller, Nicolas J./0000-0002-1059-3191; Trkola, Alexandra/0000-0003-1013-876X; Huber, Michael/0000-0002-0384-0000; Schuurmans, Mace M./0000-0001-5404-7566	Clinical Research Priority Program 'Viral Infectious Diseases' of the University of Zurich	Clinical Research Priority Program 'Viral Infectious Diseases' of the University of Zurich	Funding was provided by the Clinical Research Priority Program 'Viral Infectious Diseases' of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Berger C, 2001, J MED VIROL, V64, P505, DOI 10.1002/jmv.1078; Berger C, 2007, J MED VIROL, V79, P1147, DOI 10.1002/jmv.20899; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carratala Jordi, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 2, P63, DOI 10.1016/S0213-005X(12)70084-8; De Clercq E, 2001, REV MED VIROL, V11, P381, DOI 10.1002/rmv.336; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Emery VC, 2001, CLIN INFECT DIS, V32, P1357, DOI 10.1086/320000; Fisher CE, 2016, CLIN INFECT DIS, V62, P313, DOI 10.1093/cid/civ871; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; Garbino J, 2004, AM J RESP CRIT CARE, V170, P1197, DOI 10.1164/rccm.200406-781OC; Gorzer I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122975; Gorzer I, 2014, J HEART LUNG TRANSPL, V33, P320, DOI 10.1016/j.healun.2013.12.007; Gregson AL, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0529-6; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Khalifah AP, 2004, AM J RESP CRIT CARE, V170, P181, DOI 10.1164/rccm.200310-1359OC; Kidd IM, 2000, TRANSPLANTATION, V69, P2400, DOI 10.1097/00007890-200006150-00032; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kumar D, 2010, CURR OPIN INFECT DIS, V23, P374, DOI 10.1097/QCO.0b013e32833bc19d; Lewandowska DW, 2015, DIAGN MICR INFEC DIS, V83, P133, DOI 10.1016/j.diagmicrobio.2015.06.017; Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Maggi F, 2003, J VIROL, V77, P2418, DOI 10.1128/JVI.77.4.2418-2425.2003; Maggi F, 2001, J MED VIROL, V65, P418, DOI 10.1002/jmv.2051; Magnusson J, 2013, TRANSPLANTATION, V95, P383, DOI 10.1097/TP.0b013e318271d7f0; Manuel O, 2009, TRANSPLANTATION, V87, P719, DOI 10.1097/TP.0b013e3181963262; Mendez JC, 2001, J INFECT DIS, V183, P179, DOI 10.1086/317929; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Petty TJ, 2014, J CLIN MICROBIOL, V52, P3351, DOI 10.1128/JCM.01389-14; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; Razonable RR, 2013, AM J TRANSPLANT, V13, P67, DOI 10.1111/ajt.12008; Sayah DM, 2013, CLIN TRANSPLANT, V27, pE64, DOI 10.1111/ctr.12054; Schuurmans M.M., 2013, SWISS MED WEEKLY, V143; Schuurmans MM, 2012, RESPIRATION, V84, P163, DOI 10.1159/000339345; Schuurmans MM, 2014, EURASIAN J PULMONOL, V16, P144, DOI 10.5152/ejp.2014.87597; Schwartz KL, 2014, PEDIATRICS, V133, pE1541, DOI 10.1542/peds.2013-3344; Solonenko SA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-320; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Wunderli W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027483; Young JC, 2015, AM J TRANSPLANT, V15, P200, DOI 10.1111/ajt.13031; Yun ZB, 2000, TRANSPLANTATION, V69, P1733; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	47	42	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177340	10.1371/journal.pone.0177340	http://dx.doi.org/10.1371/journal.pone.0177340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542207	gold, Green Accepted, Green Published			2022-12-27	WOS:000402058800016
J	Ogna, VF; Blanchard, A; Vargas-Poussou, R; Ogna, A; Baron, S; Bertocchio, JP; Prot-Bertoye, C; Nevoux, J; Dubourg, J; Maruani, G; Mendes, M; Garcia-Castano, A; Treard, C; Lepottier, N; Houillier, P; Courbebaisse, M				Ogna, Valentina Forni; Blanchard, Anne; Vargas-Poussou, Rosa; Ogna, Adam; Baron, Stephanie; Bertocchio, Jean-Philippe; Prot-Bertoye, Caroline; Nevoux, Jerome; Dubourg, Julie; Maruani, Gerard; Mendes, Margarida; Garcia-Castano, Alejandro; Treard, Cyrielle; Lepottier, Nelly; Houillier, Pascal; Courbebaisse, Marie			Signification of distal urinary acidification defects in hypocitraturic patients	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; SJOGRENS-SYNDROME; CITRATE; EXCRETION; MUTATIONS; BAND-3	Background and objectives Hypocitraturia has been associated with metabolic acidosis and mineral disorders. The aim of this study was to investigate the occurrence of urinary acidification defects underlying hypocitraturia. Materials and methods This retrospective observational study included 67 patients (32 men), aged 40.7 +/- 15.1 years with hypocitraturia (< 1.67 mmol /24-h) and nephrolithiasis, nephrocalcinosis, and/or bone demineralization, referred to our center from 2000 to 2015. We aimed to assess renal distal acidification capacity, prevalence and mechanisms of urinary acidification defects. Patients with low baseline plasma HCO3-(< 22 mmol/L) were studied by bicarbonate loading or furo-semide/fludrocortisone tests. Patients with normal baseline plasma HCO3- had an ammonium-chloride challenge test. A normal response was a decrease in urinary pH < 5.3 and an increase in urinary NH4+ >= 33 mu mol/min and defined idiopathic hypocitraturia. Results Eleven patients (16.4%) had low HCO3- and overt distal acidification defect. Three had a mutation in the gene encoding AE1, 4 had Gougerot-Sjogren syndrome and no cause was found in the remaining 4 cases. Fifty-six patients (83.6%) had normal HCO3-; of those, 33 (58.9%) had idiopathic hypocitraturia. Among the 23 (41%) remaining patients, 12 were unable to increase urinary NH4+ excretion (among them, 8 were able to decrease urinary pH and 4 were not) whereas 11 were able to increase urinary NH4+ excretion but unable to decrease urinary pH. These 11 patients had higher fasting urinary calcium, reflecting bone resorption, than the other 12 patients: median 0.41 [0.24-0.47] vs. 0.22 [0.08-0.37] mmol/mmol creatinine (P = 0.04). Conclusions Patients with hypocitraturia and normal plasma HCO3- frequently show a latent acidification defect that can be further dissected into one of several subtypes based on urinary pH and NH4+ response to the acid load. Those patients with impaired urine acidification capacity but preserved NH4+ excretion exhibit particularly high calciuria and should be identified to optimize nephrolithiasis prevention.	[Ogna, Valentina Forni; Blanchard, Anne; Dubourg, Julie; Mendes, Margarida] Hop Europeen Georges Pompidou, AP HP, Ctr Invest Clin, Paris, France; [Blanchard, Anne; Vargas-Poussou, Rosa] Ctr Reference Malad Renales Hereditaires Enfant &, Paris, France; [Blanchard, Anne; Baron, Stephanie; Bertocchio, Jean-Philippe; Prot-Bertoye, Caroline; Houillier, Pascal; Courbebaisse, Marie] Univ Paris 05, Fac Med, Paris, France; [Vargas-Poussou, Rosa; Garcia-Castano, Alejandro; Treard, Cyrielle; Lepottier, Nelly] Hop Europeen Georges Pompidou, AP HP, Serv Genet, Paris, France; [Ogna, Adam; Maruani, Gerard] Hop Raymond Poincare, AP HP, INSERM CIC 14 29, Garches, France; [Baron, Stephanie; Bertocchio, Jean-Philippe; Prot-Bertoye, Caroline; Houillier, Pascal; Courbebaisse, Marie] Hop Europeen Georges Pompidou, AP HP, Unite Renale, Dept Physiol, Paris, France; [Nevoux, Jerome] Hop Bicetre, AP HP, Serv ORL, Paris, France; [Nevoux, Jerome] Univ Paris Saclay, Paris, France; [Nevoux, Jerome] INSERM 1182, Paris, France; [Maruani, Gerard; Courbebaisse, Marie] CNRS, UMR 8253, INSERM U1151, Inst Necker Enfants Malades, Paris, France; [Courbebaisse, Marie] CNRS ERL8228, INSERM, UMR 51138, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Courbebaisse, M (corresponding author), Univ Paris 05, Fac Med, Paris, France.; Courbebaisse, M (corresponding author), Hop Europeen Georges Pompidou, AP HP, Unite Renale, Dept Physiol, Paris, France.; Courbebaisse, M (corresponding author), CNRS, UMR 8253, INSERM U1151, Inst Necker Enfants Malades, Paris, France.	marie.courbebaisse@aphp.fr	; Bertocchio, Jean-Philippe/Q-1768-2016	prot-bertoye, caroline/0000-0003-1373-1323; BLANCHARD, Anne/0000-0002-0815-0586; Bertocchio, Jean-Philippe/0000-0002-4104-702X; Dubourg, Julie/0000-0002-5514-8075; Baron, Stephanie/0000-0002-0375-6968				Arrabal-Polo MA, 2013, BJU INT, V111, P622, DOI 10.1111/j.1464-410X.2012.11292.x; Arampatzis S, 2012, UROL RES, V40, P53, DOI 10.1007/s00240-011-0397-3; Araujo NC, 2000, BRAZ J MED BIOL RES, V33, P205, DOI 10.1590/S0100-879X2000000200007; Baffle D, NEPHROL DIAL TRANSPL, V27, P3691; BATLLE DC, 1981, KIDNEY INT, V20, P389, DOI 10.1038/ki.1981.151; Bruce LJ, 1997, J CLIN INVEST, V100, P1693, DOI 10.1172/JCI119694; BUCKALEW VM, 1968, AM J MED, V45, P32, DOI 10.1016/0002-9343(68)90005-3; CARLISLE EJF, 1991, PEDIATR NEPHROL, V5, P242, DOI 10.1007/BF01095965; Chow K, 2004, KIDNEY INT, V65, P1724, DOI 10.1111/j.1523-1755.2004.00566.x; COHEN EP, 1992, J AM SOC NEPHROL, V3, P264; Dhayat NA, 2015, J AM SOC NEPHROL; DONNELLY S, 1992, AM J KIDNEY DIS, V19, P272, DOI 10.1016/S0272-6386(13)80009-1; DUBOSE TD, 1985, J CLIN INVEST, V75, P1116, DOI 10.1172/JCI111805; ELKINTON JR, 1960, AM J MED, V29, P554, DOI 10.1016/0002-9343(60)90090-5; Forni Ogna V, BMC MED, V13, P40; Fry AC, 2012, J AM SOC NEPHROL, V23, P1238, DOI 10.1681/ASN.2012020112; HALPERIN ML, 1974, J CLIN INVEST, V53, P669, DOI 10.1172/JCI107604; HESS B, 1994, NEPHROL DIAL TRANSPL, V9, P642, DOI 10.1093/ndt/9.6.642; Jorgensen K., 1987, SCAND J CLIN LAB INV, P287; KOK DJ, 1990, KIDNEY INT, V37, P51, DOI 10.1038/ki.1990.7; NUTBOURNE D, 1961, CLIN SCI, V20, P263; Pongchaiyakul C, 2004, NEPHROL DIAL TRANSPL, V19, P3029, DOI 10.1093/ndt/gfh534; Rysava R, 1997, NEPHROL DIAL TRANSPL, V12, P1869, DOI 10.1093/ndt/12.9.1869; SIMPSON DP, 1983, AM J PHYSIOL, V244, pF223, DOI 10.1152/ajprenal.1983.244.3.F223; Vallet M, 2015, KIDNEY INT, V88, P137, DOI 10.1038/ki.2015.52; Vargas-Poussou R, 2006, J AM SOC NEPHROL, V17, P1437, DOI 10.1681/ASN.2005121305; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Walsh SB, 2007, KIDNEY INT, V71, P1310, DOI 10.1038/sj.ki.5002220; WRONG O, 1959, Q J MED, V28, P259; WRONG OM, 1993, Q J MED, V86, P513, DOI 10.1093/qjmed/86.8.513	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177329	10.1371/journal.pone.0177329	http://dx.doi.org/10.1371/journal.pone.0177329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542241	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600007
J	Calciano, L; Corsico, AG; Pirina, P; Trucco, G; Jarvis, D; Janson, C; Accordini, S				Calciano, Lucia; Corsico, Angelo Guido; Pirina, Pietro; Trucco, Giulia; Jarvis, Deborah; Janson, Christer; Accordini, Simone			Assessment of asthma severity in adults with ever asthma: A continuous score	PLOS ONE			English	Article							RESPIRATORY SYMPTOMS; PERSISTENT ASTHMA; YOUNG-ADULTS; DETERMINANTS; DIAGNOSIS; CHILDREN; BURDEN; INDEX	Background In epidemiological studies, continuous measures of asthma severity should be used to catch the heterogeneity of phenotypes. This study aimed at developing and validating continuous measures of asthma severity in adult patients with ever asthma from the general population, to be used in epidemiological studies. Methods Respiratory symptoms, anti-asthmatic treatment and lung function were measured on 520 patients with ever asthma aged 20-64 years from the general Italian population (GEIRD study; 2007/2010). The variables that represent the same dimension of asthma severity were identified through an exploratory factor analysis and were summarized through a multiple factor analysis. Results Only respiratory symptoms and anti-asthmatic treatment were summarized in a continuous score (STS). STS ranges from 0 (no symptoms/treatment) to 10 (maximum symptom frequency and treatment intensity). STS was positively correlated with the Global Initiative for Asthma classification of asthma severity computed on the 137 cases with a doctor's diagnosis (Spearman's coefficient = 0.61, p-value<0.0001) (concurrent validity). Furthermore, using a cohort of 1,097 European asthmatics (ECRHS II study; 1999/2002), increasing STS levels at baseline (1991/1993) were positively associated with long-term outcomes (hospitalization and lost workdays for breathing problems, asthma attack frequency and use of asthma controllers) (predictive validity). Finally, the STS scores computed from the GEIRD and ECRHS II data were comparable (Lin's coefficient = 0.95, p-value<0.0001) (replication analysis). Conclusions STS is a valid and replicable measure of asthma severity in adults, which could be used in association studies.	[Calciano, Lucia; Accordini, Simone] Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy; [Corsico, Angelo Guido] Univ Pavia, IRCCS, Div Resp Dis, San Matteo & Hosp Fdn, Pavia, Italy; [Pirina, Pietro] Univ Sassari, Inst Resp Dis, Sassari, Italy; [Trucco, Giulia] Univ Turin, Dept Publ Hlth & Pediat, Turin, Italy; [Jarvis, Deborah] Imperial Coll, Natl Heart & Lung Inst, London, England; [Janson, Christer] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	University of Verona; IRCCS Fondazione San Matteo; University of Pavia; University of Sassari; University of Turin; Imperial College London; Uppsala University	Calciano, L (corresponding author), Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy.	lucia.calciano@univr.it	Corsico, Angelo Guido/AAC-8138-2019	Corsico, Angelo Guido/0000-0002-8716-4694; Jarvis, Deborah/0000-0002-1753-3896; Calciano, Lucia/0000-0001-9801-5080	Cariverona Foundation; Italian Ministry of Health [RF-2009-1471235]; Chiesi Farmaceutici; Italian Medicines Agency (AIFA)	Cariverona Foundation(Fondazione Cariverona); Italian Ministry of Health(Ministry of Health, Italy); Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); Italian Medicines Agency (AIFA)	The GEIRD project was funded by the Cariverona Foundation (Bando 2006), the Italian Ministry of Health (RF-2009-1471235), Chiesi Farmaceutici and the Italian Medicines Agency (AIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2013, WIRES COMPUT STAT, V5, P149, DOI 10.1002/wics.1246; Accordini S, 2008, ALLERGY, V63, P116, DOI 10.1111/j.1398-9995.2007.01523.x; Accordini S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151292; Accordini S, 2013, INT ARCH ALLERGY IMM, V160, P93, DOI 10.1159/000338998; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 2014, GLOB STRAT ASTHM MAN; Awasthi S, 2012, INDIAN J PEDIATR, V79, P1311, DOI 10.1007/s12098-012-0817-6; Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; Bai J, 1998, CHEST, V114, P1343, DOI 10.1378/chest.114.5.1343; Bildstrup L, 2015, J ASTHMA, V52, P687, DOI 10.3109/02770903.2015.1005840; Birnbaum HG, 2009, J ASTHMA, V46, P67, DOI 10.1080/02770900802503099; Blakey JD, 2012, CLIN EXP ALLERGY, V42, P617, DOI 10.1111/j.1365-2222.2012.03962.x; Bouzigon E, 2007, EUR RESPIR J, V30, P253, DOI 10.1183/09031936.00162206; Cazzoletti L, 2010, INT ARCH ALLERGY IMM, V151, P70, DOI 10.1159/000232572; de Marco R, 2005, INT ARCH ALLERGY IMM, V138, P225, DOI 10.1159/000088723; de Marco R, 2010, INT ARCH ALLERGY IMM, V152, P255, DOI 10.1159/000283034; Drasgow F., 1988, ENCY STAT SCI; Gorsuch R.L., 1988, HDB MULTIVARIATE EXP, P231, DOI DOI 10.1007/978-1-4613-0893-5_6; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Killian KJ, 2000, AM J RESP CRIT CARE, V162, P490, DOI 10.1164/ajrccm.162.2.9905079; Lang A, 2010, PEDIAT ALLERG IMM-UK, V21, P945, DOI 10.1111/j.1399-3038.2010.01072.x; Lowhagen O, 2012, ALLERGY, V67, P713, DOI 10.1111/j.1398-9995.2012.02821.x; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Marks GB, 2005, EUR RESPIR J, V26, P3, DOI 10.1183/09031936.05.00055305; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Osborne J. W., 2012, PRACTICAL ASSESSMENT, V17, P15, DOI DOI 10.7275/H0BD-4D11; Pekkanen J, 2005, EUR RESPIR J, V26, P28, DOI 10.1183/09031936.05.00120104; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Rage E, 2009, OCCUP ENVIRON MED, V66, P182, DOI 10.1136/oem.2007.038349; Raherison C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007146; Ringsberg KC, 2002, RESP MED, V96, P305, DOI 10.1053/rmed.2001.1281; Rose G., 1992, STRATEGY PREVENTIVE; Sistek D, 2001, EUR RESPIR J, V17, P214, DOI 10.1183/09031936.01.17202140; Sunyer J, 2007, ALLERGY, V62, P142, DOI 10.1111/j.1398-9995.2006.01184.x; Sunyer J, 2004, RESP MED, V98, P1025, DOI 10.1016/j.rmed.2004.01.013; The European Community Respiratory Health Survey Steering Committee. The European Community Respiratory Health Survey II, 2002, EUR RESPIR J, V20, P1071; THOMPSON S, 1984, EUR J RESPIR DIS, V65, P185; Ungar WJ, 2002, AM J RESP CRIT CARE, V165, P190, DOI 10.1164/ajrccm.165.2.2102012; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Weiss K B, 1993, Pharmacoeconomics, V4, P14, DOI 10.2165/00019053-199304010-00004; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8	43	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177538	10.1371/journal.pone.0177538	http://dx.doi.org/10.1371/journal.pone.0177538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542217	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400050
J	Harada, H; Kai, H; Shibata, R; Niiyama, H; Nishiyama, Y; Murohara, T; Yoshida, N; Katoh, A; Ikeda, H				Harada, Haruhito; Kai, Hisashi; Shibata, Rei; Niiyama, Hiroshi; Nishiyama, Yasuhiro; Murohara, Toyoaki; Yoshida, Noriko; Katoh, Atsushi; Ikeda, Hisao			New diagnostic index for sarcopenia in patients with cardiovascular diseases	PLOS ONE			English	Article							DISTAL MYOPATHY; RIMMED VACUOLES; ADIPONECTIN; DEFINITION; CONSENSUS	Background Sarcopenia is an aging and disease-related syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength, with the risk of frailty and poor quality of life. Sarcopenia is diagnosed by a decrease in skeletal muscle index (SMI) and reduction of either handgrip strength or gait speed. However, measurement of SMI is difficult for general physicians because it requires special equipment for bioelectrical impedance assay or dual-energy X-ray absorptiometry. The purpose of this study was, therefore, to explore a novel, simple diagnostic method of sarcopenia evaluation in patients with cardiovascular diseases (CVD). Methods We retrospectively investigated 132 inpatients with CVD (age: 72 +/- 12 years, age range: 27-93 years, males: 61%) Binomial logistic regression and correlation analyses were used to assess the associations of sarcopenia with simple physical data and biomarkers, including muscle-related inflammation makers and nutritional markers. Results Sarcopenia was present in 29.5% of the study population. Serum concentrations of adiponectin and sialic acid were significantly higher in sarcopenic than non-sarcopenic CVD patients. Stepwise multivariate binomial logistic regression analysis revealed that adiponectin, sialic acid, sex, age, and body mass index were independent factors for sarcopenia detection. Sarcopenia index, obtained from the diagnostic regression formula for sarcopenia detection including the five independent factors, indicated a high accuracy in ROC curve analysis (sensitivity 94.9%, specificity 69.9%) and the cutoff value for sarcopenia detection was -1.6134. Sarcopenia index had a significant correlation with the conventional diagnostic parameters of sarcopenia. Conclusions Our new sarcopenia index using simple parameters would be useful for diagnosing sarcopenia in CVD patients.	[Harada, Haruhito; Kai, Hisashi; Niiyama, Hiroshi; Nishiyama, Yasuhiro; Katoh, Atsushi] Kurume Univ, Med Ctr, Dept Cardiol, Kurume, Fukuoka, Japan; [Shibata, Rei] Nagoya Univ, Dept Adv Cardiovasc Therapeut, Nagoya, Aichi, Japan; [Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Nagoya, Aichi, Japan; [Yoshida, Noriko] Kurume Univ, Inst Hlth & Sports Sci, Kurume, Fukuoka, Japan; [Ikeda, Hisao] Teikyo Univ, Fac Fukuoka Med Technol, Dept Phys Therapy, Omuta, Japan	Kurume University; Nagoya University; Nagoya University; Kurume University; Teikyo University	Harada, H (corresponding author), Kurume Univ, Med Ctr, Dept Cardiol, Kurume, Fukuoka, Japan.	harada_haruhito@med.kurume-u.ac.jp						Abou-Samra M, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0051-9; Celeste FV, 2014, HUM MUTAT, V35, P915, DOI 10.1002/humu.22583; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fiaschi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034782; Fiaschi T, 2009, CELL RES, V19, P584, DOI 10.1038/cr.2009.39; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081929; Hanisch F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080520; Harada H, 2016, J NUTR HLTH AGING; Huang C, 2015, NUTR METAB CARDIOVAS, V25, P594, DOI 10.1016/j.numecd.2015.03.010; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Ignacio de Ulíbarri J., 2005, Nutr. Hosp., V20, P38; Karvonen-Gutierrez CA, 2015, J GERONTOL A; Kung T, 2011, J CACHEXIA SARCOPENI, V2, P63, DOI 10.1007/s13539-011-0020-z; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2007, HUM MOL GENET, V16, P115, DOI 10.1093/hmg/ddl446; Sente T, 2016, J CACHEXIA SARCOPENI, V7, P261, DOI 10.1002/jcsm.12086; Shibata R, 2012, CURR MED CHEM, V19, P5459, DOI 10.2174/092986712803833164; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V55, pE9, DOI 10.1016/j.archger.2012.06.015; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009	21	31	32	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178123	10.1371/journal.pone.0178123	http://dx.doi.org/10.1371/journal.pone.0178123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542531	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400144
J	Lains, I; Duarte, D; Barros, AS; Martins, AS; Gil, J; Miller, JB; Marques, M; Mesquita, TAN; Kim, IK; Cachulo, MD; Vavvas, D; Carreira, IM; Murta, JN; Silva, R; Miller, JW; Husain, D; Gil, AM				Lains, Ines; Duarte, Daniela; Barros, Antonio S.; Martins, Ana Sofia; Gil, Joao; Miller, John B.; Marques, Marco; Mesquita, Tania; Kim, Ivana K.; da Luz Cachulo, Maria; Vavvas, Demetrios; Carreira, Isabel M.; Murta, Joaquim N.; Silva, Rufino; Miller, Joan W.; Husain, Deeba; Gil, Ana M.			Human plasma metabolomics in age-related macular degeneration (AMD) using nuclear magnetic resonance spectroscopy	PLOS ONE			English	Article							OXIDATIVE STRESS; NMR-SPECTROSCOPY; METABONOMICS; SIGNATURES; PREVALENCE; DISEASE; CANCER; EYE	Purpose To differentiate the plasma metabolomic profile of patients with age related macular degeneration (AMD) from that of controls, by Nuclear Magnetic Resonance (NMR) spectroscopy. Methods Two cohorts (total of 396 subjects) representative of central Portugal and Boston, USA phenotypes were studied. For each cohort, subjects were grouped according to AMD stage (early, intermediate and late). Multivariate analysis of plasma NMR spectra was performed, followed by signal integration and univariate analysis. Results Small changes were detected in the levels of some amino acids, organic acids, dimethyl sulfone and specific lipid moieties, thus providing some biochemical information on the disease. The possible confounding effects of gender, smoking history and age were assessed in each cohort and found to be minimal when compared to that of the disease. A similar observation was noted in relation to age-related comorbidities. Furthermore, partially distinct putative AMD metabolite fingerprints were noted for the two cohorts studied, reflecting the importance of nutritional and other lifestyle habits in determining AMD metabolic response and potential biomarker fingerprints. Notably, some of the metabolite changes detected were noted as potentially differentiating controls from patients diagnosed with early AMD. Conclusion For the first time, this study showed metabolite changes in the plasma of patients with AMD as compared to controls, using NMR. Geographical origins were seen to affect AMD patients A metabolic profile and some metabolites were found to be valuable in potentially differentiating controls from early stage AMD patients. Metabolomics has the potential of identifying biomarkers for AMD, and further work in this area is warranted.	[Lains, Ines; Miller, John B.; Kim, Ivana K.; Vavvas, Demetrios; Miller, Joan W.; Husain, Deeba] Harvard Med Sch, Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA USA; [Lains, Ines; Gil, Joao; Marques, Marco; da Luz Cachulo, Maria; Carreira, Isabel M.; Murta, Joaquim N.; Silva, Rufino] Univ Coimbra FMUC, Fac Med, Coimbra, Portugal; [Lains, Ines; Gil, Joao; Marques, Marco; Mesquita, Tania; da Luz Cachulo, Maria; Silva, Rufino] Assoc Innovat & Biomed Res Light & Image AIBILI, Coimbra, Portugal; [Lains, Ines; Gil, Joao; Marques, Marco; da Luz Cachulo, Maria; Murta, Joaquim N.; Silva, Rufino] CHUC, Dept Ophthalmol, Coimbra, Portugal; [Duarte, Daniela; Barros, Antonio S.; Martins, Ana Sofia; Gil, Ana M.] Univ Aveiro, Dept Chem, CICECO Aveiro Inst Mat, UA, Aveiro, Portugal	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Aveiro	Gil, AM (corresponding author), Univ Aveiro, Dept Chem, CICECO Aveiro Inst Mat, UA, Aveiro, Portugal.	agil@ua.pt	Murta, Joaquim/V-5494-2017; Silva, Rufino M/J-2817-2012; Carreira, Isabel M/C-7711-2018; Gil, Ana/O-3871-2019; Miller, John J/GZG-5663-2022; Barros, António S./B-5847-2009; Duarte, Daniela/AAD-3491-2020	Murta, Joaquim/0000-0001-8926-5176; Silva, Rufino M/0000-0001-8676-0833; Carreira, Isabel M/0000-0001-6842-1707; Gil, Ana/0000-0003-3766-4364; Barros, António S./0000-0002-9103-5852; Duarte, Daniela/0000-0001-9460-1162; Quadrado Gil, Joao/0000-0001-9032-1008; Martins, Ana Sofia/0000-0001-6865-5853; Cachulo, Maria Luz/0000-0002-0900-4548; Vavvas, Demetrios/0000-0002-8622-6478; Husain, Deeba/0000-0002-8494-0950; Kim, Ivana/0000-0003-0310-6129; Lains, Ines/0000-0002-8136-4724	Portuguese Foundation for Science and Technology [HMSP-ICJ/0006/2013]; Miller Retina Research Fund (MEE); Miller Champalimaud Award (MEE); CICECOAveiro Institute of Materials [POCI-01-0145FEDER-007679, UlD /CTM/50011/2013]; national funds through the FCT/MEC; FEDER; FCT funds; Fundacao para a Ciencia e a Tecnologia (FCT) [HMSP-ICJ/ 0006/2013]; NATIONAL EYE INSTITUTE [R21EY023079, R01EY025362] Funding Source: NIH RePORTER	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Miller Retina Research Fund (MEE); Miller Champalimaud Award (MEE); CICECOAveiro Institute of Materials; national funds through the FCT/MEC(Portuguese Foundation for Science and Technology); FEDER(European Commission); FCT funds(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was funded by the Portuguese Foundation for Science and Technology (HMSP-ICJ/0006/2013), the Miller Retina Research Fund (MEE) and the Miller Champalimaud Award (MEE). This work was also developed within the scope of the project CICECOAveiro Institute of Materials, POCI-01-0145FEDER-007679 (FCT ref. UlD /CTM/50011/2013), financed by national funds through the FCT/MEC and when appropriate co-financed by FEDER under the PT2020 Partnership Agreement. We also acknowledge the Portuguese National NMR Network (RNRMN), supported by FCT funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the Fundacao para a Ciencia e a Tecnologia (FCT) (HMSP-ICJ/ 0006/2013), the Miller Retina Research Fund (MEE) and the Miller Champalimaud Award (MEE). This work was also developed within the scope of the project CICECO-Aveiro Institute of Materials, POCI-01-0145-FEDER-007679 (FCT Ref. UID /CTM /50011/2013), financed by national funds through the FCT/MEC and when appropriate co-financed by FEDER under the PT2020 Partnership Agreement. AMG acknowledges the Portuguese National NMR Network (RNRMN), supported by FCT funds.	Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Barba I, 2010, INVEST OPHTH VIS SCI, V51, P4416, DOI 10.1167/iovs.10-5348; Burgess LG, 2015, INVEST OPHTH VIS SCI, V56, P5020, DOI 10.1167/iovs.15-16702; Cachulo MD, 2015, OPHTHALMOLOGICA, V233, P119, DOI 10.1159/000371584; Chen LY, 2016, DIABETES, V65, P1099, DOI 10.2337/db15-0661; Chen LY, 2011, J PROTEOME RES, V10, P4876, DOI 10.1021/pr2004874; Danis RP, 2013, INVEST OPHTH VIS SCI, V54, P4548, DOI 10.1167/iovs.13-11804; Diaz SO, 2013, J PROTEOME RES, V12, P2946, DOI 10.1021/pr4002355; Duarte IF, 2012, PROG NUCL MAG RES SP, V62, P51, DOI 10.1016/j.pnmrs.2011.11.002; Duarte IF, 2010, VIRCHOWS ARCH, V457, P715, DOI 10.1007/s00428-010-0993-6; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Guo JG, 2014, GRAEF ARCH CLIN EXP, V252, P925, DOI 10.1007/s00417-014-2619-1; Handa JT, 2012, MOL ASPECTS MED, V33, P418, DOI 10.1016/j.mam.2012.03.006; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Hong T, 2011, SURV OPHTHALMOL, V56, P184, DOI 10.1016/j.survophthal.2010.08.007; Karamichos D, 2015, EXP EYE RES, V132, P1, DOI 10.1016/j.exer.2015.01.007; Klein R, 2014, JAMA OPHTHALMOL, V132, P446, DOI 10.1001/jamaophthalmol.2013.7671; Li M, 2014, MOL BIOSYST, V10, P1055, DOI 10.1039/c3mb70386j; Li X, 2011, MOL BIOSYST, V7, P2228, DOI 10.1039/c0mb00341g; Martens H., 1992, MULTIVARIATE CALIBRA; Midelfart A, 2009, ACTA OPHTHALMOL, V87, P697, DOI 10.1111/j.1755-3768.2009.01516.x; Mitta VP, 2013, JAMA OPHTHALMOL, V131, P507, DOI 10.1001/jamaophthalmol.2013.2303; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; Pinto J, 2014, ANALYST, V139, P1168, DOI 10.1039/c3an02188b; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rocha CM, 2011, J PROTEOME RES, V10, P4314, DOI 10.1021/pr200550p; Sobrin L, 2013, PROG RETIN EYE RES; Suhre K, 2012, NAT REV GENET, V13, P759, DOI 10.1038/nrg3314; Tan SZ, 2016, EYE, V30, P773, DOI 10.1038/eye.2016.37; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Ugurlu N, 2013, CURR EYE RES, V38, P497, DOI 10.3109/02713683.2013.774023; Veselkov KA, 2009, ANAL CHEM, V81, P56, DOI 10.1021/ac8011544; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yonekawa Y, 2015, J CLIN MED, V4, P343, DOI 10.3390/jcm4020343; Young Stephen P, 2009, J Ocul Biol Dis Infor, V2, P235; Young SP, 2009, MOL VIS, V15, P1210	40	39	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177749	10.1371/journal.pone.0177749	http://dx.doi.org/10.1371/journal.pone.0177749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542375	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400075
J	Unt, T; Solvak, M; Vassil, K				Unt, Taavi; Solvak, Mihkel; Vassil, Kristjan			Does Internet voting make elections less social? Group voting patterns in Estonian e-voting log files (2013-2015)	PLOS ONE			English	Article							POLITICAL CONTEXT; VOTER TURNOUT; HOUSEHOLD; BRITAIN; CHOICE	Remote Internet voting places the control and secrecy of the immediate voting environment on the shoulder of the individual voter but it also turns voting into yet another on-line activity thus endangering the well-known social nature of voting and possibly reducing the crucial sense of civic duty that is important for a healthy democracy. There is however a complete lack of evidence to what degree this actually materializes once electronic voting is introduced. This paper uses individual level log data on Internet voting in Estonian elections between 2013-2015 to inspect if Internet voting retains the social nature of the voting act. We do so by examining if Internet voting in groups takes place and what implications it has for voting speed. We find strong evidence of e-voting in pairs. Same aged male-female pairs seem to be voting in close proximity to each other, consistent with spouses or partners voting together. Also, female-female and female-male pairs with large age differences seem to be voting together, consistent with a parent voting with an adult aged offspring. With regards to voting speed we see the second vote in a vote pair being considerably faster than the first vote, again indicating a shared voting act. We end with a discussion of how the onset of electronic voting does not make elections less social, but does make vote secrecy more a choice rather than a requirement.	[Unt, Taavi; Solvak, Mihkel; Vassil, Kristjan] Univ Tartu, Johan Skytte Inst Polit Studies, Tartu, Estonia; [Solvak, Mihkel] Univ Tartu, Ulikooli 18, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu	Solvak, M (corresponding author), Univ Tartu, Johan Skytte Inst Polit Studies, Tartu, Estonia.; Solvak, M (corresponding author), Univ Tartu, Ulikooli 18, EE-50090 Tartu, Estonia.	mihkel.solvak@ut.ee	Solvak, Mihkel/HDO-3302-2022	Solvak, Mihkel/0000-0003-0179-4036				Andersen R, 2006, EUR SOCIOL REV, V22, P215, DOI 10.1093/esr/jci053; BBC World, JUSTIN TIMBERLAKE IN; Bhatti Y, 2012, J ELECT PUBLIC OPIN, V22, P380, DOI 10.1080/17457289.2012.721375; Ciarrochi J, 2016, DEV PSYCHOL, V52, P272, DOI 10.1037/dev0000070; Cutts D, 2009, AM J POLIT SCI, V53, P726, DOI 10.1111/j.1540-5907.2009.00397.x; Fieldhouse E, 2012, J POLIT, V74, P856, DOI 10.1017/S0022381612000345; Gerber AS, 2008, AM POLIT SCI REV, V102, P33, DOI 10.1017/S000305540808009X; Heiberg S, P EL VOT 2014 EVOTE2, P7; Heiberg S, LOG ANAL ESTONIAN IN; HUCKFELDT R, 1991, J POLIT, V53, P122, DOI 10.2307/2131724; Karp JA, 2005, J POLIT, V67, P825, DOI 10.1111/j.1468-2508.2005.00341.x; Lazarsfeld P. F., 1948, PEOPLES CHOICE VOTER, V2nd; MCCLOSKY H, 1959, AM POLIT SCI REV, V53, P757, DOI 10.2307/1951942; Pattie C, 2001, ELECT STUD, V20, P17, DOI 10.1016/S0261-3794(99)00032-3; Sanders CE, 2000, ADOLESCENCE, V35, P237; Solvak M., 2016, E VOTING ESTONIA TEC; Stepanikova I, 2010, COMPUT HUM BEHAV, V26, P329, DOI 10.1016/j.chb.2009.11.002; STOKER L, 1995, AM POLIT SCI REV, V89, P421, DOI 10.2307/2082435; Stromer-Galley J, 2003, PS-POLIT SCI POLIT, V36, P727, DOI 10.1017/S1049096503003020; US Vote Foundation, FUT VOT END END VER; WEATHERFORD MS, 1982, AM J POLIT SCI, V26, P117, DOI 10.2307/2110843; Wolfinger NH, 2008, SOC FORCES, V86, P1513, DOI 10.1353/sof.0.0031; Zuckerman A, 2007, PARTISAN FAMILIES TH; ZUCKERMAN AS, 1994, J POLIT, V56, P1008, DOI 10.2307/2132071; Zuckerman AS, 1998, EUR J POLIT RES, V33, P285, DOI 10.1023/A:1006818818213	25	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177864	10.1371/journal.pone.0177864	http://dx.doi.org/10.1371/journal.pone.0177864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542348	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400104
J	Meyer, T; Nikoubashman, O; Kabelitz, L; Muller, M; Othman, A; Afat, S; Kramer, M; Wiesmann, M; Brockmann, MA; Brockmann, C				Meyer, Tareq; Nikoubashman, Omid; Kabelitz, Lisa; Mueller, Marguerite; Othman, Ahmed; Afat, Saif; Kramer, Martin; Wiesmann, Martin; Brockmann, Marc A.; Brockmann, Carolin			Endovascular stentectomy using the snare over stent-retriever (SOS) technique: An experimental feasibility study	PLOS ONE			English	Article								Feasibility of endovascular stentectomy using a snare over stent-retriever (SOS) technique was evaluated in a silicon flow model and an in vivo swine model. In vitro, stentectomy of different intracranial stents using the SOS technique was feasible in 22 out of 24 (92%) retrieval maneuvers. In vivo, stentectomy was successful in 10 out of 10 procedures (100%). In one case self-limiting vasospasm was observed angiographically as a technique related complication in the animal model. Endovascular stentectomy using the SOS technique is feasible in an experimental setting and may be transferred to a clinical scenario.	[Meyer, Tareq; Nikoubashman, Omid; Kabelitz, Lisa; Mueller, Marguerite; Othman, Ahmed; Afat, Saif; Wiesmann, Martin; Brockmann, Marc A.; Brockmann, Carolin] Univ Hosp RWTH Aachen, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany; [Meyer, Tareq; Brockmann, Marc A.; Brockmann, Carolin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuroradiol, Mainz, Germany; [Nikoubashman, Omid] Forschungszentrum Julich, Inst Neurosci & Med 4, Med Imaging Phys, Julich, Germany; [Kramer, Martin] Justus Liebig Univ, Dept Vet Clin Sci, Small Anim Clin, Giessen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Johannes Gutenberg University of Mainz; Helmholtz Association; Research Center Julich; Justus Liebig University Giessen	Brockmann, C (corresponding author), Univ Hosp RWTH Aachen, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany.; Brockmann, C (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuroradiol, Mainz, Germany.	brockmann@gmx.de	Wiesmann, Martin/GLU-1902-2022; Afat, Saif/AAF-7183-2020; Afat, Saif/AAF-6679-2020	Afat, Saif/0000-0002-6861-6245; Othman, Ahmed/0000-0002-3827-8695; othman, ahmed mohamed abdel ghany/0000-0002-0405-8918				Ansari S, 2011, WORLD NEUROSURG, V76, pS24, DOI 10.1016/j.wneu.2011.02.031; Barburoglu M, 2015, WORLD NEUROSURGERY; Broadbent LP, 2003, AM J NEURORADIOL, V24, P1819; Castano C, 2016, J NEUROINTERVENTIONA; Chapot R., 2015, INTERVENT NEURORADIO, V21, P160; Kerl HU, 2012, CLIN NEURORADIOL, V22, P47, DOI 10.1007/s00062-011-0128-8; Kerl HU, 2014, NEUROSURGERY, V74, P321, DOI 10.1227/NEU.0000000000000253; Kung DK, 2012, CASE REPORTS MED, V2012; Meyer T, 2015, CLIN NEURORADIOL S25, P18; Miley JT, 2015, WORLD J RADIOL, V7, P139, DOI 10.4329/wjr.v7.i6.139; Oh Yul, 2012, Neurointervention, V7, P50, DOI 10.5469/neuroint.2012.7.1.50; Parthasarathy Rajsrinivas, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-012547; Schechter MA, 2013, J VASC SURG, V57, P276, DOI 10.1016/j.jvs.2012.09.002; Turek G, 2015, J NEUROSURG, P1	14	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178197	10.1371/journal.pone.0178197	http://dx.doi.org/10.1371/journal.pone.0178197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542580	Green Submitted, gold, Green Published			2022-12-27	WOS:000402062800052
J	Zainabadi, K; Liu, CJ; Guarente, L				Zainabadi, Kayvan; Liu, Cassie J.; Guarente, Leonard			SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; EXTENDS LIFE-SPAN; BONE-FORMATION; CALORIE RESTRICTION; HISTONE DEACETYLASE; OSTEOCALCIN GENE; IMPROVES HEALTH; STANDARD DIET; BETA-CATENIN; PPAR-GAMMA	Activation of SIRT1 has previously been shown to protect mice against osteoporosis through yet ill-defined mechanisms. In this study, we outline a role for SIRT1 as a positive regulator of the master osteoblast transcription factor, RUNX2. We find that ex vivo deletion of sirt1 leads to decreased expression of runx2 downstream targets, but not runx2 itself, along with reduced osteoblast differentiation. Reciprocally, treatment with a SIRT1 agonist promotes osteoblast differentiation, as well as the expression of runx2 downstream targets, in a SIRT1-dependent manner. Biochemical and luciferase reporter assays demonstrate that SIRT1 interacts with and promotes the transactivation potential of RUNX2. Intriguingly, mice treated with the SIRT1 agonist, resveratrol, show similar increases in the expression of RUNX2 targets in their calvaria (bone tissue), validating SIRT1 as a physiologically relevant regulator of RUNX2.	[Zainabadi, Kayvan; Liu, Cassie J.; Guarente, Leonard] MIT, Dept Biol, Koch Inst, Glenn Ctr Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zainabadi, Kayvan] Univ Maryland, Sch Med, Div Malaria Res, Inst Global Hlth, Baltimore, MD 21201 USA	Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland Baltimore	Zainabadi, K (corresponding author), MIT, Dept Biol, Koch Inst, Glenn Ctr Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zainabadi, K (corresponding author), Univ Maryland, Sch Med, Div Malaria Res, Inst Global Hlth, Baltimore, MD 21201 USA.	kayvan@alum.mit.edu			NIH; Glenn Foundation for Medical Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research	This work was supported by grants from the NIH and The Glenn Foundation for Medical Research to LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the NIH and The Glenn Foundation for Medical Research.	Artsi H, 2014, ENDOCRINOLOGY, V155, P3508, DOI 10.1210/en.2014-1334; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Durbin SM, 2014, J BONE MINER METAB, V32, P38, DOI 10.1007/s00774-013-0469-2; Edwards JR, 2013, J BONE MINER RES, V28, P960, DOI 10.1002/jbmr.1824; Graff J, 2013, J NEUROSCI, V33, P8951, DOI 10.1523/JNEUROSCI.5657-12.2013; Gurt I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134391; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hawse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019429; Helfrich MH, 2003, METHODS MOL MED, P80; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Holleville N, 2007, DEV BIOL, V304, P860, DOI 10.1016/j.ydbio.2007.01.003; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Iyer S, 2014, J BIOL CHEM, V289, P24069, DOI 10.1074/jbc.M114.561803; Jensen ED, 2007, CRIT REV EUKAR GENE, V17, P187; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; Kane AE, 2016, J GERONTOL A-BIOL, V71, P333, DOI 10.1093/gerona/glu315; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kawaguchi H, 2005, J BONE MINER METAB, V23, P275, DOI 10.1007/s00774-005-0599-2; Kim HN, 2015, MOL ENDOCRINOL, V29, P1498, DOI 10.1210/me.2015-1133; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Ornstrup MJ, 2014, J CLIN ENDOCR METAB, V99, P4720, DOI 10.1210/jc.2014-2799; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shakibaei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035712; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Zhang R, 1997, J BIOL CHEM, V272, P110, DOI 10.1074/jbc.272.1.110; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200	52	44	49	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178520	10.1371/journal.pone.0178520	http://dx.doi.org/10.1371/journal.pone.0178520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542607	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800099
J	Wang, SS; Yang, CJ; Liu, YJ; Shao, Z; Jackson, T				Wang, Shanshan; Yang, Chunjuan; Liu, Yijun; Shao, Zhi; Jackson, Todd			Early and late stage processing abnormalities in autism spectrum disorders: An ERP study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BILATERAL STIMULUS ARRAYS; INDEX FOCUSED ATTENTION; SELECTIVE-ATTENTION; MISMATCH NEGATIVITY; CHILDREN; IMPAIRMENT	This research assessed event-related potentials (ERPs) elicited during the processing of different kinds of visual stimuli among children with Autism Spectrum Disorder (ASD) (n = 15) and typically developing (TD) children (n = 19). Within a simple visual oddball paradigm, participating children passively viewed fruit and vegetable images that were used as standard stimuli in addition to images of these foods with their usual colors modified to create novel stimuli and cartoon depictions of these images (i.e., "deviant" stimuli). Analyses revealed significant main effect differences between the groups for P100, N100 and P300 components; ASD group children showing longer P100 latencies, weaker N100 amplitudes and larger P300 amplitudes than did the TD group. A Group x Hemisphere interaction also emerged for N400 amplitudes but differences were not significant in simple-effects analyses. Together these results suggested children with ASD may be characterized by lower attention resource allocation and engagement during early stages of processing visual stimuli. However, ERPs in later processing stages suggested children with ASD and TD children have similar neural responses in attending to visual images as stimulus presentations continue.	[Wang, Shanshan; Liu, Yijun; Jackson, Todd] Southwest Univ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Yang, Chunjuan; Shao, Zhi] Chongqing Ninth Peoples Hosp, Rehabil Ctr Children Autism, Chongqing, Peoples R China; [Jackson, Todd] Univ Macau, Dept Psychol, Macau, Peoples R China	Southwest University - China; University of Macau	Jackson, T (corresponding author), Southwest Univ, Key Lab Cognit & Personal, Chongqing, Peoples R China.; Jackson, T (corresponding author), Univ Macau, Dept Psychol, Macau, Peoples R China.	toddjackson@hotmail.com			Chinese National Natural Science Foundation [31371037]; Chongqing 100 Persons Fellowship	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chongqing 100 Persons Fellowship	This work was supported by grants from the Chinese National Natural Science Foundation (#31371037) and a Chongqing 100 Persons Fellowship. Professor Todd Jackson received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Azizian A, 2007, J COGNITIVE NEUROSCI, V19, P2071, DOI 10.1162/jocn.2007.19.12.2071; BARRETT SE, 1990, BRAIN COGNITION, V14, P201, DOI 10.1016/0278-2626(90)90029-N; Blackford T, 2012, COGNITION, V123, P84, DOI 10.1016/j.cognition.2011.12.007; Boyd BA, 2010, AUTISM RES, V3, P78, DOI 10.1002/aur.124; CELESIA GG, 1992, CURR OPIN NEUROL NEU, V5, P733; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Clery H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00062; Clery H, 2013, PSYCHOPHYSIOLOGY, V50, P240, DOI 10.1111/psyp.12006; Coles MGH, 1995, ELECTROPHYSIOLOGY MI, P40; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; FRIEDMAN D, 1993, PSYCHOPHYSIOLOGY, V30, P383, DOI 10.1111/j.1469-8986.1993.tb02060.x; Frodl T, 2002, PSYCHOPHYSIOLOGY, V39, P175, DOI 10.1017/S0048577201392077; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Gomez Gonzalez Carlos M., 1994, Brain Topography, V7, P41; Gomot M, 2012, INT J PSYCHOPHYSIOL, V83, P240, DOI 10.1016/j.ijpsycho.2011.09.017; Gomot M, 2011, J AUTISM DEV DISORD, V41, P705, DOI 10.1007/s10803-010-1091-y; Hall GBC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010804; HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hopf JM, 2002, J NEUROPHYSIOL, V88, P2088, DOI 10.1152/jn.2002.88.4.2088; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Jeste SS, 2009, J AUTISM DEV DISORD, V39, P495, DOI 10.1007/s10803-008-0652-9; KARAYANIDIS F, 1995, PSYCHOPHYSIOLOGY, V32, P335, DOI 10.1111/j.1469-8986.1995.tb01216.x; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Larson MJ, 2011, PSYCHIAT RES, V187, P198, DOI 10.1016/j.psychres.2010.11.006; Lopez BR, 2005, J AUTISM DEV DISORD, V35, P445, DOI 10.1007/s10803-005-5035-x; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Marsh LE, 2011, NEUROIMAGE, V56, P1511, DOI 10.1016/j.neuroimage.2011.02.003; MCEVOY RE, 1993, J CHILD PSYCHOL PSYC, V34, P563, DOI 10.1111/j.1469-7610.1993.tb01036.x; McPherson WB, 1999, PSYCHOPHYSIOLOGY, V36, P53, DOI 10.1017/S0048577299971196; Mecklinger A, 1996, COGNITIVE BRAIN RES, V4, P211, DOI 10.1016/S0926-6410(96)00034-1; NAATANEN R, 1979, BIOL PSYCHOL, V8, P81, DOI 10.1016/0301-0511(79)90053-X; NAATANEN R, 1995, EAR HEARING, V16, P6; Sokhadze E, 2009, APPL PSYCHOPHYS BIOF, V34, P37, DOI 10.1007/s10484-009-9074-5; Sokhadze Estate M, 2012, J Neurother, V16, P12; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Whitehouse AJO, 2006, J CHILD PSYCHOL PSYC, V47, P857, DOI 10.1111/j.1469-7610.2006.01624.x; Yamazaki T, 2000, BRAIN TOPOGR, V12, P159, DOI 10.1023/A:1023467806268	43	9	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178542	10.1371/journal.pone.0178542	http://dx.doi.org/10.1371/journal.pone.0178542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542618	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500088
J	Joestl, J; Lang, N; Bukaty, A; Tiefenboeck, TM; Platzer, P				Joestl, Julian; Lang, Nikolaus; Bukaty, Adam; Tiefenboeck, Thomas M.; Platzer, Patrick			Osteoporosis associated vertebral fractures-Health economic implications	PLOS ONE			English	Article							VITAMIN-D; PERCUTANEOUS VERTEBROPLASTY; NONSURGICAL MANAGEMENT; COMPRESSION FRACTURES; KYPHOPLASTY; PREVALENCE; SURVIVAL; IMPACT; RISK	Introduction Osteoporosis-associated vertebral fractures represent an increasing clinical and public health problem, one with important socioeconomic effects within western countries. The purpose of this study was to analyse demographic, medical, gender and socioeconomic aspects of osteoporotic vertebral fractures of the thoracic or lumbar spine over a period of at least 10-years. Material and methods Included for analysis were 694 patients who had suffered a vertebral fracture due to primary or secondary osteoporosis, and who were treated at our Level-I trauma center between 2000 and 2013. Collected data included demographic, medical and socioeconomic aspects. Results Clinical results revealed that 669 patients (96%) were treated conservatively. The remaining 25 patients (4%) underwent surgical therapy: 4 were treated with vertebroplasty, 15 with kyphoplasty and 6 patients with posterior stabilization. The mean age was 75.6 years (range: 50-98), with the vast majority of patients being female (n = 515). A statistically significant demographic difference (i.e., increase) in fractures was observed between the age groups 60-69 and 70-79 (p = 0.041). Concerning socioeconomic aspects, statistical analysis showed that the number of sick leaves and the need for professional domestic help was higher in female patients. Concerning treatment costs, statistical analysis did not reveal any significant differences between female and male patients. Conclusion Significant gender differences-to the detriment of the female population-could be demonstrated within this study. A regrettably low rate of adequate treatment after diagnosis of osteoporosis and its associated fractures-specifically relating to primary and secondary prevention-could also be identified. To prospectively avoid complications and consequential cost increases, more awareness of the necessity for prevention, early diagnosis and adequate treatment of osteoporosis and its related fractures should be considered.	[Joestl, Julian; Lang, Nikolaus; Tiefenboeck, Thomas M.; Platzer, Patrick] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Bukaty, Adam] Med Univ Vienna, Div Gen Anaesthesia & Intens Care Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Joestl, J (corresponding author), Med Univ Vienna, Dept Trauma Surg, Vienna, Austria.	julian.joestl@meduniwien.ac.at		Tiefenboeck, Thomas/0000-0002-8698-8341				Amin S, 2014, J BONE MINER RES, V29, P581, DOI 10.1002/jbmr.2072; Aras EL, 2015, COST EFFECTIVENESS S; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Chen AT, 2013, J BONE JOINT SURG AM, V95A, P1729, DOI 10.2106/JBJS.K.01649; Chen LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123153; Cooper C, 1992, J BONE MINER RES, V7; Dempster David W, 2011, Am J Manag Care, V17 Suppl 6, pS164; Epstein S, 2006, DRUG AGING, V23, P617, DOI 10.2165/00002512-200623080-00001; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Haussler B, 2007, OSTEOPOROSIS INT, V18, P77, DOI 10.1007/s00198-006-0206-y; Hazzard MA, 2014, ASIAN SPINE J, V8, P605, DOI 10.4184/asj.2014.8.5.605; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hillmeier J, 2004, ORTHOPADE, V33, P893, DOI 10.1007/s00132-004-0669-5; Hilmi I, 2013, J CLIN ENDOCR METAB, V98, P2415, DOI 10.1210/jc.2013-1147; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Lange A, 2014, SPINE, V39, P318, DOI 10.1097/BRS.0000000000000135; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Maier GS, 2015, BONE JOINT J, V97B, P89, DOI 10.1302/0301-620X.97B1.34558; Orsini LS, 2005, OSTEOPOROSIS INT, V16, P359, DOI 10.1007/s00198-004-1694-2; Papanastassiou ID, 2012, EUR SPINE J, V21, P1826, DOI 10.1007/s00586-012-2314-z; Qu B, 2014, OSTEOPOROSIS INT, V25, P1853, DOI 10.1007/s00198-014-2699-0; Svedbom A, 2013, OSTEOPOROSIS INT, V24, P355, DOI 10.1007/s00198-012-2102-y; Wang H, 2015, PAIN PHYSICIAN, V18, P209; Yan DL, 2011, ARCH ORTHOP TRAUM SU, V131, P645, DOI 10.1007/s00402-010-1188-y	24	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178209	10.1371/journal.pone.0178209	http://dx.doi.org/10.1371/journal.pone.0178209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542552	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400069
J	Stein, AM; Munive, V; Fernandez, AM; Nunez, A; Aleman, IT				Miki Stein, Angelica; Munive, Victor; Fernandez, Ana M.; Nunez, Angel; Torres Aleman, Ignacio			Acute exercise does not modify brain activity and memory performance in APP/PS1 mice	PLOS ONE			English	Article							MOUSE MODEL; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; THETA RHYTHM; EEG; ASSOCIATION; NETWORK; SLEEP; OSCILLATIONS; SUPPRESSION	Age is the main risk factor for Alzheimer A s disease (AD). With an increasingly aging population, development of affordable screening techniques to determine cognitive status will help identify population-at-risk for further follow-up. Because physical exercise is known to modulate cognitive performance, we used it as a functional test of cognitive health. Mice were submitted to treadmill running at moderate speed for 30 min, and their brain activity was monitored before and after exercise using electrocorticogram (ECG) recordings. After exercise, normal, but not APP/PS1 mice, a well established AD model, showed significantly increased ECG theta rhythm. At the same time normal, but not AD mice, showed significantly enhanced performance in a spatial memory test after exercise. Therefore, we postulate that a running bout coupled to pre-and post-exercise brain activity recordings will help identify individuals with cognitive alterations, by determining the presence or absence of exercise-specific changes in brain activity. Work in humans using a bout of moderate exercise plus electroencephalography, a clinically affordable procedure, is warranted.	[Miki Stein, Angelica; Munive, Victor; Fernandez, Ana M.; Torres Aleman, Ignacio] Cajal Inst Neurobiol, Madrid, Spain; [Miki Stein, Angelica; Munive, Victor; Fernandez, Ana M.; Torres Aleman, Ignacio] Ciberned, Madrid, Spain; [Miki Stein, Angelica] Univ Estadual Paulista, Sao Paulo, Brazil; [Nunez, Angel] Univ Autonoma Madrid, Sch Med, Madrid, Spain	CIBERNED; Universidade Estadual Paulista; Autonomous University of Madrid	Aleman, IT (corresponding author), Cajal Inst Neurobiol, Madrid, Spain.; Aleman, IT (corresponding author), Ciberned, Madrid, Spain.	torres@cajal.csic.es	Herrera, Victor Munive/AAW-4463-2020; Stein, Angelica/ABE-3716-2020; Nuñez, Angel/Y-9137-2019; Torres-Aleman, Ignacio/A-1613-2008	Stein, Angelica/0000-0002-2404-808X; Nuñez, Angel/0000-0002-8013-4812; Torres-Aleman, Ignacio/0000-0001-8107-7947; Fernandez, Ana M./0000-0001-5160-3854	Capes [PDSE 99999.010743/2014-06]; Fapesp [2013/19729-0]; Universidade Estadual Paulista (Brazil); FPI fellowship; Ciberned;  [SAF2013-40710-R/SAF2016-76462 AEI/FEDER]	Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Universidade Estadual Paulista (Brazil); FPI fellowship(Spanish Government); Ciberned(Instituto de Salud Carlos III); 	AMS was supported by Capes PDSE 99999.010743/2014-06 and Fapesp 2013/19729-0, Universidade Estadual Paulista (Brazil). VM is a recipient of an FPI fellowship. We are thankful to L. Guinea for excellent technical support. This work was funded by grants SAF2013-40710-R/SAF2016-76462 AEI/FEDER, and by Ciberned.	Born HA, 2015, NEUROSCIENCE, V286, P251, DOI 10.1016/j.neuroscience.2014.11.051; Born HA, 2014, J NEUROSCI, V34, P3826, DOI 10.1523/JNEUROSCI.5171-13.2014; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Brummer V, 2011, MED SCI SPORT EXER, V43, P1863, DOI 10.1249/MSS.0b013e3182172a6f; Byun KH, 2014, NEUROIMAGE, V98, P336, DOI 10.1016/j.neuroimage.2014.04.067; Crabbe JB, 2004, PSYCHOPHYSIOLOGY, V41, P563, DOI 10.1111/j.1469-8986.2004.00176.x; Dimitrova J, 2016, AGING CLIN EXP RES; Dubois B, 2016, ALZHEIMERS DEMENT, V12, P292, DOI 10.1016/j.jalz.2016.02.002; Enders H, 2016, J NEUROPHYSIOL, V115, P379, DOI 10.1152/jn.00497.2015; Faigle R, 2013, J CLIN NEUROPHYSIOL, V30, P505, DOI 10.1097/WNP.0b013e3182a73db9; Fernandez AM, 2012, MOL PSYCHIATR, V17, P705, DOI 10.1038/mp.2011.128; Fonseca LC, 2009, CLIN EEG NEUROSCI, V40, P168, DOI 10.1177/155005940904000309; Forbes D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub3; Goutagny R, 2013, EUR J NEUROSCI, V37, P1896, DOI 10.1111/ejn.12233; Hoffmann K, 2016, J ALZHEIMERS DIS, V50, P443, DOI 10.3233/JAD-150817; Huttenrauch M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.65; Hyodo K, 2016, NEUROIMAGE, V125, P291, DOI 10.1016/j.neuroimage.2015.09.062; Ittner AA, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0149-z; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jyoti A, 2015, NEUROBIOL AGING, V36, P2768, DOI 10.1016/j.neurobiolaging.2015.07.001; Jyoti A, 2010, J ALZHEIMERS DIS, V22, P873, DOI 10.3233/JAD-2010-100879; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lulic T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173672; Mancuso M, 2003, EXP NEUROL, V182, P421, DOI 10.1016/S0014-4886(03)00092-X; Muller J, 2017, MAYO CLIN PROC, V92, P211, DOI 10.1016/j.mayocp.2016.10.020; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Patten AR, 2013, LEARN MEMORY, V20, P642, DOI 10.1101/lm.030635.113; Paul CM, 2009, BEHAV BRAIN RES, V203, P151, DOI 10.1016/j.bbr.2009.05.022; Pedersen BK, 2009, EXP PHYSIOL, V94, P1153, DOI 10.1113/expphysiol.2009.048561; Platt B, 2011, BIOCHEM SOC T, V39, P874, DOI 10.1042/BST0390874; Rivas J, 1996, EXP BRAIN RES, V108, P113; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Rubio SE, 2012, FASEB J, V26, P4458, DOI 10.1096/fj.12-208413; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schneider F, 2014, PHYSIOL BEHAV, V135, P25, DOI 10.1016/j.physbeh.2014.05.041; Sellers KK, 2016, CELL REP, V16, P2864, DOI 10.1016/j.celrep.2016.08.055; Shah H, 2016, LANCET NEUROL, V15, P1283, DOI 10.1016/S1474-4422(16)30235-6; Siette J, 2014, LEARN MEMORY, V21, P73, DOI 10.1101/lm.032557.113; Siwek ME, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/781731; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STRANAHAN AM, 2008, NEUROBIOL AGING; Takimoto M, 2014, J APPL PHYSIOL, V116, P1238, DOI 10.1152/japplphysiol.01288.2013; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van der Hiele K, 2007, CLIN NEUROPHYSIOL, V118, P1931, DOI 10.1016/j.clinph.2007.05.070; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; Vissing J, 1996, J CEREBR BLOOD F MET, V16, P729, DOI 10.1097/00004647-199607000-00025; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003	49	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178247	10.1371/journal.pone.0178247	http://dx.doi.org/10.1371/journal.pone.0178247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542392	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400072
J	Zhu, XH; Li, B; Ma, CM; Zhu, C; Wu, L; Liu, H				Zhu, Xiao Hong; Li, Bing; Ma, Chun Mei; Zhu, Cheng; Wu, Li; Liu, Hui			Late Neolithic phytolith and charcoal records of human activities and vegetation change in Shijiahe culture, Tanjialing site, China	PLOS ONE			English	Article							ORYZA-SATIVA POACEAE; ENVIRONMENTAL-CHANGE; CLIMATE-CHANGE; HOLOCENE; ARCHAEOLOGY; YANGTZE; COLLAPSE; WILD; SEA; CLASSIFICATION	There is significant archaeological evidence marking the collapse of the Shijiahe culture in the middle reaches of the Yangtze River in China during the late Neolithic Period. However, the causes for this cultural collapse remain unclear. Our sedimentary records from a 3.3 m long profile and 76 phytolith and charcoal samples from the Tanjialing archaeological sites provide records of interactions between an ancient culture and vegetation change. During the early Shijiahe culture (c, 4850-4400 cal BP), the climate was warm and humid. Fire was intensively used to clear the vegetation. In the mid-period of the Shijiahe culture (c, 4400-4200 cal BP), the climate became slightly dry-cold and this was accompanied by decreasing water, leading to settlements. From c, 4200 cal BP, severe drought eroded the economic foundation of rice-cultivation. These conditions forced people to abandon the Shijiahe ancient city to find water in other regions, leading to the collapse of the Shijiahe culture.	[Zhu, Xiao Hong; Ma, Chun Mei; Zhu, Cheng] Nanjing Univ, Coll Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China; [Zhu, Xiao Hong] Jiangxi Normal Univ, Coll Business, Nanchang, Jiangxi, Peoples R China; [Li, Bing] Hebei Normal Univ, Coll Resources & Environm, Shijiazhuang, Peoples R China; [Wu, Li] Anhui Normal Univ, Coll Terr Resources & Tourism, Wuhu, Peoples R China; [Wu, Li] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Peoples R China; [Liu, Hui] Hubei Prov Inst Cultural Rel & Archaeol, Wuhan, Peoples R China	Nanjing University; Jiangxi Normal University; Hebei Normal University; Anhui Normal University; Chinese Academy of Sciences; Institute of Earth Environment, CAS	Ma, CM; Zhu, C (corresponding author), Nanjing Univ, Coll Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China.	chunmeima@nju.edu.cn; zhuchengnj@126.com	Wu, Li/E-3821-2013	Wu, Li/0000-0003-2578-2769	National Natural Science Foundation of China [41171163, 41371204]; Major Program of National Social Science Foundation of China [11ZD183]; Open Foundation of State Key Laboratory of Loess and Quaternary Geology, Institute of Earth Environment, CAS [SKLLQG1422]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of National Social Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of State Key Laboratory of Loess and Quaternary Geology, Institute of Earth Environment, CAS(Chinese Academy of Sciences); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was jointly funded by the National Natural Science Foundation of China (Grant Nos. 41171163, 41371204), Major Program of National Social Science Foundation of China (Grant No. 11&ZD183), Open Foundation of State Key Laboratory of Loess and Quaternary Geology, Institute of Earth Environment, CAS (Grant No. SKLLQG1422) and Priority Academic Program Development of Jiangsu Higher Education Institutions.	Andersen ST, 1986, PALAEOECOLOGICAL STU, P165; [Anonymous], 1997, EARTH SCI FRONT; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; BROWN DA, 1984, J ARCHAEOL SCI, V11, P345, DOI 10.1016/0305-4403(84)90016-5; Chen F. H., 1991, HOLOCENE, V1, P151, DOI [DOI 10.1177/095968369100100207, 10.1177/095968369100100207]; Chen FH, 1999, J PALEOLIMNOL, V22, P159, DOI 10.1023/A:1008093300257; CLARK JS, 1988, QUATERNARY RES, V30, P81, DOI 10.1016/0033-5894(88)90089-0; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; Dalfes N, 1997, NATO ASI SER, P1; deMenocal PB, 2001, SCIENCE, V292, P667, DOI 10.1126/science.1059827; Deng ZH, 2013, ARCHAEOLOGY, P91; Feng DL, 1998, ACTA PHYTOPATHOLOGIC, V28; Fujiwara H, 1978, ARCHAEOLOGY NATURAL, V11, P9; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Fuller DQ, 2009, WORLD ARCHAEOL, V41, P88, DOI 10.1080/00438240802668321; Goudie AS, 2006, GEOMORPHOLOGY, V79, P384, DOI 10.1016/j.geomorph.2006.06.023; Grimm E.C., 1992, TILIA SOFTWARE VERSI; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Gu Y., 2013, EARTH SCI J CHINA U, V38, P133; Guo LX, 2000, JIANGHAN ARCHAEOLOGY, V110, P3; Guo WM, 2010, CULTURE SOC LIYANG P, V95, P312; Hu C, 2008, EARTH PLANETARY SCI, V266; Hubei Provincial Institute of Cultural Relic and Archaeology, 2009, JIANGHAN ARCHAEOL, V110, P3; Ian J., 2010, COMPLETED TRANSLATIO, P937; Itzstein-Davey F, 2007, HOLOCENE, V17, P875, DOI 10.1177/0959683607080517; Itzstein-Davey F, 2007, J ARCHAEOL SCI, V34, P2101, DOI 10.1016/j.jas.2007.02.018; Jian ZM, 2000, EARTH PLANET SC LETT, V184, P305, DOI 10.1016/S0012-821X(00)00321-6; JIANG QH, 1995, REV PALAEOBOT PALYNO, V89, P481, DOI 10.1016/0034-6667(95)00033-9; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Jones D.M., 2002, ENV ARCHAEOLOGY GUID; Kerr RA, 1998, SCIENCE, V279, P325, DOI 10.1126/science.279.5349.325; Kirch PV, 2005, ANNU REV ENV RESOUR, V30, P409, DOI 10.1146/annurev.energy.29.102403.140700; Kondo R., 1994, OPAL PHYTOLITHS NZ; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Li B, 2013, QUATERN INT, V308, P45, DOI 10.1016/j.quaint.2013.05.041; [李宜垠 Li Yiyin], 2009, [古地理学报, Journal of Palaeogeography], V11, P702; Liu JQ, 2000, CHINESE SCI BULL, V45, P1712, DOI 10.1007/BF02898993; Lu HY, 2006, QUATERNARY SCI REV, V25, P945, DOI 10.1016/j.quascirev.2005.07.014; Lu HouYuan, 1997, Estado actual de los estudios de fitolitos en suelas y plantas. Primer encuentro Europeo sobre el estudio de fitolitos., P159; Lu HY, 2003, ESTUAR COAST SHELF S, V58, P587, DOI 10.1016/S0272-7714(03)00137-9; Mao X, 2014, EARTH SCI J CHINA U, V39, P1545; Meng H.P., 2012, ARCHAEOLOGY, V8, P29; Meng HP, 1997, PREHISTORIC CULTURE, P80; MILLSPAUGH SH, 1995, HOLOCENE, V5, P283, DOI 10.1177/095968369500500303; Mulholland S. C., 1992, PHYTOLITH SYSTEMATIC, P65; Ohlson M, 2000, HOLOCENE, V10, P519, DOI 10.1191/095968300667442551; PATTERSON JM, 1987, J ADOLESCENCE, V10, P163, DOI 10.1016/S0140-1971(87)80086-6; Pearsall D.M., 2013, PALEOETHNOBOTANY HDB; PEARSALL DM, 1995, ECON BOT, V49, P183, DOI 10.1007/BF02862923; Perry CA, 2000, P NATL ACAD SCI USA, V97, P12433, DOI 10.1073/pnas.230423297; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D. R., 1998, SILICA BODIES TROPIC; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Runge F, 1999, REV PALAEOBOT PALYNO, V107, P23, DOI 10.1016/S0034-6667(99)00018-4; Shi CX, 2009, EARTH SCI FRONTIERS, V16, P20; Shijiahe Archaeological Team, 2003, SHIJ ARCH REP DENGJ, P281; Shijiahe Archaeological Team, 1999, SHIJ ARCH REP, P51; Tinner W, 1998, HOLOCENE, V8, P31, DOI 10.1191/095968398667205430; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Wang F., 1999, CHINESE GEOGR SCI, V9, P87; Wang Jian, 2009, Journal of Landscape Research, V1, P60; Wang S., 1992, CLIMATES ENV HOLOCEN, P146; Wang WM, 2003, CHINESE SCI BULL, V48, P2005, DOI 10.1360/02wd0447; Wang Xiaocui, 2012, Hupo Kexue, V24, P480; Wang Y., 1993, STUDY PHYTOLITH ITS; Wei KY, 1998, J QUATERNARY SCI, V13, P55, DOI 10.1002/(SICI)1099-1417(199801/02)13:1<55::AID-JQS332>3.0.CO;2-S; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995; Weiss H, 2001, SCIENCE, V291, P609, DOI 10.1126/science.1058775; Weiss H., 2000, ENV DISASTER ARCHAEO, P75; Wu L, 2015, CENTRAL CHINA ACTA G, V70, P1149; Wu L., 2012, GEOSCI FRONT, V3, P875, DOI [DOI 10.1016/j.gsf.2012.02.006, 10.1016/j.gsf.2012.02.006]; Wu WX, 2004, QUATERN INT, V117, P153, DOI 10.1016/S1040-6182(03)00125-3; Xu J.H., 1998, SCI CHINA SER D, V28, P366; Yang X.D, 1998, J LAKE SCI, V10, P23; Yang Zhirong, 1998, SCI GEOGRAPHICA SINI, V18, P479; YAO TD, 1992, ANN GLACIOL, V16, P21; Yasuda Y, 2004, QUATERN INT, V123, P149, DOI 10.1016/j.quaint.2004.02.016; Yoshida S, 1962, SOIL SCI PLANT NUTR, V8; Yuan SX, 1994, CULTURAL RELICS, P89; Zhao ZJ, 1998, ECON BOT, V52, P134, DOI 10.1007/BF02861201; Zheng Z, 2000, QUATERNARY RES, V53, P330, DOI 10.1006/qres.1999.2126; Zhu C., 1997, ACTA GEOGRAPH SIN, V52, P268; [朱诚 ZHU Cheng], 2007, [地理学报, Acta Geographica Sinica], V62, P227; Zhu Y.X., 1997, CHINESE SCI BULL, V42, P1972	85	7	8	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177287	10.1371/journal.pone.0177287	http://dx.doi.org/10.1371/journal.pone.0177287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542219	gold, Green Submitted, Green Published			2022-12-27	WOS:000401672600006
J	Fang, J; Xiao, L; Chen, R; Zhao, ZH				Fang, Jie; Xiao, Li; Chen, Rebecca; Zhao, Zhihe			Conditional removal of the canonical TGF-beta 1 signaling delays condylar cartilage degeneration induced by a partial discectomy in mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TEMPOROMANDIBULAR-JOINT; ARTICULAR-CARTILAGE; TGF-BETA; OSTEOARTHRITIS; CHONDROCYTES; GENE; DIFFERENTIATION; INHIBITION; RECEPTOR	Recent emerging data indicate that the increase in the expression and activity of the transforming growth factor beta 1 (Tgf-beta 1) signaling may have detrimental effect to mature articular cartilage of knee joints. However, there is no information about whether or not this is the case in condylar cartilages. The objective of this study is to investigate the protein expression and activity of Tgf-beta 1 signaling in degenerative condylar cartilages. We also investigate biological effects of the conditional deletion of transforming growth factor receptor type II (Tgfbr2) in condylar cartilage of adult mice after a partial discectomy. Two mouse models of osteoarthritis (OA) were used to examine protein expressions of Tgf-beta 1 and p-Smad2/3 in condylar cartilages at early degenerative stages. In addition, cartilage specific Tgfbr2-deficient adult mice were subjected to a partial discectomy. The morphological condition of condylar cartilages was evaluated in mice at 4 and 12 weeks after the surgery. We found that protein levels of Tgf-beta 1 and p-Smad2/3 were increased in the degenerative condylar cartilage of the mouse models. The conditional removal of Tgfbr2 in mature condylar cartilage significantly delayed the progressive progression of the cartilage degeneration induced by a partial discectomy. We conclude that the increase in the expression and activity of Tgf-beta 1 signaling may have detrimental effect to mature condylar cartilages. Therefore, inhibition of Tgf-beta 1 signaling may be able to protect condylar cartilages from being degraded in mature temporomandibular joints.	[Fang, Jie; Zhao, Zhihe] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Fang, Jie; Xiao, Li; Chen, Rebecca] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA USA; [Xiao, Li] Sichuan Acad Med Sci, Dept Stomatol, Chengdu, Sichuan, Peoples R China; [Xiao, Li] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China	Sichuan University; Harvard University; Harvard School of Dental Medicine; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Zhao, ZH (corresponding author), Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.	zhzhao@scu.edu.cn		Zhao, Zhihe/0000-0003-2955-1706	National Natural Science Foundation of China [31470904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grant from the National Natural Science Foundation of China, 31470904 (to ZHZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AC, 2001, OSTEOARTHR CARTILAGE, V9, P128, DOI 10.1053/joca.2000.0368; Chen R, 2015, AM J PATHOL, V185, P2875, DOI 10.1016/j.ajpath.2015.07.003; Cohen WA, 2014, J ORAL PATHOL MED, V43, P162, DOI 10.1111/jop.12113; Dimitroulis G, 2005, INT J ORAL MAX SURG, V34, P345, DOI 10.1016/j.ijom.2004.10.013; GALERA P, 1992, J CELL PHYSIOL, V153, P596, DOI 10.1002/jcp.1041530322; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldberg MB, 1999, J OROFAC PAIN, V13, P291; Heinemeier KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8335; Jiao K, 2014, J DENT RES, V93, P140, DOI 10.1177/0022034513513034; Kawamura I, 2012, J BIOL CHEM, V287, P29101, DOI 10.1074/jbc.M112.349415; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Long E, 2016, ARCH ORAL BIOL, V67, P68, DOI 10.1016/j.archoralbio.2016.03.004; Osterberg Tor, 1992, Journal of Craniomandibular Disorders, V6, P237; Schlaak JF, 1996, CLIN EXP RHEUMATOL, V14, P155; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279; Xu L, 2003, ARTHRITIS RHEUM, V48, P2509, DOI 10.1002/art.11233; Xu L, 2009, OSTEOARTHR CARTILAGE, V17, P917, DOI 10.1016/j.joca.2009.01.002; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	23	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177826	10.1371/journal.pone.0177826	http://dx.doi.org/10.1371/journal.pone.0177826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542404	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672400092
J	Gabay, Y; Karni, A; Banai, K				Gabay, Yafit; Karni, Avi; Banai, Karen			The perceptual learning of time-compressed speech: A comparison of training protocols with different levels of difficulty	PLOS ONE			English	Article							ADAPTIVE PROCEDURES; JAPANESE LISTENERS; ADAPTATION; THRESHOLD; DISCRIMINATION; VARIABILITY; ADJUSTMENT; EXPOSURE; TALKER; SYSTEM	Speech perception can improve substantially with practice (perceptual learning) even in adults. Here we compared the effects of four training protocols that differed in whether and how task difficulty was changed during a training session, in terms of the gains attained and the ability to apply (transfer) these gains to previously un-encountered items (tokens) and to different talkers. Participants trained in judging the semantic plausibility of sentences presented as time-compressed speech and were tested on their ability to reproduce, in writing, the target sentences; trail-by-trial feedback was afforded in all training conditions. In two conditions task difficulty (low or high compression) was kept constant throughout the training session, whereas in the other two conditions task difficulty was changed in an adaptive manner (incrementally from easy to difficult, or using a staircase procedure). Compared to a control group (no training), all four protocols resulted in significant post-training improvement in the ability to reproduce the trained sentences accurately. However, training in the constant-high-compression protocol elicited the smallest gains in deciphering and reproducing trained items and in reproducing novel, untrained, items after training. Overall, these results suggest that training procedures that start off with relatively little signal distortion ("easy" items, not far removed from standard speech) may be advantageous compared to conditions wherein severe distortions are presented to participants from the very beginning of the training session.	[Gabay, Yafit; Banai, Karen] Univ Haifa, Dept Commun Sci & Disorders, Haifa, Israel; [Gabay, Yafit; Karni, Avi] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, Dept Learning Disabil, Haifa, Israel; [Gabay, Yafit] Univ Haifa, Dept Special Educ, Haifa, Israel; [Karni, Avi] Univ Haifa, Sagol Dept Neurobiol, Haifa, Israel	University of Haifa; University of Haifa; University of Haifa; University of Haifa	Gabay, Y (corresponding author), Univ Haifa, Dept Commun Sci & Disorders, Haifa, Israel.; Gabay, Y (corresponding author), Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, Dept Learning Disabil, Haifa, Israel.	ygabay@edu.haifa.ac.il	Gabay, Yafit/P-8315-2019; Banai, Karen/J-1448-2019	Gabay, Yafit/0000-0002-7899-3044; Banai, Karen/0000-0002-2990-0470	National Institute of Psychobiology in Israel	National Institute of Psychobiology in Israel	This research was supported by a grant from the National Institute of Psychobiology in Israel to KB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from the National Institute of Psychobiology in Israel to KB. We thank Yizhar Lavner for helping to implement the different training protocols.	Adank P, 2009, J ACOUST SOC AM, V126, P2649, DOI 10.1121/1.3216914; Agnew JA, 2004, BRAIN LANG, V88, P21, DOI 10.1016/S0093-934X(03)00157-3; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Altmann GT, 1993, FACTORS AFFECTING AD; Amir O., 2013, STUD MEDIA COMMUN, V1, P131, DOI 10.11114/smc.v1i1.119; Amitay S, 2006, J ACOUST SOC AM, V119, P1616, DOI 10.1121/1.2164988; Anderson S, 2013, HEARING RES, V300, P18, DOI 10.1016/j.heares.2013.03.006; Baddeley A. D., 1992, IMPLICIT MEMORY ERRO; Banai K, 2016, J ACOUST SOC AM, V140, P1686, DOI 10.1121/1.4962499; Banai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118465; Banai K, 2014, J ACOUST SOC AM, V136, P1908, DOI 10.1121/1.4895684; Banai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047099; Bent T, 2011, J EXP PSYCHOL HUMAN, V37, P1607, DOI 10.1037/a0024281; Bjork E. L., 2011, PSYCHOL REAL WORLD E, P56, DOI DOI 10.1017/CBO9781107415324.004; Bjork RA, 2015, AM J PSYCHOL, V128, P241; Bradlow AR, 1997, J ACOUST SOC AM, V101, P2299, DOI 10.1121/1.418276; Brand T, 2002, J ACOUST SOC AM, V111, P2801, DOI 10.1121/1.1479152; Davis MH, 2007, HEARING RES, V229, P132, DOI 10.1016/j.heares.2007.01.014; Davis MH, 2005, J EXP PSYCHOL GEN, V134, P222, DOI 10.1037/0096-3445.134.2.222; Dupoux E, 1997, J EXP PSYCHOL HUMAN, V23, P914, DOI 10.1037/0096-1523.23.3.914; Gabay Y, 2015, J EXP PSYCHOL HUMAN, V41, P1124, DOI 10.1037/xhp0000073; Golomb JD, 2007, J ACOUST SOC AM, V121, P1701, DOI 10.1121/1.2436635; HAGERMAN B, 1995, SCAND AUDIOL, V24, P71, DOI 10.3109/01050399509042213; Heald SLM, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00035; Holmes J., 2009, DEV SCI, V12; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Karawani H, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02066; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Levitt H, 1992, J Am Acad Audiol, V3, P119; Li TH, 2009, EAR HEARING, V30, P238, DOI 10.1097/AUD.0b013e31819769ac; LIVELY SE, 1993, J ACOUST SOC AM, V94, P1242, DOI 10.1121/1.408177; Loebach JL, 2010, J EXP PSYCHOL HUMAN, V36, P224, DOI 10.1037/a0017609; Maddox GB, 2015, MEM COGNITION, V43, P760, DOI 10.3758/s13421-014-0499-6; Moore DR, 2009, PHILOS T R SOC B, V364, P409, DOI 10.1098/rstb.2008.0187; Mussgens DM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00642; Nahum M, 2010, VISION RES, V50, P391, DOI 10.1016/j.visres.2009.09.004; Norris D, 2008, PSYCHOL REV, V115, P357, DOI 10.1037/0033-295X.115.2.357; Pallier C, 1998, MEM COGNITION, V26, P844, DOI 10.3758/BF03211403; Peelle JE, 2005, J EXP PSYCHOL HUMAN, V31, P1315, DOI 10.1037/0096-1523.31.6.1315; Polat U, 1995, PLASTICITY SPATIAL I, P111; Prior A, 2006, PSYCHOPHYSIOLOGY, V43, P440, DOI 10.1111/j.1469-8986.2006.00426.x; Sebastian-Galles N, 2000, PERCEPT PSYCHOPHYS, V62, P834, DOI 10.3758/BF03206926; Squires EJ, 1997, NEUROPSYCHOLOGIA, V35, P1103, DOI 10.1016/S0028-3932(97)00039-0; Stacey PC, 2008, J SPEECH LANG HEAR R, V51, P526, DOI 10.1044/1092-4388(2008/038); Svirsky MA, 2015, HEARING RES, V322, P163, DOI 10.1016/j.heares.2014.10.008; TERRACE HS, 1964, SCIENCE, V144, P78, DOI 10.1126/science.144.3614.78; Verhelst W, 1993, OVERLAP ADD TECHNIQU, P554, DOI 10.1109/ICASSP.1993.319366; Vlahou EL, 2012, J EXP PSYCHOL GEN, V141, P363, DOI 10.1037/a0025014; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; WINGFIELD A, 1975, J SPEECH HEAR RES, V18, P96, DOI 10.1044/jshr.1801.96; Wright BA, 2015, J ACOUST SOC AM, V138, P928, DOI 10.1121/1.4927411; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262	55	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176488	10.1371/journal.pone.0176488	http://dx.doi.org/10.1371/journal.pone.0176488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28545039	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400008
J	Long, S				Long, Stephen			Short-term impacts and value of a periodic no take zone (NTZ) in a community-managed small-scale lobster fishery, Madagascar	PLOS ONE			English	Article							PANULIRUS-HOMARUS-RUBELLUS; SPINY-LOBSTERS; FISHING EFFORT; BIODIVERSITY; COMANAGEMENT; LIVELIHOODS; RESOURCES; OUTCOMES; COAST; REEF	The small-scale lobster fisheries of Madagascar's impoverished southeast coast account for the majority of national catch and export, making a significant contribution to the regional economy. Data suggests catches have declined, likely due to over-exploitation. In response, the community of Sainte Luce has established a locally managed marine area (LMMA) to manage their lobster fishery, including a 13 km 2 periodic no take zone (NTZ). Participatory monitoring data were used to assess compliance, identify changes in catch per unit effort (CPUE) associated with the NTZ and consider the short-term value of the NTZ. Compliance is low for measures dictated by national legislation (minimum landing size (MLS), national closed season, prohibition on landing berried females), but may be higher for those designed by the community (NTZ). Upon NTZ opening in July 2015, an estimated 435% increase in catch was observed compared with the mean for the preceding five months, a product of increased effort and significantly higher CPUE. Zero Altered Negative Binomial modelling showed CPUE was significantly higher during the NTZ opening in 2015 and in 2016 when the opening period had been moved. Whilst it is unlikely that tangible ecological benefits have accrued from NTZ operation, there have been important socio-economic effects. Specifically, there was a 33% increase in the price fishers received, a significant effect at the bottom of the value chain. Temporary increases in catch and income acted as a catalyst, engaging neighbouring communities in fishery management, resulting in two additional NTZs. Attention is drawn to the fact that current national legislation may be sub-optimal and should be reviewed. Successful management of the regional fishery will require the state and industry to support communities in adopting community-based management. The NTZ measure considered here may be an effective tool to achieve this.	[Long, Stephen] SEED Madagascar, Ambinanikely, Tolagnaro, Madagascar; [Long, Stephen] UCL, Dept Geog, London, England	University of London; University College London	Long, S (corresponding author), SEED Madagascar, Ambinanikely, Tolagnaro, Madagascar.; Long, S (corresponding author), UCL, Dept Geog, London, England.	stephen.long@seedmadagascar.org		Long, Stephen/0000-0001-8454-9364	Food and Agriculture Organisation (FAO)-SmartFish programme of the Indian Ocean Commission (IOC), Mauritius; Jeremy Willson Charitable Trust (JWCT); Institut Halieutique et des Sciences Marines (IHSM)	Food and Agriculture Organisation (FAO)-SmartFish programme of the Indian Ocean Commission (IOC), Mauritius; Jeremy Willson Charitable Trust (JWCT); Institut Halieutique et des Sciences Marines (IHSM)	The study was funded by the Food and Agriculture Organisation (FAO)-SmartFish programme of the Indian Ocean Commission (IOC), Mauritius. SL received financial support to meet personal costs from the Jeremy Willson Charitable Trust (JWCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research would not have possible without: the staff of ONG Azafady and SEED Madagascar particularly E. Ellis and S. Randrianantenaina; data collection by C. Andry, assisted by international volunteers from the SEED Madagascar Conservation and Pioneer programmes; and the co-operation of collecteurs, rabbateurs and operateurs (Madapeche and Martin Pecheur). Data from Fig 1 was provided by DRRHP/URL, with thanks to C. Razafimandimby (DRRHP), E. Ranaivoson (URL) and A. Suzelys (URL). P. Clark of the Natural History Museum provided taxonomic assistance. Additional support from the Institut Halieutique et des Sciences Marines (IHSM) was provided by T. Lavitra, M. Rabenevanana and J. Victor, who produced a French translation of the abstract. M. Darling served as an invaluable sounding board for statistical approaches. Comments on the draft manuscript from A. Burtenshaw-Devries and M. Jacobs were extremely helpful. The comments from anonymous reviewers significantly improved the final manuscript.	Al-Marzouqi A., 2007, Western Indian Ocean Journal of Marine Science, V6, P159; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; Antona M, 2004, ENVIRON DEV ECON, V9, P825, DOI 10.1017/S1355770X04001640; Barnes-Mauthe M, 2013, FISH RES, V147, P175, DOI 10.1016/j.fishres.2013.05.011; Bartlett CY, 2009, CONSERV BIOL, V23, P1475, DOI 10.1111/j.1523-1739.2009.01293.x; Benbow S, 2014, AFR J MAR SCI, V36, P31, DOI 10.2989/1814232X.2014.893256; Bene C, 2010, DEV POLICY REV, V28, P325, DOI 10.1111/j.1467-7679.2010.00486.x; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; Booth JD, 2000, SPINY LOBSTERS FISHE, P556; Caddy JF, 1998, CANADIAN SPECIAL PUB, P359; Charbonnier D, 1961, LA PECHE MARITIME, P1; Chubb C., 2000, SPINY LOBSTERS FISHE, P243; Cinner J, 2014, CONSERV LETT, V7, P224, DOI 10.1111/conl.12057; Clausen A., 2013, NATURAL CAPITAL ACCO; Cohen PJ, 2013, GLOBAL ENVIRON CHANG, V23, P1702, DOI 10.1016/j.gloenvcha.2013.08.010; Cohen PJ, 2013, MAR POLICY, V37, P278, DOI 10.1016/j.marpol.2012.05.010; De Bruin GHP, 1962, SPINY LOBSTERS CEYLO; Fabinyi M, 2010, HUM ECOL, V38, P415, DOI 10.1007/s10745-010-9329-z; FAO, 2007, FAO FISHERIES TECHNI; FIGIS (Fisheries Global Information System), 2015, FISH COMM TRAD 1976, P1976; FIGIS (Fisheries Global Information System), 2015, GLOB CAPT PROD 1950; Food and Agriculture Organization (FAO), 2009, GLOB C SMALL SCAL FI; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Gendron L, 2002, CAN J FISH AQUAT SCI, V59, P899, DOI 10.1139/F02-068; GEORGE RW, 1967, EVOLUTION, V21, P803, DOI 10.1111/j.1558-5646.1967.tb03435.x; Gnanalingam G, 2015, MAR POLICY, V61, P39, DOI 10.1016/j.marpol.2015.06.033; Govan H., 2009, STATUS POTENTIAL LOC; Harris A., 2011, MADAGASCAR CONSERV D, V6; Harris A., 2007, MADAG CONSERV DEV, V2, P43, DOI DOI 10.4314/MCD.V2I1.44129; Health N Council MR, 2004, AUSTR COD PRACT CAR; Hogg Forrest, 2013, Palms, V57, P133; Holloway G., 2014, Madagascar Conservation and Development, V9, P36, DOI 10.4314/mcd.v9i1.7; Holthius LB, 1991, MARINE LOBSTERS WORL; Holthuis UB, 2006, ZOOSYSTEMA, V28, P417; Jackman S., 2008, PSCL CLASSES METHODS; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Jupiter SD, 2012, CORAL REEFS, V31, P321, DOI 10.1007/s00338-012-0888-x; Jupiter Stacy D., 2014, Pacific Conservation Biology, V20, P165; Kaufmann JC, 2014, EARTH CONSERV DEV, P320; Kennington WJ, 2013, LOBSTERS: BIOLOGY, MANAGEMENT, AQUACULTURE AND FISHERIES, 2ND EDITION, P36; Kulmiye AJ, 2006, AFR J MAR SCI, V28, P51, DOI 10.2989/18142320609504133; Kulmiye AJ, 2005, NEW ZEAL J MAR FRESH, V39, P539, DOI 10.1080/00288330.2005.9517332; Le Manach F, 2012, MAR POLICY, V36, P218, DOI 10.1016/j.marpol.2011.05.007; LeManach F., 2011, FISHERIES CTR RES RE, V19, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; MAEP, 2004, TCPMAGO170A MAEP; Malleret-King D., 2006, NEW GLASS ARCHITECTU; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Mayol T, 2013, MADAG CONSERV DEV, V8, P91, DOI [10.4314/MCD.V8I2.8, DOI 10.4314/mcd.v8i2.8]; Mohan R, 1997, MAR FRESHWATER RES, V48, P1085, DOI 10.1071/MF97157; Monnereau I, 2015, MARE PUBL SER, V13, P223, DOI 10.1007/978-3-319-17034-3_12; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oliver TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129075; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Phillips BF, 2005, NEW ZEAL J MAR FRESH, V39, P231, DOI 10.1080/00288330.2005.9517303; Phillips BF, 2013, LOBSTERS: BIOLOGY, MANAGEMENT, AQUACULTURE AND FISHERIES, 2ND EDITION, P289; POLLOCK DE, 1993, B MAR SCI, V53, P937; Pomeroy RS, 2011, SMALL-SCALE FISHERIES MANAGEMENT: FRAMEWORKS AND APPROACHES FOR THE DEVELOPING WORLD, P75, DOI 10.1079/9781845936075.0075; R Core Team, 2021, R LANGUAGE ENV STAT; RADHAKRISHNAN EV, 1995, CRUSTACEANA, V68, P151, DOI 10.1163/156854095X01303; Rakotondrazafy Andriamampandry R., 2015, MEDITERRANEA EB; Rakotoson LR, 2006, OCEAN COAST MANAGE, V49, P855, DOI 10.1016/j.ocecoaman.2006.08.003; Reddy MM, 2014, J CRUSTACEAN BIOL, V34, P773, DOI 10.1163/1937240X-00002284; Rocliffe S., 2016, EXPERIENCES PERIODIC; Sabatini G, TOLAGNARO MADAGASCAR; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Salas S, 2007, FISH RES, V87, P5, DOI 10.1016/j.fishres.2007.06.015; Scales IR, 2014, EARTH CONSERV DEV, P1; Skinner F., 2016, PHASE 2 PROJECT COMM; Stamatopoulos C., 2004, SAFETY SAMPLING METH; Stamatopoulos Constantine, 2002, SAMPLE BASED FISHERY; Steyn E, 2011, NEW ZEAL J MAR FRESH, V45, P85, DOI 10.1080/00288330.2010.538067; Tewfik A, 2004, FISH RES, V69, P21, DOI 10.1016/j.fishres.2004.04.004; United Nations Development Programme (UNDP), 2015, HUM DEV REP 2015 WOR; Vega A., 1991, 19 CRIP LA PAZ SECR, V19; World Bank, 2015, MAD SYST COUNTR DIAG; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur Alain F., 2009, P1	78	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177858	10.1371/journal.pone.0177858	http://dx.doi.org/10.1371/journal.pone.0177858			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542323	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400103
J	Anklam, K; Kulow, M; Yamazaki, W; Dopfer, D				Anklam, Kelly; Kulow, Megan; Yamazaki, Wataru; Dopfer, Dorte			Development of real-time PCR and loop-mediated isothermal amplification (LAMP) assays for the differential detection of digital dermatitis associated treponemes	PLOS ONE			English	Article							DAIRY-CATTLE; CALIFORNIA DAIRY; RAPID DETECTION; PREVALENCE; LESIONS; DNA; UNIQUE	Bovine digital dermatitis (DD) is a severe infectious cause of lameness in cattle worldwide, with important economic and welfare consequences. There are three treponeme phylogroups (T. pedis, T. phagedenis, and T. medium) that are implicated in playing an important causative role in DD. This study was conducted to develop real-time PCR and loopmediated isothermal amplification (LAMP) assays for the detection and differentiation of the three treponeme phylogroups associated with DD. The real-time PCR treponeme phylogroup assays targeted the 16S-23S rDNA intergenic space (ITS) for T. pedis and T. phagedenis, and the flagellin gene (flaB2) for T. medium. The 3 treponeme phylogroup LAMP assays targeted the flagellin gene (flaB2) and the 16S rRNA was targeted for the Treponeme ssp. LAMP assay. The real-time PCR and LAMP assays correctly detected the target sequence of all control strains examined, and no cross-reactions were observed, representing 100% specificity. The limit of detection for each of the three treponeme phylogroup realtime PCR and LAMP assays was <= 70 fg/mu l. The detection limit for the Treponema spp. LAMP assay ranged from 7-690 fg/mu l depending on phylogroup. Treponemes were isolated from 40 DD lesion biopsies using an immunomagnetic separation culture method. The treponeme isolation samples were then subjected to the real-time PCR and LAMP assays for analysis. The treponeme phylogroup real-time PCR and LAMP assay results had 100% agreement, matching on all isolation samples. These results indicate that the developed assays are a sensitive and specific test for the detection and differentiation of the three main treponeme phylogroups implicated in DD.	[Anklam, Kelly; Kulow, Megan; Dopfer, Dorte] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Yamazaki, Wataru] Univ Miyazaki, Fac Agr, Dept Vet Sci, Miyazaki, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Miyazaki	Anklam, K (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA.	kelly.anklam@wisc.edu	Yamazaki, Wataru/ACT-3267-2022	Yamazaki, Wataru/0000-0002-7874-8014	Japan Society for the Promotion of Science KAKENHI [JP26450406]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Japan Society for the Promotion of Science KAKENHI, grant number JP26450406. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ArgaezRodriguez FDJ, 1997, PREV VET MED, V32, P275, DOI 10.1016/S0167-5877(97)00031-7; Berry SL, 2012, VET J, V193, P654, DOI 10.1016/j.tvjl.2012.06.048; BLOWEY RW, 1988, VET REC, V122, P505, DOI 10.1136/vr.122.21.505; Brandt S, 2011, VET MICROBIOL, V148, P161, DOI 10.1016/j.vetmic.2010.08.031; Bruijnis MRN, 2012, ANIMAL, V6, P962, DOI 10.1017/S1751731111002606; Clegg SR, 2016, APPL ENVIRON MICROB, V82, P4523, DOI 10.1128/AEM.00025-16; Cogoni V, 2012, MICROBIOL-SGM, V158, P759, DOI 10.1099/mic.0.055939-0; Demirkan I, 1999, Vet Rec, V145, P497; Demirkan I, 2001, J MED MICROBIOL, V50, P1061, DOI 10.1099/0022-1317-50-12-1061; Dopfer D, 1997, VET REC, V140, P620, DOI 10.1136/vr.140.24.620; Evans NJ, 2008, VET MICROBIOL, V130, P141, DOI 10.1016/j.vetmic.2007.12.019; Evans NJ, 2009, J CLIN MICROBIOL, V47, P689, DOI 10.1128/JCM.01914-08; Gandelman OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014155; Goto M, 2007, LETT APPL MICROBIOL, V45, P100, DOI 10.1111/j.1472-765X.2007.02142.x; Hernandez J, 2001, J AM VET MED ASSOC, V218, P1611, DOI 10.2460/javma.2001.218.1611; Holzhauer M, 2006, J DAIRY SCI, V89, P580, DOI 10.3168/jds.S0022-0302(06)72121-X; Houston S, 2015, INFECT IMMUN, V83, P4204, DOI 10.1128/IAI.00643-15; Klitgaard K, 2008, J CLIN MICROBIOL, V46, P3012, DOI 10.1128/JCM.00670-08; Klitgaard K, 2013, J CLIN MICROBIOL, V51, P2212, DOI 10.1128/JCM.00320-13; Lim KT, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/895816; Liu W., 2016, INT J MOL SCI, V17; Moore LJ, 2005, VET MICROBIOL, V111, P199, DOI 10.1016/j.vetmic.2005.10.016; Moter A, 1998, J CLIN MICROBIOL, V36, P1399, DOI 10.1128/JCM.36.5.1399-1403.1998; Nordhoff M, 2008, VET MICROBIOL, V131, P293, DOI 10.1016/j.vetmic.2008.04.019; Nordhoff M, 2008, VET MICROBIOL, V127, P334, DOI 10.1016/j.vetmic.2007.09.011; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Read DH, 1998, J VET DIAGN INVEST, V10, P67, DOI 10.1177/104063879801000112; Seyrig G, 2015, J MICROBIOL METH, V119, P223, DOI 10.1016/j.mimet.2015.11.004; Stamm LV, 2002, J CLIN MICROBIOL, V40, P3463, DOI 10.1128/JCM.40.9.3463-3469.2002; Tie Z, 2012, J BIOMED BIOTECHNOL; Valasek MA, 2005, ADV PHYSIOL EDUC, V29, P151, DOI 10.1152/advan.00019.2005; Walker RL, 1995, VET MICROBIOL, V47, P343, DOI 10.1016/0378-1135(95)00114-X; WEINBERG A, 1991, J BACTERIOL, V173, P6935, DOI 10.1128/jb.173.21.6935-6947.1991; Wells SJ, 1999, PREV VET MED, V38, P11, DOI 10.1016/S0167-5877(98)00132-9; Whay HR, 1997, VET J, V154, P155, DOI 10.1016/S1090-0233(97)80053-6; Wilson-Welder JH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-280; Yamamoto Y, 2002, CLIN DIAGN LAB IMMUN, V9, P508, DOI 10.1128/CDLI.9.3.508-514.2002; Yang J, 2013, TRANSBOUND EMERG DIS, V60, P238, DOI 10.1111/j.1865-1682.2012.01335.x; Yano T, 2010, VET MICROBIOL, V143, P352, DOI 10.1016/j.vetmic.2009.12.009	39	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178349	10.1371/journal.pone.0178349	http://dx.doi.org/10.1371/journal.pone.0178349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542573	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800079
J	Fernandez-Sanchez, L; Bravo-Osuna, I; Lax, P; Arranz-Romera, A; Maneu, V; Esteban-Perez, S; Pinilla, I; Puebla-Gonzalez, MD; Herrero-Vanrell, R; Cuenca, N				Fernandez-Sanchez, Laura; Bravo-Osuna, Irene; Lax, Pedro; Arranz-Romera, Alicia; Maneu, Victoria; Esteban-Perez, Sergio; Pinilla, Isabel; del Mar Puebla-Gonzalez, Maria; Herrero-Vanrell, Rocio; Cuenca, Nicolas			Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats	PLOS ONE			English	Article							PHOTORECEPTOR CELL-DEATH; CONTROLLED DRUG-DELIVERY; RETINITIS-PIGMENTOSA; GANGLION-CELLS; MOUSE MODELS; RHODOPSIN; TUDCA; PLGA; BILE; SURVIVAL	Successful drug therapies for treating ocular diseases require effective concentrations of neuroprotective compounds maintained over time at the site of action. The purpose of this work was to assess the efficacy of intravitreal controlled delivery of tauroursodeoxycholic acid (TUDCA) encapsulated in poly(D, L-lactic-co-glycolic acid) (PLGA) microspheres for the treatment of the retina in a rat model of retinitis pigmentosa. PLGA microspheres (MSs) containing TUDCA were produced by the O/W emulsion-solvent evaporation technique. Particle size and morphology were assessed by light scattering and scanning electronic microscopy, respectively. Homozygous P23H line 3 rats received a treatment of intravitreal injections of TUDCA-PLGA MSs. Retinal function was assessed by electroretinography at P30, P60, P90 and P120. The density, structure and synaptic contacts of retinal neurons were analyzed using immunofluorescence and confocal microscopy at P90 and P120. TUDCA-loaded PLGA MSs were spherical, with a smooth surface. The production yield was 78%, the MSs mean particle size was 23 mu m and the drug loading resulted 12.5 +/- 0.8 mu g TUDCA/mg MSs. MSs were able to deliver the loaded active compound in a gradual and progressive manner over the 28-day in vitro release study. Scotopic electroretinografic responses showed increased ERG a- and b-wave amplitudes in TUDCA-PLGA-MSstreated eyes as compared to those injected with unloaded PLGA particles.TUDCA-PLGAMSs- treated eyes showed more photoreceptor rows than controls. The synaptic contacts of photoreceptors with bipolar and horizontal cells were also preserved in P23H rats treated with TUDCA-PLGA MSs. This work indicates that the slow and continuous delivery of TUDCA from PLGA-MSs has potential neuroprotective effects that could constitute a suitable therapy to prevent neurodegeneration and visual loss in retinitis pigmentosa.	[Fernandez-Sanchez, Laura; Lax, Pedro; Cuenca, Nicolas] Univ Alicante, Dept Physiol Genet & Microbiol, Alicante, Spain; [Bravo-Osuna, Irene; Arranz-Romera, Alicia; Esteban-Perez, Sergio; del Mar Puebla-Gonzalez, Maria; Herrero-Vanrell, Rocio] Univ Complutense Madrid, Fac Pharm, Dept Pharm & Pharmaceut Technol, Madrid, Spain; [Maneu, Victoria] Univ Alicante, Dept Opt Pharmacol & Anat, Alicante, Spain; [Pinilla, Isabel] Lozano Blesa Univ Hosp, Dept Ophthalmol, Zaragoza, Spain; [Pinilla, Isabel] Aragon Inst Hlth Res IIS Aragon, Zaragoza, Spain; [Herrero-Vanrell, Rocio] San Carlos Clin Hosp IdISSC, Sanit Res Inst, Madrid, Spain; [Herrero-Vanrell, Rocio] Univ Complutense Madrid, Ind Pharm Inst, Madrid, Spain; [Cuenca, Nicolas] Univ Alicante, Inst Ramon Margalef, Alicante, Spain	Universitat d'Alacant; Complutense University of Madrid; Universitat d'Alacant; Lozano Blesa University Clinical Hospital; Complutense University of Madrid; Universitat d'Alacant	Cuenca, N (corresponding author), Univ Alicante, Dept Physiol Genet & Microbiol, Alicante, Spain.; Herrero-Vanrell, R (corresponding author), Univ Complutense Madrid, Fac Pharm, Dept Pharm & Pharmaceut Technol, Madrid, Spain.; Herrero-Vanrell, R (corresponding author), San Carlos Clin Hosp IdISSC, Sanit Res Inst, Madrid, Spain.; Herrero-Vanrell, R (corresponding author), Univ Complutense Madrid, Ind Pharm Inst, Madrid, Spain.; Cuenca, N (corresponding author), Univ Alicante, Inst Ramon Margalef, Alicante, Spain.	rociohv@ucm.es; cuenca@ua.es	bravo-osuna, irene/M-3469-2015; Cuenca, Nicolas/I-2007-2015; Pérez, Sergio Esteban/K-6400-2017; Maneu, Victoria/N-4147-2014; Lax, Pedro/M-9074-2014; Fernandez-Sanchez, Laura/AAB-5663-2019	bravo-osuna, irene/0000-0003-3133-7872; Cuenca, Nicolas/0000-0002-6767-5710; Pérez, Sergio Esteban/0000-0003-4832-0778; Maneu, Victoria/0000-0002-5265-1361; Lax, Pedro/0000-0001-6931-1008; Fernandez-Sanchez, Laura/0000-0002-3629-0156	Spanish Ministry of Economy and Competitiveness [MINECO-FEDER BFU2015-67139-R, MICINN-FEDER MAT 2013-43127R]; Institute de Salud Carlos III [RETICS-FEDER RD16/0008/0016, RD16/0008/0009]; Complutense Research Group [UCM920415]; Generalitat Valenciana [PROMETEO/2016/158]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Institute de Salud Carlos III(Instituto de Salud Carlos III); Complutense Research Group; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by The Spanish Ministry of Economy and Competitiveness (MINECO-FEDER BFU2015-67139-R, to NC; MICINN-FEDER MAT 2013-43127R to RH-V) (http://www.mineco.gob.es); Institute de Salud Carlos III (RETICS-FEDER RD16/0008/0016, to NC; RD16/0008/0009 to RH-V) (http://www.oftared.com/); Complutense Research Group (UCM920415) to RH-V (https://www.ucm.es/); and Generalitat Valenciana PROMETEO/2016/158 to NC (http://www.gva.es).	Abrego G, 2015, EUR J PHARM BIOPHARM, V95, P261, DOI 10.1016/j.ejpb.2015.01.026; Andres-Guerrero V, 2015, J CONTROL RELEASE, V211, P105, DOI 10.1016/j.jconrel.2015.05.279; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; Boatright JH, 2006, MOL VIS, V12, P1706; Boatright Jeffrey H, 2009, J Ocul Biol Dis Infor, V2, P149; Castro-Caldas M, 2012, MOL NEUROBIOL, V46, P475, DOI 10.1007/s12035-012-8295-4; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Checa-Casalengua P, 2011, J CONTROL RELEASE, V156, P92, DOI 10.1016/j.jconrel.2011.06.023; Chennamaneni SR, 2013, J CONTROL RELEASE, V167, P53, DOI 10.1016/j.jconrel.2013.01.007; COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384; Cortez LM, 2015, J VIROL, V89, P7660, DOI 10.1128/JVI.01165-15; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; Cuenca N, 2014, PROG RETIN EYE RES, V43, P17, DOI 10.1016/j.preteyeres.2014.07.001; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Duan WM, 2002, CELL TRANSPLANT, V11, P195; Elia AE, 2015, EUR J NEUROL; Esquiva G, 2013, INVEST OPHTH VIS SCI, V54, P4605, DOI 10.1167/iovs.13-12120; Fernandez-Sanchez L, 2015, MOLECULES, V20, P13875, DOI 10.3390/molecules200813875; Fernaandez-Saanchez L, 2014, INVEST OPHTH VIS SCI, V55, P6059, DOI 10.1167/iovs.14-14421; Fernandez-Sanchez L, 2012, HUM GENE THER, V23, P1290, DOI 10.1089/hum.2012.067; Fernandez-Sanchez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043074; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Fu YB, 2014, ADV EXP MED BIOL, V801, P791, DOI 10.1007/978-1-4614-3209-8_99; Garcia-Ayuso D, 2010, EXP EYE RES; Garcia-Ayuso D, 2015, INVEST OPHTH VIS SCI, V56, P4592, DOI 10.1167/iovs.15-16808; Gaspar JM, 2013, NEUROSCIENCE, V253, P380, DOI 10.1016/j.neuroscience.2013.08.053; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; GIORDANO GG, 1995, CURR EYE RES, V14, P761, DOI 10.3109/02713689508995797; Gomez-Vicente V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137826; Gong J, 2006, BRAIN RES, V1082, P73, DOI 10.1016/j.brainres.2006.01.111; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Herrero-Vanrell R, 2001, ADV DRUG DELIVER REV, V52, P5, DOI 10.1016/S0169-409X(01)00200-9; Herrero-Vanrell R, 2011, INVEST OPHTHALMOL, V52, P3251, DOI 10.1016/i.exer.2015.10.012; Herrero-Vanrell R, 2014, PROG RETIN EYE RES, V42, P27, DOI 10.1016/j.preteyeres.2014.04.002; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jiang C, 2007, MOL VIS, V13, P1783; Jones BW, 2012, JPN J OPHTHALMOL, V56, P289, DOI 10.1007/s10384-012-0147-2; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299; KHOOBEHI B, 1991, OPHTHALMIC SURG LAS, V22, P175; Kolomiets B, 2010, NEUROBIOL DIS, V38, P47, DOI 10.1016/j.nbd.2009.12.025; Lawson EC, 2016, ADV EXP MED BIOL, V854, P431, DOI 10.1007/978-3-319-17121-0_57; Lax P, 2011, J PINEAL RES, V50, P183, DOI 10.1111/j.1600-079X.2010.00827.x; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mantopoulos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024245; Mao SR, 2007, INT J PHARM, V334, P137, DOI 10.1016/j.ijpharm.2006.10.036; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Muller LPD, 2015, J COMP NEUROL, V523, P1443, DOI 10.1002/cne.23751; Noailles A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0186-3; Oveson BC, 2011, J NEUROCHEM, V116, P144, DOI 10.1111/j.1471-4159.2010.07092.x; Paganelli F, 2010, EXPERT OPIN DRUG DEL, V7, P955, DOI 10.1517/17425247.2010.498817; Phillips MJ, 2008, INVEST OPHTH VIS SCI, V49, P2148, DOI 10.1167/iovs.07-1012; Pinilla I, 2005, NEUROSCI LETT, V382, P16, DOI 10.1016/j.neulet.2005.02.055; Pinilla I, 2016, EXP EYE RES, V150, P122, DOI 10.1016/j.exer.2015.10.012; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Puthussery T, 2010, ADV EXP MED BIOL, V664, P525, DOI 10.1007/978-1-4419-1399-9_60; RADOMSKY ML, 1990, BIOMATERIALS, V11, P619, DOI 10.1016/0142-9612(90)90018-L; Ran X, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau047; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Rong XF, 2014, INT J NANOMED, V9, P3057, DOI 10.2147/IJN.S64100; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Veloso Jr AA., 1997, INVEST OPHTHALMOL, V38; Viana RJS, 2009, CELL MOL LIFE SCI, V66, P1094, DOI 10.1007/s00018-009-8746-x; WONG P, 1994, BIOCHEM CELL BIOL, V72, P489, DOI 10.1139/o94-066; Yasukawa T, 2004, PROG RETIN EYE RES, V23, P253, DOI 10.1016/j.preteyeres.2004.02.003; Zhang HB, 2003, INVEST OPHTH VIS SCI, V44, P2858, DOI 10.1167/iovs.03-0072; Zhang T, 2012, INVEST OPHTH VIS SCI, V53, P3349, DOI 10.1167/iovs.12-9851	73	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177998	10.1371/journal.pone.0177998	http://dx.doi.org/10.1371/journal.pone.0177998			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542454	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800034
J	Gawli, K; Ramesh, N; Unniappan, S				Gawli, Kavishankar; Ramesh, Naresh; Unniappan, Suraj			Nesfatin-1-like peptide is a novel metabolic factor that suppresses feeding, and regulates whole-body energy homeostasis in male Wistar rats	PLOS ONE			English	Article							FOOD-INTAKE; INSULIN-SECRETION; BINDING-PROTEIN; NUCLEOBINDIN; MICE; CELLS; EXPRESSION; OBESITY; WEIGHT; CALNUC	Nucleobindin-1 has high sequence similarity to nucleobindin-2, which encodes the anorectic and metabolic peptide, nesfatin-1. We previously reported a nesfatin-1-like peptide (NLP), anorectic in fish and insulinotropic in mice islet beta-like cells. The main objective of this research was to determine whether NLP is a metabolic regulator in male Wistar rats. A single intraperitoneal (IP) injection of NLP (100 mu g/kg BW) decreased food intake and increased ambulatory movement, without causing any change in total activity or energy expenditure when compared to saline-treated rats. Continuous subcutaneous infusion of NLP (100 mu g/kg BW) using osmotic mini-pumps for 7 days caused a reduction in food intake on days 3 and 4. Similarly, water intake was also reduced for two days (days 3 and 4) with the effect being observed during the dark phase. This was accompanied by an increased RER and energy expenditure. However, decreased whole-body fat oxidation, and total activity were observed during the long-term treatment (7 days). Body weight gain was not significantly different between control and NLP infused rats. The expression of mRNAs encoding adiponectin, resistin, ghrelin, cholecystokinin and uncoupling protein 1 (UCP1) were significantly upregulated, while leptin and peptide YY mRNA expression was downregulated in NLP-treated rats. These findings indicate that administration of NLP at 100 mu g/kg BW reduces food intake and modulates whole body energy balance. In summary, NLP is a novel metabolic peptide in rats.	[Gawli, Kavishankar; Ramesh, Naresh; Unniappan, Suraj] Univ Saskatchewan, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Dept Vet Biomed Sci, Saskatoon, SK, Canada	University of Saskatchewan	Unniappan, S (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Dept Vet Biomed Sci, Saskatoon, SK, Canada.	suraj.unniappan@usask.ca			Canadian Institutes of Health Research (CIHR); Saskatchewan Health Research Foundation (SHRF); Canada Foundation for Innovation (CFI); SHRF; University of Saskatchewan; College of Graduate and Post-doctoral studies (CGPS), University of Saskatchewan	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation (SHRF); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); SHRF; University of Saskatchewan; College of Graduate and Post-doctoral studies (CGPS), University of Saskatchewan	SU is a recipient of an open operating grant and a New Investigator Salary Award award from the Canadian Institutes of Health Research (CIHR), an Establishment Grant from the Saskatchewan Health Research Foundation (SHRF). The CLAMS was purchased using a Leaders Opportunities Fund from the Canada Foundation for Innovation (CFI). KG received a postdoctoral research fellowship from the SHRF. NR is a recipient of college of graduate and postdoctoral studies (CGPS) Dean's scholarship from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SU is a recipient of an open operating grant and a New Investigator Salary Award from the Canadian Institutes of Health Research (CIHR), an Establishment Grant from the Saskatchewan Health Research Foundation (SHRF). The CLAMS was purchased using a Leaders Opportunities Fund from the Canada Foundation for Innovation (CFI). KG received a postdoctoral research fellowship from the SHRF. NR is a recipient of the Dean's scholarship from the College of Graduate and Post-doctoral studies (CGPS), University of Saskatchewan.	Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Blundell JE, 2015, OBES REV, V16, P67, DOI 10.1111/obr.12257; Diamanti-Kandarakis E, 2012, INT J OBES LOND, V33, P981; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Garcia-Galiano D, 2010, J NEUROSCI, V30, P7783, DOI 10.1523/JNEUROSCI.5828-09.2010; Goebel M, 2011, PEPTIDES, V32, P36, DOI 10.1016/j.peptides.2010.09.027; Gonzalez R, 2011, ENDOCRINOLOGY, V152, P3628, DOI 10.1210/en.2010-1471; Gonzalez R, 2012, GEN COMP ENDOCR, V176, P341, DOI 10.1016/j.ygcen.2011.11.021; Gupta R, 2012, J MOL BIOL, V421, P378, DOI 10.1016/j.jmb.2012.04.017; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hofmann T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132058; Kubota T, 2001, IMMUNOL LETT, V75, P111, DOI 10.1016/S0165-2478(00)00290-X; Leclerc P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002229; Lents CA, 2013, DOMEST ANIM ENDOCRIN, V45, P89, DOI 10.1016/j.domaniend.2013.06.002; Li ZR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071513, 10.1371/journal.pone.0074635]; Lin P, 2000, P NATL ACAD SCI USA, V97, P674, DOI 10.1073/pnas.97.2.674; Lin P, 2007, J NEUROCHEM, V100, P1505, DOI 10.1111/j.1471-4159.2006.07336.x; Lin P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-15; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; Mortazavi S, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00022; Nair N, 2016, GEN COMP ENDOCR, V234, P142, DOI 10.1016/j.ygcen.2016.02.015; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Petersson U, 2004, BONE, V34, P949, DOI 10.1016/j.bone.2004.01.019; Prinz P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00422; Ramesh N, 2016, BIOCHEM BIOPH RES CO, V472, P201, DOI 10.1016/j.bbrc.2016.02.095; Ramesh N, 2015, GEN COMP ENDOCR, V216, P182, DOI 10.1016/j.ygcen.2015.04.011; Reidelberger R, 2014, AM J PHYSIOL-ENDOC M, V307, pE619, DOI 10.1152/ajpendo.00024.2014; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; Stengel A, 2010, PEPTIDES, V31, P357, DOI 10.1016/j.peptides.2009.11.019; Sundarrajan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28377; Tsukumo Y, 2009, J BIOL CHEM, V284, P27500, DOI 10.1074/jbc.M109.021592; Unniappan S, 2006, DIABETOLOGIA, V49, P1915, DOI 10.1007/s00125-006-0310-8; Unniappan S, 2008, AM J PHYSIOL-REG I, V295, pR51, DOI 10.1152/ajpregu.00234.2007; Valencia CA, 2008, FEBS LETT, V582, P286, DOI 10.1016/j.febslet.2007.12.019; WANG SN, 1994, PATHOL INT, V44, P844, DOI 10.1111/j.1440-1827.1994.tb01682.x; Wernecke K, 2014, OBESITY, V22, P1662, DOI 10.1002/oby.20736; Williams P, 2014, CELL TISSUE RES, V358, P331, DOI 10.1007/s00441-014-1948-z; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	42	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178329	10.1371/journal.pone.0178329	http://dx.doi.org/10.1371/journal.pone.0178329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542568	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800071
J	Wang, YY; Zhang, J; Zhang, L; Gao, P; Wu, XY				Wang, Yuanyuan; Zhang, Juan; Zhang, Lian; Gao, Ping; Wu, Xiaoyan			Adiponectin attenuates high glucose-induced apoptosis through the AMPK/p38 MAPK signaling pathway in NRK-52E cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TYPE-2 DIABETIC-PATIENTS; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; ENDOTHELIAL-CELL; NADPH OXIDASE; CANCER; RESISTIN; LIVER	Excessive apoptosis of proximal tubule cell is closely related to the development of diabetes. Recent evidence suggests that adiponectin (ADPN) protects cells from high glucose induced apoptosis. However, the precise mechanisms remain poorly understood. We sought to investigate the role of p38 mitogen-activated protein kinase (p38 MAPK) and AMP activated protein kinase (AMPK) in anti-apoptotic of adiponectin under high glucose condition in rat tubular NRK-52E cells. Cells were cultured in constant and oscillating high glucose media with or without recombinant rat adiponectin for 48 h. Cell counting kit-8 (CCK-8) was used to detect cell viability, flow cytometry and Hoechst Staining were applied to investigate cell apoptosis, and western blotting was used to examine protein expression, such as phospho-AMPK and phospho-p38MAPK. Exposure to oscillating high glucose exerted lower cell viability and higher early apoptosis than constant high glucose, which were both partially prevented by adiponectin. Further studies revealed that adiponectin suppressed p38MAPK phosphorylation, but led to an increase in AMPK a phosphorylation. Compared to stable high glucose group, blockage of p38MAPK cascade with SB203580 attenuated apoptosis significantly, but failed to affect the phosphorylation level of AMPK. While AMPK inhibitor, Compound C, increased apoptosis and remarkably inhibited the p38MAPK phosphorylation. Adiponectin exert a crucial protective role against apoptosis induced by high glucose via AMPK/p38MAPK pathway.	[Wang, Yuanyuan; Zhang, Juan; Zhang, Lian; Gao, Ping; Wu, Xiaoyan] Wuhan Univ, Dept Nephrol, Zhongnan Hosp, Wuhan, Hubei, Peoples R China	Wuhan University	Wu, XY (corresponding author), Wuhan Univ, Dept Nephrol, Zhongnan Hosp, Wuhan, Hubei, Peoples R China.	wuxychh@163.com	Lv, Yuanjie/AER-0767-2022; Wang, Yuan/HHC-1520-2022; wangwangwang, yuanyaun/HHN-6432-2022		National Natural Science Foundation of China [2011N5FL]; Natural Science Foundation of Hubei Province [2013CFA074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the National Natural Science Foundation of China (No: 2011N5FL, http://www.nsfc.gov.cn/) and the Natural Science Foundation of Hubei Province (No: 2013CFA074, http://www.hbstd.gov.cn/).	Aleidi S, 2015, SAUDI PHARM J, V23, P250, DOI 10.1016/j.jsps.2014.11.011; Bondor CI, 2015, INT UROL NEPHROL, V47, P1173, DOI 10.1007/s11255-015-1004-2; Brown KA, 2009, CANCER RES, V69, P5392, DOI 10.1158/0008-5472.CAN-09-0108; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Guan GY, 2014, ENDOCRINE, V47, P764, DOI 10.1007/s12020-014-0186-1; Habib SL, 2013, WORLD J DIABETES, V4, P27, DOI 10.4239/wjd.v4.i2.27; Huang BQ, 2014, ONCOTARGET, V5, P4732, DOI 10.18632/oncotarget.1963; Imai K, 2006, BIOCHEM BIOPH RES CO, V351, P595, DOI 10.1016/j.bbrc.2006.10.056; Ishijima N, 2015, CANCER SCI, V106, P567, DOI 10.1111/cas.12633; Jiang QL, 2015, MOL CELL BIOCHEM, V399, P113, DOI 10.1007/s11010-014-2238-5; Jing YY, 2015, J HEPATOL, V62, P1319, DOI 10.1016/j.jhep.2014.12.032; Jung DS, 2008, AM J PHYSIOL-RENAL, V295, pF595, DOI 10.1152/ajprenal.00624.2007; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Kim A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08394; Kim MJ, 2014, MOL PHARMACOL, V86, P284, DOI 10.1124/mol.114.093039; Kim N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120104; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Lai XH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-10; Langer S, 2016, J NEPHROL, V29, P765, DOI 10.1007/s40620-015-0258-1; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Li X, 2012, CHINESE MED J-PEKING, V125, P4209, DOI 10.3760/cma.j.issn.0366-6999.2012.23.009; Martindale JJ, 2005, J BIOL CHEM, V280, P669, DOI 10.1074/jbc.M406690200; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Rojas E, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0463-7; Shao BL, 2014, REDOX BIOL, V2, P694, DOI 10.1016/j.redox.2014.05.005; Sun JZ, 2010, J MOL ENDOCRINOL, V44, P179, DOI 10.1677/JME-09-0088; Tsai CH, 2015, ONCOTARGET, V6, P258, DOI 10.18632/oncotarget.2724; Weisova P, 2011, ANTIOXID REDOX SIGN, V14, P1863, DOI 10.1089/ars.2010.3544; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang YQ, 2015, AM J PHYSIOL-ENDOC M, V309, pE275, DOI 10.1152/ajpendo.00577.2014; Zhao HY, 2011, CHINESE MED J-PEKING, V124, P2540, DOI 10.3760/cma.j.issn.0366-6999.2011.16.026	33	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178215	10.1371/journal.pone.0178215	http://dx.doi.org/10.1371/journal.pone.0178215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542560	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800055
J	Jeon, JP; Koh, IU; Choi, NH; Kim, BJ; Han, BG; Lee, S				Jeon, Jae-Pil; Koh, In-Uk; Choi, Nak-Hyun; Kim, Bong-Jo; Han, Bok-Ghee; Lee, Suman			Differential DNA methylation of MSI2 and its correlation with diabetic traits	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; ADIPOSE-TISSUE; EXPRESSION; BMI; HYPERGLYCEMIA; EPIGENETICS; SIGNATURE; ENHANCER; SMOKING; INSULIN	Differential DNA methylation with hyperglycemia is significantly associated with Type 2 Diabetes (T2D). Longtime extended exposure to high blood glucose levels can affect the epigenetic signatures in all organs. However, the relevance of the differential DNA methylation changes with hyperglycemia in blood with pancreatic islets remains unclear. We investigated differential DNA methylation in relation to glucose homeostasis based on the Oral Glucose Tolerance Test (OGTT) in a population-based cohort. We found a total of 382 differential methylation sites from blood DNA in hyperglycemia and type 2 diabetes subgroups using a longitudinal and cross-sectional approach. Among them, three CpG sites were overlapped; they were mapped to the MSI2 and CXXC4 genes. In a DNA methylation replication study done by pyrosequencing (n = 440), the CpG site of MSI2 were shown to have strong associations with the T2D group (p value = 2.20E-16). The differential methylation of MSI2 at chr17:55484635 was associated with diabetes-related traits, in particular with insulin sensitivity (QUICKI, p value = 2.20E-16) and resistance (HOMA-IR, p value = 1.177E-07). In human pancreatic islets, at the single-base resolution (using whole-genome bisulfite sequencing), the 292 CpG sites in the +/- 5kb at chr17: 55484635 were found to be significantly hypo-methylated in donors with T2D (average decrease = 13.91%, 95% confidence interval (CI) = 4.18 similar to 17.06) as compared to controls, and methylation patterns differed by sex (-9.57%, CI = -16.76 similar to -6.89) and age (0.12%, CI = -11.17 similar to 3.77). Differential methylation of the MSI2 gene (chr17: 55484635) in blood and islet cells is strongly related to hyperglycemia. Our findings suggest that epigenetic perturbation on the target site of MSI2 gene in circulating blood and pancreatic islets should represent or affect hyperglycemia.	[Jeon, Jae-Pil] Natl Res Inst Hlth, Ctr Biomed Sci, Cheongju, South Korea; [Koh, In-Uk; Choi, Nak-Hyun; Kim, Bong-Jo; Han, Bok-Ghee; Lee, Suman] Natl Res Inst Hlth, Ctr Genome Sci, Cheongju, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science	Han, BG; Lee, S (corresponding author), Natl Res Inst Hlth, Ctr Genome Sci, Cheongju, South Korea.	bokghee@nih.go.kr; smnl93@gmail.com			Korean National Institute of Health [2009-N00435-00, 2014-ND73001-00, 2016-NI73004-00, 2017-NI73003-00]	Korean National Institute of Health	This work was supported by intramural grants (2009-N00435-00, 2014-ND73001-00, 2016-NI73004-00 and 2017-NI73003-00) from the Korean National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yong-Sung Kim and Jong Ryul Park at KRIBB for advising pyrosequencing experiment. This work was supported by intramural grants (2009-N00435-00, 2014-ND73001-00, 2016-NI73004-00 and 2017-NI73003-00) from the Korean National Institute of Health. Epidemiological and biochemical data including the OGTT and DNA samples for this study were provided by the National Biobank of Korea and the Korean Genome and Epidemiology Study (KoGES) according to the approval of the sample and data access committee.	Alegra-Torres JA, 2011, EPIGENOMICS-UK, V3, P267, DOI [10.2217/EPI.11.22, 10.2217/epi.11.22]; Campion J, 2010, PROG MOL BIOL TRANSL, V94, P291, DOI 10.1016/S1877-1173(10)94011-8; Choi HJ, 2012, PHYSIOL GENOMICS, V44, P1179, DOI 10.1152/physiolgenomics.00179.2011; Danovi SA, 2010, NAT REV CANCER, V10, P602, DOI 10.1038/nrc2919; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Demerath EW, 2015, HUM MOL GENET, V24, P4464, DOI 10.1093/hmg/ddv161; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Dogan MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-151; Drong AW, 2012, CLIN PHARMACOL THER, V92, P707, DOI 10.1038/clpt.2012.149; ELAYAT AA, 1995, J ANAT, V186, P629; Florath I, 2016, DIABETOLOGIA, V59, P130, DOI 10.1007/s00125-015-3773-7; Goto T, 2005, TRANSPL P, V37, P3430, DOI 10.1016/j.transproceed.2005.09.041; Hall E, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0522-z; Hidalgo B, 2014, DIABETES, V63, P801, DOI 10.2337/db13-1100; Hope KJ, 2011, CURR OPIN HEMATOL, V18, P203, DOI 10.1097/MOH.0b013e328347888a; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Kim Y, 2016, INT J EPIDEMIOL; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim Unhee, 2012, Methods Mol Biol, V863, P359, DOI 10.1007/978-1-61779-612-8_23; Multhaup ML, 2015, CELL METAB, V21, P138, DOI 10.1016/j.cmet.2014.12.014; Na YK, 2014, MOL CELLS, V37, P467, DOI 10.14348/molcells.2014.0073; Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459; Park JH, 2007, BIOCHEM BIOPH RES CO, V358, P513, DOI 10.1016/j.bbrc.2007.04.169; Ronn T, 2015, HUM MOL GENET, V24, P3792, DOI 10.1093/hmg/ddv124; Sales LB, 2013, TOXICOL IN VITRO, V27, P1634, DOI 10.1016/j.tiv.2013.04.005; Shim SM, 2016, J HUM GENET, V61, P241, DOI 10.1038/jhg.2015.140; Song MA, 2007, ELECTROPHORESIS, V28, P2379, DOI 10.1002/elps.200600852; Szabat M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.119; Tekpli X, 2012, INT J CANCER, V131, P1509, DOI 10.1002/ijc.27421; Teschendorff AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008274; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]	34	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177406	10.1371/journal.pone.0177406	http://dx.doi.org/10.1371/journal.pone.0177406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542303	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500022
J	Kaffarnik, MF; Ahmadi, N; Lock, JF; Wuensch, T; Pratschke, J; Stockmann, M; Malinowski, M				Kaffarnik, Magnus F.; Ahmadi, Navid; Lock, Johan F.; Wuensch, Tilo; Pratschke, Johann; Stockmann, Martin; Malinowski, Maciej			Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study	PLOS ONE			English	Article							HEPATIC-DYSFUNCTION; EARLY-DIAGNOSIS; RECEPTOR; TRANSPLANTATION; MORTALITY; SEPSIS; INJURY; ALPHA	Aim To investigate the relationship between the degree of liver dysfunction, quantified by maximal liver function capacity (LiMAx test) and endothelin-1, TNF-alpha and IL-6 in septic surgical patients. Methods 28 septic patients (8 female, 20 male, age range 35-80y)were prospectively investigated on a surgical intensive care unit. Liver function, defined by LiMAx test, and measurements of plasma levels of endothelin-1, TNF-alpha and IL-6 were carried out within the first 24 hours after onset of septic symptoms, followed by day 2, 5 and 10. Patients were divided into 2 groups (group A: LiMAx >= 100 mu g/kg/h, moderate liver dysfunction; group B: LiMAx < 100 mu g/kg/h, severe liver dysfunction) for analysis and investigated regarding the correlation between endothelin-1 and the severity of liver failure, quantified by LiMAx test. Results Group B showed significant higher results for endothelin-1 than patients in group A(P = 0.01, d5; 0.02, d10). For TNF-alpha, group B revealed higher results than group A, with a significant difference on day 10 (P = 0.005). IL-6 showed a non-significant trend to higher results in group B. The Spearman's rank correlation coefficient revealed a significant correlation between LiMAx and endothelin-1 (-0.434; P < 0.001), TNF-alpha (-0.515; P < 0.001) and IL-6 (-0.590; P < 0.001). Conclusions Sepsis-related hepatic dysfunction is associated with elevated plasma levels of endothelin-1, TNF-alpha and IL-6. Low LiMAx results combined with increased endothelin-1 and TNF-alpha and a favourable correlation between LiMAx and cytokine values support the findings of a crucial role of Endothelin-1 and TNF-alpha in development of septic liver failure.	[Kaffarnik, Magnus F.; Ahmadi, Navid; Lock, Johan F.; Wuensch, Tilo; Pratschke, Johann; Stockmann, Martin; Malinowski, Maciej] Charite Univ Med Berlin, Dept Gen Visceral & Transplantat Surg, Augustenburger Pl 1, Berlin, Germany; [Lock, Johan F.] Univ Hosp Wuerzburg, Dept Gen Visceral Vasc & Paediat Surg, Wurzburg, Germany; [Malinowski, Maciej] Univ Hosp Homburg, Dept Gen Visceral Vasc & Paediat Surg, Homburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; Universitatsklinikum des Saarlandes	Kaffarnik, MF (corresponding author), Charite Univ Med Berlin, Dept Gen Visceral & Transplantat Surg, Augustenburger Pl 1, Berlin, Germany.	magnus.kaffarnik@charite.de	Lock, Johan/AAA-8114-2020	Lock, Johan/0000-0002-9007-3937; Ahmadi, Navid/0000-0003-3246-5905	Charite-University Hospital, Berlin	Charite-University Hospital, Berlin	The study was funded by research grants of the Charite-University Hospital, Berlin. B.R.A.H. M.S. GmbH, (Hennigsdorf, Germany) supported this study by provision of CT-proET-1 assay kits (BRAHMS CRproET1 Kryptor, Material Transfer Agreement). This does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahde R, 2014, HEPATOLOGY, V59, P1107, DOI 10.1002/hep.26766; Bahde R, 2013, HEPATOLOGY, V57, P320, DOI 10.1002/hep.26005; Battistini B, 1996, SHOCK, V5, P167, DOI 10.1097/00024382-199603000-00002; Brauner JS, 2000, INTENS CARE MED, V26, P305, DOI 10.1007/s001340051154; Brienza N, 2006, INTENS CARE MED, V32, P267, DOI 10.1007/s00134-005-0023-3; Chan CC, 2001, HEPATOLOGY, V33, P816, DOI 10.1053/jhep.2001.23079; Demirci E, 2015, DRUG RES, V65, P272, DOI 10.1055/s-0034-1377024; Eakes AT, 1998, AM J PHYSIOL-GASTR L, V274, pG1068, DOI 10.1152/ajpgi.1998.274.6.G1068; Freeman BD, 2014, LIFE SCI, V118, P110, DOI 10.1016/j.lfs.2014.04.021; Harbrecht BG, 2002, J TRAUMA, V53, P517, DOI 10.1097/00005373-200209000-00020; Iwai M, 1998, HEPATOLOGY, V28, P503, DOI 10.1002/hep.510280230; Kaffarnik MF, 2013, CRIT CARE, V17, DOI 10.1186/cc13089; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lock JF, 2010, LIVER TRANSPLANT, V16, P172, DOI 10.1002/lt.21973; McKenna S, 2015, J IMMUNOL, V195, P3866, DOI 10.4049/jimmunol.1501017; Nagai H, 2010, J SURG RES, V162, P46, DOI 10.1016/j.jss.2007.07.024; Norris EJ, 2013, SHOCK, V39, P168, DOI 10.1097/SHK.0b013e3182736688; Oki M, 2014, LIFE SCI, V118, P364, DOI 10.1016/j.lfs.2014.02.008; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Piechota Mariusz, 2007, J Intensive Care Med, V22, P232, DOI 10.1177/0885066607301444; Quinto BMR, 2015, CYTOKINE, V71, P255, DOI 10.1016/j.cyto.2014.10.024; Schuetz P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-22; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stockmann M, 2010, TRANSPL INT, V23, P1023, DOI 10.1111/j.1432-2277.2010.01089.x; Stockmann M, 2010, HPB, V12, P139, DOI 10.1111/j.1477-2574.2009.00151.x; Stockmann M, 2009, ANN SURG, V250, P119, DOI 10.1097/SLA.0b013e3181ad85b5; Strassburg CP, 2003, BEST PRACT RES CL GA, V17, P369, DOI 10.1016/S1521-6918(03)00025-8; Struck J, 2005, PEPTIDES, V26, P2482, DOI 10.1016/j.peptides.2005.05.010; Tschaikowsky K, 2000, CRIT CARE MED, V28, P1854, DOI 10.1097/00003246-200006000-00028; Wanecek M, 2000, EUR J PHARMACOL, V407, P1, DOI 10.1016/S0014-2999(00)00675-0; Zhao Ruo-Zhi, 2005, Biochem Biophys Res Commun, V327, P985, DOI 10.1016/j.bbrc.2004.12.109	31	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178237	10.1371/journal.pone.0178237	http://dx.doi.org/10.1371/journal.pone.0178237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542386	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800050
J	Macedo, RS; Teixeira, WG; Correa, MM; Martins, GC; Vidal-Torrado, P				Macedo, Rodrigo S.; Teixeira, Wenceslau G.; Correa, Marcelo M.; Martins, Gilvan C.; Vidal-Torrado, Pablo			Pedogenetic processes in anthrosols with pretic horizon (Amazonian Dark Earth) in Central Amazon, Brazil	PLOS ONE			English	Article							INDIAN BLACK EARTH; CARBON; TERRA	Anthrosols known as Amazonian Dark Earth (ADE) have borne witness to the intensification of sedentary patterns and the demographic increase in Central Amazon. As a result, a recurring pattern has been observed of mounds with ADE arising from domestic activities and the disposal of waste. The objective of this research was to demonstrate the relationship of these anthropic activities with pedogenetic formation processes of ADE in the municipality of Iranduba, Brazil. Disturbed and undisturbed soil samples were taken from two areas of ADE (pretic horizon) and from a non-anthropic pedon. Physical, chemical, micromorphological and SEM-EDS analyses were performed. The coarse material of the pretic horizons consisted predominantly of quartz, iron nodules, ceramics and charcoal fragments, and the fine material is organo-mineral. There was a direct relationship between the color of pretic horizons and the number of charcoal fragments. The thickness of the ADE results from the redistribution of charcoal at depth through bioturbation, transforming subsurface horizons into anthropic horizons. ADE presents granular microaggregates of geochemical and zoogenetic origin. Degradation of iron nodules is intensified in pretic horizons, promoting a reverse pedogenic process contributing to the xanthization process. Surprisingly the anthropic activities also favor clay dispersion and argilluviation; clay coatings on the ceramic fragments and in the pores demonstrate that this is a current process. Processes identified as contributing to ADE genesis included: i) addition of organic residues and ceramic artifacts (cumulization) with the use of fire; ii) mechanical action of humans, roots and macrofauna (bioturbation); iii) melanization of deeper horizons as a result of bioturbation; iv) argilluviation and degradation of iron nodules. This study offers new support to archaeological research in respect to ADE formation processes in Central Amazon and confirmed the hypothesis that ancient anthropic activities may trigger and/or accelerate pedogenetic processes previously credited only to natural causes.	[Macedo, Rodrigo S.; Vidal-Torrado, Pablo] Univ Sao Paulo, Soil Sci Dept, Piracicaba, SP, Brazil; [Teixeira, Wenceslau G.] Embrapa Solos, Rio De Janeiro, RJ, Brazil; [Correa, Marcelo M.] Univ Fed Rural Pernambuco, Unidade Acad Garanhuns, Garanhuns, PE, Brazil; [Martins, Gilvan C.] Embrapa Amazonia Ocidental, Manaus, Amazonas, Brazil	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal Rural de Pernambuco (UFRPE); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Vidal-Torrado, P (corresponding author), Univ Sao Paulo, Soil Sci Dept, Piracicaba, SP, Brazil.	pvidal@usp.br	Correa, Marcelo/AAI-1232-2021; Vidal-Torrado, Pablo/C-4020-2012; Teixeira, Wenceslau G/P-3723-2014	Correa, Marcelo/0000-0003-0929-4634; Vidal-Torrado, Pablo/0000-0001-9228-9910; Teixeira, Wenceslau G/0000-0002-2010-6078	Sao Paulo Research Foundation (FAPESP)/Brazil [FAPESP 2010/51934-5, FAPESP 2012/06064-8]; CAPES [FAPESP 2010/51934-5, FAPESP 2012/06064-8]; EMBRAPA; CNPq [304741/2013-2]	Sao Paulo Research Foundation (FAPESP)/Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Sao Paulo Research Foundation (FAPESP)/Brazil and CAPES, by granting PhD scholarships within the country (FAPESP 2010/51934-5) and abroad (FAPESP 2012/06064-8). EMBRAPA is a government research institution (https://www.embrapa.br/en/home) which provided financial support in the form of authors' salaries and/or research materials to authors WGT and GCM. CNPq provided a research grant of PVT (304741/2013-2). The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully thank the FAPESP (2010/51934-5) and CAPES for the doctoral scholarships granted to the first author and CNPq (304741/2013-2) for the research grant of the last author. We would like to thank Embrapa Amazonia Ocidental-Amazonas/Brasil for the logistic support and the Caldeirao Project. We would like to give thanks to Marcia Regina Calegari for enormous help in the fieldwork and the technicians Sonia Moraes and Jose Luiz Vicente for the preparation of the thin sections.	[Anonymous], 1966, AMAZON SOILS RECONNA; Archanjo BS, 2014, ENVIRON SCI TECHNOL, V48, P7445, DOI 10.1021/es501046b; Arroyo-Kalin M., 2009, P99, DOI 10.1007/978-1-4020-9031-8_5; Arroyo-Kalin M., 2009, P33, DOI 10.1007/978-1-4020-9031-8_3; Arroyo-Kalin MA, 2010, ARQUEOLOGIA AMAZONIC, V2, P367; Arroyo-Kalin M, 2012, QUATERN INT, V249, P4, DOI 10.1016/j.quaint.2011.08.004; Birk JJ, 2011, J ARCHAEOL SCI, V38, P1209, DOI 10.1016/j.jas.2010.12.015; Bouma J., 1990, MICROMORPHOLOGY HYDR, P257, DOI [10.1016/S0166-2481(08)70338-6, DOI 10.1016/S0166-2481(08)70338-6]; BREWER R, 1976, FABRIC MINERAL ANAL; Bullock P, 1985, HDB THIN SECTION DES; Coelho M. R., 2001, Revista Brasileira de Ciencia do Solo, V25, P371, DOI 10.1590/S0100-06832001000200013; Cooper M, 2005, SCI AGR, V62, P256, DOI 10.1590/S0103-90162005000300009; Costa ML, 2011, AN ACAD BRAS CIENC, V73, P461; Empresa Brasileira de Pesquisa Agropecuaria-Embrapa, 2011, MAN MET AN SOL; Heckenberger MJ, 1999, LAT AM ANTIQ, V10, P353, DOI 10.2307/971962; IBGE, 2007, BAS CART INT DIG BRA; IUSS Working Group WRB, 2015, 106 IUSS; Jungerius PD, 1999, CATENA, V34, P349, DOI 10.1016/S0341-8162(98)00106-4; Kampf N, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P77, DOI 10.1007/1-4020-2597-1_5; Kampf N., 2005, TOPICS SOIL SCI, V6, P277; Kern DC, 2004, AMAZONIAN DARK EARTHS: EXPLORATIONS IN SPACE AND TIME, P19; Lemos VP, 2009, REM-REV ESC MINAS, V62, P139, DOI 10.1590/S0370-44672009000200004; Lima HN, 2002, GEODERMA, V110, P1, DOI 10.1016/S0016-7061(02)00141-6; Lima HN, 2010, TERRAS PRETAS INDIO, P212; Lindbo DL, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P129, DOI 10.1016/B978-0-444-53156-8.00008-8; Madari BE, 2010, TERRAS PRETAS INDIO, P172; Murphy C.P., 1986, THIN SECTION PREPARA; Nakamura F. M., 2014, Diversity, V6, P339, DOI 10.3390/d6020339; Neves EG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P29, DOI 10.1007/1-4020-2597-1_3; Neves EG, 2006, ARQUEOLOGIA AMAZOINA; Oonk S, 2009, J ARCHAEOL SCI, V36, P1215, DOI 10.1016/j.jas.2009.01.010; Ruivo MDP, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P243, DOI 10.1007/1-4020-2597-1_13; Santos RD., 2013, MANUAL DESCRICAO COL, V6; Schaefer CEGR, 2004, AUST J SOIL RES, V42, P401, DOI 10.1071/SR03106; Schaefer CER, 2001, AUST J SOIL RES, V39, P909, DOI 10.1071/SR00093; Schellekens J, 2017, GEODERMA, V288, P154, DOI 10.1016/j.geoderma.2016.11.001; Schmidt MJ, 2014, J ARCHAEOL SCI, V42, P152, DOI 10.1016/j.jas.2013.11.002; Silva AMS, 1999, NEW J CHEM, V23, P329, DOI 10.1590/S0100-06831999000200017; SOMBROEK WG, 1993, AMBIO, V22, P417; Souza KR, 2011, THESIS; Tardy Y., 1992, PETROLOGIE LATERITES, P459; Taube PS, 2013, ORG GEOCHEM, V58, P96, DOI 10.1016/j.orggeochem.2013.02.004; Teixeira WG, 2008, DIGITAL SOIL MAPPING WITH LIMITED DATA, P327, DOI 10.1007/978-1-4020-8592-5_29; Teixeira WG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P271, DOI 10.1007/1-4020-2597-1_15; Zech W., 1990, Humic substances in soil and crop sciences: selected readings. Proceedings of a symposium cosponsored by the International Humic Substances Society, Chicago, Illinois, December 2, 1985., P187	45	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178038	10.1371/journal.pone.0178038	http://dx.doi.org/10.1371/journal.pone.0178038			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542442	gold, Green Submitted, Green Published			2022-12-27	WOS:000402058800034
J	Miller, C; Pachanski, MJ; Kirkland, ME; Kosinski, DT; Mane, J; Bunzel, M; Cao, J; Souza, S; Thomas-Fowlkes, B; Di Salvo, J; Weinglass, AB; Li, XY; Myers, RW; Knagge, K; Carrington, PE; Hagmann, WK; Trujillo, ME				Miller, Corin; Pachanski, Michele J.; Kirkland, Melissa E.; Kosinski, Daniel T.; Mane, Joel; Bunzel, Michelle; Cao, Jin; Souza, Sarah; Thomas-Fowlkes, Brande; Di Salvo, Jerry; Weinglass, Adam B.; Li, Xiaoyan; Myers, Robert W.; Knagge, Kevin; Carrington, Paul E.; Hagmann, William K.; Trujillo, Maria E.			GPR40 partial agonist MK-2305 lower fasting glucose in the Goto Kakizaki rat via suppression of endogenous glucose production	PLOS ONE			English	Article							DEPENDENT INSULIN-SECRETION; PANCREATIC BETA-CELLS; RECEPTOR 1 AGONIST; TYPE-2; GLUCONEOGENESIS; GLYCOGENOLYSIS; TAK-875; STIMULATION; IMPROVES; OBESITY	GPR40 (FFA1) is a fatty acid receptor whose activation results in potent glucose lowering and insulinotropic effects in vivo. Several reports illustrate that GPR40 agonists exert glucose lowering in diabetic humans. To assess the mechanisms by which GPR40 partial agonists improve glucose homeostasis, we evaluated the effects of MK-2305, a potent and selective partial GPR40 agonist, in diabetic Goto Kakizaki rats. MK-2305 decreased fasting glucose after acute and chronic treatment. MK-2305-mediated changes in glucose were coupled with increases in plasma insulin during hyperglycemia and glucose challenges but not during fasting, when glucose was normalized. To determine the mechanism(s) mediating these changes in glucose metabolism, we measured the absolute contribution of precursors to glucose production in the presence or absence of MK-2305. MK-2305 treatment resulted in decreased endogenous glucose production (EGP) driven primarily through changes in gluconeogenesis from substrates entering at the TCA cycle. The decrease in EGP was not likely due to a direct effect on the liver, as isolated perfused liver studies showed no effect of MK-2305 ex vivo and GPR40 is not expressed in the liver. Taken together, our results suggest MK-2305 treatment increases glucose stimulated insulin secretion (GSIS), resulting in changes to hepatic substrate handling that improve glucose homeostasis in the diabetic state. Importantly, these data extend our understanding of the underlying mechanisms by which GPR40 partial agonists reduce hyperglycemia.	[Miller, Corin; Bunzel, Michelle; Cao, Jin] Merck & Co Inc, Dept Translat Imaging Biomarkers, Kenilworth, NJ USA; [Pachanski, Michele J.; Kirkland, Melissa E.; Kosinski, Daniel T.; Mane, Joel; Trujillo, Maria E.] Merck & Co Inc, In Vivo Pharmacol, Kenilworth, NJ 07033 USA; [Souza, Sarah; Thomas-Fowlkes, Brande; Di Salvo, Jerry; Weinglass, Adam B.; Myers, Robert W.] Merck & Co Inc, In Vitro Pharmacol, Kenilworth, NJ USA; [Li, Xiaoyan; Carrington, Paul E.] Merck & Co Inc, Cardiometab Dis, Kenilworth, NJ USA; [Myers, Robert W.] David H Murdock Res Inst, Kannapolis, NC USA; [Hagmann, William K.] Merck & Co Inc, Chem, Kenilworth, NJ USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Trujillo, ME (corresponding author), Merck & Co Inc, In Vivo Pharmacol, Kenilworth, NJ 07033 USA.	maria_trujillo@merck.com	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022		Merck and Co Inc.	Merck and Co Inc.(Merck & Company)	The funder Merck and Co Inc. provided support in the form of salaries for authors [CM, MJP, MEK, DTK, JM, MB, JC, SS, BTF, JD, ABW, XL, RWM, KK, PEC, WKH, MET], study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adkins A, 2003, DIABETES, V52, P2213, DOI 10.2337/diabetes.52.9.2213; [Anonymous], 2005, DIABETES-METAB RES, V21, P495; Aoki K, 2004, LIFE SCI, V74, P3075, DOI 10.1016/j.lfs.2003.10.031; Araki T, 2012, DIABETES OBES METAB, V14, P271, DOI 10.1111/j.1463-1326.2011.01525.x; Basu R, 2005, DIABETES, V54, P1942, DOI 10.2337/diabetes.54.7.1942; Basu R, 2004, DIABETES, V53, P2042, DOI 10.2337/diabetes.53.8.2042; Bergman RN, 1997, RECENT PROG HORM RES, V52, P359; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; COHEN SM, 1987, BIOCHEMISTRY-US, V26, P563, DOI 10.1021/bi00376a031; DEFRONZO RA, 1992, DIABETOLOGIA, V35, P389, DOI 10.1007/BF00401208; Delgado TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034042; Edgerton DS, 2001, DIABETES, V50, P1872, DOI 10.2337/diabetes.50.8.1872; Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807; Gastaldelli A, 2000, DIABETES, V49, P1367, DOI 10.2337/diabetes.49.8.1367; Hauge M, 2015, MOL METAB, V4, P3, DOI 10.1016/j.molmet.2014.10.002; Houze JB, 2012, BIOORG MED CHEM LETT, V22, P1267, DOI 10.1016/j.bmcl.2011.10.118; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Li XL, 2013, IEEE CONF IMAGING SY, P1, DOI 10.1109/IST.2013.6729651; Lin DK, 2011, COMPUT FLUIDS, V40, P333, DOI 10.1016/j.compfluid.2010.08.018; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Negoro N, 2012, J MED CHEM, V55, P3960, DOI 10.1021/jm300170m; Nielsen MF, 1998, DIABETES, V47, P1735, DOI 10.2337/diabetes.47.11.1735; Petersen KF, 1998, J CLIN INVEST, V101, P1203, DOI 10.1172/JCI579; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; ROSSETTI L, 1993, J CLIN INVEST, V92, P2963, DOI 10.1172/JCI116919; Sena CM, 2007, DIABETES METAB, V33, P296, DOI 10.1016/j.diabet.2007.03.002; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Wang S-P, 2016, AM J PHYSL ENDOCRINO; Yashiro H, 2012, J PHARMACOL EXP THER, V340, P483, DOI 10.1124/jpet.111.187708	36	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0176182	10.1371/journal.pone.0176182	http://dx.doi.org/10.1371/journal.pone.0176182			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542610	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058800001
J	Takeshita, S; Kanai, T; Kawamura, Y; Yoshida, Y; Nonoyama, S				Takeshita, Seiichiro; Kanai, Takashi; Kawamura, Yoichi; Yoshida, Yusuke; Nonoyama, Shigeaki			A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease	PLOS ONE			English	Article							CORONARY-ARTERY LESIONS; GAMMA-GLOBULIN THERAPY; INITIAL TREATMENT; RESISTANCE; CANCER; TRIAL; INTERVENTION	Background We recently reported that the combination of the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) is a novel and useful predictor of intravenous immunoglobulin (IVIG)-resistance in Kawasaki disease (KD). In the present study, to evaluate the effectiveness of the new risk score, we compared its predictive validity to that of previously reported risk scores. Materials and methods The laboratory records of 437 patients with KD before IVIG therapy were retrospectively analyzed, and the IVIG-responsive (n = 344) and IVIG-resistant (n = 93) patients were compared. The validity of the new score (the combination of NLR >= 3.83 and PLR >= 150) for predicting IVIG resistance in KD was compared to that of the Kobayashi, Egami and Sano risk scores. Results The new score and the Kobayashi score displayed high sensitivity (0.72 and 0.70 respectively) and specificity (0.67 and 0.68 respectively), while the Egami and Sano scores showed high specificity (0.71 and 0.81 respectively) but relatively low sensitivity (0.56 and 0.45 respectively). The odds ratios (ORs) for the new score, the Kobayashi score, the Egami score and the Sano score were 5.34 (95% confidence interval [Cl] 3.22-8.85), 4.87 (95% Cl 2.96-8.01), 3.14 (95% Cl 1.96-5.03) and 3.53 (95% Cl 2.17-5.77) respectively. Conclusions The predictive validity of the combination of NLR >= 3.83 and PLR >= 150, which is a simple and convenient indicator, was equal to or higher than that of the other risk scores. This suggests that the new score could be a widely available marker for predicting IVIG resistance in KD.	[Takeshita, Seiichiro] Natl Def Med Coll, Div Nursing, Tokorozawa, Saitama, Japan; [Kanai, Takashi; Kawamura, Yoichi; Yoshida, Yusuke; Nonoyama, Shigeaki] Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama, Japan; [Kanai, Takashi] Japan Self Def Forces Cent Hosp, Dept Pediat, Setagaya Ku, Tokyo, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan	Takeshita, S (corresponding author), Natl Def Med Coll, Div Nursing, Tokorozawa, Saitama, Japan.	takeshit@ndmc.ac.jp		Kanai, Takashi/0000-0002-2665-6775	KAKENHI [16K10082]; Japan Kawasaki Disease Research Center; Japan Blood Products Organization	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Kawasaki Disease Research Center; Japan Blood Products Organization	This study was supported by a Grant-in-Aid for Scientific Research (KAKENHI, 16K10082) and grants from the Japan Kawasaki Disease Research Center and the Kawasaki Disease Research from Japan Blood Products Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrakis MG, 2003, AM J CLIN ONCOL-CANC, V26, P135, DOI 10.1097/00000421-200304000-00007; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; Burns JC, 2017, ARTHRITIS RHEUMATOL, V69, P268, DOI 10.1002/art.39975; Cho KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133934; Cicek G, 2015, ANGIOLOGY, V66, P441, DOI 10.1177/0003319714535970; Cummings M, 2015, BRIT J CANCER, V113, P311, DOI 10.1038/bjc.2015.200; Davies S, 2015, ARCH DIS CHILD, V100, P366, DOI 10.1136/archdischild-2014-307397; Demir F, 2015, BALK MED J, V32, P371, DOI 10.5152/balkanmedj.2015.151108; Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050; Galeotti C, 2016, DRUG DISCOV TODAY, V21, P1850, DOI 10.1016/j.drudis.2016.08.004; Galeotti C, 2015, TRENDS MOL MED, V21, P145, DOI 10.1016/j.molmed.2015.01.005; Ha KS, 2015, AM J CARDIOL, V116, P301, DOI 10.1016/j.amjcard.2015.04.021; Kanai T, 2011, CIRCULATION, V124, P2822, DOI 10.1161/CIRCULATIONAHA.111.028423; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawamura Y, 2016, J PEDIATR-US, V178, P281, DOI 10.1016/j.jpeds.2016.07.035; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Kibata T, 2016, INT J CARDIOL, V214, P209, DOI 10.1016/j.ijcard.2016.03.017; Klinger MHF, 2002, J INTERF CYTOK RES, V22, P913, DOI 10.1089/10799900260286623; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Lian L, 2015, CANCER BIOMARK, V15, P899, DOI 10.3233/CBM-150534; Muta H, 2006, ACTA PAEDIATR, V95, P189, DOI 10.1080/08035250500327328; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Ogata S, 2012, PEDIATRICS, V129, pE17, DOI 10.1542/peds.2011-0148; Ozyurtlu F, 2016, CLIN APPL THROMB-HEM, V22, P60; Rigante D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030278; Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z; Sleeper LA, 2011, J PEDIATR-US, V158, P831, DOI 10.1016/j.jpeds.2010.10.031; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Tremoulet AH, 2014, LANCET, V383, P1731, DOI 10.1016/S0140-6736(13)62298-9; Wu GN, 2015, THORAC CANCER, V6, P275, DOI 10.1111/1759-7714.12178; Yodying H, 2016, ANN SURG ONCOL, V23, P646, DOI 10.1245/s10434-015-4869-5; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	35	30	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0176957	10.1371/journal.pone.0176957	http://dx.doi.org/10.1371/journal.pone.0176957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542183	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058800005
J	Siebelink, MJ; Verhagen, AAE; Roodbol, PF; Albers, MJIJ; Van de Wiel, HBM				Siebelink, Marion J.; Verhagen, A. A. Eduard; Roodbol, Petrie F.; Albers, Marcel J. I. J.; Van de Wiel, Harry B. M.			Education on organ donation and transplantation in primary school; teachers' support and the first results of a teaching module	PLOS ONE			English	Article							PEDIATRIC ORGAN; TISSUE DONATION; ATTITUDES; FAMILIES	Organ and tissue donation can also involve children. Because of its sensitivity, this topic requires careful decision making. Children have the ability to carefully reflect on this subject and enjoy participating in family discussions about it. Therefore, what children need is proper information. When schools are used to educate children about this subject, information about teacher support for this type of lesson along with its effects on the depth of family discussions is important. Methods: A questionnaire was sent to all 7,542 primary schools in the Netherlands. The goal was to gather information on teachers' perspectives about a neutral lesson devoted to organ and tissue donation, and also on the best age to start giving such a lesson. The second part of our study examined the effects of a newly developed lesson among 269 primary school pupils. The school response was 23%. Of these, 70% were positive towards a lesson; best age to start was 10-11 years. Pupils reported 20% more family discussions after school education and enjoyed learning more about this topic. There is significant support in primary schools for a school lesson on organ and tissue donation. Educational programs in schools support family discussions.	[Siebelink, Marion J.] Univ Groningen, Univ Med Ctr Groningen, Groningen Transplant Ctr, Groningen, Netherlands; [Verhagen, A. A. Eduard] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat, Groningen, Netherlands; [Roodbol, Petrie F.] Hanze Univ Appl Sci Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Albers, Marcel J. I. J.] St Elizabeth Hosp, Tilburg, Netherlands; [Van de Wiel, Harry B. M.] Univ Groningen, Univ Med Ctr Groningen, Wenckebach Inst Med Educ, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Elisabeth-TweeSteden Ziekenhuis (ETZ); University of Groningen	Siebelink, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen Transplant Ctr, Groningen, Netherlands.	m.j.siebelink@umcg.nl	Verhagen, Eduard/F-9784-2013	Verhagen, Eduard/0000-0001-9555-6922; van de Wiel, Harry/0000-0001-7179-6649; Siebelink, Marion/0000-0001-5366-1732	Dutch government, Ministerie van Volksgezondheid, Welzijn en Sport; Dutch Heart Foundation, Hartstichting [2011T001]; European Society for Education and Communication	Dutch government, Ministerie van Volksgezondheid, Welzijn en Sport; Dutch Heart Foundation, Hartstichting; European Society for Education and Communication	The digital lesson was funded by the Dutch government, Ministerie van Volksgezondheid, Welzijn en Sport to MJS. Part B was supported by a grant from the Dutch Heart Foundation, Hartstichting, number 2011T001 to MJS. All funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the participating primary schools and their pupils for sharing their knowledge and experience and the Dutch Transplant Foundation and Podium for their cooperation in developing this lesson. The digital lesson www.donordenkers.nl was presented with the Comenius award by the European Society for Education and Communication.	Cantarovich F, 2000, TRANSPLANT P, V32, P55, DOI 10.1016/S0041-1345(99)00874-X; Eichner JM, 2010, PEDIATRICS, V125, P822, DOI 10.1542/peds.2010-0081; Randhawa G, 1998, TRANSPLANTATIONSMEDI, V10, P38; Rodrigue JR, 2006, AM J TRANSPLANT, V6, P190, DOI 10.1111/j.1600-6143.2005.01130.x; Sheldon M, 2004, CAMB Q HEALTHC ETHIC, V13, P119; Siebelink MJ, 2012, EUR J PUBLIC HEALTH, V22, P529, DOI 10.1093/eurpub/ckr088; Siebelink MJ, 2012, TRANSPL INT, V25, P265, DOI 10.1111/j.1432-2277.2011.01407.x; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; Waldrop DP, 2004, DEATH STUD, V28, P643, DOI 10.1080/07481180490476489; WALKER JA, 1990, CAN MED ASSOC J, V142, P1383	10	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178128	10.1371/journal.pone.0178128	http://dx.doi.org/10.1371/journal.pone.0178128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UA	28531238	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058400058
J	Mohammed, H; Kassa, M; Assefa, A; Tadesse, M; Kebede, A				Mohammed, Hussein; Kassa, Moges; Assefa, Ashenafi; Tadesse, Mekonnen; Kebede, Amha			Genetic polymorphism of Merozoite Surface Protein-2 (MSP-2) in Plasmodium falciparum isolates from Pawe District, North West Ethiopia	PLOS ONE			English	Article							POPULATION-STRUCTURE; UNSTABLE MALARIA; DIVERSITY; CHILDREN; AREA; EPIDEMIOLOGY; MULTIPLICITY; INFECTIONS; DYNAMICS; DENSITY	Background In malaria endemic regions, Plasmodium falciparum infection is characterized by extensive genetic diversity. Describing this diversity provides important information about the local malaria situation. This study was conducted to evaluate the extent of genetic diversity of P. falciparum in Pawe district, North West Ethiopia, using the highly polymorphic merozoite surface protein 2 gene. Methods Atotal of 92 isolates from patients with uncomplicated P. falciparum attending Pawe Health Centre were collected from September to December 2013. Genomic DNA was extracted using the Chelex method and analyzed by length polymorphism following gel electrophoresis of DNA products from nested PCR of msp2 (block 3), targeting allelic families of FC27 and 3D7/IC. Results There were twenty-two different msp2 alleles, 11 corresponding to the 3D7/IC and 11 to the FC27 allelic family. The frequency of isolates of the msp2 3D7/IC allelic family was higher (51%) compared to FC27 (49%). The majority of the isolates (76%) contained multiple infections and the overall mean multiplicity of infection was 2.8 (CI 95% 2.55-3.03). The heterozygosity index was 0.66 for msp2. There was no statically significant difference in the multiplicity of infection by age or parasite density. Conclusions The results of this study show that P. falciparum polymorphismsare extensive in Northwest Ethiopia and most of the infections are composed of multiple clones.	[Mohammed, Hussein; Kassa, Moges; Assefa, Ashenafi; Tadesse, Mekonnen; Kebede, Amha] Ethiopian Publ Hlth Inst, Bacterial Parasit & Zoonot Dis Res Directorate, Addis Ababa, Ethiopia		Mohammed, H (corresponding author), Ethiopian Publ Hlth Inst, Bacterial Parasit & Zoonot Dis Res Directorate, Addis Ababa, Ethiopia.	hussein_ehnri@yahoo.com		Assefa, Ashenafi/0000-0001-6093-6685	Federal Ministry of Health Ethiopia (FMOH); International Atomic Energy Agency (IAEA); Ethiopian Public Health (EPHI); Federal Ministry of Health; Ethiopian Public Health Institute (EPHI)	Federal Ministry of Health Ethiopia (FMOH); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Ethiopian Public Health (EPHI); Federal Ministry of Health; Ethiopian Public Health Institute (EPHI)	The study was funded by Federal Ministry of Health Ethiopia (FMOH), the International Atomic Energy Agency (IAEA) and Ethiopian Public Health (EPHI). The funders had no role in the study design, data collection and analysis, or collection and analysis, or decision to publication, and preparation of the manuscript.; We are grateful to the staffs of Pawe Health Center and the study participants. This study was supported by the Federal Ministry of Health, the International Atomic Energy Agency (IAEA) and Ethiopian Public Health Institute (EPHI). Wealsothank to Dr Robert Commons forreviewing andimproving themanuscript.	Anthony TG, 2005, J INFECT DIS, V191, P1558, DOI 10.1086/429338; Arnot D, 1998, T ROY SOC TROP MED H, V92, P580, DOI 10.1016/S0035-9203(98)90773-8; Atroosh WM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-233; Babiker HA, 1999, T ROY SOC TROP MED H, V93, pS11, DOI 10.1016/S0035-9203(99)90321-8; Babiker HA, 2000, PARASITOLOGY, V120, P105, DOI 10.1017/S0031182099005387; Babiker HA, 1997, AM J TROP MED HYG, V56, P141, DOI 10.4269/ajtmh.1997.56.141; Bakhiet AMA, 2015, ACTA TROP, V148, P97, DOI 10.1016/j.actatropica.2015.04.013; Basco LK, 2004, AM J TROP MED HYG, V70, P238, DOI 10.4269/ajtmh.2004.70.238; Chitarra V, 1999, MOL CELL, V3, P457, DOI 10.1016/S1097-2765(00)80473-6; Dolmazon V, 2008, ACTA TROP, V107, P37, DOI 10.1016/j.actatropica.2008.04.012; Farnert A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-241; Federal Ministry of Health Ethiopia (FMOH), 2014, NAT STRAT P IN PRESS; Federal Ministry of Health of Ethiopia, 2014, HSDP 4 ANN PERF REP; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Gomez D, 2002, AM J TROP MED HYG, V67, P611, DOI 10.4269/ajtmh.2002.67.611; Hamid Muzamil M Abdel, 2013, N Am J Med Sci, V5, P95, DOI 10.4103/1947-2714.107524; Hoffmann EHE, 2006, GENE, V376, P224, DOI 10.1016/j.gene.2006.03.011; Khaireh BA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-201; Kiwanuka GN, 2009, J VECTOR DIS, V46, P1; Lawrence G, 2000, VACCINE, V18, P1925, DOI 10.1016/S0264-410X(99)00444-2; Mara SE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-419; Mayengue PI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-276; Mohammed H, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0604-8; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; NEI M, 1978, GENETICS, V89, P583; Ntoumi F, 2001, Bull Soc Pathol Exot, V94, P183; Ntoumi F., 2001, Parassitologia (Rome), V42, P197; Ogouyemi-Hounto A, 2013, PARASITE, V20, DOI 10.1051/parasite/2013039; Ojurongbe O, 2011, W INDIAN MED J, V60, P19; Pembe IM, 2011, MALARIA J, V10, P276; Peyerl-Hoffmann G, 2001, TROP MED INT HEALTH, V6, P607, DOI 10.1046/j.1365-3156.2001.00761.x; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; President's Malaria Initiative Ethiopia, 2015, MAL OP PLAN FY; Smith T, 1999, T ROY SOC TROP MED H, V93, pS35, DOI 10.1016/S0035-9203(99)90325-5; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Soulama I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-135; WHO, 2015, WORLDMALARIA REP	37	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177559	10.1371/journal.pone.0177559	http://dx.doi.org/10.1371/journal.pone.0177559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542247	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672600017
J	Beyreuther, E; Bruchner, K; Krause, M; Schmidt, M; Szabo, R; Pawelke, J				Beyreuther, Elke; Bruechner, Kerstin; Krause, Mechthild; Schmidt, Margret; Szabo, Rita; Pawelke, Joerg			An optimized small animal tumour model for experimentation with low energy protons	PLOS ONE			English	Article							LASER-DRIVEN; CELL-LINE; CANCER; MATRIGEL; FADU	Background The long-term aim of developing laser based particle acceleration towards clinical application requires not only substantial technological progress, but also the radiobiological characterization of the resulting ultra-short and ultra-intensive particle beam pulses. After comprehensive cell studies a mouse ear tumour model was established allowing for the penetration of low energy protons (similar to 20 MeV) currently available at laser driven accelerators. The model was successfully applied for a first tumour growth delay study with laser driven electrons, whereby the need of improvements crop out. Methods To optimise the mouse ear tumour model with respect to a stable, high take rate and a lower number of secondary tumours, Matrigel was introduced for tumour cell injection. Different concentrations of two human tumour cell lines (FaDu, LN229) and Matrigel were evaluated for stable tumour growth and fulfilling the allocation criteria for irradiation experiments. The originally applied cell injection with PBS was performed for comparison and to assess the long-term stability of the model. Finally, the optimum suspension of cells and Matrigel was applied to determine applicable dose ranges for tumour growth delay studies by 200 kV Xray irradiation. Results Both human tumour models showed a high take rate and exponential tumour growth starting at a volume of similar to 10 mm(3). As disclosed by immunofluorescence analysis these small tumours already interact with the surrounding tissue and activate endothelial cells to form vessels. The formation of delimited, solid tumours at irradiation size was shown by standard H&E staining and a realistic dose range for inducing tumour growth delay without permanent tumour control was obtained for both tumour entities. Conclusion The already established mouse ear tumour model was successfully upgraded now providing stable tumour growth with high take rate for two tumour entities (HNSCC, glioblastoma) that are of interest for future irradiation experiments at experimental accelerators.	[Beyreuther, Elke; Bruechner, Kerstin; Krause, Mechthild; Pawelke, Joerg] Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Beyreuther, Elke; Bruechner, Kerstin; Krause, Mechthild; Schmidt, Margret; Pawelke, Joerg] Tech Univ Dresden, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Beyreuther, Elke; Bruechner, Kerstin; Krause, Mechthild; Schmidt, Margret; Pawelke, Joerg] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Bruechner, Kerstin] Tech Univ Dresden, Dresden, Germany; [Krause, Mechthild] Tech Univ Dresden, Dept Radiotherapy & Radiat Oncol, Fac Med, Dresden, Germany; [Krause, Mechthild] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Krause, Mechthild] German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany; [Krause, Mechthild] German Canc Res Ctr, Heidelberg, Germany; [Krause, Mechthild; Schmidt, Margret] Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany; [Szabo, Rita] ELI HU Nonprofit Ltd, Attosecond Light Pulse Source, Szeged, Hungary	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; ELI-HU Research & Development Non-Profit	Beyreuther, E (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany.; Beyreuther, E (corresponding author), Tech Univ Dresden, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany.; Beyreuther, E (corresponding author), Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany.	E.Beyreuther@hzdr.de		Krause, Mechthild/0000-0003-1776-9556; Beyreuther, Elke/0000-0002-0582-1444	German Federal Ministry of Education and Research (BMBF) [03ZIK445, 03Z1N511]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by the German Federal Ministry of Education and Research (BMBF), grant nos. 03ZIK445 and 03Z1N511.	Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Bin JH, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4769372; Daido H, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/5/056401; DISERENS AC, 1981, ACTA NEUROPATHOL, V53, P21, DOI 10.1007/BF00697180; Doria D, 2012, AIP ADV, V2, DOI 10.1063/1.3699063; Fernandez-Palomo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119924; Fliedner FP, 2016, BMC MED IMAGING, V16, DOI 10.1186/s12880-016-0105-4; Helbig L, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-207; Jermann M., 2015, INT J PART THER, V2, P50, DOI 10.14338/IJPT-15-00013; Kraft SD, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/085003; Krause M, 2007, RADIOTHER ONCOL, V83, P316, DOI 10.1016/j.radonc.2007.04.014; Ledingham KWD, 2007, BRIT J RADIOL, V80, P855, DOI 10.1259/bjr/29504942; Oppelt M, 2015, RADIAT ENVIRON BIOPH, V54, P155, DOI 10.1007/s00411-014-0582-1; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schurer M, 2012, BIOMED ENG-BIOMED TE, V57, P62, DOI 10.1515/bmt-2012-4244; SUIT HD, 1965, CELLULAR RAD BIOL, P514; Yaromina A, 2010, RADIOTHER ONCOL, V96, P116, DOI 10.1016/j.radonc.2010.04.020; Yogo A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3551623; Zeil K, 2013, APPL PHYS B-LASERS O, V110, P437, DOI 10.1007/s00340-012-5275-3	21	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177428	10.1371/journal.pone.0177428	http://dx.doi.org/10.1371/journal.pone.0177428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545054	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400042
J	Ekwaru, JP; Ohinmaa, A; Tran, BX; Setayeshgar, S; Johnson, JA; Veugelers, PJ				Ekwaru, John Paul; Ohinmaa, Arto; Bach Xuan Tran; Setayeshgar, Solmaz; Johnson, Jeffrey A.; Veugelers, Paul J.			Cost-effectiveness of a school-based health promotion program in Canada: A life-course modeling approach	PLOS ONE			English	Article							CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; OVERWEIGHT; PREVALENCE; ADULTHOOD; MORTALITY; QUALITY; IMPACT; CHILDREN; ASTHMA	Background The Alberta Project Promoting active Living and healthy Eating in Schools (APPLE Schools) has been recognized as a "best practice" in preventing childhood obesity. To inform decision making on the economic implications of APPLE Schools and to justify investment, we evaluated the project's cost-effectiveness following a life-course approach. Methods We developed a state transition model for the lifetime progression of body weight status comparing elementary school students attending APPLE Schools and control schools. This model quantified the lifetime impact of APPLE Schools in terms of prevention of excess body weight, chronic disease and improved quality-adjusted life years (QALY), from a school system's cost perspective. Both costs and health outcomes were discounted to their present value using 3% discount rate. Results The incremental cost-effectiveness ratio(ICER) of APPLE schools was CA$33,421 per QALY gained, and CA$ 1,555, CA$ 1,709 and CA$ 14,218 per prevented person years of excess weight, obesity and chronic disease, respectively. These estimates show that APPLE Schools is cost effective at a threshold of ICER < CA$ 50,000. In probabilistic sensitivity analysis, APPLE Schools was cost effective more than 64% of the time per QALY gained, when using a threshold of ICER < CA$ 50,000, and more than 93% of the time when using a threshold of ICER < CA$ 100,000. Conclusion School-based health promotion, such as APPLE Schools is a cost-effective intervention for obesity prevention and reduction of chronic disease risk over the lifetime. Expanding the coverage and allocating resources towards school-based programs like the APPLE Schools program, is likely to reduce the public health burden of obesity and chronic diseases.	[Ekwaru, John Paul; Ohinmaa, Arto; Setayeshgar, Solmaz; Johnson, Jeffrey A.; Veugelers, Paul J.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Bach Xuan Tran] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam	University of Alberta; Hanoi Medical University	Veugelers, PJ (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	paul.veugelers@ualberta.ca		Veugelers, Paul/0000-0001-8996-0822	Collaborative Research and Innovation Opportunities (CRIO) Team program from Alberta Innovates Health Solutions; Alberta Health; School of Public Health at the University of Alberta; Canadian Institutes for Health Research, Heart and Stroke Foundation of Canada; Canadian Population Health Initiative; Canada Research Chair in Population Health and AlHS Health Scholarship	Collaborative Research and Innovation Opportunities (CRIO) Team program from Alberta Innovates Health Solutions; Alberta Health; School of Public Health at the University of Alberta; Canadian Institutes for Health Research, Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of CanadaCanadian Institutes of Health Research (CIHR)); Canadian Population Health Initiative; Canada Research Chair in Population Health and AlHS Health Scholarship	The present study was funded through the Collaborative Research and Innovation Opportunities (CRIO) Team program from Alberta Innovates Health Solutions awarded to Paul J. Veugelers (PJV) and Arto Ohinmaa (AO). J. A. Johnson is a Centennial Professor with the School of Public Health. The REAL kids Alberta evaluation was funded through a contract with Alberta Health. APPLE Schools was funded through a philanthropic donation to the School of Public Health at the University of Alberta. The research was funded by an operating grant by the Canadian Institutes for Health Research, Heart and Stroke Foundation of Canada and Canadian Population Health Initiative and a Canada Research Chair in Population Health and AlHS Health Scholarship to Dr. Paul J. Veugelers. All interpretations and opinions in the present study are those of the authors.	Anis AH, 2010, OBES REV, V11, P31, DOI 10.1111/j.1467-789X.2009.00579.x; Birmingham CL, 1999, CAN MED ASSOC J, V160, P483; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2015, CAN CANC STAT 2015; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Ellison LF, 2012, HEALTH REP, V23, P7; Faught E, 2016, PUBLIC HEALTH NUTR, V19, P822, DOI 10.1017/S1368980015002049; Ferland A, 2015, HEALTH PROMOT INT, V30, P106, DOI 10.1093/heapro/dau095; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fung C, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-27; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025; Johansen HL, 2006, CAN J CARDIOL, V22, P65, DOI 10.1016/S0828-282X(06)70242-2; Kopec JA, 2007, J RHEUMATOL, V34, P386; Korber K, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0071-5; Kuhle S, 2011, INT J PEDIATR OBES, V6, P142, DOI 10.3109/17477166.2010.486834; Lehnert T, 2012, OBES REV, V13, P537, DOI 10.1111/j.1467-789X.2011.00980.x; Lhachimi SK, 2013, OBES REV, V14, P523, DOI 10.1111/obr.12029; Malecka-Tendera E, 2006, INT J OBESITY, V30, pS1, DOI 10.1038/sj.ijo.0803367; McAuley KA, 2010, OBESITY, V18, P131, DOI 10.1038/oby.2009.148; Moodie M, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-63; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Naukkarinen J, 2012, INT J OBESITY, V36, P1017, DOI 10.1038/ijo.2011.192; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; OECD, PURCH POW PAR GDP RE; Organization for Economic Co operation and Development (OECD), CONS PRIC IND; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Pelletier C, 2012, CHRON DIS INJ CAN, V33, P53; Ploeg KAV, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1132; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Rittenhouse B., 1996, USES MODELS EC EVALU; Robitaille C, 2012, CAN MED ASSOC J, V184, pE49, DOI 10.1503/cmaj.101863; Schultz Susan E, 2003, Health Rep, V14, P41; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Starc G, 2011, PUBLIC HEALTH NUTR, V14, P49, DOI 10.1017/S1368980010000741; Statistics Canada, 2010, CAN HLTH MEAS SURV C; Statistics Canada, 2015, TABL 105 0501 D HLTH; Statistics Canada, CAN COMM HLTH SURV D; Statistics Canada, 2015, TABL 053 0003 EL LIF; Statistics Canada, 2015, TABL 103 0550 D NEW; Tran B, VALUE HLTH, V16, pA391; Tran BX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102242; Tran Bach Xuan, 2013, Cost Eff Resour Alloc, V11, P3, DOI 10.1186/1478-7547-11-3; Vandentorren S, 2003, EUR RESPIR J, V21, P462, DOI 10.1183/09031936.03.00030303; Vander Ploeg KA, 2014, PEDIATRICS, V133, pE371, DOI 10.1542/peds.2013-2383; Venn AJ, 2007, MED J AUSTRALIA, V186, P458, DOI 10.5694/j.1326-5377.2007.tb00997.x; Veugelers PJ, 2005, CAN MED ASSOC J, V173, P607, DOI 10.1503/cmaj.050445; Veugelers PJ, 2005, AM J PUBLIC HEALTH, V95, P432, DOI 10.2105/AJPH.2004.045898; Wang LY, 2008, J SCHOOL HEALTH, V78, P619, DOI 10.1111/j.1746-1561.2008.00357.x; Wang LY, 2003, OBES RES, V11, P1313, DOI 10.1038/oby.2003.178; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; World Health Organization, 1997, WHOTB97224	55	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177848	10.1371/journal.pone.0177848	http://dx.doi.org/10.1371/journal.pone.0177848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542399	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400099
J	Hansen, NSR; Byberg, S; Jacobsen, LH; Bjerregaard-Andersen, M; Jensen, AKG; Martins, C; Aaby, P; Jensen, JS; Benn, CS; Whittle, H				Hansen, Nadja Skadkaer; Byberg, Stine; Jacobsen, Lars Hervig; Bjerregaard-Andersen, Morten; Jensen, Aksel Karl Georg; Martins, Cesario; Aaby, Peter; Jensen, Jorgen Skov; Benn, Christine Stabell; Whittle, Hilton			Effect of early measles vaccine on pneumococcal colonization: A randomized trial from Guinea-Bissau	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; HOSPITAL ADMISSIONS; INFLUENZA-VIRUS; CHILDREN; DISEASE; INFECTIONS; MORTALITY; IMMUNIZATION	Background Measles vaccine (MV) may have non-specific beneficial effects for child health and particularly seems to prevent respiratory infections. Streptococcus pneumoniae is the leading cause of bacterial pneumonia among children worldwide, and nasopharyngeal colonization precedes infection. Objective We investigated whether providing early MV at 18 weeks of age reduced pneumococcal colonization and/or density up to 9 months of age. Method The study was conducted in 2013-2014 in Guinea-Bissau. Pneumococcal vaccine was not part of the vaccination program. Infants aged 18 weeks were block-randomized 2: 1 to early or no early MV; at age 9 months, all children were offered MV as per current policy. Nasopharyngeal swabs were taken at baseline, age 6.5 months, and age 9 months. Pneumococcal density was determined by q-PCR. Prevalence ratios of pneumococcal colonization and recent antibiotic treatment (yes/no) by age 6.5 months (PR6.5) and age 9 months (PR9) were estimated using Poisson regression with robust variance estimates while the pneumococcal geometric mean ratio (GMR6.5 and GMR9) was obtained using OLS regression. Results Analyses included 512 children; 346 early MV-children and 166 controls. At enrolment, the pneumococcal colonization prevalence was 80% (411/512). Comparing early MV-children with controls, the PR6.5 was 1.02 (95% CI = 0.94-1.10), and the PR9 was 1.04 (0.96-1.12). The GMR(6.5) was 1.02 (0.55-1.89), and the GMR9 was 0.69 (0.39-1.21). Early MV-children tended to be less frequently treated with antibiotics prior to follow up (PR6.5 0.60 (0.34-1.05) and PR9 0.87 (0.50-1.53)). Antibiotic treatment was associated with considerably lower colonization rates, PR6.5 0.85 (0.71-1.01) and PR9 0.66 (0.52-0.84), as well as lower pneumococcal density, GMR(6.5) 0.32 (0.12-0.86) and GMR(9) 0.52 (0.18-1.52). Conclusion Early MV at age 18 weeks had no measurable effect on pneumococcal colonization prevalence or density. Higher consumption of antibiotics among controls may have blurred an effect of early MV.	[Hansen, Nadja Skadkaer; Byberg, Stine; Jacobsen, Lars Hervig; Bjerregaard-Andersen, Morten; Jensen, Aksel Karl Georg; Aaby, Peter; Benn, Christine Stabell] Statens Serum Inst, Res Ctr Vitamins & Vaccines CVIVA, Bandim Hlth Project, Copenhagen, Denmark; [Hansen, Nadja Skadkaer; Byberg, Stine; Jacobsen, Lars Hervig; Bjerregaard-Andersen, Morten; Jensen, Aksel Karl Georg; Martins, Cesario; Aaby, Peter; Benn, Christine Stabell] INDEPTH Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Bjerregaard-Andersen, Morten] Odense Univ Hosp, Dept Endocrinol, Odense, Denmark; [Jensen, Aksel Karl Georg] Univ Copenhagen, Sect Biostat, Copenhagen, Denmark; [Jensen, Jorgen Skov] Statens Serum Inst, Dept Microbiol & Infect Control, Copenhagen, Denmark; [Benn, Christine Stabell] Univ Southern Denmark, Inst Clin Res, Odense Univ Hosp, Odense Patient Data Explorat Network, Odense, Denmark; [Whittle, Hilton] London Sch Hyg & Trop Med, London, England	Statens Serum Institut; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Statens Serum Institut; University of Southern Denmark; Odense University Hospital; University of London; London School of Hygiene & Tropical Medicine	Hansen, NSR (corresponding author), Statens Serum Inst, Res Ctr Vitamins & Vaccines CVIVA, Bandim Hlth Project, Copenhagen, Denmark.; Hansen, NSR (corresponding author), INDEPTH Network, Bandim Hlth Project, Bissau, Guinea Bissau.	nadjaskadkaer@gmail.com		Bjerregaard-Andersen, Morten/0000-0002-4128-5714; Aaby, Peter/0000-0001-8331-1389; Byberg, Stine/0000-0002-3626-3609	Danish Council for Independent Research [9683-1095]; Aase og Einar Danielsens Fond [10-001037]; Danish National Research Foundation [DNRF108]; European Research Council [ERC-2009-StG-243149]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Aase og Einar Danielsens Fond; Danish National Research Foundation(Danmarks Grundforskningsfond); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Danish Council for Independent Research [9683-1095], NSH; http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research; Aase og Einar Danielsens Fond [10-001037], NSH, http://www.danielsensfond.dk/default.aspx; Danish National Research Foundation [DNRF108], NSH, http://dg.dk/en/; European Research Council [grant: ERC-2009-StG-243149], CB, https://ec.europa.eu/programmes/horizon2020/en/h2020-section/european-research-council.	Aaby P, 2005, VACCINE, V23, P1746, DOI 10.1016/j.vaccine.2004.02.054; Aaby P, 2004, VACCINE, V22, P3014, DOI 10.1016/j.vaccine.2004.02.009; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2012, BMJ OPEN, V2; Aaby P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013335; Aaby P, 2016, PEDIATR INFECT DIS J, V35, P1247, DOI 10.1097/INF.0000000000001269; Adetifa IMO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030548; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Benn CS, 2014, VACCINE, V32, P5468, DOI 10.1016/j.vaccine.2014.07.090; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bottomley C, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-014-0022-3; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Coles CL, 2012, J NUTR, V142, P1088, DOI 10.3945/jn.111.156844; Dabernat H, 1998, J ANTIMICROB CHEMOTH, V41, P253, DOI 10.1093/jac/41.2.253; Do VA, 2017, J INFECT DIS; Haiman T, 2002, PEDIATR INFECT DIS J, V21, P642, DOI 10.1097/00006454-200207000-00008; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; International Vaccine Access Center (IVAC) JHBSoPH, 2013, VIMS REP GLOB VACC I; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; JPT Higgins KS-W. A Reingold, 2014, SYSTEMATIC REV NONSP; Kaltoft MS, 2008, J MICROBIOL METH, V75, P540, DOI 10.1016/j.mimet.2008.08.010; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Martins CL, 2014, J INFECT DIS, V209, P1731, DOI 10.1093/infdis/jit804; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Meeting of the Strategic Advisory Group of Experts on immunization, 2014, HLTH SECTION SECRETA, V89, P221; Mueller JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052464; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; National Center for Immunization and Respiratory Diseases C USA, PCR DET CHAR BACT ME; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Resti M, 2009, CLIN THER, V31, P1266, DOI 10.1016/j.clinthera.2009.06.010; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; Roth A, 2006, EXPERT REV VACCINES, V5, P277, DOI 10.1586/14760584.5.2.277; Saukkoriipi A, 2015, EUR J CLIN MICROBIOL, V34, P697, DOI 10.1007/s10096-014-2278-5; Short KR, 2012, FUTURE MICROBIOL, V7, P609, DOI [10.2217/FMB.12.29, 10.2217/fmb.12.29]; Sorup S, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv204; Sorup S, 2015, VACCINE, V33, P237, DOI 10.1016/j.vaccine.2014.07.110; Sorup S, 2014, JAMA-J AM MED ASSOC, V311, P826, DOI 10.1001/jama.2014.470; Sorup S, 2011, INT J EPIDEMIOL, V40, P955, DOI 10.1093/ije/dyr063	44	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177547	10.1371/journal.pone.0177547	http://dx.doi.org/10.1371/journal.pone.0177547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545041	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000401487700053
J	Velasquez-Mao, AJ; Tsao, CJM; Monroe, MN; Legras, X; Bissig-Choisat, B; Bissig, KD; Ruano, R; Jacot, JG				Velasquez-Mao, Aaron J.; Tsao, Christopher J. M.; Monroe, Madeline N.; Legras, Xavier; Bissig-Choisat, Beatrice; Bissig, Karl-Dimiter; Ruano, Rodrigo; Jacot, Jeffrey G.			Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells	PLOS ONE			English	Article							PLURIPOTENCY; MODULATION; GENERATION; THERAPY; NANOG	Congenital heart defects are the most common birth defect. The limiting factor in tissue engineering repair strategies is an autologous source of functional cardiomyocytes. Amniotic fluid contains an ideal cell source for prenatal harvest and use in correction of congenital heart defects. This study aims to investigate the potential of amniotic fluid-derived stem cells (AFSC) to undergo non-viral reprogramming into induced pluripotent stem cells (iPSC) followed by growth-factor-free differentiation into functional cardiomyocytes. AFSC from human second trimester amniotic fluid were transfected by non-viral vesicle fusion with modified mRNA of OCT4, KLF4, SOX2, LIN28, cMYC and nuclear GFP over 18 days, then differentiated using inhibitors of GSK3 followed 48 hours later by inhibition of WNT. AFSC-derived iPSC had high expression of OCT4, NANOG, TRA-1-60, and TRA-1-81 after 18 days of mRNA transfection and formed teratomas containing mesodermal, ectodermal, and endodermal germ layers in immunodeficient mice. By Day 30 of cardiomyocyte differentiation, cells contracted spontaneously, expressed connexin 43 and beta-myosin heavy chain organized in sarcomeric banding patterns, expressed cardiac troponin T and beta-myosin heavy chain, showed upregulation of NKX2.5, ISL-1 and cardiac troponin T with downregulation of POU5F1, and displayed calcium and voltage transients similar to those in developing cardiomyocytes. These results demonstrate that cells from human amniotic fluid can be differentiated through a pluripotent state into functional cardiomyocytes.	[Velasquez-Mao, Aaron J.; Tsao, Christopher J. M.; Monroe, Madeline N.; Jacot, Jeffrey G.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Legras, Xavier; Bissig-Choisat, Beatrice; Bissig, Karl-Dimiter] Baylor Coll Med, Ctr Cell & Gene Therapy, Dept Mol & Cellular Biol, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Ruano, Rodrigo] Maternal Fetal Med Texas Childrens Hosp, Dept Obstet & Gynecol, Houston, TX USA; [Jacot, Jeffrey G.] Texas Childrens Hosp, Congenital Heart Surg Serv, Houston, TX 77030 USA; [Jacot, Jeffrey G.] Univ Colorado Denver, Dept Bioengn, Aurora, CO 80204 USA	Rice University; Baylor College of Medicine; Baylor College of Medicine; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Jacot, JG (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.; Jacot, JG (corresponding author), Texas Childrens Hosp, Congenital Heart Surg Serv, Houston, TX 77030 USA.; Jacot, JG (corresponding author), Univ Colorado Denver, Dept Bioengn, Aurora, CO 80204 USA.	jeffrey.jacot@ucdenver.edu			American Heart Association [14BGIA18750004]; National Science Foundation [CBET-1547838]; National Institutes of Health [1R01HL130436-01]; Texas Children's Hospital; National Heart Lung and Blood Institute (NHLBI) [R01HL134510]; Texas Hepatocellular Carcinoma Consortium (THCCC) [RP150587]; Diana Helis Henry; Adrienne Helis Malvin Medical Research Foundations; Directorate For Engineering [1724640] Funding Source: National Science Foundation	American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Children's Hospital; National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Texas Hepatocellular Carcinoma Consortium (THCCC); Diana Helis Henry; Adrienne Helis Malvin Medical Research Foundations; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by grants from the American Heart Association (14BGIA18750004 to J. Jacot), the National Science Foundation (CBET-1547838 to J. Jacot), the National Institutes of Health (1R01HL130436-01 to J. Jacot), and Texas Children's Hospital. K.D. B. is supported by the National Heart Lung and Blood Institute (NHLBI) grant R01HL134510, the Texas Hepatocellular Carcinoma Consortium (THCCC) (CPRIT #RP150587) and the Diana Helis Henry and Adrienne Helis Malvin Medical Research Foundations.; This work was supported in part by grants from the American Heart Association (14BGIA18750004 to J. Jacot), the National Science Foundation (CBET-1547838 to J. Jacot), the National Institutes of Health (1R01HL130436-01 to J. Jacot), and Texas Children's Hospital. K.D.B. is supported by the National Heart Lung and Blood Institute (NHLBI) grant R01HL134510, the Texas Hepatocellular Carcinoma Consortium (THCCC) (CPRIT #RP150587) and the Diana Helis Henry and Adrienne Helis Malvin Medical Research Foundations. We wish to also acknowledge Frank Braun for his technical support with qRT-PCR and western blot developing.	Akhyari P, 2002, CIRCULATION, V106, pI137, DOI 10.1161/01.cir.0000032893.55215.fc; Bar-Nur O, 2014, NAT METHODS, V11, P1170, DOI [10.1038/nmeth.3142, 10.1038/NMETH.3142]; Batalov I, 2015, BIOMARK INSIGHTS, V10, P71, DOI 10.4137/BMI.S20050; Benavides OM, 2012, TISSUE ENG PT A, V18, P1123, DOI [10.1089/ten.tea.2011.0392, 10.1089/ten.TEA.2011.0392]; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Connell JP, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034103; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Gao Y, 2014, ANN BIOMED ENG, V42, P2490, DOI 10.1007/s10439-014-1114-5; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Jiang GH, 2016, STEM CELL TRANSL MED, V5, P1595, DOI 10.5966/sctm.2016-0016; Jiang GH, 2014, STEM CELLS DEV, V23, P2613, DOI 10.1089/scd.2014.0110; Kim J, 2007, CELL PROLIFERAT, V40, P75; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Malik Nasir, 2013, Methods Mol Biol, V997, P23, DOI 10.1007/978-1-62703-348-0_3; Moschidou D, 2012, MOL THER, V20, P1953, DOI 10.1038/mt.2012.117; Okano H, 2013, CIRC RES, V112, P523, DOI 10.1161/CIRCRESAHA.111.256149; Qin MD, 2016, INT J BIOL SCI, V12, P558, DOI 10.7150/ijbs.11051; Riegler J, 2015, CIRC RES, V117, P720, DOI 10.1161/CIRCRESAHA.115.306985; Schwarz BA, 2014, CURR BIOL, V24, P347, DOI 10.1016/j.cub.2013.12.050; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Xu HS, 2012, CELL RES, V22, P142, DOI 10.1038/cr.2011.171; Yagel S, 1997, CIRCULATION, V96, P550	29	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177824	10.1371/journal.pone.0177824	http://dx.doi.org/10.1371/journal.pone.0177824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545044	gold, Green Published, Green Submitted			2022-12-27	WOS:000401487700085
J	Gontijo, FD; de Melo, AT; Pascon, RC; Fernandes, L; Paes, HC; Alspaugh, JA; Vallim, MA				Gontijo, Fabiano de Assis; de Melo, Amanda Teixeira; Pascon, Renata C.; Fernandes, Larissa; Paes, Hugo Costa; Alspaugh, J. Andrew; Vallim, Marcelo A.			The role of Aspartyl aminopeptidase (Ape4) in Cryptococcus neoformans virulence and authophagy	PLOS ONE			English	Article							VACUOLE TARGETING PATHWAY; HIGH-TEMPERATURE GROWTH; USTILAGO-MAYDIS; PULMONARY INFECTION; CANDIDA-ALBICANS; SELF-DIGESTION; AUTOPHAGY; YEAST; CELL; IDENTIFICATION	In order to survive and cause disease, microbial pathogens must be able to proliferate at the temperature of their infected host. We identified novel microbial features associated with thermotolerance in the opportunistic fungal pathogen Cryptococcus neoformans using a random insertional mutagenesis strategy, screening for mutants with defective growth at 37 degrees C. Among several thermosensitive mutants, we identified one bearing a disruption in a gene predicted to encode the Ape4 aspartyl aminopeptidase protein. Ape4 metalloproteases in other fungi, including Saccharomyces cerevisiae, are activated by nitrogen starvation, and they are required for autophagy and the cytoplasm-to-vacuole targeting (Cvt) pathway. However, none have been previously associated with altered growth at elevated temperatures. We demonstrated that the C. neoformans ape4 mutant does not grow at 37 degrees C, and it also has defects in the expression of important virulence factors such as phospholipase production and capsule formation. C. neoformans Ape4 activity was required for this facultative intracellular pathogen to survive within macrophages, as well as for virulence in an animal model of cryptococcal infection. Similar to S. cerevisiae Ape4, the C. neoformans GFP-Ape4 fusion protein co-localized with intracytoplasmic vesicles during nitrogen depletion. APE4 expression was also induced by the combination of nutrient and thermal stress. Together these results suggest that autophagy is an important cellular process for this microbial pathogen to survive within the environment of the infected host.	[Gontijo, Fabiano de Assis; de Melo, Amanda Teixeira; Pascon, Renata C.; Vallim, Marcelo A.] Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil; [Fernandes, Larissa] Univ Brasilia, Fac Ceilandia, Ceilandia, DF, Brazil; [Paes, Hugo Costa] Univ Brasilia, Fac Med, Brasilia, DF, Brazil; [Alspaugh, J. Andrew] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Brasilia; Universidade de Brasilia; Duke University	Vallim, MA (corresponding author), Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil.	marcelo.vallim@unifesp.br	Alspaugh, Andrew/AAB-1664-2019; de melo, amanda teixeira/U-1811-2019; Pascon, Renata/E-1494-2012; Vallim, Marcelo/J-2624-2013	Alspaugh, Andrew/0000-0003-3009-627X; de melo, amanda teixeira/0000-0003-3867-8522; Pascon, Renata/0000-0001-9902-9396; Vallim, Marcelo/0000-0002-6929-0566; Fernandes, Larissa/0000-0002-2814-7501	FAPESP [2007/50536-3, 2015/04400-9, 2011/51298-4, 2016/14542-8]; NIH [AI050128, AI074677]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074677, R01AI050128, R21AI050128, R56AI074677] Funding Source: NIH RePORTER	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by FAPESP grants (2007/50536-3 and 2015/04400-9) to MAV, (2011/51298-4 and 2016/14542-8) to RCP and NIH grants (AI050128 and AI074677) to JAA	Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; de Gontijo FA, 2014, FUNGAL GENET BIOL, V70, P12, DOI 10.1016/j.fgb.2014.06.003; Devenish RJ, 2015, CURR BIOL, V25, pR238, DOI 10.1016/j.cub.2015.01.045; Hecht Karen A, 2014, Cell Logist, V4, pe28023; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Kozubowski L, 2009, CELL MICROBIOL, V11, P370, DOI 10.1111/j.1462-5822.2008.01273.x; Kronstad James W., 2011, Mycobiology, V39, P143, DOI 10.5941/MYCO.2011.39.3.143; Lam WC, 2013, EUKARYOT CELL, V12, P118, DOI 10.1128/EC.05305-11; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Magditch D. A., 2012, PLoS Pathogens, V8, pe1002936, DOI 10.1371/journal.ppat.1002936; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nadal M, 2010, MOL PLANT PATHOL, V11, P463, DOI [10.1111/J.1364-3703.2010.00620.X, 10.1111/j.1364-3703.2010.00620.x]; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nichols CB, 2009, EUKARYOT CELL, V8, P181, DOI 10.1128/EC.00351-08; Nicola AM, 2012, METHODS MOL BIOL, V844, P189, DOI 10.1007/978-1-61779-527-5_14; Nieto-Jacobo F, 2012, EUKARYOT CELL, V11, P1154, DOI 10.1128/EC.00115-12; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; O'Meara TR, 2012, CLIN MICROBIOL REV, V25, P387, DOI 10.1128/CMR.00001-12; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; Oliveira DL, 2016, FUTURE MICROBIOL, V11, P1404, DOI 10.2217/fmb-2016-0090; Paiva JA, 2013, CURR OPIN INFECT DIS, V26, P168, DOI 10.1097/QCO.0b013e32835ebcb7; PALIWAL DK, 1978, A VAN LEEUW J MICROB, V44, P243, DOI 10.1007/BF00643226; Palmer GE, 2007, MICROBIOL-SGM, V153, P51, DOI 10.1099/mic.0.2006/001610-0; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; PRICE MF, 1982, SABOURAUDIA, V20, P7; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Rex JH, 2001, CLIN MICROBIOL REV, V14, P643, DOI 10.1128/CMR.14.4.643-658.2001; Richie DL, 2007, EUKARYOT CELL, V6, P2437, DOI 10.1128/EC.00224-07; Shintani M, 2011, BIOMED RES-TOKYO, V32, P379, DOI 10.2220/biomedres.32.379; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Singh N, 2000, Transpl Infect Dis, V2, P101, DOI 10.1034/j.1399-3062.2000.020302.x; Skowyra Michael L, 2012, Methods Mol Biol, V845, P165, DOI 10.1007/978-1-61779-539-8_11; Suzuki K, 2011, DEV CELL, V21, P358, DOI 10.1016/j.devcel.2011.06.023; Tanaka C, 2014, J CELL BIOL, V207, P91, DOI 10.1083/jcb.201402128; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Umekawa M., 2012, INT J CELL BIOL, V2012, DOI [DOI 10.1155/2012/142634, 10.1155/ 2012/142634]; Vallim MA, 2005, EUKARYOT CELL, V4, P1066, DOI 10.1128/EC.4.6.1066-1078.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wagner-Vogel G, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0358-z; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x; Yuga M, 2011, J BIOL CHEM, V286, P13704, DOI 10.1074/jbc.M110.173906; Zaragoza O, 2004, INFECT IMMUN, V72, P4271, DOI 10.1128/IAI.72.7.4271-4274.2004; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0; ZEBEDEE SL, 1994, ANTIMICROB AGENTS CH, V38, P1507, DOI 10.1128/AAC.38.7.1507	64	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177461	10.1371/journal.pone.0177461	http://dx.doi.org/10.1371/journal.pone.0177461			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542452	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800017
J	He, JW; Shao, GN; Wei, XJ; Huang, FL; Sheng, ZH; Tang, SQ; Hu, PS				He, Jiwai; Shao, Gaoneng; Wei, Xiangjin; Huang, Fenglin; Sheng, Zhonghua; Tang, Shaoqing; Hu, Peisong			Fine mapping and candidate gene analysis of qTAC8, a major quantitative trait locus controlling tiller angle in rice (Oryza sativa L.)	PLOS ONE			English	Article							PLANT ARCHITECTURE; SHOOT GRAVITROPISM; LAZY1	Rice tiller angle is an important agronomic trait that contributes to crop production and plays a vital role in high yield breeding. In this study, a recombinant inbred line (RIL) population derived from the cross of a glabrous tropical japonica rice D50 and an indica rice HB277, was used to investigate quantitative trait loci (QTLs) controlling rice tiller angle. Two major QTLs, qTAC8 and qTAC9, were detected. While qTAC9 mapped with a previously identified gene (TAC1), using a BC2F2 population qTAC8 was mapped to a 16.5 cM region between markers RM7049 and RM23175. Position of qTAC8 was narrowed to a 92 kb DNA region by two genetic segregating populations. Finally, one opening reading frame (ORF) was regarded as a candidate gene according to genomic sequencing and qRT-PCR analysis. In addition, a set of four near isogenic lines (NILs) were created to investigate the genetic relationship between those two QTLs, and one line carrying qTAC8 and qTAC9 presented additive effect of tiller angle, suggesting that these QTLs are involved in different genetic pathways. Our results provide a foundation for the cloning of qTAC8 and genetic improvement of the rice plant architecture.	[He, Jiwai; Shao, Gaoneng; Wei, Xiangjin; Huang, Fenglin; Sheng, Zhonghua; Tang, Shaoqing; Hu, Peisong] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Huang, Fenglin] Hunan Acad Agr Sci, Hunan Rice Res Inst, Changsha, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Hunan Academy of Agricultural Sciences	Hu, PS (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	peisonghu@126.com	huang, fenglin/AAW-6130-2021	Wei, Xiangjin/0000-0002-1190-5222	National Key Research and Development Program of China [National Key Research and Development Program of China (2016YFD0101801]; National S&T Major Project of China [2016ZX08001006]; National Natural Science Foundation of China [31501285, 31521064]	National Key Research and Development Program of China; National S&T Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program of China (2016YFD0101801), the National S&T Major Project of China (2016ZX08001006) and the National Natural Science Foundation of China (grants 31501285, 31521064).; This work was supported by the National Key Research and Development Program of China (2016YFD0101801), the National S&T Major Project of China (2016ZX08001006) and the National Natural Science Foundation of China (grants 31501285, 31521064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YN, 2012, PLANT BIOTECHNOL J, V10, P139, DOI 10.1111/j.1467-7652.2011.00637.x; Dong HJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006412; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Li ZK, 1999, EUPHYTICA, V109, P79, DOI 10.1023/A:1003533001014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Qian Q., 2000, YI CHUAN XUE BAO, V28, P29; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao Gao-neng, 2009, Zhongguo Shuidao Kexue, V23, P94; Shen SQ, 2004, J AGR BIOTECH, V13, P16; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Wu XR, 2013, PLANT PHYSIOL, V161, P317, DOI 10.1104/pp.112.208496; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Xu YB, 1998, CROP SCI, V38, P12, DOI 10.2135/cropsci1998.0011183X003800010002x; Xu YB, 1993, ACTA AGR ZHEJIANGENS, V1; Yang ShouRen, 1996, Chinese Journal of Rice Science, V10, P115; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Yu Chuan-Yuan, 2005, Acta Genetica Sinica, V32, P948	22	13	14	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178177	10.1371/journal.pone.0178177	http://dx.doi.org/10.1371/journal.pone.0178177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542427	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800048
J	Lai, XL; Friedman, A				Lai, Xiulan; Friedman, Avner			Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model	PLOS ONE			English	Article							SECRETING TUMOR VACCINE; GM-CSF; DENDRITIC CELLS; ANTI-PD-1 ANTIBODY; PANCREATIC-CANCER; T-CELLS; PHASE-I; SAFETY; IMMUNOTHERAPY; BLOCKADE	In this paper we consider a combination therapy of cancer. One drug is a vaccine which activates dendritic cells so that they induce more T cells to infiltrate the tumor. The other drug is a checkpoint inhibitor, which enables the T cells to remain active against the cancer cells. The two drugs are positively correlated in the sense that an increase in the amount of each drug results in a reduction in the tumor volume. We consider the question whether a treatment with combination of the two drugs at certain levels is preferable to a treatment by one of the drugs alone at 'roughly' twice the dosage level; if that is the case, then we say that there is a positive 'synergy' for this combination of dosages. To address this question, we develop a mathematical model using a system of partial differential equations. The variables include dendritic and cancer cells, CD4(+) and CD8(+) T cells, IL-12 and IL-2, GM-CSF produced by the vaccine, and a T cell checkpoint inhibitor associated with PD-1. We use the model to explore the efficacy of the two drugs, separately and in combination, and compare the simulations with data from mouse experiments. We next introduce the concept of synergy between the drugs and develop a synergy map which suggests in what proportion to administer the drugs in order to achieve the maximum reduction of tumor volume under the constraint of maximum tolerated dose.	[Lai, Xiulan] Renmin Univ China, Inst Math Sci, Beijing, Peoples R China; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA	Renmin University of China; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lai, XL (corresponding author), Renmin Univ China, Inst Math Sci, Beijing, Peoples R China.	xiulanlai@ruc.edu.cn	Lai, Xiula/GMX-1854-2022		Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]; Renmin University of China; International Postdoctoral Exchange Fellowship Program; Office of China Postdoctoral Council	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); Renmin University of China; International Postdoctoral Exchange Fellowship Program; Office of China Postdoctoral Council	This work is supported by the Mathematical Biosciences Institute and the National Science Foundation (Grant DMS 0931642), and the Renmin University of China and the International Postdoctoral Exchange Fellowship Program 2016 by the Office of China Postdoctoral Council.; This work is supported by the Mathematical Biosciences Institute and the National Science Foundation (Grant DMS 0931642), and the Renmin University of China and the International Postdoctoral Exchange Fellowship Program 2016 by the Office of China Postdoctoral Council.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Ali OA, 2015, CANC IMMUNOLOGY RES; Blinman P, 2012, ANN ONCOL, V23, P1104, DOI 10.1093/annonc/mdr559; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; DAcunto B., 2004, SERIES ADV MATH APPL, V67; Dale DC, 1998, AM J HEMATOL, V57, P7, DOI 10.1002/(SICI)1096-8652(199801)57:1<7::AID-AJH2>3.0.CO;2-0; de Pillis LG, 2006, J THEOR BIOL, V238, P841, DOI 10.1016/j.jtbi.2005.06.037; Dumortier H, 2005, J IMMUNOL, V175, P855, DOI 10.4049/jimmunol.175.2.855; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; FIEHN C, 1992, Z RHEUMATOL, V51, P121; Fu J, 2014, CANCER RES, V74, P4042, DOI 10.1158/0008-5472.CAN-13-2685; Gong JL, 2000, P NATL ACAD SCI USA, V97, P2715, DOI 10.1073/pnas.050587197; Guo CQ, 2013, ADV CANCER RES, V119, P421, DOI 10.1016/B978-0-12-407190-2.00007-1; Gupta R, 2010, DISCOV MED, V10, P52; Haabeth OAW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00174; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hao W, 2017, B MATH BIOL IN PRESS; Hao WR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148738; He JB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13110; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Jaffee EM, 2001, J CLIN ONCOL, V19, P145, DOI 10.1200/JCO.2001.19.1.145; Janco JMT, 2015, J IMMUNOL, V194, P2985, DOI 10.4049/jimmunol.1403134; Joshi B, 2009, J THEOR BIOL, V259, P820, DOI 10.1016/j.jtbi.2009.05.001; Kaufman HL, 2014, J IMMUNOTHER CANCER, V13, P2; Kleponis J, 2015, CANCER BIOL MED, V12, P201, DOI 10.7497/j.issn.2095-3941.2015.0046; Laheru D, 2008, CLIN CANCER RES, V14, P1455, DOI 10.1158/1078-0432.CCR-07-0371; Lee CK, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-391; Li B, 2009, CLIN CANCER RES, V15, P1623, DOI 10.1158/1078-0432.CCR-08-1825; Liao KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091844; Lutz E, 2011, ANN SURG, V253, P328, DOI 10.1097/SLA.0b013e3181fd271c; Ma Y, 2013, J CANCER, V4, P36, DOI 10.7150/jca.5046; Mailliard RB, 2002, J EXP MED, V195, P473, DOI 10.1084/jem.20011662; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marshall DA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010981; Maute RL, 2015, P NATL ACAD SCI USA, V112, pE6506, DOI 10.1073/pnas.1519623112; Muppidi M.R., 2015, J TARGET THER CANC, V4, P47; Owonikoko TK, 2015, J CLIN ONCOL, V33, P534, DOI 10.1200/JCO.2014.59.5033; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Rini B, 2014, SEMIN ONCOL, V41, pS30, DOI 10.1053/j.seminoncol.2014.09.005; Rosenblatt J, 2011, J IMMUNOTHER, V34, P409, DOI 10.1097/CJI.0b013e31821ca6ce; Saenz R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-211; Serre R, 2016, CANCER RES, V76, P4931, DOI 10.1158/0008-5472.CAN-15-3567; Shi L, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-74; Shui YB, 2003, INVEST OPHTH VIS SCI, V44, P3911, DOI 10.1167/iovs.02-1226; Simmons AD, 2007, CANCER IMMUNOL IMMUN, V56, P1653, DOI 10.1007/s00262-007-0315-2; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Soares KC, 2015, J IMMUNOTHER, V38, P1, DOI 10.1097/CJI.0000000000000062; Steptoe RJ, 2000, TRANSPL IMMUNOL, V8, P49, DOI 10.1016/S0966-3274(00)00010-1; Swart M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00233; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Tian HW, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2016.25; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; van der Burg SH, 2016, NAT REV CANCER, V16, P219, DOI 10.1038/nrc.2016.16; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504; Zandarashvili L, 2013, J BIOL CHEM, V288, P11621, DOI 10.1074/jbc.M113.449942	61	57	58	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178479	10.1371/journal.pone.0178479	http://dx.doi.org/10.1371/journal.pone.0178479			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542574	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800095
J	Schabort, DWP; Kilian, SG; du Preez, JC				Schabort, Du Toit W. P.; Kilian, Stephanus G.; du Preez, James C.			Elucidation of new condition-dependent roles for fructose-1,6-bisphosphatase linked to cofactor balances	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; UNCOUPLING PROTEINS; METABOLIC-FLUX; GLUCOSE; ACID; EXPRESSION	The cofactor balances in metabolism is of paramount importance in the design of a metabolic engineering strategy and understanding the regulation of metabolism in general. ATP, NAD(+) and NADP(+) balances are central players linking the various fluxes in central metabolism as well as biomass formation. NADP+ is especially important in the metabolic engineering of yeasts for xylose fermentation, since NADPH is required by most yeasts in the initial step of xylose utilisation, including the fast-growing Kluyveromyces marxianus. In this simulation study of yeast metabolism, the complex interplay between these cofactors was investigated; in particular, how they may affect the possible roles of fructose-1,6-bisphosphatase, the pentose phosphate pathway, glycerol production and the pyruvate dehydrogenase bypass. Using flux balance analysis, it was found that the potential role of fructose-1,6-bisphosphatase was highly dependent on the cofactor specificity of the oxidative pentose phosphate pathway and on the carbon source. Additionally, the excessive production of ATP under certain conditions might be involved in some of the phenomena observed, which may have been overlooked to date. Based on these findings, a strategy is proposed for the metabolic engineering of a future xylose-fermenting yeast for biofuel production.	[Schabort, Du Toit W. P.; Kilian, Stephanus G.; du Preez, James C.] Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa	University of the Free State	Schabort, DWP (corresponding author), Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa.	SchabortDWP@ufs.ac.za			National Research Foundation of South Africa (ZA), CSPG-Thuthuka (PhD Track) [TTK20110831000026600, UID: 80657]	National Research Foundation of South Africa (ZA), CSPG-Thuthuka (PhD Track)	This work was funded by the National Research Foundation of South Africa (ZA), CSPG-Thuthuka (PhD Track), http://www.nrf.ac.za/, Reference: TTK20110831000026600, UID: 80657, Awarded to: Mr WPD Schabort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DA, 2007, FEMS YEAST RES, V7, P819, DOI 10.1111/j.1567-1364.2007.00242.x; Alff-Tuomala S, 2016, APPL MICROBIOL BIOT, V100, P969, DOI 10.1007/s00253-015-7038-7; Basso TO, 2011, METAB ENG, V13, P694, DOI 10.1016/j.ymben.2011.09.005; Blank LM, 2005, FEMS YEAST RES, V5, P545, DOI 10.1016/j.femsyr.2004.09.008; de Kok S, 2012, FEMS YEAST RES, V12, P387, DOI 10.1111/j.1567-1364.2012.00799.x; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2; Jarmuszkiewicz W, 2001, ACTA BIOCHIM POL, V48, P145; Klein CJL, 1998, MICROBIOL-SGM, V144, P13, DOI 10.1099/00221287-144-1-13; Krasowska A, 2010, BIOCHEM BIOPH RES CO, V395, P51, DOI 10.1016/j.bbrc.2010.03.133; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Luevano-Martinez LA, 2010, BBA-BIOENERGETICS, V1797, P81, DOI 10.1016/j.bbabio.2009.09.003; Luevano-Martinez LA, 2012, FEBS LETT, V586, P1073, DOI 10.1016/j.febslet.2012.03.009; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Naylor CE, 2001, ACTA CRYSTALLOGR D, V57, P635, DOI 10.1107/S0907444901003420; NEWSHOLME EA, 1984, TRENDS BIOCHEM SCI, V9, P277, DOI 10.1016/0968-0004(84)90165-8; NEWSHOLME EA, 1972, BIOCHEM J, V128, P89, DOI 10.1042/bj1280089; Papagianni M, 2007, BIOTECHNOL ADV, V25, P244, DOI 10.1016/j.biotechadv.2007.01.002; Peksel A, 2002, APPL MICROBIOL BIOT, V58, P157, DOI 10.1007/s00253-001-0839-x; Piper P, 1998, EMBO J, V17, P4257, DOI 10.1093/emboj/17.15.4257; Runquist D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-49; Saint-Prix F, 2004, MICROBIOL-SGM, V150, P2209, DOI 10.1099/mic.0.26999-0; Schabort DTWP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156242; Schilling CH, 1999, BIOTECHNOL PROGR, V15, P288, DOI 10.1021/bp9900357; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Voet D., 2011, BIOCHEMISTRY	28	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177319	10.1371/journal.pone.0177319	http://dx.doi.org/10.1371/journal.pone.0177319			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542187	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800014
J	Boyle, NR; Sengupta, N; Morgan, JA				Boyle, Nanette R.; Sengupta, Neelanjan; Morgan, John A.			Metabolic flux analysis of heterotrophic growth in Chlamydomonas reinhardtii	PLOS ONE			English	Article							MICROALGA CHLORELLA PROTOTHECOIDES; BALANCE ANALYSIS; PHOTOAUTOTROPHIC METABOLISM; CARBON METABOLISM; ESCHERICHIA-COLI; MAPPING MATRICES; AMINO-ACID; NETWORKS; ACETATE; C-13	Despite the wealth of knowledge available for C. reinhardtii, the central metabolic fluxes of growth on acetate have not yet been determined. In this study, C-13-metabolic flux analysis (C-13-MFA) was used to determine and quantify the metabolic pathways of primary metabolism in C. reinhardtii cells grown under heterotrophic conditions with acetate as the sole carbon source. Isotopic labeling patterns of compartment specific biomass derived metabolites were used to calculate the fluxes. It was found that acetate is ligated with coenzyme A in the three subcellular compartments (cytosol, mitochondria and plastid) included in the model. Two citrate synthases were found to potentially be involved in acetyl-coA metabolism; one localized in the mitochondria and the other acting outside the mitochondria. Labeling patterns demonstrate that Acetyl-coA synthesized in the plastid is directly incorporated in synthesis of fatty acids. Despite having a complete TCA cycle in the mitochondria, it was also found that a majority of the malate flux is shuttled to the cytosol and plastid where it is converted to oxaloacetate providing reducing equivalents to these compartments. When compared to predictions by flux balance analysis, fluxes measured with C-13-MFA were found to be suboptimal with respect to biomass yield; C. reinhardtii sacrifices biomass yield to produce ATP and reducing equivalents.	[Boyle, Nanette R.; Sengupta, Neelanjan; Morgan, John A.] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA; [Boyle, Nanette R.] Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA; [Sengupta, Neelanjan] Becton Dickinson Adv Bioproc, Cockeysville, MD USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Colorado School of Mines	Boyle, NR (corresponding author), Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA.; Boyle, NR (corresponding author), Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA.	nboyle@mines.edu	Morgan, John/B-8609-2018	Morgan, John/0000-0002-5326-4988; Sengupta, Neelanjan/0000-0003-4381-9588	National Science Foundation [NSF-MCB-0615700]; National Science Foundation Graduate Research Fellowship; NSF graduate research fellowship	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NSF graduate research fellowship(National Science Foundation (NSF))	National Science Foundation NSF-MCB-0615700 awarded to JAM and supported NS. NRB was supported by National Science Foundation Graduate Research Fellowship.; We would like to thank Dr. M. Spalding of Iowa State University for helpful discussion on the targeting of enzymes. We would also like to acknowledge J. O'Grady of Purdue University for his assistance with the calculation of biomass precursors. Nanette Boyle was supported with a NSF graduate research fellowship; Neelanjan Sengupta and John Morgan were supported by NSF-MCB-0615700.	Allen DK, 2007, PHYTOCHEMISTRY, V68, P2197, DOI 10.1016/j.phytochem.2007.04.010; Alonso AP, 2011, METAB ENG, V13, P96, DOI 10.1016/j.ymben.2010.10.002; Alonso AP, 2007, METAB ENG, V9, P419, DOI 10.1016/j.ymben.2007.06.002; Alonso AP, 2010, METAB ENG, V12, P488, DOI 10.1016/j.ymben.2010.04.002; Antoniewicz MR, 2007, METAB ENG, V9, P277, DOI 10.1016/j.ymben.2007.01.003; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Atteia A, 2009, MOL BIOL EVOL, V26, P1533, DOI 10.1093/molbev/msp068; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; Blaby IK, 2013, PLANT CELL, V25, P4305, DOI 10.1105/tpc.113.117580; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Boyle NR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-4; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Chen F, 1996, J APPL PHYCOL, V8, P15, DOI 10.1007/BF02186216; Chen F, 1996, PROCESS BIOCHEM, V31, P601, DOI 10.1016/S0032-9592(96)00006-4; Dal'Molin CGD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S4-S5; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fischer E, 2005, NAT GENET, V37, P636, DOI 10.1038/ng1555; GERHARDT R, 1984, PLANT PHYSIOL, V75, P542, DOI 10.1104/pp.75.3.542; Goodson C, 2011, EUKARYOT CELL, V10, P1592, DOI 10.1128/EC.05242-11; Grafahrend-Belau E, 2009, PLANT PHYSIOL, V149, P585, DOI 10.1104/pp.108.129635; Harris E., 2004, ADV PHOTOSYNTHESIS R, V7, P1; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Imam S, 2015, PLANT J, V84, P1239, DOI 10.1111/tpj.13059; Iyer VV, 2008, PLANT CELL ENVIRON, V31, P506, DOI 10.1111/j.1365-3040.2008.01781.x; Johnson X, 2013, EUKARYOT CELL, V12, P776, DOI 10.1128/EC.00318-12; Knoop H, 2010, PLANT PHYSIOL; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Lee JY, 2011, BIOTECHNOL BIOENG, V108, P742, DOI 10.1002/bit.22989; Li YT, 2010, METAB ENG, V12, P387, DOI 10.1016/j.ymben.2010.02.002; MacLeod JK, 2001, J MASS SPECTROM, V36, P500, DOI 10.1002/jms.147; Manichaikul A, 2009, NAT METHODS, V6, P589, DOI [10.1038/NMETH.1348, 10.1038/nmeth.1348]; Masakapalli SK, 2010, PLANT PHYSIOL, V152, P602, DOI 10.1104/pp.109.151316; Matsuda F, 2007, PHYTOCHEMISTRY, V68, P2290, DOI 10.1016/j.phytochem.2007.03.031; May P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-209; Merchant S. S., 2012, CURR OPIN BIOTECH, V23, P1; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; Montagud A, 2011, BIOTECHNOL J, V6, P330, DOI 10.1002/biot.201000109; Moroney JV, 2007, EUKARYOT CELL, V6, P1251, DOI 10.1128/EC.00064-07; Muthuraj M, 2013, PHOTOSYNTH RES, V118, P167, DOI 10.1007/s11120-013-9943-x; Petridou S, 1997, PLANT MOL BIOL, V33, P381, DOI 10.1023/A:1005728411921; Poolman MG, 2009, PLANT PHYSIOL, V151, P1570, DOI 10.1104/pp.109.141267; Qian X, 2017, BBA-BIOENERGETICS, V1858, P276, DOI 10.1016/j.bbabio.2016.12.007; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; SAMEJIMA H, 1958, J GEN MICROBIOL, V18, P107, DOI 10.1099/00221287-18-1-107; Schmidt K, 1999, J BIOTECHNOL, V71, P175, DOI 10.1016/S0168-1656(99)00021-8; Schmidt K, 1997, BIOTECHNOL BIOENG, V55, P831, DOI 10.1002/(SICI)1097-0290(19970920)55:6<831::AID-BIT2>3.0.CO;2-H; Schwender J, 2003, J BIOL CHEM, V278, P29442, DOI 10.1074/jbc.M303432200; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Selinski J, 2014, MOL PLANT, V7, P170, DOI 10.1093/mp/sst151; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; Shastri AA, 2007, PHYTOCHEMISTRY, V68, P2302, DOI 10.1016/j.phytochem.2007.03.042; Sheehan J, 2009, NAT BIOTECHNOL, V27, P1128, DOI 10.1038/nbt1209-1128; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Sriram G, 2004, PLANT PHYSIOL, V136, P3043, DOI 10.1104/pp.104.050625; Timmins M, 2009, J BIOL CHEM, V284, P35996, DOI 10.1074/jbc.A109.003541; Vu TT, 2013, BIOTECHNOL J, V8, P619, DOI 10.1002/biot.201200315; Vu TT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002460; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Wiechert W, 1997, BIOTECHNOL BIOENG, V55, P101, DOI 10.1002/(SICI)1097-0290(19970705)55:1<101::AID-BIT12>3.0.CO;2-P; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; WILLEFORD KO, 1989, PLANT PHYSIOL, V90, P788, DOI 10.1104/pp.90.3.788; Williams TCR, 2010, PLANT PHYSIOL, V154, P311, DOI 10.1104/pp.110.158535; Wu C, 2015, PLANT PHYSIOL, V167, P586, DOI 10.1104/pp.114.250688; Xiong W, 2010, PLANT PHYSIOL, V154, P1001, DOI 10.1104/pp.110.158956; Zhang HM, 2003, BIOCHEM ENG J, V16, P211, DOI 10.1016/S1369-703X(03)00070-6; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4; ZUPKE C, 1994, BIOTECHNOL PROGR, V10, P489, DOI 10.1021/bp00029a006; [No title captured]	74	31	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177292	10.1371/journal.pone.0177292	http://dx.doi.org/10.1371/journal.pone.0177292			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542252	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500018
J	Herrera-Carrillo, E; Ben Berkhout				Herrera-Carrillo, Elena; Ben Berkhout			Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; SHORT-INTERFERING RNAS; GENE-THERAPY; LENTIVIRAL VECTORS; MAMMALIAN-CELLS; SYSTEMATIC ANALYSIS; T-CELLS; SHRNA; DICER; EXPRESSION	Allogeneic transplantation of blood stem cells from a CCR5-Delta 32 homozygous donor to an HIV-infected individual, the "Berlin patient", led to a cure. Since then there has been a search for approaches that mimic this intervention in a gene therapy setting. RNA interference (RNAi) has evolved as a powerful tool to regulate gene expression in a sequence-specific manner and can be used to inactivate the CCR5 mRNA. Short hairpin RNA (shRNA) mole-cules can impair CCR5 expression, but these molecules may cause unintended side effects and they will not be processed in cells that lack Dicer, such as monocytes. Dicer-independent RNAi pathways have opened opportunities for new AgoshRNA designs that rely exclusively on Ago2 for maturation. Furthermore, AgoshRNA processing yields a single active guide RNA, thus reducing off-target effects. In this study, we tested different AgoshRNA designs against CCR5. We selected AgoshRNAs that potently downregulated CCR5 expression on human T cells and peripheral blood mononuclear cells (PBMC) and that had no apparent adverse effect on T cell development as assessed in a competitive cell growth assay. CCR5 knockdown significantly protected T cells from CCR5 tropic HIV-1 infection.	[Herrera-Carrillo, Elena; Ben Berkhout] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Ben Berkhout (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Amsterdam, Netherlands.	b.berkhout@amc.uva.nl		Herrera Carrillo, Elena/0000-0001-9986-8552	Nederlandse Organisatie voor Wetenschappelijk Onderzoek - Chemische Wetenschappen (NWO-CW); Zorg Onderzoek Nederland - Medische Wetenschappen (ZonMw); Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen (NWO-CW); Zorg Onderzoek Nederland-Medische Wetenschappen (ZonMw)	Nederlandse Organisatie voor Wetenschappelijk Onderzoek - Chemische Wetenschappen (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Zorg Onderzoek Nederland - Medische Wetenschappen (ZonMw)(Netherlands Organization for Health Research and Development); Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Zorg Onderzoek Nederland-Medische Wetenschappen (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen (NWO-CW, Top Grant) and Zorg Onderzoek Nederland-Medische Wetenschappen (ZonMw, Translational Gene Therapy Grant). We thank Berend Hooibrink for expertise in cell sorting and maintenance of the flow cytometry facility. The authors declare no conflict of interest.; This work was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek - Chemische Wetenschappen (NWO-CW, Top Grant) and Zorg Onderzoek Nederland - Medische Wetenschappen (ZonMw, Translational Gene Therapy Grant).	An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Berkhout B, 2014, FUTURE MICROBIOL, V9, P561, DOI 10.2217/fmb.14.5; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; Dharmacon, SID CENT; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Eekels JJM, 2012, GENE THER, V19, P1058, DOI 10.1038/gt.2011.191; Egerer L, 2015, ADV EXP MED BIOL, V848, P191, DOI 10.1007/978-1-4939-2432-5_10; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Genscript, SIRN SOFTW; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Harwig A, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.19; Herrera-Carrillo E, 2015, GENE THER, V22, P485, DOI 10.1038/gt.2015.11; Herrera-Carrillo E, 2016, NUCL ACIDS RES; Herrera-Carrillo E, 2015, RNA BIOL, V12, P447, DOI 10.1080/15476286.2015.1022024; Herrera-Carrillo E, 2014, RNA, V20, P1410, DOI 10.1261/rna.043950.113; Herrera-Carrillo E, 2014, J VIROL METHODS, V203, P88, DOI 10.1016/j.jviromet.2014.03.021; Hutter G, 2014, NEW ENGL J MED, V371, P2437, DOI 10.1056/NEJMc1412279; Hutter G, 2011, AIDS, V25, P273, DOI 10.1097/QAD.0b013e328340fe28; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Invivogen, SIRN WIZ V3 1; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Kedzierska K, 2002, CURR MED CHEM, V9, P1893, DOI 10.2174/0929867023368935; Kiem HP, 2012, CELL STEM CELL, V10, P137, DOI 10.1016/j.stem.2011.12.015; KITANO K, 1990, BLOOD, V76, P1980; Knoepfel Stefanie A, 2012, World J Virol, V1, P79, DOI 10.5501/wjv.v1.i3.79; Kordelas L, 2014, NEW ENGL J MED, V371, P880, DOI 10.1056/NEJMc1405805; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; Li MJ, 2005, METHOD ENZYMOL, V392, P218, DOI 10.1016/S0076-6879(04)92013-7; Liu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128618; Liu YP, 2013, NUCLEIC ACIDS RES, V41, P3723, DOI 10.1093/nar/gkt036; Liu YP, 2011, METHODS MOL BIOL, V721, P293, DOI 10.1007/978-1-61779-037-9_18; Llibre JM, 2012, ANTIVIR THER, V17, P355, DOI 10.3851/IMP1917; Mcintyre GJ, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-1; Mock U, 2015, NUCLEIC ACIDS RES, V43, P5560, DOI 10.1093/nar/gkv469; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Pang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096445; Park YK, 2008, NUCLEIC ACIDS RES, V36, pW97, DOI 10.1093/nar/gkn280; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Schopman NCT, 2010, ANTIVIR RES, V86, P204, DOI 10.1016/j.antiviral.2010.02.320; Schubert S, 2005, J MOL BIOL, V348, P883, DOI 10.1016/j.jmb.2005.03.011; Seppen J, 2002, J HEPATOL, V36, P459, DOI 10.1016/S0168-8278(01)00308-7; Shimizu S, 2010, BLOOD, V115, P1534, DOI 10.1182/blood-2009-04-215855; Shimizu Saki, 2009, Genet Vaccines Ther, V7, P8, DOI 10.1186/1479-0556-7-8; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Spanevello F, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.24; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Thermofisher, SYNTH RNAI ANAL; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; USHIJIMA H, 1993, PATHOBIOLOGY, V61, P145, DOI 10.1159/000163783; Weiss RA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-57; Westerhout EM, 2007, NUCLEIC ACIDS RES, V35, P4322, DOI 10.1093/nar/gkm437; Whitehead, SIRN DES TOOL; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	71	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177935	10.1371/journal.pone.0177935	http://dx.doi.org/10.1371/journal.pone.0177935			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542329	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500045
J	van der Horst, K; Sleddens, EFC				van der Horst, Klazine; Sleddens, Ester F. C.			Parenting styles, feeding styles and food-related parenting practices in relation to toddlers' eating styles: A cluster-analytic approach	PLOS ONE			English	Article							BODY-MASS INDEX; BEHAVIOR QUESTIONNAIRE; WEIGHT STATUS; CHILD WEIGHT; RESTRICTING ACCESS; PHYSICAL-ACTIVITY; OBESITY; ADIPOSITY; ASSOCIATIONS; CONSUMPTION	Introduction Toddlers' eating behaviors are influenced by the way parents interact with their children. The objective of this study was to explore how five major constructs of general parenting behavior cluster in parents of toddlers. These parenting clusters were further explored to see how they differed in the use of feeding strategies (i.e. feeding styles and food parenting practices) and by reported child eating styles. Methods An online survey with 1005 mothers/caregivers (legal guardians) with at least one child between 12 and 36 months old was conducted in the United States in 2012, assessing general parenting behavior, feeding style, food parenting practices and the child eating styles. Results A three cluster solution of parenting style was found and clusters were labelled as overprotective/supervising, authoritarian, and authoritative. The clusters differed in terms of general parenting behaviors. Both overprotective and authoritative clusters showed high scores on structure, behavioral control, and nurturance. The overprotective cluster scored high on overprotection. The 'authoritarian' cluster showed lowest levels of nurturance, structure and behavioral control. Overprotective and authoritative parents showed very similar patterns in the use of food parenting practices, e.g. monitoring food intake, modeling, and promoting healthy food intake and availability at home. Overprotective parents also reported higher use of pressure to eat and involvement. Authoritarian parents reported high use of giving the child control over their food behaviors, emotion regulation, using food as a reward, and controlling food intake for weight control. Children's eating styles did not largely vary by parenting cluster. Conclusion This study showed that a relatively new parenting style of overprotection is relevant for children's eating behaviors. Overprotective parents reported food parenting practices that are known to be beneficial for children's food intake, such as modelling healthy food intake, as well as more unfavorable practices such as pressure. Longitudinal data on parenting practices and their relation to healthy eating in children is needed to inform communication and interventions for parents, reinforcing key feeding strategies which have positive effects on child eating behaviors and addressing parenting styles that have unintended negative effects.	[van der Horst, Klazine] Nestle Res Ctr, Inst Nutr Sci, Lausanne, Switzerland; [Sleddens, Ester F. C.] Maastricht Univ, Med Ctr, Dept Hlth Promot, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands	Nestle SA; Maastricht University; Maastricht University Medical Centre (MUMC)	van der Horst, K (corresponding author), Nestle Res Ctr, Inst Nutr Sci, Lausanne, Switzerland.	Klazine.vanderhorst@rdls.nestle.com		van der Horst, Klazine/0000-0001-7265-428X; van der Borgh-Sleddens, Ester/0000-0002-9421-6712	Nestec Ltd.; Netherlands Heart Foundation [2014T037]	Nestec Ltd.(Nestle SA); Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was partly funded by Nestec Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salary for author KVDH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. This study was also partially funded by the Netherlands Heart Foundation (project number 2014T037) awarded to Ester Sleddens	Afonso L, 2016, AM J CLIN NUTR, V103, P861, DOI 10.3945/ajcn.115.120824; Baranowski T, 2013, CHILD OBES, V9, pS1, DOI 10.1089/chi.2013.0040; BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372; Blissett J, 2008, APPETITE, V50, P477, DOI 10.1016/j.appet.2007.10.003; Blissett J, 2011, APPETITE, V57, P826, DOI 10.1016/j.appet.2011.05.318; Brown KA, 2008, APPETITE, V50, P252, DOI 10.1016/j.appet.2007.07.010; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Cislak A, 2012, CHILD CARE HLTH DEV, V38, P321, DOI 10.1111/j.1365-2214.2011.01285.x; Clark HR, 2007, J PUBLIC HEALTH-UK, V29, P132, DOI 10.1093/pubmed/fdm012; Collins C, 2014, J HUM NUTR DIET, V27, P557, DOI 10.1111/jhn.12192; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487; Dovey TM, 2008, APPETITE, V50, P181, DOI 10.1016/j.appet.2007.09.009; Ek A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147257; Faith MS, 2004, OBES RES, V12, P1711, DOI 10.1038/oby.2004.212; Faith MS, 2005, MATERN CHILD NUTR, V1, P164, DOI 10.1111/j.1740-8709.2005.00024.x; Fisher JO, 1999, APPETITE, V32, P405, DOI 10.1006/appe.1999.0231; Fisher JO, 1999, AM J CLIN NUTR, V69, P1264; Frankel LA, 2014, APPETITE, V76, P166, DOI 10.1016/j.appet.2014.01.077; Gregory JE, 2010, APPETITE, V54, P550, DOI 10.1016/j.appet.2010.02.013; Hancock KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100686; Hennessy E, 2010, APPETITE, V54, P369, DOI 10.1016/j.appet.2010.01.004; Hughes SO, 2013, CHILD OBES, V9, pS95, DOI 10.1089/chi.2013.0032; Hughes SO, 2012, APPETITE, V58, P393, DOI 10.1016/j.appet.2011.11.011; Hughes SO, 2005, APPETITE, V44, P83, DOI 10.1016/j.appet.2004.08.007; Hurley KM, 2011, J NUTR, V141, P495, DOI 10.3945/jn.110.130047; Jansen PW, 2014, AM J CLIN NUTR, V100, P1329, DOI 10.3945/ajcn.114.088922; Jansen PW, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-130; Janssen I, 2015, PREV MED, V73, P55, DOI 10.1016/j.ypmed.2015.01.015; JOHNSON SL, 1994, PEDIATRICS, V94, P653; Maccoby E., 1983, HDB CHILD PSYCHOL SO, V4, P1; Musher-Eizenman D, 2007, J PEDIATR PSYCHOL, V32, P960, DOI 10.1093/jpepsy/jsm037; Padilla-Walker LM, 2012, J ADOLESCENCE, V35, P1177, DOI 10.1016/j.adolescence.2012.03.007; Patrick H, 2005, APPETITE, V44, P243, DOI 10.1016/j.appet.2002.07.001; Shloim N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01849; Sleddens EFC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-15; Sleddens EFC, 2011, INT J PEDIATR OBES, V6, pE12, DOI 10.3109/17477166.2011.566339; Sleddens EFC, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-49; Spruijt-Metz D, 2002, AM J CLIN NUTR, V75, P581, DOI 10.1093/ajcn/75.3.581; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; van der Horst K, 2016, APPETITE, V103, P286, DOI 10.1016/j.appet.2016.04.027; Vandeweghe L, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00928; Vaughn AE, 2016, NUTR REV, V74, P98, DOI 10.1093/nutrit/nuv061; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Viana V, 2008, BRIT J NUTR, V100, P445, DOI 10.1017/S0007114508894391; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Webber L, 2010, AM J CLIN NUTR, V92, P1423, DOI 10.3945/ajcn.2010.30112; Webber L, 2010, J AM DIET ASSOC, V110, P1718, DOI 10.1016/j.jada.2010.08.007	48	25	25	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178149	10.1371/journal.pone.0178149	http://dx.doi.org/10.1371/journal.pone.0178149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542555	gold, Green Submitted, Green Published			2022-12-27	WOS:000402061500065
J	Baxter, P; Ashurst, E; Read, R; Kennedy, J; Belpaeme, T				Baxter, Paul; Ashurst, Emily; Read, Robin; Kennedy, James; Belpaeme, Tony			Robot education peers in a situated primary school study: Personalisation promotes child learning	PLOS ONE			English	Article							ENGAGEMENT; CLASSROOM; SUPPORT; PHYSICS; DESIGN; TUTORS	The benefit of social robots to support child learning in an educational context over an extended period of time is evaluated. Specifically, the effect of personalisation and adaptation of robot social behaviour is assessed. Two autonomous robots were embedded within two matched classrooms of a primary school for a continuous two week period without experimenter supervision to act as learning companions for the children for familiar and novel subjects. Results suggest that while children in both personalised and non-personalised conditions learned, there was increased child learning of a novel subject exhibited when interacting with a robot that personalised its behaviours, with indications that this benefit extended to other class-based performance. Additional evidence was obtained suggesting that there is increased acceptance of the personalised robot peer over a non-personalised version. These results provide the first evidence in support of peer-robot behavioural personalisation having a positive influence on learning when embedded in a learning environment for an extended period of time.	[Baxter, Paul] Univ Lincoln, Sch Comp Sci, Lincoln Ctr Autonomous Syst, Lincoln, England; [Baxter, Paul; Ashurst, Emily; Read, Robin; Kennedy, James; Belpaeme, Tony] Plymouth Univ, Cognit Inst, Ctr Robot & Neural Syst, Plymouth, Devon, England; [Belpaeme, Tony] Univ Ghent, IMEC, IDLab, Ghent, Belgium	University of Lincoln; University of Plymouth; Ghent University; IMEC	Baxter, P (corresponding author), Univ Lincoln, Sch Comp Sci, Lincoln Ctr Autonomous Syst, Lincoln, England.; Baxter, P (corresponding author), Plymouth Univ, Cognit Inst, Ctr Robot & Neural Syst, Plymouth, Devon, England.	pbaxter@lincoln.ac.uk	Belpaeme, Tony/AAR-8743-2020	Belpaeme, Tony/0000-0001-5207-7745; Kennedy, James/0000-0003-2760-8318; Baxter, Paul/0000-0002-7299-9234	EU FP7 projects ALIZ-E [248116]; DREAM [611391]; H project L2TOR [688014]	EU FP7 projects ALIZ-E; DREAM; H project L2TOR	This work was supported by the EU FP7 projects ALIZ-E (grant number 248116) and DREAM (grant number 611391, http://dream2020. eu/), and H2020 project L2TOR (grant number 688014, http://www.t2tor.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Baroni I, 2014, IEEE ROMAN, P936, DOI 10.1109/ROMAN.2014.6926373; Bartneck C, 2009, INT J SOC ROBOT, V1, P195, DOI 10.1007/s12369-009-0013-7; Baxter P., 2016, 2 WORKSH EV CHILD RO; Baxter P, 2015, 1 INT WORKSH ED ROB; Baxter P, 2016, ACMIEEE INT CONF HUM, P391, DOI 10.1109/HRI.2016.7451777; Baxter P, 2013, ACMIEEE INT CONF HUM, P77, DOI 10.1109/HRI.2013.6483509; Baxter P, 2012, ACMIEEE INT CONF HUM, P105; Baxter PE, 2013, BIOL INSPIR COGN ARC, V6, P30, DOI 10.1016/j.bica.2013.07.002; Belpaeme T, 2012, J HUM-ROBOT INTERACT, V1, P33, DOI 10.5898/JHRI.1.2.Belpaeme; Bloom BS, 1984, ED RES, V136, P4, DOI DOI 10.3102/0013189X013006004; Broadbent E, 2009, INT J SOC ROBOT, V1, P319, DOI 10.1007/s12369-009-0030-6; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Cassell J, 2003, USER MODEL USER-ADAP, V13, P89, DOI 10.1023/A:1024026532471; Castellano G., 2009, P 2009 INT C MULTIMO, P119, DOI [10.1145/1647314.1647336, DOI 10.1145/1647314.1647336]; Coninx A, 2016, J HUM-ROBOT INTERACT, V5, P32, DOI 10.5898/JHRI.5.1.Coninx; Crook C, 1998, COMPUT EDUC, V30, P237, DOI 10.1016/S0360-1315(97)00067-5; Dario P, 2001, J ROBOTIC SYST, V18, P673, DOI 10.1002/rob.8106; Dautenhahn K, 2004, RO-MAN 2004: 13TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, PROCEEDINGS, P17, DOI 10.1109/ROMAN.2004.1374720; Dautenhahn K., 2004, PRAGMAT COGN, V12, P1, DOI [10.1075/pc.12.1.03dau, DOI 10.1075/PC.12.1.03DAU]; Di Paolo E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00163; Dillenbourg P., 1999, COLLABORATIVE LEARNI, P1, DOI DOI 10.1016/S0360-1315(00)00011-7; Dillenbourg P, 2013, COMPUT EDUC, V69, P485, DOI 10.1016/j.compedu.2013.04.013; Duffy BR, 2003, ROBOT AUTON SYST, V42, P177, DOI 10.1016/S0921-8890(02)00374-3; Fridin M, 2014, INT J HUM-COMPUT INT, V30, P459, DOI 10.1080/10447318.2014.888500; Gordon AT, 2011, ASSESSING SOCIAL SUP; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; HALL P, 1991, BIOMETRICS, V47, P757, DOI 10.2307/2532163; Harms C., 2004, 7 ANN INT WORKSH PRE; Henkemans OAB, 2013, PATIENT EDUC COUNS, V92, P174, DOI 10.1016/j.pec.2013.04.012; Hood D, 2015, HRI 2015; Hughes JN, 2006, J SCHOOL PSYCHOL, V43, P465, DOI 10.1016/j.jsp.2005.10.001; Janssen Joris B., 2011, Social Robotics. Proceedings Third International Conference (ICSR 2011), P153, DOI 10.1007/978-3-642-25504-5_16; Kanda T, 2004, HUM-COMPUT INTERACT, V19, P61, DOI 10.1207/s15327051hci1901&2_4; Kanda T, 2007, IEEE T ROBOT, V23, P962, DOI 10.1109/TRO.2007.904904; Kanda T, 2012, ACMIEEE INT CONF HUM, P351; Kennedy J, 2015, ACMIEEE INT CONF HUM, P67, DOI 10.1145/2696454.2696457; Kennedy J, 2014, ACMIEEE INT CONF HUM, P198, DOI 10.1145/2559636.2559820; Kennedy J, 2015, INT J SOC ROBOT, V7, P293, DOI 10.1007/s12369-014-0277-4; Kennedy J, 2013, INT CONF AFFECT, P728, DOI 10.1109/ACII.2013.135; Kidd CD, 2008, INTELLI GENT ROBOTS, P22; Kirby R, 2010, ROBOT AUTON SYST, V58, P322, DOI 10.1016/j.robot.2009.09.015; Klem AM, 2004, J SCHOOL HEALTH, V74, P262, DOI 10.1111/j.1746-1561.2004.tb08283.x; Koay K.L., 2011, MIXED REALITY HUMAN, P133, DOI DOI 10.1007/978-94-007-0582-1_8; Kose-Bagci H, 2009, ADV ROBOTICS, V23, P1951, DOI 10.1163/016918609X12518783330360; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Lange V., 2008, J PHYS AGENTS, V2, P13, DOI DOI 10.14198/JOPHA.2008.2.2.03; Lee MK, 2012, ACMIEEE INT CONF HUM, P319; Leite Iolanda, 2012, Social Robotics. 4th International Conference (ICSR 2012). Proceedings, P298, DOI 10.1007/978-3-642-34103-8_30; Leite Iolanda, 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P669, DOI 10.1109/ROMAN.2009.5326256; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Leyzberg D., 2012, P 34 ANN C COGN SCI, P1882; Leyzberg D, 2014, ACMIEEE INT CONF HUM, P423, DOI 10.1145/2559636.2559671; Li J, 2015, INT J HUM-COMPUT ST, V77, P23, DOI 10.1016/j.ijhcs.2015.01.001; Looije R., 2012, 2012 RO-MAN: The 21st IEEE International Symposium on Robot and Human Interactive Communication, P718, DOI 10.1109/ROMAN.2012.6343836; Meltzer DE, 2002, AM J PHYS, V70, P1259, DOI 10.1119/1.1514215; Meltzoff AN, 2010, NEURAL NETWORKS, V23, P966, DOI 10.1016/j.neunet.2010.09.005; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Moriguchi Y, 2011, INTERACT STUD, V12, P107, DOI 10.1075/is.12.1.04mor; Nook EC, 2015, EMOTION, V15, P569, DOI 10.1037/a0039166; Okita SY, 2011, ACM T INTERACT INTEL, V1, DOI 10.1145/2030365.2030370; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Prince M, 2004, J ENG EDUC, V93, P223, DOI 10.1002/j.2168-9830.2004.tb00809.x; Reeves B, 1996, MEDIA EQUATION PEOPL; Richman WL, 1999, J APPL PSYCHOL, V84, P754, DOI 10.1037/0021-9010.84.5.754; Ros R., 2011, P 13 INT C MULTIMODA, P335, DOI DOI 10.1145/2070481.2070545; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; S Ivaldi, 2016, INT J SOC ROBOT, P1; Saerbeck M, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1613; Tanaka F, 2012, J HUM-ROBOT INTERACT, V1, P78, DOI 10.5898/JHRI.1.1.Tanaka; Tapus A, 2007, IEEE ROBOT AUTOM MAG, V14, P35, DOI 10.1109/MRA.2007.339605; Tapus A, 2008, INTEL SERV ROBOT, V1, P169, DOI 10.1007/s11370-008-0017-4; VERBA M, 1994, HUM DEV, V37, P125, DOI 10.1159/000278249; Vollmer AL, 2014, INT J SOCIAL ROBOTIC; Wainer Joshua, 2007, 16th IEEE International Conference on Robot and Human Interactive Communication, P872; Wainer J., 2006, ROMAN 2006 THE15TH I, P117, DOI DOI 10.1109/ROMAN.2006.314404; Woods S, 2007, INTERACT STUD, V8, P281, DOI 10.1075/is.8.2.06woo; Zaki J, 2013, PERSPECT PSYCHOL SCI, V8, P296, DOI 10.1177/1745691613475454	79	81	81	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178126	10.1371/journal.pone.0178126	http://dx.doi.org/10.1371/journal.pone.0178126			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UE	28542648	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000402058800042
J	Parikh, A; Rizzo, JA; Canetta, P; Forster, C; Sise, M; Maarouf, O; Singer, E; Elger, A; Elitok, S; Schmidt-Ott, K; Barasch, J; Nickolas, TL				Parikh, Amay; Rizzo, John A.; Canetta, Pietro; Forster, Catherine; Sise, Meghan; Maarouf, Omar; Singer, Eugenia; Elger, Antje; Elitok, Saban; Schmidt-Ott, Kai; Barasch, Jonathon; Nickolas, Thomas L.			Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; GELATINASE-ASSOCIATED LIPOCALIN; PROGNOSTIC STRATIFICATION; MORTALITY; BIOMARKERS; MODELS; PREDICTION; DIALYSIS; THERAPY	Introduction Urine neutrophil gelatinase-associated lipocalin (uNGAL) is a sensitive and specific diagnostic test for acute kidney injury (AKI) in the Emergency Department (ED), but its economic impact has not been investigated. We hypothesized that uNGAL used in combination with serum creatinine (sCr) would reduce costs in the management of AKI in patients presenting to the ED in comparison to using sCr alone. Materials and methods A cost simulation model was developed for clinical algorithms to diagnose AKI based on sCr alone vs. uNGAL plus sCr (uNGAL+sCr). A cost minimization analysis was performed to determine total expected costs for patients with AKI. uNGAL test characteristics were validated with eight-hundred forty-nine patients with sCr >= 1.5 from a completed study of 1635 patients recruited from EDs at two U.S. hospitals from 2007-8. Biomarker test, AKI work-up, and diagnostic imaging costs were incorporated. Results For a hypothetical cohort of 10,000 patients, the model predicted that the expected costs were $900 per patient (pp) in the sCr arm and $950 in the uNGAL+sCr arm. uNGAL+sCr resulted in 1,578 fewer patients with delayed diagnosis and treatment than sCr alone (2,013 vs. 436 pts) at center 1 and 1,973 fewer patients with delayed diagnosis and treatment than sCr alone at center 2 (2,227 vs. 254 patients). Although initial evaluation costs at each center were $50 pp higher in with uNGAL+sCr, total costs declined by $408 pp at Center 1 and by $522 pp at Center 2 due to expected reduced delays in diagnosis and treatment. Sensitivity analyses confirmed savings with uNGAL + sCr for a range of cost inputs. Discussion Using uNGAL with sCr as a clinical diagnostic test for AKI may improve patient management and reduce expected costs. Any cost savings would likely result from avoiding delays in diagnosis and treatment and from avoidance of unnecessary testing in patients given a false positive AKI diagnosis by use of sCr alone.	[Parikh, Amay; Canetta, Pietro; Forster, Catherine; Sise, Meghan; Barasch, Jonathon; Nickolas, Thomas L.] Columbia Univ, Med Ctr, New York, NY 10027 USA; [Rizzo, John A.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Rizzo, John A.] SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA; [Maarouf, Omar] Staten Isl Univ Hosp, Staten Isl, NY USA; [Singer, Eugenia; Elger, Antje; Elitok, Saban; Schmidt-Ott, Kai] Charite, Helios Clin Berlin, Max Delbruck Ctr Mol Med, Berlin, Germany	Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Northwell Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Parikh, A (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.	amaypmd@gmail.edu	Parikh, Amay/G-6904-2016; Schmidt-Ott, Kai/F-4588-2011	Schmidt-Ott, Kai/0000-0002-7700-7142; Canetta, Pietro/0000-0003-1130-5486; Parikh, Amay/0000-0002-7332-0625; Forster, Catherine/0000-0002-6233-1070				[Anonymous], 2010, CLIN LAB FEE SCHED; Arora P, 1999, J AM SOC NEPHROL, V10, P1281; Bedford M., 2016, DEV RISK MODELS PRED; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2006, CURR OPIN CRIT CARE, V12, P557, DOI 10.1097/01.ccx.0000247443.86628.68; Brown JR, 2016, AM J NEPHROL, V43, P261, DOI 10.1159/000445846; Chertow GM, 2006, KIDNEY INT, V70, P1120, DOI 10.1038/sj.ki.5001579; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Fischer MJ, 2005, AM J KIDNEY DIS, V46, P1049, DOI 10.1053/j.ajkd.2005.09.006; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Kate RJ, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0277-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2000, NEPHROL DIAL TRANSPL, V15, P8, DOI 10.1093/oxfordjournals.ndt.a027977; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Nickolas TL, 2008, CURR OPIN NEPHROL HY, V17, P127, DOI 10.1097/MNH.0b013e3282f4e525; Nickolas TL, 2012, J AM COLL CARDIOL, V59, P246, DOI 10.1016/j.jacc.2011.10.854; Nickolas TL, 2010, COMP URINAR IN PRESS; Obrador GT, 1998, AM J KIDNEY DIS, V31, P398, DOI 10.1053/ajkd.1998.v31.pm9506677; Parikh CR, 2006, AM J TRANSPLANT, V6, P1639, DOI 10.1111/j.1600-6143.2006.01352.x; Pronovost PJ, 2006, CRIT CARE MED, V34, pS18, DOI 10.1097/01.CCM.0000208369.12812.92; Shapiro NI, 2010, ANN EMERG MED, V56, P52, DOI 10.1016/j.annemergmed.2010.02.010; SHUSTERMAN N, 1987, AM J MED, V83, P65, DOI 10.1016/0002-9343(87)90498-0; Siew ED, 2009, J AM SOC NEPHROL, V20, P1823, DOI 10.1681/ASN.2008070673; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Wagener G, 2008, AM J KIDNEY DIS, V52, P425, DOI 10.1053/j.ajkd.2008.05.018; Wang L, 2008, NEPHRON CLIN PRACT, V108, pC176, DOI 10.1159/000117814; Wavamunno MD, 2005, KIDNEY INT, V67, pS128, DOI 10.1111/j.1523-1755.2005.09429.x; Ympa YP, 2005, AM J MED, V118, P827, DOI 10.1016/j.amjmed.2005.01.069; Zwang O, 2006, J HOSP MED, V1, P272, DOI 10.1002/jhm.115	34	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178091	10.1371/journal.pone.0178091	http://dx.doi.org/10.1371/journal.pone.0178091			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542336	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000401672600045
J	Zemanova, V; Pavlik, M; Pavlikova, D				Zemanova, Veronika; Pavlik, Milan; Pavlikova, Daniela			Cadmium toxicity induced contrasting patterns of concentrations of free sarcosine, specific amino acids and selected microelements in two Noccaea species	PLOS ONE			English	Article							ADENOSYL-L-METHIONINE; ABIOTIC STRESS; GLYCINE BETAINE; ALANINE AMINOTRANSFERASE; PLANT-RESPONSES; SOLANUM TORVUM; ACTIVE-SITE; CAERULESCENS; ARABIDOPSIS; METABOLISM	Cadmium (Cd) toxicity affects numerous metabolic processes in plants. In the presence of Cd, plants accumulate specific amino acids which may be beneficial to developing Cd tolerance. Our study aimed to characterize the changes in the metabolism of selected free amino acids that are associated with Cd tolerance, and investigate the levels of selected microelements in order to relate these changes to the adaptation strategies of two metallophytes-Noccaea caerulescens (Redlschlag, Austria) and Noccaea praecox (Mezica, Slovenia). The plants were exposed to Cd contamination (90 mg Cd/kg soil) for 120 days in a pot experiment. Our results showed higher Cd accumulation in N. praecox compared to N. caerulescens. Cadmium contamination reduced the zinc and nickel levels in both species and a mixed effect was determined for copper and manganese content. Differences in free amino acid metabolism were observed between the two metallophytes growing under Cd-free and Cd-loaded conditions. Under Cd-free conditions, aromatic amino acids (phenylalanine, tryptophan and tyrosine) and branched-chain amino acids (leucine, isoleucine and valine) were accumulated more in the leaves of N. praecox than in N. caerulescens. Cd stress increased the content of these amino acids in both species but this increase was significant only in N. caerulescens leaves. Marked differences in the responses of the two species to Cd stress were shown for alanine, phenylalanine, threonine and sarcosine. Cadmium contamination also induced an increase of threonine as alanine and sarcosine decrease, which was larger in N. caerulescens than in N. praecox. All these factors contribute to the higher adaptation of N. praecox to Cd stress.	[Zemanova, Veronika; Pavlik, Milan] Acad Sci Czech Republ, Inst Expt Bot, Isotope Lab, Prague, Czech Republic; [Pavlikova, Daniela] Czech Univ Life Sci, Dept Agroenvironm Chem & Plant Nutr, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Zemanova, V (corresponding author), Acad Sci Czech Republ, Inst Expt Bot, Isotope Lab, Prague, Czech Republic.; Pavlikova, D (corresponding author), Czech Univ Life Sci, Dept Agroenvironm Chem & Plant Nutr, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic.	veronika.zemanova@biomed.cas.cz; pavlikova@af.czu.cz	Pavlíková, Daniela/V-4971-2018; Pavlík, Milan/G-7052-2014; Zemanová, Veronika/ADF-4648-2022; Zemanova, Veronika/I-2171-2018	Pavlíková, Daniela/0000-0003-3341-5053; Pavlík, Milan/0000-0003-4209-9937; Zemanova, Veronika/0000-0001-7115-8348	Czech University of Life Sciences - CIGA [20142004]; CIGA (Czech University of Life Sciences Prague) [20142004]	Czech University of Life Sciences - CIGA; CIGA (Czech University of Life Sciences Prague)	This research was supported by Czech University of Life Sciences - CIGA project No. 20142004. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by CIGA project No. 20142004 (Czech University of Life Sciences Prague).	Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bor M, 2009, ACTA PHYSIOL PLANT, V31, P655, DOI 10.1007/s11738-008-0255-2; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Cosgrove DJ, 1999, ANNU REV PLANT PHYS, V50, P391, DOI 10.1146/annurev.arplant.50.1.391; DalCorso G, 2008, J INTEGR PLANT BIOL, V50, P1268, DOI 10.1111/j.1744-7909.2008.00737.x; Das ZA, 2016, ENVIRON EXP BOT, V122, P78, DOI 10.1016/j.envexpbot.2015.09.006; DITOPPI LS, 1999, ENV EXP BOT, V41; Egleston ES, 2008, LIMNOL OCEANOGR, V53, P2462, DOI 10.4319/lo.2008.53.6.2462; Fernandez-Ocana A, 2011, J PLANT PHYSIOL, V168, P1303, DOI 10.1016/j.jplph.2011.01.020; Field LS, 2002, J BIOENERG BIOMEMBR, V34, P373, DOI 10.1023/A:1021202119942; Garg R, 2015, PLANT MOL BIOL REP, V33, P388, DOI 10.1007/s11105-014-0753-x; Gonneau C, 2014, PLANT SOIL, V384, P271, DOI 10.1007/s11104-014-2208-4; Gosar M, 2011, APPL GEOCHEM, V26, P1855, DOI 10.1016/j.apgeochem.2011.06.009; He YH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/471429; Hernandez LE, 1997, J EXP BOT, V48, P1375, DOI 10.1093/jxb/48.7.1375; Hjorth M, 2006, PESTIC BIOCHEM PHYS, V86, P138, DOI 10.1016/j.pestbp.2006.02.006; Ibrahim RK, 1998, PLANT MOL BIOL, V36, P1, DOI 10.1023/A:1005939803300; Jiang JS, 2016, PLANT SCI, V249, P93, DOI 10.1016/j.plantsci.2016.05.004; Jin SX, 2014, PLANT BIOTECHNOL J, V12, P1274, DOI 10.1111/pbi.12224; Joshi V, 2010, AMINO ACIDS, V39, P933, DOI 10.1007/s00726-010-0505-7; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Komatsu S, 2009, AMINO ACIDS, V36, P137, DOI 10.1007/s00726-008-0043-8; Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0; Krishnakumar RV, 1996, CRYST RES TECHNOL, V31, P203, DOI 10.1002/crat.2170310214; Li YT, 2003, CHEM COMMUN, P2884, DOI 10.1039/b310543a; Limami AM, 2008, J EXP BOT, V59, P2325, DOI 10.1093/jxb/ern102; Liu GS, 2010, PLANT CELL, V22, P3845, DOI 10.1105/tpc.110.079392; Liu XL, 2011, ECOTOXICOLOGY, V20, P1422, DOI 10.1007/s10646-011-0699-9; Martin S, 2012, BIOL PLANTARUM, V56, P729, DOI 10.1007/s10535-012-0056-8; Miyashita Y, 2007, PLANT J, V49, P1108, DOI 10.1111/j.1365-313X.2006.03023.x; Moffatt BA, 2001, PHYSIOL PLANTARUM, V113, P435, DOI 10.1034/j.1399-3054.2001.1130401.x; Mori T, 2013, BIOCHEM J, V455, P339, DOI 10.1042/BJ20130597; Mustafiz A, 2014, PLANT J, V78, P951, DOI 10.1111/tpj.12521; Mustafiz A, 2010, METHODS MOL BIOL, V639, P95, DOI 10.1007/978-1-60761-702-0_6; Nikiforova VJ, 2006, AMINO ACIDS, V30, P173, DOI 10.1007/s00726-005-0251-4; Niu XL, 2014, ENVIRON EXP BOT, V104, P16, DOI 10.1016/j.envexpbot.2014.03.003; Nuccio ML, 1998, PLANT J, V16, P487, DOI 10.1046/j.1365-313x.1998.00316.x; Oda A, 2005, PHYSIOL PLANTARUM, V124, P515, DOI 10.1111/j.1399-3054.2005.00528.x; Pavlik M, 2017, J PLANT PHYSIOL, V208, P94, DOI 10.1016/j.jplph.2016.09.014; Pavlik M, 2012, ECOTOX ENVIRON SAFE, V79, P101, DOI 10.1016/j.ecoenv.2011.12.009; Pavlik M, 2010, ECOTOX ENVIRON SAFE, V73, P1309, DOI 10.1016/j.ecoenv.2010.07.008; Pavlikova D, 2008, ECOTOX ENVIRON SAFE, V70, P223, DOI 10.1016/j.ecoenv.2007.07.006; Pavlikova D, 2014, J PLANT PHYSIOL, V171, P559, DOI 10.1016/j.jplph.2013.11.016; Pavlikova D, 2014, ECOTOX ENVIRON SAFE, V100, P166, DOI 10.1016/j.ecoenv.2013.10.028; Planchais S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00330; Polacco JC, 2013, PLANT SCI, V199, P79, DOI 10.1016/j.plantsci.2012.10.010; Popko J, 2010, PLANT BIOLOGY, V12, P242, DOI 10.1111/j.1438-8677.2009.00305.x; Puschenreiter M, 2005, PLANT SOIL, V271, P205, DOI 10.1007/s11104-004-2387-5; Reeves RD, 2001, INT J PHYTOREMEDIAT, V3, P145, DOI 10.1080/15226510108500054; Rice Evans CA, 1996, FREE RADIC BIOL MED, V20, P933, DOI DOI 10.1016/0891-5849(95)02227-9; Rocha M, 2010, PLANT PHYSIOL, V152, P1501, DOI 10.1104/pp.109.150045; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Sanjaya, 2008, PLANT CELL ENVIRON, V31, P1074, DOI 10.1111/j.1365-3040.2008.01819.x; Seher Y, 2013, PLANT SYST EVOL, V299, P403, DOI [10.1007/s00606-012-0730-5, 10.1007/s00606-]; Shah K, 2001, PLANT SCI, V161, P1135, DOI 10.1016/S0168-9452(01)00517-9; Signorelli S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115349; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tamas L, 2015, J PLANT PHYSIOL, V173, P1, DOI 10.1016/j.jplph.2014.08.018; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tewari BB, 2012, J CHIL CHEM SOC, V57, P995, DOI 10.4067/S0717-97072012000100009; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Turkel N, 2015, BIOINORG CHEM APPL, V2015, DOI 10.1155/2015/374782; Tzin Vered, 2010, Arabidopsis Book, V8, pe0132, DOI 10.1199/tab.0132; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Visioli G, 2014, ENVIRON EXP BOT, V105, P10, DOI 10.1016/j.envexpbot.2014.04.001; Vogel-Mikus K, 2008, NEW PHYTOL, V179, P712, DOI 10.1111/j.1469-8137.2008.02519.x; Whittaker JW, 2002, INT J QUANTUM CHEM, V90, P1529, DOI 10.1002/qua.10422; Witt S, 2012, MOL PLANT, V5, P401, DOI 10.1093/mp/ssr102; Witte CP, 2011, PLANT SCI, V180, P431, DOI 10.1016/j.plantsci.2010.11.010; Xie Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115279; Xu J, 2012, NEW PHYTOL, V196, P125, DOI 10.1111/j.1469-8137.2012.04236.x; Xu J, 2012, NEW PHYTOL, V196, P110, DOI 10.1111/j.1469-8137.2012.04235.x; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; YANG WJ, 1995, PLANT PHYSIOL, V107, P621, DOI 10.1104/pp.107.2.621; Yoo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3833; Zarubova P, 2015, ENVIRON SCI POLLUT R, V22, P18801, DOI 10.1007/s11356-015-5043-0; Zemanova V, 2014, PLANT SOIL ENVIRON, V60, P426, DOI 10.17221/544/2014-PSE; Zemanova V, 2016, ARCH ENVIRON CON TOX, V70, P464, DOI 10.1007/s00244-015-0198-8; Zemanova V, 2015, J PLANT PHYSIOL, V180, P27, DOI 10.1016/j.jplph.2015.02.012; Zoghlami LB, 2011, AFR J BIOTECHNOL, V10, P567	82	33	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177963	10.1371/journal.pone.0177963	http://dx.doi.org/10.1371/journal.pone.0177963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542385	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672600035
J	de la Tour, CB; Mathieu, M; Meyer, L; Dupaigne, P; Passot, F; Servant, P; Sommer, S; Le Cam, E; Confalonieri, F				de la Tour, Claire Bouthier; Mathieu, Martine; Meyer, Laura; Dupaigne, Pauline; Passot, Fanny; Servant, Pascale; Sommer, Suzanne; Le Cam, Eric; Confalonieri, Fabrice			In vivo and in vitro characterization of DdrC, a DNA damage response protein in Deinococcus radiodurans bacterium	PLOS ONE			English	Article							STRAND BREAK REPAIR; IONIZING-RADIATION; PPRA PROTEIN; RESISTANCE; RADIORESISTANCE; RECOMBINATION; REPLICATION; PERSPECTIVE; ACCURATE; GENOME	The bacterium Deinococcus radiodurans possesses a set of Deinococcus-specific genes highly induced after DNA damage. Among them, ddrC (dr0003) was recently re-annotated, found to be in the inverse orientation and called A2G07_00380. Here, we report the first in vivo and in vitro characterization of the corrected DdrC protein to better understand its function in irradiated cells. In vivo, the Delta ddrC null mutant is sensitive to high doses of UV radiation and the ddrC deletion significantly increases UV-sensitivity of Delta uvrA or Delta uvsE mutant strains. We show that the expression of the DdrC protein is induced after gamma-irradiation and is under the control of the regulators, DdrO and IrrE. DdrC is rapidly recruited into the nucleoid of the irradiated cells. In vitro, we show that DdrC is able to bind single-and double-stranded DNA with a preference for the single-stranded DNA but without sequence or shape specificity and protects DNA from various nuclease attacks. DdrC also condenses DNA and promotes circularization of linear DNA. Finally, we show that the purified protein exhibits a DNA strand annealing activity. Altogether, our results suggest that DdrC is a new DNA binding protein with pleiotropic activities. It might maintain the damaged DNA fragments end to end, thus limiting their dispersion and extensive degradation after exposure to ionizing radiation. DdrC might also be an accessory protein that participates in a single strand annealing pathway whose importance in DNA repair becomes apparent when DNA is heavily damaged.	[de la Tour, Claire Bouthier; Mathieu, Martine; Meyer, Laura; Passot, Fanny; Servant, Pascale; Sommer, Suzanne; Confalonieri, Fabrice] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Dupaigne, Pauline; Le Cam, Eric] Univ Paris Saclay, Univ Paris Sud, CNRS, Signalisat Noyaux & Innovat Cancerol,UMR 8126, 114 Rue E Vaillant, Villejuif, France; [Passot, Fanny] Lund Univ, Mol Cell Biol unit, Biol Dept, Lund, Sweden	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Lund University	de la Tour, CB (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	claire.bouthier@i2bc.paris-saclay.fr	Dupaigne, Pauline/C-6873-2019; Servant, pascale/V-9016-2017	Le cam, Eric/0000-0002-6832-6117; Passot, Fanny/0000-0002-0257-816X; Dupaigne, Pauline/0000-0001-7033-4055	Centre National de la Recherche Scientifique; University Paris-Sud, Electricite de France [RB2017-02]; Agence Nationale de la Recherche [ANR-12-BSV8-0012]; foundation ARC [SLS220120605310]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud, Electricite de France; Agence Nationale de la Recherche(French National Research Agency (ANR)); foundation ARC	This work was supported by the Centre National de la Recherche Scientifique, the University Paris-Sud, Electricite de France (RB2017-02 to FC), the Agence Nationale de la Recherche (ANR-12-BSV8-0012 to ELC) and the foundation ARC (program SLS220120605310 to ELC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Confalonieri F, 2011, J PHYS CONF SER, V261, DOI 10.1088/1742-6596/261/1/012005; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; de Groot A, 2014, GENOME BIOL EVOL, V6, P932, DOI 10.1093/gbe/evu069; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; de la Tour CB, 2011, DNA REPAIR, V10, P1223, DOI 10.1016/j.dnarep.2011.09.010; de la Tour CB, 2009, EXTREMOPHILES, V13, P827, DOI 10.1007/s00792-009-0270-2; Devigne A, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00036-15; Devigne A, 2015, MOL MICROBIOL, V96, P1069, DOI 10.1111/mmi.12991; Devigne A, 2013, DNA REPAIR, V12, P265, DOI 10.1016/j.dnarep.2013.01.004; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; Hua X, 2016, GENOME ANNOUNC, V4; Ishino Y, 2015, CURR OPIN MICROBIOL, V25, P103, DOI 10.1016/j.mib.2015.05.010; Jolivet E, 2006, MOL MICROBIOL, V59, P338, DOI 10.1111/j.1365-2958.2005.04946.x; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kota S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085288; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Ludanyi M, 2014, MOL MICROBIOL, V94, P434, DOI 10.1111/mmi.12774; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; McGovern S, 2016, NUCLEIC ACIDS RES, V44, P4785, DOI 10.1093/nar/gkw149; Mennecier S, 2004, MOL GENET GENOMICS, V272, P460, DOI 10.1007/s00438-004-1077-6; MOSELEY BEB, 1983, J GEN MICROBIOL, V129, P2437; Murakami M, 2006, BBA-PROTEINS PROTEOM, V1764, P20, DOI 10.1016/j.bbapap.2005.10.017; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Norais CA, 2009, J BIOL CHEM, V284, P21402, DOI 10.1074/jbc.M109.010454; Passot FM, 2015, MOL MICROBIOL, V97, P759, DOI 10.1111/mmi.13064; Selvam K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069007; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Sugiman-Marangos SN, 2016, P NATL ACAD SCI USA, V113, P4308, DOI 10.1073/pnas.1520847113; Tanaka M, 2005, J BACTERIOL, V187, P3693, DOI 10.1128/JB.187.11.3693-3697.2005; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Vujicic-Zagar A, 2009, J MOL BIOL, V386, P704, DOI 10.1016/j.jmb.2008.12.062; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; Wang YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122071; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Xu GZ, 2010, DNA REPAIR, V9, P805, DOI 10.1016/j.dnarep.2010.04.006	40	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177751	10.1371/journal.pone.0177751	http://dx.doi.org/10.1371/journal.pone.0177751			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542368	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400077
J	Kugita, M; Nishii, K; Yamaguchi, T; Suzuki, A; Yuzawa, Y; Horie, S; Higashihara, E; Nagao, S				Kugita, Masanori; Nishii, Kazuhiro; Yamaguchi, Tamio; Suzuki, Atsushi; Yuzawa, Yukio; Horie, Shigeo; Higashihara, Eiji; Nagao, Shizuko			Beneficial effect of combined treatment with octreotide and pasireotide in PCK rats, an orthologous model of human autosomal recessive polycystic kidney disease	PLOS ONE			English	Article							CONGENITAL HEPATIC-FIBROSIS; LIVER-DISEASE; SOMATOSTATIN ANALOGS; GROWTH; KINASE; CYSTOGENESIS; PROGRESSION; INHIBITION; ACTIVATION; SOM230	Increased intracellular cyclic AMP (cAMP) in renal tubular epithelia accelerates the progression of polycystic kidney disease (PKD). Thus, decreasing cAMP levels by an adenylyl cyclase inhibitory G protein activator is considered to be an effective approach in ameliorating PKD. In fact, pasireotide (PAS) was effective in reducing disease progression in animal models of PKD. However, hyperglycemia caused by the administration of PAS is an adverse effect in its clinical use. Whereas, co-administration of octreotide (OCT) with PAS did not increase serum glucose in normal rats. In the current study, we examined the efficacy of combined treatment with OCT and PAS in PCK rats, an autosomal recessive PKD model. Four-week-old PCK males were treated with the long-acting release type of OCT, PAS, or a combination of both (OCT/PAS) for 12 weeks. After termination, serum and renal tissue were used for analyses. Kidney weight, kidney weight per body weight, renal cyst area, renal Ki67 expression, and serum urea nitrogen were significantly decreased either in the PAS or OCT/PAS group, compared with vehicle. Renal tissue cAMP content was significantly decreased by PAS or OCT/PAS treatment, but not OCT, compared with vehicle. As a marker of cellular mTOR signaling activity, renal phospho-S6 kinase expression was significantly decreased by OCT/PAS treatment compared with vehicle, OCT, or PAS. Serum glucose was significantly increased by PAS administration, whereas no difference was shown between vehicle and OCT/PAS, possibly because serum glucagon was decreased either by the treatment of OCT alone or co-application of OCT/PAS. In conclusion, since serum glucose levels are increased by the use of PAS, its combination with OCT may reduce the risk of hyperglycemia associated with PAS monotherapy against PKD progression.	[Kugita, Masanori; Nagao, Shizuko] Fujita Hlth Univ, Educ & Res Ctr Anim Models Human Dis, Toyoake, Aichi, Japan; [Nishii, Kazuhiro] Fujita Hlth Univ, Sch Hlth Sci, Fac Rehabil, Toyoake, Aichi, Japan; [Yamaguchi, Tamio] Suzuka Univ Med Sci, Dept Clin Nutr, Fac Hlth Sci, Suzuka, Mie, Japan; [Suzuki, Atsushi] Fujita Hlth Univ, Div Endocrinol & Metab, Dept Internal Med, Toyoake, Aichi, Japan; [Yuzawa, Yukio] Fujita Hlth Univ, Dept Nephrol, Sch Med, Toyoake, Aichi, Japan; [Horie, Shigeo] Juntendo Univ, Dept Urol, Sch Med, Bunkyo Ku, Tokyo, Japan; [Higashihara, Eiji] Kyorin Univ, Dept Urol, Sch Med, Mitaka, Tokyo, Japan	Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Juntendo University; Kyorin University	Nagao, S (corresponding author), Fujita Hlth Univ, Educ & Res Ctr Anim Models Human Dis, Toyoake, Aichi, Japan.	shizun@fujita-hu.ac.jp		Nagao, Shizuko/0000-0003-2014-9411	 [22590351];  [15K08435]	; 	This work was supported by a Grant-in-Aid for Scientific Research (C) grant numbers: 22590351, 15K08435 (https://www.isps.go.jp/ english/index.html) to SN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caroli A, 2013, LANCET, V382, P1485, DOI 10.1016/S0140-6736(13)61407-5; Caroli A, 2010, CLIN J AM SOC NEPHRO, V5, P783, DOI 10.2215/CJN.05380709; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Grantham JJ, 2011, NAT REV NEPHROL, V7, P556, DOI 10.1038/nrneph.2011.109; Hogan MC, 2012, NEPHROL DIAL TRANSPL, V27, P3532, DOI 10.1093/ndt/gfs152; Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291; Liu CY, 2013, MOL MED REP, V8, P861, DOI 10.3892/mmr.2013.1588; Masyuk TV, 2007, GASTROENTEROLOGY, V132, P1104, DOI 10.1053/j.gastro.2006.12.039; Masyuk TV, 2013, HEPATOLOGY, V58, P409, DOI 10.1002/hep.26140; Nagao S, 2003, KIDNEY INT, V63, P427, DOI 10.1046/j.1523-1755.2003.00755.x; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; NAKAMURA T, 1993, J AM SOC NEPHROL, V3, P1378; Sanzen T, 2001, AM J PATHOL, V158, P1605, DOI 10.1016/S0002-9440(10)64116-8; Schmid HA, 2008, MOL CELL ENDOCRINOL, V286, P69, DOI 10.1016/j.mce.2007.09.006; Schmid HA, 2012, J ENDOCRINOL, V212, P49, DOI 10.1530/JOE-11-0224; Shenouda M, 2014, AM J THER, V21, P164, DOI 10.1097/MJT.0b013e31824c3eb4; Sideris L, 2012, ONCOLOGIST, V17, P747, DOI 10.1634/theoncologist.2011-0458; Sweeney WE, 2011, PEDIATR NEPHROL, V26, P675, DOI 10.1007/s00467-010-1656-1; Torres VE, 2004, KIDNEY INT, V66, P1766, DOI 10.1111/j.1523-1755.2004.00952.x; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Turkbey B, 2009, PEDIATR RADIOL, V39, P100, DOI 10.1007/s00247-008-1064-x; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Weckbecker G, 2002, ENDOCRINOLOGY, V143, P4123, DOI 10.1210/en.2002-220219; Willey CJ, 2016, NEPHROL DIAL TRANSPL, V19; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yoshihara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081480; Yoshihara D, 2011, AM J PHYSIOL-RENAL, V300, pF465, DOI 10.1152/ajprenal.00460.2010	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177934	10.1371/journal.pone.0177934	http://dx.doi.org/10.1371/journal.pone.0177934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542433	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400118
J	Paquette, R; Tanton, C; Burns, F; Prah, P; Shahmanesh, M; Field, N; Macdowall, W; Gravningen, K; Sonnenberg, P; Mercer, CH				Paquette, Rachelle; Tanton, Clare; Burns, Fiona; Prah, Philip; Shahmanesh, Maryam; Field, Nigel; Macdowall, Wendy; Gravningen, Kirsten; Sonnenberg, Pam; Mercer, Catherine H.			Illicit drug use and its association with key sexual risk behaviours and outcomes: Findings from Britain's third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)	PLOS ONE			English	Article							SUBSTANCE USE; TRANSMITTED INFECTIONS; UNPLANNED PREGNANCY; SENSATION SEEKING; BISEXUAL MEN; SOUTH LONDON; CLUB DRUGS; YOUNG MEN; GAY MEN; HEALTH	Objectives We explore the hypothesis that using illicit drugs other than, or in addition to, cannabis is associated with sexual risk behaviour and sexual health outcomes in the British population. Methods We analysed data, separately by gender, reported by sexually-active participants (those reporting > = 1 partners/past year) aged 16-44 years (3,395 men, 4,980 women) in Britain's third National Survey of Sexual Attitudes and Lifestyles (Natsal-3), a probability survey undertaken 2010-12 involving computer-assisted personal-interview and computer-assisted self-interview. Analyses accounted for the stratification, clustering and weighting of the data. Multivariable logistic regression was used to calculate adjusted odds ratios. Results Use of illicit drugs other than, or in addition to, cannabis in the past year was reported by 11.5% (95% Cl: 10.4%-12.8%) of men and 5.5% (4.8%-6.3%) of women. Use of these types of drugs was more common among those < 35 years, those who reported poor general and/or sexual health behaviours, e.g. binge drinking > = weekly (age-adjusted ORs, aAORs, 10.91 (6.27-18.97) men; 9.95 (6.11 -16.19) women); having > = 2 condomless partners in the past year (aAOR: 5.50 (3.61-8.39) men; 5.24 (3.07 -8.94) women). Participants reporting illicit drug use were more likely (than those who did not) to report sexual health clinic attendance (ORs after adjusting for age, sexual identity and partner numbers: 1.79 (1.28 -2.51) men; 1.99 (1.34-2.95) women), chlamydia testing (1.42 (1.06-1.92) men; 1.94 (1.40- 2.70) women), unplanned pregnancy (2.93 (1.39-6.17) women), and among men only, sexually transmitted infection diagnoses (3.10 (1.63-5.89)). Conclusions In Britain, those reporting recent illicit drug use were more likely to report other markers of poor general and sexual health. They were also more likely to attend sexual health clinics so these should be considered appropriate settings to implement holistic interventions to maximise health gain.	[Paquette, Rachelle; Tanton, Clare; Burns, Fiona; Prah, Philip; Shahmanesh, Maryam; Field, Nigel; Gravningen, Kirsten; Sonnenberg, Pam; Mercer, Catherine H.] UCL, Res Dept Infect & Populat Hlth, London, England; [Macdowall, Wendy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London, England; [Gravningen, Kirsten] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; UiT The Arctic University of Tromso; University Hospital of North Norway	Mercer, CH (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	c.mercer@ucl.ac.uk	Field, Nigel/ABG-3948-2020	Mercer, Catherine/0000-0002-4220-5034; Field, Nigel/0000-0002-2825-6652; Tanton, Clare/0000-0002-4612-1858; Macdowall, Wendy/0000-0001-5868-8336; Shahmanesh, Maryam/0000-0001-7129-8535	Medical Research Council [G0701757]; Wellcome Trust [084840]; Economic and Social Research Council and Department of Health; MRC [G0701757] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council and Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Natsal-3 was supported by grants from the Medical Research Council www.mrc.ac.uk; G0701757) and the Wellcome Trust (www.wellcome.as.uk; 084840), with contributions from the Economic and Social Research Council and Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Natsal-3 is a collaboration between University College London (London, UK), the London School of Hygiene and Tropical Medicine (London, UK), NatCen Social Research, Public Health England (formerly the Health Protection Agency), and the University of Manchester (Manchester, UK). Natsal-3 was supported by grants from the Medical Research Council (www.mrc.ac.uk; G0701757) and the Wellcome Trust (www.wellcome.ac.uk; 084840), with contributions from the Economic and Social Research Council and Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the study participants; the team of interviewers from NatCen Social Research; and operations and computing staff from NatCen Social Research.	Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Benotsch EG, 2013, J ADOLESCENT HEALTH, V52, P307, DOI 10.1016/j.jadohealth.2012.06.011; Bourne A, 2015, SEX TRANSM INFECT, V91, P564, DOI 10.1136/sextrans-2015-052052; Bourne A, 2016, J PUBLIC HLTH; Bourne A., 2014, CHEMSEX STUDY DRUG U; Bourne A, 2015, INT J DRUG POLICY, V26, P1171, DOI 10.1016/j.drugpo.2015.07.013; Brodbeck J, 2006, AIDS BEHAV, V10, P599, DOI 10.1007/s10461-006-9103-9; Brook G, 2014, INT J STD AIDS, V25, P391, DOI 10.1177/0956462413512807; Chakraborty K, 2011, INDIAN J MED RES, V133, P594; Craig R, 2011, HLTH SURVEY ENGLAND; Daskalopoulou M, 2014, LANCET HIV, V1, pE22, DOI 10.1016/S2352-3018(14)70001-3; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Downing MJ, 2015, J HLTH PSYCHOL; Elkins IJ, 2006, J ABNORM PSYCHOL, V115, P26, DOI 10.1037/0021-843X.115.1.26; Erens B, 2013, NAT SURV SEX ATT LIF, V1; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Fendrich M, 2013, ADDICT BEHAV, V38, P1715, DOI 10.1016/j.addbeh.2012.09.005; Field N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010521; Field N, 2013, LANCET, V382, P1830, DOI 10.1016/S0140-6736(13)62222-9; Gahlinger PM, 2004, AM FAM PHYSICIAN, V69, P2619; Heiligenberg M, 2012, SEX TRANSM DIS, V39, P518, DOI 10.1097/OLQ.0b013e3182515601; Hickson F, 2010, ADDICT RES THEORY, V18, P14, DOI 10.3109/16066350902770433; Home Office, 2014, DRUG MIS FIND 2013 1; Hunter LJ, 2014, POSTGRAD MED J, V90, P133, DOI 10.1136/postgradmedj-2012-131428; Johnson MW, 2017, PSYCHOPHARMACOLOGY, V234, P599, DOI 10.1007/s00213-016-4493-5; Lewis J., 2007, RES ETHICS REV, V3, P73; Li J, 2014, SEX TRANSM INFECT, V90, P125, DOI 10.1136/sextrans-2013-051195; Macdowall W, 2013, LANCET, V382, P1845, DOI 10.1016/S0140-6736(13)62300-4; McKetin R, 2014, DRUG ALCOHOL REV, V33, P436, DOI 10.1111/dar.12147; Melendez-Torres GJ, 2016, CURR OPIN INFECT DIS, V29, P58, DOI 10.1097/QCO.0000000000000234; Mercer CH, 2007, AM J PUBLIC HEALTH, V97, P1126, DOI 10.2105/AJPH.2006.086439; Mercer CH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3149-z; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Metrik J, 2016, J STUD ALCOHOL DRUGS, V77, P104, DOI 10.15288/jsad.2016.77.104; Mohammed H, 2016, SEX TRANSM INFECT, V92, P454, DOI 10.1136/sextrans-2016-052740; Newcomb ME, 2014, DRUG ALCOHOL DEPEN, V141, P65, DOI 10.1016/j.drugalcdep.2014.05.005; Newcomb ME, 2011, AIDS BEHAV, V15, P565, DOI 10.1007/s10461-010-9832-7; Pappas MK, 2011, AIDS CARE, V23, P1410, DOI 10.1080/09540121.2011.565027; Park A, 2012, BRIT SOCIAL ATTITUDE; Quinn PD, 2013, DEV PSYCHOPATHOL, V25, P223, DOI 10.1017/S0954579412000284; SIMON W, 1986, ARCH SEX BEHAV, V15, P97, DOI 10.1007/BF01542219; Simon W., 2003, QUAL SOCIOL, V26, P491, DOI [10.1023/B:QUAS.0000005053.99846.e5, DOI 10.1023/B:QUAS.0000005053.99846.E5]; Singer M, 2017, LANCET, V389, P941, DOI 10.1016/S0140-6736(17)30003-X; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Spauwen LWL, 2015, SEX TRANSM INFECT, V91, P31, DOI 10.1136/sextrans-2014-051626; Tolou-Shams M, 2013, J GAY LESBIAN MENT H, V17, P96, DOI 10.1080/19359705.2013.740210; United Nations Office on Drugs and Crime, 2015, 2015 WORLD DRUG REP; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; Wellings K, 2013, LANCET, V382, P1759, DOI 10.1016/S0140-6736(13)62378-8; Wells BE, 2011, AIDS BEHAV, V15, P509, DOI 10.1007/s10461-010-9767-z; World Health Organization, 2006, DEF SEX HLTH REP TEC	52	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177922	10.1371/journal.pone.0177922	http://dx.doi.org/10.1371/journal.pone.0177922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542366	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000401672400114
J	Takeuchi, N; Sugiyama, S; Inui, K; Kanemoto, K; Nishihara, M				Takeuchi, Nobuyuki; Sugiyama, Shunsuke; Inui, Koji; Kanemoto, Kousuke; Nishihara, Makoto			New paradigm for auditory paired pulse suppression	PLOS ONE			English	Article							PREPULSE INHIBITION; PREFRONTAL CORTEX; SCHIZOPHRENIA-PATIENTS; CORTICAL RESPONSES; BRAIN POTENTIALS; EVOKED RESPONSES; MARTINOTTI CELLS; P50 SUPPRESSION; GATING DEFICIT; ECHOIC MEMORY	Sensory gating is a mechanism of sensory processing used to prevent an overflow of irrelevant information, with some indexes, such as prepulse inhibition (PPI) and P50 suppression, often utilized for its evaluation. In addition, those are clinically important for diseases such as schizophrenia. In the present study, we investigated long-latency paired-pulse suppression of change-related cortical responses using magnetoencephalography. The test change-related response was evoked by an abrupt increase in sound pressure by 15 dB in a continuous sound composed of a train of 25-ms pure tones at 65 dB. By inserting a leading change stimulus (prepulse), we observed suppression of the test response. In Experiment 1, we examined the effects of conditioning-test intervals (CTI) using a 25-ms pure tone at 80 dB as both the test and prepulse. Our results showed clear suppression of the test response peaking at a CTI of 600 ms, while maximum inhibition was approximately 30%. In Experiment 2, the effects of sound pressure on prepulse were examined by inserting prepulses 600 ms prior to the test stimulus. We found that a paired-pulse suppression greater than 25% was obtained by prepulses larger than 77 dB, i.e., 12 dB louder than the background, suggesting that long latency suppression requires a relatively strong prepulse to obtain adequate suppression, different than short-latency paired-pulse suppression reported in previous studies. In Experiment 3, we confirmed similar levels of suppression using electroencephalography. These results suggested that two identical change stimuli spaced by 600 ms were appropriate for observing the long-latency inhibition. The present method requires only a short inspection time and is non-invasive.	[Takeuchi, Nobuyuki; Kanemoto, Kousuke] Aichi Med Univ, Neuropsychiat Dept, Nagakute, Aichi, Japan; [Sugiyama, Shunsuke] Gifu Univ, Dept Psychiat & Psychotherapy, Gifu, Japan; [Inui, Koji] Aichi Human Serv Ctr, Inst Human Dev Res, Kasugai, Aichi, Japan; [Inui, Koji] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi, Japan; [Nishihara, Makoto] Aichi Med Univ, Multidisciplinary Pain Ctr, Nagakute, Aichi, Japan	Aichi Medical University; Gifu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Aichi Medical University	Takeuchi, N (corresponding author), Aichi Med Univ, Neuropsychiat Dept, Nagakute, Aichi, Japan.	jamjam053@yahoo.co.jp		Takeuchi, Nobuyuki/0000-0001-8252-3662	JSPS KAKENHI [JP25351001, JP25461791]; ImPACT Program of the Council [2015-PM11-23-01]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ImPACT Program of the Council	This study was supported by JSPS KAKENHI Grant Numbers JP25351001 to K.I. and JP25461791 to M.N., and the ImPACT Program (2015-PM11-23-01) of the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan) to K.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by JSPS KAKENHI Grant Numbers JP25351001 to K.I. and JP25461791 to M.N., and the ImPACT Program (2015-PM11-23-01) of the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan) to K.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are grateful to Yasuyuki Takeshima for his technical support.	ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; Amenedo E, 1998, BIOL PSYCHOL, V48, P235, DOI 10.1016/S0301-0511(98)00040-4; Anderer P, 1996, ELECTROEN CLIN NEURO, V99, P458, DOI 10.1016/S0013-4694(96)96518-9; Anokhin AP, 2007, SCHIZOPHR RES, V89, P312, DOI 10.1016/j.schres.2006.08.009; Becker J, 2011, ARQ NEURO-PSIQUIAT, V69, P460, DOI 10.1590/S0004-282X2011000400010; Boutros NN, 2006, J NEUROPSYCH CLIN N, V18, P409, DOI 10.1176/appi.neuropsych.18.3.409; Boutros NN, 2009, SCHIZOPHR RES, V113, P339, DOI 10.1016/j.schres.2009.05.019; BOWERY NG, 1993, ANNU REV PHARMACOL, V33, P109, DOI 10.1146/annurev.pa.33.040193.000545; Bramon E, 2004, SCHIZOPHR RES, V70, P315, DOI 10.1016/j.schres.2004.01.004; Brockhaus-Dumke A, 2008, BIOL PSYCHIAT, V64, P376, DOI 10.1016/j.biopsych.2008.02.006; Cadenhead KS, 2005, BIOL PSYCHIAT, V57, P1504, DOI 10.1016/j.biopsych.2005.03.003; Cheng CH, 2016, J AFFECT DISORDERS, V203, P199, DOI 10.1016/j.jad.2016.06.010; CULLUM CM, 1993, SCHIZOPHR RES, V10, P131, DOI 10.1016/0920-9964(93)90048-N; Dalecki A, 2011, PSYCHOPHYSIOLOGY, V48, P1692, DOI 10.1111/j.1469-8986.2011.01262.x; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; Fuerst DR, 2007, PSYCHOPHYSIOLOGY, V44, P620, DOI 10.1111/j.1469-8986.2007.00524.x; Ghisolfi ES, 2006, J PSYCHIATR RES, V40, P535, DOI 10.1016/j.jpsychires.2006.02.006; Greenwood TA, 2016, AM J PSYCHIAT, V173, P385, DOI 10.1176/appi.ajp.2015.15050605; Holstein DH, 2013, PSYCHIAT RES, V205, P117, DOI 10.1016/j.psychres.2012.08.013; Inui K, 2004, CEREB CORTEX, V14, P851, DOI 10.1093/cercor/bhh043; Inui K, 2006, CEREB CORTEX, V16, P18, DOI 10.1093/cercor/bhi080; Inui K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155972; Inui K, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-588; Inui K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-135; Inui K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-135; Inui K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-80; IRAGUI VJ, 1993, PSYCHOPHYSIOLOGY, V30, P10, DOI 10.1111/j.1469-8986.1993.tb03200.x; Javitt DC, 2015, AM J PSYCHIAT, V172, P17, DOI 10.1176/appi.ajp.2014.13121691; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Kodaira M, 2013, BEHAV BRAIN RES, V256, P27, DOI 10.1016/j.bbr.2013.07.045; Krishnamurthy P, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00060; Kunugi H, 2007, NEUROSCI RES, V59, P23, DOI 10.1016/j.neures.2007.05.006; Lewis DA, 2014, CURR OPIN NEUROBIOL, V26, P22, DOI 10.1016/j.conb.2013.11.003; LUND JS, 1993, J COMP NEUROL, V328, P282, DOI 10.1002/cne.903280209; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Melchitzky DS, 2008, SYNAPSE, V62, P456, DOI 10.1002/syn.20514; NAGAMOTO HT, 1989, BIOL PSYCHIAT, V25, P549, DOI 10.1016/0006-3223(89)90215-1; Nishihara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106553; Nishihara M, 2011, NEUROSCI RES, V71, P145, DOI 10.1016/j.neures.2011.07.004; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Otsuru N, 2012, PSYCHOPHARMACOLOGY, V224, P327, DOI 10.1007/s00213-012-2757-2; Potter D, 2006, SCHIZOPHRENIA BULL, V32, P692, DOI 10.1093/schbul/sbj050; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Smith DM, 2013, CLIN NEUROPHYSIOL, V124, P1329, DOI 10.1016/j.clinph.2013.02.004; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Yamashiro K, 2011, PSYCHOPHYSIOLOGY, V48, P23, DOI 10.1111/j.1469-8986.2010.01038.x; Zaitsev AV, 2005, CEREB CORTEX, V15, P1178, DOI 10.1093/cercor/bhh218	50	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177747	10.1371/journal.pone.0177747	http://dx.doi.org/10.1371/journal.pone.0177747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542290	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400074
J	Friedrichs-Maeder, CL; Griffa, A; Schneider, J; Huppi, PS; Truttmann, A; Hagmann, P				Friedrichs-Maeder, Cecilia L.; Griffa, Alessandra; Schneider, Juliane; Huppi, Petra Susan; Truttmann, Anita; Hagmann, Patric			Exploring the role of white matter connectivity in cortex maturation	PLOS ONE			English	Article							DIFFUSION MRI TRACTOGRAPHY; HUMAN CORTICAL DEVELOPMENT; CEREBRAL-CORTEX; HUMAN BRAIN; GRAY-MATTER; PERIVENTRICULAR LEUKOMALACIA; ELECTRICAL-ACTIVITY; WATER DIFFUSION; NERVOUS-SYSTEM; INFANT BRAIN	The maturation of the cortical gray matter (GM) and white matter (WM) are described as sequential processes following multiple, but distinct rules. However, neither the mechanisms driving brain maturation processes, nor the relationship between GM and WM maturation are well understood. Here we use connectomics and two MRI measures reflecting maturation related changes in cerebral microstructure, namely the Apparent Diffusion Coefficient (ADC) and the T1 relaxation time (T1), to study brain development. We report that the advancement of GM and WM maturation are inter-related and depend on the underlying brain connectivity architecture. Particularly, GM regions and their incident WM connections show corresponding maturation levels, which is also observed for GM regions connected through a WM tract. Based on these observations, we propose a simple computational model supporting a key role for the connectome in propagating maturation signals sequentially from external stimuli, through primary sensory structures to higher order functional cortices.	[Friedrichs-Maeder, Cecilia L.; Griffa, Alessandra; Hagmann, Patric] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Griffa, Alessandra; Hagmann, Patric] Ecole Polytech Fed Lausanne, Signal Proc Lab LTSS, Lausanne, Switzerland; [Schneider, Juliane; Truttmann, Anita] CHU Vaudois, Dept Pediat, Clin Neonatol & Follow Up, Lausanne, Switzerland; [Schneider, Juliane] Univ Toronto, Hosp Sick Children, Div Neurol, Toronto, ON, Canada; [Huppi, Petra Susan] Univ Geneva, Dept Pediat, Div Dev & Growth, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Geneva	Friedrichs-Maeder, CL (corresponding author), CHU Vaudois, Dept Radiol, Lausanne, Switzerland.	ceciliamaeder@gmail.com	Huppi, Petra S/A-4079-2009; Schneider, Juliane/Q-4054-2018; Huppi, Petra/A-4079-2009	Huppi, Petra S/0000-0002-7383-6648; Griffa, Alessandra/0000-0003-1923-1653; Huppi, Petra/0000-0002-7063-4215	Swiss National Science Foundation [33CM30D124101, 51AU40_125759]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The research and authors were supported by the Swiss National Science Foundation (#33CM30D124101, #51AU40_125759).	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andiman SE, 2010, BRAIN PATHOL, V20, P803, DOI 10.1111/j.1750-3639.2010.00380.x; [Anonymous], NETWORKS AN INTRODUC; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ball G, 2013, P NATL ACAD SCI USA, V110, P9541, DOI 10.1073/pnas.1301652110; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P1397; BARKOVICH AJ, 1988, RADIOLOGY, V166, P173, DOI 10.1148/radiology.166.1.3336675; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bewick Viv, 2004, Crit Care, V8, P196, DOI 10.1186/cc2857; Brodmann K, 1909, VERGLEICHENDE LOKALI; Chittajallu R, 2010, NAT NEUROSCI, V13, P1240, DOI 10.1038/nn.2639; Conel JL, 1939, THE POSTNATAL DEVELO, V1; Croteau-Chonka EC, 2016, NEUROIMAGE, V125, P413, DOI 10.1016/j.neuroimage.2015.10.038; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; de Reus MA, 2013, NEUROIMAGE, V70, P402, DOI 10.1016/j.neuroimage.2012.12.066; Dean JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004669; deIpolyi AR, 2005, NEUROIMAGE, V27, P579, DOI 10.1016/j.neuroimage.2005.04.027; Deoni SCL, 2015, NEUROIMAGE, V115, P147, DOI 10.1016/j.neuroimage.2015.04.058; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Deoni SCL, 2011, J NEUROSCI, V31, P784, DOI 10.1523/JNEUROSCI.2106-10.2011; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Dubowitz L M, 1980, Brain Dev, V2, P3; Flechsig PE, 1920, THIEME G, V1; French L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001049; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gilmore JH, 2012, CEREB CORTEX, V22, P2478, DOI 10.1093/cercor/bhr327; Giorgio A, 2008, NEUROIMAGE, V39, P52, DOI 10.1016/j.neuroimage.2007.07.043; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldman-Rakic PSRP, 1984, CEREBRAL DOMINANCE B, P179; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Guillery RW, 2005, TRENDS NEUROSCI, V28, P512, DOI 10.1016/j.tins.2005.08.006; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hanganu-Opatz IL, 2010, BRAIN RES REV, V64, P160, DOI 10.1016/j.brainresrev.2010.03.005; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hirata A, 2010, J NEUROPHYSIOL, V103, P1147, DOI 10.1152/jn.00955.2009; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Huppi PS, 1998, PEDIATR RES, V44, P584; Jeon T, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fhana.2015.00158, 10.3389/fnana.2015.00158]; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Kaas JH, 2001, CURR OPIN NEUROBIOL, V11, P498, DOI 10.1016/S0959-4388(00)00240-3; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; Kidokoro H, 2014, PEDIATRICS, V134, pE444, DOI 10.1542/peds.2013-2336; Kilb W, 2011, EUR J NEUROSCI, V34, P1677, DOI 10.1111/j.1460-9568.2011.07878.x; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Kiss JZ, 2014, CURR OPIN NEUROL, V27, P133, DOI 10.1097/WCO.0000000000000068; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kulikova S, 2015, BRAIN STRUCT FUNCT, V220, P3657, DOI 10.1007/s00429-014-0881-y; Kunz N, 2014, NEUROIMAGE, V96, P288, DOI 10.1016/j.neuroimage.2014.03.057; Leipsic P. F. O., 1901, LANCET, V158, P1027, DOI [10.1016/S0140-6736(01)01429-5, DOI 10.1016/S0140-6736(01)01429-5]; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Leroy F, 2011, J NEUROSCI, V31, P1500, DOI 10.1523/JNEUROSCI.4141-10.2011; Levine D, 1999, RADIOLOGY, V210, P751, DOI 10.1148/radiology.210.3.r99mr47751; Lobel U, 2009, NEURORADIOLOGY, V51, P253, DOI 10.1007/s00234-008-0488-1; Marques JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069294; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Marret S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062683; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; Melbourne A, 2014, NEUROIMAGE, V89, P23, DOI 10.1016/j.neuroimage.2013.11.048; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nossin-Manor R, 2012, RADIOLOGY, V263, P510, DOI 10.1148/radiol.12110367; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Pujol J, 2006, NEUROLOGY, V66, P339, DOI 10.1212/01.wnl.0000201049.66073.8d; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Roalf DR, 2016, NEUROIMAGE, V125, P903, DOI 10.1016/j.neuroimage.2015.10.068; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Schmidt R, 2016, NEUROIMAGE, V124, P762, DOI 10.1016/j.neuroimage.2015.04.005; Schneider J, 2016, AM J NEURORADIOL, V37, P155, DOI 10.3174/ajnr.A4510; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Smyser TA, 2015, CEREB CORTEX, DOI DOI 10.1093/CERCOR/BHV164; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Steriade M, 1997, THALAMUS V 1 ORGANIS, V1; Stuber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Travis K, 2005, DEV NEUROSCI-BASEL, V27, P277, DOI 10.1159/000086707; Van Essen DC, 2005, PROG BRAIN RES, V149, P173, DOI 10.1016/S0079-6123(05)49013-5; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Wierenga LM, 2016, HUM BRAIN MAPP, V37, P717, DOI 10.1002/hbm.23062; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Zalesky A, 2016, NEUROIMAGE, V142, P397, DOI 10.1016/j.neuroimage.2016.06.035; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	101	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177466	10.1371/journal.pone.0177466	http://dx.doi.org/10.1371/journal.pone.0177466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545040	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700051
J	Forder, L; He, X; Franklin, A				Forder, Lewis; He, Xun; Franklin, Anna			Colour categories are reflected in sensory stages of colour perception when stimulus issues are resolved	PLOS ONE			English	Article							RIGHT VISUAL-FIELD; SPATIAL ATTENTION; VISION; LANGUAGE; COMPONENTS; GREEN; HUES; RED; ERP	Debate exists about the time course of the effect of colour categories on visual processing. We investigated the effect of colour categories for two groups who differed in whether they categorised a blue-green boundary colour as the same-or different-category to a reliably-named blue colour and a reliably-named green colour. Colour differences were equated in just-noticeable differences to be equally discriminable. We analysed event-related potentials for these colours elicited on a passive visual oddball task and investigated the time course of categorical effects on colour processing. Support for category effects was found 100 ms after stimulus onset, and over frontal sites around 250 ms, suggesting that colour naming affects both early sensory and later stages of chromatic processing.	[Forder, Lewis; Franklin, Anna] Univ Sussex, Sch Psychol, Sussex Colour Grp, Falmer, England; [He, Xun] Bournemouth Univ, Cognit & Cognit Neurosci Res Ctr, Dept Psychol, Poole, Dorset, England	University of Sussex; Bournemouth University	Franklin, A (corresponding author), Univ Sussex, Sch Psychol, Sussex Colour Grp, Falmer, England.	anna.franklin@sussex.ac.uk	He, Xun/AAH-3641-2019; Franklin, Anna/B-5812-2017	Forder, Lewis/0000-0002-2119-1219; He, Xun/0000-0002-0558-0433; Franklin, Anna/0000-0003-2201-4377	European Research Council [283605]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by a European Research Council Starting Grant (project "CATEGORIES") 283605 (to AF) .http://erc.europa.eu/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androulaki A, 2006, J GREEK LINGUIST, V7, P3; Anllo-Vento L, 1998, HUM BRAIN MAPP, V6, P216, DOI 10.1002/(SICI)1097-0193(1998)6:4<216::AID-HBM3>3.0.CO;2-6; Athanasopoulos P, 2010, COGNITION, V116, P437, DOI 10.1016/j.cognition.2010.05.016; Bird CM, 2014, P NATL ACAD SCI USA, V111, P4590, DOI 10.1073/pnas.1315275111; Boutonnet B, 2015, J NEUROSCI, V35, P9329, DOI 10.1523/JNEUROSCI.5111-14.2015; BOYNTON RM, 1990, VISION RES, V30, P1311, DOI 10.1016/0042-6989(90)90005-6; Brouwer GJ, 2013, J NEUROSCI, V33, P15454, DOI 10.1523/JNEUROSCI.2472-13.2013; Brown AM, 2011, J VISION, V11, DOI 10.1167/11.12.2; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Clifford A, 2012, BRAIN COGNITION, V80, P126, DOI 10.1016/j.bandc.2012.04.011; Clifford A, 2010, BIOL PSYCHOL, V85, P275, DOI 10.1016/j.biopsycho.2010.07.014; Czigler I, 2004, NEUROSCI LETT, V364, P149, DOI 10.1016/j.neulet.2004.04.048; Czigler I, 2002, PSYCHOPHYSIOLOGY, V39, P869, DOI 10.1111/1469-8986.3960869; Czigler I., 2013, BRAIN TOPOGR; Czigler I, 2007, J PSYCHOPHYSIOL, V21, P224, DOI 10.1027/0269-8803.21.34.224; Daoutis CA, 2006, VIS COGN, V14, P217, DOI 10.1080/13506280500158670; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Drivonikou GV, 2007, P NATL ACAD SCI USA, V104, P1097, DOI 10.1073/pnas.0610132104; Dunn BR, 1998, BRAIN COGNITION, V36, P355, DOI 10.1006/brcg.1998.0998; Fletcher RJ, 1980, CITY U COLOUR VISION; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fonteneau E, 2007, NEUROREPORT, V18, P1323, DOI 10.1097/WNR.0b013e3282c48c33; Gilbert AL, 2006, P NATL ACAD SCI USA, V103, P489, DOI 10.1073/pnas.0509868103; HE JC, 1995, VISION RES, V35, P2579, DOI 10.1016/0042-6989(95)00007-M; He X, 2014, J OPT SOC AM A, V31, pA322, DOI 10.1364/JOSAA.31.00A322; Hill B, 1997, ACM T GRAPHIC, V16, P109, DOI 10.1145/248210.248212; Holmes A, 2009, BRAIN COGNITION, V69, P426, DOI 10.1016/j.bandc.2008.09.003; Ishihara S., 1987, ISHIHARA TEST COLOUR; Jameson KA, 2001, PSYCHON B REV, V8, P244, DOI 10.3758/BF03196159; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; JORDAN G, 1995, VISION RES, V35, P613, DOI 10.1016/0042-6989(94)00153-D; Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100; Kay P, 1999, AM ANTHROPOL, V101, P743, DOI 10.1525/aa.1999.101.4.743; Kranjec A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098604; Lindsey DT, 2014, J VISION, V14, DOI 10.1167/14.2.17; Luck S.J., 2005, INTRO EVENT RELATED; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Lupyan G, 2015, REV PHILOS PSYCHOL, V6, P547, DOI 10.1007/s13164-015-0253-4; Lupyan G, 2013, P NATL ACAD SCI USA, V110, P14196, DOI 10.1073/pnas.1303312110; Linhares JMM, 2008, J OPT SOC AM A, V25, P2918, DOI 10.1364/JOSAA.25.002918; Macpherson F, 2015, REV PHILOS PSYCHOL, V6, P571, DOI 10.1007/s13164-015-0254-3; MAHNY M, 1994, COLOR RES APPL, V19, P105; Malkoc G, 2005, J OPT SOC AM A, V22, P2154, DOI 10.1364/JOSAA.22.002154; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; Otake S, 2000, J OPT SOC AM A, V17, P615, DOI 10.1364/JOSAA.17.000615; Persichetti AS, 2015, J VISION, V15, DOI 10.1167/15.6.18; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pylyshyn Z, 1999, BEHAV BRAIN SCI, V22, P341, DOI 10.1017/S0140525X99002022; Regier T, 2005, P NATL ACAD SCI USA, V102, P8386, DOI 10.1073/pnas.0503281102; Roberson D, 2005, COGNITIVE PSYCHOL, V50, P378, DOI 10.1016/j.cogpsych.2004.10.001; Sharpe LT, 1998, J NEUROSCI, V18, P10053; Thierry G, 2009, P NATL ACAD SCI USA, V106, P4567, DOI 10.1073/pnas.0811155106; Webster MA, 2000, J OPT SOC AM A, V17, P1545, DOI 10.1364/JOSAA.17.001545; Webster MA, 2002, J OPT SOC AM A, V19, P1951, DOI 10.1364/JOSAA.19.001951; Winawer J, 2007, P NATL ACAD SCI USA, V104, P7780, DOI 10.1073/pnas.0701644104; Witzel C, 2015, J VISION, V15, DOI 10.1167/15.8.22; Witzel C, 2013, J VISION, V13, DOI 10.1167/13.7.1; Wright O, 2015, Q J EXP PSYCHOL, V68, P745, DOI 10.1080/17470218.2014.966123; Wright O, 2011, NEW DIRECTIONS IN COLOUR STUDIES, P265	60	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178097	10.1371/journal.pone.0178097	http://dx.doi.org/10.1371/journal.pone.0178097			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542426	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000402062800044
J	Mellisho, EA; Velasquez, AE; Nunez, MJ; Cabezas, JG; Cueto, JA; Fader, C; Castro, FO; Rodriguez-Alvarez, L				Mellisho, Edwin A.; Velasquez, Alejandra E.; Nunez, Maria J.; Cabezas, Joel G.; Cueto, Juan A.; Fader, Claudio; Castro, Fidel O.; Rodriguez-Alvarez, Lleretny			Identification and characteristics of extracellular vesicles from bovine blastocysts produced in vitro	PLOS ONE			English	Article							MULTIVESICULAR BODIES; AUTOPHAGY; EXOSOMES; VIVO	Extracellular vesicles (EVs) have been identified within different body fluids and cell culture media. However, there is very little information on the secretion of these vesicles during early embryonic development. The aims of this work were first to demonstrate the secretion of extracellular vesicles by pre-implantation bovine embryos and second to identify and characterize the population of EVs secreted by bovine blastocysts during the period from day seven to nine of embryo culture and its correlation with further embryo development up to day 11. Bovine embryos were produced by in vitro fertilization (IVF) or parthenogenetic activation (PA) and cultured until blastocyst stage. Blastocyst selection was performed at day 7 post IVF/PA considering two variables: stage of development and quality of embryos. Selected blastocysts were cultured in vitro for 48 hours in groups (exp. 1) or individually (exp. 2) in SOF media depleted of exosomes. At day 9 post IVF/PA the media was collected and EVs isolated by ultracentrifugation. Transmission electron microscopy revealed the presence of heterogeneous vesicles of different sizes and population: microvesicles (MVs) and exosomes (EXs) of rounded shape, enclosed by a lipid bi-layer and ranging from 30 to 385 nm of diameter. Flow cytometry analysis allowed identifying CD63 and CD9 proteins as exosome markers. Nanoparticle tracking analysis generated a large number of variables, which required the use of multivariate statistics. The results indicated that the concentration of vesicles is higher in those blastocysts with arrested development from day 9 up to day 11 of in vitro development (6.7 x 10(8) particles/ml) derived from IVF (p < 0.05), compared to PA blastocysts (4.7 x 10(8) particles/ml). Likewise, the profile (concentration and diameter) of particles secreted by embryos derived from IVF were different from those secreted by PA embryos. In conclusion, we demonstrated that bovine blastocysts secrete MVs/EXs to the culture media. Data suggest that characteristics of the population of EVs vary depending on embryo competence.	[Mellisho, Edwin A.; Velasquez, Alejandra E.; Nunez, Maria J.; Cabezas, Joel G.; Castro, Fidel O.; Rodriguez-Alvarez, Lleretny] Univ Concepcion, Dept Anim Sci, Fac Vet Sci, Lab Anim Biotechnol, Concepcion, Chile; [Cueto, Juan A.; Fader, Claudio] Natl Univ Cuyo, Lab Cell & Mol Biol, IHEM CONICET, Fac Med Sci, Mendoza, Argentina	Universidad de Concepcion; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Rodriguez-Alvarez, L (corresponding author), Univ Concepcion, Dept Anim Sci, Fac Vet Sci, Lab Anim Biotechnol, Concepcion, Chile.	llrodriguez@udec.cl	Mellisho, Edwin ALBERTO/Z-2570-2019; Mellisho, Edwin A./A-4986-2012; Rodriguez-Alvarez, Lleretny/AAH-9420-2019	Mellisho, Edwin ALBERTO/0000-0001-7171-1991; Rodriguez-Alvarez, Lleretny/0000-0003-4364-1097; Cabezas, Joel/0000-0001-8931-2630	Fondef IdeA [15110178]; Conicyt	Fondef IdeA(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Fondef IdeA ID15110178, Conicyt, http://www.conicyt.cl/fondef/lineas-de-programa/instrumentos-vigentes/programa-Idea/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baixauli F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00403; Braicu C, 2015, CELL DEATH DIFFER, V22, P34, DOI 10.1038/cdd.2014.130; Brandao DO, 2004, BIOL REPROD, V71, P2048, DOI 10.1095/biolreprod.103.025916; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Ferreira YJ, 2013, SESSION 66 EMBRYO QU, V28, P1445, DOI DOI 10.1093/HUMREP/DET200); Gedye CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105602; Hoog JL, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28680; Kawamura N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2069; Klumperman J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016857; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Melo RCN, 2014, NAT PROTOC, V9, P2382, DOI 10.1038/nprot.2014.163; Mulvey HE, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1568-3; Peterson MF, 2015, METHODS, V87, P31, DOI 10.1016/j.ymeth.2015.04.015; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rodriguez L, 2008, J ASSIST REPROD GEN, V25, P13, DOI 10.1007/s10815-007-9194-x; Saadeldin IM, 2015, STEM CELLS CLONING, V8, P103, DOI 10.2147/SCCAA.S84991; Saadeldin IM, 2014, CELL REPROGRAM, V16, P223, DOI 10.1089/cell.2014.0003; Tannetta D, 2014, CELL MOL IMMUNOL, V11, P548, DOI 10.1038/cmi.2014.42; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Velasquez AE, 2016, ZYGOTE, V24, P18, DOI 10.1017/S0967199414000677; Yang Qiwei, 2016, J Clin Epigenet, V2; Yonekawa T, 2013, ESSAYS BIOCHEM, V55, P105, DOI [10.1042/BSE0550105, 10.1042/bse0550105]	30	56	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178306	10.1371/journal.pone.0178306	http://dx.doi.org/10.1371/journal.pone.0178306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542562	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800069
J	Park, SL; Murphy, SE; Wilkens, LR; Stram, DO; Hecht, SS; Le Marchand, L				Park, Sungshim L.; Murphy, Sharon E.; Wilkens, Lynne R.; Stram, Daniel O.; Hecht, Stephen S.; Le Marchand, Loic			Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study	PLOS ONE			English	Article							TOBACCO-SPECIFIC CARCINOGEN; GENETIC POLYMORPHISMS; ETHNIC/RACIAL GROUPS; NICOTINE METABOLISM; SMOKING-BEHAVIOR; DIFFERENT RISKS; CYTOCHROME-P450; DETERMINANTS; POPULATIONS; REDUCTION	While smoking is the primary cause of lung cancer, only 11-24% of smokers develop the malignancy over their lifetime. The primary addictive agent in tobacco smoke is nicotine and variation in nicotine metabolism may influence the smoking levels of an individual. Therefore, inter-individual variation in lung cancer risk among smokers may be due in part to differences in the activity of enzymes involved in nicotine metabolism. In most smokers, cytochrome P450 2A6 (CYP2A6)-catalyzed C-oxidation accounts for >75% of nicotine metabolism, and the activity of this enzyme has been shown to correlate with the amount of nicotine and carcinogens drawn from cigarettes. We prospectively evaluated the association of urinary biomarkers of nicotine uptake (total nicotine equivalents [TNE]) and CYP2A6 activity (ratio of urinary total trans-30-hydroxycotinine to cotinine) with lung cancer risk among 2,309 Multiethnic Cohort Study participants who were current smokers at time of urine collection; 92 cases were diagnosed during a mean follow-up of 9.5 years. We found that higher CYP2A6 activity and TNE was associated with increased lung cancer risk after adjusting for age, sex, race/ ethnicity, body mass index, smoking duration, and urinary creatinine (p's = 0.002). The association for CYP2A6 activity remained even after adjusting for self-reported cigarettes per day (CPD) (Hazard Ratio [HR] per unit increase in log-CYP2A6 activity = 1.52; p = 0.005) and after adjusting for TNE (HR = 1.46; p = 0.01). In contrast, the association between TNE and lung cancer risk was of borderline statistical significance when adjusted for CPD (HR = 1.53; p = 0.06) and not statistically significant when further adjusted for CYP2A6 activity (HR = 1.30; p = 0.22). These findings suggest that CYP2A6 activity provides information on lung cancer risk that is not captured by smoking history or a (short-term) biomarker of dose. CYP2A6 activity should be further studied as a risk biomarker for smoking-related lung cancer.	[Park, Sungshim L.; Stram, Daniel O.; Hecht, Stephen S.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90007 USA; [Murphy, Sharon E.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Wilkens, Lynne R.; Le Marchand, Loic] Univ Hawaii, Canc Ctr, Epidemiol Program, Honolulu, HI 96822 USA	University of Southern California; University of Minnesota System; University of Minnesota Twin Cities; Cancer Research Center of Hawaii; University of Hawaii System	Park, SL (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90007 USA.; Le Marchand, L (corresponding author), Univ Hawaii, Canc Ctr, Epidemiol Program, Honolulu, HI 96822 USA.	sungship@usc.edu; Loic@cc.hawaii.edu			National Institute of Health/National Cancer Institute [5P01CA138338, P30CA014089, UM1CA164973]; NATIONAL CANCER INSTITUTE [P30CA077598, P01CA138338, P30CA071789] Funding Source: NIH RePORTER	National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health/National Cancer Institute, grant numbers: 5P01CA138338, P30CA014089, and UM1CA164973. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz NL, 2002, J NATL CANCER I, V94, P108, DOI 10.1093/jnci/94.2.108; Derby KS, 2008, CANCER EPIDEM BIOMAR, V17, P3526, DOI 10.1158/1055-9965.EPI-08-0424; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fujieda M, 2004, CARCINOGENESIS, V25, P2451, DOI 10.1093/carcin/bgh258; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; IARC, 2004, IARC MON EV CARC RIS, p[79, 557]; Jalas JR, 2005, CHEM RES TOXICOL, V18, P95, DOI 10.1021/tx049847p; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Liu T, 2013, ENVIRON MOL MUTAGEN, V54, P133, DOI 10.1002/em.21751; Loriot MA, 2001, PHARMACOGENETICS, V11, P39, DOI 10.1097/00008571-200102000-00005; Murphy SE, 2014, CARCINOGENESIS, V35, P2526, DOI 10.1093/carcin/bgu191; Nakajima M, 2007, CURR OPIN MOL THER, V9, P538; Nakajima M, 2006, CLIN PHARMACOL THER, V80, P282, DOI 10.1016/j.clpt.2006.05.012; Park SL, 2016, CARCINOGENESIS, V37, P269, DOI 10.1093/carcin/bgw012; Patel Y, 2014, CANC EPIDEMIOLOGY BI; Patel YM, 2016, CANC RES; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Spitz MR, 2006, CANC EPIDEMIOLOGY PR, P638; Strasser AA, 2011, CANCER EPIDEM BIOMAR, V20, P234, DOI 10.1158/1055-9965.EPI-10-0674; Tan W, 2001, INT J CANCER, V95, P96, DOI 10.1002/1097-0215(20010320)95:2&lt;96::AID-IJC1017&gt;3.0.CO;2-2; Wang HJ, 2003, CANCER RES, V63, P8057; Wassenaar CA, 2015, CARCINOGENESIS, V36, P99, DOI 10.1093/carcin/bgu235; Wassenaar CA, 2011, J NATL CANCER I, V103, P1342, DOI 10.1093/jnci/djr237; Yuan JM, 2016, INT J CANCER, V138, P2161, DOI 10.1002/ijc.29963	25	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178435	10.1371/journal.pone.0178435	http://dx.doi.org/10.1371/journal.pone.0178435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542511	Green Published, gold			2022-12-27	WOS:000402062800089
J	Willems, H; Jacobs, A; Hadiwikarta, WW; Venken, T; Valkenborg, D; Van Roy, N; Vandesompele, J; Hooyberghs, J				Willems, Hanny; Jacobs, An; Hadiwikarta, Wahyu Wijaya; Venken, Tom; Valkenborg, Dirk; Van Roy, Nadine; Vandesompele, Jo; Hooyberghs, Jef			Thermodynamic framework to assess low abundance DNA mutation detection by hybridization	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; TARGETED THERAPY; MICROARRAYS; KRAS; PARAMETERS	The knowledge of genomic DNA variations in patient samples has a high and increasing value for human diagnostics in its broadest sense. Although many methods and sensors to detect or quantify these variations are available or under development, the number of underlying physico-chemical detection principles is limited. One of these principles is the hybridization of sample target DNA versus nucleic acid probes. We introduce a novel thermodynamics approach and develop a framework to exploit the specific detection capabilities of nucleic acid hybridization, using generic principles applicable to any platform. As a case study, we detect point mutations in the KRAS oncogene on a microarray platform. For the given platform and hybridization conditions, we demonstrate the multiplex detection capability of hybridization and assess the detection limit using thermodynamic considerations; DNA containing point mutations in a background of wild type sequences can be identified down to at least 1% relative concentration. In order to show the clinical relevance, the detection capabilities are confirmed on challenging formalin-fixed paraffin-embedded clinical tumor samples. This enzyme-free detection framework contains the accuracy and efficiency to screen for hundreds of mutations in a single run with many potential applications in molecular diagnostics and the field of personalised medicine.	[Willems, Hanny; Jacobs, An; Hadiwikarta, Wahyu Wijaya; Venken, Tom; Valkenborg, Dirk; Hooyberghs, Jef] VITO, Flemish Inst Technol Res, Mol, Belgium; [Hadiwikarta, Wahyu Wijaya] KULeuven, Inst Theoret Phys, Leuven, Belgium; [Valkenborg, Dirk] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium; [Van Roy, Nadine; Vandesompele, Jo] Univ Ghent, CMGG, Ghent, Belgium; [Vandesompele, Jo] Univ Ghent, CRIG, Ghent, Belgium; [Hooyberghs, Jef] Hasselt Univ, Theoret Phys, Diepenbeek, Belgium	VITO; KU Leuven; Hasselt University; Ghent University; Ghent University; Hasselt University	Hooyberghs, J (corresponding author), VITO, Flemish Inst Technol Res, Mol, Belgium.; Hooyberghs, J (corresponding author), Hasselt Univ, Theoret Phys, Diepenbeek, Belgium.	jef.hooyberghs@vito.be	Vandesompele, Jo/W-3411-2018	Vandesompele, Jo/0000-0001-6274-0184; Willems, Hanny/0000-0001-9848-1997; VALKENBORG, Dirk/0000-0002-1877-3496; Venken, Tom/0000-0003-0773-1810				Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Ben-Yoav H, 2015, BIOSENS BIOELECTRON, V64, P579, DOI 10.1016/j.bios.2014.09.069; Burden CJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016004; Camp ER, 2015, CLIN CANCER RES, V21, P3578, DOI 10.1158/1078-0432.CCR-14-2900; Carlon E, 2006, PHYSICA A, V362, P433, DOI 10.1016/j.physa.2005.09.067; Cornett EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055919; Fuchs J, 2010, BIOPHYS J, V99, P1886, DOI 10.1016/j.bpj.2010.07.002; Gaudet M, 2009, METHODS MOL BIOL, V578, P415, DOI 10.1007/978-1-60327-411-1_26; Ginot F, 1997, HUM MUTAT, V10, P1; Hadiwikarta WW, 2015, BIOSENS BIOELECTRON, V64, P411, DOI 10.1016/j.bios.2014.09.043; Hadiwikarta WW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks475; Hadiwikarta WW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt682; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; Harrison A, 2013, NUCLEIC ACIDS RES, V41, P2779, DOI 10.1093/nar/gks1358; Hooyberghs J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.012901; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; Hooyberghs J, 2010, BIOSENS BIOELECTRON, V26, P1692, DOI 10.1016/j.bios.2010.07.039; Irving D, 2010, J PHYS CHEM B, V114, P7631, DOI 10.1021/jp100860z; Joda H, 2015, ANAL BIOCHEM, V474, P66, DOI 10.1016/j.ab.2014.11.021; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Noguera DR, 2014, APPL MICROBIOL BIOT, V98, P9595, DOI 10.1007/s00253-014-6165-x; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Stancescu M, 2016, J AM CHEM SOC, V138, P13465, DOI 10.1021/jacs.6b05628; Trapp C, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-20; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; van Grinsven B, 2011, LAB CHIP, V11, P1656, DOI 10.1039/c1lc20027e; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Wei BM, 2015, ANAL CHEM, V87, P2058, DOI 10.1021/ac504797e	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177384	10.1371/journal.pone.0177384	http://dx.doi.org/10.1371/journal.pone.0177384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542229	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800016
J	Buchet, A; Belloc, C; Leblanc-Maridor, M; Merlot, E				Buchet, Arnaud; Belloc, Catherine; Leblanc-Maridor, Mily; Merlot, Elodie			Effects of age and weaning conditions on blood indicators of oxidative status in pigs	PLOS ONE			English	Article							LIPPIA-CITRIODORA VERBASCOSIDE; GROWTH-PERFORMANCE; PLASMA-CONCENTRATIONS; ANTIOXIDANT STATUS; VITAMIN-E; STRESS; PIGLETS; TOCOPHERYL; RESPONSES; OXIDANTS	Weaning is a source of social, nutritional and environmental disorders that challenge piglet health. This study assesses the relevance of using plasma indicators of oxidative status as biomarkers of health around weaning in pigs. Blood antioxidant potential (BAP), hydroperoxides (HPO), oxidative stress index (OSI, e.g. HPO/BAP), vitamin A and E concentrations were investigated in two different trials. Trial A was carried out in an experimental unit to investigate the effects of age (from 12 to 147 days of age), weaning (at 21 or 28 days of age) and management at weaning (in optimal (OC) or deteriorated (DC) conditions) on those parameters. Trial B was performed in 16 commercial pig farms to describe the variability of these indicators on field between 26 and 75 days of age. In trial A, between 12 and 147 days of age, HPO globally increased (P < 0.001), vitamin E concentration decreased (P < 0.001) whereas BAP and vitamin A concentration remained relatively stable (P > 0.1). Vitamins E and A concentrations dropped 5 days after weaning independently of weaning age, weaning conditions and expression of diarrhea (P < 0.001). Twelve days after weaning, whatever the weaning age, HPO and OSI increased in DC compared to OC piglets (P = 0.05 and P < 0.01) and in piglets exhibiting diarrhea compared to those without diarrhea (P < 0.01 and P < 0.001). In DC pigs, BAP was also decreased (P < 0.05) 12 days after weaning. On trial B, plasma concentrations of vitamins A and E decreased and HPO increased 5 and 19 days respectively after weaning (P < 0,001). Contrarily to trial A, BAP values did not drop after weaning. Piglets which had the lowest ADG (Average Daily Gain) after weaning had greater HPO and OSI and lower vitamin A and E concentrations after weaning but also lower vitamin E concentration before weaning (P < 0.05). In conclusion, HPO or OSI seem to be good indicators of health disorders around weaning and plasma concentration of vitamin E before weaning is associated to growth after weaning.	[Buchet, Arnaud; Merlot, Elodie] INRA, Agrocampus Ouest, PEGASE, St Gilles, France; [Buchet, Arnaud] Cooperl Arc Atlantique, Lamballe, France; [Buchet, Arnaud; Belloc, Catherine; Leblanc-Maridor, Mily] INRA, ONIRIS, BIOEPAR, Nantes, France	INRAE; Institut Agro; Agrocampus Ouest; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Buchet, A (corresponding author), INRA, Agrocampus Ouest, PEGASE, St Gilles, France.; Buchet, A (corresponding author), Cooperl Arc Atlantique, Lamballe, France.; Buchet, A (corresponding author), INRA, ONIRIS, BIOEPAR, Nantes, France.	arnaud.buchet@inra.fr	Merlot, Elodie/AAQ-8761-2020	Merlot, Elodie/0000-0003-2300-0970	Integrated Management of Animal Health metaprogram of INRA for the "GISA-SEVROBUST" project; Cooperl Arc Atlantique	Integrated Management of Animal Health metaprogram of INRA for the "GISA-SEVROBUST" project; Cooperl Arc Atlantique	Authors gratefully thank A. Lacoste, B. Lieubeau, J. Herve, G. Mignot P. Mormede, JN. Sialelli and E. Terenina for their scientific contributions to the project, N. Le Floc'h for its critical advices on the manuscript and JY. Audiard, D. Boutin, B. Carrissant, R. Comte, S. Dare A, J. Delamarre, H. Demay, B. Duteil, F. Guerin, P. Knapen, A. Lecorgne, M. Lefebvre, G. Martin, N. Meziere, H. Renoult, P. Roger, Y. Surel, F. Thomas and P. Touanel for their technical assistance in lab and animal care and all pig producers who participated to this experiment. This experiment was supported by a grant from the Integrated Management of Animal Health metaprogram of INRA for the "GISA-SEVROBUST" project (www.gisa.inra.fr/en). and Cooperl Arc Atlantique. Cooperl Arc Atlantique provided support in the form of salaries for authors [AB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This experiment was supported by a grant from the Integrated Management of Animal Health metaprogram of INRA for the "GISA-SEVROBUST" project (www.gisainra.frien).and Cooperl Arc Atlantique. Cooperl Arc Atlantique provided support in the form of salaries for authors [AB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian A, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0097-5; Alberti A, 2000, RES CHEM INTERMEDIAT, V26, P253, DOI 10.1163/156856700X00769; bacterial types, 2005, ANIM HEALTH RES REV, V6, P17; BARK LJ, 1986, J ANIM SCI, V62, P1233, DOI 10.2527/jas1986.6251233x; Bates D, 2014, FITTING LINEAR MIXED; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Brambilla G, 2002, REDOX REP, V7, P159, DOI 10.1179/135100002125000406; Casamassima D, 2013, J ANIM FEED SCI, V22, P204, DOI 10.22358/jafs/65989/2013; Celi P, 2011, IMMUNOPHARM IMMUNOT, V33, P233, DOI 10.3109/08923973.2010.514917; Colson V, 2012, PHYSIOL BEHAV, V107, P59, DOI 10.1016/j.physbeh.2012.06.001; Corino C, 2007, ITAL J ANIM SCI, V6, P292, DOI 10.4081/ijas.2007.1s.292; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FUNDERBURKE DW, 1990, J ANIM SCI, V68, P155; Gyles CL, ESCHERICHIA COLI POS; Halliwell B., 2015, FREE RADICALS BIOL M; Jensen MS, 1997, J ANIM SCI, V75, P437; KAYDEN HJ, 1993, J LIPID RES, V34, P343; Lauridsen C, 2005, J ANIM SCI, V83, P1274; Lauridsen C, 2001, J NUTR BIOCHEM, V12, P219, DOI 10.1016/S0955-2863(00)00156-X; Lauritzen B, 2005, RES VET SCI, V79, P61, DOI 10.1016/j.rvsc.2004.09.011; Lenth RV, 2015, LSMEANS LEAST SQUARE; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; Madec F, 1998, PREV VET MED, V35, P53, DOI 10.1016/S0167-5877(97)00057-3; MCCRACKEN BA, 1995, J NUTR, V125, P2838; McCracken BA, 1999, J NUTR, V129, P613, DOI 10.1093/jn/129.3.613; Merlot E, 2012, ANIMAL, V6, P1290, DOI 10.1017/S1751731112000080; Moreira I, 2002, J ANIM SCI, V80, P663; Mutinati M, 2014, REPROD DOMEST ANIM, V49, P7, DOI 10.1111/rda.12230; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Oriani G, 2001, J NUTR BIOCHEM, V12, P138, DOI 10.1016/S0955-2863(00)00132-7; Palazzo M, 2011, ANIMAL, V5, P844, DOI 10.1017/S1751731110002569; Pastorelli G, 2012, CZECH J ANIM SCI, V57, P312, DOI 10.17221/6006-CJAS; Pluske J, 2003, WEANING THE PIG: CONCEPTS AND CONSEQUENCES, P15; R Core Team, 2015, LANG ENV STAT COMP; Royer E., 2016, Journees de la Recherche Porcine en France, V48, P341; Sauerwein H, 2007, J ANIM PHYSIOL AN N, V91, P369, DOI 10.1111/j.1439-0396.2006.00663.x; Sauerwein H, 2005, REDOX REP, V10, P295, DOI 10.1179/135100005X83725; Sharma RK, 1999, HUM REPROD, V14, P2801, DOI 10.1093/humrep/14.11.2801; Sivertsen T, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-1; Traber MG, 2012, MODERN NUTR HLTH DIS; Weary DM, 2008, APPL ANIM BEHAV SCI, V110, P24, DOI 10.1016/j.applanim.2007.03.025; Wilburn EE, 2008, J ANIM SCI, P86; Zhu LH, 2012, J ANIM SCI, V90, P2581, DOI [10.2527/jas.2011-4444, 10.2527/jas.2012-4444]	44	44	48	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178487	10.1371/journal.pone.0178487	http://dx.doi.org/10.1371/journal.pone.0178487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542567	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500086
J	Xu, MNA; Heidmarsson, S; Thorsteinsdottir, M; Eiriksson, FF; Omarsdottir, S; Olafsdottir, ES				Xu, Maonian; Heidmarsson, Starri; Thorsteinsdottir, Margret; Eiriksson, Finnur F.; Omarsdottir, Sesselja; Olafsdottir, Elin S.			DNA barcoding and LC-MS metabolite profiling of the lichen-forming genus Melanelia: Specimen identification and discrimination focusing on Icelandic taxa	PLOS ONE			English	Article							PARMELIACEAE LECANORALES; MONTANELIA PARMELIACEAE; SECONDARY METABOLITES; PARMELIOID LICHENS; ASCOMYCOTA; DIVERSITY; FAMILY; FUNGI; MS/MS; MELANOHALEA	Taxa in the genus Melanelia (Parmeliaceae, Ascomycota) belong to a group of saxicolous lichens with brown to black foliose thalli, which have recently undergone extensive changes in circumscription. Taxa belonging to Parmeliaceae are prolific producers of bioactive compounds, which have also been traditionally used for chemotaxonomic purposes. However, the chemical diversity of the genus Melanelia and the use of chemical data for species discrimination in this genus are largely unexplored. In addition, identification based on morphological characters is challenging due to few taxonomically informative characters. Molecular identification methods, such as DNA barcoding, have rarely been applied to this genus. This study aimed to identify the Melanelia species from Iceland using DNA barcoding approach, and to explore their chemical diversity using chemical profiling. Chemometric tools were used to see if lichen metabolite profiles determined by LC-MS could be used for the identification of Icelandic Melanelia species. Barcoding using the fungal nuclear ribosomal internal transcribed spacer region (nrITS) successfully identified three Melalenlia species occurring in Iceland, together with Montanelia disjuncta (Basionym: Melanelia disjuncta). All species formed monophyletic clades in the neighbor-joining nrITS gene tree. However, high intraspecific genetic distance of M. stygia suggests the potential of unrecognized species lineages. Principal component analysis (PCA) of metabolite data gave a holistic overview showing that M. hepatizon and M. disjuncta were distinct from the rest, without the power to separate M. agnata and M. stygia due to their chemical similarity. Orthogonal partial least-squares to latent structures-discriminate analysis (OPLS-DA), however, successfully distinguished M. agnata and M. stygia by identifying statistically significant metabolites, which lead to class differentiation. This work has demonstrated the potential of DNA barcoding, chemical profiling and chemometrics in identification of Melanelia species.	[Xu, Maonian; Thorsteinsdottir, Margret; Eiriksson, Finnur F.; Omarsdottir, Sesselja; Olafsdottir, Elin S.] Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland; [Heidmarsson, Starri] Iceland Inst Nat Hist, Akureyri Div, Akureyri, Iceland; [Thorsteinsdottir, Margret; Eiriksson, Finnur F.] ArcticMass, Reykjavik, Iceland	University of Iceland	Olafsdottir, ES (corresponding author), Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland.	elinsol@hi.is	Heiðmarsson, Starri/GVU-6467-2022; Heidmarsson, Starri/A-8305-2009; Olafsdottir, Elin Soffia/A-6946-2008	Heiðmarsson, Starri/0000-0003-0329-6882; Heidmarsson, Starri/0000-0003-0329-6882; Olafsdottir, Elin Soffia/0000-0001-7305-7129; Xu, Maonian/0000-0002-4346-8020	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA [606895]; Bergthora and Thorsteinn Scheving Thorsteinsson Fund	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA; Bergthora and Thorsteinn Scheving Thorsteinsson Fund	The study was financially supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement No. 606895 (http://cordis.europa.eu/project/rcn/109122_en.html) as well as a minor contribution from Bergthora and Thorsteinn Scheving Thorsteinsson Fund. The funders provided support in the form of salaries for author [MX], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section. The commercial affiliation Arctic Mass has no financial or competing interests in this study but two of the authors MT and FFE are partially affiliated there. Arctic Mass had the role of providing access to instruments (mass spectrometers) used in the study.	Arup U, 2007, MYCOLOGIA, V99, P42, DOI 10.3852/mycologia.99.1.42; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Blanco O, 2006, MOL PHYLOGENET EVOL, V39, P52, DOI 10.1016/j.ympev.2005.12.015; Blanco O, 2004, MYCOL RES, V108, P873, DOI 10.1017/S0953756204000723; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Crespo A, 2010, TAXON, V59, P1735, DOI 10.1002/tax.596008; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; CULBERSON WL, 1986, BRYOLOGIST, V89, P123, DOI 10.2307/3242752; DIVAKAR P.K, 2017, FUNGAL DIVERS, P1; Divakar PK, 2015, NEW PHYTOL, V208, P1217, DOI 10.1111/nph.13553; Divakar PK, 2012, AM J BOT, V99, P2014, DOI 10.3732/ajb.1200258; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elix J.A., 2001, AUSTRALASIAN LICHENO, V48, P6; ESSLINGER TL, 1978, MYCOTAXON, V7, P45; Fujimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023426; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Guzow-Krzeminska B, 2003, LICHENOLOGIST, V35, P83, DOI 10.1006/lich.2002.0429; HOLZMANN G, 1990, PHYTOCHEMISTRY, V29, P2277, DOI 10.1016/0031-9422(90)83052-3; Huneck S., 1996, IDENTIFICATION LICHE; Kelly LJ, 2011, NEW PHYTOL, V191, P288, DOI 10.1111/j.1469-8137.2011.03677.x; KRISTINSSON H, 1974, Lichenologist (London), V6, P141, DOI 10.1017/S0024282974000223; KRISTINSSON H, 1969, Bryologist, V72, P344; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Latkowska E, 2015, PHYTOCHEMISTRY, V118, P116, DOI 10.1016/j.phytochem.2015.08.016; Pogam P, 2015, ANAL CHEM, V87, P10421, DOI 10.1021/acs.analchem.5b02531; Leavitt SD, 2016, FUNGAL BIOL-UK, V120, P1374, DOI 10.1016/j.funbio.2016.06.001; Leavitt SD, 2015, MOL PHYLOGENET EVOL, V90, P85, DOI 10.1016/j.ympev.2015.04.029; Leavitt SD, 2014, ORG DIVERS EVOL, V14, P11, DOI 10.1007/s13127-013-0147-1; Leavitt SD, 2013, MOL PHYLOGENET EVOL, V66, P138, DOI 10.1016/j.ympev.2012.09.013; Liebeke M, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0615; Lumbsch HT, 1998, LICHENOLOGIST, V30, P357, DOI 10.1006/lich.1998.0147; McEvoy M, 2006, MYCOL PROG, V5, P221, DOI 10.1007/s11557-006-0514-9; Mittermeier VK, 2015, MOLECULES, V20, P18047, DOI 10.3390/molecules201018047; Musharraf SG, 2015, ANAL METHODS-UK, V7, P6066, DOI [10.1039/c5ay01091h, 10.1039/C5AY01091H]; Nelsen MP, 2011, LICHENOLOGIST, V43, P537, DOI 10.1017/S0024282911000508; Nylander J.A.A, 2004, MRMODELTEST V2; Parrot D, 2013, PHYTOCHEMISTRY, V89, P114, DOI 10.1016/j.phytochem.2013.02.002; Gomez-Serranillos MP, 2014, RSC ADV, V4, P59017, DOI 10.1039/c4ra09104c; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rossello-Mora R, 2008, ISME J, V2, P242, DOI 10.1038/ismej.2007.93; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Singh G, 2013, FUNGAL BIOL-UK, V117, P715, DOI 10.1016/j.funbio.2013.08.001; Spier L, 2007, LICHENOLOGIST, V39, P57, DOI 10.1017/S0024282906006517; Stocker-Worgotter E, 2004, BRYOLOGIST, V107, P152, DOI 10.1639/0007-2745(2004)107[0152:SCOLFC]2.0.CO;2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THELL A, 1995, NOVA HEDWIGIA, V60, P407; Thell A., 2011, NORDIC LICHEN FLORA, V4; Thi Huyen V, 2016, LICHENOL, V48, P323; Wang HY, 2009, MYCOTAXON, V107, P163, DOI 10.5248/107.163; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Xu MN, 2016, PHYTOMEDICINE, V23, P441, DOI 10.1016/j.phymed.2016.02.012	53	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178012	10.1371/journal.pone.0178012	http://dx.doi.org/10.1371/journal.pone.0178012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542495	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500053
J	Gonzalez-Jaranay, M; Tellez, L; Roa-Lopez, A; Gomez-Moreno, G; Moreu, G				Gonzalez-Jaranay, Maximino; Tellez, Luis; Roa-Lopez, Antonio; Gomez-Moreno, Gerardo; Moreu, Gerardo			Periodontal status during pregnancy and postpartum	PLOS ONE			English	Article							EXPERIMENTAL GINGIVITIS; HEALTH; WOMEN; DISEASE; HORMONES; PLAQUE; CPITN	Objectives Different studies have documented an association between periodontal disease and low birth-weight delivery. Hence, knowledge of periodontal status during pregnancy and postpartum is important in order to reduce the risks of both diseases. This study aimed to analyze periodontal status at successive stages of pregnancy and 3-6 weeks postpartum in women with initial periodontal alterations. Materials and methods Ninety-six pregnant women were examined at 8-10 weeks (pregnancy diagnosis, baseline), 21-23 weeks and 34-36 weeks of gestation and at 40 days postpartum to record plaque scores, clinically assessed gingival inflammation and probing depth (mean depth and % sites with depth > 3 mm). Bivariate and multivariate analyses were performed. Type 1 (alpha) error was established at 0.05 Results Plaque Index increased (p = 0.043) throughout pregnancy (baseline, 42%+/- 0.18); 21-23 weeks, 42.6%+/- 0.14; 34-36 weeks, 45.6%+/- 0.13 and decreased postpartum (44.8%+/- 0-13). Gingival Index increased (p < 0.001) throughout pregnancy (baseline, 56.7%+/- 0.20; 21-23 weeks, 66.36%+/- 0.17; 34-36 weeks, 74.5%+/- 0.18) and decreased postpartum (59.3% +/- 0.21). Probing Depth increased (p < 0.001) throughout pregnancy (baseline, 2.51 +/- 0.05; 21-23 weeks, 2.63 +/- 0.053; 34-36 weeks 2.81 +/- 0.055) and decreased postpartum (2.54 +/- 0.049). Percentage of sites with Probing Depth > 3 mm increased (p < 0.001) throughout pregnancy (baseline, 17.6%+/- 0.16; 21-23 weeks, 23.9%+/- 0.17; 34-36 weeks, 31.1%+/- 0.17) and decreased postpartum (21.2%+/- 0.17) but remained significantly (p < 0.02) higher than at baseline. Conclusion Periodontal status deteriorates during gestation but improves postpartum.	[Gonzalez-Jaranay, Maximino; Tellez, Luis; Roa-Lopez, Antonio; Gomez-Moreno, Gerardo; Moreu, Gerardo] Univ Granada, Dept Periodontol, Fac Dent, Granada, Spain	University of Granada	Moreu, G (corresponding author), Univ Granada, Dept Periodontol, Fac Dent, Granada, Spain.	gmoreu@ugr.es	López, Antonio Roa/R-2430-2019	López, Antonio Roa/0000-0001-7486-0933				Abraham-Inpijn L, 1996, Stomatologiia (Mosk), V75, P15; AINAMO J, 1975, INT DENT J, V25, P229; Amar S, 2000, PERIODONTOL, V1994, P79; BRABIN BJ, 1985, REV INFECT DIS, V7, P579; Chung LH, 2014, COMMUNITY DENT ORAL, V42, P151, DOI 10.1111/cdoe.12075; COHEN DW, 1969, J PERIODONTOL, V40, P563, DOI 10.1902/jop.1969.40.10.563; Consensus report, 1996, ANN PERIODONTOL, V1, P390; Cruz SS, 2009, COMMUNITY DENT ORAL, V37, P527, DOI 10.1111/j.1600-0528.2009.00492.x; Culhane J F, 2001, Matern Child Health J, V5, P127, DOI 10.1023/A:1011305300690; Figuero E, 2013, J CLIN PERIODONTOL, V40, P457, DOI 10.1111/jcpe.12053; Friedlander AH, 2007, ORAL SURG ORAL MED O, V103, P157, DOI 10.1016/j.tripleo.2006.08.001; Garbero I, 2001, PERIODONCIA, V11, P51; Gursoy M, 2010, J PERIODONTAL RES, V45, P496, DOI 10.1111/j.1600-0765.2009.01264.x; Gursoy M, 2008, J CLIN PERIODONTOL, V35, P576, DOI 10.1111/j.1600-051X.2008.01236.x; Hansen PJ, 1998, J REPROD IMMUNOL, V40, P63, DOI 10.1016/S0165-0378(98)00035-7; Kolodzinsky E, 1999, REV FUNDACION JUAN J, V9, P25; KORNMAN KS, 1980, J PERIODONTAL RES, V15, P111, DOI 10.1111/j.1600-0765.1980.tb00265.x; LOE H, 1965, J PERIODONTOL, V36, P209, DOI 10.1902/jop.1965.36.3.209; Machuca G, 1999, J PERIODONTOL, V70, P779, DOI 10.1902/jop.1999.70.7.779; Mascarenhas P, 2003, J CLIN PERIODONTOL, V30, P671, DOI 10.1034/j.1600-051X.2003.00055.x; Maybodi FR, 2015, INT J REPROD BIOMED, V13, P107; MIYAZAKI H, 1991, J CLIN PERIODONTOL, V18, P751, DOI 10.1111/j.1600-051X.1991.tb00067.x; Moreu G, 2005, J CLIN PERIODONTOL, V32, P622, DOI 10.1111/j.1600-051X.2005.00722.x; Offenbacher S, 2001, Ann Periodontol, V6, P164, DOI 10.1902/annals.2001.6.1.164; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; ONEIL TCA, 1979, J PERIODONTOL, V50, P178; Piliphat W, 2008, COMMUNITY DENT ORAL, V36, P3; Priddy K D, 1997, J Obstet Gynecol Neonatal Nurs, V26, P388, DOI 10.1111/j.1552-6909.1997.tb02720.x; RABERDURLACHER JE, 1993, J PERIODONTOL, V64, P211, DOI 10.1902/jop.1993.64.3.211; RABERDURLACHER JE, 1994, J CLIN PERIODONTOL, V21, P549, DOI 10.1111/j.1600-051X.1994.tb01172.x; RABERDURLACHER JE, 1991, J PERIODONTOL, V62, P663, DOI 10.1902/jop.1991.62.11.663; Smith JL, 1999, J FOOD PROTECT, V62, P818, DOI 10.4315/0362-028X-62.7.818; SOORIYAMOORTHY M, 1989, J CLIN PERIODONTOL, V16, P201, DOI 10.1111/j.1600-051X.1989.tb01642.x; Soory M, 2000, Dent Update, V27, P380; Suresh L, 2004, ORAL SURG ORAL MED O, V97, P672, DOI 10.1016/j.tripleo.2004.02.002; Tartaro S, 1970, Arch Stomatol (Napoli), V11, P65; Taylor DD, 2002, J REPROD IMMUNOL, V54, P15, DOI 10.1016/S0165-0378(01)00067-5; Tilakaratne A, 2000, J CLIN PERIODONTOL, V27, P787, DOI 10.1034/j.1600-051x.2000.027010787.x; Tsai C C, 1995, Gaoxiong Yi Xue Ke Xue Za Zhi, V11, P265; van Steenberghe D, 1997, CLIN PERIODONTOLOGY, P332; VITTEK J, 1982, J CLIN ENDOCR METAB, V54, P608, DOI 10.1210/jcem-54-3-608; Wellinghausen N, 2001, BRIT J NUTR, V85, pS81, DOI 10.1079/BJN2000298; ZACHARIASEN RD, 1993, WOMEN HEALTH, V20, P21, DOI 10.1300/J013v20n02_02	43	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178234	10.1371/journal.pone.0178234	http://dx.doi.org/10.1371/journal.pone.0178234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28538740	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672600047
J	Naito, H; Takahashi, T; Kamada, M; Morino, H; Yoshino, H; Hattori, N; Maruyama, H; Kawakami, H; Matsumoto, M				Naito, Hiroyuki; Takahashi, Tetsuya; Kamada, Masaki; Morino, Hiroyuki; Yoshino, Hiroyo; Hattori, Nobutaka; Maruyama, Hirofumi; Kawakami, Hideshi; Matsumoto, Masayasu			First report of a Japanese family with spinocerebellar ataxia type 10: The second report from Asia after a report from China	PLOS ONE			English	Article							ATTCT REPEAT EXPANSION; HEXANUCLEOTIDE REPEAT; BRAZILIAN FAMILIES; FREQUENCY-ANALYSIS; RNA TOXICITY; SCA10; POPULATION; PHENOTYPE; DISEASE; MODEL	Spinocerebellar ataxia type 10 (SCA10) is an autosomal-dominant cerebellar ataxia that is variably accompanied by epilepsy and other neurological disorders. It is caused by an expansion of the ATTCT pentanucleotide repeat in intron 9 of the ATXN10 gene. Until now, SCA10 was almost exclusively found in the American continents, while no cases had been identified in Japan. Here, we report the first case of an SCA10 family from Japan. The clinical manifestations in our cases were cerebellar ataxia accompanied by epilepsy, hyperreflexia and cognitive impairment. Although the primary pathology in SCA10 in humans is reportedly the loss of Purkinje cells, brain MRI revealed frontal lobe atrophy with white matter lesions. This pathology might be associated with cognitive dysfunction, indicating that the pathological process is not limited to the cerebellum. Examination of the SNPs surrounding the SCA10 locus in the proband showed the "C-expansion-G-G-C" haplotype, which is consistent with previously reported SCA10-positive individuals. This result was consistent with the findings that the SCA10 mutation may have occurred before the migration of Amerindians from East Asia to North America and the subsequent spread of their descendants throughout North and South America.	[Naito, Hiroyuki; Takahashi, Tetsuya; Maruyama, Hirofumi; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Kamada, Masaki] Kagawa Univ, Sch Med, Dept Neurol Intractable Dis Res, Takamatsu, Kagawa, Japan; [Morino, Hiroyuki; Kawakami, Hideshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Epidemiol, Hiroshima, Japan; [Yoshino, Hiroyo] Juntendo Univ, Sch Med, Res Inst Dis Old Age, Tokyo, Japan; [Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Matsumoto, Masayasu] Hoshigaoka Med Ctr, Japan Community Hlth Care Org, Osaka, Japan	Hiroshima University; Kagawa University; Hiroshima University; Juntendo University; Juntendo University	Takahashi, T (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan.	tetakaha@mac.com	Kawakami, Hideshi/ABE-4077-2021; Maruyama, Hirofumi/B-9333-2011; Kawakami, Hideshi/A-2086-2009; Morino, Hiroyuki/H-9583-2013; Takahashi, Tetsuya/ABG-8566-2021; Hattori, Nobutaka/ACR-0069-2022	Kawakami, Hideshi/0000-0002-1405-0901; Maruyama, Hirofumi/0000-0001-7613-8717; Kawakami, Hideshi/0000-0002-1405-0901; Morino, Hiroyuki/0000-0002-5190-3547; Takahashi, Tetsuya/0000-0001-6891-0842; 				Almeida T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004553; Ashizawa Tetsuo, 2012, Handb Clin Neurol, V103, P507, DOI 10.1016/B978-0-444-51892-7.00032-2; Basri R, 2007, J HUM GENET, V52, P848, DOI 10.1007/s10038-007-0182-x; Brusco A, 2004, ARCH NEUROL-CHICAGO, V61, P727, DOI 10.1001/archneur.61.5.727; Bushara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081342; Choubtum L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0425-y; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Depondt C, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000094; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Du JT, 2015, J BIOL CHEM, V290, P5979, DOI 10.1074/jbc.M114.621607; Fujigasaki H, 2002, ANN NEUROL, V51, P408, DOI 10.1002/ana.10126; Grewal RP, 2002, ARCH NEUROL-CHICAGO, V59, P1285, DOI 10.1001/archneur.59.8.1285; Kapur SS, 2012, ARCH NEUROL-CHICAGO, V69, P1200, DOI 10.1001/archneurol.2011.3044; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Leonardi L, 2014, J NEUROL, V261, P1691, DOI 10.1007/s00415-014-7394-8; Lin X, 2005, CEREBELLUM, V4, P37, DOI 10.1080/14734220510007897; Matsumura R, 2003, ACTA NEUROL SCAND, V107, P38, DOI 10.1034/j.1600-0404.2003.01347.x; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 1999, ANN NEUROL, V45, P407, DOI 10.1002/1531-8249(199903)45:3<407::AID-ANA21>3.0.CO;2-D; McFarland KN, 2014, NEUROGENETICS, V15, P59, DOI 10.1007/s10048-013-0385-6; McFarland KN, 2013, EUR J HUM GENET, V21, P1272, DOI 10.1038/ejhg.2013.32; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Ng ASL, 2015, NEUROLOGY, V85, P2060, DOI 10.1212/WNL.0000000000002045; Nozaki H, 2007, MOVEMENT DISORD, V22, P857, DOI 10.1002/mds.21443; Ogaki K, 2013, PARKINSONISM RELAT D, V19, P15, DOI 10.1016/j.parkreldis.2012.06.019; Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Roxburgh RH, 2013, J NEUROL SCI, V324, P176, DOI 10.1016/j.jns.2012.09.030; Sugihara K, 2012, MOVEMENT DISORD, V27, P1158, DOI 10.1002/mds.25092; Teive HAG, 2004, NEUROLOGY, V63, P1509; Teive HAG, 2012, CLINICS, V67, P443, DOI 10.6061/clinics/2012(05)07; Tsuji S, 2008, CEREBELLUM, V7, P189, DOI 10.1007/s12311-008-0028-x; Vale J, 2010, EUR J NEUROL, V17, P124, DOI 10.1111/j.1468-1331.2009.02757.x; Wang Jun-ling, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P501, DOI 10.3760/cma.j.issn.1003-9406.2010.05.006; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Wang K, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000026; White M, 2012, J NEUROSCI RES, V90, P706, DOI 10.1002/jnr.22786; White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984; Xia GB, 2013, J NEUROL NEUROSUR PS, V84, P1409, DOI 10.1136/jnnp-2013-305080	40	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177955	10.1371/journal.pone.0177955	http://dx.doi.org/10.1371/journal.pone.0177955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542277	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672600034
J	Eda, H; Fukui, H; Uchiyama, R; Kitayama, Y; Hara, K; Yang, M; Kodani, M; Tomita, T; Oshima, T; Watari, J; Tsutsui, H; Miwa, H				Eda, Hirotsugu; Fukui, Hirokazu; Uchiyama, Ryosuke; Kitayama, Yoshitaka; Hara, Ken; Yang, Mo; Kodani, Mio; Tomita, Toshihiko; Oshima, Tadayuki; Watari, Jiro; Tsutsui, Hiroko; Miwa, Hiroto			Effect of Helicobacter pylori infection on the link between GLP-1 expression and motility of the gastrointestinal tract	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; IRRITABLE-BOWEL-SYNDROME; GENE-EXPRESSION; INSULIN-SECRETION; ERADICATION; MICE; INFLAMMATION; DYSPEPSIA; PANCREAS; ANTIBODY	Background Although Helicobacter pylori (H. pylori) infection is closely associated with the development of peptic ulcer, its involvement in pathophysiology in the lower intestinal tract and gastrointestinal (GI) motility remains unclear. Glucagon-like peptide-1 (GLP-1) is a gut hormone produced in the lower intestinal tract and involved in GI motility. Here, we investigated the effect of H. pylori infection on the link between GLP-1 expression and motility of the GI tract. Methods C57BL/6 mice were inoculated with a H. pylori strain. Twelve weeks later, the H. pylori-infected mice underwent H. pylori eradication treatment. GI tissues were obtained from the mice at various time intervals, and evaluated for the severity of gastric inflammatory cell infiltration and immunohistochemical expression of GLP-1 and PAX6 in the colonic mucosa. Gastrointestinal transit time (GITT) was measured by administration of carmine-red solution. Results GLP-1 was expressed in the endocrine cells of the colonic mucosa, and PAX6 immunoreactivity was co-localized in such cells. The numbers of GLP-1-and PAX6-positive cells in the colon were significantly increased at 12 weeks after H. pylori infection and showed a positive correlation with each other. The GITT was significantly longer in H. pylori-infected mice than in non-infected controls and showed a positive correlation with GLP-1 expression. When H. pylori-infected mice underwent H. pylori eradication, GITT and PAX6/GLP-1 expression did not differ significantly from those in untreated H. pylori-infected mice. Conclusions H. pylori infection may impair GI motility by enhancing the colonic GLP-1/PAX6 expression.	[Eda, Hirotsugu; Fukui, Hirokazu; Kitayama, Yoshitaka; Hara, Ken; Yang, Mo; Kodani, Mio; Tomita, Toshihiko; Oshima, Tadayuki; Watari, Jiro; Miwa, Hiroto] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo, Japan; [Uchiyama, Ryosuke; Tsutsui, Hiroko] Hyogo Coll Med, Dept Microbiol, Nishinomiya, Hyogo, Japan; [Yang, Mo] Tianjin Med Univ Gen Hosp, Dept Digest Dis, Tianjin, Peoples R China	Hyogo College of Medicine; Hyogo College of Medicine; Tianjin Medical University	Fukui, H (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo, Japan.	hfukui@hyo-med.ac.jp		Tsutsui, Hiroko/0000-0001-7928-4875; Fukui, Hirokazu/0000-0002-8642-5784	Ministry of Education, Culture, Sports, Science and Technology, Japan [26460953]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 26460953 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.; We thank Mayumi Yamada and Chiyomi Itoh (Hyogo College of Medicine) for their technical assistance. This work was supported in part by Grants-in-aid for Scientific Research 26460953 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Amoto A, 2010, NEUROGASTROENT MOTIL, V22; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Budzynski J, 2014, WORLD J GASTROENTERO, V20, P5212, DOI 10.3748/wjg.v20.i18.5212; D'Elios MM, 2014, HELICOBACTER, V19, P19, DOI 10.1111/hel.12156; DuPont AW, 2008, CLIN INFECT DIS, V46, P594, DOI 10.1086/526774; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; Francois F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-37; Fukui H, 2014, BRIT J CANCER, V111, P763, DOI 10.1038/bjc.2014.336; Fukui H, 2003, LAB INVEST, V83, P1777, DOI 10.1097/01.LAB.0000106501.56339.CE; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Gerards C, 2001, DIGEST DIS, V19, P170, DOI 10.1159/000050673; Gosmain Y, 2011, DIABETES OBES METAB, V13, P31, DOI 10.1111/j.1463-1326.2011.01445.x; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Hwang I, 2015, FASEB J, V29, P2397, DOI 10.1096/fj.14-265983; Imeryuz N, 1997, AM J PHYSIOL-GASTR L, V273, pG920, DOI 10.1152/ajpgi.1997.273.4.G920; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Mizuta Y, 2006, J GASTROENTEROL, V41, P1025, DOI 10.1007/s00535-006-1966-z; Moayyedi P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002096.pub2, 10.1002/14651858.CD002096.pub4]; Moayyedi P, 2000, AM J GASTROENTEROL, V95, P1448, DOI 10.1111/j.1572-0241.2000.2126_1.x; Nauck MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE981, DOI 10.1152/ajpendo.1997.273.5.E981; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934; Rajpal DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145499; Schubert ML, 2008, GASTROENTEROLOGY, V134, P1842, DOI 10.1053/j.gastro.2008.05.021; Su YC, 2000, AM J GASTROENTEROL, V95, P1900, DOI 10.1111/j.1572-0241.2000.02252.x; Talley NJ, 2015, J GASTROENTEROL, V50, P601, DOI 10.1007/s00535-015-1076-x; Trinh DKY, 2003, DIABETES, V52, P425, DOI 10.2337/diabetes.52.2.425; Watanabe K, 2004, ANTIMICROB AGENTS CH, V48, P4582, DOI 10.1128/AAC.48.12.4582-4588.2004; Welch MG, 2014, AM J PHYSIOL-GASTR L, V307, pG848, DOI 10.1152/ajpgi.00176.2014; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Xiong F, 2016, GASTROENT RES PRACT, V2016; Yap TWC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135771	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177232	10.1371/journal.pone.0177232	http://dx.doi.org/10.1371/journal.pone.0177232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545056	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400030
J	Kaindoa, EW; Matowo, NS; Ngowo, HS; Mkandawile, G; Mmbando, A; Finda, M; Okumu, FO				Kaindoa, Emmanuel W.; Matowo, Nancy S.; Ngowo, Halfan S.; Mkandawile, Gustav; Mmbando, Arnold; Finda, Marcelina; Okumu, Fredros O.			Interventions that effectively target Anopheles funestus mosquitoes could significantly improve control of persistent malaria transmission in south-eastern Tanzania	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; WESTERN KENYA; DIPTERA; VECTOR; CULICIDAE; IDENTIFICATION; ELISA; AREA; CHALLENGE; RIVULORUM	Malaria is transmitted by many Anopheles species whose proportionate contributions vary across settings. We re-assessed the roles of Anopheles arabiensis and Anopheles funestus, and examined potential benefits of species-specific interventions in an area in southeastern Tanzania, where malaria transmission persists, four years after mass distribution of long-lasting insecticide-treated nets (LLINs). Monthly mosquito sampling was done in randomly selected households in three villages using CDC light traps and back-pack aspirators, between January-2015 and January-2016, four years after the last mass distribution of LLINs in 2011. Multiplex polymerase chain reaction (PCR) was used to identify members of An. funestus and Anopheles gambiae complexes. Enzyme-linked immunosorbent assay (ELISA) was used to detect Plasmodium sporozoites in mosquito salivary glands, and to identify sources of mosquito blood meals. WHO susceptibility assays were done on wild caught female An. funestus s.l, and physiological ages approximated by examining mosquito ovaries for parity. A total of 20,135 An. arabiensis and 4,759 An. funestus were collected. The An. funestus group consisted of 76.6% An. funestus s.s, 2.9% An. rivulorum, 7.1% An. leesoni, and 13.4% unamplified samples. Of all mosquitoes positive for Plasmodium, 82.6% were An. funestus s.s, 14.0% were An. arabiensis and 3.4% were An. rivulorum. An. funestus and An. arabiensis contributed 86.21% and 13.79% respectively, of annual entomological inoculation rate (EIR). An. arabiensis fed on humans (73.4%), cattle (22.0%), dogs (3.1%) and chicken (1.5%), but An. funestus fed exclusively on humans. The An. funestus populations were 100% susceptible to organophosphates, pirimiphos methyl and malathion, but resistant to permethrin (10.5% mortality), deltamethrin (18.7%), lambda-cyhalothrin (18.7%) and DDT (26.2%), and had reduced susceptibility to bendiocarb (95%) and propoxur (90.1%). Parity rate was higher in An. funestus (65.8%) than An. arabiensis (44.1%). Though An. arabiensis is still the most abundant vector species here, the remaining malaria transmission is predominantly mediated by An. funestus, possibly due to high insecticide resistance and high survival probabilities. Interventions that effectively target An. funestus mosquitoes could therefore significantly improve control of persistent malaria transmission in south-eastern Tanzania.	[Kaindoa, Emmanuel W.; Matowo, Nancy S.; Ngowo, Halfan S.; Mkandawile, Gustav; Mmbando, Arnold; Finda, Marcelina; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Morogoro, Tanzania; [Kaindoa, Emmanuel W.; Okumu, Fredros O.] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Matowo, Nancy S.] Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Ngowo, Halfan S.; Okumu, Fredros O.] Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland; [Mmbando, Arnold] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland	Ifakara Health Institute; University of Witwatersrand; University of Witwatersrand; University of Basel; Swiss Tropical & Public Health Institute	Kaindoa, EW (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Morogoro, Tanzania.; Kaindoa, EW (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.	ekaindoa@ihi.or.tz	Ngowo, Halfan/AFS-8039-2022	Ngowo, Halfan/0000-0003-2789-0261; Kaindoa, Dr. Emmanuel W/0000-0001-6170-5694; Matowo, Nancy/0000-0002-2302-3796	Wellcome Trust; Association of Physicians of Great Britain and Ireland [100540/Z/12/Z]; Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK) [087547/Z/08/Z]; Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]; Wellcome Masters Fellowship [WT104029/Z/14/Z]; Wellcome Trust Intermediate Research Fellowship [WT102350/Z/13/Z]; World Health Organization, Special Program for Research and Training in Tropical Diseases [B40445]	Wellcome Trust(Wellcome TrustEuropean Commission); Association of Physicians of Great Britain and Ireland; Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK)(Wellcome Trust); Carnegie Corporation of New York; Sida; Wellcome Masters Fellowship; Wellcome Trust Intermediate Research Fellowship(Wellcome Trust); World Health Organization, Special Program for Research and Training in Tropical Diseases(World Health Organization)	EK was supported by Wellcome Trust and the Association of Physicians of Great Britain and Ireland for funding this research (Grant Number: 100540/Z/12/Z), EK is also supported by the Consortium for Advanced Research Training in Africa (CARTA), which is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Wellcome Trust (UK) (Grant No: 087547/Z/08/Z), the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No:54100029)), NSM received financial supports from Wellcome Masters Fellowship, Grant number: WT104029/Z/14/Z. FOO is also supported by a Wellcome Trust Intermediate Research Fellowship (Grant number: WT102350/Z/13/Z) and a grant from World Health Organization, Special Program for Research and Training in Tropical Diseases (Grant No. B40445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], OPEN TROP MED J; Bashar K, 2013, ACTA TROP, V125, P220, DOI 10.1016/j.actatropica.2012.10.004; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; BEIER JC, 1990, J MED ENTOMOL, V27, P377, DOI 10.1093/jmedent/27.3.377; BEIER JC, 1988, J MED ENTOMOL, V25, P9, DOI 10.1093/jmedent/25.1.9; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Chaccour C, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1063-y; Coetzee M, 2004, INSECT BIOCHEM MOLEC, V34, P599, DOI 10.1016/j.ibmb.2004.03.012; Cohuet A, 2004, J MED ENTOMOL, V41, P901, DOI 10.1603/0022-2585-41.5.901; Cohuet A, 2003, AM J TROP MED HYG, V69, P200, DOI 10.4269/ajtmh.2003.69.200; Dabire KR, 2007, J MED ENTOMOL, V44, P990, DOI 10.1603/0022-2585(2007)44[990:AFDCIA]2.0.CO;2; Durnez L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-195; Geubbels E, 2015, INT J EPIDEMIOL, V44, P848, DOI 10.1093/ije/dyv068; Gillies M, 1987, ANOPHELINAE AFRICA S; GILLIES M. T., 1960, BULL ENT RES, V51, P243, DOI 10.1017/S0007485300057953; Huho B, 2013, INT J EPIDEMIOL, V42, P235, DOI 10.1093/ije/dys214; Kaindoa EW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1268-8; Kawada H, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-230; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; LINES JD, 1991, B ENTOMOL RES, V81, P77, DOI 10.1017/S0007485300053268; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Lwetoijera DW, 2014, MALARIA J, V13, P1; Maia MF, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-124; Maia MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045794; Mandike R., 2014, STRATEGY 2014 2020 P; Matowo NS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145653; Matowo NS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-137; Mboera LEG, 1998, AM J TROP MED HYG, V59, P595, DOI 10.4269/ajtmh.1998.59.595; McCann RS, 2014, AM J TROP MED HYG, V90, P597, DOI 10.4269/ajtmh.13-0614; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Mulamba C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110058; Mwangangi JM, 2013, PARASITE VECTOR, V6, P1; Mwangungulu SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156388; National Malaria Control Program NMCP Ghana, 2013, EP PROF MAL ITS CONT; National Malaria Control Programme (NMCP), 2015, TANZ SUPPL ENV ASS I; Oxborough RM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-37; Pinheiro J, 2020, R PACKAGE VERSION 31; Renggli S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-85; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sicuri E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-307; Skaug H., 2013, GEN LINEAR MIXED MOD; SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; Stevenson JC, 2016, J MED ENTOMOL; Sturrock HJ, 2013, TARGETING ASYMPTOMAT; Tanzania National Malaria Control Program Ifakara Health Institute World Health Organization, 2013, EP PROF MAL ITS CONT; United Republic of Tanzania, 2016, TANZ DEM HLTH SURV M; WHO, 2016, WORLD MALARIA REPORT; WHO, 2013, TEST PROC INS RES MA; Wilkes TJ, 1996, MED VET ENTOMOL, V10, P108, DOI 10.1111/j.1365-2915.1996.tb00092.x; World Health Organization, 1975, MAN PRACT ENT MALA 2, P1	58	65	65	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177807	10.1371/journal.pone.0177807	http://dx.doi.org/10.1371/journal.pone.0177807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542335	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000401672400087
J	Kamina, AD; Williams, N				Kamina, Anyango D.; Williams, Noreen			Non-canonical binding interactions of the RNA recognition motif (RRM) domains of P34 protein modulate binding within the 5S ribonucleoprotein particle (5S RNP)	PLOS ONE			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEIN; RIBOSOMAL-RNA; CRYSTAL-STRUCTURE; I-TASSER; DYNAMICS; BIOGENESIS; COMPLEX	RNA binding proteins are involved in many aspects of RNA metabolism. In Trypanosoma brucei, our laboratory has identified two trypanosome-specific RNA binding proteins P34 and P37 that are involved in the maturation of the 60S subunit during ribosome biogenesis. These proteins are part of the T. brucei 5S ribonucleoprotein particle (5S RNP) and P34 binds to 5S ribosomal RNA (rRNA) and ribosomal protein L5 through its N-terminus and its RNA recognition motif (RRM) domains. We generated truncated P34 proteins to determine these domains' interactions with 5S rRNA and L5. Our analyses demonstrate that RRM1 of P34 mediates the majority of binding with 5S rRNA and the N-terminus together with RRM1 contribute the most to binding with L5. We determined that the consensus ribonucleoprotein (RNP) 1 and 2 sequences, characteristic of canonical RRM domains, are not fully conserved in the RRM domains of P34. However, the aromatic amino acids previously described to mediate base stacking interactions with their RNA target are conserved in both of the RRM domains of P34. Surprisingly, mutation of these aromatic residues did not disrupt but instead enhanced 5S rRNA binding. However, we identified four arginine residues located in RRM1 of P34 that strongly impact L5 binding. These mutational analyses of P34 suggest that the binding site for 5S rRNA and L5 are near each other and specific residues within P34 regulate the formation of the 5S RNP. These studies show the unique way that the domains of P34 mediate binding with the T. brucei 5S RNP.	[Williams, Noreen] Univ Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; Univ Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Williams, N (corresponding author), Univ Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA.	nw1@buffalo.edu			National Institutes of Health (NIH) [R01 GM110227, R01 GM092719, R01 GM092719 S1]; NIH [T32 A107614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092719, R01GM110227] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants (http://www.nih.gov) R01 GM110227, R01 GM092719 to NW, supplement R01 GM092719 S1 to ADK, and by the NIH training grant T32 A107614.	Asano N, 2015, NUCLEIC ACIDS RES, V43, P4746, DOI 10.1093/nar/gkv305; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Beckmann BM, 2016, PFLUG ARCH EUR J PHY, V468, P1029, DOI 10.1007/s00424-016-1819-4; Ciganda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041398; Ciganda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030029; Ciganda M, 2011, WIRES RNA, V2, P523, DOI 10.1002/wrna.74; Clayton C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003680; Daubner GM, 2013, CURR OPIN STRUC BIOL, V23, P100, DOI 10.1016/j.sbi.2012.11.006; Deka P, 2005, J MOL BIOL, V347, P719, DOI 10.1016/j.jmb.2005.01.046; DiNitto JP, 2003, J MOL BIOL, V330, P979, DOI 10.1016/S0022-2836(03)00685-5; DiNitto JP, 2001, BIOCHEMISTRY-US, V40, P12645, DOI 10.1021/bi011439m; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Gamalinda M, 2014, GENE DEV, V28, P198, DOI 10.1101/gad.228825.113; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; Hellman KM, 2007, EUKARYOT CELL, V6, P1766, DOI 10.1128/EC.00119-07; JESSEN TH, 1991, EMBO J, V10, P3447, DOI 10.1002/j.1460-2075.1991.tb04909.x; Kharde S, 2015, NUCLEIC ACIDS RES, V43, P7083, DOI 10.1093/nar/gkv640; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Kolev NG, 2014, CELL MICROBIOL, V16, P482, DOI 10.1111/cmi.12268; Lafontaine DLJ, 2001, NAT REV MOL CELL BIO, V2, P514, DOI 10.1038/35080045; Lisbin MJ, 2000, GENETICS, V155, P1789; Mackereth CD, 2012, CURR OPIN STRUC BIOL, V22, P287, DOI 10.1016/j.sbi.2012.03.013; Madru C, 2015, GENE DEV, V29, P1432, DOI 10.1101/gad.260349.115; Matthews KR, 2015, MOL BIOCHEM PARASIT, V200, P30, DOI 10.1016/j.molbiopara.2015.01.006; McLaughlin KJ, 2011, BIOCHEMISTRY-US, V50, P1429, DOI 10.1021/bi102057m; Muto Y, 2012, WIRES RNA, V3, P229, DOI 10.1002/wrna.1107; Nagai K, 1995, Nucleic Acids Symp Ser, P1; NAGAI K, 1995, TRENDS BIOCHEM SCI, V20, P235, DOI 10.1016/S0968-0004(00)89024-6; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Perez-Canadillas JM, 2001, CURR OPIN STRUC BIOL, V11, P53, DOI 10.1016/S0959-440X(00)00164-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prohaska K, 2009, EUKARYOT CELL, V8, P77, DOI 10.1128/EC.00234-08; Rideau AP, 2006, NAT STRUCT MOL BIOL, V13, P839, DOI 10.1038/nsmb1137; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schellenberg MJ, 2006, P NATL ACAD SCI USA, V103, P1266, DOI 10.1073/pnas.0508048103; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; Tsuda K, 2011, NUCLEIC ACIDS RES, V39, P1538, DOI 10.1093/nar/gkq854; Umaer K, 2014, EUKARYOT CELL, V13, P727, DOI 10.1128/EC.00307-13; Umaer MC, 2016, ENCY CELL BIOL, P288; Wang I, 2014, NUCLEIC ACIDS RES, V42, P5949, DOI 10.1093/nar/gku193; Wang L, 2013, EUKARYOT CELL, V12, P559, DOI 10.1128/EC.00004-13; Wang L, 2013, EUKARYOT CELL, V12, P322, DOI 10.1128/EC.00316-12; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Wurst M, 2009, MOL BIOCHEM PARASIT, V163, P61, DOI 10.1016/j.molbiopara.2008.09.001; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang J, 1997, MOL BIOCHEM PARASIT, V87, P145, DOI 10.1016/S0166-6851(97)00060-1; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177890	10.1371/journal.pone.0177890	http://dx.doi.org/10.1371/journal.pone.0177890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542332	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400108
J	Klymus, KE; Marshall, NT; Stepien, CA				Klymus, Katy E.; Marshall, Nathaniel T.; Stepien, Carol A.			Environmental DNA (eDNA) metabarcoding assays to detect invasive invertebrate species in the Great Lakes	PLOS ONE			English	Article							PRIMERS; BARCODE; PCR; IDENTIFICATION; DEGRADATION; TEMPERATURE; REVEALS; REGION	Describing and monitoring biodiversity comprise integral parts of ecosystem management. Recent research coupling metabarcoding and environmental DNA (eDNA) demonstrate that these methods can serve as important tools for surveying biodiversity, while significantly decreasing the time, expense and resources spent on traditional survey methods. The literature emphasizes the importance of genetic marker development, as the markers dictate the applicability, sensitivity and resolution ability of an eDNA assay. The present study developed two metabarcoding eDNA assays using the mtDNA 16S RNA gene with lllumina MiSeq platform to detect invertebrate fauna in the Laurentian Great Lakes and surrounding waterways, with a focus for use on invasive bivalve and gastropod species monitoring. We employed careful primer design and in vitro testing with mock communities to assess ability of the markers to amplify and sequence targeted species DNA, while retaining rank abundance information. In our mock communities, read abundances reflected the initial input abundance, with regressions having significant slopes (p < 0.05) and high coefficients of determination (R-2) for all comparisons. Tests on field environmental samples revealed similar ability of our markers to measure relative abundance. Due to the limited reference sequence data available for these invertebrate species, care must be taken when analyzing results and identifying sequence reads to species level. These markers extend eDNA metabarcoding research for molluscs and appear relevant to other invertebrate taxa, such as rotifers and bryozoans. Furthermore, the sphaeriid mussel assay is group-specific, exclusively amplifying bivalves in the Sphaeridae family and providing species-level identification. Our assays provide useful tools for managers and conservation scientists, facilitating early detection of invasive species as well as improving resolution of mollusc diversity.	[Klymus, Katy E.; Marshall, Nathaniel T.; Stepien, Carol A.] Univ Toledo, Great Lakes Genet Genom Lab, Dept Environm Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Klymus, Katy E.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA; [Stepien, Carol A.] NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA	University System of Ohio; University of Toledo; United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA	Stepien, CA (corresponding author), Univ Toledo, Great Lakes Genet Genom Lab, Dept Environm Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.; Stepien, CA (corresponding author), NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA.	carol.stepien@noaa.gov	Stepien, Carol Ann/GWU-8631-2022; Stepien, Carol A./A-7898-2011; A.Stepien, Carol/AAW-5270-2020	Stepien, Carol A./0000-0002-5544-4333; Marshall, Nathaniel/0000-0002-0548-4273; Klymus, Katy/0000-0002-8843-6241	USEPA (Environmental Protection Agency) [GLRI GL 00E01289, GL -00E01149, GL-00E01898]	USEPA (Environmental Protection Agency)	This study was supported by the USEPA (Environmental Protection Agency) (GLRI GL 00E01289) to Dr. Carol A Stepien; USEPA (Environmental Protection Agency) (GL -00E01149) to Dr. Carol A Stepien; USEPA (Environmental Protection Agency) (GL-00E01898) to Dr. Carol A Stepien. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Beng KC, 2016, SCI REP-UK, V6, DOI 10.1038/srep24965; Blanco-Bercial L, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.cdf8b74881f87e3b01d56b43791626d2; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; Blomquist Thomas, 2015, Biomol Detect Quantif, V5, P30; Cannon MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep22908; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Darling JA, 2011, ENVIRON RES, V111, P978, DOI 10.1016/j.envres.2011.02.001; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Deiner K, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms12544; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Handley LL, 2015, BIOL J LINN SOC, V115, P17; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Karlsson AO, 2007, FORENSIC SCI INT, V173, P16, DOI 10.1016/j.forsciint.2007.01.019; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Lydeard C, 1997, MOL PHYLOGENET EVOL, V7, P117, DOI 10.1006/mpev.1996.0377; McMurdie P, 2014, BIOM INTERFACE PACKA; Minton RL, 2003, MOL ECOL, V12, P75, DOI 10.1046/j.1365-294X.2003.01719.x; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; National Oceanic and Atmospheric Administration, 2012, GREAT LAK AQ NON SPE; Ohio EPA, 2014, BIOL WATER QUALITY S; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pierre Taberlet, 2012, MOL ECOL, V2012, P5; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; R Core Team, 2021, R LANGUAGE ENV STAT; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Ryberg M, 2015, MOL ECOL, V24, P5770, DOI 10.1111/mec.13444; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Simberloff D, 2014, ECOL ENG, V65, P112, DOI 10.1016/j.ecoleng.2013.08.004; Sinniger F, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00092; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; US Army Corps of Engineers, 2014, GLMRIS REP NONN SPEC; US Environmental Protection Agency, 2009, PRED FUT INTR NON SP; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Wu LY, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0450-4; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zentilin L, 2007, NAT PROTOC, V2, P2092, DOI 10.1038/nprot.2007.299	57	73	77	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177643	10.1371/journal.pone.0177643	http://dx.doi.org/10.1371/journal.pone.0177643			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542313	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672400062
J	Zhai, XW; Zhang, L; Guo, YF; Yang, Y; Wang, DM; Zhang, Y; Li, P; Niu, YF; Feng, QL; Wu, BW; Cao, JM; Liu, QH				Zhai, Xu-Wen; Zhang, Li; Guo, Yun-Fei; Yang, Ying; Wang, Dong-Ming; Zhang, Yan; Li, Pan; Niu, Yi-Fan; Feng, Qi-Long; Wu, Bo-Wei; Cao, Ji-Min; Liu, Qing-Hua			The /(K1)/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat	PLOS ONE			English	Article							TRANSIENT OUTWARD CURRENT; ACTION-POTENTIAL DURATION; ACUTE MYOCARDIAL-ISCHEMIA; TRANSGENIC UP-REGULATION; RECTIFIER K+ CHANNELS; VENTRICULAR-TACHYCARDIA; POTASSIUM CURRENT; GUINEA-PIG; CARDIAC EXCITABILITY; ATRIAL-FIBRILLATION	Arrhythmogenesis in acute myocardial infarction (MI) is associated with depolarization of resting membraine potential (RMP) and decrease of inward rectifier potassium current (/(K1)) in cardiomyocytes. However, clinical anti-arrhythmic agents that primarily act on RMP by enhancing the /(K1) channel are not currently available. We hypothesized that zacopride, a selective and moderate agonist of the /(K1)/Kir2.1 channels, prevents and cures acute ischemic arrhythmias. To test this viewpoint, adult Sprague-Dawley (SD) rats were subjected to MI by ligating the left main coronary artery. The antiarrhythmic effects of zacopride (i.v. infusion) were observed in the settings of pre-treatment (zacopride given 3 min prior to coronary occlusion), post-treatment (zacopride given 3 min after coronary occlusion) and therapeutic treatment (zacopride given 30 s after the onset of the first sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) post MI). In all the three treatment modes, zacopride (15 mu g/ kg) inhibited MI-induced ventricular tachyarrhythmias, as shown by significant decreases in the premature ventricular contraction (PVC) and the duration and incidence of VT or VF. In Langendorff perfused rat hearts, the antiarrhythmic effect of 1 mu mol/L zacopride were reversed by 1 mu mol/L BaCl2, a blocker of /K-1 channel. Patch clamp results in freshly isolated rat ventricular myocytes indicated that zacopride activated the /K-1 channel and thereby reversed hypoxia-induced RMP depolarization and action potential duration (APD) prolongation. In addition, zacopride (1 mu mol/L) suppressed hypoxia-or isoproterenol-induced delayed afterdepolarizations (DADs). In Kir2. x transfected Chinese hamster ovary (CHO) cells, zacopride activated the Kir2.1 homomeric channel but not the Kir2.2 or Kir2.3 channels. These results support our hypothesis that moderately enhancing /K-1/Kir2.1 currents as by zacopride rescues ischemia-and hypoxia-induced RMP depolarization, and thereby prevents and cures acute ischemic arrhythmias. This study brings a new viewpoint to antiarrhythmic theories and provides a promising target for the treatment of acute ischemic arrhythmias.	[Zhai, Xu-Wen; Feng, Qi-Long; Wu, Bo-Wei] Shanxi Med Univ, Dept Physiol, Taiyuan, Peoples R China; [Zhang, Li] Shanxi Prov Childrens Hosp, Taiyuan, Peoples R China; [Guo, Yun-Fei; Yang, Ying; Zhang, Yan; Li, Pan; Niu, Yi-Fan; Liu, Qing-Hua] Shanxi Med Univ, Dept Pathophysiol, Taiyuan, Peoples R China; [Wang, Dong-Ming] Shanxi Med Univ, Hosp 2, Taiyuan, Peoples R China; [Cao, Ji-Min] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Dept Physiol,Inst Basic Med Sci, Beijing, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Liu, QH (corresponding author), Shanxi Med Univ, Dept Pathophysiol, Taiyuan, Peoples R China.; Cao, JM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Dept Physiol,Inst Basic Med Sci, Beijing, Peoples R China.	caojimin@126.com; liuqh20041206@163.com	Liu, Qinghua/HCH-3099-2022		National Natural Science Foundation of China [31200864, 81670313]; Shanxi Scholarship Council of China [2016-059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanxi Scholarship Council of China	This work was supported by grants from the National Natural Science Foundation of China (No. 31200864 to QL and No. 81670313 to JC) and Research Project Supported by Shanxi Scholarship Council of China (No. 2016-059 to QL).	Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; APKON M, 1991, J GEN PHYSIOL, V97, P973, DOI 10.1085/jgp.97.5.973; Baldo MP, 2008, J CARDIOVASC PHARM, V52, P375, DOI 10.1097/FJC.0b013e31818a2bb0; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Cha TJ, 2004, CIRCULATION, V110, P1520, DOI 10.1161/01.CIR.0000142052.03565.87; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; Chung MK, 1997, CIRCULATION, V95, P2517, DOI 10.1161/01.CIR.95.11.2517; CLARKSON CW, 1983, CIRC RES, V52, P543, DOI 10.1161/01.RES.52.5.543; Collins A, 2005, J CELL PHYSIOL, V202, P76, DOI 10.1002/jcp.20093; CORABOEUF E, 1980, J PHYSIOL-PARIS, V76, P97; Curtis MJ, 2013, PHARMACOL THERAPEUT, V139, P213, DOI 10.1016/j.pharmthera.2013.04.008; de Boer TP, 2010, ACTA PHYSIOL, V199, P243, DOI 10.1111/j.1748-1716.2010.02108.x; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Dhamoon AS, 2004, CIRC RES, V94, P1332, DOI 10.1161/01.RES.0000128408.66946.67; Elnakish MT, 2017, PHARMACOL RES, V115, P309, DOI 10.1016/j.phrs.2016.11.033; Gaborit N, 2005, CIRCULATION, V112, P471, DOI 10.1161/CIRCULATIONAHA.104.506857; Gomez R, 2009, CIRC RES, V105, P383, DOI 10.1161/CIRCRESAHA.109.197558; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS AS, 1954, SCIENCE, V119, P200, DOI 10.1126/science.119.3085.200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Huang SS, 2001, DRUG DEVELOP RES, V53, P244, DOI 10.1002/ddr.1193; ITO H, 1992, PFLUG ARCH EUR J PHY, V422, P280, DOI 10.1007/BF00376214; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; KOUMI S, 1995, J PHYSIOL-LONDON, V486, P661, DOI 10.1113/jphysiol.1995.sp020842; Li JD, 2004, AM J PHYSIOL-HEART C, V287, pH2790, DOI 10.1152/ajpheart.00114.2004; Li Shanshuang, 2006, Exp Clin Cardiol, V11, P280; Liu QH, 2012, J CARDIOVASC PHARM, V59, P37, DOI 10.1097/FJC.0b013e3182350bcc; Liu YG, 1997, AM J PHYSIOL-HEART C, V273, pH1637, DOI 10.1152/ajpheart.1997.273.4.H1637; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; Lopatin AN, 2014, CARDIAC ELECTROPHYSI, P33; Mackall JA, 2010, CARDIAC INTENSIVE CA, P3; MILL JG, 1991, BRAZ J MED BIOL RES, V24, P855; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Piao L, 2007, BASIC RES CARDIOL, V102, P416, DOI 10.1007/s00395-007-0659-y; POGWIZD SM, 1994, CIRCULATION, V90, P1441, DOI 10.1161/01.CIR.90.3.1441; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Pogwizd SM, 1997, CIRCULATION, V95, P2528, DOI 10.1161/01.CIR.95.11.2528; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; SCHOMIG A, 1991, EUR HEART J, V12, P38, DOI 10.1093/eurheartj/12.suppl_F.38; Sedlis S P, 1992, Cardiovasc Clin, V22, P3; Sejersted OM, 2000, PHYSIOL REV, V80, P1411, DOI 10.1152/physrev.2000.80.4.1411; Shaw RM, 1997, CARDIOVASC RES, V35, P256, DOI 10.1016/S0008-6363(97)00093-X; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Sun XY, 2005, J PHYSIOL-LONDON, V564, P411, DOI 10.1113/jphysiol.2004.077263; TANDE PM, 1990, J CARDIOVASC PHARM, V16, P401, DOI 10.1097/00005344-199009000-00008; TERZIC A, 1995, AM J PHYSIOL-CELL PH, V269, pC525, DOI 10.1152/ajpcell.1995.269.3.C525; Verkerk AO, 1996, J MOL CELL CARDIOL, V28, P2443, DOI 10.1006/jmcc.1996.0237; Watanabe I, 1997, J CARDIOVASC ELECTR, V8, P1229, DOI 10.1111/j.1540-8167.1997.tb01012.x; WIT AL, 1992, HEART CARDIOVASCULAR, P2113; Workman AJ, 2000, BASIC RES CARDIOL, V95, P250, DOI 10.1007/s003950050188; Zhang HG, 2005, CARDIOVASC RES, V66, P493, DOI 10.1016/j.cardiores.2005.01.020; Zhang L, 2013, SCI CHINA LIFE SCI, V56, P788, DOI 10.1007/s11427-013-4531-z	53	15	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177600	10.1371/journal.pone.0177600	http://dx.doi.org/10.1371/journal.pone.0177600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542320	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400056
J	Baqir, M; Makol, A; Osborn, TG; Bartholmai, BJ; Ryu, JH				Baqir, Misbah; Makol, Ashima; Osborn, Thomas G.; Bartholmai, Brian J.; Ryu, Jay H.			Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; SYSTEMIC-SCLEROSIS; DOUBLE-BLIND; CYCLOPHOSPHAMIDE; HYPERTENSION; PLACEBO; PREDICTOR; SURVIVAL; TRIALS	Background and objective Interstitial lung disease (ILD) remains the number one cause of mortality in scleroderma (SSc). Our goal was to determine the effectiveness of mycophenolate mofetil (MMF) in treating SSc-ILD in a retrospective study. Methods A retrospective, computer-assisted search was performed to identify patients with SSc-ILD treated with MMF from 1997 through 2014. We used a novel software tool, Computer-Aided Lung Informatics for Pathology Evaluation and Rating (CALIPER), to quantify parenchymal lung abnormalities on high-resolution computed tomography. Lung function was evaluated at baseline, 6, 12, and 24 months of MMF therapy. Results We identified 46 patients (28 females) with SSc-ILD (mean age at diagnosis 55 y) treated with MMF for at least 1 year (majority on 2 gm/day). Twenty-one patients (45.7%) stopped using MMF during the follow up period after the first 12 months, and they took MMF for a median of 2.12 years (range, 0.91-8.93 years). Only 4 discontinued MMF because of disease progression. Compared to baseline, the mean percentage change in forced vital capacity (95% CI) at 6, 12, and 24 months, respectively, was 1.01% (-2.38%-4.39%) (n = 26), 2.06% (-1.09%-5.22%) (n = 31), and -0.07% (-3.31%-3.17%) (n = 30), and the mean percentage change in ILD as measured by CALIPER (95% CI) was -5.40% (-18.62%-7.83%) (n = 18), -1.51% (-14.69%-11.68%) (n = 17), and -8.35% (-20.71%-4.02%) (n = 22). The mean right ventricular systolic pressure (RVSP) remained stable over the study period. Conclusions MMF is well tolerated and slows the rate of decline in lung function in SSc-ILD patients, even at doses lower at 3 g/day.	[Baqir, Misbah; Ryu, Jay H.] Mayo Clin, Dept Internal Med, Div Pulm & Crit Care Med, Rochester, MN 55902 USA; [Makol, Ashima; Osborn, Thomas G.] Mayo Clin, Dept Internal Med, Div Rheumatol, Rochester, MN USA; [Bartholmai, Brian J.] Mayo Clin, Dept Radiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Baqir, M (corresponding author), Mayo Clin, Dept Internal Med, Div Pulm & Crit Care Med, Rochester, MN 55902 USA.	baqir.misbah@mayo.edu		Makol, Ashima/0000-0002-8748-898X; Ryu, Jay/0000-0002-9576-2272	CTSA from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR000135]	CTSA from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was made possible by CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.	Gerbino AJ, 2008, CHEST, V133, P455, DOI 10.1378/chest.06-2861; Herzog EL, 2014, ARTHRITIS RHEUMATOL, V66, P1967, DOI 10.1002/art.38702; Hoyles RK, 2006, ARTHRITIS RHEUM-US, V54, P3962, DOI 10.1002/art.22204; Iudici M, 2015, AUTOIMMUN REV, V14, P575, DOI 10.1016/j.autrev.2015.02.002; Khanna D, 2011, ARTHRITIS RHEUM-US, V63, P3078, DOI 10.1002/art.30467; Koh ET, 1996, BRIT J RHEUMATOL, V35, P989; Koutroumpas A, 2010, CLIN RHEUMATOL, V29, P1167, DOI 10.1007/s10067-010-1498-z; Launay D, 2007, J RHEUMATOL, V34, P1005; Liossis SNC, 2006, RHEUMATOLOGY, V45, P1005, DOI 10.1093/rheumatology/kei211; Lopes AJ, 2011, J BRAS PNEUMOL, V37, P144, DOI 10.1590/S1806-37132011000200003; Nadrous HF, 2005, CHEST, V128, p616S, DOI 10.1378/chest.128.6_suppl.616S-a; Nannini C, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2534; Nathan SD, 2008, RESP MED, V102, P1305, DOI 10.1016/j.rmed.2008.03.022; Nihtyanova SI, 2007, RHEUMATOLOGY, V46, P442, DOI 10.1093/rheumatology/kel244; Panopoulos ST, 2013, LUNG, V191, P483, DOI 10.1007/s00408-013-9499-8; Simeon-Aznar CP, 2011, CLIN RHEUMATOL, V30, P1393, DOI 10.1007/s10067-011-1823-1; Plastiras SC, 2006, ARTHRIT RHEUM-ARTHR, V55, P598, DOI 10.1002/art.22099; STEEN VD, 1994, ARTHRITIS RHEUM, V37, P1283, DOI 10.1002/art.1780370903; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Tashkin DP, 2016, LANCET RESP MED, V4, P708, DOI 10.1016/S2213-2600(16)30152-7; Tzouvelekis A, 2012, PULM MED, V2012, DOI 10.1155/2012/143637; Walker UA, 2007, ANN RHEUM DIS, V66, P754, DOI 10.1136/ard.2006.062901; White B, 2000, ANN INTERN MED, V132, P947, DOI 10.7326/0003-4819-132-12-200006200-00004; Zamora AC, 2008, RESP MED, V102, P150, DOI 10.1016/j.rmed.2007.07.021; Zhang YF, 2015, SCAND J RHEUMATOL, V44, P412, DOI 10.3109/03009742.2015.1023829	25	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177107	10.1371/journal.pone.0177107	http://dx.doi.org/10.1371/journal.pone.0177107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542177	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800008
J	Chen, C; Tsai, LT; Lin, CF; Huang, CC; Chang, YT; Chen, RY; Lyu, SY				Chen, Chiehfeng; Tsai, Liang-Ting; Lin, Ching-Feng; Huang, Chun-Ching; Chang, Yao-Tsung; Chen, Ruey-Yu; Lyu, Shu-Yu			Factors influencing interest in recreational sports participation and its rural-urban disparity	PLOS ONE			English	Article							TIME PHYSICAL-ACTIVITY; GENDER-DIFFERENCES; SELF-EFFICACY; BARRIER; RISK	Objectives Recreational sports are important leisure activities. However, most studies investigating barrier factors and motivation for participation in recreational sports have been limited to specific areas (e.g., a city or school) or demographic groups (e.g., adolescents). Therefore, this study set out to gain a more comprehensive understanding of the behavioral and socioeconomic factors influencing interest in recreational sports participation in Taiwan, as well as to evaluate the effect of any urban-rural divide. Methods This study analyzed data collected by the "Taiwan Social Change Survey" (program five, wave 3) "Leisure Lif" questionnaire. We used hierarchical linear modeling to assess respondent interest in recreational sports participation and evaluated the influence of behavioral factors, socioeconomic factors, and residence location (urban/rural). Results Of the 2,146 participants in this study, 50.3% were male, and the average age was 43.9 years. Location of residence (urban/rural) accounted for 35.3% of the variation in interest in recreational sports participation, while the remaining 64.7% came from the individual level. Participants who lived in rural settings were less interested in recreational sports than their urban counterparts. Gender, educational attainment, participation frequency, health-motivated interest, and appearance-motivated interest were also associated with interest in recreational sports participation. Conclusions Different communication strategies may be needed to effectively reach different demographic groups. We suggest that future public health campaigns aiming to increase recreational sports participation include tailored interventions and messages to effectively encourage leisure physical activities among all, regardless of demographic boundaries.	[Chen, Chiehfeng] Taipei Med Univ, Wan Fang Hosp, Evidence Based Med Ctr, Div Plast Surg,Dept Surg, Taipei, Taiwan; [Chen, Chiehfeng] Taipei Med Univ, Cochrane Taiwan, Coll Med, Dept Publ Hlth,Sch Med, Taipei, Taiwan; [Tsai, Liang-Ting] Natl Taiwan Ocean Univ, Taiwan Marine Educ Ctr, Keelung, Taiwan; [Lin, Ching-Feng; Chang, Yao-Tsung; Chen, Ruey-Yu; Lyu, Shu-Yu] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Lin, Ching-Feng] Minist Hlth & Welf, Keelung Hosp, Keelung, Taiwan; [Lin, Ching-Feng] Fu Jen Catholic Univ, Dept Publ Hlth, New Taipei, Taiwan; [Huang, Chun-Ching] Natl Taipei Univ Nursing & Hlth Sci, Dept Exercise & Hlth Sci, Taipei, Taiwan; [Lyu, Shu-Yu] Natl Taipei Univ Nursing & Hlth Sci, Dept Leisure Ind & Hlth Promot, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; National Taiwan Ocean University; Taipei Medical University; Fu Jen Catholic University; National Taipei University of Nursing & Health Science (NTUNHS); National Taipei University of Nursing & Health Science (NTUNHS)	Chen, RY; Lyu, SY (corresponding author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.; Lyu, SY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Leisure Ind & Hlth Promot, Taipei, Taiwan.	rueyyu@tmu.edu.tw; sylyu2016@ntunhs.edu.tw		Chen, Chiehfeng/0000-0002-1595-6553	Taipei Municipal Wanfang Hospital [104TMU-WFH-05, 105TMU-WFH-03]	Taipei Municipal Wanfang Hospital	The authors would like to thank the Taipei Municipal Wanfang Hospital (Managed by Taipei Medical University) (grant numbers: 104TMU-WFH-05 and 105TMU-WFH-03) for supporting this study.; This work was supported by Taipei Municipal Wanfang Hospital (Managed by Taipei Medical University) (grant numbers: 104TMU-WFH-05 and 105TMU-WFH-03).	Arnadottir SA, 2009, SCAND J PUBLIC HEALT, V37, P409, DOI 10.1177/1403494809102776; Blanchard CM, 2007, ANN BEHAV MED, V34, P323, DOI 10.1007/BF02874557; Brenner DR, 2016, LUNG CANCER, V95, P17, DOI 10.1016/j.lungcan.2016.01.021; Carroll S, 2014, AUST J RURAL HEALTH, V22, P15, DOI 10.1111/ajr.12081; Chang LY, 2008, TAIWAN SOCIAL CHANGE; Chin DL, 2016, INT J NURS STUD, V57, P60, DOI 10.1016/j.ijnurstu.2016.01.009; Cleland V, 2015, J AGING PHYS ACTIV, V23, P55, DOI [10.1123/japa.2012-0271, 10.1123/JAPA.2012-0271]; Del Duca GF, 2016, PUBLIC HEALTH, V134, P12, DOI 10.1016/j.puhe.2016.01.016; Edwards MB, 2014, J RURAL HEALTH, V30, P379, DOI 10.1111/jrh.12072; Fan JX, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140189; Francis S, 2014, FASEB J, V28; Gomes CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150017; Honda T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2362-5; Huai PC, 2016, ENDOCRINE, V52, P226, DOI 10.1007/s12020-015-0769-5; Jonsdottir IH, 2010, PREV MED, V51, P373, DOI 10.1016/j.ypmed.2010.07.019; Kim C, 2015, J OCCUP HEALTH, V57, P259, DOI 10.1539/joh.14-0028-OA; Kim HK, 2010, J CLIN NURS, V19, P876, DOI 10.1111/j.1365-2702.2009.03054.x; Kopcakova J, 2014, INT J ENV RES PUB HE, V11, P11167, DOI 10.3390/ijerph111111167; Marques A, 2015, CAD SAUDE PUBLICA, V31, P1061, DOI 10.1590/0102-311X00101614; Morris KS, 2008, HEALTH EDUC RES, V23, P744, DOI 10.1093/her/cym067; Paech J, 2012, REHABILITATION, V51, P212, DOI 10.1055/s-0031-1277185; Peer N, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19216; Ptomey LT, 2016, DISABIL HEALTH J, V9, P162, DOI 10.1016/j.dhjo.2015.07.003; Roubal AM, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140378; Shores KA, 2010, PREV MED, V50, pS13, DOI 10.1016/j.ypmed.2009.07.023; Solomon E, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-129; Teramoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128424; Uijtdewilligen L, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-8; Wang J., 2011, J ENVIRON SCI, V24, P1; Warner-Smith P., 2002, Leisure Studies, V21, P39, DOI 10.1080/02614360110112688; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Willey JZ, 2015, ANN EPIDEMIOL, V25, P475, DOI 10.1016/j.annepidem.2015.04.001; Zheng J, 2015, RURAL REMOTE HEALTH, V15	33	11	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178052	10.1371/journal.pone.0178052	http://dx.doi.org/10.1371/journal.pone.0178052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542455	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800040
J	Starke, SD; Baber, C				Starke, Sandra Dorothee; Baber, Chris			Spontaneous bimanual independence during parallel tapping and sawing	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; STOPS WALKING; COORDINATION; PERFORMANCE; ABILITY; FINGER; PEOPLE; FALLS; TIME	The performance of complex polyrhythms-rhythms where the left and right hand move at different rates-is usually the province of highly trained individuals. However, studies in which hand movement is guided haptically show that even novices can perform polyrhythms with no or only brief training. In this study, we investigated whether novices are able to tap with one hand by matching different rates of a metronome while sawing with the other hand. This experiment was based on the assumption that saw movement is controlled consistently at a predictable rate without the need for paying primary attention to it. It would follow that consciously matching different stipulated metronome rates with the other hand would result in the spontaneous performance of polyrhythms. Six experimental conditions were randomised: single handed tapping and sawing as well as four bimanual conditions with expected ratios of 1:1 (performed with and without matching a metronome) as well as 3:4 and 4:3 (performed matching a metronome). Results showed that participants executed the saw movement at a consistent cycle duration of 0.44 [0.20] s to 0.51 [0.19] s across single and bimanual conditions, with no significant effect of the condition on the cycle duration (p = 0.315). Similarly, free tapping was executed at a cycle duration of 0.48 [0.22] s. In the bimanual conditions, we found that for a ratio of 4:3 (4 taps against 3 sawing cycles per measure), the observed and predicted ratio of 0.75 were not significantly different (p = 0.369), supporting our hypothesis of the spontaneous adoption of polyrhythms. However, for a ratio of 3:4 (3 taps against 4 sawing cycles per measure), the observed and predicted ratio differed (p = 0.016), with a trend towards synchronisation. Our findings show that bimanual independence when performing complex polyrhythms can in principle be achieved if the movement of one hand can be performed without paying much-if any-attention to it. In this paradigm, small rhythmic arm movements are possibly driven by an intrinsic timing which leads to spontaneous convergence on a cycle duration of around 0.5 s, while the movement of the other hand can be controlled consciously to occur at desired rates.	[Starke, Sandra Dorothee; Baber, Chris] Univ Birmingham, Coll Engn & Phys Sci, Sch Engn, Birmingham, W Midlands, England	University of Birmingham	Starke, SD (corresponding author), Univ Birmingham, Coll Engn & Phys Sci, Sch Engn, Birmingham, W Midlands, England.	SandraDStarke@gmail.com	Baber, Chris/A-7412-2014	Baber, Chris/0000-0002-1830-2272; Starke, Sandra/0000-0002-1434-7094				Aoki T, 2010, MED SCI SPORT EXER, V42, P449, DOI 10.1249/MSS.0b013e3181b7f3e1; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Baber C, 2015, APPL ERGON, V51, P211, DOI 10.1016/j.apergo.2015.05.002; Boonstra TW, 2007, NEUROIMAGE, V36, P370, DOI 10.1016/j.neuroimage.2007.03.012; Buchanan JJ, 2006, J MOTOR BEHAV, V38, P163, DOI 10.3200/JMBR.38.3.163-184; Daffertshofer A, 2005, BIOL CYBERN, V92, P101, DOI 10.1007/s00422-004-0539-6; DEUTSCH D, 1983, PERCEPT PSYCHOPHYS, V34, P331, DOI 10.3758/BF03203045; Ennos A.R., 2007, STAT DATA HANDLING S; Field A., 2013, DISCOVERING STAT USI; Hyndman D, 2004, J NEUROL NEUROSUR PS, V75, P994, DOI 10.1136/jnnp.2003.016014; Jancke L, 1998, NEUROSCI LETT, V252, P37, DOI 10.1016/S0304-3940(98)00540-0; KELSO JAS, 1990, ATTENTION PERFORM, V8, P139; Kelso JAS, 1988, NEURAL SYNERGETIC CO; Klaiman E, 2006, EXP BRAIN RES, V171, P204, DOI 10.1007/s00221-005-0263-z; Klapp ST, 1998, J MOTOR BEHAV, V30, P301, DOI 10.1080/00222899809601346; KLAPP ST, 1979, MEM COGNITION, V7, P375, DOI 10.3758/BF03196942; KNIGHTS RM, 1967, PERCEPT MOTOR SKILL, V25, P717, DOI 10.2466/pms.1967.25.3.717; Kovacs AJ, 2010, J EXP PSYCHOL HUMAN, V36, P936, DOI 10.1037/a0019259; Kovacs AJ, 2010, EXP BRAIN RES, V201, P249, DOI 10.1007/s00221-009-2031-y; Kovacs AJ, 2009, EXP BRAIN RES, V193, P129, DOI 10.1007/s00221-008-1676-2; Krampe RT, 2000, J EXP PSYCHOL HUMAN, V26, P206, DOI 10.1037/0096-1523.26.1.206; Li Y, 2009, ACTA PSYCHOL, V130, P183, DOI 10.1016/j.actpsy.2008.12.003; Lutz K, 2005, NEUROSCI LETT, V373, P61, DOI 10.1016/j.neulet.2004.09.058; McAuley JD, 2006, J EXP PSYCHOL GEN, V135, P348, DOI 10.1037/0096-3445.135.3.348; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Mechsner F, 2007, J NEUROPSYCHOL, V1, P259, DOI 10.1348/174866407X230688; Neumann O., 1984, COGNITION MOTOR PROC, P255, DOI [10.1007/978-3-642-69382-3_17, DOI 10.1007/978-3-642-69382-3_]; Nitz JC, 2003, AUSTRALAS J AGEING, V22, P97, DOI 10.1111/j.1741-6612.2003.tb00475.x; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pellecchia GL, 2005, COGNITIVE SCI, V29, P531, DOI 10.1207/s15516709cog0000_12; PEPER CE, 1995, J EXP PSYCHOL HUMAN, V21, P1117, DOI 10.1037/0096-1523.21.5.1117; PETERS M, 1977, NEUROPSYCHOLOGIA, V15, P461, DOI 10.1016/0028-3932(77)90099-9; PETERS M, 1989, AUST J PSYCHOL, V41, P215, DOI 10.1080/00049538908260084; PETERS M, 1981, Q J EXP PSYCHOL-A, V33, P95, DOI 10.1080/14640748108400772; Repp B.H., 2006, ADV COGN PSYCHOL, V2, P163, DOI DOI 10.2478/V10053-008-0053-9; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Rosenbaum DA, 2006, J EXP PSYCHOL HUMAN, V32, P1266, DOI 10.1037/0096-1523.32.5.1266; Siu KC, 2007, GAIT POSTURE, V25, P121, DOI 10.1016/j.gaitpost.2006.02.002; Starke SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173281; Sternad D, 2000, J MOTOR BEHAV, V32, P249, DOI 10.1080/00222890009601376; SUMMERS JJ, 1993, J EXP PSYCHOL HUMAN, V19, P416, DOI 10.1037/0096-1523.19.2.416; Todd NPM, 2002, PSYCHOL RES-PSYCH FO, V66, P26, DOI 10.1007/s004260100071; TREFFNER PJ, 1993, J EXP PSYCHOL HUMAN, V19, P1221, DOI 10.1037/0096-1523.19.6.1221; Volman MJM, 2000, PSYCHOL RES-PSYCH FO, V63, P62, DOI 10.1007/PL00008168; Whitall J, 1996, HUM MOVEMENT SCI, V15, P129, DOI 10.1016/0167-9457(95)00038-0; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yokus H, 2015, EDUC SCI-THEOR PRACT, V15, P239, DOI 10.12738/estp.2015.1.1917	48	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178188	10.1371/journal.pone.0178188	http://dx.doi.org/10.1371/journal.pone.0178188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542581	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000402062800049
J	Borena, W; Hofer, T; Stiasny, K; Aberle, SW; Gaber, M; Von Laer, D; Schennach, H				Borena, Wegene; Hofer, Tamara; Stiasny, Karin; Aberle, Stephan W.; Gaber, Manfred; Von Laer, Dorothee; Schennach, Harald			No molecular or serological evidence of Zikavirus infection among healthy blood donors living in or travelling to regions where Aedes albopictus circulates	PLOS ONE			English	Article							ZIKA VIRUS; MOSQUITOS	Background Previous studies have shown that Zika virus can infect and be transmitted by A. albopictus. The World Health organization (WHO) has raised concerns of autochthonous transmission of the virus in regions where the vector is endemic. The aim of this pilot study was to assess the occurrence of Zika virus (ZIKV) in western Austria (Tyrol) especially after a history of travel to A. albopictus endemic regions. Methods The study participants were healthy blood donors at randomly selected donation sites in the west Austrian region Tyrol. Rest blood (plasma) samples were tested for the presence of ZIKV nucleic acid and antibodies against the virus. Results Mean age of the study participants was 44.6 (SD = 12.9) and 58.8% were men. Eighty percent reported to have received vaccine against TBEV, whereas only 4.9 and 0.9% had received YFV and JEV vaccines. Three out of 1001 (0.03%) participants tested positive solely for ZIKV IgM antibody but not for other flaviviruses. Only one individual had ZIKV IgG antibody. All four donors were negative in the neutralization (confirmation) assay. No viral RNA was detected in any of the samples. Conclusion The null finding of our study refutes WHO's initial fear of global expansion of ZIKV infection including its occurrence in Europe. There appears to be no urgent need to introduce universal screening of donated blood for ZIKV in central Europe at least until the next warm season. Further, Euroimmun anti-Zika ELISA proved to be a highly suitable and reliable test system in populations with high prevalence of TBEV infection and/or immunization.	[Borena, Wegene; Hofer, Tamara; Von Laer, Dorothee] Med Univ Innsbruck, Div Virol, Innsbruck, Austria; [Stiasny, Karin; Aberle, Stephan W.] Med Univ Vienna, Ctr Virol, Vienna, Austria; [Gaber, Manfred] Tyrolean Red Cross Blood Donor Serv, Innsbruck, Austria; [Schennach, Harald] Med Univ Hosp Innsbruck, Cent Inst Blood Transfus & Immunol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Innsbruck	Borena, W (corresponding author), Med Univ Innsbruck, Div Virol, Innsbruck, Austria.	wegene.borena@i-med.ac.at		Stiasny, Karin/0000-0002-1902-8674; von Laer, Dorothee/0000-0001-5825-7237; Borena, Wegene/0000-0001-8011-5825	MFF Tirol [271]	MFF Tirol	Support was provided by MFF Tirol, project Nr. 271. The fund provided was used to buy test kits.	Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664; [Anonymous], WHO DIR GEN SUMM OUT; Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005; Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Gallian P, 2016, BLOOD; Gulland A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2887; Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1739; Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437; Huzly D, 2016, EURO SURVEILL, V21; Kunze U, 2015, CENT EUR J PUBL HEAL, V23, P223; Lupton Kelly, 2016, Br J Nurs, V25, P200, DOI 10.12968/bjon.2016.25.4.198; Musso D, 2014, EURO SURVEILL, V19; Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112; Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163; Stiasny K, 2013, EURO SURVEILL, V18; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348	17	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178175	10.1371/journal.pone.0178175	http://dx.doi.org/10.1371/journal.pone.0178175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542611	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500069
J	Luo, YH; Li, Z; Guo, HS; Cao, HY; Song, CY; Guo, XP; Zhang, YB				Luo, Yanhong; Li, Zhi; Guo, Husheng; Cao, Hongyan; Song, Chunying; Guo, Xingping; Zhang, Yanbo			Predicting congenital heart defects: A comparison of three data mining methods	PLOS ONE			English	Article							BRAIN IMAGE CLASSIFICATION; RISK-FACTORS; WAVELET TRANSFORM; 1ST TRIMESTER; DISEASE; MACHINE; PROFILE; CHINA; MODEL	Congenital heart defects (CHD) is one of the most common birth defects in China. Many studies have examined risk factors for CHD, but their predictive abilities have not been evaluated. In particular, few studies have attempted to predict risks of CHD from, necessarily unbalanced, population-based cross-sectional data. Therefore, we developed and validated machine learning models for predicting, before and during pregnancy, women's risks of bearing children with CHD. We compared the results of these models in a large-scale, comprehensive population-based retrospective cross-sectional epidemiological survey of birth defects in six counties in Shanxi Province, China, covering 2006 to 2008. This contained 78 cases of CHD among 33831 live births. We constructed nine synthetic variables to use in the models: maternal age, annual per capita income, family history, maternal history of illness, nutrition and folic acid deficiency, maternal illness in pregnancy, medication use in pregnancy, environmental risk factors in pregnancy, and unhealthy maternal lifestyle in pregnancy. The machine learning algorithms Weighted Support Vector Machine (WSVM) and Weighted Random Forest (WRF) were trained on, and a logistic regression (Logit) was fitted to, two-thirds of the data. Their predictive abilities were then tested in the remaining data. True positive rate (TPR), true negative rate (TNR), accuracy (ACC), area under the curves (AUC), G-means, and Weighted accuracy (WTacc) were used to compare the classification performance of the models. Median values, from repeating the data partitioning 1000 times, were used in all comparisons. The TPR and TNR of the three classifiers were above 0.65 and 0.93, respectively, better than any reported in the literature. TPR, wtACC, AUC and G were highest for WSVM, showing that it performed best. All three models are precise enough to identify groups at high risk of CHD. They should all be considered for future investigations of other birth defects and diseases.	[Luo, Yanhong; Li, Zhi; Cao, Hongyan; Zhang, Yanbo] Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Shanxi Province, Peoples R China; [Guo, Husheng] Shanxi Univ, Sch Comp & Informat Technol, Taiyuan, Shanxi Province, Peoples R China; [Song, Chunying; Guo, Xingping] Populat & Family Planning Commiss Shanxi Prov, Taiyuan, Shanxi Province, Peoples R China	Shanxi Medical University; Shanxi University	Zhang, YB (corresponding author), Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Shanxi Province, Peoples R China.	sxmuzyb@126.com			National Natural Science Foundation of China [81502897]; Key research and development projects of Shanxi Province [201603D321101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key research and development projects of Shanxi Province	This research was supported by a grant from the National Natural Science Foundation of China, grant no:81502897 (https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list) and Key research and development projects of Shanxi Province, 201603D321101 (http://www.sxinfo.gov.cn/ldxx/index.jhtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from the National Natural Science Foundation of China (grant no:81502897) and Key research and development projects of Shanxi Province (201603D321101). We thank Yuehua Cui, Qing Lv, and Xuejuan Zhang who gave helpful advice on the manuscript.	Agopian AJ, 2012, BIRTH DEFECTS RES A, V94, P141, DOI 10.1002/bdra.22883; Austin PC, 2013, J CLIN EPIDEMIOL, V66, P398, DOI 10.1016/j.jclinepi.2012.11.008; Bahado-Singh RO, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.056; Bhattacharyya S, 2011, DECIS SUPPORT SYST, V50, P602, DOI 10.1016/j.dss.2010.08.008; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Caliskan AC, 2009, TURK KLIN TIP BILIM, V29, P1098; Cao HY, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0783-x; Chen C., 2004, TECHNICAL REPORT; Cooper JN, 2015, COMPUT BIOL MED, V57, P54, DOI 10.1016/j.compbiomed.2014.11.009; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dadvand P, 2009, PAEDIATR PERINAT EP, V23, P58, DOI 10.1111/j.1365-3016.2008.00987.x; Delen D, 2005, ARTIF INTELL MED, V34, P113, DOI 10.1016/j.artmed.2004.07.002; Dilber D, 2010, EUR J PEDIATR, V169, P543, DOI 10.1007/s00431-009-1064-3; Duan FF, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1054-z; Easton JF, 2014, COMPUT BIOL MED, V54, P199, DOI 10.1016/j.compbiomed.2014.09.003; Hill MG, 2014, COMPUT ELECTRON AGR, V108, P250, DOI 10.1016/j.compag.2014.08.011; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kamkar I, 2015, J BIOMED INFORM, V53, P277, DOI 10.1016/j.jbi.2014.11.013; Li Jiangeng, 2009, COMPUTER ENG APPL, V45, P131; Liu SW, 2009, J EPIDEMIOL, V19, P122, DOI 10.2188/jea.JE20080039; Liu YH, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6050142; Luo L., 2006, P 25 IEEE INT C COMP, P1, DOI DOI 10.1109/INFOCOM.2006.114; Musicant D.R., 2003, FLAIRS C, P356; National Health and Family Planning Commission of PRC, 2012, NAT STOCKT REP BIRTH; Patel SS, 2013, PEDIATR CARDIOL, V34, P1535, DOI 10.1007/s00246-013-0775-4; Pino-Mejias R, 2008, J APPL STAT, V35, P233, DOI 10.1080/02664760701832976; Rahman QA, 2015, IEEE T NANOBIOSCI, V14, P505, DOI 10.1109/TNB.2015.2426213; Sainz JA, 2015, AN PEDIATR, V82, P27, DOI 10.1016/j.anpedi.2013.10.039; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Tapak L, 2013, HEALTHC INFORM RES, V19, P177, DOI 10.4258/hir.2013.19.3.177; Wang JF, 2010, BIOMED ENVIRON SCI, V23, P167, DOI 10.1016/S0895-3988(10)60048-7; Wang M, 2014, CHILD NERV SYST, V30, P665, DOI 10.1007/s00381-013-2305-3; Wang SH, 2015, ENTROPY-SWITZ, V17, P6663, DOI 10.3390/e17106663; Wen YL, 2015, FRONT GENET, V6, P64; Wieczorek A, 2008, ULTRASOUND OBST GYN, V31, P284, DOI 10.1002/uog.5177; Yu C.-N. J., 2009, P 26 ANN INT C MACHI, P1169, DOI [10.1145/1553374.1553523, DOI 10.1145/1553374.1553523]; Zhang YD, 2015, INT J IMAG SYST TECH, V25, P317, DOI 10.1002/ima.22144; Zhang YD, 2015, J MED IMAG HEALTH IN, V5, P1395, DOI 10.1166/jmihi.2015.1542	40	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e017781	10.1371/journal.pone.0177811	http://dx.doi.org/10.1371/journal.pone.0177811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542318	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500039
J	Moreira, MA; Lessa, LS; Bortoli, FR; Lopes, A; Xavier, EP; Ceretta, RA; Soanego, FGF; Tomasi, CD; Pires, PDS; Ceretta, LB; Perry, IDS; Simoes, PW				Moreira, Marcelo Aldrighi; Lessa, Luiza Silveira; Bortoli, Francieli Regina; Lopes, Abigail; Xavier, Eduardo Picolo; Ceretta, Renan Antonio; Faustini Soanego, Fernanda Guglielmi; Tomasi, Cristiane Damiani; Simoes Pires, Patricia Duarte; Ceretta, Luciane Bisognin; Schweigert Perry, Ingrid Dalira; Simoes, Priscyla Waleska			Meta-analysis of magnetic resonance imaging accuracy for diagnosis of oral cancer	PLOS ONE			English	Article							SALIVARY-GLAND TUMORS; FINE-NEEDLE-ASPIRATION; CONTRAST-ENHANCED MRI; DIFFERENTIAL-DIAGNOSIS; COMPUTED-TOMOGRAPHY; MALIGNANT-TUMORS; PAROTID TUMORS; DCE-MRI; DIFFUSION; BENIGN	Objective To establish the diagnostic accuracy of magnetic resonance imaging (MRI) as an auxiliary means for the diagnosis of oral cancer through a systematic review and meta-analysis. Methods An exhaustive search of publications from 1986 to 2016 was performed of Medline, Embase and Cochrane (and related databases), including grey literature. Primary diagnostic accuracy studies that assessed oral cancer (target condition) using MRI (index test) were included. Diagnostic threshold, sensitivity and meta-regression analyses were performed. A meta-analysis was performed using Meta-DiSc (R) v. 1.4 software. Results A total of 24 primary studies were assessed, comprising 1,403 oral cancer lesions. Nine studies used diffusion-weighted MRI, with a diagnostic odds ratio (DOR) of 30.7 (95% confidence interval [CI]: 12.7-74.3) and area under the curve (AUC) of 0.917 (95% CI: 0.915-0.918); seven studies used dynamic contrast-enhanced MRI, with a DOR of 48.1 (95% CI: 22.4-103.2) and AUC of 0.936 (95% CI: 0.934-0.937); and 13 studies used traditional MRI, with a DOR of 23.9 (95% CI: 13.2-43.3) and AUC of 0.894 (95% CI: 0.894-0.895). Meta-regression analysis indicated that the magnetic field strength may have influenced the heterogeneity of the results obtained (p = 0.0233) using traditional MRI. Sensitivity analysis revealed a discrete reduction of inconsistency in some subgroups. Conclusion The three types of MRI assessed exhibited satisfactory accuracy compared to biopsy. Considering the relevance of early treatment and screening and that better health care results in improved survival rates and quality of life for oral cancer patients, we suggest the use of MRI as a part of the pre-treatment and monitoring protocol at public health services.	[Moreira, Marcelo Aldrighi; Lessa, Luiza Silveira; Lopes, Abigail; Tomasi, Cristiane Damiani; Ceretta, Luciane Bisognin; Schweigert Perry, Ingrid Dalira; Simoes, Priscyla Waleska] Univ Extremo Sul Catarinense UNESC, Unidade Acad Ciencias Saude UNASAU, Grad Program Publ Hlth PPGSCol, Criciuma, SC, Brazil; [Moreira, Marcelo Aldrighi; Lopes, Abigail; Xavier, Eduardo Picolo; Ceretta, Luciane Bisognin; Simoes, Priscyla Waleska] Univ Extremo Sul Catarinense UNESC, Lab Informat & Commun Technol Hlth TlSaude, Criciuma, SC, Brazil; [Lessa, Luiza Silveira; Ceretta, Renan Antonio; Faustini Soanego, Fernanda Guglielmi; Simoes Pires, Patricia Duarte; Ceretta, Luciane Bisognin; Simoes, Priscyla Waleska] Univ Extremo Sul Catarinense UNESC, Unidade Acad Ciencias Saude UNASAU, Dent Course, Criciuma, SC, Brazil; [Bortoli, Francieli Regina] Univ Fed Santa Catarina, Florianopolis, SC, Brazil; [Simoes, Priscyla Waleska] Univ Fed ABC UFABC, Engn Modeling & Appl Social Sci Ctr CECS, Sao Bernardo Do Campo, SP, Brazil	Universidade do Extremo Sul Catarinense; Universidade do Extremo Sul Catarinense; Universidade do Extremo Sul Catarinense; Universidade Federal de Santa Catarina (UFSC)	Simoes, PW (corresponding author), Univ Extremo Sul Catarinense UNESC, Unidade Acad Ciencias Saude UNASAU, Grad Program Publ Hlth PPGSCol, Criciuma, SC, Brazil.; Simoes, PW (corresponding author), Univ Extremo Sul Catarinense UNESC, Lab Informat & Commun Technol Hlth TlSaude, Criciuma, SC, Brazil.; Simoes, PW (corresponding author), Univ Extremo Sul Catarinense UNESC, Unidade Acad Ciencias Saude UNASAU, Dent Course, Criciuma, SC, Brazil.; Simoes, PW (corresponding author), Univ Fed ABC UFABC, Engn Modeling & Appl Social Sci Ctr CECS, Sao Bernardo Do Campo, SP, Brazil.	pritsimoes@gmail.com	Simões, Priscyla Waleska/D-7834-2013; TOMASI, CRISTIANE/J-4792-2017	Simões, Priscyla Waleska/0000-0003-1782-0542; TOMASI, CRISTIANE/0000-0002-1813-765X; Ceretta, Renan Antonio/0000-0002-5586-9550				Acha Amelia, 2005, Med Oral Patol Oral Cir Bucal, V10, P95; Aghaghazvini L, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140166; Ai ST, 2013, FRONT BIOSCI-LANDMRK, V18, P1098, DOI 10.2741/4166; Alibek S, 2007, ACAD RADIOL, V14, P701, DOI 10.1016/j.acra.2007.03.004; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; AUSTIN JR, 1992, HEAD NECK-J SCI SPEC, V14, P58, DOI 10.1002/hed.2880140113; Bammer Roland, 2003, Top Magn Reson Imaging, V14, P461, DOI 10.1097/00002142-200312000-00004; Bartels S, 2000, HEAD NECK-J SCI SPEC, V22, P781, DOI 10.1002/1097-0347(200012)22:8<781::AID-HED6>3.0.CO;2-B; Bernstein JM, 2014, ORAL ONCOL, V50, P963, DOI 10.1016/j.oraloncology.2014.07.011; Chikui T, 2000, ORAL SURG ORAL MED O, V90, P369, DOI 10.1067/moe.2000.107355; Christe A, 2011, AM J NEURORADIOL, V32, P1202, DOI 10.3174/ajnr.A2520; Deeks JJ, 1996, BAILLIERE CLIN OB GY, V10, P613, DOI 10.1016/S0950-3552(96)80008-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eida S, 2007, AM J NEURORADIOL, V28, P116; Fassnacht W, 2013, B-ENT, V9, P83; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fontes KBFD, 2013, BRAZ ORAL RES, V27, P122, DOI 10.1590/S1806-83242013000100018; Hayashi T, 2003, AM J NEURORADIOL, V24, P1330; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hisatomi M, 2007, ORAL ONCOL, V43, P940, DOI 10.1016/j.oraloncology.2006.11.009; Inci E, 2010, TURK KLIN TIP BILIM, V30, P1339, DOI 10.5336/medsci.2009-14994; Inohara H, 2008, ACTA OTO-LARYNGOL, V128, P1152, DOI 10.1080/00016480701827533; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Ishii J, 1999, ORAL SURG ORAL MED O, V87, P39, DOI 10.1016/S1079-2104(99)70292-1; Kato H, 2015, EUR RADIOL, V25, P3247, DOI 10.1007/s00330-015-3755-7; Kim S, 2008, MAGN RESON IMAGING C, V16, P585, DOI 10.1016/j.mric.2008.07.006; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; King AD, 2004, EUR J RADIOL, V52, P264, DOI 10.1016/j.ejrad.2004.03.004; Knottnerus JA, 2003, J CLIN EPIDEMIOL, V56, P1118, DOI 10.1016/S0895-4356(03)00206-3; Lam PD, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140685; Langlais R P, 2000, Dent Clin North Am, V44, P411; Lee FKH, 2012, EUR J RADIOL, V81, P784, DOI 10.1016/j.ejrad.2011.01.089; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lenz M, 2000, EUR J RADIOL, V33, P203, DOI 10.1016/S0720-048X(99)00143-6; Li CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112267; LLOYD GAS, 1986, BRIT J RADIOL, V59, P675, DOI 10.1259/0007-1285-59-703-675; Macaskill P, 2010, COCHRANE HDB SYSTEMA, V1st; Matsuzaki H, 2012, EUR J RADIOL, V81, P3306, DOI 10.1016/j.ejrad.2012.04.009; Mignogna MD, 2004, EUR J CANCER PREV, V13, P139, DOI 10.1097/00008469-200404000-00008; Motoori K, 2005, J COMPUT ASSIST TOMO, V29, P506, DOI 10.1097/01.rct.0000164672.34261.33; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Okamoto K, 2000, EUR RADIOL, V10, P1342, DOI 10.1007/s003309900310; Paris J, 2005, EUR ARCH OTO-RHINO-L, V262, P27, DOI 10.1007/s00405-003-0730-8; Prades J-M, 2007, Morphologie, V91, P44, DOI 10.1016/j.morpho.2007.05.003; Prehn RB, 1998, OTOLARYNG HEAD NECK, V119, P628, DOI 10.1016/S0194-5998(98)70024-5; Ram S, 2005, INT J ORAL MAX SURG, V34, P521, DOI 10.1016/j.ijom.2004.10.008; Reitsma H, 2009, ASSESSING METHODOLOG; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rudack C, 2007, HEAD FACE MED, V3, P1; Sakamoto M, 2014, INT J ORAL MAX SURG, V43, P1035, DOI 10.1016/j.ijom.2014.03.008; Schueler S, 2012, ANN INTERN MED, V156, P323, DOI 10.7326/0003-4819-156-4-201202210-00018; Sciubba JJ, 2001, J AM DENT ASSOC, V132, p12S, DOI 10.14219/jada.archive.2001.0380; Silvers AR, 1998, RADIOL CLIN N AM, V36, P941, DOI 10.1016/S0033-8389(05)70070-1; SOM PM, 1988, J COMPUT ASSIST TOMO, V12, P65, DOI 10.1097/00004728-198801000-00012; Som PM, 1991, HEAD NECK IMAGING, P277; Suenaga S, 2001, DENTOMAXILLOFAC RAD, V30, P314, DOI 10.1038/sj.dmfr.4600634; Sumi M, 2014, EUR RADIOL, V24, P223, DOI 10.1007/s00330-013-3002-z; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Sun J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/395895; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Takashima K, 1997, INFECT IMMUN, V65, P257, DOI 10.1128/IAI.65.1.257-260.1997; Trullenque-Eriksson A, 2009, MED ORAL PATOL ORAL, V14, pE210; TSURUDA JS, 1990, AM J ROENTGENOL, V155, P1059, DOI 10.2214/ajr.155.5.2120936; Turner F, 2008, Rev Laryngol Otol Rhinol (Bord), V129, P175; Vandecaveye V, 2007, JBR-BTR, V90, P492; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Weber AL, 2003, NEUROIMAG CLIN N AM, V13, P443, DOI 10.1016/S1052-5149(03)00037-6; Werning JW., 2011, ORAL CANC DIAGNOSIS; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yabuuchi H, 2003, RADIOLOGY, V226, P345, DOI 10.1148/radiol.2262011486; Yerli H, 2010, DENTOMAXILLOFAC RAD, V39, P349, DOI 10.1259/dmfr/15047967; Yuan J, 2012, CLIN RADIOL, V67, P216, DOI 10.1016/j.crad.2011.07.052; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	73	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177462	10.1371/journal.pone.0177462	http://dx.doi.org/10.1371/journal.pone.0177462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542622	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500026
J	Norregaard, K; Jorgensen, JT; Simon, M; Melander, F; Kristensen, LK; Bendix, PM; Andresen, TL; Oddershede, LB; Kjaer, A				Norregaard, Kamilla; Jorgensen, Jesper T.; Simon, Marina; Melander, Fredrik; Kristensen, Lotte K.; Bendix, Pol M.; Andresen, Thomas L.; Oddershede, Lene B.; Kjaer, Andreas			F-18-FDG PET/CT-based early treatment response evaluation of nanoparticle-assisted photothermal cancer therapy	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; GOLD NANOSHELLS; NANOMEDICINE; ABLATION; TUMORS; NANOMATRYOSHKAS; TRANSDUCERS; PENETRATION; MECHANISM; NANOCAGES	Within the field of nanoparticle-assisted photothermal cancer therapy, focus has mostly been on developing novel heat-generating nanoparticles with the right optical and dimensional properties. Comparison and evaluation of their performance in tumor-bearing animals are commonly assessed by changes in tumor volume; however, this is usually a late-occurring event. This study implements 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography imaging to perform early evaluation of the treatment outcome of photothermal therapy. Silica-gold nanoshells (NS) are administered intravenously to nude mice bearing human neuroendocrine tumor xenografts and the tumors are irradiated by a near-infrared laser. The animals are positron emission tomography scanned with 2-deoxy-2-[F-18] fluoro-D-glucose one day before and one day after treatment. Using this setup, a significant decrease in tumor uptake of 2-deoxy-2-[F-18] fluoro-D-glucose is found already one day after therapy in the group receiving NS and laser treatment compared to control animals. At this time point no change in tumor volume can be detected. Moreover, the change in tumor uptake, is used to stratify the animals into responders and non-responders, where the responding group matched improved survival. Overall, these findings support the use of 2-deoxy-2-[F-18] fluoroD- glucose positron emission tomography imaging for preclinical and clinical evaluation and optimization of photothermal therapy.	[Norregaard, Kamilla; Jorgensen, Jesper T.; Simon, Marina; Kristensen, Lotte K.; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Norregaard, Kamilla; Jorgensen, Jesper T.; Simon, Marina; Kristensen, Lotte K.; Kjaer, Andreas] Rigshosp, Cluster Mol Imaging, Copenhagen, Denmark; [Norregaard, Kamilla; Jorgensen, Jesper T.; Simon, Marina; Kristensen, Lotte K.; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Melander, Fredrik; Andresen, Thomas L.] Tech Univ Denmark, DTU Nanotech, Ctr Nanomed & Theranost, Lyngby, Denmark; [Bendix, Pol M.; Oddershede, Lene B.] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Technical University of Denmark; University of Copenhagen; Niels Bohr Institute	Kjaer, A (corresponding author), Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark.; Kjaer, A (corresponding author), Rigshosp, Cluster Mol Imaging, Copenhagen, Denmark.; Kjaer, A (corresponding author), Univ Copenhagen, Copenhagen, Denmark.	akjaer@sund.ku.dk	Jørgensen, Jesper Tranekjær/AAY-3085-2020; Kjaer, Andreas/E-8932-2015	Jørgensen, Jesper Tranekjær/0000-0001-7573-9596; Simon, Marina/0000-0001-8133-8668; Norregaard, Kamilla/0000-0003-1953-9703; Kjaer, Andreas/0000-0002-2706-5547; Bendix, Poul Martin/0000-0001-8838-8887; Andresen, Thomas Lars/0000-0002-1048-127X; Melander, Fredrik/0000-0002-3670-6633	Lun beckFonden [506800-50-34062]; Novo Nordisk Foundation [NNF140C0011361]; Lundbeck Foundation; Novo Nordisk Foundation; Lundbeck Foundation [R105-2011-9829] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0017912, NNF14OC0011361] Funding Source: researchfish	Lun beckFonden; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Lun beckFonden (506800-50-34062), http://www.lundbeckfonden.com, LBO and AK, and by Novo Nordisk Foundation (NNF140C0011361), http://novonordiskfonden.dk, LBO and AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support from the Lundbeck Foundation and Novo Nordisk Foundation is gratefully acknowledged.	Ayala-Orozco C, 2014, J CONTROL RELEASE, V191, P90, DOI 10.1016/j.jconrel.2014.07.038; Ayala-Orozco C, 2014, ACS NANO, V8, P6372, DOI 10.1021/nn501871d; Bardhan R, 2010, NANO LETT, V10, P4920, DOI 10.1021/nl102889y; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Chen F, 2015, NANOMEDICINE-UK, V10, P1, DOI 10.2217/nnm.14.186; Chen JY, 2010, SMALL, V6, P811, DOI 10.1002/smll.200902216; Choi CHJ, 2010, P NATL ACAD SCI USA, V107, P1235, DOI 10.1073/pnas.0914140107; Coughlin AJ, 2014, SMALL, V10, P556, DOI 10.1002/smll.201302217; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; Day ES, 2011, J NEURO-ONCOL, V104, P55, DOI 10.1007/s11060-010-0470-8; Gad SC, 2012, INT J TOXICOL, V31, P584, DOI 10.1177/1091581812465969; Hansen AE, 2015, ACS NANO, V9, P6985, DOI 10.1021/acsnano.5b01324; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Huang XH, 2010, ACS NANO, V4, P5887, DOI 10.1021/nn102055s; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Jorgensen JT, 2016, SCI REP-UK, V6, DOI 10.1038/srep30076; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Liu Y, 2015, THERANOSTICS, V5, P946, DOI 10.7150/thno.11974; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Pang B, 2016, ACS NANO, V10, P3121, DOI 10.1021/acsnano.5b07968; Schwartz JA, 2009, CANCER RES, V69, P1659, DOI 10.1158/0008-5472.CAN-08-2535; Stern JM, 2008, J UROLOGY, V179, P748, DOI 10.1016/j.juro.2007.09.018; Stern JM, 2016, INT J TOXICOL, V35, P38, DOI 10.1177/1091581815600170; Stolik S, 2000, J PHOTOCH PHOTOBIO B, V57, P90, DOI 10.1016/S1011-1344(00)00082-8; Sun XL, 2014, ACS NANO, V8, P8438, DOI 10.1021/nn502950t; Sykes EA, 2014, ACS NANO, V8, P5696, DOI 10.1021/nn500299p; Wang YC, 2013, ACS NANO, V7, P2068, DOI 10.1021/nn304332s; Webb JA, 2014, NANOSCALE, V6, P2502, DOI 10.1039/c3nr05112a; Xiao YL, 2012, THERANOSTICS, V2, P757, DOI 10.7150/thno.4756; Xie HA, 2010, INT J PHARMACEUT, V395, P324, DOI 10.1016/j.ijpharm.2010.06.005; Zhang F, 2015, THERANOSTICS, V5, P1444, DOI 10.7150/thno.13398	34	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177997	10.1371/journal.pone.0177997	http://dx.doi.org/10.1371/journal.pone.0177997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542311	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500052
J	Teixeira, AD; Games, PD; Katz, BB; Tomich, JM; Zanuncio, JAC; Serrao, JE				Teixeira, Aparecida das Dores; Games, Patricia D.; Katz, Benjamin B.; Tomich, John M.; Zanuncio, Jose A. C.; Serrao, Jose Eduardo			Proteomic analysis in the Dufour's gland of Africanized Apis mellifera workers (Hymenoptera: Apidae)	PLOS ONE			English	Article							BOMBUS-TERRESTRIS L-(HYMENOPTERA; OXIDATIVE STRESS-RESPONSE; ODORANT-BINDING PROTEINS; HONEY-BEE; PHEROMONE BINDING; ARGININE KINASE; QUEEN-SIGNAL; EXPRESSION; CERANA; CASTE	The colony of eusocial bee Apis mellifera has a reproductive queen and sterile workers performing tasks such as brood care and foraging. Chemical communication plays a crucial role in the maintenance of sociability in bees with many compounds released by the exocrine glands. The Dufour's gland is a non-paired gland associated with the sting apparatus with important functions in the communication between members of the colony, releasing volatile chemicals that influence workers roles and tasks. However, the protein content in this gland is not well studied. This study identified differentially expressed proteins in the Dufour's glands of nurse and forager workers of A. mellifera through 2D-gel electrophoresis and mass spectrometry. A total of 131 spots showed different expression between nurse and forager bees, and 28 proteins were identified. The identified proteins were categorized into different functions groups including protein, carbohydrate, energy and lipid metabolisms, cytoskeleton-associated proteins, detoxification, homeostasis, cell communication, constitutive and allergen. This study provides new insights of the protein content in the Dufour's gland contributing to a more complete understanding of the biological functions of this gland in honeybees.	[Teixeira, Aparecida das Dores; Games, Patricia D.; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Katz, Benjamin B.; Tomich, John M.] Kansas State Univ, Biotechnol Core Facil, Manhattan, KS 66506 USA; [Katz, Benjamin B.; Tomich, John M.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Zanuncio, Jose A. C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Kansas State University; Kansas State University; Universidade Federal de Vicosa	Serrao, JE (corresponding author), Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil.	jeserrao@ufv.br		Games, Patricia/0000-0001-7603-2816; TOMICH, JOHN/0000-0001-7848-8307; Serrao, Jose Eduardo/0000-0002-0477-4252	Brazilian research agencies CNPq; FAPEMIG	Brazilian research agencies CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by Brazilian research agencies CNPq and FAPEMIG. These funder supplied grants for usage in reagents. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla FC, 2006, REV BRAS ENTOMOL, V50, P153, DOI 10.1590/S0085-56262006000200002; Abdalla Fabio Camargo, 2001, Revista Brasileira de Entomologia, V45, P123; Abdalla FC, 2004, J BRAZIL CHEM SOC, V15, P621, DOI 10.1590/S0103-50532004000500002; Abdalla FC, 1999, NETH J ZOOL, V49, P139, DOI 10.1163/156854299505650; Abdalla FC, 2004, ACTA HISTOCHEM CYTOC, V37, P65, DOI 10.1267/ahc.37.65; Abdalla FC, 1999, NETH J ZOOL, V49, P251, DOI 10.1163/156854299505722; Abdalla FC, 2004, REV BRAS ENTOMOL, V48, P1; Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1; Amsalem E, 2009, P R SOC B, V276, P1295, DOI 10.1098/rspb.2008.1688; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; BARROWS EM, 1986, J KANSAS ENTOMOL SOC, V59, P480; Blatt J, 2001, J EXP BIOL, V204, P2709; Blomquist G. J., 2012, INSECT ENDOCRINOLOGY, P523; BOITEUX A, 1981, PHILOS T ROY SOC B, V293, P5, DOI 10.1098/rstb.1981.0056; Bonckaert W, 2012, J CHEM ECOL, V38, P42, DOI 10.1007/s10886-011-0055-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chen XB, 2015, CELL STRESS CHAPERON, V20, P169, DOI 10.1007/s12192-014-0535-2; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cruz-Landim C., 1996, ANAIS SEGUNDO ENCONT, V2, P67; DOUMEN C, 1990, J COMP PHYSIOL B, V160, P449, DOI 10.1007/BF01075677; Dunkov B, 2006, INSECT BIOCHEM MOLEC, V36, P300, DOI 10.1016/j.ibmb.2006.01.007; Elekonich MM, 2009, CELL STRESS CHAPERON, V14, P219, DOI 10.1007/s12192-008-0063-z; Elias-Santos D, 2013, APIDOLOGIE, V44, P684, DOI 10.1007/s13592-013-0217-6; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Erban T, 2014, APIDOLOGIE, V45, P53, DOI 10.1007/s13592-013-0230-9; Esteves FG, 2017, J PROTEOMICS, V151, P122, DOI 10.1016/j.jprot.2016.01.009; Falcon T, 2014, INSECT BIOCHEM MOLEC, V50, P68, DOI 10.1016/j.ibmb.2014.04.006; Fang Y, 2014, MOL CELL PROTEOMICS, V13, P2306, DOI 10.1074/mcp.M114.037846; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Fruttero LL, 2014, INSECT BIOCHEM MOLEC, V52, P1, DOI 10.1016/j.ibmb.2014.06.002; Garcia L, 2009, J PROTEOME RES, V8, P1464, DOI 10.1021/pr800823r; Garibaldi LA, 2016, SCIENCE, V351, P388, DOI 10.1126/science.aac7287; GMEINBAUER R, 1993, J INSECT PHYSIOL, V39, P959, DOI 10.1016/0022-1910(93)90005-C; Grimaldi David, 2005, pi; Grunwald T, 2006, J ALLERGY CLIN IMMUN, V117, P848, DOI 10.1016/j.jaci.2005.12.1331; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Hrassnigg N, 2003, AMINO ACIDS, V24, P205, DOI 10.1007/s00726-002-0311-y; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Katzav-Gozansky T, 2004, P ROY SOC B-BIOL SCI, V271, P2065, DOI 10.1098/rspb.2004.2839; Katzav-Gozansky T, 2003, INSECT SOC, V50, P20, DOI 10.1007/s000400300003; Katzav-Gozansky T, 2002, APIDOLOGIE, V33, P525, DOI 10.1051/apido:2002035; Katzav-Gozansky T, 2000, J INSECT PHYSIOL, V46, P993, DOI 10.1016/S0022-1910(99)00209-7; Katzav-Gozansky T, 2007, NATURWISSENSCHAFTEN, V94, P407, DOI 10.1007/s00114-006-0206-y; Kim BY, 2014, J ASIA-PAC ENTOMOL, V17, P695, DOI 10.1016/j.aspen.2014.07.002; Konus M, 2013, COMP BIOCHEM PHYS D, V8, P152, DOI 10.1016/j.cbd.2013.04.001; Krishna SH, 2002, CATAL REV, V44, P499, DOI 10.1081/CR-120015481; Kucharski R, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0007; Lattorff HMG, 2013, TRENDS GENET, V29, P641, DOI 10.1016/j.tig.2013.08.002; Li JK, 2010, J PROTEOME RES, V9, P6578, DOI 10.1021/pr100768t; Li JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013455; Malka O, 2008, NATURWISSENSCHAFTEN, V95, P553, DOI 10.1007/s00114-008-0358-z; Martin SJ, 2005, APIDOLOGIE, V36, P543, DOI 10.1051/apido:2005041; Martin SJ, 2004, NATURWISSENSCHAFTEN, V91, P232, DOI 10.1007/s00114-004-0517-9; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Michener CD, 1974, SOCIAL BEHAV BEES; MINGARRO I, 1995, FEBS LETT, V372, P131, DOI 10.1016/0014-5793(95)00964-B; Mitra A, 2013, J HYMENOPT RES, V35, P33, DOI 10.3897/JHR.35.4783; Mitra A, 2011, J INSECT PHYSIOL, V57, P280, DOI 10.1016/j.jinsphys.2010.11.014; Miura E, 2007, PLANT CELL, V19, P1313, DOI 10.1105/tpc.106.049270; MUNNEKE LR, 1988, BIOCHEM GENET, V26, P131, DOI 10.1007/BF00555494; Nelson DL, 2014, PRINCIPIOS BIOQUIRNI; NICHOL H, 1990, TISSUE CELL, V22, P767, DOI 10.1016/0040-8166(90)90042-8; PAGE RE, 1981, ENVIRON ENTOMOL, V10, P359, DOI 10.1093/ee/10.3.359; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; PICKETT JA, 1982, J CHEM ECOL, V8, P163, DOI 10.1007/BF00984013; Richard FJ, 2011, J CHEM ECOL, V37, P1027, DOI 10.1007/s10886-011-9999-z; Roat TC, 2014, ECOTOXICOLOGY, V23, P1659, DOI 10.1007/s10646-014-1305-8; Scharlaken B, 2007, ARCH INSECT BIOCHEM, V65, P223, DOI 10.1002/arch.20179; Schwaighofer A, 2014, BIOCHEM BIOPH RES CO, V446, P1042, DOI 10.1016/j.bbrc.2014.03.054; SEVERSON DW, 1990, EXPERIENTIA, V46, P737, DOI 10.1007/BF01939951; Tan K, 2015, J INSECT PHYSIOL, V82, P33, DOI 10.1016/j.jinsphys.2015.08.003; Van der Horst DJ, 2009, MOL CELL BIOCHEM, V326, P105, DOI 10.1007/s11010-008-0011-3; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Winston M., 1987, The biology of the honey bee.; Wolschin F, 2007, ANAL BIOANAL CHEM, V389, P1095, DOI 10.1007/s00216-007-1523-5; Woyciechowski M, 2012, CURR BIOL, V22, P707, DOI 10.1016/j.cub.2012.02.063; Yan HR, 2013, CELL STRESS CHAPERON, V18, P415, DOI 10.1007/s12192-012-0394-7; Yao PB, 2014, FREE RADICAL BIO MED, V68, P335, DOI 10.1016/j.freeradbiomed.2013.12.020; Yao PB, 2013, J INSECT PHYSIOL, V59, P273, DOI 10.1016/j.jinsphys.2012.11.005; Zheng AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020428; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009	86	2	2	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177415	10.1371/journal.pone.0177415	http://dx.doi.org/10.1371/journal.pone.0177415			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542566	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500023
J	Die, JV; Arora, R; Rowland, LJ				Die, Jose V.; Arora, Rajeev; Rowland, Lisa J.			Proteome dynamics of cold-acclimating Rhododendron species contrasting in their freezing tolerance and thermonasty behavior	PLOS ONE			English	Article							LOW-TEMPERATURE TOLERANCE; BOX RNA HELICASE; PERSICA L BATSCH; ARABIDOPSIS-THALIANA; SEASONAL-CHANGES; 25-KDA DEHYDRIN; GENE-EXPRESSION; LEAF MOVEMENTS; HARDINESS; STRESS	To gain a better understanding of cold acclimation in rhododendron and in woody perennials in general, we used the 2D-DIGE technique to analyze the rhododendron proteome during the seasonal development of freezing tolerance. We selected two species varying in their cold acclimation ability as well as their thermonasty response (folding of leaves in response to low temperature). Proteins were extracted from leaves of non-acclimated (NA) and cold acclimated (CA) plants of the hardier thermonastic species, R. catawbiense (Cata.), and from leaves of cold acclimated plants of the less hardy, non-thermonastic R. ponticum (Pont.). All three protein samples (Cata. NA, Cata. CA, and Pont. CA) were labeled with different CyDyes and separated together on a single gel. Triplicate gels were run and protein profiles were compared resulting in the identification of 72 protein spots that consistently had different abundances in at least one pair-wise comparison. From the 72 differential spots, we chose 56 spots to excise and characterize further by mass spectrometry (MS). Changes in the proteome associated with the seasonal development of cold acclimation were identified from the Cata. CA-Cata. NA comparisons. Differentially abundant proteins associated with the acquisition of superior freezing tolerance and with the thermonastic response were identified from the Cata. CA-Pont. CA comparisons. Our results indicate that cold acclimation in rhododendron involves increases in abundance of several proteins related to stress (freezing/desiccation tolerance), energy and carbohydrate metabolism, regulation/signaling, secondary metabolism (possibly involving cell wall remodeling), and permeability of the cell membrane. Cold acclimation also involves decreases in abundance of several proteins involved in photosynthesis. Differences in freezing tolerance between genotypes can probably be attributed to observed differences in levels of proteins involved in these functions. Also differences in freezing tolerance may be attributed to higher levels of some constitutive protective proteins in Cata. than in Pont. that may be required to overcome freeze damage, such as glutathione peroxidase, glutamine synthetase, and a plastid-lipid-associated protein.	[Die, Jose V.; Rowland, Lisa J.] ARS, USDA, Beltsville, MD 20705 USA; [Arora, Rajeev] Iowa State Univ, Dept Hort, Ames, IA USA	United States Department of Agriculture (USDA); Iowa State University	Rowland, LJ (corresponding author), ARS, USDA, Beltsville, MD 20705 USA.	Jeannine.Rowland@ars.usda.gov	Die, Jose V./H-3381-2019	Die, Jose V./0000-0002-7506-8590				Amme S, 2006, J EXP BOT, V57, P1537, DOI 10.1093/jxb/erj129; Arora R, 1997, PHYSIOL PLANTARUM, V101, P8, DOI 10.1034/j.1399-3054.1997.1010102.x; ARORA R, 1994, PLANT PHYSIOL, V105, P95, DOI 10.1104/pp.105.1.95; ARORA R, 1992, PLANT PHYSIOL, V99, P1562, DOI 10.1104/pp.99.4.1562; Baier M, 2005, J EXP BOT, V56, P1449, DOI 10.1093/jxb/eri161; Bertrand A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0751-2; Cansev A, 2009, J AGR SCI-CAMBRIDGE, V147, P51, DOI 10.1017/S0021859608008058; Chen KT, 2013, PLANT CELL ENVIRON, V36, P892, DOI 10.1111/pce.12027; Cutler AJ, 1999, TRENDS PLANT SCI, V4, P472, DOI 10.1016/S1360-1385(99)01497-1; Dai XB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-321; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; Die JV, 2016, ENVIRON EXP BOT, V124, P11, DOI 10.1016/j.envexpbot.2015.12.003; Die JV, 2014, ENVIRON EXP BOT, V106, P87, DOI 10.1016/j.envexpbot.2013.12.017; ESEN A, 1978, ANAL BIOCHEM, V89, P264, DOI 10.1016/0003-2697(78)90749-2; Fujii K, 2005, PROTEOMICS, V5, P4274, DOI 10.1002/pmic.200401286; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guan QM, 2013, PLANT CELL, V25, P342, DOI 10.1105/tpc.112.108340; Gusta LV, 2013, PHYSIOL PLANTARUM, V147, P4, DOI 10.1111/j.1399-3054.2012.01611.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harris GC, 2006, PLANT SCI, V170, P314, DOI 10.1016/j.plantsci.2005.08.024; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Herman EM, 2006, J EXP BOT, V57, P3601, DOI 10.1093/jxb/erl111; Janmohammadi M, 2015, PHYTOCHEMISTRY, V117, P76, DOI 10.1016/j.phytochem.2015.06.003; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Karlson D, 2002, J BIOL CHEM, V277, P35248, DOI 10.1074/jbc.M205774200; Kim JY, 2007, PLANT J, V50, P439, DOI 10.1111/j.1365-313X.2007.03057.x; Kim MH, 2009, J BIOL CHEM, V284, P23454, DOI 10.1074/jbc.M109.025791; Knight MR, 2012, NEW PHYTOL, V195, P737, DOI 10.1111/j.1469-8137.2012.04239.x; Kosova K, 2015, INT J MOL SCI, V16, P20913, DOI 10.3390/ijms160920913; Langenkamper G, 2001, J EXP BOT, V52, P1545, DOI 10.1093/jexbot/52.360.1545; Levitt J, 1980, CHILLING FREEZING HI; Li B, 2015, FRONT PLANT SCI, V6, P1600; Lim C. C., 1998, American Rhododendron Society Journal, V52, P143; Lim CC, 1998, J AM SOC HORTIC SCI, V123, P246, DOI 10.21273/JASHS.123.2.246; Lim CC, 1999, THEOR APPL GENET, V99, P912, DOI 10.1007/s001220051312; Lim CC, 2014, FRONT PLANT SCI, V5, P1562; Marian CO, 2004, NEW PHYTOL, V161, P773, DOI 10.1111/j.1469-8137.2003.01001.x; Nilsen ET, 2014, ENVIRON EXP BOT, V106, P34, DOI 10.1016/j.envexpbot.2014.01.005; NILSEN ET, 1992, BOT J LINN SOC, V110, P205, DOI 10.1111/j.1095-8339.1992.tb00291.x; Oquist G, 2003, ANNU REV PLANT BIOL, V54, P329, DOI 10.1146/annurev.arplant.54.072402 .115741; Peng YH, 2008, PHYSIOL PLANTARUM, V132, P44, DOI 10.1111/j.1399-3054.2007.00988.x; R_Core_Team, 2015, R LANG ENV STAT COMP; Renaut J, 2006, PHYSIOL PLANTARUM, V126, P97, DOI 10.1111/j.1399-3054.2006.00617.x; Renaut J, 2004, PLANT BIOLOGY, V6, P81, DOI 10.1055/s-2004-815733; Renaut J, 2008, TREE GENET GENOMES, V4, P589, DOI 10.1007/s11295-008-0134-4; Rstudio Team, 2015, RSTUDIO INT DEV R; SAKAI A, 1986, J AM SOC HORTIC SCI, V111, P273; Sakai A, 1987, COLD ACCLIMATION PLA, P97; Salzman RA, 1996, PLANT CELL ENVIRON, V19, P713, DOI 10.1111/j.1365-3040.1996.tb00406.x; Strimbeck GR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00884; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Wang W, 2006, ELECTROPHORESIS, V27, P2782, DOI 10.1002/elps.200500722; Wang X, 2009, PLANT SCI, V177, P607, DOI 10.1016/j.plantsci.2009.08.009; Wang X, 2008, J AM SOC HORTIC SCI, V133, P768, DOI 10.21273/JASHS.133.6.768; Wei H, 2005, THEOR APPL GENET, V111, P1347, DOI 10.1007/s00122-005-0064-6; Wei H, 2005, PLANTA, V221, P406, DOI 10.1007/s00425-004-1440-1; WEISER CJ, 1970, SCIENCE, V169, P1269, DOI 10.1126/science.169.3952.1269; Wisniewski M, 2003, HORTSCIENCE, V38, P952, DOI 10.21273/HORTSCI.38.5.952; Wisniewski ME, 1993, CYTOLOGY HISTOLOGY H, P299; Youssef A, 2010, PLANT J, V61, P436, DOI 10.1111/j.1365-313X.2009.04067.x; Zarter CR, 2006, NEW PHYTOL, V172, P272, DOI 10.1111/j.1469-8137.2006.01815.x; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005	64	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177389	10.1371/journal.pone.0177389	http://dx.doi.org/10.1371/journal.pone.0177389			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542212	gold, Green Submitted, Green Published			2022-12-27	WOS:000402058800017
J	Flokou, A; Aletras, V; Niakas, D				Flokou, Angeliki; Aletras, Vassilis; Niakas, Dimitris			A window-DEA based efficiency evaluation of the public hospital sector in Greece during the 5-year economic crisis	PLOS ONE			English	Article							TOTAL FACTOR PRODUCTIVITY; HEALTH-CARE; PERFORMANCE; UNEMPLOYMENT; BOOTSTRAP; IRELAND; MODELS; SCORES; OUTPUT; COST	The main objective of this study was to apply the non-parametric method of Data Envelopment Analysis (DEA)to measure the efficiency of Greek NHS hospitals between 2009-2013. Hospitals were divided into four separate groups with common characteristics which allowed comparisons to be carried out in the context of increased homogeneity. The window-DEA method was chosen since it leads to increased discrimination on the results especially when applied to small samples and it enables year-by-year comparisons of the results. Three inputs -hospital beds, physicians and other health professionals-and three outputs-hospitalized cases, surgeries and outpatient visits-were chosen as production variables in an input-oriented 2-year window DEA model for the assessment of technical and scale efficiency as well as for the identification of returns to scale. The Malmquist productivity index together with its components (i.e. pure technical efficiency change, scale efficiency change and technological scale) were also calculated in order to analyze the sources of productivity change between the first and last year of the study period. In the context of window analysis, the study identified the individual efficiency trends together with "all-windows" best and worst performers and revealed that a high level of technical and scale efficiency was maintained over the entire 5-year period. Similarly, the relevant findings of Malmquist productivity index analysis showed that both scale and pure technical efficiency were improved in 2013 whilst technological change was found to be in favor of the two groups with the largest hospitals.	[Flokou, Angeliki; Aletras, Vassilis; Niakas, Dimitris] Hellen Open Univ, Sch Social Sci, Patras, Greece; [Aletras, Vassilis] Univ Macedonia, Dept Business Adm, Thessaloniki, Greece	Hellenic Open University; University of Macedonia	Flokou, A (corresponding author), Hellen Open Univ, Sch Social Sci, Patras, Greece.	aggi@flokou.gr		Niakas, Dimitris/0000-0003-0528-755X; ALETRAS, VASSILIS/0000-0002-3367-7777				Aletras V, 2007, HEALTH POLICY, V83, P236, DOI 10.1016/j.healthpol.2007.01.008; Asmild M, 2004, J PROD ANAL, V21, P67, DOI 10.1023/B:PROD.0000012453.91326.ec; Athanassopoulos A, 2001, EUR J OPER RES, V133, P416, DOI 10.1016/S0377-2217(00)00180-6; ATKINSON SE, 1995, J PROD ANAL, V6, P137, DOI 10.1007/BF01073408; Avkiran N.K., 2004, STUD EC FINANCE, V22, P61, DOI DOI 10.1108/EB043383; BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078; Berg S.A., 1992, SCANDINAVIAN J EC, V9, P89; CAVES DW, 1982, ECONOMETRICA, V50, P1393, DOI 10.2307/1913388; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Charnes A., 1984, ANN OPERATIONS RES, V2, P95, DOI [https://doi.org/10.1007/BF01874734, DOI 10.1007/BF01874734, 10.1007/BF01874734]; Charnes A., 1994, DATA ENVELOPMENT ANA; Chilingerian J, 2011, HDB DATA ENVELOPMENT, P495; Chung SH, 2008, EXPERT SYST APPL, V35, P379, DOI 10.1016/j.eswa.2007.07.011; Cooper WW, 2011, INT SER OPER RES MAN, V164, P1, DOI 10.1007/978-1-4419-6151-8_1; Cooper WW., 2007, DATA ENVELOPMENT ANA, V2nd; Cullinane K., 2004, REV NETWORK EC, V3, P184, DOI DOI 10.2202/1446-9022.1050; Cullinane K., 2006, RES TRANSP ECON, V17, P517, DOI DOI 10.1016/S0739-8859(06)17023-7; Dimas G, 2012, OPER RES-GER, V12, P15, DOI 10.1007/s12351-010-0082-2; Drydakis N, 2015, SOC SCI MED, V128, P43, DOI 10.1016/j.socscimed.2014.12.025; Dyson RG, 2001, EUR J OPER RES, V132, P245, DOI 10.1016/S0377-2217(00)00149-1; Economou C, 2014, EC CRISIS HLTH SYSTE; Economou M, 2013, J AFFECT DISORDERS, V145, P308, DOI 10.1016/j.jad.2012.08.008; Economou M, 2011, LANCET, V378, P1459, DOI 10.1016/S0140-6736(11)61638-3; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fare R., 1994, DATA ENVELOPMENT ANA, P253, DOI DOI 10.1007/978-94-011-0637-5_13; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Flokou A, 2011, J MED SYST, V35, P1001, DOI 10.1007/s10916-010-9533-9; Gannon B, 2005, ECON SOC REV, V36, P273; Gannon B, 2008, APPL ECON LETT, V15, P131, DOI 10.1080/13504850600706115; Harrison Jeffrey P, 2004, J Med Syst, V28, P411, DOI 10.1023/B:JOMS.0000041168.28200.8c; Hellenic Statistical Authority (ELSTAT), 2015, LIV COND GREC; Hellenic Statistical Authority (ELSTAT), 2008, MIGR FLOWS 2014 EST; Helmig B, 2001, Health Serv Manage Res, V14, P263, DOI 10.1258/0951484011912762; Ifanti AA, 2014, HEALTH POLICY, V117, P210, DOI 10.1016/j.healthpol.2014.03.014; Kazley A.S., 2009, SOCIO-ECON PLAN SCI, V43, P209, DOI [DOI 10.1016/j.seps.2008.10.001, DOI 10.1016/J.SEPS.2008.10.001]; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; Kontodimopoulos N, 2006, J MED SYST, V30, P333, DOI 10.1007/s10916-005-9005-9; Lyroudi K, 2006, HEALTH SERV MANAG RE, V19, P67, DOI 10.1258/095148406776829059; Madianos MG, 2014, EUR J PSYCHIAT, V28, P39, DOI 10.4321/S0213-61632014000100004; Magnussen J, 1996, HEALTH SERV RES, V31, P21; Malkoutzis N., 2011, YOUNG GREEKS CRISIS; Malmquist S, 1953, TRABAJOS ESTATISTICA, V4, P1209, DOI [DOI 10.1007/BF03006863, 10.1007/BF03006863]; Maniadakis N, 2004, EUR J OPER RES, V154, P396, DOI 10.1016/S0377-2217(03)00177-2; Maniadakis N., 2007, EUR RES STUD, V11, P95; Matsaganis M, 2013, IDENT MODERN EUR, P152; McKillop DG, 1999, ECON SOC REV, V30, P175; MERSHA T, 1989, OMEGA-INT J MANAGE S, V17, P159, DOI 10.1016/0305-0483(89)90007-8; Niakas D, 2013, INT J HEALTH SERV, V43, P597, DOI 10.2190/HS.43.4.a; NUNAMAKER TR, 1983, HEALTH SERV RES, V18, P183; Organisation for Economic Co-operation and Development (OECD), OECD STAT EXTR GROSS; Ozcan V.A., 1992, KNOWLEDGE TECHNOLOGY, V5, P1; OZCAN YA, 1993, HEALTH SERV RES, V27, P719; Polyzos N, 2012, HIPPOKRATIA, V16, P350; Pulina M, 2010, EUR J OPER RES, V204, P613, DOI 10.1016/j.ejor.2009.11.006; Rachiotis G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007295; Sathye M, 2003, EUR J OPER RES, V148, P662, DOI 10.1016/S0377-2217(02)00471-X; Shephard RW, 1970, THEORY COST PRODUCTI; SHERMAN HD, 1984, MED CARE, V22, P922, DOI 10.1097/00005650-198410000-00005; Simar L, 1999, EUR J OPER RES, V115, P459, DOI 10.1016/S0377-2217(97)00450-5; Simar L, 1998, MANAGE SCI, V44, P49, DOI 10.1287/mnsc.44.1.49; Simar L, 2000, J PROD ANAL, V13, P49, DOI 10.1023/A:1007864806704; Simou E, 2014, HEALTH POLICY, V115, P111, DOI 10.1016/j.healthpol.2014.02.002; Skroumpelos A., 2014, DISEASES-BASEL, V2, P93, DOI [10.3390/diseases2020093, DOI 10.3390/DISEASES2020093]; Souliotis K, 2016, EUR J HEALTH ECON, V17, P159, DOI 10.1007/s10198-015-0666-0; Sufian F, 2007, INT J PRODUCT PERFOR, V56, P99, DOI 10.1108/17410400710722626; TULKENS H, 1995, EUR J OPER RES, V80, P474, DOI 10.1016/0377-2217(94)00132-V; Vlachadis N, 2014, LANCET, V383, P691, DOI 10.1016/S0140-6736(14)60250-6; Wang K, 2013, MATH COMPUT MODEL, V58, P1117, DOI 10.1016/j.mcm.2011.11.067; Webb R., 2003, INT J EC BUSINESS, V10, P305, DOI DOI 10.1080/1357151032000126256; Yang HH, 2009, TELECOMMUN POLICY, V33, P98, DOI 10.1016/j.telpol.2008.11.001; Yfantopoulos J., 2014, Health, V6, P2227, DOI 10.4236/health.2014.616258; Zavras D, 2013, EUR J PUBLIC HEALTH, V23, P206, DOI 10.1093/eurpub/cks143	72	39	39	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177946	10.1371/journal.pone.0177946	http://dx.doi.org/10.1371/journal.pone.0177946			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UE	28542362	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058800031
J	Vakkasoglu, AS; Srikant, S; Gaudet, R				Vakkasoglu, Ahmet S.; Srikant, Sriram; Gaudet, Rachelle			D-helix influences dimerization of the ATP-binding cassette (ABC) transporter associated with antigen processing 1 (TAP1) nucleotide-binding domain	PLOS ONE			English	Article							INWARD-FACING CONFORMATION; CRYSTAL-STRUCTURE; MALTOSE TRANSPORTER; P-GLYCOPROTEIN; PEPTIDE TRANSPORTER; MECHANISM; INTERMEDIATE; ARCHITECTURE; SUPERFAMILY; COMPLEX	ATP-binding cassette (ABC) transporters form a large family of transmembrane importers and exporters. Using two nucleotide-binding domains (NBDs), which form a canonical ATP-sandwich dimer at some point within the transport cycle, the transporters harness the energy from ATP binding and hydrolysis to drive substrate transport. However the structural elements that enable and tune the dimerization propensity of the NBDs have not been fully elucidated. Here we compared the biochemical properties of the NBDs of human and rat TAP1, a subunit of the heterodimeric transporter associated with antigen processing (TAP). The isolated human TAP1 NBD was monomeric in solution, in contrast to the previously observed ATP-mediated homodimerization of the isolated rat TAP1 NBD. Using a series of human-rat chimeric constructs, we identified the D-helix, an a-helix N-terminal to the conserved D-loop motif, as an important determinant of NBD dimerization. The ATPase activity of our panel of TAP1 NBD constructs largely correlated with dimerization ability, indicating that the observed dimerization uses the canonical ATP-sandwich interface. The N-terminus of the D-helix from one protomer interacts with the ATP-binding Walker A motif of the second protomer at the ATP-sandwich interface. However, our mutational analysis indicated that residues farther from the interface, within the second and third turn of the D-helix, also influence dimerization. Overall, our data suggest that although the D-helix sequence is not conserved in ABC transporters, its precise positioning within the NBD structure has a critical role in NBD dimerization.	[Vakkasoglu, Ahmet S.; Srikant, Sriram; Gaudet, Rachelle] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Gaudet, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	gaudet@mcb.harvard.edu	Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Srikant, Sriram/0000-0003-3904-0336				Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J LIPID RES, V42, P1007; Eggensperger S, 2015, BIOL CHEM, V396, P1059, DOI 10.1515/hsz-2014-0320; Grossmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6419; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hohl M, 2014, P NATL ACAD SCI USA, V111, P11025, DOI 10.1073/pnas.1400485111; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jones PM, 2012, J PHYS CHEM A, V116, P3004, DOI 10.1021/jp211139s; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Procko E, 2008, BIOCHEMISTRY-US, V47, P5699, DOI 10.1021/bi7024854; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2009, CURR OPIN IMMUNOL, V21, P84, DOI 10.1016/j.coi.2009.02.003; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Wilkens Stephan, 2015, F1000Prime Rep, V7, P14, DOI 10.12703/P7-14	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178238	10.1371/journal.pone.0178238	http://dx.doi.org/10.1371/journal.pone.0178238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542489	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800051
J	Giannoulatou, E; Maher, GJ; Ding, ZH; Gillis, AJM; Dorssers, LCJ; Hoischen, A; Rajpert-De Meyts, E; McVean, G; Wilkie, AOM; Looijenga, LHJ; Goriely, A				Giannoulatou, Eleni; Maher, Geoffrey J.; Ding, Zhihao; Gillis, Ad J. M.; Dorssers, Lambert C. J.; Hoischen, Alexander; Rajpert-De Meyts, Ewa; McVean, Gilean; Wilkie, Andrew O. M.; Looijenga, Leendert H. J.; Goriely, Anne		WGS500 Consortium	Whole-genome sequencing of spermatocytic tumors provides insights into the mutational processes operating in the male germline	PLOS ONE			English	Article							CARCINOMA IN-SITU; SELFISH SPERMATOGONIAL SELECTION; DE-NOVO MUTATIONS; CELL TUMORS; EXPRESSION PATTERN; POINT MUTATIONS; HUMAN TESTES; SEMINOMA; CANCER; DISORDERS	Adult male germline stem cells (spermatogonia) proliferate by mitosis and, after puberty, generate spermatocytes that undertake meiosis to produce haploid spermatozoa. Germ cells are under evolutionary constraint to curtail mutations and maintain genome integrity. Despite constant turnover, spermatogonia very rarely form tumors, so-called spermatocytic tumors (SpT). In line with the previous identification of FGFR3 and HRAS selfish mutations in a subset of cases, candidate gene screening of 29 SpTs identified an oncogenic NRAS mutation in two cases. To gain insights in the etiology of SpT and into properties of the male germline, we performed whole-genome sequencing of five tumors (4/5 with matched normal tissue). The acquired single nucleotide variant load was extremely low (similar to 0.2 per Mb), with an average of 6 (2-9) non-synonymous variants per tumor, none of which is likely to be oncogenic. The observed mutational signature of SpTs is strikingly similar to that of germline de novo mutations, mostly involving C>T transitions with a significant enrichment in the ACG trinucleotide context. The tumors exhibited extensive aneuploidy (50-99 autosomes/tumor) involving whole-chromosomes, with recurrent gains of chr9 and chr20 and loss of chr7, suggesting that aneuploidy itself represents the initiating oncogenic event. We propose that SpT etiology recapitulates the unique properties of male germ cells; because of evolutionary constraints to maintain low point mutation rate, rare tumorigenic driver events are caused by a combination of gene imbalance mediated via whole-chromosome aneuploidy. Finally, we propose a general framework of male germ cell tumor pathology that accounts for their mutational landscape, timing and cellular origin.	[Giannoulatou, Eleni; Maher, Geoffrey J.; Ding, Zhihao; Wilkie, Andrew O. M.; Goriely, Anne] Univ Oxford, Clin Genet Grp, MRC, Weatherall Inst Mol Med, Oxford, England; [Giannoulatou, Eleni; Maher, Geoffrey J.; Ding, Zhihao; Wilkie, Andrew O. M.; Goriely, Anne] Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford, England; [Gillis, Ad J. M.; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Rajpert-De Meyts, Ewa] Rigshosp, Copenhagen Univ Hosp, Dept Growth & Reprod, Copenhagen, Denmark; [McVean, Gilean] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Giannoulatou, Eleni] Univ New South Wales, Victor Chang Cardiac Res Inst, Sydney, NSW, Australia	University of Oxford; University of Oxford; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Rigshospitalet; University of Copenhagen; University of Oxford; Wellcome Centre for Human Genetics; University of New South Wales Sydney; Victor Chang Cardiac Research Institute	Goriely, A (corresponding author), Univ Oxford, Clin Genet Grp, MRC, Weatherall Inst Mol Med, Oxford, England.; Goriely, A (corresponding author), Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford, England.	anne.goriely@imm.ox.ac.uk	Hoischen, Alexander/D-1282-2013; Wilkie, Andrew/AAC-3820-2020; Goriely, Anne/AAR-1133-2020; Rajpert-De Meyts, Ewa/H-6526-2019; Looijenga, Leendert/B-8145-2019; Knight, Julian Charles/W-2399-2019; Hoischen, Alexander/AGF-7293-2022	Hoischen, Alexander/0000-0002-8072-4476; Wilkie, Andrew/0000-0002-2972-5481; Rajpert-De Meyts, Ewa/0000-0002-5946-7559; Looijenga, Leendert/0000-0002-8146-1911; Knight, Julian Charles/0000-0002-0377-5536; Hoischen, Alexander/0000-0002-8072-4476; Ding, Zhihao/0000-0003-0961-2284; Giannoulatou, Eleni/0000-0002-7084-6736; Goriely, Anne/0000-0001-9229-7216	Wellcome [091182, 102731]; Medical Research Council (MRC) through the WIMM Strategic Alliance [G0902418, MC_UU_12025]; High-Throughput Genomics core facility; Wellcome Trust [090532 Z/09/Z]	Wellcome; Medical Research Council (MRC) through the WIMM Strategic Alliance(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); High-Throughput Genomics core facility; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was primarily supported by grants from the Wellcome (www.wellcome.ac.uk) [091182 (to AG and AOMW) and 102731 (to AOMW)]. We acknowledge funding from the Medical Research Council (MRC-www.mrc.ac.uk) through the WIMM Strategic Alliance (G0902418 and MC_UU_12025) and the support of the High-Throughput Genomics core facility by the Wellcome Trust Grant 090532 Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Berney DM, 2016, HISTOPATHOLOGY, V69, P7, DOI 10.1111/his.12958; Bishop EF, 2007, MODERN PATHOL, V20, P1036, DOI 10.1038/modpathol.3800933; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Brabrand S, 2015, NEOPLASIA, V17, P167, DOI 10.1016/j.neo.2014.12.005; Carriere P, 2007, J UROLOGY, V178, P125, DOI 10.1016/j.juro.2007.03.024; Cha DS, 2012, BBA-MOL CELL RES, V1823, P1847, DOI 10.1016/j.bbamcr.2012.07.006; Chemes HE, 2001, INT J ANDROL, V24, P2, DOI 10.1046/j.1365-2605.2001.00260.x; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cutcutache I, 2015, EUR UROL, V68, P77, DOI 10.1016/j.eururo.2014.12.040; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ekvall S, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0239-1; Endo T, 2015, P NATL ACAD SCI USA, V112, pE2347, DOI 10.1073/pnas.1505683112; FLOYD C, 1988, CANCER-AM CANCER SOC, V61, P409, DOI 10.1002/1097-0142(19880115)61:2<409::AID-CNCR2820610234>3.0.CO;2-6; Ghazarian AA, 2015, CANCER-AM CANCER SOC, V121, P4181, DOI 10.1002/cncr.29643; Giannoulatou E, 2013, P NATL ACAD SCI USA, V110, P20152, DOI 10.1073/pnas.1311381110; Goldmann JM, 2016, NAT GENET; Goriely A, 2016, NAT GENET, V48, P823, DOI 10.1038/ng.3629; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; Guo Y, 2008, CLIN ORTHOP RELAT R, V466, P2039, DOI 10.1007/s11999-008-0344-y; Hammoud SS, 2015, GENE DEV, V29, P2312, DOI 10.1101/gad.261925.115; Honecker F, 2004, J PATHOL, V203, P849, DOI 10.1002/path.1587; Hutson John M, 2012, Front Endocrinol (Lausanne), V3, P176, DOI 10.3389/fendo.2012.00176; Jorgensen Anne, 2014, Biomol Concepts, V5, P331, DOI 10.1515/bmc-2014-0014; Jorgensen A, 2013, J PATHOL, V229, P588, DOI 10.1002/path.4154; Jorgensen A, 2012, MOL HUM REPROD, V18, P523, DOI 10.1093/molehr/gas030; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kristensen DG, 2014, BRIT J CANCER, V110, P668, DOI 10.1038/bjc.2013.727; Kubo N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1833-5; Kurtovic-Kozaric A, 2015, LEUKEMIA, V29, P126, DOI 10.1038/leu.2014.144; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lim J, 2011, J PATHOL, V224, P473, DOI 10.1002/path.2919; Litchfield K, 2016, NAT REV UROL; Litchfield K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6973; Liu YH, 2015, NATURE, V520, P697, DOI 10.1038/nature14418; Looijenga LHJ, 2011, J PATHOL, V224, P431, DOI 10.1002/path.2939; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Looijenga LHJ, 2003, APMIS, V111, P161, DOI 10.1034/j.1600-0463.2003.11101201.x; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Maher GJ, 2014, ANDROLOGY-US, V2, P304, DOI 10.1111/j.2047-2927.2013.00175.x; Maher GJ, 2016, P NATL ACAD SCI USA, V113, P2454, DOI 10.1073/pnas.1521325113; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; MULLER J, 1987, INT J ANDROL, V10, P147, DOI 10.1111/j.1365-2605.1987.tb00176.x; Newman AM, 2014, BIOINFORMATICS, V30, P3390, DOI 10.1093/bioinformatics/btu549; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Paulsson K, 2015, NAT GENET, V47, P672, DOI 10.1038/ng.3301; Pham Trang T, 2013, Genes Cancer, V4, P419, DOI 10.1177/1947601913513950; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Rajpert-De Meyts E, 2003, HISTOPATHOLOGY, V42, P217, DOI 10.1046/j.1365-2559.2003.01587.x; Rajpert-De Meyts E, 2016, LANCET, V387, P1762, DOI 10.1016/S0140-6736(15)00991-5; Rijlaarsdam MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122146; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenberg C, 1998, GENE CHROMOSOME CANC, V23, P286, DOI 10.1002/(SICI)1098-2264(199812)23:4<286::AID-GCC2>3.0.CO;2-6; SKAKKEBAEK NE, 1987, INT J ANDROL, V10, P19, DOI 10.1111/j.1365-2605.1987.tb00161.x; Stoop H, 2001, LAB INVEST, V81, P919, DOI 10.1038/labinvest.3780302; Suzuki T, 2010, MOL CELL BIOL, V30, P2473, DOI 10.1128/MCB.01093-09; TAKAHASHI H, 1993, CANCER-AM CANCER SOC, V72, P549, DOI 10.1002/1097-0142(19930715)72:2<549::AID-CNCR2820720235>3.0.CO;2-L; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Taylor-Weiner A, 2016, NATURE, V540, P114, DOI 10.1038/nature20596; Tsuchiy D, 2013, CURR BIOL, V23, P1505, DOI 10.1016/j.cub.2013.06.031; Turner TN, 2016, AM J HUM GENET, V98, P58, DOI 10.1016/j.ajhg.2015.11.023; Ulbright TM, 2016, WHO CLASSIFICATION T, P189; Verdorfer R, 2004, J PATHOL, V204, P277, DOI 10.1002/path.1634; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yau C, 2013, BIOINFORMATICS, V29, P2482, DOI 10.1093/bioinformatics/btt416; Zhang HE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-244; Zhang T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006293; Zuccala E, 2016, NAT REV GENET, V17, P7, DOI 10.1038/nrg.2015.13	73	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178169	10.1371/journal.pone.0178169	http://dx.doi.org/10.1371/journal.pone.0178169			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542371	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400066
J	Sauce, B; Goes, CP; Forti, I; do Monte, BGO; Watanabe, IM; Cunha, J; Peripato, AC				Sauce, Bruno; Goes, Carolina P.; Forti, Isabela; do Monte, Bruno Gabriel O.; Watanabe, Isabela M.; Cunha, Joao; Peripato, Andrea C.			A link between thrifty phenotype and maternal care across two generations of intercrossed mice	PLOS ONE			English	Article							FORCED SWIMMING TEST; ELEVATED PLUS-MAZE; INDIVIDUAL-DIFFERENCES; EPIGENETIC MECHANISMS; GENETIC ARCHITECTURE; MILK EJECTION; ANIMAL-MODEL; OPEN-FIELD; LG/J; STRESS	Maternal effects are causal influences from mother to offspring beyond genetic information, and have lifelong consequences for multiple traits. Previously, we reported that mice whose mothers did not nurse properly had low birth weight followed by rapid fat accumulation and disturbed development of some organs. That pattern resembles metabolic syndromes known collectively as the thrifty phenotype, which is believed to be an adaptation to a stressful environment which prepares offspring for reduced nutrient supply. The potential link between maternal care, stress reactivity, and the thrifty phenotype, however, has been poorly explored in the human and animal literature: only a couple of studies even mention (much less, test) these concepts under a cohesive framework. Here, we explored this link using mice of the parental inbred strains SM/J and LG/J-who differ dramatically in their maternal care-and the intercrossed generations F1 and F2. We measured individual differences in 15 phenotypes and used structural equation modeling to test our hypotheses. We found a remarkable relationship between thrifty phenotype and lower quality of maternal behaviors, including nest building, pup retrieval, grooming/licking, and nursing. To our knowledge, this is the first study to show, in any mammal, a clear connection between the natural variation in thrifty phenotype and maternal care. Both traits in the mother also had a substantial effect on survival rate in the F3 offspring. To our surprise, however, stress reactivity seemed to play no role in our models. Furthermore, the strain of maternal grandmother, but not of paternal grandmother, affected the variation of maternal care in F2 mice, and this effect was mediated by thrifty phenotype in F2. Since F1 animals were all genetically identical, this finding suggests that maternal effects pass down both maternal care and thrifty phenotype in these mice across generations via epigenetic transmission.	[Sauce, Bruno] Rutgers State Univ, Dept Psychol, Program Behav & Syst Neurosci, Piscataway, NJ USA; [Goes, Carolina P.] Univ Sao Paulo, Inst Biomed Sci, Program Cellular Biol & Histol, Sao Paulo, Brazil; [Forti, Isabela; do Monte, Bruno Gabriel O.; Watanabe, Isabela M.; Cunha, Joao; Peripato, Andrea C.] Univ Fed Sao Carlos, Ctr Hlth & Biol Sci, Dept Genet & Evolut, Sao Carlos, SP, Brazil	Rutgers State University New Brunswick; Universidade de Sao Paulo; Universidade Federal de Sao Carlos	Peripato, AC (corresponding author), Univ Fed Sao Carlos, Ctr Hlth & Biol Sci, Dept Genet & Evolut, Sao Carlos, SP, Brazil.	peripato@ufscar.br	Goes, Carolina P./AAG-3896-2019; Sauce, Bruno/X-4365-2018	Goes, Carolina P./0000-0002-4086-3519; Sauce, Bruno/0000-0002-9544-0150	Fundacao de Amparo a pesquisa do Estado de Sao Paulo [2004/14583-9, 2013/22339-0, 2007/06254-3]	Fundacao de Amparo a pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by grants 2004/14583-9 and 2013/22339-0 from Fundacao de Amparo a pesquisa do Estado de Sao Paulo (http://www.fapesp.br/en/) to AP, and grant 2007/06254-3 from from Fundacao de Amparo a pesquisa do Estado de Sao Paulo (http://www.fapesp.br/en/) to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TW, 1957, J AM STAT ASSOC, V52, P200, DOI 10.2307/2280845; Andreatini R, 1999, BRAZ J MED BIOL RES, V32, P1121, DOI 10.1590/S0100-879X1999000900011; Austin J.T., 2006, PSYCHOL RES HDB GUID, P241, DOI [DOI 10.4135/9781412976626.N16, 10.4135/9781412976626.n16]; Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005; Bekku N, 2005, PSYCHOPHARMACOLOGY, V183, P300, DOI 10.1007/s00213-005-0179-0; Berghanel A, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1304; BRINDLEY DN, 1989, CLIN SCI, V77, P453, DOI 10.1042/cs0770453; Bult A, 1997, BEHAV GENET, V27, P231, DOI 10.1023/A:1025610130282; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Champagne FA, 2007, PHYSIOL BEHAV, V91, P325, DOI 10.1016/j.physbeh.2007.03.014; Champagne FA, 2009, NEUROSCI BIOBEHAV R, V33, P593, DOI 10.1016/j.neubiorev.2007.10.009; Cheverud JM, 2001, MAMM GENOME, V12, P3, DOI 10.1007/s003350010218; Chiavegatto S, 2012, BRAIN BEHAV, V2, P365, DOI 10.1002/brb3.58; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Chou C.P., 1995, ESTIMATES TESTS STRU; Ducottet C, 2005, BEHAV BRAIN RES, V156, P153, DOI 10.1016/j.bbr.2004.05.018; Ehrich TH, 2005, DIABETES, V54, P1863, DOI 10.2337/diabetes.54.6.1863; Goes CP, 2012, MAMM GENOME, V23, P770, DOI 10.1007/s00335-012-9431-1; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HART BL, 1990, PHYSIOL BEHAV, V48, P383, DOI 10.1016/0031-9384(90)90332-X; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Hrbek T, 2006, MAMM GENOME, V17, P417, DOI 10.1007/s00335-005-0038-7; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HUIZINGA HA, 1986, LIVEST PROD SCI, V15, P11, DOI 10.1016/0301-6226(86)90051-5; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2079, DOI 10.1210/jc.2007-2850; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Kline R.B., 2011, PRINCIPLES PRACTICE; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lee HK, 1999, DIABETES RES CLIN PR, V45, P127, DOI 10.1016/S0168-8227(99)00042-X; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MacKinnon DP, 2007, BEHAV RES METHODS, V39, P384, DOI 10.3758/BF03193007; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MOODY TW, 1988, ANN NY ACAD SCI, V525, P281, DOI 10.1111/j.1749-6632.1988.tb38613.x; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Noguera JC, 2011, FUNCT ECOL, V25, P1144, DOI 10.1111/j.1365-2435.2011.01856.x; Numan M., 2003, HORM BR BEHAV; Peripato AC, 2004, J EVOLUTION BIOL, V17, P593, DOI 10.1111/j.1420-9101.2004.00702.x; Peripato AC, 2002, AM NAT, V160, pS173, DOI 10.1086/342900; Peripato AC, 2002, GENETICS, V162, P1341; Petry CJ, 1997, P NUTR SOC, V56, P233, DOI 10.1079/PNS19970028; Plotsky PM, 2005, NEUROPSYCHOPHARMACOL, V30, P2192, DOI 10.1038/sj.npp.1300769; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; RUSSELL JA, 1980, J PHYSIOL-LONDON, V303, P403, DOI 10.1113/jphysiol.1980.sp013295; Sauce B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00395; Sauce Bruno, 2012, Frontiers in Genetics, V3, P90, DOI 10.3389/fgene.2012.00090; Schafer JL, 2010, ANAL INCOMPLETE MULT; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Wells JCK, 2003, J THEOR BIOL, V221, P143, DOI 10.1006/jtbi.2003.3183; Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238	61	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177954	10.1371/journal.pone.0177954	http://dx.doi.org/10.1371/journal.pone.0177954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542485	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672600033
J	Bauer, GR; Braimoh, J; Scheim, AI; Dharma, C				Bauer, Greta R.; Braimoh, Jessica; Scheim, Ayden I.; Dharma, Christoffer			Transgender-inclusive measures of sex/gender for population surveys: Mixed-methods evaluation and recommendations	PLOS ONE			English	Article							HEALTH; SEX; VALIDITY; IDENTITY; PEOPLE	Given that an estimated 0.6% of the U.S. population is transgender (trans) and that large health disparities for this population have been documented, government and research organizations are increasingly expanding measures of sex/gender to be trans inclusive. Options suggested for trans community surveys, such as expansive check-all-that-apply gender identity lists and write-in options that offer maximum flexibility, are generally not appropriate for broad population surveys. These require limited questions and a small number of categories for analysis. Limited evaluation has been undertaken of trans-inclusive population survey measures for sex/gender, including those currently in use. Using an internet survey and follow-up of 311 participants, and cognitive interviews from a maximum-diversity sub-sample (n = 79), we conducted a mixed-methods evaluation of two existing measures: a two-step question developed in the United States and a multidimensional measure developed in Canada. We found very low levels of item missingness, and no indicators of confusion on the part of cisgender (non-trans) participants for both measures. However, a majority of interview participants indicated problems with each question item set. Agreement between the two measures in assessment of gender identity was very high (K = 0.9081), but gender identity was a poor proxy for other dimensions of sex or gender among trans participants. Issues to inform measure development or adaptation that emerged from analysis included dimensions of sex/gender measured, whether non-binary identities were trans, Indigenous and cultural identities, proxy reporting, temporality concerns, and the inability of a single item to provide a valid measure of sex/gender. Based on this evaluation, we recommend that population surveys meant for multi-purpose analysis consider a new Multidimensional Sex/Gender Measure for testing that includes three simple items (one asked only of a small sub-group) to assess gender identity and lived gender, with optional additions. We provide considerations for adaptation of this measure to different contexts.	[Bauer, Greta R.; Braimoh, Jessica; Scheim, Ayden I.; Dharma, Christoffer] Univ Western Ontario, Schulich Sch Med & Dent, Epidemiol & Biostat, London, ON, Canada	Western University (University of Western Ontario)	Bauer, GR (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Epidemiol & Biostat, London, ON, Canada.	greta.bauer@schulich.uwo.ca	Bauer, Greta/ABG-1472-2020; Dharma, Christoffer/ABH-5987-2020	Dharma, Christoffer/0000-0002-5223-5755; Scheim, Ayden/0000-0001-8498-9829; Bauer, Greta/0000-0003-0663-7160	Canadian Institutes of Health Research, Institute of Gender and Health [MOP-130489]; Vanier Scholarship; Trudeau Foundation Scholarship	Canadian Institutes of Health Research, Institute of Gender and Health(Canadian Institutes of Health Research (CIHR)); Vanier Scholarship; Trudeau Foundation Scholarship	This research was funded by the Canadian Institutes of Health Research, Institute of Gender and Health (MOP-130489). Ayden Scheim's work was supported by a Vanier Scholarship and a Trudeau Foundation Scholarship. The funders had no role in the study design, analysis or preparation of results.	[Anonymous], 2011, PSEUD SPP PATH SAF D, P1; Australian Bureau of Statistics, 2016, STAND SEX GEND VAR 2; Bauer GR., 2012, GENDER SEX HLTH RES, P59; Bowleg L, 2008, SEX ROLES, V59, P312, DOI 10.1007/s11199-008-9400-z; Bradburn Norman M., 2004, ASKING QUESTIONS; Bradford JB, 2005, VIRGINIA TRANSGENDER; Cary NC, 2013, SAS STAT SOFTWARE VE; Collins P.H., 1999, REVISIONING GENDER, P261; Combahee River Collective, 1978, CAPITALIST PATRIARCH; Conron K.J., 2014, BEST PRACTICES ASKIN, VCA2014, P9; Crenshaw K., 1990, STANFORD LAW REV, V43, P1241, DOI 10.2307/1229039; Creswell J.W., 2003, HDB MIXED METHODS SO, V209, P209, DOI DOI 10.4135/9781506335193; Dillman D. R., 2007, MAIL INTERNET SURVEY; Drennan J, 2003, J ADV NURS, V42, P57, DOI 10.1046/j.1365-2648.2003.02579.x; Flores AR, 2016, MANY ADULTS IDENTIFY, P1; Fowler F.J., 2009, SURV RES METHODS-GER; Glen F, 2012, TECHNICAL NOTE MEASU, P1; Grant J.M., 2011, INJUSTICE EVERY TURN; Groves RM, 2009, SURVEY METHODOLOGY; Habarta N, 2015, AM J PUBLIC HEALTH, V105, P1917, DOI 10.2105/AJPH.2015.302659; Herman JL, 2014, BEST PRACT ASK QUEST, P1; James K., 2016, SYSTEMS MAP GENDER I; Jans M., 2015, P AM ASS PUBL OP RES; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Lang Sabine, 1997, INTRO 2 SPIRIT PEOPL, P1; Lombardi E, 2016, SEX RES SOC POLICY, V13, P288, DOI 10.1007/s13178-016-0220-6; Mavhu W, 2008, CULT HEALTH SEX, V10, P563, DOI 10.1080/13691050801948102; Meier S. C., 2013, INT HDB DEMOGRAPHY S, P289, DOI DOI 10.1007/978-94-007-5512-3_16; Nfn Scout Gates GJ, 2014, BEST PRACTICES ASKIN, P44; Preves SE., 2003, INTERSEX IDENTITY CO; QSR International Pty Ltd, 2013, NVIVO QUAL DAT AN SO; [Questionnaire Team Canadian Partnership for Tomorrow Project], 2010, ONT HLTH STUD BAS QU; Reisner SL, 2016, LANCET, V388, P412, DOI 10.1016/S0140-6736(16)00684-X; Reisner SL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1224; Reisner SL, 2014, ARCH SEX BEHAV, V43, P1503, DOI 10.1007/s10508-014-0314-2; Reisner SL., 2015, TRANSGENDER STUD Q, V2, P34, DOI DOI 10.1215/23289252-2848877; Robinson M, 2017, J BISEXUALITY, V17, P7, DOI 10.1080/15299716.2016.1261266; Sausa L. A., 2009, RECOMMENDATIONS INCL, P1; Scheim AI, 2015, J SEX RES, V52, P1, DOI 10.1080/00224499.2014.893553; Snider J A, 1998, Chronic Dis Can, V19, P19; StataCorp, 2015, STAT STAND GEND ID, P1; Statistics Canada, 2013, CAN COMM HLTH SURV Q; Tate CC, 2013, J SEX RES, V50, P767, DOI 10.1080/00224499.2012.690110; Willis GB, 1999, QUESTION APPRAISAL S	44	163	163	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178043	10.1371/journal.pone.0178043	http://dx.doi.org/10.1371/journal.pone.0178043			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542498	gold, Green Submitted, Green Published			2022-12-27	WOS:000402062800038
J	Cetinel, S; Semenchenko, V; Cho, JY; Sharaf, MG; Damji, KF; Unsworth, LD; Montemagno, C				Cetinel, Sibel; Semenchenko, Valentyna; Cho, Jae-Young; Sharaf, Mehdi Ghaffari; Damji, Karim F.; Unsworth, Larry D.; Montemagno, Carlo			UV-B induced fibrillization of crystallin protein mixtures	PLOS ONE			English	Article							HUMAN GAMMA-D; SECONDARY STRUCTURE ANALYSES; CIRCULAR-DICHROISM SPECTRA; AMYLOID FIBRIL FORMATION; AGE-RELATED-CHANGES; ALPHA-A-CRYSTALLIN; TRYPTOPHAN FLUORESCENCE; LENS CRYSTALLINS; MECHANISM; CATARACT	Environmental factors, mainly oxidative stress and exposure to sunlight, induce the oxidation, cross-linking, cleavage, and deamination of crystallin proteins, resulting in their aggregation and, ultimately, cataract formation. Various denaturants have been used to initiate the aggregation of crystallin proteins in vitro. All of these regimens, however, are obviously far from replicating conditions that exist in vivo that lead to cataract formation. In fact, it is our supposition that only UV-B radiation may mimic the observed in vivo cause of crystallin alteration leading to cataract formation. This means of inducing cataract formation may provide the most appropriate in vitro platform for in-depth study of the fundamental cataractous fibril properties and allow for testing of possible treatment strategies. Herein, we showed that cataractous fibrils can be formed using UV-B radiation from alpha:beta:gamma crystallin protein mixtures. Characterization of the properties of formed aggregates confirmed the development of amyloid-like fibrils, which are in cross-beta-pattern and possibly in anti-parallel beta-sheet arrangement. Furthermore, we were also able to confirm that the presence of the molecular chaperone, alpha-crystallin, was able to inhibit fibril formation, as observed for 'naturally' occurring fibrils. Finally, the time-dependent fibrillation profile was found to be similar to the gradual formation of age-related nuclear cataracts. This data provided evidence for the initiation of fibril formation from physiologically relevant crystallin mixtures using UV-B radiation, and that the formed fibrils had several traits similar to that expected from cataracts developing in vivo.	[Cetinel, Sibel; Sharaf, Mehdi Ghaffari; Unsworth, Larry D.; Montemagno, Carlo] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Cetinel, Sibel; Sharaf, Mehdi Ghaffari; Montemagno, Carlo] Univ Alberta, Ingenu Lab, Edmonton, AB, Canada; [Semenchenko, Valentyna; Cho, Jae-Young; Unsworth, Larry D.] Natl Inst Nanotechnol NINT, 11421,Saskatchewan Dr NW, Edmonton, AB, Canada; [Damji, Karim F.] Univ Alberta, Dept Ophthalmol & Visual Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta; National Research Council Canada; University of Alberta	Unsworth, LD; Montemagno, C (corresponding author), Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada.; Montemagno, C (corresponding author), Univ Alberta, Ingenu Lab, Edmonton, AB, Canada.; Unsworth, LD (corresponding author), Natl Inst Nanotechnol NINT, 11421,Saskatchewan Dr NW, Edmonton, AB, Canada.	lunswort@ualberta.ca; montemag@ualberta.ca		Cho, Jae-Young/0000-0002-1868-6464	Alberta Innovates - Technology Futures [20090279/PSI14420-2011]; Canada Research Chair [229249]	Alberta Innovates - Technology Futures; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was funded by Alberta Innovates - Technology Futures (Grant # 20090279/PSI14420-2011) and Canada Research Chair (Award Reference # 229249 as Tier 1 in Integrative Technology). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Sampson L, 2010, J MOL BIOL, V401, P134, DOI 10.1016/j.jmb.2010.05.067; AMBACH W, 1994, DOC OPHTHALMOL, V88, P165, DOI 10.1007/BF01204614; [Anonymous], 1969, ACTA OPHTHALMOL, V47, P5; Bilbao J, 2010, JOURNAL OF GEOPHYSIC, P115; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bolder SG, 2007, LANGMUIR, V23, P4144, DOI 10.1021/la063048k; Chen JJ, 2008, BIOCHEMISTRY-US, V47, P10705, DOI 10.1021/bi800499k; Chen JJ, 2006, BIOCHEMISTRY-US, V45, P11552, DOI 10.1021/bi060988v; Chen J, 2009, BIOCHEMISTRY-US, V48, P3708, DOI 10.1021/bi802177g; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Cormier AR, 2012, BIOMACROMOLECULES, V13, P1794, DOI 10.1021/bm300313h; Davies MJ, 2001, J PHOTOCH PHOTOBIO B, V63, P114, DOI 10.1016/S1011-1344(01)00208-1; Dyer JM, 2006, PHOTOCH PHOTOBIO SCI, V5, P698, DOI 10.1039/b603030k; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Frederikse PH, 2000, CURR EYE RES, V20, P462, DOI 10.1076/0271-3683(200006)20:6;1-Y;FT462; Ganea E, 2001, CURR PROTEIN PEPT SC, V2, P205, DOI 10.2174/1389203013381107; GRAINGER RM, 1992, TRENDS GENET, V8, P349, DOI 10.1016/0168-9525(92)90280-H; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; HOTT JL, 1993, PHOTOCHEM PHOTOBIOL, V57, P312; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kessel L, 2011, BMC OPHTHALMOLOGY, P11; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lee JS, 1997, J PROTEIN CHEM, V16, P283, DOI 10.1023/A:1026305025816; Liao JH, 2002, BIOCHEM BIOPH RES CO, V295, P854, DOI 10.1016/S0006-291X(02)00784-2; Lin SY, 1999, J PHOTOCH PHOTOBIO B, V49, P29, DOI 10.1016/S1011-1344(99)00010-X; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; Mafia K, 2008, MOL VIS, V14, P234; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Marchesan S, 2014, NANOSCALE, V6, P5172, DOI 10.1039/c3nr06752a; Markossian KA, 2009, INT J MOL SCI, V10, P1314, DOI 10.3390/ijms10031314; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Mizdrak J, 2008, FREE RADICAL BIO MED, V44, P1108, DOI 10.1016/j.freeradbiomed.2007.12.003; Moran SD, 2013, BIOCHEMISTRY-US, V52, P6169, DOI 10.1021/bi4008353; Moran SD, 2012, J AM CHEM SOC, V134, P18410, DOI 10.1021/ja307898g; Muranov KO, 2011, EXP EYE RES, V92, P76, DOI 10.1016/j.exer.2010.11.005; Oriowo OM, 2001, INVEST OPHTH VIS SCI, V42, P2596; Ostrovsky MA, 2002, MOL VIS, V8, P72; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Reddy GB, 2001, BIOCHEM BIOPH RES CO, V282, P712, DOI 10.1006/bbrc.2001.4642; Roberts JE, 2001, J PHOTOCH PHOTOBIO B, V64, P136, DOI 10.1016/S1011-1344(01)00196-8; Schafheimer N, 2013, PHOTOCHEM PHOTOBIOL, V89, P1106, DOI 10.1111/php.12096; Sergeev YV, 2005, INVEST OPHTH VIS SCI, V46, P3263, DOI 10.1167/iovs.05-0112; Sergeev YV, 2005, INVEST OPHTHALMOL, P46; SIEZEN RJ, 1983, BIOCHIM BIOPHYS ACTA, V748, P56, DOI 10.1016/0167-4838(83)90027-4; Sliney DH, 2005, PHOTOCHEM PHOTOBIOL, V81, P483, DOI 10.1562/2005-02-14-RA-439.1; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Su S, 2011, INVEST OPHTH VIS SCI, V52, P4182, DOI 10.1167/iovs.10-7094; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Varma SD, 2008, J OCUL PHARMACOL TH, V24, P439, DOI 10.1089/jop.2008.0035; Vazquez S, 2004, INVEST OPHTH VIS SCI, V45, P879, DOI 10.1167/iovs.03-0558; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102486; Xia Z, 2013, SCI REPORTS, P3; Yang JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130681; YU NT, 1975, J BIOL CHEM, V250, P2196; Zhou P, 2012, FASEB J, V26, P4897, DOI 10.1096/fj.12-213702; Zhu XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060146, 10.1371/journal.pone.0062731, 10.3389/fnsyn.2013.00008, 10.1371/journal.pone.0070631, 10.1371/journal.pone.0081900, 10.1371/journal.pone.0070686]	62	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177991	10.1371/journal.pone.0177991	http://dx.doi.org/10.1371/journal.pone.0177991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542382	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800033
J	Copot, D; De Keyser, R; Derom, E; Ionescu, C				Copot, Dana; De Keyser, Robin; Derom, Eric; Ionescu, Clara			Structural changes in the COPD lung and related heterogeneity	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FORCED OSCILLATION TECHNIQUE; RESPIRATORY IMPEDANCE; FRACTAL GEOMETRY; IDENTIFICATION; EMPHYSEMA; DEVICE; SYSTEM	This paper proposes a mathematical framework for understanding how the structural changes in the COPD lung reflect in model parameters. The core of the analysis is a correlation between the heterogeneity in the lung as COPD degree changes (GOLD II, III and IV) and the nonlinearity index evaluated using the forced oscillation technique. A low frequency evaluation of respiratory impedance models and nonlinearity degree is performed since changes in tissue mechanics are related to viscoelastic properties. Simulation analysis of our model indicates a good correlation to expected changes in heterogeneity and nonlinear effects. A total of 43 COPD diagnosed patients are evaluated, distributed as GOLD II (18), GOLD III (15) and GOLD IV (10). Experimental data supports the claims and indicate that the proposed model and index for nonlinearity is well-suited to capture COPD structural changes.	[Copot, Dana; De Keyser, Robin; Ionescu, Clara] Univ Ghent, Dept Elect Energy Syst & Automat, Technol Pk 914, B-9052 Ghent, Belgium; [Derom, Eric] Ghent Univ Hosp, Dept Resp Dis, Pintelaan 185,7K12, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital	Copot, D (corresponding author), Univ Ghent, Dept Elect Energy Syst & Automat, Technol Pk 914, B-9052 Ghent, Belgium.	dana.copot@ugent.be	Ionescu, Clara Mihaela/O-7006-2014; Copot, Dana/M-6345-2019	Ionescu, Clara Mihaela/0000-0001-7685-035X; Copot, Dana/0000-0002-6010-830X	Flanders Research Center (FWO) [1283415N]; project FWO [G008113N]	Flanders Research Center (FWO); project FWO	C. M. lonescu is a post-doc fellow of Flanders Research Center (FWO) grant nr. 1283415N. D. Copot acknowledges the support of the project FWO nr. G008113N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Bates JHT, 2009, LUNG MECHANICS: AN INVERSE MODELING APPROACH, P1, DOI 10.1017/CBO9780511627156; Boser SR, 2005, AM J RESP CRIT CARE, V172, P817, DOI 10.1164/rccm.200411-1463OC; Gabano JD, 2011, SIGNAL PROCESS, V91, P531, DOI 10.1016/j.sigpro.2010.02.005; Gabano JD, 2011, SIGNAL PROCESS, V91, P938, DOI 10.1016/j.sigpro.2010.09.013; HANTOS Z, 1986, J APPL PHYSIOL, V60, P123, DOI 10.1152/jappl.1986.60.1.123; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Ionescu C., 2014, 19 WORD C INT FED AU, P5363; Ionescu C., 2013, SERIES BIOENGINEERIN; Ionescu C., 2011, AM CONTR C; Ionescu C., 2009, IFAC P VOLUMES, V42, P994; Ionescu CM, 2014, IEEE T INSTRUM MEAS, V63, P124, DOI 10.1109/TIM.2013.2277519; Ionescu CM, 2011, IEEE T BIOMED CIRC S, V5, P83, DOI 10.1109/TBCAS.2010.2077636; Ionescu CM, 2009, IEEE T BIO-MED ENG, V56, P949, DOI 10.1109/TBME.2008.2007807; Irvin CG, 2000, AM J RESP CRIT CARE, V161, P50, DOI 10.1164/ajrccm.161.1.9804053; Karimi R., RESP RES, V15; Liou JL, 2010, WEAR, V268, P431, DOI 10.1016/j.wear.2009.08.033; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; LUTCHEN KR, 1987, FASEB J, V46, P510; Machado JT, 2011, COMMUN NONLINEAR SCI, V16, P1140, DOI 10.1016/j.cnsns.2010.05.027; Maes H, 2014, IEEE T INSTRUM MEAS, V63, P603, DOI 10.1109/TIM.2013.2282188; Magin Richard L., 2004, Critical Reviews in Biomedical Engineering, V32, P1, DOI 10.1615/CritRevBiomedEng.v32.10; Magleby R., 2008, 453 BEE; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Olarte O, 2016, BIOMED SIGNAL PROCES, V30, P127, DOI 10.1016/j.bspc.2016.06.004; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Oustaloup A, 2014, DIVERSITY AND NON-INTEGER DIFFERENTIATION FOR SYSTEM DYNAMICS, P1, DOI 10.1002/9781118760864; Oustaloup A., 1995, DERIVATION NONENTIER; Parameswaran H, 2006, J APPL PHYSIOL, V100, P186, DOI 10.1152/japplphysiol.00424.2005; Petak F, 1998, J APPL PHYSIOL, V84, P1680, DOI 10.1152/jappl.1998.84.5.1680; PONDER E, 1962, J GEN PHYSIOL, V45, P545, DOI 10.1085/jgp.45.3.545; Sorensen L., 2009, P SPIE DIG LIB C MED, V7260, P1; Sorensen L, 2010, IEEE T MED IMAGING, V29, P559, DOI 10.1109/TMI.2009.2038575; SUKI B, 1992, RESP PHYSIOL, V90, P271, DOI 10.1016/0034-5687(92)90108-9; SUKI B, 1994, NATURE, V368, P615, DOI 10.1038/368615a0; Tourassi GD, 2001, COMPUT BIOL MED, V31, P15, DOI 10.1016/S0010-4825(00)00024-X; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; WEIBEL ER, 1991, AM J PHYSIOL, V261, pL361, DOI 10.1152/ajplung.1991.261.6.L361; West B. J., 1990, STUDIES NONLINEAR PH, V1; West JB., 2008, WESTS RESP PHYSL ESS, V9th	40	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177969	10.1371/journal.pone.0177969	http://dx.doi.org/10.1371/journal.pone.0177969			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542377	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800031
J	Takahashi, K; Kim, R; Lauhan, C; Park, Y; Nguyen, NG; Vestweber, D; Dominguez, MG; Valenzuela, DM; Murphy, AJ; Yancopoulos, GD; Gale, NW; Takahashi, T				Takahashi, Keiko; Kim, Rachel; Lauhan, Colette; Park, Yuna; Nguyen, Nghiep G.; Vestweber, Dietmar; Dominguez, Melissa G.; Valenzuela, David M.; Murphy, Andrew J.; Yancopoulos, George D.; Gale, Nicholas W.; Takahashi, Takamune			Expression of receptor-type protein tyrosine phosphatase in developing and adult renal vasculature	PLOS ONE			English	Article							BLOOD-VESSEL DEVELOPMENT; VE-PTP; IN-VIVO; RPTP-MU; SHEAR-STRESS; MICE; TIE-2; CADHERIN; CELLS; PHOSPHORYLATION	Renal vascular development is a coordinated process that requires ordered endothelial cell proliferation, migration, intercellular adhesion, and morphogenesis. In recent decades, studies have defined the pivotal role of endothelial receptor tyrosine kinases (RPTKs) in the development and maintenance of renal vasculature. However, the expression and the role of receptor tyrosine phosphatases (RPTPs) in renal endothelium are poorly understood, though coupled and counterbalancing roles of RPTKs and RPTPs are well defined in other systems. In this study, we evaluated the promoter activity and immunolocalization of two endothelial RPTPs, VE-PTP and PTP mu, in developing and adult renal vasculature using the heterozygous LacZ knock-in mice and specific antibodies. In adult kidneys, both VE-PTP and PTP mu were expressed in the endothelium of arterial, glomerular, and medullary vessels, while their expression was highly limited in peritubular capillaries and venous endothelium. VE-PTP and PTP mu promoter activity was also observed in medullary tubular segments in adult kidneys. In embryonic (E12.5, E13.5, E15.5, E17.5) and postnatal (P0, P3, P7) kidneys, these RPTPs were expressed in ingrowing renal arteries, developing glomerular microvasculature (as early as the S-shaped stage), and medullary vessels. Their expression became more evident as the vasculatures matured. Peritubular capillary expression of VE-PTP was also noted in embryonic and postnatal kidneys. Compared to VE-PTP, PTP mu immunoreactivity was relatively limited in embryonic and neonatal renal vasculature and evident immunoreactivity was observed from the P3 stage. These findings indicate 1) VE-PTP and PTP mu are expressed in endothelium of arterial, glomerular, and medullary renal vasculature, 2) their expression increases as renal vascular development proceeds, suggesting that these RPTPs play a role in maturation and maintenance of these vasculatures, and 3) peritubular capillary VE-PTP expression is down-regulated in adult kidneys, suggesting a role of VE-PTP in the development of peritubular capillaries.	[Takahashi, Keiko; Kim, Rachel; Lauhan, Colette; Park, Yuna; Takahashi, Takamune] Vanderbilt Univ, Sch Med, Div Nephrol & Hypertens, Nashville, TN 37212 USA; [Nguyen, Nghiep G.] Univ Oklahoma, Coll Med, Oklahoma City, OK 73190 USA; [Vestweber, Dietmar] Max Planck Inst Mol Biomed, Munster, Germany; [Dominguez, Melissa G.; Valenzuela, David M.; Murphy, Andrew J.; Gale, Nicholas W.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Yancopoulos, George D.; Takahashi, Takamune] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	Vanderbilt University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Max Planck Society; Regeneron; Vanderbilt University	Takahashi, T (corresponding author), Vanderbilt Univ, Sch Med, Div Nephrol & Hypertens, Nashville, TN 37212 USA.; Takahashi, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	takamune.takahashi@vanderbilt.edu		Kim, Rachel/0000-0002-0538-5195; Park, Yuna/0000-0001-9981-5493	National Institutes of Health (NIH) [DK 97332, HL109715, DK38517]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart, Lung, and Blood Institute (NHLBI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097332, R01DK038517] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants DK 97332 (TT), HL109715 (TT), and DK38517 (TT); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK http://www.niddk.nih.gov/; and the National Heart, Lung, and Blood Institute (NHLBI) http://www.nhlbi.nih.gov/.MGD, DMV, AJM, GDY, NWG are employees of Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. provided the VE-PTPtlacZ/+ mice, but did not have any additional role in the salary support, study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2003, NEPHROL DIAL TRANSPL, V18, P2, DOI 10.1093/ndt/gfg1056; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Bianchi C, 1999, EXP CELL RES, V248, P329, DOI 10.1006/excr.1999.4428; BRADYKALNAY SM, 1993, J CELL BIOL, V122, P961, DOI 10.1083/jcb.122.4.961; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Craig SEL, 2015, SEMIN CELL DEV BIOL, V37, P108, DOI 10.1016/j.semcdb.2014.09.004; Desai CJ, 1997, CURR OPIN NEUROBIOL, V7, P70, DOI 10.1016/S0959-4388(97)80122-5; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Frye M, 2015, J EXP MED, V212, P2267, DOI 10.1084/jem.20150718; GEBBINK MFBG, 1995, J CELL BIOL, V131, P251, DOI 10.1083/jcb.131.1.251; GEBBINK MFBG, 1993, J BIOL CHEM, V268, P16101; Gomez RA, 1997, MICROSC RES TECHNIQ, V39, P254, DOI 10.1002/(SICI)1097-0029(19971101)39:3<254::AID-JEMT5>3.0.CO;2-K; Gurnik S, 2016, ACTA NEUROPATHOL, V131, P753, DOI 10.1007/s00401-016-1551-3; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Kim W, 2006, J AM SOC NEPHROL, V17, P2474, DOI 10.1681/ASN.2006020109; Kolatsi-Joannou M, 2001, DEV DYNAM, V222, P120, DOI 10.1002/dvdy.1170; Koop EA, 2005, AM J PHYSIOL-HEART C, V288, pH1218, DOI 10.1152/ajpheart.00512.2004; Koop EA, 2003, INT J DEV BIOL, V47, P345; Langille BL, 2001, MICROCIRCULATION, V8, P195, DOI 10.1038/sj.mn.7800085; Mantilidewi KI, 2014, J BIOL CHEM, V289, P6451, DOI 10.1074/jbc.M113.529503; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Pitera JE, 2004, AM J PATHOL, V165, P1895, DOI 10.1016/S0002-9440(10)63242-7; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Robert B, 1998, AM J PHYSIOL-RENAL, V275, pF164, DOI 10.1152/ajprenal.1998.275.1.F164; Robert B, 1996, AM J PHYSIOL-RENAL, V271, pF744, DOI 10.1152/ajprenal.1996.271.3.F744; Robert B, 2001, PEDIATR NEPHROL, V16, P294, DOI 10.1007/s004670000534; Shen JK, 2014, J CLIN INVEST, V124, P4564, DOI 10.1172/JCI74527; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Takahashi T, 1998, KIDNEY INT, V53, P826, DOI 10.1046/j.1523-1755.1998.00822.x; Takahashi T, 2001, J AM SOC NEPHROL, V12, P2673, DOI 10.1681/ASN.V12122673; Wallner EI, 1997, MICROSC RES TECHNIQ, V39, P261; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Woolf AS, 2009, J AM SOC NEPHROL, V20, P239, DOI 10.1681/ASN.2008020243; Yuan HT, 1999, J AM SOC NEPHROL, V10, P1722; Zondag GCM, 2000, J BIOL CHEM, V275, P11264, DOI 10.1074/jbc.275.15.11264	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177192	10.1371/journal.pone.0177192	http://dx.doi.org/10.1371/journal.pone.0177192			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542220	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800011
J	Edgar, GJ; Stuart-Smith, RD; Thomson, RJ; Freeman, DJ				Edgar, Graham J.; Stuart-Smith, Rick D.; Thomson, Russell J.; Freeman, Debbie J.			Consistent multi-level trophic effects of marine reserve protection across northern New Zealand	PLOS ONE			English	Article							REEF HABITATS; ROCKY; FISH; KELP; PATTERNS; DENSITY; CASCADE; INVERTEBRATES; ABUNDANCE; TRENDS	Through systematic Reef Life Survey censuses of rocky reef fishes, invertebrates and macroalgae at eight marine reserves across northern New Zealand and the Kermadec Islands, we investigated whether a system of no-take marine reserves generates consistent biodiversity outcomes. Ecological responses of reef assemblages to protection from fishing, including potential trophic cascades, were assessed using a control-impact design for the six marine reserves studied with associated reference sites, and also by comparing observations at reserve sites with predictions from random forest models that assume reserve locations are fished. Reserve sites were characterised by higher abundance and biomass of large fishes than fished sites, most notably for snapper Chrysophrys auratus, with forty-fold higher observed biomass inside relative to out. In agreement with conceptual models, significant reserve effects not only reflected direct interactions between fishing and targeted species (higher large fish biomass; higher snapper and lobster abundance), but also second order interactions (lower urchin abundance), third order interactions (higher kelp cover), and fourth order interactions (lower understory algal cover). Unexpectedly, we also found: (i) a consistent trend for higher (similar to 20%) Ecklonia cover across reserves relative to nearby fished sites regardless of lobster and urchin density, (ii) an inconsistent response of crustose coralline algae to urchin density, (iii) low cover of other understory algae in marine reserves with few urchins, and (iv) more variable fish and benthic invertebrate communities at reserve relative to fished locations. Overall, reef food webs showed complex but consistent responses to protection from fishing in well-enforced temperate New Zealand marine reserves. The small proportion of the northeastern New Zealand coastal zone located within marine reserves (similar to 0.2%) encompassed a disproportionately large representation of the full range of fish and benthic invertebrate biodiversity within this region.	[Edgar, Graham J.; Stuart-Smith, Rick D.] Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Thomson, Russell J.] Western Sydney Univ, Ctr Res Math, Parramatta Campus, Penrith, NSW, Australia; [Freeman, Debbie J.] Dept Conservat Te Papa Atawhai, Wellington, New Zealand	University of Tasmania; Western Sydney University	Edgar, GJ (corresponding author), Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	g.edgar@utas.edu.au	Stuart-Smith, Rick/I-5214-2019; Stuart-Smith, Rick D/M-1829-2013; Edgar, Graham/AAY-3797-2020; Thomson, Russell J/H-5653-2012	Stuart-Smith, Rick/0000-0002-8874-0083; Stuart-Smith, Rick D/0000-0002-8874-0083; Edgar, Graham/0000-0003-0833-9001; Thomson, Russell J/0000-0003-4949-4120	National Geographic Society [9223-12]; Department of Conservation, Science Investigation [4498]; Australian Research Council Linkage Grant [LP100200122]	National Geographic Society(National Geographic Society); Department of Conservation, Science Investigation; Australian Research Council Linkage Grant(Australian Research Council)	Field surveys were supported by National Geographic Society grant #9223-12 (http://www.nationalgeographic.com/explorers/grants-programs/cre/). Analysis of data from the New Zealand surveys was partly funded by the Department of Conservation, Science Investigation number 4498 (http://www.doc.govt.nz/), and Australian Research Council Linkage Grant LP100200122 (http://www.arc.gov.au/).; We thank Reef Life Survey divers who contributed to data collection: Peter Southwood, Andrew Green, Anna Berthelson, Bob Edgar, Charlie Bedford, Christine Kibele, Ian Shaw, Jared Kibele, Kirsten Rodgers, Paul Caiger, Richard Hughes and Sam Griffiths; Richard Taylor for assistance with local surveys; Toni Cooper, Just Berkhout and Jemina Stuart-Smith for data management and photoquadrat digitization; and Helen Curtis for producing Fig 1. Field surveys were supported by National Geographic Society grant #922312. Development of the Reef Life Survey program was facilitated by the Commonwealth Environment Research Facilities Program of the Australian Government. Analysis of data from the New Zealand surveys was partly funded by the Department of Conservation, Science Investigation number 4498, and Australian Research Council Linkage Grant LP100200122.	Althaus F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141039; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2008, PERMANOVA PRIMER GUI; ANDREW NL, 1993, MAR ECOL PROG SER, V99, P89, DOI 10.3354/meps099089; Babcock RC, 2013, NEW ZEAL J MAR FRESH, V47, P360, DOI 10.1080/00288330.2013.810160; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Ballantine B, 2014, BIOL CONSERV, V176, P297, DOI 10.1016/j.biocon.2014.01.014; Ballantine WJ, 2008, HYDROBIOLOGIA, V606, P35, DOI 10.1007/s10750-008-9347-7; Ballantine W.J., 1991, Leigh Laboratory Bulletin, V25, P1; Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; COLE RG, 1992, MAR ECOL PROG SER, V82, P207, DOI 10.3354/meps082207; Cole RG, 1999, J ECOL, V87, P963, DOI 10.1046/j.1365-2745.1999.00418.x; Department of Conservation and Ministry of Environment, 2000, NEW ZEAL BIOD STR; Department of Conservation and Ministry of Fisheries, 2005, MAR PROT ARE POL IMP; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Edgar GJ, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.7; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Edgar GJ, 2012, ENVIRON CONSERV, V39, P271, DOI 10.1017/S0376892912000185; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Freeman DT, 2012, ENVIRON CONSERV, V39, P295, DOI 10.1017/S037689291200015X; Haggitt TR, 2003, MAR BIOL, V143, P1201, DOI 10.1007/s00227-003-1152-2; Hesse J, 2016, NEW ZEAL J MAR FRESH, V50, P339, DOI 10.1080/00288330.2016.1146309; JONES GP, 1992, J EXP MAR BIOL ECOL, V159, P217, DOI 10.1016/0022-0981(92)90038-C; KENNELLY SJ, 1993, J EXP MAR BIOL ECOL, V168, P35, DOI 10.1016/0022-0981(93)90115-5; Langlois TJ, 2005, CONSERV BIOL, V19, P1763, DOI 10.1111/j.1523-1739.2005.00278.x; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Melville AJ, 2001, AUSTRAL ECOL, V26, P102, DOI 10.1111/j.1442-9993.2001.01089.pp.x; Ministry of Fisheries and Department of Conservation, 2008, MAR PROT AR CLASS PR; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Newcombe EM, 2010, MAR ECOL PROG SER, V408, P161, DOI 10.3354/meps08589; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Shears NT, 2008, ECOL APPL, V18, P1860, DOI 10.1890/07-1776.1; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Shears NT, 2004, INDIRECT EFFECTS MAR; Silverman BW., 1986, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; Soler GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140270; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stuart-Smith RD, 2008, J EXP MAR BIOL ECOL, V365, P116, DOI 10.1016/j.jembe.2008.08.002; Stuart-Smith RD, 2017, BIOSCIENCE, V67, P134, DOI 10.1093/biosci/biw180; Taylor RB, 1998, MAR ECOL PROG SER, V172, P37, DOI 10.3354/meps172037; Thompson S., 1991, FISH CAPE RODNEY OKA; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x	46	21	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177216	10.1371/journal.pone.0177216	http://dx.doi.org/10.1371/journal.pone.0177216			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542268	Green Published, gold, Green Accepted			2022-12-27	WOS:000402061500015
J	Kim, SC; Lim, YW; Kwon, SY; Jo, WL; Ju, SH; Park, CJ; Lee, CW; Kim, YS				Kim, Seung-Chan; Lim, Young-Wook; Kwon, Soon-Yong; Jo, Woo-Lam; Ju, Sung-Hun; Park, Chan-Joo; Lee, Choong-Woo; Kim, Yong-Sik			Level of surgical experience is associated with change in hip center of rotation following cementless total hip arthroplasty: A radiographic assessment	PLOS ONE			English	Article							ACETABULAR COMPONENT; FEMORAL COMPONENTS; ORIENTATION; DISLOCATION; PLACEMENT; ACCURACY; WEAR; REPLACEMENT; ANTEVERSION; FIXATION	Objectives After total hip arthroplasty (THA), restoration of hip center of rotation (COR) is essential to ensure stability of the prosthetic hip and longevity of the prosthesis. Our aim was to determine whether, and how, the COR changed postoperatively compared to the native COR following implantation of a cementless acetabular component in anatomical position and to compare the accuracy of cup placement between two surgeons with different levels of surgical experience. Materials and methods We evaluated 145 patients (145 hips) who underwent unilateral primary THA, who had no distorted acetabulum on the affected hip and a normal contralateral hip. Hip reconstruction was radiologically and clinically assessed at a minimum 2-year follow-up. Perioperative change in COR, initial cup position, offset, leg-length discrepancy (LLD), radiographic cup orientation, Harris Hip Score (HHS), component loosening, and dislocations were compared between the highly experienced surgeon and less-experienced surgeon groups. Results The COR was significantly displaced in the superior and medial directions postoperatively. Significant differences were identified in the vertical COR change, initial cup position, LLD, cup inclination, and cups within safe zones, but not in the horizontal COR change, offset parameters, cup anteversion, or HHS. There were no radiographic evidence of component loosening in both groups, but three dislocations (7%) only in the group operated on by the less-experienced surgeon (p = 0.027). Conclusions We found that the postoperative COR tended to be displaced in the superior and medial directions, and that the level of surgical experience strongly affected the accuracy and consistency of cup placement, particularly in COR position and cup inclination.	[Kim, Seung-Chan; Lim, Young-Wook; Jo, Woo-Lam; Ju, Sung-Hun; Park, Chan-Joo; Lee, Choong-Woo; Kim, Yong-Sik] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Kwon, Soon-Yong] Catholic Univ Korea, Coll Med, Yeouido St Marys Hosp, Dept Orthopaed Surg, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Kim, YS (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Orthopaed Surg, Seoul, South Korea.	yongsik@korea.com		Lim, Young-Wook/0000-0001-5648-9755				Abolghasemian M, 2013, J ARTHROPLASTY, V28, P1031, DOI 10.1016/j.arth.2012.07.042; Biedermann R, 2005, J BONE JOINT SURG BR, V87B, P762, DOI 10.1302/0301-620X.87B6; Bosker BH, 2007, ARCH ORTHOP TRAUM SU, V127, P375, DOI 10.1007/s00402-007-0294-y; Callanan MC, 2011, CLIN ORTHOP RELAT R, V469, P319, DOI 10.1007/s11999-010-1487-1; D'Lima DD, 2000, J BONE JOINT SURG AM, V82A, P315, DOI 10.2106/00004623-200003000-00003; Delp SL, 1996, CLIN ORTHOP RELAT R, P137; ENGH CA, 1990, CLIN ORTHOP RELAT R, P107; Hirakawa K, 2001, CLIN ORTHOP RELAT R, P135; JOHNSTON RC, 1979, J BONE JOINT SURG AM, V61, P639, DOI 10.2106/00004623-197961050-00001; Kennedy JG, 1998, J ARTHROPLASTY, V13, P530, DOI 10.1016/S0883-5403(98)90052-3; KHAN MAA, 1981, J BONE JOINT SURG BR, V63, P214, DOI 10.1302/0301-620X.63B2.7217144; Kim S-C, J ARTHROPLASTY; Kim YS, 2008, CLIN ORTHOP RELAT R, V466, P294, DOI 10.1007/s11999-007-0056-8; Kurtz WB, 2010, J ARTHROPLASTY, V25, P624, DOI 10.1016/j.arth.2009.03.024; Latimer HA, 1996, J BONE JOINT SURG AM, V78A, P975, DOI 10.2106/00004623-199607000-00001; Lee YK, 2014, J ARTHROPLASTY, V29, P586, DOI 10.1016/j.arth.2013.07.023; Leslie IJ, 2009, CLIN ORTHOP RELAT R, V467, P2259, DOI 10.1007/s11999-009-0830-x; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217, DOI 10.2106/00004623-197860020-00014; Lim YW, 2013, J ARTHROPLASTY, V28, P1791, DOI 10.1016/j.arth.2013.02.022; Little NJ, 2009, CLIN ORTHOP RELAT R, V467, P2895, DOI 10.1007/s11999-009-0845-3; Long WT, 2010, CLIN ORTHOP RELAT R, V468, P400, DOI 10.1007/s11999-009-1071-8; Pagnano MW, 1996, J BONE JOINT SURG AM, V78A, P1004, DOI 10.2106/00004623-199607000-00004; Ranawat CS, 2001, J ARTHROPLASTY, V16, P715, DOI 10.1054/arth.2001.24442; Reize Patrik, 2008, Am J Orthop (Belle Mead NJ), V37, P360; RUSSOTTI GM, 1991, J BONE JOINT SURG AM, V73A, P587, DOI 10.2106/00004623-199173040-00016; Saxler G, 2004, INT ORTHOP, V28, P198, DOI 10.1007/s00264-004-0542-5; Shin WC, 2015, BONE JOINT J, V97B, P611, DOI 10.1302/0301-620X.97B5.34735; Shon WY, 2005, J ARTHROPLASTY, V20, P427, DOI 10.1016/j.arth.2004.09.058; Wan ZN, 2008, J ARTHROPLASTY, V23, P51, DOI 10.1016/j.arth.2007.06.008; Widmer KH, 2004, J ARTHROPLASTY, V19, P387, DOI 10.1016/j.arth.2003.10.016; Widmer KH, 2004, J ORTHOP RES, V22, P815, DOI 10.1016/j.orthres.2003.11.001	31	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178300	10.1371/journal.pone.0178300	http://dx.doi.org/10.1371/journal.pone.0178300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542504	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500080
J	Ashraf, Z; Rafiq, M; Nadeem, H; Hassan, M; Afzal, S; Waseem, M; Afzal, K; Latip, J				Ashraf, Zaman; Rafiq, Muhammad; Nadeem, Humaira; Hassan, Mubashir; Afzal, Samina; Waseem, Muhammad; Afzal, Khurram; Latip, Jalifah			Carvacrol derivatives as mushroom tyrosinase inhibitors; synthesis, kinetics mechanism and molecular docking studies	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; ANTIOXIDANT; THYMOL; DOPAMINE; OXIDASES; QUALITY; ACID	The present work describesthe development of highly potent mushroom tyrosinase inhibitor better than the standard kojic acid. Carvacrol derivatives 4a-f and 6a-d having substituted benzoic acid and cinnamic acidresidues were synthesized with the aim to possess potent tyrosinase inhibitory activity. The structures of the synthesized compounds were ascertained by their spectroscopic data (FTIR, (HNMR)-H-1, (CNMR)-C-13 and Mass Spectroscopy). Mushroom tyrosinase inhibitory activity of synthesized compounds was determined and it was found that one of the derivative 6c possess higher activity (IC50 0.0167 mu M) than standard kojic acid (IC50 16.69 mu M). The derivatives 4c and 6b also showed good tyrosinase inhibitory activity with (IC50 16.69 mu M) and (IC50 16.69 mu M) respectively. Lineweaver-Burk and Dixon plots were used for the determination of kinetic mechanism of the compounds 4c and 6b and 6c. The kinetic analysis revealed that compounds 4c and 6b showed mixed-type inhibition while 6c is a non-competitive inhibitor having Ki values19 mu M, 10 mu M, and 0.05 mu Mrespectively. The enzyme inhibitory kinetics further showed that compounds 6b and 6c formed irreversible enzyme inhibitor complex while 4c bind reversibly with mushroom tyrosinase. The docking studies showed that compound 6c have maximum binding affinity against mushroom tyrosinase (PDBID: 2Y9X) with binding energy value (-7.90 kcal/mol) as compared to others. The 2-hydroxy group in compound 6c interacts with amino acid HIS85 which is present in active binding site. The wet lab results are in good agreement with the dry lab findings. Based upon our investigation we may propose that the compound 6c is promising candidate for the development of safe cosmetic agent.	[Ashraf, Zaman] Allama Iqbal Open Univ, Dept Chem, Islamabad, Pakistan; [Rafiq, Muhammad] Islamia Univ Bahawalpur, Dept Biochem & Biotechnol, Baghdad ul Jadeed Campus, Bahawalpur, Pakistan; [Nadeem, Humaira] Riphah Int Univ, Riphah Inst Pharmaceut Sci, Dept Pharmaceut Chem, Islamabad, Pakistan; [Hassan, Mubashir] Kongju Natl Univ, Dept Biol, Coll Nat Sci, Gongju, South Korea; [Afzal, Samina; Afzal, Khurram] BahauddinZakria Univ, Dept Pharm, Fac Pharm, Multan, Pakistan; [Waseem, Muhammad] Allama Iqbal Open Univ, Dept Biol, Islamabad, Pakistan; [Latip, Jalifah] Univ Kebangsaan Malaysia, Sch Chem Sci & Food Technol, Fac Sci & Technol, Bangi, Selangor, Malaysia	Islamia University of Bahawalpur; Kongju National University; Universiti Kebangsaan Malaysia	Latip, J (corresponding author), Univ Kebangsaan Malaysia, Sch Chem Sci & Food Technol, Fac Sci & Technol, Bangi, Selangor, Malaysia.	jalifah@ukm.edu.my	ashraf, zaman/AAH-2147-2021; Hassan, Mubashir/V-8187-2017	ashraf, zaman/0000-0002-6620-9080; Hassan, Mubashir/0000-0003-2532-1866	Universiti Kebangsaan Malaysia [DIP-2015-015]	Universiti Kebangsaan Malaysia	The authors are especially grateful to Universiti Kebangsaan Malaysia for financial assistance under the DIP-2015-015 research grant.	AESCHBACH R, 1994, FOOD CHEM TOXICOL, V32, P31, DOI 10.1016/0278-6915(84)90033-4; [Anonymous], 2008, STUD DISC VERS 2 1; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Ashraf Z, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122151; Ashraf Z, 2015, J ENZYM INHIB MED CH, V30, P874, DOI 10.3109/14756366.2014.979346; Ashraf Z, 2015, BIOORGAN MED CHEM, V23, P5870, DOI 10.1016/j.bmc.2015.06.068; Ashraf Z, 2015, EUR J MED CHEM, V98, P203, DOI 10.1016/j.ejmech.2015.05.031; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen WC, 2015, SCI REP-UK, V5, DOI 10.1038/srep07995; Chen ZY, 2014, BIOORGAN MED CHEM, V22, P3279, DOI 10.1016/j.bmc.2014.04.060; Finlay AY, 1997, BRIT J DERMATOL, V136, P305, DOI 10.1111/j.1365-2133.1997.tb14934.x; Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r; Jukic M, 2005, CROAT CHEM ACTA, V78, P105; Kadekaro AL, 2003, ANN NY ACAD SCI, V994, P359, DOI 10.1111/j.1749-6632.2003.tb03200.x; Kim JM, 1995, J FOOD SCI, V60, P1364, DOI 10.1111/j.1365-2621.1995.tb04592.x; Lovell S.C., 2003, PROTEINS STRUCT FUNC, V50, P437, DOI [10.1002/prot.10286, DOI 10.1002/PROT.10286]; Lynde C B, 2006, Skin Therapy Lett, V11, P1; MAYER AM, 1987, PHYTOCHEMISTRY, V26, P11; Menezes JCJMDS, 2011, EUR J MED CHEM, V46, P773, DOI 10.1016/j.ejmech.2010.12.016; Miliovsky M, 2013, EUR J MED CHEM, V66, P185, DOI 10.1016/j.ejmech.2013.05.040; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Petit L., 2003, International Journal of Cosmetic Science, V25, P169, DOI 10.1046/j.1467-2494.2003.00182.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pires DEV, 2015, J MED CHEM, V58, P4066, DOI 10.1021/acs.jmedchem.5b00104; Prota G, 1995, Fortschr Chem Org Naturst, V64, P93; Prota G., 1992, MELANINS MELANOGENES; Qiu L, 2005, BIOORGAN MED CHEM, V13, P6206, DOI 10.1016/j.bmc.2005.06.034; Rattanangkool E, 2013, EUR J MED CHEM, V66, P296, DOI 10.1016/j.ejmech.2013.05.047; Rendon M, 2006, J AM ACAD DERMATOL, V54, pS272, DOI 10.1016/j.jaad.2005.12.039; Riley PA, 2003, PIGM CELL RES, V16, P548, DOI 10.1034/j.1600-0749.2003.00069.x; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Seo WD, 2010, EUR J MED CHEM, V45, P2010, DOI 10.1016/j.ejmech.2010.01.049; Shiino M, 2001, BIOORGAN MED CHEM, V9, P1233, DOI 10.1016/S0968-0896(01)00003-7; SLOMINSKI A, 1990, J THEOR BIOL, V143, P123, DOI 10.1016/S0022-5193(05)80292-9; SLOMINSKI A, 1991, LIFE SCI, V48, P2075, DOI 10.1016/0024-3205(91)90164-7; SLOMINSKI A, 1991, EXPERIENTIA, V47, P721, DOI 10.1007/BF01958826; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Ultee A, 1998, J APPL MICROBIOL, V85, P211, DOI 10.1046/j.1365-2672.1998.00467.x; Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935; van Holde KE, 2001, J BIOL CHEM, V276, P15563, DOI 10.1074/jbc.R100010200; Walsh SE, 2003, J APPL MICROBIOL, V94, P240, DOI 10.1046/j.1365-2672.2003.01825.x; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Yamaguchi Y, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017046; Yanishlieva NV, 1999, FOOD CHEM, V64, P59, DOI 10.1016/S0308-8146(98)00086-7; Yi W, 2010, EUR J MED CHEM, V45, P639, DOI 10.1016/j.ejmech.2009.11.007; Yi W, 2009, FOOD CHEM, V117, P381, DOI 10.1016/j.foodchem.2009.03.108; Zhu YJ, 2011, FOOD CHEM, V124, P298, DOI 10.1016/j.foodchem.2010.06.036	49	40	41	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178069	10.1371/journal.pone.0178069	http://dx.doi.org/10.1371/journal.pone.0178069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542395	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058800036
J	Brodowski, L; Burlakov, J; Hass, S; von Kaisenberg, C; von Versen-Hoynck, F				Brodowski, Lars; Burlakov, Jennifer; Hass, Sarah; von Kaisenberg, Constantin; von Versen-Hoeynck, Frauke			Impaired functional capacity of fetal endothelial cells in preeclampsia	PLOS ONE			English	Article							PLACENTAL VASCULAR DEVELOPMENT; GROWTH-FACTOR; INHIBITS ANGIOGENESIS; PROGENITOR CELLS; ADULT LIFE; IN-VITRO; HYPOXIA; EXPRESSION; OXYGEN; RISK	Objectives Preeclampsia is one of the main contributers to maternal and fetal morbidity and mortality during pregnancy. A history of preeclampsia puts mother and offspring at an increased cardiovascular risk in later life. We hypothesized that at the time of birth functional impairments of fetal endothelial cells can be detected in pregnancies complicated by preeclampsia and that a therapeutic intervention using 1,25 (OH)(2) vitamin D-3 can reverse the adverse effects of preeclampsia on cell function. Methods Human umbilical vein endothelial cells (HUVEC) were isolated from umbilical cords obtained from preeclamptic (N = 12) and uncomplicated pregnancies (N = 13, control). Placental villous tissue fragments from uncomplicated term pregnancies were incubated in explant culture for 48 h at 2% (hypoxia), 8% or 21% O-2. Explant conditioned media (CM) was collected and pooled according to oxygen level. We compared the ability of preeclampsia vs. control HUVEC to migrate, proliferate, and form tubule-like networks in a Matrigel assay, in the presence/absence of CM and 1,25(OH)(2) vitamin D-3. Results HUVEC from preeclamptic pregnancies showed reduced migration (P = 0.04) and tubule formation (P = 0.04), but no change in proliferation (P = 0.16) compared to healthy pregnancies. Placental villous explant CM derived from 2% O-2 incubations significantly reduced HUVEC migration, when compared to non-CM (P = 0.04). Vitamin D-3 improved HUVEC function in neither of the groups. There was no significant difference in VEGF gene expression between healthy and preeclamptic pregnancies and no effect of Vitamin D-3 on VEGF expression. Conclusions Reduced functional abilities of fetal endothelial cells from preeclamptic pregnancies suggests that disease pathways, possibly originating from the dysfunctional placenta, negatively impact fetal endothelium. The neutral effect of 1,25(OH)(2) vitamin D-3 contrasts with previous findings that vitamin D rescues the poor migration, proliferation and tubule formation exhibited by cord blood fetal endothelial progenitor cells from preeclamptic pregnancies. Further investigations to distinguish pathways by which offspring exposed to preeclampsia are at risk for cardiovascular disease are needed.	[Brodowski, Lars; Burlakov, Jennifer; Hass, Sarah; von Kaisenberg, Constantin; von Versen-Hoeynck, Frauke] Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany	Hannover Medical School	von Versen-Hoynck, F (corresponding author), Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany.	vonVersen-Hoeynck.Frauke@mh-hannover.de	von Kaisenberg, Constantin/AAR-2756-2021; von Versen-Höynck, Frauke/H-3719-2019	von Versen-Höynck, Frauke/0000-0002-1924-5695	Deutsche Forschungsgemeinschaft [VE490/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by a grant from the Deutsche Forschungsgemeinschaft (VE490/7-1) to Frauke von Versen-Hoynck. http://www.dfg.de/en/.	Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Albert DM, 2007, INVEST OPHTH VIS SCI, V48, P2327, DOI 10.1167/iovs.06-1210; Annabi B, 2003, STEM CELLS, V21, P337, DOI 10.1634/stemcells.21-3-337; AUGUST P, 1992, AM J OBSTET GYNECOL, V166, P1295, DOI 10.1016/S0002-9378(11)90625-5; Bainbridge SA, 2009, AM J PHYSIOL-CELL PH, V297, pC440, DOI 10.1152/ajpcell.00593.2008; Brodowski L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098527; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Dunn WB, 2009, PLACENTA, V30, P974, DOI 10.1016/j.placenta.2009.08.008; Egorova AD, 2012, IN VITRO CELL DEV-AN, V48, P21, DOI 10.1007/s11626-011-9470-z; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Grundmann M, 2012, AM J PHYSIOL-CELL PH, V303, pC954, DOI 10.1152/ajpcell.00030.2012; Halhali A, 2004, J STEROID BIOCHEM, V89-90, P553, DOI 10.1016/j.jsbmb.2004.03.069; Halhali A, 2013, J STEROID BIOCH MOL; Haugen M, 2009, EPIDEMIOLOGY, V20, P720, DOI 10.1097/EDE.0b013e3181a70f08; Hisa T, 1996, ARCH DERMATOL RES, V288, P262, DOI 10.1007/s004030050058; Hwang HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.060; Indelicato M, 2010, J CELL PHYSIOL, V223, P359, DOI 10.1002/jcp.22041; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jayet PY, 2010, CIRCULATION, V122, P488, DOI 10.1161/CIRCULATIONAHA.110.941203; Kajantie E, 2002, CLIN ENDOCRINOL, V57, P635, DOI 10.1046/j.1365-2265.2002.01659.x; Kajantie E, 2009, STROKE, V40, P1176, DOI 10.1161/STROKEAHA.108.538025; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Kingdom JCP, 1999, ADV EXP MED BIOL, V474, P259; Kumazaki K, 2002, HUM PATHOL, V33, P1069, DOI 10.1053/hupa.2002.129420; Lazdam M, 2010, HYPERTENSION, V56, P159, DOI 10.1161/HYPERTENSIONAHA.110.150235; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Levine MJ, 2004, J NUTR, V134, P2244, DOI 10.1093/jn/134.9.2244; Lewandowski AJ, 2014, EARLY HUM DEV, V90, P725, DOI 10.1016/j.earlhumdev.2014.08.012; Lewandowski AJ, 2012, CIRCULATION, V126; Mantell DJ, 2000, CIRC RES, V87, P214, DOI 10.1161/01.RES.87.3.214; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Moyes AJ, 2011, REPROD SCI, V18, P374, DOI 10.1177/1933719110385131; Munarin F, 2015, IEEE ENG MED BIO, P1741, DOI 10.1109/EMBC.2015.7318714; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; OLSEN SF, 1990, BRIT J NUTR, V64, P599, DOI 10.1079/BJN19900063; Pan C. C., 2016, ONCOTARGET, DOI 10.18632/oncotarget.9307; Rebsamen MC, 2002, CIRCULATION RES, V91; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Roberts JM, 2000, SEMIN PERINATOL, V24, P24, DOI 10.1016/S0146-0005(00)80050-6; Robinson NJ, 2008, LAB INVEST, V88, P293, DOI 10.1038/labinvest.3700746; Schlaeppi JM, 1997, ENDOCR RES, V23, P213, DOI 10.3109/07435809709031855; Sipos PI, 2010, PLACENTA, V31, P1, DOI 10.1016/j.placenta.2009.10.006; Trollmann R, 2003, AM J OBSTET GYNECOL, V188, P517, DOI 10.1067/mob.2003.138; von Versen-Hoynck F, 2009, PLACENTA, V30, P434, DOI 10.1016/j.placenta.2009.02.004; von Versen-Hoynck F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098990; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Zhao LX, 2012, J CELL MOL MED, V16, P1840, DOI 10.1111/j.1582-4934.2011.01479.x	52	19	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178340	10.1371/journal.pone.0178340	http://dx.doi.org/10.1371/journal.pone.0178340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542561	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058800055
J	He, R; Gu, XB; Lai, WM; Peng, XR; Yang, GY				He, Ran; Gu, Xiaobin; Lai, Weimin; Peng, Xuerong; Yang, Guangyou			Transcriptome-microRNA analysis of Sarcoptes scabiei and host immune response	PLOS ONE			English	Article							HOUSE-DUST MITE; IMD PATHWAYS; RNA-SEQ; DROSOPHILA; INFESTATION; ALIGNMENT; TOLL; GENERATION; REGULATORS; INHIBITORS	Scabies is a parasitic disease, caused by the mite Sarcoptes scabiei, and is considered one of the top 50 epidemic diseases and one the most common human skin disease, worldwide. Allergic dermatitis, including an intense itch, is a common symptom, however diagnosis is difficult and there is currently no effective vaccine. The goal of this study was to examine the immune interaction mechanism of both S. scabiei and infected hosts. mRNA-seq and micro-RNA-seq were conducted on the S. scabiei mite and on infected and uninfected hosts. We focused on differential expression of unigenes and microRNAs, as well as the real targets of unigenes in enriched immune signaling pathways. S. scabiei enhanced host immune function and decreased metabolism after infection, while the immune response of the host inhibited S. scabiei proliferation and metabolism signaling pathways. Differentially expressed unigenes of S. scabiei were enriched in the JAK-STAT signaling pathway and the Toll-like receptor signaling pathway. The differential expression analysis indicated that microRNAs of S. scabiei and hosts have major roles in regulating immune interactions between parasites and hosts.	[He, Ran; Gu, Xiaobin; Lai, Weimin; Yang, Guangyou] Sichuan Agr Univ, Dept Parasitol, Coll Vet Med, Wenjiang, Peoples R China; [Peng, Xuerong] Sichuan Agr Univ, Dept Chem, Coll Life & Basic Sci, Wenjiang, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Yang, GY (corresponding author), Sichuan Agr Univ, Dept Parasitol, Coll Vet Med, Wenjiang, Peoples R China.	guangyou1963@aliyun.com			Research Fund for the Chengdu Research of Giant Panda Breeding [CPF2014-17]	Research Fund for the Chengdu Research of Giant Panda Breeding	This work was supported by a grant from the Research Fund for the Chengdu Research of Giant Panda Breeding (Project No. CPF2014-17). The funder had no role in study design, sample collection, data analysis, preparation or publication of the manuscript.; This work was supported by a grant from the Research Fund for the Chengdu Research of Giant Panda Breeding (Project No. CPF2014-17). We would like to thank Hai Lin and Nengxing Shen (College of Veterinary Medicine, Sichuan Agricultural University, China) for their help.	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews RM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000554; Andrews S., 2010, FASTQC QUALITY CONTR; Angelone-Alasaad S, 2015, PARASITE VECTOR, V8, P1; Arlian LG, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004188; Arlian LG, 2000, VET PARASITOL, V90, P315, DOI 10.1016/S0304-4017(00)00251-X; ARLIAN LG, 1988, J MED ENTOMOL, V25, P240, DOI 10.1093/jmedent/25.4.240; Arlian LG, 2002, ANNU REV ENTOMOL, V47, P395, DOI 10.1146/annurev.ento.47.091201.145224; Beckham SA, 2009, J BIOL CHEM, V284, P34413, DOI 10.1074/jbc.M109.061911; Berrios X, 2004, PEDIATR NEPHROL, V19, P306, DOI 10.1007/s00467-003-1340-9; Burge SW, 2012, NUCLEIC ACIDS RES; Casais R, 2015, VET PARASITOL, V214, P315, DOI 10.1016/j.vetpar.2015.07.011; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Devaney E, 2010, TRENDS PARASITOL, V26, P428, DOI 10.1016/j.pt.2010.05.003; Engelman D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002167; Enright AJ, 2004, GENOME BIOL, V5; Fang F, 2015, PARASITE VECTOR, V8, P1; Fischer K, 2003, AM J TROP MED HYG, V68, P61, DOI 10.4269/ajtmh.2003.68.1.0680061; Fischer K, 2014, INT J PARASITOL, V44, P955, DOI 10.1016/j.ijpara.2014.08.003; Gu XB, 2014, EXP APPL ACAROL, V63, P401, DOI 10.1007/s10493-014-9780-4; Gu XB, 2014, EXP APPL ACAROL, V62, P225, DOI 10.1007/s10493-013-9736-0; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamel D, 2015, PARASITOL RES, V114, P535, DOI 10.1007/s00436-014-4215-z; Han HX, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-120; Hay RJ, 2012, CLIN MICROBIOL INFEC, V18, P313, DOI 10.1111/j.1469-0691.2012.03798.x; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Hoefig KP, 2008, CURR OPIN IMMUNOL, V20, P281, DOI 10.1016/j.coi.2008.05.005; Holt DC, 2013, CELL TISSUE RES, V351, P339, DOI 10.1007/s00441-012-1369-9; Hu L, 2016, PARASITOL RES, V115, P2661, DOI 10.1007/s00436-016-5013-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Karthikeyan K., 2009, INDIAN J DERMATOL, V75, P71; Kenyon F, 2002, VET PARASITOL, V105, P317, DOI 10.1016/S0304-4017(02)00015-8; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kozomara A., 2010, NUCLEIC ACIDS RES; Lalor PF, 2002, J IMMUNOL, V169, P983, DOI 10.4049/jimmunol.169.2.983; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levi A, 2011, LASER MED SCI, V26, P291, DOI 10.1007/s10103-011-0894-1; Liu QA, 2010, PARASITOL RES, V107, P501, DOI 10.1007/s00436-010-1927-6; Liu XS, 2014, PARASITOLOGY, V141, P725, DOI 10.1017/S0031182013002047; Mahmood W, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002525; Mika A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040489; Mika A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001563; Mika A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001331; Myllymaki H, 2014, SCAND J IMMUNOL, V79, P377, DOI 10.1111/sji.12170; Nong X, 2014, PARASITOL RES, V113, P1201, DOI 10.1007/s00436-014-3758-3; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Pearen MA, 2006, ENDOCRINOLOGY, V147, P5217, DOI 10.1210/en.2006-0447; Pearen MA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-448; Rampton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065354; Reynolds SL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002872; Rider SD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1198-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulte LN, 2012, NUCLEIC ACIDS RES; Singh SK, 2014, VET PARASITOL, V206, P253, DOI 10.1016/j.vetpar.2014.10.024; Stewart GA, 2003, CLIN EXP ALLERGY, V33, P3, DOI 10.1046/j.1365-2222.2003.01601.x; Sun XH, 2014, TRENDS CARDIOVAS MED, V24, P105, DOI 10.1016/j.tcm.2013.09.002; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Terada Y, 2010, VET DERMATOL, V21, P608, DOI 10.1111/j.1365-3164.2010.00895.x; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Toet HM, 2014, VET PARASITOL, V205, P263, DOI 10.1016/j.vetpar.2014.07.012; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walton SF, 2004, ADV PARASIT, V57, P309, DOI 10.1016/S0065-308X(04)57005-7; Walton SF, 2007, CLIN MICROBIOL REV, V20, P268, DOI 10.1128/CMR.00042-06; Walton SF, 2010, CLIN VACCINE IMMUNOL, V17, P1428, DOI 10.1128/CVI.00195-10; Zhang RH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-336; Zhang RH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-176; Zheng Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1353-1	71	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177733	10.1371/journal.pone.0177733	http://dx.doi.org/10.1371/journal.pone.0177733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542251	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800025
J	Jang, Y; Kim, JH; Lee, K				Jang, Yeonsoo; Kim, Jeong Hyun; Lee, Kyunghwa			Validation of the revised piper fatigue scale in Koreans with chronic hepatitis B	PLOS ONE			English	Article							CANCER-PATIENTS; NUMBER; COMPONENTS; DISEASE	Purpose The purpose of the study was to evaluate the construct validity and reliability of the Korean version of the revised Piper Fatigue Scale (PFS) in Koreans with chronic hepatitis B. Methods A total of 146 chronic hepatitis B patients completed the Korean version of the revised PFS. A descriptive analysis was performed to determine the subjects' demographic characteristics; the construct validity was examined using exploratory factor analysis; and internal consistency reliability of the scale was estimated for the meaningful total scale and factors. Results The factor analysis supported the original four-factor structure based on Kaiser Criterion and Minimum Average Partial (MAP): Behavioral/Severity, Affective meaning, Sensory, & Cognitive/Mood. In the 22 items in the original instrument, patient/impatient, relaxed/tense, and exhilarated/depressed were re-identified from the cognitive/mood subscale and sensory subscale. The Cronbach's alpha of the 22-item Korean version of the revised PFS was 0.96 for the total scale, and the range of Cronbach's alpha for subscales was 0.90 to 0.93. Conclusions The results of the study revealed that the 22-item Korean version of the revised PFS is valid and reliable in Koreans with chronic hepatitis B. Further studies ascertaining the psychometric properties of the revised PFS need to be performed in Korean patients.	[Jang, Yeonsoo] Yonsei Univ, Mo Im Kim Nursing Res Inst, Coll Nursing, Seoul, South Korea; [Kim, Jeong Hyun; Lee, Kyunghwa] Yonsei Univ, Grad Sch, Dept Nursing, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Lee, K (corresponding author), Yonsei Univ, Grad Sch, Dept Nursing, Seoul, South Korea.	lkh82711@hanmail.net		Lee, Kyunghwa/0000-0003-0210-9176; Jang, Yeonsoo/0000-0002-1898-025X	National Research Foundation of Korea - Korean government [NRF-2011-0024717]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government)	This research was supported by a National Research Foundation of Korea grant funded by the Korean government, NRF-2011-0024717 (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Annunziata MA, 2010, TUMORI J, V96, P276, DOI 10.1177/030089161009600215; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Crane PB, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00055; Dagnelie PC, 2006, J CLIN EPIDEMIOL, V59, P642, DOI 10.1016/j.jclinepi.2005.09.015; Giacalone A, 2010, SUPPORT CARE CANCER, V18, P1191, DOI 10.1007/s00520-009-0741-0; Gledhill Jane A, 2002, Rech Soins Infirm, P50; Hair J. F, 1987, MULTIVARIATE ANAL RE, V2nd; Jakobsson S, 2013, EUR J ONCOL NURS, V17, P808, DOI 10.1016/j.ejon.2013.07.004; Jeong K, 2014, ASIAN ONCOLOGY NURSI, V14; Kim J. Y., 2012, INT J HIGH ENG, V14, P1, DOI [10.7855/IJHE.2012.14.4.163, DOI 10.7855/IJHE.2012.14.4.163]; Kim YA, 2013, TREND SEROPREVALENCE; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Ledesma RD, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [https://doi.org/10.7275/wjnc-nm63, DOI 10.7275/WJNC-NM63]; Lee E.O., 2009, NURSING RES STAT ANA; Lee EH, 1999, J KOREAN ACAD NURS, V29, P485, DOI DOI 10.4040/jkan.1999.29.3.485; Nelson NP, 2016, EPIDEMIOLOGY HEPATIT, P607; Park H.A., 2005, J NURSING QUERY, V14, P46; Piper B F, 1998, Oncol Nurs Forum, V25, P677; Piper B.F., 1989, MANAGEMENT PAIN FATI, P199; Romkens TEH, 2011, J CROHNS COLITIS, V5, P332, DOI 10.1016/j.crohns.2011.02.008; Ruscio J, 2012, PSYCHOL ASSESSMENT, V24, P282, DOI 10.1037/a0025697; Schmitt TA, 2011, J PSYCHOEDUC ASSESS, V29, P304, DOI 10.1177/0734282911406653; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Soon Kim Keum, 2007, [The Journal of Fundamentals of Nursing, 기본간호학회지], V14, P331; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Tsay SL, 2004, AM J CHINESE MED, V32, P407, DOI 10.1142/S0192415X04002065; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; VELICER WF, 1976, EDUC PSYCHOL MEAS, V36, P149, DOI 10.1177/001316447603600114; Yi Myungsun, 2007, Taehan Kanho Hakhoe Chi, V37, P665; Yu DSF, 2004, WESTERN J NURS RES, V26, P307, DOI 10.1177/0193945903260554; Zagheri TM, 2006, J MED EDUC, V10, P19; Zwick W. R., 1982, PSYCHOL BULL, V1982, P253, DOI DOI 10.1207/S15327906MBR1702_; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432; 박은혜, 2015, [The Journal of Fundamentals of Nursing, 기본간호학회지], V22, P387, DOI 10.7739/jkafn.2015.22.4.387	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177690	10.1371/journal.pone.0177690	http://dx.doi.org/10.1371/journal.pone.0177690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UE	28542250	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058800022
J	Owili, PO; Muga, MA; Pan, WC; Kuo, HW				Owili, Patrick Opiyo; Muga, Miriam Adoyo; Pan, Wen-Chi; Kuo, Hsien-Wen			Indoor secondhand tobacco smoke and risk of under-five mortality in 23 sub-Saharan Africa countries: A population based study and meta-analysis	PLOS ONE			English	Article							INFANT-DEATH-SYNDROME; PASSIVE SMOKING; EXPOSURE; CHILDHOOD	Background Inhalation of secondhand smoke from tobacco results in serious health outcomes among under-five children, and yet, few studies have assessed its effect on under-five mortality. We investigated the association between frequency of exposure to household tobacco smoke and risk of under-five mortality in sub-Saharan Africa (SSA). Methods Demographic Health Survey data of under-five children from 23 SSA countries (n = 787,484) were used. Cox proportional hazard models described the association between exposure to tobacco smoke and the risk of under-five mortality in each country, with age as the time-to-event indicator. Meta-analysis was used to investigate the overall effect of tobacco smoke in SSA. Results The association between tobacco smoke exposure and the risk of under-five mortality attenuated in eight countries (Burkina Faso, Benin, Congo, Gabon, Guinea, Liberia, Togo, and Zambia) after adjustment, while the hazard ratios (HR) of daily exposure to tobacco smoke in Kenya (HR = 1.40; 95% CI, 1.16-1.70) and Namibia (HR = 1.40; 1.07-1.83) grew. The children in rural areas in SSA were 1.08 (95% CI, 1.04-1.13) times more likely to die than their urban peers. In general, the exposure to household tobacco smoke was associated with an increased risk of under-five mortality in SSA (HR = 1.09; 95% CI, 1.06-1.13). Conclusions This study provided evidence of a positive association between exposure to household tobacco smoke and risk of under-five mortality in SSA. Policymakers in low- and middle-income countries, where tobacco control as a child health issue is relatively neglected, should integrate tobacco control measures with other child health promotion policies.	[Owili, Patrick Opiyo] Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Int PhD Program Environm Sci & Technol, Taipei, Taiwan; [Muga, Miriam Adoyo] Great Lakes Univ Kisumu, Inst Community Hlth & Dev, Kisumu, Kenya; [Pan, Wen-Chi; Kuo, Hsien-Wen] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Sch Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Pan, WC; Kuo, HW (corresponding author), Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Sch Med, Taipei, Taiwan.	wenchipan@ym.edu.tw; hwkuo@ym.edu.tw	Owili, Patrick Opiyo/J-8948-2019	Owili, Patrick Opiyo/0000-0002-9417-8947; Pan, Wen-Chi/0000-0002-0588-8083; Muga, Miriam/0000-0002-9180-5394; Kuo, Hsien-Wen/0000-0003-4184-4333	Taiwan Ministry of Science and Technology [MOST 105-2314-B-010-018]	Taiwan Ministry of Science and Technology	This study was supported by Taiwan Ministry of Science and Technology Grant MOST 105-2314-B-010-018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetunji JA, 2011, ETHICAL ISSUES COLLE; Anderson HR, 1997, THORAX, V52, P1003, DOI 10.1136/thx.52.11.1003; [Anonymous], 2015, WHO REP GLOB TOB EP; [Anonymous], 2015, GOOGL EARTH PRO AFR; [Anonymous], 2015, LEV TRENDS CHILD MOR; Ayo-Yusuf OA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-580; Britton J, 2005, THORAX, V60, P794, DOI 10.1136/thx.2005.045336; Chomba E, 2010, ACTA OBSTET GYNECOLO, V89; De Beyer J, 2003, TOBACCO CONTROL POLI, pxviii; Dean AG, 2016, EPI INFO DATABASE ST; Demographic Health Survey Program, 2016, DEM HLTH SURV DHS PR; Dybing E, 1999, HUM EXP TOXICOL, V18, P202, DOI 10.1191/096032799678839914; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Moritsugu KP, 2007, AM J PREV MED, V32, P542, DOI 10.1016/j.amepre.2007.02.026; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Semba RD, 2008, AM J PUBLIC HEALTH, V98, P1824, DOI 10.2105/AJPH.2007.119289; StataCorp, 2013, STATA STAT SOFTW REL; Strachan DP, 1997, THORAX, V52, P905, DOI 10.1136/thx.52.10.905; The Cochrane Collaboration, 2014, REV MAN REVMAN COMP; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; United Nations, 2016, SUST DEV GOALS 2016; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2016, GLOB HLTH OBS GHO DA; World Health Organization, 2015, HLTH 2015 MDGS MILL, DOI 10.1007/BF01918387; World Health Organization Media centre, 2016, HOUS AIR POLL HLTH W; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP	26	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177271	10.1371/journal.pone.0177271	http://dx.doi.org/10.1371/journal.pone.0177271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542166	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058800014
J	Mathews, B; Yang, C; Lehman, EB; Mincemoyer, C; Verdiglione, N; Levi, BH				Mathews, Ben; Yang, Chengwu; Lehman, Erik B.; Mincemoyer, Claudia; Verdiglione, Nicole; Levi, Benjamin H.			Educating early childhood care and education providers to improve knowledge and attitudes about reporting child maltreatment: A randomized controlled trial	PLOS ONE			English	Article							SEXUAL-ABUSE; NATIONAL-SURVEY; UNITED-STATES; PROGRAM; WEB; PROFESSIONALS; EXPERIENCES; BURDEN; HEALTH; RATES	Early childhood care and education providers (CCPs) work with over 7 million young children. These children are vulnerable to physical, sexual and emotional abuse, and neglect. However, CCPs make less than 1% of all reports of suspected child abuse and neglect that are made to child protective services. CCPs are therefore an untapped resource in the public health response to child maltreatment. However, their knowledge and attitudes about duties to report child maltreatment are poorly understood. Moreover, no rigorous research has tested whether their knowledge and attitudes about reporting child maltreatment can be improved. These gaps in knowledge are important because knowledge of the duty and positive attitudes towards it produce more effective reporting, and little evidence exists about how to enhance cognitive and affective attributes. Using the CONSORT approach, we report a single-blind test-retest randomized controlled trial evaluating iLook Out for Child Abuse, a customized online educational intervention for CCPs to increase knowledge and attitudes towards the reporting duty. 762 participants were randomized with results analyzed for 741 participants (372 in the intervention group; 369 in the control). Knowledge of the reporting duty increased in the intervention group from 13.54 to 16.19 out of 21 (2.65 increase, 95% CI: (2.37, 2.93); large effect size 0.95, p < 0.001); the control group remained stable, moving from 13.54 to 13.59 (0.05 increase, 95% CI: (-0.12, 0.22); negligible effect size 0.03, p = 0.684). Attitudes were enhanced on all 13 items for the intervention group, remaining stable in the control, with significant differences between groups on all items (p < 0.05). Gains were largely sustained at four month follow-up. Findings support education for CCPs and other professions. Future research should also explore effects of education on reporting behavior.	[Mathews, Ben] Queensland Univ Technol, Australian Ctr Hlth Law Res, Brisbane, Qld, Australia; [Yang, Chengwu] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Div Biostat & Bioinformat, Hershey, PA USA; [Yang, Chengwu] Penn State Univ, Off Scholarship Learning & Educ Res OSLER, Hershey, PA USA; [Lehman, Erik B.] Penn State Univ, Dept Publ Hlth Sci, Coll Med, Div Biostat & Bioinformat, Hershey, PA USA; [Mincemoyer, Claudia] Penn State Univ, Dept Agr Econ Sociol & Educ, University Pk, PA 16802 USA; [Verdiglione, Nicole] Penn State Hershey Childrens Hosp, Pediat Clin Res Off, Hershey, PA USA; [Levi, Benjamin H.] Penn State Univ, Dept Pediat, Coll Med, Hershey, PA USA	Queensland University of Technology (QUT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Mathews, B (corresponding author), Queensland Univ Technol, Australian Ctr Hlth Law Res, Brisbane, Qld, Australia.	b.mathews@qut.edu.au	Yang, Chengwu/X-6178-2018; Mathews, Ben/A-9125-2012	Yang, Chengwu/0000-0003-0561-2340; Mathews, Ben/0000-0003-0421-0016	Penn State University Center for the Protection of Children; Penn State Red Cap: the Penn State Clinical & Translational Research Institute, Pennsylvania State University CTSA; NIH/NCATS [UL1 TR000127]	Penn State University Center for the Protection of Children; Penn State Red Cap: the Penn State Clinical & Translational Research Institute, Pennsylvania State University CTSA; NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for iLookOut was provided by Penn State University Center for the Protection of Children. The four month follow-up was funded by Penn State Red Cap: the Penn State Clinical & Translational Research Institute, Pennsylvania State University CTSA, NIH/NCATS Grant Number UL1 TR000127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2005, HANDBOOK OF ATTITUDES, P173; Alvarez KM, 2004, AGGRESS VIOLENT BEH, V9, P563, DOI 10.1016/j.avb.2003.07.001; Barber-Madden R, 1983, Child Abuse Negl, V7, P25, DOI 10.1016/0145-2134(83)90026-1; Carter YH, 2006, ARCH DIS CHILD, V91, P740, DOI 10.1136/adc.2005.092007; Cerezo MA, 2004, CHILD ABUSE NEGLECT, V28, P1153, DOI 10.1016/j.chiabu.2004.06.007; CRENSHAW WB, 1995, CHILD ABUSE NEGLECT, V19, P1095, DOI 10.1016/0145-2134(95)00071-F; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Dimitrov Dimiter M, 2003, Work, V20, P159; Eisbach SS, 2010, J SPEC PEDIATR NURS, V15, P317, DOI 10.1111/j.1744-6155.2010.00259.x; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Feng JY, 2005, CHILD ABUSE NEGLECT, V29, P783, DOI 10.1016/j.chiabu.2004.11.006; Finkelhor D, 2007, CHILD ABUSE NEGLECT, V31, P7, DOI 10.1016/j.chiabu.2006.06.008; Finkelhor D, 2015, JAMA PEDIATR, V169, P746, DOI 10.1001/jamapediatrics.2015.0676; Flaherty EG, 2013, JAMA PEDIATR, V167, P622, DOI 10.1001/jamapediatrics.2013.22; Fraser JA, 2010, INT J NURS STUD, V47, P146, DOI 10.1016/j.ijnurstu.2009.05.015; Freeh LJ, 2012, REPORT SPECIAL INVES; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Gunn VL, 2005, AMBUL PEDIATR, V5, P96, DOI 10.1367/A04-094R.1; Hawkins R., 2001, CHILD ABUSE REV, V10, P301, DOI DOI 10.1002/CAR.699; Hein G, 2016, SCIENCE, V351, P1074, DOI 10.1126/science.aac7992; Jenny C, 2008, PEDIATRICS, V122, P667, DOI 10.1542/peds.2008-1885; Jones R, 2008, PEDIATRICS, V122, P259, DOI 10.1542/peds.2007-2312; Kenny MC, 2007, CHILD ABUSE NEGLECT, V31, P671, DOI 10.1016/j.chiabu.2006.12.008; Kenny MC, 2004, CHILD ABUSE NEGLECT, V28, P1311, DOI 10.1016/j.chiabu.2004.06.010; Knowles M. S., 2015, ADULT LEARNER; Kohl PL, 2009, CHILD MALTREATMENT, V14, P17, DOI 10.1177/1077559508326030; Laughlin L., 2013, CURRENT POPULATION R, P70; Letourneau EJ, 2016, CHILD MALTREATMENT, V21, P74, DOI 10.1177/1077559515615232; Mathews B, 2015, COCHRANE DB SYST REV, V2015; Mathews B, 2008, CHILD MALTREATMENT, V13, P50, DOI 10.1177/1077559507310613; Mathews B, 2011, AUST J TEACH EDUC, V36, P13, DOI 10.14221/ajte.2011v36n11.4; MCGRATH P, 1987, CHILD ABUSE NEGLECT, V11, P125, DOI 10.1016/0145-2134(87)90041-X; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; PALUSCI VJ, 1995, CHILD ABUSE NEGLECT, V19, P1031, DOI 10.1016/0145-2134(95)00065-G; Paranal R, 2012, J CHILD SEX ABUS, V21, P507, DOI 10.1080/10538712.2012.697106; Rheingold Alyssa A, 2015, Prev Sci, V16, P374, DOI 10.1007/s11121-014-0499-6; Rheingold AA, 2012, J CHILD SEX ABUS, V21, P422, DOI 10.1080/10538712.2012.675422; Schulz KF, 2010, LANCET, V375, P1144, DOI 10.1016/S0140-6736(10)60413-8; Sedlak A. J., 2010, US DEP HLTH HUM SERV; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Smeekens AEFN, 2011, ARCH DIS CHILD, V96, P330, DOI 10.1136/adc.2010.190801; Socolar RRS, 1998, PEDIATRICS, V101, P817, DOI 10.1542/peds.101.5.817; SOLOMON RL, 1949, PSYCHOL BULL, V46, P137, DOI 10.1037/h0062958; Starling Suzanne P, 2003, Child Maltreat, V8, P242, DOI 10.1177/1077559503257113; Starling SP, 2009, PEDIATRICS, V123, pE595, DOI 10.1542/peds.2008-2938; U.S. Department of Health and Human Services, 2019, CHILD MALTREATMENT; United States Census Bureau, 2009 2013 AM COMM SU; US Department of Health and Human Services Administration for Child and Families Administration on Children Youth and Families Children's Bureau, 2015, CHILD MALTR 2013; Walsh K, 2012, J CHILD SEX ABUS, V21, P399, DOI 10.1080/10538712.2012.675424; Widom CS, 2012, AM J PUBLIC HEALTH, V102, P1135, DOI 10.2105/AJPH.2011.300636	52	22	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177777	10.1371/journal.pone.0177777	http://dx.doi.org/10.1371/journal.pone.0177777			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PW	28542285	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672600022
J	Osamura, T; Kawakami, T; Kido, R; Ishii, M; Arai, H				Osamura, Tatsuya; Kawakami, Takuro; Kido, Reiko; Ishii, Masaharu; Arai, Hiroyuki			Specific expression and function of the A-type cytochrome c oxidase under starvation conditions in Pseudomonas aeruginosa	PLOS ONE			English	Article							RHODOBACTER-SPHAEROIDES; AEROBIC RESPIRATION; TERMINAL OXIDASES; ESCHERICHIA-COLI; PHOTOSYNTHESIS; SHEWANELLA; EVOLUTION; INSERTION; BACTERIA; PAO1	Pseudomonas aeruginosa has one A-type (caa(3)) and multiple C-type (cbb(3)) cytochrome c oxidases as well as two quinol oxidases for aerobic respiration. The caa(3) oxidase is highly efficient in creating a proton gradient across the cell membrane, but it is not expressed under normal growth conditions and its physiological role has not been investigated. In the present study, a mutant strain deficient in the coxBA-PA0107-coxC genes encoding caa(3) exhibited normal growth under any test conditions, but it had low relative fitness under carbon starvation conditions, indicating that the expression of caa(3) is advantageous under starvation conditions. A mutant that lacked four terminal oxidase gene clusters except for the cox genes was unable to grow aerobically because of low expression level of caa3. However, suppressor mutants that grew aerobically using caa(3) as the only terminal oxidase emerged after aerobic subculturing. Analyses of the suppressor mutants revealed that a mutation of roxS encoding a sensor kinase of a two-component regulator RoxSR was necessary for the aerobic growth in synthetic medium. Two additional mutations in the 50-flanking region of coxB were necessary for the aerobic growth in LB medium. Although the expression level of caa(3) was higher in the suppressor mutants, their growth rates were lower than when the other terminal oxidases were utilized, suggesting that caa(3) was not suited for utilization as the only terminal oxidase. Overexpression of the cox genes also inhibited the aerobic growth of the wild-type strain. These results indicate that caa(3) is tightly regulated to be expressed only under starvation conditions at low level and it functions in cooperation with other terminal oxidases to facilitate survival in nutrient starvation conditions.	[Osamura, Tatsuya; Kawakami, Takuro; Kido, Reiko; Ishii, Masaharu; Arai, Hiroyuki] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Arai, H (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan.	aharai@mail.ecc.u-tokyo.ac.jp			 [15H01393];  [20380046]	; 	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life (15H01393, HA) of The Ministry of Education, Culture, Sports, Science and Technology, Japan and a Grant-in-Aid for Scientific Research (B) (20380046, HA) of the Japan Society for the Promotion of Science (JSPS). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2008, J BACTERIOL, V190, P286, DOI 10.1128/JB.01375-07; Arai H, 2014, J BACTERIOL, V196, P4206, DOI 10.1128/JB.02176-14; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; BOSMA G, 1987, EUR J BIOCHEM, V165, P657, DOI 10.1111/j.1432-1033.1987.tb11491.x; Branden G, 2006, BBA-BIOENERGETICS, V1757, P1052, DOI 10.1016/j.bbabio.2006.05.020; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Flory JE, 1997, MICROBIOL-SGM, V143, P3101, DOI 10.1099/00221287-143-10-3101; Frangipani E, 2009, FEMS MICROBIOL LETT, V298, P234, DOI 10.1111/j.1574-6968.2009.01726.x; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; GABEL C, 1993, J BACTERIOL, V175, P128, DOI 10.1128/JB.175.1.128-132.1993; Hirai T, 2016, P NATL ACAD SCI USA, V113, P12815, DOI 10.1073/pnas.1613308113; Kawakami T, 2010, ENVIRON MICROBIOL, V12, P1399, DOI 10.1111/j.1462-2920.2009.02109.x; Kim YJ, 2007, J BACTERIOL, V189, P5617, DOI 10.1128/JB.00443-07; Kishikawa J, 2010, J BIOSCI BIOENG, V110, P42, DOI 10.1016/j.jbiosc.2009.12.006; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Le Laz S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19726; Le Laz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086343; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LUDWIG B, 1980, BIOCHIM BIOPHYS ACTA, V594, P177, DOI 10.1016/0304-4173(80)90008-7; Lyons JA, 2012, NATURE, V487, P514, DOI 10.1038/nature11182; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SARASTE M, 1991, EUR J BIOCHEM, V195, P517, DOI 10.1111/j.1432-1033.1991.tb15732.x; SCHUMPERLI D, 1982, CELL, V30, P865, DOI 10.1016/0092-8674(82)90291-4; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; Wu JA, 2010, MBIO, V1, DOI 10.1128/mBio.00272-10; Zhou GQ, 2013, ISME J, V7, P1752, DOI 10.1038/ismej.2013.62	32	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177957	10.1371/journal.pone.0177957	http://dx.doi.org/10.1371/journal.pone.0177957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542449	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400120
J	Xiao, WF; Chen, P; Xiao, JS; Wang, L; Liu, TH; Wu, YF; Dong, FF; Jiang, YM; Pan, MH; Zhang, YH; Lu, C				Xiao, Wenfu; Chen, Peng; Xiao, Jinshu; Wang, La; Liu, Taihang; Wu, Yunfei; Dong, Feifan; Jiang, Yaming; Pan, Minhui; Zhang, Youhong; Lu, Cheng			Comparative transcriptome profiling of a thermal resistant vs. sensitive silkworm strain in response to high temperature under stressful humidity condition	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DOMESTICATED SILKWORM; TOLERANCE; ACCLIMATION; GENOME; SERINE; KEGG	Thermotolerance is important particularly for poikilotherms such as insects. Understanding the mechanisms by which insects respond to high temperatures can provide insights into their adaptation to the environment. Therefore, in this study, we performed a transcriptome analysis of two silkworm strains with significantly different resistance to heat as well as humidity; the thermo-resistant strain 7532 and the thermos-sensitive strain Knobbed. We identified in total 4,944 differentially expressed genes (DEGs) using RNA-Seq. Among these, 4,390 were annotated and 554 were novel. Gene Ontology (GO) analysis of 747 DEGs identified between RT_48h (Resistant strain with high-temperature Treatment for 48 hours) and ST_48h (Sensitive strain with high-temperature Treatment for 48 hours) showed significant enrichment of 12 GO terms including metabolic process, extracellular region and serine-type peptidase activity. Moreover, we discovered 12 DEGs that may contribute to the heat-humidity stress response in the silkworm. Our data clearly showed that 48h post-exposure may be a critical time point for silkworm to respond to high temperature and humidity. These results provide insights into the genes and biological processes involved in high temperature and humidity tolerance in the silkworm, and advance our understanding of thermal tolerance in insects.	[Xiao, Wenfu; Chen, Peng; Wang, La; Liu, Taihang; Wu, Yunfei; Dong, Feifan; Jiang, Yaming; Pan, Minhui; Lu, Cheng] Southwest Univ, State Key Lab Silkworm Genome Biol, Key Lab Sericultural Biol & Genet Breeding, Minist Agr, Chongqing, Peoples R China; [Xiao, Wenfu; Xiao, Jinshu; Zhang, Youhong] Sichuan Acad Agr Sci, Sericultural Res Inst, Nanchong, Sichuan, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China; Sichuan Academy of Agricultural Sciences (SAAS)	Lu, C (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Key Lab Sericultural Biol & Genet Breeding, Minist Agr, Chongqing, Peoples R China.; Zhang, YH (corresponding author), Sichuan Acad Agr Sci, Sericultural Res Inst, Nanchong, Sichuan, Peoples R China.	sczhangyh@126.com; lucheng@swu.edu.cn			National Natural Science Foundation of China [31602009, 31572466, 31472152]; China Agriculture Research System [CARS-22]; Sichuan Province financial innovation ability promotion project [016JYGC10-27-01]; Youth Foundation of Sichuan Academy of Agricultural Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Sichuan Province financial innovation ability promotion project; Youth Foundation of Sichuan Academy of Agricultural Sciences	This work was supported by grants from National Natural Science Foundation of China (Nos. 31602009, 31572466 and 31472152), China Agriculture Research System (CARS-22), Sichuan Province financial innovation ability promotion project (2016JYGC10-27-01), and Youth Foundation of Sichuan Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Chown SL, 2011, J INSECT PHYSIOL, V57, P1070, DOI 10.1016/j.jinsphys.2011.05.004; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leal M, 2012, AM NAT, V180, P815, DOI 10.1086/668077; Li JS, 2012, MOL BIOL REP, V39, P8447, DOI 10.1007/s11033-012-1698-5; Li QR, 2014, GENE, V549, P85, DOI 10.1016/j.gene.2014.07.050; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043023; Liu ZD, 2006, J INSECT PHYSIOL, V52, P1012, DOI 10.1016/j.jinsphys.2006.06.008; Manjunatha HB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20401; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Moseley P, 2000, IMMUNOPHARMACOLOGY, V48, P299, DOI 10.1016/S0162-3109(00)00227-7; Nayak MK, 2008, PEST MANAG SCI, V64, P971, DOI 10.1002/ps.1586; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Nguyen CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094346; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Pagabeleguem S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1805-x; Parkash R, 2014, COMP BIOCHEM PHYS A, V175, P46, DOI 10.1016/j.cbpa.2014.05.006; Parkash R, 2014, COMP BIOCHEM PHYS A, V169, P33, DOI 10.1016/j.cbpa.2013.12.007; Seebacher F, 2005, J COMP PHYSIOL B, V175, P453, DOI 10.1007/s00360-005-0010-6; Sejerkilde M, 2003, J INSECT PHYSIOL, V49, P719, DOI 10.1016/S0022-1910(03)00095-7; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tamaki FK, 2015, BIOCHEM BIOPH RES CO, V467, P885, DOI 10.1016/j.bbrc.2015.10.049; Tanigawa M, 2016, J INSECT PHYSIOL, V87, P20, DOI 10.1016/j.jinsphys.2016.01.006; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vermeulen CJ, 2013, J EVOLUTION BIOL, V26, P1890, DOI 10.1111/jeb.12183; Wang H, 2014, MOL BIOL REP, V41, P6039, DOI 10.1007/s11033-014-3481-2; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	42	10	10	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177641	10.1371/journal.pone.0177641	http://dx.doi.org/10.1371/journal.pone.0177641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542312	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672400061
J	Promworn, Y; Kaewprommal, P; Shaw, PJ; Intarapanich, A; Tongsima, S; Piriyapongsa, J				Promworn, Yuttachon; Kaewprommal, Pavita; Shaw, Philip J.; Intarapanich, Apichart; Tongsima, Sissades; Piriyapongsa, Jittima			ToNER: A tool for identifying nucleotide enrichment signals in feature-enriched RNA-seq data	PLOS ONE			English	Article							TRANSCRIPTOME	Background Biochemical methods are available for enriching 50 ends of RNAs in prokaryotes, which are employed in the differential RNA-seq (dRNA-seq) and the more recent Cappable-seq protocols. Computational methods are needed to locate RNA 50 ends from these data by statistical analysis of the enrichment. Although statistical-based analysis methods have been developed for dRNA-seq, they may not be suitable for Cappable-seq data. The more efficient enrichment method employed in Cappable-seq compared with dRNA-seq could affect data distribution and thus algorithm performance. Results We present Transformation of Nucleotide Enrichment Ratios (ToNER), a tool for statistical modeling of enrichment from RNA-seq data obtained from enriched and unenriched libraries. The tool calculates nucleotide enrichment scores and determines the global transformation for fitting to the normal distribution using the Box-Cox procedure. From the transformed distribution, sites of significant enrichment are identified. To increase power of detection, meta-analysis across experimental replicates is offered. We tested the tool on Cappableseq and dRNA-seq data for identifying Escherichia coli transcript 50 ends and compared the results with those from the TSSAR tool, which is designed for analyzing dRNA-seq data. When combining results across Cappable-seq replicates, ToNER detects more known transcript 50 ends than TSSAR. In general, the transcript 50 ends detected by ToNER but not TSSAR occur in regions which cannot be locally modeled by TSSAR. Conclusion ToNER uses a simple yet robust statistical modeling approach, which can be used for detecting RNA 50ends from Cappable-seq data, in particular when combining information from experimental replicates. The ToNER tool could potentially be applied for analyzing other RNA-seq datasets in which enrichment for other structural features of RNA is employed. The program is freely available for download at ToNER webpage (http://www4a. biotec.or.th/GI/tools/toner) and GitHub repository (https://github.com/PavitaKae/ToNER).	[Promworn, Yuttachon; Kaewprommal, Pavita; Shaw, Philip J.; Tongsima, Sissades; Piriyapongsa, Jittima] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Intarapanich, Apichart] NSTDA, Natl Elect & Comp Technol Ctr NECTEC, Pathum Thani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Electronics & Computer Technology Center (NECTEC)	Piriyapongsa, J (corresponding author), NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand.	jittima.pir@biotec.or.th			platform technology, National Center for Genetic Engineering and Biotechnology, Thailand [P-15-51103, P-12-01270]	platform technology, National Center for Genetic Engineering and Biotechnology, Thailand	This project is supported by the platform technology, National Center for Genetic Engineering and Biotechnology, Thailand (http:// www.biotec.or.th) with grant number P-15-51103 and P-12-01270, funded to JP and PJS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman F, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-89; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cui XD, 2016, BIOINFORMATICS, V32, P378, DOI 10.1093/bioinformatics/btw281; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Ettwiller L, 2016, BMC GENOMICS, P17; Forstner KU, 2014, BIOINFORMATICS, V30, P3421, DOI 10.1093/bioinformatics/btu533; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Hardwick SA, 2016, NAT METHODS, V13, P792, DOI [10.1038/NMETH.3958, 10.1038/nmeth.3958]; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Jorjani H, 2014, BIOINFORMATICS, V30, P971, DOI 10.1093/bioinformatics/btt752; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meng J, 2014, METHODS, V69, P274, DOI 10.1016/j.ymeth.2014.06.008; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sibbritt T, 2013, WIRES RNA, V4, P397, DOI 10.1002/wrna.1166; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	20	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178483	10.1371/journal.pone.0178483	http://dx.doi.org/10.1371/journal.pone.0178483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542466	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800097
J	Van Wynsberge, S; Andrefouet, S; Gaertner-Mazouni, N; Tiavouane, J; Grulois, D; Lefevre, J; Pinsky, ML; Fauvelot, C				Van Wynsberge, Simon; Andrefouet, Serge; Gaertner-Mazouni, Nabila; Tiavouane, Josina; Grulois, Daphne; Lefevre, Jerome; Pinsky, Malin L.; Fauvelot, Cecile			Considering reefscape configuration and composition in biophysical models advance seascape genetics	PLOS ONE			English	Article							CORAL-REEF; GIANT CLAM; POPULATION-STRUCTURE; LARVAL CONNECTIVITY; SELF-RECRUITMENT; DISPERSAL; LANDSCAPE; PATCHINESS; DRIVERS; ECOLOGY	Previous seascape genetics studies have emphasized the role of ocean currents and geographic distances to explain the genetic structure of marine species, but the role of benthic habitat has been more rarely considered. Here, we compared the population genetic structure observed in West Pacific giant clam populations against model simulations that accounted habitat composition and configuration, geographical distance, and oceanic currents. Dispersal determined by geographical distance provided a modelled genetic structure in better agreement with the observations than dispersal by oceanic currents, possibly due to insufficient spatial resolution of available oceanographic and coastal circulation models. Considering both habitat composition and configuration significantly improved the match between simulated and observed genetic structures. This study emphasizes the importance of a reefscape genetics approach to population ecology, evolution and conservation in the sea.	[Van Wynsberge, Simon; Gaertner-Mazouni, Nabila] Univ Polynesie Francaise, UMR EIO 241, Lab Excellence CORAIL, Tahiti, French Polynesi, France; [Van Wynsberge, Simon; Andrefouet, Serge; Tiavouane, Josina; Grulois, Daphne; Fauvelot, Cecile] Univ La Reunion, UMR ENTROPIE 9220, CNRS, Lab Excellence CORAIL,Ctr IRD Noumea,Inst Rech De, Noumea, New Caledonia; [Lefevre, Jerome] Ctr IRD Noumea, UMR LEGOS 065, Noumea, New Caledonia; [Lefevre, Jerome] Ctr IRD Noumea, UMR MIO 235, Noumea, New Caledonia; [Pinsky, Malin L.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ USA; [Pinsky, Malin L.] Rutgers State Univ, Inst Earth Ocean & Atmospher Sci, New Brunswick, NJ USA	Ifremer; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Rutgers State University New Brunswick; Rutgers State University New Brunswick	Van Wynsberge, S (corresponding author), Univ Polynesie Francaise, UMR EIO 241, Lab Excellence CORAIL, Tahiti, French Polynesi, France.; Van Wynsberge, S (corresponding author), Univ La Reunion, UMR ENTROPIE 9220, CNRS, Lab Excellence CORAIL,Ctr IRD Noumea,Inst Rech De, Noumea, New Caledonia.	simon.vanwynsberge@gmail.com	Pinsky, Malin L./K-2884-2015	Pinsky, Malin L./0000-0002-8523-8952; Lefevre, Jerome/0000-0001-9875-2398; Fauvelot, Cecile/0000-0003-0806-1222	Ministere de lEnseignement Superieur et de la Recherche; BeN-Co project (ZONECO program, New Caledonia); TriMax project (LabEx CORAIL, Agence Nationale de la Recherche)	Ministere de lEnseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); BeN-Co project (ZONECO program, New Caledonia); TriMax project (LabEx CORAIL, Agence Nationale de la Recherche)(French National Research Agency (ANR))	This work is part of SVW and JT PhD theses, supported by a fellowship from Ministere de lEnseignement Superieur et de la Recherche to Universite de la Polynesie francaise. Genetic analyses were co-funded by the BeN-Co project (ZONECO program, New Caledonia, www.zoneco.nc) and the TriMax project (LabEx CORAIL, Agence Nationale de la Recherche, www.labex-corail.fr). Sampling was conducted during cruises COBELO (http://dx.doi.org/10.17600/13100100) and BIBELOT (http://dx.doi.org/10.17600/14003700) on board RV Alis, and during the New Caledonia leg of the Global Reef Expedition of the Khaled Bin Sultan Living Ocean Foundation, on board RV Golden Shadow (www.livingoceansfoundation.org).	Alberto F, 2010, ECOLOGY, V91, P49, DOI 10.1890/09-0050.1; Andrefouet S, 2009, CORAL REEFS, V28, P691, DOI 10.1007/s00338-009-0503-y; Andrefouet S., 2006, P 10 INT COR REEF S, P1732; Belkhir K., 2004, GENETIX 4 05 POPULAT; Benzie JAH, 1997, EVOLUTION, V51, P768, DOI 10.1111/j.1558-5646.1997.tb03660.x; Bidegain G, 2013, ECOL MODEL, V268, P78, DOI 10.1016/j.ecolmodel.2013.07.020; Bonneton P, 2007, J COASTAL RES, P762; Carr SD, 2008, FISH OCEANOGR, V17, P1, DOI 10.1111/j.1365-2419.2007.00447.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Christie MR, 2010, MOL ECOL, V19, P1042, DOI 10.1111/j.1365-294X.2010.04524.x; Couvelard X, 2008, J PHYS OCEANOGR, V38, P2185, DOI 10.1175/2008JPO3903.1; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crandall ED, 2012, MOL ECOL, V21, P5579, DOI 10.1111/mec.12031; Cravatte S, 2015, J MARINE SYST, V148, P249, DOI 10.1016/j.jmarsys.2015.03.004; Cuif M, 2014, PROG OCEANOGR, V122, P105, DOI 10.1016/j.pocean.2013.12.006; D'Aloia CC, 2014, MOL ECOL, V23, P2902, DOI 10.1111/mec.12782; D'Aloia CC, 2013, MOL ECOL, V22, P2563, DOI 10.1111/mec.12274; Davies SW, 2015, MOL ECOL, V24, P70, DOI 10.1111/mec.13005; DeBoer TS, 2008, CONSERV BIOL, V22, P1255, DOI 10.1111/j.1523-1739.2008.00983.x; Dumas P, 2014, J EXP MAR BIOL ECOL, V452, P63, DOI 10.1016/j.jembe.2013.12.002; ELLNER S, 1994, AM NAT, V143, P403, DOI 10.1086/285610; Fahrig L, 2005, ECOSYSTEM FUNCTION IN HETEROGENEOUS LANDSCAPES, P95, DOI 10.1007/0-387-24091-8_6; Fogarty MJ, 2007, OCEANOGRAPHY, V20, P112, DOI 10.5670/oceanog.2007.34; Friedman KJ, 2003, PACIFIC REGIONAL OCE; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gilbert A, 2011, STATUT POPULATIONS I; Goudet J, 1996, GENETICS, V144, P1933; Grulois D, 2015, CONSERV GENET RESOUR, V7, P73, DOI 10.1007/s12686-014-0290-9; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341; JAMESON SC, 1976, PAC SCI, V30, P219; Johansson ML, 2015, MOL ECOL, V24, P4866, DOI 10.1111/mec.13371; Jones GP, 2009, CORAL REEFS, V28, P303, DOI 10.1007/s00338-008-0440-1; Kittiwattanawong Kongkiat, 1997, Phuket Marine Biological Center Special Publication, V17, P109; Kool JT, 2011, GLOBAL ECOL BIOGEOGR, V20, P695, DOI 10.1111/j.1466-8238.2010.00637.x; Kool JT, 2010, ECOGRAPHY, V33, P597, DOI 10.1111/j.1600-0587.2009.06012.x; Legendre P, 2015, METHODS ECOL EVOL, V6, P1239, DOI 10.1111/2041-210X.12425; Liggins L, 2013, GEOGR COMPASS, V7, P173, DOI 10.1111/gec3.12031; Lowe RJ, 2015, ANNU REV MAR SCI, V7, P43, DOI 10.1146/annurev-marine-010814-015834; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lucas J. S, 1988, ACIAR MONOGRAPH, V9, P21; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; Neo ML, 2015, J EXP MAR BIOL ECOL, V469, P76, DOI 10.1016/j.jembe.2015.04.012; Orsini L, 2013, MOL ECOL, V22, P583, DOI 10.1111/mec.12117; Pinsky ML, 2012, ECOL APPL, V22, P1257, DOI 10.1890/11-1240.1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; Sale PF, 2010, PRESERVING REEF CONN; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Selkoe KA, 2016, LANDSCAPE GENETICS: CONCEPTS, METHODS, APPLICATIONS, P220; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Simons RD, 2013, J MARINE SYST, V119, P19, DOI 10.1016/j.jmarsys.2013.03.004; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; von der Heyden S, 2014, B MAR SCI, V90, P123, DOI 10.5343/bms.2012.1079; Wantiez L, 2013, COMMUNAUTES BIOL HAB; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; Weir B. S., 1996, GENETIC DATA ANAL; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White C, 2010, P R SOC B, V282; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101; WRIGHT S, 1946, GENETICS, V31, P39	68	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178239	10.1371/journal.pone.0178239	http://dx.doi.org/10.1371/journal.pone.0178239			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542261	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800058
J	Wen, JR; Scoles, DR; Facelli, JC				Wen, Jingran; Scoles, Daniel R.; Facelli, Julio C.			Molecular dynamics analysis of the aggregation propensity of polyglutamine segments	PLOS ONE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; MONOMERIC POLYGLUTAMINE; CAG REPEAT; SIMULATIONS; PROTEIN; DISEASES; STABILITY; EXPANSION; PEPTIDES; GENE	Protein misfolding and aggregation is a pathogenic feature shared among at least ten polyglutamine (polyQ) neurodegenerative diseases. While solvent-solution interaction is a key factor driving protein folding and aggregation, the solvation properties of expanded polyQ tracts are not well understood. By using GPU-enabled all-atom molecular dynamics simulations of polyQ monomers in an explicit solvent environment, this study shows that solventpolyQ interaction propensity decreases as the lengths of polyQ tract increases. This study finds a predominance in long-distance interactions between residues far apart in polyQ sequences with longer polyQ segments, that leads to significant conformational differences. This study also indicates that large loops, comprised of parallel beta-structures, appear in long polyQ tracts and present new aggregation building blocks with aggregation driven by longdistance intra-polyQ interactions. Finally, consistent with previous observations using coarse-grain simulations, this study demonstrates that there is a gain in the aggregation propensity with increased polyQ length, and that this gain is correlated with decreasing ability of solvent-polyQ interaction. These results suggest the modulation of solvent-polyQ interactions as a possible therapeutic strategy for treating polyQ diseases.	[Wen, Jingran; Facelli, Julio C.] Univ Utah, Dept Biomed Informat, Salt Lake City, UT 84112 USA; [Scoles, Daniel R.] Univ Utah, Dept Neurol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Facelli, JC (corresponding author), Univ Utah, Dept Biomed Informat, Salt Lake City, UT 84112 USA.	Julio.Facelli@utah.edu		facelli, julio/0000-0003-1449-477X	Department of Biomedical Informatics in honor of Homer	Department of Biomedical Informatics in honor of Homer	JW was partially supported by the Richard A. Fay and Carole M. Fay Endowed Graduate Fellowship for the Department of Biomedical Informatics in honor of Homer R. Warner, MD, PhD.	Almeida B, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00076; Babin V, 2011, PROTEINS, V79, P937, DOI 10.1002/prot.22935; Buchanan LE, 2014, P NATL ACAD SCI USA, V111, P5796, DOI 10.1073/pnas.1401587111; Case D., 2015, AMBER, V14; CHAN HS, 1991, ANNU REV BIOPHYS BIO, V20, P447, DOI 10.1146/annurev.biophys.20.1.447; Chiang HL, 2014, J COMPUT CHEM, V35, P1430, DOI 10.1002/jcc.23633; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Deng L, 2012, J PHYS CHEM B, V116, P10135, DOI 10.1021/jp210683n; Gedde U. W., 1999, POLYM PHYS; Hayre NR, 2012, BIOPHYS J, V102, P1443, DOI 10.1016/j.bpj.2012.02.017; Hong L, 2009, J POLYM SCI POL PHYS, V47, P207, DOI 10.1002/polb.21634; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ignatova Z, 2006, J BIOL CHEM, V281, P12959, DOI 10.1074/jbc.M511523200; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Laghaei R, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3383244; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Matilla-Duenas A, 2014, CEREBELLUM, V13, P269, DOI 10.1007/s12311-013-0539-y; Matilla-Duenas A, 2010, CEREBELLUM, V9, P148, DOI 10.1007/s12311-009-0144-2; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Miettinen MS, 2012, J PHYS CHEM B, V116, P10259, DOI 10.1021/jp305065c; Mishra R, 2015, ORG BIOMOL CHEM, V13, P4155, DOI 10.1039/c4ob02589j; Mohan RD, 2014, CURR OPIN GENET DEV, V26, P96, DOI 10.1016/j.gde.2014.06.008; Moradi M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002501; Nakano M, 2013, J MOL MODEL, V19, P1627, DOI 10.1007/s00894-012-1712-9; Nakano M, 2010, J PHYS CHEM B, V114, P7056, DOI 10.1021/jp9122024; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Racine J, 2006, J APPL ECONOMET, V21, P133, DOI 10.1002/jae.885; Rhys NH, 2013, SOFT MATTER, V9, P2359, DOI 10.1039/c2sm27565a; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Robertson AL, 2010, CURR MED CHEM, V17, P3058; Rub U, 2013, PROG NEUROBIOL, V104, P38, DOI 10.1016/j.pneurobio.2013.01.001; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Scarafone N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031253; Schafmeister CEAF, 1995, ROMANOVSKI VLADIMIR; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Stork M, 2005, BIOPHYS J, V88, P2442, DOI 10.1529/biophysj.104.052415; Tobelmann MD, 2011, BIOPHYS J, V100, P2773, DOI 10.1016/j.bpj.2011.04.028; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Vitalis A, 2007, BIOPHYS J, V93, P1923, DOI 10.1529/biophysj.107.110080; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; Wang YT, 2010, J PHYS CHEM B, V114, P8735, DOI 10.1021/jp1007768; Wen J, 2016, J BIOMOLECULAR STRUC, P1; Wetzel R., 2010, MISFOLDING AGGREGATI, P305; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99; Zhou ZL, 2011, J BIOMOL STRUCT DYN, V28, P743, DOI 10.1080/07391102.2011.10508603; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	55	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178333	10.1371/journal.pone.0178333	http://dx.doi.org/10.1371/journal.pone.0178333			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542401	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800073
J	Liu, H; Rose, ME; Ma, XC; Culver, S; Dixon, CE; Graham, SH				Liu, Hao; Rose, Marie E.; Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward; Graham, Steven H.			In vivo transduction of neurons with TAT-UCH-L1 protects brain against controlled cortical impact injury	PLOS ONE			English	Article							TERMINAL HYDROLASE L1; SPINAL-CORD-INJURY; DYSTROPHY GAD MOUSE; NEURODEGENERATIVE DISEASE; NERVOUS-SYSTEM; MUTANT UCH-L1; UBIQUITIN; UCHL1; AUTOPHAGY; AXONS	Many mechanisms or pathways are involved in secondary post-traumatic brain injury, such as the ubiquitin-proteasome pathway (UPP), axonal degeneration and neuronal cell apoptosis. UCH-L1 is a protein that is expressed in high levels in neurons and may have important roles in the UPP, autophagy and axonal integrity. The current study aims to evaluate the role of UCH-L1 in post-traumatic brain injury (TBI) and its potential therapeutic effects. A novel protein was constructed that fused the protein transduction domain (PTD) of transactivating transduction (TAT) protein with UCH-L1 (TAT-UCH-L1) in order to promote neuronal transduction. The TAT-UCH-L1 protein was readily detected in brain by immunoblotting and immunohistochemistry after i.p. administration in mice. TBI was induced in mice using the controlled cortical impact (CCI) model. TAT-UCH-L1 treatment significantly attenuated K48-linkage polyubiquitin (polyUb)-protein accumulation in hippocampus after CCI compared to vehicle controls, but had no effects on K65-linkage polyUb-protein. TAT-UCH-L1 treatment also attenuated expression of Beclin-1 and LC3BII after CCI. TAT-UCH-L1-treated mice had significantly increased spared tissue volumes and increased survival of CA3 neurons 21 d after CCI compared to control vehicle-treated mice. Axonal injury, detected by APP immunohistochemistry, was reduced in thalamus 24 h and 21 d after CCI in TAT-UCH-L1-treated mice. These results suggest that TAT-UCH-L1 treatment improves function of the UPP and decreases activation of autophagy after CCI. Furthermore, TATUCH- -L1 treatment also attenuates axonal injury and increases hippocampal neuronal survival after CCI. Taken together these results suggest that UCH-L1 may play an important role in the pathogenesis of cell death and axonal injury after TBI.	[Liu, Hao; Rose, Marie E.; Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward; Graham, Steven H.] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15219 USA; [Liu, Hao; Rose, Marie E.; Graham, Steven H.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA; [Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Graham, SH (corresponding author), VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15219 USA.; Graham, SH (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA.	Steven.Graham@va.gov			Department of Veterans Affairs Rehabilitation Research & Development Service [1I01RX000310-01]; National Institutes of Health National Institute of Neurological Disorders and Stroke [R01NS37459]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037459] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000310] Funding Source: NIH RePORTER	Department of Veterans Affairs Rehabilitation Research & Development Service(US Department of Veterans Affairs); National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	Support was provided by the Department of Veterans Affairs Rehabilitation Research & Development Service [http://www.rehab.research.va.gov/]; 1I01RX000310-01 (SHG); and National Institutes of Health National Institute of Neurological Disorders and Stroke [http://www. ninds.nih.gov/]; R01NS37459 (SHG).	Acosta SA, 2015, STROKE, V46, P2616, DOI 10.1161/STROKEAHA.115.009854; Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Castegna A, 2004, J NEUROCHEM, V88, P1540, DOI 10.1046/j.1471-4159.2003.02288.x; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Costes S, 2014, AUTOPHAGY, V10, P1004, DOI 10.4161/auto.28478; Coulombe J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00129; Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; Gong B, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00004; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Goto A, 2009, NEUROCHEM INT, V54, P330, DOI 10.1016/j.neuint.2008.12.012; Graham SH, 2017, AGEING RES REV, V34, P30, DOI 10.1016/j.arr.2016.09.011; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Huang WL, 2007, EUR J NEUROSCI, V25, P362, DOI 10.1111/j.1460-9568.2006.05284.x; Jara JH, 2015, CEREB CORTEX, V25, P4259, DOI 10.1093/cercor/bhu318; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kim H, 2014, 2014 EIGHTH IEEE/ACM INTERNATIONAL SYMPOSIUM ON NETWORKS-ON-CHIP (NOCS), P9, DOI 10.1109/NOCS.2014.7008756; Koharudin LMI, 2010, P NATL ACAD SCI USA, V107, P6835, DOI 10.1073/pnas.1002295107; Liu H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.323; Liu H, 2016, BIOCHEM BIOPH RES CO, V472, P648, DOI 10.1016/j.bbrc.2016.03.003; Liu H, 2011, NEUROBIOL DIS, V41, P318, DOI 10.1016/j.nbd.2010.09.020; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Lombardino AJ, 2005, P NATL ACAD SCI USA, V102, P8036, DOI 10.1073/pnas.0503239102; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Noor NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062120; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Poon WW, 2013, J BIOL CHEM, V288, P16937, DOI 10.1074/jbc.M113.463711; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shen H, 2006, APOPTOSIS, V11, P1049, DOI 10.1007/s10495-006-6303-8; SWANSON RA, 1990, STROKE, V21, P322, DOI 10.1161/01.STR.21.2.322; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Tramutola A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2756068; Yin W, 2006, NEUROBIOL DIS, V21, P358, DOI 10.1016/j.nbd.2005.07.015; Zhang MM, 2012, J NEUROCHEM, V120, P1129, DOI 10.1111/j.1471-4159.2011.07644.x; Zhu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093334	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178049	10.1371/journal.pone.0178049	http://dx.doi.org/10.1371/journal.pone.0178049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542502	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500058
J	Noto, T; Barnagian, D; Castro, JB				Noto, Torben; Barnagian, Derrick; Castro, Jason B.			Genome-scale investigation of olfactory system spatial heterogeneity	PLOS ONE			English	Article							GENE-EXPRESSION; SENSORY NEURONS; MOUSE-BRAIN; BULB; PATTERNS; DOMAINS; INNATE; SUBDIVISIONS; ORGANIZATION; PROJECTIONS	The early olfactory system is organized in parallel, with numerous, specialized subsystems established by the modular and topographic projections of sensory inputs. While these anatomical sub-systems are in many cases demarcated by well-known marker genes, we stand to learn considerably more about their possible functional specializations from comprehensive, genome-scale descriptions of their molecular anatomy. Here, we leverage the resources of the Allen Brain Atlas (ABA)-a spatially registered compendium of gene expression for the mouse brain-to investigate the early olfactory system's genomic anatomy. We cluster thousands of genes across thousands of voxels in the ABA to derive several novel parcellations of the olfactory system, and concomitantly discover novel sets of enriched, subregion-specific genes that can serve as a starting point for future inquiry.	[Noto, Torben] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Barnagian, Derrick] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Castro, Jason B.] Bates Coll, Neurosci Program, Lewiston, ME 04240 USA	University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT)	Castro, JB (corresponding author), Bates Coll, Neurosci Program, Lewiston, ME 04240 USA.	jcastro@bates.edu			NIH-NIGMS [P20GM103423]; NSF-CAREER [NSF 1553279]	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF-CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the NIH-NIGMS (P20GM103423) to JBC and NSF-CAREER NSF 1553279 to JBC.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip	Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5904, DOI 10.1111/bph.13349; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Berghard A, 1996, J NEUROSCI, V16, P909; Bohland JW, 2010, METHODS, V50, P105, DOI 10.1016/j.ymeth.2009.09.001; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Cembrowski MS, 2016, NEURON, V89, P351, DOI 10.1016/j.neuron.2015.12.013; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Grange Pascal BJW, 2012, BRAIN GENE EXPRESSIO; Greer PL, 2016, CELL, V165, P1734, DOI 10.1016/j.cell.2016.05.001; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Hawrylycz M, 2010, METHODS, V50, P113, DOI 10.1016/j.ymeth.2009.09.005; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Huilgol D, 2013, NAT NEUROSCI, V16, P157, DOI 10.1038/nn.3297; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Jia CP, 1997, DEV BRAIN RES, V102, P209, DOI 10.1016/S0165-3806(97)00097-7; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lin DM, 2004, P NATL ACAD SCI USA, V101, P12718, DOI 10.1073/pnas.0404872101; Mainen ZF, 2007, NAT NEUROSCI, V10, P1511, DOI 10.1038/nn1207-1511; Menashe I, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003128; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Munger SD, 2010, CURR BIOL, V20, P1438, DOI 10.1016/j.cub.2010.06.021; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Paatero P, 1997, CHEMOMETR INTELL LAB, V37, P23, DOI 10.1016/S0169-7439(96)00044-5; Plato, 1956, PHAEDRUS; Ramsden HL, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004032; SHAPIRO LS, 1995, J MORPHOL, V224, P331, DOI 10.1002/jmor.1052240307; SHINOHARA H, 1992, J NEUROSCI, V12, P1275; Swanson LW, 2007, BRAIN RES REV, V55, P356, DOI 10.1016/j.brainresrev.2006.12.006; TANIGUCHI K, 1993, NEUROSCI LETT, V158, P185, DOI 10.1016/0304-3940(93)90260-R; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Yoshihara Y, 1997, J NEUROSCI, V17, P5830	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178087	10.1371/journal.pone.0178087	http://dx.doi.org/10.1371/journal.pone.0178087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542411	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500060
J	Rizos, T; Bartsch, AJ; Johnson, TD; Dittgen, F; Nichols, TE; Malzahn, U; Veltkamp, R				Rizos, Timolaos; Bartsch, Andreas J.; Johnson, Timothy D.; Dittgen, Felix; Nichols, Thomas E.; Malzahn, Uwe; Veltkamp, Roland			Voxelwise distribution of acute ischemic stroke lesions in patients with newly diagnosed atrial fibrillation: Trigger of arrhythmia or only target of embolism?	PLOS ONE			English	Article							INSULAR CORTEX LESIONS; BRAIN INFARCTION; ROBUST; DIFFERENTIATION; LOCALIZATION; OPTIMIZATION; REGISTRATION; ASSOCIATION; DIFFUSION; RISK	Objective Atrial fibrillation (AF) is frequently detected after ischemic stroke for the first time, and brain regions involved in autonomic control have been suspected to trigger AF. We examined whether specific brain regions are associated with newly detected AF after ischemic stroke. Methods Patients with acute cerebral infarctions on diffusion-weighted magnetic resonance imaging were included in this lesion mapping study. Lesions were mapped and modeled voxelwise using Bayesian Spatial Generalised Linear Mixed Modeling to determine differences in infarct locations between stroke patients with new AF, without AF and with AF already known before the stroke. Results 582 patients were included (median age 68 years; 63.2% male). AF was present in 109/582 patients [(18.7%); new AF: 39/109 (35.8%), known AF: 70/109 (64.2%)]. AF patients had larger infarct volumes than patients without AF (mean: 29.7 +/- 45.8 ml vs. 15.2 +/- 35.1 ml; p<0.001). Lesions in AF patients accumulated in the right central middle cerebral artery territory. Increasing stroke size predicted progressive cortical but not pontine and thalamic involvement. Patients with new AF had more frequently lesions in the right insula compared to patients without AF when stroke size was not accounted for, but no specific brain region was more frequently involved after adjustment for infarct volume. Controlled for stroke size, left parietal involvement was less likely for patients with new AF than for those without AF or with known AF. Conclusions In the search for brain areas potentially triggering cardiac arrhythmias infarct size should be accounted for. After controlling for infarct size, there is currently no evidence that ischemic stroke lesions of specific brain areas are associated with new AF compared to patients without AF. This challenges the neurogenic hypothesis of AF according to which a relevant proportion of new AF is triggered by ischemic brain lesions of particular locations.	[Rizos, Timolaos; Dittgen, Felix; Veltkamp, Roland] Heidelberg Univ, Dept Neurol, Heidelberg, Germany; [Bartsch, Andreas J.] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Bartsch, Andreas J.; Nichols, Thomas E.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, Oxford, England; [Bartsch, Andreas J.] Univ Wurzburg, Dept Neuroradiol, Wurzburg, Germany; [Johnson, Timothy D.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry, W Midlands, England; [Nichols, Thomas E.] Univ Warwick, Warwick Mfg Grp, Coventry, W Midlands, England; [Malzahn, Uwe] Univ Hosp Wurzburg, Clin Trial Ctr Wurzburg, Wurzburg, Germany; [Veltkamp, Roland] Imperial Coll London, Dept Stroke Med, London, England	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Oxford; University of Wurzburg; University of Michigan System; University of Michigan; University of Warwick; University of Warwick; University of Wurzburg; Imperial College London	Rizos, T (corresponding author), Heidelberg Univ, Dept Neurol, Heidelberg, Germany.	timolaos.rizos@med.uni-heidelberg.de	Nichols, Thomas E./N-9902-2017	Nichols, Thomas E./0000-0002-4516-5103	University of Heidelberg; Wellcome Trust [100309/A/12/Z] Funding Source: researchfish	University of Heidelberg; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the University of Heidelberg. The funding source provided support in the form of salaries for authors [TR, AB, RV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2006, ANN NEUROL, V59, P691, DOI 10.1002/ana.20806; Algra A, 2003, STROKE, V34, P2871, DOI 10.1161/01.STR.0000099964.34430.2D; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Ay H, 2006, NEUROLOGY, V66, P1325, DOI 10.1212/01.wnl.0000206077.13705.6d; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Benjamini Y, 2001, ANN STAT, V29, P1165; Boes AD, 2015, BRAIN, V138, P3061, DOI 10.1093/brain/awv228; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Ge T, 2014, ANN APPL STAT, V8, P1095, DOI 10.1214/14-AOAS718; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Grond M, 2013, STROKE, V44, P3357, DOI 10.1161/STROKEAHA.113.001884; Higgins P, 2014, STROKE, V45, P2134, DOI 10.1161/STROKEAHA.114.005405; Horstmann S, 2015, EUR J NEUROL, V22, P1355, DOI 10.1111/ene.12608; Jaakkola J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168010; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; PAGE RL, 1994, CIRCULATION, V89, P224, DOI 10.1161/01.CIR.89.1.224; Palma Jose-Alberto, 2014, Neurology, V83, P261, DOI 10.1212/WNL.0000000000000605; Patten M, 2006, J CARDIOVASC ELECTR, V17, P1216, DOI 10.1111/j.1540-8167.2006.00609.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rincon F, 2008, STROKE, V39, P2425, DOI 10.1161/STROKEAHA.107.506055; Rizos T, 2016, STROKE, V47, P336, DOI 10.1161/STROKEAHA.115.011465; Rizos T, 2012, STROKE, V43, P2689, DOI 10.1161/STROKEAHA.112.654954; Roche FDR, 2002, PACE, V25, P1587, DOI 10.1046/j.1460-9592.2002.01587.x; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Schaefer PW, 2002, AM J NEURORADIOL, V23, P1785; Scheitz JF, 2015, STROKE, V46, P1196, DOI 10.1161/STROKEAHA.115.008681; Seifert F, 2015, J NEUROL, V262, P1182, DOI 10.1007/s00415-015-7684-9; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sposato LA, 2015, LANCET NEUROL, V14, P377, DOI 10.1016/S1474-4422(15)70027-X; Sposato LA, 2014, NEUROLOGY, V82, P1180, DOI 10.1212/WNL.0000000000000265; TIMSIT SG, 1993, NEUROLOGY, V43, P728, DOI 10.1212/WNL.43.4.728; TIMSIT SG, 1992, STROKE, V23, P486, DOI 10.1161/01.STR.23.4.486; Tokgozoglu SL, 1999, STROKE, V30, P1307, DOI 10.1161/01.STR.30.7.1307; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	41	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177474	10.1371/journal.pone.0177474	http://dx.doi.org/10.1371/journal.pone.0177474			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542605	gold, Green Published			2022-12-27	WOS:000402061500028
J	Sagawa, S; Price, MN; Deutschbauer, AM; Arkin, AP				Sagawa, Shiori; Price, Morgan N.; Deutschbauer, Adam M.; Arkin, Adam P.			Validating regulatory predictions from diverse bacteria with mutant fitness data	PLOS ONE			English	Article							BINDING TRANSCRIPTION FACTORS; DNA; MICROARRAYS; NETWORKS	Although transcriptional regulation is fundamental to understanding bacterial physiology, the targets of most bacterial transcription factors are not known. Comparative genomics has been used to identify likely targets of some of these transcription factors, but these predictions typically lack experimental support. Here, we used mutant fitness data, which measures the importance of each gene for a bacterium's growth across many conditions, to test regulatory predictions from RegPrecise,a curated collection of comparative genomics predictions. Because characterized transcription factors often have correlated fitness with one of their targets (either positively or negatively), correlated fitness patterns provide support for the comparative genomics predictions. At a false discovery rate of 3%, we identified significant cofitness for at least one target of 158 TFs in 107 ortholog groups and from 24 bacteria. Thus, high-throughput genetics can be used to identify a high-confidence subset of the sequence-based regulatory predictions.	[Sagawa, Shiori] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Sagawa, Shiori; Price, Morgan N.; Deutschbauer, Adam M.; Arkin, Adam P.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Price, MN (corresponding author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol, Berkeley, CA 94720 USA.	morgannprice@yahoo.com	Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; , ENIGMA/0000-0002-0894-2831; Price, Morgan/0000-0002-4251-0362	U.S. Department of Energy, Office of Science, Office of Biological & Environmental Research [DE-AC02-05CH11231]	U.S. Department of Energy, Office of Science, Office of Biological & Environmental Research(United States Department of Energy (DOE))	This material by ENIGMA- Ecosystems and Networks Integrated with Genes and Molecular Assemblies (http://enigma.lbl.gov), a Scientific Focus Area Program at Lawrence Berkeley National Laboratory is based upon work supported by the U.S. Department of Energy, Office of Science, Office of Biological & Environmental Research under contract number DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Charoensawan V, 2010, NUCLEIC ACIDS RES, V38, P7364, DOI 10.1093/nar/gkq617; Deutschbauer A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002385; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Galagan J., 2012, SYSTEMS BIOL, P43; Haft D.H., 2012, TIGRFAMS GENOME PROP; Ishihama A., 2016, NUCLEIC ACIDS RES, P5; Katja Decker, 1999, MOL MICROBIOL, V32.4, P777; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Meysman P., 2013, NUCL ACIDS; Moreno-Campuzano S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-147; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Price MN, 2016, BIORXIV; Rajeev L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r99; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Shao WJ, 2014, MBIO, V5, DOI 10.1128/mBio.01398-14; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Tan K, 2005, GENOME RES, V15, P312, DOI 10.1101/gr.3069205; Wendisch VF, 2003, J BIOTECHNOL, V104, P273, DOI 10.1016/S0168-1656(03)00147-0; Wetmore KM, 2015, MBIO, V6, DOI 10.1128/mBio.00306-15; Wu WS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-188	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178258	10.1371/journal.pone.0178258	http://dx.doi.org/10.1371/journal.pone.0178258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542589	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500078
J	Yhim, HY; Lee, J; Lee, JY; Lee, JO; Bang, SM				Yhim, Ho-Young; Lee, Juhyun; Lee, Ji Yun; Lee, Jeong-Ok; Bang, Soo-Mee			Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study	PLOS ONE			English	Article							ASSESSMENT SERVICE DATABASE; MAJOR ORTHOPEDIC-SURGERY; CLINICAL-PRACTICE GUIDELINES; ASIAN PATIENTS; TIME-COURSE; REPLACEMENT; THROMBOSIS; RISK; PREVENTION; HEALTH	Background Limited data is available regarding the pharmacological prophylaxis for venous thromboembolism (VTE) in Asian patients undergoing total knee arthroplasty or total hip arthroplasty (TKA/THA). Methods We performed a population-based epidemiological study using the Health Insurance Review and Assessment Service database to estimate the rate of pharmacological thromboprophylaxis and its impact on VTE in Korean patients who underwent TKA/THA between 2009 and 2013. Results We identified 306,912 cases (TKA, 261,260; THA, 45,652). The pharmacological thromboprophylaxis rate was 57.16% (TKA, 58.32%; THA, 50.51%), which increased from 42.81% in 2009 to 65.92% in 2013 (P = 0.0165). Both low-molecular-weight-heparin (22.42%) and rivar-oxaban (22.71%) were the most common drugs for prophylaxis. The number of patients aged >= 60 years (87.31% vs. 81.01%, P < 0.0001), cases requiring general anesthesia (20.70% vs. 18.37%, P < 0.0001), and cases requiring long hospital stay (median, 13 days vs. 12 days, P < 0.0001) were significantly greater in the pharmacological prophylaxis group. The incidence of VTE within 3 months of surgery was 1.52% (TKA, 1.46%; THA, 1.87%). Patients with pharmacological prophylaxis had higher VTE rates (TKA, 1.69% vs. 1.14%; THA, 2.30% vs. 1.43%) than those without prophylaxis, with advanced age, use of general anesthesia, and a longer hospital stay increasing the risk of VTE. However, rivaroxaban significantly reduced the incidence of VTE following TKA (0.82% vs. 1.14%; odd ratio [OR], 0.72; 95% CI, 0.65-0.79). Moreover, >= 10 days of pharmacological thromboprophylaxis was significantly associated with lower incidence of VTE after TKA (1.33% vs. 1.52%; OR, 0.87; 95% CI, 0.81-0.94). Conclusion This represents the largest epidemiological study showing a gradual increase in the use of pharmacological prophylaxis in Korean patients undergoing TKA/THA. Although the incidence of VTE is still low without pharmacological prophylaxis, this study demonstrates that the incidence of VTE can be reduced further using appropriate pharmacological thromboprophylaxis strategies.	[Yhim, Ho-Young] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Jeonju, South Korea; [Yhim, Ho-Young] Chonbuk Natl Univ, Biomed Res Inst, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Jeonju, South Korea; [Lee, Juhyun; Lee, Ji Yun; Lee, Jeong-Ok; Bang, Soo-Mee] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University Hospital; Seoul National University (SNU)	Bang, SM (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	smbang7@snu.ac.kr			Seoul National University Bundang Hospital [13-2015-025]	Seoul National University Bundang Hospital	This work was supported by a grant from the Seoul National University Bundang Hospital (13-2015-025). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would especially like to thank the Big Data Division, Healthcare Data Convergence Department, Korean Health Insurance Review & Assessment Services for data retrieval. This work was supported by a grant from Seoul National University Bundang Hospital (13-2015-025).	Bang SM, 2014, J KOREAN MED SCI, V29, P164, DOI 10.3346/jkms.2014.29.2.164; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cohen AT, 2010, THROMB HAEMOSTASIS, V104, P919, DOI 10.1160/TH10-03-0190; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Haas SB, 2008, J BONE JOINT SURG AM, V90A, P2764; Jang MJ, 2011, J THROMB HAEMOST, V9, P2519, DOI 10.1111/j.1538-7836.2011.04518.x; Jang MJ, 2011, J THROMB HAEMOST, V9, P85, DOI 10.1111/j.1538-7836.2010.04108.x; Jorgensen CC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003965; Kim DS, 2010, SOC WORK PUBLIC HLTH, V25, P127, DOI 10.1080/19371910903070333; Kim Kang-Il, 2013, Knee Surg Relat Res, V25, P43, DOI 10.5792/ksrr.2013.25.2.43; Lachiewicz Paul F, 2009, Instr Course Lect, V58, P795; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lee CH, 2013, J THROMB HAEMOST, V11, P1930, DOI 10.1111/jth.12375; Lee CH, 2012, J THROMB HAEMOST, V10, P56, DOI 10.1111/j.1538-7836.2011.04555.x; Leizorovicz A, 2005, J THROMB HAEMOST, V3, P28, DOI 10.1111/j.1538-7836.2004.01094.x; Leizorovicz A, 2007, HAEMATOLOGICA, V92, P1194, DOI 10.3324/haematol.10819; Liew Ngoh Chin, 2003, Asian J Surg, V26, P154, DOI 10.1016/S1015-9584(09)60375-4; Lussana F, 2014, THROMB RES, V134, P599, DOI 10.1016/j.thromres.2014.06.027; Pedersen AB, 2010, J BONE JOINT SURG AM, V92A, P2156, DOI 10.2106/JBJS.I.00882; Pedersen AB, 2015, THROMB RES, V135, P322, DOI 10.1016/j.thromres.2014.11.029; Pedersen AB, 2011, J BONE JOINT SURG AM, V93A, P1281, DOI [10.2106/JBJSJ.00676, 10.2106/JBJS.J.00676]; Piovella F, 2005, J THROMB HAEMOST, V3, P2664, DOI 10.1111/j.1538-7836.2005.01621.x; Rahme E, 2008, CAN MED ASSOC J, V178, P1545, DOI 10.1503/cmaj.071388; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Warwick D, 2007, J BONE JOINT SURG BR, V89B, P799, DOI 10.1302/0301-620X.89B6.18844; White RH, 1998, ARCH INTERN MED, V158, P1525, DOI 10.1001/archinte.158.14.1525; Yhim HY, 2014, J THROMB HAEMOST, V12, P1035, DOI 10.1111/jth.12611	29	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178214	10.1371/journal.pone.0178214	http://dx.doi.org/10.1371/journal.pone.0178214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542415	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500073
J	Shah, D; Ali, M; Shukla, D; Jain, S; Aakalu, VK				Shah, Dhara; Ali, Marwan; Shukla, Deepak; Jain, Sandeep; Aakalu, Vinay Kumar			Effects of histatin-1 peptide on human corneal epithelial cells	PLOS ONE			English	Article							HUMAN SALIVA; PROLIFERATION; MIGRATION; ADHESION; ASSAYS; LINES; FATE	Purpose Ocular surface and corneal epithelial wounds are common and potentially debilitating problems. Ideal treatments for these injuries would promote epithelial healing without inflammation, infection and scarring. In addition the best treatments would be cost-efficient, effective, non-toxic and easily applied. Histatin-1 peptides have been shown to be safe and effective enhancers of epithelial wound healing in other model systems. We sought to determine whether histatin-1 peptides could enhance human corneal epithelial wound healing in vitro. Methods Histatin-1 peptides were applied to human corneal epithelial cells and compared over useful dose ranges in scratch assays using time-lapse microscopy. In addition, path finding analysis, cell spreading assays, toxicity and proliferation assays were performed to further characterize the effects of histatin-1 peptide on human corneal limbal epithelial ( HCLE). Results Histatin-1 enhanced human corneal epithelial wound healing in typical wound healing models. There was minimal toxicity and no significant enhancement of proliferation of corneal epithelium in response to histatin-1 application. Corneal epithelial spreading and pathfinding appeared to be enhanced by the application of histatin-1 peptides. Conclusions Histatin-1 peptide may enhance migration of HCLE cells and wound healing in vitro. These peptides may have benefit in corneal epithelial wounds and need to be investigated further.	[Shah, Dhara; Ali, Marwan; Aakalu, Vinay Kumar] Univ Illinois, Lacrimal Cell Biol Lab, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA; [Shukla, Deepak; Jain, Sandeep] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Aakalu, VK (corresponding author), Univ Illinois, Lacrimal Cell Biol Lab, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	vaakalu@uic.edu		Shukla, Deepak/0000-0002-3039-6953	National Eye Institute [K08 EY024339]; National Eye Institute Core grant [P30EY001792]; Eversight Research Grant; Fight For Sight; NATIONAL EYE INSTITUTE [K08EY024339, R01EY024966, R01EY023656, P30EY001792] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Eye Institute Core grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Eversight Research Grant; Fight For Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute: K08 EY024339; National Eye Institute Core grant P30EY001792 (https://nei.nih.gov/); Fight For Sight: Grant in Aid (http://www.fightforsight.org/); Eversight Research Grant (http://eversightvision.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Naby W, 2017, INVEST OPHTH VIS SCI, V58, P1425, DOI 10.1167/iovs.16-19957; Ali M, 2016, CURR EYE RES, V9, P1; Ashby B.D., 2014, AUSTIN J CLIN OPHTHA, V1, P1017, DOI DOI 10.1073/pnas.1019055108; BAUM BJ, 1976, ARCH BIOCHEM BIOPHYS, V177, P427, DOI 10.1016/0003-9861(76)90455-0; Borrelli M, 2010, AM J OPHTHALMOL, V150, P894, DOI 10.1016/j.ajo.2010.05.010; Campese M, 2009, ARCH ORAL BIOL, V54, P345, DOI 10.1016/j.archoralbio.2008.11.010; Cao ZY, 2015, METHODS MOL BIOL, V1207, P317, DOI 10.1007/978-1-4939-1396-1_21; Duque A, 2011, J NEUROSCI, V31, P15205, DOI 10.1523/JNEUROSCI.3092-11.2011; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Helmerhorst EJ, 2001, J BIOL CHEM, V276, P5643, DOI 10.1074/jbc.M008229200; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Leong YY, 2015, OCUL SURF, V13, P103, DOI 10.1016/j.jtos.2014.10.003; Liu CY, 2015, PROG MOL BIOL TRANSL, V134, P61, DOI 10.1016/bs.pmbts.2015.05.002; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Melino S, 2014, FEBS J, V281, P657, DOI 10.1111/febs.12612; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; Riss TL, 2004, CELL VIABILITY ASSAY; Shah D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148018; Singh Parul, 2013, Oman J Ophthalmol, V6, P83, DOI 10.4103/0974-620X.116624; van Dijk IA, 2015, FASEB J, V29, P3124, DOI 10.1096/fj.14-266825; Van Goethem F, 2006, TOXICOL IN VITRO, V20, P1, DOI 10.1016/j.tiv.2005.05.002; van 't Hof W, 2013, HISTATINS MULTIFUNCT, P167; Wang LY, 2011, MOL VIS, V17, P2835; Wirostko B, 2015, OCUL SURF, V13, P204, DOI 10.1016/j.jtos.2014.12.005	27	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5								10.1371/journal.pone.0178030	http://dx.doi.org/10.1371/journal.pone.0178030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542418	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800033
J	Steffl, M; Chrudimsky, J; Tufano, JJ				Steffl, Michal; Chrudimsky, Jan; Tufano, James J.			Using relative handgrip strength to identify children at risk of sarcopenic obesity	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; GRIP STRENGTH; ADOLESCENTS; DEFINITION; WEAKNESS; HEALTH	Identifying children at risk of developing childhood sarcopenic obesity often requires specialized equipment and costly testing procedures, so cheaper and quicker methods would be advantageous, especially in field-based settings. The purpose of this study was to determine the relationships between the muscle-to-fat ratio (MFR) and relative handgrip strength, and to determine the ability of handgrip strength relative to body mass index (grip-to-BMI) to identify children who are at risk of developing sarcopenic obesity. Grip-to-BMI was measured in 730 Czech children (4 to 14 yrs). Bioelectrical impedance was used to estimate body fat mass and skeletal muscle mass, from which the MFR was calculated. The area under the curve (AUC) was 0.791 (95% CI 0.692-0.890, p < 0.001) in girls 4-9; 0.789 (95% CI 0.688-0.890, p < 0.001) in girls 10-14 years old; 0.719 (95% CI 0.607-0.831, p = 0.001) in boys 4-9; and 0.896 (95% CI 0.823-0.969, p < 0.001) in boys 10-14 years old. Calculated using the grip-to-BMI ratio, the OR (95% CI) for girls to be at risk of sarcopenic obesity identified by MFR was 9.918 (4.243-23.186, p < 0.001) and was 11.515 (4.280-30.982, p < 0.001) for boys. The grip-to-BMI ratio can be used to predict the presence of sarcopenic obesity in children, which can play a role in pediatric health interventions.	[Steffl, Michal; Chrudimsky, Jan; Tufano, James J.] Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic	Charles University Prague	Tufano, JJ (corresponding author), Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic.	james.j.tufano@gmail.com	Steffl, Michal/P-6804-2016; Tufano, James J/O-7363-2017; Tufano, James/AAD-4416-2019; Chrudimsky, Jan/J-6362-2017	Steffl, Michal/0000-0001-7297-8145; Tufano, James J/0000-0001-8325-0344; Tufano, James/0000-0001-8325-0344; Chrudimsky, Jan/0000-0003-0026-1916	 [Q 41]		This research was supported by the project Q 41. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the project Q 41.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bianco A, 2015, INT J OCCUP MED ENV, V28, P445, DOI 10.13075/ijomeh.1896.00393; Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007; Cauley JA, 2015, J CLIN DENSITOM, V18, P499, DOI 10.1016/j.jocd.2015.04.013; Coles N, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4116; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Cohen DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093150; Ertem K, 2003, ISOKINET EXERC SCI, V11, P219, DOI 10.3233/IES-2003-0150; Febrer A, 2010, J REHABIL MED, V42, P228, DOI 10.2340/16501977-0507; Fess E, 1981, CLIN ASSESSMENT RECO, V1st; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Kim K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153383; Legrand D, 2013, ARCH GERONTOL GERIAT, V57, P345, DOI 10.1016/j.archger.2013.06.003; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Matsudo VK, 2015, REV BRAS CIN DES HUM, V17, P1, DOI DOI 10.5007/1980-0037.2015V17N1P1; McCarthy HD, 2014, PEDIATR OBES, V9, P249, DOI 10.1111/j.2047-6310.2013.00168.x; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; Morley JE, 2014, J CACHEXIA SARCOPENI, V5, P253, DOI 10.1007/s13539-014-0161-y; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Park BS, 2013, DIABETES METAB J, V37, P458, DOI 10.4093/dmj.2013.37.6.458; Peterson MD, 2016, J AM MED DIR ASSOC, V17, P933, DOI 10.1016/j.jamda.2016.06.007; Ploegmakers JJW, 2013, J PHYSIOTHER, V59, P255, DOI 10.1016/S1836-9553(13)70202-9; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Russell MK, 2015, NUTR CLIN PRACT, V30, P211, DOI 10.1177/0884533615570094; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121799; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113999; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Wind AE, 2010, EUR J PEDIATR, V169, P281, DOI 10.1007/s00431-009-1010-4	29	37	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177006	10.1371/journal.pone.0177006	http://dx.doi.org/10.1371/journal.pone.0177006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542196	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058800006
J	Mourady, D; Richa, S; Karam, R; Papazian, T; Moussa, FH; El Osta, N; Kesrouani, A; Azouri, J; Jabbour, H; Hajj, A; Khabbaz, LR				Mourady, Danielle; Richa, Sami; Karam, Rita; Papazian, Tatiana; Moussa, Fabienne Hajj; El Osta, Nada; Kesrouani, Assaad; Azouri, Joseph; Jabbour, Hicham; Hajj, Aline; Khabbaz, Lydia Rabbaa			Associations between quality of life, physical activity, worry, depression and insomnia: A cross-sectional designed study in healthy pregnant women	PLOS ONE			English	Article							SLEEP QUALITY; POPULATION; SYMPTOMS; PREVALENCE; POSTPARTUM; VALIDATION; TRIAL	Health-related quality of life (QOL) is reported to be reduced during pregnancy. Associations between QOL, physical activity (PA), insomnia, depression and worry are insufficiently investigated among pregnant women. The aim of this study was to evaluate QOL and PA patterns among healthy pregnant women, and to examine how QOL might correlate to PA, sleep, worry and depression. This is an observational cross-sectional study, conducted among a convenient sample of 141 healthy pregnant women using five questionnaires: WHOQOL-brief (WHO quality of life questionnaire, brief version, ISI (Insomnia Severity Index), PSWQ (Penn State Worry Questionnaire), ZSRDS (Zung Self-Rating Depression Scale), and Pregnancy Physical Activity Questionnaire (PPAQ). Pre-gestational BMI was inversely correlated to overall health while education was positively correlated to psychological health, social relationships and environment domains. Smoking before and during pregnancy significantly impacted the general health and psychological health. Total and light PA were positively correlated to psychological health and social relationships. Sports/exercise showed positive correlations with several QOL domains. Insomnia and depression were significantly associated with a decrease in all domains of QOL, while worries were associated with a decrease in physical, psychological and environmental domains. There were significant negative correlations between ZSRDS scores and total activity. PA, worries, depression and insomnia affected QOL during pregnancy. Furthermore, pregnant women presenting depression had a reduced total PA. Sleep and mental health as well as encouraging PA during pregnancy are necessary to improve the quality of life of pregnant women.	[Mourady, Danielle; Papazian, Tatiana; Moussa, Fabienne Hajj; Hajj, Aline; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Med, Beirut, Lebanon; [Mourady, Danielle; Papazian, Tatiana; Moussa, Fabienne Hajj; Hajj, Aline; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Beirut, Lebanon; [Richa, Sami; Kesrouani, Assaad; Jabbour, Hicham] St Joseph Univ Beirut, Fac Med, Beirut, Lebanon; [Richa, Sami] St Joseph Univ Beirut, Hotel Dieu France Hosp, Dept Psychiat, Beirut, Lebanon; [Karam, Rita] Lebanese Univ, Fac Sci, LECP, Beirut, Lebanon; [Karam, Rita] Minist Publ Hlth, Qual Assurance Pharmaceut Prod Program, Beirut, Lebanon; [El Osta, Nada] St Joseph Univ, Fac Med, Dept Publ Hlth, Beirut, Lebanon; [Kesrouani, Assaad] St Joseph Univ Beirut, Hotel Dieu France Hosp, Dept Obstet & Gynecol, Beirut, Lebanon; [Azouri, Joseph] Mt Liban Hosp, Dept Obstet & Gynecol, Beirut, Lebanon; [Jabbour, Hicham] St Joseph Univ Beirut, Hotel Dieu France Hosp, Dept Anesthesia & Crit Care, Beirut, Lebanon	Lebanese University; American University of Beirut; American University of Beirut	Khabbaz, LR (corresponding author), St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Med, Beirut, Lebanon.	lydia.khabbaz@usj.edu.lb	EL OSTA, Nada/GRS-4789-2022; richa, sami/ABF-6036-2020; Papazian, Tatiana/AAH-4745-2021	Jabbour, Hicham/0000-0003-1033-850X; Kesrouani, Assaad/0000-0002-8810-5493				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; AlDukhayel A, 2015, INT J HEALTH SCI-IJH, V9, P9; Battle CL, 2015, J MIDWIFERY WOM HEAL, V60, P479, DOI 10.1111/jmwh.12271; Berntsen S, 2014, SCAND J MED SCI SPOR, V24, P594, DOI 10.1111/sms.12034; Bien A, 2015, INT J ENV RES PUB HE, V13; Cheville AL, 2013, J PAIN SYMPTOM MANAG, V45, P811, DOI 10.1016/j.jpainsymman.2012.05.006; de Moraes EV, 2016, REV BRAS GINECOL OBS, V38, P293, DOI 10.1055/s-0036-1585072; de Wit L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0595-z; Dorheim SK, 2012, BEHAV SLEEP MED, V10, P152, DOI 10.1080/15402002.2012.660588; Downs DS, 2008, ANN BEHAV MED, V36, P54, DOI 10.1007/s12160-008-9044-9; Fieril KP, 2015, ACTA OBSTET GYN SCAN, V94, P35, DOI 10.1111/aogs.12525; Gholami A, 2013, INT J PREVENTIVE MED, V4, P809; Hatoum HT, 1998, AM J MANAG CARE, V4, P79; Huberty Jennifer L, 2016, Prev Med Rep, V3, P353, DOI 10.1016/j.pmedr.2016.04.004; Karacam Z, 2009, MIDWIFERY, V25, P344, DOI 10.1016/j.midw.2007.03.006; Kirkby R, 2005, ANN SAUDI MED, V25, P205, DOI 10.5144/0256-4947.2005.205; Ko YL, 2016, EUR J SPORT SCI, V16, P374, DOI 10.1080/17461391.2015.1028468; Kolu P, 2014, MATERN CHILD HLTH J, V18, P2098, DOI 10.1007/s10995-014-1457-4; Lacasse A, 2008, BJOG-INT J OBSTET GY, V115, P1484, DOI 10.1111/j.1471-0528.2008.01891.x; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mindell JA, 2015, SLEEP MED, V16, P483, DOI 10.1016/j.sleep.2014.12.006; Ohaeri JU, 2009, ANN SAUDI MED, V29, P98, DOI 10.4103/0256-4947.51790; Penacoba-Puente C, 2011, ACTA OBSTET GYN SCAN, V90, P1030, DOI 10.1111/j.1600-0412.2011.01208.x; PRITCHARD CW, 1994, J EPIDEMIOL COMMUN H, V48, P377, DOI 10.1136/jech.48.4.377; Richardsen KR, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0401-y; Ross CE, 1997, J HEALTH SOC BEHAV, V38, P275, DOI 10.2307/2955371; Santos PC, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.22455; Smith M. T., 2003, ARTHRITIS RHEUMATISM, V49, pS184, DOI DOI 10.1002/ART.11409; Statham H, 1997, BIRTH-ISS PERINAT C, V24, P223, DOI 10.1111/j.1523-536X.1997.tb00595.x; Sut HK, 2016, J PERINAT NEONAT NUR, V30, P302, DOI 10.1097/JPN.0000000000000181; Sut HK, 2016, J PERINATAL NEONATAL; Taylor DJ, 2007, SLEEP, V30, P213, DOI 10.1093/sleep/30.2.213	32	52	53	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178181	10.1371/journal.pone.0178181	http://dx.doi.org/10.1371/journal.pone.0178181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UA	28542529	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058400067
J	Cheong, SH; Sa, OG; Absalon-Medina, VA; Schneider, A; Butler, WR; Gilbert, RO				Cheong, Soon Hon; Sa Filho, Ocilon G.; Absalon-Medina, Victor A.; Schneider, Augusto; Butler, W. R.; Gilbert, Robert O.			Uterine and systemic inflammation influences ovarian follicular function in postpartum dairy cows	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; REPRODUCTIVE-PERFORMANCE; SUBCLINICAL ENDOMETRITIS; ENERGY-BALANCE; INTRAMAMMARY INFECTION; TRANSITION PERIOD; GRANULOSA-CELLS; 1ST OVULATION; RISK-FACTORS; FERTILITY	The objective of this study was to determine the effects of uterine and systemic inflammatory responses to uterine bacterial contamination at calving in dairy cows on the growth and ovulatory outcomes of the first dominant follicle postpartum. Ovulatory capability of the first dominant follicle postpartum was predicted in 53 multiparous cows by using a combination of follicle growth characteristics and circulating estradiol concentrations. Endotoxin levels were assayed in follicular fluid samples that were aspirated the day after ovulatory outcome prediction. Plasma levels of haptoglobin, a proinflammatory acute phase protein, and paraoxonase, a negative acute phase protein were determined. Uterine bacteria and inflammation were evaluated in three uterine fluid samples from each cow collected on the day of calving, the day after follicle aspiration, and at 35 days postpartum. Cows that had a strong initial uterine inflammatory response (robust recruitment of polymorphonuclear leukocytes of >= 35% and cows with uterine pH < 8.5 on the day of calving) were more likely to have an ovulatory first dominant follicle. Follicular fluid endotoxin levels were higher in non-ovulatory cows compared with ovulatory cows. Endotoxin levels in circulation were not different between ovulatory groups but were higher prepartum than on day 7 and 14 postpartum. Systemic inflammation characterized by elevated haptoglobin concentrations was higher in non-ovulatory cows despite similar bacterial contamination and circulating endotoxin levels. Paraoxonase activity in follicular fluid was significantly associated with the paraoxonase activity in plasma, however, plasma paraoxonase concentrations were not different between non-ovulatory and ovulatory cows. Cows with a higher uterine bacterial load on the day of calving had slower ovarian follicle growth. In summary, a robust uterine inflammatory response on the day of calving was positively associated with ovarian function while elevated systemic inflammation during the early postpartum period was negatively associated with the ovulatory status of the first dominant follicle postpartum.	[Cheong, Soon Hon; Gilbert, Robert O.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Sa Filho, Ocilon G.; Absalon-Medina, Victor A.; Schneider, Augusto; Butler, W. R.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Absalon-Medina, Victor A.] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA; [Schneider, Augusto] Univ Fed Pelotas, Dept Nutr, Pelotas, Brazil; [Gilbert, Robert O.] Ross Univ, Sch Vet Med, Dept Clin Sci, Basseterre, St Kitts & Nevi	Cornell University; Cornell University; University of Pennsylvania; Universidade Federal de Pelotas	Cheong, SH; Gilbert, RO (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA.; Gilbert, RO (corresponding author), Ross Univ, Sch Vet Med, Dept Clin Sci, Basseterre, St Kitts & Nevi.	cheong@cornell.edu; RoGilbert@rossvet.edu.kn	Gilbert, Robert/J-9107-2012; Schneider, Augusto/B-5011-2014; Butler, Walter/GQH-5350-2022	Gilbert, Robert/0000-0002-1528-243X; Schneider, Augusto/0000-0002-3410-2860; Cheong, Soon Hon/0000-0001-9002-7589; Butler, Walter/0000-0001-5195-7433	National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2007-35203-18420]	National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This project was supported by National Research Initiative Competitive Grant no. 2007-35203-18420 from the USDA National Institute of Food and Agriculture to ROG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia DF, 1997, ENDOCRINOLOGY, V138, P4273, DOI 10.1210/en.138.10.4273; Beam SW, 1997, BIOL REPROD, V56, P133, DOI 10.1095/biolreprod56.1.133; Bionaz M, 2007, J DAIRY SCI, V90, P1740, DOI 10.3168/jds.2006-445; Bittar JHJ, 2014, J DAIRY SCI, V97, P3558, DOI 10.3168/jds.2013-7533; Bradley AJ, 2004, VET CLIN N AM-FOOD A, V20, P547, DOI 10.1016/j.cvfa.2004.06.010; Butler ST, 2006, J DAIRY SCI, V89, P2938, DOI 10.3168/jds.S0022-0302(06)72566-8; Butler ST, 2004, REPRODUCTION, V127, P537, DOI 10.1530/rep.1.00079; CANFIELD RW, 1990, DOMEST ANIM ENDOCRIN, V7, P323, DOI 10.1016/0739-7240(90)90038-2; Cheong SH, 2012, THERIOGENOLOGY, V77, P1217, DOI 10.1016/j.theriogenology.2011.10.029; Cheong SH, 2012, THERIOGENOLOGY, V77, P858, DOI 10.1016/j.theriogenology.2011.09.009; Cheong SH, 2011, J DAIRY SCI, V94, P762, DOI 10.3168/jds.2010-3439; Cheong SH, 2015, BIOL REPROD; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Crowe MA, 2008, REPROD DOMEST ANIM, V43, P20, DOI 10.1111/j.1439-0531.2008.01210.x; de Boer MW, 2014, J DAIRY SCI, V97, P3983, DOI 10.3168/jds.2013-7450; de Campos FT, 2017, THERIOGENOLOGY, V89, P244, DOI 10.1016/j.theriogenology.2016.11.013; Dourey A, 2011, RES VET SCI, V91, pE149, DOI 10.1016/j.rvsc.2010.11.011; ETHERINGTON WG, 1984, CAN J COMP MED, V48, P245; Galvao KN, 2010, REPROD DOMEST ANIM, V45, pE207, DOI 10.1111/j.1439-0531.2009.01517.x; Galvao KN, 2009, J DAIRY SCI, V92, P4906, DOI 10.3168/jds.2008-1984; Gilbert RO, 2005, THERIOGENOLOGY, V64, P1879, DOI 10.1016/j.theriogenology.2005.04.022; Gilbert RO, 2016, THERIOGENOLOGY, V85, P1367, DOI 10.1016/j.theriogenology.2015.10.045; Gilbert RO, 2012, REPROD FERT DEVELOP, V24, P252, DOI 10.1071/RD11915; Gobikrushanth M, 2016, THERIOGENOLOGY, V86, P1842, DOI 10.1016/j.theriogenology.2016.06.003; Green MJ, 2002, J DAIRY SCI, V85, P2589, DOI 10.3168/jds.S0022-0302(02)74343-9; Herath S, 2007, REPRODUCTION, V134, P683, DOI 10.1530/REP-07-0229; Huszenicza G, 1999, REPROD DOMEST ANIM, V34, P237, DOI 10.1111/j.1439-0531.1999.tb01246.x; Huzzey JM, 2009, J DAIRY SCI, V92, P621, DOI 10.3168/jds.2008-1526; JONES GE, 1984, RES VET SCI, V37, P87, DOI 10.1016/S0034-5288(18)31933-7; JUNEJA NL, 1965, FERTIL STERIL, V16, P361; Kasimanickam R, 2004, THERIOGENOLOGY, V62, P9, DOI 10.1016/j.theriogenology.2003.03.001; KNICKERBOCKER JJ, 1988, DOMEST ANIM ENDOCRIN, V5, P91, DOI 10.1016/0739-7240(88)90011-2; Krause ART, 2014, ANIM REPROD SCI, V145, P8, DOI 10.1016/j.anireprosci.2013.12.016; LeBlanc SJ, 2014, ANIMAL, V8, P54, DOI 10.1017/S1751731114000524; Lucy MC, 2001, J DAIRY SCI, V84, P1277, DOI 10.3168/jds.S0022-0302(01)70205-6; MARSCHKE RJ, 1985, J DAIRY SCI, V68, P1263, DOI 10.3168/jds.S0022-0302(85)80955-3; Mateus L, 2003, ANIM REPROD SCI, V76, P143, DOI 10.1016/S0378-4320(02)00248-8; Moore SG, 2014, J DAIRY SCI, V97, P2740, DOI 10.3168/jds.2013-7278; Moran B, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2938-1; OLSON JD, 1984, AM J VET RES, V45, P2251; PETER AT, 1990, THERIOGENOLOGY, V33, P1011, DOI 10.1016/0093-691X(90)90062-X; Quesnell RR, 2012, J DAIRY SCI, V95, P117, DOI 10.3168/jds.2011-4289; Riddle WT, 2007, THERIOGENOLOGY, V68, P395, DOI 10.1016/j.theriogenology.2007.05.050; Schneider A, 2013, REPROD DOMEST ANIM, V48, P989, DOI 10.1111/rda.12198; Schneider A, 2013, RES VET SCI, V95, P269, DOI 10.1016/j.rvsc.2013.02.010; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; THATCHER WW, 1973, J DAIRY SCI, V56, P608, DOI 10.3168/jds.S0022-0302(73)85227-0; Vieira-Neto A, 2014, J DAIRY SCI, V97, P5415, DOI 10.3168/jds.2013-7725; Walsh RB, 2007, J DAIRY SCI, V90, P315, DOI 10.3168/jds.2007-0389; Williams EJ, 2007, THERIOGENOLOGY, V68, P549, DOI 10.1016/j.theriogenology.2007.04.056; Williams EJ, 2008, AM J REPROD IMMUNOL, V60, P462, DOI 10.1111/j.1600-0897.2008.00645.x	51	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177356	10.1371/journal.pone.0177356	http://dx.doi.org/10.1371/journal.pone.0177356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542500	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600009
J	Braha, D; de Aguiar, MAM				Braha, Dan; de Aguiar, Marcus A. M.			Voting contagion: Modeling and analysis of a century of US presidential elections	PLOS ONE			English	Article							MASS-MEDIA; STOCHASTIC RESONANCE; OPINION DYNAMICS; SOCIAL-INFLUENCE; BEHAVIOR; DECISION; STATISTICS; DIVERSITY; REGIONS; HEALTH	Social influence plays an important role in human behavior and decisions. Sources of influence can be divided as external, which are independent of social context, or as originating from peers, such as family and friends. An important question is how to disentangle the social contagion by peers from external influences. While a variety of experimental and observational studies provided insight into this problem, identifying the extent of contagion based on large-scale observational data with an unknown network structure remains largely unexplored. By bridging the gap between the large-scale complex systems perspective of collective human dynamics and the detailed approach of social sciences, we present a parsimonious model of social influence, and apply it to a central topic in political science-elections and voting behavior. We provide an analytical expression of the county vote-share distribution, which is in excellent agreement with almost a century of observed U.S. presidential election data. Analyzing the social influence topography over this period reveals an abrupt phase transition from low to high levels of social contagion, and robust differences among regions. These results suggest that social contagion effects are becoming more instrumental in shaping large-scale collective political behavior, with implications on democratic electoral processes and policies.	[Braha, Dan; de Aguiar, Marcus A. M.] New England Complex Syst Inst, Cambridge, MA 02139 USA; [Braha, Dan] Univ Massachusetts, Dartmouth, MA 02747 USA; [de Aguiar, Marcus A. M.] Univ Estadual Campinas, Campinas, SP, Brazil	University of Massachusetts System; University Massachusetts Dartmouth; Universidade Estadual de Campinas	Braha, D (corresponding author), New England Complex Syst Inst, Cambridge, MA 02139 USA.; Braha, D (corresponding author), Univ Massachusetts, Dartmouth, MA 02747 USA.	braha@necsi.edu	de Aguiar, Marcus A M/C-9137-2012; de Aguiar, Marcus A. M./N-1377-2019	de Aguiar, Marcus A M/0000-0003-1379-7568; 				Acemoglu D, 2013, MATH OPER RES, V38, P1, DOI 10.1287/moor.1120.0570; Alexander C, 2001, J ADOLESCENT HEALTH, V29, P22, DOI 10.1016/S1054-139X(01)00210-5; [Anonymous], 2012, VONTING ELECT COLLEC; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Araujo NAM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012446; Armoudian M, 2010, OXFORD HDB AM ELECTI, P300; Beck PA, 2002, AM POLIT SCI REV, V96, P57, DOI 10.1017/S0003055402004239; Bernardes AT, 2002, EUR PHYS J B, V25, P123, DOI 10.1140/e10051-002-0013-y; Bianco WT, 2014, AM POLITICS TODAY; Boccara N, 2007, ARXIV07041790; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Borghesi C, 2010, EUR PHYS J B, V75, P395, DOI 10.1140/epjb/e2010-00151-1; Borghesi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036289; Braha D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048596; Bryan FM, 2010, NEW ENGLAND PRINCETO, P532; Burnham WD, 1970, CRITICAL ELECT MAINS; Campbell Angus., 1960, AM VOTER; Carletti T, 2006, EUROPHYS LETT, V74, P222, DOI 10.1209/epl/i2005-10536-9; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chatterjee A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01049; Chinellato DD, 2015, J STAT PHYS, V159, P221, DOI 10.1007/s10955-015-1189-x; Chinellato DD, 2007, ARXIV07054607V2; Costa LD, 2011, ADV PHYS, V60, P329, DOI 10.1080/00018732.2011.572452; Costa RN, 2003, PHYSICA A, V322, P698, DOI 10.1016/S0378-4371(02)01823-X; Costa RN, 1999, PHYS REV E, V60, P1067, DOI 10.1103/PhysRevE.60.1067; Dalton RJ, 1998, AM POLIT SCI REV, V92, P111, DOI 10.2307/2585932; de Aguiar MAM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031901; DOWNS A, 1957, J POLIT ECON, V65, P135, DOI 10.1086/257897; Everitt B. S., 1981, FINITE MIXTURE DISTR, DOI 10.1007/978-94-009-5897-5; Felgueiras M, 2014, AIP CONF PROC, V1618, P523, DOI 10.1063/1.4897790; Fernandez-Gracia J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.158701; Florida R., 2002, RISE CREATIVE CLASS; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Galam S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046123; Galam S, 1997, PHYSICA A, V238, P66, DOI 10.1016/S0378-4371(96)00456-6; Galam S, 2005, EUROPHYS LETT, V70, P705, DOI 10.1209/epl/i2004-10526-5; Galam S, 2004, PHYSICA A, V333, P453, DOI 10.1016/j.physa.2003.10.041; Galam S, 2012, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-1-4614-2032-3; Galam S, 2002, EUR PHYS J B, V25, P403, DOI 10.1140/epjb/e20020045; Galam S, 2016, MIND SOC, V15, P117, DOI DOI 10.1007/S11299-015-0175-Y; Galam S, 2016, ARXIV160903933; Galam S, 2007, PHYSICA A, V381, P366, DOI 10.1016/j.physa.2007.03.034; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gilens M, 2007, J POLIT, V69, P1160, DOI 10.1111/j.1468-2508.2007.00615.x; Goncalves B, 2015, COMPUT SOC SCI, P1, DOI 10.1007/978-3-319-14011-7; Gonzalez-Avella JC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.065102; Harmon D, 2011, ARXIV11022620; Harmon D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131871; Helbing D, 2015, J STAT PHYS, V158, P735, DOI 10.1007/s10955-014-1024-9; Heppen J, 2003, PROF GEOGR, V55, P191; Hero RE, 2000, FACES INEQUALITY SOC; Hillygus S, 2010, OXFORD HDB AM ELECTI, P326, DOI DOI 10.1093/OXFORDHB/9780199235476.001.0001; HUCKFELDT R, 1991, J POLIT, V53, P122, DOI 10.2307/2131724; Huckfeldt R.R., 1995, CITIZENS POLITICS SO; JONES AM, 1994, J HEALTH ECON, V13, P93, DOI 10.1016/0167-6296(94)90006-X; Just M. R., 1996, CROSSTALK CITIZENS C; KENNY CB, 1992, AM J POLIT SCI, V36, P259, DOI 10.2307/2111432; Kinder DR, 1987, NEWS MATTERS; Kleiber C., 2003, STAT SIZE DISTRIBUTI, DOI 10.1002/0471457175; Klimek P, 2012, P NATL ACAD SCI USA, V109, P16469, DOI 10.1073/pnas.1210722109; KRUG SE, 1973, J SOC PSYCHOL, V91, P73, DOI 10.1080/00224545.1973.9922648; Kuperman M, 2002, EUR PHYS J B, V26, P387, DOI 10.1140/epjb/e20020104; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Lazarsfeld P. F., 1948, PEOPLES CHOICE VOTER, V2nd; Li Q, 2013, J STAT PHYS, V151, P92, DOI 10.1007/s10955-012-0625-4; Lichtman AJ, 2010, PRINCETON ENCY AM PO, P281; Liggett T M, 2012, INTERACTING PARTICLE; Lyra ML, 2003, EUROPHYS LETT, V62, P131, DOI 10.1209/epl/i2003-00371-6; Lyst J., 2002, ANN REV COMPUTATIONA, V9, P253; Mantovani MC, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.024802; Mazzitello KI, 2007, INT J MOD PHYS C, V18, P1475, DOI 10.1142/S0129183107011492; McClurg SD, 2004, AM POLIT RES, V32, P406, DOI 10.1177/1532673X03260581; Mobilia M, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/08/P08029; Mobilia M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.028701; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; MORAN PAP, 1950, BIOMETRIKA, V37, P178, DOI 10.1093/biomet/37.1-2.178; Nickerson DW, 2008, AM POLIT SCI REV, V102, P49, DOI 10.1017/S0003055408080039; NOWAK A, 1990, PSYCHOL REV, V97, P362, DOI 10.1037/0033-295X.97.3.362; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Palombi F, 2014, J STAT PHYS, V156, P336, DOI 10.1007/s10955-014-1003-1; Plaut VC, 2002, J PERS SOC PSYCHOL, V83, P160, DOI 10.1037//0022-3514.83.1.160; Putnam R., 2000, BOWLING ALONE COLLAP; Rentfrow PJ, 2013, J PERS SOC PSYCHOL, V105, P996, DOI 10.1037/a0034434; Rubin RL, 1981, PRESS PARTY PRESIDEN; SAH RK, 1991, J POLIT ECON, V99, P1272, DOI 10.1086/261800; San Miguel M, 2005, COMPUT SCI ENG, V7, P67, DOI 10.1109/MCSE.2005.114; Schaffner BF, 2011, POLITICS PARTIES ELE; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Shao J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018701; Shibanai Y, 2001, J CONFLICT RESOLUT, V45, P80, DOI 10.1177/0022002701045001004; Singh P, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046104; Sundquist James L., 2011, DYNAMICS PARTY SYSTE; Tessone CJ, 2005, PHYSICA A, V351, P106, DOI 10.1016/j.physa.2004.12.012; Valente T.W., 2005, MODELS METHODS SOCIA, VVolume 28, P98, DOI DOI 10.1017/CBO9780511811395.006; Wattenberg M, 1994, DECLINE AM POLITICAL; Wu YK, 2012, ELECTRON J LINEAR AL, V23, P790; Xie J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011130; Xie J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033215; Yildiz ME., 2013, ACM T EC COMPUTATION, V1, p19:1, DOI DOI 10.1145/2538508	104	37	37	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177970	10.1371/journal.pone.0177970	http://dx.doi.org/10.1371/journal.pone.0177970			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542409	gold, Green Published			2022-12-27	WOS:000401672400123
J	Beheshti, R; Jones-Smith, JC; Igusa, T				Beheshti, Rahmatollah; Jones-Smith, Jessica C.; Igusa, Takeru			Taking dietary habits into account: A computational method for modeling food choices that goes beyond price	PLOS ONE			English	Article							AGENT-BASED SIMULATION; NUTRIENT DENSITY; COST; CONSUMPTION; CHILDREN; BEHAVIOR; HEALTH; IMPACT; OPTIMIZATION; QUALITY	Computational models have gained popularity as a predictive tool for assessing proposed policy changes affecting dietary choice. Specifically, they have been used for modeling dietary changes in response to economic interventions, such as price and income changes. Herein, we present a novel addition to this type of model by incorporating habitual behaviors that drive individuals to maintain or conform to prior eating patterns. We examine our method in a simulated case study of food choice behaviors of low-income adults in the US. We use data from several national datasets, including the National Health and Nutrition Examination Survey (NHANES), the US Bureau of Labor Statistics and the USDA, to parameterize our model and develop predictive capabilities in 1) quantifying the influence of prior diet preferences when food budgets are increased and 2) simulating the income elasticities of demand for four food categories. Food budgets can increase because of greater affordability (due to food aid and other nutritional assistance programs), or because of higher income. Our model predictions indicate that low-income adults consume unhealthy diets when they have highly constrained budgets, but that even after budget constraints are relaxed, these unhealthy eating behaviors are maintained. Specifically, diets in this population, before and after changes in food budgets, are characterized by relatively low consumption of fruits and vegetables and high consumption of fat. The model results for income elasticities also show almost no change in consumption of fruit and fat in response to changes in income, which is in agreement with data from the World Bank's International Comparison Program (ICP). Hence, the proposed method can be used in assessing the influences of habitual dietary patterns on the effectiveness of food policies.	[Beheshti, Rahmatollah; Igusa, Takeru] Johns Hopkins Global Obes Prevent Ctr, Baltimore, MD 21205 USA; [Beheshti, Rahmatollah; Igusa, Takeru] Johns Hopkins Whiting Sch Engn, Baltimore, MD 21218 USA; [Beheshti, Rahmatollah; Igusa, Takeru] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Jones-Smith, Jessica C.] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle	Beheshti, R (corresponding author), Johns Hopkins Global Obes Prevent Ctr, Baltimore, MD 21205 USA.; Beheshti, R (corresponding author), Johns Hopkins Whiting Sch Engn, Baltimore, MD 21218 USA.; Beheshti, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	r.b@jhu.edu	Igusa, Takeru/A-3218-2010	Igusa, Takeru/0000-0002-3632-2867; Jones-Smith, Jessica/0000-0001-8962-1695; Beheshti, Rahmatollah/0000-0001-8912-3063	Global Obesity Prevention Center (GOPC) at Johns Hopkins University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Office of the Director, National Institutes of Health (OD) [U54HD070725]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD070725, R00HD073327] Funding Source: NIH RePORTER	Global Obesity Prevention Center (GOPC) at Johns Hopkins University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of the Director, National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this publication was supported by the Global Obesity Prevention Center (GOPC) at Johns Hopkins University, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Office of the Director, National Institutes of Health (OD) under award number U54HD070725. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], BR J NUTR; [Anonymous], 2008, DEV CNPP PRIC DAT; Atshin A, 2017, PLOS ONE, V12; Bartfeld J., 2015, SNAP MATTERS FOOD ST; Beheshti R, 2016, J NUTR; Bellisle F., 2005, EUFIC REV, V17, P1; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Briend A, 2003, J PEDIATR GASTR NUTR, V36, P12, DOI 10.1097/00005176-200301000-00006; Brimblecombe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083587; Champagne F, 2001, Prog Brain Res, V133, P287; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; Darmon N, 2002, AM J CLIN NUTR, V75, P245, DOI 10.1093/ajcn/75.2.245; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; Dibari F, 2012, J NUTR, V142, P955, DOI 10.3945/jn.111.156943; Dowler E, 2008, POVERTY FOOD NUTR WH, P34; Drewnowski A, 2010, AM J CLIN NUTR, V92, P1181, DOI 10.3945/ajcn.2010.29300; Dykstra H, 2016, J NUTR, V146, P630, DOI 10.3945/jn.115.225516; Falk LW, 1996, J NUTR EDUC, V28, P257; Ford ES, 2013, AM J CLIN NUTR, V97, P848, DOI 10.3945/ajcn.112.052662; Furst T, 1996, APPETITE, V26, P247, DOI 10.1006/appe.1996.0019; HAINES PS, 1988, AM J AGR ECON, V70, P543, DOI 10.2307/1241492; Hall KD, 2014, AM J PUBLIC HEALTH, V104, P1169, DOI 10.2105/AJPH.2014.301931; Hammond RA, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00082; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Hlaing LM, 2015, BR J NUTR, P1; Huang KS, 1996, AM J AGR ECON, V78, P21, DOI 10.2307/1243775; Kuo LE, 2008, ANN NY ACAD SCI, V1148, P232, DOI 10.1196/annals.1410.035; Langellier BA, 2016, SSM-POPUL HLTH, V2, P757, DOI 10.1016/j.ssmph.2016.10.006; Li Y, 2016, J URBAN HEALTH, V93, P244, DOI 10.1007/s11524-016-0028-y; Maillot M, 2011, J NUTR, V141, P333, DOI 10.3945/jn.110.131920; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; Mela DJ, 2001, OBES RES, V9, p249S, DOI 10.1038/oby.2001.127; Nader PR, 2012, CHILD OBES, V8, P195, DOI 10.1089/chi.2012.0004; Pag?n, 2016, CURRENT NUTR REPORTS, V5, P245, DOI DOI 10.1007/s13668-016-0179-1; Rambeloson ZJ, 2008, PUBLIC HEALTH NUTR, V11, P395, DOI 10.1017/S1368980007000511; Santika O, 2009, J NUTR, V139, P135, DOI 10.3945/jn.108.092270; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Seale JL, 2006, REV INCOME WEALTH, P603; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; Spruijt-Metz D, 2015, TRANSL BEHAV MED, V5, P335, DOI 10.1007/s13142-015-0324-1; De Carvalho IST, 2015, FOOD NUTR BULL, V36, P75, DOI 10.1177/156482651503600107; van Dooren C, 2015, SUSTAINABILITY-BASEL, V7, P12837, DOI 10.3390/su70912837; Wilensky U., 1999, CTR CONNECTED LEARNI; Wilson N, 2016, BMC NUTR, V2, P1; Zhang DL, 2014, AM J PUBLIC HEALTH, V104, P1217, DOI 10.2105/AJPH.2014.301934	46	7	7	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							0178348	10.1371/journal.pone.0178348	http://dx.doi.org/10.1371/journal.pone.0178348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542615	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800078
J	Juneja, S; Gupta, A; Moon, S; Resch, S				Juneja, Sandeep; Gupta, Aastha; Moon, Suerie; Resch, Stephen			Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP)	PLOS ONE			English	Article							ANTIRETROVIRAL MEDICINES; IMPROVE ACCESS	The Medicines Patent Pool (MPP) was established in 2010 to ensure timely access to lowcost generic versions of patented antiretroviral (ARV) medicines in low-and middle-income countries (LMICs) through the negotiation of voluntary licences with patent holders. While robust data on the savings generated by MPP and other major global public health initiatives is important, it is also difficult to quantify. In this study, we estimate the savings generated by licences negotiated by the MPP for ARV medicines to treat HIV/AIDS in LMICs for the period 2010-2028 and generate a cost-benefit ratio-based on people living with HIV (PLHIVs) in any new countries which gain access to an ARV due to MPP licences and the price differential between originator's tiered price and generics price, within the period where that ARV is patented. We found that the direct savings generated by the MPP are estimated to be USD 2.3 billion (net present value) by 2028, representing an estimated cost-benefit ratio of 1: 43, which means for every USD 1 spent on MPP, the global public health community saves USD 43. The saving of USD 2.3 billion is equivalent to more than 24 million PLHIV receiving first-line ART in LMICs for 1 year at average prices today.	[Juneja, Sandeep; Gupta, Aastha] Med Patent Pool, Geneva, Switzerland; [Moon, Suerie; Resch, Stephen] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Gupta, A (corresponding author), Med Patent Pool, Geneva, Switzerland.	agupta@medicinespatentpool.org	juneja, sandeep/AAP-3404-2020	Juneja, Sandeep/0000-0002-3735-3120; Moon, Suerie/0000-0001-8504-1212				Accenture, 2012, ACC DEV PARTN INV BA; AMIN T, 2007, VOLUNTARY LICENSING; Gupta A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164619; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Medecins Sans Frontieres, UNT WEB ANT PRIC RED; Medicines Patent Pool, MED PAT LIC DAT; Medicines Patent Pool, OR WORK MPP LIC AGR; Medicines Patent Pool, SUBL WORK MPP LIC AG; Medicines Patent Pool, IND ASS STAT KPMG; Medicines Patent Pool, PROGR ACH MED PAT PO; Moon S, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-39; [MPP UNITAID], PAT LIC ANT SNAPSH; 't Hoen E, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-15; UNAIDS, 2015, UND FAST TRACK ACC A; UNAIDS (Joint United Nations Programme on HIV and AIDS), 2016, FAST TRACK COMM END; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; Waning B, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-9; [WIPO WTO WHO], 2013, PROM ACC MED TECHN I; WIPO, STUD PROM ACC MED TE; World Health Organization, GLOB PRIC REP MECH H; World Health Organization, 2007, VOL LIC PRACT PHARM; World Health Organization, CONS GUID US ANT DRU	22	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177770	10.1371/journal.pone.0177770	http://dx.doi.org/10.1371/journal.pone.0177770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542239	Green Published, gold			2022-12-27	WOS:000402062800025
J	Liu, JH; Zhang, B				Liu, Jianhui; Zhang, Bin			Robust consensus tracking control of multiple mechanical systems under fixed and switching interaction topologies	PLOS ONE			English	Article							MULTIAGENT SYSTEMS; ADAPTIVE-CONTROL; LEADER; NETWORKS; AGENTS	Consensus tracking problems for multiple mechanical systems are considered in this paper, where information communications are limited between individuals and the desired trajectory is available to only a subset of the mechanical systems. A distributed tracking algorithm based on computed torque approach is proposed in the fixed interaction topology case, in which a robust feedback term is developed for each agent to estimate the external disturbances and the unknown agent dynamics. Then the result is extended to address the case under switching interaction topologies by using Lyapunov approaches and sufficient conditions are given. Two examples and numerical simulations are presented to validate the effectiveness of the proposed robust tracking method.	[Liu, Jianhui] Beihang Univ BUAA, Sch Automat Sci & Elect Engn, Beijing 100876, Peoples R China; [Zhang, Bin] Beijing Univ Posts & Telecommun, Sch Automat, Beijing 100876, Peoples R China	Beihang University; Beijing University of Posts & Telecommunications	Zhang, B (corresponding author), Beijing Univ Posts & Telecommun, Sch Automat, Beijing 100876, Peoples R China.	zb362301@126.com		liu, jianhui/0000-0002-5829-9709	National Natural Science Foundation of China (NSFC) [61603050]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (NSFC: 61603050) and the Fundamental Research Funds for the Central Universities.	Arteaga MA, 2004, IEEE T ROBOTIC AUTOM, V20, P297, DOI 10.1109/TRA.2003.820872; Consolini L, 2008, AUTOMATICA, V44, P1343, DOI 10.1016/j.automatica.2007.09.019; CRAIG JJ, 1987, INT J ROBOT RES, V6, P16, DOI 10.1177/027836498700600202; Dong WJ, 2011, AUTOMATICA, V47, P2023, DOI 10.1016/j.automatica.2011.05.025; Fax JA, 2004, IEEE T AUTOMAT CONTR, V49, P1465, DOI 10.1109/TAC.2004.834433; Hong YG, 2008, AUTOMATICA, V44, P846, DOI 10.1016/j.automatica.2007.07.004; Hong YG, 2006, AUTOMATICA, V42, P1177, DOI 10.1016/j.automatica.2006.02.013; Hou ZG, 2009, IEEE T SYST MAN CY B, V39, P636, DOI 10.1109/TSMCB.2008.2007810; Hu GQ, 2012, SYST CONTROL LETT, V61, P134, DOI 10.1016/j.sysconle.2011.10.004; Jadbabaie A, 2003, IEEE T AUTOMAT CONTR, V48, P988, DOI 10.1109/TAC.2003.812781; Khalil H.K., 2007, NONLINEAR SYSTEMS, V3rd; Khoo SY, 2009, IEEE-ASME T MECH, V14, P219, DOI 10.1109/TMECH.2009.2014057; Lawton JRT, 2003, IEEE T ROBOTIC AUTOM, V19, P933, DOI 10.1109/TRA.2003.819598; Lewis F., 2003, ROBOT MANIPULATOR CO; Li W, 2017, IEEE T AEROSPACE ELE, V53; Li WL, 2012, IEEE T AUTOMAT CONTR, V57, P230, DOI 10.1109/TAC.2011.2161838; Lin P, 2008, SYST CONTROL LETT, V57, P643, DOI 10.1016/j.sysconle.2008.01.002; Liu Y, 2010, INT J CONTROL, V83, P527, DOI 10.1080/00207170903267039; Nedic A, 2010, IEEE T AUTOMAT CONTR, V55, P922, DOI 10.1109/TAC.2010.2041686; Olfati-Saber R, 2007, P IEEE, V95, P215, DOI 10.1109/JPROC.2006.887293; Ren W, 2005, P AMER CONTR CONF, P1859, DOI 10.1109/ACC.2005.1470239; Ren W, 2005, IEEE T AUTOMAT CONTR, V50, P655, DOI 10.1109/TAC.2005.846556; Schilling R.J., 1996, FUNDAMENTALS ROBOTIC; SLOTINE JJE, 1987, INT J ROBOT RES, V6, P49, DOI 10.1177/027836498700600303; Tanner HG, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P2010; Wang L, 2010, IEEE T AUTOMAT CONTR, V55, P950, DOI 10.1109/TAC.2010.2041610; Yang JM, 1999, IEEE T ROBOTIC AUTOM, V15, P578, DOI 10.1109/70.768190; Zhang B, 2015, J FRANKLIN I, V352, P1521, DOI 10.1016/j.jfranklin.2015.01.023	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178330	10.1371/journal.pone.0178330	http://dx.doi.org/10.1371/journal.pone.0178330			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542460	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800072
J	Metta, E; Bailey, A; Kessy, F; Geubbels, E; Haisma, H				Metta, Emmy; Bailey, Ajay; Kessy, Flora; Geubbels, Eveline; Haisma, Hinke			Illness experiences of diabetes in the context of malaria in settings experiencing double burden of disease in southeastern Tanzania	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; QUALITY-OF-LIFE; FALCIPARUM-MALARIA; SELF-CARE; COMMUNITY; RISK; TUBERCULOSIS; MELLITUS; ADULTS; UNCERTAINTY	Background Tanzania is doubly burdened with both non-communicable and infectious diseases, but information on how Tanzanians experience the co-existence of these conditions is limited. Using Kleinman's eight prompting questions the study synthesizes explanatory models from patients to describe common illness experiences of diabetes in a rural setting where malaria is the predominant health threat. Methods We conducted 17 focus group discussions with adult members of the general community, diabetes patients, neighbours and relatives of diabetes patients to gain insight into shared experiences. To gain in-depth understanding of the individual illness experiences, we conducted 41 in-depth interviews with malaria or diabetes patients and family members of diabetes patients. The analysis followed grounded theory principles and the illness experiences were derived from the emerging themes. Results The illness experiences showed that malaria and diabetes are both perceived to be severe and fatal conditions, but over the years people have learned to live with malaria and the condition is relatively manageable compared with diabetes. In contrast, diabetes was perceived as a relatively new disease, with serious life-long consequences. Uncertainty, fear of those consequences, and the increased risk for severe malaria and other illnesses impacted diabetes patients and their families' illness experiences. Unpredictable ailments and loss of consciousness, memory, libido, and functional incapability were common problems reported by diabetes patients. These problems had an effect on their psychological and emotional health and limited their social life. Direct and indirect costs of illness pushed individuals and their families further into poverty and were more pronounced for diabetes patients. Conclusion The illness experiences revealed both malaria and diabetes as distressing conditions, however, diabetes showed a higher level of stress because of its chronicity. Strategies for supporting social, emotional, and psychological well-being that build on the patient accounts are likely to improve illness experiences and quality of life for the chronically ill patient.	[Metta, Emmy; Geubbels, Eveline] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Metta, Emmy; Bailey, Ajay; Haisma, Hinke] Univ Groningen, Fac Spatial Sci, Populat Res Ctr, Groningen, Netherlands; [Kessy, Flora] Mzumbe Univ, Dar Es Salaam, Tanzania	Ifakara Health Institute; University of Groningen	Metta, E (corresponding author), Ifakara Hlth Inst, Dar Es Salaam, Tanzania.; Metta, E (corresponding author), Univ Groningen, Fac Spatial Sci, Populat Res Ctr, Groningen, Netherlands.	emetta@ihi.or.tz		Geubbels, Eveline/0000-0002-9702-5460; Bailey, Ajay/0000-0003-3163-6805	Netherlands Organization for International Cooperation in Higher Education (NUFFIC) [NICHE/TZA/005]; Ifakara Health and Demographic Surveillance System (HDSS)	Netherlands Organization for International Cooperation in Higher Education (NUFFIC); Ifakara Health and Demographic Surveillance System (HDSS)	This study is part of The Netherlands Initiative for Capacity building in Higher Education (NICHE/TZA/005) funded by the Netherlands Organization for International Cooperation in Higher Education (NUFFIC) to EM as part of her PhD studies. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; We acknowledge the support received from the Ifakara Health and Demographic Surveillance System (HDSS) and the MZIMA project team members during the data collection processes. We are very grateful to the village leaders, the district diabetes clinic authorities and to the community members who participated in or otherwise contributed to these results.	Acquah S, 2014, EVIDENCE INSULIN RES, V2014; Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Ahmad L.A., 2010, CLIN DIABETES, V28, P53, DOI DOI 10.2337/DIACLIN.28.2.53; Apostolo JLA, 2007, REV LAT-AM ENFERM, V15, P575, DOI 10.1590/S0104-11692007000400009; Andreassen S, 2007, INT J QUAL STUD HEAL, V2, P114, DOI DOI 10.1080/17482620701305589; Aspray TJ, 2000, T ROY SOC TROP MED H, V94, P637, DOI 10.1016/S0035-9203(00)90216-5; Aujoulat I, 2007, QUAL HEALTH RES, V17, P772, DOI 10.1177/1049732307302665; Bailey DE, 2009, PSYCHOSOMATICS, V50, P138, DOI 10.1176/appi.psy.50.2.138; Balogun E.A., 2013, BIOKEMISTRI, V24, P38; Brown WV, 2008, AM J CARDIOL, V102, p10L, DOI 10.1016/j.amjcard.2008.09.068; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Danquah I, 2010, EMERG INFECT DIS, V16, P1601, DOI 10.3201/eid1610.100399; Davis E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045980; De Berardis G, 2002, DIABETES CARE, V25, P284, DOI 10.2337/diacare.25.2.284; de-Graft Aikins Ama, 2010, Global Health, V6, P6, DOI 10.1186/1744-8603-6-6; Debono Miguel, 2007, Psychol Health Med, V12, P545, DOI 10.1080/13548500701235740; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Faurholt-Jepsen D, 2013, TROP MED INT HEALTH, V18, P822, DOI 10.1111/tmi.12120; Faurholt-Jepsen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024215; Gallagher EB, 1999, J NERV MENT DIS, V187, P648, DOI 10.1097/00005053-199910000-00013; Geubbels E, 2013, 12 IND SCI C 2013 28; Gregg EW, 2002, DIABETES CARE, V25, P61, DOI 10.2337/diacare.25.1.61; Habib T, 2010, ANTROCOM, V6, P79; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Haraka F, 2015, PLOS ONE, V10; Harchut K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-159; Helman C G, 1981, J R Coll Gen Pract, V31, P548; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-317; Hofmann B, 2002, J MED PHILOS, V27, P651, DOI 10.1076/jmep.27.6.651.13793; Holmes MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000244; IDF, 2019, IDF DIABETES ATLAS; Ikekpeazu EJ, 2010, AS J MED SCI, V2, P214; Ishengoma DS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-338; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jezewski, 2002, MEXICAN AM EXPLANATO; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kleinman A., 1988, ILLNESS NARRATIVES; Kleinman A., 1980, PATIENTS HEALERS CON; Kornum JB, 2008, DIABETES CARE, V31, P1541, DOI 10.2337/dc08-0138; Lwilla F, 2003, TROP MED INT HEALTH, V8, P204, DOI 10.1046/j.1365-3156.2003.00999.x; Makundi EA, 2007, AM J TROP MED HYG, V77, P106, DOI 10.4269/ajtmh.2007.77.106; Mboera LEG, 2013, MALARIA WORLD J, V4, P1; Mboera LEG, 2007, AM J TROP MED HYG, V77, P112, DOI 10.4269/ajtmh.2007.77.112; Metta E, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0768-5; Metta E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1504-0; Metta E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-249; Mfinanga S, 2012, TANZANIA J HLTH RES, V13; Mlozi MR, 2014, TANZANIA J HLTH RES, V17; Mohapatra KM., 2001, INT J DIABETES DEV C, V2, P156; MoHSW, MIDT AN REV PERF HLT; MoHSW, 2008, HLTH SECT STRAT PLAN; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Mukeshimana MM, 2014, J CLIN NURS, V23, P541, DOI 10.1111/jocn.12199; Nombo C, 2007, AIDS MEETS POVERTY I; President's Malaria Initiative (PMI), MAL OP PLAN MOP TANZ; Royer A., 1998, LIFE CHRONIC ILLNESS; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Saydah SH, 2002, AM J EPIDEMIOL, V156, P714, DOI 10.1093/aje/kwf111; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; SHALEV O, 1992, POSTGRAD MED J, V68, P281, DOI 10.1136/pgmj.68.798.281; Smithson P, 2009, IFAKARA HLTH I SPOTL, V2, P1; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and ICF International, 2013, TANZ HIV AIDS MAL IN; Thomsen RW, 2005, CLIN INFECT DIS, V40, P628, DOI 10.1086/427699; Thomsen RW, 2004, DIABETES CARE, V27, P1143, DOI 10.2337/diacare.27.5.1143; Thorne S, 2003, QUAL HEALTH RES, V13, P1337, DOI 10.1177/1049732303258039; Toombs S Kay, 1995, Second Opin, V21, P11; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123575; WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201; WHO, WORLD MAL REP GEN; WHO, TANZ STEPS SURV 2012; Yew VW, 2014, J SOCIAL SCI HUMANIT, V9, P116; Zimmet P, DIABETES EPIDEMIC FU	79	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178394	10.1371/journal.pone.0178394	http://dx.doi.org/10.1371/journal.pone.0178394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542578	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800085
J	Noh, JY; Lim, S; Song, JY; Choi, WS; Jeong, HW; Heo, JY; Lee, J; Seo, YB; Lee, JS; Wie, SH; Kim, YK; Park, KH; Jung, SI; Kim, SW; Lee, SH; Lee, HS; Yoon, YH; Cheong, HJ; Kim, WJ				Noh, Ji Yun; Lim, Sooyeon; Song, Joon Young; Choi, Won Suk; Jeong, Hye Won; Heo, Jung Yeon; Lee, Jacob; Seo, Yu Bin; Lee, Jin-Soo; Wie, Seong Heon; Kim, Young Keun; Park, Kyung Hwa; Jung, Sook-In; Kim, Shin Woo; Lee, Sun Hee; Lee, Han Sol; Yoon, Young Hoon; Cheong, Hee Jin; Kim, Woo Joo			Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season	PLOS ONE			English	Article								In the 2016-2017 season, the A(H3N2) influenza epidemic presented an unusual early peak pattern compared with past seasons in South Korea. The interim vaccine effectiveness (VE) of influenza vaccination in preventing laboratory-confirmed influenza was estimated using test-negative design through the tertiary hospital-based influenza surveillance system in South Korea. From 1 September, 2016 to 7 January, 2017, adjusted VE of influenza vaccination in preventing laboratory-confirmed A(H3N2) was -52.1% (95% confidence interval [CI], -147.2 to 6.4); -70.0% (95% CI, -212.0 to 7.4) in 19-64 years and 4.3% (95% CI, -137.8 to 61.5) in the elderly. Circulating A(H3N2) viruses belonged to the three phylogenetic subclades of 3C. 2a, differently to A/Hong Kong/4801/2014, the current vaccine strain. Amino acid substitutions in hemagglutinin of circulating viruses seem to contribute to low VE. In conclusion, interim VE analysis presented that the protection of laboratory-confirmed influenza by seasonal influenza vaccination did not show the statistical significance in South Korea in the 2016-2017 influenza season.	[Noh, Ji Yun; Song, Joon Young; Choi, Won Suk; Cheong, Hee Jin; Kim, Woo Joo] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Noh, Ji Yun; Lim, Sooyeon; Song, Joon Young; Choi, Won Suk; Cheong, Hee Jin; Kim, Woo Joo] Korea Univ, Coll Med, Asia Pacific Influenza Inst, Seoul, South Korea; [Jeong, Hye Won; Heo, Jung Yeon] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Div Infect Dis, Cheongju, South Korea; [Lee, Jacob; Seo, Yu Bin] Hallym Univ, Sch Med, Kangnam Sacred Heart Hosp, Div Infect Dis,Dept Internal Med, Chunchon, South Korea; [Lee, Jin-Soo] Inha Univ, Coll Med, Dept Internal Med, Div Infect Dis, Incheon, South Korea; [Wie, Seong Heon] Catholic Univ Korea, Sch Med, St Vincents Hosp, Div Infect Dis,Dept Internal Med, Suwon, South Korea; [Kim, Young Keun] Yonsei Univ, Wonju Coll Med, Dept Infect Dis, Wonju, South Korea; [Park, Kyung Hwa; Jung, Sook-In] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea; [Kim, Shin Woo] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Lee, Sun Hee] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea; [Lee, Han Sol; Kim, Woo Joo] Korea Univ, Coll Med, Brain Korea Plus Biomed Sci 21, Seoul, South Korea; [Yoon, Young Hoon] Korea Univ, Coll Med, Dept Emergency Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Chungbuk National University; Hallym University; Inha University; Catholic University of Korea; Yonsei University; Chonnam National University; Kyungpook National University; Pusan National University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, WJ (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.; Kim, WJ (corresponding author), Korea Univ, Coll Med, Asia Pacific Influenza Inst, Seoul, South Korea.; Kim, WJ (corresponding author), Korea Univ, Coll Med, Brain Korea Plus Biomed Sci 21, Seoul, South Korea.	wjkim@korea.ac.kr	Choi, Won Suk/V-2730-2017; LEE, SUN HEE/AAB-5714-2022; YOON, Young-Hoon/ABA-8810-2020	Choi, Won Suk/0000-0001-5874-4764; LEE, SUN HEE/0000-0003-2093-3628; Cheong, Hee Jin/0000-0002-2532-1463; Song, Joon Young/0000-0002-0148-7194; Yoon, Young-Hoon/0000-0002-1916-2080; Heo, Jung Yeon/0000-0002-6548-1939	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea); Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea [A103001]; National Research Foundation of Korea (NRF) Grant - Korean Government (MSIP) [NRF-2016R1A5A1010148]	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea); Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) Grant - Korean Government (MSIP)(National Research Foundation of Korea)	This work was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea), which is a part of the Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant no.: A103001) and by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) (NRF-2016R1A5A1010148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castilla J, 2017, EURO SURVEILLANCE B, V22; European Centre for Disease Prevention and Control, 2016, INFL VIR CHAR SUMM E; Feng S, 2016, VACCINE, V34, P1672, DOI 10.1016/j.vaccine.2016.02.039; Flannery B, 2017, MMWR-MORBID MORTAL W, V66, P167, DOI 10.15585/mmwr.mm6606a3; Flannery B, 2016, J INFECT DIS, V214, P1010, DOI 10.1093/infdis/jiw181; Harvala H, 2017, EURO SURVEILLANCE B, V22; Hergens MP, 2017, EURO SURVEILLANCE B, V22; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; Kissling E, 2017, EURO SURVEILLANCE B, V22; Korea Centers for Disease Control and Prevention, WEEKL SENT SURV REP; Leung VK, 2016, EURO SURVEILLANCE B, V21; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Skowronski DM, 2017, EURO SURVEILLANCE B, V22; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valenciano M, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.7.30139; Valenciano M, 2015, VACCINE, V33, P2813, DOI 10.1016/j.vaccine.2015.04.012; WHO, REC COMP INFL VIR VA; World Health Organization, INFL LAB SURV INF GL	19	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178010	10.1371/journal.pone.0178010	http://dx.doi.org/10.1371/journal.pone.0178010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542417	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800035
J	Qin, ZY; Zhang, XG				Qin, Zhiyi; Zhang, Xuegong			The identification of switch-like alternative splicing exons among multiple samples with RNA-Seq data	PLOS ONE			English	Article							CELL-DIFFERENTIATION; ALU EXONS; PROTEOME; PROGRAM	Alternative splicing is an ubiquitous phenomenon in most human genes and has important functions. The switch-like exon is the type of exon that has a high level of usage in some tissues, but has a low level of usage in the other tissues. They usually undergo strong tissue-specific regulations. There is still a lack a systematic method to identify switch-like exons from multiple RNA-seq samples. We proposed a novel method called iterative Tertile Absolute Deviation around the mode (iTAD) to profile the distribution of exon relative usages among multiple samples and to identify switch-like exons and other types of exons using a robust statistic estimator. We validated the method with simulation data, and applied it on RNA-seq data of 16 human body tissues and detected 3,100 switch-like exons. We found that switch-like exons tend to be more associated with Alu elements in their flanking intron regions than other types of exons.	[Qin, Zhiyi; Zhang, Xuegong] Tsinghua Univ, TNLIST, Dept Automat, MOE Key Lab Bioinformat,Bioinformat Div, Beijing, Peoples R China; [Qin, Zhiyi; Zhang, Xuegong] Tsinghua Univ, TNLIST, Dept Automat, Ctr Synthet & Syst Biol, Beijing, Peoples R China; [Zhang, Xuegong] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Zhang, XG (corresponding author), Tsinghua Univ, TNLIST, Dept Automat, MOE Key Lab Bioinformat,Bioinformat Div, Beijing, Peoples R China.; Zhang, XG (corresponding author), Tsinghua Univ, TNLIST, Dept Automat, Ctr Synthet & Syst Biol, Beijing, Peoples R China.; Zhang, XG (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China.	zhangxg@tsinghua.edu.cn		Zhang, Xuegong/0000-0002-9684-5643	National Natural Science Foundation of China [61673231]; TNLIST, Tsinghua University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); TNLIST, Tsinghua University	This work is supported by National Natural Science Foundation of China grant No. 61673231 and by internal funding of our institution TNLIST, Tsinghua University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar I, 2003, J BIOL CHEM, V278, P5802, DOI 10.1074/jbc.M207178200; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Donoho D.L., 1983, NOTION BREAKDOWN POI; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng HJ, 2013, CANCER LETT, V340, P179, DOI 10.1016/j.canlet.2012.11.010; Gao ZH, 2012, MOL CELL BIOL, V32, P2794, DOI 10.1128/MCB.00570-12; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lin L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0876-5; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Venables JP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3480; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Xing Y, 2005, PLOS GENET, V1, P323, DOI 10.1371/journal.pgen.0010034; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178320	10.1371/journal.pone.0178320	http://dx.doi.org/10.1371/journal.pone.0178320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542625	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800070
J	Sigruener, A; Wolfrum, C; Boettcher, A; Kopf, T; Liebisch, G; Orso, E; Schmitz, G				Sigruener, Alexander; Wolfrum, Christian; Boettcher, Alfred; Kopf, Thomas; Liebisch, Gerhard; Orso, Evelyn; Schmitz, Gerd			Lipidomic and metabolic changes in the P4-type ATPase ATP10D deficient C57BL/6J wild type mice upon rescue of ATP10D function	PLOS ONE			English	Article							HIGH-THROUGHPUT QUANTIFICATION; GENETIC-CONTROL; HDL LEVELS; EXTRACTION; OBESITY; ACID; PHOSPHATIDYLCHOLINE; LIPIN-1; SAMPLES; MOUSE	Background Sequence variants near the human gene for P4-type ATPase, class V, type 10D (ATP10D) were shown to significantly associate with circulating hexosylceramide d18:1/16:0 and d18:1/24:1 levels, obesity, insulin resistance, plasma high density lipoprotein (HDL), coronary stenotic index and intracranial atherosclerotic index. In mice Atp10d is associated with HDL modulation and C57BL/6 mice expressing a truncated, non-functional form of ATP10D easily develop obesity and insulin resistance on high-fat diet. Results We analyzed metabolic differences of ATP10D deficient C57BL/6J wild type and ATP10D transgenic C57BL/6J BAC129 mice. ATP10D transgenic mice gain 25% less weight on high-fat diet concomitant with a reduced increase in fat cell mass but independent of adipocyte size change. ATP10D transgenic mice also had 26% lower triacylglycerol levels with approximately 76% bound to very low density lipoprotein while in ATP10D deficient wild type mice 57% are bound to low density lipoprotein. Furthermore increased oxygen consumption and CO2 production, 38% lower glucose and 69% lower insulin levels and better insulin sensitivity were observed in ATP10D transgenic mice. Besides decreased hexosylceramide species levels were detected. Part of these effects may be due to reduced hepatic stearoyl-CoA desaturase 1 (SCD1) expression in ATP10D transgenic mice, which was reflected by altered fatty acid and lipid species patterns. There was a significant decrease in the hepatic 18:1 to 18:0 free fatty acid ratio in transgenic mice. The ratio of 16:1 to 16:0 was not significantly different. Interestingly both ratios were significantly reduced in plasma total fatty acids. Summary In summary we found that ATP10D reduces high-fat diet induced obesity and improves insulin sensitivity. ATP10D transgenic mice showed altered hepatic expression of lipid-metabolism associated genes, including Scd1, along with changes in hepatic and plasma lipid species and plasma lipoprotein pattern.	[Sigruener, Alexander; Boettcher, Alfred; Kopf, Thomas; Liebisch, Gerhard; Orso, Evelyn; Schmitz, Gerd] Regensburg Univ, Med Ctr, Inst Clin Chem & Lab Med, Regensburg, Germany; [Wolfrum, Christian] ETH, Inst Mol Syst Biol, Zurich, Switzerland	University of Regensburg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sigruener, A (corresponding author), Regensburg Univ, Med Ctr, Inst Clin Chem & Lab Med, Regensburg, Germany.	alexander.sigruener@ukr.de	Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Wolfrum, Christian/0000-0002-3862-6805	European Community's Seventh Framework Programme (FP7) [202272]	European Community's Seventh Framework Programme (FP7)	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown JM, 2010, CURR OPIN LIPIDOL, V21, P192, DOI 10.1097/MOL.0b013e32833854ac; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Deevska GM, 2011, BIOCHIMIE, V93, P32, DOI 10.1016/j.biochi.2010.05.016; Dhar MS, 2006, J NUTR BIOCHEM, V17, P811, DOI 10.1016/j.jnutbio.2006.01.002; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Ecker J, 2012, J CHROMATOGR B, V897, P98, DOI 10.1016/j.jchromb.2012.04.015; Flamant S, 2003, MAMM GENOME, V14, P21, DOI 10.1007/s00335-002-3032-3; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Hurst SE, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/152902; Innis-Whitehouse W, 1998, J LIPID RES, V39, P679; JIAO S, 1990, J LIPID RES, V31, P467; Kengia JT, 2013, ATHEROSCLEROSIS, V231, P158, DOI 10.1016/j.atherosclerosis.2013.08.034; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Kopf T, 2013, J CHROMATOGR B, V938, P22, DOI 10.1016/j.jchromb.2013.08.016; LANDSCHULZ KT, 1994, BIOCHEM BIOPH RES CO, V200, P763, DOI 10.1006/bbrc.1994.1516; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2002, CLIN CHEM, V48, P2217; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES; Machleder D, 1997, J CLIN INVEST, V99, P1406, DOI 10.1172/JCI119300; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; Mehrabian M, 2000, J LIPID RES, V41, P1936; Meissburger B, 2011, EMBO MOL MED, V3, P637, DOI 10.1002/emmm.201100172; Naito T, 2015, J BIOL CHEM, V290, P15004, DOI 10.1074/jbc.M115.655191; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Riekhof WR, 2009, BBA-MOL CELL BIOL L, V1791, P620, DOI 10.1016/j.bbalip.2009.02.013; Scherer M, 2010, ANAL CHEM, V82, P8794, DOI 10.1021/ac1021826; Scherer M, 2010, J LIPID RES, V51, P2001, DOI 10.1194/jlr.D005322; Scherer M, 2009, CLIN CHEM, V55, P1218, DOI 10.1373/clinchem.2008.113779; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Summers SA, 2010, CURR OPIN LIPIDOL; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178368	10.1371/journal.pone.0178368	http://dx.doi.org/10.1371/journal.pone.0178368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542499	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800082
J	Zhang, YZ; Yu, YQ; Yuan, Y; Yu, K; Yang, HD; Li, XL; Min, XW; Zhang, C; He, MA; Zhang, XM; Wu, TC				Zhang, Yizhi; Yu, Yanqiu; Yuan, Yu; Yu, Kuai; Yang, Handong; Li, Xiulou; Min, Xinwen; Zhang, Ce; He, Meian; Zhang, Xiaomin; Wu, Tangchun			Association of drinking pattern with risk of coronary heart disease incidence in the middle-aged and older Chinese men: Results from the Dongfeng-Tongji cohort	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; CARDIOVASCULAR-DISEASE; CONSUMPTION; PREVALENCE; METAANALYSIS; METABOLISM; MORTALITY; ETHANOL; IMPACT; DEATH	Background Epidemiologic studies have found that moderate alcohol consumption was associated with a decreased risk of coronary heart disease (CHD) incidence. Nevertheless, whether the drinking pattern is associated with CHD incidence still remains inconclusive. Methods We included 8,469 Chinese men aged 45-81 years, who were free of CHD, stroke, or cancer at baseline from Dongfeng-Tongji cohort. A semi-structured questionnaire was used to collect information on alcohol consumption and other covariates. Cox proportional hazard regression model was applied to estimate the multivariable-adjusted hazard rations (HRs) and 95% confidence intervals (95% CIs). Results During an average of 4.36 years of follow-up, we identified 959 incident CHD events. Compared with non-drinkers, the multivariable-adjusted HR (95% CI) of CHD incidence was 0.84 (0.71-0.98) in current drinkers. With respect to drinking pattern, men who consumed 20.01-40 grams ethanol once a time had a 24% lower risk of incident CHD (HR = 0.76, 95% CI = 0.62, 0.94) compared with non-drinkers. The adjusted HRs (95% CI) of CHD incidence were 0.80 (0.65, 0.99), 1.02 (0.84, 1.22), and 0.75 (0.59-0.96) in subjects who consumed 0.01-10, 10.01-30, and > 30 grams ethanol per day, respectively. Participants who consumed 20.01-40 grams ethanol per time with less than 5 times per week had the lowest risk of CHD incidence (HR = 0.73, 95% CI = 0.52, 0.96). No significant associations were observed between type or frequency of alcohol consumption and CHD incidence. Conclusions Drinking was associated with a lower risk of CHD incidence in middle-aged and older Chinese men and moderate quantity of ethanol amounts once a time with lower frequency could been considered as a healthy drinking pattern, which might modify the relationship between alcohol consumption and incident CHD.	[Zhang, Yizhi; Yu, Yanqiu; Yuan, Yu; Yu, Kuai; He, Meian; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tongji Med Coll, Wuhan, Peoples R China; [Zhang, Yizhi; Yu, Yanqiu; Yuan, Yu; Yu, Kuai; He, Meian; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Minist Educ,Key Lab Environm & Hlth, Wuhan, Peoples R China; [Yang, Handong; Li, Xiulou; Min, Xinwen; Zhang, Ce] Hubei Univ Med, Dept Cardiovasc Dis, Dongfeng Cent Hosp, Shiyan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hubei University of Medicine	Wu, TC (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tongji Med Coll, Wuhan, Peoples R China.; Wu, TC (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Minist Educ,Key Lab Environm & Hlth, Wuhan, Peoples R China.	wut@mails.tjmu.edu.cn	Zhang, Xiaomin/F-3206-2018; Zhang, Xiaomin/GVT-8927-2022	Min, Xinwen/0000-0002-8429-6560	National Natural Science Foundation of China [81230069, 81390542]; National Key Program of Research and Development of China [2016YFC0900800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program of Research and Development of China	This research was supported by the National Natural Science Foundation of China (81230069 and 81390542) and the National Key Program of Research and Development of China (2016YFC0900800)	Albert CM, 1999, CIRCULATION, V100, P944, DOI 10.1161/01.CIR.100.9.944; Arriola L, 2010, HEART, V96, P124, DOI 10.1136/hrt.2009.173419; Athyros VG, 2007, ANGIOLOGY, V58, P689, DOI 10.1177/0003319707306146; Bazzano LA, 2009, INT J CARDIOL, V135, P78, DOI 10.1016/j.ijcard.2008.03.038; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053258; Cheng HG, 2015, ADDICTION, V110, P761, DOI 10.1111/add.12876; Cochrane J, 2003, ALCOHOL ALCOHOLISM, V38, P537, DOI 10.1093/alcalc/agg111; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Creswell KG, 2014, CLIN PSYCHOL SCI, V2, P602, DOI 10.1177/2167702613512795; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Fairbairn CE, 2015, CLIN PSYCHOL SCI, V3, P686, DOI 10.1177/2167702614548892; Hao W, 2005, ADDICTION, V100, P737, DOI 10.1111/j.1360-0443.2005.01036.x; He L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-34; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Hou J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129677; Hurley TD, 2012, ALCOHOL RES-CURR REV, V34, P339; Lai XF, 2016, INT J CARDIOL, V224, P299, DOI 10.1016/j.ijcard.2016.09.035; Lee SL, 2015, BIOCHEM PHARMACOL, V95, P71, DOI 10.1016/j.bcp.2015.03.003; Li Z, 2016, INT J CARDIOL, V215, P257, DOI 10.1016/j.ijcard.2016.04.095; Millwood IY, 2013, INT J EPIDEMIOL, V42, P816, DOI 10.1093/ije/dyt078; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Peirce RS, 2000, HEALTH PSYCHOL, V19, P28, DOI 10.1037/0278-6133.19.1.28; Pelletier R, 2009, PSYCHOSOM MED, V71, P301, DOI 10.1097/PSY.0b013e3181988175; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rehm J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3026-9; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Roth GA, 2015, NEW ENGL J MED, V372, P1333, DOI 10.1056/NEJMoa1406656; Samokhvalov AV, 2010, ALCOHOL CLIN EXP RES, V34, P1871, DOI 10.1111/j.1530-0277.2010.01275.x; Wang F, 2013, INT J EPIDEMIOL, V42, P731, DOI 10.1093/ije/dys053; World Health Organization, 1977, THE INTERNATIONAL CL; World Health Organization, INT STAT CLASS DIS H; Xiang YT, 2009, ALCOHOL CLIN EXP RES, V33, P1111, DOI 10.1111/j.1530-0277.2009.00933.x; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	36	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178070	10.1371/journal.pone.0178070	http://dx.doi.org/10.1371/journal.pone.0178070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542413	Green Submitted, gold, Green Published			2022-12-27	WOS:000402062800042
J	Comaskey, B; Roos, NP; Brownell, M; Enns, MW; Chateau, D; Ruth, CA; Ekuma, O				Comaskey, Brenda; Roos, Noralou P.; Brownell, Marni; Enns, Murray W.; Chateau, Dan; Ruth, Chelsea A.; Ekuma, Okechukwu			Maternal depression and anxiety disorders (MDAD) and child development: A Manitoba population-based study	PLOS ONE			English	Article							COGNITIVE-DEVELOPMENT; PRENATAL DEPRESSION; BEHAVIOR PROBLEMS; PHYSICAL HEALTH; CORTISOL-LEVELS; MENTAL-HEALTH; PREGNANCY; SYMPTOMS; MOTHERS; RISK	Objective To examine the association between maternal depression and anxiety disorders (MDAD) and child development assessed during the kindergarten year. Methods Administrative data from several health and social databases in Manitoba, Canada, were used to study 18,331 mother-child pairs. MDAD over the period from one year prior to the child's birth to the kindergarten year was defined using physician diagnoses and filled prescriptions. Child development was assessed during the kindergarten year using the Early Development Instrument (EDI) which measures vulnerability across five domains of development. Structural equation modeling was used to examine associations between timing, recurrence and severity of MDAD and child outcomes. Health at Birth (preterm, low birth weight, neonatal intensive care stay and long birth hospitalization), Family Context (teen mother, lone parent, socio-economic status (SES)), child age and child sex were covariates. Results MDAD had a modest negative association with child EDI scores across all models tested, particularly for social, emotional and physical development. Prenatal MDAD had a stronger negative association with outcomes than other time periods; however, recurrent MDAD had a stronger negative association with outcomes than any specific time period or MDAD severity. The influence of MDAD was mediated by Family Context, which had a strong, negative association with outcomes, particularly language and cognitive development. Conclusion The number of time periods a child was exposed to MDAD in early childhood was more negatively associated with five areas of child development than timing or severity. Prenatal exposure may be more sensitive to MDAD than other time periods. The familial context (teen mother, lone parenthood and low SES) had a stronger influence on child outcomes than MDAD. Findings can be used to inform interventions which address maternal mental health from the prenatal period onward, and to support disadvantaged families to encourage healthy birth outcomes, early childhood development and school readiness.	[Comaskey, Brenda; Roos, Noralou P.; Brownell, Marni; Enns, Murray W.; Chateau, Dan] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Comaskey, Brenda; Roos, Noralou P.; Brownell, Marni; Chateau, Dan; Ruth, Chelsea A.; Ekuma, Okechukwu] Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada; [Enns, Murray W.] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada; [Ruth, Chelsea A.] Univ Manitoba, Sect Neonatol, Dept Pediat, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Comaskey, B (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.; Comaskey, B (corresponding author), Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada.	brenda.comaskey@gmail.com	Ruth, Chelsea/AAP-9657-2021	Roos, Noralou/0000-0002-0802-2082; Ruth, Chelsea/0000-0002-7097-0542; Enns, Murray/0000-0002-8375-0151; Brownell, Marni/0000-0001-7673-4404	Evelyn Shapiro Award for Health Services Research;  [2010-2011-33]	Evelyn Shapiro Award for Health Services Research; 	BC received funding from the Evelyn Shapiro Award for Health Services Research. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; We gratefully acknowledge Manitoba Health, Seniors and Active Living, the Health Information Privacy Committee (HIPC) and Healthy Child Manitoba for access to the data. We also acknowledge the Manitoba Centre for Health Policy (MCHP) for use of the data in the Population Health Research Data Repository under project #2010-2011-33 and the programming support of Charles Burchill, MCHP Associate Director of Data Access and Use. The results and conclusions are those of the authors and no official endorsement by the Manitoba Centre for Health Policy, Manitoba Health, Seniors and Active Living, or other data providers is intended or should be inferred. B. Comaskey had full access to the data used in the study and takes full responsibility for integrity and accuracy of the data cleaning and analysis.	ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Appelbaum M, 1999, DEV PSYCHOL, V35, P1297; Bagner DM, 2010, J AM ACAD CHILD PSY, V49, P699, DOI 10.1016/j.jaac.2010.03.012; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bennett IM, 2010, PSYCHIAT SERV, V61, P386, DOI 10.1176/ps.2010.61.4.386; Berle JO, 2005, ARCH WOMEN MENT HLTH, V8, P181, DOI 10.1007/s00737-005-0090-z; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bigatti SM, 2001, CHILD PSYCHIAT HUM D, V32, P147, DOI 10.1023/A:1012250824091; Brennan PA, 2000, DEV PSYCHOL, V36, P759, DOI 10.1037/0012-1649.36.6.759; Brownell M, 2012, ARE MANITOBAS CHILDR; Brownell MD, 2016, EARLY CHILD RES Q, V35, P6, DOI 10.1016/j.ecresq.2015.10.004; Chen JH, 2014, EARLY HUM DEV, V90, P73, DOI 10.1016/j.earlhumdev.2013.09.015; Cicchetti D, 1998, DEV PSYCHOPATHOL, V10, P283, DOI 10.1017/S0954579498001618; D'Angiulli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007692; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; Dix T, 2014, DEV PSYCHOPATHOL, V26, P111, DOI 10.1017/S0954579413000898; Eisenhower AS, 2009, SOC SCI MED, V68, P89, DOI 10.1016/j.socscimed.2008.09.033; Elgar FJ, 2004, CLIN PSYCHOL REV, V24, P441, DOI 10.1016/j.cpr.2004.02.002; Essex MJ, 2001, BRIT J PSYCHIAT, V179, P151, DOI 10.1192/bjp.179.2.151; Feinstein L, 2004, CHILD DEV, V75, P1329, DOI 10.1111/j.1467-8624.2004.00743.x; Field T, 2008, INT J NEUROSCI, V118, P95, DOI 10.1080/00207450601042144; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Fihrer I, 2009, J AFFECT DISORDERS, V119, P116, DOI 10.1016/j.jad.2009.03.001; Forget-Dubois N., 2007, EARLY EDUC DEV, V18, P405, DOI [10.1080/10409280701610796, DOI 10.1080/10409280701610796]; Fransoo RR, 2008, CAN J PUBLIC HEALTH, V99, P344, DOI 10.1007/BF03403769; Glover V, 2014, BEST PRACT RES CL OB, V28, P25, DOI 10.1016/j.bpobgyn.2013.08.017; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Guhn M., 2007, EARLY EDUC DEV, V18, P369, DOI [10.1080/10409280701610622, DOI 10.1080/10409280701610622]; HAMMEN C, 1990, DEV PSYCHOL, V26, P24, DOI 10.1037/0012-1649.26.1.24; Hammen C, 2003, ARCH GEN PSYCHIAT, V60, P253, DOI 10.1001/archpsyc.60.3.253; Hatcher L., 1994, STEP BY STEP APPROAC; Hertzman C, 1999, DEVELOPMENTAL HEALTH AND THE WEALTH OF NATIONS, P21; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Huot RL, 2004, ANN NY ACAD SCI, V1032, P234, DOI 10.1196/annals.1314.028; Janus M., 2007, EARLY ED DEV, V18, P375, DOI [10.1080/10409280701610796a, DOI 10.1080/10409280701610796A]; Janus M, 2004, NORMATIVE DATA EARLY; Janus M, 2007, CAN J BEHAV SCI, V39, P1, DOI 10.1037/cjbs2007001; Janus M, 2011, SOC INDIC RES, V103, P283, DOI 10.1007/s11205-011-9846-1; Jensen SKG, 2014, DEPRESS ANXIETY, V31, P599, DOI 10.1002/da.22147; Jutte DP, 2010, ACAD PEDIATR, V10, P293, DOI 10.1016/j.acap.2010.06.008; Jutte DP, 2010, EPIDEMIOLOGY, V21, P314, DOI 10.1097/EDE.0b013e3181d61e61; Karoly LA., 2005, EARLY CHILDHOOD INTE; KELLER MB, 1986, ARCH GEN PSYCHIAT, V43, P930; Kline RB, 2005, PRINCIPLES PRACTICE; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Leckman-Westin E, 2009, J CHILD PSYCHOL PSYC, V50, P1176, DOI 10.1111/j.1469-7610.2009.02083.x; Lester BM, 2013, CLIN OBSTET GYNECOL, V56, P556, DOI 10.1097/GRF.0b013e318299d2a8; Letourneau NL, 2013, J PEDIATR NURS, V28, P223, DOI 10.1016/j.pedn.2012.07.014; LeWinn KZ, 2009, INT J EPIDEMIOL, V38, P1700, DOI 10.1093/ije/dyp200; Luoma I, 2001, J AM ACAD CHILD PSY, V40, P1367, DOI 10.1097/00004583-200112000-00006; McCain M.N., 2007, EARLY YEARS STUDY 2; Muhajarine N, 2011, SOC INDIC RES, V103, P299, DOI 10.1007/s11205-011-9847-0; Murray L, 1996, J CHILD PSYCHOL PSYC, V37, P927, DOI 10.1111/j.1469-7610.1996.tb01490.x; MURRAY L, 1992, J CHILD PSYCHOL PSYC, V33, P543, DOI 10.1111/j.1469-7610.1992.tb00890.x; Mustard CA, 1999, HEALTH PLACE, V5, P157, DOI 10.1016/S1353-8292(99)00008-8; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; O'Donnell KJ, 2014, DEV PSYCHOPATHOL, V26, P393, DOI 10.1017/S0954579414000029; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pampalon R, 2009, HEALTH REP, V20, P85; Pariante CM, 2014, BIOCHEM SOC T, V42, P582, DOI 10.1042/BST20130246; Raposa E, 2014, J ADOLESCENT HEALTH, V54, P88, DOI 10.1016/j.jadohealth.2013.07.038; Roos LL, 2013, SOC INDIC RES, V110, P385, DOI 10.1007/s11205-011-9936-0; Rouse C, 2005, FUTURE CHILD, V15, P5, DOI 10.1353/foc.2005.0010; Santos R., 2012, EARLY DEV INSTRUMENT; SAS Institute Inc, 2011, SAS 9 3 COMP SOFTW; SAS Institute Inc, 2012, STRUCT EQ MOD US SAS; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Sohr-Preston SL, 2006, CLIN CHILD FAM PSYCH, V9, P65, DOI 10.1007/s10567-006-0004-2; WHO, 2013, GUID ATC CLASS DDD A; Zumbo B.D., 2007, EARLY EDUC DEV, V18, P453, DOI [10.1080/10409280701610838, DOI 10.1080/10409280701610838]	72	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177065	10.1371/journal.pone.0177065	http://dx.doi.org/10.1371/journal.pone.0177065			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542256	gold, Green Submitted, Green Published			2022-12-27	WOS:000402061500011
J	Zhang, XN; Ma, ZJ; Wang, Y; Sun, B; Guo, X; Pan, CQ; Chen, LM				Zhang, Xiao-na; Ma, Ze-jun; Wang, Ying; Sun, Bei; Guo, Xin; Pan, Cong-qing; Chen, Li-ming			Angelica Dahurica ethanolic extract improves impaired wound healing by activating angiogenesis in diabetes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; TUBE FORMATION; IMPERATORIN; EXPRESSION; KINASE; GROWTH; ERK; INFLAMMATION; DYSFUNCTION	Abnormal angiogenesis plays an important role in impaired wound healing and development of chronic wounds in diabetes mellitus. Angelica dahurica radix is a common traditional Chinese medicine with wide spectrum medicinal effects. In this study, we analyzed the potential roles of Angelica dahurica ethanolic extract (ADEE) in correcting impaired angiogenesis and delayed wound healing in diabetes by using streptozotocin-induced diabetic rats. ADEE treatment accelerated diabetic wound healing through inducing angiogenesis and granulation tissue formation. The angiogenic property of ADEE was subsequently verified ex vivo using aortic ring assays. Furthermore, we investigated the in vitro angiogenic activity of ADEE and its underlying mechanisms using human umbilical vein endothelial cells. ADEE treatment induced HUVECs proliferation, migration, and tube formation, which are typical phenomena of angiogenesis, in dose-dependent manners. These effects were associated with activation of angiogenic signal modulators, including extracellular signal-regulated kinase 1/2 (ERK1/2), Akt, endothelial nitric oxide synthase (eNOS) as well as increased NO production, and independent of affecting VEGF expression. ADEE-induced angiogenic events were inhibited by the MEK inhibitor PD98059, the PI3K inhibitor Wortmannin, and the eNOS inhibitor L-NAME. Our findings highlight an angiogenic role of ADEE and its ability to protect against impaired wound healing, which may be developed as a promising therapy for impaired angiogenesis and delayed wound healing in diabetes.	[Zhang, Xiao-na] Tianjin Med Univ, Gen Hosp, Dept Endocrinol & Metab, Tianjin, Peoples R China; [Ma, Ze-jun; Wang, Ying; Sun, Bei; Guo, Xin; Pan, Cong-qing; Chen, Li-ming] Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Key Lab Hormone & Dev, Minist Hlth,Metab Dis Hosp, Tianjin, Peoples R China; [Ma, Ze-jun; Wang, Ying; Sun, Bei; Guo, Xin; Pan, Cong-qing; Chen, Li-ming] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Pan, CQ; Chen, LM (corresponding author), Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Key Lab Hormone & Dev, Minist Hlth,Metab Dis Hosp, Tianjin, Peoples R China.; Pan, CQ; Chen, LM (corresponding author), Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China.	cq.pan@163.com; xfx22081@vip.163.com			National Natural Science Foundation of China [81273916]; Youth Incubation Fund of Tianjin Medical University General Hospital [ZYYFY2016019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Incubation Fund of Tianjin Medical University General Hospital	This work was supported by the National Natural Science Foundation of China (No. 81273916) and Youth Incubation Fund of Tianjin Medical University General Hospital (No. ZYYFY2016019).	Amano K, 2003, HYPERTENSION, V41, P156, DOI 10.1161/01.HYP.0000053552.86367.12; [Anonymous], J NANOMATERIALS, DOI DOI 10.1155/2016/2319741; Bowling FL, 2015, NAT REV ENDOCRINOL, V11, P606, DOI 10.1038/nrendo.2015.130; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Buckley S, 1999, AM J PHYSIOL-LUNG C, V277, pL159, DOI 10.1152/ajplung.1999.277.1.L159; Cao YJ, 2013, PHYTOMEDICINE, V20, P1048, DOI 10.1016/j.phymed.2013.04.021; Chevallier A, 2001, ENCY MED PLANTS; Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Hashimoto A, 2006, ATHEROSCLEROSIS, V189, P350, DOI 10.1016/j.atherosclerosis.2006.01.022; Hsu PC, 2014, J ETHNOPHARMACOL, V156, P358, DOI 10.1016/j.jep.2014.08.029; Huang YH, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/308126; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Ji LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056703; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Lan CCE, 2013, DIABETES, V62, P2530, DOI 10.2337/db12-1714; Lee MY, 2011, FOOD CHEM TOXICOL, V49, P1047, DOI 10.1016/j.fct.2011.01.010; Li B, 2014, PHYTOCHEM ANALYSIS, V25, P229, DOI 10.1002/pca.2496; Li Y, 2015, ENDOCRINOLOGY, V156, P4257, DOI 10.1210/en.2015-1228; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Maiwulanjiang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116761; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; Maver T, 2015, INT J DERMATOL, V54, P740, DOI 10.1111/ijd.12766; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nie H, 2009, CHIN J INTEGR MED, V15, P442, DOI 10.1007/s11655-009-0442-z; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pierce GF, 2001, AM J PATHOL, V159, P399, DOI 10.1016/S0002-9440(10)61709-9; RUBANYI GM, 1991, J CELL BIOCHEM, V46, P27, DOI 10.1002/jcb.240460106; Sarker SD, 2004, CURR MED CHEM, V11, P1479, DOI 10.2174/0929867043365189; Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014; Shemyakin A, 2012, CIRCULATION, V126, P2943, DOI 10.1161/CIRCULATIONAHA.112.140335; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y; Somanath PR, 2008, ANGIOGENESIS, V11, P277, DOI 10.1007/s10456-008-9111-7; Takeo M, 2015, COLD SPRING HARB PER, V5; Toda N, 2010, PHARMACOL THERAPEUT, V127, P189, DOI 10.1016/j.pharmthera.2010.04.009; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Wang N, 2013, FITOTERAPIA, V90, P38, DOI 10.1016/j.fitote.2013.07.007; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Yang BH, 2004, J CELL PHYSIOL, V200, P360, DOI 10.1002/jcp.20025; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zhang Xianqi, 2005, J Tradit Chin Med, V25, P219; Zhang Y, 2012, FITOTERAPIA, V83, P60, DOI 10.1016/j.fitote.2011.09.011; Zhao H, 2012, EUR J DERMATOL, V22, P58, DOI 10.1684/ejd.2011.1599; Zhao X, 2002, AM J PHYSIOL-HEART C, V283, pH2371, DOI 10.1152/ajpheart.00383.2002; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557	51	31	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177862	10.1371/journal.pone.0177862	http://dx.doi.org/10.1371/journal.pone.0177862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542422	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500041
J	Chen, PX; Zhang, YL; Xu, JW; Yu, MH; Huang, JH; Zhao, L; Zhou, WL				Chen, Peng-Xiao; Zhang, Yi-Lin; Xu, Jia-Wen; Yu, Ming-Hao; Huang, Jie-Hong; Zhao, Lei; Zhou, Wen-Liang			Sodium tanshinone IIA sulfonate stimulated Cl- secretion in mouse trachea	PLOS ONE			English	Article							SURFACE LIQUID; CHLORIDE SECRETION; EPITHELIAL-CELLS; AIRWAY; MECHANISM; PATHOGENESIS; INHIBITION; ACTIVATION; PHYSIOLOGY; APOPTOSIS	Sodium tanshinone IIA sulfonate (STS) is a derivate of tanshinone IIA, a lipophilic compound in Salvia miltiorrhiza. This study aimed to investigate the effect of STS on ion transport in mouse tracheal epithelium and the mechanisms underlying it. Short-circuit current (Isc) was measured to evaluate the effect of STS on transepithelial ion transport. Intracellular Ca2+ imaging was performed to observe intracellular Ca2+ concentration ([Ca2+](i)) changes induced by STS in primary cultured mouse tracheal epithelial cells. Results showed that the apical application of STS at mouse trachea elicited an increase of Isc, which was abrogated by atropine, an antagonist of muscarinic acetylcholine receptor (mAChR). By removing ambient Cl-or applying blockers of Ca2+-activated Cl-channel (CaCC), the response of STS-induced Isc was suppressed. Moreover, STS elevated the [Ca2+] i in mouse tracheal epithelial cells. As a result, STS stimulated Cl-secretion in mouse tracheal epithelium via CaCC in an mAChR-dependent way. Due to the critical role of Cl-secretion in airway hydration, our findings suggested that STS may be used to ameliorate the airway dehydration symptom in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).	[Chen, Peng-Xiao; Zhang, Yi-Lin; Xu, Jia-Wen; Yu, Ming-Hao; Huang, Jie-Hong; Zhou, Wen-Liang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhao, Lei] Guangzhou Med Univ, Sch Basic Sci, Dept Physiol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University	Zhou, WL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.; Zhao, L (corresponding author), Guangzhou Med Univ, Sch Basic Sci, Dept Physiol, Guangzhou, Guangdong, Peoples R China.	crystal-zl@163.com; lsszwl@aliyun.com	xu, jia/GSD-6347-2022	Zhang, Yi-Lin/0000-0001-5350-8279	National Natural Science Foundation of China [31271247, 81471445]; State Key Program of National Natural Science Foundation of China [31230034]; Natural Science Foundation of Guangdong Province [2016A030313301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by: 1. National Natural Science Foundation of China (No. 31271247, No. 81471445), www.nsfc.gov.cn/; 2. State Key Program of National Natural Science Foundation of China (No. 31230034), www.nsfc.gov.cn/; 3. The Natural Science Foundation of Guangdong Province (Grant 2016A030313301), http://gonggao.gdstc.goy.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher RC, 1999, J PHYSIOL-LONDON, V516, P631, DOI 10.1111/j.1469-7793.1999.0631u.x; Boucher Richard C, 2004, Proc Am Thorac Soc, V1, P66, DOI 10.1513/pats.2306018; Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004; Cuthbert AW, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12398; Dejima K, 2006, ARCH OTOLARYNGOL, V132, P1352, DOI 10.1001/archotol.132.12.1352; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Feng Y, 2015, ASIAN PAC J TROP MED, V8, P957, DOI 10.1016/j.apjtm.2015.10.003; Fischer A, 1996, ANN NY ACAD SCI, V805, P717; Ghosh A, 2015, CELL MOL LIFE SCI, V72, P3637, DOI 10.1007/s00018-015-1946-7; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hollenhorst MI, 2012, BRIT J PHARMACOL, V166, P1388, DOI 10.1111/j.1476-5381.2012.01883.x; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Krasteva G, 2012, HISTOCHEM CELL BIOL, V138, P365, DOI 10.1007/s00418-012-0993-5; Krasteva-Christ G, 2015, INT IMMUNOPHARMACOL, V29, P158, DOI 10.1016/j.intimp.2015.05.028; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; LEE YH, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1039/C4CC06435F); Li MH, 2008, J ETHNOPHARMACOL, V120, P419, DOI 10.1016/j.jep.2008.09.013; Lin JC, 2015, EXP CELL RES, V334, P260, DOI 10.1016/j.yexcr.2015.02.026; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Ming JCK, 2011, J ETHNOPHARMACOL, V138, P201, DOI 10.1016/j.jep.2011.08.081; Qiu XL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/715790; Racke K, 2004, PULM PHARMACOL THER, V17, P181, DOI 10.1016/j.pupt.2004.03.001; Rehman R, 2013, INT IMMUNOPHARMACOL, V15, P597, DOI 10.1016/j.intimp.2013.02.010; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Sun DD, 2008, EUR J PHARMACOL, V590, P317, DOI 10.1016/j.ejphar.2008.06.005; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Talavera K, 2008, FASEB J, V22, P1343, DOI 10.1096/fj.07-9591com; Tarran Robert, 2005, Journal of General Physiology, V127, P591; [王建荣 Wang Jianrong], 2004, [中草药, Chinese Traditional and Herbal Drugs], V35, P1390; Wei F, 2015, WORLD J GASTROENTERO, V21, P1444, DOI 10.3748/wjg.v21.i5.1444; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Wu DXY, 1998, AM J PHYSIOL-LUNG C, V274, pL388, DOI 10.1152/ajplung.1998.274.3.L388; Yang L, 2007, EXP MOL MED, V39, P65, DOI 10.1038/emm.2007.8; Yang RF, 2008, J CARDIOVASC PHARM, V51, P396, DOI 10.1097/FJC.0b013e3181671439; Yang Y, 2008, EUR J PHARMACOL, V598, P9, DOI 10.1016/j.ejphar.2008.09.013; Zhang SY, 2011, AM J RHINOL ALLERGY, V25, P307, DOI 10.2500/ajra.2011.25.3643; Zhang Y, 2015, ALLERGY ASTHMA IMMUN, V7, P367, DOI 10.4168/aair.2015.7.4.367; Zheng LH, 2015, RESP PHYSIOL NEUROBI, V205, P120, DOI 10.1016/j.resp.2014.09.025; Zholos AV, 2015, CURR NEUROPHARMACOL, V13, P279, DOI 10.2174/1570159X13666150331223118	43	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178226	10.1371/journal.pone.0178226	http://dx.doi.org/10.1371/journal.pone.0178226			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542554	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058400071
J	Ohno, H; Takeda, K; Niwa, S; Tsujinaka, T; Hanazono, Y; Hirano, Y; Miki, K				Ohno, Hiraku; Takeda, Kazuki; Niwa, Satomi; Tsujinaka, Tomotaka; Hanazono, Yuya; Hirano, Yu; Miki, Kunio			Crystallographic characterization of the high-potential iron-sulfur protein in the oxidized state at 0.8 angstrom resolution	PLOS ONE			English	Article							PHOTOSYNTHETIC REACTION-CENTER; THERMOCHROMATIUM-TEPIDUM; ELECTRON-TRANSFER; RHODOFERAX-FERMENTANS; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; FE4S4 CLUSTERS; RADIATION; SITE; REFINEMENT	High-potential iron-sulfur protein (HiPIP) is a soluble electron carrier protein of photosynthetic bacteria with an Fe4S4 cluster. Although structural changes accompanying the electron transfer are important for understanding of the functional mechanism, the changes have not been clarified in sufficient detail. We previously reported the high-resolution crystal structures of HiPIP from a thermophilic purple bacterium Thermochromatium tepidum in the reduced state. In order to perform a detailed comparison between the structures in different redox states, the oxidized structure should also be revealed at high resolution. Therefore, in the present study we performed a crystallographic analysis of oxidized HiPIP and a structural comparison with the reduced form at a high resolution of 0.8 angstrom. The comparison highlighted small but significant contraction in the iron-sulfur cluster. The changes in Fe-S bond lengths were similar to that predicted by theoretical calculation, although some discrepancies were also found. Almost distances between the sulfur atoms of the iron-sulfur cluster and the protein environment are elongated upon the oxidation. Positional changes of hydrogen atoms in the protein environment, such as on the amide-hydrogen of Cys75 in the proximity of the iron-sulfur cluster, were also observed in the accurate analyses. None of the water molecules exhibited significant changes in position or anisotropy of atomic displacement parameter between the two states, while the orientations of some water molecules were different.	[Ohno, Hiraku; Takeda, Kazuki; Niwa, Satomi; Tsujinaka, Tomotaka; Hanazono, Yuya; Hirano, Yu; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto, Japan; [Hirano, Yu] Natl Inst Quantum & Radiol Sci & Technol, Tokai Quantum Beam Sci Ctr, Tokai, Ibaraki, Japan	Kyoto University; National Institutes for Quantum Science & Technology	Miki, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto, Japan.	miki@kuchem.kyoto-u.ac.jp	Takeda, Kazuki/AAQ-9238-2021	Niwa, Satomi/0000-0002-2648-8257; Takeda, Kazuki/0000-0002-4094-6816	Ministry of Education, Culture, Sports, Science and Technology of Japan [23657073]; Grants-in-Aid for Scientific Research [15J02413] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (No. 23657073 to K.T.) and Photon and Quantum Basic Research Coordinated Development Program (to K.M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to Messrs. H. Jonotsuka, M. Kosugi, N. Hashimoto and H. Maeda for assistance in the crystallization and data collection, and to Mmes. Y. Nishikawa and E. Tsutsumi for assistance in the cultivation and purification. Thanks are also due to beamline staff for their help in data collection at SPring-8 (Proposal Nos. 2010A1237, 2010B1284, 2015B1037 and 2016A2737 to K.T.). This work was supported by Grant-in-Aid for Scientific Research (No. 23657073 to K.T.) and Photon and Quantum Basic Research Coordinated Development Program (to K.M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	[Anonymous], THE PYMOL MOLECULAR; BENNING MM, 1994, BIOCHEMISTRY-US, V33, P2476, DOI 10.1021/bi00175a016; BERTINI I, 1995, BIOCHEMISTRY-US, V34, P9851, DOI 10.1021/bi00031a005; BREITER DR, 1991, J BIOL CHEM, V266, P18660; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carter C. W., 2001, HDB METALLOPROTEINS, V1, P602; CARTER CW, 1974, J BIOL CHEM, V249, P6339; CARTER CW, 1974, J BIOL CHEM, V249, P4212; CARTER CW, 1972, P NATL ACAD SCI USA, V69, P3526, DOI 10.1073/pnas.69.12.3526; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corbett MC, 2007, ACTA CRYSTALLOGR D, V63, P951, DOI 10.1107/S0907444907035160; Dey A, 2005, INORG CHEM, V44, P8349, DOI 10.1021/ic050981m; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gonzalez A, 2003, ACTA CRYSTALLOGR D, V59, P1582, DOI 10.1107/S0907444903014604; HENDERSON R, 1990, P ROY SOC B-BIOL SCI, V241, P6, DOI 10.1098/rspb.1990.0057; Hirano Y, 2016, NATURE, V534, P281, DOI 10.1038/nature18001; Hochkoeppler A, 1996, P NATL ACAD SCI USA, V93, P6998, DOI 10.1073/pnas.93.14.6998; Improta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024533; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerfeld CA, 1998, BIOCHEMISTRY-US, V37, P13911, DOI 10.1021/bi9810252; Liu LJ, 2002, ACTA CRYSTALLOGR D, V58, P1085, DOI 10.1107/S0907444902006261; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Murray JW, 2004, J APPL CRYSTALLOGR, V37, P513, DOI 10.1107/S0021889804010660; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; Nogi T, 2000, ACTA CRYSTALLOGR D, V56, P656, DOI 10.1107/S0907444900003127; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; RAYMENT I, 1992, J MOL BIOL, V228, P672, DOI 10.1016/0022-2836(92)90849-F; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sigfridsson E, 2001, INORG CHEM, V40, P2509, DOI 10.1021/ic000752u; Stelter M, 2010, J BIOL INORG CHEM, V15, P303, DOI 10.1007/s00775-009-0603-8; Takeda K, 2010, J STRUCT BIOL, V169, P135, DOI 10.1016/j.jsb.2009.09.012; Torres RA, 2003, J AM CHEM SOC, V125, P1923, DOI 10.1021/ja0211104; Venturoli G, 2004, BIOCHEMISTRY-US, V43, P437, DOI 10.1021/bi035384v; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zanello P, 2017, COORDIN CHEM REV, V335, P172, DOI 10.1016/j.ccr.2016.10.003	36	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178183	10.1371/journal.pone.0178183	http://dx.doi.org/10.1371/journal.pone.0178183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542634	gold, Green Published, Green Submitted			2022-12-27	WOS:000402058400068
J	Banuelos, J; Cao, Y; Shin, SC; Bochner, BS; Avila, P; Li, SH; Jiang, X; Lingen, MW; Schleimer, RP; Lu, NZ				Banuelos, Jesus; Cao, Yun; Shin, Soon Cheon; Bochner, Bruce S.; Avila, Pedro; Li, Shihong; Jiang, Xin; Lingen, Mark W.; Schleimer, Robert P.; Lu, Nick Z.			Granulocyte colony-stimulating factor blockade enables dexamethasone to inhibit lipopolysaccharide-induced murine lung neutrophils	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; HIGH-DOSE METHYLPREDNISOLONE; G-CSF; GLUCOCORTICOID-RECEPTOR; BONE-MARROW; PLASMA-LEVELS; TNF-ALPHA; BLOOD; CELLS; EXPRESSION	Glucocorticoids promote neutrophilic inflammation, the mechanisms of which are poorly characterized. Using a lipopolysaccharide (LPS)-induced acute murine lung injury model, we determined the role of granulocyte colony-stimulating factor (G-CSF) in mouse lung neutrophil numbers in the absence and presence of dexamethasone, a potent glucocorticoid. G-CSF was blocked using a neutralizing antibody. Airway neutrophil numbers, cytokine levels, and lung injury parameters were measured. Glucocorticoid treatment maintained LPS-induced airway G-CSF while suppressing TNF and IL-6. The addition of anti-G-CSF antibodies enabled dexamethasone to decrease airway G-CSF, neutrophils, and lung injury scores. In LPS-challenged murine lungs, structural cells and infiltrating leukocytes produced G-CSF. In vitro using BEAS 2B bronchial epithelial cells, A549 lung epithelial cells, human monocyte-derived macrophages, and human neutrophils, we found that dexamethasone and proinflammatory cytokines synergistically induced G-CSF. Blocking G-CSF production in BEAS 2B cells using shRNAs diminished the ability of BEAS 2B cells to protect neutrophils from undergoing spontaneous apoptosis. These data support that G-CSF plays a role in upregulation of airway neutrophil numbers by dexamethasone in the LPS-induced acute lung injury model.	[Banuelos, Jesus; Cao, Yun; Shin, Soon Cheon; Bochner, Bruce S.; Avila, Pedro; Schleimer, Robert P.; Lu, Nick Z.] Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA; [Li, Shihong; Jiang, Xin; Lingen, Mark W.] Univ Chicago, Dept Pharmacol, Chicago, IL 60637 USA; [Li, Shihong; Jiang, Xin; Lingen, Mark W.] Univ Chicago, Human Tissue Resource Ctr, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; University of Chicago; University of Chicago	Lu, NZ (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA.	nickzlu@northwestern.edu			National Institute of Allergy and Infectious Diseases [R56HL133058, R37HL068546, U19AI106683, R01AI72265]; Ernest S. Bazley Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL133058, R37HL068546] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ernest S. Bazley Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Allergy and Infectious Diseases, R56HL133058 (to NZL), R37HL068546 (to RPS), U19AI106683 (Chronic Rhinosinusitis Integrative Studies Program (CRISP) (to RPS), R01AI72265 (to BSB), and support from the Ernest S. Bazley Foundation (NZL, BSB, RPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2000, EUR RESPIR J, V15, P895, DOI 10.1034/j.1399-3003.2000.15e14.x; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Azoulay E, 2001, CHEST, V120, P1695, DOI 10.1378/chest.120.5.1695; Bajrami B, 2016, J EXP MED, V213, P1999, DOI 10.1084/jem.20160393; Banuelos J, 2016, ALLERGY, V71, P640, DOI 10.1111/all.12840; Banuelos J, 2016, ALLERGY; Banuelos J, 2016, CYTOKINE GROWTH F R, V31, P27, DOI 10.1016/j.cytogfr.2016.05.002; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Basu S, 2002, INT J MOL MED, V10, P3; BROUDY VC, 1987, J IMMUNOL, V139, P464; Cao Y, 2013, BLOOD, V121, P1553, DOI 10.1182/blood-2012-05-432336; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; COX G, 1992, AM J RESP CELL MOL, V7, P507, DOI 10.1165/ajrcmb/7.5.507; Crockard AD, 1998, INT J CLIN LAB RES, V28, P110, DOI 10.1007/s005990050029; DALE DC, 1975, J CLIN INVEST, V56, P808, DOI 10.1172/JCI108159; Files DC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010283; Henley D, 2016, PHARMACOL THERAPEUT, V166, P128, DOI 10.1016/j.pharmthera.2016.06.020; HOGG JC, 1995, ANNU REV PHYSIOL, V57, P97, DOI 10.1146/annurev.ph.57.030195.000525; Hsu J, 2012, J ALLERGY CLIN IMMUN, V129, pAB62, DOI 10.1016/j.jaci.2011.12.727; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jilma B, 1998, J CLIN ENDOCR METAB, V83, P1037, DOI 10.1210/jc.83.3.1037; Jung HS, 2013, CURR PROB SURG, V50, P451, DOI 10.1067/j.cpsurg.2013.08.009; Karlin L, 2005, BONE MARROW TRANSPL, V36, P245, DOI 10.1038/sj.bmt.1705037; KOEFFLER HP, 1987, BLOOD, V70, P55; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lamontagne F, 2013, CAN MED ASSOC J, V185, P216, DOI 10.1503/cmaj.120582; Leung DYM, 1997, J EXP MED, V186, P1567, DOI 10.1084/jem.186.9.1567; LILES WC, 1995, BLOOD, V86, P3181; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Peters AM, 1998, CLIN SCI, V94, P7, DOI 10.1042/cs0940007; Rankin SM, 2010, J LEUKOCYTE BIOL, V88, P241, DOI 10.1189/jlb.0210112; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schuld A, 2001, PSYCHONEUROENDOCRINO, V26, P65, DOI 10.1016/S0306-4530(00)00039-1; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Sivertson KL, 2007, CELL IMMUNOL, V246, P34, DOI 10.1016/j.cellimm.2007.05.003; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Takahashi Y, 1999, ACTA HAEMATOL-BASEL, V101, P124, DOI 10.1159/000040937; Takatsuka H, 2002, CHEST, V121, P1716, DOI 10.1378/chest.121.5.1716; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Tuncer AM, 1996, LEUKEMIA RES, V20, P265, DOI 10.1016/0145-2126(95)00140-9; Wakayama T, 1996, ENDOCR J, V43, P67, DOI 10.1507/endocrj.43.67; Witek-Janusek L, 1999, PEDIATR RES, V45, P224, DOI 10.1203/00006450-199902000-00011; Wu I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.193; Yang ZG, 2017, EXP THER MED, V13, P1215, DOI 10.3892/etm.2017.4154; You QH, 2014, CYTOKINE, V66, P78, DOI 10.1016/j.cyto.2013.12.019; Zijlstra GJ, 2014, EUR RESPIR J, V44, P361, DOI 10.1183/09031936.00209513	48	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177884	10.1371/journal.pone.0177884	http://dx.doi.org/10.1371/journal.pone.0177884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542361	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672600028
J	Fujita, K; Tokuda, H; Kuroyanagi, G; Yamamoto, N; Kainuma, S; Kawabata, T; Sakai, G; Matsushima-Nishiwaki, R; Kozawa, O; Otsuka, T				Fujita, Kazuhiko; Tokuda, Haruhiko; Kuroyanagi, Gen; Yamamoto, Naohiro; Kainuma, Shingo; Kawabata, Tetsu; Sakai, Go; Matsushima-Nishiwaki, Rie; Kozawa, Osamu; Otsuka, Takanobu			HSP90 inhibitors potentiate PGF(2 alpha)-induced IL-6 synthesis via p38 MAP kinase in osteoblasts	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INTERLEUKIN-6 SYNTHESIS; CYCLIC-AMP; RHO-KINASE; CANCER; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; PROSTAGLANDIN-E2; MECHANISMS; RESORPTION; PATHWAYS	Heat shock protein 90 (HSP90) that is ubiquitously expressed in various tissues, is recognized to be a major molecular chaperone. We have previously reported that prostaglandin F-2 alpha(PGF(2 alpha)), a potent bone remodeling mediator, stimulates the synthesis of interleukin-6 (IL-6) through p44/p42 mitogen-activated protein (MAP) kinase and p38 MAP kinase in osteoblast-like MC3T3-E1 cells, and that Rho-kinase acts at a point upstream of p38 MAP kinase. In the present study, we investigated the involvement of HSP90 in the PGF(2 alpha)-stimulated IL-6 synthesis and the underlying mechanism in MC3T3-E1 cells. Geldanamycin, an inhibitor of HSP90, significantly amplified both the PGF(2 alpha)-stimulated IL-6 release and the mRNA expression levels. In addition, other HSP90 inhibitors, 17-allylamino-17demethoxy-geldanamycin (17-AAG) and 17-dimethylamino-ethylamino-17-demethoxy-geldanamycin (17-DMAG) and onalespib, enhanced the PGF(2 alpha)-stimulated IL-6 release. Geldanamycin, 17-AAG and onalespib markedly strengthened the PGF(2 alpha)-induced phosphorylation of p38 MAP kinase. Geldanamycin and 17-AAG did not affect the PGF(2 alpha)-induced phosphorylation of p44/p42 MAP kinase and myosin phosphatase targeting subunit (MYPT-1), a substrate of Rho-kinase, and the protein levels of RhoA and Rho-kinase. In addition, HSP90-siRNA enhanced the PGF(2 alpha)-induced phosphorylation of p38 MAP kinase. Furthermore, SB203580, an inhibitor of p38 MAP kinase, significantly suppressed the amplification by geldanamycin, 17-AAG or 17-DMAG of the PGF(2 alpha)-stimulated IL-6 release. Our results strongly suggest that HSP90 negatively regulates the PGF(2 alpha)-stimulated IL-6 synthesis in osteoblasts, and that the effect of HSP90 is exerted through regulating p38 MAP kinase activation.	[Fujita, Kazuhiko; Kuroyanagi, Gen; Yamamoto, Naohiro; Kainuma, Shingo; Kawabata, Tetsu; Sakai, Go; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Aichi, Japan; [Fujita, Kazuhiko; Tokuda, Haruhiko; Kuroyanagi, Gen; Yamamoto, Naohiro; Kainuma, Shingo; Kawabata, Tetsu; Sakai, Go; Matsushima-Nishiwaki, Rie; Kozawa, Osamu] Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan; [Tokuda, Haruhiko] Natl Ctr Geriatr & Gerontol, Biobank Med Genome Ctr, Dept Clin Lab, Obu, Aichi, Japan	Nagoya City University; Gifu University; National Center for Geriatrics & Gerontology	Kozawa, O (corresponding author), Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan.	okozawa@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26462289, 15K10487]; Ministry of Health, Labour and Welfare of Japan [H25-Aging General-004]; National Center for Geriatrics and Gerontology (NCGG), Japan [25-4, 26-12]; Grants-in-Aid for Scientific Research [15K10487] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center for Geriatrics and Gerontology (NCGG), Japan(National Center for Geriatrics & Gerontology); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by a Grant-in-Aid for Scientific Research (26462289, 15K10487) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a; a Grant-in-Aid for Scientific Research (H25-Aging General-004) from the Ministry of Health, Labour and Welfare of Japan, http://www.mhlw.go.jp/stf/ seisakunitsuite/bunya/hokabunya/kenkyujigyou/; the Research Funding for Longevity Sciences (25-4, 26-12) from National Center for Geriatrics and Gerontology (NCGG), Japan, http://www.ncgg.go.jpiresearch/index.html.; We are very grateful to Mrs.Yumiko Kurokawa for her skillful technical assistance. The present study was supported in part by a Grant-in-Aid for Scientific Research (26462289, 15K10487) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid for Scientific Research (H25-Aging-General-004) from the Ministry of Health, Labour and Welfare of Japan, and the Research Funding for Longevity Sciences (25-4, 26-12) from National Center for Geriatrics and Gerontology (NCGG), Japan.	Adachi S, 2010, ONCOL REP, V23, P1709, DOI 10.3892/or_00000815; Agas D, 2013, J CELL PHYSIOL, V228, P25, DOI 10.1002/jcp.24117; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; Chiosis G, 2006, EXPERT OPIN THER TAR, V10, P37, DOI 10.1517/14728222.10.1.37; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Fazzalari NL, 2011, OSTEOPOROSIS INT, V22, P2003, DOI 10.1007/s00198-011-1611-4; Ferraldeschi R, 2016, CANCER RES, V76, P2731, DOI 10.1158/0008-5472.CAN-15-2186; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Gardner CR, 2001, PROSTAG LEUKOTR ESS, V64, P117, DOI 10.1054/plef.2001.0250; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jez JM, 2003, CHEM BIOL, V10, P361, DOI 10.1016/S1074-5521(03)00075-9; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kato K, 1996, J NEUROCHEM, V66, P946; Kozawa O, 1997, AM J PHYSIOL-ENDOC M, V272, pE208, DOI 10.1152/ajpendo.1997.272.2.E208; KOZAWA O, 1992, EXP CELL RES, V198, P130, DOI 10.1016/0014-4827(92)90158-5; Kozawa O, 2002, J CELL BIOCHEM, V86, P357, DOI 10.1002/jcb.10221; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Minamitani C, 2008, MOL CELL ENDOCRINOL, V291, P27, DOI 10.1016/j.mce.2008.05.011; Mori M, 2015, INT J ONCOL, V46, P47, DOI 10.3892/ijo.2014.2727; Ochel HJ, 2001, CELL STRESS CHAPERON, V6, P105, DOI 10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2; Price JT, 2005, CANCER RES, V65, P4929, DOI 10.1158/0008-5472.CAN-04-4458; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Prowse PDH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058898; RAISZ LG, 1990, ENDOCRINOLOGY, V126, P1076, DOI 10.1210/endo-126-2-1076; Sauvage F, 2017, J CONTROL RELEASE, V248, P133, DOI 10.1016/j.jconrel.2017.01.013; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Tokuda H, 1999, CELL SIGNAL, V11, P325, DOI 10.1016/S0898-6568(98)00048-5; Verma S, 2016, BIOCHIMIE, V127, P227, DOI 10.1016/j.biochi.2016.05.018; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177878	10.1371/journal.pone.0177878	http://dx.doi.org/10.1371/journal.pone.0177878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542188	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600027
J	Wilson, NM; Gurney, ME; Dietrich, WD; Atkins, CM				Wilson, Nicole M.; Gurney, Mark E.; Dietrich, W. Dalton; Atkins, Coleen M.			Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury	PLOS ONE			English	Article							CYCLIC-AMP-PHOSPHODIESTERASE; SELECTIVE PDE4B; LEUKOCYTE ACCUMULATION; SYNAPTIC PLASTICITY; BARRIER DISRUPTION; SIGNALING PATHWAY; RESPONSE ELEMENT; NEURONAL INJURY; GENE-EXPRESSION; PROTEIN-LEVELS	Traumatic brain injury (TBI) initiates a deleterious inflammatory response that exacerbates pathology and worsens outcome. This inflammatory response is partially mediated by a reduction in cAMP and a concomitant upregulation of cAMP-hydrolyzing phosphodiesterases (PDEs) acutely after TBI. The PDE4B subfamily, specifically PDE4B2, has been found to regulate cAMP in inflammatory cells, such as neutrophils, macrophages and microglia. To determine if PDE4B regulates inflammation and subsequent pathology after TBI, adult male Sprague Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury (2 +/- 0.2 atm) and were then treated with a PDE4B - selective inhibitor, A33, or vehicle for up to 3 days post-surgery. Treatment with A33 reduced markers of microglial activation and neutrophil infiltration at 3 and 24 hrs after TBI, respectively. A33 treatment also reduced cortical contusion volume at 3 days post-injury. To determine whether this treatment paradigm attenuated TBI-induced behavioral deficits, animals were evaluated over a period of 6 weeks after surgery for forelimb placement asymmetry, contextual fear conditioning, water maze performance and spatial working memory. A33 treatment significantly improved contextual fear conditioning and water maze retention at 24 hrs post-training. However, this treatment did not rescue sensorimotor or working memory deficits. At 2 months after surgery, atrophy and neuronal loss were measured. A33 treatment significantly reduced neuronal loss in the pericontusional cortex and hippocampal CA3 region. This treatment paradigm also reduced cortical, but not hippocampal, atrophy. Overall, these results suggest that acute PDE4B inhibition may be a viable treatment to reduce inflammation, pathology and memory deficits after TBI.	[Wilson, Nicole M.; Dietrich, W. Dalton; Atkins, Coleen M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Gurney, Mark E.] Tetra Discovery Partners, Grand Rapids, MI USA	University of Miami	Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA.	catkins@med.miami.edu			National Institutes of Health/National Institute of Neurological Disorders and Stroke [RO1 NS056072]; WDD [F31 NS089351]; Miami Project to Cure Paralysis; National Institutes of Health/National Institute of Mental Health [R44 MH091791]; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH091791, R44MH091791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS089351, R01NS056072, R25NS083064] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); WDD; Miami Project to Cure Paralysis; National Institutes of Health/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke RO1 NS056072 to CMA and WDD, F31 NS089351 to NMW, and The Miami Project to Cure Paralysis. MEG acknowledges support by the National Institutes of Health/National Institute of Mental Health R44 MH091791. The funder, Tetra Discovery Partners, provided support in the form of salary for MEG, but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'authors contributions' section.	Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Atkins CM, 2012, J NEUROSCI RES, V90, P1861, DOI 10.1002/jnr.23069; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; Blackman BE, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203604; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chang CI, 2000, J IMMUNOL, V165, P2134, DOI 10.4049/jimmunol.165.4.2134; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Corraliza IM, 1995, BIOCHEM BIOPH RES CO, P206; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dash PK, 2007, LEARN MEMORY, V14, P554, DOI 10.1101/lm.558707; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; DETMERS PA, 1994, J IMMUNOL, V153, P2137; Eigler A, 1998, J LEUKOCYTE BIOL, V63, P101, DOI 10.1002/jlb.63.1.101; Erdely A, 2006, AM J PHYSIOL-LUNG C, V290, pL534, DOI 10.1152/ajplung.00326.2005; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; FitzGerald O, 2014, NAT REV RHEUMATOL, V10, P385, DOI 10.1038/nrrheum.2014.77; Flora G, 2013, CELL TRANSPLANT, V22, P2203, DOI 10.3727/096368912X658872; Fox D, 2014, CELL SIGNAL, V26, P657, DOI 10.1016/j.cellsig.2013.12.003; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Ghosh M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0463-9; Ghosh M, 2012, GLIA, V60, P1839, DOI 10.1002/glia.22401; Ghosh M, 2010, TRANSL NEUROSCI, V1, P101, DOI 10.2478/v10134-010-0012-0; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GOTOH S, 1986, J IMMUNOL, V137, P643; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hagen TJ, 2014, BIOORG MED CHEM LETT, V24, P4031, DOI 10.1016/j.bmcl.2014.06.002; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hatinen S, 2008, RESTOR NEUROL NEUROS, V26, P493; Havekes R, 2016, J NEUROSCI, V36, P8936, DOI 10.1523/JNEUROSCI.0248-16.2016; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Houslay MD, 2010, NAT BIOTECHNOL, V28, P38, DOI 10.1038/nbt0110-38; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Li LX, 2011, METAB BRAIN DIS, V26, P37, DOI 10.1007/s11011-011-9235-0; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LYNN WA, 1991, J IMMUNOL, V147, P3072; Ma DM, 1999, MOL PHARMACOL, V55, P50, DOI 10.1124/mol.55.1.50; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Moretti L, 2012, LANCET NEUROL, P11; Moy AB, 1998, AM J PHYSIOL-LUNG C, V274, pL1024, DOI 10.1152/ajplung.1998.274.6.L1024; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P91, DOI 10.1038/nrd3657; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Naganuma K, 2009, BIOORG MED CHEM LETT, V19, P3174, DOI 10.1016/j.bmcl.2009.04.121; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Oliva AA, 2012, J NEUROCHEM, V123, P1019, DOI 10.1111/jnc.12049; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Reyes-Irisarri E, 2008, SYNAPSE, V62, P74, DOI 10.1002/syn.20459; Reyes-Irisarri E, 2007, J NEUROPATH EXP NEUR, V66, P923, DOI 10.1097/nen.0b013e3181567c31; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Robichaud A, 2001, NEUROPHARMACOLOGY, V40, P262, DOI 10.1016/S0028-3908(00)00142-8; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SCHWABE U, 1976, MOL PHARMACOL, V12, P900; Sheldon KE, 2013, J IMMUNOL, V191, P2290, DOI 10.4049/jimmunol.1202102; Shepherd MC, 2004, BRIT J PHARMACOL, V142, P339, DOI 10.1038/sj.bjp.0705770; SHEPPARD H, 1975, J CYCLIC NUCL PROT, V1, P237; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Siegmund B, 1997, EUR J PHARMACOL, V321, P231, DOI 10.1016/S0014-2999(96)00947-8; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Soares HD, 1995, J NEUROSCI, V15, P8223; SOMMER N, 1995, NAT MED, V1, P244, DOI 10.1038/nm0395-244; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sugerman DE, 2012, J TRAUMA ACUTE CARE, P73; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Truettner JS, 2016, J CEREB BLOOD FLOW M; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Vander Top EA, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-61; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wang P, 1999, MOL PHARMACOL, V56, P170, DOI 10.1124/mol.56.1.170; Wei LH, 2000, AM J PHYSIOL-CELL PH, V279, pC248, DOI 10.1152/ajpcell.2000.279.1.C248; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson NM, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00005; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Ye YQ, 2014, INT J MOL SCI, V15, P12651, DOI 10.3390/ijms150712651; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40115; Zhou XM, 2005, AM J PHYSIOL-LUNG C, V288, pL655, DOI 10.1152/ajplung.00327.2004; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	128	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178013	10.1371/journal.pone.0178013	http://dx.doi.org/10.1371/journal.pone.0178013			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542295	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672600042
J	Hakimi, O; Ternette, N; Murphy, R; Kessler, BM; Carr, A				Hakimi, Osnat; Ternette, Nicola; Murphy, Richard; Kessler, Benedikt M.; Carr, Andrew			A quantitative label-free analysis of the extracellular proteome of human supraspinatus tendon reveals damage to the pericellular and elastic fibre niches in torn and aged tissue	PLOS ONE			English	Article							ROTATOR CUFF TENDON; IN-SITU HYBRIDIZATION; CONNECTIVE-TISSUE; HEALING TENDON; MESSENGER-RNA; SHOULDER PAIN; VI COLLAGEN; EXPRESSION; LOCALIZATION; DEGENERATION	Tears of the human supraspinatus tendon are common and often cause painful and debilitating loss of function. Progressive failure of the tendon leading to structural abnormality and tearing is accompanied by numerous cellular and extra-cellular matrix (ECM) changes in the tendon tissue. This proteomics study aimed to compare torn and aged rotator cuff tissue to young and healthy tissue, and provide the first ECM inventory of human supraspinatus tendon generated using label-free quantitative LC-MS/MS. Employing two digestion protocols (trypsin and elastase), we analysed grain-sized tendon supraspinatus biopsies from older patients with torn tendons and from healthy, young controls. Our findings confirm measurable degradation of collagen fibrils and associated proteins in old and torn tendons, suggesting a significant loss of tissue organisation. A particularly marked reduction of cartilage oligomeric matrix protein (COMP) raises the possibility of using changes in levels of this glycoprotein as a marker of abnormal tissue, as previously suggested in horse models. Surprisingly, and despite using an elastase digestion for validation, elastin was not detected, suggesting that it is not highly abundant in human supraspinatus tendon as previously thought. Finally, we identified marked changes to the elastic fibre, fibrillin-rich niche and the pericellular matrix. Further investigation of these regions may yield other potential biomarkers and help to explain detrimental cellular processes associated with tendon ageing and tendinopathy.	[Hakimi, Osnat; Murphy, Richard; Carr, Andrew] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Ternette, Nicola] Univ Oxford, Jenner Inst, Oxford, England; [Kessler, Benedikt M.] Nuffield Dept Med, Mass Spectrometry Lab, TDI, Oxford, England; [Hakimi, Osnat] Fed Univ State Rio de Janeiro, Dept Genet & Mol Biol, Rio De Janeiro, Brazil	University of Oxford; University of Oxford; Jenner Institute; University of Oxford	Hakimi, O (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.; Hakimi, O (corresponding author), Fed Univ State Rio de Janeiro, Dept Genet & Mol Biol, Rio De Janeiro, Brazil.	osnat.hakimi@unirio.br	Hakimi, Osnat/O-3889-2019; Kessler, Benedikt/AAY-8614-2021	Kessler, Benedikt/0000-0002-8160-2446; Hakimi, Osnat/0000-0002-8839-4846; Ternette, Nicola/0000-0002-9283-0743	NIHR (MSK Biomedical Research Unit)	NIHR (MSK Biomedical Research Unit)	The work presented in this manuscript was funded by NIHR (MSK Biomedical Research Unit).; This work was supported by the NIHR (MSK Biomedical Research Unit)	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Bank RA, 1999, ANN RHEUM DIS, V58, P35, DOI 10.1136/ard.58.1.35; Bongers PM, 2001, BMJ-BRIT MED J, V322, P64, DOI 10.1136/bmj.322.7278.64; Buckley MR, 2013, CONNECT TISSUE RES, V54, P374, DOI 10.3109/03008207.2013.847096; Chaudhury S, 2011, J BONE JOINT SURG BR, V93B, P370, DOI 10.1302/0301-620X.93B3.25470; Chaudhury S, 2016, J SHOULDER ELBOW SUR; Dakin SG, 2014, J BIOL CHEM, V289, P4919, DOI 10.1074/jbc.M113.511972; Dean BJF, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0691-5; Dean BJF, 2014, BRIT J SPORT MED, V48, P1620, DOI 10.1136/bjsports-2013-093178; Fallon J, 2002, J ORTHOP RES, V20, P920, DOI 10.1016/S0736-0266(02)00032-2; Fenwick SA, 2002, ARTHRITIS RES, V4, P252, DOI 10.1186/ar416; Gibson MA, 1998, J HISTOCHEM CYTOCHEM, V46, P871, DOI 10.1177/002215549804600802; Goodier HCJ, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0947-8; Grant TM, 2013, J ANAT, V222, P573, DOI 10.1111/joa.12048; Hamada K, 1997, J ORTHOPAED RES, V15, P24, DOI 10.1002/jor.1100150105; HATAMOCHI A, 1989, J BIOL CHEM, V264, P3494; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Jensen SA, 2016, BIOCHEM J, V473, P827, DOI 10.1042/BJ20151108; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Karonen T, 1997, BRIT J DERMATOL, V137, P51, DOI 10.1046/j.1365-2133.1997.17671859.x; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Lamande SR, 1998, J BIOL CHEM, V273, P7423, DOI 10.1074/jbc.273.13.7423; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Little D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096526; Lo IKY, 2005, ARTHROSCOPY, V21, P645, DOI 10.1016/j.arthro.2005.03.008; Murphy RJ, 2013, OPER TECH ORTHOP, V23, P56, DOI 10.1053/j.oto.2013.05.003; Nho SJ, 2008, AM J SPORT MED, V36, P987, DOI 10.1177/0363546508317344; Penner AS, 2002, J BIOL CHEM, V277, P35044, DOI 10.1074/jbc.M206363200; RILEY GP, 1994, ANN RHEUM DIS, V53, P359, DOI 10.1136/ard.53.6.359; Ritty TM, 2003, STRUCTURE, V11, P1179, DOI 10.1016/S0969-2126(03)00181-3; Ritty TM, 2002, ANAT RECORD, V268, P430, DOI 10.1002/ar.10175; ROARK EF, 1995, J HISTOCHEM CYTOCHEM, V43, P401, DOI 10.1177/43.4.7534784; Sardone F, 2015, MATRIX BIOL; Sejersen MHJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119974; Sengle G, 2015, MATRIX BIOL, V47, P3, DOI 10.1016/j.matbio.2015.05.002; Shindle MK, 2011, J SHOULDER ELB SURG, V20, P917, DOI 10.1016/j.jse.2011.02.015; Shirachi I, 2011, ARTHROSCOPY, V27, P1173, DOI 10.1016/j.arthro.2011.03.078; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; Sodersten F, 2012, CONNECTIVE TISSUE RE, V54; Soedersten F, 2010, RES VET SCI, V88, P251; Sugawara Y, 2010, J PERIODONTAL RES, V45, P52, DOI 10.1111/j.1600-0765.2008.01196.x; Thakkar D, 2014, CONNECT TISSUE RES, V55, P397, DOI 10.3109/03008207.2014.959119; Thomopoulos S, 2002, J ORTHOP RES, V20, P454, DOI 10.1016/S0736-0266(01)00144-9; Thorpe C. T., 2016, J ANATOMY; Thorpe CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20455; Tilley JMR, 2014, BONE JOINT RES, V3, P252, DOI 10.1302/2046-3758.38.2000251; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835	49	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							0177656	10.1371/journal.pone.0177656	http://dx.doi.org/10.1371/journal.pone.0177656			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542244	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400064
J	Jiang, W; Wang, SY; Liu, X; Zheng, HQ; Wei, BY				Jiang, Wen; Wang, Shiyu; Liu, Xiang; Zheng, Hanqing; Wei, Boya			Evidence conflict measure based on OWA operator in open world	PLOS ONE			English	Article							DECISION-MAKING; COMBINATION METHOD; ATTRIBUTE WEIGHTS; BELIEF FUNCTIONS; PAYOFFS; FUSION; MODEL	Dempster-Shafer evidence theory has been extensively used in many information fusion systems since it was proposed by Dempster and extended by Shafer. Many scholars have been conducted on conflict management of Dempster-Shafer evidence theory in past decades. However, how to determine a potent parameter to measure evidence conflict, when the given environment is in an open world, namely the frame of discernment is incomplete, is still an open issue. In this paper, a new method which combines generalized conflict coefficient, generalized evidence distance, and generalized interval correlation coefficient based on ordered weighted averaging (OWA) operator, to measure the conflict of evidence is presented. Through ordered weighted average of these three parameters, the combinatorial coefficient can still measure the conflict effectively when one or two parameters are not valid. Several numerical examples demonstrate the effectiveness of the proposed method.	[Jiang, Wen; Wang, Shiyu; Wei, Boya] Northwestern Polytech Univ, Sch Elect & Informat, Xian 710072, Shaanxi, Peoples R China; [Liu, Xiang] CASC, Shanghai Inst Spaceflight Control Technol, Infrared Detect Technol Res & Dev Ctr, Shanghai 200233, Peoples R China; [Zheng, Hanqing] Shanghai Inst Spaceflight Control Technol, Shanghai 200233, Peoples R China	Northwestern Polytechnical University; China Aerospace Science & Technology Corporation (CASC)	Jiang, W (corresponding author), Northwestern Polytech Univ, Sch Elect & Informat, Xian 710072, Shaanxi, Peoples R China.	jiangwen@nwpu.edu.cn		jiang, wen/0000-0001-5429-2748	National Natural Science Foundation of China [61671384]; Natural Science Basic Research Plan in Shaanxi Province of China [2016JM6018]; SAST [SAST2016083]; Seed Foundation of Innovation and Creation for Graduate Students in Northwestern Polytechnical University [Z2016122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China; SAST; Seed Foundation of Innovation and Creation for Graduate Students in Northwestern Polytechnical University	The work is partially supported by National Natural Science Foundation of China (Grant No. 61671384), Natural Science Basic Research Plan in Shaanxi Province of China (Program No. 2016JM6018), the Fund of SAST (Program No. SAST2016083), the Seed Foundation of Innovation and Creation for Graduate Students in Northwestern Polytechnical University (Program No. Z2016122).r The work is partially supported by National Natural Science Foundation of China (Grant No. 61671384), Natural Science Basic Research Plan in Shaanxi Province of China (Program No. 2016JM6018), the Fund of SAST (Program No. SAST2016083), the Seed Foundation of Innovation and Creation for Graduate Students in Northwestern Polytechnical University (Program No. Z2016122).	An S, 2016, IEEE T CYBERNETICS, V46, P3073, DOI 10.1109/TCYB.2015.2496425; Bernardo JM., 2001, BAYESIAN THEORY; Chin KS, 2015, INFORM SCIENCES, V325, P70, DOI 10.1016/j.ins.2015.07.003; Dabarera R, 2016, IEEE T SIGNAL INF PR, V2, P336, DOI 10.1109/TSIPN.2016.2571839; Silva LGD, 2016, INFORM SCIENCES, V346, P275, DOI 10.1016/j.ins.2016.01.080; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Deng XY, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040922; Deng XY, 2016, IEEE T CYBERNETICS, V46, P2070, DOI 10.1109/TCYB.2015.2462352; Deng Y, 2015, APPL INTELL, V43, P530, DOI 10.1007/s10489-015-0661-2; Destercke S, 2013, IEEE T CYBERNETICS, V43, P585, DOI 10.1109/TSMCB.2012.2212703; Ekel P, 2016, INFORM SCIENCES, V361, P100, DOI 10.1016/j.ins.2016.04.030; Filev D, 1998, FUZZY SET SYST, V94, P157, DOI 10.1016/S0165-0114(96)00254-0; Frikha A, 2014, INFORM FUSION, V18, P20, DOI 10.1016/j.inffus.2013.04.010; Fu C, 2015, COMPUT IND ENG, V81, P109, DOI 10.1016/j.cie.2014.12.031; Grubbs FE, 1968, INTRO PROBABILITY TH; Haenni R., 2002, Information Fusion, V3, P237, DOI 10.1016/S1566-2535(02)00076-3; He Y, 2012, J SYST ENG ELECTRON, V23, P1, DOI 10.1109/JSEE.2012.00001; Hu Y, 2016, AERONAUT J, V120, P956, DOI 10.1017/aer.2016.38; Islam MS, 2016, WATER RESOUR MANAG, V30, P2831, DOI 10.1007/s11269-016-1326-6; Jiang W, 2017, APPL SOFT COMPUT, V57, P672, DOI 10.1016/j.asoc.2017.04.008; Jiang W, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040721; Jiang W, 2017, APPL INTELL, V46, P630, DOI 10.1007/s10489-016-0851-6; Jiang W, 2017, CHAOS, V27, DOI 10.1063/1.4977186; Jiang W, 2016, COMPUT IND ENG, V101, P260, DOI 10.1016/j.cie.2016.09.009; Jiang W, 2017, J INTELL FUZZY SYST, V32, P1931, DOI 10.3233/JIFS-16139; Jiang W, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091509; Joussleme A.-L., 2001, Information Fusion, V2, P91, DOI 10.1016/S1566-2535(01)00026-4; Lefevre E., 2002, Information Fusion, V3, P149, DOI 10.1016/S1566-2535(02)00053-2; Lefevre E, 2013, DECIS SUPPORT SYST, V56, P326, DOI 10.1016/j.dss.2013.06.012; Lin Y, 2016, J SUPERCOMPUT, V72, P2874, DOI 10.1007/s11227-016-1681-3; Liu J, 2016, INFORM SCIENCES, V369, P100, DOI 10.1016/j.ins.2016.06.032; Liu WR, 2006, ARTIF INTELL, V170, P909, DOI 10.1016/j.artint.2006.05.002; LIU ZG, 2016, PATTERN RECOGN, V52, P85, DOI DOI 10.1016/J.PATC0G.2015.10.001; Ma JB, 2016, INFORM SCIENCES, V333, P10, DOI 10.1016/j.ins.2015.11.011; Martinez O, 2017, INTELL DATA ANAL, V21, P181, DOI 10.3233/IDA-150291; Monks U, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16111798; Murphy CK, 2000, DECIS SUPPORT SYST, V29, P1, DOI 10.1016/S0167-9236(99)00084-6; Paul R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050614; Perez A, 2016, IMAGE VISION COMPUT, V55, P149, DOI 10.1016/j.imavis.2016.04.010; Rao SS, 2013, J MECH DESIGN, V135, DOI 10.1115/1.4024229; Rikhtegar N, 2014, ECON RES-EKON ISTRAZ, V27, P378, DOI 10.1080/1331677X.2014.966971; Samuels SM, 1968, INTRO PROBABILITY TH; Sarabi-Jamab A, 2013, KNOWL-BASED SYST, V54, P114, DOI 10.1016/j.knosys.2013.08.030; Shafer G.A., 1976, MATH THEORY EVIDENCE; SMETS P, 1990, IEEE T PATTERN ANAL, V12, P447, DOI 10.1109/34.55104; Sriboonchitta S, 2016, KNOWL-BASED SYST, V106, P179; Wang JW, 2016, INT J DISTRIB SENS N, V12, DOI 10.1177/155014773218784; Wu C, 2014, 6 CHIN INF FUS C P, P110; Yager RR, 2016, IEEE T CYBERNETICS, V46, P869, DOI 10.1109/TCYB.2015.2417121; Yager RR, 2013, INT J INTELL SYST, V28, P1039, DOI 10.1002/int.21615; YAGER RR, 1987, INFORM SCIENCES, V41, P93, DOI 10.1016/0020-0255(87)90007-7; Yager RR, 2008, STUD FUZZ SOFT COMP, V219, P1, DOI 10.1007/978-3-540-44792-4; YAGER RR, 1988, IEEE T SYST MAN CYB, V18, P183, DOI 10.1109/21.87068; Yang JB, 2013, ARTIF INTELL, V205, P1, DOI 10.1016/j.artint.2013.09.003; Yang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147799; Yang Y, 2016, KNOWL-BASED SYST, V94, P114, DOI 10.1016/j.knosys.2015.11.014; Yu C, 2015, EXPERT SYST APPL, V42, P5139, DOI 10.1016/j.eswa.2015.02.038; Zadeh L.A., 1986, AI MAG, V7, P85, DOI DOI 10.1609/AIMAG.V7I2.542; Zhang XG, 2016, P I MECH ENG B-J ENG, V230, P562, DOI 10.1177/0954405414551105; Zhao YX, 2016, INFORM SCIENCES, V367, P125, DOI 10.1016/j.ins.2016.05.039	60	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177828	10.1371/journal.pone.0177828	http://dx.doi.org/10.1371/journal.pone.0177828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542271	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400093
J	Lim, W; Lee, J; Lim, Y; Bae, DH; Park, H; Kim, DS; Jung, K				Lim, Woosang; Lee, Jungsoo; Lim, Yongsub; Bae, Doo-Hwan; Park, Haesun; Kim, Dae-Shik; Jung, Kyomin			Hierarchical ordering with partial pairwise hierarchical relationships on the macaque brain data sets	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; ORGANIZATION; AREAS	Hierarchical organizations of information processing in the brain networks have been known to exist and widely studied. To find proper hierarchical structures in the macaque brain, the traditional methods need the entire pairwise hierarchical relationships between cortical areas. In this paper, we present a new method that discovers hierarchical structures of macaque brain networks by using partial information of pairwise hierarchical relationships. Our method uses a graph-based manifold learning to exploit inherent relationship, and computes pseudo distances of hierarchical levels for every pair of cortical areas. Then, we compute hierarchy levels of all cortical areas by minimizing the sum of squared hierarchical distance errors with the hierarchical information of few cortical areas. We evaluate our method on the macaque brain data sets whose true hierarchical levels are known as the FV91 model. The experimental results show that hierarchy levels computed by our method are similar to the FV91 model, and its errors are much smaller than the errors of hierarchical clustering approaches.	[Lim, Woosang; Bae, Doo-Hwan] Korea Adv Inst Sci & Technol, Sch Comp, Daejeon, South Korea; [Lee, Jungsoo; Kim, Dae-Shik] Korea Adv Inst Sci & Technol, Sch Elect Engn, Daejeon, South Korea; [Lim, Yongsub] Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Park, Haesun] Georgia Tech, Sch Computat Sci & Engn, Atlanta, GA USA; [Jung, Kyomin] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); University System of Georgia; Georgia Institute of Technology; Seoul National University (SNU)	Jung, K (corresponding author), Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea.	kjung@snu.ac.kr	Kim, Dae-Shik/C-2071-2011	Lim, Woosang/0000-0002-6615-5801	KAIST Graduate Research Fellowship via Kim-Bo-Jung Fund; Google Ph.D. Fellowship in machine learning; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2016R1A2B2009759]; Brain Korea 21 Plus Project	KAIST Graduate Research Fellowship via Kim-Bo-Jung Fund; Google Ph.D. Fellowship in machine learning(Google Incorporated); National Research Foundation of Korea (NRF) grant - Korea government (MSIP); Brain Korea 21 Plus Project	W. Lim acknowledges support from the 2015 KAIST Graduate Research Fellowship via Kim-Bo-Jung Fund and the 2016 Google Ph.D. Fellowship in machine learning. K. Jung was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2016R1A2B2009759), and supported by the Brain Korea 21 Plus Project in 2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; W. Lim acknowledges support from the 2015 KAIST Graduate Research Fellowship via Kim-Bo-Jung Fund and the 2016 Google Ph.D. Fellowship in machine learning. K. Jung was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP) (2016R1A2B2009759), and supported by the Brain Korea 21 Plus Project in 2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone P, 2000, J NEUROSCI, V20, P3263, DOI 10.1523/JNEUROSCI.20-09-03263.2000; Batardiere A, 2002, CEREB CORTEX, V12, P453, DOI 10.1093/cercor/12.5.453; Belkin M, 2002, ADV NEUR IN, V14, P585; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Boly M, 2012, P NATL ACAD SCI USA, V109, P5856, DOI 10.1073/pnas.1111133109; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fogel F., 2014, ADV NEURAL INFORM PR, V27, P900; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Grant S, 2005, EUR J NEUROSCI, V22, P681, DOI 10.1111/j.1460-9568.2005.04232.x; Gupte Mangesh, 2011, P 20 INT C WORLD WID, P557, DOI DOI 10.1145/1963405.1963484; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Hilgetag CC, 1996, SCIENCE, V271, P776, DOI 10.1126/science.271.5250.776; Hilgetag CC, 2000, PHILOS T R SOC B, V355, P71, DOI 10.1098/rstb.2000.0550; Krumnack A, 2010, FRONT NEUROINFORM, P4; Li J, 2007, J MACH LEARN RES, V8, P1687; Lind P, 2003, J CHEM INF COMP SCI, V43, P1855, DOI 10.1021/ci034107s; Mahadevan S., 2005, ADV NEURAL INFORM PR, P843; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Markov NT, 2014, J COMP NEUROL, V522, P225, DOI 10.1002/cne.23458; Markova NT, 2013, P NATL ACAD SCI USA, V110, P5187, DOI 10.1073/pnas.1218972110; Meunier D, 2009, FRONT NEUROINFORM, P3; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Reid AT, 2009, NEUROIMAGE, V47, P611, DOI 10.1016/j.neuroimage.2009.04.061; Vezoli J, 2004, NEUROSCIENTIST, V10, P476, DOI 10.1177/1073858404268478; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076315; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	31	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177373	10.1371/journal.pone.0177373	http://dx.doi.org/10.1371/journal.pone.0177373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545042	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672400039
J	Neitlich, PN; Hoef, JMV; Berryman, SD; Mines, A; Geiser, LH; Hasselbach, LM; Shiel, AE				Neitlich, Peter N.; Hoef, Jay M. Ver; Berryman, Shanti D.; Mines, Anaka; Geiser, Linda H.; Hasselbach, Linda M.; Shiel, Alyssa E.			\Trends in spatial patterns of heavy metal deposition on national park service lands along the Red Dog Mine haul road, Alaska, 2001-2006	PLOS ONE			English	Article								Spatial patterns of Zn, Pb and Cd deposition in Cape Krusenstern National Monument (CAKR), Alaska, adjacent to the Red Dog Mine haul road, were characterized in 2001 and 2006 using Hylocomium moss tissue as a biomonitor. Elevated concentrations of Cd, Pb, and Zn in moss tissue decreased logarithmically away from the haul road and the marine port. The metals concentrations in the two years were compared using Bayesian posterior predictions on a new sampling grid to which both data sets were fit. Posterior predictions were simulated 200 times both on a coarse grid of 2,357 points and by distance-based strata including subsets of these points. Compared to 2001, Zn and Pb concentrations in 2006 were 31 to 54% lower in the 3 sampling strata closest to the haul road (0-100, 100-2000 and 2000-4000 m). Pb decreased by 40% in the stratum 4,000-5,000 m from the haul road. Cd decreased significantly by 38% immediately adjacent to the road (0-100m), had an 89% probability of a small decrease 100-2000 m from the road, and showed moderate probabilities (56-71%) for increase at greater distances. There was no significant change over time (with probabilities all <= 85%) for any of the 3 elements in more distant reference areas (40-60 km). As in 2001, elemental concentrations in 2006 were higher on the north side of the road. Reductions in deposition have followed a large investment in infrastructure to control fugitive dust escapement at the mine and port sites, operational controls, and road dust mitigation. Fugitive dust escapement, while much reduced, is still resulting in elevated concentrations of Zn, Pb and Cd out to 5,000 m from the haul road. Zn and Pb levels were slightly above arctic baseline values in southern CAKR reference areas.	[Neitlich, Peter N.; Berryman, Shanti D.; Mines, Anaka; Hasselbach, Linda M.] Natl Pk Serv, Alaska Reg Off, Anchorage, AK 99501 USA; [Hoef, Jay M. Ver] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Marine Mammal Lab, Seattle, WA 98115 USA; [Geiser, Linda H.] US Forest Serv, USDA, Washington, DC 20250 USA; [Shiel, Alyssa E.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	United States Department of the Interior; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University	Neitlich, PN (corresponding author), Natl Pk Serv, Alaska Reg Off, Anchorage, AK 99501 USA.	peter_neitlich@nps.gov	Ver Hoef, Jay/C-8577-2017	Ver Hoef, Jay/0000-0003-4302-6895	National Park Service's Arctic Network (Inventory and Monitoring Program)	National Park Service's Arctic Network (Inventory and Monitoring Program)	This research was funded by the National Park Service's Arctic Network (Inventory and Monitoring Program). The authors worked for (or on behalf of) national parks partnered with the Arctic Network, rather than directly for the network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders did, however, provide a high-level review of the document for scientific merit. For more information about the NPS Arctic Network, please see: https:// science.riature.nps.gov/im/units/arcn/.; This research was funded by the National Park Service's Arctic Network, Inventory and Monitoring Program. We appreciate the reviews of this document from: Teck, Inc., Alison Kelley (Northwest Alaska Native Association), Scott Shock, Roxolana Kashuba and others (Exponent, Inc.), Dr. Robert Winfree (US National Park Service), Joel Hard (US National Park Service), Dr. Leigh Welling, (US National Park Service), Dr. Jim Lawler (US National Park Service), and Dr. Eric Wald (US National Park Service). Our great appreciation to Alex Rupprecht for field assistance. We appreciate the editorial suggestions of Dr. Vipin Chandra Kalia, Dr. Kendra Zamzow and an anonymous reviewer. Our thanks to Johanna Salatas (Teck, Inc) for compiling concentrate production data.	Alaska Department of Environmental Conservation, SPILL PREV RESP DIV; Alaska Department of Environmental Conservation, 2017, OIL OTH HAZ SUBST PO; Banerjee S., 2004, HIERARCHICAL MODELIN; Berger JO, 2001, J AM STAT ASSOC, V96, P1361, DOI 10.1198/016214501753382282; Brumbaugh WG, 2016, 20165096 US GEOL SUR; Brumbaugh WG, 2005, 20085040 US GEOL SUR; Brumbaugh WG, 2011, ENVIRON MONIT ASSESS, V182, P325, DOI 10.1007/s10661-011-1879-z; Brumbaugh WG, 2010, ENVIRON MONIT ASSESS, V170, P73, DOI 10.1007/s10661-009-1216-y; Brumelis G, 1997, ANN BOT-LONDON, V79, P679, DOI 10.1006/anbo.1997.0401; Csavina J, 2012, SCI TOTAL ENVIRON, V433, P58, DOI 10.1016/j.scitotenv.2012.06.013; Daly C, 2002, ALASKA AVERAGE MONTH; De Oliveira V, 1997, J AM STAT ASSOC, V92, P1422, DOI 10.1080/01621459.1997.10473663; Dolgopolova A, 2006, APPL GEOCHEM, V21, P563, DOI 10.1016/j.apgeochem.2005.12.014; ESRI, 2006, ARCGIS VERS 9 2 10 4; Exponent Inc., 2007, DEL MOUNT TRAN SYST; Exponent Inc., 2011, FUG DUST RISK MAN DU; FORD J, 1995, SCI TOTAL ENVIRON, V160-61, P323, DOI 10.1016/0048-9697(95)04366-9; Ford J., 2001, HEAVY METALS MOSSES; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gough LP, 1988, 1458 USGS; Hasselbach L, 2005, SCI TOTAL ENVIRON, V348, P211, DOI 10.1016/j.scitotenv.2004.12.084; Jorgenson MT, 2009, NPSARCNNRTRD2009270; National Park Service, 2006, MANAGEMENT POLICIES; Panda S K, 2016, LICHENOLOGIST; Pye K., 1987, AEOLIAN DUST DUST DE; Sangster D. F., 2000, Environmental Reviews, V8, P115, DOI 10.1139/a00-008; SENES Consultants Limited, 2005, RED DOG OP; SENES Consultants Ltd, 2007, DRAFT EM SUMM REP FU; Sims D. B., 2013, Environment and Pollution, V2, P22; Tetra Tech, 2009, RED DOG MIN EXT AQQ; Trimble, 2005, GEOEXPLORER 2005 SER	31	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177936	10.1371/journal.pone.0177936	http://dx.doi.org/10.1371/journal.pone.0177936			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542369	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400119
J	Thongprayoon, C; Cheungpasitporn, W; Thamcharoen, N; Ungprasert, P; Kittanamongkolchai, W; Mao, MA; Sakhuja, A; Greason, KL; Kashani, K				Thongprayoon, Charat; Cheungpasitporn, Wisit; Thamcharoen, Natanong; Ungprasert, Patompong; Kittanamongkolchai, Wonngarm; Mao, Michael A.; Sakhuja, Ankit; Greason, Kevin L.; Kashani, Kianoush			Association of frailty status with acute kidney injury and mortality after transcatheter aortic valve replacement: A systematic review and meta-analysis	PLOS ONE			English	Review							PSOAS MUSCLE AREA; 2-YEAR OUTCOMES; CARDIAC-SURGERY; GAIT SPEED; IMPACT; RISK; IMPLANTATION; INDEX; PREDICTOR; MORBIDITY	Objective Frailty is a common condition in patients with severe aortic stenosis (AS) undergoing trans-catheter aortic valve replacement (TAVR). The aim of this systematic review was to assess the impact of frailty status on acute kidney injury (AKI) and mortality after TAVR. Methods A systematic literature search was conducted using MEDLINE, EMBASE, and Cochrane databases from the inception through November 2016. The protocol for this study is registered with PROSPERO (International Prospective Register of Systematic Reviews; no. CRD42016052350). Studies that reported odds ratios, relative risks or hazard ratios comparing the risk of AKI after TAVR in frail vs. non-frail patients were included. Mortality risk was evaluated among the studies that reported AKI-related outcomes. Pooled risk ratios (RR) and 95% confidence interval (CI) were calculated using a random-effect, generic inverse variance method. Results Eight cohort studies with a total of 10,498 patients were identified and included in the meta-analysis. The pooled RR of AKI after TAVR among the frail patients was 1.19 (95% CI 0.97 - 1.46, I-2 = 0), compared with non-frail patients. When the meta-analysis was restricted only to studies with standardized AKI diagnosis according to Valve Academic Research Consortium (VARC)-2 criteria, the pooled RRs of AKI in frail patients was 1.16 (95% CI 0.91 - 1.47, I-2 = 0). Within the selected studies, frailty status was significantly associated with increased mortality ( RR 2.01; 95% CI 1.44 - 2.80, I 2 = 58). Conclusion The findings from our study suggest no significant association between frailty status and AKI after TAVR. However, frailty status is associated with mortality after TAVR and may aid appropriate patient selection for TAVR.	[Thongprayoon, Charat; Cheungpasitporn, Wisit; Kittanamongkolchai, Wonngarm; Mao, Michael A.; Kashani, Kianoush] Mayo Clin, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Thongprayoon, Charat; Thamcharoen, Natanong] Bassett Med Ctr, Dept Med, Cooperstown, NY USA; [Ungprasert, Patompong] Mayo Clin, Dept Internal Med, Div Rheumatol, Rochester, MN USA; [Sakhuja, Ankit; Kashani, Kianoush] Mayo Clin, Dept Internal Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA; [Greason, Kevin L.] Mayo Clin, Dept Surg, Div Cardiovasc Surg, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kashani, K (corresponding author), Mayo Clin, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA.; Kashani, K (corresponding author), Mayo Clin, Dept Internal Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA.	kashani.kianoush@mayo.edu	Thongprayoon, Charat/J-4184-2019; Kittanamongkolchai, Wonngarm/GLU-0111-2022; Cheungpasitporn, Wisit/H-8194-2019	Thongprayoon, Charat/0000-0002-8313-3604; Cheungpasitporn, Wisit/0000-0001-9954-9711; Kashani, Kianoush/0000-0003-2184-3683				Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Alfredsson J, 2016, CIRCULATION, V133, P1351, DOI 10.1161/CIRCULATIONAHA.115.020279; Baek SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156444; Barzilay JI, 2007, ARCH INTERN MED, V167, P635, DOI 10.1001/archinte.167.7.635; Chen MA, 2015, J GERIATR CARDIOL, V12, P44, DOI 10.11909/j.issn.1671-5411.2015.01.006; Cheungpasitporn W, 2017, J RENAL INJ PREV, V6, P16, DOI 10.15171/jrip.2017.03; Cheungpasitporn W, 2016, J RENAL INJ PREV, V5, P1, DOI 10.15171/jrip.2016.01; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Elhmidi Y, 2014, ARCH CARDIOVASC DIS, V107, P133, DOI 10.1016/j.acvd.2014.01.002; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Garg L, 2017, AM J CARDIOL, V119, P457, DOI 10.1016/j.amjcard.2016.10.019; Green P, 2015, AM J CARDIOL, V116, P264, DOI 10.1016/j.amjcard.2015.03.061; Green P, 2012, JACC-CARDIOVASC INTE, V5, P974, DOI 10.1016/j.jcin.2012.06.011; Herzog R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-154; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hinterbuchner L, 2016, EUR J CARDIOVASC NUR, V15, P384, DOI 10.1177/1474515115596640; Kappetein AP, 2012, EUR HEART J, V33, P2403, DOI 10.1093/eurheartj/ehs255; Kleczynski P, 2017, AM HEART J, V185, P52, DOI 10.1016/j.ahj.2016.12.005; Kleczynski P, 2016, J INVASIVE CARDIOL, V28, P493; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Koifman E, 2016, CATHETER CARDIO INTE, V88, P118, DOI 10.1002/ccd.26377; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Puls M, 2014, EUROINTERVENTION, V10, P609, DOI 10.4244/EIJY14M08_03; Reardon MJ, 2015, J AM COLL CARDIOL, V66, P113, DOI 10.1016/j.jacc.2015.05.017; Revenig LM, 2015, J AM COLL SURGEONS, V220, P904, DOI 10.1016/j.jamcollsurg.2015.01.053; Saji M, 2016, AM J CARDIOL, V118, P251, DOI 10.1016/j.amjcard.2016.04.043; Sepehri A, 2014, J THORAC CARDIOV SUR, V148, P3110, DOI 10.1016/j.jtcvs.2014.07.087; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stortecky S, 2012, EUROINTERVENTION J E, V8, pN215; Thiele RH, 2015, CLIN J AM SOC NEPHRO, V10, P500, DOI 10.2215/CJN.07830814; Thongprayoon C, 2016, RENAL FAILURE, P1; Thongprayoon C, 2017, J RENAL INJ PREV, V6, P216, DOI 10.15171/jrip.2017.41; Thongprayoon C, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.01.35; Thongprayoon Charat, 2016, J Evid Based Med, V9, P188, DOI 10.1111/jebm.12208; Thongprayoon C, 2016, NEPHROLOGY, V21, P1041, DOI 10.1111/nep.12704; Thongprayoon Charat, 2016, World J Nephrol, V5, P482, DOI 10.5527/wjn.v5.i5.482; Thongprayoon C, 2016, CLIN KIDNEY J, V9, P560, DOI 10.1093/ckj/sfw055; Thongprayoon C, 2016, J AM SOC NEPHROL, V27, P1854, DOI 10.1681/ASN.2015050577; Thongprayoon C, 2015, AM J NEPHROL, V41, P372, DOI 10.1159/000431337; Travison TG, 2011, J CLIN ENDOCR METAB, V96, P2464, DOI 10.1210/jc.2011-0143; Yamamoto M, 2017, AM J CARDIOL, V119, P770, DOI 10.1016/j.amjcard.2016.11.019; Yamamoto M, 2015, AM J CARDIOL, V115, P227, DOI 10.1016/j.amjcard.2014.10.026	47	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177157	10.1371/journal.pone.0177157	http://dx.doi.org/10.1371/journal.pone.0177157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545062	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672400024
J	Timmer, A; Peplies, J; Westphal, M; Kaltz, B; Ballauff, A; Classen, M; Laass, MW; Koletzko, S				Timmer, Antje; Peplies, Jenny; Westphal, Max; Kaltz, Birgit; Ballauff, Antje; Classen, Martin; Laass, Martin W.; Koletzko, Sibylle			Transition from pediatric to adult medical care - A survey in young persons with inflammatory bowel disease	PLOS ONE			English	Article							NORTH-AMERICAN SOCIETY; HEALTH-CARE; IMPROVE TRANSITION; READINESS SKILLS; ADOLESCENTS; PATIENT; IBD; RECOMMENDATIONS; GASTROENTEROLOGY; PERSPECTIVES	Background Transition to adult health services is a vulnerable phase in young persons with chronic disease. We describe how young persons with inflammatory bowel disease in Germany and Austria experience care during the transitional age, focusing on differences by type of provider (pediatric vs. adult specialist, no specialist). Methods This was a follow up survey in patients previously registered with a pediatric IBD registry. Patients aged 15 to 25 received a postal questionnaire, including a measure of health care experience and satisfaction. Descriptive analyses were stratified by age. Sub-analyses in the 18-20 year age group compared health care experience by type of provider. Determinants of early or late transfer were examined using multinomial logistic regression. Results 619 patients responded to the survey; 605 questionnaires were available for analysis. Usual age of completing transition was 18. Earlier transfer was more common with low parental SES (OR 1.8, 95% CI 0.7 to 4.6), and less common with advanced schooling (OR 0.5, 95% CI 0.2 to 1.2). Structured transition was uncommon. 48% of the respondents had not received any preceding transition advice. Overall satisfaction with IBD care was high, especially with respect to interpersonal aspects, but less so in aspects of continuity of care. Conclusions Despite high overall patient satisfaction, relevant deficiencies in transitional care were documented. Some of these were associated with lower parental social status. Differences in health care satisfaction by type of provider (adult vs. pediatric) were small.	[Timmer, Antje] Carl von Ossietzky Univ Oldenburg, Med Fac, Dept Hlth Serv Res, Div Epidemiol & Biometry, Oldenburg, Germany; [Timmer, Antje; Peplies, Jenny; Westphal, Max] Leibniz Inst Prevent Res & Epidemiol BIPS GmbH, Dept Clin Epidemiol, Bremen, Germany; [Peplies, Jenny] Inst Publ Hlth & Nursing Res IPP, Fac Human & Hlth Sci, Bremen, Germany; [Kaltz, Birgit] German Crohns Dis & Ulcerat Colitis Assoc Registe, Berlin, Germany; [Ballauff, Antje] Ctr Childrens & Adolescent Med, Krefeld, Germany; [Classen, Martin] Klinikum Links Der Weser, Childrens Hosp, Bremen, Germany; [Laass, Martin W.] Tech Univ, Childrens Hosp, Med Fac Carl Gustav Carus, Dresden, Germany; [Koletzko, Sibylle] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Div Pediat Gastroenterol & Hepatol, Munich, Germany	Carl von Ossietzky Universitat Oldenburg; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munich	Timmer, A (corresponding author), Carl von Ossietzky Univ Oldenburg, Med Fac, Dept Hlth Serv Res, Div Epidemiol & Biometry, Oldenburg, Germany.; Timmer, A (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS GmbH, Dept Clin Epidemiol, Bremen, Germany.	antje.timmer@uni-oldenburg.de	Timmer, Antje/N-8056-2015	Timmer, Antje/0000-0001-9579-0516; Laass, Martin/0000-0003-3670-3640	DCCV Research Grant; patient organization DCCV	DCCV Research Grant; patient organization DCCV	This work was supported by 2009 DCCV Research Grant "Patient oriented Research in IBD" (AT); URL: https://www.dccv.de/betroffene-angehoerige/beratung-informationen/forschung/preistraeger-stipendiaten/. Funding was provided by the patient organization DCCV. BK (author) is an elected representative of DCCV and provided input into the study design, instrument development and manuscript preparation and review.	Amer Acad Pediat, 2011, PEDIATRICS, V128, P182, DOI 10.1542/peds.2011-0969; Baldassano R, 2002, J PEDIATR GASTR NUTR, V34, P245, DOI 10.1097/00005176-200203000-00001; Bensen R, 2016, J PEDIATR GASTR NUTR, V63, P488, DOI 10.1097/MPG.0000000000001199; Bishop J, 2014, ADOLESC HEALTH MED T, V5, P1, DOI 10.2147/AHMT.S37956; Bollegala Natasha, 2013, J Crohns Colitis, V7, pe55, DOI 10.1016/j.crohns.2012.05.010; Buderus S, 2015, DTSCH ARZTEBL INT, V112, P121, DOI 10.3238/arztebl.2015.0121; Campbell Fiona, 2016, Cochrane Database Syst Rev, V4, pCD009794, DOI 10.1002/14651858.CD009794.pub2; Cervesi C, 2013, J PEDIATR GASTR NUTR, V57, P39, DOI 10.1097/MPG.0b013e31828b5fd4; Cooley WC, 2013, JAMA PEDIATR, V167, P897, DOI 10.1001/jamapediatrics.2013.2578; Crow R, 2002, Health Technol Assess, V6, P1; de Silva PSA, 2014, INFLAMM BOWEL DIS, V20, P1458, DOI 10.1097/MIB.0000000000000045; Escher JC, 2009, DIGEST DIS, V27, P382, DOI 10.1159/000228578; Fernandes S., 2010, INT J CHILD ADOLESCE, V3, P507; Fishman LN, 2014, J PEDIATR GASTR NUTR, V59, P221, DOI 10.1097/MPG.0000000000000405; Goodhand J, 2011, J CROHNS COLITIS, V5, P509, DOI 10.1016/j.crohns.2011.03.015; Gray WN, 2016, INFLAMM BOWEL DIS, V22, P372, DOI 10.1097/MIB.0000000000000642; Gray WN, 2015, INFLAMM BOWEL DIS, V21, P1641, DOI 10.1097/MIB.0000000000000419; Gray WN, 2015, INFLAMM BOWEL DIS, V21, P1125, DOI 10.1097/MIB.0000000000000352; Greenley RN, 2010, J PEDIATR PSYCHOL, V35, P857, DOI 10.1093/jpepsy/jsp120; Hait E, 2006, INFLAMM BOWEL DIS, V12, P70, DOI 10.1097/01.MIB.0000194182.85047.6a; Heath G, 2016, PATIENT ED COUNS; Herrmann- Lingen C, 2011, HADS D HOSP ANXIETY; Huang JS, 2012, CLIN GASTROENTEROL H, V10, P626, DOI 10.1016/j.cgh.2012.02.017; Hummel TZ, 2013, J PEDIATR GASTR NUTR, V57, P219, DOI 10.1097/MPG.0b013e3182935474; Jockel KH, 1997, MEASUREMENT QUANTIFI; Kahn Stacy A, 2016, Gastroenterol Hepatol (N Y), V12, P403; Keller KM, 2010, MONATSSCHR KINDERH, V158, P738, DOI 10.1007/s00112-010-2196-2; Leung Y, 2011, INFLAMM BOWEL DIS, V17, P2169, DOI 10.1002/ibd.21576; Louis E, 2015, J CROHNS COLITIS, V9, P685, DOI 10.1093/ecco-jcc/jjv085; Mackner LM, 2013, J PEDIATR GASTR NUTR, V56, P449, DOI 10.1097/MPG.0b013e3182841263; Minden K, 2014, Z RHEUMATOL, V73, P526, DOI 10.1007/s00393-014-1377-0; Muther S, 2014, MONATSSCHR KINDERH, V162, P711, DOI 10.1007/s00112-014-3103-z; Paine CW, 2014, INFLAMM BOWEL DIS, V20, P2083, DOI 10.1097/MIB.0000000000000136; Plevinsky JM, 2014, CHILD CARE HLTH DEV; Radke M, 2015, DEUT MED WOCHENSCHR, V140, P673, DOI 10.1055/s-0041-101713; Rutishauser C, 2014, EUR J PEDIATR, V173, P1067, DOI 10.1007/s00431-014-2291-9; Sadlo A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-97; Scholz D, 2011, KINDER JUGENDMEDIZIN, V11, P283; Schwartz LA, 2011, CHILD CARE HLTH DEV, V37, P883, DOI 10.1111/j.1365-2214.2011.01282.x; Sebastian S, 2012, J CROHNS COLITIS, V6, P830, DOI 10.1016/j.crohns.2012.01.010; Sonneveld HM, 2013, CHILD CARE HLTH DEV, V39, P69, DOI 10.1111/j.1365-2214.2011.01354.x; Timmer A, 2012, DCCV J, V111, P81; Timmer A, 2009, J CLIN EPIDEMIOL, V62, P771, DOI 10.1016/j.jclinepi.2008.07.020; van Groningen J, 2012, INFLAMM BOWEL DIS, V18, P2310, DOI 10.1002/ibd.22937; van Staa AL, 2011, CHILD CARE HLTH DEV, V37, P821, DOI 10.1111/j.1365-2214.2011.01261.x; Whitfield EP, 2015, J PEDIATR GASTR NUTR, V60, P36, DOI 10.1097/MPG.0000000000000555; Winkler J., 2009, WISMAR DISCUSSION PA; Wright EK, 2014, INTERN MED J, V44, P490, DOI 10.1111/imj.12402; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zijlstra M, 2013, J CROHNS COLITIS, V7, pE375, DOI 10.1016/j.crohns.2013.02.017	50	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177757	10.1371/journal.pone.0177757	http://dx.doi.org/10.1371/journal.pone.0177757			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542322	Green Published, Green Accepted, gold			2022-12-27	WOS:000401672400078
J	Young, B; King, JL; Budowle, B; Armogida, L				Young, Brian; King, Jonathan L.; Budowle, Bruce; Armogida, Luigi			A technique for setting analytical thresholds in massively parallel sequencing-based forensic DNA analysis	PLOS ONE			English	Article							ION PGM(TM); KIT; PLATFORM; STRS; MICROHAPLOTYPES; MARKERS; UTILITY; SYSTEM; NOISE; LOCI	Amplicon (targeted) sequencing by massively parallel sequencing (PCR-MPS) is a potential method for use in forensic DNA analyses. In this application, PCR-MPS may supplement or replace other instrumental analysis methods such as capillary electrophoresis and Sanger sequencing for STR and mitochondrial DNA typing, respectively. PCR-MPS also may enable the expansion of forensic DNA analysis methods to include new marker systems such as single nucleotide polymorphisms (SNPs) and insertion/deletions (indels) that currently are assayable using various instrumental analysis methods including microarray and quantitative PCR. Acceptance of PCR-MPS as a forensic method will depend in part upon developing protocols and criteria that define the limitations of a method, including a defensible analytical threshold or method detection limit. This paper describes an approach to establish objective analytical thresholds suitable for multiplexed PCR-MPS methods. A definition is proposed for PCR-MPS method background noise, and an analytical threshold based on background noise is described.	[Young, Brian; Armogida, Luigi] NicheVis Forens, Akron, OH 44311 USA; [King, Jonathan L.; Budowle, Bruce] Univ North Texas, Hlth Sci Ctr, Ctr Human Identificat, 3500 Camp Bowie Blvd, Ft Worth, TX USA; [Budowle, Bruce] King Abdulaziz Univ, CEGMR, Jeddah, Saudi Arabia	University of North Texas System; University of North Texas Denton; University of North Texas Health Science Center; King Abdulaziz University	Young, B (corresponding author), NicheVis Forens, Akron, OH 44311 USA.	brian@nichevision.com		Young, Brian/0000-0001-5665-7990; King, Jonathan/0000-0003-4541-1789	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice [2015-DN-BX- K067]; NicheVision, Inc.	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice; NicheVision, Inc.	This work was supported in part by award no. 2015-DN-BX- K067, awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect those of the U.S. Department of Justice. NicheVision, Inc. provided support in the form of salaries for authors BY, LA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applied Biosystems, APPL BIOS PUB; Bornman DM, 2012, BIOTECHNIQUES; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Bregu J, 2013, J FORENSIC SCI, V58, P120, DOI 10.1111/1556-4029.12008; Churchill JD, 2016, FORENSIC SCI INT-GEN, V20, P20, DOI 10.1016/j.fsigen.2015.09.009; Churchill JD, 2015, CROAT MED J, V56, P218, DOI 10.3325/cmj.2015.56.218; Coble MD, 2005, J FORENSIC SCI, V50, P43; Flores S, 2014, FORENSIC SCI INT-GEN, V10, P33, DOI 10.1016/j.fsigen.2014.01.005; Fordyce SL, 2015, FORENSIC SCI INT-GEN, V14, P132, DOI 10.1016/j.fsigen.2014.09.020; Friis SL, 2016, FORENSIC SCI INT-GEN, V21, P68, DOI 10.1016/j.fsigen.2015.12.006; Gettings KB, 2015, FORENSIC SCI GENE S; Gilder JR, 2007, J FORENSIC SCI, V52, P97, DOI 10.1111/j.1556-4029.2006.00318.x; Guo F, 2016, FORENSIC SCI INT-GEN, V23, P111, DOI 10.1016/j.fsigen.2016.04.004; Hoogenboom J, 2017, FORENSIC SCI INT-GEN, V27, P27, DOI 10.1016/j.fsigen.2016.11.007; Illumina, 2015, FORENSEQTM UN AN SOF; Kidd KK, 2014, FORENSIC SCI INT-GEN, V12, P215, DOI 10.1016/j.fsigen.2014.06.014; Leclair B., 2004, J FORENSIC SCI, V49, P1, DOI [10.1520/jfs2003312, DOI 10.1520/JFS2003312]; Novroski NMM, 2016, FORENSIC SCI INT-GEN, V25, P214, DOI 10.1016/j.fsigen.2016.09.007; Scheible M, 2014, FORENSIC SCI INT-GEN, V12, P107, DOI 10.1016/j.fsigen.2014.04.010; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Scientific Working Group on DNA Analysis Methods (SWGDAM), SWGDAM INT GUID AUT; Van Neste C, 2014, FORENSIC SCI INT-GEN, V9, P1, DOI 10.1016/j.fsigen.2013.10.012; Vilsen SB, 2015, FORENS SCI INT-GEN S, V5, pE416, DOI 10.1016/j.fsigss.2015.09.165; Warshauer DH, 2013, FORENSIC SCI INT-GEN, V7, P409, DOI 10.1016/j.fsigen.2013.04.005; Wendt FR, 2016, FORENSIC SCI INT-GEN, V25, P198, DOI 10.1016/j.fsigen.2016.09.005; Zeng XP, 2015, FORENSIC SCI INT-GEN, V19, P172, DOI 10.1016/j.fsigen.2015.07.015; Zubakov D, 2015, FORENSIC SCI INT-GEN, V17, P122, DOI 10.1016/j.fsigen.2015.04.002	27	13	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178005	10.1371/journal.pone.0178005	http://dx.doi.org/10.1371/journal.pone.0178005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542338	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400129
J	Wani, NA; Vettical, BS; Hong, SB				Wani, Nisar Ahmad; Vettical, Binoy S.; Hong, Seung B.			First cloned Bactrian camel (Camelus bactrianus) calf produced by interspecies somatic cell nuclear transfer: A step towards preserving the critically endangered wild Bactrian camels	PLOS ONE			English	Article							CYTOPLASM SUPPORTS DEVELOPMENT; IN-VITRO; TRANSFER EMBRYOS; SKIN FIBROBLASTS; BOVINE OOCYTES; CAT OOCYTES; TRICHOSTATIN; DROMEDARIUS; COMPETENCE; DEVELOP	Studies were conducted to explore the possibility of employing dromedary camel (Camelus dromedarius) oocytes as recipient cytoplasts for the development of interspecies somatic cell nuclear transfer (iSCNT) embryos using skin fibroblast cells of an adult Bactrian camel (Camelus bactrianus) and Llama (Llama glama) as donor nuclei. Also, the embryos reconstructed with Bactrian cells were transferred into the uterus of synchronized dromedary camel recipients to explore the possibility of using them as surrogate mothers. Serum-starved skin fibroblast cells were injected into the perivitelline space of enucleated mature oocytes, collected from super-stimulated dromedary camels, and fused using an Eppendorf electroporator. After activation with 5 mu M ionomycin and 6-dimethylaminopurine, they were cultured at 38.5 degrees C in an atmosphere of 5% CO2, 5% O-2, and 90% N-2 in air. In experiment 1, Day 7 blastocysts were stained with Hoechst to count their cell numbers, while in experiment 2, they were transferred to synchronized dromedary recipients. A lower number (P < 0.05) of blastocysts were obtained from reconstructs utilizing fibroblast cells from Llama when compared with those reconstructed with dromedary and Bactrian fibroblast cells. However, no difference was observed in their cell numbers. In experiment 2, a higher (P < 0.05) proportion of blastocysts were obtained from the cleaved embryos reconstructed with Bactrian fibroblast cells when compared to those reconstructed with dromedary cells. Twenty-six Day 7 blastocysts reconstructed with Bactrian cells were transferred to 23 synchronized dromedary recipients with 5 pregnancies established on Day 30, however, only one of the pregnancies developed to term and a healthy calf weighing 33 kgs was born after completing 392 days of gestation. Unfortunately, the calf died on day 7 due to acute septicemia. In conclusion, the present study reports, for the first time, birth of a cloned Bactrian calf by iSCNT using dromedary camel as a source for oocytes as well as a surrogate for carrying the pregnancy to term.	[Wani, Nisar Ahmad; Vettical, Binoy S.; Hong, Seung B.] Reprod Biotechnol Ctr, Dubai, U Arab Emirates		Wani, NA (corresponding author), Reprod Biotechnol Ctr, Dubai, U Arab Emirates.	nwani@reprobiotech.ae	Vettical, Binoy S/ABA-9952-2021	Vettical, Binoy S/0000-0003-1428-7885; Wani, Nisar/0000-0002-9149-5840	H.H. Sheikh Hamadan bin Mohammed bin Rashid al Makhtoum, Crown Prince of Dubai, UAE	H.H. Sheikh Hamadan bin Mohammed bin Rashid al Makhtoum, Crown Prince of Dubai, UAE	This study was kindly sponsored by H.H. Sheikh Hamadan bin Mohammed bin Rashid al Makhtoum, Crown Prince of Dubai, UAE.; The authors are grateful to Mr. A.N. Siddiqui, Rasaluddin, Mazhar Islam for their help in handling and treatment of animals. We are highly thankful to Dr. Ali Ridha, administrative director, for his unconditional support. This study was kindly sponsored by H.H. Sheikh Hamadan bin Mohammed bin Rashid al Makhtoum, Crown Prince of Dubai, UAE.	Agab H, 1999, WORLD ANIM REV, P42; Chang KH, 2003, FERTIL STERIL, V80, P1380, DOI 10.1016/j.fertnstert.2003.07.006; Chaudhary Z. I., 2000, Selected topics on camelids., P466; CHEN BX, 1980, ACTA VET ZOOTECH SIN, V11, P65; Chen JQ, 2007, MOL REPROD DEV, V74, P568, DOI 10.1002/mrd.20647; Dominko T, 1999, BIOL REPROD, V60, P1496, DOI 10.1095/biolreprod60.6.1496; Gomez MC, 2008, CLONING STEM CELLS, V10, P469, DOI 10.1089/clo.2008.0021; Gomez MC, 2004, CLONING STEM CELLS, V6, P247, DOI 10.1089/clo.2004.6.247; Hashem MA, 2007, MOL REPROD DEV, V74, P403, DOI 10.1002/mrd.20528; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; Hosseini SM, 2012, CELL REPROGRAM, V14, P155, DOI 10.1089/cell.2011.0061; Hwang I., 2012, REPROD FERTIL DEV, DOI 10. 1071/RD12256; Illmensee K, 2006, FERTIL STERIL, V85, P1248, DOI 10.1016/j.fertnstert.2005.10.026; Kenneth L., 2001, CURR BIOL, V11, P245; Kim MK, 2007, CLONING STEM CELLS, V9, P130, DOI 10.1089/clo.2006.0034; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Liu SZ, 2004, MOL REPROD DEV, V69, P296, DOI 10.1002/mrd.20091; Loi P, 2001, NAT BIOTECHNOL, V19, P962, DOI 10.1038/nbt1001-962; Mastromonaco GF, 2007, BIOL REPROD, V76, P514, DOI 10.1095/biolreprod.106.058040; Ryder OA, 2000, SCIENCE, V288, P275, DOI 10.1126/science.288.5464.275; Seifert H.S., 1996, TROPICAL ANIMAL HLTH; Shi DS, 2007, BIOL REPROD, V77, P285, DOI 10.1095/biolreprod.107.060210; Shi LH, 2008, DEV DYNAM, V237, P640, DOI 10.1002/dvdy.21450; Srirattana K, 2012, CELL REPROGRAM, V14, P248, DOI 10.1089/cell.2011.0099; Sugimura S, 2009, THERIOGENOLOGY, V72, P549, DOI 10.1016/j.theriogenology.2009.04.011; Uhm SJ, 2007, MOL REPROD DEV, V74, P1538, DOI 10.1002/mrd.20755; Visscher PM, 2001, NATURE, V409, P303, DOI 10.1038/35053160; Wani NA, 2008, THERIOGENOLOGY, V69, P591, DOI 10.1016/j.theriogenology.2007.11.011; Wani NA, 2010, THERIOGENOLOGY, V74, P436, DOI 10.1016/j.theriogenology.2010.02.026; Wani NA, 2009, ANIM REPROD SCI, V111, P69, DOI 10.1016/j.anireprosci.2008.02.005; Wani NA, 2010, BIOL REPROD, V82, P373, DOI 10.1095/biolreprod.109.081083; Wen DC, 2005, J EXP ZOOL PART A, V303A, P689, DOI 10.1002/jez.a.191; Wernery U, 2002, INFECT DIS CAMELIDS, P79; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilson RT, 1984, THE CAMEL; Wooding FBP, 2003, REPRODUCTION, V126, P239, DOI 10.1530/reprod/126.2.239; Yin XJ, 2006, ANIM REPROD SCI, V95, P307, DOI 10.1016/j.anireprosci.2005.10.009; Zhao ZJ, 2006, J REPROD DEVELOP, V52, P449, DOI 10.1262/jrd.17095	38	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177800	10.1371/journal.pone.0177800	http://dx.doi.org/10.1371/journal.pone.0177800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545049	Green Published, gold, Green Submitted			2022-12-27	WOS:000401487700081
J	Fang, JS; Wang, L; Li, YC; Lian, WW; Pang, XC; Wang, H; Yuan, DS; Wang, Q; Liu, AL; Du, GH				Fang, Jiansong; Wang, Ling; Li, Yecheng; Lian, Wenwen; Pang, Xiaocong; Wang, Hong; Yuan, Dongsheng; Wang, Qi; Liu, Ai-Lin; Du, Guan-Hua			AlzhCPI: A knowledge base for predicting chemical-protein interactions towards Alzheimer's disease	PLOS ONE			English	Article							TARGET-DIRECTED LIGANDS; DRUG DISCOVERY; MULTITARGET; DATABASE; MODELS; QSAR	Alzheimer's disease (AD) is a complicated progressive neurodegeneration disorder. To confront AD, scientists are searching for multi-target-directed ligands (MTDLs) to delay disease progression. The in silico prediction of chemical-protein interactions (CPI) can accelerate target identification and drug discovery. Previously, we developed 100 binary classifiers to predict the CPI for 25 key targets against AD using the multi-target quantitative structureactivity relationship (mt-QSAR) method. In this investigation, we aimed to apply the mtQSAR method to enlarge the model library to predict CPI towards AD. Another 104 binary classifiers were further constructed to predict the CPI for 26 preclinical AD targets based on the naive Bayesian (NB) and recursive partitioning (RP) algorithms. The internal 5-fold cross-validation and external test set validation were applied to evaluate the performance of the training sets and test set, respectively. The area under the receiver operating characteristic curve (ROC) for the test sets ranged from 0.629 to 1.0, with an average of 0.903. In addition, we developed a web server named AlzhCPI to integrate the comprehensive information of approximately 204 binary classifiers, which has potential applications in network pharmacology and drug repositioning. AlzhCPI is available online at http://rcidm.org/AlzhCPI/index. html. To illustrate the applicability of AlzhCPI, the developed system was employed for the systems pharmacology-based investigation of shichangpu against AD to enhance the understanding of the mechanisms of action of shichangpu from a holistic perspective.	[Fang, Jiansong; Wang, Hong; Yuan, Dongsheng; Wang, Qi] Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou, Guangdong, Peoples R China; [Fang, Jiansong; Wang, Qi] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Encephalopathy, Guangzhou, Guangdong, Peoples R China; [Wang, Ling; Li, Yecheng] South China Univ Technol, Sch Biosci & Bioengn, Guangdong Prov Key Lab Fermentat & Enzyme Engn, Preincubator Innovat Drugs & Med, Guangzhou, Guangdong, Peoples R China; [Lian, Wenwen; Pang, Xiaocong; Liu, Ai-Lin; Du, Guan-Hua] Chinese Acad Med Sci, Inst Mat Med, Beijing, Peoples R China; [Lian, Wenwen; Pang, Xiaocong; Liu, Ai-Lin; Du, Guan-Hua] Peking Union Med Coll, Beijing, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; South China University of Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, Q (corresponding author), Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou, Guangdong, Peoples R China.; Wang, Q (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Encephalopathy, Guangzhou, Guangdong, Peoples R China.; Liu, AL; Du, GH (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Beijing, Peoples R China.; Liu, AL; Du, GH (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	wqitcm@qq.com; liuailin@imm.ac.cn; dugh@imm.ac.cn		Wang, Qi/0000-0001-7626-676X	National Natural Science Foundation of China [81603318, 81673627, 81473740]; CAMS Initiative for Innovative Medicine [2016-I2M-3007]; Guangdong Provincial Major Science and Technology for Special Program of China [2012A080202017]; South China Chinese Medicine Collaborative Innovation Center [A1AFD01514A05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine; Guangdong Provincial Major Science and Technology for Special Program of China; South China Chinese Medicine Collaborative Innovation Center	This work was supported by the National Natural Science Foundation of China (No. 81603318, No. 81673627, No. 81473740), CAMS Initiative for Innovative Medicine (No.2016-I2M-3007), Guangdong Provincial Major Science and Technology for Special Program of China (No.2012A080202017), and South China Chinese Medicine Collaborative Innovation Center (No.A1AFD01514A05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (No. 81603318, No.81673627, No.81473740), CAMS Initiative for Innovative Medicine (No.201612M-3-007), Guangdong Provincial Major Science and Technology for Special Program of China (No.2012A080202017).	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Baig MH, 2016, CURR PHARM DESIGN, V22, P572, DOI 10.2174/1381612822666151125000550; Boutet E, 2016, METHODS MOL BIOL, V1374, P23, DOI 10.1007/978-1-4939-3167-5_2; Cao YY, 2013, MOL DIVERS, V17, P515, DOI 10.1007/s11030-013-9452-z; Chen L, 2011, MOL PHARMACEUT, V8, P889, DOI 10.1021/mp100465q; Cheng FX, 2012, MOL BIOSYST, V8, P2373, DOI 10.1039/c2mb25110h; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Fang JS, 2015, J CHEM INF MODEL, V55, P149, DOI 10.1021/ci500574n; Fang JS, 2015, MOL DIVERS, V19, P149, DOI 10.1007/s11030-014-9561-3; Fang JS, 2013, J CHEM INF MODEL, V53, P3009, DOI 10.1021/ci400331p; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Guzior N, 2015, CURR MED CHEM, V22, P373; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; [胡增峣 Hu Zengyao], 2012, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V28, P252; Huang L, 2014, EUR J MED CHEM, V87, P429, DOI 10.1016/j.ejmech.2014.09.081; Kotecha R, 2016, ONCOTARGET, V7, P52517, DOI 10.18632/oncotarget.9593; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Li G., 2013, ZHONGCAOYAO, V44, P808; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Luo C, 2014, J CHINA PRESCRIPTION, V12, P120; Luo ZH, 2013, J MED CHEM, V56, P9089, DOI 10.1021/jm401047q; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Medina-Franco JL, 2013, DRUG DISCOV TODAY, V18, P495, DOI 10.1016/j.drudis.2013.01.008; Misra S, 2013, NEUROL SCI, V34, P831, DOI 10.1007/s10072-013-1316-x; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Qin C, 2014, NUCLEIC ACIDS RES, V42, pD1118, DOI 10.1093/nar/gkt1129; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Rognan D, 2010, MOL INFORM, V29, P176, DOI 10.1002/minf.200900081; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Wang SC, 2012, MOL PHARMACEUT, V9, P996, DOI 10.1021/mp300023x; [吴春华 Wu Chunhua], 2014, [中国药物化学杂志, Chinese Journal of Medicinal Chemistry], V24, P209; Wu TY, 2011, TAIWAN J OBSTET GYNE, V50, P131, DOI 10.1016/j.tjog.2011.04.004; Xue RC, 2013, NUCLEIC ACIDS RES, V41, pD1089, DOI 10.1093/nar/gks1100; Yan X, 2012, MOL DIVERS, V16, P759, DOI 10.1007/s11030-012-9403-0; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zanni R, 2014, CURR COMPUT-AID DRUG, V10, P129, DOI 10.2174/157340991002140708105124; Zhang F, 2015, BIOMED CHROMATOGR, V29, P890, DOI 10.1002/bmc.3371; Zhang S, 2016, MOL NEUROBIOL, V53, P83, DOI 10.1007/s12035-014-8950-z; Zheng MH, 2014, MOL DIVERS, V18, P829, DOI 10.1007/s11030-014-9545-3	44	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178347	10.1371/journal.pone.0178347	http://dx.doi.org/10.1371/journal.pone.0178347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542505	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800077
J	Karttunen, MJ; Czopka, T; Goedhart, M; Early, JJ; Lyons, DA				Karttunen, Marja J.; Czopka, Tim; Goedhart, Marieke; Early, Jason J.; Lyons, David A.			Regeneration of myelin sheaths of normal length and thickness in the zebrafish CNS correlates with growth of axons in caliber	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS LESIONS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OLIGODENDROCYTE PRECURSOR CELLS; SPINAL-CORD-INJURY; CONDUCTION-VELOCITY; PROGENITOR CELLS; MOUSE MODEL; IN-VIVO; REMYELINATION	Demyelination is observed in numerous diseases of the central nervous system, including multiple sclerosis (MS). However, the endogenous regenerative process of remyelination can replace myelin lost in disease, and in various animal models. Unfortunately, the process of remyelination often fails, particularly with ageing. Even when remyelination occurs, it is characterised by the regeneration of myelin sheaths that are abnormally thin and short. This imperfect remyelination is likely to have implications for the restoration of normal circuit function and possibly the optimal metabolic support of axons. Here we describe a larval zebrafish model of demyelination and remyelination. We employ a drug-inducible cell ablation system with which we can consistently ablate 2/3rds of oligodendrocytes in the larval zebrafish spinal cord. This leads to a concomitant demyelination of 2/3rds of axons in the spinal cord, and an innate immune response over the same time period. We find restoration of the normal number of oligodendrocytes and robust remyelination approximately two weeks after induction of cell ablation, whereby myelinated axon number is restored to control levels. Remarkably, we find that myelin sheaths of normal length and thickness are regenerated during this time. Interestingly, we find that axons grow significantly in caliber during this period of remyelination. This suggests the possibility that the active growth of axons may stimulate the regeneration of myelin sheaths of normal dimensions.	[Karttunen, Marja J.; Czopka, Tim; Goedhart, Marieke; Early, Jason J.; Lyons, David A.] Univ Edinburgh, Ctr Neuroregenerat, MS Soc Ctr Translat Res, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland; [Czopka, Tim] Tech Univ Munich, Inst Neuronal Cell Biol, Munich, Germany	University of Edinburgh; Technical University of Munich	Lyons, DA (corresponding author), Univ Edinburgh, Ctr Neuroregenerat, MS Soc Ctr Translat Res, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland.	david.lyons@ed.ac.uk	Czopka, Tim/N-4970-2015	Czopka, Tim/0000-0002-6824-8112; Lyons, David/0000-0003-1166-4454; Early, Jason/0000-0003-4313-6445	Lister Institute of Preventative Medicine; Medical Research Council [1292846] Funding Source: researchfish; Wellcome Trust [102836/Z/13/Z] Funding Source: researchfish	Lister Institute of Preventative Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Lister Institute of Preventative Medicine (DL), Research Prize (no grant number), http://www.lister-institute.org.uk/.	Albert M, 2007, BRAIN PATHOL, V17, P129, DOI 10.1111/j.1750-3639.2006.00043.x; Almeida R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164432; Almeida RG, 2011, DEVELOPMENT, V138, P4443, DOI 10.1242/dev.071001; Bechler ME, 2015, CURR BIOL, V25, P2411, DOI 10.1016/j.cub.2015.07.056; Bin JM, BPL, V2, P3; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; BLAKEMORE WF, 1981, J NEUROL SCI, V49, P273, DOI 10.1016/0022-510X(81)90084-8; BLAKEMORE WF, 1974, NATURE, V249, P577, DOI 10.1038/249577a0; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chung A-Y, 2013, MOL CELLS; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Davie CA, 1995, BRAIN, V118, P1583, DOI 10.1093/brain/118.6.1583; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Ettle B, 2016, MOL NEUROBIOL MOL NE, P1; Etxeberria A, 2016, J NEUROSCI, V36, P6937, DOI 10.1523/JNEUROSCI.0908-16.2016; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fang Y, 2014, BIOL OPEN; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Filley CM, 2016, J NEUROPHYSIOL, V116, P2093, DOI 10.1152/jn.00221.2016; Ford MC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9073; Franklin RJM, 1999, J NEUROSCI RES, V58, P207, DOI 10.1002/(SICI)1097-4547(19991015)58:2<207::AID-JNR1>3.0.CO;2-1; Franklin RJM, 2002, NEUROREPORT, V13, P923, DOI 10.1097/00001756-200205240-00001; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020594; Franklin RJM, 2012, NAT REV NEUROL, V8, P624, DOI 10.1038/nrneurol.2012.200; Fyffe-Maricich SL, 2013, J NEUROSCI, V33, P18402, DOI 10.1523/JNEUROSCI.2381-13.2013; Gautier HOB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9518; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Ginsberg MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044736; GLEDHILL RF, 1973, NATURE, V244, P443, DOI 10.1038/244443a0; Goebbels S, 2016, NAT NEUROSCI; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Gritsch S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6472; HALTER JA, 1991, J THEOR BIOL, V148, P345, DOI 10.1016/S0022-5193(05)80242-5; Hickey WF, 1999, J NEUROIMMUNOL, V98, P37, DOI 10.1016/S0165-5728(99)00079-X; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; James ND, 2011, J NEUROSCI, V31, P18543, DOI 10.1523/JNEUROSCI.4306-11.2011; Kasibhatla S., 2006, CSH PROTOC, V2006; Kaya F, 2012, J NEUROSCI, V32, P12885, DOI 10.1523/JNEUROSCI.2252-12.2012; KOLES ZJ, 1972, J PHYSIOL-LONDON, V227, P351, DOI 10.1113/jphysiol.1972.sp010036; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Koudelka S, 2016, CURR BIOL, P1; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Liebetanz D, 2006, EXP NEUROL, V202, P217, DOI 10.1016/j.expneurol.2006.05.032; Lloyd AF, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00060; Locatelli G, 2012, NAT NEUROSCI, V15, P543, DOI 10.1038/nn.3062; Love S, 2006, J CLIN PATHOL, V59, P1151, DOI 10.1136/jcp.2005.031195; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; LUDWIN SK, 1984, J NEUROL SCI, V64, P193, DOI 10.1016/0022-510X(84)90037-6; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Mei F, 2014, NAT MED, P1; Mei F, 2016, ELIFE, V5, DOI 10.7554/eLife.18246; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Micheva KD, 2016, ELIFE, V5, DOI 10.7554/eLife.15784; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; Munzel EJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0077-y; Natrajan MS, 2015, BRAIN, V138, P3581, DOI 10.1093/brain/awv289; Nave KA, 2014, JAMA PSYCHIAT, V71, P582, DOI 10.1001/jamapsychiatry.2014.189; Olmos-Serrano JL, 2016, DOWN SYNDROME DEVELO, P1; OZAWA K, 1994, BRAIN, V117, P1311, DOI 10.1093/brain/117.6.1311; Papastefanaki F, 2015, GLIA, V63, P1101, DOI 10.1002/glia.22809; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; PERIER O, 1965, BRAIN, V88, P937, DOI 10.1093/brain/88.5.937; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; Powers BE, 2013, P NATL ACAD SCI USA, V110, P4075, DOI 10.1073/pnas.1210293110; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Saab AS, 2013, CURR OPIN NEUROBIOL, V23, P1065, DOI 10.1016/j.conb.2013.09.008; Saab AS, 2016, NEURON, P1; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Samanta J, 2015, NATURE, V526, P448, DOI 10.1038/nature14957; Seidl AH, 2014, NEUROSCIENCE, V276, P126, DOI 10.1016/j.neuroscience.2013.06.047; Sekizar S, 2015, DEV NEUROSCI-BASEL, V37, P232, DOI 10.1159/000380817; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; Tomassy GS, 2016, TRENDS CELL BIOL, V26, P135, DOI 10.1016/j.tcb.2015.09.002; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Traka M, 2010, BRAIN, V133, P3017, DOI 10.1093/brain/awq247; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Wake H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8844; WAXMAN SG, 1972, J CELL BIOL, V53, P210, DOI 10.1083/jcb.53.1.210; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; WAXMAN SG, 1984, BRAIN RES, V292, P179, DOI 10.1016/0006-8993(84)90905-3; WAXMAN SG, 1970, NATURE, V227, P283, DOI 10.1038/227283a0; Williams A, 2007, GLIA, V55, P1300, DOI 10.1002/glia.20546; Wolswijk G, 1998, J NEUROSCI, V18, P601; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002	99	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178058	10.1371/journal.pone.0178058	http://dx.doi.org/10.1371/journal.pone.0178058			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542521	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800041
J	Rodriguez-Lopez, M; Wagner, P; Perez-Vicente, R; Crispi, F; Merlo, J				Rodriguez-Lopez, Merida; Wagner, Philippe; Perez-Vicente, Raquel; Crispi, Fatima; Merlo, Juan			Revisiting the discriminatory accuracy of traditional risk factors in preeclampsia screening	PLOS ONE			English	Article							GESTATIONAL HYPERTENSION; 1ST-TRIMESTER PREDICTION; PREGNANCY; SMOKING; OBESITY; COHORT; HEALTH	Background Preeclampsia (PE) is associated with a high risk of perinatal morbidity and mortality. However, there is no consensus in the definition of high-risk women. Aim To question current definition of high PE risk and propose a definition that considers individual heterogeneity to improves risk classification. Methods A stratified analysis by parity was conducted using the Swedish Birth Register between 2002-2010 including 626.600 pregnancies. The discriminatory accuracy (DA) of traditional definitions of high-risk women was compared with a new definition based on 1) specific combinations of individual variables and 2) a centile cut-off of the probability of PE predicted by a multiple logistic regression model. Results None of the classical risk-factors alone reached an acceptable DA. In multiparous, any combination of a risk-factor with previous PE or HBP reached a + LR> 10. The combination of obesity and multiple pregnancy reached a good DA particularly in the presence of previous preeclampsia (positive likelihood ratio (LR+) = 26.5 or chronic hypertension (HBP) LR+ = 40.5. In primiparous, a LR+> 15 was observed in multiple pregnancies with the simultaneous presence of obesity and diabetes mellitus or with HBP. Predicted probabilities above 97 centile in multiparous and 99 centile in primiparous provided high (LR+ = 12.5), and moderate (LR+ = 5.85), respectively. No one risk factor alone or in combination provided a LR-sufficiently low to rule-out the disease. Conclusions In preeclampsia prediction the combination of specific risk factors provided a better discriminatory accuracy than traditional single risk approach. Our results contribute to a more personalized risk estimation of preeclampsia.	[Rodriguez-Lopez, Merida; Wagner, Philippe; Perez-Vicente, Raquel; Merlo, Juan] Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden; [Rodriguez-Lopez, Merida; Crispi, Fatima] Univ Barcelona, Fetal I D Fetal Med Res Ctr, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Hosp Clin, Barcelona, Spain; [Rodriguez-Lopez, Merida; Crispi, Fatima] Univ Barcelona, Hosp St Joan de Deu, Inst Clin Ginecol Obstet & Neonatol, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Rodriguez-Lopez, Merida; Crispi, Fatima] Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain	Lund University; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Rodriguez-Lopez, M (corresponding author), Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden.; Rodriguez-Lopez, M (corresponding author), Univ Barcelona, Fetal I D Fetal Med Res Ctr, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Hosp Clin, Barcelona, Spain.; Rodriguez-Lopez, M (corresponding author), Univ Barcelona, Hosp St Joan de Deu, Inst Clin Ginecol Obstet & Neonatol, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain.; Rodriguez-Lopez, M (corresponding author), Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain.	merida.rdguez@gmail.com	Rodriguez-Lopez, Merida/N-9273-2017; Merlo, Juan/E-2136-2011	Rodriguez-Lopez, Merida/0000-0001-8245-0811; Merlo, Juan/0000-0001-8379-9708	Erasmus + Programme of the European Union [2013-0040]; Swedish Research Council (PI: JM) [2013-2484]; "la Caixa" Foundation; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR SGR [928]	Erasmus + Programme of the European Union; Swedish Research Council (PI: JM)(Swedish Research Council); "la Caixa" Foundation(La Caixa Foundation); Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR SGR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was partially supported by the Erasmus + Programme of the European Union (Framework Agreement number: 2013-0040) to MR-L. This publication reflects the views only of the author, and the Commission cannot be held responsible for any use, which may be made of the information contained therein. This work was also supported by the Swedish Research Council (PI: JM, 2013-2484). Additionally, the research leading to these results has received funding from "la Caixa" Foundation; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK) and AGAUR 2014 SGR grant no 928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy, 2013, OBSTET GYNECOL, V122, P1122, DOI [DOI 10.1097/01.AOG.0000437382.03963.88, 10.1097/01.AOG.0000437382.03963.88]; Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753; Baschat AA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.018; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Choi BCK, 1997, EPIDEMIOLOGY, V8, P80, DOI 10.1097/00001648-199701000-00013; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Craici Iasmina, 2008, Ther Adv Cardiovasc Dis, V2, P249, DOI 10.1177/1753944708094227; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Egeland GM, 2016, HYPERTENSION, V67, P1173, DOI 10.1161/HYPERTENSIONAHA.116.07099; England LJ, 2002, AM J OBSTET GYNECOL, V186, P1035, DOI 10.1067/mob.2002.122404; Goetzinger KR, 2014, AM J PERINAT, V31, P1049, DOI 10.1055/s-0034-1371705; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; HUNTER S, 1992, BRIT HEART J, V68, P540; Juarez SP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005388; Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Li X, 2016, PREGNANCY HYPERTENS, V6, P66, DOI 10.1016/j.preghy.2015.11.004; McGee S, 2002, J GEN INTERN MED, V17, P646; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2013, WORKING PAPERS UNIT; Merlo J, 2015, EUR J PUBLIC HEALTH, V25, P910, DOI 10.1093/eurpub/ckv209; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; Moon M, J MATERN FETAL NEONA, V28, P2028; Munkhaugen J, 2009, NEPHROL DIAL TRANSPL, V24, P3744, DOI 10.1093/ndt/gfp320; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Oliveira N, 2014, ULTRASOUND OBST GYN, V44, P279, DOI 10.1002/uog.13435; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Petersson K, BMC HLTH SERV RES, V14, P364; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Poon LC, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/297397; Redman CW, HEART, V97, P1967; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Robinson C, 2015, AM J PERINATOL; Ros HS, 1998, AM J EPIDEMIOL, V147, P1062; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sohlberg S, 2012, AM J HYPERTENS, V25, P120, DOI 10.1038/ajh.2011.175; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082; World Health Organization, 2011, WHO REC PREV TREATM; Wright D, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.018; Yoo Wonsuk, 2012, Int J Appl Sci Technol, V2, P268	43	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178528	10.1371/journal.pone.0178528	http://dx.doi.org/10.1371/journal.pone.0178528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542517	gold, Green Submitted, Green Published			2022-12-27	WOS:000402062800101
J	Rodriguez-Gonzalez, A; Sarabeev, V; Balbuena, JA				Rodriguez-Gonzalez, Abril; Sarabeev, Volodimir; Antonio Balbuena, Juan			Evolutionary morphology in shape and size of haptoral anchors in 14 Ligophorus spp. (Monogenea: Dactylogyridae)	PLOS ONE			English	Article							MULLET MUGIL-CEPHALUS; PHYLOGENETIC SIGNAL; HOST-SPECIFICITY; GEOMETRIC MORPHOMETRICS; TELEOSTEI MUGILIDAE; PARASITES; CONSERVATISM; INTEGRATION; MODULARITY; PATTERNS	The search for phylogenetic signal in morphological traits using geometric morphometrics represents a powerful approach to estimate the relative weights of convergence and shared evolutionary history in shaping organismal form. We assessed phylogenetic signal in the form of ventral and dorsal haptoral anchors of 14 species of Ligophorus occurring on grey mullets (Osteichthyes: Mugilidae) from the Mediterranean, the Black Sea and the Sea of Azov. The phylogenetic relationships among these species were mapped onto the morphospaces of shape and size of dorsal and ventral anchors and two different tests were applied to establish whether the spatial positions in the morphospace were dictated by chance. Overall significant phylogenetic signal was found in the data. Allometric effects on anchor shape were moderate or non-significant in the case of evolutionary allometry. Relatively phylogenetically distant species occurring on the same host differed markedly in anchor morphology indicating little influence of host species on anchor form. Our results suggest that common descent and shared evolutionary history play a major role in determining the shape and, to a lesser degree in the size of haptoral anchors in Ligophorus spp. The present approach allowed tracing paths of morphological evolution in anchor shape. Species with narrow anchors and long shafts were associated predominately with Liza saliens. This morphology was considered to be ancestral relative to anchors of species occurring on Liza haematocheila and M. cephalus possessing shorter shafts and longer roots. Evidence for phylogenetic signal was more compelling for the ventral anchors, than for the dorsal ones, which could reflect different functional roles in attachment to the gills. Although phylogeny and homoplasy may act differently in other monogeneans, the present study delivers a common framework to address effectively the relationships among morphology, phylogeny and other traits, such as host specificity or niche occupancy.	[Rodriguez-Gonzalez, Abril; Antonio Balbuena, Juan] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Marine Zool Unit, Sci Pk, Valencia, Spain; [Sarabeev, Volodimir] Zaporizhzhia Natl Univ, Dept Biol, Zhaporizhzhia, Ukraine	University of Valencia; Ministry of Education & Science of Ukraine; Zaporizhzhia National University	Rodriguez-Gonzalez, A (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Marine Zool Unit, Sci Pk, Valencia, Spain.	arogon5@uv.es	Sarabeev, Volodimir/H-9936-2018; Balbuena, Juan Antonio/O-6404-2014	Balbuena, Juan Antonio/0000-0003-4006-1353; Rodriguez Gonzalez, Abril/0000-0002-9940-5299; Sarabeev, Volodimir/0000-0003-4724-3141	Consejo Nacional de Ciencia y Tecnologia (CONACYT-CONCYTEY) of the Mexican Government; Consejo Nacional de Ciencia y Tecnologia (CONACYT-CONCYTEY) of the Yucatan State, Mexico [204397]; National Plan for Scientific Research, Development and Technological Innovation of Spain [CGL2008-02701]; Generalitat Valenciana, Spain [2015/018]; Ministry of Economy and Competitivity, Spain [CGL2015-71146]; MINECO-FEDER, UE	Consejo Nacional de Ciencia y Tecnologia (CONACYT-CONCYTEY) of the Mexican Government; Consejo Nacional de Ciencia y Tecnologia (CONACYT-CONCYTEY) of the Yucatan State, Mexico; National Plan for Scientific Research, Development and Technological Innovation of Spain; Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Ministry of Economy and Competitivity, Spain(Spanish Government); MINECO-FEDER, UE(Spanish Government)	A.R.G. benefited from a PhD student grant from the Consejo Nacional de Ciencia y Tecnologia (CONACYT-CONCYTEY) of the Mexican Government and Yucatan State, Mexico (Scholarship No. 204397) www.conacyt.mx, www.siies.yucatan.gob.mx. This study was funded by the National Plan for Scientific Research, Development and Technological Innovation of Spain (CGL2008-02701), http://www.idi.mineco.gob.es/ Generalitat Valenciana, Spain (Prometeo Project 2015/018), www.gva.es and Ministry of Economy and Competitivity, Spain (CGL2015-71146) MINECO-FEDER, UE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2014, SYST BIOL, V63, P685, DOI 10.1093/sysbio/syu030; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; [Anonymous], 2014, MODERN PHYLOGENETIC; Armbruster JW, 2016, EVOL ECOL, V30, P435, DOI 10.1007/s10682-015-9811-6; Blasco-Costa I, 2012, PARASITOL INT, V61, P619, DOI 10.1016/j.parint.2012.06.004; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Desdevises Y, 2002, BIOL J LINN SOC, V77, P431, DOI 10.1046/j.1095-8312.2002.00114.x; Desdevises Y, 2001, INT J PARASITOL, V31, P205, DOI 10.1016/S0020-7519(00)00163-6; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; EUZET L, 1983, ANN PARASIT HUM COMP, V58, P325, DOI 10.1051/parasite/1983584325; Diniz JAF, 2012, EVOLUTION, V66, P1079, DOI 10.1111/j.1558-5646.2011.01499.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Felsenstein J., 2004, INFERRING PHYLOGENIE; Froese R, FISHBASE; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Huyse T, 2005, TRENDS PARASITOL, V21, P469, DOI 10.1016/j.pt.2005.08.009; Jarkovsky J, 2004, PARASITOL RES, V92, P95, DOI 10.1007/s00436-003-0993-4; Khang TF, 2016, PEERJ, V4, DOI 10.7717/peerj.1668; Klingenberg CP, 2012, J EVOLUTION BIOL, V25, P115, DOI 10.1111/j.1420-9101.2011.02410.x; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Kmentova N, 2016, PEERJ, V4, DOI 10.7717/peerj.1629; Koehler AV, 2012, EVOL ECOL, V26, P1497, DOI 10.1007/s10682-012-9558-2; Krasnov BR, 2015, PARASITE DIVERSITY AND DIVERSIFICATION: EVOLUTIONARY ECOLOGY MEETS PHYLOGENETICS, P351; Krasnov BR, 2011, ECOGRAPHY, V34, P751, DOI 10.1111/j.1600-0587.2010.06597.x; Laurent P, 2006, MOL PHYLOGENET EVOL, V38, P241, DOI 10.1016/j.ympev.2005.08.013; Lim LHS, 2009, SYST PARASITOL, V73, P13, DOI 10.1007/s11230-008-9167-1; Liu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12246; Llopis-Belenguer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142365; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Mallet J, 2010, BIOL PHILOS, V25, P497, DOI 10.1007/s10539-010-9213-7; Mandeng FDM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1181-y; Mendlova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037268; Morand S, 2002, INT J PARASITOL, V32, P111, DOI 10.1016/S0020-7519(01)00347-2; Morand S, 2015, PARASITE DIVERSITY AND DIVERSIFICATION: EVOLUTIONARY ECOLOGY MEETS PHYLOGENETICS, P1; Mouillot D, 2005, OIKOS, V109, P447, DOI 10.1111/j.0030-1299.2005.13590.x; Mouillot D, 2006, ECOGRAPHY, V29, P596, DOI 10.1111/j.0906-7590.2006.04507.x; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Poisot T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026252; Pronkina NV, 2010, MORSKY ECOL ZH, V9, P53; R Development Core Team, 2014, R LANG ENV STAT COMP; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Richter S, 2014, J ZOOL SYST EVOL RES, V52, P338, DOI 10.1111/jzs.12061; Rodriguez-Gonzalez A, 2016, PARASITOL RES, V115, P3519, DOI 10.1007/s00436-016-5117-z; Rodriguez-Gonzalez A, 2015, ACTA PARASITOL, V60, P767, DOI 10.1515/ap-2015-0109; Rodriguez-Gonzalez A, 2015, INT J PARASITOL, V45, P295, DOI 10.1016/j.ijpara.2015.01.005; Rohlf FJ, TPS SERIES; Sanfilippo D., 1978, THESIS; Sarabeev V., 2013, Vestnik Zoologii Supplement, V28, P1; Sarabeev V, 2015, PARASITOL INT, V64, P6, DOI 10.1016/j.parint.2015.01.001; Sarabeev V, 2014, PARASITOL INT, V63, P9, DOI 10.1016/j.parint.2013.10.001; Sasal P, 1998, ECOGRAPHY, V21, P639, DOI 10.1111/j.1600-0587.1998.tb00557.x; Timi JT, 2003, J FISH BIOL, V63, P90, DOI 10.1046/j.1095-8649.2003.00131.x; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Vignon M, 2010, PARASITOL INT, V59, P183, DOI 10.1016/j.parint.2010.01.006; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	58	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178367	10.1371/journal.pone.0178367	http://dx.doi.org/10.1371/journal.pone.0178367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542570	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500083
J	Watts, AG; Miniota, J; Joseph, HA; Brady, OJ; Kraemer, MUG; Grills, AW; Morrison, S; Esposito, DH; Nicolucci, A; German, M; Creatore, MI; Nelson, B; Johansson, MA; Brunette, G; Hay, SI; Khan, K; Cetron, M				Watts, Alexander G.; Miniota, Jennifer; Joseph, Heather A.; Brady, Oliver J.; Kraemer, Moritz U. G.; Grills, Ardath W.; Morrison, Stephanie; Esposito, Douglas H.; Nicolucci, Adriano; German, Matthew; Creatore, Maria I.; Nelson, Bradley; Johansson, Michael A.; Brunette, Gary; Hay, Simon I.; Khan, Kamran; Cetron, Marty			Elevation as a proxy for mosquito-borne Zika virus transmission in the Americas	PLOS ONE			English	Article							AEDES-AEGYPTI; VECTORIAL CAPACITY; DENGUE; ALBOPICTUS; CHIKUNGUNYA; BEHAVIOR; CLIMATE; IMPACT; FEVER; RISK	Introduction When Zika virus (ZIKV) first began its spread from Brazil to other parts of the Americas, national-level travel notices were issued, carrying with them significant economic consequences to affected countries. Although regions of some affected countries were likely unsuitable for mosquito-borne transmission of ZIKV, the absence of high quality, timely surveillance data made it difficult to confidently demarcate infection risk at a sub-national level. In the absence of reliable data on ZIKV activity, a pragmatic approach was needed to identify subnational geographic areas where the risk of ZIKV infection via mosquitoes was expected to be negligible. To address this urgent need, we evaluated elevation as a proxy for mosquito-borne ZIKV transmission. Methods For sixteen countries with local ZIKV transmission in the Americas, we analyzed (i) modelled occurrence of the primary vector for ZIKV, Aedes aegypti, (ii) human population counts, and (iii) reported historical dengue cases, specifically across 100-meter elevation levels between 1,500m and 2,500m. Specifically, we quantified land area, population size, and the number of observed dengue cases above each elevation level to identify a threshold where the predicted risks of encountering Ae. aegypti become negligible. Results Above 1,600m, less than 1% of each country's total land area was predicted to have Ae. aegypti occurrence. Above 1,900m, less than 1% of each country's resident population lived in areas where Ae. aegypti was predicted to occur. Across all 16 countries, 1.1% of historical dengue cases were reported above 2,000m. Discussion These results suggest low potential for mosquito-borne ZIKV transmission above 2,000m in the Americas. Although elevation is a crude predictor of environmental suitability for ZIKV transmission, its constancy made it a pragmatic input for policy decision-making during this public health emergency.	[Watts, Alexander G.; Miniota, Jennifer; Nicolucci, Adriano; German, Matthew; Creatore, Maria I.; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Joseph, Heather A.; Grills, Ardath W.; Morrison, Stephanie; Esposito, Douglas H.; Nelson, Bradley; Brunette, Gary; Cetron, Marty] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Brady, Oliver J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England; [Brady, Oliver J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England; [Kraemer, Moritz U. G.; Hay, Simon I.] Univ Oxford, Oxford Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Morrison, Stephanie] Ctr Dis Control & Prevent, Eagle Med Serv, LLC Div Global Migrat & Quarantine, Atlanta, GA USA; [Creatore, Maria I.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Johansson, Michael A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA; [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Khan, Kamran] Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Oxford; Centers for Disease Control & Prevention - USA; University of Toronto; Centers for Disease Control & Prevention - USA; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Toronto	Watts, AG (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	wattsa@smh.ca	Brady, Oliver/P-9421-2019; Hay, Simon Iain/F-8967-2015	Brady, Oliver/0000-0002-3235-2129; Hay, Simon Iain/0000-0002-0611-7272; Johansson, Michael/0000-0002-5090-7722	U.S. Centers for Disease Control and Prevention; Canadian Institutes of Health Research; Bill & Melinda Gates Foundation [OPP1119467, OPP1093011, OPP1106023, OPP1132415]; Senior Research Fellowship from the Wellcome Trust [095066]; RAPIDD program of the Science & Technology Directorate; Department of Homeland Security; International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS; European Commission 7th Framework Programme) [21893]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Senior Research Fellowship from the Wellcome Trust; RAPIDD program of the Science & Technology Directorate; Department of Homeland Security(United States Department of Homeland Security (DHS)); International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS; European Commission 7th Framework Programme)	Funding for this research came in part from the U.S. Centers for Disease Control and Prevention and the Canadian Institutes of Health Research. OJB is funded by a grant from the Bill & Melinda Gates Foundation (OPP1119467). SIH is funded by a Senior Research Fellowship from the Wellcome Trust (#095066), and grants from the Bill & Melinda Gates Foundation (OPP1119467, OPP1093011, OPP1106023 and OPP1132415). SIH would also like to acknowledge funding support from the RAPIDD program of the Science & Technology Directorate, and the Department of Homeland Security. MUGK receives funding from the International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS; European Commission 7th Framework Programme (#21893).	Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968; Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; Danielson J. J., 2011, GLOBAL MULTIRESOLUTI, DOI 10.3133/ofr20111073; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Fong IW, 2017, EMERG INF DIS 21ST C, P101, DOI 10.1007/978-3-319-50890-0_6; Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244; Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; ORNL, 2014, LANDSCAN 2013; Pan American Health Organization WHO, 2016, ZIK EP UPD; Paz-Bailey G., 2017, N ENGL J MED, DOI [10.1056/NEJMoa1613108, DOI 10.1056/NEJMOA1613108]; Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2; Shlim DR, 2009, CDC HLTH INFORM INT, P242; Stone CM, 2012, AM J TROP MED HYG, V87, P727, DOI 10.4269/ajtmh.2012.12-0123; Suarez M. F., 1981, Biomedica, V1, P225; Thavara U, 2001, J VECTOR ECOL, V26, P172; Thu Hlaing Myat, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P280; Townsend Peterson A, 2016, PLOS CURR; US Census Bureau, 2013, WORLD POP HIST EST W; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; WHO, 2017, DENG SEV DENG; Woolhouse M, 2011, PHILOS T R SOC B, V366, P2045, DOI 10.1098/rstb.2010.0387; World Health Organization, 2005, INT HLTH REG, P82, DOI [10.1177/146642407109100301, DOI 10.1177/146642407109100301]	39	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178211	10.1371/journal.pone.0178211	http://dx.doi.org/10.1371/journal.pone.0178211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542540	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000402061500072
J	Lu, Y; Gu, YC; Ding, XW; Wang, JQ; Chen, JW; Miao, CH				Lu, Yan; Gu, Yuechao; Ding, Xiaowei; Wang, Jiaqiang; Chen, Jiawei; Miao, Changhong			Intracellular Ca2+ homeostasis and JAK1/STAT3 pathway are involved in the protective effect of propofol on BV2 microglia against hypoxia-induced inflammation and apoptosis	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; CELLS; ISCHEMIA; RECEPTOR; INJURY; BRAIN; STAT3; PHOSPHORYLATION; ACTIVATION; RESPONSES	Background Perioperative hypoxia may induce microglial inflammation and apoptosis, resulting in brain injury. The neuroprotective effect of propofol against hypoxia has been reported, but the underlying mechanisms are far from clear. In this study, we explored whether and how propofol could attenuate microglia BV2 cells from CoCl2-induced hypoxic injury. Methods Mouse microglia BV2 cells were pretreated with propofol, and then stimulated with CoCl2. TNF-alpha level in the culture medium was measured by ELISA kit. Cell apoptosis and intracellular calcium concentration were measured by flow cytometry analysis. The effect of propofol on CoCl2-modulated expression of Ca2+/Calmodulin (CaM)-dependent protein kinase II (CAMKII alpha), phosphorylated CAMKIIa (pCAMKII alpha), STAT3, pSTAT3(Y705), pSTAT3(S727), ERK1/2, pERK1/2, pNFkB(p65), pro-caspase3, cleaved caspase 3, JAK1, pJAK1, JAK2, pJAK2 were detected by Western blot. Results In BV2 cell, CoCl2 treatment time-dependently increased TNF-alpha release and induced apoptosis, which were alleviated by propofol. CoCl2 (500 mu mol/L, 8h) treatment increased intracellular Ca2+ level, and caused the phosphorylation of CAMKIIa, ERK1/2 and NFkB (p65), as well as the activation of caspase 3. More importantly, these effects could be modulated by 25 mu mol/L propofol via maintaining intracellular Ca2+ homeostasis and via up-regulating the phosphorylation of JAK1 and STAT3 at Tyr705. Conclusion Propofol could protect BV2 microglia from hypoxia-induced inflammation and apoptosis. The potential mechanisms may involve the maintaining of intracellular Ca2+ homeostasis and the activation of JAK1/STAT3 pathway.	[Lu, Yan; Gu, Yuechao; Ding, Xiaowei; Wang, Jiaqiang; Chen, Jiawei; Miao, Changhong] Fudan Univ, Shanghai Canc Ctr, Dept Anesthesiol, Shanghai Shi, Peoples R China; [Lu, Yan; Gu, Yuechao; Ding, Xiaowei; Wang, Jiaqiang; Chen, Jiawei; Miao, Changhong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Shi, Peoples R China	Fudan University; Fudan University	Chen, JW; Miao, CH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Anesthesiol, Shanghai Shi, Peoples R China.; Chen, JW; Miao, CH (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Shi, Peoples R China.	jiawei_chen@hotmail.com; anesthesiology2016@126.com			Nature Science Foundation of Shanghai [14ZR1407500]	Nature Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by the Nature Science Foundation of Shanghai (No: 14ZR1407500).	Anttila J.E., 2016, PROG NEUROPSYCHOPHAR; Banerjee C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004018; Bell JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00096; Ben Haim L, 2015, J NEUROSCI, V35, P2817, DOI 10.1523/JNEUROSCI.3516-14.2015; Breit A, 2015, MOL ENDOCRINOL, V29, P445, DOI 10.1210/me.2014-1300; Chen H, 2016, INT J OPTOMECHATRONI, V10, P1, DOI 10.1080/15599612.2015.1095956; Chen J, 2015, NEUROSCIENCE, V305, P117, DOI 10.1016/j.neuroscience.2015.07.076; Farber K, 2006, GLIA, V54, P656, DOI 10.1002/glia.20412; Geiseler SJ, 2016, NEUROSCIENCE, V334, P39, DOI 10.1016/j.neuroscience.2016.07.034; Hillmer EJ, 2016, CYTOKINE GROWTH F R, V31, P1, DOI 10.1016/j.cytogfr.2016.05.001; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Kim OS, 2002, J BIOL CHEM, V277, P40594, DOI 10.1074/jbc.M203885200; KOCHS E, 1992, ANESTHESIOLOGY, V76, P245, DOI 10.1097/00000542-199202000-00014; Korvers L, 2016, CELL CALCIUM; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Lam SY, 2012, HISTOCHEM CELL BIOL, V137, P303, DOI 10.1007/s00418-011-0900-5; Lee SH, 2015, STEM CELLS, V33, P1490, DOI 10.1002/stem.1938; Lemoine S, 2013, ANESTHESIOLOGY, V118, P1373, DOI 10.1097/ALN.0b013e31828a7039; Li HR, 2017, BIOMED PHARMACOTHER, V86, P324, DOI 10.1016/j.biopha.2016.12.036; Li J, 2014, ACTA BIOMATER, V10, P2866, DOI 10.1016/j.actbio.2014.02.032; Mandal T, 2014, CELL SIGNAL, V26, P1725, DOI 10.1016/j.cellsig.2014.04.003; McDonough A, 2016, NEUROTHERAPEUTICS, V13, P748, DOI 10.1007/s13311-016-0465-z; Milanovic D, 2016, NEUROTOX RES, V30, P434, DOI 10.1007/s12640-016-9629-1; Muraoka O, 2003, NEUROCHEM INT, V42, P591, DOI 10.1016/S0197-0186(02)00160-2; Murase S, 2014, EUR J NEUROSCI, V39, P557, DOI 10.1111/ejn.12412; Murase S, 2012, J NEUROSCI, V32, P15511, DOI 10.1523/JNEUROSCI.2940-12.2012; Shao JX, 2013, J NEUROIMMUNOL, V254, P83, DOI 10.1016/j.jneuroim.2012.09.012; Shimizu T, 2016, MOL CELL BIOL, V36, P2728, DOI 10.1128/MCB.00139-16; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Yan Z, 2016, CLIN IMMUNOL; Yang P, 2014, CELL BIOCHEM BIOPHYS, V70, P1527, DOI 10.1007/s12013-014-0088-0; Yoo YC, 2013, J SURG RES, V183, P783, DOI 10.1016/j.jss.2013.02.017; You L, 2011, MOL BIOL REP, V38, P437, DOI 10.1007/s11033-010-0126-y; Yuan L, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0541-7; Zhang DX, 2014, BRAIN INJURY, V28, P1758, DOI 10.3109/02699052.2014.947624; Zhang J., 2016, OXID MED CELL LONGEV, V2016; Zhang T, 2016, NAT MED, V22, P175, DOI 10.1038/nm.4017; Zhang Y, 2016, NEUROTOX RES; Zhou CH, 2015, ANESTH ANALG, V120, P1361, DOI 10.1213/ANE.0000000000000645; Zhou JM, 2016, CELL STRESS CHAPERON, V21, P1037, DOI 10.1007/s12192-016-0728-y; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082729; Zhu ML, 2015, ANESTH ANALG, V120, P781, DOI 10.1213/ANE.0000000000000616	42	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178098	10.1371/journal.pone.0178098	http://dx.doi.org/10.1371/journal.pone.0178098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542400	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058800038
J	Oshima, H; Iwase, T; Ishikawa, K; Yamamoto, K; Terasaki, H				Oshima, Hisaaki; Iwase, Takeshi; Ishikawa, Kohei; Yamamoto, Kentaro; Terasaki, Hiroko			Long-term results after limited macular translocation surgery for wet age-related macular degeneration	PLOS ONE			English	Article							SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; PHOTODYNAMIC THERAPY; RETINAL SEPARATION; VISUAL FUNCTION; RETINOTOMY; MANAGEMENT; RELOCATION; SECONDARY; CELLS	Purpose To evaluate the long-term results of limited macular translocation (LMT) surgery with radial chorioscleral outfolding in patients with wet age-related macular degeneration (AMD) and subfoveal choroidal neovascularization (CNV). In addition, to identify the factors associated with the final best-corrected visual acuity (BCVA). Methods The medical records of 20 eyes of 20 consecutive patients (65.2 +/- 9.8 years) who had undergone LMT for the treatment of wet AMD and were followed for at least 5 years, were reviewed. The surgical outcomes including the BCVA, degree of foveal displacement, and complications were recorded. Results The mean foveal displacement was 1332 +/- 393 mu m after the LMT. The CNV was removed in 16 eyes and photocoagulated in 4 eyes. The mean preoperative VA was 0.83 +/- 0.33 logMAR units which significantly improved to 0.59 +/- 0.37 logMAR units at 1 year after the surgery (P = 0.015). This BCVA was maintained at 0.59 +/- 0.41 logMAR units on the final examination. The final BCVA was significantly correlated with that at 1 year after the surgery (r = 0.83, P<0.001). Multiple linear regression analysis showed that the final BCVA was significantly correlated with the BCVA at 1 year after the surgery (P<0.001), a recurrence of a CNV (P = 0.001), and the age (P = 0.022). Conclusions LMT improves the BCVA significantly at 1 year, and the improved BCVA lasted for at least 5 years. These results indicate that the impaired function of the sensory retina at the fovea can recover on the new RPE after the displacement for at least 5 years. The ability to maintain good retinal function on the new RPE for a long period is important for future treatments of CNVs such as the transplantation of RPE cells and stem cells.	[Oshima, Hisaaki; Iwase, Takeshi; Ishikawa, Kohei; Yamamoto, Kentaro; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi, Japan	Nagoya University	Iwase, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi, Japan.	tiwase@med.nagoya-u.ac.jp			Grants-in-Aid for Scientific Research [17K11421] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Benner JD, 2001, GRAEF ARCH CLIN EXP, V239, P815, DOI 10.1007/s004170100339; Chang AA, 2003, CLIN EXP OPHTHALMOL, V31, P103, DOI 10.1046/j.1442-9071.2003.00614.x; de Juan E, 1998, AM J OPHTHALMOL, V125, P635, DOI 10.1016/S0002-9394(98)00018-X; Du HJ, 2011, SEMIN OPHTHALMOL, V26, P216, DOI 10.3109/08820538.2011.577498; Eong KGA, 2001, AM J OPHTHALMOL, V131, P244, DOI 10.1016/S0002-9394(00)00788-1; Fujii GY, 2002, AM J OPHTHALMOL, V134, P69, DOI 10.1016/S0002-9394(02)01511-8; Fujikado T, 2001, AM J OPHTHALMOL, V131, P101, DOI 10.1016/S0002-9394(00)00770-4; GASS JDM, 1984, AM J OPHTHALMOL, V98, P700; Gelisken F, 2001, AM J OPHTHALMOL, V131, P518, DOI 10.1016/S0002-9394(00)00813-8; Glacet-Bernard A, 2007, AM J OPHTHALMOL, V143, P68, DOI 10.1016/j.ajo.2006.09.041; Imai K, 1998, AM J OPHTHALMOL, V125, P627, DOI 10.1016/S0002-9394(98)00023-3; Kadonosono K, 2001, AM J OPHTHALMOL, V132, P790, DOI 10.1016/S0002-9394(01)01140-0; Kamei M, 2004, AM J OPHTHALMOL, V138, P574, DOI 10.1016/j.ajo.2004.05.029; Kamei M, 2001, AM J OPHTHALMOL, V132, P149, DOI 10.1016/S0002-9394(01)01047-9; Kokkinaki M, 2011, STEM CELLS, V29, P825, DOI 10.1002/stem.635; Lewis H, 1999, AM J OPHTHALMOL, V128, P135, DOI 10.1016/S0002-9394(99)00207-X; Lewis H, 2001, AM J OPHTHALMOL, V132, P156, DOI 10.1016/S0002-9394(01)01088-1; MACHEMER R, 1993, GRAEF ARCH CLIN EXP, V231, P635, DOI 10.1007/BF00921957; MACHEMER R, 1993, GRAEF ARCH CLIN EXP, V231, P629, DOI 10.1007/BF00921956; Macular translocation, 2000, OPHTHALMOLOGY, V107, P1015; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mateo Carlos, 2004, Semin Ophthalmol, V19, P29, DOI 10.1080/08820530490520013; Michels S, 2006, AM J OPHTHALMOL, V141, P396, DOI 10.1016/j.ajo.2005.08.046; Parameswaran S, 2010, STEM CELLS, V28, P695, DOI 10.1002/stem.320; Pieramici DJ, 2000, AM J OPHTHALMOL, V130, P419, DOI 10.1016/S0002-9394(00)00533-X; QUIGLEY HA, 1990, ARCH OPHTHALMOL-CHIC, V108, P51, DOI 10.1001/archopht.1990.01070030057028; Takeuchi K, 2012, EYE, V26, P52, DOI 10.1038/eye.2011.302; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177241	10.1371/journal.pone.0177241	http://dx.doi.org/10.1371/journal.pone.0177241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542257	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058800013
J	Wang, XH; Zhang, DJ; Guan, B; Qi, Q; Tong, SZ				Wang, Xuehong; Zhang, Dongjie; Guan, Bo; Qi, Qing; Tong, Shouzheng			Optimum water supplement strategy to restore reed wetland in the Yellow River Delta	PLOS ONE			English	Article							PHRAGMITES-AUSTRALIS; COASTAL WETLAND; CLIMATE-CHANGE; SOIL; SALINITY; IMPACTS; GROWTH; DEPTH; CHINA; PLANT	In order to supply optimum water to restore reed wetlands used for bird habitats, a field investigation and greenhouse experiment were conducted. Three water supplementation stages (early stage at 20 May, middle stage at 20 July and later stage at 20 September, respectively) and five depths (0, 10, 15, 20 and 35 cm over the surface, respectively) were established, with three replicates for each treatment combination. Reed growth characteristics (survival rate, height, density and biomass) and soil properties of field investigation and experiment were recorded to determine the impacts of water supplementation on reed wet-land restoration. The field investigation showed that reeds in natural wetlands grow better than those in degraded wetlands and soil properties in degraded wetlands were significantly different from soils in natural wetlands. With freshwater supplementation, reed growth characteristics and soil properties greatly improved. As water depth increased, reed growth decreased gradually. Reeds grew best in shallow water depth (<= 10cm) than in the greater flooding depths. Saturated soils with no standing water at the early stage of reed growth increased reed survival and water depth can be increased as the reeds grow. During the process of water supplementation, soil salinity was reduced significantly. Soil salinity was reduced dramatically at early and middle stages of reed growth, but it increased slightly at the later stage. Soil pH increased greatly during the experiment. Soil total nitrogen (TN) and total organic carbon (TOC) showed contrasting changes, with soil TN decreasing and TOC increasing. To best manage reed wetlands restoration, we suggest saturating wetland in the spring to stimulate reed germination, increasing surface water depth up to 15cm at the stage of reed rapid growth, and then reducing water depth during the later growth stage.	[Wang, Xuehong; Zhang, Dongjie; Qi, Qing; Tong, Shouzheng] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Jilin, Peoples R China; [Zhang, Dongjie; Qi, Qing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Guan, Bo] Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Shandong, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Tong, SZ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Jilin, Peoples R China.	tongshouzheng@neigae.ac.cn		DONGJIE, ZHANG/0000-0002-2768-9077	National Natural Science Foundation of China [41301052, 31300325]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper is supported by the National Natural Science Foundation of China (41301052 and 1300325), http://www.nsfc.gov.cn/publish/portal1/.	Abegunrin TP, 2016, CATENA, V139, P167, DOI 10.1016/j.catena.2015.12.014; Akbarimoghaddam H., 2011, Trakia Journal of Sciences, V9, P43; Bano A, 2009, BIOL FERT SOILS, V45, P405, DOI 10.1007/s00374-008-0344-9; Coops H, 1996, AQUAT BOT, V54, P11, DOI 10.1016/0304-3770(96)01025-X; Cui BS, 2009, ECOL ENG, V35, P1090, DOI 10.1016/j.ecoleng.2009.03.022; [崔保山 CUI BaoShan], 2008, [生态学报, Acta Ecologica Sinica], V28, P1408; DAVIS T, 1994, RAMS CONV MAN GUID C; Deegan BM, 2007, AQUAT BOT, V86, P309, DOI 10.1016/j.aquabot.2006.11.006; Dwire KA, 2004, OECOLOGIA, V139, P309, DOI 10.1007/s00442-004-1498-2; Garbey C, 2006, HYDROBIOLOGIA, V570, P41, DOI 10.1007/s10750-006-0159-3; Gorai M, 2010, FLORA MORPHOL DISTRI, p1 ; Greenwood ME, 2006, WETLANDS, V26, P854, DOI 10.1672/0277-5212(2006)26[854:EOSATO]2.0.CO;2; Guan B, 2011, CLEAN-SOIL AIR WATER, V39, P1029, DOI 10.1002/clen.201000557; HELLINGS SE, 1992, J APPL ECOL, V29, P41, DOI 10.2307/2404345; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Kaelke CM, 2003, PLANT SOIL, V254, P167, DOI 10.1023/A:1024903912325; Kaur B, 2000, APPL SOIL ECOL, V15, P283, DOI 10.1016/S0929-1393(00)00079-2; Lal R, 2001, CLIMATIC CHANGE, V51, P35, DOI 10.1023/A:1017529816140; Li SN, 2009, ECOL ENG, V35, P1719, DOI 10.1016/j.ecoleng.2009.07.009; Mamilov A, 2004, SOIL SCI PLANT NUTR, V50, P839, DOI 10.1080/00380768.2004.10408544; Meyerson LA, 2000, WETLANDS ECOLOGY MAN, V8, P89, DOI DOI 10.1023/A:1008432200133; Mitsch WJ, 2005, ECOL ENG, V24, P243, DOI 10.1016/j.ecoleng.2005.02.006; Mitsch WJ, 1996, ECOL APPL, V6, P77, DOI 10.2307/2269554; Mu CongRu, 2000, Chinese Journal of Applied Ecology, V11, P123; Pathak H, 1998, SOIL BIOL BIOCHEM, V30, P695, DOI 10.1016/S0038-0717(97)00208-3; Paul D, 2013, J BASIC MICROB, V53, P101, DOI 10.1002/jobm.201100288; Rasul G, 2006, APPL SOIL ECOL, V31, P1, DOI 10.1016/j.apsoil.2005.04.007; Shand P, 2017, PROCED EARTH PLAN SC, V17, P456, DOI 10.1016/j.proeps.2016.12.115; Shrivastava P, 2015, SAUDI J BIOL SCI, V22, P123, DOI 10.1016/j.sjbs.2014.12.001; Strand JA, 2001, J ECOL, V89, P166, DOI 10.1046/j.1365-2745.2001.00530.x; Surendran U, 2016, AGR WATER MANAGE, V178, P21, DOI 10.1016/j.agwat.2016.08.016; Tiner R.W., 1999, WETLAND INDICATORS G; Vaezi AR, 2017, SCI TOTAL ENVIRON, V583, P382, DOI 10.1016/j.scitotenv.2017.01.078; Vretare V, 2001, AQUAT BOT, V69, P127, DOI 10.1016/S0304-3770(01)00134-6; Wallace J, 2012, J HYDROL, V475, P84, DOI 10.1016/j.jhydrol.2012.09.032; Wang SL, 2013, MAR POLLUT BULL, V76, P7, DOI 10.1016/j.marpolbul.2013.08.025; Wang XH, 2012, ENVIRON MANAGE, V49, P325, DOI 10.1007/s00267-011-9757-6; White SD, 2002, AQUAT BOT, V73, P115, DOI 10.1016/S0304-3770(02)00010-4; Wijte AHBM, 1996, AM J BOT, V83, P1337, DOI 10.2307/2446119; Xue XZ, 2004, J ENVIRON MANAGE, V71, P271, DOI 10.1016/j.jenvman.2004.03.006; Yang ZF, 2009, COMMUN NONLINEAR SCI, V14, P2469, DOI 10.1016/j.cnsns.2007.12.015; Yu JB, 2012, CLEAN-SOIL AIR WATER, V40, P1154, DOI 10.1002/clen.201100743; Yu W.Y., 2008, ACTA ECOL SIN, V28, P4594, DOI [10.1016/S1872-2032(08)60081-5, DOI 10.1016/S1872-2032(08)60081-5]	43	9	9	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177692	10.1371/journal.pone.0177692	http://dx.doi.org/10.1371/journal.pone.0177692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542169	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800023
J	Cheng, QP; Li, HX; Xu, YL; Chen, S; Liao, YH; Deng, F; Li, JF				Cheng, Qunpeng; Li, Hongxia; Xu, Yilu; Chen, Song; Liao, Yuhua; Deng, Fang; Li, Jianfen			Study on the adsorption of nitrogen and phosphorus from biogas slurry by NaCl-modified zeolite	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; WASTE-WATER; NATURAL ZEOLITE; AQUEOUS-SOLUTION; ACTIVATED CARBON; ION-EXCHANGE; AMMONIUM REMOVAL; PIG SLURRY; FLY-ASH; ADSORBENT	A NaCl-modified zeolite was used to simultaneously remove nitrogen and phosphate from biogas slurry. The effect of pH, contact time and dosage of absorbants on the removal efficiency of nitrogen and phosphate were studied. The results showed that the highest removal efficiency of NH4+-N (92.13%) and PO43--P (90.3%) were achieved at pH 8. While the zeolite doses ranged from 0.5 to 5 g/100 ml, NH4+-N and PO43--P removal efficiencies ranged from 5.19% to 94.94% and 72.16% to 91.63% respectively. The adsorption isotherms of N and P removal with NaCl-modified zeolite were well described by Langmuir models, suggesting the homogeneous sorption mechanisms. While through intra-particle diffusion model to analyze the influence of contact time, it showed that the adsorption process of NH4+-N and PO43--P followed the second step of intra-particle diffusion model. The surface diffusion adsorption step was very fast which was finished in a short time.	[Cheng, Qunpeng; Li, Hongxia; Li, Jianfen] Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Peoples R China; [Xu, Yilu] Univ Newcastle, Global Ctr Environm Remediat, Adv Technol Ctr, Fac Sci & Informat Technol, Callaghan, NSW, Australia; [Liao, Yuhua; Deng, Fang; Li, Jianfen] Huazhong Univ Sci & Technol, Sch Environm Sci & Engn, Wuhan, Peoples R China	Wuhan Polytechnic University; University of Newcastle; Huazhong University of Science & Technology	Li, JF (corresponding author), Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Peoples R China.	whpu123@126.com			Wuhan Polytechnic University [2015070504020222]; Wuhan high-tech industry science and technology innovation team projects [2015070504020222]	Wuhan Polytechnic University; Wuhan high-tech industry science and technology innovation team projects	This research was supported by Wuhan high-tech industry science and technology innovation team projects (No. 2015070504020222) from Wuhan Polytechnic University.r This research was supported by Wuhan high-tech industry science and technology innovation team projects (No. 2015070504020222). The authors would also like to thank the Analytical and Test Center of Huazhong University of Science and Technology for carrying out the analysis of samples.r I confirmed that the research support from, "Wuhan high-tech industry science and technology innovation team projects (No. 2015070504020222)" was an academic grant from Wuhan Polytechnic University.	Alshameri A, 2014, J TAIWAN INST CHEM E, V45, P554, DOI 10.1016/j.jtice.2013.05.008; APHA, 1995, STANDARD METHODS EXA; Chen KN, 2013, ENVIRON TECHNOL, V34, P1489, DOI 10.1080/09593330.2012.758659; Chen XY, 2012, BIORESOURCE TECHNOL, V110, P79, DOI 10.1016/j.biortech.2012.01.096; Cheng S, 2016, RSC ADV, V6, P78936, DOI 10.1039/c6ra14082c; Egashira R, 2012, PROCEDIA ENGINEER, V42, P49, DOI 10.1016/j.proeng.2012.07.394; Fenton O, AGR WASTEWATERS; Fenton O, 2012, ALGAL RES, V1, P49, DOI 10.1016/j.algal.2012.03.003; Flynn CJO, 2013, J ENVIRON MANAGE, V128, P690, DOI 10.1016/j.jenvman.2013.06.020; Garg RN, 2005, ENVIRON MONIT ASSESS, V107, P1, DOI 10.1007/s10661-005-2021-x; Guo XJ, 2013, J ENVIRON SCI-CHINA, V25, P954, DOI 10.1016/S1001-0742(12)60115-6; Huang HM, 2010, J HAZARD MATER, V175, P247, DOI 10.1016/j.jhazmat.2009.09.156; Inglezakis VJ, 2005, J COLLOID INTERF SCI, V281, P68, DOI 10.1016/j.jcis.2004.08.082; Jiang C, 2013, J COLLOID INTERF SCI, V402, P246, DOI 10.1016/j.jcis.2013.03.057; Jones Susan H, 2010, NANOPOROUS CARBON ZE; Karadag D, 2006, J HAZARD MATER, V136, P604, DOI 10.1016/j.jhazmat.2005.12.042; Li WY, 2016, PROCESS SAF ENVIRON, V102, P150, DOI 10.1016/j.psep.2016.03.001; Lin L, 2014, SEP PURIF TECHNOL, V133, P351, DOI 10.1016/j.seppur.2014.07.010; Lin L, 2013, BIORESOURCE TECHNOL, V136, P302, DOI 10.1016/j.biortech.2013.02.106; Magriotis ZM, 2014, APPL CLAY SCI, V91-92, P55, DOI 10.1016/j.clay.2014.02.007; Maranon E, 2006, J HAZARD MATER, V137, P1402, DOI 10.1016/j.jhazmat.2006.03.069; Meng SL, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1556-7; Murnane JG, 2016, ZEOLITE COMBINED ALU; O'Flynn CJ, 2012, J ENVIRON MANAGE, V113, P78, DOI 10.1016/j.jenvman.2012.08.026; O' Flynn CJ, 2013, ENVIRON SCI POLLUT R, V20, P6019, DOI 10.1007/s11356-013-1630-0; Onyango MS, 2007, IND ENG CHEM RES, V46, P894, DOI 10.1021/ie060742m; Saeedi R, 2012, ENVIRON ENG SCI, V29, P93, DOI 10.1089/ees.2011.0077; Saltali K, 2007, J HAZARD MATER, V141, P258, DOI 10.1016/j.jhazmat.2006.06.124; Sen Gupta S, 2014, RSC ADV, V4, P28537, DOI 10.1039/c4ra03673e; Sprynskyy M, 2005, SEP PURIF TECHNOL, V46, P155, DOI 10.1016/j.seppur.2005.05.004; Terry PA, 2009, ENVIRON ENG SCI, V26, P691, DOI 10.1089/ees.2007.0222; Thornton A, 2007, J HAZARD MATER, V147, P883, DOI 10.1016/j.jhazmat.2007.01.111; Nguyen TC, 2015, CHEM ENG J, V270, P393, DOI 10.1016/j.cej.2015.02.047; Ugurlu M, 2011, MICROPOR MESOPOR MAT, V139, P173, DOI 10.1016/j.micromeso.2010.10.039; von Eckstaedt SV, 2016, CHEMOSPHERE, V144, P257, DOI 10.1016/j.chemosphere.2015.08.048; Wang H, 2016, RSC ADV, V6, P55809, DOI 10.1039/c6ra12169a; Wang JZ, 2012, J ENVIRON QUAL, V41, P1221, DOI 10.2134/jeq2011.0373; Wang YQ, 2006, J HAZARD MATER, V136, P735, DOI 10.1016/j.jhazmat.2006.01.002; Yu Q, 2016, RSC ADV; Zhao Y, 2016, ENV ENG SCI; Zhu NY, 2016, CHEMOSPHERE, V164, P32, DOI 10.1016/j.chemosphere.2016.08.036	41	29	29	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0176109	10.1371/journal.pone.0176109	http://dx.doi.org/10.1371/journal.pone.0176109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542420	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600002
J	Krah, A; Kato-Yamada, Y; Takada, S				Krah, Alexander; Kato-Yamada, Yasuyuki; Takada, Shoji			The structural basis of a high affinity ATP binding epsilon subunit from a bacterial ATP synthase	PLOS ONE			English	Article							THERMOPHILIC F-1-ATPASE; ESCHERICHIA-COLI; INHIBITOR PROTEIN; BOVINE F-1-ATPASE; HIGH-THROUGHPUT; FORCE; MITOCHONDRIAL; ROTATION; SITE; TRANSITIONS	The epsilon subunit from bacterial ATP synthases functions as an ATP sensor, preventing ATPase activity when the ATP concentration in bacterial cells crosses a certain threshold. The R103A/R115A double mutant of the e subunit from thermophilic Bacillus PS3 has been shown to bind ATP two orders of magnitude stronger than the wild type protein. We use molecular dynamics simulations and free energy calculations to derive the structural basis of the high affinity ATP binding to the R103A/R115A double mutant. Our results suggest that the double mutant is stabilized by an enhanced hydrogen-bond network and fewer repulsive contacts in the ligand binding site. The inferred structural basis of the high affinity mutant may help to design novel nucleotide sensors based on the e subunit from bacterial ATP synthases.	[Krah, Alexander; Takada, Shoji] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan; [Krah, Alexander] Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea; [Kato-Yamada, Yasuyuki] Rikkyo Univ, Dept Life Sci, Coll Sci, Toshima Ku, Tokyo, Japan	Kyoto University; Korea Institute for Advanced Study (KIAS); Rikkyo University	Krah, A (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan.; Krah, A (corresponding author), Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea.	alexkrah@kias.re.kr		Krah, Alexander/0000-0001-8871-5550	Japan Society for the Promotion of Science [P13705]; JSPS KAKENHI [15K07013]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AK was supported by a Postdoctoral Fellowship for Foreign Researchers from the Japan Society for the Promotion of Science (JSPS-ID: P13705) (https://www.jsps.go.ip/). Computational resources have been provided by the Okazaki Research Centre for Computational Sciences (to ST; https://ccportal.ims.ac.jp/en/). Part of this work was supported by JSPS KAKENHI (15K07013 to YKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2001, EMBO J, V20, P6990, DOI 10.1093/emboj/20.24.6990; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; DROBINSKAYA IY, 1985, FEBS LETT, V182, P419, DOI 10.1016/0014-5793(85)80346-X; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; Feniouk BA, 2010, BIOPHYS J, V98, P434, DOI 10.1016/j.bpj.2009.10.023; Ferguson SA, 2016, P NATL ACAD SCI USA, V113, P10860, DOI 10.1073/pnas.1612035113; Hatsugai N, 2012, PLANT CELL PHYSIOL, V53, P1768, DOI 10.1093/pcp/pcs119; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Homeyer N, 2014, J CHEM THEORY COMPUT, V10, P3331, DOI 10.1021/ct5000296; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Kato S, 2007, J BIOL CHEM, V282, P37618, DOI 10.1074/jbc.M707509200; Kato-Yamada Y, 2005, FEBS LETT, V579, P6875, DOI 10.1016/j.febslet.2005.11.036; Kato-Yamada Y, 2003, J BIOL CHEM, V278, P36013, DOI 10.1074/jbc.M306140200; Kato-Yamada Y, 2016, BIOCHEM BIOPH RES CO, V469, P1129, DOI 10.1016/j.bbrc.2015.12.121; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Krah A, 2016, BBA-BIOENERGETICS, V1857, P332, DOI 10.1016/j.bbabio.2016.01.007; Krah A, 2015, PROG BIOPHYS MOL BIO, V119, P94, DOI 10.1016/j.pbiomolbio.2015.06.005; Krah A, 2015, BBA-BIOENERGETICS, V1847, P1101, DOI 10.1016/j.bbabio.2015.05.018; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; SHARP KA, 1990, J PHYS CHEM-US, V94, P7684, DOI 10.1021/j100382a068; Shirakihara Y, 2015, FEBS J, V282, P2895, DOI 10.1111/febs.13329; Sobti M, 2016, ELIFE, V5, DOI 10.7554/eLife.21598; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yagi H, 2010, BIOCHEM J, V425, P85, DOI 10.1042/BJ20091247; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Yoshida T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39618	57	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177907	10.1371/journal.pone.0177907	http://dx.doi.org/10.1371/journal.pone.0177907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542497	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400111
J	Laroque, A; Min-Oo, G; Tam, M; Ponka, P; Stevenson, MM; Gros, P				Laroque, Aurelie; Min-Oo, Gundula; Tam, Mifong; Ponka, Prem; Stevenson, Mary M.; Gros, Philippe			The mouse Char10 locus regulates severity of pyruvate kinase deficiency and susceptibility to malaria	PLOS ONE			English	Article							RECOMBINANT CONGENIC STRAINS; CEREBRAL MALARIA; GENETIC-CONTROL; RESISTANCE LOCUS; RED-CELL; INFECTION; ANEMIA; MICE; IDENTIFICATION; EXPRESSION	Pyruvate kinase (PKLR) deficiency protects mice and humans against blood-stage malaria. Although mouse strain AcB62 carries a malaria-protective Pklr(I90N) genetic mutation, it is phenotypically susceptible to blood stage malaria induced by infection with Plasmodium chabaudi AS, suggesting a genetic modifier of the Pklr(I90N) protective effect. Linkage analysis in a F2 cross between AcB62 (Pklr(I90N)) and another PK deficient strain CBA/Pk (Pklr(G338D)) maps this modifier (designated Char10) to chromosome 9 (LOD = 10.8, 95% Bayesian CI = 50.7-75Mb). To study the mechanistic basis of the Char10 effect, we generated an incipient congenic line (Char10C) that harbors the Char10 chromosome 9 segment from AcB62 fixed on the genetic background of CBA/Pk. The Char10 effect is shown to be highly penetrant as the Char10C line recapitulates the AcB62 phenotype, displaying high parasitemia following P. chabaudi infection, compared to CBA/Pk. Char10C mice also display a reduction in anemia phenotypes associated with the Pklr(G338D) mutation including decreased splenomegaly, decreased circulating reticulocytes, increased density of mature erythrocytes, increased hematocrit, as well as decreased iron overload in kidney and liver and decreased serum iron. Erythroid lineage analyses indicate that the number of total TER119(+) cells as well as the numbers of the different CD71(+)/CD44(+) erythroblast sub-populations were all found to be lower in Char10C spleen compared to CBA/Pk. Char10C mice also displayed lower number of CFU-E per spleen compared to CBA/Pk. Taken together, these results indicate that the Char10 locus modulates the severity of pyruvate kinase deficiency by regulating erythroid responses in the presence of PK-deficiency associated haemolytic anemia.	[Laroque, Aurelie; Min-Oo, Gundula; Gros, Philippe] McGill Univ, Biochem Dept, Montreal, PQ, Canada; [Tam, Mifong; Stevenson, Mary M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Ponka, Prem] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Ponka, Prem] McGill Univ, Physiol Dept, Montreal, PQ, Canada	McGill University; McGill University; Lady Davis Institute; McGill University; McGill University	Gros, P (corresponding author), McGill Univ, Biochem Dept, Montreal, PQ, Canada.	philippe.gros@mcgill.ca			Canadian Institutes for Health Research [MOP-119342]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by research grants to PG from the Canadian Institutes for Health Research (MOP-119342). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves J, 2010, BLOOD CELL MOL DIS, V44, P62, DOI 10.1016/j.bcmd.2009.09.008; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Ayi K, 2008, NEW ENGL J MED, V358, P1805, DOI 10.1056/NEJMoa072464; Ayi K, 2009, J INFECT DIS, V200, P1289, DOI 10.1086/605843; Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; Berghout J, 2010, GENES IMMUN, V11, P310, DOI 10.1038/gene.2009.79; Bongfen SE, 2009, TRENDS PARASITOL, V25, P417, DOI 10.1016/j.pt.2009.05.012; Burt RA, 1999, IMMUNOGENETICS, V50, P278, DOI 10.1007/s002510050603; Campino S, 2005, GENES IMMUN, V6, P416, DOI 10.1038/sj.gene.6364219; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Dondorp AM, 1999, BRIT J HAEMATOL, V105, P505, DOI 10.1111/j.1365-2141.1999.01367.x; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Hernandez-Valladares M, 2004, MAMM GENOME, V15, P390, DOI 10.1007/s00335-004-3042-4; Jelkmann W, 2013, TRANSFUS MED HEMOTH, V40, P302, DOI 10.1159/000356193; Khatib R, 2009, PEDIATR RADIOL, V39, P17, DOI 10.1007/s00247-008-1049-9; Koulnis M, 2011, JOVE-J VIS EXP, DOI 10.3791/2809; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Laroque A, 2012, GENES IMMUN, V13, P155, DOI 10.1038/gene.2011.67; Libregts SF, 2011, BLOOD, V118, P2578, DOI 10.1182/blood-2010-10-315218; Lin E, 2006, INFECT IMMUN, V74, P5814, DOI 10.1128/IAI.01690-05; Machado P, 2010, BRIT J HAEMATOL, V149, P775, DOI 10.1111/j.1365-2141.2010.08165.x; Min-Oo G, 2005, CELL MICROBIOL, V7, P753, DOI 10.1111/j.1462-5822.2005.00524.x; Min-Oo G, 2004, GENES IMMUN, V5, P168, DOI 10.1038/sj.gene.6364069; Min-Oo G, 2003, NAT GENET, V35, P357, DOI 10.1038/ng1260; Min-Oo G, 2010, GENES IMMUN, V11, P113, DOI 10.1038/gene.2009.78; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Min-Oo G, 2007, BLOOD CELL MOL DIS, V39, P63, DOI 10.1016/j.bcmd.2007.03.003; Min-Oo G, 2010, ANTIMICROB AGENTS CH, V54, P3262, DOI 10.1128/AAC.01719-09; Min-Oo G, 2010, EXP PARASITOL, V125, P315, DOI 10.1016/j.exppara.2010.02.009; Ohno T, 2004, IMMUNOGENETICS, V56, P675, DOI 10.1007/s00251-004-0739-1; Ohno T, 2001, IMMUNOGENETICS, V53, P736, DOI 10.1007/s00251-001-0390-z; Perkins DJ, 2011, INT J BIOL SCI, V7, P1427, DOI 10.7150/ijbs.7.1427; Rocha JL, 2004, MAMM GENOME, V15, P100, DOI 10.1007/s00335-003-2308-6; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005; TORRANCE JD, 1980, TISSUE IRON STORES, P90; Torre S, 2013, GENES IMMUN, V14, P249, DOI 10.1038/gene.2013.16; TURRINI F, 1992, BLOOD, V80, P801; Weatherall DJ, 2008, BRIT J HAEMATOL, V141, P276, DOI 10.1111/j.1365-2141.2008.07085.x; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009	46	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177818	10.1371/journal.pone.0177818	http://dx.doi.org/10.1371/journal.pone.0177818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542307	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400089
J	Li, YJ; Dungey, H; Yanchuk, A; Apiolaza, LA				Li, Yongjun; Dungey, Heidi; Yanchuk, Alvin; Apiolaza, Luis A.			Improvement of non-key traits in radiata pine breeding programme when long-term economic importance is uncertain	PLOS ONE			English	Article							GENOMIC SELECTION; WOOD-QUALITY; SILVICULTURAL REGIMES; OBJECTIVES; INDEXES; GROWTH; VALUES; PROFIT; ACCURACY; DIAMETER	Diameter at breast height (DBH), wood density (DEN) and predicted modulus of elasticity (PME) are considered as 'key traits' (KT) in the improvement in radiata pine breeding programmes in New Zealand. Any other traits which are also of interest to radiata pine breeders and forest growers are called 'non-key traits' (NKTs). External resin bleeding (ERB), internal checking (IC), number of heartwood rings (NHR) are three such non-key traits which affect wood quality of radiata pine timber. Economic importance of the KTs and NKTs is hard to define in radiata pine breeding programmes due to long rotation period. Desired-gain index (DGIs) and robust selection were proposed to incorporate NKTs into radiata pine breeding programme in order to deal with the uncertainty of economic importance. Four desired-gain indices A-D were proposed in this study. The desired-gain index A (DGI-A) emphasized growth and led to small decrease in ERB and small increase in IC and NHR. The expected genetic gains of all traits in the desired-gain index B (DGI-B) were in the favourable directions (positive genetic gains in the key traits and negative genetic gains in the non-key traits). The desired-gain index C (DGI-C) placed emphasis on wood density, leading to favourable genetic gain in the NKTs but reduced genetic gains for DBH and PME. The desired-gain index D (DGI-D) exerted a bit more emphasis on the non-key traits, leading large favourable reduction in the non-key traits and lower increase in the key traits compared with the other DGIs. When selecting both the key traits and the non-key traits, the average EBVs of six traits were all in the same directions as the expected genetic gains except for DBH in the DGI-D. When the key traits were measured and selected, internal checking always had a negative (favourable) genetic gain but ERB and NHR had unfavourable genetic gain in the most of time. After removing some individuals with high sensitivity to the change of economic weights, robust desired-gain selection made genetic gains of all the key and non-key traits to move a little bit toward unfavourable directions in the four indices. It is concluded that desired-gain index combined with robust selection concept is an efficient way for selecting the key and non-key traits in radiata pine breeding programmes.	[Li, Yongjun; Dungey, Heidi] Scion, New Zealand Forest Res Inst, Rotorua, New Zealand; [Yanchuk, Alvin] British Columbia Forest Serv, Tree Improvement Branch, Victoria, BC, Canada; [Apiolaza, Luis A.] Univ Canterbury, Coll Engn, Sch Forestry, Christchurch, New Zealand	Scion; University of Canterbury	Li, YJ (corresponding author), Scion, New Zealand Forest Res Inst, Rotorua, New Zealand.	Yongjun.Li@scionresearch.com		Apiolaza, Luis/0000-0003-0958-3540; Dungey, Heidi/0000-0003-2589-3928	Radiata Pine Breeding Company	Radiata Pine Breeding Company	The authors acknowledge the Radiata Pine Breeding Company for providing funding for this manuscript. The funder (the Radiata Pine Breeding Company) provided funding and data for this study and reviewed the manuscript.; The authors would like to acknowledge the Radiata Pine Breeding Company for providing fund and data for this study and reviewing the manuscript, Mari Suontama and Charlie Low for their valuable suggestions and comments.	Apiolaza LA, 2001, CAN J FOREST RES, V31, P654, DOI 10.1139/cjfr-31-4-654; Apiolaza LA, 2001, IUFRO S DEV EUC FUT; Bateson J, 2014, NEW ZEALAND TREE GRO, V2014, P15; Berlin M, 2012, SCAND J FOREST RES, V27, P681, DOI 10.1080/02827581.2012.672586; Berlin M, 2010, SILVA FENN, V44, P643, DOI 10.14214/sf.132; Cheng C, 2007, THE 3RD INTERNATIONA; COTTERILL PP, 1990, SUCCESSFUL TREE BREE; Cown Dave J., 2011, New Zealand Journal of Forestry Science, V41, P41; DEKKERS JCM, 1991, LIVEST PROD SCI, V29, P131, DOI 10.1016/0301-6226(91)90062-U; DEKKERS JCM, 1995, ANIM SCI, V61, P165, DOI 10.1017/S1357729800013667; Dubey M.K., 2010, THESIS; Evison DC, 2015, CAN J FOREST RES, V45, P135, DOI 10.1139/cjfr-2014-0363; Falconer DS, 1996, INTRODUCTION TO QUAN; Francis J. K., 1994, Tree Planters' Notes, V45, P10; GIBSON JP, 1990, THEOR APPL GENET, V80, P801, DOI 10.1007/BF00224195; Gilmour AR, 2009, ASREML USER GUIDE RE; Grattapaglia D, 2011, TREE GENET GENOMES, V7, P241, DOI 10.1007/s11295-010-0328-4; Greaves B. L., 1997, Forest Genetics, V4, P35; Greaves BL, 1997, FOREST SCI, V43, P465; Hazel LN, 1943, GENETICS, V28, P476; Hazel LN, 1942, J HERED, V33, P393, DOI 10.1093/oxfordjournals.jhered.a105102; Isik F., 2011, BMC P S7, V5, P18, DOI DOI 10.1186/1753-6561-5-S7-I8; Isik F, 2016, PLANT SCI, V242, P108, DOI 10.1016/j.plantsci.2015.08.006; ITOH Y, 1987, GENET SEL EVOL, V19, P69, DOI 10.1186/1297-9686-19-1-69; Ivkovic M, 2006, CAN J FOREST RES, V36, P2920, DOI 10.1139/X06-161; Ceron-Rojas JJ, 2008, J AGR BIOL ENVIR ST, V13, P440, DOI 10.1198/108571108X378911; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Kennedy SG, 2014, NEW ZEAL J FOR SCI, V44, DOI 10.1186/s40490-014-0012-9; Kennedy SG, 2013, TREE GENET GENOMES, V9, P1313, DOI 10.1007/s11295-013-0639-3; Koots KR, 1998, CAN J ANIM SCI, V78, P29, DOI 10.4141/A97-038; Kumar S., 2008, New Zealand Journal of Forestry Science, V38, P88; Kumar S, 2008, CAN J FOREST RES, V38, P2372, DOI 10.1139/X08-086; Kumar S, 2004, CAN J FOREST RES, V34, P2601, DOI [10.1139/x04-128, 10.1139/X04-128]; Lee J, 2003, RPBC REPORT 141; Lexer C, 2012, NEW PHYTOL, V196, P652, DOI 10.1111/j.1469-8137.2012.04362.x; Maclaren P, 2002, NEW ZEALAND JOURNAL; Marchal A, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-015-0423-1; Mason Euan, 2012, New Zealand Journal of Forestry, V57, P13; Munoz P., 2012, GENETICS; PONZONI RW, 1989, ANIM PROD, V49, P35, DOI 10.1017/S0003356100004232; PONZONI RW, 1986, J ANIM BREED GENET, V103, P342, DOI 10.1111/j.1439-0388.1986.tb00096.x; Price K, 1997, DR DOBBS J, V22, P18; Ratcliffe B, 2015, HEREDITY, V115, P547, DOI 10.1038/hdy.2015.57; Resende M.F.R., 2011, BMC P, V5, pO14, DOI DOI 10.1186/1753-6561-5-S7-014; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; SCHNEEBERGER M, 1992, J ANIM BREED GENET, V109, P180, DOI 10.1111/j.1439-0388.1992.tb00395.x; Shelbourne CJA, 1997, IUFRO 97 GENETICS RA; VANDEPITTE WM, 1977, ANN GENET SEL ANIM, V9, P87, DOI 10.1051/1297-9686-9-1-87; Wu H. X., 2008, New Zealand Journal of Forestry Science, V38, P56; Xie C, 1997, GENET SEL EVOL, V29, P193, DOI 10.1051/gse:19970206; YAMADA Y, 1975, JPN J GENET, V50, P33, DOI 10.1266/jjg.50.33	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177806	10.1371/journal.pone.0177806	http://dx.doi.org/10.1371/journal.pone.0177806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542558	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672400086
J	Pezzoli, P; Antfolk, J; Santtila, P				Pezzoli, Patrizia; Antfolk, Jan; Santtila, Pekka			Phenotypic factor analysis of psychopathology reveals a new body-related transdiagnostic factor	PLOS ONE			English	Article							INTERMITTENT EXPLOSIVE DISORDER; SUBSTANCE USE DISORDERS; MENTAL-DISORDERS; HIERARCHICAL STRUCTURE; PSYCHIATRIC-DISORDERS; LIFETIME COMORBIDITY; PREDICTIVE-VALIDITY; GENDER-DIFFERENCES; BIFACTOR MODELS; META-STRUCTURE	Comorbidity challenges the notion of mental disorders as discrete categories. An increasing body of literature shows that symptoms cut across traditional diagnostic boundaries and interact in shaping the latent structure of psychopathology. Using exploratory and confirmatory factor analysis, we reveal the latent sources of covariation among nine measures of psychopathological functioning in a population-based sample of 13024 Finnish twins and their siblings. By implementing unidimensional, multidimensional, second-order, and bifactor models, we illustrate the relationships between observed variables, specific, and general latent factors. We also provide the first investigation to date of measurement invariance of the bifactor model of psychopathology across gender and age groups. Our main result is the identification of a distinct "Body" factor, alongside the previously identified Internalizing and Externalizing factors. We also report relevant cross-disorder associations, especially between body-related psychopathology and trait anger, as well as substantial sex and age differences in observed and latent means. The findings expand the meta-structure of psychopathology, with implications for empirical and clinical practice, and demonstrate shared mechanisms underlying attitudes towards nutrition, self-image, sexuality and anger, with gender-and age-specific features.	[Pezzoli, Patrizia; Antfolk, Jan; Santtila, Pekka] Abo Akad Univ, Dept Psychol, Turku, Finland; [Antfolk, Jan] Turku Brain & Mind Ctr, Turku, Finland	Abo Akademi University	Pezzoli, P (corresponding author), Abo Akad Univ, Dept Psychol, Turku, Finland.	patrizia.pezzoli@abo.fi	Pezzoli, Patrizia/AAI-1996-2019; Antfolk, Jan/D-2926-2018	Pezzoli, Patrizia/0000-0002-2425-5249; Antfolk, Jan/0000-0003-0334-4987	Academy of Finland [298513, 287800]	Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland (http://www.aka.fi/en), grants 298513 (JA) and 287800 (PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Albrecht A., 2014, J SOCIAL SCI RES, V6, P915, DOI 10.24297/jssr.v6i1.3453; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], VERS 23 0; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Blanco C, 2013, JAMA PSYCHIAT, V70, P199, DOI 10.1001/jamapsychiatry.2013.281; Bonifay W., 2017, SCIENCE; Brodbeck J, 2014, COMPR PSYCHIAT, V55, P714, DOI 10.1016/j.comppsych.2013.11.001; Bruno Falissard, 2012, PSY VAR PROC US PSYC; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Carragher N, 2015, SOC PSYCH PSYCH EPID, V50, P339, DOI 10.1007/s00127-014-1004-z; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1080/10705510701301834; Chen FN, 2001, SOCIOL METHOD RES, V29, P468, DOI 10.1177/0049124101029004003; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Derogatis, 2001, BRIEF SYMPTOM INVENT; Derogatis LR, 2002, J SEX MARITAL THER, V28, P317, DOI 10.1080/00926230290001448; Derogatis LR, 1998, DEROGATIS SEXUAL FUN, P269; Dowle M., 2017, PACKAGE DATA TABLE R; Eaton N. R, 2010, CONT DIRECTIONS PSYC, P223; Eaton NR, 2015, SOC PSYCH PSYCH EPID, V50, P171, DOI 10.1007/s00127-014-1001-2; Eaton NR, 2013, J ABNORM PSYCHOL, V122, P86, DOI 10.1037/a0029598; Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780; Eaton NR, 2011, PSYCHOL AGING, V26, P987, DOI 10.1037/a0024406; Epskamp S., 2021, PACKAGE PSYCHONETRIC; Espeset EMS, 2012, EUR EAT DISORD REV, V20, P451, DOI 10.1002/erv.2183; Fincham D, 2009, PSYCHOPATHOLOGY, V42, P92, DOI 10.1159/000203341; Forbes M. K., 2015, ARCH SEX BEHAV, P1; Forbes MK, 2013, ARCH SEX BEHAV, V42, P23, DOI 10.1007/s10508-012-9948-0; Forbush KT, 2013, PSYCHOL MED, V43, P97, DOI 10.1017/S0033291712001092; Forbush KT, 2010, J ABNORM PSYCHOL, V119, P282, DOI 10.1037/a0019189; GARNER DM, 1979, PSYCHOL MED, V9, P273, DOI 10.1017/S0033291700030762; Giovanni Abbate-Daga, 2011, Depress Res Treat, V2011, P194732, DOI 10.1155/2011/194732; Green SB, 2015, EDUC MEAS-ISSUES PRA, V34, P14, DOI 10.1111/emip.12100; Hancock GR, 1997, MEAS EVAL COUNS DEV, V30, P91, DOI 10.1080/07481756.1997.12068926; Hare R. D., 2003, HARE PSYCHOPATHY CHE, V2nd; Haslam N, 2012, PSYCHOL MED, V42, P903, DOI 10.1017/S0033291711001966; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Johansson A, 2013, TWIN RES HUM GENET, V16, P150, DOI 10.1017/thg.2012.108; Kendler K. S., 2011, AM J PSYCHIAT; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Kenny D. A., 1998, RESPECIFICATION LATE; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P669, DOI 10.1001/archpsyc.63.6.669; Kessler RC, 2011, ARCH GEN PSYCHIAT, V68, P90, DOI 10.1001/archgenpsychiatry.2010.180; Keyes KM, 2013, PSYCHOL MED, V43, P1673, DOI 10.1017/S0033291712002292; Keyes KM, 2016, DEPRESS ANXIETY, V33, P101, DOI 10.1002/da.22428; Kim H, 2015, J ABNORM PSYCHOL, V124, P1064, DOI 10.1037/abn0000113; Kotov R, 2011, SCHIZOPHRENIA BULL, V37, P1168, DOI 10.1093/schbul/sbq024; Kotov R, 2011, ARCH GEN PSYCHIAT, V68, P1003, DOI 10.1001/archgenpsychiatry.2011.107; Kramer MD, 2008, PSYCHOL MED, V38, P51, DOI 10.1017/S0033291707001572; Krueger RF, 2003, J ABNORM PSYCHOL, V112, P437, DOI 10.1037/0021-843X.112.3.437; Krueger RF, 2007, J ABNORM PSYCHOL, V116, P645, DOI 10.1037/0021-843X.116.4.645; Krueger RF, 2015, WORLD PSYCHIATRY, V14, P27, DOI 10.1002/wps.20175; Lahey BB, 2012, J ABNORM PSYCHOL, V121, P971, DOI 10.1037/a0028355; Lubke GH, 2005, PSYCHOL METHODS, V10, P21, DOI 10.1037/1082-989X.10.1.21; Markon KE, 2011, PSYCHOL BULL, V137, P856, DOI 10.1037/a0023678; MCDONALD RP, 1978, BRIT J MATH STAT PSY, V31, P59, DOI 10.1111/j.2044-8317.1978.tb00573.x; Milhausen RR, 2015, ARCH SEX BEHAV, V44, P1621, DOI 10.1007/s10508-014-0328-9; Mitchell KS, 2014, INT J EAT DISORDER, V47, P860, DOI 10.1002/eat.22300; Morey LC, 2013, J ABNORM PSYCHOL, V122, P836, DOI 10.1037/a0034003; Munn-Chernoff MA, 2013, BEHAV GENET, V43, P427, DOI 10.1007/s10519-013-9603-0; Muthen B, 2006, ADDICTION, V101, P6, DOI 10.1111/j.1360-0443.2006.01583.x; Muthen BO, 1995, SOCIOL METHODOL, V25, P267, DOI 10.2307/271070; Nackers LM, 2015, MENOPAUSE, V22, P1175, DOI 10.1097/GME.0000000000000452; Noordhof A, 2015, J ABNORM CHILD PSYCH, V43, P577, DOI 10.1007/s10802-014-9923-4; Oberski D, 2014, J STAT SOFTW, V57, P1; Peat CM, 2011, PSYCHOL MEN MASCULIN, V12, P195, DOI 10.1037/a0021478; Pornprasertmanit S., 2013, SEMTOOLS USEFUL TOOL; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Raiche G, 2010, NFACTORS R PACKAGE P; Reise SP, 2012, MULTIVAR BEHAV RES, V47, P667, DOI 10.1080/00273171.2012.715555; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; Ruscio J., 2006, INTRO TAXOMETRIC MET; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seeley JR, 2011, J ABNORM PSYCHOL, V120, P308, DOI 10.1037/a0022621; Shallcross AJ, 2013, J PERS SOC PSYCHOL, V104, P734, DOI 10.1037/a0031180; Slevec JH, 2011, CLIN PSYCHOL REV, V31, P515, DOI 10.1016/j.cpr.2010.12.002; Spielberger C. D., 1999, PSYCHOL ASSESSMENT R; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Steinmetz H., 2013, METHODOLOGY; Striegel-Moore RH, 2009, INT J EAT DISORDER, V42, P471, DOI 10.1002/eat.20625; Team RC, 2016, LANG ENV STAT COMP; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; Werner KB, 2015, PSYCHIAT ANN, V45, P195, DOI 10.3928/00485713-20150401-08; Witkiewitz K, 2013, J ABNORM CHILD PSYCH, V41, P223, DOI 10.1007/s10802-012-9674-z; Wittchen HU, 2009, INT J METH PSYCH RES, V18, P189, DOI 10.1002/mpr.298; Wright AGC, 2015, PSYCHOL MED, V45, P2309, DOI 10.1017/S0033291715000252; Wright AGC, 2013, J ABNORM PSYCHOL, V122, P281, DOI 10.1037/a0030133; Yoshimasu K, 2011, PSYCHIAT RES, V186, P384, DOI 10.1016/j.psychres.2010.07.018	93	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177674	10.1371/journal.pone.0177674	http://dx.doi.org/10.1371/journal.pone.0177674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542328	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400066
J	Amdisen, C; Jespersen, B; Moldrup, U; Keller, AK				Amdisen, Chris; Jespersen, Bente; Moldrup, Ulla; Keller, Anna K.			The unsuitability of implantable Doppler probes for the early detection of renal vascular complications - a porcine model for prevention of renal transplant loss	PLOS ONE			English	Article							COOK-SWARTZ DOPPLER; KIDNEY-TRANSPLANTATION; SURGICAL COMPLICATIONS; FREE FLAPS; THROMBOSIS; ISCHEMIA; MICRODIALYSIS; PIGS; FLOW	Background Vascular occlusion is a rare, but serious complication after kidney transplantation often resulting in graft loss. We therefore aimed to develop an experimental porcine model for stepwise reduction of the renal venous blood flow and to compare an implantable Doppler probe and microdialysis for fast detection of vascular occlusion. Methods In 20 pigs, implantable Doppler probes were placed on the renal artery and vein and a microdialysis catheter was placed in the renal cortex. An arterial flowprobe served as gold standard. Following two-hour baseline measurements, the pigs were randomised to stepwise venous occlusion, complete venous occlusion, complete arterial occlusion or controls. Results All parameters were stable through baseline measurements. Glutamate and lactate measured by microdialysis increased significantly (p = 0.02 and p = 0.03 respectively) 30 minutes after a 2/3 (66%) reduction in renal blood flow. The implantable Doppler probe was not able to detect flow changes until there was total venous occlusion. Microdialysis detected changes in local metabolism after both arterial and venous occlusion; the implantable Doppler probe could only detect vascular occlusions on the vessel it was placed. Conclusions We developed a new model for stepwise renal venous blood flow occlusion. Furthermore, the first comparison of the implantable Doppler probe and microdialysis for detection of renal vascular occlusions was made. The implantable Doppler probe could only detect flow changes after a complete occlusion, whereas microdialysis detected changes earlier, and could detect both arterial and venous occlusion. Based on these results, the implantable Doppler probe for early detection of vascular occlusions cannot be recommended.	[Amdisen, Chris] Aarhus Univ Hosp, Inst Clin Med, Aarhus, Denmark; [Amdisen, Chris; Jespersen, Bente] Aarhus Univ Hosp, Dept Renal Med, Aarhus, Denmark; [Moldrup, Ulla; Keller, Anna K.] Aarhus Univ Hosp, Dept Urol, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Amdisen, C (corresponding author), Aarhus Univ Hosp, Inst Clin Med, Aarhus, Denmark.; Amdisen, C (corresponding author), Aarhus Univ Hosp, Dept Renal Med, Aarhus, Denmark.	camd@clin.au.dk		Jespersen, Bente/0000-0001-7196-2870; Amdisen, Chris/0000-0003-3262-8524	Helen and Ejnar Biornows Foundation; Institute of Clinical Medicine, Aarhus University hospital; Soster & Verner Lipperts foundation; Institute of Clinical Medicine; Soster and Verner Lipperts foundation	Helen and Ejnar Biornows Foundation; Institute of Clinical Medicine, Aarhus University hospital; Soster & Verner Lipperts foundation; Institute of Clinical Medicine; Soster and Verner Lipperts foundation	This work was supported by the Helen and Ejnar Biornows Foundation (http://www.bjoemowsfond..dk/); Institute of Clinical Medicine, Aarhus University hospital (http://clin.au.dk/en/) and the Soster & Verner Lipperts foundation (http ://lippertsfond.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was generously donated by: the Helen and Ejnar Bjornow foundation, the Institute of Clinical Medicine and the Soster and Verner Lipperts foundation. The funding sources had no involvement in any part of the study.	Aktas S, 2011, TRANSPL P, V43, P557, DOI 10.1016/j.transproceed.2011.01.007; Barba J, 2013, SCAND J UROL, V47, P63, DOI 10.3109/00365599.2012.700945; Brown ED, 2000, RADIOGRAPHICS, V20, P607, DOI 10.1148/radiographics.20.3.g00ma14607; Crane J, 2011, EXP CLIN TRANSPLANT, V9, P118; de Jong KP, 2012, TRANSPLANTATION, V94, P958, DOI 10.1097/TP.0b013e318269e6ad; Fonouni H, 2013, LANGENBECK ARCH SURG, V398, P87, DOI 10.1007/s00423-012-1010-0; Fonouni H, 2012, NEPHROL DIAL TRANSPL, V27, P541, DOI 10.1093/ndt/gfr308; Frost MW, 2015, MICROSURG, V35, P262, DOI 10.1002/micr.22331; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; HJORTDAL VE, 1994, PLAST RECONSTR SURG, V93, P375, DOI 10.1097/00006534-199402000-00024; HJORTDAL VE, 1992, PLAST RECONSTR SURG, V89, P521, DOI 10.1097/00006534-199203000-00021; Humar A, 2005, SEMIN DIALYSIS, V18, P505, DOI 10.1111/j.1525-139X.2005.00097.x; Keller AK, 2009, TRANSPL P, V41, P44, DOI 10.1016/j.transproceed.2008.10.089; Keller AK, 2013, MESSENGERS RENAL GRA, V45, P1172; Keller AK, 2013, TRANSPLANTATION, V95, P275, DOI 10.1097/TP.0b013e318276a1c8; Keller AK, 2008, J UROLOGY, V179, P371, DOI 10.1016/j.juro.2007.08.088; Keller AK, 2009, J UROLOGY, V182, P1854, DOI 10.1016/j.juro.2009.03.015; Oliver DW, 2005, BRIT J PLAST SURG, V58, P366, DOI 10.1016/j.bjps.2004.12.003; PENNY MJ, 1994, TRANSPLANTATION, V58, P565, DOI 10.1097/00007890-199409150-00007; Ponticelli C, 2009, NEPHROL DIAL TRANSPL, V24, P1388, DOI 10.1093/ndt/gfp003; Rozen W, 2010, J RECONSTR MICROSURG, V27; Rozen WM, 2010, MICROSURG, V30, P354, DOI 10.1002/micr.20720; Rozen WM, 2009, MICROSURGERY; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Schmulder A, 2011, MICROSURG, V31, P1, DOI 10.1002/micr.20816; Smit JM, 2009, J PLAST RECONSTR AES, V62, P1286, DOI 10.1016/j.bjps.2008.06.007; SWARTZ WM, 1988, PLAST RECONSTR SURG, V81, P149, DOI 10.1097/00006534-198802000-00001; Weld KJ, 2008, J ENDOUROL, V22, P571, DOI 10.1089/end.2007.0256; Weld KJ, 2009, J UROLOGY, V181, P878, DOI 10.1016/j.juro.2008.10.068; Whitaker IS, 2010, J RECONSTR MICROSURG, V26, P409, DOI 10.1055/s-0030-1249607	30	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178301	10.1371/journal.pone.0178301	http://dx.doi.org/10.1371/journal.pone.0178301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542429	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800066
J	Killick-Cole, CL; Singleton, WGB; Bienemann, AS; Asby, DJ; Wyatt, MJ; Boulter, LJ; Barua, NU; Gill, SS				Killick-Cole, Clare L.; Singleton, William G. B.; Bienemann, Alison S.; Asby, Daniel J.; Wyatt, Marcella J.; Boulter, Lisa J.; Barua, Neil U.; Gill, Steven S.			Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; HISTONE DEACETYLASE INHIBITOR; ACTIVATING ACVR1 MUTATIONS; BRAIN-STEM GLIOMA; LEUKEMIA-CELLS; PHASE-I; ACID; GLIOBLASTOMA; CARBOPLATIN; EXPRESSION	Targeting epigenetic changes in diffuse intrinsic pontine glioma (DIPG) may provide a novel treatment option for patients. This report demonstrates that sodium valproate, a histone deacetylase inhibitor (HDACi), can increase the cytotoxicity of carboplatin in an additive and synergistic manner in DIPG cells in vitro. Sodium valproate causes a dose-dependent decrease in DIPG cell viability in three independent ex vivo cell lines. Furthermore, sodium valproate caused an increase in acetylation of histone H3. Changes in cell viability were consistent with an induction of apoptosis in DIPG cells in vitro, determined by flow cytometric analysis of Annexin V staining and assessment of apoptotic markers by western blotting. Subsequently, immunofluorescent staining of neuronal and glial markers was used to determine toxicity in normal rat hippocampal cells. Pre-treatment of cells with sodium valproate enhanced the cytotoxic effects of carboplatin, in three DIPG cell lines tested. These results demonstrate that sodium valproate causes increased histone H3 acetylation indicative of HDAC inhibition, which is inversely correlated with a reduction in cell viability. Cell viability is reduced through an induction of apoptosis in DIPG cells. Sodium valproate potentiates carboplatin cytotoxicity and prompts further work to define the mechanism responsible for the synergy between these two drugs and determine in vivo efficacy. These findings support the use of sodium valproate as an adjuvant treatment for DIPG.	[Killick-Cole, Clare L.; Singleton, William G. B.; Bienemann, Alison S.; Asby, Daniel J.; Wyatt, Marcella J.; Boulter, Lisa J.; Barua, Neil U.; Gill, Steven S.] Univ Bristol, Sch Clin Sci, Funct Neurosurg Res Grp, Southmead Hosp, Learning & Res Bldg, Bristol, Avon, England; [Singleton, William G. B.; Barua, Neil U.; Gill, Steven S.] North Bristol NHS Trust, Dept Neurosurg, Bristol, Avon, England	Southmead Hospital; University of Bristol; North Bristol NHS Trust	Killick-Cole, CL; Gill, SS (corresponding author), Univ Bristol, Sch Clin Sci, Funct Neurosurg Res Grp, Southmead Hosp, Learning & Res Bldg, Bristol, Avon, England.; Gill, SS (corresponding author), North Bristol NHS Trust, Dept Neurosurg, Bristol, Avon, England.	clare.killick-cole@bristol.ac.uk; steven.gill@nbt.nhs.uk		Asby, Daniel/0000-0002-1219-8347; Singleton, William/0000-0001-8836-7613	Functional Neurosurgery Research Fund; MRC [MR/J005134/1, G0601745, MR/N001370/1] Funding Source: UKRI; Medical Research Council [G0601745, MR/J005134/1, MR/N001370/1] Funding Source: researchfish	Functional Neurosurgery Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Functional Neurosurgery Research Fund, held by Southmead Hospital Charities. SG and NB are advisers to Renishaw PLC. Neither Functional Neurosurgery Research Fund nor Renishaw had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132266; Arvidsson Y, 2016, NEUROENDOCRINOLOGY, V103, P578, DOI 10.1159/000441849; Atmaca A, 2007, BRIT J CANCER, V97, P177, DOI 10.1038/sj.bjc.6603851; Barua NU, 2013, ACTA NEUROCHIR, V155, P1459, DOI 10.1007/s00701-013-1700-6; Barua NU, 2016, DRUG DELIV, V23, P167, DOI 10.3109/10717544.2014.908248; Barua NU, 2014, BRAIN PATHOL, V24, P117, DOI 10.1111/bpa.12082; Bokelmann I, 2008, MOL MED, V14, P20, DOI 10.2119/2007-00084.Bokelmann; Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936; Castel D, 2015, ACTA NEUROPATHOL, V130, P815, DOI 10.1007/s00401-015-1478-0; Catalano MG, 2004, J CLIN ENDOCRINOLOGY, V90, P1383; Felix FHC, 2011, PEDIATR HEMAT ONCOL, V28, P556, DOI 10.3109/08880018.2011.563774; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cinatl J, 1997, ANTI-CANCER DRUG, V8, P958, DOI 10.1097/00001813-199711000-00007; Das CM, 2007, J NEURO-ONCOL, V85, P159, DOI 10.1007/s11060-007-9402-7; Donaldson SS, 2006, J CLIN ONCOL, V24, P1266, DOI 10.1200/JCO.2005.04.6599; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Falchook GS, 2013, INVEST NEW DRUG, V31, P1192, DOI 10.1007/s10637-013-0003-3; Felisbino MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029144; Fortunati N, 2008, CANCER LETT, V259, P156, DOI 10.1016/j.canlet.2007.10.006; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Halvorson KG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118926; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Hashizume R, 2012, J NEURO-ONCOL, V110, P305, DOI 10.1007/s11060-012-0973-6; Hennika T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169485; Kawagoe R, 2002, LEUKEMIA RES, V26, P495, DOI 10.1016/S0145-2126(01)00151-5; Li YF, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00058; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Paugh BS, 2013, CANCER RES, V73, P6219, DOI 10.1158/0008-5472.CAN-13-1491; Pilatrino C, 2005, CANCER-AM CANCER SOC, V104, P101, DOI 10.1002/cncr.21132; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Ramalingam SS, 2007, CLIN CANCER RES, V13, P3605, DOI 10.1158/1078-0432.CCR-07-0162; Redjal N, 2016, J NEURO-ONCOL, V127, P505, DOI 10.1007/s11060-016-2054-8; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Singleton WGB, 2016, NEURO-ONCOLOGY, V18, P131; Taylor KR, 2014, NAT GENET, V46, P457, DOI 10.1038/ng.2925; van Zanten SEMV, 2015, EXPERT REV ANTICANC, V15, P157, DOI 10.1586/14737140.2015.974563; Wagner S, 2009, TURK J CANC, V39, P104; WIESER HG, 1991, EPILEPSY RES, V9, P154, DOI 10.1016/0920-1211(91)90028-E; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yeow WS, 2006, BRIT J CANCER, V94, P1436, DOI 10.1038/sj.bjc.6603132	45	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0176855	10.1371/journal.pone.0176855	http://dx.doi.org/10.1371/journal.pone.0176855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542253	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800005
J	Holinka, LG; O'Donnell, V; Risatti, GR; Azzinaro, P; Arzt, J; Stenfeldt, C; Velazquez-Salinas, L; Carlson, J; Gladue, DP; Borca, MV				Holinka, Lauren G.; O'Donnell, Vivian; Risatti, Guillermo R.; Azzinaro, Paul; Arzt, Jonathan; Stenfeldt, Carolina; Velazquez-Salinas, Lauro; Carlson, Jolene; Gladue, Douglas P.; Borca, Manuel V.			Early protection events in swine immunized with an experimental live attenuated classical swine fever marker vaccine, FlagT4G	PLOS ONE			English	Article							HOG-CHOLERA VIRUS; INTERFERON SYNTHESIS; CHINESE STRAIN; VIRULENCE; CSFV; PESTIVIRUSES; INHIBITION; INFECTION; APOPTOSIS; CYTOKINES	Prophylactic vaccination using live attenuated classical swine fever (CSF) vaccines has been a very effective method to control the disease in endemic regions and during outbreaks in previously disease-free areas. These vaccines confer effective protection against the disease at early times post-vaccination although the mechanisms mediating the protection are poorly characterized. Here we present the events occurring after the administration of our in-house developed live attenuated marker vaccine, FlagT4Gv. We previously reported that FlagT4Gv intramuscular (IM) administered conferred effective protection against intranasal challenge with virulent CSFV (BICv) as early as 7 days post-vaccination. Here we report that FlagT4Gv is able to induce protection against disease as early as three days post-vaccination. Immunohistochemical testing of tissues from FlagT4Gv-inoculated animals showed that tonsils were colonized by the vaccine virus by day 3 post-inoculation. There was a complete absence of BICv in tonsils of FlagT4Gv-inoculated animals which had been intranasal (IN) challenged with BICv 3 days after FlagT4Gv infection, confirming that FlagT4Gv inoculation confers sterile immunity. Analysis of systemic levels of 19 different cytokines in vaccinated animals demonstrated an increase of IFN-alpha three days after FlagT4Gv inoculation compared with mock infected controls.	[Holinka, Lauren G.; O'Donnell, Vivian; Azzinaro, Paul; Arzt, Jonathan; Stenfeldt, Carolina; Velazquez-Salinas, Lauro; Carlson, Jolene; Gladue, Douglas P.; Borca, Manuel V.] ARS, Plum Isl Anim Dis Ctr, USDA, Greenport, NY 11944 USA; [O'Donnell, Vivian; Risatti, Guillermo R.] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA; [Azzinaro, Paul; Velazquez-Salinas, Lauro] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Carlson, Jolene] Kansas State Univ, Coll Vet Med, Biosecur Res Inst, Manhattan, KS 66506 USA; [Carlson, Jolene] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	United States Department of Agriculture (USDA); University of Connecticut; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Kansas State University; Kansas State University	Borca, MV (corresponding author), ARS, Plum Isl Anim Dis Ctr, USDA, Greenport, NY 11944 USA.	manuel.borca@ars.usda.gov	Stenfeldt, Carolina/AAG-7940-2021; Gladue, Douglas/P-6280-2018; O'Donnell, Vivian/ACY-4611-2022; Velazquez-Salinas, Lauro/AAF-3951-2021	Gladue, Douglas/0000-0002-7894-0233; Stenfeldt, Carolina/0000-0002-2074-3886; Arzt, Jonathan/0000-0002-7517-7893	State of Kansas National Bio and Agro-Defense Facility Fund (NBAF); Institute for Infectious Animal Diseases (IIAD); ARS/USDA-University of Connecticut SCA [58-1940-1-190]	State of Kansas National Bio and Agro-Defense Facility Fund (NBAF); Institute for Infectious Animal Diseases (IIAD); ARS/USDA-University of Connecticut SCA	This project was partially funded through the State of Kansas National Bio and Agro-Defense Facility Fund (NBAF) and Institute for Infectious Animal Diseases (IIAD) Career Development Program. We also thank ARS/USDA-University of Connecticut SCA# 58-1940-1-190 for partially supporting this work. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank the Plum Island Animal Disease Center Animal Resource Branch for excellent technical assistance. This project was partially funded through the State of Kansas National Bio and Agro-Defense Facility Fund (NBAF) and Institute for Infectious Animal Diseases (IIAD) Career Development Program. We also thank ARS/USDA-University of Connecticut SCA# 58-1940-1-190 for partially supporting this work.	Becher P, 2003, VIROLOGY, V311, P96, DOI 10.1016/S0042-6822(03)00192-2; Bensaude E, 2004, J GEN VIROL, V85, P1029, DOI 10.1099/vir.0.19637-0; BIRONT P, 1987, VET MICROBIOL, V14, P105, DOI 10.1016/0378-1135(87)90002-2; Carlson J, 2016, VIRUSES, P8; Choi C, 2004, ARCH VIROL, V149, P875, DOI 10.1007/s00705-003-0275-6; DAHLE J, 1995, BERL MUNCH TIERARZTL, V108, P20; de Smit AJ, 2001, VACCINE, V19, P1467, DOI 10.1016/S0264-410X(00)00347-9; Dong XY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-286; EDWARDS S, 1991, VET MICROBIOL, V29, P101, DOI 10.1016/0378-1135(91)90118-Y; Fernandez-Sainz I, 2015, VIROLOGY, V483, P284, DOI 10.1016/j.virol.2015.04.024; Fernandez-Sainz I, 2010, J VIROL, V84, P1536, DOI 10.1128/JVI.02050-09; FERRARI M, 1992, COMP IMMUNOL MICROB, V15, P221, DOI 10.1016/0147-9571(92)90095-9; Graham SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029310; Graham SP, 2012, VACCINE, V30, P2742, DOI 10.1016/j.vaccine.2012.02.029; Holinka LG, 2014, VIROLOGY, V471, P13, DOI 10.1016/j.virol.2014.09.021; Holinka LG, 2009, VIROLOGY, V384, P106, DOI 10.1016/j.virol.2008.10.039; KADEN V, 1982, ARCH EXP VET MED, V36, P593; Lai SS, 1982, ROLES PROTECTION PIG, P126; Leifer I, 2009, J VIROL METHODS, V158, P114, DOI 10.1016/j.jviromet.2009.02.002; Magkouras I, 2008, J GEN VIROL, V89, P2501, DOI 10.1099/vir.0.2008/003749-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renson P, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-9; Risatti GR, 2005, VIROLOGY, V343, P116, DOI 10.1016/j.virol.2005.08.015; Rosengard AM, 1999, MOL IMMUNOL, V36, P685, DOI 10.1016/S0161-5890(99)00081-4; Tamura T, 2012, J VIROL, V86, P8602, DOI 10.1128/JVI.00551-12; Tarradas J, 2014, VIRUS RES, V185, P82, DOI 10.1016/j.virusres.2014.03.004; TERPSTRA C, 1990, DEUT TIERARZTL WOCH, V97, P77; van Oirschot JT, 2003, VET MICROBIOL, V96, P367, DOI 10.1016/j.vetmic.2003.09.008	28	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177433	10.1371/journal.pone.0177433	http://dx.doi.org/10.1371/journal.pone.0177433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542321	Green Submitted, Green Published, gold			2022-12-27	WOS:000402061500024
J	Arias-Mutis, OJ; Marrachelli, VG; Ruiz-Sauri, A; Alberola, A; Morales, JM; Such-Miquel, L; Monleon, D; Chorro, FJ; Such, L; Zarzoso, M				Julian Arias-Mutis, Oscar; Marrachelli, Vannina G.; Ruiz-Sauri, Amparo; Alberola, Antonio; Manuel Morales, Jose; Such-Miquel, Luis; Monleon, Daniel; Chorro, Francisco J.; Such, Luis; Zarzoso, Manuel			Development and characterization of an experimental model of diet-induced metabolic syndrome in rabbit	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; HIGH-FAT DIET; TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; OBESITY; ATHEROSCLEROSIS; ACIDS; HYPERTENSION; POPULATION	Metabolic syndrome (MetS) has become one of the main concerns for public health because of its link to cardiovascular disease. Murine models have been used to study the effect of MetS on the cardiovascular system, but they have limitations for studying cardiac electrophysiology. In contrast, the rabbit cardiac electrophysiology is similar to human, but a detailed characterization of the different components of MetS in this animal is still needed. Our objective was to develop and characterize a diet-induced experimental model of MetS that allows the study of cardiovascular remodeling and arrhythmogenesis. Male NZW rabbits were assigned to control (n = 15) or MetS group (n = 16), fed during 28 weeks with high-fat, high-sucrose diet. We measured weight, morphological characteristics, blood pressure, glycaemia, standard plasma biochemistry and the metabolomic profile at weeks 14 and 28. Liver histological changes were evaluated using hematoxylin-eosin staining. A mixed model ANOVA or unpaired t-test were used for statistical analysis (P<0.05). Weight, abdominal contour, body mass index, systolic, diastolic and mean arterial pressure increased in the MetS group at weeks 14 and 28. Glucose, triglycerides, LDL, GOT-AST, GOT/GPT, bilirubin and bile acid increased, whereas HDL decreased in the MetS group at weeks 14 and 28. We found a 40% increase in hepatocyte area and lipid vacuoles infiltration in the liver from MetS rabbits. Metabolomic analysis revealed differences in metabolites related to fatty acids, energetic metabolism and microbiota, compounds linked with cardiovascular disease. Administration of high-fat and high-sucrose diet during 28 weeks induced obesity, glucose intolerance, hypertension, non-alcoholic hepatic steatosis and metabolic alterations, thus reproducing the main clinical manifestations of the metabolic syndrome in humans. This experimental model should provide a valuable tool for studies into the mechanisms of cardiovascular problems related to MetS, with special relevance in the study of cardiovascular remodeling, arrhythmias and SCD.	[Julian Arias-Mutis, Oscar; Marrachelli, Vannina G.; Monleon, Daniel; Chorro, Francisco J.] Hlth Res Inst INCLIVA, Valencia, Spain; [Julian Arias-Mutis, Oscar; Marrachelli, Vannina G.; Alberola, Antonio; Such, Luis] Univ Valencia, Dept Physiol, Valencia, Spain; [Ruiz-Sauri, Amparo; Monleon, Daniel] Univ Valencia, Dept Pathol, Valencia, Spain; [Manuel Morales, Jose] Univ Valencia, UCIM, Valencia, Spain; [Such-Miquel, Luis; Zarzoso, Manuel] Univ Valencia, Dept Physiotherapy, Valencia, Spain; [Chorro, Francisco J.] Clin Hosp Valencia, Dept Cardiol, Valencia, Spain; [Chorro, Francisco J.] Inst Salud Carlos III, CIBERCV, Madrid, Spain	University of Valencia; University of Valencia; University of Valencia; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III	Zarzoso, M (corresponding author), Univ Valencia, Dept Physiotherapy, Valencia, Spain.	manuel.zarzoso@uv.es	Monleon, Daniel/GNP-4083-2022; marrachelli, vannina G/L-6041-2014; Saurí, Amparo Ruiz/R-5395-2018; Zarzoso, Manuel/AAA-6129-2019; tatay, jose manuel morales/L-7972-2014; Monleon, Daniel/A-5078-2010; Chorro, Francisco J/AAB-6766-2020; Arias-Mutis, Oscar/AAA-5858-2019	Monleon, Daniel/0000-0002-4803-1573; marrachelli, vannina G/0000-0002-4097-3312; Zarzoso, Manuel/0000-0003-3372-4497; tatay, jose manuel morales/0000-0002-4404-6735; Monleon, Daniel/0000-0002-4803-1573; Such-Miquel, Luis/0000-0001-8499-7183; Alberola, Antonio/0000-0001-8531-4161	Generalitat Valenciana [GV2015-062, PROMETEOII/2014/037]; Universitat de Valencia [UV-INV-PRECOMP14-206372]; Ministry of Economy, Industry and Competitiviness of Spain [SAF2014-52875R]; Institutode Salud Carlos III [CB16/11/00486, PIE15/00013]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universitat de Valencia; Ministry of Economy, Industry and Competitiviness of Spain; Institutode Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Generalitat Valenciana (GV2015-062 and PROMETEOII/2014/037): http://www.ceice.gva.es/web/ciencia; Universitat de Valencia (UV-INV-PRECOMP14-206372): http://www.uv.es/uvweb/college/en/research-tech-transfer/funding/presentation-news-1285946409813.html; Ministry of Economy, Industry and Competitiviness of Spain (SAF2014-52875R): https://sede.micinn.gob.es/portal/site/eSede?lang_choosen=en; and Institutode Salud Carlos III (CB16/11/00486 and PIE15/00013): http://www.eng.isciii.es/ISCIII/es/general/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Generalitat Valenciana (GV2015-062), Universitat de Valencia (UV-INV-PRECOMP14-206372) to MZ, Ministry of Economy, Industry and Competitiviness of Spain (SAF2014-52875R) to DM, Generalitat Valenciana (PROMETEOII/2014/037) to FJC and Instituto de Salud Carlos III (CB16/11/00486 and PIE15/00013). We thank Mariano Munoz, Ana Diaz and Eva Blanch for their excellent technical assistance. The authors gratefully acknowledge useful discussions with Dr. Jose T. Real.	Abu Bakar MH, 2015, MOL BIOSYST, V11, P1742, DOI 10.1039/c5mb00158g; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Carroll JF, 1996, AM J PHYSIOL-HEART C, V271, pH373, DOI 10.1152/ajpheart.1996.271.1.H373; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; D'Aversa F, 2013, INTERN EMERG MED, V8, pS11, DOI 10.1007/s11739-013-0916-z; de Grooth GJ, 2004, J LIPID RES, V45, P1967, DOI 10.1194/jlr.R400007-JLR200; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fan J, 2000, J Atheroscler Thromb, V7, P26; Filippi A, 2008, J CARDIOVASC MED, V9, P595, DOI 10.2459/JCM.0b013e3282f2c9d0; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Greiner TU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110359; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Guo XY, 2016, DIABETES RES CLIN PR, V115, P76, DOI 10.1016/j.diabres.2016.03.007; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; He XY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030300; Helfenstein T, 2011, INT J EXP PATHOL, V92, P40, DOI 10.1111/j.1365-2613.2010.00753.x; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; Hookana E, 2011, HEART RHYTHM, V8, P1570, DOI 10.1016/j.hrthm.2011.06.031; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Krauss RM, 2004, MED CLIN N AM, V88, P897, DOI 10.1016/j.mcna.2004.04.004; Lengyel C, 2001, BRIT J PHARMACOL, V132, P101, DOI 10.1038/sj.bjp.0703777; Liu EQ, 2005, METABOLISM, V54, P132, DOI 10.1016/j.metabol.2004.07.021; Messana I, 1998, CLIN CHEM, V44, P1529; Morrow JP, 2014, ACTA PHYSIOL, V211, P13, DOI 10.1111/apha.12276; NELSON RW, 1990, AM J VET RES, V51, P1357; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Ning B, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0024-3; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Park S, 2015, MOL CELLS, V38, P587, DOI 10.14348/molcells.2015.0126; Polakof S, 2016, EUROPEAN J NUTR; Reuter S, 2015, ACTA PHYSIOL, V214, P291, DOI 10.1111/apha.12530; Sahebkar A, 2017, J CELLULAR PHYSL; Semenkovich CF, 1997, DIABETES, V46, P327, DOI 10.2337/diabetes.46.3.327; Stancakova A, 2012, DIABETES, V61, P1895, DOI 10.2337/db11-1378; van Bilsen M, 2014, ACTA PHYSIOL, V211, P476, DOI 10.1111/apha.12308; Verkest KR, 2014, VET J, V199, P24, DOI 10.1016/j.tvjl.2013.09.057; Vishram JKK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107294; Waqar AB, 2010, ATHEROSCLEROSIS, V213, P148, DOI 10.1016/j.atherosclerosis.2010.07.051; Wong SK, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0123-9; Xu FG, 2013, J CLIN ENDOCR METAB, V98, pE1060, DOI 10.1210/jc.2012-4132; Yin Weidong, 2002, Int J Exp Diabetes Res, V3, P179, DOI 10.1080/15604280214274; Yokota A, 2012, GUT MICROBES, V3, P455, DOI 10.4161/gmic.21216; Zarzoso M, 2014, ACTA PHYSIOL, V211, P36, DOI 10.1111/apha.12185; Zhang X, 2016, TOXICOL PATHOL, V44, P358, DOI 10.1177/0192623316630835; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108; Zhao S, 2008, J ANIM PHYSIOL AN N, V92, P105, DOI 10.1111/j.1439-0396.2007.00723.x	48	22	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178315	10.1371/journal.pone.0178315	http://dx.doi.org/10.1371/journal.pone.0178315			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542544	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058800054
J	Peng, XL; Liu, Y; Liang, BS; Du, ZM				Peng, Xiaolong; Liu, Yong; Liang, Baosheng; Du, Zhimin			Interface condition for the Darcy velocity at the water-oil flood front in the porous medium	PLOS ONE			English	Article							MULTIPHASE FLOW; NUMERICAL-SIMULATION	Flood front is the jump interface where fluids distribute discontinuously, whose interface condition is the theoretical basis of a mathematical model of the multiphase flow in porous medium. The conventional interface condition at the jump interface is expressed as the continuous Darcy velocity and fluid pressure (named CVCM). Our study has inspected this conclusion. First, it is revealed that the principle of mass conservation has no direct relation to the velocity conservation, and the former is not the true foundation of the later, because the former only reflects the kinetic characteristic of the fluid particles at one position(the interface), but not the different two parts of fluid on the different side of the interface which required by the interface conditions. Then the reasonableness of CVCM is queried from the following three aspects:(1) Using Mukat's two phase seepage equation and the mathematical method of apagoge, we have disproved the continuity of each fluid velocity;(2) Since the analytical solution of the equation of Buckley-Leveret equations is acquirable, its velocity jumps at the flood front presents an appropriate example to disprove the CVCM;(3) The numerical simulation model gives impractical result that flood front would stop moving if CVCM were used to calculate the velocities at the interface between two gridcells. Subsequently, a new one, termed as Jump Velocity Condition Model (JVCM), is deduced from Muskat's two phase seepage equations and Darcy's law without taking account of the capillary force and compressibility of rocks and fluids. Finally, several cases are presented. And the comparisons of the velocity, pressure difference and the front position, which are given by JVCM, CVCM and SPU, have shown that the result of JVCM is the closest to the exact solution.	[Peng, Xiaolong; Liu, Yong; Du, Zhimin] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Liang, Baosheng] Chevron North Amer Explorat & Dev, Houston, TX USA	Southwest Petroleum University	Peng, XL (corresponding author), Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	pengxl@swpu.edu.cn		Peng, Xiaolong/0000-0001-8163-4459	Ministry of Science and Technology of China [2011ZX05060-004, 2011ZX0514-004]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China 2011ZX05060-004 and 2011ZX0514-004 (http//www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz K., 1986, PETROLEUM RESERVOIR; Brenner K, 2013, COMPUTAT GEOSCI, V17, P573, DOI 10.1007/s10596-013-9345-3; Brooks RH, 1991, HYDRAULIC PROPERTIES; Buckley SE, 1942, T AM I MIN MET ENG, V146, P107, DOI 10.2118/942107-G; Chu J, 2013, SIAM J MULTISCALE MO, V10, P515; Costa VAF, 2004, NUMER HEAT TR A-APPL, V45, P675, DOI 10.1080/10407780490424839; DATTAGUPTA A, 1995, ADV WATER RESOUR, V18, P9, DOI 10.1016/0309-1708(94)00021-V; Doster F, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123030; Haggerty R, 2000, WATER RESOUR RES, V36, P3467, DOI 10.1029/2000WR900214; HASSANIZADEH SM, 1989, WATER RESOUR RES, V25, P1705, DOI 10.1029/WR025i007p01705; Huber R, 2000, COMPUTAT GEOSCI, V4, P141, DOI 10.1023/A:1011559916309; Hyman JM, 1983, PHYSICA D, V12, P396; Jenny P, 2005, MULTISCALE MODEL SIM, V3, P50, DOI 10.1137/030600795; LeVeque RJ, 2002, CAMBRIDGE TEXTS APPL, V31, DOI DOI 10.1017/CBO9780511791253; Lunati I, 2006, J COMPUT PHYS, V216, P616, DOI 10.1016/j.jcp.2006.01.001; Mozolevski I, 2013, J COMPUT APPL MATH, V242, P12, DOI 10.1016/j.cam.2012.09.045; Muskat M, 1937, FLOW HETEROGENEOUS F; Nataf F., 2002, INTERFACE CONNECTION, DOI DOI 10.1007/978-94-010-0510-4_9; Peng DL, 2007, MODELING 2 PHASE FLO; Reddy JN, 2000, FINITE ELEMENT METHO; Schweizer B, 2007, DISCRETE CONTINUOUS; Szymkiewicz A, 2013, GEOPLANET-EARTH PLAN, P1, DOI 10.1007/978-3-642-23559-7; Tveit S, 2012, COMPUTAT GEOSCI, V16, P809, DOI 10.1007/s10596-012-9289-z; Valdes-Parada FJ, 2005, J POROUS MEDIA, V8, P557, DOI 10.1615/JPorMedia.v8.i6.20; Wu YS, 2009, COMMUN COMPUT PHYS, V6, P85	25	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177187	10.1371/journal.pone.0177187	http://dx.doi.org/10.1371/journal.pone.0177187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542612	Green Published, gold			2022-12-27	WOS:000402058800010
J	Schulze, J; Kaiser, O; Paasche, G; Lamm, H; Pich, A; Hoffmann, A; Lenarz, T; Warnecke, A				Schulze, Jennifer; Kaiser, Odett; Paasche, Gerrit; Lamm, Hans; Pich, Andreas; Hoffmann, Andrea; Lenarz, Thomas; Warnecke, Athanasia			Effect of hyperbaric oxygen on BDNF-release and neuroprotection: Investigations with human mesenchymal stem cells and genetically modified NIH3T3 fibroblasts as putative cell therapeutics	PLOS ONE			English	Article							SPIRAL-GANGLION NEURONS; MARROW STROMAL CELLS; NEUROTROPHIC FACTOR; IN-VITRO; AUDITORY NEURONS; HAIR-CELLS; NEURITE OUTGROWTH; NITRIC-OXIDE; EXPRESSION; SURVIVAL	Hyperbaric oxygen therapy (HBOT) is a noninvasive widely applied treatment that increases the oxygen pressure in tissues. In cochlear implant (CI) research, intracochlear application of neurotrophic factors (NTFs) is able to improve survival of spiral ganglion neurons (SGN) after deafness. Cell-based delivery of NTFs such as brain-derived neurotrophic factor (BDNF) may be realized by cell-coating of the surface of the CI electrode. Human mesenchymal stem cells (MSC) secrete a variety of different neurotrophic factors and may be used for the development of a biohybrid electrode in order to release endogenously-derived neuroprotective factors for the protection of residual SGN and for a guided outgrowth of dendrites in the direction of the CI electrode. HBOT could be used to influence cell behaviour after transplantation to the inner ear. The aim of this study was to investigate the effect of HBOT on the proliferation, BDNF-release and secretion of neuroprotective factors. Thus, model cells (an immortalized fibroblast cell line (NIH3T3)-native and genetically modified) and MSCs were repeatedly (3 x - 10 x) exposed to 100% oxygen at different pressures. The effects of HBO on cell proliferation were investigated in relation to normoxic and normobaric conditions (NOR). Moreover, the neuroprotective and neuroregenerative effects of HBO-treated cells were analysed by cultivation of SGN in conditioned medium. Both, the genetically modified NIH3T3/BDNF and native NIH3T3 fibroblasts, showed a highly significant increased proliferation after five days of HBOT in comparison to normoxic controls. By contrast, the number of MSCs was decreased in MSCs treated with 2.0 bar of HBO. Treating SGN cultures with supernatants of fibroblasts and MSCs significantly increased the survival rate of SGN. HBO treatment did not influence (increase / reduce) this effect. Secretome analysis showed that HBO treatment altered the protein expression pattern in MSCs.	[Schulze, Jennifer; Kaiser, Odett; Paasche, Gerrit; Lamm, Hans; Lenarz, Thomas; Warnecke, Athanasia] Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany; [Schulze, Jennifer; Kaiser, Odett; Paasche, Gerrit; Lenarz, Thomas; Warnecke, Athanasia] Cluster Excellence Hearing4all, Hannover, Germany; [Pich, Andreas] Hannover Med Sch, Core Facil Prote, Hannover, Germany; [Hoffmann, Andrea] Hannover Med Sch, Dept Orthopaed Surg, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Schulze, J (corresponding author), Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany.; Schulze, J (corresponding author), Cluster Excellence Hearing4all, Hannover, Germany.	Schulze.Jennifer.HNO@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022; Hoffmann, Andrea/AAG-4488-2020	Hoffmann, Andrea/0000-0003-2318-8985	DFG Cluster of Excellence [EXC 1077/1]	DFG Cluster of Excellence(German Research Foundation (DFG))	This work was supported by DFG Cluster of Excellence EXC 1077/1 "Hearing4all", http:// hearing4all.eu/, JS, OK.	ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Arnhold S, 2006, EUR J CELL BIOL, V85, P551, DOI 10.1016/j.ejcb.2006.01.015; Bae KS, 2011, YONSEI MED J, V52, P401, DOI 10.3349/ymj.2011.52.3.401; Bailey EM, 2014, J NEUROSCI, V34, P13110, DOI 10.1523/JNEUROSCI.1014-14.2014; Budenz CL, 2015, SCI REP, V5, P1; Chikar JA, 2012, BIOMATERIALS, V33, P1982, DOI 10.1016/j.biomaterials.2011.11.052; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; Colombari GC, 2011, EUR ARCH OTO-RHINO-L, V268, P49, DOI 10.1007/s00405-010-1338-4; Conconi MT, 2003, J INVEST MED, V51, P227, DOI 10.1136/jim-51-04-24; Dimitrijevich SD, 1999, WOUND REPAIR REGEN, V7, P53; Fernandez KA, 2015, J NEUROSCI, V35, P7509, DOI 10.1523/JNEUROSCI.5138-14.2015; Flores-Otero J, 2011, J COMP NEUROL, V519, P1455, DOI 10.1002/cne.22576; Geng CK, 2015, ASIAN PAC J TROP MED, V8, P469, DOI [10.1016/j.apjtm.2015.05.001, 10.1016/S1995-7645(14)60362-X]; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gillespie LN, 2001, NEUROREPORT, V12, P275, DOI 10.1097/00001756-200102120-00019; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Jin YL, 2013, CELL TISSUE RES, V351, P15, DOI 10.1007/s00441-012-1526-1; Jochim N, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-48; Kang Thomas S, 2004, Arch Facial Plast Surg, V6, P31, DOI 10.1001/archfaci.6.1.31; Kishino A, 2001, NEUROREPORT, V12, P1067, DOI 10.1097/00001756-200104170-00040; Kitaoka Y, 2016, EXP EYE RES, V152, P71, DOI 10.1016/j.exer.2016.09.007; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; Kunnavatana SS, 2005, ARCH OTOLARYNGOL, V131, P809, DOI 10.1001/archotol.131.9.809; Lagarde MMM, 2013, J NEUROSCI, V33, P1564, DOI 10.1523/JNEUROSCI.3088-12.2013; Lai R. C., 2012, INT J PROTEOMICS, V2012, P1; Lamm K, 1998, ADV OTO-RHINO-LARYNG, V54, P59; Lee CC, 2006, J BIOMED SCI, V13, P143, DOI 10.1007/s11373-005-9037-7; LEFEBVRE PP, 1994, NEUROREPORT, V5, P865, DOI 10.1097/00001756-199404000-00003; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lin SS, 2014, STEM CELL RES, V12, P260, DOI 10.1016/j.scr.2013.10.007; Matsuoka AJ, 2006, LARYNGOSCOPE, V116, P1363, DOI 10.1097/01.mlg.0000225986.18790.75; May LA, 2013, J CLIN INVEST, V123, P3577, DOI 10.1172/JCI68480; McGuinness SL, 2005, OTOL NEUROTOL, V26, P1064, DOI 10.1097/01.mao.0000185063.20081.50; Miller JM, 2007, J NEUROSCI RES, V85, P1959, DOI 10.1002/jnr.21320; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Monzack EL, 2013, HEARING RES, V303, P20, DOI 10.1016/j.heares.2013.01.008; Nakaizumi T, 2004, AUDIOL NEURO-OTOL, V9, P135, DOI 10.1159/000077264; Perez P, 2011, AGING DIS, V2, P231; Pirvola U, 1997, J NEUROBIOL, V33, P1019, DOI 10.1002/(SICI)1097-4695(199712)33:7<1019::AID-NEU11>3.0.CO;2-A; PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; ROBERTS GP, 1994, BRIT J DERMATOL, V131, P630, DOI 10.1111/j.1365-2133.1994.tb04973.x; Roemer A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0408-y; Sabirzhanov B, 2012, J NEUROCHEM, V123, P542, DOI 10.1111/j.1471-4159.2012.07927.x; Schack LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065943; Schack LM, 2013, STEM CELLS DEV, V22, P3226, DOI 10.1089/scd.2013.0290; Schimmang T, 2014, NEUROSCIENCE, V283, P26, DOI 10.1016/j.neuroscience.2014.07.025; Schwieger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133680; Seo JH, 2012, YONSEI MED J, V53, P1059, DOI 10.3349/ymj.2012.53.6.1059; Shyu KG, 2008, LIFE SCI, V83, P65, DOI 10.1016/j.lfs.2008.05.005; Stover T, 2007, LARYNGO RHINO OTOL, V86, P352, DOI 10.1055/s-2006-945005; Teixeira FG, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0124-z; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Tompach PC, 1997, INT J ORAL MAX SURG, V26, P82, DOI 10.1016/S0901-5027(05)80632-0; Venetsanou K, 2012, EUR J APPL PHYSIOL, V112, P677, DOI 10.1007/s00421-011-2027-8; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Wan GQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03564; Wang XL, 2007, NEUROREPORT, V18, P1753, DOI 10.1097/WNR.0b013e3282f0ec09; Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7; Warnecke A, 2012, HEARING RES, V289, P86, DOI 10.1016/j.heares.2012.04.007; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wise AK, 2010, MOL THER, V18, P1111, DOI 10.1038/mt.2010.28; Yang HJ, 2016, J MOL NEUROSCI J MOL	66	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178182	10.1371/journal.pone.0178182	http://dx.doi.org/10.1371/journal.pone.0178182			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542481	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800045
J	Yang, LJ; Zhang, XJ; Zhang, X; Wang, JR; Luo, MC; Yang, MJ; Wang, H; Xiang, LB; Zeng, FS; Yu, DZ; Fu, DL; Rosewarne, GM				Yang, Lijun; Zhang, Xuejiang; Zhang, Xu; Wang, Jirui; Luo, Mingcheng; Yang, Mujun; Wang, Hua; Xiang, Libo; Zeng, Fansong; Yu, Dazhao; Fu, Daolin; Rosewarne, Garry M.			Identification and evaluation of resistance to powdery mildew and yellow rust in a wheat mapping population	PLOS ONE			English	Article							ADULT-PLANT RESISTANCE; F-SP TRITICI; QUANTITATIVE TRAIT LOCI; WILD EMMER WHEAT; STRIPE-RUST; COMMON WHEAT; LEAF RUST; WINTER-WHEAT; MICROSATELLITE MARKERS; DURABLE RESISTANCE	Deployment of cultivars with genetic resistance is an effective approach to control the diseases of powdery mildew (PM) and yellow rust (YR). Chinese wheat cultivar XK0106 exhibits high levels of resistance to both diseases, while cultivar E07901 has partial, adult plant resistance (APR). The aim of this study was to map resistance loci derived from the two cultivars and analyze their effects against PM and YR in a range of environments. A doubled haploid population (388 lines) was used to develop a framework map consisting of 117 SSR markers, while a much higher density map using the 90K Illumina iSelect SNP array was produced with a subset of 80 randomly selected lines. Seedling resistance was characterized against a range of PM and YR isolates, while field scores in multiple environments were used to characterize APR. Composite interval mapping (CIM) of seedling PM scores identified two QTLs (QPm. haas-6A and QPm. haas-2A), the former being located at the Pm21 locus. These QTLs were also significant in field scores, as were Qpm. haas-3A and QPm. haas-5A. QYr. haas-1B-1 and QYr. haas-2A were identified in field scores of YR and were located at the Yr24/26 and Yr17 chromosomal regions respectively. A second 1B QTL, QYr. haas-1B-2 was also identified. QPm. haas-2A and QYr. haas-1B-2 are likely to be new QTLs that have not been previously identified. Effects of the QTLs were further investigated in multiple environments through the testing of selected lines predicted to contain various QTL combinations. Significant additive interactions between the PM QTLs highlighted the ability to pyramid these loci to provide higher level of resistance. Interactions between the YR QTLs gave insights into the pathogen populations in the different locations as well as showing genetic interactions between these loci.	[Yang, Lijun] Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China; [Yang, Lijun; Zhang, Xuejiang; Wang, Hua; Xiang, Libo; Zeng, Fansong; Yu, Dazhao] Hubei Acad Agr Sci, Key Lab Integrated Pest Management Crop Cent Chin, Minist Agr, Inst Plant Protect & Soil Sci, Wuhan, Peoples R China; [Zhang, Xu] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China; [Wang, Jirui] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China; [Luo, Mingcheng] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Yang, Mujun] Yunnan Acad Agr Sci, Food Crops Res Inst, Kunming, Peoples R China; [Fu, Daolin] Shandong Agr Univ, Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Rosewarne, Garry M.] Sichuan Acad Agr Sci, Crop Res Inst, Int Maize & Wheat Improvement Ctr CIMMYT, Chengdu, Peoples R China; [Rosewarne, Garry M.] Agr Victoria, Dept Econ Dev Jobs Transport & Resources, Horsham, Vic, Australia	Wuhan University; Hubei Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Jiangsu Academy of Agricultural Sciences; Sichuan Agricultural University; University of California System; University of California Davis; Yunnan Academy of Agricultural Sciences; Shandong Agricultural University; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Sichuan Academy of Agricultural Sciences (SAAS)	Yu, DZ (corresponding author), Hubei Acad Agr Sci, Key Lab Integrated Pest Management Crop Cent Chin, Minist Agr, Inst Plant Protect & Soil Sci, Wuhan, Peoples R China.; Rosewarne, GM (corresponding author), Sichuan Acad Agr Sci, Crop Res Inst, Int Maize & Wheat Improvement Ctr CIMMYT, Chengdu, Peoples R China.; Rosewarne, GM (corresponding author), Agr Victoria, Dept Econ Dev Jobs Transport & Resources, Horsham, Vic, Australia.	Dazhaoyu@china.com; garry.rosewarne@ecodev.vic.gov.au		Luo, Ming-Cheng/0000-0002-9744-5887	Special Fund for Agro-scientific Research in the Public Interest [201303016]; National 973 Plan Project [2013C13127701]; fund of the Modern Agro-industry Technology Research System [CARS-3]; Hubei Province Agricultural Science and Technology Innovation Center [2011-620-003-03]	Special Fund for Agro-scientific Research in the Public Interest; National 973 Plan Project(National Basic Research Program of China); fund of the Modern Agro-industry Technology Research System; Hubei Province Agricultural Science and Technology Innovation Center	This study was supported by Special Fund for Agro-scientific Research in the Public Interest (201303016) and National 973 Plan Project (2013C13127701); by the fund of the Modern Agro-industry Technology Research System (CARS-3) and by Hubei Province Agricultural Science and Technology Innovation Center (2011-620-003-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbag GM, 2012, THEOR APPL GENET, V125, P109, DOI 10.1007/s00122-012-1819-5; BENNETT FGA, 1984, PLANT PATHOL, V33, P279, DOI 10.1111/j.1365-3059.1984.tb01324.x; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Case AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091758; Chantret N, 2000, THEOR APPL GENET, V100, P1217, DOI 10.1007/s001220051427; CHEN PD, 1995, THEOR APPL GENET, V91, P1125, DOI 10.1007/BF00223930; Chen WQ, 2009, PLANT DIS, V93, P1093, DOI 10.1094/PDIS-93-11-1093; Cheng P, 2014, THEOR APPL GENET, V127, P2267, DOI 10.1007/s00122-014-2378-8; Dracatos PM, 2016, THEOR APPL GENET, V129, P65, DOI 10.1007/s00122-015-2609-7; Gu Jian, 2008, Journal of Triticeae Crops, V28, P1; Han DJ, 2015, PLANT DIS, V99, P754, DOI 10.1094/PDIS-08-14-0865-RE; Hao YF, 2015, THEOR APPL GENET, V128, P465, DOI 10.1007/s00122-014-2445-1; Hao YF, 2011, THEOR APPL GENET, V123, P1401, DOI 10.1007/s00122-011-1675-8; Herrera-Foessel SA, 2011, THEOR APPL GENET, V122, P239, DOI 10.1007/s00122-010-1439-x; Hua W, 2009, THEOR APPL GENET, V119, P223, DOI 10.1007/s00122-009-1031-4; Huang XQ, 2004, EUPHYTICA, V137, P203, DOI 10.1023/B:EUPH.0000041576.74566.d7; Jia Q. Z., 2012, GANSU AGR SCI TECHNO, V32, P3; Kou YJ, 2010, CURR OPIN PLANT BIOL, V13, P181, DOI 10.1016/j.pbi.2009.12.010; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Li GQ, 2006, THEOR APPL GENET, V112, P1434, DOI 10.1007/s00122-006-0245-y; Li ZF, 2014, CROP SCI, V54, P1907, DOI 10.2135/cropsci2014.02.0162; Lillemo M, 2008, THEOR APPL GENET, V116, P1155, DOI 10.1007/s00122-008-0743-1; LIMPERT E, 1987, J PHYTOPATHOL, V120, P1, DOI 10.1111/j.1439-0434.1987.tb04408.x; Line RF, 1992, US DEP AGR TECH B, P1968; Liu SX, 2001, CROP SCI, V41, P1268, DOI 10.2135/cropsci2001.4141268x; Liu TG, 2010, PLANT DIS, V94, P1163, DOI 10.1094/PDIS-94-9-1163C; Liu Z, 1999, PLANT BREEDING, V118, P215, DOI 10.1046/j.1439-0523.1999.118003215.x; Lowe I, 2011, THEOR APPL GENET, V123, P143, DOI 10.1007/s00122-011-1573-0; Ma JX, 2001, EUPHYTICA, V120, P219, DOI 10.1023/A:1017510331721; Markell SG, 2008, PHYTOPATHOLOGY, V98, P632, DOI 10.1094/PHYTO-98-6-0632; Mcintosh R.A., 2014, CATALOGUE GENE SYMBO; McIntosh RA, 1996, EUPHYTICA, V89, P395; Mester D, 2003, GENETICS, V165, P2269; Mingeot D, 2002, PLANT BREEDING, V121, P133, DOI 10.1046/j.1439-0523.2002.00679.x; Paillard S, 2012, THEOR APPL GENET, V125, P955, DOI 10.1007/s00122-012-1885-8; PAYNE P I, 1986, Genetica Agraria, V40, P231; Peng JH, 1999, THEOR APPL GENET, V98, P862, DOI 10.1007/s001220051145; Peng JH, 2000, GENETICA, V109, P199, DOI 10.1023/A:1017573726512; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Qi XL, 2010, MOL PLANT BREED, V4, P1; Rosewarne GM, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0317-2; Rosewarne GM, 2013, THEOR APPL GENET, V126, P2427, DOI 10.1007/s00122-013-2159-9; SAARI EE, 1975, PLANT DIS REP, V59, P377; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Singh R. P., 2000, Acta Phytopathologica et Entomologica Hungarica, V35, P133; Singh RP, 2011, EUPHYTICA, V179, P175, DOI 10.1007/s10681-010-0322-9; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Tucker DM, 2007, EUPHYTICA, V155, P1, DOI 10.1007/s10681-006-9295-0; Van Ooijen JW, 2007, JOINMAP 4 0 SOFTWARE; Wan AM, 2007, AUST J AGR RES, V58, P605, DOI 10.1071/AR06142; Wang C, 2008, EUPHYTICA, V159, P359, DOI 10.1007/s10681-007-9524-1; Wang ChunMei, 2007, Acta Agronomica Sinica, V33, P1595; Wang LF, 2002, EUPHYTICA, V124, P71, DOI 10.1023/A:1015689817857; Wang S, 2007, WINDOWS QTL CARTOGRA, V2, P5; Wang Shumin, 2014, Biomed Res Int, V2014, P507353, DOI 10.1155/2014/507353; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; Xie CJ, 2003, THEOR APPL GENET, V106, P341, DOI 10.1007/s00122-002-1022-1; Yang EN, 2013, THEOR APPL GENET, V126, P1721, DOI 10.1007/s00122-013-2087-8; [杨立军 Yang Lijun], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P3354; Yang LJ, 2014, HUBEI AGR SCI, V53, P6009; [袁凤平 Yuan Fengping], 2014, [麦类作物学报, Journal of Triticeae Crops], V34, P1577; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zeng FS, 2014, J INTEGR AGR, V13, P2424, DOI 10.1016/S2095-3119(13)60669-3; Zhang XJ, 2013, PLOS ONE, V8; ZHUANG QS, 2003, CHINESE WHEAT IMPROV, P469	65	9	9	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177905	10.1371/journal.pone.0177905	http://dx.doi.org/10.1371/journal.pone.0177905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542459	Green Published, gold			2022-12-27	WOS:000402058800030
J	Pegos, VR; Santos, RML; Medrano, FJ; Balan, A				Pegos, Vanessa R.; Santos, Rodrigo M. L.; Medrano, Francisco J.; Balan, Andrea			Structural features of PhoX, one of the phosphate-binding proteins from Pho regulon of Xanthomonas citri	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; TRANSPORTER; SPECIFICITY; ALIGNMENT; RECEPTOR; SYSTEM; PST	In Escherichia coli, the ATP-Binding Cassette transporter for phosphate is encoded by the pstSCAB operon. PstS is the periplasmic component responsible for affinity and specificity of the system and has also been related to a regulatory role and chemotaxis during depletion of phosphate. Xanthomonas citri has two phosphate-binding proteins: PstS and PhoX, which are differentially expressed under phosphate limitation. In this work, we focused on PhoX characterization and comparison with PstS. The PhoX three-dimensional structure was solved in a closed conformation with a phosphate engulfed in the binding site pocket between two domains. Comparison between PhoX and PstS revealed that they originated from gene duplication, but despite their similarities they show significant differences in the region that interacts with the permeases.	[Pegos, Vanessa R.] Univ Estadual Campinas, UNICAMP, IB, Campinas, SP, Brazil; [Pegos, Vanessa R.] Ctr Nacl Energia & Mat CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Santos, Rodrigo M. L.] Univ Mogi Das Cruzes UMC, Mogi Das Cruzes, SP, Brazil; [Santos, Rodrigo M. L.] Univ Fed Sao Paulo, UNIFESP, Diadema, SP, Brazil; [Medrano, Francisco J.] CSIC, Ctr Invest Biol, Madrid, Spain; [Balan, Andrea] Univ Sao Paulo, Inst Ciencias Biomed II ICBII, Sao Paulo, SP, Brazil	Universidade Estadual de Campinas; Universidade de Mogi das Cruzes; Universidade Federal de Sao Paulo (UNIFESP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidade de Sao Paulo	Balan, A (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed II ICBII, Sao Paulo, SP, Brazil.	abalan@usp.br	Medrano, Francisco Javier/ABF-9860-2020; Balan, Andrea/D-1891-2014	Balan, Andrea/0000-0001-6199-3198	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)" for Vanessa Pegos PhD fellowship; Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP" [2011/20468-1, 2013/09172-9]	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)" for Vanessa Pegos PhD fellowship; Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP"(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)" for Vanessa Pegos PhD fellowship and the Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP" for the research grants 2011/20468-1 and 2013/09172-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Burut-Archanai S, 2009, BIOCHEM BIOPH RES CO, V378, P383, DOI 10.1016/j.bbrc.2008.11.012; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crepin S, 2011, VET MICROBIOL, V153, P82, DOI 10.1016/j.vetmic.2011.05.043; Dintner S, 2011, J BACTERIOL, V193, P3851, DOI 10.1128/JB.05175-11; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Ferraris DM, 2014, PROTEINS, V82, P2268, DOI 10.1002/prot.24548; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Gupta DK, 2014, CHEMOSPHERE, V108, P134, DOI 10.1016/j.chemosphere.2014.01.030; Jacobsen SM, 2008, FEMS IMMUNOL MED MIC, V52, P180, DOI 10.1111/j.1574-695X.2007.00358.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monds RD, 2006, APPL ENVIRON MICROB, V72, P1910, DOI 10.1128/AEM.72.3.1910-1924.2006; Moreno-Letelier A, 2011, INT J EVOL BIOL, V2011, P1, DOI [10.4061/2011/781642, DOI 10.4061/2011/781642]; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nikata T, 1996, MOL GEN GENET, V250, P692, DOI 10.1007/s004380050122; Nylander JAA, 2004, MRMODELTEST ESCV2 PR; Pegos VR, 2014, ACTA CRYSTALLOGR F, V70, P1604, DOI 10.1107/S2053230X14021840; Pegos VR, 2014, J PROTEOMICS, V108, P78, DOI 10.1016/j.jprot.2014.05.005; Pireddu L, 2011, BIOINFORMATICS, V27, P2159, DOI 10.1093/bioinformatics/btr325; Rico-Jimenez M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28967; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe M, 2007, ACTA CRYSTALLOGR D, V63, P1185, DOI 10.1107/S0907444907048299; VANVEEN HW, 1994, BIOCHEMISTRY-US, V33, P1766, DOI 10.1021/bi00173a020; Vyas NK, 2003, STRUCTURE, V11, P765, DOI 10.1016/S0969-2126(03)00109-6; Wang ZM, 1997, NAT STRUCT BIOL, V4, P519, DOI 10.1038/nsb0797-519; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Wittmore L, 2004, NUCLEIC ACIDS RES, V32, P668; Wu H, 1999, J BIOSCI BIOENG, V87, P273, DOI 10.1016/S1389-1723(99)80031-0; Yao NH, 1996, BIOCHEMISTRY-US, V35, P2079, DOI 10.1021/bi952686r	39	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178162	10.1371/journal.pone.0178162	http://dx.doi.org/10.1371/journal.pone.0178162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542513	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058400064
J	Motomura, K; Okada, N; Morita, H; Hara, M; Tamari, M; Orimo, K; Matsuda, G; Imadome, KI; Matsuda, A; Nagamatsu, T; Fujieda, M; Sago, H; Saito, H; Matsumoto, K				Motomura, Kenichiro; Okada, Naoko; Morita, Hideaki; Hara, Mariko; Tamari, Masato; Orimo, Keisuke; Matsuda, Go; Imadome, Ken-Ichi; Matsuda, Akio; Nagamatsu, Takeshi; Fujieda, Mikiya; Sago, Haruhiko; Saito, Hirohisa; Matsumoto, Kenji			A Rho-associated coiled-coil containing kinases (ROCK) inhibitor, Y-27632, enhances adhesion, viability and differentiation of human term placenta-derived trophoblasts in vitro	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; CELL-FUSION; E-CADHERIN; ACTIN CYTOSKELETON; EXPRESSION; CYTOTROPHOBLASTS; SYNCYTIN; CULTURE; MODELS; LINES	Although human term placenta-derived primary cytotrophoblasts (pCTBs) represent a good human syncytiotrophoblast (STB) model, in vitro culture of pCTBs is not always easily accomplished. Y-27632, a specific inhibitor of Rho-associated coiled-coil containing kinases (ROCK), reportedly prevented apoptosis and improved cell-to-substrate adhesion and culture stability of dissociated cultured human embryonic stem cells and human corneal endothelial cells. The Rho kinase pathway regulates various kinds of cell behavior, some of which are involved in pCTB adhesion and differentiation. In this study, we examined Y-27632's potential for enhancing pCTB adhesion, viability and differentiation. pCTBs were isolated from term, uncomplicated placentas by trypsin-DNase I-Dispase II treatment and purified by HLA class I-positive cell depletion. Purified pCTBs were cultured on uncoated plates in the presence of epidermal growth factor (10 ng/ml) and various concentrations of Y-27632. pCTB adhesion to the plates was evaluated by phase-contrast imaging, viability was measured by WST-8 assay, and differentiation was evaluated by immunofluorescence staining, expression of fusogenic genes and hCG-beta production. Ras-related C3 botulinum toxin substrate 1 (Rac1; one of the effector proteins of the Rho family) and protein kinase A (PKA) involvement was evaluated by using their specific inhibitors, NSC-23766 and H-89. We found that Y-27632 treatment significantly enhanced pCTB adhesion to plates, viability, cell-to-cell fusion and hCG-beta production, but showed no effects on pCTB proliferation or apoptosis. Furthermore, NSC-23766 and H-89 each blocked the effects of Y-27632, suggesting that Y-27632 significantly enhanced pCTB differentiation via Rac1 and PKA activation. Our findings suggest that Rac1 and PKA may be interactively involved in CTB differentiation, and addition of Y-27632 to cultures may be an effective method for creating a stable culture model for studying CTB and STB biology in vitro.	[Motomura, Kenichiro; Okada, Naoko; Morita, Hideaki; Hara, Mariko; Tamari, Masato; Orimo, Keisuke; Matsuda, Akio; Saito, Hirohisa; Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan; [Motomura, Kenichiro; Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo, Japan; [Matsuda, Go; Imadome, Ken-Ichi] Natl Res Inst Child Hlth & Dev, Div Adv Med Virus Infect, Tokyo, Japan; [Nagamatsu, Takeshi] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo, Japan; [Fujieda, Mikiya] Kochi Med Sch, Dept Pediat, Kochi, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; University of Tokyo; Kochi University	Motomura, K; Matsumoto, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan.; Motomura, K (corresponding author), Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo, Japan.	motomura-k@ncchd.go.jp; matsumoto-k@ncchd.go.jp	Morita, Hideaki/S-2214-2016; 岡田, 直子/GRI-9555-2022; Nagamatsu, Takeshi/AAH-1402-2019; Nagamatsu, Takeshi/AAC-5201-2021; Morita, Hideaki/ADL-2008-2022	Morita, Hideaki/0000-0003-0928-8322; 岡田, 直子/0000-0002-3378-5778; Nagamatsu, Takeshi/0000-0003-1480-5785; Saito, Hirohisa/0000-0002-6630-8337	Ministry of Education, Culture, Sports, Science, and Technology [MEXT: 15K21655]; National Center for Child Health and Development [24-3]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT: 15K21655) to KMo (https://www.jsps.go.jp/english/indexhtml) and from the National Center for Child Health and Development (24-3) to KMa (Mtps://mw.ncchd.go.jp/center/information/entrusthtml#). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghababaei M, 2015, CELL DEATH DIFFER, V22, P1970, DOI 10.1038/cdd.2015.44; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Ark M, 2005, PLACENTA, V26, P81, DOI 10.1016/j.placenta.2004.03.012; Bachmann VA, 2013, P NATL ACAD SCI USA, V110, P8531, DOI 10.1073/pnas.1215902110; Benirschke K., 2012, PATHOLOGY HUMAN PLAC, P55, DOI DOI 10.1007/978-3-642-23941-0_6; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Borges M, 2003, PLACENTA, V24, P959, DOI 10.1016/S0143-4004(03)00173-5; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Chang CW, 2011, MOL CELL BIOL, V31, P3820, DOI 10.1128/MCB.05582-11; Collett GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030453; COUTIFARIS C, 1991, DEVELOPMENT, V113, P767; Daoud G, 2005, J PHYSIOL-LONDON, V566, P409, DOI 10.1113/jphysiol.2005.089326; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Diaz P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090961; FEINMAN MA, 1986, J CLIN ENDOCR METAB, V63, P1211, DOI 10.1210/jcem-63-5-1211; Fradet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040596; Frank HG, 2001, PLACENTA, V22, pS107, DOI 10.1053/plac.2001.0644; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gierman LM, 2015, PLACENTA, V36, P1246, DOI 10.1016/j.placenta.2015.09.004; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; Guilbert LJ, 2002, PLACENTA, V23, P175, DOI 10.1053/plac.2001.0756; Haider S, 2016, P NATL ACAD SCI USA, V113, pE7710, DOI 10.1073/pnas.1612335113; Hiden U, 2013, AM J PATHOL, V182, P1563, DOI 10.1016/j.ajpath.2013.01.011; Ishikawa A, 2014, CYTOSKELETON, V71, P241, DOI 10.1002/cm.21165; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; KAO LC, 1988, DEV BIOL, V130, P693, DOI 10.1016/0012-1606(88)90361-2; Keryer G, 1998, J CELL SCI, V111, P995; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Lin L, 2000, PLACENTA, V21, P73, DOI 10.1053/plac.1999.0443; Malhotra SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11210; Marchetti T, 2014, J THROMB HAEMOST, V12, P910, DOI 10.1111/jth.12570; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; MORRISH DW, 1987, J CLIN ENDOCR METAB, V65, P1282, DOI 10.1210/jcem-65-6-1282; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Okumura N, 2016, SCI REP-UK, V6, DOI 10.1038/srep26113; Okumura N, 2014, INVEST OPHTH VIS SCI, V55, P318, DOI 10.1167/iovs.13-12225; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Orendi K, 2011, PLACENTA, V32, pS49, DOI 10.1016/j.placenta.2010.11.023; Park KH, 2012, TOXICOL SCI, V128, P247, DOI 10.1093/toxsci/kfs139; Petroff MG, 2006, METH MOLEC MED, V121, P203; Pidoux G, 2014, J CELL SCI, V127, P4172, DOI 10.1242/jcs.149609; Pidoux G, 2010, AM J PHYSIOL-CELL PH, V298, pC1517, DOI 10.1152/ajpcell.00484.2008; Riddell MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081273; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Shibukawa Y, 2010, MOL BIOL CELL, V21, P3973, DOI 10.1091/mbc.E10-03-0261; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Williams JLR, 2008, AM J PHYSIOL-REG I, V295, pR1204, DOI 10.1152/ajpregu.00193.2008; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	52	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177994	10.1371/journal.pone.0177994	http://dx.doi.org/10.1371/journal.pone.0177994			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542501	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672600038
J	Nekimken, AL; Mazzochette, EA; Goodman, MB; Pruitt, BL				Nekimken, Adam L.; Mazzochette, Eileen A.; Goodman, Miriam B.; Pruitt, Beth L.			Forces applied during classical touch assays for Caenorhabditis elegans	PLOS ONE			English	Article							NEURONS; SENSITIVITY; MECHANICS; PROTEIN	For decades, Caenorhabditis elegans roundworms have been used to study the sense of touch, and this work has been facilitated by a simple behavioral assay for touch sensation. To perform this classical assay, an experimenter uses an eyebrow hair to gently touch a moving worm and observes whether or not the worm reverses direction. We used two experimental approaches to determine the manner and moment of contact between the eyebrow hair tool and freely moving animals and the forces delivered by the classical assay. Using high-speed video (2500 frames/second), we found that typical stimulus delivery events include a brief moment when the hair is contact with the worm's body and not the agar substrate. To measure the applied forces, we measured forces generated by volunteers mimicking the classical touch assay by touching a calibrated microcantilever. The mean (61 mu N) and median forces (26 mu N) were more than ten times higher than the 2-mu N force known to saturate the probability of evoking a reversal in adult C. elegans. We also considered the eyebrow hairs as an additional source of variation. The stiffness of the sampled eyebrow hairs varied between 0.07 and 0.41 N/m and was correlated with the free length of hair. Collectively, this work establishes that the classical touch assay applies enough force to saturate the probability of evoking reversals in adult C. elegans in spite of its variability among trials and experimenters and that increasing the free length of the hair can decrease the applied force.	[Nekimken, Adam L.; Goodman, Miriam B.; Pruitt, Beth L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Mazzochette, Eileen A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Goodman, Miriam B.; Pruitt, Beth L.] Stanford Univ, Mol & Cellular Physiol Dept, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Pruitt, BL (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.; Pruitt, BL (corresponding author), Stanford Univ, Mol & Cellular Physiol Dept, Stanford, CA 94305 USA.	pruitt@stanford.edu		Pruitt, Beth L./0000-0002-4861-2124; Goodman, Miriam B./0000-0002-5810-1272	National Institute of Biomedical Imaging and Bioengineering [5R01EB006745-08]; National Institute of Neurological Disorders and Stroke [4R01NS047715-12]; National Institute of Neurological Disorders andStroke [5R01NS092099-02, 1F31NS100318-01]; National Institutes of Health [R01EB006745, R01NS092099, R01NS047715, F31NS100318]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS100318, R01NS047715] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Neurological Disorders andStroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grant Number: 5R01EB006745-08 to BLP and MBG from the National Institute of Biomedical Imaging and Bioengineering (http://www.nibib.nih.gov/), Grant Number: 4R01NS047715-12 to MBG from the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/), Grant Number: 5R01NS092099-02 to MBG from the National Institute of Neurological Disorders andStroke (http://www.ninds.nih.gov/), and Grant Number: 1F31NS100318-01 to ALN from the National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Matt Hopcroft, Frederic Loizeau, and Tom Larsen for helpful discussions; Anthony Ricci for the loan of the high-speed camera and stereomicroscope; Sylvia Fechner for performing the touch assays for high-speed video. This work was funded by in part by the National Institutes of Health under grants R01EB006745, R01NS092099, R01NS047715 and F31NS100318.	CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chalfie Martin, 2014, WormBook, DOI 10.1895/wormbook.1.172.1; Chen XY, 2014, J NEUROSCI, V34, P6522, DOI 10.1523/JNEUROSCI.0022-14.2014; Corsi AK, 2015, GENETICS, V200, P387, DOI 10.1534/genetics.115.176099; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Park SJ, 2007, P NATL ACAD SCI USA, V104, P17376, DOI 10.1073/pnas.0702138104; Park SJ, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3574362; Petzold BC, 2013, INTEGR BIOL-UK, V5, P853, DOI [10.1039/c3ib20293c, 10.1039/c3b20293c]; Petzold BC, 2011, BIOPHYS J, V100, P1977, DOI 10.1016/j.bpj.2011.02.035; Pruitt BL, 2003, SENSOR ACTUAT A-PHYS, V104, P68, DOI 10.1016/S0924-4247(02)00485-5; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; THOMAS JH, 1990, GENETICS, V124, P855; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030; Zhang Y, 2002, MECH DEVELOP, V119, P3, DOI 10.1016/S0925-4773(02)00293-9	16	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178080	10.1371/journal.pone.0178080	http://dx.doi.org/10.1371/journal.pone.0178080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542494	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600044
J	Jamme, M; Raimbourg, Q; Chauveau, D; Seguin, A; Presne, C; Perez, P; Gobert, P; Wynckel, A; Provot, F; Delmas, Y; Mousson, C; Servais, A; Vrigneaud, L; Veyradier, A; Rondeau, E; Coppo, P; Thrombotic, F; Centre, MR				Jamme, Matthieu; Raimbourg, Quentin; Chauveau, Dominique; Seguin, Amelie; Presne, Claire; Perez, Pierre; Gobert, Pierre; Wynckel, Alain; Provot, Francois; Delmas, Yahsou; Mousson, Christiane; Servais, Aude; Vrigneaud, Laurence; Veyradier, Agnss; Rondeau, Eric; Coppo, Paul; Thrombotic, French; Centre, Microangiopathies Reference			Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome	PLOS ONE			English	Article							THROMBOTIC-THROMBOCYTOPENIC PURPURA; COMPLEMENT INHIBITOR ECULIZUMAB; PROGNOSTIC-FACTORS; MICROANGIOPATHIES; PATHOPHYSIOLOGY; MUTATIONS; IMPACT	Chronic kidney disease (CKD) is a frequent and serious complication of atypical haemolytic uremic syndrome (aHUS). We aimed to develop a simple accurate model to predict the risk of renal dysfunction in aHUS based on clinical and biological features available at hospital admission. Renal function at 1-year follow-up, based on an estimated glomerular filtration rate <60mL/min/1.73m(2) as assessed by the Modification of Diet in Renal Disease equation, was used as an indicator of significant CKD. Prospectively collected data from a cohort of 156 aHUS patients who did not receive eculizumab were used to identify predictors of CKD. Covariates associated with renal impairment were identified by multivariate analysis. The model performance was assessed and a scoring system for clinical practice was constructed from the regression coefficient. Multivariate analyses identified three predictors of CKD: a high serum creatinine level, a high mean arterial pressure and a mildly decreased platelet count. The prognostic model had a good discriminative ability (area under the curve=.84). The scoring system ranged from 0 to 5, with corresponding risks of CKD ranging from 18% to 100%. This model accurately predicts development of 1-year CKD in patients with aHUS using clinical and biological features available on admission. After further validation, this model may assist in clinical decision making.	[Jamme, Matthieu; Chauveau, Dominique; Seguin, Amelie; Presne, Claire; Perez, Pierre; Gobert, Pierre; Wynckel, Alain; Provot, Francois; Delmas, Yahsou; Mousson, Christiane; Servais, Aude; Vrigneaud, Laurence; Veyradier, Agnss; Rondeau, Eric; Coppo, Paul] Hop St Antoine, AP HP, Ctr Reference Microangiopathies Thrombot, Paris, France; [Jamme, Matthieu] Hop Tenon, AP HP, Urgences Nephrolog & Transplantat Renale, Paris, France; [Raimbourg, Quentin] Hop Bichat Claude Bernard, AP HP, Serv Nephrol, Paris, France; [Chauveau, Dominique] Hop Rangueil, Serv Nephrol Immunol Clin, Toulouse, France; [Seguin, Amelie] Ctr Hosp Univ Caen, Serv Reanimat Me dicale, Normandy, France; [Presne, Claire] Hop Sud, Serv Nephrol Med Interne, Amiens, France; CHU Brabois, Serv Nephrol Immunol, Serv Reanimat, Nancy, France; [Wynckel, Alain] Hop Gen Henri Duffaut, Serv Med Interne & Nephrol, Avignon, France; [Wynckel, Alain] Hop Albert Calmette, Serv Nephrol, Lille, France; [Delmas, Yahsou] CHU Bordeaux, Serv Nephrol Transplantat Dialyse, Bordeaux, France; [Vrigneaud, Laurence] Hop Necker Enfants Malad, AP HP, Serv Nephrol, Dijon, France; [Vrigneaud, Laurence] Ctr Hosp Valenciennes, Serv Med Interne, Nephrol & Med Vasc, Valenciennes, France; [Veyradier, Agnss; Rondeau, Eric] Hop Lariboisiere, AP HP, Serv Hematol Biol, Paris, France; [Coppo, Paul] Hop St Antoine, AP HP, Serv Hematol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; CHU de Caen NORMANDIE; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU de Nancy; Universite de Lille - ISITE; CHU Lille; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; CH de Valenciennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Coppo, P (corresponding author), Hop St Antoine, AP HP, Ctr Reference Microangiopathies Thrombot, Paris, France.	paul.coppo@aphp.fr		Servais, Aude/0000-0002-8165-8212	National Plan for Rare Diseases of the French Ministry of Health (Direction Generale de l'Offre de Soin (DGOS))	National Plan for Rare Diseases of the French Ministry of Health (Direction Generale de l'Offre de Soin (DGOS))	This work was supported by the National Plan for Rare Diseases of the French Ministry of Health (Direction Generale de l'Offre de Soin (DGOS)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Patients were recruited with the help of the members of the Reference Centre for Thrombotic Microangiopathies (CNR-MAT)(www,cnr-mat.fr). We thank S. Thouzeau, S. Savigny, S. Capdenat (Laboratoire d'Hematologie, Hopital Lariboisiere, Paris) and S. Malot (Centre de Reference des Microangiopathies Thrombotiques, HOpital Saint-Antoine, AP-HP, Paris) for technical assistance. This work was also supported by the National Plan for Rare Diseases of the French Ministry of Health (Direction Generale de l'Offre de Soin (DGOS)).	Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; Coppo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010208; Coppo Paul, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P36; Dierkes F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030886; Fakhouri F, 2016, AM J KIDNEY DIS OFF; Fakhouri F, 2013, EUR J INTERN MED, V24, P492, DOI 10.1016/j.ejim.2013.05.008; Fremeaux-Bacchi V, 2013, CLIN J AM SOC NEPHRO, V8, P554, DOI 10.2215/CJN.04760512; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; George JN, 2014, NEW ENGL J MED, V371, P654, DOI 10.1056/NEJMra1312353; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Hollenbeck M, 1998, NEPHROL DIAL TRANSPL, V13, P76, DOI 10.1093/ndt/13.1.76; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Licht C, 2015, KIDNEY INT; Mariotte E, 2016, LANCET HAEMATOL, V3, pE237, DOI [10.1016/s2352-3026(16)30018-7, 10.1016/S2352-3026(16)30018-7]; Nguyen L, 2009, TRANSFUSION, V49, P392, DOI 10.1111/j.1537-2995.2008.02030.x; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; Pene F, 2005, INTENS CARE MED, V31, P71, DOI 10.1007/s00134-004-2505-0; Phillips EH, 2016, J THROMB HAEMOST, V14, P175, DOI 10.1111/jth.13189; SCHIEPPATI A, 1992, J AM SOC NEPHROL, V2, P1640; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tostivint I, 2002, NEPHROL DIAL TRANSPL, V17, P1228, DOI 10.1093/ndt/17.7.1228; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214	25	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177894	10.1371/journal.pone.0177894	http://dx.doi.org/10.1371/journal.pone.0177894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542627	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400109
J	Marino, N; Illingworth, S; Kodialbail, P; Patel, A; Calderon, H; Lear, R; Fisher, KD; Champion, BR; Brown, ACN				Marino, Nalini; Illingworth, Sam; Kodialbail, Prithvi; Patel, Ashvin; Calderon, Hugo; Lear, Rochelle; Fisher, Kerry D.; Champion, Brian R.; Brown, Alice C. N.			Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes	PLOS ONE			English	Article							ADVERSE EVENTS; IPILIMUMAB; NIVOLUMAB; PEMBROLIZUMAB; ONCOLOGY	Oncolytic viruses which infect and kill tumour cells can also be genetically modified to express therapeutic genes that augment their anti-cancer activities. Modifying oncolytic viruses to produce effective cancer therapies is challenging as encoding transgenes often attenuates virus activity or prevents systemic delivery in patients due to the risk of off-target expression of transgenes in healthy tissues. To overcome these issues we aimed to generate a readily modifiable virus platform using the oncolytic adenovirus, enadenotucirev. Enadenotucirev replicates in human tumour cells but not cells from healthy tissues and can be delivered intravenously because it is stable in human blood. Here, the enadenotucirev genome was used to generate plasmids into which synthesised transgene cassettes could be directly cloned in a single step reaction. The platform enabled generation of panels of reporter viruses to identify cloning sites and transgene cassette designs where transgene expression could be linked to the virus life cycle. It was demonstrated using these viruses that encoded transgene proteins could be successfully expressed in tumour cells in vitro and tumours in vivo. The expression of transgenes did not impact either the oncolytic activity or selective properties of the virus. The effectiveness of this approach as a drug delivery platform for complex therapeutics was demonstrated by inserting multiple genes in the virus genome to encode full length anti-VEGF antibodies. Functional antibody could be synthesised and secreted from infected tumour cells without impacting the activity of the virus particle in terms of oncolytic potency, manufacturing yields or selectivity for tumour cells. In vivo, viral particles could be efficaciously delivered intravenously to disseminated orthotopic tumours.	[Marino, Nalini; Illingworth, Sam; Kodialbail, Prithvi; Patel, Ashvin; Calderon, Hugo; Lear, Rochelle; Fisher, Kerry D.; Champion, Brian R.; Brown, Alice C. N.] PsiOxus Therapeut Ltd, 154B Brook Dr,Milton Pk, Abingdon, Oxon, England		Brown, ACN (corresponding author), PsiOxus Therapeut Ltd, 154B Brook Dr,Milton Pk, Abingdon, Oxon, England.	alice.brown@psioxus.com	Calderon, Hugo/AAB-2006-2019	Calderon, Hugo/0000-0002-8902-4302	PsiOxus Therapeutics Ltd; Cancer Research UK [17720] Funding Source: researchfish	PsiOxus Therapeutics Ltd; Cancer Research UK(Cancer Research UK)	The work is funded by the investors of PsiOxus Therapeutics Ltd, a private company. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcoser SY, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-124; Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; Bird SW, 2015, VIROLOGY, V479, P444, DOI 10.1016/j.virol.2015.03.044; Buchbinder EI, 2016, NAT REV CLIN ONCOL, V13, P77, DOI 10.1038/nrclinonc.2015.237; Burns MC, 2016, EXPERT OPIN ORPHAN D, V4, P867, DOI 10.1080/21678707.2016.1191348; Calvo E, 2014, ANN ONCOL, V25, DOI 10.1093/annonc/mdu342.17; Calvo E, 2014, J CLIN ONCOL, V32, p5s; Cawood R, 2012, TRENDS MOL MED, V18, P564, DOI 10.1016/j.molmed.2012.07.007; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Di Y, 2014, GENE THER, V21, P440, DOI 10.1038/gt.2014.2; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Fisher K, 2006, CURR OPIN MOL THER, V8, P301; Greig SL, 2016, DRUGS, V76, P147, DOI 10.1007/s40265-015-0522-7; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Hodi FS, 2016, LANCET ONCOL; Hoos A, 2016, NAT REV DRUG DISCOV, V15, P235, DOI 10.1038/nrd.2015.35; Hu JCC, 2006, CLIN CANCER RES, V12, P6737, DOI 10.1158/1078-0432.CCR-06-0759; Jin F, 2005, MOL THER, V12, P1052, DOI 10.1016/j.ymthe.2005.07.696; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Keller BA, 2016, J MOL MED; Kelly E, 2007, MOL THER, V15, P651, DOI 10.1038/sj.mt.6300108; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Kuhn I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002409; Lawler S. E., 2016, JAMA ONCOL; Lichty BD, 2014, NAT REV CANCER, V14, P559, DOI 10.1038/nrc3770; Marquez-Rodas I, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.27; Marrone KA, 2016, CLIN PHARMACOL THER, V100, P242, DOI 10.1002/cpt.394; McNeish IA, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.tps5611; Michot JM, 2016, EUR J CANCER, V54, P139, DOI 10.1016/j.ejca.2015.11.016; Pol J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1117740; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Tahtinen S, 2015, CANCER IMMUNOL RES, V3, P915, DOI 10.1158/2326-6066.CIR-14-0220-T; Tartari F, 2016, CANCER TREAT REV, V48, P20, DOI 10.1016/j.ctrv.2016.06.002; Tollefson A.E., 2007, METHODS MOL MED, V130, P223; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wang S, 2016, CLIN CANC RES; Workenhe ST, 2014, MOL THER, V22, P123, DOI 10.1038/mt.2013.238; Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095	41	22	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177810	10.1371/journal.pone.0177810	http://dx.doi.org/10.1371/journal.pone.0177810			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542292	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400088
J	Scott, M; Jacob, A; Hendrie, D; Parsons, R; Girdler, S; Falkmer, T; Falkmer, M				Scott, Melissa; Jacob, Andrew; Hendrie, Delia; Parsons, Richard; Girdler, Sonya; Falkmer, Torbjorn; Falkmer, Marita			Employers' perception of the costs and the benefits of hiring individuals with autism spectrum disorder in open employment in Australia	PLOS ONE			English	Article							YOUNG-ADULTS; VOCATIONAL-REHABILITATION; SUPPORTED EMPLOYEES; MONETARY BENEFITS; DISABILITIES; ATTITUDES; WORKERS; PEOPLE; PERSPECTIVES; OUTCOMES	d Research has examined the benefits and costs of employing adults with autism spectrum disorder (ASD) from the perspective of the employee, taxpayer and society, but few studies have considered the employer perspective. This study examines the benefits and costs of employing adults with ASD, from the perspective of employers. Fifty-nine employers employing adults with ASD in open employment were asked to complete an online survey comparing employees with and without ASD on the basis of job similarity. The findings suggest that employing an adult with ASD provides benefits to employers and their organisations without incurring additional costs.	[Scott, Melissa; Jacob, Andrew; Parsons, Richard; Girdler, Sonya; Falkmer, Torbjorn; Falkmer, Marita] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia; [Scott, Melissa; Girdler, Sonya; Falkmer, Torbjorn; Falkmer, Marita] Cooperat Res Ctr Living Autism Autism CRC, Brisbane, Qld, Australia; [Hendrie, Delia] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Parsons, Richard] Curtin Univ, Sch Pharm, Perth, WA, Australia; [Falkmer, Torbjorn] Linkoping Univ, Dept Med & Hlth Sci IMH, Rehabil Med, Linkoping, Sweden; [Falkmer, Marita] Jonkoping Univ, Inst Disabil Res, Sch Educ & Commun, CHILD Programme, Jonkoping, Sweden	Curtin University; Curtin University; Curtin University; Linkoping University; Jonkoping University	Scott, M (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia.; Scott, M (corresponding author), Cooperat Res Ctr Living Autism Autism CRC, Brisbane, Qld, Australia.	melissa.scott@curtin.edu.au	Girdler, Sonya/ABC-9629-2021	Girdler, Sonya/0000-0001-7992-0800; Hendrie, Delia/0000-0001-5022-5281	Bankwest Curtin Economics Centre; Cooperative Research Centre for Living with Autism (Autism CRC); Australian Government's Cooperative Research Centres Program; Curtin University	Bankwest Curtin Economics Centre; Cooperative Research Centre for Living with Autism (Autism CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Curtin University	The authors acknowledge the financial support of the Bankwest Curtin Economics Centre and the Cooperative Research Centre for Living with Autism (Autism CRC), established and supported under the Australian Government's Cooperative Research Centres Program. The authors acknowledge the financial support of Curtin University to Melissa Scott through the Australian Postgraduate Award Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS. ABoSC, 2013, DIS AG CAR AUSTR SUM; ABS. ABoSC, 2014, AUT AUSTR 2012; American Psychiatric Association, 2014, DIAGN STAT MAN MENT, Vfifth; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2008, SAS 9 2; Baldwin S, 2014, J AUTISM DEV DISORD, V44, P2440, DOI 10.1007/s10803-014-2112-z; BallabanGil K, 1996, PEDIATR NEUROL, V15, P217, DOI 10.1016/S0887-8994(96)00219-6; Burgess S, 2014, AJIDD-AM J INTELLECT, V119, P64, DOI 10.1352/1944-7558-119.1.64; Burke J, 2013, AUST J REHABIL COUNS, V19, P21, DOI 10.1017/jrc.2013.2; Capo Leisa C., 2001, Work, V16, P201; Chen JL, 2015, REV J AUTISM DEV DIS, V2, P115, DOI 10.1007/s40489-014-0041-6; Cimera R. E., 2002, J VOCATIONAL REHABIL, V17, P23; Cimera RE, 2006, J VOCAT REHABIL, V24, P137; Cimera RE, 2012, AUTISM, V16, P87, DOI 10.1177/1362361311408129; Cimera RE, 2009, J VOCAT REHABIL, V30, P111, DOI 10.3233/JVR-2009-0457; Cimera RE, 2009, AUTISM, V13, P285, DOI 10.1177/1362361309103791; Copeland J, 2007, UNPUB; de Schipper E, 2016, AUTISM RES, P1; Development OfEC-oa, 2010, SICKN DIS WORK BREAK; Eaves LC, 2008, J AUTISM DEV DISORD, V38, P739, DOI 10.1007/s10803-007-0441-x; Economist OotC, 2015, EC OOTC; FABIAN ES, 1995, J REHABIL, V61, P42; Gilbride D, 2000, J REHABIL, V66, P17; Graffam J., 2002, J VOCAT REHAB, V17, P251; GREENWOOD R, 1987, J REHABIL, V53, P37; Hagner D., 2005, FOCUS AUTISM OTHER D, V20, P91, DOI [10.1177/10883576050200020501, DOI 10.1177/10883576050200020501]; Hendricks D, 2010, J VOCAT REHABIL, V32, P125, DOI 10.3233/JVR-2010-0502; Hernandez B, 2000, J REHABIL, V66, P4; Hernandez B, 2007, J VOCAT REHABIL, V27, P191; Hernandez B, 2010, J REHABIL, V76, P15; Hillier A, 2007, CAREER DEV EXCEPTION, V30, P125; Hurlbutt K., 2004, FOCUS AUTISM OTHER D, V19, P215, DOI [10.1177/10883576040190040301, DOI 10.1177/10883576040190040301]; Jacob A, 2015, PLOS ONE, V10; Jarbrink K, 2007, RES DEV DISABIL, V28, P94, DOI 10.1016/j.ridd.2005.11.002; Ju S, 2013, J VOCAT REHABIL, V38, P113, DOI 10.3233/JVR-130625; Kenny L, 2016, AUTISM, V20, P442, DOI 10.1177/1362361315588200; Knapp M, 2009, AUTISM, V13, P317, DOI 10.1177/1362361309104246; Kregel J., 1999, FOCUS AUTISM OTHER D, V14, P130; Kregel J, 1994, J VOCATIONAL REHABIL, V4, P165, DOI [10.3233/JVR-1994-4305, DOI 10.3233/JVR-1994-4305]; Krieger B, 2012, WORK, V43, P141, DOI 10.3233/WOR-2012-1392; Lopez B, 2014, BARRIERS EMPLOTMENT; Lorenz T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147040; Luecking RG, 2008, J VOCAT REHABIL, V29, P3; Mavranezouli I, 2014, AUTISM, V18, P975, DOI 10.1177/1362361313505720; Morgan RL, 2012, J APPL REHABILITATIO, V43, P27; Muller E., 2003, J VOCAT REHABIL, V18, P163; Nations U, 1948, UN DECL HUM RIGHTS P; Olney MF, 2000, J REHABIL, V66, P51; Qualtrics, 2005, QUALTR PROV; Reform RGoW, 2014, NEW SYST BETT EMPL S; Responsibility ACfCS, 2014, 10 YEAR PROGR PROSP; Rosenblatt M., 2008, EXIST MESSAGE ADULTS; Samorodov A, 1996, INDICATORS COST EFFE; Schaller J, 2005, REHABIL COUNS BULL, V49, P4, DOI 10.1177/00343552050490010201; Scott M., 2015, PLOS ONE, V10; Scott M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139281; Smith K, 2004, J VOCATIONAL REHABIL, V21; Taylor JL, 2011, J AUTISM DEV DISORD, V41, P566, DOI 10.1007/s10803-010-1070-3; Tse John, 1994, Australia and New Zealand Journal of Developmental Disabilities, V19, P139; Unger D. D., 2002, FOCUS AUTISM DEV DIS, V17, P2, DOI [10.1177/108835760201700101, DOI 10.1177/108835760201700101]; Wehman P., 2003, J VOCATIONAL REHABIL, V18, P131	61	52	53	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177607	10.1371/journal.pone.0177607	http://dx.doi.org/10.1371/journal.pone.0177607			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542465	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400058
J	Yamazaki, T; Hatano, Y; Handa, T; Kato, S; Hoida, K; Yamamura, R; Fukuyama, T; Uematsu, T; Kobayashi, N; Kimura, H; Yamagata, K				Yamazaki, Taiga; Hatano, Yu; Handa, Tetsuya; Kato, Sakiko; Hoida, Kensuke; Yamamura, Rui; Fukuyama, Takashi; Uematsu, Takayuki; Kobayashi, Noritada; Kimura, Hiroshi; Yamagata, Kazuo			Targeted DNA methylation in pericentromeres with genome editing-based artificial DNA methyltransferase	PLOS ONE			English	Article							DE-NOVO METHYLATION; EMBRYONIC STEM-CELLS; MOUSE; CHROMATIN; DYNAMICS; HETEROCHROMATIN; VISUALIZATION; DEMETHYLATION; TRANSCRIPTION; DNMT3A	To study the impact of epigenetic changes on biological functions, the ability to manipulate the epigenetic status of certain genomic regions artificially could be an indispensable technology. "Epigenome editing" techniques have gradually emerged that apply TALE or CRISPR/Cas9 technologies with various effector domains isolated from epigenetic code writers or erasers such as DNA methyltransferase, 5-methylcytosine oxidase, and histone modification enzymes. Here we demonstrate that a TALE recognizing a major satellite, consisting of a repeated sequence in pericentromeres, could be fused with the bacterial CpG methyltransferase, SssI. ChIP-qPCR assays demonstrated that the fusion protein TALMaj-SssI preferentially bound to major chromosomal satellites in cultured cell lines. Then, TALMaj-SssI was expressed in fertilized mouse oocytes with hypomethylated major satellites (10-20% CpG islands). Bisulfite sequencing revealed that the DNA methylation status was increased specifically in major satellites (50-60%), but not in minor satellites or other repeat elements, such as Intracisternal A-particle (IAP) or long interspersed nuclear elements-1 (Line1) when the expression level of TALMaj-SssI is optimized in the cell. At a microscopic level, distal ends of chromosomes at the first mitotic stage were dramatically highlighted by the mCherry-tagged methyl CpG binding domain of human MBD1 (mCherry-MBD-NLS). Moreover, targeted DNA methylation to major satellites did not interfere with kinetochore function during early embryonic cleavages. Co-injection of dCas9 fused with SssI and guide RNA (gRNA) recognizing major satellite sequences enabled increment of the DNA methylation in the satellites, but a few off-target effects were also observed in minor satellites and retrotransposons. Although CRISPR can be applied instead of the TALE system, technical improvements to reduce off-target effects are required. We have demonstrated a new method of introducing DNA methylation without the need of other binding partners using the CpG methyltransferase, SssI.	[Yamazaki, Taiga; Yamamura, Rui; Fukuyama, Takashi; Uematsu, Takayuki; Kobayashi, Noritada] Kitasato Univ, Med Ctr, Div Biomed Res, Kitamoto, Saitama, Japan; [Hatano, Yu; Kato, Sakiko; Hoida, Kensuke; Yamagata, Kazuo] KINDAI Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan; [Handa, Tetsuya; Kimura, Hiroshi] Tokyo Inst Technol, Inst Innovat Res, Cell Biol Unit, Midori Ku, Yokohama, Kanagawa, Japan	Kitasato University; Tokyo Institute of Technology	Yamazaki, T (corresponding author), Kitasato Univ, Med Ctr, Div Biomed Res, Kitamoto, Saitama, Japan.; Yamagata, K (corresponding author), KINDAI Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan.	tyamazak@insti.kitasato-u.ac.jp; yamagata@waka.kindai.ac.jp	Kimura, Hiroshi/B-9524-2015; UEMATSU, TAKAYUKI/H-8034-2017	Kimura, Hiroshi/0000-0003-0854-083X; UEMATSU, TAKAYUKI/0000-0002-3680-7231; Handa, Tetsuya/0000-0001-7707-0195	JSPS KAKENHI [JP24700954, JP15K14924, JP25116005, JP25712035, JP26660250]; Kitasato University Medical Center; Kitasato University Research Grant; Grants-in-Aid for Scientific Research [15K14924, 16K09585] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kitasato University Medical Center; Kitasato University Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers JP24700954 (TY), JP15K14924 (TY), JP25116005 (HK and KY), JP25712035 (KY) and JP26660250 (KY). This work was also supported by Grant-in-Aid for Research from Kitasato University Medical Center (TY), and Kitasato University Research Grant for Young Researchers (TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrup K, 2005, BRIT J CANCER, V92, P1934, DOI 10.1038/sj.bjc.6602560; Anton T, 2014, NUCLEUS-PHILA, V5, P163, DOI 10.4161/nucl.28488; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Bernstein DL, 2015, J CLIN INVEST, V125, P1998, DOI 10.1172/JCI77321; Bollati V, 2009, CARCINOGENESIS, V30, P1330, DOI 10.1093/carcin/bgp149; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Chaikind B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096931; Chaikind B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044852; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Darii MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1654, DOI 10.1016/j.bbapap.2009.07.016; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hori T, 2014, DEV CELL, V29, P740, DOI 10.1016/j.devcel.2014.05.001; Hu JB, 2014, NUCLEIC ACIDS RES, V42, P4375, DOI 10.1093/nar/gku109; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kawasaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03658; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kungulovski G, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0002-z; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lo CL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42047; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Mizutani E, 2012, DEV BIOL, V364, P56, DOI 10.1016/j.ydbio.2012.01.001; Molina O, 2016, CHROMOSOME RES, V24, P495, DOI 10.1007/s10577-016-9539-3; Morita S, 2016, NAT BIOTECHNOL; Nettersheim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082881; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Saksouk N, 2014, MOL CELL, V56, P580, DOI 10.1016/j.molcel.2014.10.001; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stolzenburg S, 2015, ONCOGENE, V34, P5427, DOI 10.1038/onc.2014.470; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Ueda J, 2014, STEM CELL REP, V2, P910, DOI 10.1016/j.stemcr.2014.05.008; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; WADDINGTON CH, 1956, EVOLUTION, V10, P1, DOI 10.2307/2406091; Yamagata K, 2005, GENESIS, V43, P71, DOI 10.1002/gene.20158; Yamagata K, 2007, DEV BIOL, V312, P419, DOI 10.1016/j.ydbio.2007.09.041; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yamazaki T, 2007, J REPROD DEVELOP, V53, P1035, DOI 10.1262/jrd.19059; Yamazaki T, 2007, DEV BIOL, V304, P409, DOI 10.1016/j.ydbio.2006.12.046	53	17	17	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177764	10.1371/journal.pone.0177764	http://dx.doi.org/10.1371/journal.pone.0177764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542388	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400079
J	Evers, C; Fischer, C; Dikow, N; Schott, S				Evers, Christina; Fischer, Christine; Dikow, Nicola; Schott, Sarah			Familial breast cancer: Genetic counseling over time, including patients A expectations and initiators considering the Angelina Jolie effect	PLOS ONE			English	Article							HEREDITARY BREAST; OVARIAN-CANCER; PRIMARY-CARE; RISK; IMPACT; WOMEN; BRCA1; HISTORY; ADHERENCE; AWARENESS	Purpose The German Consortium for hereditary breast/ovarian cancer (GC-HBOC) aims for nationwide access to professional, individualized yet structured care for families at high risk. The identification of such families remains key for optimal care. Our study evaluates counselees' characteristics, referral practices, expectations and motivations in respect to their first genetic consultation. The impact of the Angelina Jolie Effect (AJE) was prospectively assessed. Methods All counselees could participate through a questionnaire. Groups were built in respect to neoadjuvant chemotherapy (FT) and before/after AJE. Results The 917 (88.5%) counselees (FT: 8.2%) were on average female (97.3%), with a mean age of 44.6, had children (71.9%), higher education (88%), personal (46.4%) or at least one firstdegree relative (74.6%) with BC/OC or known BRCA1/2 mutation (11.8%), were in a relationship (76.1%), and living in a village (40.7%). The AJE is associated with significantly fewer cancelations (p = 0.005), more attendance among men (4.2% vs. 0.8%, p = 0.002), and people with familial BRCA1/2 (14.8% vs. 7.5%, p = 0.003). The majority seek information regarding their cancer risk (83%) or relatives' risk (74.8%), HBOC (69.1%), and surveillance programs for themselves (66.6%) or relatives (60.6%). Conclusion Enhanced media awareness of genetic cancer motivates patients, including other patient groups. A higher number of participants, including more men, are attending GC due to the AJE. In terms of the rising complexity of genetic testing, the analysis of patients' expectations and initiators for GC suggests that there is an urgent need to develop to participate motivation analysis. The factors revealed as impediments to accessing GC-HBOC guide recommendations to optimize access to genetic counseling. Medical educational programs for primary gynecologists and families at risk might be options to reach more participants.	[Evers, Christina; Fischer, Christine; Dikow, Nicola] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Schott, Sarah] Univ Hosp Heidelberg, Dept Gynecol & Obstet, Heidelberg, Germany; [Schott, Sarah] German Consortium Translat Canc Res DKTK, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Schott, S (corresponding author), Univ Hosp Heidelberg, Dept Gynecol & Obstet, Heidelberg, Germany.; Schott, S (corresponding author), German Consortium Translat Canc Res DKTK, Heidelberg, Germany.	sarah.schott@med.uni-heidelberg.de	Schott, Sarah/D-5242-2018	Schott, Sarah/0000-0002-1714-1147	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing.	Armstrong J, 2015, JAMA ONCOL, V1, P1251, DOI 10.1001/jamaoncol.2015.3048; Armstrong J, 2015, J GENET COUNS, V24, P18, DOI 10.1007/s10897-014-9750-3; Armstrong K, 2005, JAMA-J AM MED ASSOC, V293, P1729, DOI 10.1001/jama.293.14.1729; Bhatti J, 2015, MED DECIS MAKING, V35, P4, DOI 10.1177/0272989X14558882; Borzekowski DLG, 2014, GENET MED, V16, P516, DOI 10.1038/gim.2013.181; Brain K, 2000, J MED GENET, V37, P197, DOI 10.1136/jmg.37.3.197; Burstein HJ, 2013, J NATL COMPR CANC NE, V11, P631, DOI 10.6004/jnccn.2013.0081; Christie J, 2012, ANN SURG ONCOL, V19, P4003, DOI 10.1245/s10434-012-2460-x; Cragun D, 2015, BREAST CANCER RES TR, V151, P169, DOI 10.1007/s10549-015-3374-7; Timoteo ARD, 2015, HERED CANCER CLIN PR, V13, DOI 10.1186/s13053-014-0022-x; Dunlop K, 2014, AUST FAM PHYSICIAN, V43, P76; Engel C, 2015, MED GENET-BERLIN, V27, P217, DOI 10.1007/s11825-015-0043-5; Evans DGR, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0442-6; Gadzicki D, 2011, J COMMUN GENET, V2, P53, DOI 10.1007/s12687-011-0042-4; Goldberg JI, 2006, EXPERT REV ANTICANC, V6, P1205, DOI 10.1586/14737140.6.8.1205; Hallowell N, 2005, J Genet Couns, V14, P207, DOI 10.1007/s10897-005-0384-3; Hallowell N, 2006, SOCIOL HEALTH ILL, V28, P969, DOI 10.1111/j.1467-9566.2006.00515.x; Kelly KM, 2015, J BEHAV MED, V38, P766, DOI 10.1007/s10865-014-9613-2; Knapke S, 2016, GENET MED, V18, P410, DOI 10.1038/gim.2015.98; Kosenko KA, 2015, J HEALTH COMMUN, V21, P1; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Levy DE, 2011, GENET MED, V13, P349, DOI 10.1097/GIM.0b013e3182091ba4; Lodder L, 2001, EUR J HUM GENET, V9, P492, DOI 10.1038/sj.ejhg.5200668; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; McCarthy AM, 2013, CANCER-AM CANCER SOC, V119, P3596, DOI 10.1002/cncr.28268; Morgan D, 2010, GENET MED, V12, P25, DOI 10.1097/GIM.0b013e3181c60955; Nelson HD, 2014, ANN INTERN MED, V160, P255, DOI 10.7326/M13-1684; Noar SM, 2015, MED DECIS MAKING, V35, P16, DOI 10.1177/0272989X14556130; O'Neill SC, 2015, J COMMUN GENET, V6, P55, DOI 10.1007/s12687-014-0201-5; Pagan JA, 2009, AM J PREV MED, V37, P524, DOI 10.1016/j.amepre.2009.07.021; Quillin JM, 2014, J COMMUN GENET, V5, P179, DOI 10.1007/s12687-013-0161-1; Rhiem K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3369; Sermijn E, 2016, FAM CANCER, V15, P155, DOI 10.1007/s10689-015-9854-4; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Staudigl C, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2472-1; Tai YC, 2007, J NATL CANCER I, V99, P1811, DOI 10.1093/jnci/djm203; Tinley ST, 2004, AM J MED GENET A, V125A, P5, DOI 10.1002/ajmg.a.20431; Vetter L, 2016, BREAST CANCER RES TR, V156, P289, DOI 10.1007/s10549-016-3748-5; Wood ME, 2014, J CLIN ONCOL, V32, P824, DOI 10.1200/JCO.2013.51.4661	39	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177893	10.1371/journal.pone.0177893	http://dx.doi.org/10.1371/journal.pone.0177893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542378	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800028
J	Neisius, U; Olson, E; Rossi, SH; Ibrahim, HA; Currie, G; Dominiczak, AF; Delles, C				Neisius, Ulf; Olson, Erin; Rossi, Sabrina H.; Ibrahim, Hagar A.; Currie, Gemma; Dominiczak, Anna F.; Delles, Christian			Evaluation of the systemic micro- and macrovasculature in stable angina: A case-control study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; INTIMA-MEDIA THICKNESS; ENDOTHELIAL FUNCTION; PREDICTIVE-VALUE; CAROTID PLAQUE; RISK-FACTORS; ATHEROSCLEROSIS; DIAGNOSIS; GUIDELINES	Aims The diagnosis of stable angina involves the use of probability estimates based on clinical presentation, age, gender and cardiovascular risk factors. In view of the link between the cardiac and systemic vasculature we tested whether non-invasive measures of systemic micro-and macrovascular structure and function differentiate between individuals with flowlimiting coronary artery disease (CAD) and those with normal coronary arteries (NCA). Methods and results We recruited 84 patients undergoing elective coronary angiography for investigation of symptoms of stable angina. Patients were selected for either having significant CAD or NCA (n = 43/41; age, 56 +/- 7 vs 57 +/- 7 years, P = 0.309). Only microvascular endothelial function, measured using the Endo-PAT2000 device to determine reactive hyperaemia index (CAD vs. NCA; 1.9 [1.5; 2.3] vs. 2.1 [1.8; 2.4], P = 0.03) and sonographic carotid plaque score (CAD vs. NCA; 3.0 [1.5; 4.5] vs. 1.2 [0; 2.55], P< 0.001) were significantly different between patients with CAD and NCA. No significant differences were detected in reflection magnitude (CAD vs. NCA; 1.7 [1.5; 1.8] % vs 1.7 [1.5; 1.9] %, P = 0.342), pulse wave velocity (CAD vs. NCA; 7.8 +/- 1.4 m/sec vs. 8.3 +/- 1.5 m/sec, P = 0.186), carotid intima-media thickness (CAD vs. NCA; 0.73 +/- 0.10 mm vs. 0.75 +/- 0.10 mm, P = 0.518) or carotid distensibility (CAD vs. NCA; 3.8 +/- 1.2 10-3/kPa vs. 3.4 +/- 0.9 10-3/kPa, P = 0.092). Also, the c-statistic of the pre-test probability based on history and traditional risk factors (c = 0.665; 95% CI, 0.540-0.789) was improved by the addition of the inverse RHI (c = 0.720; 95% CI, 0.605-0.836), carotid plaque score (c = 0.770, 95% CI, 0.659-0.881), and of both markers in combination (c = 0.801; 95% CI, 0.701-0.900). Conclusion There are distinct differences in the systemic vasculature between patients with CAD and NCA that may have the potential to guide diagnostic and therapeutic decisions. Carotid artery plaque burden and microvascular function appear to be most promising in this context.	[Neisius, Ulf; Olson, Erin; Rossi, Sabrina H.; Ibrahim, Hagar A.; Currie, Gemma; Dominiczak, Anna F.; Delles, Christian] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Neisius, Ulf] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Cardiovasc Div, Boston, MA USA	University of Glasgow; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Delles, C (corresponding author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	Christian.Delles@glasgow.ac.uk	Stefanadis, Christodoulos/ABH-2232-2020; Dominiczak, Anna F/P-9390-2017	Stefanadis, Christodoulos/0000-0001-5974-6454; Dominiczak, Anna F/0000-0003-4913-3608	European Union's Sixth Framework Programme Network of Excellence InGenious HyperCare; Seventh Framework Programme Collaborative Project EU-MASCARA; Seventh Framework Programme Collaborative Project HOMAGE; British Heart Foundation Centre of Excellence award [RE/13/5/30177]; National Institute for Health Research [ACF-2014-14-008] Funding Source: researchfish	European Union's Sixth Framework Programme Network of Excellence InGenious HyperCare; Seventh Framework Programme Collaborative Project EU-MASCARA; Seventh Framework Programme Collaborative Project HOMAGE; British Heart Foundation Centre of Excellence award; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by the European Unions Sixth Framework Programme Network of Excellence InGenious HyperCare (AFD), the Seventh Framework Programme Collaborative Projects EU-MASCARA and HOMAGE (CD) and the British Heart Foundation Centre of Excellence award RE/13/5/30177 (AFD). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fiadh AH, 2015, AM J CARDIOL, V115, P609, DOI 10.1016/j.amjcard.2014.12.011; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Brook RD, 2006, ARTERIOSCL THROM VAS, V26, P656, DOI 10.1161/01.ATV.0000200079.18690.60; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Dzau VJ, 2006, CIRCULATION, V114, P2850, DOI 10.1161/CIRCULATIONAHA.106.655688; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Genders TSS, 2011, EUR HEART J, V32, P1316, DOI 10.1093/eurheartj/ehr014; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Ikeda N, 2012, EUR HEART J, V33, P113, DOI 10.1093/eurheartj/ehr399; Inaba Y, 2012, ATHEROSCLEROSIS, V220, P128, DOI 10.1016/j.atherosclerosis.2011.06.044; Kallikazaros I, 1999, STROKE, V30, P1002, DOI 10.1161/01.STR.30.5.1002; Laurent S, 2015, EARLY VASCULAR AGING (EVA): NEW DIRECTIONS IN CARDIOVASCULAR PROTECTION, P105; Mancia G, 2007, BLOOD PRESSURE, V16, P135, DOI 10.1080/08037050701461084; Matsuo Y, 2012, ATHEROSCLEROSIS, V223, P365, DOI 10.1016/j.atherosclerosis.2012.05.023; Matsuzawa Y, 2015, CORONARY ARTERY DIS, V26, P231, DOI 10.1097/MCA.0000000000000208; Matsuzawa Y, 2010, J AM COLL CARDIOL, V55, P1688, DOI 10.1016/j.jacc.2009.10.073; Michelsen MM, 2016, JACC-CARDIOVASC IMAG, V9, P411, DOI 10.1016/j.jcmg.2016.02.005; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Neisius U, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0246-y; Pries AR, 2008, CARDIOVASC RES, V80, P165, DOI 10.1093/cvr/cvn136; PRYOR DB, 1991, AM J MED, V90, P553; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; Weissgerber A, 2016, CLIN RES CARDIOL, V105, P172, DOI 10.1007/s00392-015-0900-x; Westerhof BE, 2006, HYPERTENSION, V48, P595, DOI 10.1161/01.HYP.0000238330.08894.17	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178412	10.1371/journal.pone.0178412	http://dx.doi.org/10.1371/journal.pone.0178412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542516	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000402062800086
J	Nordenstedt, N; Marcenaro, D; Chilagane, D; Mwaipopo, B; Rajamaki, ML; Nchimbi-Msolla, S; Njau, PJR; Mbanzibwa, DR; Valkonen, JPT				Nordenstedt, Noora; Marcenaro, Delfia; Chilagane, Daudi; Mwaipopo, Beatrice; Rajamaki, Minna-Liisa; Nchimbi-Msolla, Susan; Njau, Paul J. R.; Mbanzibwa, Deusdedith R.; Valkonen, Jari P. T.			Pathogenic seedborne viruses are rare but Phaseolus vulgaris endornaviruses are common in bean varieties grown in Nicaragua and Tanzania	PLOS ONE			English	Article							MOSAIC-NECROSIS-VIRUS; CYTOPLASMIC MALE-STERILITY; BELL PEPPER ENDORNAVIRUS; SMALL INTERFERING RNAS; NUCLEOTIDE-SEQUENCE; DEGENERATE PRIMERS; GERMPLASM LINES; GENOME SEQUENCE; RESISTANCE; TRANSMISSION	Common bean (Phaseolus vulgaris) is an annual grain legume that was domesticated in Mesoamerica (Central America) and the Andes. It is currently grown widely also on other continents including Africa. We surveyed seedborne viruses in new common bean varieties introduced to Nicaragua (Central America) and in landraces and improved varieties grown in Tanzania (eastern Africa). Bean seeds, harvested from Nicaragua and Tanzania, were grown in insect-controlled greenhouse or screenhouse, respectively, to obtain leaf material for virus testing. Equal amounts of total RNA from different samples were pooled (30-36 samples per pool), and small RNAs were deep-sequenced (Illumina). Assembly of the reads (21-24 nt) to contiguous sequences and searches for homologous viral sequences in data-bases revealed Phaseolus vulgaris endornavirus 1 (PvEV-1) and PvEV-2 in the bean varieties in Nicaragua and Tanzania. These viruses are not known to cause symptoms in common bean and are considered non-pathogenic. The small-RNA reads from each pool of samples were mapped to the previously characterized complete PvEV-1 and PvEV-2 sequences (genome lengths ca. 14 kb and 15 kb, respectively). Coverage of the viral genomes was 87.9-99.9%, depending on the pool. Coverage per nucleotide ranged from 5 to 471, confirming virus identification. PvEV-1 and PvEV-2 are known to occur in Phaseolus spp. in Central America, but there is little previous information about their occurrence in Nicaragua, and no information about occurrence in Africa. Aside from Cowpea mild mosaic virus detected in bean plants grown from been seeds harvested from one region in Tanzania, no other pathogenic seedborne viruses were detected. The low incidence of infections caused by pathogenic viruses transmitted via bean seeds may be attributable to new, virus-resistant CB varieties released by breeding programs in Nicaragua and Tanzania.	[Nordenstedt, Noora; Marcenaro, Delfia; Rajamaki, Minna-Liisa; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Marcenaro, Delfia] Nicaraguan Inst Agr Technol CNIAB INTA, Managua, Nicaragua; [Chilagane, Daudi; Mwaipopo, Beatrice; Nchimbi-Msolla, Susan; Njau, Paul J. R.] Sokoine Univ Agr, Morogoro, Tanzania; [Chilagane, Daudi; Mwaipopo, Beatrice; Mbanzibwa, Deusdedith R.] Mikocheni Agr Res Inst, Dar Es Salaam, Tanzania	University of Helsinki; Sokoine University of Agriculture	Valkonen, JPT (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.; Mbanzibwa, DR (corresponding author), Mikocheni Agr Res Inst, Dar Es Salaam, Tanzania.	mbanzibwad@yahoo.co.uk; jari.valkonen@helsinki.fi	Rajamäki, Minna-Liisa/AAY-5758-2020; Mbanzibwa, Deusdedith/GZB-1649-2022	Rajamäki, Minna-Liisa/0000-0002-7952-0433; Mbanzibwa, Deusdedith Rugaihukamu/0000-0002-1588-5150; Valkonen, Jari/0000-0002-3704-9911	Bill & Melinda Gates Foundation [OPP1112522, OPP1130216]; Ministry for Foreign Affairs of Finland [36419901, HEL67338-129, 36421515]; Ministry of Agriculture and Forestry, Finland [2221/03.01.02/2015]; European Cooperation in Science and Technology (FA COST Action) [FM407]; Program for Emerging Agricultural Research Leaders (PEARL) [OPP1112522]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry for Foreign Affairs of Finland; Ministry of Agriculture and Forestry, Finland; European Cooperation in Science and Technology (FA COST Action); Program for Emerging Agricultural Research Leaders (PEARL)	This work was supported financially by the Bill & Melinda Gates Foundation (PEARL grant OPP1112522 to D. Mbanzibwa and subproject of the NextGen Phytosanitation programme OPP1130216 to J. Valkonen), the Ministry for Foreign Affairs of Finland (grants 36419901, HEL67338-129 and 36421515 to J. Valkonen), Ministry of Agriculture and Forestry, Finland (grant 2221/03.01.02/2015 to J. Valkonen), and European Cooperation in Science and Technology (FA COST Action FM407), none of which had any role in data collection or analysis, decision to publish, or manuscript preparation. The Nicaraguan Institute of Agricultural Technology (INTA) and Mikocheni Agricultural Research Institute, Tanzania, financially supported the collection of research material but had no role in decision to publish or manuscript preparation.; We thank Dr. Aldo Rojas and Dr. Juan Carlos Rosas, Nicaragua, for collaboration and sharing valuable information. We also thank the personnel of La Compailia and the Nicaraguan Institute of Agricultural Technology (INTA), Nicaragua, Ms. Hilda Bachwenkizi and Mr. Deogratias Mark of Mikocheni Agricultural Research Institute, Tanzania, and Yaqi Bi, Katrin Artola, Milton Untiveros and Juha Kiveld, Finland, for assistance. The farmers all over Tanzania are thanked for collaboration and providing us with bean seeds. This study was part of the Nicaragua-Finland Agrobiotechnology and Human Capacity Building Program (NIFAPRO) carried out jointly by INTA and University of Helsinki. Participation of the Ministry of Agriculture, Livestock and Forestry (MAGFOR), National University of Agriculture (UNA), Ministry of Foreign Affairs of Nicaragua, and Ministry for Foreign Affairs of Finland in the Steering Committee of NIFAPRO is gratefully acknowledged. The study was also part of the Program for Emerging Agricultural Research Leaders (PEARL; OPP1112522) and linked to the NextGen Phytosanitation programme (OPP1130216) of the Bill & Melinda Gates Foundation.	Anjum F, 2016, CROP PROT, V88, P131, DOI 10.1016/j.cropro.2016.06.002; [Anonymous], 2016, GEN END; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Beaver JS, 2015, J PLANT REGIST, V9, P208, DOI 10.3198/jpr2014.09.0061crg; Bi YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042758; Blair MW, 2007, THEOR APPL GENET, V114, P261, DOI 10.1007/s00122-006-0428-6; Caldo RA, 2004, PLANT CELL, V16, P2514, DOI 10.1105/tpc.104.023382; Candresse T, 2016, ARCH VIROL, V161, P741, DOI 10.1007/s00705-015-2709-3; Carstens EB, 2009, ARCH VIROL, V154, P1181, DOI 10.1007/s00705-009-0400-2; Chacon MI, 2005, THEOR APPL GENET, V110, P432, DOI 10.1007/s00122-004-1842-2; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ferrufino A, 2013, CATALOGO SEMILLAS GR; Flores-Estevez N, 2003, PLANT DIS, V87, P21, DOI 10.1094/PDIS.2003.87.1.21; FRISCHMUTH T, 1990, VIROLOGY, V178, P461, DOI 10.1016/0042-6822(90)90343-P; FUENTES AL, 1990, PLANT DIS, V74, P938, DOI 10.1094/PD-74-0938B; Fukuhara T, 2006, ARCH VIROL, V151, P995, DOI 10.1007/s00705-005-0688-5; Gallitelli D, 2000, VIRUS RES, V71, P9, DOI 10.1016/S0168-1702(00)00184-2; Gamez R., 1973, VIRUS FRIJOL CTR AM; Garrido-Ramirez ER, 2000, PHYTOPATHOLOGY, V90, P1224, DOI 10.1094/PHYTO.2000.90.11.1224; GRILL LK, 1981, P NATL ACAD SCI-BIOL, V78, P7043, DOI 10.1073/pnas.78.11.7043; Hall R, 1991, COMPENDIUM BEAN DIS; Hillocks RJ, 2006, EUPHYTICA, V150, P215, DOI 10.1007/s10681-006-9112-9; Hord MJ, 2001, PLANT DIS, V85, P952, DOI 10.1094/PDIS.2001.85.9.952; Hull R., 2004, SO BEAN MOSAIC VIRUS; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jimenez OR, 2012, PLANT GENET RESOUR-C, V10, P108, DOI 10.1017/S1479262112000081; JOHANSEN E, 1994, ANNU REV PHYTOPATHOL, V32, P363, DOI 10.1146/annurev.py.32.090194.002051; Karkashian J, 2011, PLANT DIS, V95, P901, DOI 10.1094/PDIS-03-10-0165; Kashif M, 2012, PLANT DIS, V96, P1430, DOI 10.1094/PDIS-03-12-0268-RE; Khankhum S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01905; Khankhum S, 2015, ARCH VIROL, V160, P1131, DOI 10.1007/s00705-015-2335-0; Kontra L, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005935; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kutnjak D, 2015, J VIROL, V89, P4760, DOI 10.1128/JVI.03685-14; LEFEBVRE A, 1990, PLANT MOL BIOL, V14, P477, DOI 10.1007/BF00027494; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Marcenaro D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168662; Maule AJ, 1996, TRENDS MICROBIOL, V4, P153, DOI 10.1016/0966-842X(96)10016-0; Melgarejo TA, 2007, ARCH VIROL, V152, P1941, DOI 10.1007/s00705-007-1008-z; Melotto M, 1996, GENOME, V39, P1216, DOI 10.1139/g96-155; MINK GI, 1987, PLANT DIS, V71, P557, DOI 10.1094/PD-71-0557F; MORALES FJ, 1988, PLANT DIS, V72, P1020, DOI 10.1094/PD-72-1020; MORALES FJ, 1987, PLANT DIS, V71, P51, DOI 10.1094/PD-71-0051; Myers J.R., 2000, ANN REPORT BEAN IMPR, P13; Njau PJR, 2000, SEED SCI TECHNOL, V28, P85; Okada R, 2013, J GEN VIROL, V94, P220, DOI 10.1099/vir.0.044487-0; Okada R, 2011, J GEN VIROL, V92, P2664, DOI 10.1099/vir.0.034686-0; OTHMAN Y, 1995, VIROLOGY, V206, P287, DOI 10.1016/S0042-6822(95)80044-1; Palukaitis P., 2003, CUCUMBER MOSAIC VIRU; Prophete E, 2014, J PLANT REGIST, V8, P49, DOI 10.3198/jpr2013.08.0046crg; Rojas A, 2005, ARCH VIROL, V150, P1281, DOI 10.1007/s00705-005-0509-x; ROJAS MR, 1993, PLANT DIS, V77, P340, DOI 10.1094/PD-77-0340; Roossinck MJ, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00767; Roossinck MJ, 2011, J GEN VIROL, V92, P2674, DOI 10.1099/vir.0.034702-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santalla M., 1999, BASE: Biotechnologie, Agronomie, Societe et Environnement, V3, P225; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Seguin J, 2014, J VIROL METHODS, V195, P120, DOI 10.1016/j.jviromet.2013.10.013; Segundo E, 2008, EUR J PLANT PATHOL, V122, P579, DOI 10.1007/s10658-008-9328-8; Sela N, 2012, J VIROL, V86, P7721, DOI 10.1128/JVI.00983-12; Sengooba TN, 1997, PLANT PATHOL, V46, P95, DOI 10.1046/j.1365-3059.1997.d01-12.x; Shang HH, 2015, ARCH VIROL, V160, P1827, DOI 10.1007/s00705-015-2426-y; Singh SP, 2010, CROP SCI, V50, P2199, DOI 10.2135/cropsci2009.03.0163; Singh SP, 2000, CROP SCI, V40, P1565, DOI 10.2135/cropsci2000.4061565x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tryphone MT, 2013, PLANT BREEDING LAB F, P121, DOI [10.5772/52823, DOI 10.5772/52823]; Vallejos CE, 2006, GENETICS, V172, P1229, DOI 10.1534/genetics.105.050815; Valverde RA, 2007, VIRUS GENES, V35, P399, DOI 10.1007/s11262-007-0092-1; Wang QC, 2008, MOL PLANT PATHOL, V9, P237, DOI [10.1111/j.1364-3703.2007.00456.x, 10.1111/J.1364-3703.2007.00456.X]; Worrall EA, 2015, ADV VIRUS RES, V93, P1, DOI 10.1016/bs.aivir.2015.04.002; Wortmann CS, 2004, USITC PUBL, V297; Wyatt SD, 1996, PHYTOPATHOLOGY, V86, P1288, DOI 10.1094/Phyto-86-1288; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng Y, 2017, VIROLOGY, V500, P130, DOI 10.1016/j.virol.2016.10.017	74	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178242	10.1371/journal.pone.0178242	http://dx.doi.org/10.1371/journal.pone.0178242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542624	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800059
J	Schneeberger, PHH; Pothier, JF; Buhlmann, A; Duffy, B; Beuret, C; Utzinger, J; Frey, JE				Schneeberger, Pierre H. H.; Pothier, Joel F.; Buhlmann, Andreas; Duffy, Brion; Beuret, Christian; Utzinger, Jurg; Frey, Jurg E.			Development and evaluation of a bioinformatics approach for designing molecular assays for viral detection	PLOS ONE			English	Article							REAL-TIME PCR; USUTU-VIRUS; EPIDEMIOLOGY; HANTAVIRUS; INFECTION; DIAGNOSTICS; FLAVIVIRUS; EMERGENCE; ALIGNMENT; OUTBREAK	Background Viruses belonging to the Flaviviridae and Bunyaviridae families show considerable genetic diversity. However, this diversity is not necessarily taken into account when developing diagnostic assays, which are often based on the pairwise alignment of a limited number of sequences. Our objective was to develop and evaluate a bioinformatics workflow addressing two recurrent issues of molecular assay design: (i) the high intraspecies genetic diversity in viruses and (ii) the potential for cross-reactivity with close relatives. Methodology The workflow developed herein was based on two consecutive BLASTn steps; the first was utilized to select highly conserved regions among the viral taxon of interest, and the second was employed to assess the degree of similarity of these highly-conserved regions to close relatives. Subsequently, the workflow was tested on a set of eight viral species, including various strains from the Flaviviridae and Bunyaviridae families. Principal findings The genetic diversity ranges from as low as 0.45% variable sites over the complete genome of the Japanese encephalitis virus to more than 16% of variable sites on segment L of the Crimean-Congo hemorrhagic fever virus. Our proposed bioinformatics workflow allowed the selection-based on computing scores-of the best target for a diagnostic molecular assay for the eight viral species investigated. Conclusions/Significance Our bioinformatics workflow allowed rapid selection of highly conserved and specific genomic fragments among the investigated viruses, while considering up to several hundred complete genomic sequences. The pertinence of this workflow will increase in parallel to the number of sequences made publicly available. We hypothesize that our workflow might be utilized to select diagnostic molecular markers for higher organisms with more complex genomes, provided the sequences are made available.	[Schneeberger, Pierre H. H.; Frey, Jurg E.] Agroscope, Dept Methods Dev & Analyt, Wadenswil, Switzerland; [Schneeberger, Pierre H. H.; Beuret, Christian] Fed Off Civil Protect, Spiez Lab, Dept Virol, Spiez, Switzerland; [Schneeberger, Pierre H. H.; Utzinger, Jurg] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Schneeberger, Pierre H. H.; Utzinger, Jurg] Univ Basel, Basel, Switzerland; [Pothier, Joel F.; Duffy, Brion] Zurich Univ Appl Sci ZHAW, Inst Nat Resource Sci, Environm Genom & Syst Biol Res Grp, Wadenswil, Switzerland; [Buhlmann, Andreas] Agroscope, Inst Food Sci, Dept Foods Plant Origin, Wadenswil, Switzerland	Swiss Federal Research Station Agroscope; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Zurich University of Applied Sciences; Swiss Federal Research Station Agroscope	Schneeberger, PHH (corresponding author), Agroscope, Dept Methods Dev & Analyt, Wadenswil, Switzerland.; Schneeberger, PHH (corresponding author), Fed Off Civil Protect, Spiez Lab, Dept Virol, Spiez, Switzerland.; Schneeberger, PHH (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Schneeberger, PHH (corresponding author), Univ Basel, Basel, Switzerland.	pierre.schneeberger@unibas.ch	Pothier, Joël F./H-9344-2013	Pothier, Joël F./0000-0002-9604-7780; Schneeberger, Pierre/0000-0002-8586-4937	armasuisse project ARAMIS [2011/22-16 / 353003285]	armasuisse project ARAMIS	This work was supported by armasuisse project ARAMIS no. 2011/22-16 / 353003285. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avise JC, 2012, MOLECULAR MARKERS NA; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Burke DS, 2001, FIELDS VIROLOGY, P1043, DOI 10.1093/emboj/cdg270; Burt FJ, 2005, EPIDEMIOL INFECT, V133, P659, DOI 10.1017/S0950268805003730; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Ferreira AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112312; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Grobbelaar AA, 2011, EMERG INFECT DIS, V17, P2270, DOI 10.3201/eid1712.111035; Hartline J, 2013, AM J EMERG MED, V31, P978, DOI 10.1016/j.ajem.2013.02.001; Hujakka H, 2003, J VIROL METHODS, V108, P117, DOI 10.1016/S0166-0934(02)00282-3; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Leyssen P, 2000, CLIN MICROBIOL REV, V13, P67, DOI 10.1128/CMR.13.1.67-82.2000; Li DX, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.1; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Montgomery JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001840; Mulatti P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-26; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Petersen LR, 2012, NEW ENGL J MED, V367, P1281, DOI 10.1056/NEJMp1210537; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6054; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneeberger PHH, 2016, INFECT GENET EVOL, V40, P389, DOI 10.1016/j.meegid.2015.08.044; Sloan LM, 2008, J CLIN MICROBIOL, V46, P1996, DOI 10.1128/JCM.00032-08; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Steinmetz HW, 2011, VET MICROBIOL, V148, P207, DOI 10.1016/j.vetmic.2010.09.018; Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Belkum A, 2001, CLIN MICROBIOL REV, V14, P547, DOI 10.1128/CMR.14.3.547-560.2001; Vazquez A, 2011, EURO SURVEILL, V16; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Wen HC, 2014, J CLIN MICROBIOL, V52, P3200, DOI 10.1128/JCM.00921-14	42	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178195	10.1371/journal.pone.0178195	http://dx.doi.org/10.1371/journal.pone.0178195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542435	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800051
J	Yeakley, JM; Shepard, PJ; Goyena, DE; VanSteenhouse, HC; McComb, JD; Seligmann, BE				Yeakley, Joanne M.; Shepard, Peter J.; Goyena, Diana E.; VanSteenhouse, Harper C.; McComb, Joel D.; Seligmann, Bruce E.			A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; GENE-EXPRESSION; DISCOVERY; MULTIPLEX	The use of gene expression signatures to classify compounds, identify efficacy or toxicity, and differentiate close analogs relies on the sensitivity of the method to identify modulated genes. We used a novel ligation-based targeted whole transcriptome expression profiling assay, TempO-Seq r, to determine whether previously unreported compound-responsive genes could be identified and incorporated into a broad but specific compound signature. TempO-Seq exhibits 99.6% specificity, single cell sensitivity, and excellent correlation with fold differences measured by RNA-Seq (R-2 = 0.9) for 20,629 targets. Unlike many expression assays, TempO-Seq does not require RNA purification, cDNA synthesis, or capture of targeted RNA, and lacks a 30 end bias. To investigate the sensitivity of the TempO-Seq assay to identify significantly modulated compound-responsive genes, we derived whole transcriptome profiles from MCF-7 cells treated with the histone deacetylase inhibitor Trichostatin A (TSA) and identified more than 9,000 differentially expressed genes. The TSA profile for MCF-7 cells overlapped those for HL-60 and PC-3 cells in the Connectivity Map (cMAP) database, suggesting a common TSA-specific expression profile independent of baseline gene expression. A 43-gene cell-independent TSA signature was extracted from cMAP and confirmed in TempO-Seq MCF-7 data. Additional genes that were not previously reported to be TSA responsive in the cMAP database were also identified. TSA treatment of 5 cell types revealed 1,136 differentially expressed genes in common, including 785 genes not previously reported to be TSA responsive. We conclude that TSA induces a specific expression signature that is consistent across widely different cell types, that this signature contains genes not previously associated with TSA responses, and that TempO-Seq provides the sensitive differential expression detection needed to define such compound-specific, cell-independent, changes in expression.	[Yeakley, Joanne M.; Shepard, Peter J.; Goyena, Diana E.; VanSteenhouse, Harper C.; McComb, Joel D.; Seligmann, Bruce E.] BioSpyder Technol Inc, Carlsbad, CA 92008 USA		Yeakley, JM (corresponding author), BioSpyder Technol Inc, Carlsbad, CA 92008 USA.	joyeakley@biospyder.com		VanSteenhouse, Harper/0000-0002-9401-5929	National Human Genome Research Institute, National Institutes of Health [R43HG007339, R44HG007815]; National Center for Advancing Translational Sciences, National Institutes of Health [HHSN271201300011C, HHSN271201400052C]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG007339] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants R43HG007339 (JY) and R44HG007815 (JY) from the National Human Genome Research Institute, National Institutes of Health (https://www.genome.gov/), and by contracts HHSN271201300011C (JY) and HHSN271201400052C (JY) from the National Center for Advancing Translational Sciences, National Institutes of Health (http://ncats.nih.gov/).All authors are employed by BioSpyder Technologies, Inc. The funders provided support in the form of salaries for the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodi K, 2013, J Biomol Tech, V24, P73, DOI 10.7171/jbt.13-2402-002; Chen H, 2015, CANCERS, V7, P1699, DOI 10.3390/cancers7030859; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Foster WR, 2007, TOXICOL PATHOL, V35, P621, DOI 10.1080/01926230701419063; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Johnson PH, 2002, MOL CANCER THER, V1, P1293; Johnson RL, 2008, ANAL BIOCHEM, V375, P237, DOI 10.1016/j.ab.2007.12.028; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Larman HB, 2014, NUCLEIC ACIDS RES, V42, P9146, DOI 10.1093/nar/gku636; Li Hairi, 2012, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0413s98; Li HR, 2012, P NATL ACAD SCI USA, V109, P4609, DOI 10.1073/pnas.1200305109; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Micheva-Viteva S, 2011, J BIOL CHEM, V286, P21083, DOI 10.1074/jbc.M110.195537; Moore PS, 2004, BBA-MOL CELL RES, V1693, P167, DOI 10.1016/j.bbamcr.2004.07.001; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson D., 2013, CANCER RES, V73, P4146, DOI [10.1158/1538-7445.am2013-4146, DOI 10.1158/1538-7445.AM2013-4146]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	22	83	86	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178302	10.1371/journal.pone.0178302	http://dx.doi.org/10.1371/journal.pone.0178302			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542535	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800067
J	Bicho, N; Cascalheira, J; Goncalves, C				Bicho, Nuno; Cascalheira, Joao; Goncalves, Celia			Early Upper Paleolithic colonization across Europe: Time and mode of the Gravettian diffusion	PLOS ONE			English	Article							RADIOCARBON CHRONOLOGY; NEOLITHIC TRANSITION; CULTURAL-DIFFUSION; FRANCE; MIDDLE; AURIGNACIAN; DISPERSAL; DATES	This study presents new models on the origin, speed and mode of the wave-of-advance leading to the definitive occupation of Europe's outskirts by Anatomically Modern Humans, during the Gravettian, between c. 37 and 30 ka ago. These models provide the estimation for possible demic dispersal routes for AMH at a stable spread rate of c. 0.7 km/year, with the likely origin in Central Europe at the site of Geissenklosterle in Germany and reaching all areas of the European landscape. The results imply that: 1. The arrival of the Gravettian populations into the far eastern European plains and to southern Iberia found regions with very low human occupation or even devoid of hominins; 2. Human demography was likely lower than previous estimates for the Upper Paleolithic; 3. The likely early AMH paths across Europe followed the European central plains and the Mediterranean coast to reach to the ends of the Italian and Iberian peninsulas.	[Bicho, Nuno; Cascalheira, Joao; Goncalves, Celia] Univ Algarve, Fac Ciencias Humanas & Sociais, Interdisciplinary Ctr Archaeol & Evolut Human Beh, ICArEHB, Campus Gambelas, Faro, Portugal	Universidade do Algarve	Bicho, N (corresponding author), Univ Algarve, Fac Ciencias Humanas & Sociais, Interdisciplinary Ctr Archaeol & Evolut Human Beh, ICArEHB, Campus Gambelas, Faro, Portugal.	nbicho@ualg.pt	Cascalheira, João/B-8343-2014; Bicho, Nuno/J-2841-2012	Cascalheira, João/0000-0003-0321-8892; Bicho, Nuno/0000-0001-9655-0549; Goncalves, Celia/0000-0001-6354-9437	Portuguese Science Foundation (Fundagao para a Ciencia e Tecnologia); National Geographic Society; Wenner-Gren Foundation for Anthropological Research; Fundagao para a Ciencia e Tecnologia	Portuguese Science Foundation (Fundagao para a Ciencia e Tecnologia); National Geographic Society(National Geographic Society); Wenner-Gren Foundation for Anthropological Research; Fundagao para a Ciencia e Tecnologia	We would like to thank the Portuguese Science Foundation (Fundagao para a Ciencia e Tecnologia), National Geographic Society, and Wenner-Gren Foundation for Anthropological Research for funding field and laboratory work at the site of Vale Boi, Algarve, Portugal, as well to Fundagao para a Ciencia e Tecnologia for doctoral and postdoctoral grants to Cascalheira and Gongalves. (PT-http://www.fct.pt fct pti), SFRH/BPD/96277/2013 and UID/ARQ/04211/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batten DC, 2007, P 34 C FARG US APR 2; Bell T., 2000, MAP ARCHAEOLOGY SPAT, P85; Bocquet-Appel JP, 2000, J ARCHAEOL SCI, V27, P551, DOI 10.1006/jasc.1999.0471; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; Douka K, 2014, J HUM EVOL, V68, P1, DOI 10.1016/j.jhevol.2013.12.007; Douka K, 2010, RADIOCARBON, V52, P735, DOI 10.1017/S0033822200045756; Fort J, 1999, PHYS REV LETT, V82, P867, DOI 10.1103/PhysRevLett.82.867; Fort J, 2004, CAMB ARCHAEOL J, V14, P53, DOI 10.1017/S0959774304000046; Fort J, 2003, ANTIQUITY, V77, P520, DOI 10.1017/S0003598X00092577; Fort J, 2015, HUM BIOL, V87, P141, DOI 10.13110/humanbiology.87.3.0141; Fort J, 2012, P NATL ACAD SCI USA, V109, P18669, DOI 10.1073/pnas.1200662109; Hamilton MJ, 2007, P NATL ACAD SCI USA, V104, P15625, DOI 10.1073/pnas.0704215104; Herzog I, 2013, PUBL INST ARCHAEOL, P179; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Higham T, 2011, J HUM EVOL, V61, P549, DOI 10.1016/j.jhevol.2011.06.005; Higham T, 2011, ANTIQUITY, V85, P235, DOI 10.1017/S0003598X00067570; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Hughes JK, 2007, J HUM EVOL, V53, P465, DOI 10.1016/j.jhevol.2006.12.011; Jacobs Z, 2015, J ARCHAEOL SCI, V54, P110, DOI 10.1016/j.jas.2014.11.020; Jerardino A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113672; Mithen S, 2002, J HUM EVOL, V43, P433, DOI 10.1006/jhev.2002.0584; OTTE M, 1990, CURR ANTHROPOL, V31, P577, DOI 10.1086/203904; Parslow CA, 2009, SOCIAL INTERACTION P; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Talamo S, 2011, RADIOCARBON, V53, P443, DOI 10.1017/S0033822200034573; Tobler W. R., 1993, 3 PRESENTATIONS GEOG; Vermeersch PM, RADIOCARBON PALAEOLI; White D., 2012, LEAST COST ANAL SOCI; Whitley T.G., 2008, CONDITIONAL GIS SURF; Wood RE, 2010, RADIOCARBON, V52, P600, DOI 10.1017/S003382220004563X; Wood RE, 2013, P NATL ACAD SCI USA, V110, P2781, DOI 10.1073/pnas.1207656110; Zilhao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008880	34	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178506	10.1371/journal.pone.0178506	http://dx.doi.org/10.1371/journal.pone.0178506			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EV8VE	28542642	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500087
J	Li, X; Dong, H; Zhang, YF; Zhang, GX				Li, Xuan; Dong, Hao; Zhang, Yifeng; Zhang, Guoxin			CO2 insufflation versus air insufflation for endoscopic submucosal dissection: A meta-analysis of randomized controlled trials	PLOS ONE			English	Article								Background Carbon dioxide (CO2) insufflation is increasingly used for endoscopic submucosal dissection (ESD) owing to the faster absorption of CO2 as compared to that of air. Studies comparing CO2 insufflation and air insufflation have reported conflicting results. Objectives This meta-analysis is aimed to assess the efficacy and safety of use of CO2 insufflation for ESD. Methods Clinical trials of CO2 insufflation versus air insufflation for ESD were searched in PubMed, Embase, the Cochrane Library and Chinese Biomedical Literature Database. We performed a meta-analysis of all randomized controlled trials (RCTs). Results Eleven studies which compared the use of CO2 insufflation and air insufflation, with a combined study population of 1026 patients, were included in the meta-analysis (n = 506 for CO2 insufflation; n = 522 for air insufflation). Abdominal pain and VAS scores at 6h and 24h post-procedure in the CO2 insufflation group were significantly lower than those in the air insufflation group, but not at 1h and 3h after ESD. The percentage of patients who experienced pain 1h and 24h post-procedure was obviously decreased. Use of CO2 insufflation was associated with lower VAS scores for abdominal distention at 1h after ESD, but not at 24h after ESD. However, no significant differences were observed with respect to postoperative transcutaneous partial pressure carbon dioxide (PtcCO(2)), arterial blood carbon dioxide partial pressure (PaCO2), oxygen saturation (SpO(2)%), abdominal circumference, hospital stay, white blood cell (WBC) counts, C-Reactive protein (CRP) level, dosage of sedatives used, incidence of dysphagia and other complications. Conclusion Use of CO2 insufflation for ESD was safe and effective with regard to abdominal discomfort, procedure time, and the residual gas volume. However, there appeared no significant differences with respect to other parameters namely, PtcCO(2), PaCO2, SpO(2)%, abdominal circumference, hospital stay, sedation dosage, complications, WBC, CRP, and dysphagia.	[Li, Xuan; Zhang, Yifeng; Zhang, Guoxin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Li, Xuan; Zhang, Yifeng; Zhang, Guoxin] Nanjing Med Univ, Sch Clin Med 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Dong, Hao] Second Hosp Nanjing, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhang, GX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.; Zhang, GX (corresponding author), Nanjing Med Univ, Sch Clin Med 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.	guoxinz@njmu.edu.cn			National Natural Science Foundation of China [81470830]; Jiangsu Standard Diagnosis, Treatment Research for Key Diseases [BE 2015716]; Jiangsu Higher Education Institutions [JX 10231802]; Science and Technology Development Projects of Suzhou [SYS201304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Standard Diagnosis, Treatment Research for Key Diseases; Jiangsu Higher Education Institutions; Science and Technology Development Projects of Suzhou	This project was funded by National Natural Science Foundation of China (J.L., No. 81470830), Jiangsu Standard Diagnosis, Treatment Research for Key Diseases (BE 2015716), the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX 10231802) and Science and Technology Development Projects of Suzhou (SYS201304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bretthauer M, 2002, GUT, V50, P604, DOI 10.1136/gut.50.5.604; Cheng Y, 2012, WORLD J GASTROENTERO, V18, P5622, DOI 10.3748/wjg.v18.i39.5622; Enomoto S, 2007, ENDOSCOPY, V39, pE156, DOI 10.1055/s-2006-925254; Fellow JPHS, 2008, ANAL DATA UNDERTAKIN; Feng H, 2014, CHINA MODERN DOCTOR; Gotoda T, 2010, BRIT J SURG, V97, P868, DOI 10.1002/bjs.7033; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Kikuchi T, 2010, SURG ENDOSC, V24, P2231, DOI 10.1007/s00464-010-0939-8; Kim SY, 2015, GASTROINTEST ENDOSC, V82, P1018, DOI 10.1016/j.gie.2015.05.043; Liu X, 2016, CHINA J ENDOSCOPY; Lord AC, 2014, WORLD J GASTROENTERO, V20, P2193, DOI 10.3748/wjg.v20.i9.2193; Maeda Y, 2013, ENDOSCOPY, V45, P335, DOI 10.1055/s-0032-1326199; Maeda Y, 2016, WORLD J GASTROENTERO, V22, P7373, DOI 10.3748/wjg.v22.i32.7373; Nonaka S, 2010, SURG ENDOSC, V24, P1638, DOI 10.1007/s00464-009-0824-5; Onogi F, 2011, J GASTROEN HEPATOL, V26, P60; ROGERS BHG, 1985, GASTROINTEST ENDOSC, V31, P108; Rosenthal R., 1986, METAANALYSIS QUANTIT, V1, P77; Saito Y, 2007, GASTROINTEST ENDOSC, V65, P537, DOI 10.1016/j.gie.2006.11.002; Suzuki T, 2010, ENDOSCOPY, V42, P1021, DOI 10.1055/s-0030-1255969; Takada J, 2015, WORLD J GASTROENTERO, V21, P8195, DOI 10.3748/wjg.v21.i26.8195; Takada J, 2015, SURG ENDOSC, V29, P1963, DOI 10.1007/s00464-014-3892-0; Tanioka D, 2008, GASTROINTEST ENDOSC, V67, pAB279, DOI 10.1016/j.gie.2008.03.785; Wang W, 2010, NANO LETT, V10, P2012, DOI 10.1021/nl904057p; Yamano H, 2010, J GASTROENTEROL, V45, P1235, DOI 10.1007/s00535-010-0286-5; Zhan LL, 2015, CHINESE J DIGESTIVE, V4, P246	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177909	10.1371/journal.pone.0177909	http://dx.doi.org/10.1371/journal.pone.0177909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542645	gold, Green Submitted, Green Published			2022-12-27	WOS:000402061500043
J	Kim, SJ; Cho, KJ; Oh, S				Kim, Seong Jae; Cho, Kyong Jin; Oh, Sejong			Development of machine learning models for diagnosis of glaucoma	PLOS ONE			English	Article							FIBER LAYER MEASUREMENTS; OPTICAL COHERENCE TOMOGRAPHY; DETECTION ABILITY; CLASSIFIERS; THICKNESS; MYOPIA; SENSITIVITY	The study aimed to develop machine learning models that have strong prediction power and interpretability for diagnosis of glaucoma based on retinal nerve fiber layer (RNFL) thickness and visual field (VF). We collected various candidate features from the examination of retinal nerve fiber layer (RNFL) thickness and visual field (VF). We also developed synthesized features from original features. We then selected the best features proper for classification (diagnosis) through feature evaluation. We used 100 cases of data as a test dataset and 399 cases of data as a training and validation dataset. To develop the glaucoma prediction model, we considered four machine learning algorithms: C5.0, random forest (RF), support vector machine (SVM), and k-nearest neighbor (KNN). We repeatedly composed a learning model using the training dataset and evaluated it by using the validation dataset. Finally, we got the best learning model that produces the highest validation accuracy. We analyzed quality of the models using several measures. The random forest model shows best performance and C5.0, SVM, and KNN models show similar accuracy. In the random forest model, the classification accuracy is 0.98, sensitivity is 0.983, specificity is 0.975, and AUC is 0.979. The developed prediction models show high accuracy, sensitivity, specificity, and AUC in classifying among glaucoma and healthy eyes. It will be used for predicting glaucoma against unknown examination records. Clinicians may reference the prediction results and be able to make better decisions. We may combine multiple learning models to increase prediction accuracy. The C5.0 model includes decision rules for prediction. It can be used to explain the reasons for specific predictions.	[Kim, Seong Jae] Gyeongsang Natl Univ, Coll Med, Dept Ophthalmol, Jinju, South Korea; [Cho, Kyong Jin] Dankook Univ, Coll Med, Dept Ophthalmol, Cheonan, South Korea; [Oh, Sejong] Dankook Univ, Dept Software Sci, Yongin, South Korea	Gyeongsang National University; Dankook University; Dankook University	Oh, S (corresponding author), Dankook Univ, Dept Software Sci, Yongin, South Korea.	sejongoh@dankook.ac.kr		Oh, Sejong/0000-0002-9365-274X	Dankook University	Dankook University	This study was conducted by the research fund of Dankook University in 2015.; This study was conducted by the research fund of Dankook University in 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASMAN P, 1992, ARCH OPHTHALMOL-CHIC, V110, P812, DOI 10.1001/archopht.1992.01080180084033; Barella KA, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/789129; Bizios D, 2010, ACTA OPHTHALMOL, V88, P44, DOI 10.1111/j.1755-3768.2009.01784.x; Caruana Rich, 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865.[38]X; Chan KL, 2002, IEEE T BIO-MED ENG, V49, P963, DOI 10.1109/TBME.2002.802012; Choi YJ, 2013, INVEST OPHTH VIS SCI, V54, P2296, DOI 10.1167/iovs.12-10530; Dietterich T.G., 2002, HDB BRAIN THEORY NEU; Goldbaum MH, 2002, INVEST OPHTH VIS SCI, V43, P162; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Kotsiantis SB, 2007, FRONT ARTIF INTEL AP, V160, P3; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Leung CKS, 2006, INVEST OPHTH VIS SCI, V47, P5171, DOI 10.1167/iovs.06-0545; Liu B, 2016, BIOINFORMATICS, V32, P2411, DOI 10.1093/bioinformatics/btw186; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Ozdek SC, 2000, BRIT J OPHTHALMOL, V84, P264, DOI 10.1136/bjo.84.3.264; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rauscher FM, 2009, J GLAUCOMA, V18, P501, DOI 10.1097/IJG.0b013e318193c2be; Seol BR, 2015, INVEST OPHTH VIS SCI, V56, P8306, DOI 10.1167/iovs.15-18141; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Silva FR, 2013, ARQ BRAS OFTALMOL, V76, P170, DOI 10.1590/S0004-27492013000300008; Simundic AM, 2008, MED BIOL SCI, V22, P61; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192	25	98	104	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177726	10.1371/journal.pone.0177726	http://dx.doi.org/10.1371/journal.pone.0177726			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542342	Green Submitted, gold, Green Published			2022-12-27	WOS:000402058800024
J	Charkiewicz, K; Goscik, J; Blachnio-Zabielska, A; Raba, G; Sakowicz, A; Kalinka, J; Chabowski, A; Laudanski, P				Charkiewicz, Karol; Goscik, Joanna; Blachnio-Zabielska, Agnieszka; Raba, Grzegorz; Sakowicz, Agata; Kalinka, Jaroslaw; Chabowski, Adrian; Laudanski, Piotr			Sphingolipids as a new factor in the pathomechanism of preeclampsia - Mass spectrometry analysis	PLOS ONE			English	Article							CERAMIDE; PATHOPHYSIOLOGY; PROSTACYCLIN; METABOLISM	Objective(s) and design The aim of the study was to analyse a panel of 11 sphingolipids in plasma and three blood fractions (platelet-poor plasma, platelets and red blood cells) of women with mild preeclampsia. Materials and methods We recruited 21 women between 25-40 weeks gestation with diagnosed mild preeclampsia to the study group and 36 healthy women with uncomplicated pregnancies, who corresponded with the study group according to gestational age, to the control group. To assess the concentration of 11 sphingolipids in the blood plasma and blood fractions, we used ultra-high performance liquid chromatography coupled with triple quadrupole mass spectrometry (UHPLC/MS/MS). Results We showed a significant increase in the concentration of eight sphingolipids in the plasma of women with preeclampsia in comparison to the control group: Sph (p = 0.0032), S1P (p = 0.0289), C20-Cer (p < 0.0001), C18-Cer (p < 0.0001), C16-Cer (p = 0.012), C18: 1-Cer (p = 0.003), C22-Cer (p = 0.0071), and C24: 1-Cer (p = 0.0085). Conclusion We showed that selected sphingolipids, especially C20-Cer and C18-Cer, are totally new factors in the pathomechanism of PE and that these bioactive lipids may play an important role in apoptosis and autophagy.	[Charkiewicz, Karol; Laudanski, Piotr] Med Univ Bialystok, Dept Perinatol & Obstet, Bialystok, Poland; [Goscik, Joanna] Bialystok Tech Univ, Fac Comp Sci, Bialystok, Poland; [Blachnio-Zabielska, Agnieszka] Dept Hyg Epidemiol & Metab Disorders, Bialystok, Poland; [Blachnio-Zabielska, Agnieszka; Chabowski, Adrian] Med Univ Bialystok, Dept Physiol, Bialystok, Poland; [Raba, Grzegorz] Univ Rzeszow, Inst Obstet & Emergency Med, Zurawica, Podkarpackie, Poland; [Sakowicz, Agata] Med Univ Lodz, Dept Med Biotechnol, Lodz, Poland; [Kalinka, Jaroslaw] Med Univ Lodz, Dept Perinatol, Lodz, Poland	Medical University of Bialystok; Bialystok University of Technology; Medical University of Bialystok; University of Rzeszow; Medical University Lodz; Medical University Lodz	Laudanski, P (corresponding author), Med Univ Bialystok, Dept Perinatol & Obstet, Bialystok, Poland.	plauda@umb.edu.pl	Goscik, Joanna/S-6541-2018; Raba, Grzegorz/HGE-9974-2022; Chabowski, Adrian/T-2225-2018; Blachnio-Zabielsk, Agnieszka U/A-4879-2018	Goscik, Joanna/0000-0003-0433-6145; Chabowski, Adrian/0000-0002-7407-8156; Blachnio-Zabielsk, Agnieszka U/0000-0002-8055-0576; Raba, Grzegorz/0000-0002-9196-8548; Laudanski, Piotr/0000-0001-8955-8198; Kalinka, Jaroslaw/0000-0002-6956-4950; Sakowicz, Agata/0000-0002-5083-2046	National Science Centre, Poland [2015/19/N/NZ5/01434]; Leading National Scientific Center, Medical University of Bialystok, Poland [101/KNOW/2015, 36/KNOW/2013]; Polpharma Scientific Foundation	National Science Centre, Poland(National Science Centre, Poland); Leading National Scientific Center, Medical University of Bialystok, Poland; Polpharma Scientific Foundation	This work was supported by grant numbers: 2015/19/N/NZ5/01434 from National Science Centre, Poland and 101/KNOW/2015, 36/KNOW/2013 from The Leading National Scientific Center, Medical University of Bialystok, Poland. Study sponsored by a Polpharma Scientific Foundation.; This work was supported by grant numbers: 2015/19/N/NZ5/01434 from National Science Centre, Poland and 101/KNOW/2015, 36/KNOW/2013 from The Leading National Scientific Center, Medical University of Bialystok, Poland. Study sponsored by a Polpharma Scientific Foundation. The manuscript has undergone professional English editing by Elsevier editors. Details of ethics approval: The study protocol was approved by the Local Ethical Committee of Medical University of Bialystok, Poland, and an informed consent was obtained from each patient (no ethics committee approval: R-I-002/377/2016).	Anderson UD, 2012, PLACENTA, V33, pS42, DOI 10.1016/j.placenta.2011.11.021; Andraweera PH, 2017, REPROD BIOMED ONLINE; Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337, DOI 10.1152/ajpheart.2001.281.6.H2337; Blachnio-Zabielska A, 2016, ADV MED SCI-POLAND, V61, P72, DOI 10.1016/j.advms.2015.09.006; Blachnio-Zabielska AU, 2012, RAPID COMMUN MASS SP, V26, P1134, DOI 10.1002/rcm.6216; Borodzicz S, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0053-y; Bounds Kelsey R, 2015, Front Cardiovasc Med, V2, P20, DOI 10.3389/fcvm.2015.00020; Carty DM, 2008, TRENDS CARDIOVAS MED, V18, P186, DOI 10.1016/j.tcm.2008.07.002; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Charkiewicz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127732; CHEN G, 1993, AM J OBSTET GYNECOL, V169, P1106, DOI 10.1016/0002-9378(93)90264-J; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Davison JM, 2004, J AM SOC NEPHROL, V15, P2440, DOI 10.1097/01.ASN.0000135975.90889.60; de Lima VJ, 2011, SAO PAULO MED J, V129, P73, DOI 10.1590/S1516-31802011000200004; Ermini Leonardo C I, 2013, MASS SPECTROMETRY IM, V34, pA10; Ganss R, 2017, TRENDS ENDOCRIN MET, V28, P73, DOI 10.1016/j.tem.2016.09.004; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hartmann D, 2012, INT J BIOCHEM CELL B, V44, P620, DOI 10.1016/j.biocel.2011.12.019; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Johnstone ED, 2005, J LIPID RES, V46, P1833, DOI 10.1194/jlr.M500095-JLR200; Kang Se-Chan, 2013, Front Endocrinol (Lausanne), V4, P67, DOI 10.3389/fendo.2013.00067; Kim SY, 2004, J KOREAN MED SCI, V19, P688, DOI 10.3346/jkms.2004.19.5.688; Kim Young Ju, 2013, Obstet Gynecol Sci, V56, P2, DOI 10.5468/OGS.2013.56.1.2; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; Laakso M., 2017, J LIPID RES; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Laudanski P, 2016, PROSTAG OTH LIPID M, V123, P40, DOI 10.1016/j.prostaglandins.2016.04.005; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Lim MY, 2016, GUT; Liu HS, 1998, INT J GYNECOL OBSTET, V63, P1, DOI 10.1016/S0020-7292(98)00101-5; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; NEIGER R, 1992, AM J PERINAT, V9, P378, DOI 10.1055/s-2007-999269; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Romanowicz L, 2010, PATHOBIOLOGY, V77, P78, DOI 10.1159/000278289; Romanowicz L, 2009, CLIN BIOCHEM, V42, P1719, DOI 10.1016/j.clinbiochem.2009.07.011; Seki N., 2013, PHARM PHARM, V4, P628, DOI DOI 10.4236/PP.2013.48089; SHAPIRO SS, 1965, ANAL VARIANCE TEST N; Siddiqui IA, 2014, ANN MED HEALTH SCI R, V4, P638, DOI 10.4103/2141-9248.139358; Sigruener A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085724; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021817; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Vargas-Rojas MI, 2016, J MATERN-FETAL NEO M, V29, P1642, DOI 10.3109/14767058.2015.1057811; Wetzka B, 1997, HUM REPROD, V12, P2313, DOI 10.1093/humrep/12.10.2313; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yang J, 2004, CELL BIOCHEM BIOPHYS, V40, P323, DOI 10.1385/CBB:40:3:323; Yogi A, 2011, HYPERTENSION, V57, P809, DOI 10.1161/HYPERTENSIONAHA.110.162719; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278	52	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177601	10.1371/journal.pone.0177601	http://dx.doi.org/10.1371/journal.pone.0177601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542236	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672600018
J	Pugazhendhi, S; Baskaran, K; Santhanam, S; Ramakrishna, BS				Pugazhendhi, Srinivasan; Baskaran, Kirankumar; Santhanam, Srikanth; Ramakrishna, Balakrishnan S.			Association of ATG16L1 gene haplotype with inflammatory bowel disease in Indians	PLOS ONE			English	Article							CROHNS-DISEASE; GASTROENTEROLOGY CONSENSUS; ULCERATIVE-COLITIS; ADAPTIVE IMMUNITY; SUSCEPTIBILITY; IL23R; POPULATION; NOD2; AUTOPHAGY; VARIANTS	Inflammatory bowel disease (IBD) is characterized by multigenic inheritance. Defects in autophagy related genes are considered to show genetic heterogeneity between populations. We evaluated the association of several single nucleotide polymorphisms (SNPs) in the autophagy related 16 like 1 (ATG16L1) gene with IBD in Indians. The ATG16L1 gene was genotyped for ten different SNPs using DNA extracted from peripheral blood of 234 patients with Crohn's disease (CD), 249 patients with ulcerative colitis (UC) and 393 healthy controls The SNPs rs2241880, rs4663396, rs3792106, rs10210302, rs3792109, rs2241877, rs6737398, rs11682898, rs4663402 and rs4663421 were genotyped using the Sequenom MassArray platform. PLINK was used for the association analysis and pairwise linkage disequilibrium (LD) values. Haplotype analysis was done using Haploview. All SNPs were in Hardy Weinberg equilibrium in cases and controls. The G allele at rs6737398 exhibited a protective association with both CD and UC. The T allele at rs4663402 and C allele at rs4663421 were positively associated with CD and UC. The T allele at rs2241877 exhibited protective association with UC only. The AA genotype at rs4663402 and the GG genotype at rs4663421 were protectively associated with both CD and UC. Haplotype analysis revealed that all the SNPs in tight LD (D' = 0.76-1.0) and organized in a single haplotype block. Haplotype D was positively associated with IBD (P = 5.8 x 10(-6) for CD and 0.002 for UC). SNPs in ATG16L1 were associated with IBD in Indian patients. The relevance to management of individual patients requires further study.	[Pugazhendhi, Srinivasan; Baskaran, Kirankumar; Santhanam, Srikanth; Ramakrishna, Balakrishnan S.] Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore, Tamil Nadu, India; [Pugazhendhi, Srinivasan] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Ramakrishna, Balakrishnan S.] SRM Inst Med Sci, Madras, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; University of Kansas; University of Kansas Medical Center; SRM Institute of Science & Technology Chennai	Ramakrishna, BS (corresponding author), Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore, Tamil Nadu, India.; Ramakrishna, BS (corresponding author), SRM Inst Med Sci, Madras, Tamil Nadu, India.	wurama@hotmail.com	Ramakrishna, Balakrishnan/D-6808-2015; Srinivasan, Pugazhendhi/M-5184-2019	Srinivasan, Pugazhendhi/0000-0002-1748-1416; Ramakrishna, Balakrishnan/0000-0001-5090-9501				Baptista ML, 2008, INFLAMM BOWEL DIS, V14, P674, DOI 10.1002/ibd.20372; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baskaran K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114665; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Csongei V, 2010, WORLD J GASTROENTERO, V16, P176, DOI 10.3748/wjg.v16.i2.176; Cummings JRF, 2007, INFLAMM BOWEL DIS, V13, P941, DOI 10.1002/ibd.20162; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fowler EV, 2008, AM J GASTROENTEROL, V103, P2519, DOI 10.1111/j.1572-0241.2008.02023.x; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lakatos PL, 2008, DIGEST LIVER DIS, V40, P867, DOI 10.1016/j.dld.2008.03.022; Lappalainen M, 2008, INFLAMM BOWEL DIS, V14, P1118, DOI 10.1002/ibd.20431; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001; Munz C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00009; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Okazaki T, 2008, INFLAMM BOWEL DIS, V14, P1528, DOI 10.1002/ibd.20512; Palomino-Morales RJ, 2009, GENES IMMUN, V10, P356, DOI 10.1038/gene.2009.25; Perricone C, 2008, GASTROENTEROLOGY, V134, P368, DOI 10.1053/j.gastro.2007.11.017; Peter I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-63; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramakrishna BS, 2015, INDIAN J GASTROENTER, V34, P3, DOI 10.1007/s12664-015-0539-6; Ramakrishna BS, 2012, INDIAN J GASTROENTER, V31, P307, DOI 10.1007/s12664-012-0259-0; Roberts RL, 2007, AM J GASTROENTEROL, V102, P2754, DOI 10.1111/j.1572-0241.2007.01525.x; Sadabad MS, 2015, GUT, V64, P1546, DOI 10.1136/gutjnl-2014-307289; Schmid D, 2006, J MOL MED-JMM, V84, P194, DOI 10.1007/s00109-005-0014-4; Sventoraityte J, 2010, WORLD J GASTROENTERO, V16, P359, DOI 10.3748/wjg.v16.i3.359; Van Limbergen J, 2013, GUT, V62, P331, DOI 10.1136/gutjnl-2012-303165; Walker DG, 2011, GUT, V60, pA223, DOI 10.1136/gut.2011.239301.470; Weersma RK, 2008, AM J GASTROENTEROL, V103, P621, DOI 10.1111/j.1572-0241.2007.01660.x; Yamazaki K, 2007, J HUM GENET, V52, P575, DOI 10.1007/s10038-007-0156-z; Yang SK, 2009, INFLAMM BOWEL DIS, V15, P1385, DOI 10.1002/ibd.20921; Zhang J, 2014, SCAND J GASTROENTERO, V49, P1201, DOI 10.3109/00365521.2014.936031; Zhi Jia, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P649	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178291	10.1371/journal.pone.0178291	http://dx.doi.org/10.1371/journal.pone.0178291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542425	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672600049
J	Arora, K; Sequeira, JM; Hernandez, AI; Alarcon, JM; Quadros, EV				Arora, Kaveri; Sequeira, Jeffrey M.; Hernandez, Alejandro I.; Alarcon, Juan M.; Quadros, Edward V.			Behavioral alterations are associated with vitamin B-12 deficiency in the transcobalamin receptor/CD320 KO mouse	PLOS ONE			English	Article							ACTIVE PLACE AVOIDANCE; SYNAPTIC DYSFUNCTION; OXIDATIVE STRESS; COBALAMIN; HOMOCYSTEINE; MICE; INFORMATION; PLASTICITY; GLUTAMATE; MODEL	Vitamin B-12 (cobalamin) deficiency is prevalent worldwide and causes megaloblastic anemia and neurologic deficits. While the anemia can be treated, the neurologic deficits can become refractive to treatment as the disease progresses. Therefore, timely intervention is critical for a favorable outcome. Moreover, the metabolic basis for the neuro-pathologic changes and the role of cobalamin deficiency in the pathology still remains unexplained. Using a transcobalamin receptor/CD320 knockout mouse that lacks the receptor for cellular uptake of transcobalamin bound cobalamin, we aimed to determine whether cobalamin deficiency in the central nervous system produced functional neurologic deficits in the mouse that would parallel those observed in humans. Our behavioral analyses indicate elevated anxiety and deficits in learning, memory and set-shifting of a spatial memory task in the KO mouse. Consistent with the behavioral deficits, the knockout mouse shows impaired expression of the early phase of hippocampal long-term potentiation along with reduced expression of GluR1, decreased brain mass and a significant reduction in the size of nuclei of the hippocampal pyramidal neurons. Our study suggests that the CD320 knockout mouse develops behavioral deficits associated with cobalamin deficiency and therefore could provide a model to understand the metabolic and genetic basis of neuro-pathologic changes due to cobalamin deficiency.	[Arora, Kaveri] Suny Downstate Med Ctr, Grad Program Mol & Cellular Biol, Brooklyn, NY 11203 USA; [Sequeira, Jeffrey M.; Quadros, Edward V.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Hernandez, Alejandro I.; Alarcon, Juan M.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Pathol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Quadros, EV (corresponding author), Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA.	Edward.quadros@downstate.edu		Quadros, Edward/0000-0002-7663-8014; Pohlman, Kaveri/0000-0002-1154-1406	US National Institutes of Health grant [R01DK064732, R21NS091830]	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by US National Institutes of Health grant R01DK064732 to EVQ and by R21NS091830 to JMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMANOLIS DP, 1978, J NEUROPATH EXP NEUR, V37, P273, DOI 10.1097/00005072-197805000-00006; Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; ALLEN RH, 1993, FASEB J, V7, P1344, DOI 10.1096/fasebj.7.14.7901104; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Anderson Shanna, 2016, Integr Med (Encinitas), V15, P48; Bailey KR, 2009, FRONT NEUROSCI, P77; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Berciano MT, 2007, J STRUCT BIOL, V158, P410, DOI 10.1016/j.jsb.2006.12.008; Biancheri R, 2001, NEUROPEDIATRICS, V32, P14, DOI 10.1055/s-2001-12217; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P205, DOI 10.1016/S0149-7634(01)00009-4; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; CANNATA JJB, 1965, J BIOL CHEM, V240, P3249; CHANARIN I, 1985, BLOOD, V66, P479; CHRISTMAS AJ, 1970, NEUROPHARMACOLOGY, V9, P17, DOI 10.1016/0028-3908(70)90044-4; Cimadevilla JM, 2000, J NEUROSCI METH, V102, P155, DOI 10.1016/S0165-0270(00)00288-0; Cimadevilla JM, 2001, BRAIN RES BULL, V54, P559, DOI 10.1016/S0361-9230(01)00448-8; DASTUR DK, 1975, AM J CLIN NUTR, V28, P1255, DOI 10.1093/ajcn/28.11.1255; Daval JL, 2009, P NATL ACAD SCI USA, V106, pE1, DOI 10.1073/pnas.0809217106; Faverzani JL, 2017, CELL MOL NEUROBIOL; Fenton AA, 2000, J GEN PHYSIOL, V116, P211, DOI 10.1085/jgp.116.2.211; Fernandez-Fernandez D, 2016, J NEUROSCI RES, V94, P266, DOI 10.1002/jnr.23701; Ghemrawi R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.69; GREEN R, 1995, BAILLIERE CLIN HAEM, V8, P533, DOI 10.1016/S0950-3536(05)80220-3; GREEN R, 1975, NATURE, V254, P148, DOI 10.1038/254148a0; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Guest J, 2015, NUTR NEUROSCI, V18, P355, DOI 10.1179/1476830515Y.0000000041; Gurkas E, 2015, GENET COUNSEL, V26, P425; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Head E, 2009, NEUROBIOL AGING, V30, P1125, DOI 10.1016/j.neurobiolaging.2007.10.001; HEALTON EB, 1991, MEDICINE, V70, P229, DOI 10.1097/00005792-199107000-00001; Hill MN, 2006, EUR J NEUROSCI, V24, P1845, DOI 10.1111/j.1460-9568.2006.05061.x; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Kalita J, 2013, NUTR NEUROSCI, V16, P39, DOI 10.1179/1476830512Y.0000000028; Kamat PK, 2015, J CELL PHYSIOL, V230, P378, DOI 10.1002/jcp.24722; KNOWLES JF, 1976, J ANAT, V121, P461; Kumar S., 2021, FRONT PSYCHOL, V12, DOI DOI 10.3389/fpsyg.2021.577529; Lachner C, 2012, J NEUROPSYCH CLIN N, V24, P5, DOI 10.1176/appi.neuropsych.11020052; Lai SC, 2013, FASEB J, V27, P2468, DOI 10.1096/fj.12-219055; Lai SC, 2011, EXP CELL RES, V317, P1603, DOI 10.1016/j.yexcr.2011.02.016; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Liu Hui, 2013, Shengli Xuebao, V65, P61; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; Malek N, 2015, SCOT MED J, V60, P44, DOI 10.1177/0036933014561948; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Pawlak R, 2013, NUTR REV, V71, P110, DOI 10.1111/nure.12001; Per A., 2009, HIPPOCAMPUS BOOK; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Ramulu Surekha, 2013, J Oral Maxillofac Pathol, V17, P23, DOI 10.4103/0973-029X.110698; Reynolds E H, 2014, Handb Clin Neurol, V120, P927, DOI 10.1016/B978-0-7020-4087-0.00061-9; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Rudy JW, 2008, PSYCHOLOGY, V4032, P5032; Sachdev PS, 2005, PROG NEURO-PSYCHOPH, V29, P1152, DOI 10.1016/j.pnpbp.2005.06.026; Sachdev PS, 2002, NEUROLOGY, V58, P1539, DOI 10.1212/WNL.58.10.1539; Santini E, 2015, J NEUROSCI, V35, P16213, DOI 10.1523/JNEUROSCI.2246-15.2015; Save E, 2000, HIPPOCAMPUS, V10, P64, DOI 10.1002/(SICI)1098-1063(2000)10:1<64::AID-HIPO7>3.3.CO;2-P; Scalabrino G, 1997, EXP NEUROL, V144, P258, DOI 10.1006/exnr.1996.6376; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Skaggs WE, 1998, J NEUROSCI, V18, P8455; Smith BT, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-30; Stuchlik A, 2009, BEHAV BRAIN RES, V200, P144, DOI 10.1016/j.bbr.2009.01.010; TAYLOR RT, 1967, J BIOL CHEM, V242, P1509; TREIT D, 1986, PHARMACOL BIOCHEM BE, V25, P561, DOI 10.1016/0091-3057(86)90141-3; TREIT D, 1987, BRAIN RES BULL, V19, P401, DOI 10.1016/0361-9230(87)90143-2; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yang M, 2004, PHYSIOL BEHAV, V81, P465, DOI 10.1016/j.physbeh.2004.02.010; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zinyuk L, 2000, P NATL ACAD SCI USA, V97, P3771, DOI 10.1073/pnas.050576397; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	75	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177156	10.1371/journal.pone.0177156	http://dx.doi.org/10.1371/journal.pone.0177156			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545069	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400023
J	Bianchi, E; Boekelheide, K; Sigman, M; Hall, SJ; Hwang, K				Bianchi, Enrica; Boekelheide, Kim; Sigman, Mark; Hall, Susan J.; Hwang, Kathleen			Ghrelin modulates testicular damage in a cryptorchid mouse model	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; HORMONE SECRETAGOGUE RECEPTOR; HUMAN TESTIS; HEAT-STRESS; EXPRESSION; TEMPERATURE; SPERMATOGENESIS; SPERMATOCYTES; HYPERTHERMIA; GONADOTROPIN	Cryptorchidism or undescended testis (UDT) is a common congenital abnormality associated with increased risk for developing male infertility and testicular cancer. This study elucidated the effects of endogenous ghrelin or growth hormone secretagogue receptor (GHSR) deletion on mouse reproductive performance and evaluated the ability of ghrelin to prevent testicular damage in a surgical cryptorchid mouse model. Reciprocal matings with heterozygous/homozygous ghrelin and GHSR knockout mice were performed. Litter size and germ cell apoptosis were recorded and testicular histological evaluations were performed. Wild type and GHSR knockout adult mice were subjected to creation of unilateral surgical cryptorchidism that is a model of heat-induced germ cell death. All mice were randomly separated into two groups: treatment with ghrelin or with saline. To assess testicular damage, the following endpoints were evaluated: testis weight, seminiferous tubule diameter, percentage of seminiferous tubules with spermatids and with multinucleated giant cells. Our findings indicated that endogenous ghrelin deletion altered male fertility. Moreover, ghrelin treatment ameliorated the testicular weight changes caused by surgically induced cryptorchidism. Testicular histopathology revealed a significant preservation of spermatogenesis and seminiferous tubule diameter in the ghrelin-treated cryptorchid testes of GHSR KO mice, suggesting that this protective effect of ghrelin was mediated by an unknown mechanism. In conclusion, ghrelin therapy could be useful to suppress testicular damage induced by hyperthermia, and future investigations will focus on the underlying mechanisms by which ghrelin mitigates testicular damage.	[Bianchi, Enrica; Sigman, Mark; Hwang, Kathleen] Rhode Isl Hosp, Div Urol, Providence, RI 02903 USA; [Bianchi, Enrica; Boekelheide, Kim; Sigman, Mark; Hall, Susan J.; Hwang, Kathleen] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Hwang, K (corresponding author), Rhode Isl Hosp, Div Urol, Providence, RI 02903 USA.; Hwang, K (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Kathleen_Hwang@brown.edu	Sigman, Mark/P-3343-2019; Hwang, Kathleen/ABE-1339-2021	Bianchi, Enrica/0000-0002-8135-9730	Lifespan Hospital Research Fund; Krishnamurthi Endowment Fund	Lifespan Hospital Research Fund; Krishnamurthi Endowment Fund	This work was supported by Lifespan Hospital Research Fund and Krishnamurthi Endowment Fund.	Agoulnik AI, 2012, METHODS MOL BIOL, V825, P127, DOI 10.1007/978-1-61779-436-0_11; ALLAN DJ, 1992, CELL PROLIFERAT, V25, P241, DOI 10.1111/j.1365-2184.1992.tb01399.x; Arakawa Y, 2004, BIOMED RES-TOKYO, V25, P245, DOI 10.2220/biomedres.25.245; Barqawi A, 2004, ASIAN J ANDROL, V6, P47; Barreiro ML, 2004, MOL CELL ENDOCRINOL, V226, P1, DOI 10.1016/j.mce.2004.07.015; Barreiro ML, 2003, BIOL REPROD, V68, P1631, DOI 10.1095/biolreprod.102.008862; Barreiro ML, 2002, BIOL REPROD, V67, P1768, DOI 10.1095/biolreprod.102.006965; BARTKE A, 1995, ENDOCRINOLOGY, V136, P3, DOI 10.1210/en.136.1.3; BEAVER JP, 1995, EUR J CELL BIOL, V68, P47; Bianchi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153968; Bianchi E, 2016, J SURG RES, V201, P226, DOI 10.1016/j.jss.2015.10.044; BILLIG H, 1995, ENDOCRINOLOGY, V136, P5, DOI 10.1210/en.136.1.5; Blanchard KT, 1996, TOXICOL APPL PHARM, V137, P141, DOI 10.1006/taap.1996.0066; Cataldo L, 1997, EXP CELL RES, V231, P206, DOI 10.1006/excr.1996.3447; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; De Ambrogi Marco, 2003, Med Sci Monit, V9, pRA217; Dong MH, 2006, CURR OPIN GASTROEN, V22, P599, DOI 10.1097/01.mog.0000245540.87784.75; Dundar M, 2005, PATHOL ONCOL RES, V11, P170; Feng HL, 1999, FERTIL STERIL, V71, P85, DOI 10.1016/S0015-0282(98)00401-4; Ferguson Lydia, 2013, Front Endocrinol (Lausanne), V4, P32, DOI 10.3389/fendo.2013.00032; Gaytan F, 2004, J CLIN ENDOCR METAB, V89, P400, DOI 10.1210/jc.2003-031375; Granado M, 2009, MOL CELL ENDOCRINOL, V309, P67, DOI 10.1016/j.mce.2009.06.006; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Green M. C., 1991, HDB GENETICALLY STAN; Heiskanen P, 1996, PEDIATR RES, V40, P351, DOI 10.1203/00006450-199608000-00026; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; Hikim APS, 2003, ENDOCRINOLOGY, V144, P3167, DOI 10.1210/en.2003-0175; Huang CX, 2009, PEPTIDES, V30, P2286, DOI 10.1016/j.peptides.2009.09.004; Ikeda M, 1999, BIOL REPROD, V61, P393, DOI 10.1095/biolreprod61.2.393; Ilhan T, 2013, BIOTECH HISTOCHEM, V88, P10, DOI 10.3109/10520295.2012.724083; Ishikawa T, 2005, J ANDROL, V26, P281; Kheradmand A, 2009, ANDROLOGIA, V41, P335, DOI 10.1111/j.1439-0272.2009.00932.x; Kheradmand A, 2014, J PEDIATR SURG, V49, P593, DOI 10.1016/j.jpedsurg.2013.10.003; Kheradmand A, 2012, TISSUE CELL, V44, P308, DOI 10.1016/j.tice.2012.04.009; Kim MS, 2004, MOL ENDOCRINOL, V18, P2291, DOI 10.1210/me.2003-0459; Klonisch T, 2004, DEV BIOL, V270, P1, DOI 10.1016/j.ydbio.2004.02.018; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3; KORMANO M, 1967, J REPROD FERTIL, V14, P427; Kumar V, 2011, J ANDROL, V33, P114, DOI 10.2164/jandrol.110.011320; Li Y, 2009, J ANDROL, V30, P325, DOI 10.2164/jandrol.108.005934; Lin WW, 1997, FERTIL STERIL, V68, P1065, DOI 10.1016/S0015-0282(97)00372-5; Liu F, 2012, TISSUE CELL, V44, P281, DOI 10.1016/j.tice.2012.04.005; Liu KY, 2011, CELL PHYSIOL BIOCHEM, V27, P613, DOI 10.1159/000329983; Liu K, 2009, REGUL PEPTIDES, V155, P62, DOI 10.1016/j.regpep.2009.03.003; Lue YH, 2002, J ANDROL, V23, P799; Matsuki S, 2003, BIOCHEM BIOPH RES CO, V312, P843, DOI 10.1016/j.bbrc.2003.10.191; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; Miller DW, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-60; Morgentaler A, 1999, J ANDROL, V20, P189; Nagaya N, 2003, REGUL PEPTIDES, V114, P71, DOI 10.1016/S0167-0115(03)00117-4; NAKAMURA M, 1987, ARCH ANDROLOGY, V19, P127, DOI 10.3109/01485018708986808; NISHIMUNE Y, 1978, FERTIL STERIL, V29, P95; Perez-Crespo M, 2008, MOL REPROD DEV, V75, P40, DOI 10.1002/mrd.20759; Rasoulpour RJ, 2003, AM J PATHOL, V163, P2595, DOI 10.1016/S0002-9440(10)63614-0; Richburg JH, 1996, TOXICOL APPL PHARM, V137, P42, DOI 10.1006/taap.1996.0055; SHIKONE T, 1994, BIOL REPROD, V51, P865, DOI 10.1095/biolreprod51.5.865; Sirotkin AV, 2008, DOMEST ANIM ENDOCRIN, V34, P125, DOI 10.1016/j.domaniend.2006.11.005; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Taati M, 2012, J PHYSIOL BIOCHEM, V68, P91, DOI 10.1007/s13105-011-0122-2; Tena-Sempere M, 2005, J Endocrinol Invest, V28, P26; Tena-Sempere M, 2002, ENDOCRINOLOGY, V143, P717, DOI 10.1210/en.143.2.717; van Brakel J, 2015, ANDROLOGY-US, V3, P888, DOI 10.1111/andr.12070; Wang W, 2010, REGUL PEPTIDES, V161, P43, DOI 10.1016/j.regpep.2009.12.017; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; Yao P, 2007, FOOD CHEM TOXICOL, V45, P1333, DOI 10.1016/j.fct.2007.01.016; Yin YZ, 1998, BIOL REPROD, V58, P492, DOI 10.1095/biolreprod58.2.492	68	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177995	10.1371/journal.pone.0177995	http://dx.doi.org/10.1371/journal.pone.0177995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542403	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672400128
J	Galiana, A; Coy, J; Gimeno, A; Guzman, NM; Rosales, F; Merino, E; Royo, G; Rodriguez, JC				Galiana, Antonio; Coy, Javier; Gimeno, Adelina; Marco Guzman, Noemi; Rosales, Francisco; Merino, Esperanza; Royo, Gloria; Carlos Rodriguez, Juan			Evaluation of the Sepsis Flow Chip assay for the diagnosis of blood infections	PLOS ONE			English	Article								Background Blood infections are serious complex conditions that generally require rapid diagnosis and treatment. The big challenge is to reduce the time necessary to make a diagnosis with current clinical microbiological methods so as to improve the treatment given to patients. Methods In this study, we assess for the first time the Sepsis Flow Chip assay, which is a novel diagnostic assay for simultaneous rapid-detection of the vast majority of bloodstream pathogens, including Gram-positive and Gram-negative bacteria and fungi, in the same assay, and for the detection of most common antibiotic resistance genes. The SFC assay is based on multiplex PCR and low density DNA arrays. Results Positive blood cultures from 202 consecutive bacteremia patients were analyzed by SFC assay and the results were compared with the results obtained by the gold standard methodology used in clinical microbiology diagnostic laboratories (EUCAST guidelines). SFC assay overall sensitivity and specificity for bacterial identification were 93.3% and 100% respectively and sensitivity and specificity for the identification of antibiotic genetic resistance determinants were 93.6% and 100% respectively. Conclusions This is the first evaluation of SFC assay in clinical samples. This new method appears to be very promising by combining the high number of distinct pathogens and genetic resistance determinants identified in a single assay. Further investigations should be done to evaluate the usefulness of this assay in combination with clinical multidisciplinary groups (stewardship), in order for the results to be applied appropriately to the management of patients 'infectious processes.	[Galiana, Antonio; Royo, Gloria] Hosp Gen Univ Elche, Fdn Fomento Invest Sanitaria & Biomed Comunidad V, Dept Microbiol, Elche, Spain; [Coy, Javier; Gimeno, Adelina; Marco Guzman, Noemi; Rosales, Francisco; Carlos Rodriguez, Juan] Hosp Gen Univ Alicante, Dept Microbiol, Inst Invest Sanitaria & Biomed Alicante ISABIAL F, Alicante, Spain; [Merino, Esperanza] Hosp Gen Univ Alicante, Dept Infect Dis, Inst Invest Sanitaria & Biomed Alicante ISABIAL F, Alicante, Spain	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL)	Rodriguez, JC (corresponding author), Hosp Gen Univ Alicante, Dept Microbiol, Inst Invest Sanitaria & Biomed Alicante ISABIAL F, Alicante, Spain.	rodriguez_juadia@gva.es	Merino de Lucas, Esperanza/AFQ-1126-2022; Merino, Esperanza/AAV-3244-2021; Guzman, Noemi M/AAA-5348-2019; Gimeno Gascón, Adelina/AAS-5928-2020	Merino de Lucas, Esperanza/0000-0003-3854-4874; Gimeno Gascón, Adelina/0000-0003-3728-3182; Galiana, Antonio/0000-0002-1134-1914; Guzman, Noemi M/0000-0002-3789-2095; RODRIGUEZ DIAZ, JUAN CARLOS/0000-0001-8007-5739	Hospital General Universitario de Alicante [UGP-14-270]; Fundacion Soria Melguizo; FISABIO [UGP-14-216]	Hospital General Universitario de Alicante; Fundacion Soria Melguizo; FISABIO	This work was supported by Hospital General Universitario de Alicante (UGP-14-270) http://alicante.san.gva.es/; Fundacion Soria Melguizo (no number) http://www.f-soria.es/; and FISABIO (UGP-14-216) httplifisabio.san.gva.es/.	Aitken SL, 2015, DIAGN MICROBIOL INFE, V81; Altun O, 2013, J CLIN MICROBIOL, V51, P4130, DOI 10.1128/JCM.01835-13; Avdic E, 2014, INFECT DIS CLIN N AM; Bartlett JG, 2013, CLIN INFECT DIS; Bloos F, 2014, VIRULENCE, V5, P154, DOI 10.4161/viru.27393; Bork JT, 2015, ANTIMICROB AGENTS CH, V59, P1593, DOI 10.1128/AAC.04259-14; Canton R, 2013, ENFERM INFECC MICROB, V31; Chalupka AN, 2012, CRITICAL CARE CLIN; Findlay J, 2014, J ANTIMICROB CHEMOTH, V70; Garcia- Fernandez S, 2014, J ANTIMICROB CHEMOTH, V70; Goff DA, 2012, PHARMACOTHERAPY; Gould IM, 2007, INT J ANTIMICROB AGE, V30; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Hall M, 2011, 62 NCHS; Hill JT, 2014, J CLIN MICROBIOL, V52, P3805, DOI 10.1128/JCM.01537-14; Hrabak J, 2014, CLIN MICROBIOL INFEC, V20, P839, DOI 10.1111/1469-0691.12678; Huang AM, 2013, CLIN INFECT DIS, V57, P1237, DOI 10.1093/cid/cit498; Kaki R, 2011, J ANTIMICROBIAL CHEM; Kim DK, 2016, ANN LAB MED, V36, P162, DOI 10.3343/alm.2016.36.2.162; Kollet MH, 2008, CLIN INFECT DIS, V47; Kuehn BM, 2013, JAMA, V310; Leclercq R, 2013, CLIN MICROBIOLOGY IN; Mammina C, 2013, SCAND J INFECT DIS, V45, P629, DOI 10.3109/00365548.2013.782614; Martinez- Martinez L, 2015, CARBAPENEMASES ENTER, V30; Miriagou V, 2010, CLIN MICROBIOLOGY IN; Mwaigwisya S, 2015, EXPERT REV MOL DIAGN, V15, P681, DOI 10.1586/14737159.2015.1029459; Nordmann P, 2012, CLIN MICROBIOLOGY IN; Nordmann P, 2012, TRENDS MOL MED; Orsini J, 2012, J CLIN MED RES, V4; Perez KK, 2014, J INFECT, V69; Raman G, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1123-5; Rodel J, 2015, DIAGN MICROBIOL INFE, V84; Roschanski N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100956; Salimnia H, 2016, J CLIN MICROBIOL, V54, P687, DOI 10.1128/JCM.01679-15; Scheetz MH, 2009, J ANTIMICROB CHEMOTH, V63, P816, DOI 10.1093/jac/dkp004; Schuts EC, 2016, LANCET INFECT DIS; Sothoron C, 2015, J CLIN MICROBIOL, V53, P3627, DOI 10.1128/JCM.02161-15; Srinivasan R, 2015, PLOS ONE, V10; Swayne R, 2013, INT J ANTIMICROB AG, V42, P352, DOI 10.1016/j.ijantimicag.2013.06.018; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Vardakas KZ, 2015, EUR J CLIN MICROBIOL, V34, P2149, DOI 10.1007/s10096-015-2466-y; Wojewoda CM, 2013, J CLIN MICROBIOL, V51, P2072, DOI 10.1128/JCM.00831-13; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004	43	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177627	10.1371/journal.pone.0177627	http://dx.doi.org/10.1371/journal.pone.0177627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542614	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400060
J	Osigus, HJ; Eitel, M; Schierwater, B				Osigus, Hans-Juergen; Eitel, Michael; Schierwater, Bernd			Deep RNA sequencing reveals the smallest known mitochondrial micro exon in animals: The placozoan cox1 single base pair exon	PLOS ONE			English	Article							GENOME; EVOLUTION; DNA; ORGANIZATION; INTRONS; MTDNA	The phylum Placozoa holds a key position for our understanding of the evolution of mitochondrial genomes in Metazoa. Placozoans possess large mitochondrial genomes which harbor several remarkable characteristics such as a fragmented cox1 gene and trans-splicing cox1 introns. A previous study also suggested the existence of cox1 mRNA editing in Trichoplax adhaerens, yet the only formally described species in the phylum Placozoa. We have analyzed RNA-seq data of the undescribed sister species, Placozoa sp. H2 ("Panama" clone), with special focus on the mitochondrial mRNA. While we did not find support for a previously postulated cox1 mRNA editing mechanism, we surprisingly found two independent transcripts representing intermediate cox1 mRNA splicing stages. Both transcripts consist of partial cox1 exon as well as overlapping intron fragments. The data suggest that the cox1 gene harbors a single base pair (cytosine) micro exon. Furthermore, conserved group I intron structures flank this unique micro exon also in other placozoans. We discuss the evolutionary origin of this micro exon in the context of a self-splicing intron gain in the cox1 gene of the last common ancestor of extant placozoans.	[Osigus, Hans-Juergen; Eitel, Michael; Schierwater, Bernd] Univ Vet Med Hannover, Ecol & Evolut, ITZ, Hannover, Germany; [Schierwater, Bernd] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Schierwater, Bernd] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Schierwater, Bernd] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Eitel, Michael] Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, Paleontol & Geobiol, Munich, Germany	University of Veterinary Medicine Hannover, Foundation; Yale University; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); University of Munich	Osigus, HJ (corresponding author), Univ Vet Med Hannover, Ecol & Evolut, ITZ, Hannover, Germany.	h.j.osigus@ecolevol.de			Studienstiftung des deutschen Volkes; Deutsche Forschungsgemeinschaft [Schi 277/26-1, 29-1]	Studienstiftung des deutschen Volkes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	HJO acknowledges a doctoral fellowship of the Studienstiftung des deutschen Volkes. This project has been funded by the Deutsche Forschungsgemeinschaft (Schi 277/26-1 & 29-1), http/www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HJO acknowledges a doctoral fellowship of the Studienstiftung des deutschen Volkes. We would like to thank C. Heffelfinger, M. Moreno and S. L. Dellaporta for help and support.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P328, DOI 10.1016/j.ympev.2012.10.020; Breton S, 2014, TRENDS GENET, V30, P555, DOI 10.1016/j.tig.2014.09.002; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; Burger G, 2009, TRENDS GENET, V25, P381, DOI 10.1016/j.tig.2009.07.003; Collins AG, 2005, INTEGR COMP BIOL, V45, P585, DOI 10.1093/icb/45.4.585; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; DeSalle R, 2017, FRONT BIOSCI-LANDMRK, V22, P873, DOI 10.2741/4522; Eitel M, 2010, MOL ECOL, V19, P2315, DOI 10.1111/j.1365-294X.2010.04617.x; Eitel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057131; Feindt W, 2016, MITOCHONDRIAL DNA B, V1, P574, DOI 10.1080/23802359.2016.1192510; Feindt W, 2016, MITOCHONDRIAL DNA B, V1, P497, DOI 10.1080/23802359.2016.1192504; Guo L, 2015, SCI REP-UK, V5, DOI 10.1038/srep18087; Herzog R, 2016, MITOCHONDRIAL DNA B, V1, P783, DOI 10.1080/23802359.2016.1186523; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Lavrov DV, 2016, GENOME BIOL EVOL, V8, P2896, DOI 10.1093/gbe/evw195; Lavrov DV, 2013, MOL BIOL EVOL, V30, P865, DOI 10.1093/molbev/mss274; Li YI, 2015, GENOME RES, V25, P1, DOI 10.1101/gr.181990.114; Miyazawa H, 2012, ZOOL SCI, V29, P223, DOI 10.2108/zsj.29.223; Osigus HJ, 2013, MOL PHYLOGENET EVOL, V69, P339, DOI 10.1016/j.ympev.2013.07.016; Osigus HJ, 2013, MOL PHYLOGENET EVOL, V66, P551, DOI 10.1016/j.ympev.2012.05.028; Pett W, 2011, MITOCHONDR DNA, V22, P130, DOI 10.3109/19401736.2011.624611; SCHIERWATER B, 1991, J EXP ZOOL, V260, P413, DOI 10.1002/jez.1402600316; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; Schierwater B, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00005; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Schuster A, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0928-9; Shao RF, 2012, GENOME BIOL EVOL, V4, P1088, DOI 10.1093/gbe/evs088; Signorovitch AY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030013; Xavier BB, 2012, FUNGAL BIOL-UK, V116, P802, DOI 10.1016/j.funbio.2012.04.013	35	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177959	10.1371/journal.pone.0177959	http://dx.doi.org/10.1371/journal.pone.0177959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542197	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400121
J	Piatek, MJ; Henderson, V; Fearn, A; Chaudhry, B; Werner, A				Piatek, Monica J.; Henderson, Victoria; Fearn, Amy; Chaudhry, Bill; Werner, Andreas			Ectopically expressed Slc34a2a sense-antisense transcripts cause a cerebellar phenotype in zebrafish embryos depending on RNA complementarity and Dicer	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; SODIUM-PHOSPHATE COTRANSPORTER; GENE-EXPRESSION; NONCODING RNAS; INJECTION; IDENTIFICATION; INTERFERENCE; SUPPRESSOR; DEFECTS; PROTEIN	Natural antisense transcripts (NATs) are complementary to protein coding genes and potentially regulate their expression. Despite widespread occurrence of NATs in the genomes of higher eukaryotes, their biological role and mechanism of action is poorly understood. Zebrafish embryos offer a unique model system to study sense-antisense transcript interplay at whole organism level. Here, we investigate putative antisense transcript-mediated mechanisms by ectopically co-expressing the complementary transcripts during early zebrafish development. In zebrafish the gene Slc34a2a (Na-phosphate transporter) is bi-directionally transcribed, the NAT predominantly during early development up to 48 hours after fertilization. Declining levels of the NAT, Slc34a2a(as), coincide with an increase of the sense transcript. At that time, sense and antisense transcripts co-localize in the endoderm at near equal amounts. Ectopic expression of the sense transcript during embryogenesis leads to specific failure to develop a cerebellum. The defect is RNA-mediated and dependent on sense-antisense complementarity. Overexpression of a Slc34a2a paralogue (Slc34a2b) or the NAT itself had no phenotypic consequences. Knockdown of Dicer rescued the brain defect suggesting that RNA interference is required to mediate the phenotype. Our results corroborate previous reports of Slc34a2a-related endo-siRNAs in two days old zebrafish embryos and emphasize the importance of coordinated expression of sense-antisense transcripts. Our findings suggest that RNAi is involved in gene regulation by certain natural antisense RNAs.	[Piatek, Monica J.; Henderson, Victoria; Fearn, Amy; Werner, Andreas] Newcastle Univ, Inst Cell & Mol Biosci, RNA Interest Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Chaudhry, Bill] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Werner, A (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, RNA Interest Grp, Newcastle Upon Tyne, Tyne & Wear, England.	andreas.werner@ncl.ac.uk			British Heart Foundation [PG/15/58/31611] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Andrews OE, 2014, SCI REP-UK, V4, DOI 10.1038/srep05222; [Anonymous], 2005, HIGH THROUGHPUT EXPR; Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y; Brand M, 1995, THE ZEBRAFISH SCIENC, V3, P2; Carlile M, 2008, PHYSIOL GENOMICS, V34, P95, DOI 10.1152/physiolgenomics.00004.2008; Carlile M, 2009, NUCLEIC ACIDS RES, V37, P2274, DOI 10.1093/nar/gkp088; Casadei R, 2011, GENE EXPR PATTERNS, V11, P271, DOI 10.1016/j.gep.2011.01.003; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; D'Aniello E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003689; Danesin C, 2009, DEV CELL, V16, P576, DOI 10.1016/j.devcel.2009.03.007; Echeverri K, 2007, DEV BIOL, V301, P388, DOI 10.1016/j.ydbio.2006.10.003; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Faghihi MA, 2009, NAT REV MOL CELL BIO, P10; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r38; FJOSE A, 1992, MECH DEVELOP, V39, P51, DOI 10.1016/0925-4773(92)90025-F; Graham C, 2003, AM J PHYSIOL-RENAL, V284, pF727, DOI 10.1152/ajprenal.00356.2002; Gullerova M, 2012, NAT STRUCT MOL BIOL, V19, P1193, DOI 10.1038/nsmb.2392; Holder N, 1999, METH MOL B, V97, P487, DOI 10.1385/1-59259-270-8:487; Jin JM, 2014, METHODS MOL BIOL, V1173, P99, DOI 10.1007/978-1-4939-0931-5_9; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kelly A, 2011, BRIEF FUNCT GENOMICS, V10, P189, DOI 10.1093/bfgp/elr014; Khorkova O, 2014, HUM MOL GENET, V23, pR54, DOI 10.1093/hmg/ddu207; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Lepoivre C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-914; Li YX, 2000, DEV BIOL, V217, P394, DOI 10.1006/dbio.1999.9540; Ling KH, 2016, GENOMICS, V107, P88, DOI 10.1016/j.ygeno.2016.01.006; Lopez P, 2016, MOL CELL BIOL, V36, P1480, DOI 10.1128/MCB.01096-15; Molder T, 2016, BIOTECHNIQUES, V61, P61, DOI 10.2144/000114441; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Nalbant P, 1999, J PHYSIOL-LONDON, V520, P79, DOI 10.1111/j.1469-7793.1999.00079.x; Nusslein-Volhard Christiane, 2002, GREAT CLARENDON STRE; Oates AC, 2000, DEV BIOL, V224, P20, DOI 10.1006/dbio.2000.9761; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Piatek MJ, 2016, GENOMICS; Portal MM, 2015, NAT STRUCT MOL BIOL, V22, P89, DOI 10.1038/nsmb.2934; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Tufarelli C, 2001, GENOMICS, V71, P307, DOI 10.1006/geno.2000.6394; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Wagner CA, 2014, PFLUG ARCH EUR J PHY, V466, P139, DOI 10.1007/s00424-013-1418-6; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Weinberg MS, 2016, NUCLEIC ACIDS RES, V44, P6505, DOI 10.1093/nar/gkw139; Werner A, 2001, AM J PHYSIOL-REG I, V280, pR301, DOI 10.1152/ajpregu.2001.280.2.R301; Werner A, 2007, PHYSIOL GENOMICS, V28, P294, DOI 10.1152/physiolgenomics.00127.2006; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; Westerfield M, 1993, ZEBRAFISH BOOK; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Yamanaka Y, 2015, CELL REP, V11, P967, DOI 10.1016/j.celrep.2015.04.011; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhao XF, 2008, FEBS J, V275, P2177, DOI 10.1111/j.1742-4658.2008.06371.x; Zhao ZX, 2001, DEV BIOL, V229, P215, DOI 10.1006/dbio.2000.9982; Zimmermann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107023; Zucchelli S, 2015, RNA BIOL, V12, P771, DOI 10.1080/15476286.2015.1060395	58	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178219	10.1371/journal.pone.0178219	http://dx.doi.org/10.1371/journal.pone.0178219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542524	Green Submitted, gold, Green Published			2022-12-27	WOS:000401672400145
J	Ullah, R; Khan, S; Ali, H; Bilal, M; Saleem, M				Ullah, Rahat; Khan, Saranjam; Ali, Hina; Bilal, Muhammad; Saleem, Muhammad			Identification of cow and buffalo milk based on Beta carotene and vitamin-A concentration using fluorescence spectroscopy	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; GEOGRAPHIC ORIGIN; CHEESE; INFECTION; TOOL; FAT	The current study presents the application of fluorescence spectroscopy for the identification of cow and buffalo milk based on beta-carotene and vitamin-A which is of prime importance from the nutritional point of view. All samples were collected from healthy animals of different breeds at the time of lactation in the vicinity of Islamabad, Pakistan. Cow and buffalo milk shows differences at fluorescence emission appeared at band position 382 nm, 440 nm, 505 nm and 525 nm both in classical geometry (right angle) setup as well as front face fluorescence setup. In front face fluorescence geometry, synchronous fluorescence emission shows clear differences at 410 nm and 440 nm between the milk samples of both these species. These fluorescence emissions correspond to fats, vitamin-A and beta-carotene. Principal Component Analysis (PCA) further highlighted these differences by showing clear separation between the two data sets on the basis of features obtained from their fluorescence emission spectra. These results indicate that classical geometry (fixed excitation wavelength) as well as front face (synchronous fluorescence emission) of cow and buffalo milk nutrients could be used as fingerprint from identification point of view. This same approach can effectively be used for the determination of adulterants in the milk and other dairy products.	[Ullah, Rahat; Khan, Saranjam; Ali, Hina; Bilal, Muhammad; Saleem, Muhammad] Natl Inst Lasers & Optron NILOP, Agri & Biophoton Div, Islamabad, Pakistan		Ullah, R; Khan, S (corresponding author), Natl Inst Lasers & Optron NILOP, Agri & Biophoton Div, Islamabad, Pakistan.	rahat_khalil@yahoo.com; k.saranjam@yahoo.com	Khan, Bilal/AAC-4207-2020; Ali, Hina/AAS-4353-2021; Bilal, Muhammad/A-5001-2017; Ullah, Rahat/AAX-6428-2021	Bilal, Muhammad/0000-0001-5937-7310; Ullah, Rahat/0000-0002-9836-6056				Abdi H., 2010, PRINCIPAL COMPONENT, V2; Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Arnhold T, 2002, J NUTR, V132, P197, DOI 10.1093/jn/132.2.197; Birlouez-Aragon I, 1998, INT DAIRY J, V8, P771, DOI 10.1016/S0958-6946(98)00119-8; Boubellouta T, 2008, APPL SPECTROSC, V62, P490, DOI 10.1366/000370208784344406; Christensen J, 2003, J DAIRY SCI, V86, P1101, DOI 10.3168/jds.S0022-0302(03)73692-3; Dufour E, 1997, LAIT, V77, P657, DOI 10.1051/lait:1997647; Dufour E, 2001, INT DAIRY J, V11, P465, DOI 10.1016/S0958-6946(01)00086-3; Dufour E, 2000, INT DAIRY J, V10, P81, DOI 10.1016/S0958-6946(00)00025-X; Fragaki G, 2005, J AGR FOOD CHEM, V53, P2810, DOI 10.1021/jf040279t; Hammami M, 2010, FOOD CHEM, V122, P1344, DOI 10.1016/j.foodchem.2010.03.107; Jamshidkhan C, 2005, THERMOCHIM ACTA, V432, P106; Jamshidkhan C., 2006, JOURNAL OF COLLOID A, V299, P636; Karoui R, 2007, FOOD CHEM, V104, P409, DOI 10.1016/j.foodchem.2006.09.020; Karoui R, 2006, LAIT, V86, P155, DOI 10.1051/lait:2005047; Karoui R, 2005, LAIT, V85, P223, DOI 10.1051/lait:2005008; Karoui R, 2004, LAIT, V84, P359, DOI 10.1051/lait:2004010; Karoui R, 2003, LAIT, V83, P251, DOI 10.1051/lait:2003014; Khan S, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.095005; Khan S, 2016, BIOMED OPT EXPRESS, V7, P2249, DOI 10.1364/BOE.7.002249; Khan S, 2016, OPTIK, V127, P2086, DOI 10.1016/j.ijleo.2015.11.060; Kulmyrzaev A, 2002, LAIT, V82, P725, DOI 10.1051/lait:2002045; LiChan ECY, 1996, TRENDS FOOD SCI TECH, V7, P361, DOI 10.1016/S0924-2244(96)10037-6; Lindmark-Mansson H, 2003, INT DAIRY J, V13, P409, DOI 10.1016/S0958-6946(03)00032-3; Marouzi S, 2017, INT J BIOL MACROMOL, V97, P688, DOI 10.1016/j.ijbiomac.2017.01.047; Miller GD, 2007, HANDBOOK OF DAIRY FO; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Omidvar Z, 2011, J BIOMOL STRUCT DYN, V29, P181, DOI 10.1080/07391102.2011.10507382; Parodi PW, 2004, AUST J DAIRY TECHNOL, V59, P3; Rodriguez MAP, 2014, FOOD CHEM, V156, P170, DOI 10.1016/j.foodchem.2014.01.092; Raynal-Ljutovac K, 2008, SMALL RUMINANT RES, V79, P57, DOI 10.1016/j.smallrumres.2008.07.009; Sharif-Barfeh Z, 2017, J SOLUTION CHEM, V46, P488, DOI 10.1007/s10953-017-0590-2; Skjervold PO, 2003, J FOOD SCI, V68, P1161, DOI 10.1111/j.1365-2621.2003.tb09618.x; Tome D, 2009, AM J CLIN NUTR, V90, p838S, DOI 10.3945/ajcn.2009.27462W; Ullah R, 2016, JOURNAL OF RAMAN SPE, V48, P363; Ullah R, 2016, JOURNAL OF RAMAN SPE; Ullah R, 2016, OPTIK, V127, P5186, DOI 10.1016/j.ijleo.2016.03.049; Wold JP, 2002, J DAIRY SCI, V85, P1693, DOI 10.3168/jds.S0022-0302(02)74242-2	38	26	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178055	10.1371/journal.pone.0178055	http://dx.doi.org/10.1371/journal.pone.0178055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542353	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400136
J	Liu, XX; Shen, BM; Du, P; Wang, N; Wang, JX; Li, JR; Sun, AH				Liu, Xiaoxiang; Shen, Bimiao; Du, Peng; Wang, Nan; Wang, Jiaxue; Li, Jianrong; Sun, Aihua			Transcriptomic analysis of the response of Pseudomonas fluorescens to epigallocatechin gallate by RNA-seq	PLOS ONE			English	Article							TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; ANTIGEN CHAIN-LENGTH; HYDROGEN-PEROXIDE; STRESS-RESPONSE; BIOFILM FORMATION; SIGMA FACTORS; UP-REGULATION; SOS RESPONSE; EFFLUX PUMPS; GENE	Epigallocatechin gallate (EGCG) is a main constituent of green tea polyphenols that are widely used as food preservatives and are considered to be safe for consumption. However, the underlying antimicrobial mechanism of EGCG and the bacterial response to EGCG are not clearly understood. In the present study, a genome-wide transcriptional analysis of a typical spoilage bacterium, Pseudomonas fluorescens that responded to EGCG was performed using RNA-seq technology. A total of 26,365,414 and 23,287,092 clean reads were generated from P. fluorescens treated with or without 1 mM EGCG and the clean reads were aligned to the reference genome. Differential expression analysis revealed 291 upregulated genes and 134 downregulated genes and the differentially expressed genes (DEGs) were verified using RT-qPCR. Most of the DGEs involved in iron uptake, antioxidation, DNA repair, efflux system, cell envelope and cell-surface component synthesis were significantly upregulated by EGCG treatment, while most genes associated with energy production were downregulated. These transcriptomic changes are likely to be adaptive responses of P. fluorescens to iron limitation and oxidative stress, as well as DNA and envelope damage caused by EGCG. The expression of specific genes encoding the extra-cytoplasmic function sigma factor (PvdS, RpoE and AlgU) and the two-component sensor histidine kinase (BaeS and RpfG) were markedly changed by EGCG treatment, which may play important roles in regulating the stress responses of P. fluorescens to EGCG. The present data provides important insights into the molecular action of EGCG and the possible cross-resistance mediated by EGCG on P. fluorescens, which may ultimately contribute to the optimal application of green tea polyphenols in food preservation.	[Liu, Xiaoxiang; Du, Peng; Sun, Aihua] Hangzhou Med Coll, Fac Basic Med, Hangzhou, Zhejiang, Peoples R China; [Shen, Bimiao; Wang, Jiaxue] Hangzhou Med Coll, Dept Lab Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Nan] Zhejiang Shuren Univ, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China; [Li, Jianrong] Bohai Univ, Food Safety Key Lab Liaoning Prov, Jinzhou, Liaoning, Peoples R China	Hangzhou Medical College; Hangzhou Medical College; Zhejiang Shuren University; Bohai University	Sun, AH (corresponding author), Hangzhou Med Coll, Fac Basic Med, Hangzhou, Zhejiang, Peoples R China.	aihuasun@126.com	Wang, Nan/GRY-3150-2022; LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022		National Natural Sciences Foundation of China [31501581, 31471639, 31401500]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This work was supported by Grants from the National Natural Sciences Foundation of China (31501581, http://www.nsfc.gov.cn) to XL, and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (http://325rc.zjwjw.gov.cn:8081/zjmedrc/html/index.htm) to XL and AS, and the National Natural Sciences Foundation of China (31471639 and 31401500, http://www.nsfc.gov.cn/) to JL and NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram V, 2013, FOOD CHEM, V139, P804, DOI 10.1016/j.foodchem.2013.01.100; Andreani NA, 2015, INT J FOOD MICROBIOL, V213, P88, DOI 10.1016/j.ijfoodmicro.2015.05.024; Arakawa H, 2004, BIOL PHARM BULL, V27, P277, DOI 10.1248/bpb.27.277; Bikels-Goshen T, 2010, INT J FOOD MICROBIOL, V138, P26, DOI 10.1016/j.ijfoodmicro.2010.01.011; Borodina T, 2011, METHOD ENZYMOL, V500, P79, DOI 10.1016/B978-0-12-385118-5.00005-0; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; Cai LY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00981; Caldera L, 2014, CURR MICROBIOL, V68, P133, DOI 10.1007/s00284-013-0430-6; Carraro L, 2014, MICROB BIOTECHNOL, V7, P265, DOI 10.1111/1751-7915.12119; Cho YS, 2007, CURR MICROBIOL, V55, P501, DOI 10.1007/s00284-007-9021-8; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Cui Y, 2012, FOOD MICROBIOL, V29, P80, DOI 10.1016/j.fm.2011.08.019; Dahlsten E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089958; Decimo M, 2014, J FOOD SCI, V79, pM2081, DOI 10.1111/1750-3841.12645; den Besten HMW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013746; Dreier J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00660; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Dueholm MS, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00898-14; Elhabiri M, 2007, INORG CHIM ACTA, V360, P353, DOI 10.1016/j.ica.2006.07.110; Tran ENH, 2014, MICROBIOL-SGM, V160, P589, DOI 10.1099/mic.0.074955-0; Fan WJ, 2008, FOOD CHEM, V108, P148, DOI 10.1016/j.foodchem.2007.10.057; Friedman M, 2007, MOL NUTR FOOD RES, V51, P116, DOI 10.1002/mnfr.200600173; Gradisar H, 2007, J MED CHEM, V50, P264, DOI 10.1021/jm060817o; Han XL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-35; He L, 2016, J FOOD SCI, V81, pM1466, DOI 10.1111/1750-3841.13312; Hesketh A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-226; Hider RC, 2001, METHOD ENZYMOL, V335, P190; Inoue A, 2008, J BACTERIOL, V190, P7298, DOI 10.1128/JB.00551-08; IRINO N, 1986, MOL GEN GENET, V205, P298, DOI 10.1007/BF00430442; Kawaji S, 2010, VET MICROBIOL, V145, P252, DOI 10.1016/j.vetmic.2010.03.025; Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011; Kumar SR, 2013, J BACTERIOL, V195, P4569, DOI 10.1128/JB.00737-13; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Levinger O, 2012, APPL ENVIRON MICROB, V78, P7954, DOI 10.1128/AEM.02253-12; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; Liang WD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/760904; Liang W, 2016, FEBS J, V283, P446, DOI 10.1111/febs.13587; Lim CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039139; Liu XX, 2013, FOLIA MICROBIOL, V58, P211, DOI 10.1007/s12223-012-0198-2; Liu XX, 2012, WORLD J MICROB BIOT, V28, P3373, DOI 10.1007/s11274-012-1149-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Nakayama M, 2015, BIOSCI BIOTECH BIOCH, V79, P845, DOI 10.1080/09168451.2014.993356; Osawa K, 2013, MICROBIOL IMMUNOL, V57, P616, DOI 10.1111/1348-0421.12084; Paget MS, 2015, BIOMOLECULES, V5, P1245, DOI 10.3390/biom5031245; Palma M, 2004, J BACTERIOL, V186, P248, DOI 10.1128/JB.186.1.248-252.2004; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Medina CAP, 2016, INT J RADIAT BIOL, V92, P321, DOI 10.3109/09553002.2016.1152412; Qin TT, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.12.09; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Serra DO, 2016, MOL MICROBIOL, V101, P136, DOI 10.1111/mmi.13379; Shen Q, 2015, ANAL BIOANAL CHEM, V407, P1475, DOI 10.1007/s00216-014-8365-8; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Thode SK, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0342-7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Vittal R, 2004, MOL CANCER THER, V3, P1091; Vuong QV, 2011, FOOD REV INT, V27, P227, DOI 10.1080/87559129.2011.563397; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang R, 2008, J FOOD ENG, V87, P505, DOI 10.1016/j.jfoodeng.2008.01.002; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Yi SM, 2010, INT J FOOD MICROBIOL, V144, P111, DOI 10.1016/j.ijfoodmicro.2010.09.005; Yi SM, 2011, J SCI FOOD AGR, V91, P1591, DOI 10.1002/jsfa.4352; Yoda Yoshiyuki, 2004, Journal of Infection and Chemotherapy, V10, P55, DOI 10.1007/s10156-003-0284-0; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]; Zhang YJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00636; Zhang YM, 2004, J BIOL CHEM, V279, P30994, DOI 10.1074/jbc.M403697200; Zhou H, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0072-4; Zhu JL, 2015, J MICROBIOL, V53, P829, DOI 10.1007/s12275-015-5123-3; Zhu QY, 1997, J AGR FOOD CHEM, V45, P4624, DOI 10.1021/jf9706080	76	20	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177938	10.1371/journal.pone.0177938	http://dx.doi.org/10.1371/journal.pone.0177938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545064	Green Published, Green Submitted, gold			2022-12-27	WOS:000401487700097
J	Choi, HM; Kim, HC; Kang, DR				Choi, Hayon Michelle; Kim, Hyeon Chang; Kang, Dae Ryong			Sex differences in hypertension prevalence and control: Analysis of the 2010-2014 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							GENDER-DIFFERENCES	Although not fully understood, sex may affect both the prevalence and control rate of hypertension. The present study was designed to investigate factors associated with hypertension prevalence and control among Korean adults. We analyzed 27,887 individuals (12,089 males and 15,798 females) aged 30 years or older who participated in the fifth (2010-2012) and sixth (2013-2014) Korea National Health and Nutrition Examination Survey. Multiple logistic regression models were applied to delineate factors associated with the prevalence and control of hypertension separately for men and women. Overall, the prevalence of hypertension was higher in men (34.6%) than in women (30.8%). However, after the age of 60 years, hypertension was more prevalent in females than in males. Regardless of sex, the older the participants were, the more likely they were to have hypertension. Factors positively associated with hypertension prevalence were old age, low education, and high BMI in women (p< 0.001) and increasing age, low income, alcohol intake, and high BMI in men (p< 0.001). The overall control rate of hypertension was higher in women (51.3%) than in men (44.8%). However, after the age of 60 years, hypertension control rates were higher in men than in women. Factors decreasing hypertension control were white-collared women and young age, alcohol consumption in men. Sex differences in hypertension prevalence and control were discovered among Korean adults. After the age of 60, females were more likely to have hypertension and less likely to maintain hypertension control than males of the same age range. Accordingly, sex-specific approaches are recommended for effective blood pressure management.	[Choi, Hayon Michelle] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kang, Dae Ryong] Yonsei Univ, Wonju Coll Med, Inst Genom Cohort, Ctr Biomed Data Sci, Wonju, South Korea	Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University	Kang, DR (corresponding author), Yonsei Univ, Wonju Coll Med, Inst Genom Cohort, Ctr Biomed Data Sci, Wonju, South Korea.	dr.kang@yonsei.ac.kr	; Kim, Hyeon Chang/F-8796-2019	Kang, Dae Ryong/0000-0002-8792-9730; Kim, Hyeon Chang/0000-0001-7867-1240; Choi, Hayon Michelle/0000-0002-0622-8554	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C0992]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C0992).	Ann D, 2013, PREVALENCE HYPERTENS; Aram V., 2003, 7 REPORT JOINT NATL; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Buttar Harpal S, 2005, Exp Clin Cardiol, V10, P229; Chu Sang Hui, 2015, J Prev Med Public Health, V48, P38, DOI 10.3961/jpmph.14.043; Daugherty SL, 2011, J HYPERTENS, V29, P1005, DOI 10.1097/HJH.0b013e3283449512; Doumas M, 2013, CURR HYPERTENS REP, V15, P321, DOI 10.1007/s11906-013-0359-y; Everett B, 2015, BIODEMOGR SOC BIOL, V61, P1, DOI 10.1080/19485565.2014.929488; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Husain K, 2014, WORLD J CARDIOL, V6, P245, DOI 10.4330/wjc.v6.i5.245; Martiniuk ALC, 2007, J HYPERTENS, V25, P73, DOI 10.1097/HJH.0b013e328010775f; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004; McAlister FA1 WK, 2011, CHANGES RATES AWAREN, V183, P1007; Neupane D, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000074; Nilsson PM1 CJ, 2011, TRENDS BLOOD PRESSUR, V20, P348; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Organization WH, 2000, GLOB STRAT PREV CONT; Organization WH, 2000, AS PAC PERSP RED OB; Sandberg K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-7; Suh DC1 KB, 2009, TRENDS BLOOD PRESSUR, V27, P1908; Wang J1 GL, 2011, LONG TERM RECENT PRO, V34, P1579; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8	23	74	77	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178334	10.1371/journal.pone.0178334	http://dx.doi.org/10.1371/journal.pone.0178334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542557	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800074
J	Seleka, M; Treurnicht, FK; Tempia, S; Hellferscee, O; Mtshali, S; Cohen, AL; Buys, A; McAnerney, JM; Besselaar, TG; Pretorius, M; von Gottberg, A; Walaza, S; Cohen, C; Madhi, SA; Venter, M				Seleka, Mpho; Treurnicht, Florette K.; Tempia, Stefano; Hellferscee, Orienka; Mtshali, Senzo; Cohen, Adam L.; Buys, Amelia; McAnerney, Johanna M.; Besselaar, Terry G.; Pretorius, Marthi; von Gottberg, Anne; Walaza, Sibongile; Cohen, Cheryl; Madhi, Shabir A.; Venter, Marietjie			Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014	PLOS ONE			English	Article							B VIRUSES; MONOCLONAL-ANTIBODIES; EVOLUTIONARY PATTERN; ANTIGENIC DRIFT; INFECTION; HEMAGGLUTININ; VACCINE; PCR; RECOMMENDATIONS; SURVEILLANCE	Background Studies describing the epidemiology of influenza B lineages in South Africa are lacking. Methods We conducted a prospective study to describe the circulation of influenza B/Victoria and B/Yamagata lineages among patients of all ages enrolled in South Africa through three respiratory illness surveillance systems between 2005 and 2014: (i) the Viral Watch (VW) program enrolled outpatients with influenza-like illness (ILI) from private healthcare facilities during 2005-2014; (ii) the influenza-like illnesses program enrolled outpatients in public healthcare clinics (ILI/PHC) during 2012-2014; and (iii) the severe acute respiratory illnesses (SARI) program enrolled inpatients from public hospitals during 2009-2014. Influenza B viruses were detected by virus isolation during 2005 to 2009 and by real-time reverse transcription polymerase chain reaction from 2009-2014. Clinical and epidemiological characteristics of patients hospitalized with SARI and infected with different influenza B lineages were also compared using unconditional logistic regression. Results Influenza viruses were detected in 22% (8,706/39,804) of specimens from patients with ILI or SARI during 2005-2014, of which 24% (2,087) were positive for influenza B. Influenza B viruses predominated in all three surveillance systems in 2010. B/Victoria predominated prior to 2011 (except 2008) whereas B/Yamagata predominated thereafter (except 2012). B lineages co-circulated in all seasons, except in 2013 and 2014 for SARI and ILI/PHC surveillance. Among influenza B-positive SARI cases, the detection of influenza B/Yamagata compared to influenza B/Victoria was significantly higher in individuals aged 45-64 years (adjusted odds ratio [aOR]: 4.2; 95% confidence interval [CI]: 1.1-16.5) and >= 65 years (aOR: 12.2; 95% CI: 2.3-64.4) compared to children aged 0-4 years, but was significantly lower in HIV-infected patients (aOR: 0.4; 95% CI: 0.2-0.9). Conclusion B lineages co-circulated in most seasons except in 2013 and 2014. Hospitalized SARI cases display differential susceptibility for the two influenza B lineages, with B/Victoria being more prevalent among children and HIV-infected persons.	[Seleka, Mpho; Treurnicht, Florette K.; Tempia, Stefano; Hellferscee, Orienka; Buys, Amelia; McAnerney, Johanna M.; Pretorius, Marthi; von Gottberg, Anne; Walaza, Sibongile; Cohen, Cheryl; Madhi, Shabir A.] NHLS, NICD, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Program, Atlanta, GA USA; [Hellferscee, Orienka; von Gottberg, Anne] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Mtshali, Senzo] NHLS, NICD, Sequencing Core Facil, Johannesburg, South Africa; [Cohen, Adam L.; Besselaar, Terry G.] WHO, Global Influenza Program, Geneva, Switzerland; [Walaza, Sibongile; Madhi, Shabir A.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Venter, Marietjie] Univ Pretoria, Dept Med Virol, Zoonoses Res Unit, Pretoria, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); World Health Organization; South African Medical Research Council; University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; University of Pretoria	Treurnicht, FK (corresponding author), NHLS, NICD, Ctr Resp Dis & Meningitis, Johannesburg, South Africa.	florettet@nicd.ac.za	Hellferscee, Orienka/AAN-6202-2020; Venter, Marietjie/P-9604-2016	Hellferscee, Orienka/0000-0001-9246-8927; Venter, Marietjie/0000-0003-2696-824X; von Gottberg, Anne/0000-0002-0243-7455; Cohen, Cheryl/0000-0003-0376-2302; Pretorius, Marthi/0000-0003-2163-6158	National Institute for Communicable Diseases (NICD); US Centers for Disease Control and Prevention [5U51/IP000155]; National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP001048] Funding Source: NIH RePORTER	National Institute for Communicable Diseases (NICD); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the National Institute for Communicable Diseases (NICD) (http://www.nicd.ac.za/) and the US Centers for Disease Control and Prevention (https://www.cdc.gov/) grant number 5U51/IP000155.	Africa DoHRoS, 2017, NATIONAL INFLUENZA P; Barr IG, 2006, COMMUN DIS INTELL, V30, P350; Barr IG, 2016, EURO SURVEILLANCE BU, V21; BERTON MT, 1984, J VIROL, V52, P919, DOI 10.1128/JVI.52.3.919-927.1984; Besselaar TG, 2004, VIRUS RES, V103, P61, DOI 10.1016/j.virusres.2004.02.014; Besselaar TG, 2004, J MED VIROL, V73, P71, DOI 10.1002/jmv.20063; Budgell E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120226; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; de Barros ENC, 2016, BRAZ J INFECT DIS, V20, P81, DOI 10.1016/j.bjid.2015.09.009; Cohen AL, 2014, EMERG INFECT DIS, V20, P1162, DOI 10.3201/eid2007.131869; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117716; Cohen C, 2015, PEDIATR INFECT DIS J, V34, P66, DOI 10.1097/INF.0000000000000478; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139431; Fox A, 2015, J INFECTION, V70, P187, DOI 10.1016/j.jinf.2014.09.003; Francis T, 1940, SCIENCE, V92, P405, DOI 10.1126/science.92.2392.405; Gutierrez-Pizarraya A, 2012, J INFECTION, V65, P423, DOI 10.1016/j.jinf.2012.07.004; Heikkinen T, 2014, CLIN INFECT DIS, V59, P1519, DOI 10.1093/cid/ciu664; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; Klimov AI, 2012, VACCINE, V30, P6461, DOI 10.1016/j.vaccine.2012.07.089; Kuo SM, 2016, J FORMOS MED ASSOC, V115, P510, DOI 10.1016/j.jfma.2016.01.017; McAnerney JM, 2015, INFLUENZA OTHER RESP, V9, P209, DOI 10.1111/irv.12314; McAnerney JM, 2015, INFLUENZA OTHER RESP, V9, P143, DOI 10.1111/irv.12305; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Moa AM, 2017, INFLUENZA OTHER RESP, V11, P102, DOI 10.1111/irv.12432; Ntshoe GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094681; Owen R, 2008, COMMUN DIS INTELL, V32, P208; Perosa AH, 2015, MEM I OSWALDO CRUZ, V110, P606, DOI 10.1590/0074-02760150044; Pretorius MA, 2016, J CLIN VIROL, V75, P21, DOI 10.1016/j.jcv.2015.12.004; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Puig-Barbera J, 2015, GLOBAL INFLUENZA HOS; Radovanov J, 2015, SRP ARK CELOK LEK, V143, P429, DOI 10.2298/SARH1508429R; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; Socan M, 2014, J CLIN VIROL, V61, P156, DOI 10.1016/j.jcv.2014.06.018; Vijaykrishna D, 2015, ELIFE, V4, DOI 10.7554/eLife.05055; Walaza S, 2016, SAMJ S AFR MED J, V106, P251, DOI [10.7196/samj.2016.v106i3.10586, 10.7196/SAMJ.2016.v106i3.10586]; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; WEBSTER RG, 1981, J GEN VIROL, V54, P243, DOI 10.1099/0022-1317-54-2-243; WHO, 2014, WHO SURVEILLANCE CAS; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Xu CL, 2015, AM J EPIDEMIOL, V182, P705, DOI 10.1093/aje/kwv110; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3	43	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177655	10.1371/journal.pone.0177655	http://dx.doi.org/10.1371/journal.pone.0177655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542324	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800021
J	Singh, D; Singh, CK; Kumari, S; Tomar, RSS; Karwa, S; Singh, R; Singh, RB; Sarkar, SK; Pal, M				Singh, Dharmendra; Singh, Chandan Kumar; Kumari, Shanti; Tomar, Ram Sewak Singh; Karwa, Sourabh; Singh, Rajendra; Singh, Raja Bahadur; Sarkar, Susheel Kumar; Pal, Madan			Discerning morpho-anatomical, physiological and molecular multiformity in cultivated and wild genotypes of lentil with reconciliation to salinity stress	PLOS ONE			English	Article							LENS-CULINARIS MEDIK.; SALT TOLERANCE; NACL SALINITY; SATIVA L.; GROWTH; MECHANISMS; FIELD; MICROSATELLITE; PEROXIDASE; METABOLISM	One hundred and sixty two genotypes of different Lens species were screened for salinity tolerance in hydroponics at 40, 80 and 120 mM sodium chloride (NaCl) for 30 d. The germination, seedling growth, biomass accumulation, seedling survivability, salinity scores, root and shoot anatomy, sodium ion (Na+), chloride ion (Cl-) and potassium ion (K+) concentrations, proline and antioxidant activities were measured to evaluate the performance of all the genotypes. The results were compared in respect of physiological (Na+, K+ and Cl-) and seed yield components obtained from field trials for salinity stress conducted during two years. Expression of salt tolerance in hydroponics was found to be reliable indicator for similarity in salt tolerance between genotypes and was evident in saline soil based comparisons. Impressive genotypic variation for salinity tolerance was observed among the genotypes screened under hydroponic and saline field conditions. Plant concentrations of Na+ and Cl- at 120 mM NaCl were found significantly correlated with germination, root and shoot length, fresh and dry weight of roots and shoots, seedling survivability, salinity scores and K+ under controlled conditions and ranked the genotypes along with their seed yield in the field. Root and shoot anatomy of tolerant line (PDL-1) and wild accession (ILWL-137) showed restricted uptake of Na+ and Cl- due to thick layer of their epidermis and endodermis as compared to sensitive cultigen (L-4076). All the genotypes were scanned using SSR markers for genetic diversity, which generated high polymorphism. On the basis of cluster analysis and population structure the contrasting genotypes were grouped into different classes. These markers may further be tested to explore their potential in marker-assisted selection.	[Singh, Dharmendra; Singh, Chandan Kumar; Kumari, Shanti] ICAR Indian Agr Res Inst, Div Genet, New Delhi, India; [Singh, Rajendra] ICAR Indian Agr Res Inst, Div Soil Sci & Agr Chem, New Delhi, India; [Singh, Raja Bahadur] Raja Balwant Singh Coll, ICAR All India Coordinated Res Project Salt Affec, Agra, Uttar Pradesh, India; [Tomar, Ram Sewak Singh] ICAR Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India; [Karwa, Sourabh; Pal, Madan] ICAR Indian Agr Res Inst, Div Plant Physiol, New Delhi, India; [Sarkar, Susheel Kumar] ICAR Indian Agr Stat Res Inst, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute	Singh, D (corresponding author), ICAR Indian Agr Res Inst, Div Genet, New Delhi, India.; Singh, R (corresponding author), ICAR Indian Agr Res Inst, Div Soil Sci & Agr Chem, New Delhi, India.; Pal, M (corresponding author), ICAR Indian Agr Res Inst, Div Plant Physiol, New Delhi, India.	dsingh_gen@iari.res.in; rajendra.singh_phyto@yahoo.com; madanpal@yahoo.com	TOMAR, RAM SEWAK SINGH/AAF-5619-2021; karwa, sourabh D/O-5266-2018; PAL, MRINAL/ABG-9676-2020; Tomar, Dr. Rukam Singh/I-3474-2013	TOMAR, RAM SEWAK SINGH/0000-0001-9959-4395; karwa, sourabh D/0000-0002-6232-6765; PAL, MRINAL/0000-0002-1032-272X; Tomar, Dr. Rukam Singh/0000-0001-9156-5311	ICAR-Indian Agricultural Research Institute (IARI), New Delhi; National Phytotron Facility, IARI, New Delhi; Indian Agricultural Research Institute, New Delhi [JAN 09/16]; Indian Agricultural Research Institute, New Delhi	ICAR-Indian Agricultural Research Institute (IARI), New Delhi; National Phytotron Facility, IARI, New Delhi; Indian Agricultural Research Institute, New Delhi(Indian Council of Agricultural Research (ICAR)); Indian Agricultural Research Institute, New Delhi(Indian Council of Agricultural Research (ICAR))	This work was supported in part by the Director, Joint Director (Res), ICAR-Indian Agricultural Research Institute (IARI), New Delhi, Head, Division of Genetics and Incharge, National Phytotron Facility, IARI, New Delhi to carry out all the research activities, Indian Agricultural Research Institute, New Delhi, and Project no- JAN 09/16 [http://www.iari.res.in/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Director, Joint Director (Res), ICAR-Indian Agricultural Research Institute (IARI), New Delhi, Head, Division of Genetics and Incharge, National Phytotron Facility, IARI, New Delhi, for providing support to carry out all the research activities. The authors also acknowledge the support of Dr. Ashutosh Sarkar, Co-ordinator of ICARDA for providing seeds of various Lens species. We sincerely thank Dr. Shiv Kumar Agarwal for providing origin of wild accessions. The financial support from Indian Agricultural Research Institute, New Delhi is gratefully acknowledged	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahmad P., 2011, OXIDATIVE STRESS ROL; Ahmad Parvaiz, 2010, Archives of Agronomy and Soil Science, V56, P575, DOI 10.1080/03650340903164231; Akhtar P, 2009, PAK J BOT, V41, P3075; Al-Mutawa M. M., 2003, International Journal of Agriculture and Biology, V5, P226; Almodares A., 2007, Journal of Biological Sciences, V7, P1492; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bahmani K., 2015, Australian Journal of Crop Science, V9, P321; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Carrasco-Rios L, 2014, CHILEAN J AGR RES, V74; CASTILLO FJ, 1984, PLANT PHYSIOL, V74, P846, DOI 10.1104/pp.74.4.846; Ceccoli G, 2011, BIOCELL, V35, P9; Chartzoulakis K, 2000, SCI HORTIC-AMSTERDAM, V86, P247, DOI 10.1016/S0304-4238(00)00151-5; Daei G, 2009, J PLANT PHYSIOL, V166, P617, DOI 10.1016/j.jplph.2008.09.013; DEMELO DF, 1994, PLANT PHYSIOL BIOCH, V32, P405; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dua R. P., 1998, Indian Journal of Plant Physiology, V3, P102; Dua RP, 1997, INDIAN J AGR SCI, V67, P440; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ebbisa A., 2015, INT J INNOVATIVE APP, V3, P1; ELSHAIENY AHAH, 2015, EUR J EXP BIOL, V5, P22; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Farhana Naz, 2014, American-Eurasian Journal of Agricultural & Environmental Sciences, V14, P1304; Flood PJ, 2011, TRENDS PLANT SCI, V16, P327, DOI 10.1016/j.tplants.2011.02.005; Flowers T. J., 1983, Inorganic plant nutrition, P651; Gregorio GB, 1997, THESIS; Gupta M, 2012, J GENET, V91, P279, DOI 10.1007/s12041-012-0180-4; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Ikram-ul-Haq, 2012, J ZHEJIANG UNIV-SC B, V13, P533, DOI 10.1631/jzus.B1200027; Ismail A, 2014, J EXP BOT, V65, P2963, DOI 10.1093/jxb/eru159; Jain N, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200539; James RA, 2011, J EXP BOT, V62, P2939, DOI 10.1093/jxb/err003; Jin L, 2008, ACTA AGRONO SIN, V34, P1901, DOI DOI 10.1016/S1875-2780(09)60015-8; Kahraman A, 2004, CROP SCI, V44, P13, DOI 10.2135/cropsci2004.0013; Kanawapee N, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue6-fulltext-4; Kaur S, 2014, THEOR APPL GENET, V127, P703, DOI 10.1007/s00122-013-2252-0; Kitajima K., 2000, Seeds: the ecology of regeneration in plant communities, P331, DOI 10.1079/9780851994321.0331; Krishnamurthy L, 2014, PLANT SCI, V227, P51, DOI 10.1016/j.plantsci.2014.07.001; Kushwaha UKS, 2015, AGR BIOL SCI J, V1, P16; Lawson T, 2012, CURR OPIN BIOTECH, V23, P215, DOI 10.1016/j.copbio.2011.12.012; Lee DH, 2001, J PLANT PHYSIOL, V158, P737, DOI 10.1078/0176-1617-00174; Liu K, 2004, POWER MARKER NEW GEN; Lopez R, 1999, SOIL SCI PLANT NUTR, V45, P659, DOI 10.1080/00380768.1999.10415829; MAAS E V, 1986, Applied Agricultural Research, V1, P12; Mahmood A., 2008, Agriculturae Conspectus Scientificus, V73, P137; Mansuri S. M., 2012, African Journal of Biotechnology, V11, P9362; Marschner H., 1986, Mineral nutrition of higher plants.; Marti MC, 2011, J EXP BOT, V62, P3863, DOI 10.1093/jxb/err076; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Murillo-Amador B, 2000, PHYTON-INT J EXP BOT, V67, P71; Murillo-Amador B, 2001, AUST J EXP AGR, V41, P81, DOI 10.1071/EA00055; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Paz RC, 2014, PLANT BIOLOGY, V16, P1042, DOI 10.1111/plb.12156; Poustini K, 2004, FIELD CROP RES, V85, P125, DOI 10.1016/S0378-4290(03)00157-6; Pritchard JK, 2000, GENETICS, V155, P945; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Rohlf F. J., 2000, NTSYS PC NUMERICAL T; Sakina A, 2015, J AGRO CROP SCI; Samineni S, 2011, ENVIRON EXP BOT, V71, P260, DOI 10.1016/j.envexpbot.2010.12.014; Sarker BC, 2015, BANGL J BOT, V44, P73; Shahbaz M, 2013, CRIT REV PLANT SCI, V32, P237, DOI 10.1080/07352689.2013.758544; Shahzad A, 2012, GENET MOL RES, V11, P679, DOI 10.4238/2012.March.19.2; Singh D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147213; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanyolac B., 2010, J AGR BIOTECHNOL SUS, V2, P1; Tavakkoli E, 2012, J EXP BOT, V63, P3853, DOI 10.1093/jxb/ers085; Tavakkoli E, 2012, FIELD CROP RES, V127, P99, DOI 10.1016/j.fcr.2011.10.016; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Unal B. T., 2014, Bulgarian Journal of Agricultural Science, V20, P883; Vadez V, 2007, FIELD CROP RES, V104, P123, DOI 10.1016/j.fcr.2007.05.014; Viegas Ricardo Almeida, 1999, Revista Brasileira de Fisiologia Vegetal, V11, P153; Wang ZF, 2011, EUPHYTICA, V178, P297, DOI 10.1007/s10681-010-0287-8; Wei WX, 2003, PLANT SOIL, V250, P183, DOI 10.1023/A:1022832107999; Zeng LH, 2004, PLANT SCI, V166, P1275, DOI 10.1016/j.plantsci.2004.01.005	78	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177465	10.1371/journal.pone.0177465	http://dx.doi.org/10.1371/journal.pone.0177465			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542267	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800018
J	Yamashita, T; Asaoka, R; Kii, Y; Terasaki, H; Murata, H; Sakamoto, T				Yamashita, Takehiro; Asaoka, Ryo; Kii, Yuya; Terasaki, Hiroto; Murata, Hiroshi; Sakamoto, Taiji			Structural parameters associated with location of peaks of peripapillary retinal nerve fiber layer thickness in young healthy eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OPEN-ANGLE GLAUCOMA; AXIAL LENGTH; JAPANESE POPULATION; TENSION GLAUCOMA; BODY HEIGHT; MYOPIA; VARIABILITY; PROGRESSION; SECTORS	The location of the peaks of the circumpapillary retinal nerve fiber layer (cpRNFL) thickness is affected by several ocular parameters. In this study, we have generated equations that can determine the peaks of the cpRNFL. This study was a prospective, observational, cross sectional study of 118 healthy right eyes. The axial length, optic disc tilt, superiortemporal (ST)-and inferiortemporal (IT)-peaks of the cpRNFL thickness, and angles of the ST and IT retinal arteries (RA) and veins (RV) were determined. The correlations between the location of the ST-and IT-peaks and ocular structural parameters and the sex, body height and weight were calculated. The best fit equations to generate the location of the ST/IT-peaks were determined using corrected-Akaike Information Criteria. The location of the ST-peak was 0.72+(0.40 x ST-RA)+(0.27 x ST-RV)+(0.14 x height)-(0.47 x papillo-macular-position) -(0.11 x disc tilt) with a coefficient of correlation of 0.61 (P<0.0001). The location of the IT-peak was 21.88+(0.53 x IT-RA)+(0.15 x IT-RV)+(0.041 x corneal thickness)-(1.00 x axial length) with a coefficient of correlation of 0.59 (P<0.0001). The location of ST/IT peaks is determined by different parameters of the ocular structure. These equations allow clinicians to obtain an accurate location of the peaks for a more accurate diagnosis of glaucoma.	[Yamashita, Takehiro; Kii, Yuya; Terasaki, Hiroto; Sakamoto, Taiji] Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima, Japan; [Asaoka, Ryo; Murata, Hiroshi] Univ Tokyo, Dept Ophthalmol, Tokyo, Japan	Kagoshima University; University of Tokyo	Sakamoto, T (corresponding author), Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp		Sakamoto, Taiji/0000-0003-0287-3801	Japan Society for the Promotion of Science and Suda; Suda memorial glaucoma research grant; Grants-in-Aid for Scientific Research [17K11426] Funding Source: KAKEN	Japan Society for the Promotion of Science and Suda; Suda memorial glaucoma research grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was sponsored in part by a grant from the Japan Society for the Promotion of Science and Suda memorial glaucoma research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenthal EZ, 2000, OPHTHALMOLOGY, V107, P2278, DOI 10.1016/S0161-6420(00)00341-9; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Fujino Y, 2016, INVEST OPHTH VIS SCI, V57, P3152, DOI 10.1167/iovs.16-19461; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Hoh ST, 2006, OPHTHALMOLOGY, V113, P773, DOI 10.1016/j.ophtha.2006.01.058; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2035, DOI 10.1001/jama.2013.5099; Hong S, 2010, INVEST OPHTH VIS SCI, V51, P4067, DOI 10.1167/iovs.09-4301; Hong SW, 2010, INVEST OPHTH VIS SCI, V51, P3515, DOI 10.1167/iovs.09-4888; Hood DC, 2008, J GLAUCOMA, V17, P519, DOI 10.1097/IJG.0b013e3181629a02; Hood DC, 2010, J GLAUCOMA, V19, P158, DOI 10.1097/IJG.0b013e3181af31ec; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Lamparter J, 2013, INVEST OPHTH VIS SCI, V54, P6074, DOI 10.1167/iovs.13-11902; Leung CKS, 2006, INVEST OPHTH VIS SCI, V47, P5171, DOI 10.1167/iovs.06-0545; Leung DYL, 2009, OPHTHALMOLOGY, V116, P1250, DOI 10.1016/j.ophtha.2009.02.003; Mistlberger A, 1999, OPHTHALMOLOGY, V106, P2027, DOI 10.1016/S0161-6420(99)90419-0; MOTOLKO M, 1982, ARCH OPHTHALMOL-CHIC, V100, P1074, DOI 10.1001/archopht.1982.01030040052005; Nangia V, 2010, GRAEF ARCH CLIN EXP, V248, P1657, DOI 10.1007/s00417-010-1448-0; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Vajaranant TS, 2010, CURR OPIN OPHTHALMOL, V21, P91, DOI 10.1097/ICU.0b013e3283360b7e; Wang DC, 2011, INVEST OPHTH VIS SCI, V52, P7949, DOI 10.1167/iovs.11-7684; Yamashita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122191; Yamashita T, 2014, INVEST OPHTH VIS SCI, V55, P5176, DOI 10.1167/iovs.14-14105; Yamashita T, 2014, ACTA OPHTHALMOL, V92, pE481, DOI 10.1111/aos.12382; Yamashita T, 2013, INVEST OPHTH VIS SCI, V54, P7478, DOI 10.1167/iovs.13-12586; Yin G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043172; Yoo YC, 2012, OPTOMETRY VISION SCI, V89, P4, DOI 10.1097/OPX.0b013e3182358008; Zangwill LM, 2000, OPHTHALMOLOGY, V107, P1309, DOI 10.1016/S0161-6420(00)00168-8	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177247	10.1371/journal.pone.0177247	http://dx.doi.org/10.1371/journal.pone.0177247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542289	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800012
J	Battin, C; Hennig, A; Mayrhofer, P; Kunert, R; Zlabinger, GJ; Steinberger, P; Paster, W				Battin, Claire; Hennig, Annika; Mayrhofer, Patrick; Kunert, Renate; Zlabinger, Gerhard J.; Steinberger, Peter; Paster, Wolfgang			A human monocytic NF-kappa B fluorescent reporter cell line for detection of microbial contaminants in biological samples	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSE; CUTTING EDGE; ESCHERICHIA-COLI; DENDRITIC CELLS; DROSOPHILA TOLL; IN-VITRO; ACTIVATION; LIPOPOLYSACCHARIDE; RECOGNITION	Sensing of pathogens by innate immune cells is essential for the initiation of appropriate immune responses. Toll-like receptors (TLRs), which are highly sensitive for various structurally and evolutionary conserved molecules derived from microbes have a prominent role in this process. TLR engagement results in the activation of the transcription factor NF-kappa B, which induces the expression of cytokines and other inflammatory mediators. The exquisite sensitivity of TLR signalling can be exploited for the detection of bacteria and microbial contaminants in tissue cultures and in protein preparations. Here we describe a cellular reporter system for the detection of TLR ligands in biological samples. The well-characterized human monocytic THP-1 cell line was chosen as host for an NF-kappa B-inducible enhanced green fluorescent protein reporter gene. We studied the sensitivity of the resultant reporter cells for a variety of microbial components and observed a strong reactivity towards TLR1/2 and TLR2/6 ligands. Mycoplasma lipoproteins are potent TLR2/6 agonists and we demonstrate that our reporter cells can be used as reliable and robust detection system for mycoplasma contaminations in cell cultures. In addition, a TLR4-sensitive subline of our reporters was engineered, and probed with recombinant proteins expressed in different host systems. Bacterially expressed but not mammalian expressed proteins induced strong reporter activity. We also tested proteins expressed in an E. coli strain engineered to lack TLR4 agonists. Such preparations also induced reporter activation in THP-1 cells highlighting the importance of testing recombinant protein preparations for microbial contaminations beyond endotoxins. Our results demonstrate the usefulness of monocytic reporter cells for high-throughput screening for microbial contaminations in diverse biological samples, including tissue culture supernatants and recombinant protein preparations. Fluorescent reporter assays can be measured on standard flow cytometers and in contrast to established detection methods, like luciferase-based systems or Limulus Amebocyte Lysate tests, they do not require costly reagents.	[Battin, Claire; Hennig, Annika; Steinberger, Peter; Paster, Wolfgang] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Div Immune Receptors & Cell Activat T, Vienna, Austria; [Mayrhofer, Patrick; Kunert, Renate] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Zlabinger, Gerhard J.] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Div Clin & Expt Immunol, Vienna, Austria; [Paster, Wolfgang] Childrens Canc Res Inst, Dept Clin Cell Biol, Vienna, Austria; [Paster, Wolfgang] Childrens Canc Res Inst, FACS Core Unit, Vienna, Austria	Medical University of Vienna; University of Natural Resources & Life Sciences, Vienna; Medical University of Vienna; Saint Anna Children's Hospital; Saint Anna Children's Hospital	Steinberger, P; Paster, W (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Div Immune Receptors & Cell Activat T, Vienna, Austria.; Paster, W (corresponding author), Childrens Canc Res Inst, Dept Clin Cell Biol, Vienna, Austria.; Paster, W (corresponding author), Childrens Canc Res Inst, FACS Core Unit, Vienna, Austria.	peter.steinberger@meduniwien.ac.at; wolfgang.paster@meduniwien.ac.at	Kunert, Renate E/B-9185-2018; Mayrhofer, Patrick/M-6458-2018	Kunert, Renate E/0000-0002-3397-3621; Battin, Claire/0000-0002-0254-8032; Steinberger, Peter/0000-0001-6848-4097; Paster, Wolfgang/0000-0002-5537-2886; Mayrhofer, Patrick/0000-0003-4763-5911; Zlabinger, Gerhard/0000-0002-7478-4173	Christian Doppler Society [PA624LI001]; Austrian Science Fund (FWF) [P 25056] Funding Source: researchfish	Christian Doppler Society; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the in-house project PA624LI001 and the Christian Doppler Society (https://www.cdg.ac.at; CD10262401) awarded to P.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SE, 2010, BIOLOGICALS, V38, P211, DOI 10.1016/j.biologicals.2010.03.002; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; COOPER JF, 1971, J LAB CLIN MED, V78, P138; De Nardo D, 2015, CYTOKINE, V74, P181, DOI 10.1016/j.cyto.2015.02.025; Deifl S, 2014, ALLERGY, V69, P1602, DOI 10.1111/all.12501; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Geng S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13436; Gualdoni GA, 2015, SCI REP-UK, V5, DOI 10.1038/srep12016; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hofer J, 2016, FASEB J, V30, P1492, DOI 10.1096/fj.15-275594; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; ISSEKUTZ AC, 1983, J IMMUNOL METHODS, V61, P275, DOI 10.1016/0022-1759(83)90221-1; Jutz S, 2016, J IMMUNOL METHODS, V430, P10, DOI 10.1016/j.jim.2016.01.007; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li Y, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-016-0113-6; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Margreitter C, 2016, J MOL RECOGNIT, V29, P266, DOI 10.1002/jmr.2527; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Muroi M, 2003, INFECT IMMUN, V71, P3221, DOI 10.1128/IAI.71.6.3221-3226.2003; Muta T, 2001, EUR J BIOCHEM, V268, P4580, DOI 10.1046/j.1432-1327.2001.02385.x; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Ratzinger F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07438; Rosskopf S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31580; Schwarz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113840; Seya T, 2005, J ENDOTOXIN RES, V11, P369, DOI 10.1179/096805105X67292; Siednienko Jakub, 2009, V517, P3, DOI 10.1007/978-1-59745-541-1_1; Smith DR, 2017, REV FISH BIOL FISHER, V27, P135, DOI 10.1007/s11160-016-9461-y; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Uphoff CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/267678; Yoshimura A, 1999, J IMMUNOL, V163, P1; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Zakharova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009900; Zhang CY, 2013, CELL MOL IMMUNOL, V10, P84, DOI 10.1038/cmi.2012.57	59	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178220	10.1371/journal.pone.0178220	http://dx.doi.org/10.1371/journal.pone.0178220			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542462	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500075
J	Sengupta, N; Reardon, DC; Gerard, PD; Baldwin, WS				Sengupta, Namrata; Reardon, Delaney C.; Gerard, Patrick D.; Baldwin, William S.			Exchange of polar lipids from adults to neonates in Daphnia magna: Perturbations in sphingomyelin allocation by dietary lipids and environmental toxicants	PLOS ONE			English	Article							UNSATURATED FATTY-ACIDS; NUCLEAR RECEPTOR CAR; CHOLESTEROL HOMEOSTASIS; LIFE-SPAN; DROSOPHILA; METABOLISM; REPRODUCTION; DHR96; ACTIVATION; GROWTH	Because xenosensing nuclear receptors are also lipid sensors that regulate lipid allocation, we hypothesized that toxicant-induced modulation of HR96 activity would alter lipid profiles and the balance between adult survival and neonate production following exposure in Daphnia magna. Adult daphnids were exposed to unsaturated fatty acid-and toxicant-activators or inhibitors of HR96 and later starved to test whether chemical exposure altered allocation toward survival or reproduction. The HR96 activators, linoleic acid and atrazine, decreased reproduction as expected with concomitant changes in the expression of HR96 regulated genes such as magro. The HR96 inhibitors, docosahexaenoic acid (DHA) and triclosan, increased reproduction or neonate starvation survival, respectively. However, pre-exposure to triclosan increased in neonate survival at the expense of reproductive maturation. Lipidomic analysis revealed that sphingomyelins (SM) are predominantly found in neonates and therefore we propose are important in development. DHA and triclosan increased neonatal SM, consistent with HR96' s regulation of Niemann-Pick genes. While DHA altered expression of magro, Niemann-Pick 1b, mannosidase, and other HR96-regulated genes as expected, triclosan primarily perturbed sphingomyelinase and mannosidase expression indicating different but potentially overlapping mechanisms for perturbing SM. Overall, SM appears to be a key lipid in Daphnia maturation and further support was provided by carmofur, which inhibits sphingomyelin/ceramide metabolism and in turn severely represses Daphnia maturation and initial brood production. In conclusion, toxicants can perturb lipid allocation and in turn impair development and reproduction.	[Sengupta, Namrata; Baldwin, William S.] Clemson Univ, Environm Toxicol Program, Clemson, SC 29634 USA; [Reardon, Delaney C.; Baldwin, William S.] Clemson Univ, Biol Sci, Clemson, SC 29634 USA; [Gerard, Patrick D.] Clemson Univ, Math Sci, Clemson, SC USA	Clemson University; Clemson University; Clemson University	Baldwin, WS (corresponding author), Clemson Univ, Environm Toxicol Program, Clemson, SC 29634 USA.; Baldwin, WS (corresponding author), Clemson Univ, Biol Sci, Clemson, SC 29634 USA.	Baldwin@clemson.edu			National Institute of Environmental Health Sciences, National Institutes of Health [R15ES017321]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES017321] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences, a part of the National Institutes of Health (https://www. nih.gov), Grant number: R15ES017321, received by WSB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, ANN BOOK ASTM STAND, P1, DOI [10.1520/D2216-10.N, DOI 10.1520/D2216-10.N]; Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; BALDWIN WS, 1995, ENVIRON TOXICOL CHEM, V14, P945, DOI 10.1002/etc.5620140604; Barata C, 1998, FUNCT ECOL, V12, P442, DOI 10.1046/j.1365-2435.1998.00201.x; Becker C, 2005, LIMNOL OCEANOGR, V50, P388, DOI 10.4319/lo.2005.50.1.0388; Benoit JB, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100008; Boersma M, 1997, EVOL ECOL, V11, P439, DOI 10.1023/A:1018484824003; Brett MT, 2006, LIMNOL OCEANOGR, V51, P2428, DOI 10.4319/lo.2006.51.5.2428; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Brown MR, 1997, AQUACULTURE, V151, P315, DOI 10.1016/S0044-8486(96)01501-3; Bujold M, 2010, MOL CELL BIOL, V30, P793, DOI 10.1128/MCB.01327-09; Bunescu A, 2010, MOL BIOSYST, V6, P121, DOI 10.1039/b915417e; Bychek EA, 1999, BIOCHEMISTRY-MOSCOW+, V64, P543; Catala A, 2013, J LIPIDS, V2013, DOI 10.1155/2013/710290; Chang JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145818; Chevalier J, 2015, ENVIRON TOXICOL CHEM, V34, P1760, DOI 10.1002/etc.2979; Cutler RG, 2014, MECH AGEING DEV, V143, P9, DOI 10.1016/j.mad.2014.11.002; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Du X, 2015, AQUAT TOXICOL, V165, P231, DOI 10.1016/j.aquatox.2015.06.009; Ferre A P, 2004, BIOL PEROXISOME P S1, V53, pS43; Ginjupalli GK, 2015, ENVIRON TOXICOL CHEM, V34, P527, DOI 10.1002/etc.2804; Ginjupalli GK, 2013, CHEMOSPHERE, V92, P1260, DOI 10.1016/j.chemosphere.2013.04.061; Greiner-Tollersrud O., 2000, LYSOSOMAL STORAGE DI; Grun F, 2009, MOL ENDOCRINOL, V23, P1127, DOI 10.1210/me.2008-0485; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hartwich M, 2012, OIKOS, V121, P1702, DOI 10.1111/j.1600-0706.2011.20461.x; Heckmann LH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-175; Hernandez J. P., 2009, Current Pharmacogenomics & Personalized Medicine, V7, P81; Herr DR, 2003, DEVELOPMENT, V130, P2443, DOI 10.1242/dev.00456; Horner MA, 2009, GENE DEV, V23, P2711, DOI 10.1101/gad.1833609; Huang WD, 2004, J CLIN INVEST, V113, P137, DOI 10.1172/JCI200418385; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Isaac Giorgis, 2007, Genet Eng (N Y), V28, P129, DOI 10.1007/978-0-387-34504-8_8; Jee BC, 2011, GYNECOL OBSTET INVES, V72, P32, DOI 10.1159/000322222; John K, 2016, AM J PHYSIOL-ENDOC M, V310, pE249, DOI 10.1152/ajpendo.00478.2015; Jordao R, 2016, SCI TOTAL ENVIRON, V545, P127, DOI 10.1016/j.scitotenv.2015.12.097; Jordao R, 2015, ENVIRON HEALTH PERSP, V123, P813, DOI 10.1289/ehp.1409163; Karimullina E, 2012, AQUAT TOXICOL, V116, P69, DOI 10.1016/j.aquatox.2012.03.005; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Koskinen H, 2004, BIOCHEM BIOPH RES CO, V320, P745, DOI 10.1016/j.bbrc.2004.06.024; Latta LC, 2011, J EXP ZOOL PART A, V315A, P610, DOI 10.1002/jez.710; Leao BCS, 2015, THERIOGENOLOGY, V84, P127, DOI 10.1016/j.theriogenology.2015.02.023; LeBlanc GA, 2012, ENVJMMONO201223JT033, P23; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Li YC, 2014, GEN COMP ENDOCR, V206, P30, DOI 10.1016/j.ygcen.2014.07.022; Lima D, 2015, J TOXICOL ENV HEAL A, V78, P747, DOI 10.1080/15287394.2015.1028301; Litoff EJ, 2014, GENE, V552, P116, DOI 10.1016/j.gene.2014.09.024; Lu CY, 2010, J NUTR BIOCHEM, V21, P338, DOI 10.1016/j.jnutbio.2009.01.007; Lu PP, 2015, HEPATOLOGY, V61, P1908, DOI 10.1002/hep.27719; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Lynn DA, 2015, P NATL ACAD SCI USA, V112, P15378, DOI 10.1073/pnas.1514012112; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Olmstead AW, 2002, J EXP ZOOL, V293, P736, DOI 10.1002/jez.10162; Phan VH, 2007, DEV BIOL, V309, P329, DOI 10.1016/j.ydbio.2007.07.021; Pizzirani D, 2013, J MED CHEM, V56, P3518, DOI 10.1021/jm301879g; Putman A, 2015, J PLANKTON RES, V37, P752, DOI 10.1093/plankt/fbv043; Ravet JL, 2012, INLAND WATERS, V2, P199, DOI 10.5268/IW-2.4.546; Roling J.A., 2006, ENVIRON TOXICOL CHEM, V25, P62; Roth AG, 2009, ANGEW CHEM INT EDIT, V48, P7560, DOI 10.1002/anie.200903288; Sadowski MC, 2014, ONCOTARGET, V5, P9362, DOI 10.18632/oncotarget.2433; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sengupta N, 2016, CHEMOSPHERE, V144, P2302, DOI 10.1016/j.chemosphere.2015.11.015; Sengupta N, 2015, CHEMOSPHERE, V128, P299, DOI 10.1016/j.chemosphere.2015.02.027; Shindo S, 2007, BIOCHEM J, V401, P735, DOI 10.1042/BJ20061238; Sieber MH, 2012, CELL METAB, V15, P122, DOI 10.1016/j.cmet.2011.11.011; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Spruiell K, 2014, J BIOL CHEM, V289, P3244, DOI 10.1074/jbc.M113.494575; Taipale SJ, 2011, OIKOS, V120, P1674, DOI 10.1111/j.1600-0706.2011.19415.x; Tauler R, 2016, ENVIRON SCI TECHNOL, V50, P13565; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; US EPA, 2002, METH MEAS AC TOX EFF, P266; VERRETH J, 1994, AQUACULTURE, V126, P137, DOI 10.1016/0044-8486(94)90255-0; von Elert E, 2002, LIMNOL OCEANOGR, V47, P1764, DOI 10.4319/lo.2002.47.6.1764; Wacker A, 2007, FUNCT ECOL, V21, P738, DOI 10.1111/j.1365-2435.2007.01274.x; Wahlang B, 2016, TOXICOL SCI, V149, P396, DOI 10.1093/toxsci/kfv250; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157	78	9	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178131	10.1371/journal.pone.0178131	http://dx.doi.org/10.1371/journal.pone.0178131			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542405	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500063
J	Trudeau, MP; Verma, H; Sampedro, F; Urriola, PE; Shurson, GC; Goyal, SM				Trudeau, Michaela P.; Verma, Harsha; Sampedro, Fernando; Urriola, Pedro E.; Shurson, Gerald C.; Goyal, Sagar M.			Environmental persistence of porcine coronaviruses in feed and feed ingredients	PLOS ONE			English	Article							EPIDEMIC DIARRHEA VIRUS; HEAT-TREATMENT; RISK-FACTORS; SALMONELLA; PREVALENCE; SURVIVAL; PEDV	Porcine Epidemic Diarrhea Virus (PEDV), Porcine Delta Corona Virus (PDCoV), and Transmissible Gastroenteritis Virus (TGEV) are major threats to swine health and contaminated feed plays a role in virus transmission. The objective of our study was to characterize inactivation of PEDV, PDCoV, and TGEV in various feed ingredient matrices. Samples of complete feed, spray dried porcine plasma, meat meal, meat and bone meal, blood meal, corn, soybean meal, and corn dried distillers grains with solubles were weighed (5 g/sample) into scintillation vials and inoculated with 1 mL of PEDV, PDCoV, or TGEV. Samples were incubated at room temperature for up to 56 days. Aliquots were removed at various time points followed by preparing serial 10-fold dilutions and inoculating in cell cultures to determine the amount of surviving virus. Inactivation kinetics were determined using the Weibull model, which estimates a delta value indicating the time necessary to reduce virus concentration by 1 log. Delta values of various ingredients were compared and analyzed as to their nutrient composition. Soybean meal had the greatest delta value (7.50 days) for PEDV (P < 0.06) as compared with all other ingredients. High delta values (P < 0.001) were observed in soybean meal for PDCoV (42.04 days) and TGEV (42.00 days). There was a moderate correlation between moisture content and the delta value for PDCoV (r = 0.49, P = 0.01) and TGEV (r = 0.41, P = 0.02). There was also a moderate negative correlation between TGEV survival and ether extract content (r = -0.51, P = 0.01). In conclusion, these results indicate that the first log reduction of PDCoV and TGEV takes the greatest amount of time in soybean meal. In addition to this, moisture and ether content appear to be an important determinant of virus survival in feed ingredients.	[Trudeau, Michaela P.; Urriola, Pedro E.; Shurson, Gerald C.] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Verma, Harsha; Sampedro, Fernando; Urriola, Pedro E.; Goyal, Sagar M.] Univ Minnesota, Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Goyal, SM (corresponding author), Univ Minnesota, Vet Populat Med, St Paul, MN 55108 USA.	goyal001@umn.edu	Sampedro, Fernando/AAH-8332-2020	Sampedro, Fernando/0000-0003-1155-2751; Shurson, Gerald/0000-0001-7095-4799; Urriola, Pedro E/0000-0003-4090-6627	National Pork Board [14-274]	National Pork Board	This study was funded by the National Pork Board (#14-274) and awarded to SG. More information can be found at http://www.pork.org/ pork-checkoff-research/pedv/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrpt.	Alonso C, 2014, VET RES, V45, DOI 10.1186/s13567-014-0073-z; [Anonymous], 2002, J FOOD PROTECT, V65, P999; Bowman AS, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0348-2; Cavanagh D, 2005, BIRK ADV INFECT DIS, P1; Cottingim KM, 2017, PORCINE HEALTH MANAG, V3, DOI 10.1186/s40813-016-0048-8; Cottingim KM, 2015, LEM C; de Groot RJ, 2012, VIRUS TAXONOMY, P806; Dee S, 2015, PORCINE HEALTH MANAG, V1, DOI 10.1186/s40813-015-0003-0; Dee S, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0176-9; DUNCAN MS, 1972, POULTRY SCI, V51, P797, DOI 10.3382/ps.0510797; Ganwu L, 2014, GENOME ANNOUNC, V2; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Gerber PF, 2014, VET MICROBIOL, V174, P86, DOI 10.1016/j.vetmic.2014.09.008; Goyal S.M., 2013, 13 215 ENV STABILITY, P1; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Jaquette CB, 1996, APPL ENVIRON MICROB, V62, P2212, DOI 10.1128/AEM.62.7.2212-2215.1996; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Leman AD, 1986, DIS SWINE, Vxiii; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; Mertens D., 2005, OFFICIAL METHODS ANA, V18th ed., P1; Norkin LC, 2012, VIROLOGY MOL BIOL PA, P235; Pasick J, 2014, TRANSBOUND EMERG DIS, V61, P397, DOI 10.1111/tbed.12269; Podolak R, 2010, J FOOD PROTECT, V73, P1919, DOI 10.4315/0362-028X-73.10.1919; Pujols J, 2014, VET MICROBIOL, V174, P427, DOI 10.1016/j.vetmic.2014.10.021; Quist-Rybachuk GV, 2015, VET MICROBIOL, V181, P283, DOI 10.1016/j.vetmic.2015.10.010; Sampedro F, 2014, RISK ASSESSMENT FEED; Schumacher L.L., 2015, KANSAS AGR EXP STN R, V1; Torres GJ, 2011, PREV VET MED, V98, P81, DOI 10.1016/j.prevetmed.2010.11.009; Trudeau M, 2015, LEM C; Trudeau MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158128; Van Immerseel F, 2006, AVIAN PATHOL, V35, P182, DOI 10.1080/03079450600711045; Whyte P, 2003, J FOOD SAFETY, V23, P13, DOI 10.1111/j.1745-4565.2003.tb00348.x; Woode G. N., 1969, Veterinary Bulletin, V39, P239; Zhang J., 2016, VIRUS RES	34	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178094	10.1371/journal.pone.0178094	http://dx.doi.org/10.1371/journal.pone.0178094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542235	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500061
J	Wang, GQ; Yin, RF; Zhou, P; Ding, Z				Wang, Guiqin; Yin, Renfu; Zhou, Paul; Ding, Zhuang			Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies	PLOS ONE			English	Article							H1N1 INFLUENZA-VIRUS; VACCINE; RECOGNITION; RESPONSES; STEM	Hemagglutinin (HA) head has long been considered to be able to elicit only a narrow, strain-specific antibody response as it undergoes rapid antigenic drift. However, we previously showed that a heterologous prime-boost strategy, in which mice were primed twice with DNA encoding HA and boosted once with virus-like particles (VLP) from an H5N1 strain A/Thailand/1(KAN)-1/2004 (noted as TH DDV), induced anti-head broad cross-H5 neutralizing antibody response. To explain why TH DDV immunization could generate such breadth, we systemically compared the neutralization breadth and potency between TH DDV sera and immune sera elicited by TH DDD (three times of DNA immunizations), TH VVV (three times of VLP immunizations), TH DV (one DNA prime plus one VLP boost) and TK DDV (plasmid DNA and VLP derived from another H5N1 strain, A/Turkey/65596/2006). Then we determined the antigenic sites (AS) on TH HA head and the key residues of the main antigenic site. Through the comparison of different regiments, we found that the combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost caused that TH DDV immunization generate broad neutralizing antibodies. Antigenic analysis showed that TH DDV, TH DV, TH DDD and TH VVV sera recognize the common antigenic site AS1. Antibodies directed to AS1 contribute to the largest proportion of the neutralizing activity of these immune sera. Residues 188 and 193 in AS1 are the key residues which are responsible for neutralization breadth of the immune sera. Interestingly, residues 188 and 193 locate in classical antigen sites but are relatively conserved among the 16 tested strains and 1,663 HA sequences from NCBI database. Thus, our results strongly indicate that it is feasible to develop broad cross-H5 influenza vaccines against HA head.	[Wang, Guiqin; Yin, Renfu; Ding, Zhuang] Jilin Univ, Coll Vet Med, Lab Infect Dis, Chinese Minist Educ,Key Lab Zoonosis Res, Changchun, Peoples R China; [Wang, Guiqin; Zhou, Paul] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China	Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Ding, Z (corresponding author), Jilin Univ, Coll Vet Med, Lab Infect Dis, Chinese Minist Educ,Key Lab Zoonosis Res, Changchun, Peoples R China.	dingzhuang@jlu.edu.cn			Chinese National Science Foundation [31400790]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese National Science Foundation (grant number: 31400790) and grant recipient is Guiqin Wang.	Andrews Sarah F., 2015, SCI TRANSL MED, V7; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Ducatez MF, 2011, P NATL ACAD SCI USA, V108, P349, DOI 10.1073/pnas.1012457108; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Khurana S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006366; Krammer F, 2015, CELL HOST MICROBE, V18, P395, DOI 10.1016/j.chom.2015.10.003; Krammer F, 2012, J VIROL, V86, P10302, DOI 10.1128/JVI.01336-12; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Neu KE, 2016, CURR OPIN IMMUNOL, V42, P48, DOI 10.1016/j.coi.2016.05.012; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Wang GQ, 2014, J INFECT DIS, V209, P676, DOI 10.1093/infdis/jit414; Weaver EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018314; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Zhou F, 2012, J VIROL, V86, P6970, DOI 10.1128/JVI.06930-11; Zuo T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9855	26	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0176854	10.1371/journal.pone.0176854	http://dx.doi.org/10.1371/journal.pone.0176854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542275	Green Published, gold, Green Submitted			2022-12-27	WOS:000402061500008
J	Blystad, I; Warntjes, JBM; Smedby, O; Lundberg, P; Larsson, EM; Tisell, A				Blystad, Ida; Warntjes, J. B. Marcel; Smedby, Orjan; Lundberg, Peter; Larsson, Elna-Marie; Tisell, Anders			Quantitative MRI for analysis of peritumoral edema in malignant gliomas	PLOS ONE			English	Article							RECURRENT GLIOBLASTOMA; TUMOR PROGRESSION; PATTERN-ANALYSIS; PSEUDOPROGRESSION; DIFFUSION; BRAIN; DIFFERENTIATION; QUANTIFICATION; PERFUSION; RESECTION	Background and purpose Damage to the blood-brain barrier with subsequent contrast enhancement is a hallmark of glioblastoma. Non-enhancing tumor invasion into the peritumoral edema is, however, not usually visible on conventional magnetic resonance imaging. New quantitative techniques using relaxometry offer additional information about tissue properties. The aim of this study was to evaluate longitudinal relaxation R-1, transverse relaxation R-2, and proton density in the peritumoral edema in a group of patients with malignant glioma before surgery to assess whether relaxometry can detect changes not visible on conventional images. Methods In a prospective study, 24 patients with suspected malignant glioma were examined before surgery. A standard MRI protocol was used with the addition of a quantitative MR method (MAGIC), which measured R-1, R-2, and proton density. The diagnosis of malignant glioma was confirmed after biopsy/surgery. In 19 patients synthetic MR images were then created from the MAGIC scan, and ROIs were placed in the peritumoral edema to obtain the quantitative values. Dynamic susceptibility contrast perfusion was used to obtain cerebral blood volume (rCBV) data of the peritumoral edema. Voxel-based statistical analysis was performed using a mixed linear model. Results R-1, R-2, and rCBV decrease with increasing distance from the contrast-enhancing part of the tumor. There is a significant increase in R1 gradient after contrast agent injection (P<.0001). There is a heterogeneous pattern of relaxation values in the peritumoral edema adjacent to the contrast-enhancing part of the tumor. Conclusion Quantitative analysis with relaxometry of peritumoral edema in malignant gliomas detects tissue changes not visualized on conventional MR images. The finding of decreasing R-1 and R-2 means shorter relaxation times closer to the tumor, which could reflect tumor invasion into the peritumoral edema. However, these findings need to be validated in the future.	[Blystad, Ida; Smedby, Orjan] Linkoping Univ, Dept Radiol, Linkoping, Sweden; [Blystad, Ida; Smedby, Orjan] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Blystad, Ida; Warntjes, J. B. Marcel; Smedby, Orjan; Lundberg, Peter; Larsson, Elna-Marie; Tisell, Anders] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Warntjes, J. B. Marcel] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Smedby, Orjan] KTH Royal Inst Technol, Sch Technol & Hlth, Stockholm, Sweden; [Lundberg, Peter; Tisell, Anders] Linkoping Univ, Dept Radiat Phys, Linkoping, Sweden; [Lundberg, Peter; Tisell, Anders] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Larsson, Elna-Marie] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Royal Institute of Technology; Linkoping University; Linkoping University; Uppsala University	Blystad, I (corresponding author), Linkoping Univ, Dept Radiol, Linkoping, Sweden.; Blystad, I (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.; Blystad, I (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden.	ida.blystad@regionostergotland.se		Blystad, Ida/0000-0002-8857-5698; Smedby, Orjan/0000-0002-7750-1917	Medical Research Council of Southeast Sweden [FORSS-234551]	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Medical Research Council of Southeast Sweden, grant number FORSS-234551 (http://www.fou.nu/is/forss/).	Akbari H, 2016, NEUROSURGERY, V78, P572, DOI 10.1227/NEU.0000000000001202; Akbari H, 2014, RADIOLOGY, V273, P502, DOI 10.1148/radiol.14132458; Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Blasel S, 2010, ACTA NEUROCHIR, V152, P1893, DOI 10.1007/s00701-010-0774-7; Boxerman JL, 2014, AM J CLIN ONCOL; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Chaichana KL, 2014, NEURO-ONCOLOGY, V16, P113, DOI 10.1093/neuonc/not137; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Deoni SCL, QUANTITATIVE RELAXOM; Eisele SC, 2016, CURR TREAT OPTION ON, V17, DOI 10.1007/s11864-016-0413-5; Ellingson BM, 2012, J NEURO-ONCOL, V106, P111, DOI 10.1007/s11060-011-0638-x; Grabowski MM, 2014, J NEUROSURG, V121, P1115, DOI 10.3171/2014.7.JNS132449; Hattingen E, 2013, NEURO-ONCOLOGY, V15, P1395, DOI 10.1093/neuonc/not105; da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397; Jain R, 2014, RADIOLOGY, V272, P484, DOI 10.1148/radiol.14131691; Lemee JM, 2015, J NEURO-ONCOL, V122, P53, DOI 10.1007/s11060-014-1695-8; Lemercier P, 2014, AM J ROENTGENOL, V203, P163, DOI 10.2214/AJR.13.11186; Lescher S, 2014, NEURORADIOLOGY; Li YM, 2016, J NEUROSURG, V124, P977, DOI 10.3171/2015.5.JNS142087; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Prager AJ, 2015, AM J NEURORADIOL, V36, P877, DOI 10.3174/ajnr.A4218; Saitta L, 2011, EUR RADIOL, V21, P1068, DOI 10.1007/s00330-010-2004-3; Shiroishi MS, 2016, NEURO-ONCOLOGY, V18, P467, DOI 10.1093/neuonc/nov179; Wang S, 2016, AM J NEURORADIOL, V37, P28, DOI 10.3174/ajnr.A4474; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; Yan JL, 2016, J NEUROSURG, P1; Young RJ, 2013, CLIN IMAG, V37, P41, DOI 10.1016/j.clinimag.2012.02.016; Zetterling M, 2016, J NEUROSURG, V125, P1155, DOI 10.3171/2015.10.JNS15583; Zhang H, 2014, EUR J RADIOL, V83, P2181, DOI 10.1016/j.ejrad.2014.09.018	29	49	53	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177135	10.1371/journal.pone.0177135	http://dx.doi.org/10.1371/journal.pone.0177135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542553	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800007
J	Jun, HY; Kim, TH; Choi, JW; Lee, YH; Lee, KK; Yoon, KH				Jun, Hong Young; Kim, Tae-Hoon; Choi, Jin Woo; Lee, Young Hwan; Lee, Kang Kyoo; Yoon, Kwon-Ha			Evaluation of connectivity map-discovered celastrol as a radiosensitizing agent in a murine lung carcinoma model: Feasibility study of diffusion-weighted magnetic resonance imaging	PLOS ONE			English	Article							TUMOR RESPONSE; CANCER; MRI; RADIATION; CHEMOTHERAPY; THERAPY; CHEMORADIOTHERAPY; INHIBITION; MECHANISMS; MOLECULES	This study was designed to identify potential radiosensitizing (RS) agents for combined radio-and chemotherapy in a murine model of human lung carcinoma, and to evaluate the in vivo effect of the RS agents using diffusion-weighted magnetic resonance imaging (DWMRI). Radioresistance-associated genes in A549 and H460 cells were isolated on the basis of their gene expression profiles. Celastrol was selected as a candidate RS by using connectivity mapping, and its efficacy in lung cancer radiotherapy was tested. Mice inoculated with A549 carcinoma cells were treated with single ionizing radiation (SIR), single celastrol (SC), or celastrol-combined ionizing radiation (CCIR). Changes in radiosensitization over time were assessed using DW-MRI before and at 3, 6, and 12 days after therapy initiation. The tumors were stained with hematoxylin and eosin at 6 and 12 days after therapy. The percentage change in the apparent diffusion coefficient (ADC) value in the CCIR group was significantly higher than that in the SC and SIR group on the 12 th day (Mann-Whitney U-test, p = 0.05; Kruskal-Wallis test, p < 0.05). A significant correlation (Spearman's rho correlation coefficient of 0.713, p = 0.001) was observed between the mean percentage tumor necrotic area and the mean ADC values after therapy initiation. These results suggest that the novel radiosensitizing agent celastrol has therapeutic effects when combined with ionizing radiation (IR), thereby maximizing the therapeutic effect of radiation in non-small cell lung carcinoma. In addition, DW-MRI is a useful noninvasive tool to monitor the effects of RS agents by assessing cellularity changes and sequential therapeutic responses.	[Jun, Hong Young; Kim, Tae-Hoon; Yoon, Kwon-Ha] Wonkwang Univ Hosp, Imaging Sci Res Ctr, Iksan, South Korea; [Choi, Jin Woo] Kyung Hee Univ, Coll Pharm, Lab Pharmacogenet, Seoul, South Korea; [Lee, Young Hwan; Yoon, Kwon-Ha] Wonkwang Univ, Sch Med, Dept Radiol, Iksan, South Korea; [Lee, Kang Kyoo] Wonkwang Univ, Sch Med, Dept Radiat Oncol, Iksan, South Korea	Wonkwang University; Kyung Hee University; Wonkwang University; Wonkwang University	Yoon, KH (corresponding author), Wonkwang Univ Hosp, Imaging Sci Res Ctr, Iksan, South Korea.; Yoon, KH (corresponding author), Wonkwang Univ, Sch Med, Dept Radiol, Iksan, South Korea.	khy1646@wku.ac.kr		Kim, Tae-Hoon/0000-0002-2552-0665	National Research Foundation of Korea; Korean government (MSIP) [NRF-2016M3A9A7918501]; Ministry of Health and Welfare, Republic of Korea [HI16C0062, HI12C0110]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MSIP); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the National Research Foundation of Korea and the Korean government (MSIP), NRF-2016M3A9A7918501 (Professor Kwon-Ha Yoon); the Ministry of Health and Welfare, Republic of Korea, HI16C0062 (Professor Kwon-Ha Yoon); and the Ministry of Health and Welfare, Republic of Korea, HI12C0110, (Professor Kwon-Ha Yoon).	Charles-Edwards Elizabeth M, 2006, Cancer Imaging, V6, P135, DOI 10.1102/1470-7330.2006.0021; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Hassane DC, 2010, BLOOD, V116, P5983, DOI 10.1182/blood-2010-04-278044; Heijmen L, 2012, CRIT REV ONCOL HEMAT, V83, P194, DOI 10.1016/j.critrevonc.2011.12.008; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Im Chang-Nim, 2013, Genomics & Informatics, V11, P245, DOI 10.5808/GI.2013.11.4.245; Jiang QW, 2015, ONCOTARGET, V6, P32790, DOI 10.18632/oncotarget.5411; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kumaraswamy S, 2008, CANCER RES, V68, P3819, DOI 10.1158/0008-5472.CAN-08-0016; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee JH, 2011, INT J MOL MED, V27, P441, DOI 10.3892/ijmm.2011.601; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu Y, 2015, INT J GYNECOL CANCER, V25, P1073, DOI 10.1097/IGC.0000000000000472; Matsuoka Y, 2014, EUR UROL, V65, P186, DOI 10.1016/j.eururo.2012.10.010; Morris ZS, 2014, J CLIN ONCOL, V32, P2886, DOI 10.1200/JCO.2014.55.1366; Morse DL, 2007, NMR BIOMED, V20, P602, DOI 10.1002/nbm.1127; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Provencio M, 2014, TRANSL LUNG CANCER R, V3, P89, DOI 10.3978/j.issn.2218-6751.2014.03.06; Seo HR, 2011, CHEM-BIOL INTERACT, V193, P34, DOI 10.1016/j.cbi.2011.04.009; Setty AR, 2005, SEMIN ARTHRITIS RHEU, V34, P773, DOI 10.1016/j.semarthrit.2005.01.011; Sharma U, 2009, NMR BIOMED, V22, P104, DOI 10.1002/nbm.1245; Shi HS, 2012, INT J NANOMED, V7, P2601, DOI 10.2147/IJN.S31439; Sinkus R, 2012, EUR J CANCER, V48, P425, DOI 10.1016/j.ejca.2011.11.034; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Tian JQ, 2012, CLIN CANCER RES, V18, P3366, DOI 10.1158/1078-0432.CCR-11-3179; Vandecaveye V, 2012, INT J RADIAT ONCOL, V82, P1098, DOI 10.1016/j.ijrobp.2011.02.044; Vogel-Claussen J, 2007, CANCER BIOL THER, V6, P1469; Vokes EE, 2007, J CLIN ONCOL, V25, P1698, DOI 10.1200/JCO.2006.07.3569; Wang BS, 2014, TUMOR BIOL, V35, P81, DOI 10.1007/s13277-013-1009-3; Wang Y, 2011, RADIOGRAPHICS, V31, pE13, DOI 10.1148/rg.313105174; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zoberi I, 2002, CANCER LETT, V175, P165, DOI 10.1016/S0304-3835(01)00719-4	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178204	10.1371/journal.pone.0178204	http://dx.doi.org/10.1371/journal.pone.0178204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542649	Green Published, gold, Green Submitted			2022-12-27	WOS:000402058800047
J	Shiehzadegan, S; Thuy, JLV; Szabla, N; Angilletta, MJ; VandenBrooks, JM				Shiehzadegan, Shayan; Thuy, Jacqueline Le Vinh; Szabla, Natalia; Angilletta, Michael J., Jr.; VandenBrooks, John M.			More oxygen during development enhanced flight performance but not thermal tolerance of Drosophila melanogaster	PLOS ONE			English	Article							TEMPERATURE-DEPENDENT BIOGEOGRAPHY; DISCONTINUOUS GAS-EXCHANGE; MALE BODY-SIZE; ATMOSPHERIC OXYGEN; SPECIES PRODUCTION; DESICCATION RESISTANCE; CARBON-DIOXIDE; LIMITATION; HYPOXIA; METABOLISM	High temperatures can stress animals by raising the oxygen demand above the oxygen supply. Consequently, animals under hypoxia could be more sensitive to heating than those exposed to normoxia. Although support for this model has been limited to aquatic animals, oxygen supply might limit the heat tolerance of terrestrial animals during energetically demanding activities. We evaluated this model by studying the flight performance and heat tolerance of flies (Drosophila melanogaster) acclimated and tested at different concentrations of oxygen (12%, 21%, and 31%). We expected that flies raised at hypoxia would develop into adults that were more likely to fly under hypoxia than would flies raised at normoxia or hyperoxia. We also expected flies to benefit from greater oxygen supply during testing. These effects should have been most pronounced at high temperatures, which impair locomotor performance. Contrary to our expectations, we found little evidence that flies raised at hypoxia flew better when tested at hypoxia or tolerated extreme heat better than did flies raised at normoxia or hyperoxia. Instead, flies raised at higher oxygen levels performed better at all body temperatures and oxygen concentrations. Moreover, oxygen supply during testing had the greatest effect on flight performance at low temperature, rather than high temperature. Our results poorly support the hypothesis that oxygen supply limits performance at high temperatures, but do support the idea that hyperoxia during development improves performance of flies later in life.	[Shiehzadegan, Shayan; Thuy, Jacqueline Le Vinh; Angilletta, Michael J., Jr.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Szabla, Natalia] Jagiellonian Univ, Inst Environm Studies, Krakow, Poland; [VandenBrooks, John M.] Midwestern Univ, Dept Physiol, Glendale, AZ 85308 USA	Arizona State University; Arizona State University-Tempe; Jagiellonian University; Midwestern University	VandenBrooks, JM (corresponding author), Midwestern Univ, Dept Physiol, Glendale, AZ 85308 USA.	jvandenbrooks@midwestern.edu		Szabla, Natalia/0000-0002-2925-9580	School of Life Sciences; Barrett Honors College at Arizona State University; Midwestern University; EU resources under the European Social Fund [POKL 04.01.01-00-053/09]	School of Life Sciences; Barrett Honors College at Arizona State University; Midwestern University; EU resources under the European Social Fund	This research was funded by the School of Life Sciences, the Barrett Honors College at Arizona State University, and Midwestern University. N. Szabla was supported by project co-founded from EU resources under the European Social Fund (POKL 04.01.01-00-053/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Marcin Czarnoleski for discussions related to the ideas in this paper. This research was funded by the School of Life Sciences, the Barrett Honors College at Arizona State University, and Midwestern University. N. Szabla was supported by project co-founded from EU resources under the European Social Fund (POKL 04.01.01-00-053/09).	Alcock J, 2006, ETHOLOGY, V112, P691, DOI 10.1111/j.1439-0310.2006.01204.x; Ali SS, 2010, J BIOL CHEM, V285, P32522, DOI 10.1074/jbc.M110.155432; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Bartholomew NR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15298; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Boardman L, 2012, P ROY SOC B-BIOL SCI, V279, P893, DOI 10.1098/rspb.2011.1243; Bubliy OA, 2012, J EVOLUTION BIOL, V25, P1180, DOI 10.1111/j.1420-9101.2012.02506.x; BURKETT BN, 1974, BIOL BULL-US, V147, P274, DOI 10.2307/1540449; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Callier V, 2015, J EXP BIOL, V218, P2927, DOI 10.1242/jeb.125849; Centanin L, 2010, J INSECT PHYSIOL, V56, P447, DOI 10.1016/j.jinsphys.2009.05.008; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Coelho JR, 2001, J INSECT BEHAV, V14, P345, DOI 10.1023/A:1011119312500; Condon C, 2015, ECOL EVOL, V5, P1873, DOI 10.1002/ece3.1472; Ern R, 2015, SCI REPORTS, P5; Feder ME, 1999, AM ZOOL, V39, P857; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; Frederich M, 2000, AM J PHYSIOL-REG I, V279, pR1531, DOI 10.1152/ajpregu.2000.279.5.R1531; Gibbs AG, 1997, J EXP BIOL, V200, P1821; Greenberg S, 1996, J INSECT PHYSIOL, V42, P991, DOI 10.1016/S0022-1910(96)00071-6; Harrison JF, 1998, J EXP BIOL, V201, P1739; Harrison JF, 2010, ATMOSPHERIC OXYGEN L; Harrison JF, 2008, MOL MIGRATION PRESSU, P293; Harrison JF, 2013, ECOL EVOL, V3, P1305, DOI 10.1002/ece3.551; Harrison JF, 2010, P ROY SOC B-BIOL SCI, V277, P1937, DOI 10.1098/rspb.2010.0001; He JZ, 2013, COMP BIOCHEM PHYS A, V165, P207, DOI 10.1016/j.cbpa.2013.03.007; Heinrich EC, 2013, J EXP BIOL, V216, P4473, DOI 10.1242/jeb.088450; Henry JR, 2004, J EXP BIOL, V207, P3559, DOI 10.1242/jeb.01189; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; HILLEL D., 1971, Soil and Water: Physical Principles and Processes. (Physiological Ecology: a Series of Monographs and Treatises).; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hulbert AJ, 2003, J EXP BIOL, V206, P2303, DOI 10.1242/jeb.00399; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Kaiser A, 2007, P NATL ACAD SCI USA, V104, P13198, DOI 10.1073/pnas.0611544104; Klok CJ, 2009, J EVOLUTION BIOL, V22, P2496, DOI 10.1111/j.1420-9101.2009.01866.x; Klok CJ, 2010, J INSECT PHYSIOL, V56, P461, DOI 10.1016/j.jinsphys.2009.08.004; Klok CJ, 2004, J EXP BIOL, V207, P2361, DOI 10.1242/jeb.01023; Le Vinh Thuy J, 2016, BIOL LETT; Lighton JRB, 2004, J EXP BIOL, V207, P4463, DOI 10.1242/jeb.01284; Logue JA, 2000, J EXP BIOL, V203, P2105; LOUDON C, 1989, J EXP BIOL, V147, P217; MARDEN JH, 1989, ECOLOGY, V70, P496, DOI 10.2307/1937553; Matthews PGD, 2012, BIOL LETTERS, V8, P682, DOI 10.1098/rsbl.2012.0137; Matzkin LM, 2007, FLY, V1, P268, DOI 10.4161/fly.5293; McCue MD, 2013, PHYSIOL BIOCHEM ZOOL, V86, P257, DOI 10.1086/669932; Molich AB, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.10901; Peck LS, 2005, J EXP ZOOL PART A, V303A, P968, DOI 10.1002/jez.a.211; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Portner HO, 2010, J EXP BIOL, P213; R Core Team, 2021, R LANGUAGE ENV STAT; Rascon B, 2010, J EXP BIOL, V213, P3441, DOI 10.1242/jeb.044867; Samejima Y, 2010, BEHAV ECOL SOCIOBIOL, V64, P685, DOI 10.1007/s00265-009-0886-3; Serrano-Meneses MA, 2007, ANIM BEHAV, V73, P987, DOI 10.1016/j.anbehav.2006.08.012; Smith AA, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0947; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Suarez RK, 2000, PHYSIOL BIOCHEM ZOOL, V73, P765, DOI 10.1086/318112; Van Dijk PLM, 1999, J EXP BIOL, V202, P3611; Van Voorhies WA, 2009, J EXP BIOL, V212, P3132, DOI 10.1242/jeb.031179; VandenBrooks JM, 2012, EVOL BIOL, V39, P83, DOI 10.1007/s11692-011-9138-3; Verberk WCEP, 2013, INTEGR COMP BIOL, V53, P609, DOI 10.1093/icb/ict015; Verberk WCEP, 2016, COMP BIOCHEM PHYS A, V192, P64, DOI 10.1016/j.cbpa.2015.10.020; Verberk WCEP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0473; WIGGLESWORTH VB, 1982, TISSUE CELL, V14, P501, DOI 10.1016/0040-8166(82)90043-X; Woods HA, 1999, AM ZOOL, V39, P244; Woods HA, 2004, J EXP BIOL, V207, P2267, DOI 10.1242/jeb.00991; Zuur Alain F., 2009, P1	69	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177827	10.1371/journal.pone.0177827	http://dx.doi.org/10.1371/journal.pone.0177827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542380	Green Published, Green Submitted, gold			2022-12-27	WOS:000402058800027
J	Barlow, RS; McMillan, KE; Duffy, LL; Fegan, N; Jordan, D; Mellor, GE				Barlow, Robert S.; McMillan, Kate E.; Duffy, Lesley L.; Fegan, Narelle; Jordan, David; Mellor, Glen E.			Antimicrobial resistance status of Enterococcus from Australian cattle populations at slaughter	PLOS ONE			English	Article							ESCHERICHIA-COLI; FOOD; DAPTOMYCIN; TIGECYCLINE; FAECIUM; ANIMALS; HEALTH; SUSCEPTIBILITY; SALMONELLA; PREVALENCE	Antimicrobial agents are used in cattle production systems for the prevention and control of bacterial associated diseases. A consequence of their use is the potential development of antimicrobial resistance (AMR). Enterococcus faecium and Enterococcus faecalis that are resistant to antimicrobials are of increased concern to public health officials throughout the world as they may compromise the ability of various treatment regimens to control disease and infection in human medicine. Australia is a major exporter of beef; however it does not have an ongoing surveillance system for AMR in cattle or foods derived from these animals. This study examined 910 beef cattle, 290 dairy cattle and 300 veal calf faecal samples collected at slaughter for the presence of enterococci. Enterococcus were isolated from 805 (88.5%) beef cattle faeces, 244 (84.1%) dairy cattle faeces and 247 (82.3%) veal calf faeces with a total of 800 enterococci subsequently selected for AMR testing. The results of AMR testing identified high levels of resistance to antimicrobials that are not critically or highly important to human medicine with resistance to flavomycin (80.2%) and lincomycin (85.4-94.2%) routinely observed. Conversely, resistance to antibiotics considered critically or highly important to human medicine such as tigecycline, daptomycin, vancomycin and linezolid was not present in this study. There is minimal evidence that Australian cattle production practices are responsible for disproportionate contributions to AMR development and in general resistance to antimicrobials of critical and high importance in human medicine was low regardless of the isolate source. The low level of antimicrobial resistance in Enterococcus from Australian cattle is likely to result from comprehensive controls around the use of antimicrobials in food-production animals in Australia. Nevertheless, continued monitoring of the effects of all antimicrobial use is required to support Australia's reputation as a supplier of safe and healthy food.	[Barlow, Robert S.; McMillan, Kate E.; Duffy, Lesley L.; Mellor, Glen E.] CSIRO Agr & Food, Coopers Plains, Brisbane, Qld, Australia; [Fegan, Narelle] CSIRO Agr & Food, Werribee, Vic, Australia; [Jordan, David] New South Wales Dept Primary Ind, Wollongbar, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); NSW Department of Primary Industries	Barlow, RS (corresponding author), CSIRO Agr & Food, Coopers Plains, Brisbane, Qld, Australia.	Robert.Barlow@csiro.au	Duffy, Lesley L/G-1667-2011; McMillan, Kate/T-5838-2019; Barlow, Robert/AFQ-3671-2022; Jordan, David/P-7281-2019; Fegan, Narelle/K-5316-2012; Barlow, Robert/H-6759-2013; Mellor, Glen/P-8717-2019	Duffy, Lesley L/0000-0001-6347-528X; McMillan, Kate/0000-0001-8179-2502; Barlow, Robert/0000-0001-8913-1178; Fegan, Narelle/0000-0002-1729-9630; Barlow, Robert/0000-0001-8913-1178; Mellor, Glen/0000-0003-2849-2687	Meat & Livestock Australia (MLA); Commonwealth Scientific and Industrial Research Organisation (CSIRO)	Meat & Livestock Australia (MLA)(Meat and Livestock Australia); Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	The authors received funding from Meat & Livestock Australia (MLA) and the Commonwealth Scientific and Industrial Research Organisation (CSIRO) for this work.; The authors thank Dr Darren Trott, Dr Sam Abraham, Dr John Turnidge and Dr Stephen Page for their assistance with the design of the study and analysis of results. We gratefully acknowledge funding from Meat & Livestock Australia and the Commonwealth Scientific and Industrial Research Organisation (CSIRO). We also acknowledge the significant contribution of samples from processing establishments, without which this project would not have been possible.	Aarestrup FM, 1999, INT J ANTIMICROB AG, V12, P279, DOI 10.1016/S0924-8579(99)90059-6; Abraham S, 2014, INT J ANTIMICROB AG, V43, P126, DOI 10.1016/j.ijantimicag.2013.10.014; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Barlow R., 2008, PILOT SURVEY ANTIMIC; Barlow RS, 2015, J FOOD PROTECT, V78, P912, DOI 10.4315/0362-028X.JFP-14-476; Barton M., 2003, COMMUNICABLE DIS I S, V27, P121; Butaye P, 1998, J CLIN MICROBIOL, V36, P1907, DOI 10.1128/JCM.36.7.1907-1911.1998; Cattoir V, 2015, ANTIMICROB AGENTS CH, V59, P239, DOI 10.1128/AAC.04174-14; Collignon P, 2006, J INFECT DIS, V194, P8, DOI 10.1086/504922; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Department of Agriculture Fisheries and Forestry, 2007, PILOT SURVEILLANCE P; Diaz L, 2014, ANTIMICROB AGENTS CH, V58, P4527, DOI 10.1128/AAC.02686-14; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P24, DOI 10.1128/JCM.33.1.24-27.1995; Fiedler S, 2016, J ANTIMICROB CHEMOTH, V71, P871, DOI 10.1093/jac/dkv420; Hammerum AM, 2012, CLIN MICROBIOL INFEC, V18, P619, DOI 10.1111/j.1469-0691.2012.03829.x; Hao HH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01626; Heuer OE, 2006, CLIN INFECT DIS, V43, P911, DOI 10.1086/507534; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Jackson CR, 2011, LETT APPL MICROBIOL, V52, P41, DOI 10.1111/j.1472-765X.2010.02964.x; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Ke DB, 1999, J CLIN MICROBIOL, V37, P3497, DOI 10.1128/JCM.37.11.3497-3503.1999; Kelesidis T, 2011, CLIN INFECT DIS, V52, P228, DOI 10.1093/cid/ciq113; Meat & Livestock Australia, 2016, FAST FACTS 2016 AUST; Ramos S, 2012, ANN MICROBIOL, V62, P1485, DOI 10.1007/s13213-011-0402-7; Rathe M, 2010, APMIS, V118, P66, DOI 10.1111/j.1600-0463.2009.02559.x; Szmolka A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00258; Walsh C, 2008, CURR DRUG TARGETS, V9, P808, DOI 10.2174/138945008785747761; World Health Organisation, 2011, CRIT IMP ANT HUM NED	29	14	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177728	10.1371/journal.pone.0177728	http://dx.doi.org/10.1371/journal.pone.0177728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542602	gold, Green Published, Green Submitted			2022-12-27	WOS:000401672400071
J	Dagnino-Leone, J; Figueroa, M; Mella, C; Vorphal, MA; Kerff, F; Vasquez, AJ; Bunster, M; Martinez-Oyanedel, J				Dagnino-Leone, Jorge; Figueroa, Maximiliano; Mella, Claudia; Alejandra Vorphal, Maria; Kerff, Frederic; Jose Vasquez, Aleikar; Bunster, Marta; Martinez-Oyanedel, Jose			Structural models of the different trimers present in the core of phycobilisomes from Gracilaria chilensis based on crystal structures and sequences	PLOS ONE			English	Article							TERMINAL ENERGY ACCEPTOR; CYANOBACTERIAL PHYCOBILISOMES; CONFORMATIONAL FLEXIBILITY; MOLECULAR CHARACTERIZATION; 2.2 ANGSTROM; L-CM; LIGHT; ALLOPHYCOCYANIN; LINKER; PHYCOCYANOBILIN	Phycobilisomes (PBS) are accessory light harvesting protein complexes that directionally transfer energy towards photosystems. Phycobilisomes are organized in a central core and rods radiating from it. Components of phycobilisomes in Gracilaria chilensis (Gch) are Phycobiliproteins (PBPs), Phycoerythrin (PE), and Phycocyanin (PC) in the rods, while Allophycocyanin (APC) is found in the core, and linker proteins (L). The function of such complexes depends on the structure of each component and their interaction. The core of PBS from cyanobacteria is mainly composed by cylinders of trimers of alpha and beta subunits forming heterodimers of Allophycocyanin, and other components of the core including subunits alpha(II) and beta(18). As for the linkers, Linker core (L-C) and Linker core membrane (L-CM) are essential for the final emission towards photoreaction centers. Since we have previously focused our studies on the rods of the PBS, in the present article we investigated the components of the core in the phycobilisome from the eukaryotic algae, Gracilaria chilensis and their organization into trimers. Transmission electron microscopy provided the information for a three cylinders core, while the three dimensional structure of Allophycocyanin purified from Gch was determined by X-ray diffraction method and the biological unit was determined as a trimer by size exclusion chromatography. The protein sequences of all the components of the core were obtained by sequencing the corresponding genes and their expression confirmed by transcriptomic analysis. These subunits have seldom been reported in red algae, but not in Gracilaria chilensis. The subunits not present in the crystallographic structure were modeled to build the different composition of trimers. This article proposes structural models for the different types of trimers present in the core of phycobilisomes of Gch as a first step towards the final model for energy transfer in this system.	[Dagnino-Leone, Jorge; Figueroa, Maximiliano; Mella, Claudia; Alejandra Vorphal, Maria; Jose Vasquez, Aleikar; Bunster, Marta; Martinez-Oyanedel, Jose] Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile; [Kerff, Frederic] Univ Liege, Ctr Ingn Proteines, Liege, Belgium	Universidad de Concepcion; University of Liege	Bunster, M; Martinez-Oyanedel, J (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile.	mbunster@udec.cl; jmartine@udec.cl		Bunster, Marta/0000-0002-2261-2484; Dagnino-Leone, Jorge/0000-0002-5354-6782	FONDECYT [113.0256]; FONDECYT Doctoral [21120260]; CONICYT scholarship	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDECYT Doctoral; CONICYT scholarship(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT 113.0256 grant to MB, FONDECYT Doctoral grant 21120260 to JDL, CONICYT scholarship to JDL and CR_Lab Biofisica Molecular 2015-2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Adir N., 2006, COMPLEX INTRACELLULA, VVolume 2, P47; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Vorphal MA, 2017, MAR GENOM, V31, P17, DOI 10.1016/j.margen.2016.11.001; Arteni AA, 2009, BBA-BIOENERGETICS, V1787, P272, DOI 10.1016/j.bbabio.2009.01.009; BIRD CJ, 1986, CAN J BOT, V64, P2928, DOI 10.1139/b86-387; CAPUANO V, 1991, J BIOL CHEM, V266, P7239; Chang LF, 2015, CELL RES, V25, P726, DOI 10.1038/cr.2015.59; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Contreras-Martel C, 2001, ACTA CRYSTALLOGR D, V57, P52, DOI 10.1107/S0907444900015274; Contreras-Martel C, 2007, BIOPHYS CHEM, V125, P388, DOI 10.1016/j.bpc.2006.09.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueroa M, 2012, PROTEIN SCI, V21, P1921, DOI 10.1002/pro.2176; Frisch MJ, GAUSSIAN 09 REV A, V1; Gao X, 2012, MOL MICROBIOL, V85, P907, DOI 10.1111/j.1365-2958.2012.08152.x; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Goller AH, 2001, CHEMPHYSCHEM, V2, P665, DOI 10.1002/1439-7641(20011119)2:11<665::AID-CPHC665>3.0.CO;2-O; Guan XY, 2007, INT J BIOL SCI, V3, P434; Hagopian JC, 2004, J MOL EVOL, V59, P464, DOI 10.1007/s00239-004-2638-3; Harris D, 2016, P NATL ACAD SCI USA, V113, pE1655, DOI 10.1073/pnas.1523680113; HOUMARD J, 1990, P NATL ACAD SCI USA, V87, P2152, DOI 10.1073/pnas.87.6.2152; Jallet D, 2012, BBA-BIOENERGETICS, V1817, P1418, DOI 10.1016/j.bbabio.2011.11.020; Kuzminov FI, 2014, J PHOTOCH PHOTOBIO B, V133, P153, DOI 10.1016/j.jphotobiol.2014.03.012; Liu JY, 1999, J BIOL CHEM, V274, P16945, DOI 10.1074/jbc.274.24.16945; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUNDELL DJ, 1983, J BIOL CHEM, V258, P902; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; MacColl R, 2004, BBA-BIOENERGETICS, V1657, P73, DOI 10.1016/j.bbabio.2004.04.005; MAXSON P, 1989, BIOCHIM BIOPHYS ACTA, V977, P40, DOI 10.1016/S0005-2728(89)80007-6; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; Piovesan D, 2017, NUCLEIC ACIDS RES, V45, pD1123, DOI 10.1093/nar/gkw1279; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Sun L, 2009, BACTERIOL RES DEV, P105; Tal O, 2014, J BIOL CHEM; Tang K, 2015, P NATL ACAD SCI USA, V112, P15880, DOI 10.1073/pnas.1519177113; Tu PH, 2009, J MOL STRUC-THEOCHEM, V894, P9, DOI 10.1016/j.theochem.2008.09.034; Watanabe M, 2013, PHOTOSYNTH RES, V116, P265, DOI 10.1007/s11120-013-9905-3; Webb B., 2002, CURRENT PROTOCOLS BI; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008	43	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177540	10.1371/journal.pone.0177540	http://dx.doi.org/10.1371/journal.pone.0177540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542288	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400051
J	Liu, FQ; Sulpizio, S; Kornpetpanee, S; Job, R				Liu, Fengqin; Sulpizio, Simone; Kornpetpanee, Suchada; Job, Remo			It takes biking to learn: Physical activity improves learning a second language	PLOS ONE			English	Article							COLLEGE STEP TEST; VOCABULARY ACQUISITION; ACUTE EXERCISE; BRAIN; PERFORMANCE; CHILDREN; MEMORY; REPRESENTATIONS; NEUROGENESIS; TRANSLATION	Recent studies have shown that concurrent physical activity enhances learning a completely unfamiliar L2 vocabulary as compared to learning it in a static condition. In this paper we report a study whose aim is twofold: to test for possible positive effects of physical activity when L2 learning has already reached some level of proficiency, and to test whether the assumed better performance when engaged in physical activity is limited to the linguistic level probed at training (i.e. L2 vocabulary tested by means of a Word-Picture Verification task), or whether it extends also to the sentence level ( which was tested by means of a Sentence Semantic Judgment Task). The results show that Chinese speakers with basic knowledge of English benefited from physical activity while learning a set of new words. Furthermore, their better performance emerged also at the sentential level, as shown by their performance in a Semantic Judgment task. Finally, an interesting temporal asymmetry between the lexical and the sentential level emerges, with the difference between the experimental and control group emerging from the 1(st) testing session at the lexical level but after several weeks at the sentential level.	[Liu, Fengqin] Dali Univ, Dali, Peoples R China; [Sulpizio, Simone] Univ Vita Salute San Raffaele, Milan, Italy; [Sulpizio, Simone] Fdn Marica De Vincenzi Onlus, Rovereto, TN, Italy; [Kornpetpanee, Suchada] Burapha Univ, Bangsaen, Thailand; [Job, Remo] Univ Trento, Trento, Italy	Dali University; Vita-Salute San Raffaele University; Burapha University; University of Trento	Sulpizio, S (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.; Sulpizio, S (corresponding author), Fdn Marica De Vincenzi Onlus, Rovereto, TN, Italy.	sulpizio.simone@hsr.it	Sulpizio, Simone/AAA-7077-2019	Sulpizio, Simone/0000-0002-4051-9494				[Anonymous], [No title captured]; [Anonymous], 1993, BILINGUAL LEXICON, DOI DOI 10.1075/SIBIL.6; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Boroditsky L, 2001, COGNITIVE PSYCHOL, V43, P1, DOI 10.1006/cogp.2001.0748; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Carey S., 1978, P STANFORD CHILD LAN, V15, P17; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chatterjee S, 2005, INDIAN J MED RES, V121, P32; Chatterjee S, 2004, BRIT J SPORT MED, V38, P289, DOI 10.1136/bjsm.2002.002212; Christie BR, 2008, NEUROMOL MED, V10, P47, DOI 10.1007/s12017-008-8033-2; Comesana M, 2010, PROCD SOC BEHV, V5, P199, DOI 10.1016/j.sbspro.2010.07.072; Comesana M, 2009, J EXP CHILD PSYCHOL, V104, P22, DOI 10.1016/j.jecp.2008.10.004; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Cubelli R, 2011, J EXP PSYCHOL LEARN, V37, P449, DOI 10.1037/a0021965; Daikoku T, 2017, NEUROL RES, V39, P107, DOI 10.1080/01616412.2016.1273571; Etnier JL, 1997, J SPORT EXERCISE PSY, V19, P249, DOI 10.1123/jsep.19.3.249; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Floel A, 2010, NEUROIMAGE, V49, P2756, DOI 10.1016/j.neuroimage.2009.10.043; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; GODDEN DR, 1975, BRIT J PSYCHOL, V66, P325, DOI 10.1111/j.2044-8295.1975.tb01468.x; Gold SM, 2003, J NEUROIMMUNOL, V138, P99, DOI 10.1016/S0165-5728(03)00121-8; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kempermann G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00189; Kramer AF, 2006, PSYCHOBIOLOGY PHYS A, P45; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lotto L, 1999, MEM COGNITION, V27, P674, DOI 10.3758/BF03211561; MCARDLE WD, 1972, MED SCI SPORT EXER, V4, P182; McArdle WD, 1994, ESSENTIALS EXERCISE; Ploughman M, 2008, DEV NEUROREHABIL, V11, P236, DOI 10.1080/17518420801997007; Poarch GJ, 2015, BILING-LANG COGN, V18, P357, DOI 10.1017/S1366728914000558; POTTER MC, 1984, J VERB LEARN VERB BE, V23, P23, DOI 10.1016/S0022-5371(84)90489-4; Rieber R., 2013, DIALOGUES PSYCHOL LA; Schmidt-Kassow M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064172; Schmidt-Kassow M, 2010, NEUROSCI LETT, V482, P40, DOI 10.1016/j.neulet.2010.06.089; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Song JH, 2015, PSYCHOL SCI, V26, P148, DOI 10.1177/0956797614557868; Thierry G, 2007, P NATL ACAD SCI USA, V104, P12530, DOI 10.1073/pnas.0609927104; Tonzar C, 2009, LANG LEARN, V59, P623, DOI 10.1111/j.1467-9922.2009.00519.x; Trudeau F, 2010, AM J LIFESTYLE MED, V4, P138, DOI 10.1177/1559827609351133; Uda M, 2006, BRAIN RES, V1104, P64, DOI 10.1016/j.brainres.2006.05.066; Uysal N, 2005, NEUROSCI LETT, V383, P241, DOI 10.1016/j.neulet.2005.04.054; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vega SR, 2006, BRAIN RES, V1121, P59, DOI 10.1016/j.brainres.2006.08.105; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Zheng Y., 2008, LANG TEST, V25, P408, DOI [10.1177/0265532208092433, DOI 10.1177/0265532208092433]	47	14	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177624	10.1371/journal.pone.0177624	http://dx.doi.org/10.1371/journal.pone.0177624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542333	Green Submitted, Green Published, gold			2022-12-27	WOS:000401672400059
J	Rhee, EJ; Han, K; Ko, SH; Ko, KS; Lee, WY				Rhee, Eun-Jung; Han, Kyungdo; Ko, Seung-Hyun; Ko, Kyung-Soo; Lee, Won-Young			Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: A nationwide population-based study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; LOW-DENSITY-LIPOPROTEIN; INSULIN-SECRETION; MULTIFACTORIAL INTERVENTION; GLUCOSE FLUCTUATION; OXIDATIVE STRESS; CELL APOPTOSIS; BLOOD-PRESSURE; VARIABILITY; ASSOCIATION	Background Recent studies suggest a role for hyperlipidemia in the development of diabetes. The aim of this study is to analyze the relationship between variations of total cholesterol (TC) levels and the risk for type 2 diabetes development from a Korean nationwide population-based database. Materials and methods We examined the General Health Check-up sub-dataset of the Korean National Health Insurance Service (NHIS) of 2,827,950 participants who had at least three health checkups between 2002 and 2007, and were not reported to have diabetes during that time. The variations of TC levels between the examinations were calculated as follows: TC-SD = root{Sigma(x(i) - (x) over bar)(2)/(n - 1)}. The examinees were divided into 10 groups according to TC variation, and the hazard ratio for diabetes development from 2007 to 2013, were analyzed. Results During the follow-up period, 3.4% of the participants had developed diabetes. The hazard ratio (HR) for diabetes development relative to the overall risk in the whole study population started to be higher than 1.0 from eighth decile of TC variation. The highest decile group showed an increased HR for diabetes development after adjustment for confounding variables (1.139; 95% confidence interval 1.116 similar to 1.163). These results were similar regardless of the use of anti-hyperlipidemic medication and baseline TC levels. Conclusions The participants with a large variation in TC levels showed an increased risk for diabetes development, independent of the use of anti-hyperlipidemic medications. These results suggest a relationship between fluctuations in lipid levels and the development of type 2 diabetes.	[Rhee, Eun-Jung; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Dept Biostat, Seoul, South Korea; [Ko, Seung-Hyun] Catholic Univ Korea, St Vincents Hosp, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Ko, Kyung-Soo] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Internal Med,Cardiovasc & Metab Dis Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Catholic University of Korea; Inje University	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea.	drlwy@hanmail.net	Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018	Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592				[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bacova Z, 2012, MED CHEM, V8, P65; Besseling J, 2015, JAMA-J AM MED ASSOC, V313, P1029, DOI 10.1001/jama.2015.1206; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cnop M, 2002, ENDOCRINOLOGY, V143, P3449, DOI 10.1210/en.2002-220273; Deshpande S, 2017, CURR MED RES OPIN, V33, P769, DOI 10.1080/03007995.2017.1281109; Dirkx R, 2012, J DIABETES INVEST, V3, P339, DOI 10.1111/j.2040-1124.2012.00200.x; Erion DM, 2016, BMB REP, V49, P139, DOI 10.5483/BMBRep.2016.49.3.268; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gosmanova EO, 2016, J AM COLL CARDIOL, V68, P1375, DOI 10.1016/j.jacc.2016.06.054; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Hirakawa Y, 2014, DIABETES CARE, V37, P2359, DOI 10.2337/dc14-0199; Kim M, 2012, DIABETES RES CLIN PR, V98, P132, DOI 10.1016/j.diabres.2012.04.013; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Lee J., 2016, INT J EPIDEMIOL; Lee YH, 2016, DIABETES METAB J, V40, P79, DOI 10.4093/dmj.2016.40.1.79; Park S, 2016, J AM SOC HYPERTENS, V10, P799, DOI 10.1016/j.jash.2016.08.004; Rhee EJ, 2015, ENDOCRINOL METAB, V30, P263, DOI 10.3803/EnM.2015.30.3.263; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Seo MH, 2011, J CLIN ENDOCR METAB, V96, pE2050, DOI 10.1210/jc.2011-1857; Souza JC, 2013, BBA-MOL CELL BIOL L, V1831, P769, DOI 10.1016/j.bbalip.2012.12.013; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Wada M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149452; Wu N, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0427-0; Zou X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093686	27	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176615	10.1371/journal.pone.0176615	http://dx.doi.org/10.1371/journal.pone.0176615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545051	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400011
J	Akhtar, RS; Xie, SX; Chen, YJ; Rick, J; Gross, RG; Nasrallah, IM; Van Deerlin, VM; Trojanowski, JQ; Chen-Plotkin, AS; Hurtig, HI; Siderowf, AD; Dubroff, JG; Weintraub, D				Akhtar, Rizwan S.; Xie, Sharon X.; Chen, Yin J.; Rick, Jacqueline; Gross, Rachel G.; Nasrallah, Ilya M.; Van Deerlin, Vivianna M.; Trojanowski, John Q.; Chen-Plotkin, Alice S.; Hurtig, Howard I.; Siderowf, Andrew D.; Dubroff, Jacob G.; Weintraub, Daniel			Regional brain amyloid-beta accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FLORBETAPIR F 18; APOLIPOPROTEIN-E EPSILON-4; VOLUME EFFECT CORRECTION; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; IN-VIVO; A-BETA; DIAGNOSTIC-CRITERIA; PET	Parkinson disease patients develop clinically significant cognitive impairment at variable times over their disease course, which is often preceded by milder deficits in memory, visuospatial, and executive domains. The significance of amyloid-beta accumulation to these problems is unclear. We hypothesized that amyloid-beta PET imaging by F-18-florbetapir, a radio-tracer that detects fibrillar amyloid-beta plaque deposits, would identify subjects with global cognitive impairment or poor performance in individual cognitive domains in non-demented Parkinson disease patients. We assessed 61 non-demented Parkinson disease patients with detailed cognitive assessments and F-18-florbetapir PET brain imaging. Scans were interpreted qualitatively (positive or negative) by two independent nuclear medicine physicians blinded to clinical data, and quantitatively by a novel volume-weighted method. The presence of mild cognitive impairment was determined through an expert consensus process using Level 1 criteria from the Movement Disorder Society. Nineteen participants (31.2%) were diagnosed with mild cognitive impairment and the remainder had normal cognition. Qualitative F-18-florbetapir PET imaging was positive in 15 participants (24.6%). Increasing age and presence of an APOE epsilon 4 allele were associated with higher composite F-18-florbetapir binding. In multivariable models, an abnormal F-18-florbetapir scan by expert rating was not associated with a diagnosis of mild cognitive impairment. However, F-18-florbetapir retention values in the posterior cingulate gyrus inversely correlated with verbal memory performance. Retention values in the frontal cortex, precuneus, and anterior cingulate gyrus retention values inversely correlated with naming performance. Regional cortical amyloid-beta amyloid, as measured by F-18-florbetapir PET, may be a biomarker of specific cognitive deficits in non-demented Parkinson disease patients.	[Akhtar, Rizwan S.; Rick, Jacqueline; Gross, Rachel G.; Chen-Plotkin, Alice S.; Hurtig, Howard I.; Siderowf, Andrew D.; Weintraub, Daniel] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Akhtar, Rizwan S.; Van Deerlin, Vivianna M.; Trojanowski, John Q.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA; [Akhtar, Rizwan S.; Van Deerlin, Vivianna M.; Trojanowski, John Q.] Univ Penn, Inst Aging, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xie, Sharon X.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chen, Yin J.; Nasrallah, Ilya M.; Dubroff, Jacob G.] Univ Penn, Dept Radiol, Div Nucl Med & Clin Mol Imaging, Perelman Sch Med, Philadelphia, PA 19104 USA; [Van Deerlin, Vivianna M.; Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Siderowf, Andrew D.] AVID Radiopharmaceut, Philadelphia, PA USA; [Weintraub, Daniel] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Weintraub, Daniel] Philadelphia Vet Affairs Med Ctr, Parkinsons Dis & Mental Hlth Res Educ & Clin Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Akhtar, RS (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Akhtar, RS (corresponding author), Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA.; Akhtar, RS (corresponding author), Univ Penn, Inst Aging, Perelman Sch Med, Philadelphia, PA 19104 USA.	rizwan.akhtar@uphs.upenn.edu	Akhtar, Rizwan S./ABH-7946-2020; Weintraub, Daniel/AAD-8309-2020; Weintraub, Daniel/AAC-5232-2020	Akhtar, Rizwan S./0000-0001-9808-7228; Weintraub, Daniel/0000-0003-0633-7168	National Institutes of Health [P50-NS053488, P30-AG010124, R43-NS063607, K08-NS093127]; Avid Radiopharmaceuticals; Eli Lilly and Company; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS063607, U01NS082134, U01NS097056, P50NS053488, K08NS093127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avid Radiopharmaceuticals; Eli Lilly and Company(Eli Lilly); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded or supported by the National Institutes of Health: P50-NS053488 (to S.X.X., V.M.V.D., J.Q.T., A.S.C-P., H.I.H., A.D.S., and D.W.), P30-AG010124 (to V.M.V.D. and J.Q.T.), R43-NS063607 (to Daniel M. Skovronsky, Avid Radiopharmaceuticals), and K08-NS093127(to R.S.A.); and by Avid Radiopharmaceuticals, a wholly-owned subsidiary of Eli Lilly and Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Akhtar RS, 2016, MOVEMENT DISORDERS C; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bohnen NI, 2014, MOVEMENT DISORD, V29, P1118, DOI 10.1002/mds.25929; Brendel M, 2015, NEUROIMAGE, V108, P450, DOI 10.1016/j.neuroimage.2014.11.055; Choi SR, 2012, ALZ DIS ASSOC DIS, V26, P8, DOI 10.1097/WAD.0b013e31821300bc; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Edison P, 2008, J NEUROL NEUROSUR PS, V79, P1331, DOI 10.1136/jnnp.2007.127878; Fleisher AS, 2013, NEUROBIOL AGING, V34, P1, DOI 10.1016/j.neurobiolaging.2012.04.017; Foster ER, 2010, MOVEMENT DISORD, V25, P2516, DOI 10.1002/mds.23393; Gomperts SN, 2013, NEUROLOGY, V80, P85, DOI 10.1212/WNL.0b013e31827b1a07; Gomperts SN, 2012, MOVEMENT DISORD, V27, P965, DOI 10.1002/mds.25048; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Hutton C, 2015, EUR J NUCL MED MOL I, V42, P725, DOI 10.1007/s00259-015-2988-7; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007, 10.1016/j.jalz.2013.06.001]; Joshi AD, 2015, J NUCL MED, V56, P1736, DOI 10.2967/jnumed.114.153494; Joshi A, 2012, J NUCL MED, V53, DOI 10.2967/jnumed.111.090340; Knopman DS, 2015, JAMA NEUROL, P1; Kotzbauer PT, 2012, ARCH NEUROL-CHICAGO, V69, P1326, DOI 10.1001/archneurol.2012.1608; Landau SM, 2013, J NUCL MED, V54, P70, DOI 10.2967/jnumed.112.109009; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Maetzler W, 2009, NEUROBIOL DIS, V34, P107, DOI 10.1016/j.nbd.2008.12.008; Mathis CA, 2012, SEMIN NUCL MED, V42, P423, DOI 10.1053/j.semnuclmed.2012.07.001; Mattila PM, 1998, ACTA NEUROPATHOL, V96, P417, DOI 10.1007/s004010050913; Monsell SE, 2014, PARKINSONISM RELAT D, V20, P503, DOI 10.1016/j.parkreldis.2014.02.001; Muller MLTM, 2013, MOVEMENT DISORD, V28, P296, DOI 10.1002/mds.25213; Petrou M, 2015, MOVEMENT DISORD, V30, P928, DOI 10.1002/mds.26191; Petrou M, 2012, NEUROLOGY, V79, P1161, DOI 10.1212/WNL.0b013e3182698d4a; Pfeiffer HCV, 2014, ACTA NEUROL SCAND, V129, P307, DOI 10.1111/ane.12189; Pigott K, 2015, NEUROLOGY, V85, P1276, DOI 10.1212/WNL.0000000000002001; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Rektorova I, 2014, NEURODEGENER DIS, V13, P186, DOI 10.1159/000354237; Rullmann M, 2016, J NUCL MED, V57, P198, DOI 10.2967/jnumed.115.161893; Saint-Aubert L, 2014, EUR J NUCL MED MOL I, V41, P836, DOI 10.1007/s00259-013-2656-8; Schreiber S, 2015, JAMA NEUROL, V72, P1183, DOI 10.1001/jamaneurol.2015.1633; Siderowf A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-79; Spetsieris PG, 2015, P NATL ACAD SCI USA, V112, P2563, DOI 10.1073/pnas.1411011112; Stebbins GT, 2013, MOVEMENT DISORD, V28, P668, DOI 10.1002/mds.25383; Toledo JB, 2012, ACTA NEUROPATHOL, V124, P23, DOI 10.1007/s00401-012-0983-7; Tsuang D, 2013, JAMA NEUROL, V70, P223, DOI 10.1001/jamaneurol.2013.600; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088	49	23	26	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177924	10.1371/journal.pone.0177924	http://dx.doi.org/10.1371/journal.pone.0177924			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542444	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800030
J	Bertoglia, MP; Gormaz, JG; Libuy, M; Sanhueza, D; Gajardo, A; Srur, A; Wallbaum, M; Erazo, M				Bertoglia, Maria P.; Gormaz, Juan G.; Libuy, Matias; Sanhueza, Dergica; Gajardo, Abraham; Srur, Andrea; Wallbaum, Magdalena; Erazo, Marcia			The population impact of obesity, sedentary lifestyle, and tobacco and alcohol consumption on the prevalence of type 2 diabetes: Analysis of a health population survey in Chile, 2010	PLOS ONE			English	Article							INSULIN-RESISTANCE; GROWTH-HORMONE; SMOKING; GLUCOSE; RISK; METABOLISM; NOREPINEPHRINE; MECHANISMS; CORTISOL; RELEASE	Aim To estimate the impact of tobacco use, sedentary lifestyle, obesity and alcohol consumption on type 2 diabetes mellitus (T2DM) prevalence in the Chilean population. Methods The study-included 5,293 subjects with fasting glycaemia levels from the nationwide cross-sectional health survey in 2010, commissioned by the Ministry of Health, Chile. Crude and Adjusted Odds Ratio to T2DM and its corresponding 95% confidence interval were estimated through logistic regressions. Attributable fractions and population attributable fractions were estimated. Results T2DM prevalence was 9.5%. Sedentary lifestyles and obesity were significant risk factors for T2DM. 52,4% of T2DM could be avoided if these individuals were not obese, and at a population level, 23% of T2DM could be preventable if obesity did not exist. A 64% of T2DM is explained by sedentariness, and if people would become active, a 62,2% of the cases of diabetes could be avoided. Interpretation About 79% of T2DM cases in Chile could be prevented with cost-effective strategies focused on preventing sedentary lifestyle and obesity. It's therefore urgent to implement evidence-based public health polices, aimed to decrease the prevalence of T2DM, by controlling its risk factors and consequently, reducing the complications from T2DM.	[Bertoglia, Maria P.; Libuy, Matias; Sanhueza, Dergica; Gajardo, Abraham; Erazo, Marcia] Univ Chile, Sch Publ Hlth, Publ Hlth Nutr Program, Santiago, Chile; [Gormaz, Juan G.] Univ Chile, Biomed Sci Inst, Mol & Clin Pharmacol Program, Santiago, Chile; [Srur, Andrea; Wallbaum, Magdalena] Minist Hlth Santiago, Noncommunicable Dis Dept, Santiago, Chile	Universidad de Chile; Universidad de Chile	Erazo, M (corresponding author), Univ Chile, Sch Publ Hlth, Publ Hlth Nutr Program, Santiago, Chile.	merazo@med.uchile.cl		Sanhueza, Dergica/0000-0003-4683-1603; Gajardo Cortez, Abraham Isaac Jacob/0000-0002-6387-3779; Erazo, Marcia/0000-0002-0766-9503				Alderete TL, 2013, J CLIN ENDOCR METAB, V98, P3748, DOI 10.1210/jc.2013-1138; ATTVALL S, 1993, J INTERN MED, V233, P327, DOI 10.1111/j.1365-2796.1993.tb00680.x; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Barth E, 2007, CRIT CARE MED, V35, pS508, DOI 10.1097/01.CCM.0000278047.06965.20; Byrkjeland R, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-36; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; Duclos M, 2013, DIABETES METAB, V39, P205, DOI 10.1016/j.diabet.2013.03.005; Eckardt K, 2011, REV ENDOCR METAB DIS, V12, P163, DOI 10.1007/s11154-011-9168-2; Eliasson B, 1997, ATHEROSCLEROSIS, V129, P79, DOI 10.1016/S0021-9150(96)06028-5; Eliasson B, 1997, EUR J CLIN INVEST, V27; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Gefeller O., 1990, STAT APP, V2, P323; Gunther T, 2010, MAGNESIUM RES, V23, P5, DOI 10.1684/mrh.2009.0195; Guido Di Dalmazi, 2012, J NUTR METAB; Hattori Y, 2002, HYPERTENSION, V39, P22, DOI 10.1161/hy1201.097300; He JM, 2007, HEPATOLOGY, V46, P1791, DOI 10.1002/hep.21904; Hu Frank B., 2008, OBESITY EPIDEMIOLOGY, P512; KERSHBAUM A, 1966, GERIATRICS, V21, P155; KIRSCHBAUM C, 1992, LIFE SCI, V50, P435, DOI 10.1016/0024-3205(92)90378-3; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Llorca J, 2001, Gac Sanit, V15, P61; Mancini T, 2004, CLIN ENDOCRINOL, V61, P768, DOI 10.1111/j.1365-2265.2004.02168.x; Ministerio de Salud Chile, 2003, RES ENC SAL CHIL 200; Ministerio de Salud Chile, 2009, ENC NAC SAL 2009 201; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Morgan TM, 2004, METABOLISM, V53, P578, DOI 10.1016/j.metabol.2003.12.006; Orpinas P., 1991, TEMAS SALUD MENTAL A, P185; Pietraszek A, 2010, NUTR METAB CARDIOVAS, V20, P366, DOI 10.1016/j.numecd.2010.05.001; Prospective Studies Collaboration, 2009, PREV CHRONIC DIS, V373, P1083; Seike N, 2008, ASIA PAC J CLIN NUTR, V17, P545; Shao SY, 2013, DNA CELL BIOL, V32, P41, DOI 10.1089/dna.2012.1874; Soumaya K, 2013, ADV EXP MED BIOL, V771, P240; Straub SG, 2012, AM J PHYSIOL-CELL PH, V302, pC1687, DOI 10.1152/ajpcell.00282.2011; Taksali SE, 2008, DIABETES, V57, P367, DOI 10.2337/db07-0932; Tuomi T, 2014, LANCET, V383, P1084, DOI 10.1016/S0140-6736(13)62219-9; Turner N, 2014, J ENDOCRINOL, V220, pT61, DOI 10.1530/JOE-13-0397; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2011, GLOBAL STATUS REPORT; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Health Organization, 2011, HLTH CONS SMOK 50 YE; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6	44	19	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178092	10.1371/journal.pone.0178092	http://dx.doi.org/10.1371/journal.pone.0178092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542472	Green Published, gold, Green Submitted			2022-12-27	WOS:000402062800043
J	Paulsen, O; Laird, B; Aass, N; Lea, T; Fayers, P; Kaasa, S; Klepstad, P				Paulsen, Ornulf; Laird, Barry; Aass, Nina; Lea, Tor; Fayers, Peter; Kaasa, Stein; Klepstad, Pal			The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DOUBLE-BLIND; SYMPTOM CLUSTERS; CHEMORADIATION THERAPY; PANCREATIC-CANCER; CASTLEMAN-DISEASE; NEUROPATHIC PAIN; CONTROLLED-TRIAL; CLINICAL-TRIALS	Background Systemic inflammation is associated with reduced quality of life and increased symptoms in patients with advanced cancer. The aims of this study were to examine the relationships between inflammatory biomarkers and the Patient Reported Outcome Measures (PROMs) of pain, appetite and fatigue; and to explore whether levels of baseline biomarkers were associated with changes in these PROMs following treatment with corticosteroids. Material and methods An exploratory analysis was done on a trial examining the analgesic properties of corticosteroids in patients with advanced cancer. Inclusion criteria were: > 18 years, taking opioids for moderate or severe cancer pain; pain >= 4 (numerical rating scale 0-10). Serum was extracted and levels of inflammatory biomarkers were assessed. PROMs of pain, appetite and fatigue were assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30). The relationships between PROMs and inflammatory biomarkers were examined using Spearman Rho-Rank and multiple regression analysis. Results Data were available on 49 patients. Levels of sTNF-r1, IL-6, IL-18, MIF, MCP-1, TGF-beta 1, IL-1ra, and C-reactive protein (CRP) and Erythrocyte sedimentation rate (ESR) were elevated; IL-1 beta, IL-2, IL-4, IL-8, IL-10, IL-12(p70), interferon-gamma, MIP-1 alpha, and TNF-alpha were below the level of detection. The following correlations were observed: appetite and IL-6 and CRP; fatigue and IL-1ra (r(s): 0.38-0.41, p<.01). There was no association between pretreatment biomarkers and effect from corticosteroid treatment. Conclusion In patients with advanced cancer and pain, some pro-inflammatory cytokines were related to appetite and fatigue. Inflammatory biomarkers were not associated with pain or with the efficacy of corticosteroid therapy. Further research examining the attenuation of the systemic inflammatory response and possible effects on symptoms would be of interest.	[Paulsen, Ornulf; Laird, Barry; Fayers, Peter; Kaasa, Stein; Klepstad, Pal] Norwegian Univ Sci & Technol NTNU, European Palliat Care Res Ctr, Dept Canc Res & Mol Med, Trondheim, Norway; [Paulsen, Ornulf] Telemark Hosp Trust, Palliat Care Unit, Skien, Norway; [Laird, Barry] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Aass, Nina; Kaasa, Stein] Univ Oslo, Fac Med, Oslo, Norway; [Aass, Nina; Kaasa, Stein] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Lea, Tor] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Fayers, Peter] Univ Aberdeen, Dept Publ Hlth, Aberdeen, Scotland; [Klepstad, Pal] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Klepstad, Pal] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Anesthesiol & Intens Care Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Telemark Hospital Trust; University of Edinburgh; University of Oslo; University of Oslo; Norwegian University of Life Sciences; University of Aberdeen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Paulsen, O (corresponding author), Norwegian Univ Sci & Technol NTNU, European Palliat Care Res Ctr, Dept Canc Res & Mol Med, Trondheim, Norway.; Paulsen, O (corresponding author), Telemark Hosp Trust, Palliat Care Unit, Skien, Norway.	ornulf.paulsen@sthf.no		Fayers, Peter/0000-0003-4778-1513; Paulsen, Ornulf/0000-0002-2508-9289	Telemark Hospital Trust; South-Eastern Norway Regional Health Authority	Telemark Hospital Trust; South-Eastern Norway Regional Health Authority	This work was funded by unrestricted grants from the Telemark Hospital Trust and the South-Eastern Norway Regional Health Authority, and is a part of Ornulf Paulsen's PhD project.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Al-Hashimi M, 2013, BRIT J ANAESTH, V111, P80, DOI 10.1093/bja/aet153; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Boland JW, 2014, BRIT J CANCER, V111, P866, DOI 10.1038/bjc.2014.384; Breitbart W, 2014, PSYCHO-ONCOLOGY, V23, P339, DOI 10.1002/pon.3422; BRUERA E, 1985, CANCER TREAT REP, V69, P751; Cheung YT, 2015, ANN ONCOL, V26, P1446, DOI 10.1093/annonc/mdv206; Cleeland CS, 2003, CANCER-AM CANCER SOC, V97, P2919, DOI 10.1002/cncr.11382; Davis MP, 2004, J CLIN ONCOL, V22, P1510, DOI 10.1200/JCO.2004.03.103; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; de Raaf PJ, 2013, J CLIN ONCOL, V31, P3056, DOI 10.1200/JCO.2013.49.3403; de Raaf PJ, 2012, J PAIN SYMPTOM MANAG, V44, P823, DOI 10.1016/j.jpainsymman.2011.12.279; de Raaf PJ, 2012, CANCER-AM CANCER SOC, V118, P6005, DOI 10.1002/cncr.27613; Dong ST, 2016, J PAIN SYMPTOM MANAG, V51, P88, DOI 10.1016/j.jpainsymman.2015.07.013; Dong ST, 2014, J PAIN SYMPTOM MANAG, V48, P411, DOI 10.1016/j.jpainsymman.2013.10.027; Du YJ, 2013, PROG NEURO-PSYCHOPH, V47, P69, DOI 10.1016/j.pnpbp.2013.08.004; El-Osta H, 2010, MOL CANCER THER, V9, P1485, DOI 10.1158/1535-7163.MCT-10-0156; Fayers PM, EORTC QLQ C30 SCORIN; Finley MJ, 2008, CELL IMMUNOL, V252, P146, DOI 10.1016/j.cellimm.2007.09.008; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Haywood A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010756.pub2; Heitzer E, 2012, PAIN PHYSICIAN, V15, P499; Hu JH, 2012, NEUROSCI LETT, V517, P60, DOI 10.1016/j.neulet.2012.04.026; Hurwitz HI, 2015, J CLIN ONCOL, V33, P4039, DOI 10.1200/JCO.2015.61.4578; Inagaki M, 2008, J PAIN SYMPTOM MANAG, V35, P153, DOI 10.1016/j.jpainsymman.2007.03.009; Jatoi Aminah, 2007, J Support Oncol, V5, P41; Jatoi A, 2010, SUPPORT CARE CANCER, V18, P1299, DOI 10.1007/s00520-009-0748-6; Kaasa S, 1995, EUR J CANCER, V31A, P2260, DOI 10.1016/0959-8049(95)00296-0; Knobel H, 2003, PALLIATIVE MED, V17, P664, DOI 10.1191/0269216303pm841oa; Kurzrock R, 2013, CLIN CANCER RES, V19, P3659, DOI 10.1158/1078-0432.CCR-12-3349; Laird BJ, 2013, ONCOLOGIST, V18, P1050, DOI 10.1634/theoncologist.2013-0120; Laird BJA, 2011, J PAIN SYMPTOM MANAG, V42, P1, DOI 10.1016/j.jpainsymman.2010.10.261; Laird BJA, 2011, PAIN, V152, P460, DOI 10.1016/j.pain.2010.10.035; Laird BJ, 2016, J CLIN ONCOLOGY OFFI; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Lundstrom SH, 2006, ACTA ONCOL, V45, P430, DOI 10.1080/02841860500401167; Makimura C, 2011, ANTICANCER RES, V31, P4561; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miller AH, 2008, J CLIN ONCOL, V26, P971, DOI 10.1200/JCO.2007.10.7805; Miller S, 2014, J PALLIAT MED, V17, P482, DOI 10.1089/jpm.2013.0324; Minton O, 2012, J PAIN SYMPTOM MANAG, V43, P226, DOI 10.1016/j.jpainsymman.2011.03.025; NCCN, 2016, CANC REL FAT; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Norheim KB, 2012, PLOS ONE, V7, P429, DOI 10.1371/journal.pone.0030123; Omdal R, 2005, RHEUMATOL INT, V25, P481, DOI 10.1007/s00296-004-0463-z; Paiva CE, 2013, SUPPORT CARE CANCER, V21, P1053, DOI 10.1007/s00520-012-1625-2; Paulsen O, 2014, J CLIN ONCOL, V32, P3221, DOI 10.1200/JCO.2013.54.3926; Pevida M, 2014, CELL MOL NEUROBIOL, V34, P143, DOI 10.1007/s10571-013-9995-7; Rausch SM, 2010, CANCER-AM CANCER SOC, V116, P4103, DOI 10.1002/cncr.25255; Reyes-Gibby CC, 2013, J PAIN SYMPTOM MANAG, V46, P161, DOI 10.1016/j.jpainsymman.2012.07.019; Roerink ME, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0971-z; Roxburgh CSD, 2014, BRIT J CANCER, V110, P1409, DOI 10.1038/bjc.2014.90; Saligan LN, 2012, BRAIN BEHAV IMMUN, V26, P830, DOI 10.1016/j.bbi.2012.05.004; Saligan LN, 2015, SUPPORT CARE CANCER, V23, P2461, DOI 10.1007/s00520-015-2763-0; Scheede-Bergdahl C, 2012, CLIN NUTR, V31, P85, DOI 10.1016/j.clnu.2011.07.010; Schimmer BP, 2011, GOODMAN GILMANS PHAR, V12th; Schubert C, 2007, BRAIN BEHAV IMMUN, V21, P413, DOI 10.1016/j.bbi.2006.11.004; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Slotkin JR, 2016, SPINE, V41, pE441, DOI 10.1097/BRS.0000000000001309; Tanaka T, 2004, NEUROSCI RES, V48, P463, DOI 10.1016/j.neures.2004.01.004; Wang XS, 2012, BRAIN BEHAV IMMUN, V26, P699, DOI 10.1016/j.bbi.2011.12.007; Wang XS, 2010, BRAIN BEHAV IMMUN, V24, P968, DOI 10.1016/j.bbi.2010.03.009; Yennurajalingam S, 2016, ONCOLOGIST, V21, P384, DOI 10.1634/theoncologist.2014-0260; Yennurajalingam S, 2013, J CLIN ONCOL, V31, P3076, DOI 10.1200/JCO.2012.44.4661	66	58	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177620	10.1371/journal.pone.0177620	http://dx.doi.org/10.1371/journal.pone.0177620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542626	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000402062800019
J	Portaro, S; Naro, A; Chillura, A; Billeri, L; Bramanti, A; Bramanti, P; Rodolico, C; Calabro, RS				Portaro, Simona; Naro, Antonino; Chillura, Antonino; Billeri, Luana; Bramanti, Alessia; Bramanti, Placido; Rodolico, Carmelo; Calabro, Rocco Salvatore			Toward a more personalized motor function rehabilitation in Myotonic dystrophy type 1: The role of neuroplasticity	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EXCITABILITY; MUSCULAR-DYSTROPHY; EVOKED-POTENTIALS; PROTEIN-KINASE; SILENT PERIOD; CORTEX; NEUROREHABILITATION; VARIABILITY; INVOLVEMENT	Myotonic dystrophy type 1 (DM1) is the most prevalent adult muscular dystrophy, often accompanied by impairments in attention, memory, visuospatial and executive functions. Given that DM1 is a multi-system disorder, it requires a multi-disciplinary approach, including effective rehabilitation programs, focusing on the central nervous system neuroplasticity, in order to develop patient-tailored rehabilitative procedures for motor function recovery. Herein, we performed a transcranial magnetic stimulation (TMS) study aimed at investigating central motor conduction time, sensory-motor plasticity, and cortical excitability in 7 genetically defined DM1 patients. As compared to healthy individuals, DM1 patients showed a delayed central motor conduction time and an abnormal sensory-motor plasticity, with no alteration of cortical excitability. These findings may be useful to define patient-tailored motor rehabilitative programs.	[Portaro, Simona; Naro, Antonino; Chillura, Antonino; Billeri, Luana; Bramanti, Placido; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Ist Sci Res & Care, Messina, Italy; [Bramanti, Alessia] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Rodolico, Carmelo] Natl Res Council Italy, Inst Appl Sci & Intelligent Syst ISASI Edoardo Ca, Messina, Italy	IRCCS Bonino Pulejo; University of Messina; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Applicate e Sistemi Intelligenti "Eduardo Caianiello" (ISASI-CNR)	Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Ist Sci Res & Care, Messina, Italy.	salbro77@tiscali.it	Billeri, Luana LB/V-9702-2018; PORTARO, SIMONA/GVS-8522-2022; Calabrò, Rocco S/K-7520-2016; calabro, rocco salvatore/L-9570-2019; Bramanti, Placido/K-5117-2016	calabro, rocco salvatore/0000-0002-8566-3166; RODOLICO, Carmelo/0000-0003-2543-6356; Billeri, Luana/0000-0002-0462-6364; Portaro, Simona/0000-0002-6379-1642				Alia C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00076; BARTEL PR, 1984, J NEUROL NEUROSUR PS, V47, P524, DOI 10.1136/jnnp.47.5.524; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Calabro RS, 2016, PM&R, V8, P971, DOI 10.1016/j.pmrj.2016.02.004; Di Constanzo A, 2001, EUR NEUROL, V46, P131, DOI 10.1159/000050786; Di Costanzo A, 2002, J NEUROL, V249, P1175, DOI 10.1007/s00415-002-0796-z; Di Lazzaro V, 1998, MUSCLE NERVE, V21, P662; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; GLANTZ RH, 1988, ARCH NEUROL-CHICAGO, V45, P36, DOI 10.1001/archneur.1988.00520250042017; Golaszewski S, 2016, NEUROSCI LETT, V610, P218, DOI 10.1016/j.neulet.2015.11.008; Harmon EB, 2011, J BIOL CHEM, V286, P40296, DOI 10.1074/jbc.M111.241455; Harper P S, 2002, Neuromuscul Disord, V12, P596, DOI 10.1016/S0960-8966(02)00020-2; Khoshbakht R, 2014, J CLIN NEUROSCI, V21, P1123, DOI 10.1016/j.jocn.2013.09.016; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; Liepert J, 1998, EXP BRAIN RES, V118, P421, DOI 10.1007/s002210050296; Liepert J, 2004, CLIN NEUROPHYSIOL, V115, P85, DOI 10.1016/S1388-2457(03)00322-5; Liepert J, 2001, CLIN NEUROPHYSIOL, V112, P917, DOI 10.1016/S1388-2457(01)00521-1; MACDONELL RAL, 1991, NEUROLOGY, V41, P1441, DOI 10.1212/WNL.41.9.1441; Miaux Y, 1997, NEURORADIOLOGY, V39, P166, DOI 10.1007/s002340050385; Mitsuoka T, 2003, CLIN NEUROPHYSIOL, V114, P99, DOI 10.1016/S1388-2457(02)00325-5; Mochizuki H, 2001, CLIN NEUROPHYSIOL, V112, P793, DOI 10.1016/S1388-2457(01)00512-0; Oliveri M, 1997, ELECTROMYOGR MOTOR C, V105, P297, DOI 10.1016/S0924-980X(97)00023-4; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; PANAYIOTOPOULOS CP, 1976, J NEUROL SCI, V27, P1, DOI 10.1016/0022-510X(76)90230-6; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Portaro S, 2017, J NEUROL SCI, V375, P3, DOI 10.1016/j.jns.2017.01.038; Quartarone A, 2006, J PHYSIOL-LONDON, V575, P657, DOI 10.1113/jphysiol.2006.114025; Rae MG, 2016, J NEUROPHYSIOL, V116, P1304, DOI 10.1152/jn.00248.2016; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sansone V, 2000, NEUROL SCI, V21, pS971, DOI 10.1007/s100720070012; SCHUBERT M, 1994, ELECTROEN CLIN NEURO, V90, P304, DOI 10.1016/0013-4694(94)90149-X; Serra L, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2696085; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.3.CO;2-O; Takeuchi N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00349; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x	39	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178470	10.1371/journal.pone.0178470	http://dx.doi.org/10.1371/journal.pone.0178470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542314	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800093
J	Sakai, N; Ohno, H; Tomioka, M; Iino, Y				Sakai, Naoko; Ohno, Hayao; Tomioka, Masahiro; Iino, Yuichi			The intestinal TORC2 signaling pathway contributes to associative learning in Caenorhabditis elegans	PLOS ONE			English	Article							LOCAL PROTEIN-SYNTHESIS; LONG-TERM POTENTIATION; C. ELEGANS; LIFE-SPAN; TRANSCRIPTION FACTOR; RAPAMYCIN; MTOR; COMPLEX; KINASE; MEMORY	Several types of associative learning are dependent upon the presence or absence of food, and are crucial for the survival of most animals. Target of rapamycin (TOR), a kinase which exists as a component of two complexes, TOR complex 1 (TORC1) and TOR complex 2 (TORC2), is known to act as a nutrient sensor in numerous organisms. However, the in vivo roles of TOR signaling in the nervous system remain largely unclear, partly because its multifunctionality and requirement for survival make it difficult to investigate. Here, using pharmacological inhibitors and genetic analyses, we show that TORC1 and TORC2 contribute to associative learning between salt and food availability in the nematode Caenorhabditis elegans in a process called taste associative learning. Worms migrate to salt concentrations experienced previously during feeding, but they avoid salt concentrations experienced under starvation conditions. Administration of the TOR inhibitor rapamycin causes a behavioral defect after starvation conditioning. Worms lacking either RICT-1 or SINH-1, two TORC2 components, show defects in migration to high salt levels after learning under both fed and starved conditions. We also analyzed the behavioral phenotypes of mutants of the putative TORC1 substrate RSKS-1 (the C. elegans homolog of the mammalian S6 kinase S6K) and the putative TORC2 substrates SGK-1 and PKC-2 (homologs of the serum and glucocorticoid-induced kinase 1, SGK1, and protein kinase C-alpha, PKC-alpha, respectively) and found that neuronal RSKS-1 and PKC-2, as well as intestinal SGK-1, are involved in taste associative learning. Our findings shed light on the functions of TOR signaling in behavioral plasticity and provide insight into the mechanisms by which information sensed in the intestine affects the nervous system to modulate food-searching behaviors.	[Sakai, Naoko; Ohno, Hayao; Tomioka, Masahiro; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Tomioka, Masahiro; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo, Japan	University of Tokyo; University of Tokyo	Tomioka, M; Iino, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan.; Tomioka, M; Iino, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo, Japan.	tomioka@bs.s.u-tokyo.ac.jp; iino@bs.s.u-tokyo.ac.jp	TOMIOKA, MASAHIRO/G-4890-2014	TOMIOKA, MASAHIRO/0000-0002-7537-714X; Sakai, Naoko/0000-0002-6311-5281; Ohno, Hayao/0000-0003-2635-6964	 [26291069];  [25115010];  [15K14310];  [25870172];  [10978]; Grants-in-Aid for Scientific Research [25115010] Funding Source: KAKEN	; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Y.I. was supported by a Grant-in-Aid for Scientific Research (B) 26291069, for Scientific Research on Innovative Areas 25115010, and for Challenging Exploratory Research 15K14310. M.T. was supported by a Grant-in-Aid for Japan Society for the Promotion of Science Young Scientists (B) 25870172. N.S. was supported by a Grant-in-Aid for Japan Society for the Promotion of Science Fellows 10978. The URL of Japan Society for the Promotion of Science; https://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, GENETICS, V186, P1309, DOI 10.1534/genetics.110.119768; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BRENNER S, 1974, GENETICS, V77, P71; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P84; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chen ATY, 2013, AGING CELL, V12, P932, DOI 10.1111/acel.12120; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Halloran J, 2012, NEUROSCIENCE, V223, P102, DOI 10.1016/j.neuroscience.2012.06.054; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; IslasTrejo A, 1997, J BIOL CHEM, V272, P6629, DOI 10.1074/jbc.272.10.6629; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jobim PFC, 2012, NEUROBIOL LEARN MEM, V97, P105, DOI 10.1016/j.nlm.2011.10.002; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kunitomo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3210; Lang F, 2010, J PHYSIOL-LONDON, V588, P3349, DOI 10.1113/jphysiol.2010.190926; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Law BK, 2005, CRIT REV ONCOL HEMAT, V56, P47, DOI 10.1016/j.critrevonc.2004.09.009; Lin A-L, 2015, J CEREB BLOOD FLOW M, DOI DOI 10.1177/0271678; Majumder S, 2012, AGING CELL, V11, P326, DOI 10.1111/j.1474-9726.2011.00791.x; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mizunuma M, 2014, AGING CELL, V13, P869, DOI 10.1111/acel.12248; Nukazuka A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1495; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Ohno H, 2014, SCIENCE, V345, P313, DOI 10.1126/science.1250709; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Qi SH, 2010, NEUROSCI RES, V68, P88, DOI 10.1016/j.neures.2010.06.008; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Sugi T, 2011, NAT NEUROSCI, V14, P984, DOI 10.1038/nn.2854; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Tabuse Y, 2002, J BIOCHEM, V132, P519, DOI 10.1093/oxfordjournals.jbchem.a003251; Talboom JS, 2015, NPJ AGING MECH DIS, V1, DOI 10.1038/npjamd.2015.8; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Vukojevic V, 2012, EMBO J, V31, P1453, DOI 10.1038/emboj.2012.14; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Yamada K, 2010, SCIENCE, V329, P1647, DOI 10.1126/science.1192020; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhu HH, 2013, ELIFE, V2, DOI 10.7554/eLife.00429	60	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177900	10.1371/journal.pone.0177900	http://dx.doi.org/10.1371/journal.pone.0177900			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542414	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800029
J	Silva, A; John, P				Silva, Antonio; John, Peter			Social norms don't always work: An experiment to encourage more efficient fees collection for students	PLOS ONE			English	Article							IMPACT	The use of social norms has become the tool of choice for behaviourally informed interventions. However, it is still not clear for what type of contexts and populations is this intervention effective. This randomised controlled trial with 4298 students tests the applicability of social norms to improve the late payment of university tuition fees. We find that providing information to late payers does not increase their likelihood of paying. This finding highlights how the use of social norms may not always be an effective tool in influencing behaviour.	[Silva, Antonio] UCL, Dept Anthropol, London, England; [John, Peter] UCL, Sch Publ Policy, London, England	University of London; University College London; University of London; University College London	John, P (corresponding author), UCL, Sch Publ Policy, London, England.	peter.john@ucl.ac.uk		S. Silva, Antonio/0000-0002-7029-1048				Akerlof GA, 1997, ECONOMETRICA, V65, P1005, DOI 10.2307/2171877; Allcott H, 2014, AM ECON REV, V104, P3003, DOI 10.1257/aer.104.10.3003; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Ayers I., 2009, 15386 NBER; Bohner G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104086; Branas-Garza P, 2007, J ECON PSYCHOL, V28, P477, DOI 10.1016/j.joep.2006.10.001; Cialdini RB, 2003, CURR DIR PSYCHOL SCI, V12, P105, DOI 10.1111/1467-8721.01242; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Coleman S., 2007, MINNESOTA INCOME TAX, DOI DOI 10.2139/SSRN.1393292; Coleman Stephen., 1996, MINNESOTA INCOME TAX; Croson R, 2008, EXP ECON, V11, P221, DOI 10.1007/s10683-007-9191-z; Dolan P, 2015, NEIGHBORS KNOWLEDGE; ELSTER J, 1989, J ECON PERSPECT, V3, P99, DOI 10.1257/jep.3.4.99; Eriksson K., 2009, J EVOL PSYCHOL, V7, P5, DOI [10.1556/JEP.7.2009.1.3, DOI 10.1556/JEP.7.2009.1.3]; Espinosa M, 2015, EXPERIMENTAL ECONOMICS, VOL I: ECONOMIC DECISIONS, P53; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Hall Margaret Jean, 2014, NCHS Data Brief, P1; Hallsworth M, 2016, LANCET, V387, P1743, DOI 10.1016/S0140-6736(16)00215-4; Hechter M., 2001, SOCIAL NORMS; LATANE B, 1981, PSYCHOL REV, V88, P438, DOI 10.1037/0033-295X.88.5.438; Reese G, 2014, J SOC PSYCHOL, V154, P97, DOI 10.1080/00224545.2013.855623; Sanders M., 2016, J BEHAV EXP IN PRESS; Schultz PW, 2008, SOC INFLUENCE, V3, P4, DOI 10.1080/15534510701755614; Schultz PW, 1999, BASIC APPL SOC PSYCH, V21, P25, DOI 10.1207/s15324834basp2101_3; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Wang J., 2014, USE DESCRIPTIVE NORM	26	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177354	10.1371/journal.pone.0177354	http://dx.doi.org/10.1371/journal.pone.0177354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542164	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500020
J	Jiang, X; Zhang, H; Quan, XW; Liu, ZD; Yin, YB				Jiang, Xue; Zhang, Han; Quan, Xiongwen; Liu, Zhandong; Yin, Yanbin			Disease-related gene module detection based on a multi-label propagation clustering algorithm	PLOS ONE			English	Article							NETWORKS	Detecting disease-related gene modules by analyzing gene expression data is of great significance. It is helpful for exploratory analysis of the interaction mechanisms of genes under complex disease phenotypes. The multi-label propagation algorithm (MLPA) has been widely used in module detection for its fast and easy implementation. The accuracy of MLPA greatly depends on the connections between nodes, and most existing research focuses on measuring the similarity between nodes. However, MLPA does not perform well with loose connections between disease-related genes. Moreover, the biological significance of modules obtained by MLPA has not been demonstrated. To solve these problems, we designed a double label propagation clustering algorithm (DLPCA) based on MLPA to study Huntington's disease. In DLPCA, in addition to category labels, we introduced pathogenic labels to supervise the process of multi-label propagation clustering. The pathogenic labels contain pathogenic information about disease genes and the hierarchical structure of gene expression data. Experimental results demonstrated the superior performance of DLPCA compared with other conventional gene-clustering algorithms.	[Jiang, Xue; Zhang, Han; Quan, Xiongwen] Nankai Univ, Coll Comp & Control Engn, Tianjin 300350, Peoples R China; [Jiang, Xue; Zhang, Han; Quan, Xiongwen] Nankai Univ, Tianjin Key Lab Intelligent Robot, Tianjin 300350, Peoples R China; [Liu, Zhandong] Baylor Coll Med, Dept Pediat Neurol, Houston, TX 77030 USA; [Yin, Yanbin] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Nankai University; Nankai University; Baylor College of Medicine; Northern Illinois University	Quan, XW (corresponding author), Nankai Univ, Coll Comp & Control Engn, Tianjin 300350, Peoples R China.; Quan, XW (corresponding author), Nankai Univ, Tianjin Key Lab Intelligent Robot, Tianjin 300350, Peoples R China.	quanxw@nankai.edu.cn	Yin, Yanbin/AAH-2665-2020	Yin, Yanbin/0000-0001-7667-881X; Liu, Zhandong/0000-0002-7608-0831	 [15JCYBJC18900];  [61403213]	; 	This work was supported by 15JCYBJC18900, http://www.tstc.gov.cn/zxbs/asxh/kjjh/yyjc/ (H. Z. is the receiver of the above funding), and 61403213, http://www.nsfc.gov.cn/publish/portal0/tab351/ (X. Q. is the receiver of this funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barber MJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026129; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; [陈羽中 Chen Yuzhong], 2015, [模式识别与人工智能, Pattern Recognition and Artificial Intelligence], V28, P289; Cheng H, 2009, IEEE I CONF COMP VIS, P317, DOI 10.1109/ICCV.2009.5459267; Ding ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24115; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gregory S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103018; Gwinner F, 2016, BIOINFORMATICS, V33, P1; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang T., 2010, P SIAM INT C DAT MIN, P583; Ismail B, 2011, IMAGE ANNOTATION AND; Knox SS, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-11; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Lee S, 2015, EXP NEUROBIOL, V24, P1, DOI 10.5607/en.2015.24.1.1; [雷琪 Lei Qi], 2015, [模式识别与人工智能, Pattern Recognition and Artificial Intelligence], V28, P961; Leung IXY, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066107; Lim J, 2015, DEV CELL, V32, P491, DOI 10.1016/j.devcel.2015.02.002; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Moradi F, 2014, 2014 PROCEEDINGS OF THE IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2014), P1, DOI 10.1109/ASONAM.2014.6921552; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Speriosu M, 2011, P 1 WORKSHOP UNSUPER, P53, DOI DOI 10.1017/CB09781107415324.004; Subelj L, 2011, EUR PHYS J B, V81, P353, DOI 10.1140/epjb/e2011-10979-2; Tang CY, 2015, MAGNETIC RESONANCE M, V3, P1; Tang JH, 2008, IEEE T MULTIMEDIA, V10, P620, DOI 10.1109/TMM.2008.921853; Tian Z., 2012, P SIAM INT C DAT MI, P863; Wang X, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-31; YANG Ling-peng, 2007, P 6 NTCIR WORKSH, P140; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhu X, 2003, TECHNICAL REPORT CMU	39	25	26	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178006	10.1371/journal.pone.0178006	http://dx.doi.org/10.1371/journal.pone.0178006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542379	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600039
J	Oostvogels, AJJM; Busschers, WB; Spierings, EJM; Roseboom, TJ; Gademan, MGJ; Vrijkotte, TGM				Oostvogels, Adriette J. J. M.; Busschers, Wim B.; Spierings, Eline J. M.; Roseboom, Tessa J.; Gademan, Maaike G. J.; Vrijkotte, Tanja G. M.			Pre-pregnancy weight status, early pregnancy lipid profile and blood pressure course during pregnancy: The ABCD study	PLOS ONE			English	Article							REACTIVE PROTEIN-LEVELS; BODY-MASS INDEX; MATERNAL OBESITY; ENDOTHELIAL DYSFUNCTION; ELASTIN PEPTIDES; RISK-FACTORS; PREECLAMPSIA; COMPLICATIONS; TRIGLYCERIDES; TRIMESTER	Objective Although pre-pregnancy weight status and early pregnancy lipid profile are known to influence blood pressure course during pregnancy, little is known about how these two factors interact. The association between pre-pregnancy weight status and blood pressure course during pregnancy was assessed in the prospective ABCD study and the role (independent/mediating/moderating) of early pregnancy lipid profile in this association was determined. Methods We included 2500 normal weight (<25 kg/m2) and 600 overweight (>= 25 kg/m2) women from the prospective ABCD-study with available measurements of non-fasting early pregnancy lipids [median (IQR): 13 (12-14) weeks of gestation] and blood pressure during pregnancy [mean (SD) = 10 (2.3)]. Lipids (triglycerides, total cholesterol, apolipoprotein A1, apolipoprotein B and free fatty acids) were divided into tertiles. Multilevel piecewise linear spline models were used to describe the course of systolic and diastolic blood pressure (SBP/DBP) in four time periods during gestation for overweight and normal weight women. Results Both SBP (5.3 mmHg) and DBP (3.9 mmHg) were higher in overweight compared to normal weight women and this difference remained the same over all four time periods. The difference in SBP and DBP was not mediated or moderated by the lipid profile. Lipid profile had an independent positive effect on both SBP (range 1.3-2.2 mmHg) and DBP (0.8-1.1 mmHg), but did not change blood pressure course. Conclusions Both pre-pregnancy weight status and early pregnancy lipid profile independently increase blood pressure during pregnancy. Improving pre-pregnancy weight status and early pregnancy lipid profile might result in a healthier blood pressure course during pregnancy.	[Oostvogels, Adriette J. J. M.; Busschers, Wim B.; Spierings, Eline J. M.; Gademan, Maaike G. J.; Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Roseboom, Tessa J.] Univ Amsterdam, Acad Med Ctr, Dept Gynaecol & Obstet, Amsterdam, Netherlands; [Roseboom, Tessa J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Oostvogels, AJJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands.	a.oostvogels@amc.nl		Roseboom, Tessa/0000-0003-0564-5994; Vrijkotte, Tanja/0000-0003-3641-4048	Netherlands Organization for Health Research and Development (ZonMw) (TOP) [40-00812-98-11010]	Netherlands Organization for Health Research and Development (ZonMw) (TOP)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organization for Health Research and Development (ZonMw) Grant (TOP, 40-00812-98-11010), granted to TV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bizbiz L, 1997, ATHEROSCLEROSIS, V131, P73, DOI 10.1016/S0021-9150(97)06076-0; Buuren van SG -O K, 2010, MICE MULTIVARIATE IM, V10, P1; Carpenter MW, 2007, DIABETES CARE, V30, pS246, DOI 10.2337/dc07-s224; CHIN JH, 1992, J CLIN INVEST, V89, P10, DOI 10.1172/JCI115549; Clausen T, 2001, BRIT J OBSTET GYNAEC, V108, P1081, DOI 10.1016/S0306-5456(01)00247-9; de Jonge LL, 2011, J HYPERTENS, V29, P2413, DOI 10.1097/HJH.0b013e32834c58e5; Enquobahrie DA, 2004, AM J HYPERTENS, V17, P574, DOI 10.1016/j.amjhyper.2004.03.666; Farias DR, 2016, BJOG-INT J OBSTET GY, V123, P570, DOI 10.1111/1471-0528.13293; FAURY G, 1995, J VASC RES, V32, P112, DOI 10.1159/000159084; Gademan MGJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094594; Gaillard R, 2011, J HYPERTENS, V29, P937, DOI 10.1097/HJH.0b013e328345500c; Gratacos E, 2000, EUR J OBSTET GYN R B, V92, P63, DOI 10.1016/S0301-2115(00)00427-9; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Kandimalla B. H., 2011, Archives of Physiology and Biochemistry, V117, P215, DOI 10.3109/13813455.2010.543137; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Macdonald-Wallis C, 2012, HYPERTENSION, V59, P1241, DOI 10.1161/HYPERTENSIONAHA.111.187039; Macdonald-Wallis C, 2011, J HYPERTENS, V29, P1703, DOI 10.1097/HJH.0b013e328349eec6; Magriples U, 2013, AM J PERINAT, V30, P415, DOI 10.1055/s-0032-1326987; Miller RS, 2007, PAEDIATR PERINAT EP, V21, P487, DOI 10.1111/j.1365-3016.2007.00871.x; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Ray JG, 2006, BJOG-INT J OBSTET GY, V113, P379, DOI 10.1111/j.1471-0528.2006.00889.x; Sattar N, 1998, ATHEROSCLEROSIS, V138, P229, DOI 10.1016/S0021-9150(98)00037-9; Savvidou MD, 2003, LANCET, V361, P1511, DOI 10.1016/S0140-6736(03)13177-7; Scifres CM, 2014, OBESITY, V22, P932, DOI 10.1002/oby.20576; STEWART AW, 1987, AM J EPIDEMIOL, V125, P122, DOI 10.1093/oxfordjournals.aje.a114494; Torgersen CKL, 2006, CRIT CARE NURS Q, V29, P2, DOI 10.1097/00002727-200601000-00002; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; WHO, 2014, GLOB DAT BOD MASS IN; Wolf M, 2001, OBSTET GYNECOL, V98, P757, DOI 10.1016/S0029-7844(01)01551-4; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	37	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177554	10.1371/journal.pone.0177554	http://dx.doi.org/10.1371/journal.pone.0177554			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542294	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672600016
J	Gopal, A; Greenwood, BN				Gopal, Anandasivam; Greenwood, Brad N.			Traders, guns, and money: The effects of mass shootings on stock prices of firearm manufacturers in the U.S	PLOS ONE			English	Article							STAKEHOLDER THEORY; MENTAL-ILLNESS; SUICIDE RATES; MARKET; VIOLENCE; RETURNS; IMPACT; STATE; LAWS; ORGANIZATIONS	We investigate how mass shootings influence the stock price of firearms manufacturers. While it is well known that mass shootings lead to increased firearms sales, the response from financial markets is unclear. On one hand, given the observed short-term increase in demand, firearm stock prices may rise due to the unexpected financial windfall for the firm. On the other, mass shootings may result in calls for regulation of the industry, leading to divestment of firearms stocks in spite of short-term demand. We examine this tension using a market movement event study in the wake of 93 mass shootings in the U.S. between 2009 and 2013. Findings show that stock prices of firearm manufacturers decline after shootings; each event reducing prices between 22.4 and 49.5 basis points, per day. These losses are exacerbated by the presence of a handgun and the number of victims killed, but not affected by the presence of children or location of the event. Finally, we find that these effects are most prevalent in the period 2009-2010 but disappear in later events, indicating that markets appear to have accepted mass shootings as the "new normal."	[Gopal, Anandasivam] Univ Maryland, Robert H Smith Sch Business, College Pk, MD 20742 USA; [Greenwood, Brad N.] Temple Univ, Fox Sch Business, Philadelphia, PA 19122 USA	University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Gopal, A (corresponding author), Univ Maryland, Robert H Smith Sch Business, College Pk, MD 20742 USA.	agopal@rhsmith.umd.edu	Greenwood, Brad/O-5989-2019	Greenwood, Brad/0000-0002-0772-7814				Acquisti A, 2010, GUNS PRIVACY CRIME; Ahern KR, 2012, Q J ECON, V127, P137, DOI 10.1093/qje/qjr049; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2012, VIEWS GUN LAWS UNCH; Barrett P, 2014, BLOOMBERGBUSINE 0312; Barry CL, 2013, NEW ENGL J MED, V368, P1077, DOI 10.1056/NEJMp1300512; Ben-Rephael A, 2011, J FINANC QUANT ANAL, V46, P585, DOI 10.1017/S0022109010000797; Bice DC, 2002, J LAW ECON, V45, P251, DOI 10.1086/324656; Binder, 1998, REV QUANT FINAN ACC, V11, P111, DOI [10.1023/A:1008295500105, DOI 10.1023/A:1008295500105]; Birkland TA, 2009, AM BEHAV SCI; Black DA, 1998, J LEGAL STUD, V27, P209, DOI 10.1086/468019; BOEHMER E, 1991, J FINANC ECON, V30, P253, DOI 10.1016/0304-405X(91)90032-F; Brenkert GG, 2000, BUSINESS ETHICS Q, P21; Bronars SG, 1998, AM ECON REV, V88, P475; Capps Kriston, 2016, CITYLAB         0615; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Christie Jim, 2013, REUTERS; COOK EA, 1994, J POLIT, V56, P187, DOI 10.2307/2132352; Crifasi CK, 2015, PREV MED, V79, P43, DOI 10.1016/j.ypmed.2015.07.013; Crooks E, 2013, FINANCIAL TIMES 1213; Cross BW, 2013, J CRIM JUST, V41, P452, DOI 10.1016/j.jcrimjus.2013.09.002; Daniel K, 1997, J FINANC, V52, P1035, DOI 10.2307/2329515; Depetris-Chauvin E, 2015, J PUBLIC ECON, V130, P66, DOI 10.1016/j.jpubeco.2015.04.008; Donaldson T, 2002, J BANK FINANC, V26, P1853, DOI 10.1016/S0378-4266(02)00195-4; DONALDSON T, 1995, ACAD MANAGE REV, V20, P65, DOI 10.5465/AMR.1995.9503271992; Dunfee T.W., 1991, BUS ETHICS Q, V1, P23; Durand R., 2014, STRATEGIC MANAGEMENT; DUWE G, 2002, HOMICIDE STUDIES, V0006; Edelen RM, 2001, J FINANC ECON, V59, P195, DOI 10.1016/S0304-405X(00)00085-4; FAMA EF, 1993, J FINANC ECON, V33, P3, DOI 10.1016/0304-405X(93)90023-5; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Feldmann Linda, 2012, CHRISTIAN SCI MONITO; Fisher M, 2012, WASHINGTON POST 1214; Freedman S, 2012, REV ECON STAT, V94, P499, DOI 10.1162/REST_a_00162; Gius M, 2014, APPL ECON LETT, V21, P265, DOI 10.1080/13504851.2013.854294; Graziano M, 2013, AM J NURS, V113, P23, DOI 10.1097/01.NAJ.0000434174.40289.af; Green RM, 2000, BUSINESS ETHICS Q, P203; Greenwood B, 2015, MANAGEMENT IN PRESS; Greve HR, 2010, ACAD MANAG ANN, V4, P53, DOI 10.1080/19416521003654186; Harrison JS, 2010, STRATEGIC MANAGE J, V31, P58, DOI 10.1002/smj.801; Henisz WJ, 2014, STRATEGIC MANAGE J, V35, P1727, DOI 10.1002/smj.2180; Hoberg G, 2010, NATL BUREAU EC RES; Hoberg G, 2010, REV FINANC STUD, V23, P3773, DOI 10.1093/rfs/hhq053; Hong H, 2009, J FINANC ECON, V93, P15, DOI 10.1016/j.jfineco.2008.09.001; Hudson John, 2012, ATLANTIC; Isquith E, 2015, SALONCOM; Jacob BA, 2015, Q J ECON, V130, P465, DOI 10.1093/qje/qju030; JENSEN MC, 1976, J FINANC ECON, V3, P305, DOI 10.1016/0304-405X(76)90026-X; Jonsson S, 2009, ADMIN SCI QUART, V54, P195, DOI 10.2189/asqu.2009.54.2.195; Karpoff JM, 2005, J LAW ECON, V48, P653, DOI 10.1086/430806; Kellermann AL, 2013, JAMA-J AM MED ASSOC, V309, P549, DOI 10.1001/jama.2012.208207; Kindy K, 2014, WASHINGTON POST; Kling CL, 2012, J ECON PERSPECT, V26, P3, DOI 10.1257/jep.26.4.3; Large MM, 2010, MED J AUSTRALIA, V192, P432, DOI 10.5694/j.1326-5377.2010.tb03580.x; Lawrence RG, 2004, SOCIAL SCI Q, V85, P1193; Loon YC, 2014, J FINANC ECON, V112, P91, DOI 10.1016/j.jfineco.2013.12.001; Lowe SR, 2017, TRAUMA VIOLENCE ABUS, V18, P62, DOI 10.1177/1524838015591572; Lubin G, 2010, SUICIDE LIFE-THREAT, V40, P421, DOI 10.1521/suli.2010.40.5.421; Luca Michael, 2016, IMPACT MASS SHOOTING; McCarthy J, 2014, SECT GALLUP POLL SOC; McGinty EE, 2013, AM J PSYCHIAT, V170, P494, DOI 10.1176/appi.ajp.2013.13010014; McLaughlin Tim, 2016, REUTERS; McLeigh JD, 2015, ADDRESSING GUN VIOLE; Mitchell M, 2004, J FINANC, V59, P31, DOI 10.1111/j.1540-6261.2004.00626.x; Mozaffarian D, 2013, JAMA-J AM MED ASSOC, V309, P551, DOI 10.1001/jama.2013.38; O'Toole ME, 2014, VIOLENCE GEND, V1, P107, DOI 10.1089/vio.2014.1512; Parmar BL, 2010, ACAD MANAG ANN, V4, P403, DOI 10.1080/19416520.2010.495581; PATTERSON SC, 1988, BRIT J POLIT SCI, V18, P111, DOI 10.1017/S000712340000497X; Preis T, 2013, SCI REPORTS, P3; Price EB, 2016, PROF TRAG EMP INV MA; Ramchander S, 2012, STRATEGIC MANAGE J, V33, P303, DOI 10.1002/smj.952; Roulet T, 2014, J BUS ETHICS, P1; Sanburn J, 2013, TIME MAGAZINE; Siegel MB, 2016, VIOLENCE GEND, V3, P20, DOI 10.1089/vio.2015.0047; Sommer J., 2015, NY TIMES; Thompson M, 2022, WHY GUN SALES OFTEN; Vergne J-P, 2012, ACAD MANAGEMENT J; Wallace LN, 2015, SOC SCI J, V52, P156, DOI 10.1016/j.soscij.2015.03.002; Walsh J. P., 2005, ACAD MANAGE REV, V30, P426, DOI DOI 10.5465/AMR.2005.16387898; Wermers Russ, 2003, IS MONEY REALLY SMAR; Wu L., 2013, FUTURE PREDICTION GO; YouGov, 2012, AUR LITTL CHANG OP G	82	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177720	10.1371/journal.pone.0177720	http://dx.doi.org/10.1371/journal.pone.0177720			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542296	gold, Green Published			2022-12-27	WOS:000401672400070
J	Liu, JH; Wei, XX; Li, A; Cui, YX; Xia, XY; Qin, WS; Zhang, MC; Gao, EZ; Sun, J; Gao, CL; Liu, FX; Wu, QY; Li, WW; Asan; Liu, ZH; Li, XJ				Liu, Jian-Hong; Wei, Xiu-Xiu; Li, Ang; Cui, Ying-Xia; Xia, Xin-Yi; Qin, Wei-Song; Zhang, Ming-Chao; Gao, Er-Zhi; Sun, Jun; Gao, Chun-Lin; Liu, Feng-Xia; Wu, Qiu-Yue; Li, Wei-Wei; Asan; Liu, Zhi-Hong; Li, Xiao-Jun			Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT; MOLECULAR ANALYSIS; GENE; GUIDELINES; VARIANTS; GENOME	Alport syndrome (AS) is a clinically and genetically heterogeneous, progressive nephropathy caused by mutations in COL4A3, COL4A4, and COL4A5, which encode type IV collagen. The large sizes of these genes and the absence of mutation hot spots have complicated mutational analysis by routine polymerase chain reaction (PCR)-based approaches. Here, in order to design a rapid and effective method for the genetic diagnosis of AS, we developed a strategy by utilizing targeted capture associated with next-generation sequencing (NGS) to analyze COL4A3, COL4A4, and COL4A5 simultaneously in 20 AS patients. All the coding exons and flanking sequences of COL4A3, COL4A4, and COL4A5 from the probands were captured followed by HiSeq 2500 sequencing. Candidate mutations were validated by classic Sanger sequencing and quantitative (q) PCR. Sixteen patients (16/20, 75%) showed X-linked inheritance, and four patients (4/20, 20%) showed autosomal recessive inheritance. None of the individuals had autosomal-dominant AS. Fifteen novel mutations, 6 known mutations, and 2 novel fragment deletions were detected by targeted capture and NGS. Of these novel mutations, 12, 3, and 2 mutations were detected in COL4A5, COL4A4, and COL4A3, respectively. A comparison of the clinical manifestations caused by different types of mutations in COL4A5 suggested that nonsense mutations and glycine substitution by an acidic amino acid are more severe than the other missense mutations. Pathogenic mutations were detected in 20 patients. These novel mutations can expand the genotypic spectrum of AS. Our results demonstrated that targeted capture and NGS technology are effective in the genetic diagnosis of AS.	[Liu, Jian-Hong; Li, Ang; Cui, Ying-Xia; Xia, Xin-Yi; Wu, Qiu-Yue; Li, Wei-Wei; Li, Xiao-Jun] Nanjing Univ, Inst Clin Lab Sci, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China; [Wei, Xiu-Xiu; Sun, Jun; Liu, Feng-Xia; Asan] BGI Shenzhen, BGI Tianjin, Binhai Genom Inst, Tianjin, Peoples R China; [Qin, Wei-Song; Zhang, Ming-Chao; Gao, Er-Zhi; Liu, Zhi-Hong] Nanjing Univ, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Sch Med, Nanjing, Jiangsu, Peoples R China; [Gao, Chun-Lin] Nanjing Univ, Sch Med, Jinling Hosp, Dept Pediat Nephrol, Nanjing, Jiangsu, Peoples R China; [Li, Xiao-Jun] Nanjing Univ, Dept Chem, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University; Beijing Genomics Institute (BGI); Nanjing University; Nanjing University; Nanjing University	Li, XJ (corresponding author), Nanjing Univ, Inst Clin Lab Sci, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China.; Asan (corresponding author), BGI Shenzhen, BGI Tianjin, Binhai Genom Inst, Tianjin, Peoples R China.; Liu, ZH (corresponding author), Nanjing Univ, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Sch Med, Nanjing, Jiangsu, Peoples R China.; Li, XJ (corresponding author), Nanjing Univ, Dept Chem, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China.	asan@genomics.cn; zhliunj@vip.163.com; xiaojunli62@126.com		Li, Ang/0000-0002-7403-2705	Science and Technology Program of Jiangsu Province [BL2014072]; Science and Technology Development Project of Nanjing [201402008, 201503010]; National Key Clinical Program of China [2014ZDZKO03]	Science and Technology Program of Jiangsu Province; Science and Technology Development Project of Nanjing; National Key Clinical Program of China	This work is supported by the grants from Science and Technology Program of Jiangsu Province (BL2014072), Science and Technology Development Project of Nanjing (No. 201402008), (No. 201503010), and National Key Clinical Program of China (No. 2014ZDZKO03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the patients and their families for permitting us to do this study. This work is supported by the grants from Science and Technology Program of Jiangsu Province (BL2014072), Science and Technology Development Project of Nanjing (No. 201402008), (No. 201503010), and National Key Clinical Program of China (No. 2014ZDZKO03).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alport AC, 1927, BMJ-BRIT MED J, V1927, P504, DOI 10.1136/bmj.1.3454.504; Beirowski B, 2006, J AM SOC NEPHROL, V17, P1986, DOI 10.1681/ASN.2005101044; Bekheirnia MR, 2010, J AM SOC NEPHROL, V21, P876, DOI 10.1681/ASN.2009070784; Gong W, 2006, NEPHROL DIAL TRANSPL, V21, P3146, DOI 10.1093/ndt/gfl394; Gregory MC, 1996, CONTRIB NEPHROL, V117, P1; Gross O, 2002, NEPHROL DIAL TRANSPL, V17, P1218, DOI 10.1093/ndt/17.7.1218; Heidet L, 2001, J AM SOC NEPHROL, V12, P97, DOI 10.1681/ASN.V12197; Hudson BG, 2004, J AM SOC NEPHROL, V15, P2514, DOI 10.1097/01.ASN.0000141462.00630.76; Jais JP, 2003, J AM SOC NEPHROL, V14, P2603, DOI 10.1097/01.ASN.0000090034.71205.74; Jefferson JA, 1997, NEPHROL DIAL TRANSPL, V12, P1595, DOI 10.1093/ndt/12.8.1595; Kamiyoshi N, 2016, CLIN J AM SOC NEPHRO, V11, P1441, DOI 10.2215/CJN.01000116; Kashtan CE, 2000, PEDIATR NEPHROL, V14, P502, DOI 10.1007/s004670050804; KASHTAN CE, 1993, AM J KIDNEY DIS, V22, P627, DOI 10.1016/S0272-6386(12)80424-0; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kruegel J, 2013, NAT REV NEPHROL, V9, P170, DOI 10.1038/nrneph.2012.259; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu G, 2014, GENE, V533, P547, DOI 10.1016/j.gene.2013.10.021; Longo I, 2006, NEPHROL DIAL TRANSPL, V21, P665, DOI 10.1093/ndt/gfi312; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; Malone AF, 2014, KIDNEY INT, V86, P1253, DOI 10.1038/ki.2014.305; Marcocci E, 2009, NEPHROL DIAL TRANSPL, V24, P1464, DOI 10.1093/ndt/gfn681; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mencarelli MA, 2015, J MED GENET, V52, P163, DOI 10.1136/jmedgenet-2014-102822; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Nagel Mato, 2005, Hum Mutat, V26, P60, DOI 10.1002/humu.9349; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Papazachariou L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115015; Pirson Y, 1999, KIDNEY INT, V56, P760, DOI 10.1046/j.1523-1755.1999.00601.x; POCHET JM, 1989, NEPHROL DIAL TRANSPL, V4, P1016; Renkema KY, 2014, NAT REV NEPHROL, V10, P433, DOI 10.1038/nrneph.2014.95; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Savige J, 2013, J AM SOC NEPHROL, V24, P364, DOI 10.1681/ASN.2012020148; Wei XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029500; Xie JY, 2015, J MOL CELL BIOL, V7, P184, DOI 10.1093/jmcb/mjv023	35	11	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177685	10.1371/journal.pone.0177685	http://dx.doi.org/10.1371/journal.pone.0177685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542346	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400067
J	Rao, D; Perraud, AL; Schmitz, C; Gally, F				Rao, Deviyani; Perraud, Anne-Laure; Schmitz, Carsten; Gally, Fabienne			Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter	PLOS ONE			English	Article							EPITHELIAL-CELLS; INNATE IMMUNITY; INFLAMMATION; LUNG; INFECTION; ACTIVATION; AIRWAY; IMPACT	Cigarette smoking is the primary cause of chronic obstructive pulmonary disease (COPD) with repeated and sustained infections linked to disease pathogenesis and exacerbations. The airway epithelium constitutes the first line of host defense against infection and is known to be impaired in COPD. We have previously identified Fatty Acid Binding Protein 5 (FABP5) as an important anti-inflammatory player during respiratory infections and showed that overexpression of FABP5 in primary airway epithelial cells protects against bacterial infection and inflammation. While cigarette smoke down regulates FABP5 expression, its mechanism remains unknown. In this report, we have identified three putative c-Jun binding sites on the FABP5 promoter and show that cigarette smoke inhibits the binding of c-Jun to its consensus sequence and prevents LPS-induced FABP5 expression. Using chromatin immunoprecipitation, we have determined that c-Jun binds the FABP5 promoter when stimulated with LPS but the presence of cigarette smoke greatly reduces this binding. Furthermore, cigarette smoke or a mutation in the c-Jun binding site inhibits LPS-induced FABP5 promoter activity. These data demonstrate that cigarette smoke interferes with FABP5 expression in response to bacterial infection. Thus, functional activation of FABP5 may be a new therapeutic strategy when treating COPD patients suffering from exacerbations.	[Rao, Deviyani; Perraud, Anne-Laure; Schmitz, Carsten; Gally, Fabienne] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Perraud, Anne-Laure; Schmitz, Carsten] Univ Colorado Denver, Dept Immunol & Microbiol, Denver, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gally, F (corresponding author), Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA.	gallyf@njhealth.org		Gally, Fabienne/0000-0003-0503-7411	American Lung Association [RG-266855-N]; Flight Attendant Medical Research Institute (FAMRI) [YCSA-103151]	American Lung Association; Flight Attendant Medical Research Institute (FAMRI)	This work was supported by the American Lung Association RG-266855-N (FG) and Flight Attendant Medical Research Institute (FAMRI) YCSA-103151 (FG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Baral P, 2014, AM J RESP CRIT CARE, V190, P722, DOI 10.1164/rccm.201406-1101PP; Bleck B, 1998, GENE, V215, P123, DOI 10.1016/S0378-1119(98)00262-5; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Donaldson GC, 2005, CHEST, V128, P1995, DOI 10.1378/chest.128.4.1995; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Fabbri Leonardo, 2004, COPD, V1, P105; FOSTER WM, 1985, AM REV RESPIR DIS, V132, P633; Gally F, 2013, AM J PHYSIOL-LUNG C, V305, pL64, DOI 10.1152/ajplung.00276.2012; Gally F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051784; Green RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006860; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Herr C, 2009, THORAX, V64, P144, DOI 10.1136/thx.2008.102681; HOEFFLER WK, 1994, NUCLEIC ACIDS RES, V22, P1305, DOI 10.1093/nar/22.7.1305; Laan M, 2004, J IMMUNOL, V173, P4164, DOI 10.4049/jimmunol.173.6.4164; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martin Richard J, 2006, COPD, V3, P3, DOI 10.1080/15412550500493162; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Morgan E, 2010, PPAR RES, V2010, DOI 10.1155/2010/234629; Niewoehner DE, 2006, AM J MED, V119, pS38, DOI 10.1016/j.amjmed.2006.08.006; RAMAN AS, 1983, CHEST, V83, P23, DOI 10.1378/chest.83.1.23; Razani-Boroujerdi S, 2004, CELL IMMUNOL, V230, P1, DOI 10.1016/j.cellimm.2004.07.007; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002	32	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178021	10.1371/journal.pone.0178021	http://dx.doi.org/10.1371/journal.pone.0178021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542209	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400130
J	Sarlabous, L; Torres, A; Fiz, JAA; Martinez-Llorens, JM; Gea, J; Jane, R				Sarlabous, Leonardo; Torres, Abel; Fiz, Jose A. A.; Martinez-Llorens, Juana M.; Gea, Joaquim; Jane, Raimon			Inspiratory muscle activation increases with COPD severity as confirmed by non-invasive mechanomyographic analysis	PLOS ONE			English	Article							NEURAL RESPIRATORY DRIVE; POWER OUTPUT; DIAPHRAGM; FATIGUE; ELECTROMYOGRAPHY; EXACERBATIONS; PHONOMYOGRAM; EFFICIENCY; SIGNALS; FORCE	There is a lack of instruments for assessing respiratory muscle activation during the breathing cycle in clinical conditions. The aim of the present study was to evaluate the usefulness of the respiratory muscle mechanomyogram (MMG) for non-invasively assessing the mechanical activation of the inspiratory muscles of the lower chest wall in both patients with chronic obstructive pulmonary disease (COPD) and healthy subjects, and to investigate the relationship between inspiratory muscle activation and pulmonary function parameters. Both inspiratory mouth pressure and respiratory muscle MMG were simultaneously recorded under two different respiratory conditions, quiet breathing and incremental ventilatory effort, in 13 COPD patients and 7 healthy subjects. The mechanical activation of the inspiratory muscles was characterised by the non-linear multistate Lempel-Ziv index (MLZ) calculated over the inspiratory time of the MMG signal. Subsequently, the efficiency of the inspiratory muscle mechanical activation was expressed as the ratio between the peak inspiratory mouth pressure to the amplitude of the mechanical activation. This activation estimated using the MLZ index correlated strongly with peak inspiratory mouth pressure throughout the respiratory protocol in both COPD patients (r = 0.80, p<0.001) and healthy (r = 0.82, p<0.001). Moreover, the greater the COPD severity in patients, the greater the level of muscle activation (r = -0.68, p = 0.001, between muscle activation at incremental ventilator effort and FEV1). Furthermore, the efficiency of the mechanical activation of inspiratory muscle was lower in COPD patients than healthy subjects (7.61 +/- 2.06 vs 20.42 +/- 10.81, respectively, p = 0.0002), and decreased with increasing COPD severity (r = 0.78, p<0.001, between efficiency of the mechanical activation at incremental ventilatory effort and FEV1). These results suggest that the respiratory muscle mechanomyogram is a good reflection of inspiratory effort and can be used to estimate the efficiency of the mechanical activation of the inspiratory muscles. Both, inspiratory muscle activation and inspiratory muscle mechanical activation efficiency are strongly correlated with the pulmonary function. Therefore, the use of the respiratory muscle mechanomyogram can improve the assessment of inspiratory muscle activation in clinical conditions, contributing to a better understanding of breathing in COPD patients.	[Sarlabous, Leonardo; Torres, Abel; Fiz, Jose A. A.; Jane, Raimon] Inst Bioengn Catalonia, Barcelona, Spain; [Sarlabous, Leonardo; Torres, Abel; Fiz, Jose A. A.; Jane, Raimon] Ctr Biomed Res Network Bioengn Biomat & Nanomed, Barcelona, Spain; [Sarlabous, Leonardo; Torres, Abel; Jane, Raimon] Univ Politecn Cataluna, BarcelonaTech UPC, Dept Automat Control, Barcelona, Spain; [Martinez-Llorens, Juana M.; Gea, Joaquim] Hosp del Mar, CIBERES, DCEXS, UPF,Dept Resp Med,ISCiii,IMIM, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Instituto de Salud Carlos III; Pompeu Fabra University	Torres, A (corresponding author), Inst Bioengn Catalonia, Barcelona, Spain.; Torres, A (corresponding author), Ctr Biomed Res Network Bioengn Biomat & Nanomed, Barcelona, Spain.; Torres, A (corresponding author), Univ Politecn Cataluna, BarcelonaTech UPC, Dept Automat Control, Barcelona, Spain.	abel.torres@upc.edu	Sarlabous, Leonardo/AAZ-7951-2020; Sarlabous, Leonardo/L-2333-2014; Cebrian, Abel Torres/I-5730-2014	Sarlabous, Leonardo/0000-0002-0495-8422; Sarlabous, Leonardo/0000-0002-0495-8422; Cebrian, Abel Torres/0000-0003-2678-1303; Jane, Raimon/0000-0002-6541-8729	Secretariat of Universities and Research of the Ministry of Economy and Knowledge of the Generalitat de Catalunya; Plan Nacional [SAF2014-54371]; Ministry of Economy and Competitiveness of the Spanish Government; European Regional Development Fund [DPI2015-68820-R]	Secretariat of Universities and Research of the Ministry of Economy and Knowledge of the Generalitat de Catalunya; Plan Nacional; Ministry of Economy and Competitiveness of the Spanish Government(Spanish Government); European Regional Development Fund(European Commission)	This work was supported in part by the Secretariat of Universities and Research of the Ministry of Economy and Knowledge of the Generalitat de Catalunya (consolidated research groups GRC 2014 SGR 1569 and 424, and CERCA Programme), the Plan Nacional (SAF2014-54371), and by the Ministry of Economy and Competitiveness of the Spanish Government and the European Regional Development Fund, DPI2015-68820-R (MINECO/FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the Secretariat of Universities and Research of the Ministry of Economy and Knowledge of the Generalitat de Catalunya (Consolidated research groups GRC 2014 SGR 1569 and 424, and CERCA Programme), the Plan Nacional (SAF2014-54371), and the Ministry of Economy and Competitiveness of the Spanish Government and the European Regional Development Fund, DPI2015-68820-R (MINECO/FEDER).	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Fiz JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093595; Bakke PS, 2011, EUR RESPIR J, V38, P1261, DOI 10.1183/09031936.00193809; BARRY DT, 1987, BIOPHYS J, V51, P769, DOI 10.1016/S0006-3495(87)83403-3; Ce E., 2015, SPORT SCI HLTH, V11, P1, DOI [10.1007/s11332-015-0219-z, DOI 10.1007/S11332-015-0219-Z, DOI 10.1007/s11332-015-0219-z]; Cescon C, 2006, J ELECTROMYOGR KINES, V16, P17, DOI 10.1016/j.jelekin.2005.02.005; Cramer JT, 2000, MUSCLE NERVE, V23, P1826, DOI 10.1002/1097-4598(200012)23:12<1826::AID-MUS5>3.0.CO;2-7; DAVIS JN, 1967, J NEUROL NEUROSUR PS, V30, P420, DOI 10.1136/jnnp.30.5.420; Estrada L, 2016, IEEE J BIOMED HEALTH, V20, P476, DOI 10.1109/JBHI.2015.2398934; Finucane KE, 2009, J APPL PHYSIOL, V107, P1397, DOI 10.1152/japplphysiol.91465.2008; Fiz Jose Antonio, 2004, BMC Pulm Med, V4, P8, DOI 10.1186/1471-2466-4-8; Gorman RB, 2002, AM J RESP CRIT CARE, V166, P1461, DOI 10.1164/rccm.200111-087OC; Guenette JA, 2012, EUR RESPIR J, V40, P322, DOI 10.1183/09031936.00157711; Ibitoye MO, 2014, SENSORS-BASEL, V14, P22940, DOI 10.3390/s141222940; Ibitoye MO, 2014, CLIN BIOMECH, V29, P691, DOI 10.1016/j.clinbiomech.2014.04.003; Islam MA, 2013, IEEE SENS J, V13, P2499, DOI 10.1109/JSEN.2013.2255982; Laghi F, 2003, AM J RESP CRIT CARE, V168, P10, DOI 10.1164/rccm.2206020; LAPORTA D, 1985, J APPL PHYSIOL, V58, P1469, DOI 10.1152/jappl.1985.58.5.1469; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Luo YM, 2008, CLIN SCI, V115, P233, DOI 10.1042/CS20070348; MacBean V, 2016, PHYSIOL MEAS, V37, P2050, DOI 10.1088/0967-3334/37/11/2050; Madeleine P, 2002, EUR J APPL PHYSIOL, V87, P327, DOI 10.1007/s00421-002-0655-8; Murphy PB, 2011, THORAX, V66, P602, DOI 10.1136/thx.2010.151332; NEWELL SZ, 1989, THORAX, V44, P903, DOI 10.1136/thx.44.11.903; Orizio C, 2003, EUR J APPL PHYSIOL, V90, P326, DOI 10.1007/s00421-003-0924-1; ORIZIO C, 1993, CRIT REV BIOMED ENG, V21, P201; Orizio C, 2006, MECHANOMYOGRAPHY WIL, P1; Ottenheijm CAC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-12; Petitjean M, 1997, AM J RESP CRIT CARE, V155, P1162, DOI 10.1164/ajrccm.155.3.9117004; Petitjean M, 1996, THORAX, V51, P705, DOI 10.1136/thx.51.7.705; PETITJEAN M, 1994, MUSCLE NERVE, V17, P1201, DOI 10.1002/mus.880171011; Reilly CC, 2012, EUR RESPIR J, V40, P977, DOI 10.1183/09031936.00163111; Sarlabous L, 2015, EUR RESPIR J, V46, P1808, DOI 10.1183/13993003.00434-2015; Sarlabous L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088902; Sarlabous L, 2013, J ELECTROMYOGR KINES, V23, P548, DOI 10.1016/j.jelekin.2012.12.007; Steier J, 2009, THORAX, V64, P719, DOI 10.1136/thx.2008.109728; Suh ES, 2015, THORAX, V70, P1123, DOI 10.1136/thoraxjnl-2015-207188; Torres A, 2010, EUR RESP SOC ANN C, p503s	38	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177730	10.1371/journal.pone.0177730	http://dx.doi.org/10.1371/journal.pone.0177730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542364	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400072
J	Viegas, CSB; Costa, RM; Santos, L; Videira, PA; Silva, Z; Araujo, N; Macedo, AL; Matos, AP; Vermeer, C; Simes, DC				Viegas, Carla S. B.; Costa, Ruben M.; Santos, Lucia; Videira, Paula A.; Silva, Zelia; Araujo, Nuna; Macedo, Anjos L.; Matos, Antonio P.; Vermeer, Cees; Simes, Dina C.			Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases	PLOS ONE			English	Article							VITAMIN-K SUPPRESSES; FACTOR-KAPPA-B; VASCULAR CALCIFICATION; SYNOVIAL MACROPHAGES; ARTICULAR-CARTILAGE; MATRIX VESICLES; OSTEOARTHRITIS; EXPRESSION; INSIGHTS; ACTIVATION	Calcification-related chronic inflammatory diseases are multifactorial pathological processes, involving a complex interplay between inflammation and calcification events in a positive feed-back loop driving disease progression. Gla-rich protein (GRP) is a vitamin K dependent protein (VKDP) shown to function as a calcification inhibitor in cardiovascular and articular tissues, and proposed as an anti-inflammatory agent in chondrocytes and synoviocytes, acting as a new crosstalk factor between these two interconnected events in osteoarthritis. However, a possible function of GRP in the immune system has never been studied. Here we focused our investigation in the involvement of GRP in the cell inflammatory response mechanisms, using a combination of freshly isolated human leucocytes and undifferentiated/differentiated THP-1 cell line. Our results demonstrate that VKDPs such as GRP and matrix gla protein (MGP) are synthesized and gamma-carboxylated in the majority of human immune system cells either involved in innate or adaptive immune responses. Stimulation of THP-1 monocytes/macrophages with LPS or hydroxyapatite (HA) up-regulated GRP expression, and treatments with GRP or GRP-coated basic calcium phosphate crystals resulted in the down-regulation of mediators of inflammation and inflammatory cytokines, independently of the protein gamma-carboxylation status. Moreover, overexpression of GRP in THP-1 cells rescued the inflammation induced by LPS and HA, by down-regulation of the proinflammatory cytokines TNF alpha, IL-1 beta and NFkB. Interestingly, GRP was detected at protein and mRNA levels in extracellular vesicles released by macrophages, which may act as vehicles for extracellular trafficking and release. Our data indicate GRP as an endogenous mediator of inflammatory responses acting as an anti-inflammatory agent in monocytes/macrophages. We propose that in a context of chronic inflammation and calcification-related pathologies, GRP might act as a novel molecular mediator linking inflammation and calcification events, with potential therapeutic application.	[Viegas, Carla S. B.; Costa, Ruben M.; Santos, Lucia; Araujo, Nuna; Simes, Dina C.] Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal; [Viegas, Carla S. B.; Simes, Dina C.] Univ Algarve, Ctr Marine Sci CCMAR, GenoGla Diagnost, Faro, Portugal; [Videira, Paula A.; Silva, Zelia] Univ Nova Lisboa, UCIBIO REQUIMTE Dept Ciencias Vida, Fac Ciencias & Tecnol, Caparica, Portugal; [Macedo, Anjos L.] Univ Nova Lisboa, Dept Quim, UCIBIO REQUIMTE, Fac Ciencias & Tecnol, Caparica, Portugal; [Matos, Antonio P.] Egas Moniz Cooperat Ensino Super CRL, Ctr Invest Interdisciplinar Egas Moniz, Caparica, Portugal; [Vermeer, Cees] Maastricht Univ, VitaK, Maastricht, Netherlands	Universidade do Algarve; Universidade do Algarve; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Instituto Superior de Ciencias da Saude Egas Moniz; Maastricht University	Simes, DC (corresponding author), Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal.; Simes, DC (corresponding author), Univ Algarve, Ctr Marine Sci CCMAR, GenoGla Diagnost, Faro, Portugal.	dsimes@ualg.pt	silva, zélia mc/O-7243-2015; Santos, Lúcia/U-7602-2017; Videira, P A/A-5901-2013; Simes, Dina Costa/N-2789-2014; Macedo, Anjos L/D-7216-2013; Viegas, Carla/N-6314-2019; Viegas, Carla CSB/N-6695-2014; Matos, Antonio/A-4539-2013	silva, zélia mc/0000-0001-6660-426X; Santos, Lúcia/0000-0002-3748-3697; Videira, P A/0000-0001-5987-2485; Simes, Dina Costa/0000-0002-5145-4753; Macedo, Anjos L/0000-0002-2613-4838; Viegas, Carla/0000-0002-5765-3665; Viegas, Carla CSB/0000-0002-5765-3665; Matos, Antonio/0000-0001-9386-0349	Portuguese Science and Technology Foundation (FCT) [PTDC/SAU-ORG/117266/2010, PTDC/BIM-MEC/1168/2012, UID/Multi/ 04326/2013]; FCT fellowships [SFRH/BPD/70277/2010, SFRH/BD/111824/2015]	Portuguese Science and Technology Foundation (FCT)(Portuguese Foundation for Science and Technology); FCT fellowships(Portuguese Foundation for Science and Technology)	This work was funded by projects PTDC/SAU-ORG/117266/2010 and PTDC/BIM-MEC/1168/2012, and also through project UID/Multi/ 04326/2013, all from the Portuguese Science and Technology Foundation (FCT). CSB Viegas and N Araujo are the recipients of the FCT fellowships SFRH/BPD/70277/2010 and SFRH/BD/111824/2015, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CSB Viegas and N Araujo are the recipients of the Portuguese Science and Technology Foundation (FCT) fellowships SFRH/BPD/70277/2010 and SFRH/BD/111824/2015, respectively. Authors acknowledge Dr Nuno Santos (CBME, University of Algarve, Faro, Portugal) for kindly providing the THP-1 cells used in this study.	Aldo PB, 2013, AM J REPROD IMMUNOL, V70, P80, DOI 10.1111/aji.12129; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Bondeson J, 2010, ARTHRITIS RHEUM-US, V62, P647, DOI 10.1002/art.27290; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Cavaco S, 2016, CELL MOL LIFE SCI, V73, P1051, DOI 10.1007/s00018-015-2033-9; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; Chatrou MLL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142335; Chen NX, 2015, CURR OSTEOPOROS REP, V13, P372, DOI 10.1007/s11914-015-0293-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Ciardiello C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020175; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Ea HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057352; Ea HK, 2011, ARTHRITIS RHEUM-US, V63, P10, DOI 10.1002/art.27761; Fernandez-Pisonero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109081; Fujii S, 2015, BIOORGAN MED CHEM, V23, P2344, DOI 10.1016/j.bmc.2015.03.070; Gomez-Hernandez A, 2006, J CARDIOVASC PHARM, V47, P60; Henaut L, 2016, EXPERT OPIN THER TAR, V20, P89, DOI 10.1517/14728222.2015.1081685; Houard X, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0375-6; Ikeda K, 2012, BIOCHEM BIOPH RES CO, V425, P39, DOI 10.1016/j.bbrc.2012.07.045; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kapustin AN, 2011, CIRC RES, V109, pE1, DOI 10.1161/CIRCRESAHA.110.238808; Legein B, 2013, CELL MOL LIFE SCI, V70, P3847, DOI 10.1007/s00018-013-1289-1; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Martel-Pelletier J, 2003, SEMIN ARTHRITIS RHEU, V33, P155, DOI 10.1016/S0049-0172(03)00134-3; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; New SEP, 2013, ARTERIOSCL THROM VAS, V33, P1753, DOI 10.1161/ATVBAHA.112.300128; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; New SEP, 2011, CIRC RES, V108, P1381, DOI 10.1161/CIRCRESAHA.110.234146; Ohsaki Y, 2006, BIOSCI BIOTECH BIOCH, V70, P926, DOI 10.1271/bbb.70.926; Ohsaki Y, 2010, J NUTR BIOCHEM, V21, P1120, DOI 10.1016/j.jnutbio.2009.09.011; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Popov A, 2013, J IMMUNOTOXICOL, V10, P17, DOI 10.3109/1547691X.2012.684159; Rafael MS, 2014, MOL NUTR FOOD RES, V58, P1636, DOI 10.1002/mnfr.201300941; Rahmati M, 2016, BONE, V85, P81, DOI 10.1016/j.bone.2016.01.019; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Shea MK, 2008, AM J EPIDEMIOL, V167, P313, DOI 10.1093/aje/kwm306; Shirai T, 2015, AUTOIMMUNITY, V48, P139, DOI 10.3109/08916934.2015.1027815; Smith ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060904; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Surmann-Schmitt C, 2008, J BIOL CHEM, V283, P7082, DOI 10.1074/jbc.M702792200; Tie JK, 2016, J THROMB HAEMOST, V14, P236, DOI 10.1111/jth.13217; Tintut Y, 2002, CIRCULATION, V105, P650, DOI 10.1161/hc0502.102969; Viegas CSB, 2015, ARTERIOSCL THROM VAS, V35, P399, DOI 10.1161/ATVBAHA.114.304823; Viegas CSB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/340216; Viegas CSB, 2009, AM J PATHOL, V175, P2288, DOI 10.2353/ajpath.2009.090474; Viegas CSB, 2008, J BIOL CHEM, V283, P36655, DOI 10.1074/jbc.M802761200; Viegas CS, 2016, J NUTR DISORDERS THE, V6, P3, DOI DOI 10.4172/2161-0509.1000192; Viegas CS, 2016, J CARDIOVASC DIS DIA, V4, P245; Viegas CSB, 2017, EMMUNITY IN IN PRESS; Wallin R, 2010, OSTEOARTHR CARTILAGE, V18, P1096, DOI 10.1016/j.joca.2010.05.013; Willems BAG, 2014, MOL NUTR FOOD RES, V58, P1620, DOI 10.1002/mnfr.201300743; Zhao GX, 2012, KIDNEY INT, V82, P34, DOI 10.1038/ki.2012.40	54	53	55	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177829	10.1371/journal.pone.0177829	http://dx.doi.org/10.1371/journal.pone.0177829			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542410	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400094
J	Fajardo-Ortiz, D; Lopez-Cervantes, M; Duran, L; Dumontier, M; Lara, M; Ochoa, H; Castano, VM				Fajardo-Ortiz, David; Lopez-Cervantes, Malaquias; Duran, Luis; Dumontier, Michel; Lara, Miguel; Ochoa, Hector; Castano, Victor M.			The emergence and evolution of the research fronts in HIV/AIDS research	PLOS ONE			English	Article							EMERGING RESEARCH FRONTS; HIV-1; AIDS; IDENTIFICATION; VISUALIZATION; TRANSLATION; LYMPHOCYTES; KNOWLEDGE; NETWORKS; SCIENCE	In this paper, we have identified and analyzed the emergence, structure and dynamics of the paradigmatic research fronts that established the fundamentals of the biomedical knowledge on HIV/AIDS. A search of papers with the identifiers "HIV/AIDS", "Human Immunodeficiency Virus", "HIV-1" and "Acquired Immunodeficiency Syndrome" in the Web of Science (Thomson Reuters), was carried out. A citation network of those papers was constructed. Then, a sub-network of the papers with the highest number of inter-citations (with a minimal in-degree of 28) was selected to perform a combination of network clustering and text mining to identify the paradigmatic research fronts and analyze their dynamics. Thirteen research fronts were identified in this sub-network. The biggest and oldest front is related to the clinical knowledge on the disease in the patient. Nine of the fronts are related to the study of specific molecular structures and mechanisms and two of these fronts are related to the development of drugs. The rest of the fronts are related to the study of the disease at the cellular level. Interestingly, the emergence of these fronts occurred in successive "waves" over the time which suggest a transition in the paradigmatic focus. The emergence and evolution of the biomedical fronts in HIV/AIDS research is explained not just by the partition of the problem in elements and interactions leading to increasingly specialized communities, but also by changes in the technological context of this health problem and the dramatic changes in the epidemiological reality of HIV/AIDS that occurred between 1993 and 1995.	[Fajardo-Ortiz, David; Lopez-Cervantes, Malaquias; Duran, Luis] Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico; [Dumontier, Michel] Maastricht Univ, Inst Data Sci, Maastricht, Netherlands; [Lara, Miguel] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City, DF, Mexico; [Ochoa, Hector] Colegio Frontera Sur, San Cristobal de las Casa, Chiapas, Mexico; [Castano, Victor M.] Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico; Maastricht University; Universidad Nacional Autonoma de Mexico; El Colegio de la Frontera Sur (ECOSUR); Universidad Nacional Autonoma de Mexico	Fajardo-Ortiz, D (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico.; Castano, VM (corresponding author), Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro, Mexico.	vmcastano@unam.mx; davguifaj@gmail.com	López, Héctor OCHOA Díaz/AAR-8492-2021; Fajardo-Ortiz, David/AAB-5451-2022; Castano, Victor VMC/C-1696-2018; Castano, Victor M./H-6187-2012; Castano, Victor/AAI-6204-2021	Fajardo-Ortiz, David/0000-0002-7657-7514; Dumontier, Michel/0000-0003-4727-9435				Anegon FD, 1998, SCIENTOMETRICS, V42, P229; [Anonymous], STRUCTURE SCI REVOLU; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2015, GLOB HLTH OBS IND ES; [Anonymous], [No title captured]; Baltussen A, 2004, INTENS CARE MED, V30, P902, DOI 10.1007/s00134-004-2195-7; Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132; Brzezinski M, 2015, SCIENTOMETRICS, V103, P213, DOI 10.1007/s11192-014-1524-z; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Ding Y, 2011, J INFORMETR, V5, P187, DOI 10.1016/j.joi.2010.10.008; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Fajardo D, 2016, CURR MED CHEM, V23, P3000, DOI 10.2174/0929867323666160617101823; Fajardo-Ortiz D, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0496-y; Fajardo-Ortiz D, 2014, CAD SAUDE PUBLICA, V30, P415, DOI 10.1590/0102-311X00168512; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; Garfield E, 2009, J INFORMETR, V3, P173, DOI 10.1016/j.joi.2009.03.009; Greenberg SA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2680; Greene WC, 2007, EUR J IMMUNOL, V37, pS94, DOI 10.1002/eji.200737441; Harris JK, 2010, AM J PUBLIC HEALTH, V100, P1245, DOI 10.2105/AJPH.2009.172460; Hennessey K, 2009, CUAJ-CAN UROL ASSOC, V3, P293; Higuchi K., 2012, SHAKAI CHOSA, V8, P92; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jones DS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-57; Kallings LO, 2008, J INTERN MED, V263, P218, DOI 10.1111/j.1365-2796.2007.01910.x; Kiberstis P, 2002, SCIENCE, V296, P685, DOI 10.1126/science.296.5568.685; LYERLY HK, 1987, P NATL ACAD SCI USA, V84, P4601, DOI 10.1073/pnas.84.13.4601; Medzhitov R, 2008, NATURE, V455, P591, DOI 10.1038/455591a; Merson MH, 2006, NEW ENGL J MED, V354, P2414, DOI 10.1056/NEJMp068074; Morris SA, 2003, J AM SOC INF SCI TEC, V54, P413, DOI 10.1002/asi.10227; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Shibata N, 2008, TECHNOVATION, V28, P758, DOI 10.1016/j.technovation.2008.03.009; Shibata N, 2011, TECHNOL FORECAST SOC, V78, P274, DOI 10.1016/j.techfore.2010.07.006; Shibata N, 2009, J AM SOC INF SCI TEC, V60, P571, DOI 10.1002/asi.20994; Sierra S, 2005, J CLIN VIROL, V34, P233, DOI 10.1016/j.jcv.2005.09.004; Spinelli L, 2013, BIOSYSTEMS, V113, P91, DOI 10.1016/j.biosystems.2013.05.010; TAYLOR JP, 1992, EMBO J, V11, P3395, DOI 10.1002/j.1460-2075.1992.tb05418.x; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Van Noorden R, 2014, NATURE, V514, P550, DOI 10.1038/514550a; Winther RG, 2011, SYNTHESE, V178, P397, DOI 10.1007/s11229-009-9647-0	48	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178293	10.1371/journal.pone.0178293	http://dx.doi.org/10.1371/journal.pone.0178293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542584	gold, Green Published, Green Submitted			2022-12-27	WOS:000402062800065
J	Mishra, AK; Parish, CR; Wong, ML; Licinio, J; Blackburn, AC				Mishra, Ameet K.; Parish, Christopher R.; Wong, Ma-Li; Licinio, Julio; Blackburn, Anneke C.			Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BODY-MASS INDEX; TUMOR-STROMAL INTERACTIONS; GROWTH-FACTOR; ANTAGONIST PEPTIDE; BETA-CATENIN; RISK-FACTORS; FEMALE MICE; CELLS; METFORMIN	Epidemiological studies have shown obesity to be linked with poorer outcomes in breast cancer patients. The molecular mechanisms responsible for the increased risk of invasive/ metastatic disease with obesity are complex, but may include elevated levels of adipokines such as leptin. Using physiological levels of leptin found in obesity in a novel chronic in vitro treatment model (<= 200 ng/ml for 14 days), we confirmed the occurrence of leptin-mediated changes in growth, apoptosis and metastatic behavior, and gene expression changes representing epithelial-to-mesenchymal transition (EMT) and a cancer stem cell (CSC) like phenotype in breast epithelial and cancer cell lines (MCF10A, MCF10AT1, MCF7 and MDAMB-231). Further, we have discovered that these effects were accompanied by increased expression of TGFB1, and could be significantly reduced by co-treatment with neutralizing antibody against TGFB1, indicating that the induction of these characteristics was mediated via TGFB1. Occurring in both MCF7 and MCF10AT1 cells, it suggests these actions of leptin to be independent of estrogen receptor status. By linking leptin signalling to the established TGFB1 pathway of metastasis / EMT, this study gives a direct mechanism by which leptin can contribute to the poorer outcomes of obese cancer patients. Inhibitors of TGFB1 are in currently in phase III clinical trials in other malignancies, thus identifying the connection between leptin and TGFB1 will open new therapeutic opportunities for improving outcomes for obese breast cancer patients.	[Mishra, Ameet K.; Parish, Christopher R.; Blackburn, Anneke C.] Australian Natl Univ, John Curtin Sch Med Res, ACRF Dept Canc Biol & Therapeut, Canberra, ACT, Australia; [Wong, Ma-Li; Licinio, Julio] South Australian Hlth & Med Res Inst, Mind & Brain Theme, Adelaide, SA, Australia; [Wong, Ma-Li; Licinio, Julio] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia	Australian National University; John Curtin School of Medical Research; South Australian Health & Medical Research Institute (SAHMRI); Flinders University South Australia	Blackburn, AC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, ACRF Dept Canc Biol & Therapeut, Canberra, ACT, Australia.	anneke.blackburn@anu.edu.au	Blackburn, Anneke C/B-3670-2011; Licinio, Julio/L-4244-2013; Wong, Ma-Li/ABD-5525-2020; Wong, Ma-Li/D-7903-2011	Blackburn, Anneke C/0000-0002-6589-0142; Licinio, Julio/0000-0001-6905-5884; Parish, Christopher/0000-0001-7740-0430; Mishra, Ameet/0000-0002-6491-7278; Wong, Ma-Li/0000-0003-1512-3073	Cancer Council ACT [585409]; National Health and Medical Research Council of Australia [366787]	Cancer Council ACT(Cancer Council Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	ACB was supported by Cancer Council ACT #585409 and the National Health and Medical Research Council of Australia #366787 during this time.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ando S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00340; Barone I, 2012, CANCER RES, V72, P1416, DOI 10.1158/0008-5472.CAN-11-2558; Biglia N, 2013, GYNECOL ENDOCRINOL, V29, P263, DOI 10.3109/09513590.2012.736559; Binai NA, 2010, INT J CANCER, V127, P55, DOI 10.1002/ijc.25010; Boterberg I, 2001, METASTASIS RES PROTO, P58; Briffa JF, 2015, MOL CELL ENDOCRINOL, V401, P25, DOI 10.1016/j.mce.2014.11.024; Catalano S, 2003, J BIOL CHEM, V278, P28668, DOI 10.1074/jbc.M301695200; Catalano S, 2015, J CELL MOL MED, V19, P1122, DOI 10.1111/jcmm.12517; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Cleary MP, 2004, EXP BIOL MED, V229, P182, DOI 10.1177/153537020422900207; Cleary MP, 2003, BREAST CANCER RES TR, V77, P205, DOI 10.1023/A:1021891825399; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Cufi S, 2010, CELL CYCLE, V9, P4461, DOI 10.4161/cc.9.22.14048; Dignam JJ, 2004, ANN ONCOL, V15, P850, DOI 10.1093/annonc/mdh241; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Feng HL, 2013, ONCOL RES, V21, P165, DOI 10.3727/096504014X13887748696662; Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.59; Frankenberry KA, 2004, AM J SURG, V188, P560, DOI 10.1016/j.amjsurg.2004.07.031; Fruehwald-Schultes B, 2002, METABOLISM, V51, P531, DOI 10.1053/meta.2002.31332; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Ghiasvand R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-414; Giordano C, 2016, ONCOTARGET, V7, P1262, DOI 10.18632/oncotarget.6014; Glueck CJ, 2001, METABOLISM, V50, P856, DOI 10.1053/meta.2001.24192; Gonzalez RR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2321; Grossmann ME, 2010, CANCER METAST REV, V29, P641, DOI 10.1007/s10555-010-9252-1; Haakinson DJ, 2012, ANN SURG ONCOL, V19, P3012, DOI 10.1245/s10434-012-2320-8; Han CZ, 2005, ENDOCRINE, V26, P19, DOI 10.1385/ENDO:26:1:019; Hardwick JCH, 2001, GASTROENTEROLOGY, V121, P79, DOI 10.1053/gast.2001.25490; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Hu X, 2002, J NATL CANCER I, V94, P1704, DOI 10.1093/jnci/94.22.1704; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalinsky K, 2014, CANCER INVEST, V32, P150, DOI 10.3109/07357907.2014.889706; Karaduman M, 2010, J BUON, V15, P369; Kawai M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-149; Kotiyal S, 2014, BIOCHEM BIOPH RES CO, V453, P112, DOI 10.1016/j.bbrc.2014.09.069; Kumpers P, 2007, AM J PHYSIOL-RENAL, V293, pF1355, DOI 10.1152/ajprenal.00003.2007; Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310; Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maor G, 2002, J BONE MINER RES, V17, P1034, DOI 10.1359/jbmr.2002.17.6.1034; MCNEE RK, 1987, BREAST CANCER RES TR, V9, P145, DOI 10.1007/BF01807367; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morin-Papunen LC, 1998, J CLIN ENDOCR METAB, V83, P2566, DOI 10.1210/jc.83.7.2566; Niu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067349; Otvos L, 2011, EUR J CANCER, V47, P1578, DOI 10.1016/j.ejca.2011.01.018; Park J, 2011, ENDOCR-RELAT CANCER, V18, pC25, DOI 10.1530/ERC-11-0163; Paz-Filho G, 2013, ADIPOKINES SOLUBLE F, P71; Reddy BY, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/721659; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Smith AL, 2012, CLIN CANCER RES, V18, P4514, DOI 10.1158/1078-0432.CCR-11-3224; Wada N, 2014, J CHEM NEUROANAT, V61-62, P191, DOI 10.1016/j.jchemneu.2014.09.002; Weichhaus M, 2014, ONCOL LETT, V8, P374, DOI 10.3892/ol.2014.2085; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Wu MH, 2009, BRIT J CANCER, V100, P578, DOI 10.1038/sj.bjc.6604913; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Yan D, 2012, J BIOL CHEM, V287, P8598, DOI 10.1074/jbc.M111.322800; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806; Zheng Q, 2013, ENDOCR-RELAT CANCER, V20, P797, DOI 10.1530/ERC-13-0329; Zheng Q, 2011, ENDOCR-RELAT CANCER, V18, P491, DOI 10.1530/ERC-11-0102; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311	66	36	37	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178454	10.1371/journal.pone.0178454	http://dx.doi.org/10.1371/journal.pone.0178454			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542577	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800092
J	Shao, LL; Melero, J; Zhang, N; Arulanandam, B; Baseman, J; Liu, QZ; Zhong, GM				Shao, Lili; Melero, Jose; Zhang, Nu; Arulanandam, Bernard; Baseman, Joel; Liu, Quanzhong; Zhong, Guangming			The cryptic plasmid is more important for Chlamydia muridarum to colonize the mouse gastrointestinal tract than to infect the genital tract	PLOS ONE			English	Article							TUBAL FACTOR INFERTILITY; CD8(+) T-CELLS; PROTECTIVE IMMUNITY; INTRAVAGINAL INOCULATION; IMMUNODOMINANT ANTIGEN; UROGENITAL INFECTION; RECTAL CHLAMYDIA; TRACHOMATIS; MICE; PATHOLOGY	Chlamydia has been detected in the gastrointestinal tracts of both animals and humans. However, the mechanism by which Chlamydia colonizes the gut remains unclear. Chlamydia muridarum is known to spread from the genital to the gastrointestinal tracts hematogenously. The C. muridarum plasmid is a key pathogenic determinant in the mouse upper genital tract although plasmid-deficient C. muridarum is still able to colonize the upper genital tract. We now report that plasmid-deficient C. muridarum exhibits significantly delayed/reduced spreading from the mouse genital to the gastrointestinal tracts. C. muridarum with or without plasmid maintained similar levels in the mouse circulatory system following intravenous inoculation but the hematogenous plasmid-deficient C. muridarum was significantly less efficient in colonizing the gastrointestinal tract. Consistently, plasmid-deficient C. muridarum failed to restore normal colonization in the gastrointestinal tract even after intragastric inoculation at a high dose. Thus, we have demonstrated a plasmid-dependent colonization of C. muridarum in the gastrointestinal tract, supporting the concept that C. muridarum may have acquired the plasmid for adaptation to the mouse gastrointestinal tract during oralfecal transmission. Since the plasmid is more important for C. muridarum to colonize the gastrointestinal tract than to infect the genital tract, the current study has laid a foundation for further defining the host pathways targeted by the plasmid-encoded or -regulated chlamydial effectors.	[Shao, Lili; Melero, Jose; Zhang, Nu; Baseman, Joel; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Shao, Lili; Liu, Quanzhong] Tianjin Med Univ, Dept Dermatovenereol, Gen Hosp, Tianjin, Peoples R China; [Arulanandam, Bernard] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Tianjin Medical University; University of Texas System; University of Texas at San Antonio (UTSA)	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.; Liu, QZ (corresponding author), Tianjin Med Univ, Dept Dermatovenereol, Gen Hosp, Tianjin, Peoples R China.	Liuquanzhong@medmail.com.cn; Zhongg@UTHSCSA.EDU		Zhong, Guangming/0000-0001-7053-5009	US National Institutes of Health [US NIH R01AI121989]; Tianjin Medical University General Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121989] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tianjin Medical University General Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants (to G. Zhong) from the US National Institutes of Health (US NIH R01AI121989). LS is supported by the Tianjin Medical University General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grants (to G. Zhong) from the US National Institutes of Health. LS is supported by the Tianjin Medical University General Hospital.	Budrys NM, 2012, OBSTET GYNECOL, V119, P1009, DOI 10.1097/AOG.0b013e3182519326; Campbell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101634; *CDCP, 2008, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2015, SEX TRANSM DIS TREAT; Chen CQ, 2015, INFECT IMMUN, V83, P1881, DOI 10.1128/IAI.03158-14; Chen D, 2010, J BACTERIOL, V192, P6017, DOI 10.1128/JB.00847-10; Chen JL, 2015, INFECT IMMUN, V83, P2583, DOI 10.1128/IAI.00353-15; Chen JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095076; Chen LL, 2013, INFECT IMMUN, V81, P2962, DOI 10.1128/IAI.00161-13; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Chen LL, 2009, INFECT IMMUN, V77, P3080, DOI 10.1128/IAI.00611-08; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Conrad TA, 2016, INFECT IMMUN, V84, P467, DOI 10.1128/IAI.01171-15; Craig AP, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0939-3; Dai J, 2016, INFECT IMMUN, V84, P2382, DOI 10.1128/IAI.00432-16; Dai J, 2016, MICROBES INFECT, V18, P190, DOI 10.1016/j.micinf.2015.11.003; de la Maza Luis M, 2002, Curr Opin Investig Drugs, V3, P980; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Dlugosz A, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-24; ELLIOTT PR, 1981, GUT, V22, P25, DOI 10.1136/gut.22.1.25; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Farencena A, 1997, INFECT IMMUN, V65, P2965, DOI 10.1128/IAI.65.7.2965-2969.1997; Gong SQ, 2013, J BACTERIOL, V195, P3819, DOI 10.1128/JB.00511-13; Gratrix J, 2015, CLIN INFECT DIS, V60, P398, DOI 10.1093/cid/ciu831; Gratrix J, 2014, SEX TRANSM DIS, V41, P589, DOI 10.1097/OLQ.0000000000000176; Huang YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124840; Johnson RM, 2014, IMMUNOLOGY, V142, P248, DOI 10.1111/imm.12248; Lei L, 2014, INFECT IMMUN, V82, P983, DOI 10.1128/IAI.01543-13; Li LX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003707; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Liu Y, 2014, INFECT IMMUN, V82, P5327, DOI 10.1128/IAI.02576-14; Liu YJ, 2014, J BACTERIOL, V196, P989, DOI 10.1128/JB.01161-13; Lu CX, 2013, MICROBES INFECT, V15, P329, DOI 10.1016/j.micinf.2013.02.001; Manam S, 2013, PATHOG DIS, V67, P221, DOI 10.1111/2049-632X.12032; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Musil K, 2016, INT J STD AIDS, V27, P526, DOI 10.1177/0956462415586317; Nigg C, 1944, J EXP MED, V79, P497, DOI 10.1084/jem.79.5.497; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Perry LL, 1999, INFECT IMMUN, V67, P3686, DOI 10.1128/IAI.67.7.3686-3689.1999; Peters RPH, 2014, SEX TRANSM DIS, V41, P564, DOI 10.1097/OLQ.0000000000000175; PETERSON EM, 1990, PLASMID, V23, P144, DOI 10.1016/0147-619X(90)90033-9; Qu YY, 2015, INFECT IMMUN, V83, P4056, DOI 10.1128/IAI.00841-15; Ramsey KH, 2014, INFECT IMMUN, V82, P3341, DOI 10.1128/IAI.01795-14; Rank RG, 2014, INFECT IMMUN, V82, P1362, DOI 10.1128/IAI.01244-13; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rockey DD, 2009, EXPERT REV VACCINES, V8, P1365, DOI 10.1586/ERV.09.98; Rodgers AK, 2011, FERTIL STERIL, V96, P715, DOI 10.1016/j.fertnstert.2011.06.021; Rodgers AK, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.005; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Song LH, 2014, PATHOG DIS, V70, P189, DOI 10.1111/2049-632X.12104; Tang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060345; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; Vlcek KR, 2016, IMMUNOL CELL BIOL, V94, P208, DOI 10.1038/icb.2015.74; Wang LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155880; Yang X, 1998, J IMMUNOL, V161, P1439; Yang ZS, 2014, INFECT IMMUN, V82, P3154, DOI 10.1128/IAI.01833-14; Yeruva L, 2013, ANTIMICROB AGENTS CH, V57, P6290, DOI 10.1128/AAC.01405-13; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052; Zhang HB, 2014, INFECT IMMUN, V82, P2688, DOI 10.1128/IAI.00055-14; Zhang Q, 2015, INFECT IMMUN, V83, P3568, DOI 10.1128/IAI.00673-15; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075; Zhong GM, 2017, TRENDS MICROBIOL, V25, P141, DOI 10.1016/j.tim.2016.09.006	63	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177691	10.1371/journal.pone.0177691	http://dx.doi.org/10.1371/journal.pone.0177691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542376	Green Submitted, Green Published, gold			2022-12-27	WOS:000402062800022
J	Zhu, SH; Anderson, CM; Zhuang, YL; Gamst, AC; Kohatsu, ND				Zhu, Shu-Hong; Anderson, Christopher M.; Zhuang, Yue-Lin; Gamst, Anthony C.; Kohatsu, Neal D.			Smoking prevalence in Medicaid has been declining at a negligible rate	PLOS ONE			English	Article							NONSPECIFIC PSYCHOLOGICAL DISTRESS; UNITED-STATES; CIGARETTE-SMOKING; CESSATION; SMOKERS; ADULTS; QUIT	Background In recent decades the overall smoking prevalence in the US has fallen steadily. This study examines whether the same trend is seen in the Medicaid population. Methods and findings National Health Interview Survey (NHIS) data from 17 consecutive annual surveys from 1997 to 2013 (combined N = 514,043) were used to compare smoking trends for 4 insurance groups: Medicaid, the Uninsured, Private Insurance, and Other Coverage. Rates of chronic disease and psychological distress were also compared. Results Adjusted smoking prevalence showed no detectable decline in the Medicaid population (from 33.8% in 1997 to 31.8% in 2013, trend test P = 0.13), while prevalence in the other insurance groups showed significant declines (38.6%-34.7% for the Uninsured, 21.3%-15.8% for Private Insurance, and 22.6%-16.8% for Other Coverage; all P's< 0.005). Among individuals who have ever smoked, Medicaid recipients were less likely to have quit (38.8%) than those in Private Insurance (62.3%) or Other Coverage (69.8%; both P's<0.001). Smokers in Medicaid were more likely than those in Private Insurance and the Uninsured to have chronic disease (55.0% vs 37.3% and 32.4%, respectively; both P's<0.01). Smokers in Medicaid were also more likely to experience severe psychological distress (16.2% for Medicaid vs 3.2% for Private Insurance and 7.6% for the Uninsured; both P's<0.001). Conclusions The high and relatively unchanging smoking prevalence in the Medicaid population, low quit ratio, and high rates of chronic disease and severe psychological distress highlight the need to focus on this population. A targeted and sustained campaign to help Medicaid recipients quit smoking is urgently needed.	[Zhu, Shu-Hong] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Zhu, Shu-Hong; Anderson, Christopher M.; Zhuang, Yue-Lin; Gamst, Anthony C.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Gamst, Anthony C.] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; [Kohatsu, Neal D.] Dept Hlth Care Serv, Sacramento, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhu, SH (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.; Zhu, SH (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	szhu@ucsd.edu	Zhu, Shu-Hong/AAF-5164-2019; Gamst, Anthony/AAH-9440-2019		Centers for Medicare and Medicaid Services [1B1-CMS330883]; National Cancer Institute under the State and Community Tobacco Initiative [U01-CA154280]; NATIONAL CANCER INSTITUTE [U01CA154280] Funding Source: NIH RePORTER	Centers for Medicare and Medicaid Services; National Cancer Institute under the State and Community Tobacco Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Centers for Medicare and Medicaid Services https://www.cms.gov/ (Grant #1B1-CMS330883, NDK) and by the National Cancer Institute under the State and Community Tobacco Initiative http://www.cancer gov/ (Grant#U01-CA154280, SHZ). The conclusions presented in this paper are those of the authors and do not reflect the official policy of the sponsors. The study sponsors had no role in study design; data collection, analysis, or interpretation; writing of the report; or the decision to submit for publication.	California Department of Health Care Services, 2016, DHCS STRAT QUAL IMPR; Centers for Disease Control and Prevention, 2016, VAR EST GUID NHIS 20 VAR EST GUID NHIS 20; Centers for Disease Control and Prevention, 6 18 IN ACC EV ACT; Centers for Disease Control and Prevention (CDC), 2012, TRENDS HLTH CAR COV; Data File Documentation National Health Interview Survey, 2010, DAT FIL DOC NAT HLTH; Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780; Fiore MC, 2008, TREATING TOBACCO USE, P1; Guide to Community Preventive Services, RED TOB US SEC SMOK; Hester J., 2016, CDCS 6 18 INITIATIVE; Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kotz D, 2009, TOB CONTROL, V18, P43, DOI 10.1136/tc.2008.025981; Ku L, 2016, HEALTH AFFAIR, V35, P62, DOI 10.1377/hlthaff.2015.0756; Land T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009770; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lawrence D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-256; McAfee T, 2015, NEW ENGL J MED, V372, P5, DOI 10.1056/NEJMp1411437; Messer K, 2008, AM J PUBLIC HEALTH, V98, P317, DOI 10.2105/AJPH.2007.112060; Richard P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029665; SAS Institute Inc, 2014, SAS 9 4 LANG REF; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; Sung HY, 2011, NICOTINE TOB RES, V13, P1183, DOI 10.1093/ntr/ntr148; Swartz K, 2015, HEALTH AFFAIR, V34, P1180, DOI 10.1377/hlthaff.2014.1204; Tobacco Education and Research Oversight Committee, 2014, CHANG LANDSC COUNT N; U.S. Department of Health and Human Services, 2010, END TOB EP TOB CONTR; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; US. Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL 2020; Xu X, 2015, AM J PREV MED, V48, P326, DOI 10.1016/j.amepre.2014.10.012; Zhu SH, 2012, TOB CONTROL, V21, P110, DOI 10.1136/tobaccocontrol-2011-050371; Zhuang YL, 2015, AM J PUBLIC HEALTH, V105, P373, DOI 10.2105/AJPH.2014.302222	31	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178279	10.1371/journal.pone.0178279	http://dx.doi.org/10.1371/journal.pone.0178279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542637	Green Published, Green Submitted, gold			2022-12-27	WOS:000402062800063
J	Boubriak, II; Malhas, AN; Drozdz, MM; Pytowski, L; Vaux, DJ				Boubriak, Ivan I.; Malhas, Ashraf N.; Drozdz, Marek M.; Pytowski, Lior; Vaux, David J.			Stress-induced release of Oct-1 from the nuclear envelope is mediated by JNK phosphorylation of lamin B1	PLOS ONE			English	Article							DNA-DAMAGE; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; UBIQUITIN LIGASE; HEAT-SHOCK; C-FOS; BRCA1; REPAIR; INVOLVEMENT; EXPRESSION	The nuclear lamina can bind and sequester transcription factors (TFs), a function lost if the lamina is abnormal, with missing or mutant lamin proteins. We now show that TF sequestration is not all-or-nothing, but a dynamic physiological response to external signals. We show that the binding of the ubiquitous TF, Oct-1, to lamin B1 was reversed under conditions of cellular stress caused, inter alia, by the chemical methylating agent methylmethanesulfonate (MMS). A search for lamin B1 post-translational modifications that might mediate changes in Oct-1 binding using kinase inhibitors uncovered a role for c-Jun N-terminal kinase (JNK). Phosphoproteomic and site-directed mutagenesis analyses of lamin B1 isolated from control and MMS-treated nuclei identified T575 as a JNK site phosphorylated after stress. A new phospho-T575 specific anti-peptide antibody confirmed increased interphase cellular T575 phosphorylation after cell exposure to certain stress conditions, enabling us to conclude that lamin B1 acts as an interphase kinase target, releasing Oct-1 to execute a protective response to stress.	[Boubriak, Ivan I.; Malhas, Ashraf N.; Drozdz, Marek M.; Pytowski, Lior; Vaux, David J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England	University of Oxford	Vaux, DJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.	david.vaux@path.ox.ac.uk	Boubriak, Ivan/GPX-1231-2022	Pytowski, Lior/0000-0002-8530-5123; Boubriak, Ivan/0000-0001-9845-2969; Malhas, Ashraf/0000-0001-8936-7551; Vaux, David/0000-0002-4901-9795	Medical Research Council [G0801917]; Biotechnology and Biological Science Research Council [BB/L002159/1]; MRC grant [G0801917]; BBSRC grant [BB/L002159/1]; Biotechnology and Biological Sciences Research Council [BB/L002159/1] Funding Source: researchfish; BBSRC [BB/L002159/1] Funding Source: UKRI; MRC [G0801917] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Medical Research Council (GB), www.mrc.ac.uk/, G0801917, to DJV; and Biotechnology and Biological Science Research Council (GB), http://www.bbsrc.ac.uk/, BB/L002159/1 to DJV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Svenja Hester, Ben Thomas and David Trudgian, members of the Central Proteomics Facility in the Dunn School of Pathology for mass spectrometry and proteomic analysis, and to Covalab Ltd for production of the custom anti-phosphopeptide antiserum. Human dermal fibroblasts were provided by Dr Winnok De Vos, Department of Molecular Biotechnology, Ghent University. This work was funded by MRC grant G0801917 and BBSRC grant BB/L002159/1.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Chen MC, 2015, MOL PHARMACOL, V87, P996, DOI 10.1124/mol.114.094987; Coene ED, 2011, J CELL BIOL, V192, P497, DOI 10.1083/jcb.201004136; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Drozdz M, 2016, METHODS MOL BIOL, V1411, P159, DOI 10.1007/978-1-4939-3530-7_10; Dynlacht JR, 1999, J CELL PHYSIOL, V178, P28, DOI 10.1002/(SICI)1097-4652(199901)178:1<28::AID-JCP4>3.3.CO;2-B; Fabrini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014125; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Favale NO, 2010, BBA-MOL CELL BIOL L, V1801, P1184, DOI 10.1016/j.bbalip.2010.07.003; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fiume R, 2009, FASEB J, V23, P957, DOI 10.1096/fj.08-121244; Fridlich R, 2015, DNA REPAIR, V30, P11, DOI 10.1016/j.dnarep.2015.03.002; Fritz G, 2006, MOL BIOL CELL, V17, P851, DOI 10.1091/mbc.E05-07-0606; Fukuda T, 2016, CURR CANCER DRUG TAR, V16, P101, DOI 10.2174/1568009615666151030102427; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gonzalo S, 2014, ADV EXP MED BIOL, V773, P377, DOI 10.1007/978-1-4899-8032-8_17; Haddad N, 2008, J CELL BIOCHEM, V105, P1485, DOI 10.1002/jcb.21968; Harper M, 2009, FEBS J, V276, P3137, DOI 10.1111/j.1742-4658.2009.07032.x; Hodge CD, 2016, J BIOL CHEM, V291, P9396, DOI 10.1074/jbc.M116.715698; Inamoto S, 1997, J BIOL CHEM, V272, P29852, DOI 10.1074/jbc.272.47.29852; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Jin SQ, 2001, ONCOGENE, V20, P2683, DOI 10.1038/sj.onc.1204390; Kang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019063; Kang J, 2013, FASEB J, V27, P2807, DOI 10.1096/fj.12-220897; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Kuga T, 2010, EXP CELL RES, V316, P2301, DOI 10.1016/j.yexcr.2010.05.017; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machowska M, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150094; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Malhas A, 2010, CELL CYCLE, V9, P531, DOI 10.4161/cc.9.3.10511; Malhas AN, 2011, BIOCHEM SOC T, V39, P1795, DOI 10.1042/BST20110719; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Maske CP, 2003, J CELL BIOL, V162, P1223, DOI 10.1083/jcb.200303113; Navaraj A, 2005, CANCER BIOL THER, V4, P1409, DOI 10.4161/cbt.4.12.2378; Neuzillet C, 2012, EUR J CANCER, V48, P121, DOI 10.1016/S0959-8049(12)72196-2; Ohta T, 2011, FEBS LETT, V585, P2836, DOI 10.1016/j.febslet.2011.05.005; Pance A, 2016, BBA-GENE REGUL MECH, V1859, P820, DOI 10.1016/j.bbagrm.2016.04.003; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Shimi T, 2014, ADV EXP MED BIOL, V773, P415, DOI 10.1007/978-1-4899-8032-8_19; Tong T, 2001, EXP CELL RES, V269, P64, DOI 10.1006/excr.2001.5312; Torvaldson E, 2015, NUCLEUS-PHILA, V6, P166, DOI 10.1080/19491034.2015.1017167; Van Meter M, 2016, CELL REP, V16, P2641, DOI 10.1016/j.celrep.2016.08.006; Vazquez-Arreguin K, 2016, BBA-GENE REGUL MECH, V1859, P792, DOI 10.1016/j.bbagrm.2016.02.007; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wei B, 2016, BIOCHEM BIOPH RES CO, V475, P301, DOI 10.1016/j.bbrc.2016.05.107; Xie W, 2016, METHODS MOL BIOL, V1411, P83, DOI 10.1007/978-1-4939-3530-7_4; Zhao HC, 2000, CANCER RES, V60, P6276	55	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177990	10.1371/journal.pone.0177990	http://dx.doi.org/10.1371/journal.pone.0177990			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542436	Green Published, Green Submitted, gold			2022-12-27	WOS:000402061500050
J	Pantoja, Y; Pinheiro, K; Veras, A; Araujo, F; de Sousa, AL; Guimaraes, LC; Silva, A; Ramos, RTJ				Pantoja, Yan; Pinheiro, Kenny; Veras, Allan; Araujo, Fabricio; de Sousa, Ailton Lopes; Guimaraes, Luis Carlos; Silva, Artur; Ramos, Rommel T. J.			PanWeb: A web interface for pan-genomic analysis	PLOS ONE			English	Article								With increased production of genomic data since the advent of next-generation sequencing (NGS), there has been a need to develop new bioinformatics tools and areas, such as comparative genomics. In comparative genomics, the genetic material of an organism is directly compared to that of another organism to better understand biological species. Moreover, the exponentially growing number of deposited prokaryote genomes has enabled the investigation of several genomic characteristics that are intrinsic to certain species. Thus, a new approach to comparative genomics, termed pan-genomics, was developed. In pan-genomics, various organisms of the same species or genus are compared. Currently, there are many tools that can perform pan-genomic analyses, such as PGAP (Pan-Genome Analysis Pipeline), Panseq (Pan-Genome Sequence Analysis Program) and PGAT (Prokaryotic Genome Analysis Tool). Among these software tools, PGAP was developed in the Perl scripting language and its reliance on UNIX platform terminals and its requirement for an extensive parameterized command line can become a problem for users without previous computational knowledge. Thus, the aim of this study was to develop a web application, known as PanWeb, that serves as a graphical interface for PGAP. In addition, using the output files of the PGAP pipeline, the application generates graphics using custom-developed scripts in the R programming language. PanWeb is freely available at http://www.computationalbiology.ufpa.br/panweb.	[Pantoja, Yan; Pinheiro, Kenny; Veras, Allan; Araujo, Fabricio; de Sousa, Ailton Lopes; Guimaraes, Luis Carlos; Silva, Artur; Ramos, Rommel T. J.] Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil	Universidade Federal do Para	Ramos, RTJ (corresponding author), Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil.	rommelthiago@gmail.com	Lopes, Ailton/AAT-4585-2020; Luiz Silva, Artur da Costa da/AAI-3516-2021; Guimarães, Luis/T-7186-2019; Ramos, Rommel Thiago Juca/L-9329-2013; Araujo, Fabricio A/B-9294-2018; Veras, Adonney Allan de Oliveira/AAK-6488-2020; Guimaraes, Luis Carlos/J-5689-2015	Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Araujo, Fabricio A/0000-0001-8134-5964; Veras, Adonney Allan de Oliveira/0000-0002-7227-0590; Lopes, Ailton/0000-0002-7608-252X; Guimaraes, Luis Carlos/0000-0002-7147-9448	Genomic and Proteomic Para Network (Rede Paraense de GenOmica e Protenmica); State of Para Research Foundation (Fundagao de Amparo a Pesquisa do Estado do Para); Brazilian National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq); PROPESP/UFPA	Genomic and Proteomic Para Network (Rede Paraense de GenOmica e Protenmica); State of Para Research Foundation (Fundagao de Amparo a Pesquisa do Estado do Para); Brazilian National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROPESP/UFPA	This work was part of the Genomic and Proteomic Para Network (Rede Paraense de GenOmica e Protenmica) and was supported by the State of Para Research Foundation (Fundagao de Amparo a Pesquisa do Estado do Para) and by the Brazilian National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq).; This work was supported by the State of Para Research Foundation (Fundacao de Amparo a Pesquisa do Estado do Para), by the Brazilian National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico CNPq) and by PROPESP/UFPA.	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Brittnacher MJ, 2011, BIOINFORMATICS, V27, P2429, DOI 10.1093/bioinformatics/btr418; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Hu B, 2011, BRIEF FUNCT GENOMICS, V10, P322, DOI 10.1093/bfgp/elr042; Laing C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461; Liu L, 2012, J BIOMED BIOTECHNOL, V2012; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Rust AG, 2002, DRUG DISCOV TODAY, V7, pS70, DOI 10.1016/S1359-6446(02)02289-4; Sivashankari S, 2007, BIOINFORMATION, V1, P376, DOI 10.6026/97320630001376; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; Xiao JF, 2015, GENOM PROTEOM BIOINF, V13, P73, DOI 10.1016/j.gpb.2015.01.007; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655	18	16	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178154	10.1371/journal.pone.0178154	http://dx.doi.org/10.1371/journal.pone.0178154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542514	gold, Green Published, Green Submitted			2022-12-27	WOS:000402061500067
J	Liu, L; Jiang, YD; Steinle, JJ				Liu, Li; Jiang, Youde; Steinle, Jena J.			Inhibition of HMGB1 protects the retina from ischemia-reperfusion, as well as reduces insulin resistance proteins	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; INJURY; INFLAMMATION; RECEPTOR; GLYCYRRHIZIN; BRAIN; MICE	The role of inflammation in diabetic retinal amage is well accepted. While a number of cytokines and inflammatory mediators are responsible for these changes, upstream regulators are less well studied. Additionally, the role for these upstream mediators in retinal health is unclear. In this study, we hypothesized that inhibition of high mobility group box 1 (HMGB1) could restore normal insulin signaling in retinal endothelial cells (REC) grown in high glucose, as well as protect the retina against ischemia/reperfusion (I/R)-induced retinal damage. REC were grown in normal (5mM) or high glucose (25mM) and treated with Box A or glycyrrhizin, two different HMGB1 inhibitors. Western blotting was done for HMGB1, toll-like receptor 4 (TLR4), insulin receptor, insulin receptor substrate-1 (IRS-1), and Akt. ELISA analyses were done for tumor necrosis factor alpha (TNFa) and cleaved caspase 3. In addition, C57/B6 mice were treated with glycyrrhizin, both before and after ocular I/R. Two days following I/R, retinal sections were processed for neuronal changes, while vascular damage was measured at 10 days post-I/R. Results demonstrate that both Box A and glycyrrhizin reduced HMGB1, TLR4, and TNFa levels in REC grown in high glucose. This led to reduced cleavage of caspase 3 and IRS-1 Ser307 phosphorylation, and increased insulin receptor and Akt phosphorylation. Glycyrrhizin treatment significantly reduced loss of retinal thickness and degenerate capillary numbers in mice exposed to I/R. Taken together, these results suggest that inhibition of HMGB1 can reduce retinal insulin resistance, as well as protect the retina against I/R-induced damage.	[Liu, Li; Jiang, Youde; Steinle, Jena J.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Steinle, Jena J.] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Steinle, JJ (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.; Steinle, JJ (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48201 USA.	jsteinle@med.wayne.edu	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680; Steinle, Jena/0000-0002-7539-2892	 [R01EY022330];  [P30EY04068]; NATIONAL EYE INSTITUTE [P30EY004068, R01EY022330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01EY022330 and P30EY04068. No funders had any influence on this study.	Abcouwer SF, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-149; Abu El-Asrar AM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/746415; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Berger E.A., 2016, IMMUNOL CELL BIOL; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Dvoriantchikova G, 2011, INVEST OPHTH VIS SCI, V52, P7187, DOI 10.1167/iovs.11-7793; Guzman-Ruiz R, 2014, INT J OBESITY, V38, P1545, DOI 10.1038/ijo.2014.36; Huang Y, 2007, AM J TRANSPLANT, V7, P799, DOI 10.1111/j.1600-6143.2007.01734.x; Jiang Y.-Y., 2015, SHOCK VIB, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0130400; Jiang YD, 2014, J BIOL CHEM, V289, P26395, DOI 10.1074/jbc.M114.583880; Jiang YD, 2014, MOL VIS, V20, P872; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Liu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159532; Matsui S, 2004, INT IMMUNOPHARMACOL, V4, P1633, DOI 10.1016/j.intimp.2004.07.023; Montes VN, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.11; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Nativel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076039; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068871; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Veenstra Alexander, 2015, Curr Protoc Mouse Biol, V5, P247, DOI 10.1002/9780470942390.mo140190; Wang Y., 2016, J ASIAN CONCR FED, V2, P1, DOI DOI 10.1155/2016/2543268; Wang YL, 2015, GRAEF ARCH CLIN EXP, V253, P389, DOI 10.1007/s00417-014-2832-y; Zhang JC, 2014, BRAIN RES, V1582, P176, DOI 10.1016/j.brainres.2014.07.002; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779	28	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178236	10.1371/journal.pone.0178236	http://dx.doi.org/10.1371/journal.pone.0178236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542588	Green Submitted, Green Published, gold			2022-12-27	WOS:000402058800049
J	Heim, C; Queric, NV; Lonescu, D; Schafer, N; Reitner, J				Heim, Christine; Queric, Nadia-Valerie; Lonescu, Danny; Schaefer, Nadine; Reitner, Joachim			Frutexites-like structures formed by iron oxidizing biofilms in the continental subsurface (Aspo Hard Rock Laboratory, Sweden)	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; FATTY-ACIDS; ANAEROBIC OXIDATION; RAMAN-SPECTRA; BACTERIA; REDUCTION; STEROLS; PHOTOSYNTHESIS; CALCIFICATION; STROMATOLITES	Stromatolitic iron-rich structures have been reported from many ancient environments and are often described as Frutexites, a cryptic microfossil. Although microbial formation of such structures is likely, a clear relation to a microbial precursor is lacking so far. Here we report recent iron oxidizing biofilms which resemble the ancient Frutexites structures. The living Frutexites-like biofilms were sampled at 160 m depth in the Aspo Hard Rock Laboratory in Sweden. Investigations using microscopy, 454 pyrosequencing, FISH, Raman spectros-copy, biomarker and trace element analysis allowed a detailed view of the structural components of the mineralized biofilm. The most abundant bacterial groups were involved in nitrogen and iron cycling. Furthermore, Archaea are widely distributed in the Frutexites-like biofilm, even though their functional role remains unclear. Biomarker analysis revealed abundant sterols in the biofilm most likely from algal and fungal origins. Our results indicate that the Frutexites-like biofilm was built up by a complex microbial community. The functional role of each community member in the formation of the dendritic structures, as well as their potential relation to fossil Frutexites remains under investigation.	[Heim, Christine; Queric, Nadia-Valerie; Schaefer, Nadine; Reitner, Joachim] Univ Gottingen, Dept Geobiol, Geosci Ctr, Gottingen, Germany; [Lonescu, Danny] Leibnitz Inst Freshwater Ecol & Inland Fisheries, IGB, Expt Limnol, Stechlin, Germany	University of Gottingen; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Heim, C; Reitner, J (corresponding author), Univ Gottingen, Dept Geobiol, Geosci Ctr, Gottingen, Germany.	cheim@gwdg.cle; jreitne@gwdg.de	Heim, Christine/ABH-5629-2020; Ionescu, Danny/P-3261-2017	Heim, Christine/0000-0003-4716-9316; Ionescu, Danny/0000-0002-4658-8597	German Research Foundation [FOR 571]; Open Access Publication Funds of the Gottingen University; German Research Foundation (DFG)	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation-funded Research Unit FOR 571 Geobiology of Organo- and Biofilms; Open Access Publication Funds of the Gottingen University.; We acknowledge with gratitude the detailed and constructive comments provided by the reviewers. We are grateful to SKB and its team for technical and logistic support at the Aspo Hard Rock Laboratory. Special thanks go to our technicians Wolfgang Drose and Dorothea Hause-Reitner for optimizing embedding and sectioning procedures for samples and carrying out FEM imaging. Volker Thiel is greatly acknowledged for his constructive comments on the original manuscript. The manuscript was significantly improved by Leyla Seyfullahs linguistic advice. We acknowledge the financial support by the German Research Foundation (DFG) and the Open Access Publication Funds of the Gottingen University.	Alawi M, 2007, ISME J, V1, P256, DOI 10.1038/ismej.2007.34; Anderson CR, 2003, GEOBIOLOGY, V1, P169, DOI 10.1046/j.1472-4669.2003.00013.x; Andres MS, 2006, SEDIMENT GEOL, V185, P319, DOI 10.1016/j.sedgeo.2005.12.020; Andrews JE, 2015, GEOL MAG, V152, P1, DOI 10.1017/S0016756814000107; Arp G, 2001, SCIENCE, V292, P1701, DOI 10.1126/science.1057204; Bau M, 1996, PRECAMBRIAN RES, V79, P37, DOI 10.1016/0301-9268(95)00087-9; Bohm F., 1993, FACIES, V28, P145, DOI [10.1007/BF02539734, DOI 10.1007/BF02539734]; Cavalazzi B, 2007, SEDIMENT GEOL, V200, P73, DOI 10.1016/j.sedgeo.2007.03.002; Coby AJ, 2005, APPL ENVIRON MICROB, V71, P5267, DOI 10.1128/AEM.71.9.5267-5274.2005; Cooper DC, 2003, APPL ENVIRON MICROB, V69, P3517, DOI 10.1128/AEM.69.6.3517-3525.2003; Daims H, 2016, NATURE; deFaria DLA, 1997, J RAMAN SPECTROSC, V28, P873, DOI 10.1002/(SICI)1097-4555(199711)28:11<873::AID-JRS177>3.0.CO;2-B; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; DOWLING NJE, 1986, J GEN MICROBIOL, V132, P1815; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; EDLUND A, 1985, J LIPID RES, V26, P982; Elvert M, 2003, GEOMICROBIOL J, V20, P403, DOI 10.1080/01490450303894; Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667; Frei R, 2008, PRECAMBRIAN RES, V162, P441, DOI 10.1016/j.precamres.2007.10.005; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Giner JL, 2008, PHYTOCHEMISTRY, V69, P2167, DOI 10.1016/j.phytochem.2008.05.013; Gischler E, 1996, PALAEOGEOGR PALAEOCL, V123, P297, DOI 10.1016/0031-0182(95)00125-5; GOOSSENS H, 1986, ORG GEOCHEM, V10, P683, DOI 10.1016/S0146-6380(86)80004-3; Guido A, 2016, FRUTEXITES MICROBIAL; Heim C, 2015, FRONT EARTH SC-SWITZ, V3, DOI 10.3389/feart.2015.00006; Hengsuwan M, 2015, GEOMICROBIOL J, V32, P243, DOI 10.1080/01490451.2014.962121; Ionescu D, 2015, GEOMICROBIOL J, V32, P221, DOI 10.1080/01490451.2014.887393; Ionescu D, 2015, GEOMICROBIOL J, V32, P207, DOI 10.1080/01490451.2014.884196; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Ivarsson M, 2016, FUNGAL ECOL, V20, P249, DOI 10.1016/j.funeco.2016.01.009; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kazmierczak J, 2006, NATURWISSENSCHAFTEN, V93, P119, DOI 10.1007/s00114-005-0066-x; Konhauser K., 2007, INTRO GEOMICROBIOLOG; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Laaksoharju M, 1999, APPL GEOCHEM, V14, P835, DOI 10.1016/S0883-2927(99)00023-2; Lafuente B., 2015, HIGHLIGHTS MINERALOG, P1, DOI DOI 10.1515/9783110417104-003; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Leblond JD, 2011, PHYCOL RES, V59, P129, DOI 10.1111/j.1440-1835.2011.00610.x; Lechevalier H., 1988, MICROBIAL LIPIDS; Lucker S, 2015, ISME J, V9, P708, DOI 10.1038/ismej.2014.158; Manz W, 2000, J MICROBIOL METH, V40, P125, DOI 10.1016/S0167-7012(99)00103-7; Marshall JA, 2002, J APPL PHYCOL, V14, P255, DOI 10.1023/A:1021101203543; Maslov VP, 1960, T I GEOLOGICHESKIKH, V41, P188; Mazzetti L, 2002, J RAMAN SPECTROSC, V33, P104, DOI 10.1002/jrs.830; MCLENNAN SM, 1989, REV MINERAL, V21, P169; MEIKLEJOHN J, 1953, J GEN MICROBIOL, V8, P58, DOI 10.1099/00221287-8-1-58; MYROW P M, 1991, Palaios, V6, P572, DOI 10.2307/3514920; Nielsen PH, 1997, WATER SCI TECHNOL, V36, P11, DOI 10.1016/S0273-1223(97)00318-1; Pedersen K, 1997, FEMS MICROBIOL REV, V20, P399, DOI 10.1111/j.1574-6976.1997.tb00325.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reid RP, 2000, NATURE, V406, P989, DOI 10.1038/35023158; REITNER J, 1995, FACIES, V32, P203, DOI 10.1007/BF02536869; Reitner J., 2017, PAIZ; Reitner Joachim, 1993, Facies, V29, P3, DOI 10.1007/BF02536915; Rodruiguez-Martuinez M., 2011, ENCY GEOBIOLOGY, P396, DOI DOI 10.1007/978-1-4020-9212-1_94; Romano I, 2008, INT J SYST EVOL MICR, V58, P886, DOI 10.1099/ijs.0.65457-0; Ronnback P, 2008, APPL GEOCHEM, V23, P1862, DOI 10.1016/j.apgeochem.2008.02.008; Seemann M, 1999, TETRAHEDRON LETT, V40, P1681, DOI 10.1016/S0040-4039(99)00064-7; Shiraishi F, 2008, GEOMICROBIOL J, V25, P83, DOI 10.1080/01490450801934888; TAYLOR J, 1983, J GEN MICROBIOL, V129, P3303; THIBEAU RJ, 1978, APPL SPECTROSC, V32, P532, DOI 10.1366/000370278774330739; VAINSHTEIN M, 1992, SYST APPL MICROBIOL, V15, P554, DOI 10.1016/S0723-2020(11)80115-3; van Kessel M. A. H. J., 2015, NATURE; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Wahlgren C-H, 2006, R0569 SVENSK KAMBR A; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; Westall F, 2008, SPACE SCI REV, V135, P95, DOI 10.1007/s11214-008-9354-z; Wingender J., 1999, MICROBIAL EXTRACELLU, P1; Woods AD, 2008, SEDIMENT GEOL, V209, P1, DOI 10.1016/j.sedgeo.2008.06.002; Ziegenbalg SB, 2012, CHEM GEOL, V292, P140, DOI 10.1016/j.chemgeo.2011.11.024	70	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177542	10.1371/journal.pone.0177542	http://dx.doi.org/10.1371/journal.pone.0177542			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542238	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600015
J	Marchand-Krynski, ME; Morin-Moncet, O; Belanger, AM; Beauchamp, MH; Leonard, G				Marchand-Krynski, Marie-Eve; Morin-Moncet, Olivier; Belanger, Anne-Marie; Beauchamp, Miriam H.; Leonard, Gabriel			Shared and differentiated motor skill impairments in children with dyslexia and/or attention deficit disorder: From simple to complex sequential coordination	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; DEVELOPMENTAL DYSLEXIA; HYPERACTIVITY DISORDER; BIMANUAL COORDINATION; EXECUTIVE FUNCTIONS; READING-DISABILITY; LEARNING-DEFICITS; CEREBELLAR; ADHD; COMORBIDITY	Dyslexia and Attention deficit disorder (AD) are prevalent neurodevelopmental conditions in children and adolescents. They have high comorbidity rates and have both been associated with motor difficulties. Little is known, however, about what is shared or differentiated in dyslexia and AD in terms of motor abilities. Even when motor skill problems are identified, few studies have used the same measurement tools, resulting in inconstant findings. The present study assessed increasingly complex gross motor skills in children and adolescents with dyslexia, AD, and with both Dyslexia and AD. Our results suggest normal performance on simple motor-speed tests, whereas all three groups share a common impairment on unimanual and bimanual sequential motor tasks. Children in these groups generally improve with practice to the same level as normal subjects, though they make more errors. In addition, children with AD are the most impaired on complex bimanual out-of-phase movements and with manual dexterity. These latter findings are examined in light of the Multiple Deficit Model.	[Marchand-Krynski, Marie-Eve; Morin-Moncet, Olivier; Beauchamp, Miriam H.] Univ Montreal, Res Ctr Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Marchand-Krynski, Marie-Eve; Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Marchand-Krynski, Marie-Eve; Morin-Moncet, Olivier; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Marchand-Krynski, Marie-Eve; Belanger, Anne-Marie; Leonard, Gabriel] Montreal Neurol Hosp & Inst, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Leonard, G (corresponding author), Montreal Neurol Hosp & Inst, Montreal, PQ, Canada.	gabriel.leonard@mcgill.ca			Montreal Neurological Institute (MNI); Centres of Excellence for Commercialization and Research (CECR)	Montreal Neurological Institute (MNI); Centres of Excellence for Commercialization and Research (CECR)	This study was supported by grants from the Montreal Neurological Institute (MNI-GL) and the Centres of Excellence for Commercialization and Research (CECR-GL).; This study was supported by grants from the Montreal Neurological Institute (MNI) and the Centres of Excellence for Commercialization and Research (CECR).	Association AP, 2013, DIAGN STAT MAN MENT, P59; Barkley RA, 2003, BRAIN DEV-JPN, V25, P77, DOI 10.1016/S0387-7604(02)00152-3; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barnes KA, 2010, DEV NEUROPSYCHOL, V35, P494, DOI 10.1080/87565641.2010.494750; Belanger AM, 2015, ORG HUMAN BRAIN MAPP; Biotteau M, 2015, HUM MOVEMENT SCI, V43, P78, DOI 10.1016/j.humov.2015.07.005; BOECKER H, 1994, BRAIN, V117, P1231, DOI 10.1093/brain/117.6.1231; Brookes RL, 2010, DYSLEXIA, V16, P358, DOI 10.1002/dys.420; Brookman A, 2013, PEERJ, V1, DOI 10.7717/peerj.217; Brown L., 2010, TONI 4 TEST NONVERBA; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Chaix Y, 2007, EUR J PAEDIATR NEURO, V11, P368, DOI 10.1016/j.ejpn.2007.03.006; Conners C. K., 2008, CONNERS 3 EDITION CO, V3rd; Dahan A, 2016, NEUROSCIENCE; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; Debaere F, 2003, NEUROIMAGE, V19, P764, DOI 10.1016/S1053-8119(03)00148-4; Desrochers TM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00185; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Duda TA, 2015, HUM MOVEMENT SCI, V44, P1, DOI 10.1016/j.humov.2015.08.006; Eckert MA, 2003, BRAIN, V126, P482, DOI 10.1093/brain/awg026; Germano E, 2010, DEV NEUROPSYCHOL, V35, P475, DOI 10.1080/87565641.2010.494748; Getchell N, 2007, PERCEPT MOTOR SKILL, V105, P207, DOI 10.2466/PMS.105.1.207-214; Giedd JN, 2001, ANN NY ACAD SCI, V931, P33; Gilbert DL, 2011, NEUROLOGY, V76, P615, DOI 10.1212/WNL.0b013e31820c2ebd; Gilger JW, 2001, DEV NEUROPSYCHOL, V20, P465, DOI 10.1207/S15326942DN2002_2; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Handler SM, 2011, PEDIATRICS, V127, pE818, DOI 10.1542/peds.2010-3670; Hernandez MT, 2002, NEUROPSYCHOLOGIA, V40, P384, DOI 10.1016/S0028-3932(01)00130-0; Howard JH, 2006, NEUROPSYCHOLOGIA, V44, P1131, DOI 10.1016/j.neuropsychologia.2005.10.015; Irannejad S, 2012, ANN DYSLEXIA, V62, P22, DOI 10.1007/s11881-011-0060-2; Iversen S, 2005, DYSLEXIA, V11, P217, DOI 10.1002/dys.297; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; Kaiser ML, 2015, RES DEV DISABIL, V36, P338, DOI 10.1016/j.ridd.2014.09.023; Kaplan BJ, 2001, J LEARN DISABIL-US, V34, P555, DOI 10.1177/002221940103400608; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Kibby MY, 2008, J CHILD NEUROL, V23, P368, DOI 10.1177/0883073807309235; Klimkeit EI, 2004, J CLIN EXP NEUROPSYC, V26, P999, DOI 10.1080/13803390490515568; LEONARD G, 1988, NEUROPSYCHOLOGIA, V26, P79, DOI 10.1016/0028-3932(88)90032-2; Leonard G, 2010, THE 40TH SOCIETY FOR; Loras H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098224; Lucas BR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0731-6; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Lum JAG, 2013, RES DEV DISABIL, V34, P3460, DOI 10.1016/j.ridd.2013.07.017; Makris N, 2009, DEV NEUROSCI-BASEL, V31, P36, DOI 10.1159/000207492; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; Memarmoghaddam M, 2016, J Med Life, V9, P373; Menghini D, 2010, NEUROPSYCHOLOGIA, V48, P863, DOI 10.1016/j.neuropsychologia.2009.11.003; Menghini D, 2006, NEUROIMAGE, V33, P1218, DOI 10.1016/j.neuroimage.2006.08.024; Menghini D, 2011, DEV NEUROPSYCHOL, V36, P199, DOI 10.1080/87565641.2010.549868; Moe-Nilssen R, 2003, EXP BRAIN RES, V150, P237, DOI 10.1007/s00221-003-1450-4; Molinari M, 2008, CEREBELLUM, V7, P611, DOI 10.1007/s12311-008-0060-x; Moreira RS, 2014, J PEDIAT-BRAZIL, V90, P119, DOI 10.1016/j.jped.2013.05.010; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Moura O, 2017, J CLIN EXP NEUROPSYC, V39, P296, DOI 10.1080/13803395.2016.1225007; NICOLSON RI, 1994, ANN DYSLEXIA, V44, P147, DOI 10.1007/BF02648159; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; NICOLSON RI, 1990, COGNITION, V35, P159, DOI 10.1016/0010-0277(90)90013-A; Nicolson RI, 2011, CORTEX, V47, P117, DOI 10.1016/j.cortex.2009.08.016; Nikolas MA, 2013, NEUROPSYCHOLOGY, V27, P107, DOI 10.1037/a0030685; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orban P, 2011, NEUROSCIENCE, V179, P94, DOI 10.1016/j.neuroscience.2011.01.040; Penhune VB, 2012, BEHAV BRAIN RES, V226, P579, DOI 10.1016/j.bbr.2011.09.044; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Piek JP, 2008, HUM MOVEMENT SCI, V27, P668, DOI 10.1016/j.humov.2007.11.002; Pitcher TM, 2003, DEV MED CHILD NEUROL, V45, P525, DOI 10.1111/j.1469-8749.2003.tb00952.x; Polner B., 2014, EUROPEAN ARCH PSYCHI, V265, P689, DOI [10.1007/s00702-005-0366-5, DOI 10.1007/300406-014-0531-7]; Prehn-Kristensen A, 2011, RES DEV DISABIL, V32, P2480, DOI 10.1016/j.ridd.2011.06.021; Rae C, 2002, NEUROPSYCHOLOGIA, V40, P1285, DOI 10.1016/S0028-3932(01)00216-0; Ramus F, 2003, J CHILD PSYCHOL PSYC, V44, P712, DOI 10.1111/1469-7610.00157; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Roberts B. A, 2013, J ATTENTION DISORDER; Rochelle KSH, 2006, J CHILD PSYCHOL PSYC, V47, P1159, DOI 10.1111/j.1469-7610.2006.01641.x; Roebers CM, 2014, HUM MOVEMENT SCI, V33, P284, DOI 10.1016/j.humov.2013.08.011; Rosch KS, 2013, J ABNORM CHILD PSYCH, V41, P485, DOI 10.1007/s10802-012-9690-z; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Rueda-Delgado LM, 2014, NEUROSCI BIOBEHAV R, V47, P614, DOI 10.1016/j.neubiorev.2014.10.003; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Scharoun SM, 2013, RES DEV DISABIL, V34, P4142, DOI 10.1016/j.ridd.2013.08.011; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Shanahan MA, 2006, J ABNORM CHILD PSYCH, V34, P585, DOI 10.1007/s10802-006-9037-8; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Sheikhi AR, 2013, AM J MED GENET B, V162B, P44, DOI 10.1002/ajmg.b.32119; Stoodley CJ, 2006, DYSLEXIA, V12, P276, DOI 10.1002/dys.326; Stoodley CJ, 2013, CEREBELLUM, V12, P267, DOI 10.1007/s12311-012-0407-1; Stoodley CJ, 2011, CORTEX, V47, P101, DOI 10.1016/j.cortex.2009.10.005; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Stoodley CJ, 2008, ANN NY ACAD SCI, V1145, P173, DOI 10.1196/annals.1416.003; Stoodley CJ, 2006, NEUROPSYCHOLOGIA, V44, P795, DOI 10.1016/j.neuropsychologia.2005.07.009; Swanson James M, 2012, Int J Educ Psychol Assess, V10, P51; Thurston LL, 1944, FACTORIAL STUDY PERC; Trites R, 1977, NEUROPSYCHOLOGICAL T; Tseng MH, 2004, DEV MED CHILD NEUROL, V46, P381, DOI 10.1017/S0012162204000623; Vitola ES, 2016, PSYCHOL MED, V21, P1; Wechsler D., 2002, WECHSLER INDIVIDUAL; Westendorp M, 2011, RES DEV DISABIL, V32, P2773, DOI 10.1016/j.ridd.2011.05.032; Willcutt EG, 2000, J LEARN DISABIL, V33, P179, DOI 10.1177/002221940003300206; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Willcutt EG, 2010, CORTEX, V46, P1345, DOI 10.1016/j.cortex.2010.06.009; WOLFF PH, 1990, DEV PSYCHOL, V26, P349, DOI 10.1037/0012-1649.26.3.349; Yan JH, 2002, RES Q EXERCISE SPORT, V73, P10, DOI 10.1080/02701367.2002.10608987	102	14	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177490	10.1371/journal.pone.0177490	http://dx.doi.org/10.1371/journal.pone.0177490			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542319	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672600012
J	Wallace, B; Atzberger, PJ				Wallace, Bram; Atzberger, Paul J.			Forster resonance energy transfer: Role of diffusion of fluorophore orientation and separation in observed shifts of FRET efficiency	PLOS ONE			English	Article							SINGLE-MOLECULE FRET; CONFORMATIONAL DYNAMICS; SPECTROSCOPY; DEPENDENCE; SCATTERING; PROTEINS; DONOR; IONS	Forster resonance energy transfer (FRET) is a widely used single-molecule technique for measuring nanoscale distances from changes in the non-radiative transfer of energy between donor and acceptor fluorophores. For macromolecules and complexes this observed transfer efficiency is used to infer changes in molecular conformation under differing experimental conditions. However, sometimes shifts are observed in the FRET efficiency even when there is strong experimental evidence that the molecular conformational state is unchanged. We investigate ways in which such discrepancies can arise from kinetic effects. We show that significant shifts can arise from the interplay between excitation kinetics, orientation diffusion of fluorophores, separation diffusion of fluorophores, and non-emitting quenching.	[Wallace, Bram; Atzberger, Paul J.] Univ Calif Santa Barbara, Dept Math, Santa Barbara, CA 93106 USA; [Atzberger, Paul J.] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Atzberger, PJ (corresponding author), Univ Calif Santa Barbara, Dept Math, Santa Barbara, CA 93106 USA.; Atzberger, PJ (corresponding author), Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA.	atzberg@gmail.com	Atzberger, Paul/B-2799-2016	Atzberger, Paul/0000-0001-6806-8069	National Science Foundation Career [0956210]; National Science Foundation: Division of Mathematical Sciences [1616353]; Department of Energy Advanced Scientific Computing Research [CM4 DESC0009254]; NSF CAREER [0956210]; NSF [DMS-1616353]; DOE ASCR [CM4 DESC0009254]; Direct For Mathematical & Physical Scien [1616353] Funding Source: National Science Foundation	National Science Foundation Career(National Science Foundation (NSF)); National Science Foundation: Division of Mathematical Sciences(National Science Foundation (NSF)); Department of Energy Advanced Scientific Computing Research; NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); DOE ASCR; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation Career Grant 0956210, National Science Foundation: Division of Mathematical Sciences 1616353 (www. nsf gov), and Department of Energy Advanced Scientific Computing Research CM4 DESC0009254 (http://science.energy.goviascr/).; The authors P.J.A and B.W acknowledge support from research grant NSF CAREER 0956210, NSF DMS-1616353, and DOE ASCR CM4 DESC0009254. The authors would also like to thank A. Simon, E. Lipman, and K. Plaxco for helpful discussions and suggestions. While recognizing those above the authors assume full responsibility for the content and commentary in the manuscript.	Agafonov RV, 2009, P NATL ACAD SCI USA, V106, P21625, DOI 10.1073/pnas.0909757106; Andrews DL, 2009, RESONANCE ENERGY TRA, P461; Badali D, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3598109; Bernstein J, 2016, J THEOR BIOL, V401, P109, DOI 10.1016/j.jtbi.2016.04.013; Brillinger DR, 1997, J THEOR PROBAB, V10, P429, DOI 10.1023/A:1022869817770; Camley BA, 2009, THE JOURNAL OF CHEMI, V131; Chung HS, 2009, BIOPHYS J, V98, P696; Clegg RM, 2006, REV FLUORESCENCE, V3, P1; Dean KM, 2012, BBA-MOL CELL RES, V1823, P1406, DOI 10.1016/j.bbamcr.2012.04.001; Deniz AA, 1999, P NATL ACAD SCI USA, V96, P3670, DOI 10.1073/pnas.96.7.3670; Edidin M, 2001, CURRENT PROTOCOLS IM; Fan CH, 2005, TRENDS BIOTECHNOL, V23, P186, DOI 10.1016/j.tibtech.2005.02.005; FORSTER T, 1959, DISCUSS FARADAY SOC, P7; Forster T, 1960, RAD RES S, V2, P326, DOI [DOI 10.2307/3583604, 10.2307/3583604]; Gardiner C.W., 1985, SERIES SYNERGETICS; Gurunathan K, 2010, J PHYS CHEM B, V114, P980, DOI 10.1021/jp907390n; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; HAAS E, 1978, BIOPOLYMERS, V17, P11, DOI 10.1002/bip.1978.360170103; Haas Elisha, 2012, Methods Mol Biol, V895, P467, DOI 10.1007/978-1-61779-927-3_28; Hofmann H, 2010, P NATL ACAD SCI USA, V107, P11793, DOI 10.1073/pnas.1002356107; Iqbal A, 2008, P NATL ACAD SCI USA, V105, P11176, DOI 10.1073/pnas.0801707105; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; Klose D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039492; Lakowicz JR, 2003, J FLUORESC, V13, P69, DOI 10.1023/A:1022306630924; Li HT, 2004, P NATL ACAD SCI USA, V101, P14425, DOI 10.1073/pnas.0404295101; Li ZG, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061204; Liu BY, 2012, ANALYST, V137, P3717, DOI 10.1039/c2an35434a; Makarov DE, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3212602; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Merchant KA, 2007, P NATL ACAD SCI USA, V104, P1528, DOI 10.1073/pnas.0607097104; Mori T, 2007, NATURE, V450, P750, DOI 10.1038/nature06346; Munoz-Losa A, 2009, BIOPHYS J, V96, P4779, DOI 10.1016/j.bpj.2009.03.052; Muratsugu A, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4881461; Nath A, 2012, BIOPHYS J, V103, P1940, DOI 10.1016/j.bpj.2012.09.032; Nazarov PV, 2006, BIOPHYS J, V91, P454, DOI 10.1529/biophysj.106.082867; Ni QA, 2010, ADV BIOCHEM ENG BIOT, V119, P79, DOI 10.1007/10_2008_48; Oksendal B, 2000, STOCHASTIC DIFFERENT; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Platen E., 1992, NUMERICAL SOLUTION S; Rahman MM, 2012, SCI J PHYS; Reichl L. E., 1997, MODERN COURSE STAT P; Sahoo H, 2011, J PHOTOCH PHOTOBIO C, V12, P20, DOI 10.1016/j.jphotochemrev.2011.05.001; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Schuler Benjamin, 2012, Methods Mol Biol, V896, P21, DOI 10.1007/978-1-4614-3704-8_2; Sharma M, 2006, J PHYS CHEM B, V110, P17207, DOI 10.1021/jp064364a; Shrestha D, 2015, INT J MOL SCI, V16, P6718, DOI 10.3390/ijms16046718; Sigurdsson JK, 2016, SOFT MATTER, V12, P6685, DOI 10.1039/c6sm00194g; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; STEINBERG IZ, 1968, J CHEM PHYS, V48, P2404, DOI 10.1063/1.1669460; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Ueda Y, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00163; van der Meer B. Wieb, 2014, FRET FO RSTER RESONA, P23; van der Meer BW, 2014, OPTIMIZING ORIENTATI, P63; Walczewska-Szewc K, 2014, PHYS CHEM CHEM PHYS, V16, P12317, DOI 10.1039/c4cp01222d; Watkins HM, 2015, P NATL ACAD SCI USA, V112, P6631, DOI 10.1073/pnas.1418673112; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Weiss S, 2000, NAT STRUCT BIOL, V7, P724, DOI 10.1038/78941; Wickersham CE, 2010, NANO LETT, V10, P1022, DOI 10.1021/nl904192m; Yoo TY, 2012, J MOL BIOL, V418, P226, DOI 10.1016/j.jmb.2012.01.016; Zhang J, 2007, J PHYS CHEM C, V111, P50, DOI 10.1021/jp062665e	62	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177122	10.1371/journal.pone.0177122	http://dx.doi.org/10.1371/journal.pone.0177122			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542211	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672600004
J	Chen, CJ				Chen, Changjun			Fast exploration of an optimal path on the multidimensional free energy surface	PLOS ONE			English	Article							GROWING STRING METHOD; REACTION COORDINATE DYNAMICS; TARGETED MOLECULAR-DYNAMICS; TRANSITION-STATE SEARCHES; NUDGED ELASTIC BAND; CONFORMATIONAL TRANSITIONS; CHEMICAL-REACTIONS; SIMULATION; WATER; CONSTRAINTS	In a reaction, determination of an optimal path with a high reaction rate (or a low free energy barrier) is important for the study of the reaction mechanism. This is a complicated problem that involves lots of degrees of freedom. For simple models, one can build an initial path in the collective variable space by the interpolation method first and then update the whole path constantly in the optimization. However, such interpolation method could be risky in the high dimensional space for large molecules. On the path, steric clashes between neighboring atoms could cause extremely high energy barriers and thus fail the optimization. Moreover, performing simulations for all the snapshots on the path is also time-consuming. In this paper, we build and optimize the path by a growing method on the free energy surface. The method grows a path from the reactant and extends its length in the collective variable space step by step. The growing direction is determined by both the free energy gradient at the end of the path and the direction vector pointing at the product. With fewer snapshots on the path, this strategy can let the path avoid the high energy states in the growing process and save the precious simulation time at each iteration step. Applications show that the presented method is efficient enough to produce optimal paths on either the two-dimensional or the twelve-dimensional free energy surfaces of different small molecules.	[Chen, Changjun] Huazhong Univ Sci & Technol, Sch Phys, Biomol Phys & Modeling Grp, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Chen, CJ (corresponding author), Huazhong Univ Sci & Technol, Sch Phys, Biomol Phys & Modeling Grp, Wuhan, Hubei, Peoples R China.	cjchen@hust.edu.cn			National Natural Science Foundation of China (NSFC) [31370848]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (NSFC) under Grant No. 31370848.; This work is supported by the National Natural Science Foundation of China (NSFC) under Grant No. 31370848.	Abrams JB, 2008, J PHYS CHEM B, V112, P15742, DOI 10.1021/jp805039u; Apostolakis J, 1999, J CHEM PHYS, V110, P2099, DOI 10.1063/1.477819; Babin V, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2844595; Babin V, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3355621; BALDWIN RL, 1995, BIOPHYS CHEM, V55, P127, DOI 10.1016/0301-4622(94)00146-B; BEEMAN D, 1976, J COMPUT PHYS, V20, P130, DOI 10.1016/0021-9991(76)90059-0; Behn A, 2011, J CHEM THEORY COMPUT, V7, P4019, DOI 10.1021/ct200654u; Behn A, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3664901; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bian YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129089; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Bousquet JA, 2000, BIOCHEMISTRY-US, V39, P7722, DOI 10.1021/bi9929103; Brokaw JB, 2009, J CHEM THEORY COMPUT, V5, P2050, DOI 10.1021/ct9001398; Buntings D, 2007, PARALLEL COMPUT, V33, P634, DOI 10.1016/j.parco.2007.06.003; Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601; CARTER EA, 1989, CHEM PHYS LETT, V156, P472, DOI 10.1016/S0009-2614(89)87314-2; Case D.A., 2022, AMBER 2020; Chen CJ, 2016, J PHYS CHEM B, V120, P3061, DOI 10.1021/acs.jpcb.5b11892; Chen CJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031901; Chen CJ, 2010, J COMPUT CHEM, V31, P1368, DOI 10.1002/jcc.21420; Chen C, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4801512; Ciccotti G, 2005, CHEMPHYSCHEM, V6, P1809, DOI 10.1002/cphc.200400669; Coluzza I, 2003, MOL PHYS, V101, P2885, DOI 10.1080/00268970310001592746; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; del Campo JM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2950083; Dellago C, 1998, J CHEM PHYS, V108, P1964, DOI 10.1063/1.475562; den Otter WK, 2000, J CHEM PHYS, V112, P7283, DOI 10.1063/1.481329; ELBER R, 1987, CHEM PHYS LETT, V139, P375, DOI 10.1016/0009-2614(87)80576-6; Ensing B, 2006, ACCOUNTS CHEM RES, V39, P73, DOI 10.1021/ar040198i; Fleurat-Lessard P, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1948367; Goodrow A, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2992618; Goodrow A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3156312; Henkelman G, 2000, J CHEM PHYS, V113, P9978, DOI 10.1063/1.1323224; Hu H, 2007, J CHEM THEORY COMPUT, V3, P390, DOI 10.1021/ct600240y; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Leines GD, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.020601; LEVITT M, 1983, J MOL BIOL, V168, P621, DOI 10.1016/S0022-2836(83)80306-4; Li WJ, 2012, J CHEM THEORY COMPUT, V8, P3596, DOI 10.1021/ct300022m; Lui D., 1989, MATH PROGRAM, V45, P503; Maeda S, 2013, PHYS CHEM CHEM PHYS, V15, P3683, DOI 10.1039/c3cp44063j; Maragliano L, 2007, CHEM PHYS LETT, V446, P182, DOI 10.1016/j.cplett.2007.08.017; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Matsunaga Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002555; Moradi M, 2011, CHEM PHYS LETT, V518, P109, DOI 10.1016/j.cplett.2011.10.054; Moradi M, 2009, P NATL ACAD SCI USA, V106, P20746, DOI 10.1073/pnas.0906500106; NOCEDAL J, 1980, MATH COMPUT, V35, P773, DOI 10.1090/S0025-5718-1980-0572855-7; ODAERT B, 1995, BIOCHEMISTRY-US, V34, P12820, DOI 10.1021/bi00039a043; Ovchinnikov V, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3544209; Pan AC, 2008, J PHYS CHEM B, V112, P3432, DOI 10.1021/jp0777059; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; Perisic O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101810; Peters B, 2004, J CHEM PHYS, V120, P7877, DOI 10.1063/1.1691018; Pietrucci F, 2015, P NATL ACAD SCI USA, V112, P15030, DOI 10.1073/pnas.1512486112; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Quapp W, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1885467; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Ren WQ, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4798344; Rosta E, 2014, J AM CHEM SOC, V136, P3137, DOI 10.1021/ja411408x; Rosta E, 2011, J AM CHEM SOC, V133, P8934, DOI 10.1021/ja200173a; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Schlitter J, 2003, MOL PHYS, V101, P3439, DOI 10.1080/00268970410001654863; Schlitter J, 2011, EUR PHYS J-SPEC TOP, V200, P91, DOI 10.1140/epjst/e2011-01520-2; Schlitter J, 2003, J CHEM PHYS, V118, P2057, DOI 10.1063/1.1534578; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; Sharada SM, 2012, J CHEM THEORY COMPUT, V8, P5166, DOI 10.1021/ct300659d; Sprik M, 1998, J CHEM PHYS, V109, P7737, DOI 10.1063/1.477419; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Tyka MD, 2006, J PHYS CHEM B, V110, P17212, DOI 10.1021/jp060734j; ULITSKY A, 1990, J CHEM PHYS, V92, P1510, DOI 10.1063/1.458112; Wu XW, 2001, J PHYS CHEM B, V105, P2227, DOI 10.1021/jp004048a; Zhang J, 2009, RNA, V15, P2248, DOI 10.1261/rna.1723609; Zhang J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2895050; Zhang WB, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4890728; Zimmerman PM, 2015, J COMPUT CHEM, V36, P601, DOI 10.1002/jcc.23833; Zimmerman PM, 2013, J CHEM THEORY COMPUT, V9, P3043, DOI 10.1021/ct400319w; Zimmerman PM, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4804162	79	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177740	10.1371/journal.pone.0177740	http://dx.doi.org/10.1371/journal.pone.0177740			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542475	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400073
J	Marangi, L; Mirinaviciute, G; Flem, E; Tomba, GS; Guzzetta, G; de Blasio, BF; Manfredi, P				Marangi, Luigi; Mirinaviciute, Grazina; Flem, Elmira; Tomba, Gianpaolo Scalia; Guzzetta, Giorgio; de Blasio, Birgitte Freiesleben; Manfredi, Piero			The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster	PLOS ONE			English	Article							SOCIAL CONTACTS; UNITED-STATES; COST-EFFECTIVENESS; VACCINATION; IMPACT; EPIDEMIOLOGY; EXPOSURE; HYPOTHESIS; PROTECTION; PARAMETERS	We use age-structured models for VZV transmission and reactivation to reconstruct the natural history of VZV in Norway based on available pre-vaccination serological data, contact matrices, and herpes zoster incidence data. Depending on the hypotheses on contact and transmission patterns, the basic reproduction number of varicella in Norway ranges between 3.7 and 5.0, implying a vaccine coverage between 73 and 80% to effectively interrupt transmission with a 100% vaccine efficacy against infection. The varicella force of infection peaks during early childhood (3-5 yrs) and shows a prolonged phase of higher risk during the child-bearing period, though quantitative variations can occur depending on contact patterns. By expressing the magnitude of exogenous boosting as a proportion of the force of infection, it is shown that reactivation is well described by a progressive immunity mechanism sustained by a large, though possibly below 100%, degree of exogenous boosting, in agreement with findings from other Nordic countries, implying large reproduction numbers of boosting. Moreover, magnitudes of exogenous boosting below 40% are robustly discon-firmed by data. These results bring further insight on the magnitude of immunity boosting and its relationship with reactivation.	[Marangi, Luigi; Manfredi, Piero] Univ Pisa, Dept Econ & Management, Pisa, Italy; [Mirinaviciute, Grazina; Flem, Elmira; de Blasio, Birgitte Freiesleben] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol & Modeling Infect Contr, Oslo, Norway; [Tomba, Gianpaolo Scalia] Univ Roma Tor Vergata, Dept Math, Rome, Italy; [Guzzetta, Giorgio] Kessler Fdn, Trento, Italy; [de Blasio, Birgitte Freiesleben] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo Ctr Biostat & Epidemiol, Oslo, Norway	University of Pisa; Norwegian Institute of Public Health (NIPH); University of Rome Tor Vergata; Fondazione Bruno Kessler; University of Oslo	Marangi, L (corresponding author), Univ Pisa, Dept Econ & Management, Pisa, Italy.	marangighen@gmail.com	Flem, Elmira/AFS-7695-2022; Flem, Elmira/GOG-9451-2022	Flem, Elmira/0000-0002-5099-1960; Flem, Elmira/0000-0002-5099-1960; Guzzetta, Giorgio/0000-0002-9296-9470	Norwegian Institute of Public Health; NIPH	Norwegian Institute of Public Health; NIPH	The study was funded by the Norwegian Institute of Public Health.; Luigi Marangi was funded by NIPH within collaborative agreement "Burden of VZV infection in Norway". We would like to acknowledge Arild Osen, Department of Health Data Management and Analysis, the Norwegian Institute of Public Health, for assistance during extraction and management of data on primary healthcare consultations. We warmly thank an Editor and two anonymous referees of the Journal for a number of deep and helpful suggestions which allowed to sharply improve the manuscript.	ANDERSON R M, 1991; Bonanni P, 2009, BMC MED, V7, P26, DOI DOI 10.1186/1741-7015-7-26; Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9; Brisson M, 2000, EPIDEMIOL INFECT, V125, P651, DOI 10.1017/S0950268800004714; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrillo-Santisteve P, 2014, CLIN MICROBIOL INFEC, V20, P86, DOI 10.1111/1469-0691.12580; Del Fava E, PLOS ONE IN PRESS; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Donahue J. G., 2010, American Journal of Public Health, V100, P1116, DOI 10.2105/AJPH.2009.160002; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Gaillat J, 2011, CLIN INFECT DIS, V53, P405, DOI 10.1093/cid/cir436; GARNETT GP, 1992, EPIDEMIOL INFECT, V108, P513, DOI 10.1017/S0950268800050019; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Goldman GS, 2013, VACCINE, V31, P1680, DOI 10.1016/j.vaccine.2012.05.050; Guzzetta G, AMERICAN JOURNAL OF; Guzzetta G, 2013, AM J EPIDEMIOL, V177, P1134, DOI 10.1093/aje/kws370; Hales CM, 2013, ANN INTERN MED, V159, P739, DOI 10.7326/0003-4819-159-11-201312030-00006; Heininger U, 2006, LANCET, V368, P1365, DOI 10.1016/S0140-6736(06)69561-5; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Horn J, HUM VACCIN IMMUNOT; Karhunen M, 2010, EPIDEMIOL INFECT, V138, P469, DOI 10.1017/S0950268809990768; Kawai K, CLIN INFEC DIS, DOI 10.1093/cid/ciw296; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; Marin M, 2008, PEDIATRICS, V122, pE744, DOI 10.1542/peds.2008-0567; Marinelli I, 2016, EPIDEMICS; Marziano V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2509; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nardone A, 2007, VACCINE, V25, P7866, DOI 10.1016/j.vaccine.2007.07.036; Ogunjimi B, 2015, ELIFE, V4, DOI 10.7554/eLife.07116; Ogunjimi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066485; Ogunjimi B, 2011, VIRAL IMMUNOL, V24, P151, DOI 10.1089/vim.2010.0031; Oxman MN, 2009, J AM OSTEOPATH ASSOC, V109, pS13; Pinquier D, 2011, HUM VACCINES, V7, P534, DOI 10.4161/hv.7.5.14820; Poletti P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060732; Prymula R, 2014, LANCET, V383, P1313, DOI 10.1016/S0140-6736(12)61461-5; Rimseliene G, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1581-4; Santermans E, 2015, EPIDEMICS-NETH, V11, P14, DOI 10.1016/j.epidem.2014.12.005; Sauerbrei A, 2000, J Perinatol, V20, P548, DOI 10.1038/sj.jp.7200457; Schuette MC, 1999, B MATH BIOL, V61, P1031, DOI 10.1006/bulm.1999.0126; SEILER HE, 1949, J HYG-CAMBRIDGE, V47, P253, DOI 10.1017/S002217240001456X; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; van Hoek AJ, 2011, VACCINE, V29, P2411, DOI 10.1016/j.vaccine.2011.01.037; van Lier A, 2015, EBIOMEDICINE, V2, P1494, DOI 10.1016/j.ebiom.2015.08.017; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317	45	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176845	10.1371/journal.pone.0176845	http://dx.doi.org/10.1371/journal.pone.0176845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545047	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000401672400014
J	Nordell, CJ; Wellicome, TI; Bayne, EM				Nordell, Cameron J.; Wellicome, Troy I.; Bayne, Erin M.			Flight initiation by Ferruginous Hawks depends on disturbance type, experience, and the anthropogenic landscape	PLOS ONE			English	Article							AVIAN NEST DEFENSE; RURAL POPULATIONS; PREDATION RISK; RESPONSES; URBAN; DISTANCES; BEHAVIOR; HUMANS; HABITUATION; CONCEALMENT	The expansion of humans and their related infrastructure is increasing the likelihood that wildlife will interact with humans. When disturbed by humans, animals often change their behaviour, which can result in time and energetic costs to that animal. An animal's decision to change behaviour is likely related to the type of disturbance, the individual's past experience with disturbance, and the landscape in which the disturbance occurs. In southern Alberta and Saskatchewan, we quantified probability of flight initiation from the nest by Ferruginous Hawks (Buteo regalis) during approaches to nests by investigators. We tested if probability of flight was related to different disturbance types, previous experience, and the anthropogenic landscape in which individual Ferruginous Hawks nested. Probability of flight was related to the type of approach by the investigator, the number of previous visits by investigators, and the vehicular traffic around the nest. Approaches by humans on foot resulted in a greater probability of flight than those in a vehicle. Approaches in a vehicle via low traffic volume access roads were related to increased probability of flight relative to other road types. The number of previous investigator approaches to the nest increased the probability of flight. Overall, we found support that Ferruginous Hawks show habituation to vehicles and the positive reinforcement hypotheses as probability of flight was negatively related to an index of traffic activity near the nest. Our work emphasizes that complex, dynamic processes drive the decision to initiate flight from the nest, and contributes to the growing body of work explaining how responses to humans vary within species.	[Nordell, Cameron J.; Bayne, Erin M.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Wellicome, Troy I.] Environm Canada, Edmonton, AB, Canada	University of Alberta; Environment & Climate Change Canada	Nordell, CJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	nordell@ualberta.ca		Nordell, Cameron/0000-0001-5142-6827; Bayne, Erin/0000-0002-0679-4521	Environment Canada; Alberta Environment and Parks (AEP); Canadian Department of National Defence; Saskatchewan Ministry of Environment, Agriculture and Agri-food Canada (AAFC); National Science and Engineering Research Council (NSERC); Alberta Conservation Association; Queen Elizabeth II Graduate Scholarship; Alberta Sports and Recreation; Climate Change Emissions Management Corporation	Environment Canada(CGIAR); Alberta Environment and Parks (AEP); Canadian Department of National Defence; Saskatchewan Ministry of Environment, Agriculture and Agri-food Canada (AAFC); National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Conservation Association; Queen Elizabeth II Graduate Scholarship; Alberta Sports and Recreation; Climate Change Emissions Management Corporation	The authors were supported by operating grants from Environment Canada to T.I.W., Alberta Environment and Parks (AEP), Canadian Department of National Defence, and the Saskatchewan Ministry of Environment, Agriculture and Agri-food Canada (AAFC). Additional financial support was obtained from grants awarded by the National Science and Engineering Research Council (NSERC) to E.M.B., Conservation Funds from the Alberta Conservation Association to E.M.B., the Queen Elizabeth II Graduate Scholarship (University of Alberta), Alberta Sports and Recreation, and the Climate Change Emissions Management Corporation. Industrial partners included Nexen Inc., AltaLink, L.P., Cenovus Energy, Suncor Energy, and the Petroleum Technology Alliance of Canada.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beale C. M., 2007, INT J COMP PSYCHOL, V20, P111; Beale CM, 2004, ANIM BEHAV, V68, P1065, DOI 10.1016/j.anbehav.2004.07.002; Bjorvik LM, 2015, J ORNITHOL, V156, P239, DOI 10.1007/s10336-014-1121-1; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Blumstein DT, 2004, ETHOLOGY, V110, P273, DOI 10.1111/j.1439-0310.2004.00970.x; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; BOUSKILA A, 1992, AM NAT, V139, P161, DOI 10.1086/285318; BURGER J, 1990, J COMP PSYCHOL, V104, P388, DOI 10.1037/0735-7036.104.4.388; Burhans DE, 2001, AUK, V118, P237, DOI 10.1642/0004-8038(2001)118[0237:ROSNCT]2.0.CO;2; Camp MJ, 2012, ETHOLOGY, V118, P1010, DOI 10.1111/eth.12000; Carrete M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03524; Cooper Jr W. E., 2015, ESCAPING PREDATORS I; Cooper WE, 2007, J HERPETOL, V41, P197, DOI 10.1670/0022-1511(2007)41[197:NSAAPO]2.0.CO;2; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; COX DR, 1972, J R STAT SOC B, V34, P187; de Jong A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1089, DOI 10.1007/s00265-013-1533-6; Diaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064634; Eason PK, 2006, J WILDLIFE MANAGE, V70, P1796, DOI 10.2193/0022-541X(2006)70[1796:FAFIDI]2.0.CO;2; ELLIOT RD, 1985, BEHAVIOUR, V92, P168, DOI 10.1163/156853985X00433; Environment Canada, 2009, PETR IND ACT GUID WI; ESRI. ArcGIS 10. 2, 2013, ENV SYST RES I; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Fernandez-Juricic E, 2005, BIOL CONSERV, V125, P225, DOI 10.1016/j.biocon.2005.03.020; Fisher AK, 1894, HAWKS OWLS RELATED F; Fisher RJ, 2004, CAN J ZOOL, V82, P707, DOI 10.1139/Z04-035; Fraker M, 2009, OECOLOGIA, V158, P765, DOI 10.1007/s00442-008-1185-9; Frid A, 2002, CONSERV ECOL, V6; Geist C., 2005, Animal Biodiversity and Conservation, V28, P69; Gravolin I, 2014, AVIAN BIOL RES, V7, P244, DOI 10.3184/175815514X14151981691872; Herrero S, 2005, WILDLIFE SOC B, V33, P362, DOI 10.2193/0091-7648(2005)33[362:FTFBBH]2.0.CO;2; HertPicciotto I, 1997, BIOMETRICS, V53, P1151, DOI 10.2307/2533573; HOLMES TL, 1993, WILDLIFE SOC B, V21, P461; Houston AI, 2012, OIKOS, V121, P597, DOI 10.1111/j.1600-0706.2011.19594.x; Jotikapukkana S, 2010, WILDLIFE RES, V37, P466, DOI 10.1071/WR09132; Keeley WH, 2011, J WILDLIFE MANAGE, V75, P1034, DOI 10.1002/jwmg.140; Kissinger M, 2009, ECOL ECON, V68, P2309, DOI 10.1016/j.ecolecon.2009.02.022; Knight R. L., 1995, WILDLIFE RECREATIONI; KNIGHT RL, 1986, AUK, V103, P318, DOI 10.1093/auk/103.2.318; Lee WY, 2011, ANIM COGN, V14, P817, DOI 10.1007/s10071-011-0415-4; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Lin T, 2012, ECOL INDIC, V15, P30, DOI 10.1016/j.ecolind.2011.09.018; Mccleery RA, 2009, LANDSCAPE ECOL, V24, P483, DOI 10.1007/s10980-009-9323-2; McGiffin A, 2013, EMU, V113, P154, DOI 10.1071/MU12107; McLeod EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082008; Migaj A, 2011, FERRUGINOUS HAWK ART; Mikula P, 2014, ARDEA, V102, P53, DOI 10.5253/078.102.0105; Miller RG, 2011, SURVIVAL ANAL, V2nd; Miller V, 2013, J FIELD ORNITHOL, V84, P171, DOI 10.1111/jofo.12015; Moller AP, 2014, BEHAV ECOL, V25, P1505, DOI 10.1093/beheco/aru130; Moller AP, 2014, BEHAV ECOL, V25, P960, DOI 10.1093/beheco/aru073; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Olendorff RR, 1994, STATUS BIOL MANAGEME; Price MV, 2014, CURR ZOOL, V60, P693, DOI 10.1093/czoolo/60.6.693; REDONDO T, 1989, BEHAVIOUR, V111, P161, DOI 10.1163/156853989X00646; REDONDO T, 1989, BEHAV ECOL SOCIOBIOL, V25, P369, DOI 10.1007/BF00302995; REGELMANN K, 1986, ANIM BEHAV, V34, P1206, DOI 10.1016/S0003-3472(86)80180-4; Richardson CT, 1997, WILDLIFE SOC B, V25, P634; Roche EA, 2013, WILSON J ORNITHOL, V125, P685, DOI 10.1676/12-196.1; Rowe JS., 1984, PRAIRIE FORUM, V9, P231; Runyan AM, 2004, J WILDLIFE MANAGE, V68, P1124, DOI 10.2193/0022-541X(2004)068[1124:DIDIFI]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; SCHMUTZ JK, 1984, J WILDLIFE MANAGE, V48, P1180, DOI 10.2307/3801779; SCHMUTZ JK, 1989, CAN J ZOOL, V67, P2596, DOI 10.1139/z89-366; Scobie C.A., 2015, THESIS; Stalmaster MV, 1998, WILDLIFE MONOGR, P5; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; StataCorp, 2013, STATA STAT SOFTW REL; Steidl RJ, 2000, ECOL APPL, V10, P258, DOI 10.1890/1051-0761(2000)010[0258:EEOHAB]2.0.CO;2; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Van Horn R. C., 1993, THESIS; Vincze E, 2015, ANIM COGN, V18, P291, DOI 10.1007/s10071-014-0799-z; Wam HK, 2014, EUR J WILDLIFE RES, V60, P839, DOI 10.1007/s10344-014-0841-0; Watson JL, 2014, NW NATURALIST, V95, P150; Watson JW, 2004, J RAPTOR RES, V38, P295; Wellicome TI, 2014, AVIAN CONSERV ECOL, V9, DOI 10.5751/ACE-00624-090104; WESTON J B, 1968, Great Basin Naturalist, V28, P111; WHITE CM, 1985, CONDOR, V87, P14, DOI 10.2307/1367125; Williams Kate, 2013, THESIS; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf ID, 2010, APPL ANIM BEHAV SCI, V126, P75, DOI 10.1016/j.applanim.2010.06.001; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; [No title captured]	87	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177584	10.1371/journal.pone.0177584	http://dx.doi.org/10.1371/journal.pone.0177584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542334	Green Published, gold, Green Submitted			2022-12-27	WOS:000401672400054
J	Tsuchiya, S; Higashide, T; Sugiyama, K				Tsuchiya, Shunsuke; Higashide, Tomomi; Sugiyama, Kazuhisa			Visual field changes after vitrectomy with internal limiting membrane peeling for epiretinal membrane or macular hole in glaucomatous eyes	PLOS ONE			English	Article							NERVE-FIBER LAYER; RETINAL GANGLION-CELLS; INDOCYANINE GREEN; TRIAMCINOLONE ACETONIDE; BLOOD-FLOW; PREVALENCE; APPEARANCE; AGE; SUSCEPTIBILITY; SENSITIVITY	Purpose To investigate visual field changes after vitrectomy for macular diseases in glaucomatous eyes. Methods A retrospective review of 54 eyes from 54 patients with glaucoma, who underwent vitrectomy for epiretinal membrane (ERM; 42 eyes) or macular hole (MH; 12 eyes). Standard automated perimetry (Humphrey visual field 24-2 program) was performed and analyzed preoperatively and twice postoperatively (1(st) and 2nd sessions; 4.7 +/- 2.5, 10.3 +/- 3.7 months after surgery, respectively). Postoperative visual field sensitivity at each test point was compared with the preoperative value. Longitudinal changes in mean visual field sensitivity (MVFS) of the 12 test points within 10 degrees eccentricity (center) and the remaining test points (periphery), best-corrected visual acuity (BCVA), intraocular pressure (IOP), and ganglion cell complex (GCC) thickness, and the association of factors with changes in central or peripheral MVFS over time were analyzed using linear mixed-effects models. In addition, 45 eyes from 45 patients without glaucoma who underwent vitrectomy for epiretinal membrane (ERM; 34 eyes) or macular hole (MH; 11 eyes) were similarly examined and statistically analyzed (control group). Results In glaucomatous eyes, visual field test points changed significantly and reproducibly; two points deteriorated only at the center and twelve points improved only at the periphery. Central MVFS decreased (p = 0.03), whereas peripheral MVFS increased postoperatively (p = 0.010). In the control group, no visual field test points showed deterioration, and central MVFS did not change significantly after vitrectomy. BCVA improved, GCC thickness decreased, and IOP did not change postoperatively in both groups. The linear mixed-effects models identified older age, systemic hypertension, longer axial length, and preoperative medication scores of >= 2 as risk factors for central MVFS deterioration in glaucomatous eyes. Conclusions Visual field sensitivity within 10 degrees eccentricity may deteriorate after vitrectomy for ERM or MH in glaucomatous eyes.	[Tsuchiya, Shunsuke; Higashide, Tomomi; Sugiyama, Kazuhisa] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa, Japan	Kanazawa University	Higashide, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa, Japan.	eyetomo@med.kanazawa-u.ac.jp						Almony A, 2012, RETINA-J RET VIT DIS, V32, P877, DOI 10.1097/IAE.0b013e318227ab39; Ang GS, 2010, J GLAUCOMA, V19, P275, DOI 10.1097/IJG.0b013e3181b21fb9; Asrani S, 2014, JAMA OPHTHALMOL, V132, P396, DOI 10.1001/jamaophthalmol.2013.7974; Baba T, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/372589; Baba T, 2012, OPHTHALMOLOGY, V119, P2609, DOI 10.1016/j.ophtha.2012.06.048; Cheng J, 2010, STAT MED, V29, P504, DOI 10.1002/sim.3775; De Moraes CG, 2012, AM J OPHTHALMOL, V154, P702, DOI 10.1016/j.ajo.2012.04.015; Enaida H, RETINA, V26, P631; Gurka MJ, 2011, STAT MED, V30, P2696, DOI 10.1002/sim.4293; Haritoglou C, 2001, BRIT J OPHTHALMOL, V85, P231, DOI 10.1136/bjo.85.2.231; Harman A, 2000, ANAT REC, V260, P124; Hayashi K, 2001, AM J OPHTHALMOL, V132, P41, DOI 10.1016/S0002-9394(01)00920-5; Higashide T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147782; Hood DC, 2007, INVEST OPHTH VIS SCI, V48, P3662, DOI 10.1167/iovs.06-1401; Imai H, 2010, JPN J OPHTHALMOL, V54, P435, DOI 10.1007/s10384-010-0839-4; Iriyama A, 2004, INVEST OPHTH VIS SCI, V45, P943, DOI 10.1167/iovs.03-1026; Ito Y, 2005, OPHTHALMOLOGY, V112, P1415, DOI 10.1016/j.ophtha.2005.02.023; Kadonosono K, 2006, AM J OPHTHALMOL, V142, P513, DOI 10.1016/j.ajo.2006.03.060; Kawasaki R, 2009, EYE, V23, P1045, DOI 10.1038/eye.2008.238; Kimura H, 2004, AM J OPHTHALMOL, V137, P172, DOI 10.1016/S0002-9394(03)00782-7; Lalezary M, 2014, OPHTHALMOLOGY, V121, P1983, DOI 10.1016/j.ophtha.2014.04.008; Leung CKS, 2013, OPHTHALMOLOGY, V120, P2485, DOI 10.1016/j.ophtha.2013.07.021; Levkovitch-Verbin H, 2013, MOL VIS, V19, P2011; Mitamura Y, 2005, OPHTHALMOLOGY, V112, P1766, DOI 10.1016/j.ophtha.2005.04.026; Moroi SE, 2000, OPHTHALMIC SURG LASE; Noma H, 2009, ACTA OPHTHALMOL, V87, P638, DOI 10.1111/j.1755-3768.2008.01318.x; Nukada K, 2013, INVEST OPHTH VIS SCI, V54, P2417, DOI 10.1167/iovs.12-10838; Okamoto M, 2014, OSLI RETINA, V45, P118, DOI 10.3928/23258160-20140306-04; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Peyman GA, 2000, RETINA-J RET VIT DIS, V20, P554, DOI 10.1097/00006982-200005000-00024; Rao HL, 2013, J GLAUCOMA, V22, P164, DOI 10.1097/IJG.0b013e31822e8e37; Ripandelli G, 2015, RETINA-J RET VIT DIS, V35, P498, DOI 10.1097/IAE.0000000000000330; Schadlu R, 2008, RETINA-J RET VIT DIS, V28, P853, DOI 10.1097/IAE.0b013e3181631962; Siddiqui MAR, 2007, J GLAUCOMA, V16, P205, DOI 10.1097/IJG.0b013e31802dfc35; Spaide RF, 2012, RETINA-J RET VIT DIS, V32, P1719, DOI 10.1097/IAE.0b013e3182671191; Tadayoni R, 2001, OPHTHALMOLOGY, V108, P2279, DOI 10.1016/S0161-6420(01)00856-9; Tadayoni R, 2012, BRIT J OPHTHALMOL, V96, P1513, DOI 10.1136/bjophthalmol-2012-302035; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Traynis I, 2014, JAMA OPHTHALMOL, V132, P291, DOI 10.1001/jamaophthalmol.2013.7656; Ubuka M, 2014, INVEST OPHTH VIS SCI, V55, P1625, DOI 10.1167/iovs.13-13801; Wang AL, 2007, ANN NY ACAD SCI, V1097, P64, DOI 10.1196/annals.1379.027; Yamamoto T, 2005, OPHTHALMOLOGY, V112, P1661, DOI 10.1016/j.ophtha.2005.05.012; Yamashita T, 2006, OPHTHALMOLOGY, V113, P280, DOI 10.1016/j.ophtha.2005.10.046	43	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177526	10.1371/journal.pone.0177526	http://dx.doi.org/10.1371/journal.pone.0177526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542230	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400048
J	Tunc-Ozdemir, M; Jones, AM				Tunc-Ozdemir, Meral; Jones, Alan M.			BRL3 and AtRGS1 cooperate to fine tune growth inhibition and ROS activation	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; ARABIDOPSIS; GLUCOSE; REGULATOR; KINASES; ROLES	Plasma membrane-localized leucine-rich repeat receptor-like kinases directly activates G protein complex via interaction with seven transmembrane domain Regulator of G-protein Signaling 1 (AtRGS1) protein. Brassinosteroid insensitive 1 (BRI1) LIKE3 (BRL3) phosphorylates AtRGS1 in vitro. FRET analysis showed that BRL3 and AtRGS1 interaction dynamics change in response to glucose and flg22. Both BRL3 and AtRGS1 function in glucose sensing and brl3 and rgs1-2 single mutants are hyposensitive to high glucose as well as the brl3/rgs1 double mutant. BRL3 and AtRGS1 function in the same pathway linked to high glucose sensing. Hypocotyl elongation, another sugar-mediated pathway, is also implicated to be partially mediated by BRL3 and AtRGS1 because rgs1-2, brl3-2 and brl3-2/ rgs1-2 mutants share the long hypocotyl phenotype. BRL3 and AtRGS1 modulate the flg22-induced ROS burst and block one or more components positively regulating ROS production because the brl3/ rgs1 double mutant has similar to 60% more ROS production than wild type while rgs1-2 has a partial ROS burst impairment and brl3 has slightly more ROS production. Here, we proposed a simple model where both BRL3 and AtRGS1 are part of a fine-tuning mechanism sensing glucose and flg22 to prevent excess ROS burst and control growth inhibition.	[Tunc-Ozdemir, Meral; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.; Jones, AM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu	Jones, Alan/K-7433-2012	Jones, Alan/0000-0002-2365-6462	NIGMS [R01GM065989]; NSF [MCB-0718202]	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF))	This work was supported by grants from the NIGMS (R01GM065989) and NSF (MCB-0718202) to A.M.J.	Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; Chung EH, 2014, CELL HOST MICROBE, V16, P484, DOI 10.1016/j.chom.2014.09.004; Colaneri AC, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-129; Coll-Garcia D, 2004, FEBS LETT, V563, P82, DOI 10.1016/S0014-5793(04)00255-8; Fabregas N, 2013, PLANT CELL, V25, P3377, DOI 10.1105/tpc.113.114462; Fu Y, 2014, CELL, V156, P1084, DOI 10.1016/j.cell.2014.01.013; Gao YJ, 2008, PLANT CELL PHYSIOL, V49, P1013, DOI 10.1093/pcp/pcn078; Grigston JC, 2008, FEBS LETT, V582, P3577, DOI 10.1016/j.febslet.2008.08.038; Gupta A, 2015, PLANT PHYSIOL, V168, P1091, DOI 10.1104/pp.15.00495; Huang J, 2015, POLYSACCHARIDE-BASED NANOCRYSTALS: CHEMISTRY AND APPLICATIONS, P1; Kang YH, 2017, DEVELOPMENT, V144, P272, DOI 10.1242/dev.145623; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Liao KL, 2017, J THEOR BIOL, V414, P231, DOI 10.1016/j.jtbi.2016.11.027; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Salazar-Henao JE, 2016, J EXP BOT, V67, P4951, DOI 10.1093/jxb/erw258; Schroder F, 2011, PLANT PHYSIOL, V156, P1620, DOI 10.1104/pp.111.177204; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Singh M, 2014, J EXP BOT, V65, P2981, DOI 10.1093/jxb/eru146; ten Hove CA, 2011, PLANT MOL BIOL, V76, P69, DOI 10.1007/s11103-011-9769-x; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Torres MA, 2013, MOL PLANT MICROBE IN; Tunc- Ozdemir M, 2016, METHODS IN MOLECULAR; Tunc-Ozdemir M, 2016, J BIOL CHEM; Tunc-Ozdemir M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171854; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf9558; Urano D, 2014, ANNU REV PLANT BIOL, V65, P365, DOI 10.1146/annurev-arplant-050213-040133; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2012, NAT CELL BIOL, V14, P1079, DOI 10.1038/ncb2568; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	38	16	17	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177400	10.1371/journal.pone.0177400	http://dx.doi.org/10.1371/journal.pone.0177400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545052	Green Published, Green Submitted, gold			2022-12-27	WOS:000401672400041
